FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Toskas, G
   Hund, RD
   Laourine, E
   Cherif, C
   Smyrniotopoulos, V
   Roussis, V
AF Toskas, Georgios
   Hund, Rolf-Dieter
   Laourine, Ezzedine
   Cherif, Chokri
   Smyrniotopoulos, Vangelis
   Roussis, Vassilios
TI Nanofibers based on polysaccharides from the green seaweed Ulva Rigida
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Polysaccharide ulvan; Nanofibers; Electrospinning; Ulvan/poly(vinyl
   alcohol) fibers; Crystallinity; Biomaterial
ID CELL-WALL POLYSACCHARIDES; NMR SPECTROSCOPIC CHARACTERIZATION; WEIGHT
   SULFATED POLYSACCHARIDES; CHEMICAL-STRUCTURE; POLYVINYL-ALCOHOL;
   MOLECULAR-WEIGHT; BIOLOGICAL-PROPERTIES; ANTIOXIDANT ACTIVITY; PERTUSA
   CHLOROPHYTA; IN-VITRO
AB The nanofiber ability of an ulvan-rich extract, originated from the low cost biomass of the alga Ulva rigida, has been achieved for the first time via electrospinning. Ulvan-based uniform nanofibers were produced by being blended with poly(vinyl alcohol) (PVA). The nanofibers have an average diameter controllable down to 84 nm and present a highly ordered crystalline structure under transmission electron microscopy (TEM). A new complex fiber is created, which results from ulvan-rich extract and PVA ionic assembly and involves borate esters and divalent cations. The spinnability of this anionic sulfated polysaccharide-rich extract in combination with its interesting biological and physicochemical properties can lead to new biomedical applications such as drug release systems. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Toskas, Georgios; Hund, Rolf-Dieter; Laourine, Ezzedine; Cherif, Chokri] Tech Univ Dresden, Inst Text Machinery & High Performance Mat Techno, D-01069 Dresden, Germany.
   [Smyrniotopoulos, Vangelis; Roussis, Vassilios] Univ Athens, Sch Pharm, Dept Pharmacognosy & Chem Nat Prod, GR-15771 Athens, Greece.
RP Toskas, G (reprint author), Tech Univ Dresden, Inst Text Machinery & High Performance Mat Techno, Hohestr 6, D-01069 Dresden, Germany.
EM Georgios.Toskas@tu-dresden.de
RI Cherif, Chokri/R-8818-2016
OI Cherif, Chokri/0000-0003-3835-0420
FU  [SFB 528]
FX This research was funded by the SFB 528 Project, Germany. The authors
   thank Mrs. Ortrud Trommer and Marianne Reibold for their invaluable help
   with SEM and TEM, respectively: also Petros Katapodis of the National
   Technical University of Athens, School of Chemical, Engineering,
   Division IV - Product and Process Development, Laboratory of
   Biotechnology and Laboratory of Food Chemistry and Technology, and Mr.
   Ramzi Chaouch for the technical assistance.
CR BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   Borgstrom J, 1996, MACROMOLECULES, V29, P5926, DOI 10.1021/ma960315s
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Cherif C., 2009, INT C LAT ADV HIGH T
   Chetri P, 2007, MAT SCI ENG B-SOLID, V139, P261, DOI 10.1016/j.mseb.2007.02.010
   Chiellini E, 2008, BIOMACROMOLECULES, V9, P1007, DOI 10.1021/bm701041e
   Cho K, 2010, SYNTHETIC MET, V160, P888, DOI 10.1016/j.synthmet.2010.01.041
   Chronakis IS, 2002, BIOMACROMOLECULES, V3, P793, DOI 10.1021/bm020015k
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Ghosh K, 2010, J MATER CHEM, V20, P4128, DOI 10.1039/b923139k
   GRAESSLEY WW, 1980, POLYMER, V21, P258, DOI 10.1016/0032-3861(80)90266-9
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   GRIZZUTI N, 1993, RHEOL ACTA, V32, P218, DOI 10.1007/BF00434186
   HAUG A, 1976, ACTA CHEM SCAND B, V30, P562, DOI 10.3891/acta.chem.scand.30b-0562
   HENDERSO.WG, 1973, CARBOHYD RES, V28, P1, DOI 10.1016/S0008-6215(00)82850-5
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Kaeffer B, 1999, PLANTA MED, V65, P527, DOI 10.1055/s-1999-14009
   KAWAI Y, 1969, ANAL BIOCHEM, V32, P314, DOI 10.1016/0003-2697(69)90091-8
   Klossner RR, 2008, BIOMACROMOLECULES, V9, P2947, DOI 10.1021/bm800738u
   Ko F, 2003, ADV MATER, V15, P1161, DOI 10.1002/adma.200304955
   KRIMM S, 1956, J POLYM SCI, V22, P227, DOI 10.1002/pol.1956.1202210106
   Lahaye M, 1997, SCI ALIMENT, V17, P563
   Lahaye M, 1998, CARBOHYD RES, V314, P1, DOI 10.1016/S0008-6215(98)00293-6
   Lahaye M, 1996, CARBOHYD RES, V283, P161, DOI 10.1016/0008-6215(95)00407-6
   Lahaye M, 1999, J APPL PHYCOL, V11, P1, DOI 10.1023/A:1008063600071
   Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X
   Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5
   LAHAYE M, 1993, CARBOHYD POLYM, V22, P261, DOI 10.1016/0144-8617(93)90129-R
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   LIU W, 2000, POLYM PREPR, V41, P1193
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mao WJ, 2006, J APPL PHYCOL, V18, P9, DOI 10.1007/s10811-005-9008-4
   Marvel CS, 1938, J AM CHEM SOC, V60, P1045, DOI 10.1021/ja01272a018
   McKee MG, 2004, MACROMOLECULES, V37, P1760, DOI 10.1021/ma035689h
   Morelli A, 2010, MACROMOL CHEM PHYS, V211, P821, DOI 10.1002/macp.200900562
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Paradossi G, 1999, INT J BIOL MACROMOL, V25, P309, DOI 10.1016/S0141-8130(99)00049-5
   Paradossi G, 2002, MACROMOLECULES, V35, P6404, DOI 10.1021/ma020134s
   Pengzhan Y, 2003, J APPL PHYCOL, V15, P21
   Qi HM, 2005, J APPL PHYCOL, V17, P527, DOI 10.1007/s10811-005-9003-9
   Qi HM, 2006, BIOORG MED CHEM LETT, V16, P2441, DOI 10.1016/j.bmcl.2006.01.076
   Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478
   QUEMENER B, 1990, CARBOHYD RES, V206, P277, DOI 10.1016/0008-6215(90)80067-D
   RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Robic A, 2009, J APPL PHYCOL, V21, P451, DOI 10.1007/s10811-008-9390-9
   Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023
   Robic A, 2009, BIOPOLYMERS, V91, P652, DOI 10.1002/bip.21195
   Sassaki GL, 2008, J CHROMATOGR A, V1208, P215, DOI 10.1016/j.chroma.2008.08.083
   SHIBAYAMA M, 1988, POLYMER, V29, P2066, DOI 10.1016/0032-3861(88)90182-6
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Taboada C, 2010, J SCI FOOD AGR, V90, P445, DOI 10.1002/jsfa.3836
   THIELE H, 1960, COLLOID POLYM SCI, V173, P63
   VENUGOPAL S, 2005, BIOTECHNOLOGY, V125, P147
   Webster EA, 1997, BIOMETALS, V10, P105, DOI 10.1023/A:1018379106700
   Yu PZ, 2003, PHARMACOL RES, V48, P543, DOI 10.1016/S1043-6618(03)00215-9
   Yuan ZY, 2004, COLLOID SURFACE A, V241, P173, DOI 10.1016/j.colsurfa.2004.04.030
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang HJ, 2008, CARBOHYD POLYM, V71, P428, DOI 10.1016/j.carbpol.2007.06.012
   Zhang YZ, 2008, BIOMACROMOLECULES, V9, P136, DOI 10.1021/bm701130e
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 67
TC 43
Z9 46
U1 4
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 17
PY 2011
VL 84
IS 3
BP 1093
EP 1102
DI 10.1016/j.carbpol.2010.12.075
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 732ZV
UT WOS:000288231100033
DA 2018-10-20
ER

PT J
AU Paulino, AT
   Belfiore, LA
   Kubota, LT
   Muniz, EC
   Tambourgi, EB
AF Paulino, Alexandre Tadeu
   Belfiore, Laurence Alphonse
   Kubota, Lauro Tatsuo
   Muniz, Edvani Curti
   Tambourgi, Elias Basile
TI Efficiency of hydrogels based on natural polysaccharides in the removal
   of Cd2+ ions from aqueous solutions
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Polysaccharide; Hydrogel; Cadmium; Water; Effluent
ID LOW-COST ADSORBENT; WASTE-WATER; MAGNETIC BIOMATERIAL;
   REGRESSION-ANALYSIS; POTENTIAL DEVICE; METHYLENE-BLUE; CADMIUM;
   ADSORPTION; SORPTION; EQUILIBRIUM
AB Hydrogels based on chitosan, maltodextrin and gum arabic with and without magnetite nanoparticles were employed as adsorbents for removing Cd2+ from aqueous solutions. Adsorption kinetics employing the Fickian equation inferred that the diffusion mechanism of water into hydrogels may be conducted by both the diffusion process and macromolecular structure relaxation and may be affected by the presence of magnetite nanoparticles. This effect is related to the increase in reticulation points in the hydrogel network. The following were best parameters for removing Cd2+ from aqueous solutions: pH range from 4.5 to 5.5; initial metal concentration of 200 mg L-1; and dried hydrogel mass of 100 mg. Using non-linearized isotherms described by Langmuir, Freundlich and Redlich-Peterson, it was inferred that there may be a variation in the physiochemical phenomena involving Cd2+ adsorption and the results fit better to the Langmuir or Redlich-Peterson models than the Freundlich model. The present study confirms that magnetic hydrogels and Cd2+ may be recovered after the application of an external magnetic field, unlike hydrogels without magnetic properties, which are generally recovered through the use of a chemical solvent, such as HCl or HNO3. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Paulino, Alexandre Tadeu; Tambourgi, Elias Basile] Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, BR-13083852 Campinas, SP, Brazil.
   [Paulino, Alexandre Tadeu; Belfiore, Laurence Alphonse] Colorado State Univ, Dept Chem & Biol Engn, Polymer Phys & Engn Lab, Ft Collins, CO 80523 USA.
   [Kubota, Lauro Tatsuo] Univ Estadual Campinas, Inst Chem, Dept Analyt Chem, Lab Electrochem Electroanalyt & Dev Sensors, BR-13083970 Campinas, SP, Brazil.
   [Muniz, Edvani Curti] Univ Estadual Maringa, Dept Chem, Polymer Mat & Composite Lab, BR-87050900 Maringa, Parana, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, Av Albert Einstein 500,Bloco A,Cidade Univ, BR-13083852 Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013; Inomat, Inct/H-9989-2013; Tambourgi,
   Elias/E-1863-2012; Kubota, Lauro/C-1459-2012
OI Paulino, Alexandre/0000-0001-7076-2797; Tambourgi,
   Elias/0000-0002-4734-9723; Kubota, Lauro/0000-0001-8189-2618; Muniz,
   Edvani/0000-0001-6685-1519
FU State of Sao Paulo Research Foundation (FAPESP, Brazil) [2008/00285-7];
   Coordination of Improvement of Higher Education Personnel (CAPES,
   Brazil) [5267/09-9]
FX A.T. Paulino and E.B. Tambourgi thank the State of Sao Paulo Research
   Foundation (FAPESP, Brazil) for the post-doctorate fellowship (Process
   No. 2008/00285-7). A.T. Paulino and L.A. Belfiore thank the Coordination
   of Improvement of Higher Education Personnel (CAPES, Brazil) for the
   post-doctorate fellowship abroad (Process No. 5267/09-9).
CR AGNIESZKA KP, 2009, FRESEN ENVIRON BULL, V18, P1103
   Ali I, 2006, NAT PROTOC, V1, P2661, DOI 10.1038/nprot.2006.370
   BERNARD A, 1984, EXPERIENTIA, V40, P143, DOI 10.1007/BF01963577
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   CAMPOS ML, 2005, BRAZ AGR RES, V40, P361
   CHIUNCHUNG L, 2005, ENCY CHEM PROCESSING
   DAVIS RD, 1984, EXPERIENTIA, V40, P117, DOI 10.1007/BF01963574
   Friberg L, 1971, CADMIUM ENV
   Guilherme MR, 2007, J APPL POLYM SCI, V105, P2903, DOI 10.1002/app.26287
   Gupta VK, 2008, J HAZARD MATER, V153, P759, DOI 10.1016/j.jhazmat.2007.09.021
   Gupta VK, 2009, CRIT REV ENV SCI TEC, V39, P783, DOI 10.1080/10643380801977610
   Gupta VK, 2010, J COLLOID INTERF SCI, V342, P135, DOI 10.1016/j.jcis.2009.09.065
   Gupta VK, 1997, SEPAR SCI TECHNOL, V32, P2883, DOI 10.1080/01496399708002227
   Gupta VK, 2002, ENVIRON SCI TECHNOL, V36, P3612, DOI 10.1021/es020010v
   Gupta VK, 2004, J COLLOID INTERF SCI, V275, P398, DOI 10.1016/j.jcis.2004.02.046
   Ho YS, 2005, BIORESOURCE TECHNOL, V96, P1285, DOI 10.1016/j.biortech.2004.10.021
   Jang SH, 2008, J HAZARD MATER, V159, P294, DOI 10.1016/j.jhazmat.2008.02.018
   KEITZ EL, 1980, ATMOSPHERIC CYCLES C
   Kumar KV, 2008, J HAZARD MATER, V151, P794, DOI 10.1016/j.jhazmat.2007.06.056
   Kumar KV, 2007, DYES PIGMENTS, V74, P595, DOI 10.1016/j.dyepig.2006.03.026
   Kumar M, 2009, J HAZARD MATER, V172, P1041, DOI 10.1016/j.jhazmat.2009.07.108
   Nogami EM, 2000, ECOTOX ENVIRON SAFE, V45, P291, DOI 10.1006/eesa.1999.1858
   OLESZCZUK P, 2009, ENVIRON TOXICOL, V25, P38
   Otomo PV, 2010, ECOTOXICOLOGY, V19, P362, DOI 10.1007/s10646-009-0418-y
   Paneva D., 2004, E-POLYMERS, V60, P1
   Paulino AT, 2008, ANAL SCI, V24, P1443, DOI 10.2116/analsci.24.1443
   Paulino AT, 2006, J COLLOID INTERF SCI, V301, P55, DOI 10.1016/j.jcis.2006.04.036
   Paulino AT, 2011, POLYM INT, V60, P1324, DOI 10.1002/pi.3084
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2008, REACT FUNCT POLYM, V68, P634, DOI 10.1016/j.reactfunctpolym.2007.10.028
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PERIASAMY K, 1994, IND ENG CHEM RES, V33, P317, DOI 10.1021/ie00026a022
   PRADAS EG, 1994, J CHEM TECHNOL BIOT, V59, P289, DOI 10.1002/jctb.280590312
   SALGADO PET, 1996, FUNDAMENTOS TOXICOLO, P154
   SALGADO PET, 1996, FUNDAMENTOS TOXICOLO, P443
   Stewart TJ, 2009, COLLOID POLYM SCI, V287, P1033, DOI 10.1007/s00396-009-2058-4
NR 38
TC 39
Z9 39
U1 1
U2 33
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 15
PY 2011
VL 168
IS 1
BP 68
EP 76
DI 10.1016/j.cej.2010.12.037
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 752PJ
UT WOS:000289704400008
DA 2018-10-20
ER

PT J
AU Shen, YH
   Liu, WC
   Lin, KL
   Pan, HB
   Darvell, BW
   Peng, SL
   Wen, CY
   Deng, LF
   Lu, WW
   Chang, JA
AF Shen, Yuhui
   Liu, Waiching
   Lin, Kaili
   Pan, Haobo
   Darvell, Brian W.
   Peng, Songlin
   Wen, Chunyi
   Deng, Lianfu
   Lu, William W.
   Chang, Jiang
TI Interfacial pH: A Critical Factor for Osteoporotic Bone Regeneration
SO LANGMUIR
LA English
DT Article
ID STRONTIUM RANELATE; IN-VITRO; CALCIUM SILICATE; BIOMATERIALS;
   OSTEOCLASTS; CERAMICS; DIFFERENTIATION; BIOGLASS(R); OSTEOBLASTS;
   RESORPTION
AB Osteoporosis is a disease attributed to an imbalance in communication between osteoblasts and osteoclasts, possibly arising from a locally acidic microenvironment which hinders normal cell function. However, to date, little or no attention has been paid to these cells' milieu in respect of implant materials. Although it has been claimed for a few biomaterials that they stimulate bone formation, seldom has their surface behavior been invoked to explain behavior. With degradation, ion concentrations and pH at the material's surface must vary and thus may affect osteoblast response directly. On degradation of a recently developed biomaterial, Sr-containing CaSiO(3), the interfacial pH was found to be appreciably higher than that of the bulk medium and the "standard" physiological value of 7.4. At these high values (pH > 8), both the proliferation and alkaline phosphatase (ALP) activity of osteoblasts was significantly enhanced, with a maximum response at 10% Sr substitution for Ca. This shows that the chemistry of the solid liquid interface is a critical factor in bone regeneration, although this has generally been overlooked. Thus, the interfacial pH in particular is to be considered, rather than the bulk value, and this may be of importance in many related contexts in bone-tissue engineering.
C1 [Liu, Waiching; Pan, Haobo; Peng, Songlin; Wen, Chunyi; Lu, William W.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Shen, Yuhui; Deng, Lianfu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai Inst Orthopaed & Traumatol,Dept Orthopae, Shanghai, Peoples R China.
   [Lin, Kaili; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Beijing 100864, Peoples R China.
   [Darvell, Brian W.] Kuwait Univ, Fac Dent, Dept Bioclin Sci, Safat 13060, Kuwait.
RP Pan, HB (reprint author), Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
EM haobo@hkusua.hku.hk; wwlu@hkusua.hku.hk
RI Pan, Haobo/G-3547-2011
OI WEN, Chunyi/0000-0003-1949-7822; Liu, Wai Ching/0000-0003-3816-6236
FU NSFC/RGC [N_HKU 739/10]; Hong Kong RGC [HKU7153/06E, 714908/081];
   Science and Technology Commission of Shanghai Municipality
   [09JC1415500]; Natural Science Foundation of China [30730034, 30900299]
FX This work was funded by grants from NSFC/RGC (Grant No. N_HKU 739/10),
   Hong Kong RGC HKU7153/06E &714908/081, Science and Technology Commission
   of Shanghai Municipality (Grant No. 09JC1415500), and Natural Science
   Foundation of China (Grant No. 30730034, 30900299). The authors are
   grateful for much technical support and guidance from the Electron
   Microscopy Unit of The University of Hong Kong.
CR Buclin T, 2001, OSTEOPOROSIS INT, V12, P493, DOI 10.1007/s001980170095
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Bushinsky DA, 2001, EUR J NUTR, V40, P238, DOI 10.1007/s394-001-8351-5
   Bushinsky DA, 1996, AM J PHYSIOL-RENAL, V271, pF216
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593
   Habermann B, 2010, CALCIFIED TISSUE INT, V86, P82, DOI 10.1007/s00223-009-9317-8
   Hamdy NAT, 2009, RHEUMATOLOGY, V48, pIV9, DOI 10.1093/rheumatology/kep274
   HARDA M, 1986, J DENT RES, V65, P125
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Kannan S, 2010, ACTA BIOMATER, V6, P571, DOI 10.1016/j.actbio.2009.08.009
   Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   LI ZY, 2010, J ORTHOP RES, V27, P758
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Meghji S, 2001, AM J PHYSIOL-ENDOC M, V280, pE112
   Mistry AS, 2010, J BIOMED MATER RES A, V92A, P451, DOI 10.1002/jbm.a.32371
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Ni SY, 2008, J BIOMED MATER RES A, V85A, P72, DOI 10.1002/jbm.a.31390
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105
   Pina S, 2010, ACTA BIOMATER, V6, P928, DOI 10.1016/j.actbio.2009.09.001
   Reginster JY, 2009, BONE, V45, pS131, DOI 10.1016/j.bone.2009.07.042
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   VORMANN J, 2001, EUR J NUTR, V40, P238
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhao WY, 2008, MAT SCI ENG C-BIO S, V28, P289, DOI 10.1016/j.msec.2007.01.007
NR 33
TC 37
Z9 38
U1 1
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 15
PY 2011
VL 27
IS 6
BP 2701
EP 2708
DI 10.1021/la104876w
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 730NE
UT WOS:000288039500085
PM 21309596
DA 2018-10-20
ER

PT J
AU Costa, D
   Garrain, PA
   Diawara, B
   Marcus, P
AF Costa, D.
   Garrain, P. -A.
   Diawara, B.
   Marcus, P.
TI Biomolecule-Biomaterial Interaction: A DFT-D Study of Glycine Adsorption
   and Self-Assembly on Hydroxylated Cr2O3 Surfaces
SO LANGMUIR
LA English
DT Article
ID DENSITY-FUNCTIONAL THEORY; STAINLESS-STEEL SURFACE; BOVINE
   SERUM-ALBUMIN; SINGLE-CRYSTAL SURFACES; ALPHA-AMINO-ACIDS; AB-INITIO;
   PASSIVE FILMS; SOLID-SURFACES; HYDROXYAPATITE SURFACES; FE-17-PERCENT-CR
   ALLOY
AB The adsorption of glycine, the building block of amino acids, on hydroxylated (0001)-Cr2O3 model surfaces, representing the stainless steel passive film surface, was modeled by means of the GGA + U Method. The roles of glycine coverage and surface termination (hydroxylated Cr- and O-terminated surfaces) on the adsorption mode and self-assembly properties were explored. The hydroxylated Cr-terminated Cr2O3 surface, which presents two types of (H)OH groups exhibiting different acidic character, is more reactive than the hydroxylated O-terminated surface, where one single type of OH group is present, for all adsorption modes and coverages considered. Outer sphere adsorption occurs in the zwitterion form, stabilized at low coverage through H-bond formation with coadsorbed water molecules, and at the monolayer coverage by glycine self-assembling. The OH substitution by glycinate is favored on the hydroxylated Cr-terminated surface and not on the O-terminated one. The inclusion of dispersion forces does not change the observed tendencies. An atomistic thermodynamics approach suggests that outer sphere adsorption is thermodynamically favored over inner sphere adsorption in the whole domain of glycine concentration. The obtained SAM's free energies of formation are rationalized in a model considering the balance between sublimation and solvation free energies, and extrapolated to other amino acids, to predict the SAMs formation above hydroxylated surfaces. It is found that hydrophobic AA tend to self-assemble at the surface, whereas hydrophilic ones do not.
C1 [Costa, D.; Garrain, P. -A.; Diawara, B.; Marcus, P.] Chim Paristech, Ecole Natl Super Chim Paris, CNRS ENSCP UMR 7045, Lab Physicochim Surfaces, F-75005 Paris, France.
RP Costa, D (reprint author), Chim Paristech, Ecole Natl Super Chim Paris, CNRS ENSCP UMR 7045, Lab Physicochim Surfaces, 11 Rue Pierre & Marie Curie, F-75005 Paris, France.
EM dominique-costa@chimie-paristech.fr
RI costa, dominique/G-5347-2011
CR Almora-Barrios N, 2010, LANGMUIR, V26, P14535, DOI 10.1021/la101151e
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Arrouvel C, 2007, J PHYS CHEM C, V111, P18164, DOI 10.1021/jp0741408
   Asthagiri A, 2007, MOL SIMULAT, V33, P343, DOI 10.1080/08927020601155485
   Boekfa B, 2008, J MOL STRUCT, V889, P81, DOI 10.1016/j.molstruc.2008.01.026
   BOUZOUBAA A, 2010, CORROS SCI
   Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z
   Chakarova-Kack SD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155402
   Chiche D, 2009, PHYS CHEM CHEM PHYS, V11, P11310, DOI 10.1039/b914062j
   Compere C, 2001, BIOFOULING, V17, P129, DOI 10.1080/08927010109378472
   COSTA D, 1996, ECASIA 95, pA43
   Costa D, 2008, PHYS CHEM CHEM PHYS, V10, P6360, DOI 10.1039/b806501b
   Costa D, 2007, J MOL STRUC-THEOCHEM, V806, P253, DOI 10.1016/j.theochem.2006.12.006
   Costa D, 2010, SURF SCI, V604, P932, DOI 10.1016/j.susc.2010.02.023
   Costa D, 2009, SURF SCI, V603, P2484, DOI 10.1016/j.susc.2009.05.037
   ELSHAFEI GMS, 1995, J COLLOID INTERF SCI, V176, P55, DOI 10.1006/jcis.1995.0007
   ElShafei GMS, 1997, J COLLOID INTERF SCI, V185, P140, DOI 10.1006/jcis.1996.4538
   Ernst KH, 2006, TOP CURR CHEM, V265, P209, DOI 10.1007/128_036
   FOLLIET N, UNPUB
   Frateur I, 2006, ELECTROCHIM ACTA, V51, P1550, DOI 10.1016/j.electacta.2005.02.116
   Freccero M, 2003, J AM CHEM SOC, V125, P3544, DOI 10.1021/ja028732+
   GAFFNEY JS, 1977, J AM CHEM SOC, V99, P4293, DOI 10.1021/ja00455a015
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gao YK, 2009, J COLLOID INTERF SCI, V338, P16, DOI 10.1016/j.jcis.2009.06.008
   Garrain PA, 2011, J PHYS CHEM C, V115, P719, DOI 10.1021/jp109704b
   Gordeijev J, 1999, SURF SCI, V440, P321, DOI 10.1016/S0039-6028(99)00810-9
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344
   Han JW, 2010, PHYS CHEM CHEM PHYS, V12, P8024, DOI 10.1039/b926035h
   Han JW, 2009, LANGMUIR, V25, P10737, DOI 10.1021/la901264e
   Hazen RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002162
   Heinz H, 2009, J AM CHEM SOC, V131, P9704, DOI 10.1021/ja900531f
   Imamura K, 2000, J COLLOID INTERF SCI, V229, P237, DOI 10.1006/jcis.2000.7016
   Imamura K, 2008, J BIOSCI BIOENG, V106, P273, DOI 10.1263/jbb.106.273
   Imamura K, 2010, J COLLOID INTERF SCI, V345, P474, DOI 10.1016/j.jcis.2010.01.083
   Irrera S, 2009, J MOL STRUC-THEOCHEM, V903, P49, DOI 10.1016/j.theochem.2009.01.023
   Ithurbide A, 2007, ELECTROCHIM ACTA, V53, P1336, DOI 10.1016/j.electacta.2007.04.109
   James JN, 2008, CURR OPIN COLLOID IN, V13, P60, DOI 10.1016/j.cocis.2007.08.012
   Johnson SB, 2005, LANGMUIR, V21, P6356, DOI 10.1021/la047030q
   Jonsson CM, 2010, GEOCHIM COSMOCHIM AC, V74, P2356, DOI 10.1016/j.gca.2010.01.003
   Jonsson CM, 2009, LANGMUIR, V25, P12127, DOI 10.1021/la901635t
   KITTAKA S, 1974, J COLLOID INTERF SCI, V48, P327, DOI 10.1016/0021-9797(74)90167-2
   Koppen S, 2008, J PHYS CHEM C, V112, P13600, DOI 10.1021/jp803354z
   KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251
   Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758
   Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0
   KRISDHASIMA V, 1993, J COLLOID INTERF SCI, V161, P325, DOI 10.1006/jcis.1993.1474
   Lambert JF, 2008, ORIGINS LIFE EVOL B, V38, P211, DOI 10.1007/s11084-008-9128-3
   Langel W, 2003, SURF SCI, V538, P1, DOI 10.1016/S0039-6028(03)00723-4
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Lomenech C, 2005, CHEMPHYSCHEM, V6, P1061, DOI 10.1002/cphc.200400608
   Ma H, 2002, CORROS SCI, V44, P171, DOI 10.1016/S0010-938X(01)00020-8
   Marcus P, 2002, CORROSION MECH THEOR
   Maurice V, 1996, J ELECTROCHEM SOC, V143, P1182, DOI 10.1149/1.1836616
   Monti S, 2008, LANGMUIR, V24, P3205, DOI 10.1021/la702956t
   Murray BS, 2000, J COLLOID INTERF SCI, V227, P32, DOI 10.1006/jcis.2000.6882
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Palecz B, 2000, J MOL LIQ, V84, P279, DOI 10.1016/S0167-7322(99)00194-4
   Patthey L, 1999, J CHEM PHYS, V110, P5913, DOI 10.1063/1.478491
   PAYET V, 2009, THESIS UPMC FRANCE
   PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244
   Perez P, 2003, TETRAHEDRON, V59, P3117, DOI 10.1016/S0040-4020(03)00374-0
   Persson P, 2005, GEOCHIM COSMOCHIM AC, V69, P541, DOI 10.1016/j.gca.2004.07.009
   Pradier CM, 2002, SURF INTERFACE ANAL, V34, P50, DOI 10.1002/sia.1250
   Pradier CM, 2000, SURF INTERFACE ANAL, V30, P45, DOI 10.1002/1096-9918(200008)30:1<45::AID-SIA767>3.0.CO;2-G
   Qiu TZ, 2006, J COLLOID INTERF SCI, V303, P229, DOI 10.1016/j.jcis.2006.07.053
   Raval R, 2009, CHEM SOC REV, V38, P707, DOI 10.1039/b800411k
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2009, J PHYS CHEM C, V113, P5741, DOI 10.1021/jp811193f
   Rimola A, 2008, LANGMUIR, V24, P14027, DOI 10.1021/la8029352
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   ROBERT W, 2007, J PHYS CHEM B, V111, P11968
   Rohrbach A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075413
   Rubio C, 2002, COLLOID SURFACE B, V24, P193, DOI 10.1016/S0927-7765(01)00242-9
   Sakiyama T, 2006, J BIOSCI BIOENG, V101, P434, DOI 10.1263/jbb.101.434
   SAVIO L, SMALL BIOMO IN PRESS
   STEFANOVICH EV, 1995, CHEM PHYS LETT, V244, P65, DOI 10.1016/0009-2614(95)00898-E
   Stievano L, 2007, EUR J MINERAL, V19, P321, DOI 10.1127/0935-1221/2007/0019-1731
   Stievano L, 2010, CRYST GROWTH DES, V10, P3657, DOI 10.1021/cg100525h
   Szieberth D, 2010, PHYS CHEM CHEM PHYS, V12, P11033, DOI 10.1039/c004155f
   Tkatchenko A, 2010, MRS BULL, V35, P435, DOI 10.1557/mrs2010.581
   Tonner R, 2010, CHEMPHYSCHEM, V11, P1053, DOI 10.1002/cphc.200900902
   Wei C., 2010, J PHYS CHEM C, V114, P460
   WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030
   Yang G, 2009, J PHYS CHEM B, V113, P10399, DOI 10.1021/jp903835j
   YANG WP, 1994, J ELECTROCHEM SOC, V141, P2669, DOI 10.1149/1.2059166
   YANG WP, 1994, J ELECTROCHEM SOC, V141, P111, DOI 10.1149/1.2054669
NR 88
TC 32
Z9 32
U1 1
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 15
PY 2011
VL 27
IS 6
BP 2747
EP 2760
DI 10.1021/la104317j
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 730NE
UT WOS:000288039500091
PM 21338116
DA 2018-10-20
ER

PT J
AU Yuan, SJ
   Wan, D
   Liang, B
   Pehkonen, SO
   Ting, YP
   Neoh, KG
   Kang, ET
AF Yuan, Shaojun
   Wan, Dong
   Liang, Bin
   Pehkonen, S. O.
   Ting, Y. P.
   Neoh, K. G.
   Kang, E. T.
TI Lysozyme-Coupled Poly(poly(ethylene glycol) methacrylate)-Stainless
   Steel Hybrids and Their Antifouling and Antibacterial Surfaces
SO LANGMUIR
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; SELF-ASSEMBLED MONOLAYERS;
   STAINLESS-STEEL; POLY(ETHYLENE GLYCOL); INITIATED POLYMERIZATION;
   IMMOBILIZED LYSOZYME; FOULING RESISTANCE; MICROBIAL ADHESION; BACTERIAL
   ADHESION; MULTILAYER FILMS
AB An environmentally benign approach to impart stainless steel (SS) surfaces with antifouling and antibacterial functionalities was described. Surface initiated atom transfer radical polymerization (ATRP) of poly(ethylene glycol) monomethacrylate) (PEGMA) from the SS surface-coupled catecholic L-3,4-dihydroxyphenylalanine (DOPA) with terminal alkyl halide initiator was first carried out, followed by the immobilization. of lysozyme at the chain ends of poly(ethylene glycol) branches of the grafted PEGMA Polymer brushes. The functionalized SS surfaces were shown to be effective in preventing bovine serum albumin (BSA) adsorption and in reducing bacterial adhesion and biofilm formation. The surfaces also exhibited good bactericidal effects against Escherichia colt and Staphylococcus aureus. The concomitant incorporation of antifouling hydrophilic brushes and antibacterial enzymes or peptides onto metal surfaces via catecholic anchors should be readily adaptable to other Metal substrates, and is potentially useful for biomedical and biomaterial applications.
C1 [Yuan, Shaojun; Liang, Bin] Sichuan Univ, Coll Chem Engn, Chengdu 610065, Peoples R China.
   [Wan, Dong; Ting, Y. P.; Neoh, K. G.; Kang, E. T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 119260, Singapore.
   [Pehkonen, S. O.] Univ Oulu, Thule Inst, CEWIC, FI-90014 Oulu, Finland.
RP Yuan, SJ (reprint author), Sichuan Univ, Coll Chem Engn, Chengdu 610065, Peoples R China.
EM yuanshaojun@gmail.com; simo.pehkonen@oulu.fi
RI Yuan, Shaojun/B-2145-2012; Kang, En-Tang/G-8522-2012
OI Yuan, Shaojun/0000-0002-3580-7977; Kang, En-Tang/0000-0003-0599-7834;
   Pehkonen, Simo/0000-0002-0362-9176; Neoh, Koon Gee/0000-0002-2700-1914
FU Sichuan University [208-220-413-4022]
FX The authors would like to thank Sichuan University for the financial
   support of this study under the Research Starting Fund 208-220-413-4022.
CR Alves CR, 2007, ELECTRON J BIOTECHN, V10, P160, DOI 10.2225/vol10-issue1-fulltext-4
   Appendini P., 1997, Packaging Technology & Science, V10, P271, DOI 10.1002/(SICI)1099-1522(199709/10)10:5<271::AID-PTS412>3.3.CO;2-I
   Biesalski M, 2004, MACROMOLECULES, V37, P2196, DOI 10.1021/ma035425v
   Bocking T, 2006, LANGMUIR, V22, P3494, DOI 10.1021/la030331a
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Caro A., 2009, J PHYS CHEM B, V113, P2102
   Charlot A, 2009, J MATER CHEM, V19, P4117, DOI 10.1039/b820832h
   Conte A, 2008, J FOOD PROTECT, V71, P119, DOI 10.4315/0362-028X-71.1.119
   Conte A, 2006, J FOOD PROTECT, V69, P866, DOI 10.4315/0362-028X-69.4.866
   COSTERTON WJ, 1999, SCIENCE, V284, P1318
   COSTERTON WJ, 1987, J ANN REV MICROBIOL, V41, P435
   CROWLEY SC, 1986, J CHROMATOGR, V359, P359, DOI 10.1016/0021-9673(86)80090-5
   Dong BY, 2007, LANGMUIR, V23, P7306, DOI 10.1021/la0633280
   ENMONDSON S, 2004, CHEM SOC REV, V33, P14
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Hu FX, 2006, BIOMACROMOLECULES, V7, P809, DOI 10.1021/bm050870e
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   IBRAHIM HR, 1991, J AGR FOOD CHEM, V39, P2077, DOI 10.1021/jf00011a039
   Ignatova M, 2009, LANGMUIR, V25, P891, DOI 10.1021/la802472e
   Jampala SN, 2008, LANGMUIR, V24, P8583, DOI 10.1021/la800405x
   Jiang W., 2003, COLLOID SURFACE B, V32, P275
   Khoo XJ, 2009, J AM CHEM SOC, V131, P10992, DOI 10.1021/ja9020827
   Kilian KA, 2007, BIOMATERIALS, V28, P3055, DOI 10.1016/j.biomaterials.2007.03.014
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   KJELLANDER R, 1981, J CHEM SOC FARAD T 1, V77, P2053, DOI 10.1039/f19817702053
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v
   Martin HJ, 2007, LANGMUIR, V23, P6645, DOI 10.1021/la063284v
   Martin ST, 1996, ENVIRON SCI TECHNOL, V30, P2535, DOI 10.1021/es950872e
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Muller R, 2009, BIOMATERIALS, V30, P4921, DOI 10.1016/j.biomaterials.2009.05.079
   OSTUNI E, 2001, LANGMUIR, V17, P5336
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Roosjen A, 2005, COLLOID SURFACE B, V46, P1, DOI 10.1016/j.colsurtb.2005.08.009
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Shi ZL, 2005, BIOMATERIALS, V26, P501, DOI 10.1016/j.biomaterials.2004.02.060
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Statz AR, 2008, SOFT MATTER, V4, P131, DOI 10.1039/b711944e
   VANENCKEVORT HJ, 1984, J COLLOID INTERF SCI, V98, P138, DOI 10.1016/0021-9797(84)90487-9
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Wang Q, 2009, BIOPROC BIOSYST ENG, V32, P633, DOI 10.1007/s00449-008-0286-5
   Xu FJ, 2009, BIOMACROMOLECULES, V10, P1665, DOI 10.1021/bm900307c
   Yuan SJ, 2008, J ELECTROCHEM SOC, V155, pC196, DOI 10.1149/1.2885073
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 57
TC 126
Z9 127
U1 11
U2 142
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 15
PY 2011
VL 27
IS 6
BP 2761
EP 2774
DI 10.1021/la104442f
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 730NE
UT WOS:000288039500092
PM 21338094
DA 2018-10-20
ER

PT J
AU Akkouch, A
   Zhang, Z
   Rouabhia, M
AF Akkouch, Adil
   Zhang, Ze
   Rouabhia, Mahmoud
TI A novel collagen/hydroxyapatite/poly(lactide-co-epsilon-caprolactone)
   biodegradable and bioactive 3D porous scaffold for bone regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; poly(lactide-co-epsilon-caprolactone); collagen;
   hydroxyapatite; bone regeneration; biomimetic
ID IN-VITRO; HYDROXYAPATITE COMPOSITES; BEHAVIOR; COLLAGEN;
   POLY(L-LACTIDE-CO-EPSILON-CAPROLACTONE); OSTEOBLASTS; MINERALIZATION;
   SPECTROSCOPY; NANOFIBERS; COPOLYMERS
AB The goal of this study was to design a nontoxic scaffold with both composition and microstructure suitable for bone engineering using collagen (Coll), hydroxyapatite (HA), and poly(lactide-co-epsilon-caprolactone) (PLCL). Mineralized type I Coll was produced by direct nucleation of HA particles inside self-assembled Coll fibers to obtain a Coll/HA complex, which was then added to dissolved PLCL (70: 30) in 1,4-dioxane. A 3D porous Coll/HA/PLCL scaffold was subsequently produced through freeze-drying/lyophilization and salt-leaching procedures. The resulting Coll/HA/PLCL scaffold displayed a high uniform porosity and highly interconnected pores. X-ray photoelectron spectrometer and Fourier transform infrared analyses revealed the presence of both collagen and HA particles on the surface of the Coll/HA/PLCL scaffold. Proliferation assay, microscopic observations, and gene analysis with quantitative RT-PCR showed that osteoblast cells were able to attach, proliferate, and maintain an osteoblastlike phenotype when cultured on the Coll/HA/PLCL scaffold. In summary, we produced a nontoxic scaffold that contains natural polymers (Coll and HA) and synthetic polymer (PLCL). Through its chemical composition and porous morphology, this scaffold may be useful for osteoblast growth, differentiation, and bone tissue formation. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 693-704, 2011.
C1 [Akkouch, Adil; Rouabhia, Mahmoud] Univ Laval, Fac Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] Univ Laval, Dept Surg, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] CHUQ, Quebec Biomat Inst, Quebec City, PQ, Canada.
RP Rouabhia, M (reprint author), Univ Laval, Fac Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
EM mahmoud.rouabhia@fmd.ulaval.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   CHIR; Reseau de Recherche en Sante Buccodentaire et Ossseuse; Fonds
   Emile-Beaulieu
FX Contract grant sponsors: Natural Sciences and Engineering Research
   Council of Canada (NSERC) Discovery Program, the CHIR (MR and ZZ), the
   "Reseau de Recherche en Sante Buccodentaire et Ossseuse,'' and the Fonds
   Emile-Beaulieu (MR)
CR AMIR AA, 2009, J BIOMED MATER RES B, V90, P584
   Bahri R, 2010, J CELL PHYSIOL, V222, P209, DOI 10.1002/jcp.21939
   Brostrom J, 2004, BIOMACROMOLECULES, V5, P1124, DOI 10.1021/bm049920q
   Carinci F, 2009, IMPLANT DENT, V18, P86, DOI 10.1097/ID.0b013e318192cbbe
   Cho HH, 2008, BIOMATERIALS, V29, P884, DOI 10.1016/j.biomaterials.2007.10.052
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dorairajan A, 2005, J ARTHROPLASTY, V20, P209, DOI 10.1016/j.arth.2004.09.049
   Fraitzl CR, 2008, J INVEST SURG, V21, P109, DOI 10.1080/08941930802043540
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   Ghasemi-Mobarakeh L, 2009, INT J ARTIF ORGANS, V32, P150
   Heijkants RGJC, 2006, J MATER SCI, V41, P2423, DOI 10.1007/s10853-006-7065-y
   HiljanenVainio MP, 1997, J BIOMED MATER RES, V34, P39, DOI 10.1002/(SICI)1097-4636(199701)34:1<39::AID-JBM6>3.0.CO;2-O
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708
   JENNIFER LM, 2009, J BIOMED MATER RES A, V91, P605
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   JULIAN RJ, 2006, PHIL T R SOC A, V364, P263
   Kang Y, 2006, J BIOMED MATER RES A, V77A, P331, DOI 10.1002/jbm.a.30607
   Kolovou P, 2007, NATO SEC SCI B PHYS, P267, DOI 10.1007/978-1-4020-5724-3_24
   Kronick PL, 1996, CONNECT TISSUE RES, V33, P275, DOI 10.3109/03008209609028885
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   MARKUS JB, 2006, P NATL ACAD SCI USA, V103, P12285
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murugan R, 2007, TOP APPL PHYS, V109, P301, DOI 10.1007/978-0-387-39938-6_14
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   NICK T, 2009, J BIOMED MATER RES A, V93, P738
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Okii N, 2001, NEUROL MED-CHIR, V41, P100, DOI 10.2176/nmc.41.100
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Shuai XT, 2002, BIOMACROMOLECULES, V3, P201, DOI 10.1021/bm015609m
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Sukhodub LF, 2004, J MOL STRUCT, V704, P53, DOI 10.1016/j.molstruc.2003.12.061
   Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Xie J, 2006, TISSUE ENG, V12, P449, DOI 10.1089/ten.2006.12.449
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   YUN C, 2006, J BIOMED MATER RES B, V77, P315
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
   Zhu YB, 2006, BIOMATERIALS, V27, P68, DOI 10.1016/j.biomaterials.2005.05.069
NR 48
TC 34
Z9 39
U1 0
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2011
VL 96A
IS 4
BP 693
EP 704
DI 10.1002/jbm.a.33033
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 719OZ
UT WOS:000287215600009
PM 21284080
DA 2018-10-20
ER

PT J
AU Yamada, M
   Tabuchi, S
AF Yamada, Masanori
   Tabuchi, Shinya
TI DNA-cyclodextrin-inorganic hybrid material for absorbent of various
   harmful compounds
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; Polymers; Composite material; Organic compounds
ID NUCLEIC-ACIDS; COMPOSITE; POLYMERS; CHITOSAN; BINDING; BIOENCAPSULATION;
   POLY(ALLYLAMINE); COMPLEXATION; MATRIX
AB A DNA-cyclodextrin (CD)-inorganic hybrid material was prepared by mixing the DNA, CD, and silane coupling reagents, such as 3-aminopropyltriethoxysilane (AFTES) or tetraethoxysilane (TEOS). The DNA-PCD-APTES hybrid material possessed a high water-stability. Additionally, the tensile strength of the hybrid material containing the APTES was approximately two times higher than that of hybrid material without the inorganic component. These chemical and physical properties were due to the formation of a siloxane network in the hybrid material and the electrostatic interaction between the phosphate group in the DNA and amino group in the AFTES. Furthermore, the DNA-PCD-APTES hybrid material could be immobilized on a glass filter by the coupling reaction to the silanol group in the filter. When an aqueous multi-component solution, which contained dibenzofuran, biphenyl, bisphenol A, diethylstilbestrol, and naphthalene, was applied to DNA-PCD-APTES hybrid filter, this filter could effectively accumulate various harmful compounds, such as dioxin, polychlorobiphenyl (PCB), and bisphenol A. Especially, the accumulation of diethylstilbestrol was extremely high and this value was approximately 85%. In contrast, DNA-PCD-TEOS hybrid, that was prepared by the mixing of TEOS without the amino groups, was a fragile material and could not use for the adsorbent of harmful compounds. (C) 2010 Elsevier BM. All rights reserved.
C1 [Yamada, Masanori; Tabuchi, Shinya] Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Okayama 7000005, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Fac Sci, Dept Chem, Kita Ku, Ridaicho, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU MEXT (Ministry of Education, Culture, Sports, Science and Technology of
   Japan); Wesco Scientific Promotion Foundation
FX This work was supported by matching fund subsidy for private
   universities from MEXT (Ministry of Education, Culture, Sports, Science
   and Technology of Japan). Additionally, the part of this work was
   supported by Wesco Scientific Promotion Foundation.
CR Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8
   BENDER ML, 1978, CYCRLODEXTRIN CHEM
   Coradin T, 2007, ACCOUNTS CHEM RES, V40, P819, DOI 10.1021/ar068129m
   Ehsan S, 2007, CHEMOSPHERE, V68, P150, DOI 10.1016/j.chemosphere.2006.12.018
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P469, DOI 10.1016/S0167-7799(00)01493-1
   Hollas M, 1998, J PHYS CHEM B, V102, P2947, DOI 10.1021/jp9800719
   Honma I, 2003, SOLID STATE IONICS, V162, P237, DOI 10.1016/S0167-2738(03)00260-1
   Ito N, 1996, J CHEM SOC PERK T 2, P965, DOI 10.1039/p29960000965
   Kandimalla VB, 2006, CHEM-EUR J, V12, P1074, DOI 10.1002/chem.200500178
   Kawahara M, 2000, ELECTROCHIM ACTA, V45, P1395, DOI 10.1016/S0013-4686(99)00349-7
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   Liu XD, 2008, CHEM SOC REV, V37, P2745, DOI 10.1039/b801433g
   Nishida A, 2004, B CHEM SOC JPN, V77, P1783, DOI 10.1246/bcsj.77.1783
   Plueddemann E., 1991, SILANE COUPLING AGEN
   SAENGER W, 1987, PRINCIPLES NUCL ACID
   Sainz-Rozas PR, 2005, J PHOTOCH PHOTOBIO A, V173, P248, DOI 10.1016/j.j.photochem.2005.04.022
   Satoh S, 2005, POLYM J, V37, P94, DOI 10.1295/polymj.37.94
   SEO T, 1987, MAKROMOL CHEM, V188, P2071
   Silverstein R. M., 1998, SPECTROMETRIC IDENTI
   TAKAHASHI K, 1984, TETRAHEDRON LETT, V25, P3331, DOI 10.1016/S0040-4039(01)81377-0
   TSO POP, 1964, P NATL ACAD SCI USA, V51, P17, DOI 10.1073/pnas.51.1.17
   Uragami T, 2004, BIOMACROMOLECULES, V5, P1567, DOI 10.1021/bm0498880
   Vince J, 2006, LANGMUIR, V22, P6489, DOI 10.1021/la060694a
   Wang ZJ, 2006, TALANTA, V69, P686, DOI 10.1016/j.talanta.2005.11.004
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2005, POLYMER, V46, P10102, DOI 10.1016/j.polymer.2005.07.086
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M., 2009, ANAL CHIM ACTA, V674, P249
   Yamada M, 2008, POLYMER, V49, P4658, DOI 10.1016/j.polymer.2008.08.027
   Yamada M, 2008, BIOMACROMOLECULES, V9, P3341, DOI 10.1021/bm800984p
NR 32
TC 4
Z9 4
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 15
PY 2011
VL 126
IS 1-2
BP 278
EP 283
DI 10.1016/j.matchemphys.2010.11.026
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 721JO
UT WOS:000287349600044
DA 2018-10-20
ER

PT J
AU Garrido, L
   Jimenez, I
   Ellis, G
   Cano, P
   Garcia-Martinez, JM
   Lopez, L
   de la Pena, E
AF Garrido, Leoncio
   Jimenez, Ignacio
   Ellis, Gary
   Cano, Pilar
   Garcia-Martinez, Jesus M.
   Lopez, Laura
   de la Pena, Enrique
TI Characterization of Surface-Modified Polyalkanoate Films for Biomedical
   Applications
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE gas plasma; poly(3-hydroxybutyrate-co-3-hydroxyvalerate); modification;
   substrate; biodegradable
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; BIODEGRADABLE MEDICAL
   DEVICES; OXYGEN PLASMA MODIFICATION; FREE-ENERGY; POLYMER SURFACES;
   CELL-ATTACHMENT; SMART BIOMATERIALS; MATERIALS SCIENCE; PHBV MATRICES;
   PMMA FILMS
AB Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) films prepared by solvent casting were treated with oxygen, argon, and nitrogen radiofrequency-generated plasmas. The analysis by attenuated total reflectance infrared spectroscopy and X-ray absorption near edge spectroscopy of modified surfaces showed an increase of hydroxyl and unsaturated groups, compared with unmodified surfaces. Water contact angles decreased after a short time of exposure (<30 s) for all types of plasma. At long exposure times (>30 s), the water contact angles appeared to be independent of treatment time for nitrogen and argon plasmas, whereas they continuously decreased for films treated with oxygen. HaCaT cultures on nontreated and treated PHBHV films showed that short plasma exposures of 10-20 s improve cell attachment to a greater extent than long exposure times habitually used in polymer surface plasma treatment. The film surface topology did not influence cell attachment. These results illustrate the importance of a detailed characterization of the surface physicochemistry in plasma-modified substrates designed as part of a strategy to optimize specific cell-biomaterial interactions. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 119: 3286-3296, 2011
C1 [Garrido, Leoncio; Ellis, Gary; Cano, Pilar; Garcia-Martinez, Jesus M.] CSIC, Inst Ciencia & Tecnol Polimeros, Madrid 28006, Spain.
   [Jimenez, Ignacio] CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
   [Lopez, Laura; de la Pena, Enrique] Fdn Hosp Alcorcon, Alcorcon 28922, Spain.
RP Garrido, L (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, Madrid 28006, Spain.
EM garrido@ictp.csic.es
RI Garrido, Leoncio/K-3092-2014; Garcia-Martinez, Jesus Maria/D-4837-2015;
   Jimenez, Ignacio/F-7422-2010; Ellis, Gary/C-1617-2010
OI Garrido, Leoncio/0000-0002-7587-1260; Garcia-Martinez, Jesus
   Maria/0000-0002-6541-4816; Jimenez, Ignacio/0000-0001-5605-3185; Ellis,
   Gary/0000-0003-4851-6092
FU Ministerio de Ciencia e Innovacion [CTQ2008-03229]; Instituto de Salud
   Carlos III [FIS PI05/2087, PI05/1947]; Ministerio de Ciencia e
   Innovacion (MICINN) [MAT2009-13625]; EU-FP6 "Research Infrastructure
   Action" [R II 3-CT-2004-506008]
FX Contract grant sponsor: the Ministerio de Ciencia e Innovacion; contract
   grant number: CTQ2008-03229.; Contract grant sponsor: the Instituto de
   Salud Carlos III; contract grant numbers: FIS PI05/2087, PI05/1947.;
   Contract grant sponsor: Ministerio de Ciencia e Innovacion (MICINN);
   contract grant number: MAT2009-13625.; Contract grant sponsor: the
   EU-FP6 "Research Infrastructure Action"; contract grant number: R II
   3-CT-2004-506008.
CR ADE H, 2002, CHEM APPL SYNCHROTRO, P285
   Alonso F, 2002, DIAM RELAT MATER, V11, P1161, DOI 10.1016/S0925-9635(01)00582-9
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Ariga K, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014109
   Banes AJ, 2003, FUNCTIONAL TISSUE ENGINEERING, P318, DOI 10.1007/0-387-21547-6_24
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Buchmeiser MR, 2009, J POLYM SCI POL CHEM, V47, P2219, DOI 10.1002/pola.23328
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   De Bartolo L, 2001, J MATER SCI-MATER M, V12, P959, DOI 10.1023/A:1012857031409
   Dhez O, 2003, J ELECTRON SPECTROSC, V128, P85, DOI 10.1016/S0368-2048(02)00237-2
   Eisenbarth E, 2007, ADV ENG MATER, V9, P1051, DOI 10.1002/adem.200700287
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   France RM, 1997, J CHEM SOC FARADAY T, V93, P3173, DOI 10.1039/a702311a
   Freier T., 2006, ADV POLYM SCI, V203, P1, DOI DOI 10.1007/12_073
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Hasirci V, 2003, J APPL POLYM SCI, V87, P1285, DOI 10.1002/app.11532
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   Hong S. G., 2006, E-POLYMERS, V1024, P1
   Kang IK, 2001, INT J BIOL MACROMOL, V28, P205, DOI 10.1016/S0141-8130(00)00165-3
   Kikuma J, 1996, J ELECTRON SPECTROSC, V82, P53, DOI 10.1016/S0368-2048(96)03049-6
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lucchesi C, 2008, J MATER SCI-MATER M, V19, P635, DOI 10.1007/s10856-007-0169-3
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Murphy MB, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P309, DOI 10.1016/B978-012370615-7/50026-3
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   Ozcan C, 2008, MACROMOL SYMP, V269, P128, DOI 10.1002/masy.200850916
   Ozcan C, 2007, J BIOMAT SCI-POLYM E, V18, P759, DOI 10.1163/156856207781034124
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   Saltzman WM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P279, DOI 10.1016/B978-012370615-7/50024-X
   Satriano C, 2003, NUCL INSTRUM METH B, V208, P287, DOI 10.1016/S0168-583X(03)00647-5
   Serrano F, 2007, BIOMATERIALS, V28, P650, DOI 10.1016/j.biomaterials.2006.09.018
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Urquhart SG, 2002, J PHYS CHEM B, V106, P8531, DOI 10.1021/jp0255379
   Wang YJ, 2006, J BIOMED MATER RES A, V76A, P589, DOI 10.1002/jbm.a.30575
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Wu Q, 2001, J APPL POLYM SCI, V82, P934, DOI 10.1002/app.1925.abs
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
NR 46
TC 11
Z9 11
U1 3
U2 22
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2011
VL 119
IS 6
BP 3286
EP 3296
DI 10.1002/app.32920
PG 11
WC Polymer Science
SC Polymer Science
GA 694QN
UT WOS:000285312800020
DA 2018-10-20
ER

PT J
AU Zhao, HY
   Feng, YK
   Guo, JT
AF Zhao, Haiyang
   Feng, Yakai
   Guo, Jintang
TI Grafting of Poly(ethylene glycol) Monoacrylate onto
   Polycarbonateurethane Surfaces by Ultraviolet Radiation Grafting
   Polymerization to Control Hydrophilicity
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; hydrophilic polymers; photopolymerization; polyurethanes;
   surface modification
ID PLATELET-ADHESION; VASCULAR GRAFTS; POLYURETHANE SURFACES; BLOOD
   COMPATIBILITY; ADSORPTION; DENSITY; PHOTOPOLYMERIZATION; IMMOBILIZATION;
   BIOMATERIALS; METHACRYLATE
AB In this study, we used a UV radiation grafting method to modify the surface of the biomaterial polycarbonateurethane (PCU). Hydrophilic poly(ethylene glycol) monoacrylate (PEGMA; number-average molecular weight = 526) as a macromolecular monomer was grafted onto the PCU surface by UV photopolymerization. The Fourier transform infrared and X-ray photoelectron spectroscopy results of the graft-modified PCU confirmed poly[poly(ethylene glycol) monoacrylate] block grafting onto the surface. We investigated the effects of the reaction temperature, macromolecular monomer concentration, UV irradiation time, and photoinitiator concentration on the grafting density (GD) in detail. Furthermore, we investigated the effects of GD under various process conditions on the water uptake and water contact angle. The modified materials had a high water uptake and low water contact angle, which indicated that the hydrophilicity of the PCU surface was improved significantly by the introduction of the hydrophilic poly(ethylene glycol) blocks on the surface. The anticoagulant properties of the material might also have been improved. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 119: 3717-3727, 2011
C1 [Zhao, Haiyang; Guo, Jintang] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
   [Feng, Yakai] Tianjin Univ, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China.
RP Feng, YK (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Weijin Rd 92, Tianjin 300072, Peoples R China.
EM yakaifeng@hotmail.com; jintang_guo@hotmail.com
RI feng, yakai/F-3854-2015
OI feng, yakai/0000-0002-4511-0874
FU Ministry of Education of People's Republic of China; Ministry of Science
   and Technology of China [2008DFA51170]; Scientific Research Foundation
   for the Returned Overseas Chinese Scholars, State Education Ministry
FX Contract grant sponsor: Program for New Century Excellent Talents in
   University, Ministry of Education of People's Republic of China.;
   Contract grant sponsor: International Cooperation from Ministry of
   Science and Technology of China; contract grant number: 2008DFA51170.;
   Contract grant sponsor: Scientific Research Foundation for the Returned
   Overseas Chinese Scholars, State Education Ministry.
CR Ajili SH, 2003, J APPL POLYM SCI, V89, P2496, DOI 10.1002/app.12180
   Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Cao Z, 2008, J APPL POLYM SCI, V109, P2316, DOI 10.1002/app.28305
   Chang Y, 2008, J MEMBRANE SCI, V309, P165, DOI 10.1016/j.memsci.2007.10.024
   Chen H, 2008, COLLOID SURFACE B, V61, P237, DOI 10.1016/j.colsurfb.2007.08.012
   Chen KY, 2000, BIOMATERIALS, V21, P161, DOI 10.1016/S0142-9612(99)00144-1
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   D'Arrigo P, 2007, INT J ARTIF ORGANS, V30, P133
   Damodaran VB, 2010, LANGMUIR, V26, P7299, DOI 10.1021/la9041502
   Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   Gutierrez-Villarreal MH, 2008, J APPL POLYM SCI, V110, P163, DOI 10.1002/app.28000
   He DM, 2009, PROG POLYM SCI, V34, P62, DOI 10.1016/j.progpolymsci.2008.08.004
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Iguerb O, 2008, SURF INTERFACE ANAL, V40, P386, DOI 10.1002/sia.2701
   Jo S, 2000, BIOMATERIALS, V21, P605, DOI 10.1016/S0142-9612(99)00224-0
   Joung YK, 2008, ACTA BIOMATER, V4, P960, DOI 10.1016/j.actbio.2008.02.008
   Jung IK, 2009, J BIOMAT SCI-POLYM E, V20, P1473, DOI 10.1163/092050609X12457419024109
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Korossis SA, 2000, BIO-MED MATER ENG, V10, P83
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Oh SJ, 2001, J COLLOID INTERF SCI, V238, P43, DOI 10.1006/jcis.2001.7491
   Pandiyaraj KN, 2009, MAT SCI ENG C-BIO S, V29, P796, DOI 10.1016/j.msec.2008.07.013
   Park KD, 1996, ASAIO J, V42, pM876, DOI 10.1097/00002480-199609000-00117
   Paul B, 2010, INT J CARDIOVAS IMAG, V26, P367, DOI 10.1007/s10554-009-9548-9
   Sebra RP, 2007, ACTA BIOMATER, V3, P151, DOI 10.1016/j.actbio.2006.07.010
   Stachowiak TB, 2006, CHEM MATER, V18, P5950, DOI 10.1021/cm0617034
   Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Vempaire D, 2005, PLASMA PHYS CONTR F, V47, pA153, DOI 10.1088/0741-3335/47/5A/011
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yang WT, 1996, MACROMOLECULES, V29, P3308, DOI 10.1021/ma9515543
   Yang WT, 1996, J APPL POLYM SCI, V62, P545, DOI 10.1002/(SICI)1097-4628(19961017)62:3<545::AID-APP12>3.0.CO;2-Y
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 41
TC 31
Z9 33
U1 0
U2 28
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2011
VL 119
IS 6
BP 3717
EP 3727
DI 10.1002/app.32997
PG 11
WC Polymer Science
SC Polymer Science
GA 694QN
UT WOS:000285312800070
DA 2018-10-20
ER

PT J
AU Kennedy, JE
   Higginbotham, CL
AF Kennedy, James E.
   Higginbotham, Clement L.
TI Synthesis and characterisation of styrene butadiene
   styrene-g-N-vinyl-2-pyrrolidinone for use in biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Block copolymer; Styrene butadiene styrene; N-vinyl-2-pyrrolidinone; UV
   polymerisation; Grafting
ID FREE-RADICAL COPOLYMERIZATION; SOLUTION POLYMERIZATION; GRAFTING
   REACTIONS; METHACRYLATE MONOMERS; BENZOYL PEROXIDE; ACRYLIC-ACID;
   RADIATION; INITIATOR; MEMBRANE; SOLVENTS
AB The current contribution investigates the potential use of styrene butadiene styrene (SBS) block copolymer grafted with N-vinyl-2-pyrrolidinone (NVP) for use as a novel biomaterial. SBS-g-NVP was synthesised using UV polymerisation and analytical techniques such as differential scanning calorimetry (DSC), attenuated total reflectance infrared Fourier transform spectrometry (ATR-FTIR), dynamic thermal mechanical analysis (DMTA) and goniometry were used to characterise the grafted copolymers. The ATR-FTIR spectrum for grafted SBS-g-NVP copolymer exhibits a shoulder at 1714 cm(-1), which is associated with carbonyl stretching of NVP. DSC analysis showed the grafted copolymers had broader thermographs within the butadiene rich domain resulting in increased T(g) values, suggesting that grafting occurred. Confirmation of this was established by the use of DMTA, where the T(g) (-90 degrees C) which represents the butadiene domain increased to -76 degrees C, thus proving grafting. The surface chemistries of the grafted copolymers have also been altered which is reflected in the goniometry results which show a dramatic reduction in contact angles (113 degrees to 70 degrees), which is a desired property for biomedical polymers. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kennedy, James E.; Higginbotham, Clement L.] Athlone Inst Technol, Mat Res Inst, Athlone, Westmeath, Ireland.
RP Higginbotham, CL (reprint author), Athlone Inst Technol, Mat Res Inst, Dublin Rd, Athlone, Westmeath, Ireland.
EM jkennedy@ait.ie; chigginbotham@ait.ie
FU National Development Plan, Ireland; National Development Enterprise,
   Ireland
FX This work has been funded by both the National Development Plan and
   Enterprise Ireland.
CR Cheryl L, 2002, POLYM J, V43, P823
   Devine DM, 2003, POLYMER, V44, P7851, DOI 10.1016/j.polymer.2003.10.017
   HUANG NJ, 1995, J POLYM SCI POL CHEM, V33, P2587, DOI 10.1002/pola.1995.080331505
   HUANG NJ, 1995, J POLYM SCI POL CHEM, V33, P2533, DOI 10.1002/pola.1995.080331502
   HUANG NJ, 1995, J POLYM SCI POL CHEM, V33, P2571, DOI 10.1002/pola.1995.080331504
   HUANG NJ, 1995, J POLYM SCI POL CHEM, V33, P2551, DOI 10.1002/pola.1995.080331503
   Jiang DD, 1998, EUR POLYM J, V34, P997, DOI 10.1016/S0014-3057(97)00222-X
   Kennedy JE, 2009, MAT SCI ENG C-BIO S, V29, P1655, DOI 10.1016/j.msec.2009.01.015
   Kennedy JE, 2009, J MATER SCI, V44, P889, DOI 10.1007/s10853-008-3156-2
   Kim JK, 2002, POLYMER, V43, P5005, DOI 10.1016/S0032-3861(02)00327-0
   Mateo JL, 2000, EUR POLYM J, V36, P1903, DOI 10.1016/S0014-3057(99)00260-8
   Munteanu SB, 2005, POLYM DEGRAD STABIL, V89, P501, DOI 10.1016/j.polymdegradstab.2005.01.037
   Murata H, 2004, SURF SCI, V570, P111, DOI 10.1016/j.susc.2004.06.185
   Muta H, 2002, POLYMER, V43, P103, DOI 10.1016/S0032-3861(01)00611-5
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Rohr T, 2003, ADV FUNCT MATER, V13, P264, DOI 10.1002/adfm.200304229
   Romero-Sanchez MD, 2005, INT J ADHES ADHES, V25, P19, DOI 10.1016/j.ijadhadh.2004.03.001
   Staeger M, 2002, APPL SURF SCI, V185, P231, DOI 10.1016/S0169-4332(01)00788-7
   Szaraz I, 2000, POLYMER, V41, P4831, DOI 10.1016/S0032-3861(99)00705-3
   Xiang ZC, 2001, CHEMMAG ORG, V3, P54
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   2005, INT J ADHESION ADHES, V25, P358
NR 24
TC 7
Z9 8
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 12
PY 2011
VL 31
IS 2
BP 246
EP 251
DI 10.1016/j.msec.2010.09.004
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 713AR
UT WOS:000286707900026
DA 2018-10-20
ER

PT J
AU Chen, CHD
   Chen, CC
   Shie, MY
   Huang, CH
   Ding, SJ
AF Chen, Chan-Hen David
   Chen, Chun-Cheng
   Shie, Ming-You
   Huang, Chiao-Hui
   Ding, Shinn-Jyh
TI Controlled release of gentamicin from calcium phosphate/alginate bone
   cement
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate; Bone cement; Alginate; Drug delivery
ID DRUG-DELIVERY SYSTEMS; SODIUM ALGINATE; STRENGTH; INJECTABILITY;
   VANCOMYCIN; COMPOSITE; INFECTION
AB Calcium phosphate cement (CPC) is a good biomaterial for bone defect repair and as a delivery system for active agents. The aim of this study was to explore the physicochemical properties and in vitro soaking and release behaviors of gentamicin-loaded CPC with and without alginate; in particular, for biocompatibility. MTT colorimetric assay and RT-PCR were used to detect U2OS cell viability and level of cyclooxygenase-2 (COX-2), respectively. As a result, the setting time increased after the addition of 0.5% alginate and 5% gentamicin, reaching 19 min-significantly higher than the 8 min taken by the CPC control, demonstrating the adverse effect of alginate and gentamicin on the setting reaction of CPC. Gentamicin might reduce the diametral tensile strength, while alginate did not affect the strength. The rate of gentamicin release from CPC can be extended by the presence of alginate. The addition of gentamicin did not show signs of impaired cell viability, but alginate enhanced the cell viability. COX-2 expression of U2OSs cultured in the alginate-containing cement extract was about one-third level of the cement extract without alginate. Alginate-containing CPC is not only useful as a reservoir for antibiotic delivery but it also helps stimulate bone regeneration. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
C1 [Huang, Chiao-Hui; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Biol & Biomat Sci, Taichung 402, Taiwan.
   [Chen, Chan-Hen David] Natl Chung Hsing Univ, Inst Vet Microbiol, Taichung 402, Taiwan.
   [Chen, Chun-Cheng; Ding, Shinn-Jyh] Chung Shan Med Univ, Sch Dent, Taichung 402, Taiwan.
   [Chen, Chun-Cheng; Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
   [Shie, Ming-You] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Oral Biol & Biomat Sci, Taichung 402, Taiwan.
EM sjding@csmu.edu.tw
FU National Science Council of the Republic of China [97-2221-E-005-078]
FX The authors acknowledge with appreciation the support of this research
   by the National Science Council of the Republic of China under the grant
   No. NSC 97-2221-E-005-078.
CR Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   Chen CC, 2010, J MATER SCI-MATER M, V21, P1057, DOI 10.1007/s10856-009-3948-1
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chiang TY, 2010, MATER CHEM PHYS, V120, P282, DOI 10.1016/j.matchemphys.2009.11.007
   Coon D, 2007, J ENDODONT, V33, P432, DOI 10.1016/j.joen.2006.12.001
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Dion A, 2005, BIOMATERIALS, V26, P4486, DOI 10.1016/j.biomaterials.2004.11.010
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P177, DOI 10.1023/A:1008989525461
   Fuji T, 2009, TISSUE ENG PT A, V15, P3525, DOI [10.1089/ten.tea.2009.0048, 10.1089/ten.TEA.2009.0048]
   Fung HB, 1999, CLIN THER, V21, P1131, DOI 10.1016/S0149-2918(00)80018-1
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   HONG YC, 1991, J BIOMED MATER RES, V25, P485, DOI 10.1002/jbm.820250406
   Ishikawa K, 1997, J BIOMED MATER RES, V36, P393, DOI 10.1002/(SICI)1097-4636(19970905)36:3<393::AID-JBM14>3.0.CO;2-F
   ISHIKAWA K, 1995, BIOMATERIALS, V16, P527, DOI 10.1016/0142-9612(95)91125-I
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Alves HLR, 2008, J MATER SCI-MATER M, V19, P2241, DOI 10.1007/s10856-007-3329-6
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Radin S, 1997, BIOMATERIALS, V18, P777, DOI 10.1016/S0142-9612(96)00190-1
   SAMPATH SS, 1990, J PHARM SCI, V79, P428, DOI 10.1002/jps.2600790514
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Shie MY, 2008, ACTA BIOMATER, V4, P646, DOI 10.1016/j.actbio.2007.10.011
   Son EW, 2001, ARCH PHARM RES, V24, P466, DOI 10.1007/BF02975195
   Tajima S, 2004, DENT MATER J, V23, P329, DOI 10.4012/dmj.23.329
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
   Wang XP, 2007, J BIOMED MATER RES B, V81B, P410, DOI 10.1002/jbm.b.30678
   Young AM, 2008, ACTA BIOMATER, V4, P1081, DOI 10.1016/j.actbio.2007.12.009
   Zhang Y, 2005, J BIOMED MATER RES A, V75A, P832, DOI 10.1002/jbm.a.30461
NR 32
TC 23
Z9 23
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 12
PY 2011
VL 31
IS 2
BP 334
EP 341
DI 10.1016/j.msec.2010.10.002
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 713AR
UT WOS:000286707900039
DA 2018-10-20
ER

PT J
AU Dulgar-Tulloch, AJ
   Bizios, R
   Siegel, RW
AF Dulgar-Tulloch, A. J.
   Bizios, R.
   Siegel, R. W.
TI Differentiation of human mesenchymal stem cells on nano- and micro-grain
   size titania
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Mesenchymal stem cells; Stem cell differentiation; Titania; Nanophase;
   Material chemistry; Topography
ID NANOPHASE CERAMICS; OSTEOBLAST ADHESION; BONE; PROLIFERATION;
   REGENERATION; OSTEOPONTIN; CULTURES; THERAPY; REPAIR
AB The current study investigated the osteogenic differentiation of human mesenchymal stem cells cultured on titania surfaces with grain sizes ranging from 50 to 1500 nm in either control or osteogenic medium. Characterization of osteogenic differentiation included quantification of the osteopontin and alkaline phosphatase expression by the cells, as well as of the content of calcium in the extracellular matrix. Mesenchymal stem cell differentiation was not observed on any of the grain sizes tested without dexamethasone and osteogenic-stimulating chemical agents (specifically, ascorbic acid and beta-glycerolphosphate) in the culture medium. Little-to-no mesenchymal stem cell differentiation was detected on the 50 nm substrates under osteogenic media. In contrast, osteogenic differentiation occurred earlier, and to greater extent, on the 200 nm grain size titania, compared to results obtained on either the 50 or 1500 nm grain sizes, or the glass (reference) surfaces, under osteogenic media. These results demonstrated that biomaterial substrate topography, such as ceramic grain size, affects mesenchymal stem cell differentiation in a size-dependent but, non-linear, manner. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Dulgar-Tulloch, A. J.; Siegel, R. W.] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
   [Bizios, R.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Dulgar-Tulloch, A. J.; Bizios, R.; Siegel, R. W.] Rensselaer Polytech Inst, Rensselaer Nanotechnol Ctr, Troy, NY 12180 USA.
RP Dulgar-Tulloch, AJ (reprint author), GE Global Res Ctr, 1 Res Circle,K1-5B28A, Niskayuna, NY 12309 USA.
EM dulgar@research.ge.com
FU Philip Morris USA; Nanoscale Science and Engineering Initiative of the
   National Science Foundation [DMR-0117792]
FX This work was supported by Philip Morris USA and by the Nanoscale
   Science and Engineering Initiative of the National Science Foundation
   under NSF Award Number DMR-0117792.
CR Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   CHEN Y, 1992, J BIOL CHEM, V267, P24871
   Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   DULGARTULLOCH AJ, 2005, MAT SCI ENG
   HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
NR 20
TC 6
Z9 6
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 12
PY 2011
VL 31
IS 2
BP 357
EP 362
DI 10.1016/j.msec.2010.10.010
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 713AR
UT WOS:000286707900042
DA 2018-10-20
ER

PT J
AU Shah, JS
   Venkatsurya, PKC
   Thein-Han, WW
   Misra, RDK
   Pesacreta, TC
   Somani, MC
   Karjalainen, LP
AF Shah, J. S.
   Venkatsurya, P. K. C.
   Thein-Han, W. W.
   Misra, R. D. K.
   Pesacreta, T. C.
   Somani, M. C.
   Karjalainen, L. P.
TI The role of nanocrystalline titania coating on nanostructured austenitic
   stainless steel in enhancing osteoblasts functions for regeneration of
   tissue
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Metal implant; Osteoblasts; Cell-culture proteins; Osseointegration
ID FERRITE COMPOSITE NANOPARTICLES; HIGH-PRESSURE TORSION; BIOMATERIAL
   SYSTEM; ANTIMICROBIAL ACTIVITY; PHOTOCATALYTIC SHELL; COTTON TEXTILES;
   OXIDE NANOTUBES; MAGNETIC CORE; IN-VITRO; FIBRONECTIN
AB In the context of osseointegration of metallic implants, while nanostructuring the surface favorably modulates cellular response, the disinfective attributes required during the healing process are not available. Thus, in the present study, we demonstrate that nanocrystalline titania provides cumulative benefit of enhancing osteoblasts functions to promote the efficacy of metal implants together with the disinfective attributes. To this end, the primary objective here is to examine the select functions of bone forming cells (osteoblasts) on electrocrystallized nanonodular titania-coated nanograined/ultrafine grained (NG/UFG) austenitic stainless steel. The accompanying objective is to study the disinfective/antimicrobial activity. To the best of our understanding this is the first study of nanophase titania on a non-titanium substrate. The osteoblasts functions were investigated in terms of cell attachment, proliferation, and quantitative analysis of proteins, actin and vinculin. In comparison to the bare NG/UFG substrate, the nanophase titania-coated substrate exhibited higher degree of cell attachment and proliferation which are regulated via cellular and molecular interactions with proteins, actin and vinculin. The enhanced functions of osteoblasts suggest that nanophase titania adsorbs extracellular matrix proteins, fibronectin and vitronectin from serum enhancing protein, with subsequent binding of integrins and osteoblasts precursor to titania. The antimicrobial attributes assessed in terms of degradation of methyl orange and effectiveness in killing E. coli supports the viewpoint that large surface area of titania would be instrumental in reducing the detrimental effect of biologically reactive oxygen species produced by macrophages in the vicinity of the metal bone/implant interface. In summary, the study provides some new insights concerning nanostructuring of metallic substrates with specific physical and surface properties for medical devices with significantly improved cellular response. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Shah, J. S.; Venkatsurya, P. K. C.; Thein-Han, W. W.; Misra, R. D. K.] Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
   [Pesacreta, T. C.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.
   Univ Oulu, Dept Mech Engn, Oulu 90014, Finland.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
RI Dom, Rekha/B-7113-2012; Karjalainen, Pentti/C-4763-2014
OI Karjalainen, Pentti/0000-0002-3206-9083
FU National Science Foundation [CMMI-0757799]
FX The materials processing part of the research was supported by Materials
   Manufacturing and Innovative program of National Science Foundation
   through Grant # CMMI-0757799.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arenas MA, 2000, BRIT CORROS J, V35, P232, DOI 10.1179/000705900101501308
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   El-Warrak AO, 2004, BMC MUSCULOSKEL DIS, V3, P5
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Faghihi S, 2007, ADV MATER, V19, P1069, DOI 10.1002/adma.200602276
   Globus RK, 1998, J CELL SCI, V111, P1385
   HARRIS GD, 1987, WATER RES, V21, P687, DOI 10.1016/0043-1354(87)90080-7
   Hukkanen M, 1998, CLIN ORTHOP RELAT R, P53
   HYNES RO, 1974, CELL, V3, P113, DOI 10.1016/0092-8674(74)90114-7
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Meilert KT, 2005, J MOL CATAL A-CHEM, V237, P101, DOI 10.1016/j.molcata.2005.03.040
   MEYER U, 1993, CELL MATER, V3, P129
   Misra RDK, 2010, ACTA BIOMATER, V6, P2826, DOI 10.1016/j.actbio.2009.12.017
   MISRA RDK, 2009, METALLURIGCAL MAT T, V40, P729
   NORDAHL J, 1995, CALCIFIED TISSUE INT, V57, P442, DOI 10.1007/BF00301948
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   OR S, 2006, J BIOMEDICAL MAT R A, V78, P97
   PUEBLO M, 2004, NATURE, V429, P620
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S., 2005, MAT SCI ENG C, VC119, P114
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rincon AG, 2001, J PHOTOCH PHOTOBIO A, V139, P233, DOI 10.1016/S1010-6030(01)00374-4
   Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Willmann G, 1999, ADV ENG MATER, V1, P95
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Yuranova T, 2006, J MOL CATAL A-CHEM, V244, P160, DOI 10.1016/j.molcata.2005.08.059
NR 41
TC 5
Z9 5
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 12
PY 2011
VL 31
IS 2
BP 458
EP 471
DI 10.1016/j.msec.2010.11.005
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA 713AR
UT WOS:000286707900056
DA 2018-10-20
ER

PT J
AU Wenk, E
   Merkle, HP
   Meinel, L
AF Wenk, Esther
   Merkle, Hans P.
   Meinel, Lorenz
TI Silk fibroin as a vehicle for drug delivery applications
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Silk Fibroin; Drug delivery; Kinetics; Growth factor; Gene
ID BOMBYX-MORI SILK; MESENCHYMAL STEM-CELLS; GENETICALLY-ENGINEERED SILK;
   FIBROBLAST-GROWTH-FACTOR; BIOMIMETIC NANOFIBROUS SCAFFOLDS; PROTEIN
   POLYMER HYDROGELS; IN-VIVO EVALUATION; CONTROLLED-RELEASE;
   MOLECULAR-WEIGHT; BIOMATERIAL COATINGS
AB Silk fibroin (SF), a naturally occurring protein polymer, has several unique properties making it a favorable matrix for the incorporation and delivery of a range of therapeutic agents. SF is biocompatible, slowly biodegradable, and endowed with excellent mechanical properties and processability. Novel manufacturing techniques including mild all-aqueous processes have expanded its range of application even to sensitive protein and nucleic acid therapeutics. SF matrices were demonstrated to successfully deliver protein drugs and preserve their potency. Adjustments in SF crystallinity, concentration and structure, the design of the delivery systems as well as the molecular weight and structure of the embedded agents represent important variables when it comes to precisely tailor the release kinetics of SF matrices. Other strategies to fine-tune the release from SF matrices comprise the embedment of drug loaded micro- or nanoparticles or the coating of micro- or nanoparticles with SF films. So far, the main focus of SF drug delivery systems has been on tissue regeneration applications. For instance, growth factor loaded SF scaffolds were suggested for the tissue engineering of bone and cartilage, as well as for vascular and nerve regeneration devices and wound healing products. Moreover, SF matrices were proposed for oral, transmucosal and ocular drug delivery. This article reviews SF properties and fabrication processes that affect the release from SF drug delivery systems. For illustration, we discuss a variety of examples for the incorporation of drugs into SF systems and their release. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Meinel, Lorenz] Univ Wurzburg, Fac Chem & Pharm, Inst Pharm & Food Chem, D-97070 Wurzburg, Germany.
   [Wenk, Esther; Merkle, Hans P.; Meinel, Lorenz] ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
RP Meinel, L (reprint author), Univ Wurzburg, Fac Chem & Pharm, Inst Pharm & Food Chem, D-97070 Wurzburg, Germany.
EM L.Meinel@pharmazie.uni-wuerzburg.de
RI Merkle, Hans/A-4381-2014; Meinel, Lorenz/D-9997-2015
OI Meinel, Lorenz/0000-0002-7549-7627
CR ACHARYA C, 2008, J BIOMATER APPL, V23, P497
   ALTMAN A, 2008, STEM CELLS, V27, P250
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bhrany AD, 2008, J TISSUE ENG REGEN M, V2, P365, DOI 10.1002/term.105
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brandenberger H, 1999, J ELECTROSTAT, V45, P227, DOI 10.1016/S0304-3886(98)00052-7
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CAPPELLO J, 1997, HDB BIODEGRADABLE PO, P387
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x
   Cresce AV, 2008, MOL PHARMACEUT, V5, P891, DOI 10.1021/mp800054w
   Dandu R, 2008, J BIOACT COMPAT POL, V23, P5, DOI 10.1177/0883911507085278
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413
   Dinbergs ID, 1996, J BIOL CHEM, V271, P29822, DOI 10.1074/jbc.271.47.29822
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Du CL, 2009, MAT SCI ENG C-BIO S, V29, P62, DOI 10.1016/j.msec.2008.05.010
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gohel MC, 2005, J PHARM PHARM SCI, V8, P76
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   Haugh JM, 1999, J BIOL CHEM, V274, P8958, DOI 10.1074/jbc.274.13.8958
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   HWANG D, 2008, INT J PHARMACEUT, V368, P215
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jeong L, 2009, INT J BIOL MACROMOL, V44, P222, DOI 10.1016/j.ijbiomac.2008.12.008
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   Kaplan David L., 1997, P103
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Katayama H, 2000, BIOL PHARM BULL, V23, P1229
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Kriegel C, 2008, CRIT REV FOOD SCI, V48, P775, DOI 10.1080/10408390802241325
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liebmann B, 2008, COLLOID SURFACE A, V331, P126, DOI 10.1016/j.colsurfa.2008.04.005
   Luo Y, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P359, DOI 10.1016/B978-012370615-7/50029-9
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   NAKAMURA S, 1994, ACS SYM SER, V544, P211
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nelson JL, 2002, CANCER RES, V62, P7280
   Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5
   Pace CN, 2004, PHILOS T ROY SOC B, V359, P1225, DOI 10.1098/rstb.2004.1500
   Pachence JM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P323, DOI 10.1016/B978-012370615-7/50027-5
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Parveen S, 2008, J DRUG TARGET, V16, P108, DOI [10.1080/10611860701794353, 10.1080/10611860701794353 ]
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHNEIDER A, 2008, ACTA BIOMATER, V5, P2570
   Seifert DB, 1997, BIOTECHNOL PROGR, V13, P562, DOI 10.1021/bp9700723
   Serp D, 2000, BIOTECHNOL BIOENG, V70, P41, DOI 10.1002/1097-0290(20001005)70:1<41::AID-BIT6>3.0.CO;2-U
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   SMITH JC, 1982, NATURE, V296, P154, DOI 10.1038/296154a0
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Srisuwan Y, 2009, J MACROMOL SCI A, V46, P521, DOI 10.1080/10601320902797780
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tanghetti E, 2002, ONCOGENE, V21, P3889, DOI 10.1038/sj.onc.1205407
   Tarvainen M, 2004, J CONTROL RELEASE, V96, P179, DOI 10.1016/j.jconrel.2004.01.016
   TREFILETTI V, 1980, MAKROMOL CHEM, V181, P1159
   TSUKADA M, 1994, J APPL POLYM SCI, V51, P823, DOI 10.1002/app.1994.070510505
   UEBERSAX L, 2008, THESIS ETH
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vincent TL, 2007, OSTEOARTHR CARTILAGE, V15, P752, DOI 10.1016/j.joca.2007.01.021
   Wamsley HL, 2005, TOXICOL PATHOL, V33, P577, DOI 10.1080/01926230500243060
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang X, 2008, J CONTROL RELEASE, V134, P81
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Xie F, 2006, INT J BIOL MACROMOL, V38, P284, DOI 10.1016/j.ijbiomac.2006.03.021
   YAN HB, 2008, J NANOPART RES
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
   Zilberman M, 2008, J BIOMATER APPL, V22, P391, DOI 10.1177/0885328207077591
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
   Zong XH, 2004, BIOCHEMISTRY-US, V43, P11932, DOI 10.1021/bi049455h
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 162
TC 201
Z9 210
U1 19
U2 245
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 10
PY 2011
VL 150
IS 2
BP 128
EP 141
DI 10.1016/j.jconrel.2010.11.007
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 752OG
UT WOS:000289701200002
PM 21059377
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Ruan, YH
   Lin, H
   Yao, JR
   Chen, ZR
   Shao, ZZ
AF Ruan, Yuhui
   Lin, Hong
   Yao, Jinrong
   Chen, Zhengrong
   Shao, Zhengzhong
TI Preparation of 3D Fibroin/Chitosan Blend Porous Scaffold for Tissue
   Engineering Via a Simplified Method
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; blends; chitosan; scaffolds; silk
ID MESENCHYMAL STEM-CELLS; SILK FIBROIN; IN-VITRO; BIOMATERIAL COATINGS;
   PHYSICAL-PROPERTIES; CHITOSAN SCAFFOLDS; CONTROLLED-RELEASE; CARTILAGE;
   PROLIFERATION; REGENERATION
AB In this work, we developed a simple and flexible method to manufacture a 3D porous scaffold based on the blend of regenerated silk fibroin (RSF) and chitosan (CS). No crosslinker or other toxic reagents were used in this method. The pores of resulted 3D scaffolds were connected with each other, and their sizes could be easily controlled by the concentration of the mixed solution. Compared with pure RSF scaffolds, the water absorptivities of these RSF/CS blend scaffolds with significantly enhanced mechanical properties were greatly increased. The results of MTT and RT-PCR tests indicated that the chondrocytes grew very well in these blend RSF/CS porous scaffolds. This suggested that the RSF/CS blend scaffold prepared by this new method could be a promising candidate for applications in tissue engineering.
C1 [Ruan, Yuhui; Yao, Jinrong; Shao, Zhengzhong] Fudan Univ, Adv Mat Lab, Dept Macromol Sci, Key Lab Mol Engn Polymers MOE, Shanghai 200433, Peoples R China.
   [Lin, Hong; Chen, Zhengrong] Fudan Univ, Zhongshan Hosp, Dept Orthopaed Surg, Shanghai 200032, Peoples R China.
RP Shao, ZZ (reprint author), Fudan Univ, Adv Mat Lab, Dept Macromol Sci, Key Lab Mol Engn Polymers MOE, Shanghai 200433, Peoples R China.
EM zzshao@fudan.edu.cn
RI Yao, Jinrong/J-7410-2012
FU National Natural Science Foundation of China (NSFC) [20974024,
   21034003]; Chinese Ministry of Science and Technology [2009CB930000]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC 20974024 and 21034003) and 973 Project of Chinese Ministry
   of Science and Technology (no. 2009CB930000). The authors thank Dr. Lei
   Huang for her review and suggestion.
CR Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Asawa Y, 2009, TISSUE ENG PT A, V15, P1109, DOI 10.1089/ten.tea.2007.0218
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Cho SH, 2005, J BIOMAT SCI-POLYM E, V16, P933, DOI 10.1163/1568562054414658
   Elsabee MZ, 2008, CARBOHYD POLYM, V71, P187, DOI 10.1016/j.carbpol.2007.05.022
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Guan JA, 2010, J APPL POLYM SCI, V118, P1658, DOI 10.1002/app.32579
   Haberhauer M, 2008, ADV MATER, V20, P2061, DOI 10.1002/adma.200701344
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Huang XT, 2007, ACTA CHIM SINICA, V65, P2592
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Ju YM, 2008, J BIOMED MATER RES A, V87A, P136, DOI 10.1002/jbm.a.31756
   Kang HG, 2006, J BIOMED MATER RES B, V79B, P388, DOI 10.1002/jbm.b.30553
   Khan AA, 2009, BIOTECHNOL PROGR, V25, P508, DOI [10.1021/bp.108, 10.1002/btpr.108]
   Kino-oka M, 2009, J BIOSCI BIOENG, V107, P544, DOI 10.1016/j.jbiosc.2008.12.018
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Liu L, 2008, ACTA CHIM SINICA, V66, P1919
   Ma K, 2009, BIOMATERIALS, V30, P3251, DOI 10.1016/j.biomaterials.2009.02.025
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2008, BONE, V43, P1122, DOI 10.1016/j.bone.2008.08.113
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Oliveira SM, 2009, TISSUE ENG PT A, V15, P625, DOI 10.1089/ten.tea.2008.0051
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   RENA YJ, 2009, INT J BIOL MACROMOL, V44, P372
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   She ZD, 2010, POLYM INT, V59, P55, DOI 10.1002/pi.2688
   She ZD, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045014
   Slovikova A, 2008, CHEM PAP, V62, P417, DOI 10.2478/s11696-008-0045-8
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   Tchemtchoua VT, 2009, ANAL BIOCHEM, V393, P145, DOI 10.1016/j.ab.2009.06.013
   Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867
   Wang HJ, 2005, J BIOMED MATER RES A, V74A, P523, DOI 10.1002/jbm.a.30232
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yu HY, 2008, J BIOMED MATER RES B, V86B, P541, DOI 10.1002/jbm.b.31054
   Zhu W, 2006, J APPL POLYM SCI, V99, P2375, DOI 10.1002/app.22674
   Zhu YX, 2009, J MATER SCI-MATER M, V20, P799, DOI 10.1007/s10856-008-3636-6
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 51
TC 14
Z9 14
U1 0
U2 34
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR 10
PY 2011
VL 11
IS 3
BP 419
EP 426
DI 10.1002/mabi.201000392
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 730LM
UT WOS:000288034800012
PM 21218404
DA 2018-10-20
ER

PT J
AU Guo, BL
   Finne-Wistrand, A
   Albertsson, AC
AF Guo, Baolin
   Finne-Wistrand, Anna
   Albertsson, Ann-Christine
TI Degradable and Electroactive Hydrogels with Tunable Electrical
   Conductivity and Swelling Behavior
SO CHEMISTRY OF MATERIALS
LA English
DT Article
DE degradable and conductive hydrogels; electroactive and biodegradable
   polymers; conductive polymers; tissue engineering
ID BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; ELECTROCONDUCTIVE
   HYDROGELS; PEG HYDROGELS; POLYMERS; PHOTOPOLYMERIZATION; POLYANILINE;
   ANILINE; ENCAPSULATION; POLYPYRROLE
AB Degradable electrically conducting hydrogels (DECHs), which combine the unique properties of degradable polymers and electrically conducting hydrogels, were synthesized by introducing biodegradable segments into conductive hydrogels. These DECHs were obtained by joining together the photopolymerized macromer acrylated poly(D,L-lactide)-poly(ethylene glycol)-poly(D,L-lactide) (AC-PLA-PEG-PLA-AC), glycidyl methacrylate (GMA), ethylene glycol dimethacrylate (EGDMA) network and aniline tetramer (AT) by the coupling reaction between AT and the GMA The electrical conductivity and swelling behavior of these DECHs were tuned by changing the AT content in the hydrogels, the cross-linking degree, and the environmental pH value. The good electroactivity and thermal stability of these hydrogels were demonstrated by UV-vis spectroscopy, cyclic voltammetry, and TGA tests. The chemical structure and morphology of these polymers were characterized by NMR, FT-IR, SEC, and SEM. These hydrogels possessing both degradability and electrical conductivity represent a new class of biomaterial and will lead to various new possibilities in biomedical applications.
C1 [Guo, Baolin; Finne-Wistrand, Anna; Albertsson, Ann-Christine] Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Sch Chem Sci & Engn, Dept Fibre & Polymer Technol, SE-10044 Stockholm, Sweden.
EM aila@polymer.kth.se
RI Guo, Baolin/L-6235-2018; Albertsson, Ann-Christine/Q-6107-2016; Guo,
   Baolin/A-1297-2011
OI Guo, Baolin/0000-0001-6756-1441; Albertsson,
   Ann-Christine/0000-0001-8696-9143; Guo, Baolin/0000-0001-6756-1441
FU Swedish Research Council [2008-5538]; China Scholarship Council (CSC);
   Royal Institute of Technology (KTH)
FX The authors thank the Swedish Research Council (Grant No. 2008-5538),
   the China Scholarship Council (CSC), and The Royal Institute of
   Technology (KTH) for financial support for this work.
CR Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Andreopoulos FM, 1996, J AM CHEM SOC, V118, P6235, DOI 10.1021/ja954117c
   Asoh TA, 2008, ADV MATER, V20, P2080, DOI 10.1002/adma.200702727
   Brahim S, 2002, BIOSENS BIOELECTRON, V17, P53, DOI 10.1016/S0956-5663(01)00262-7
   Brahim S, 2005, ELECTROANAL, V17, P556, DOI 10.1002/elan.200403109
   Chen R, 2003, MACROMOLECULES, V36, P6333, DOI 10.1021/ma030033+
   Chen YJ, 2000, J PHYS CHEM B, V104, P9171, DOI 10.1021/jp000152g
   Chen YJ, 2001, MACROMOLECULES, V34, P3133, DOI 10.1021/ma0008589
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Ferris CJ, 2009, SOFT MATTER, V5, P3430, DOI 10.1039/b909795c
   Gabriel S, 2007, CHEM MATER, V19, P2364, DOI 10.1021/cm062450h
   Gopalan AI, 2009, BIOMATERIALS, V30, P5999, DOI 10.1016/j.biomaterials.2009.07.047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   GUISEPPIELIE A, 1997, POLYM PREPRINTS, V38, P608
   Guo BL, 2010, MACROMOLECULES, V43, P4472, DOI 10.1021/ma100530k
   Guo BL, 2010, BIOMACROMOLECULES, V11, P855, DOI 10.1021/bm9011248
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Hou Y, 2008, BIOMATERIALS, V29, P3175, DOI 10.1016/j.biomaterials.2008.04.024
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   Jana T, 2001, LANGMUIR, V17, P5768, DOI 10.1021/la010253l
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Justin G, 2009, BIOMACROMOLECULES, V10, P2539, DOI 10.1021/bm900486d
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee WC, 2006, MACROMOL BIOSCI, V6, P846, DOI 10.1002/mabi.200600101
   Luo W, 2010, J AM CHEM SOC, V132, P2614, DOI 10.1021/ja907187f
   Malberg S, 2010, CHEM MATER, V22, P3009, DOI 10.1021/cm100520j
   Marcasuzaa P, 2010, BIOMACROMOLECULES, V11, P1684, DOI 10.1021/bm100379z
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   MILLER LL, 1987, J AM CHEM SOC, V109, P2267, DOI 10.1021/ja00242a006
   MILLER LL, 1988, MOL CRYST LIQ CRYST, V160, P297, DOI 10.1080/15421408808083024
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Niple JC, 2004, BIOELECTROMAGNETICS, V25, P369, DOI 10.1002/bem.20000
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Parsa A, 2009, ELECTROCHIM ACTA, V54, P2856, DOI 10.1016/j.electacta.2008.11.022
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quigley AF, 2009, ADV MATER, V21, P4393, DOI 10.1002/adma.200901165
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Roos AA, 2008, BIOMACROMOLECULES, V9, P2104, DOI 10.1021/bm701399m
   Rozalska I, 2004, NEW J CHEM, V28, P1235, DOI 10.1039/b404828h
   Ryner M, 2002, J POLYM SCI POL CHEM, V40, P2049, DOI 10.1002/pola.10304
   Small CJ, 1997, POLYM GELS NETW, V5, P251, DOI 10.1016/S0966-7822(96)00044-5
   Sun ZC, 2002, CHEM J CHINESE U, V23, P496
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Voepel J, 2009, J POLYM SCI POL CHEM, V47, P3595, DOI 10.1002/pola.23444
   Wang HF, 2006, MACROMOL RAPID COMM, V27, P63, DOI 10.1002/marc.200500601
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yang ZF, 2010, LANGMUIR, V26, P9386, DOI 10.1021/la100382s
   Yousaf MN, 2001, ANGEW CHEM INT EDIT, V40, P1093, DOI 10.1002/1521-3773(20010316)40:6<1093::AID-ANIE10930>3.3.CO;2-H
   Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
NR 54
TC 94
Z9 95
U1 11
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR 8
PY 2011
VL 23
IS 5
BP 1254
EP 1262
DI 10.1021/cm103498s
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 726ZP
UT WOS:000287767200025
DA 2018-10-20
ER

PT J
AU Elices, M
   Guinea, GV
   Plaza, GR
   Karatzas, C
   Riekel, C
   Agullo-Rueda, F
   Daza, R
   Perez-Rigueiro, J
AF Elices, M.
   Guinea, G. V.
   Plaza, G. R.
   Karatzas, C.
   Riekel, C.
   Agullo-Rueda, F.
   Daza, R.
   Perez-Rigueiro, J.
TI Bioinspired Fibers Follow the Track of Natural Spider Silk
SO MACROMOLECULES
LA English
DT Article
ID DRAGLINE SILK; BOMBYX-MORI; SUPERCONTRACTION STRESS;
   MECHANICAL-PROPERTIES; PROTEIN; FIBROIN; BEHAVIOR; ORGANIZATION;
   BIOMATERIAL; ORIENTATION
AB The mechanical behavior and microstructure of bioinspired fibers spun from solutions of recombinant spidroin-like proteins were extensively characterized, and compared with those of natural spider silk. fibers. It is confirmed that high performance bioinspired fibers indistinguishable from natural spider silk up to large strains can be produced through genetic engineering and conventional spinning technologies. It is also found that fibers spun from spidroin-like proteins that contain different motifs of sequence exhibit variations in their microstructure in terms of crystallinity and chain alignment, but these differences are not reflected in distinct tensile properties. This similarity in terms of their mechanical behavior indicates that bioinspired fibers are largely independent of their exact sequence of recombinant proteins and, in particular, of their proline content. Finally, it is shown that the largest differences between natural and bioinspired fibers are found at very large deformations, marking the ultimate challenge in the synthesis of silk-like fibers.
C1 [Elices, M.; Guinea, G. V.; Plaza, G. R.; Daza, R.; Perez-Rigueiro, J.] Univ Politecn Madrid, Dept Ciencia Mat, ETSI Caminos Canales & Puertos, E-28040 Madrid, Spain.
   [Karatzas, C.] Nexia Biotechnol Inc, Vaudreuil Dorion, PQ J7V 8P5, Canada.
   [Riekel, C.] European Synchroton Radiat Facil, F-38043 Grenoble, France.
   [Agullo-Rueda, F.] CSIC, Inst Ciencia Mat, E-28049 Madrid, Spain.
RP Perez-Rigueiro, J (reprint author), Univ Politecn Madrid, Dept Ciencia Mat, ETSI Caminos Canales & Puertos, E-28040 Madrid, Spain.
RI GUINEA TORTUERO, GUSTAVO VICTOR/N-1241-2014; Elices, Manuel/F-7703-2016;
   Plaza, Gustavo R./E-4455-2012; Agullo-Rueda, Fernando/A-8889-2008; Daza,
   Rafael/H-4825-2015
OI GUINEA TORTUERO, GUSTAVO VICTOR/0000-0002-4326-3746; Elices,
   Manuel/0000-0002-8204-1580; Plaza, Gustavo R./0000-0002-5555-5498;
   Agullo-Rueda, Fernando/0000-0001-9211-1987; 
FU Ministerio de Ciencia e Innovacion (Spain) [MAT 2009-10258]; Comunidad
   de Madrid [MADR.IB-CM/S-SAL/0312/2006]; Fundacion Marcelino Botin
FX The authors would like to thank Dr. Andrew Rodenhiser for the production
   of the recombinant fibers. Ultramicrotomy was performed by E. Baldonedo
   (Centro de Microscopia Electronica, Universidad Complutense de Madrid,
   Spain). Dr. A. Gil and L. Colchero (Nanotec Electronica S.L., Madrid,
   Spain) offered support for the AFM observations. The authors are
   grateful to Jose Miguel Martinez for his help with the artwork. This
   work was funded by the Ministerio de Ciencia e Innovacion (Spain) (Grant
   MAT 2009-10258), by Comunidad de Madrid (Grant
   MADR.IB-CM/S-SAL/0312/2006) and by Fundacion Marcelino Botin.
CR ARNOTT S, 1967, J MOL BIOL, V30, P201, DOI 10.1016/0022-2836(67)90252-5
   ASKARIEH G, 2010, NATURE, P236
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bell FI, 2002, NATURE, V416, P37, DOI 10.1038/416037a
   Buehler MJ, 2010, NANO TODAY, V5, P379, DOI 10.1016/j.nantod.2010.08.001
   BUEHLER MJ, 2010, NATURE NANOTECHNOL, V3, P172
   CHAWLA K. K., 1998, FIBROUS MAT
   Elices M, 2004, J APPL POLYM SCI, V92, P3537, DOI 10.1002/app.20383
   ELICES M, 2009, BIOMACROMOLECULES, V7, P1904
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FU CJ, 2009, MACROMOLECULES, V20, P7877
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Garcia R, 1999, PHYS REV B, V60, P4961, DOI 10.1103/PhysRevB.60.4961
   Garrido MA, 2002, POLYMER, V43, P4495, DOI 10.1016/S0032-3861(02)00254-9
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gosline J. M., 1994, SILK POLYM MAT SCI B, P328
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   Grubb DT, 1999, INT J BIOL MACROMOL, V24, P203, DOI 10.1016/S0141-8130(98)00086-5
   Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   HAGN F, 2010, NATURE, P239
   Hardy J.G., 2008, POLYMER, V20, P4309
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   HORCAS I, 2007, REV SCI INSTRUM, P1
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Kaplan D.L., 1991, BIOMATERIALS NOVEL M, P53
   KARATZAS CN, 2005, BIOTECHNOLOGY BIOPOL, V2, P945
   Keten S., 2010, J R SOC INTERFACE, V53, P1709
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Lock RL, 1993, Patent, Patent No. 5252285
   Marsano E, 2005, INT J BIOL MACROMOL, V37, P179, DOI 10.1016/j.ijbiomac.2005.10.005
   Marsh R.E., 1955, BIOCHIM BIOPHYS ACTA, V1, P1
   Matsumoto K, 1996, J APPL POLYM SCI, V60, P503, DOI 10.1002/(SICI)1097-4628(19960425)60:4<503::AID-APP3>3.0.CO;2-S
   Nova A., 2010, NANO LETT, V7, P2626
   PELLERIN C, 2005, MACROMOL S, P85
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Perez-Rigueiro J, 2003, POLYMER, V44, P3733, DOI 10.1016/S0032-3861(03)00245-3
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Perez-Rigueiro J., 2009, INT J BIOL MACROMOL, V2, P195
   Perez-Rigueiro J, 2007, MACROMOLECULES, V40, P5360, DOI 10.1021/ma070478o
   PEREZRIGUEIRO J, 2010, INT J BIOL MACROMOL, P555
   PEREZRIGUEIRO J, 2001, J APPL POLYM SCI, V9, P2245
   Plaza G.R., 2008, J APPL POLYM SCI, V3, P1793
   Plaza G.R., 2009, MACROMOLECULES, V22, P8977
   Plaza GR, 2006, J POLYM SCI POL PHYS, V44, P994, DOI 10.1002/polb.20751
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Riekel C, 2001, INT J BIOL MACROMOL, V29, P203, DOI 10.1016/S0141-8130(01)00166-0
   Riekel C, 1999, INT J BIOL MACROMOL, V24, P179, DOI 10.1016/S0141-8130(98)00084-1
   Riekel C, 2008, APPL SYNCHROTRON LIG, P91
   Rousseau ME, 2009, BIOMACROMOLECULES, V10, P2945, DOI 10.1021/bm9007919
   Rousseau ME, 2004, BIOMACROMOLECULES, V5, P2247, DOI 10.1021/bm049717V
   Sapede D, 2005, MACROMOLECULES, V38, P8447, DOI 10.1021/ma0507995
   Savage KN, 2004, BIOMACROMOLECULES, V5, P675, DOI 10.1021/bm034270w
   SAVAGE KN, 2008, J EXP BIOL, V12, P1937
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Termonia Y, 2000, STRUCTURAL BIOL MAT, P335
   Um IC, 2004, INT J BIOL MACROMOL, V34, P107, DOI 10.1016/j.ijbiomac.2004.03.011
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   WORK RW, 1982, TEXT RES J, V52, P349, DOI 10.1177/004051758205200508
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z
NR 73
TC 40
Z9 42
U1 1
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 8
PY 2011
VL 44
IS 5
BP 1166
EP 1176
DI 10.1021/ma102291m
PG 11
WC Polymer Science
SC Polymer Science
GA 727BV
UT WOS:000287773200009
DA 2018-10-20
ER

PT J
AU Daneshmandi, S
   Hajimoradi, M
   Soleimani, N
   Sattari, M
AF Daneshmandi, Saeed
   Hajimoradi, Monire
   Soleimani, Neda
   Sattari, Morteza
TI Modulatory effect of Acetobacter xylinum cellulose on peritoneal
   macrophages
SO IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
LA English
DT Article
DE Bacterial cellulose; macrophages; nitric oxide; MTT; TNF-alpha
ID BACTERIAL CELLULOSE; NITRIC-OXIDE; BIOMATERIALS; COMPOSITE; CELLS; ASSAY
AB Materials and methods: Mice peritoneal macrophages were lavaged and co-cultured with various concentrations of BC in microtiter plate. Viability of macrophages was determined by MTT assay. Nitric oxide (NO) amount was detected in culture supernatants of macrophages by Griess reagent and cytotoxicity effect of culture supernatants on WEHI-164 cells as tumor necrosis factor alpha alpha (TNF-alpha alpha) bioassay were done.
   Results: MTT assay for stimulated macrophages was not different (p == 0.486) and amount of NO production in all doses was the same as unstimulated control macrophages (p == 0.057). Supernatant of macrophages stimulated with 0.01 mg/mL of BC had cytotoxic effect on WEHI-164 fibrosarcoma cells (p = 0.040).
   Conclusion: In this study, we showed that BC had no effect on macrophages viability and amount of NO production. BC suppressed the release of TNF-alpha alpha from macrophages innate immune cells as indication of beneficial effect on wound healing. This data and further studies would imply use of this biomaterial for more applications.
C1 [Soleimani, Neda; Sattari, Morteza] Tarbiat Modares Univ, Sch Med Sci, Dept Bacteriol, Tehran, Iran.
   [Daneshmandi, Saeed; Hajimoradi, Monire] Tarbiat Modares Univ, Sch Med Sci, Dept Immunol, Tehran, Iran.
RP Sattari, M (reprint author), Tarbiat Modares Univ, Sch Med Sci, Dept Bacteriol, Tehran, Iran.
EM Sattarim@modares.ac.ir
OI soleimani, neda/0000-0003-0803-9818
FU Bacteriology Department, School of Medical Sciences, Tarbiat Modares
   University
FX This work was done as a grant of Bacteriology Department, School of
   Medical Sciences, Tarbiat Modares University.
CR Amorim Wander Lopes, 2009, Braz J Otorhinolaryngol, V75, P200
   Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x
   Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   BROWNETRIS M, 2003, WOUND REPAIR REGEN, V11, P1
   Cho MK, 2003, INT IMMUNOPHARMACOL, V3, P1429, DOI 10.1016/S1567-5769(03)00141-3
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   ESKANDARI MK, 1990, IMMUNOL INVEST, V19, P69, DOI 10.3109/08820139009042026
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   LIN FC, 1985, SCIENCE, V230, P822, DOI 10.1126/science.230.4727.822
   LINDE A, 1993, J PERIODONTOL, V64, P1116, DOI 10.1902/jop.1993.64.11s.1116
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   MENDENHALL HV, 1999, HDB BIOMATERIALS EVA, P481
   Mendes PN, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-12
   Panerari Angelo D'urso, 2008, Braz J Otorhinolaryngol, V74, P512
   Rezaee A, 2005, AM J BIOCH BIOTECHNO, V1, P121, DOI [10.3844/ajbbsp.2005.121.124, DOI 10.3844/AJBBSP.2005.121.124]
   SCHONFELDER U, 2004, 2 WORLD UN WOUND HEA
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Scuro Loren S., 2004, BMC Biochemistry, V5, P5, DOI 10.1186/1471-2091-5-5
   SLADOWSKI D, 1993, J IMMUNOL METHODS, V157, P203, DOI 10.1016/0022-1759(93)90088-O
   STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543
   Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001
   Wiegand C, 2006, CELLULOSE, V13, P689, DOI 10.1007/s10570-006-9073-0
   Yager Dorne R., 1997, Wound Repair and Regeneration, V5, P23, DOI 10.1046/j.1524-475X.1997.50108.x
NR 28
TC 4
Z9 4
U1 0
U2 3
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0892-3973
J9 IMMUNOPHARM IMMUNOT
JI Immunopharmacol. Immunotoxicol.
PD MAR
PY 2011
VL 33
IS 1
SI 1
BP 164
EP 168
DI 10.3109/08923973.2010.491080
PG 5
WC Immunology; Pharmacology & Pharmacy; Toxicology
SC Immunology; Pharmacology & Pharmacy; Toxicology
GA 717ZL
UT WOS:000287087800023
PM 20536339
DA 2018-10-20
ER

PT J
AU Baino, F
AF Baino, Francesco
TI Towards an ideal biomaterial for vitreous replacement: Historical
   overview and future trends
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Vitreous substitution; Silicone oil; Perfluorocarbons; Hydrogels;
   Retinal detachment
ID COMPLICATED RETINAL-DETACHMENT; ADVANCED PROLIFERATIVE
   VITREORETINOPATHY; HEAVY SILICONE OIL; PERFLUORO-N-OCTANE; INTERNAL
   TAMPONADE AGENT; PARS-PLANA VITRECTOMY; CROSS-LINKED
   POLY(1-VINYL-2-PYRROLIDINONE); MASSIVE PRERETINAL RETRACTION;
   FLUOROSILICONE COPOLYMER OIL; RANDOMIZED CLINICAL-TRIAL
AB Removal of the natural vitreous body from the eye and its substitution with a tamponade agent may be necessary in cases of complicated retinal detachment. Many materials have been variously proposed and tested over the years in an attempt to find an ideal vitreous substitute. This review highlights the evolution of research in the field of vitreous replacement and chronicles the main advances that have been made in such a context. The suitability and limitations of vitreous tamponade agents and substitutes in current clinical use are examined, and the future promise of experimentally tested biomaterials are described and discussed. Future trends in research are also considered and, specifically, the great potential of polymeric hydrogels is emphasized, as they seem to be very effective in closely mimicking the features of the natural vitreous and they could successfully act as long-term vitreous substitutes without inducing clinical complications in the patient's eye. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
RP Baino, F (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM francesco.baino@polito.it
OI Baino, Francesco/0000-0001-8860-0497
CR ALGVERE PV, 1992, ACTA OPHTHALMOL, V70, P632
   Aliyar HA, 2004, POLYM PREPR, V45, P469
   ANDO F, 1986, GRAEF ARCH CLIN EXP, V224, P32, DOI 10.1007/BF02144129
   ANDO F, 1985, AM J OPHTHALMOL, V99, P87, DOI 10.1016/S0002-9394(14)75878-7
   [Anonymous], 109935 ISO
   ARAIZ JJ, 1993, INVEST OPHTH VIS SCI, V34, P522
   Auriol S, 2008, GRAEF ARCH CLIN EXP, V246, P1383, DOI 10.1007/s00417-008-0876-6
   AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P770
   AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780
   Baino F, 2010, POLYMERS-BASEL, V2, P286, DOI 10.3390/polym2030286
   BALAZS EA, 1966, BIBL OPHTHALMOL, P230
   Batman C, 1998, OPHTHALMIC SURG LAS, V29, P144
   BEEKHUIS WH, 1987, BRIT J OPHTHALMOL, V71, P197, DOI 10.1136/bjo.71.3.197
   Benlian W., 1991, POLYM BIOMATERIALS, P397
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   BOCHOW TW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1723, DOI 10.1001/archopht.1992.01080240063031
   BORISLAV D, 1993, DOC OPHTHALMOL, V83, P79, DOI 10.1007/BF01203573
   BOTTONI F, 1993, GRAEF ARCH CLIN EXP, V231, P619, DOI 10.1007/BF00921955
   BRINTON DA, 2009, RETINAL DETACHMENT P
   BYER NE, 1994, OPHTHALMOLOGY, V101, P1503
   Caramoy A, 2010, BRIT J OPHTHALMOL, V94, P509, DOI 10.1136/bjo.2009.170852
   Cavalieri F, 2004, BIOMACROMOLECULES, V5, P2439, DOI 10.1021/bm049654g
   CHAN IM, 1984, RETINA-J RET VIT DIS, V4, P51, DOI 10.1097/00006982-198400410-00009
   CHANG S, 1985, OPHTHALMOLOGY, V92, P651
   CHANG S, 1988, AM J OPHTHALMOL, V106, P668, DOI 10.1016/0002-9394(88)90698-8
   CHANG S, 1987, AM J OPHTHALMOL, V103, P29, DOI 10.1016/S0002-9394(14)74165-0
   Chang TS, 2003, OPHTHALMOLOGY, V110, P589, DOI 10.1016/S0161-6420(02)01896-1
   Chirila T V, 1994, J Biomater Appl, V9, P121
   CHIRILA TV, 1995, CELL MATER, V5, P83
   Chirila TV, 1998, POLYM INT, V46, P183, DOI 10.1002/(SICI)1097-0126(199807)46:3<183::AID-PI941>3.3.CO;2-0
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   CHIRILA TV, 1998, HDB BIOMATERIAL PROP, P125
   Chuo JY, 2006, AM J OPHTHALMOL, V142, P931, DOI 10.1016/j.ajo.2006.08.002
   CIBIS PA, 1962, ARCH OPHTHALMOL-CHIC, V68, P590
   CIBIS PA, 1965, VITREORETINAL PATHOL
   Ciulla TA, 1998, SURV OPHTHALMOL, V43, P134, DOI 10.1016/S0039-6257(98)00014-9
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   CONSTABLE IJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P416
   CONWAY MD, 1993, INT OPHTHALMOL, V17, P259, DOI 10.1007/BF01007793
   COX MS, 1986, OPHTHALMOLOGY, V93, P646
   CRITTENDEN JJ, 1985, ARCH OPHTHALMOL-CHIC, V103, P831, DOI 10.1001/archopht.1985.01050060091032
   CUTLER N L, 1947, Trans Am Acad Ophthalmol Otolaryngol, V51, P253
   Dailey JP, 1999, J MAGN MAGN MATER, V194, P140, DOI 10.1016/S0304-8853(98)00562-9
   Dalton PD, 1995, POLYM GELS NETW, V3, P429, DOI 10.1016/0966-7822(94)00011-5
   DAMICO DJ, 1994, NEW ENGL J MED, V331, P95, DOI 10.1056/NEJM199407143310207
   DANIELE S, 1968, ARCH OPHTHALMOL-CHIC, V80, P120, DOI 10.1001/archopht.1968.00980050122020
   DAVIDORF FH, 1990, RETINA-J RET VIT DIS, V10, P297, DOI 10.1097/00006982-199010000-00013
   De Jong C., 2000, B SOC BELG OPHTHALM, P71
   DEQUEIROZ JM, 1992, RETINA-J RET VIT DIS, V12, pS33, DOI 10.1097/00006982-199212031-00008
   DESAI UR, 1992, OPHTHALMOLOGY, V99, P1542
   DEUTSCHMANN R, 1906, KLIN MONATSBL AUGENH, V44, P364
   Díaz-Llopis M., 2007, Arch Soc Esp Oftalmol, V82, P465
   DOI M, 1994, EXP EYE RES, V59, P737, DOI 10.1006/exer.1994.1160
   DOI M, 1995, EXP EYE RES, V61, P469, DOI 10.1016/S0014-4835(05)80142-3
   DUNN MW, 1969, ARCH OPHTHALMOL-CHIC, V82, P840
   Elschnig A., 1912, GRAEFES ARCH OPHTHAL, V80, P514
   Er H, 2010, OPHTHALMOLOGICA, V224, P122, DOI 10.1159/000235926
   FEDERMAN JL, 1990, OPHTHALMOLOGY, V97, P1305
   FEDERMAN JL, 1988, OPHTHALMOLOGY, V95, P870
   FERNANDEZVIGO J, 1990, J OCUL PHARMACOL, V6, P137, DOI 10.1089/jop.1990.6.137
   FERNANDEZVIGO J, 1990, RETINA-J RET VIT DIS, V10, P148, DOI 10.1097/00006982-199004000-00012
   FLORESAGUILAR M, 1995, RETINA-J RET VIT DIS, V15, P3
   FOSTER RE, 1994, AM J OPHTHALMOL, V118, P253, DOI 10.1016/S0002-9394(14)72909-5
   Foster WJ, 2006, J BIOACT COMPAT POL, V21, P221, DOI 10.1177/0883911506064368
   Fuller DG, 1982, PRESURGICAL EVALUATI
   Garcia-Valenzuela E, 2004, RETINA-J RET VIT DIS, V24, P746, DOI 10.1097/00006982-200410000-00010
   GILBERT C, 1985, BRIT J OPHTHALMOL, V69, P733, DOI 10.1136/bjo.69.10.733
   Giordano GG, 1998, PROG POLYM SCI, V23, P509, DOI 10.1016/S0079-6700(97)00046-4
   GLASER BM, 1986, OPHTHALMOLOGY, V93, P1193
   Gloor B.P., 1987, ADLERS PHYSL EYE CLI, P246
   GOMBOS GM, 1967, ACTA OPHTHALMOL, V45, P794
   GONVERS M, 1985, AM J OPHTHALMOL, V100, P239, DOI 10.1016/0002-9394(85)90788-3
   GONVERS M, 1990, GRAEF ARCH CLIN EXP, V228, P415, DOI 10.1007/BF00927253
   GRAFTON EG, 1948, AM J OPHTHALMOL, V31, P299, DOI 10.1016/0002-9394(48)91156-8
   GREMILLION CM, 1990, BRIT J OPHTHALMOL, V74, P643, DOI 10.1136/bjo.74.11.643
   GREY RHB, 1979, BRIT J OPHTHALMOL, V63, P355, DOI 10.1136/bjo.63.5.355
   Hamilton PD, 2004, INVEST OPHTH VIS SCI, V45, pU707
   HAYANO S, 1959, RINSHO GANKA, V13, P449
   Heimann H, 2008, EYE, V22, P1342, DOI 10.1038/eye.2008.61
   HEIMANN K, 1989, GRAEF ARCH CLIN EXP, V227, P152, DOI 10.1007/BF02169789
   HILTON GF, 1986, OPHTHALMOLOGY, V93, P626
   HOGENESCH TE, 1976, J BIOMED MATER RES, V10, P975, DOI 10.1002/jbm.820100615
   Holekamp NM, 2010, AM J OPHTHALMOL, V149, P32, DOI 10.1016/j.ajo.2009.07.036
   Hong Y, 1998, J BIOMED MATER RES, V39, P650, DOI 10.1002/(SICI)1097-4636(19980315)39:4<650::AID-JBM21>3.0.CO;2-9
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   Hong Y, 1996, J BIOMATER APPL, V11, P135, DOI 10.1177/088532829601100202
   HRUBY K, 1961, Klin Monbl Augenheilkd Augenarztl Fortbild, V138, P484
   Imamura Y, 2003, BRIT J OPHTHALMOL, V87, P563, DOI 10.1136/bjo.87.5.563
   Irvine AR, 1997, BRIT J OPHTHALMOL, V81, P180, DOI 10.1136/bjo.81.3.180
   Itoh R, 1999, OPHTHALMIC SURG LAS, V30, P672
   Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022
   Jonas JB, 2003, EUR J OPHTHALMOL, V13, P103
   Jonas JB, 2001, BRIT J OPHTHALMOL, V85, P1203, DOI 10.1136/bjo.85.10.1203
   JONGEBLOED WL, 1987, DOC OPHTHALMOL, V67, P183, DOI 10.1007/BF00142712
   Juzoji H, 1997, JPN J OPHTHALMOL, V41, P278, DOI 10.1016/S0021-5155(97)00070-1
   Kirchhof B, 2002, AM J OPHTHALMOL, V133, P95, DOI 10.1016/S0002-9394(01)01295-8
   Kishimoto M, 1964, Nippon Ganka Gakkai Zasshi, V68, P1145
   Kobuch K, 2001, GRAEF ARCH CLIN EXP, V239, P635, DOI 10.1007/s004170100330
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai WW, 2008, GRAEF ARCH CLIN EXP, V246, P1633, DOI 10.1007/s00417-008-0851-2
   Lappas A, 2009, ACTA OPHTHALMOL, V87, P866, DOI 10.1111/j.1755-3768.2008.01371.x
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003
   LE D, 1994, RETINA, V14, P323
   Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21
   LEAVER PK, 1979, BRIT J OPHTHALMOL, V63, P361, DOI 10.1136/bjo.63.5.361
   LEAVER PK, 1984, BRIT J OPHTHALMOL, V68, P432, DOI 10.1136/bjo.68.6.432
   LEE B, 1992, BIORHEOLOGY, V29, P521
   Lee GA, 1998, AUST NZ J OPHTHALMOL, V26, P57, DOI 10.1046/j.1440-1606.1998.00083.x
   Leone G, 2010, J MATER SCI-MATER M, V21, P2491, DOI 10.1007/s10856-010-4092-7
   Lesnoni G, 2004, RETINA-J RET VIT DIS, V24, P172, DOI 10.1097/00006982-200402000-00031
   LEWIS H, 1991, AM J OPHTHALMOL, V111, P15, DOI 10.1016/S0002-9394(14)76890-4
   Li W, 2010, EYE, V24, P21, DOI 10.1038/eye.2009.57
   Liang CP, 1998, INT OPHTHALMOL, V22, P13, DOI 10.1023/A:1006016809070
   LINCOFF A, 1982, ARCH OPHTHALMOL-CHIC, V100, P996
   LINCOFF H, 1980, ARCH OPHTHALMOL-CHIC, V98, P1610
   LINCOFF H, 1984, ARCH OPHTHALMOL-CHIC, V102, P928
   LINCOFF H, 1982, ARCH OPHTHALMOL-CHIC, V100, P1083
   Loewenstein A, 2000, OPHTHALMOLOGY, V107, P1078, DOI 10.1016/S0161-6420(00)00095-6
   Los LI, 2003, INVEST OPHTH VIS SCI, V44, P2828, DOI 10.1167/iovs.02-0588
   LUCKE KH, 1987, AM J OPHTHALMOL, V104, P624, DOI 10.1016/0002-9394(87)90176-0
   MACHEMER R, 1995, GRAEF ARCH CLIN EXP, V233, P453, DOI 10.1007/BF00183425
   Mackiewicz J, 2007, INVEST OPHTH VIS SCI, V48, P1873, DOI 10.1167/iovs.06-0941
   MADREPERLA SA, 1995, RETINA-J RET VIT DIS, V15, P87, DOI 10.1097/00006982-199515020-00001
   MARCUS DM, 1994, INT OPHTHALMOL CLIN, V34, P97, DOI 10.1097/00004397-199403430-00011
   Maruoka S, 2006, CURR EYE RES, V31, P599, DOI 10.1080/02713680600813854
   MCCUEN BW, 1986, GRAEF ARCH CLIN EXP, V224, P38, DOI 10.1007/BF02144131
   MCLEOD D, 1986, GRAEF ARCH CLIN EXP, V224, P55, DOI 10.1007/BF02144135
   Meinert H, 2000, EUR J OPHTHALMOL, V10, P189, DOI 10.5301/EJO.2008.1838
   Meng QL, 2010, GRAEF ARCH CLIN EXP, V248, P1091, DOI 10.1007/s00417-010-1351-8
   MIYAMOTO K, 1984, RETINA-J RET VIT DIS, V4, P264, DOI 10.1097/00006982-198400440-00010
   MOREIRA H, 1992, CORNEA, V11, P376, DOI 10.1097/00003226-199209000-00003
   MUELLERJ.K, 1974, A GRAEF ARCH KLIN EX, V189, P147
   Muller-Jensen K, 1968, Ber Zusammenkunft Dtsch Ophthalmol Ges, V68, P181
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   Nickerson CS, 2008, J BIOMECH, V41, P1840, DOI 10.1016/j.jbiomech.2008.04.015
   Norton E W, 1969, Trans Am Ophthalmol Soc, V67, P374
   Norton E. W. D., 1973, T AM ACAD OPHTHALMOL, V77, P85
   Noulas AV, 2004, BIOMED CHROMATOGR, V18, P457, DOI 10.1002/bmc.336
   OHIRA A, 1991, RETINA-J RET VIT DIS, V11, P259, DOI 10.1097/00006982-199111020-00012
   OHM J, 1911, AV GRAEFES ARCH OPHT, V79, P442
   OOSTERHUIS JA, 1966, ARCH OPHTHALMOL-CHIC, V76, P374, DOI 10.1001/archopht.1966.03850010376014
   OOSTERHUIS JA, 1966, ARCH OPHTHALMOL-CHIC, V76, P258, DOI 10.1001/archopht.1966.03850010260018
   ORELLANA J, 1991, OPHTHALMOLOGY, V98, P939
   Pastor JC, 1998, EUR J OPHTHALMOL, V8, P179
   PEYMAN GA, 1995, SURV OPHTHALMOL, V39, P375
   PEYMAN GA, 1992, OPHTHALMIC SURG LAS, V23, P811
   Ponsioen TL, 2010, PROG RETIN EYE RES, V29, P580, DOI 10.1016/j.preteyeres.2010.07.001
   PRUETT RC, 1979, ARCH OPHTHALMOL-CHIC, V97, P2325, DOI 10.1001/archopht.1979.01020020541006
   PRUETT RC, 1974, ARCH OPHTHALMOL-CHIC, V91, P29, DOI 10.1001/archopht.1974.03900060033008
   PRUETT RC, 1972, ARCH OPHTHALMOL-CHIC, V88, P540, DOI 10.1001/archopht.1972.01000030542015
   REFOJO M F, 1971, Journal of Biomedical Materials Research, V5, P113, DOI 10.1002/jbm.820050108
   REFOJO MF, 1973, INVEST OPHTH VISUAL, V12, P465
   RINKOFF JS, 1986, AM J OPHTHALMOL, V101, P181, DOI 10.1016/0002-9394(86)90591-X
   Rizzo S, 2007, RETINA-J RET VIT DIS, V27, P613, DOI 10.1097/01.iae.0000251228.33870.64
   Rofail M, 2005, RETINA-J RET VIT DIS, V25, P897, DOI 10.1097/00006982-200510000-00013
   Roider J, 2002, GRAEF ARCH CLIN EXP, V240, P965, DOI 10.1007/s00417-002-0574-8
   Romano MR, 2008, GRAEF ARCH CLIN EXP, V246, P1541, DOI 10.1007/s00417-008-0894-4
   ROSENGREN B, 1938, ACTA OPHTHALMOL, V16, P573
   SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609
   SCHULMAN JA, 1993, JPN J OPHTHALMOL, V37, P70
   Scott IU, 2003, AM J OPHTHALMOL, V136, P454, DOI 10.1016/S0002-9394(03)00241-1
   Scott IU, 2002, OPHTHALMOLOGY, V109, P1828, DOI 10.1016/S0161-6420(02)01184-3
   SCOTT JD, 1975, MOD PROBL OPHTHAL, V15, P285
   SCUDERI G, 1954, Ann Ottalmol Clin Ocul, V80, P213
   Sebag J, 1998, PROG POLYM SCI, V23, P415, DOI 10.1016/S0079-6700(97)00035-X
   SEBAG J, 1993, RETINA-J RET VIT DIS, V13, P8, DOI 10.1097/00006982-199313010-00003
   Sebag J, 1989, VITREOUS STRUCTURE F
   SELL CH, 1987, AM J OPHTHALMOL, V103, P24, DOI 10.1016/S0002-9394(14)74164-9
   SHAFER DM, 1958, ARCH OPHTHALMOL-CHIC, V60, P255
   STENZEL KH, 1969, SCIENCE, V164, P1282, DOI 10.1126/science.164.3885.1282
   Stolba U, 1995, BRIT J OPHTHALMOL, V79, P1106, DOI 10.1136/bjo.79.12.1106
   Su WY, 2011, J BIOMAT SCI-POLYM E, V22, P1777, DOI 10.1163/092050610X522729
   Suri S, 2006, J BIOMED MATER RES A, V79A, P650, DOI 10.1002/jbm.a.30917
   Swindle K. E., 2006, POLYM PREPR, V47, P59
   Swindle KE, 2008, J BIOMED MATER RES A, V87A, P656, DOI 10.1002/jbm.a.31769
   THOMPSON JT, 1992, ARCH OPHTHALMOL-CHIC, V110, P1594, DOI 10.1001/archopht.1992.01080230094028
   Tornambe P E, 1997, Trans Am Ophthalmol Soc, V95, P551
   VANHORN DL, 1972, INVEST OPHTH VISUAL, V11, P1028
   Versura P, 2001, OPHTHALMOLOGICA, V215, P276, DOI 10.1159/000050874
   Weinberger D, 1998, RETINA-J RET VIT DIS, V18, P233, DOI 10.1097/00006982-199803000-00007
   Wickham L, 2010, GRAEF ARCH CLIN EXP, V248, P1225, DOI 10.1007/s00417-010-1358-1
   Wolf S, 2003, RETINA-J RET VIT DIS, V23, P335, DOI 10.1097/00006982-200306000-00008
   Wong D, 1998, GRAEF ARCH CLIN EXP, V236, P234, DOI 10.1007/s004170050070
   Wong D, 2005, BRIT J OPHTHALMOL, V89, P662, DOI 10.1136/bjo.2004.055178
   Wong D, 2000, Semin Ophthalmol, V15, P25
   Wood D J, 1920, Br J Ophthalmol, V4, P413, DOI 10.1136/bjo.4.9.413
   Worst J. G. F., 1995, CISTERNAL ANATOMY VI
   Yamamoto S, 2000, Semin Ophthalmol, V15, P15
   YAMAUCHI A, 1991, POLYMER GELS, P127
   YEO JH, 1987, OPHTHALMOLOGY, V94, P1109
   Zeana D, 1999, INT OPHTHALMOL, V23, P17, DOI 10.1023/A:1006444615412
   ZIMMERMAN RL, 1980, BIOPHYS J, V29, P539, DOI 10.1016/S0006-3495(80)85152-6
NR 193
TC 44
Z9 47
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 921
EP 935
DI 10.1016/j.actbio.2010.10.030
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900002
PM 21050899
OA Green Published
DA 2018-10-20
ER

PT J
AU Fuentes, R
   Venegas, GO
   Olate, S
   Rauco, MR
   Borie, E
   Engelke, W
AF Fuentes, Ramon
   Venegas, Gonzalo Oporto
   Olate, Sergio
   Rauco, Mariana Rojas
   Borie, Eduardo
   Engelke, Wilfried
TI Histological Evaluation of Bone Regeneration Means Freeze Dried Bone
   Allograft (FDBA) in Post Exodontia Sockets
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Bone regeneration; Biomaterials; FDBA; Socket
ID ALVEOLAR RIDGE AUGMENTATION; PLATELET-RICH PLASMA; BIPHASIC
   CALCIUM-PHOSPHATE; DENTAL IMPLANT PLACEMENT; MARROW STROMAL CELLS; NEWLY
   FORMED BONE; SINUS AUGMENTATION; TRICALCIUM PHOSPHATE;
   CLINICAL-EVALUATION; COLLAGEN MEMBRANE
AB Within oral rehabilitation alveolar ridge preservation following extraction is important. This research study shows a histological, histochemical and histomorphometrical evaluation in two cases of post extraction ridge-socket preservation performed with FDBA. In two patients dental extraction procedures were performed and sockets were immediately filled with FDBA. Six months later a biopsy of grafted area was obtained and rehabilitated through dental implant. Grafted bone samples were treated for histological and histochemical analysis. Bone tissue area was measured. Laboratory analysis of three samples showed inactive bone surfaces, neither osteoblasts nor osteoclasts were found, only osteocyte and osteogenous cells were observed. These findings do not mean that tissue is metabolically inactive, rather bone genesis develop from a tissue matrix with the potential to generate undifferentiated osteocytes, and a micro environment with proteins such as bone morphogenetic proteins (BPM). Inactive biomaterial particles were not observed. Samples showed 0% and 30% bone tissue respectively. Considering histological differences between this and other research studies, it is necessary to develop further investigation to increase knowledge of processes involved in bone regeneration as well as bone quality, considering the variability that could be seen in each patient.
C1 [Fuentes, Ramon; Venegas, Gonzalo Oporto; Olate, Sergio; Borie, Eduardo] Univ La Frontera, Fac Med, Dept Odontol Integral, Temuco, Chile.
   [Rauco, Mariana Rojas] Univ Chile, Fac Med, Lab Embriol Comparada, Santiago, Chile.
   [Engelke, Wilfried] Univ Gottingen, Dept Maxillofacial Surg, Dent Ctr, Gottingen, Germany.
RP Fuentes, R (reprint author), Univ La Frontera, Fac Med, Dept Odontol Integral, Manuel Montt 112, Temuco, Chile.
EM rfuentes@ufro.cl
RI Borie, Eduardo/J-8290-2012
OI Olate, Sergio/0000-0001-8153-0676
CR Anitua E., 2000, NUEVO ENFOQUE REGENE, P49
   Antoun H, 2001, CLIN ORAL IMPLAN RES, V12, P632, DOI 10.1034/j.1600-0501.2001.120612.x
   Artzi Z, 2008, CLIN ORAL IMPLAN RES, V19, P686, DOI 10.1111/j.1600-0501.2008.01539.x
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Cenni E, 2009, J MATER SCI-MATER M, V20, P45, DOI 10.1007/s10856-008-3544-9
   Chiapasco M, 2008, CLIN ORAL IMPLAN RES, V19, P1074, DOI 10.1111/j.1600-0501.2008.01542.x
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Cordaro L, 2002, CLIN ORAL IMPLAN RES, V13, P103, DOI 10.1034/j.1600-0501.2002.130113.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   Danesh-Meyer M J, 2001, J Int Acad Periodontol, V3, P48
   Donos N, 2008, J CLIN PERIODONTOL, V35, P173, DOI 10.1111/j.1600-051X.2008.01269.x
   Fagan MC, 2008, J PERIODONTOL, V79, P1782, DOI 10.1902/jop.2008.080034 
   Feuille F, 2003, INT J PERIODONT REST, V23, P29
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Herold RW, 2002, J PERIODONTOL, V73, P213, DOI 10.1902/jop.2002.73.2.213
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Iizuka T, 2004, CLIN ORAL IMPLAN RES, V15, P607, DOI 10.1111/j.1600-0501.2004.01043.x
   Kassolis JD, 2005, J CRANIOFAC SURG, V16, P280, DOI 10.1097/00001665-200503000-00015
   Kolerman R, 2008, J PERIODONTOL, V79, P2104, DOI [10.1902/jop.2008.080117, 10.1902/jop.2008.080117 ]
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   Lee JH, 2008, CLIN ORAL IMPLAN RES, V19, P767, DOI 10.1111/j.1600-0501.2008.01520.x
   Markopoulou CE, 2003, J PERIODONTOL, V74, P982, DOI 10.1902/jop.2003.74.7.982
   Nevins ML, 2009, INT J PERIODONT REST, V29, P371
   Nevins M, 2007, INT J PERIODONT REST, V27, P421
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Oporto Venegas Gonzalo, 2008, Int. J. Morphol., V26, P853, DOI 10.4067/S0717-95022008000400013
   Rocchietta I, 2008, J CLIN PERIODONTOL, V35, P203, DOI 10.1111/j.1600-051X.2008.01271.x
   Rosen PS, 2002, J PERIODONTOL, V73, P942, DOI 10.1902/jop.2002.73.8.942
   Rosen PS, 2001, J PERIODONTOL, V72, P250, DOI 10.1902/jop.2001.72.2.250
   Schwartz Z, 2007, CLIN ORAL IMPLAN RES, V18, P204, DOI 10.1111/j.1600-0501.2006.01303.x
   Smolka W, 2006, CLIN ORAL IMPLAN RES, V17, P149, DOI 10.1111/j.1600-0501.2005.01182.x
   Suba Z, 2006, CLIN ORAL IMPLAN RES, V17, P102, DOI 10.1111/j.1600-0501.2005.01166.x
   Tonetti MS, 2008, J CLIN PERIODONTOL, V35, P168, DOI 10.1111/j.1600-051X.2008.01268.x
   Turonis James W, 2006, J Oral Implantol, V32, P55, DOI 10.1563/780.1
   Yukna RA, 2005, J PERIODONTOL, V76, P57, DOI 10.1902/jop.2005.76.1.57
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 40
TC 4
Z9 4
U1 0
U2 3
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
J9 INT J MORPHOL
JI Int. J. Morphol.
PD MAR
PY 2011
VL 29
IS 1
BP 286
EP 292
DI 10.4067/S0717-95022011000100047
PG 7
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 768ED
UT WOS:000290913400047
OA Other Gold, Bronze
DA 2018-10-20
ER

PT J
AU Andrade, LR
   Arcanjo, KDS
   Martins, HSHL
   dos Reis, JSN
   Farina, M
   Borojevic, R
   Duarte, MEL
AF Andrade, Leonardo Rodrigues
   Arcanjo, Katia Denise S.
   Martins, Humberto Saramago H. L.
   Nobre dos Reis, Joao Sergio
   Farina, Marcos
   Borojevic, Radovan
   Leite Duarte, Maria Eugenia
TI Fine structure and molecular content of human chondrocytes encapsulated
   in alginate beads
SO CELL BIOLOGY INTERNATIONAL
LA English
DT Article
DE alginate; bioengineering; cartilage; electron microscopy;
   glycosaminoglycan
ID ARTICULAR CHONDROCYTES; MATRIX SYNTHESIS; CARTILAGE; BONE;
   MICROCAPSULES; CULTURE
AB Preservation of the chondrocytic phenotype in vitro requires a 3D (three-dimensional) culture model. Diverse biomaterials have been tested as scaffolds for culture of animal chondrocytes; however, to date, none is considered a gold standard in regenerative medicine. Here, we studied the fine structure and the GAGs (glycosaminoglycans) content of human chondrocytes encapsulated in alginate beads by using electron Microscopy and radioactive sulfate [(35)S] incorporation, respectively. Cells were obtained from human cartilage, encapsulated in alginate beads and cultured for 28 days. [(35)S]Na(2)SO(4) was added to the culture media and later isolated for quantification of the sulfated GAGs found in three compartments: IC (intracellular), IB (intra-bead) and EB (extra-bead). Round cells were seen isolated or forming small groups throughout the alginate. Human chondrocytes presented the features of active cells such as euchromatic nuclei, abundant RER (rough endoplasmic reticulum) and many transport vesicles. We observed an extracellular matrix rich in collagen fibres and electrondense material adjacent to the cells. Most of the GAGs produced (74%) were found in the culture medium (EB), indicating that alginate has a limited capacity to retain the GAGs. CS (chondroitin sulfate), the major component of aggrecan, was the most prominent GAG produced by the encapsulated cells. Human chondrocytes cultured in alginate can sustain their phenotype, confirming the potential application of this biomaterial for cartilage engineering.
C1 [Andrade, Leonardo Rodrigues; Arcanjo, Katia Denise S.; Martins, Humberto Saramago H. L.; Nobre dos Reis, Joao Sergio; Farina, Marcos; Borojevic, Radovan] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Leite Duarte, Maria Eugenia] Natl Inst Traumatol & Orthopaed, Rio De Janeiro, Brazil.
RP Andrade, LR (reprint author), NIDCD, Sect Struct Cell Biol, Lab Cell Struct & Dynam, NIH, 50 S Dr,Rm 4249, Bethesda, MD 20892 USA.
EM andrade@histo.ufrj.br
RI Farina, Marcos/I-3744-2014; Andrade, Leonardo/C-9554-2011
OI Andrade, Leonardo/0000-0002-0004-5677; Borojevic,
   Radovan/0000-0002-2393-7280
FU Fundacao Universitaria Josa Bonifacio (FUJB-UFRJ); Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
FX This work was supported by the Fundacao Universitaria Josa Bonifacio
   (FUJB-UFRJ) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ).
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Carossino AM, 2007, BIOGERONTOLOGY, V8, P483, DOI 10.1007/s10522-007-9088-4
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   DIETRICH CP, 1976, ANAL BIOCHEM, V70, P645, DOI 10.1016/0003-2697(76)90496-6
   Dobratz EJ, 2009, ARCH FACIAL PLAST S, V11, P40, DOI 10.1001/archfacial.2008.509
   GarciaAbreu J, 1996, GLIA, V17, P339, DOI 10.1002/(SICI)1098-1136(199608)17:4<339::AID-GLIA8>3.0.CO;2-U
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HEINEGARD D, 1989, FASEB J, V3, P2042
   HUNZIKER EB, 1984, J CELL BIOL, V98, P277, DOI 10.1083/jcb.98.1.277
   Kessler MW, 2008, SPORTS MED ARTHROSC, V16, P246, DOI 10.1097/JSA.0b013e31818d56b3
   Lin YJ, 2009, J BIOMED MATER RES A, V88A, P23, DOI 10.1002/jbm.a.31841
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Nakagawa Yasuaki, 2006, Clin Calcium, V16, P2071
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   SAITO H, 1968, J BIOL CHEM, V243, P1536
   SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005
   Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   Wong M, 2001, J ORTHOPAED RES, V19, P493, DOI 10.1016/S0736-0266(00)90023-8
NR 21
TC 5
Z9 5
U1 0
U2 15
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 1065-6995
J9 CELL BIOL INT
JI Cell Biol. Int.
PD MAR
PY 2011
VL 35
IS 3
BP 293
EP 297
DI 10.1042/CBI20100273
PG 5
WC Cell Biology
SC Cell Biology
GA 759XR
UT WOS:000290283300015
PM 20874706
DA 2018-10-20
ER

PT J
AU Garzon-Alvarado, DA
   Velasco, MA
   Narvaez-Tovar, CA
AF Garzon-Alvarado, Diego A.
   Velasco, Marco A.
   Narvaez-Tovar, Carlos A.
TI SELF-ASSEMBLED SCAFFOLDS USING REACTION-DIFFUSION SYSTEMS: A HYPOTHESIS
   FOR BONE REGENERATION
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Scaffold; bone; reaction-diffusion system
ID RAPID PROTOTYPING TECHNIQUES; PATTERN-FORMATION; COLLAGEN SCAFFOLD;
   STRUCTURE LIBRARY; POROUS STRUCTURES; TURING PATTERNS; PART 1; TISSUE;
   DESIGN; FABRICATION
AB One area of tissue engineering concerns research into alternatives for new bone formation and replacing its function. Scaffolds have been developed to meet this requirement, allowing cell migration, bone tissue growth, transport of growth factors and nutrients, and the improvement of the mechanical properties of bone. Scaffolds are made from different biomaterials and manufactured using several techniques that, in some cases, do not allow full control over the size and orientation of the pores characterizing the scaffold. A novel hypothesis that a reaction-diffusion (RD) system can be used for designing the geometrical specifications of the bone matrix is thus presented here. The hypothesis was evaluated by making simulations in two-and three-dimensional RD systems in conjunction with the biomaterial scaffold. The results showed the methodology's effectiveness in controlling features such as the percentage of porosity, size, orientation, and interconnectivity of pores in an injectable bone matrix produced by the proposed hypothesis.
C1 [Garzon-Alvarado, Diego A.; Narvaez-Tovar, Carlos A.] Univ Nacl Colombia, Engn Modeling & Numer Methods Grp, Bogota, Colombia.
   [Velasco, Marco A.] Santo Tomas Univ, Mech Engn Applicat & Res Grp, Bogota, Colombia.
RP Garzon-Alvarado, DA (reprint author), Univ Nacl Colombia, Engn Modeling & Numer Methods Grp, Cra 30 45-03, Bogota, Colombia.
EM dagarzona@unal.edu.co; marcovelasco@usantotomas.edu.co;
   carlosnarvaez@usantotomas.edu.co
OI VELASCO, MARCO/0000-0003-4436-9443
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Boccaccio A, 2008, J MECH MED BIOL, V8, P161, DOI 10.1142/S0219519408002589
   BUTSCHER A, ACTA BIOMAT IN PRESS
   Callahan TK, 1999, PHYSICA D, V132, P339, DOI 10.1016/S0167-2789(99)00041-X
   Chaturvedi R, 2005, J R SOC INTERFACE, V2, P237, DOI 10.1098/rsif.2005.0033
   Cheah CM, 2004, TISSUE ENG, V10, P595, DOI 10.1089/107632704323061951
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   Courtin B, 1995, ACTA BIOTHEOR, V43, P373, DOI 10.1007/BF00713560
   Cowin S., 2001, BONE MECH HDB
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   DEAMORIM H, 2010, MED ENG PHYS, V32, P775
   Domingues ZR, 2004, BIOMATERIALS, V25, P327, DOI 10.1016/S0142-9612(03)00524-6
   Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018
   Fuchs B, 2008, EJSO-EUR J SURG ONC, V34, P1271, DOI 10.1016/j.ejso.2007.11.010
   FURUICHI F, 2006, SCI TECHNOL ADV MAT, V7, P219
   Garzon-Alvarado DA, 2009, COMPUT BIOL MED, V39, P554, DOI 10.1016/j.compbiomed.2009.03.012
   Goh JCH, 2004, J MECH MED BIOL, V4, P463, DOI 10.1142/S021951940400117X
   Grzybowski B., 2009, CHEM MOTION REACTION
   Grzybowski BA, 2005, SOFT MATTER, V1, P114, DOI 10.1039/b501769f
   Hao L, 2009, J MATER PROCESS TECH, V209, P5793, DOI 10.1016/j.jmatprotec.2009.06.012
   Heaney RP, 2001, OSTEOPOROSIS
   Hollinger J., 2004, BONE TISSUE ENG
   Javierre E, 2009, INT J SOLIDS STRUCT, V46, P3597, DOI 10.1016/j.ijsolstr.2009.06.010
   KALORAMA, 2005, IMPLANT BASED DENT R
   KAPRAL R, 1995, PHYSICA D, V86, P149, DOI 10.1016/0167-2789(95)00096-M
   *KAS DUOW, 2008, MAN CAT
   Kondo S, 2002, GENES CELLS, V7, P535, DOI 10.1046/j.1365-2443.2002.00543.x
   KOU XY, 2010, COMP AIDED IN PRESS
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Leppanen T, 2002, PHYSICA D, V168, P35, DOI 10.1016/S0167-2789(02)00493-1
   Li Q., 2001, COMMUN NONLINEAR SCI, V6, P68
   Ma PX, 2006, SCAFFOLDING TISSUE E
   MADZVAMUSE A, 2000, THESIS OXFORD U
   MAINI P, 1999, MATH MODELS MORPHOGE
   Maselko J, 1996, MAT SCI ENG C-BIOMIM, V4, P199, DOI 10.1016/S0928-4931(96)00146-4
   MCKENNA MJ, 1987, AM J MED, V82, P61, DOI 10.1016/0002-9343(87)90273-7
   MEINHARDT A, 1982, MODELS BIOL PATTERN
   Moreno-Atanasio R, 2010, PARTICUOLOGY, V8, P81, DOI 10.1016/j.partic.2010.01.001
   Murray JD, 2001, MATH BIOL, VI
   NAGORCKA BN, 1983, BIOSYSTEMS, V16, P323, DOI 10.1016/0303-2647(83)90015-1
   Naing MW, 2005, RAPID PROTOTYPING J, V11, P249, DOI 10.1108/13552540510612938
   Okabe A., 2000, SPATIAL TESSELLATION
   Page KM, 2005, PHYSICA D, V202, P95, DOI 10.1016/j.physd.2005.01.022
   Perilli E, 2005, J MECH MED BIOL, V5, P349, DOI 10.1142/S0219519405001473
   Petrasch J, 2008, INT J HEAT FLUID FL, V29, P315, DOI 10.1016/j.ijheatfluidflow.2007.09.001
   Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015
   Rajagopalan G, 2000, POLYMER, V41, P2591, DOI 10.1016/S0032-3861(99)00418-8
   Rajagopalan S, 2006, MED IMAGE ANAL, V10, P693, DOI 10.1016/j.media.2006.06.001
   Ramanath HS, 2007, KEY ENG MATER, V334-335, P1241, DOI 10.4028/www.scientific.net/KEM.334-335.1241
   Rekow D, 2006, J MATER SCI, V41, P5113, DOI 10.1007/s10853-006-0071-2
   Ristori S, 2007, CHEM PHYS LETT, V436, P175, DOI 10.1016/j.cplett.2007.01.023
   Roussel CJ, 2004, PROG BIOPHYS MOL BIO, V86, P113, DOI 10.1016/j.pbiomolbio.2004.03.01
   Salmoria GV, 2009, POLYM TEST, V28, P648, DOI 10.1016/j.polymertesting.2009.05.008
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Shoji H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046212
   Shoji H, 2007, JPN J IND APPL MATH, V24, P67, DOI 10.1007/BF03167508
   Singh R, 2010, ACTA BIOMATER, V6, P2342, DOI 10.1016/j.actbio.2009.11.032
   Suetsugu Y, 2009, J MATER SCI, V44, P5806, DOI 10.1007/s10853-009-3815-y
   TABOR Z, 2002, PHYS REV E, V66
   Tan JY, 2010, VIRTUAL PHYS PROTOTY, V5, P45, DOI 10.1080/17452751003759144
   Tellis BC, 2008, MAT SCI ENG C-BIO S, V28, P171, DOI 10.1016/j.msec.2006.11.010
   Tezuka K, 2005, J BONE MINER METAB, V23, P1, DOI 10.1007/s00774-004-0533-z
   Too MH, 2002, INT J ADV MANUF TECH, V19, P217, DOI 10.1007/s001700200016
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   TURK G, 1991, COMP GRAPH, V25, P289
   Utela B, 2008, J MANUFACTURING PROC, V10, P96, DOI DOI 10.1016/J.JMAPRO.2009.03.002
   Verges E, 2008, COMPUT GRAPH-UK, V32, P438, DOI 10.1016/j.cag.2008.04.001
   Volpert V, 2009, PHYS LIFE REV, V6, P267, DOI 10.1016/j.plrev.2009.10.002
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
   Yeong WY, 2006, RAPID PROTOTYPING J, V12, P229, DOI 10.1108/13552540610682741
   ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zienkiewicz OC, 2000, FINITE ELEMENT METHO, V2
NR 77
TC 5
Z9 7
U1 0
U2 5
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
EI 1793-6810
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD MAR
PY 2011
VL 11
IS 1
BP 231
EP 272
DI 10.1142/S021951941100396X
PG 42
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 764MD
UT WOS:000290632700013
DA 2018-10-20
ER

PT J
AU Sorolla, S
   Sabe, R
   Adzet, J
   Castell, JC
   Bacardit, A
   Olle, L
AF Sorolla, S.
   Sabe, R.
   Adzet, J.
   Castell, J. C.
   Bacardit, A.
   Olle, L.
TI Design of Dehydration and Stabilization Process for Biopelt
SO JOURNAL OF THE SOCIETY OF LEATHER TECHNOLOGISTS AND CHEMISTS
LA English
DT Article
ID COLLAGEN
AB The aim of the present work is to generate at laboratory scale a biomaterial developed by in-vitro technology with similar characteristics to genuine leather. The generation of an in-vitro tissue from bovine fibroblasts is carried out using a scaffold to generate a three-dimensional extra-cellular matrix (3D ECM). The development of a biopelt is by an in-vitro production at lab scale in a bioreactor with specific culturing conditions.(1) New methodologies to stabilize the biomaterial generated were investigated. In particular, the biomaterial was stabilized by immersion in solutions of vegetable tannins and cross-linking agents in an aqueous-solvent medium.
C1 [Bacardit, A.; Olle, L.] UPC, Igualada Engn Sch EEI, Igualada 08700, Spain.
   [Sorolla, S.; Sabe, R.; Adzet, J.; Castell, J. C.] AIICA, Igualada 08700, Spain.
RP Bacardit, A (reprint author), UPC, Igualada Engn Sch EEI, Placa Rei 15, Igualada 08700, Spain.
EM annab@euetii.upc.edu
OI Bacardit Dalmases, Anna/0000-0003-1871-4127
FU EU [COLL-CT-2003-500224-2]
FX The contents of this paper are part of the Dermagenesis' Project funded
   by the EU (COLL-CT-2003-500224-2, 6th FP).
CR [Anonymous], LEDER, V23, P220
   [Anonymous], 1972, Procedure of the tanning of skins, material obtained during said procedure and device, Patent No. [WO 2010/070571 A2, 2118025]
   BUECHLER P, 1986, J AM LEATHER CHEM AS, V82, P200
   CHAGNE V, 1992, J AM LEATHER CHEM AS, V88, P426
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   GRAF HD, 1977, METHOD PREPARATION L
   *IPPC, 2009, 1 DRAFT REF DOC BEST
   *IULTCS INT UN ENV, 2008, 6 IUE IULTCS
   Jeyapalina S, 2007, J SOC LEATH TECH CH, V91, P236
   KOMANOWSKY M, 1991, J AM LEATHER CHEM AS, V87
   KREMEN SS, 1959, Patent No. 2917833
   LOLLAR RM, 1943, J AM LEATHER CHEM AS, V39, P7
   Seymour S. K., 1959, US Patent, Patent No. [2917833, 3068059]
   SILVESTRE F, 1982, J AM LEATHER CHEM AS, V78, P1
   SOLER J, 2000, PROCESOS CURTIDOS
   Sorolla S, 2010, J SOC LEATH TECH CH, V94, P190
   Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u
   TELIBA B, 1993, J SOC LEATH TECH CH, V77, P174
   Ushakoff A. E., 1962, Rapid vegetable tanning, Patent No. [US 3068059, 3444625]
   YOUNG, 1998, STUDIES CONSERVATION, V43, P65
   2000, OP PREV CONT SECT CU
   2003, PREVENCIO CONTAMINAC
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SOC LEATHER TECHNOL CHEMISTS
PI MOULTON
PA 8 COPPER LEAF CLOSE, MOULTON NN3 7HS, NORTHAMPTON, ENGLAND
SN 0144-0322
J9 J SOC LEATH TECH CH
JI J. Soc. Leather Technol. Chem.
PD MAR-APR
PY 2011
VL 95
IS 2
BP 68
EP 73
PG 6
WC Materials Science, Textiles
SC Materials Science
GA 762IE
UT WOS:000290467800004
DA 2018-10-20
ER

PT J
AU Rossi, F
   Santoro, M
   Casalini, T
   Perale, G
AF Rossi, Filippo
   Santoro, Marco
   Casalini, Tommaso
   Perale, Giuseppe
TI Synthesis and characterization of lanthanum bonded agar-carbomer
   hydrogel: a promising tool for biomedical research
SO JOURNAL OF RARE EARTHS
LA English
DT Article
DE hydrogel; acrylic acid; agarose; lanthanum; luminescence; drug delivery;
   rare earths
ID IN-VIVO DEGRADATION; REGENERATIVE MEDICINE; RARE-EARTH; BEHAVIOR;
   NANOPARTICLES; BIOMATERIALS; DELIVERY; IONS
AB Agar-Carbomer (branched poly (acrylic acid)) hydrogel, an injectable bio-resorbable scaffold with a controlled nanostructure specifically designed for neural cell housing, was developed together with a new protocol for building three dimensional biohybrid cell/hydrogel systems. In order to overcome classic structural analysis inconveniences due to the high water amount, which affects instruments results and reliability, agar-Carbomer hydrogels were synthesized by microwave-assisted block copolymerization together with La3+ salts. Propylene glycol, glycerol and buffered saline solution were used as cross-linking agents and solvent, respectively. Biomaterial properties were not affected by the presence of lanthanum, and were checked via swelling and rheological analysis. Moreover, the presence of La3+ within the polymeric network was characterized by thermogravimetric analysis, environmental scanning electron microscopy and Fourier transformed infrared spectroscopy. The results showed that the rare earth presented uniform distribution in the hydrogel network due to the formation of chemical bonds after polymerization without being modified its luminescence emission spectrum that allowed hydrogel detection. These results made the obtained host-guest system a useful tool for analytical research studies concerning regenerative medical applications that could also be potentially taken up with in vivo experiments.
C1 [Rossi, Filippo; Santoro, Marco; Casalini, Tommaso; Perale, Giuseppe] Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, I-20131 Milan, Italy.
RP Rossi, F (reprint author), Politecn Milan, Dipartimento Chim Mat & Ingn Chim G Natta, Via Mancinelli 7, I-20131 Milan, Italy.
EM filippo.rossi@mail.polimi.it
RI Rossi, Filippo/D-3679-2013
OI Rossi, Filippo/0000-0003-2665-120X
CR Atala A., 2008, PRINCIPLES REGENERAT
   Ballios BG, 2010, BIOMATERIALS, V31, P2555, DOI 10.1016/j.biomaterials.2009.12.004
   Barbucci R, 2008, CARBOHYD RES, V343, P3058, DOI 10.1016/j.carres.2008.08.029
   Biamino S, 2004, J EUR CERAM SOC, V24, P3021, DOI 10.1016/j.jeurceramsoc.2003.10.005
   Binnemans K, 2009, CHEM REV, V109, P4283, DOI 10.1021/cr8003983
   Bruining MJ, 2000, BIOMACROMOLECULES, V1, P418, DOI 10.1021/bm000009t
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   BUNZLI JC, 1978, HELV CHIM ACTA, V61, P762, DOI 10.1002/hlca.19780610224
   Costa VC, 1996, CHEM MATER, V8, P783, DOI 10.1021/cm9504910
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   FLORY PJ, 1953, PRINCIPLES POLYM CHE, pCH13
   Karadag E, 2007, J APPL POLYM SCI, V104, P200, DOI 10.1002/app.25397
   Laib S, 2009, BIOMATERIALS, V30, P1568, DOI 10.1016/j.biomaterials.2008.11.031
   Lee CH, 2009, J CONTROL RELEASE, V136, P88, DOI 10.1016/j.jconrel.2009.02.013
   Liu Y, 2006, J FLUORESC, V16, P723, DOI 10.1007/s10895-006-0122-8
   Missirlis D, 2010, J BIOMED MATER RES A, V93A, P1557, DOI 10.1002/jbm.a.32648
   Nott KP, 2005, CAN J CHEM ENG, V83, P68
   PEPPAS NA, 1987, HYDROGELS MED PHARM, pCH1
   Perale G, 2009, J CONTROL RELEASE, V136, P196, DOI 10.1016/j.jconrel.2009.02.014
   Rossi F, 2010, CHEM PAP, V64, P573, DOI 10.2478/s11696-010-0052-4
   Sakurada K, 2008, ANGEW CHEM INT EDIT, V47, P5718, DOI 10.1002/anie.200700724
   Santoro M, 2011, J PHYS CHEM B, V115, P2503, DOI 10.1021/jp1111394
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Tunesi M., 2009, REGEN MED, V4, pS295
   Varghese OP, 2009, J AM CHEM SOC, V131, P8781, DOI 10.1021/ja902857b
   Yan CH, 2008, J RARE EARTH, V26, P660, DOI 10.1016/S1002-0721(08)60157-X
   Yan H, 2006, BIOMACROMOLECULES, V7, P2776, DOI 10.1021/bm0605560
   Yang LM, 2005, CARBOHYD RES, V340, P2773, DOI 10.1016/j.carres.2005.10.008
   Yu CC, 2009, J SOLID STATE CHEM, V182, P339, DOI 10.1016/j.jssc.2008.10.023
NR 31
TC 3
Z9 3
U1 4
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1002-0721
J9 J RARE EARTH
JI J. Rare Earths
PD MAR
PY 2011
VL 29
IS 3
BP 259
EP 264
DI 10.1016/S1002-0721(10)60442-5
PG 6
WC Chemistry, Applied
SC Chemistry
GA 755NX
UT WOS:000289940500014
DA 2018-10-20
ER

PT J
AU Petrova, V
   Schmauder, S
AF Petrova, V.
   Schmauder, S.
TI CRACK - INTERFACE CRACK INTERACTIONS IN FUNCTIONALLY GRADED/HOMOGENEOUS
   COMPOSITE BIMATERIALS SUBJECTED TO A HEAT FLUX
SO MECHANICS OF COMPOSITE MATERIALS
LA English
DT Article
DE functionally graded materials; interface; cracks; thermal fracture;
   thermal stress intensity factor
ID GRADED MATERIALS; THERMAL FRACTURE; MICROCRACKS; MACROCRACK
AB A bimaterial containing an interface crack and consisting of a homogeneous material and a functionally graded material (FGM) with a system of small internal cracks is considered. The thermal fracture of the biomaterial under the action of a heat flux applied to it at infinity is investigated. The problem is studied in the case where the interface crack is much larger than the internal ones. It is assumed that the thermal properties of the FGM are continuous functions of the thickness coordinate. Asymptotic analytical formulas for the thermal stress intensity factors (TSIFs) at the tips of the interface crack are obtained as series in a small parameter (the ratio between sizes of the internal and interface cracks). Then, the critical heat fluxes and the angles of propagation direction of the interface crack are calculated using the criterion of maximum circumferential stress. A parametric analysis shows that the propagation direction of the interface crack depends on the location and orientation of the system of internal cracks. The parameters of inhomogeneity of the FGM affect the value of TSIFs and, hence, the deflection angle of the interface crack.
C1 [Petrova, V.] Voronezh State Univ, Dept Math, Voronezh 394006, Russia.
   [Petrova, V.; Schmauder, S.] Univ Stuttgart, IMWF, D-70569 Stuttgart, Germany.
RP Petrova, V (reprint author), Voronezh State Univ, Dept Math, Univ Sq 1, Voronezh 394006, Russia.
EM veraep@mail.ru
RI Petrova, Vera/V-4113-2017
OI Petrova, Vera/0000-0002-9131-2469
FU German Research Foundation [Schm 746/92-1, Schm 746/106-1]
FX V. Petrova acknowledges the support of the German Research Foundation
   under grants Schm 746/92-1 and Schm 746/106-1.
CR Abanto-Bueno J, 2006, EXP MECH, V46, P179, DOI 10.1007/s11340-006-6416-6
   [Anonymous], 2000, FRACTURE SOLIDS MICR
   Birman V, 2007, APPL MECH REV, V60, P195, DOI 10.1115/1.2777164
   Noda N, 1999, J THERM STRESSES, V22, P477, DOI 10.1080/014957399280841
   Oral A, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2936238
   Panasyuk V, 1976, STRESS DISTRIBUTION
   PETROVA V, 2009, P ICF12 OTT CAN
   Romalis N. B., 1984, Mechanics of Composite Materials, V20, P35, DOI 10.1007/BF00611573
   Schmauder S, 2001, ARCH APPL MECH, V71, P182, DOI 10.1007/s004190000124
   Shbeeb NI, 1999, J APPL MECH-T ASME, V66, P492, DOI 10.1115/1.2791074
   TAMUZS V, 1994, THEOR APPL FRACT MEC, V21, P207, DOI 10.1016/0167-8442(94)90034-5
   TAMUZS V, 1993, THEOR APPL FRACT MEC, V19, P207, DOI 10.1016/0167-8442(93)90022-4
NR 12
TC 9
Z9 9
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0191-5665
J9 MECH COMPOS MATER
JI Mech. Compos. Mater.
PD MAR
PY 2011
VL 47
IS 1
BP 125
EP 136
DI 10.1007/s11029-011-9191-0
PG 12
WC Mechanics; Materials Science, Composites; Polymer Science
SC Mechanics; Materials Science; Polymer Science
GA 753RJ
UT WOS:000289797000009
DA 2018-10-20
ER

PT J
AU Hermann, R
   Uhlemann, M
   Wendrock, H
   Gerbeth, G
   Buchner, B
AF Hermann, Regina
   Uhlemann, Margitta
   Wendrock, Horst
   Gerbeth, Gunter
   Buechner, Bernd
TI Magnetic field controlled single crystal growth and surface modification
   of titanium alloys exposed for biocompatibility
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article; Proceedings Paper
CT 16th International Conference on Crystal Growth (ICCG16)/14th
   International Conference on Vapor Growth and Epitaxy (ICVGE14)
CY AUG 08-13, 2010
CL Beijing, PEOPLES R CHINA
SP Int Org Crystal Growth (IOCG), Chinese Assoc Crystal Growth (CASG)
DE Biomaterial; Floating-zone technique; Single crystal growth; Titanium
   compounds
ID FLOATING-ZONE GROWTH
AB The aim of this work is growth and characterisation of Ti55Nb45 (wt%) single crystals by floating-zone single crystal growth of intermetallic compounds using two-phase radio-frequency (RF) electromagnetic heating. Thereby, the process and, in particular, the flow field in the molten zone is influenced by additional magnetic fields. The growth of massive intermetallic single crystals is very often unsuccessful due to an unfavourable solid-liquid interface geometry enclosing concave fringes. It is generally known that the crystallization process stability is enhanced if the crystallization interface is convex. For this, a tailored magnetic two-phase stirrer system has been developed, which enables a controlled influence on the melt ranging from intensive inwards to outwards flows. Since Ti is favourably light, strong and biocompatible, it is one of the few materials that naturally match the requirements for implantation in the human body. Therefore, the magnetic system was applied to crystal growth of Ti alloys. The grown crystals were oriented and cut to cubes with the desired crystallographic orientations [1 0 0] and [1 0 1] normally on a plane. The electron backscatter diffraction (EBSD) technique was applied to clearly determine crystal orientation and to localize grain boundaries. The formation of oxidic nanotubes on Ti surfaces in dependence of the grain orientation was investigated, performed electrochemically by anodic oxidation from fluoride containing electrolyte. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Hermann, Regina; Uhlemann, Margitta; Wendrock, Horst; Buechner, Bernd] Leibniz Inst Solid State & Mat Res IFW Dresden, Dresden, Germany.
   [Gerbeth, Gunter] Forschungszentrum Dresden Rossendorf, MHD Dept, Dresden, Germany.
RP Hermann, R (reprint author), Leibniz Inst Solid State & Mat Res IFW Dresden, Dresden, Germany.
EM r.hermann@ifw-dresden.de
RI Buchner, Bernd/E-2437-2016
OI Buchner, Bernd/0000-0002-3886-2680
CR Behr G, 1999, J CRYST GROWTH, V198, P642, DOI 10.1016/S0022-0248(98)01061-6
   Croll A, 1999, PROG CRYST GROWTH CH, V38, P133
   Dold P, 2001, J CRYST GROWTH, V231, P95, DOI 10.1016/S0022-0248(01)01491-9
   Feng XJ, 2007, ELECTROCHEM COMMUN, V9, P2403, DOI 10.1016/j.elecom.2007.07.007
   Hermann R, 2010, J MATER SCI, V45, P2228, DOI 10.1007/s10853-009-4117-0
   Krauze A., 2008, P 7 PAMIR INT C FUND, P851
   Lee S.-H, 2009, Journal of Physics: Conference Series, V165, DOI 10.1088/1742-6596/165/1/012086
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Ma N, 2001, J CRYST GROWTH, V230, P118, DOI 10.1016/S0022-0248(01)01329-X
   Morthland TE, 1997, INT J HEAT MASS TRAN, V40, P3283, DOI 10.1016/S0017-9310(96)00388-2
   MUNAKATA ITT, 1999, J GROWTH, V206, P27
   OH S, 2009, P NAT ACAD SCI
   PAN X, 2009, DIPLOMARBEIT
   Priede J, 2006, IEEE T MAGN, V42, P301, DOI 10.1109/TMAG.2005.861042
   Takesue N, 2009, J CRYST GROWTH, V311, P3319, DOI 10.1016/j.jcrysgro.2009.03.052
   Takeya H, 2001, J MAGN MAGN MATER, V226, P269, DOI 10.1016/S0304-8853(00)00797-6
   TANAKA T, 1975, J CRYST GROWTH, V30, P193, DOI 10.1016/0022-0248(75)90089-5
NR 17
TC 4
Z9 4
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD MAR 1
PY 2011
VL 318
IS 1
BP 1048
EP 1052
DI 10.1016/j.jcrysgro.2010.10.196
PG 5
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 751YM
UT WOS:000289653900230
DA 2018-10-20
ER

PT J
AU Madhav, NVS
   Shankar, MSU
AF Madhav, N. V. Satheesh
   Shankar, M. S. Uma
TI A novell smart mucoadhesive biomaterial from Lallimantia royalena seed
   coat
SO SCIENCEASIA
LA English
DT Article
DE transmucosal delivery; Labiatae
AB Our aim was to isolate a novel biomaterial from the seed coat of Lallimantia royalena, a member of the Labiatae family widely available in the western part of Uttar Pradesh, India. The seed coat was isolated by the non-solvent addition method and its colour, texture, solubility, and chemical and IR spectral properties were determined. The biomaterial swelling index, colour change point, and acute animal toxicity were also studied. The mucoadhesivity of the biomaterial was determined by The shear stress, Park and Robinson, and rotating cylinder methods, and the results were compared with those of the standard polymers sodium carboxymethyl cellulose and hydroxypropylmethyl cellulose. The research study revealed that the biomaterial from L. royalena seed coat exhibits promising inbuilt mucoadhesion and good mucoretentability. The mucoadhesion of the biomaterial was also confirmed by IR spectra showing carboxyl and hydroxyl groups. Hence the isolated biomaterial from the L. royalena seed coat can serve as a powerful natural mucoadhesant and may be used to develop mucoadhesive transmucosal drug delivery systems.
C1 [Madhav, N. V. Satheesh; Shankar, M. S. Uma] DIT Fac Pharm, Novel Drug Delivery Res Lab, Dehra Dun 248009, Uttranchal, India.
RP Madhav, NVS (reprint author), DIT Fac Pharm, Novel Drug Delivery Res Lab, Dehra Dun 248009, Uttranchal, India.
EM satheesh_madhav@yahoo.com
CR ANDREAS BS, 2005, ADV DRUG DELIV REV, V57, P1713
   Chen J.L., 1970, ADHESION BIOL SYSTEM, P163, DOI DOI 10.1016/B978-0-12-469050-9.50015-6
   LEHR CM, 1992, PHARMACEUT RES, V9, P70, DOI 10.1023/A:1018931811189
   MARTIN A, 2001, PHYS CHEM PRINCIPALS, P453
   MIKOS AG, 1990, BIOADHESIVE DRUG DEL, P25
   NADKAMI KM, 1976, MED PLANTS INDIA, V1, P1191
   PARK K, 1984, INT J PHARM, V19, P107, DOI 10.1016/0378-5173(84)90154-6
   PEPPAS N A, 1985, Journal of Controlled Release, V2, P257, DOI 10.1016/0168-3659(85)90050-1
   RAO YM, 1998, INDIAN DRUGS, V35, P558
   SUBRAHMANYAM CVS, 2002, LAB MANUAL PHYS PHAR, P351
NR 10
TC 1
Z9 1
U1 0
U2 1
PU THAILANDS NATL SCIENCE & TECHNOLOGY DEVELOPMENT AGENCY
PI BANGKOK
PA PUBLIC INFORMATION DEPT, 73/1 RAMA VI RD, RAJDHEVEE, BANGKOK, 00000,
   THAILAND
SN 1513-1874
J9 SCIENCEASIA
JI Scienceasia
PD MAR
PY 2011
VL 37
IS 1
BP 69
EP 71
DI 10.2306/scienceasia1513-1874.2011.37.069
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 752AN
UT WOS:000289660000010
OA Bronze
DA 2018-10-20
ER

PT J
AU Simionescu, A
   Tedder, ME
   Chuang, TH
   Simionescu, DT
AF Simionescu, Agneta
   Tedder, Mary E.
   Chuang, Ting-Hsien
   Simionescu, Dan T.
TI Lectin and antibody-based histochemical techniques for cardiovascular
   tissue engineering
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE Heart valves; Scaffolds; Stem cells; Vascular grafts; Xenografts
ID VALVE INTERSTITIAL-CELLS; MESENCHYMAL STEM-CELLS; HEART-VALVES;
   EXTRACELLULAR-MATRIX; COLLAGEN SCAFFOLDS; DEGRADING ENZYMES; ELASTIN;
   BIOCOMPATIBILITY; DEGENERATION; BIOMATERIAL
AB Tissue engineering holds immense potential for treatment of cardiovascular diseases by creating living structures to replace diseased blood vessels, heart valves, and cardiac muscle. In a traditional approach, scaffolds are seeded with stem cells and subjected to stimuli in bioreactors that mimic physiologic conditions or are directly implanted into target sites in animal models. The expected results are significant cell changes, extensive remodeling of the scaffolds and creation of surrogate structures that would be deemed acceptable for tissue regeneration. Histochemical techniques are increasingly becoming essential tools in tissue engineering research. In our studies, we used lectin and antibody-based techniques to characterize novel collagen and elastin scaffolds and to ensure efficient removal of xenoantigens. Scaffolds were implanted in animals and infiltrated host cells were identified using antibodies to activated fibroblasts, macrophages, and lymphocytes. Stem cell-seeded scaffolds were subjected to mechanical strains and tested for differentiation into cardiovascular cells using antibody-based double immunofluorescence methods. Finally, living heart valves were constructed from scaffolds and stem cells, subjected to conditioning in a bioreactor and stem cell differentiation evaluated by immunofluorescence. Overall, these techniques have proven to be outstanding companions to biochemical, molecular biology and cell analysis methods used in tissue engineering research and development.
C1 [Simionescu, Agneta; Tedder, Mary E.; Chuang, Ting-Hsien; Simionescu, Dan T.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Simionescu, DT (reprint author), Clemson Univ, Dept Bioengn, 301 Rhodes Ctr, Clemson, SC 29634 USA.
EM dsimion@clemson.edu
FU NIH [P20RR016461, HL084194]
FX This work was funded in part by NIH grants no. P20RR016461 and no.
   HL084194. The authors wish to thank Linda Jenkins HT for help with
   histology and the Godley-Snell Animal Research Center at Clemson
   University for the animal studies.
CR *AM HEART ASS NAT, 2004, YOUTH CARD DIS STAT
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baraki H, 2009, BIOMATERIALS, V30, P6240, DOI 10.1016/j.biomaterials.2009.07.068
   Breuer CK, 1996, BIOTECHNOL BIOENG, V50, P562, DOI 10.1002/(SICI)1097-0290(19960605)50:5<562::AID-BIT11>3.0.CO;2-L
   Chuang TH, 2009, TISSUE ENG PT A, V15, P2837, DOI [10.1089/ten.tea.2008.0394, 10.1089/ten.TEA.2008.0394]
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Daneshtalab N, 2010, J PHARMACOL TOXICOL, V61, P127, DOI 10.1016/j.vascn.2009.12.002
   Hinds MT, 2004, J BIOMED MATER RES A, V69A, P55, DOI 10.1002/jbm.a.20109
   Hoerstrup SP, 2002, CIRCULATION, V106, pI143, DOI 10.1161/01.cir.0000032872.55215.05
   Ku CH, 2006, CARDIOVASC RES, V71, P548, DOI 10.1016/j.cardiores.2006.03.022
   Latif N, 2007, J HEART VALVE DIS, V16, P56
   Liao J, 2008, BIOMATERIALS, V29, P1065, DOI 10.1016/j.biomaterials.2007.11.007
   Lichtenberg Artur, 2007, V140, P309
   Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sales VL, 2010, TISSUE ENG PT A, V16, P257, DOI [10.1089/ten.tea.2009.0424, 10.1089/ten.TEA.2009.0424]
   Schaefermeier PK, 2009, ASAIO J, V55, P86, DOI 10.1097/MAT.0b013e31818f54e4
   Schmidt D, 2006, CIRCULATION, V114, pI125, DOI 10.1161/CIRCULATIONAHA.105.001040
   Simionescu DT, 2003, J HEART VALVE DIS, V12, P217
   Simionescu DT, 2003, J HEART VALVE DIS, V12, P226
   Simionescu DT, 2003, J BIOMED MATER RES A, V66A, P755, DOI 10.1002/jbm.a.10066
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Strokan V, 1998, TRANSPLANTATION, V66, P1495, DOI 10.1097/00007890-199812150-00013
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   Vorp DA, 2005, FRONT BIOSCI, V10, P768, DOI 10.2741/1571
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
NR 32
TC 2
Z9 2
U1 0
U2 7
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD MAR
PY 2011
VL 34
IS 1
BP 20
EP 28
DI 10.1179/014788811X12949268296040
PG 9
WC Cell Biology
SC Cell Biology
GA 751AK
UT WOS:000289589500003
PM 25620822
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pegueroles, M
   Aguirre, A
   Engel, E
   Pavon, G
   Gil, FJ
   Planell, JA
   Migonney, V
   Aparicio, C
AF Pegueroles, M.
   Aguirre, A.
   Engel, E.
   Pavon, G.
   Gil, F. J.
   Planell, J. A.
   Migonney, V.
   Aparicio, C.
TI Effect of blasting treatment and Fn coating on MG63 adhesion and
   differentiation on titanium: a gene expression study using real-time
   RT-PCR
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; SURFACE-ROUGHNESS; INTEGRIN
   EXPRESSION; BIOACTIVE TITANIUM; PROLIFERATION; FIBRONECTIN; MODULATION;
   CHEMISTRY; BINDING
AB Biomaterial surface properties, via alterations in the adsorbed protein layer, and the presence of specific functional groups can influence integrin binding specificity, thereby modulating cell adhesion and differentiation processes. The adsorption of fibronectin, a protein directly involved in osteoblast adhesion to the extracellular matrix, has been related to different physical and chemical properties of biomaterial surfaces. This study used blasting particles of different sizes and chemical compositions to evaluate the response of MG63 osteoblast-like cells on smooth and blasted titanium surfaces, with and without fibronectin coatings, by means of real-time reverse transcription-polymerase chain reaction (qRT-PCR) assays. This response included (a) expression of the alpha(5), alpha(v) and alpha(3) integrin subunits, which can bind to fibronectin through the RGD binding site, and (b) expression of alkaline phosphatase (ALP) and osteocalcin (OC) as cell-differentiation markers. ALP activity and synthesis of OC were also tested. Cells on SiC-blasted Ti surfaces expressed higher amounts of the alpha(5) mRNA gene than cells on Al2O3-blasted Ti surfaces. This may be related to the fact that SiC-blasted surfaces adsorbed higher amounts of fibronectin due to their higher surface free energy and therefore provided a higher number of specific cell-binding sites. Fn-coated Ti surfaces decreased alpha(5) mRNA gene expression, by favoring the formation of other integrins involved in adhesion over alpha(5)beta(1). The changes in alpha(5) mRNA expression induced by the presence of fibronectin coatings may moreover influence the osteoblast differentiation pathway, as fibronectin coatings on Ti surfaces also decreased both ALP mRNA expression and ALP activity after 14 and 21 days of cell culture.
C1 [Pegueroles, M.; Engel, E.; Gil, F. J.; Planell, J. A.; Aparicio, C.] Univ Politecn Cataluna, Biomat Biomech & Tissue Engn Grp, Dept Mat Sci & Met, E-08028 Barcelona, Spain.
   [Aguirre, A.; Engel, E.; Planell, J. A.] Inst Bioengn Catalonia IBEC, Barcelona 08028, Spain.
   [Pavon, G.; Migonney, V.] Inst Galilee, Lab Biomat & Polymeres Special, UMR 7052, F-93430 Villetaneuse, France.
RP Aparicio, C (reprint author), Univ Minnesota, Sch Dent, MDRCBB, Dept Restorat Sci, 16-212 Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.
EM marta.pegueroles@upc.edu; aaguirre@pcb.ub.es; elisabeth.engel@upc.edu;
   graciela@univ-paris13.fr; francesc.xavier.gil@upc.edu;
   japlanell@ibec.pcb.ub.es; veronique.migonney@univ-paris13.fr;
   apari003@umn.edu
RI Engel, Elisabeth/D-4365-2014; Aguirre, Aitor/A-3294-2013; Aparicio,
   Conrado/J-9903-2012
OI Engel, Elisabeth/0000-0003-4855-8874; Aparicio,
   Conrado/0000-0003-2969-6067; PEGUEROLES, MARTA/0000-0002-7895-8337;
   Aguirre, Aitor/0000-0002-1383-2792; MIGONNEY,
   VERONIQUE/0000-0002-1055-3720
FU Spanish Interministerial Commission for Science and Technology (CICYT)
   [MAT2003-08165]; Universitat Politecnica de Catalunya (UPC)
FX The authors would like to acknowledge the Spanish Interministerial
   Commission for Science and Technology (CICYT) for financial support
   under the MAT2003-08165 project. They would also like to thank Klockner
   S. L. for technical help in sample preparation and MPA, S. L. (Materias
   Primas Abrasivas) for providing the blasting particles and blasting
   machine. M. Pegueroles would like to thank the Universitat Politecnica
   de Catalunya (UPC) for grant funding to complete her PhD thesis.
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aparicio C, 2004, KEY ENG MAT, V254-2, P737, DOI 10.4028/www.scientific.net/KEM.254-256.737
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Cheng SL, 2000, J CELL BIOCHEM, V77, P265, DOI 10.1002/(SICI)1097-4644(20000501)77:2<265::AID-JCB9>3.0.CO;2-6
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   HEINO J, 1989, J BIOL CHEM, V264, P21806
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Orsini G, 2000, INT J ORAL MAX IMPL, V15, P779
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pegueroles M, 2008, SURF COAT TECH, V202, P3470, DOI 10.1016/j.surfcoat.2007.12.021
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Raz P, 2004, J BIOMED MATER RES A, V71A, P217, DOI 10.1002/jbm.a.30134
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sousa SR, 2005, J MATER SCI-MATER M, V16, P1173, DOI 10.1007/s10856-005-4725-4
   Sousa SR, 2004, LANGMUIR, V20, P9745, DOI 10.1021/la049158d
   ter Brugge PJ, 2002, TISSUE ENG, V8, P615, DOI 10.1089/107632702760240535
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 43
TC 17
Z9 20
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2011
VL 22
IS 3
BP 617
EP 627
DI 10.1007/s10856-011-4229-3
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 747EH
UT WOS:000289302600020
PM 21258846
DA 2018-10-20
ER

PT J
AU Soininen, A
   Levon, J
   Katsikogianni, M
   Myllymaa, K
   Lappalainen, R
   Konttinen, YT
   Kinnari, TJ
   Tiainen, VM
   Missirlis, Y
AF Soininen, Antti
   Levon, Jaakko
   Katsikogianni, Maria
   Myllymaa, Katja
   Lappalainen, Reijo
   Konttinen, Yrjo T.
   Kinnari, Teemu J.
   Tiainen, Veli-Matti
   Missirlis, Yannis
TI In vitro adhesion of staphylococci to diamond-like carbon polymer
   hybrids under dynamic flow conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BACTERIAL ADHESION; STAINLESS-STEEL; MICROBIAL ADHESION; BIOFILM
   FORMATION; AMORPHOUS-CARBON; DISCHARGE METHOD; SURFACES; COATINGS;
   EPIDERMIDIS; INFECTIONS
AB This study compares the ability of selected materials to inhibit adhesion of two bacterial strains commonly implicated in implant-related infections. These two strains are Staphylococcus aureus (S-15981) and Staphylococcus epidermidis (ATCC 35984). In experiments we tested six different materials, three conventional implant metals: titanium, tantalum and chromium, and three diamond-like carbon (DLC) coatings: DLC, DLC-polydimethylsiloxane hybrid (DLC-PDMS-h) and DLC-polytetrafluoroethylene hybrid (DLC-PTFE-h) coatings. DLC coating represents extremely hard material whereas DLC hybrids represent novel nanocomposite coatings. The two DLC polymer hybrid films were chosen for testing due to their hardness, corrosion resistance and extremely good non-stick (hydrophobic and oleophobic) properties. Bacterial adhesion assay tests were performed under dynamic flow conditions by using parallel plate flow chambers (PPFC). The results show that adhesion of S. aureus to DLC-PTFE-h and to tantalum was significantly (P < 0.05) lower than to DLC-PDMS-h (0.671 +/- A 0.001 x 10(7)/cm(2) and 0.751 +/- A 0.002 x 10(7)/cm(2) vs. 1.055 +/- A 0.002 x 10(7)/cm(2), respectively). No significant differences were detected between other tested materials. Hence DLC-PTFE-h coating showed as low susceptibility to S. aureus adhesion as all the tested conventional implant metals. The adherence of S. epidermidis to biomaterials was not significantly (P < 0.05) different between the materials tested. This suggests that DLC-PTFE-h films could be used as a biomaterial coating without increasing the risk of implant-related infections.
C1 [Soininen, Antti; Konttinen, Yrjo T.; Tiainen, Veli-Matti] ORTON Orthopaed Hosp, ORTON Res Inst, Helsinki 00280, Finland.
   [Levon, Jaakko; Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland.
   [Katsikogianni, Maria; Missirlis, Yannis] Univ Patras, Dept Aeronaut & Mech Engn, Lab Biomech & Biomed Engn, Patras, Greece.
   [Myllymaa, Katja; Lappalainen, Reijo] Univ Kuopio, Dept Phys, FIN-70211 Kuopio, Finland.
   [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, Tampere, Finland.
   [Kinnari, Teemu J.] Univ Helsinki, Cent Hosp, Dept Otolaryngol, Helsinki, Finland.
RP Soininen, A (reprint author), ORTON Orthopaed Hosp, ORTON Res Inst, Tenholantie 10, Helsinki 00280, Finland.
EM antti.soininen@orton.fi
OI Katsikogianni, Maria/0000-0002-1560-3993
FU Sigrid Juselius Foundation; ORTON evo-grant; ORTON Foundation; European
   Science Foundation; Danish Council for Strategic Research
FX This research work has been supported by Sigrid Juselius Foundation,
   ORTON evo-grant, ORTON Foundation, European Science Foundation
   "Regenerative Medicine" RNP, the Danish Council for Strategic Research
   "Individualized Musculoskeletal Medicine", MATERA project
   "RSHI-DLC-nanocomp". PhD-programme in Musculoskeletal Diseases and
   Biomaterials (TBGS).
CR Alakoski E, 2003, DIAM RELAT MATER, V12, P2115, DOI 10.1016/S0925-9635(03)00238-3
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Antilla A, 2003, SURF ENG, V19, P425, DOI 10.1179/026708403225006195
   ANTTILA A, 1995, MATER LETT, V24, P153, DOI 10.1016/0167-577X(95)00071-2
   Anttila A, 1999, NEW DIAM FRONT C TEC, V9, P283
   Anttila A, 1997, ADV MATER, V9, P1161, DOI 10.1002/adma.19970091507
   Anttila A, 1989, NATO ASI SERIES
   ANTTILA A, 1992, Patent No. 5078848
   Black J, 1998, HDB BIOMATERIAL PROP
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s
   Colas A., 2004, SILICONE BIOMATERIAL
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   DEMANE CQ, 1995, OTOLARYNG CLIN N AM, V28, P225
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5
   Huikko K, 2003, LAB CHIP, V3, P67, DOI 10.1039/b300345k
   Jones DS, 2006, J BIOMED MATER RES B, V78B, P230, DOI 10.1002/jbm.b.30474
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Kiuru M, 2004, MATER LETT, V58, P2213, DOI 10.1016/j.matlet.2004.01.024
   Lappalainen R, 2003, J BIOMED MATER RES B, V66B, P410, DOI 10.1002/jbm.b.10026
   LAPPALAINEN R, 1998, CLIN ORTHOP RELAT R, V352, P118
   Levon J, 2010, J BIOMED MATER RES A, V92A, P1606, DOI 10.1002/jbm.a.32486
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mascari L, 2001, ANN BIOMED ENG, V29, P956, DOI 10.1114/1.1415527
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   MEINDERS JM, 1992, J MICROBIOL METH, V16, P119, DOI 10.1016/0167-7012(92)90031-X
   Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4
   Raulio M, 2008, J IND MICROBIOL BIOT, V35, P751, DOI 10.1007/s10295-008-0343-8
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Roosjen A, 2005, COLLOID SURFACE B, V46, P1, DOI 10.1016/j.colsurtb.2005.08.009
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Shin YN, 2008, APPL SURF SCI, V255, P293, DOI 10.1016/j.apsusc.2008.06.173
   Soininen A, 2009, J BIOMED MATER RES B, V90B, P882, DOI 10.1002/jbm.b.31359
   Stavridi M, 2003, MAT SCI ENG C-BIO S, V23, P359, DOI 10.1016/S0928-4931(02)00287-4
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 47
TC 7
Z9 8
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2011
VL 22
IS 3
BP 629
EP 636
DI 10.1007/s10856-011-4231-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 747EH
UT WOS:000289302600021
PM 21243516
DA 2018-10-20
ER

PT J
AU Liu, F
   Zhang, X
   Yu, XX
   Xu, YT
   Feng, T
   Ren, DW
AF Liu, Fei
   Zhang, Xu
   Yu, Xixun
   Xu, Yuanting
   Feng, Ting
   Ren, Dawei
TI In vitro study in stimulating the secretion of angiogenic growth factors
   of strontium-doped calcium polyphosphate for bone tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ENDOTHELIAL-CELLS; EXTRACELLULAR CALCIUM; GENE-EXPRESSION; FACTOR
   DELIVERY; SCAFFOLDS; RANELATE; OSTEOBLASTS; RECEPTOR; RELEASE; ROLES
AB Angiogenesis of tissue-engineered bone remains a limited factor for the engineering of larger bone tissue constructs. Attempts to stimulate angiogenesis, using recombinant protein or gene transfer of angiogenic growth factors, have been proposed; however, these approaches have been associated with some problems regarding such as complex technique, expensive prices as well as safety problems and short half-life of angiogenic growth factors. This study was performed to determine the ability of strontium-doped calcium polyphosphate (SCPP) to induce angiogenesis via researching its effect on the mRNA expressions and protein secretion of VEGF and bFGF in/from cultured osteoblasts (ROS17/2.8 cells). We cultured osteoblasts with SCPP scaffolds containing various doses of strontium as well as calcium polyphosphate (CPP) scaffold. Through the detection of MTT and SEM, we have found that SCPP could promote cell proliferation and maintain their morphology. The results of RT-PCR and ELISA indicated that, compared with those in CPP group, the mRNA expression as well as protein levels of VEGF and bFGF in/from cultured osteoblasts were dose-dependent increasing in response to increasing strontium before reaching the peak in SCPP groups, and 8% SCPP showed the optimal promoting role. Therefore, SCPP containing proper dose of strontium could be served as a potential biomaterial with stimulating angiogenesis in bone tissue engineering and bone repair.
C1 [Liu, Fei; Zhang, Xu; Yu, Xixun; Xu, Yuanting; Ren, Dawei] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
   [Liu, Fei; Yu, Xixun] Sichuan Univ, Suzhou Inst, Suzhou 215123, Peoples R China.
   [Feng, Ting] Sichuan Univ, W China Univ Hosp 2, Chengdu 610065, Peoples R China.
RP Yu, XX (reprint author), Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
EM yuxixun@163.com
OI Yu, Xixun/0000-0002-2301-8727
FU National Natural Science Foundation of China [30870616]; Basic Research
   Program of Sichuan Province-China [07JY029-075]; Natural Science
   Foundation of Jiangsu Province-China [BK2008152]
FX This work was supported by the National Natural Science Foundation of
   China (30870616), Basic Research Program of Sichuan Province-China
   (07JY029-075) and Natural Science Foundation of Jiangsu Province-China
   (BK2008152). We would like to thank the Analysis and Testing Center,
   Sichuan University (China) for their assistance of the completion of
   scanning electron microscopy analysis.
CR Ammann P, 2005, OSTEOPOROSIS INT, V16, pS11, DOI 10.1007/s00198-004-1809-9
   Brown EM, 2003, OSTEOPOROSIS INT, V14, pS25, DOI 10.1007/s00198-002-1343-6
   Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   Chen YW, 2008, APPL SURF SCI, V255, P331, DOI 10.1016/j.apsusc.2008.06.154
   Chen YW, 2008, J MATER SCI-MATER M, V19, P2655, DOI 10.1007/s10856-007-3350-9
   Choudhary S, 2003, J BONE MINER RES, V18, P1813, DOI 10.1359/jbmr.2003.18.10.1813
   Coulombe J, 2004, BIOCHEM BIOPH RES CO, V323, P1184, DOI 10.1016/j.bbrc.2004.08.209
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   HURLEY MM, 1993, J BIOL CHEM, V268, P5588
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   KOOS RD, 1995, BIOL REPROD, V52, P1426, DOI 10.1095/biolreprod52.6.1426
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maehata Y, 2006, MATRIX BIOL, V25, P47, DOI 10.1016/j.matbio.2005.09.001
   Marie PJ, 2005, OSTEOPOROSIS INT, V16, pS7, DOI 10.1007/s00198-004-1753.8
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   PHILLIPS HS, 1990, ENDOCRINOLOGY, V127, P965, DOI 10.1210/endo-127-2-965
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RONALD EU, 2007, BIOMATERIALS, V28, P3965
   Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tian M, 2009, J MATER SCI-MATER M, V20, P1505, DOI 10.1007/s10856-009-3713-5
   Tokuda H, 2003, J ENDOCRINOL, V177, P101, DOI 10.1677/joe.0.1770101
   Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Young M F, 1992, Clin Orthop Relat Res, P275
   Zhu YB, 2004, J MATER SCI-MATER M, V15, P283, DOI 10.1023/B:JMSM.0000015489.27261.f0
NR 37
TC 24
Z9 29
U1 0
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2011
VL 22
IS 3
BP 683
EP 692
DI 10.1007/s10856-011-4247-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 747EH
UT WOS:000289302600027
PM 21287239
DA 2018-10-20
ER

PT J
AU Eberli, D
   Atala, A
   Yoo, JJ
AF Eberli, Daniel
   Atala, Anthony
   Yoo, James J.
TI One and four layer acellular bladder matrix for fascial tissue
   reconstruction
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL RECONSTRUCTION; HERNIA
   REPAIR; POLYPROPYLENE MESH; RABBIT MODEL; PROSTHETIC MATERIALS;
   TENSILE-STRENGTH; UROTHELIAL CELLS; URINARY-BLADDER; COMPOSITE MESH
AB To determine whether the use of multiple layers of acellular bladder matrix (ABM) is more suitable for the treatment of abdominal wall hernia than a single layered ABM. The feasibility, biocompatibility and mechanical properties of both materials were assessed and compared. Biocompatibility testing was performed on 4 and 1 layered ABM. The matrices were used to repair an abdominal hernia model in 24 rabbits. The animals were followed for up to 3 months. Immediately after euthanasia, the implant site was inspected and samples were retrieved for histology, scanning electron microscopy and biomechanical studies. Both acellular biomaterials demonstrated excellent biocompatibility. At the time of retrieval, there was no evidence of infection. The matrices demonstrated biomechanical properties comparable to native tissue. Three hernias (25%) were found in the single layer ABM group and only 1 hernia (8%) was found in the 4 layer ABM group. Histologically, the matrix structure was intact and the cell density within the matrices decreased with time. The dominant cell type present within the matrices shifted from lymphocytes to fibroblasts over time. Both ABMs maintained adequate strength over time when used for hernia repair, and there was an extremely low incidence of adhesion formation. The single layer ABM showed enhanced cellular integration, while the 4 layer ABM reduced hernia formation. Either of these matrices may be useful as an off-the-shelf biomaterial for patients requiring fascial repair.
C1 [Eberli, Daniel; Atala, Anthony; Yoo, James J.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27154 USA.
RP Yoo, JJ (reprint author), Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27154 USA.
EM daniel.eberli@usz.ch; jyoo@wfubmc.edu
RI Yoo, James/L-4850-2017
OI Atala, Anthony/0000-0001-8186-2160
FU Acell Inc.; Swiss National Research Foundation; Swiss Urological
   Association
FX The authors wish to thank Jennifer Olson, Ph.D. for editorial assistance
   with this manuscript. This research was supported, in part, by Acell
   Inc., the Swiss National Research Foundation and Swiss Urological
   Association.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Alimoglu O, 2003, HEPATO-GASTROENTEROL, V50, P725
   AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   BAUER JJ, 1987, ANN SURG, V206, P765, DOI 10.1097/00000658-198712000-00013
   Bellon JM, 1997, J BIOMATER APPL, V12, P121, DOI 10.1177/088532829701200203
   Butler CE, 2004, PLAST RECONSTR SURG, V114, P464, DOI 10.1097/01.PRS.0000132670.81794.7E
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Demir U, 2005, SURG TODAY, V35, P223, DOI 10.1007/s00595-004-2907-1
   Dinsmore RC, 2000, J AM COLL SURGEONS, V191, P131, DOI 10.1016/S1072-7515(00)00337-9
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Eberli D, 2010, J BIOMED MATER RES A, V93A, P1527, DOI 10.1002/jbm.a.32636
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Farhat WA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025015
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Freytes DO, 2006, J BIOMED MATER RES B, V78B, P327, DOI 10.1002/jbm.b.30491
   Hafez AT, 2004, J UROLOGY, V171, P2489, DOI 10.1097/01.ju.0000125298.26997.84
   Han J G, 2007, Hernia, V11, P419, DOI 10.1007/s10029-007-0248-x
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   JAMES NL, 1991, BIOMATERIALS, V12, P801, DOI 10.1016/0142-9612(91)90065-I
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Klinge U, 1996, LANGENBECK ARCH CHIR, V381, P323
   Klinge U, 1999, EUR J SURG, V165, P665
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y
   Krambeck AE, 2006, UROLOGY, V67, P1105, DOI 10.1016/j.urology.2005.11.036
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   Majercik S, 2006, SURG ENDOSC, V20, P1671, DOI 10.1007/s00464-005-0660-1
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Pu LLQ, 2005, PLAST RECONSTR SURG, V115, P2127, DOI 10.1097/01.PRS.0000168883.65715.2F
   Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x
   RODGERS BM, 1981, ANN SURG, V193, P606, DOI 10.1097/00000658-198105000-00010
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Soergel TM, 2003, J UROLOGY, V170, P1577, DOI 10.1097/01.ju.0000083802.87337.af
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   VOYLES CR, 1981, ANN SURG, V194, P219, DOI 10.1097/00000658-198108000-00017
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 49
TC 6
Z9 7
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2011
VL 22
IS 3
BP 741
EP 751
DI 10.1007/s10856-011-4242-6
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 747EH
UT WOS:000289302600032
PM 21286788
DA 2018-10-20
ER

PT J
AU Jayakumar, R
   Chennazhi, KP
   Srinivasan, S
   Nair, SV
   Furuike, T
   Tamura, H
AF Jayakumar, Rangasamy
   Chennazhi, Krishna Prasad
   Srinivasan, Sowmya
   Nair, Shantikumar V.
   Furuike, Tetsuya
   Tamura, Hiroshi
TI Chitin Scaffolds in Tissue Engineering
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE chitin scaffold; bone; cartilage; wound; tissue engineering;
   biomaterials; hydrogel
ID BIOMIMETIC NANOFIBROUS SCAFFOLDS; BIOACTIVE GLASS DISSOLUTION;
   BETA-CHITIN; COMPOSITE SCAFFOLDS; DEGRADATION BEHAVIOR; BLEND
   NANOFIBERS; SULFATED CHITIN; CELL ATTACHMENT; IONIC PRODUCTS; BONE
AB Tissue engineering/regeneration is based on the hypothesis that healthy stem/progenitor cells either recruited or delivered to an injured site, can eventually regenerate lost or damaged tissue. Most of the researchers working in tissue engineering and regenerative technology attempt to create tissue replacements by culturing cells onto synthetic porous three-dimensional polymeric scaffolds, which is currently regarded as an ideal approach to enhance functional tissue regeneration by creating and maintaining channels that facilitate progenitor cell migration, proliferation and differentiation. The requirements that must be satisfied by such scaffolds include providing a space with the proper size, shape and porosity for tissue development and permitting cells from the surrounding tissue to migrate into the matrix. Recently, chitin scaffolds have been widely used in tissue engineering due to their non-toxic, biodegradable and biocompatible nature. The advantage of chitin as a tissue engineering biomaterial lies in that it can be easily processed into gel and scaffold forms for a variety of biomedical applications. Moreover, chitin has been shown to enhance some biological activities such as immunological, antibacterial, drug delivery and have been shown to promote better healing at a faster rate and exhibit greater compatibility with humans. This review provides an overview of the current status of tissue engineering/regenerative medicine research using chitin scaffolds for bone, cartilage and wound healing applications. We also outline the key challenges in this field and the most likely directions for future development and we hope that this review will be helpful to the researchers working in the field of tissue engineering and regenerative medicine.
C1 [Jayakumar, Rangasamy; Chennazhi, Krishna Prasad; Srinivasan, Sowmya; Nair, Shantikumar V.] Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci & Mol Med, Cochin 682041, Kerala, India.
   [Furuike, Tetsuya; Tamura, Hiroshi] Kansai Univ, Fac Chem Mat & Bioengn, Osaka 5648680, Japan.
RP Jayakumar, R (reprint author), Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci & Mol Med, Cochin 682041, Kerala, India.
EM rjayakumar@aims.amrita.edu; drkrishnaprasadc@aims.amrita.edu;
   sowmyasrinivasan@aims.amrita.edu; shantinair@aims.amrita.edu;
   furuike@kansai-u.ac.jp; tamura@kansai-u.ac.jp
OI Chennazhi, Krishna Prasad/0000-0002-9390-0328
FU SERC Division, Department of Science and Technology (DST), India
   [SR/FT/CS-005/2008]; Department of Biotechnology (DBT), Government of
   India [BT/PR13585/NNT/28/474/2010]; DST, India, under Nanoscience and
   Nanotechnology Initiative
FX One of the authors R. Jayakumar is grateful to SERC Division, Department
   of Science and Technology (DST), India, for providing the fund under the
   scheme of "Fast Track Scheme for Young Investigators" (Ref. No.
   SR/FT/CS-005/2008). The author R. Jayakumar is also thankful to
   Department of Biotechnology (DBT), Government of India, for providing
   the fund under the scheme of Nanoscience and Nanotechnology Program
   (Ref. No. BT/PR13585/NNT/28/474/2010). S.V. Nair is also grateful to
   DST, India, which partially supported this work, under the Nanoscience
   and Nanotechnology Initiative program monitored by C.N.R. Rao.
CR Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Chow KS, 2001, J POLYM RES, V8, P27
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Foppiano S, 2007, ACTA BIOMATER, V3, P765, DOI 10.1016/j.actbio.2007.02.011
   Ge ZG, 2004, BIOMATERIALS, V25, P1049, DOI 10.1016/S0142-9612(03)00612-4
   Hay ED, 1991, CELL BIOL EXTRACELLU
   Hench LL, 2009, J EUR CERAM SOC, V29, P1257, DOI 10.1016/j.jeurceramsoc.2008.08.002
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Jayakumar R, 2008, INT J BIOL MACROMOL, V43, P32, DOI 10.1016/j.ijbiomac.2007.09.003
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Jayakumar R, 2010, PROG MATER SCI, V55, P675, DOI 10.1016/j.pmatsci.2010.03.001
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jayakumar R, 2009, INT J BIOL MACROMOL, V45, P260, DOI 10.1016/j.ijbiomac.2009.06.002
   Jayakumar R, 2009, INT J BIOL MACROMOL, V44, P107, DOI 10.1016/j.ijbiomac.2008.10.010
   Jayakumar R., 2010, BIOTECHNOL ADV UNPUB
   Jayakumar R, 2008, MACROMOL SYMP, V264, P163, DOI 10.1002/masy.200850426
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kumar PTS, 2010, CARBOHYD POLYM, V80, P761, DOI 10.1016/j.carbpol.2009.12.024
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Madhumathi K, 2010, J MATER SCI-MATER M, V21, P807, DOI 10.1007/s10856-009-3877-z
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P289, DOI 10.1016/j.ijbiomac.2009.06.009
   Madhumathi K, 2009, INT J BIOL MACROMOL, V44, P1, DOI 10.1016/j.ijbiomac.2008.09.013
   Maeda Y, 2008, INT J BIOL MACROMOL, V42, P463, DOI 10.1016/j.ijbiomac.2008.03.002
   Mezzana P, 2008, Acta Chir Plast, V50, P81
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nagahama H, 2008, CARBOHYD POLYM, V73, P456, DOI 10.1016/j.carbpol.2007.12.011
   Nagahama H, 2008, CARBOHYD POLYM, V73, P295, DOI 10.1016/j.carbpol.2007.11.034
   Nagahama H, 2009, INT J BIOL MACROMOL, V44, P333, DOI 10.1016/j.ijbiomac.2009.01.006
   Nagahama H, 2008, MACROMOL SYMP, V264, P8, DOI 10.1002/masy.200850402
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Park KE, 2006, BIOMACROMOLECULES, V7, P635, DOI 10.1021/bm0509265
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Peter M, 2009, CARBOHYD POLYM, V78, P926, DOI 10.1016/j.carbpol.2009.07.016
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Shalumon KT, 2009, CARBOHYD POLYM, V77, P863, DOI 10.1016/j.carbpol.2009.03.009
   Sowmya S, 2011, TRENDS BIOMATER ARTI, V25, P1
   Sudheesh Kumar P.T., 2011, INT J BIOL IN PRESS
   Sudheesh Kumar P.T., 2011, CARBOHYDR P IN PRESS
   Suzuki D, 2008, J MATER SCI-MATER M, V19, P1307, DOI 10.1007/s10856-007-3245-9
   Tamura H., 2010, CARBOHYD POLYM, V84, P820
   Tamura H, 2006, HOLZFORSCHUNG, V60, P480, DOI 10.1515/HF.2006.079
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tokura S, 2001, BIOMACROMOLECULES, V2, P417, DOI 10.1021/bm0001345
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wheeler DL, 2001, J BIOMED MATER RES, V55, P603, DOI 10.1002/1097-4636(20010615)55:4<603::AID-JBM1054>3.0.CO;2-N
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Zhang CX, 2005, EUR POLYM J, V41, P423, DOI 10.1016/j.europolymj.2004.10.027
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 70
TC 68
Z9 71
U1 2
U2 78
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2011
VL 12
IS 3
BP 1876
EP 1887
DI 10.3390/ijms12031876
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 740HZ
UT WOS:000288784200030
PM 21673928
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ozeki, M
   Kuroda, S
   Kon, K
   Kasugai, S
AF Ozeki, Maho
   Kuroda, Shinji
   Kon, Kazuhiro
   Kasugai, Shohei
TI Differentiation of Bone Marrow Stromal Cells into Osteoblasts in a
   Self-assembling Peptide Hydrogel: In Vitro and In Vivo Studies
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE self-assemble; hydrogel; tissue engineering; RAD16; osteogenesis
ID MESENCHYMAL STEM-CELLS; POROUS HYDROXYAPATITE; COMPLEMENTARY
   OLIGOPEPTIDE; MORPHOGENETIC PROTEIN-2; COMPOSITE SCAFFOLDS; COLLAGEN;
   OSTEOINDUCTION; DEFECTS; ATELOCOLLAGEN; REGENERATION
AB A prerequisite of tissue engineering approaches with regard to autograft is a suitable scaffold that can harbor cells and signals. Conventionally, such scaffolds have been prepared as 3D scaffolds prefabricated from synthetic or natural biomaterials. RAD16 has been introduced as a new biomaterial, where synthetic peptides self-assemble to form a hydrogel. In this study, RAD16 was examined in terms of osteogenic efficacy and feasibility of ectopic mineralization.
   Two hundred and seventy-one RAD16 was cocultured with 1 x 10(6) bone marrow cells from the femurs of 6-week-old Wistar male rats in alpha minimum essential medium supplemented with or without dexamethasone. Second, the same volume of the RAD16 construct hosting the cells with or without hydroxyapatite (HA) particles was treated in the dexamethasone medium as well, prepared in a Teflon tube, and implanted subcutaneously. Cell proliferation was prominent in the RAD16 coculture with dexamethasone at 1 week and significantly decreased by 2 weeks, whereas the other combinations remained or inclined, and their osteogenic differentiation was accelerated up to 2 weeks, as seen in increasing alkaline phosphatase (ALP) activity and mRNAs of ALP, OPN, and OCN. The RAD16 implant prepared with HA particles allowed more osteoblast-like cells and blood cells to grow inside, which was accompanied by elevating OPN gene expression and the stronger peak of VEGF gene expression at 2 weeks. Furthermore, more OPN mRNA signal was detected around the RAD16 containing HA particles by 4 weeks. On the other hand, the RAD16 alone represented lower expression of OPN gene. During the experiment, however, no ectopic mineralization was observed in both groups. Conclusively, it was suggested that the RAD16 showed feasibility of serving as a matrix for osteogenic differentiation of cocultured bone marrow cells in vitro and in vivo. Proceeding of exploration and modification of RAD16 are continuously required for cell-based tissue engineering.
C1 [Ozeki, Maho; Kuroda, Shinji; Kon, Kazuhiro; Kasugai, Shohei] Tokyo Med & Dent Univ, Grad Sch, Bunkyo Ku, Tokyo 1138549, Japan.
   [Kasugai, Shohei] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo 1138549, Japan.
RP Kuroda, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.
EM skuroda.mfc@tmd.ac.jp
FU Japan Society for the Promotion of Science [17689059, 19390513]; Tokyo
   Medical and Dental University
FX We sincerely thank Dr Keiichi Ohya and Dr Hitoyata Shimokawa,
   Pharmacology, Tokyo Medical and Dental University, and Dr Michiko
   Suzuki, Oral Implantology and Regenerative Dental Medicine, Tokyo
   Medical and Dental University, for technical help and advice. This
   research was supported by a grant from the Japan Society for the
   Promotion of Science (No. #17689059,19390513) and a grant from the
   Center of Excellence Program for Frontier Research on Molecular
   Destruction and Reconstruction of Tooth and Bone at Tokyo Medical and
   Dental University.
CR Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Choumerianou DM, 2008, TISSUE ENG PART B-RE, V14, P53, DOI 10.1089/teb.2007.0216
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Flautre B, 1999, J MATER SCI-MATER M, V10, P811, DOI 10.1023/A:1008923625599
   Garreta E, 2007, BIOMOL ENG, V24, P75, DOI 10.1016/j.bioeng.2006.05.017
   Hamada K, 2008, J BIOMED MATER RES A, V84A, P128, DOI 10.1002/jbm.a.31439
   Hasegawa N, 2006, J PERIODONTOL, V77, P1003, DOI 10.1902/jop.2006.050341
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hou LT, 2007, J PERIODONTOL, V78, P335, DOI 10.1902/jop.2007.060106
   Ikeuchi M, 2002, J BIOMED MATER RES, V60, P61, DOI 10.1002/jbm.1281
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   KURASHINA K, 2005, BIOMATERIALS, V26, P4550
   Kusumoto K, 1996, J CRANIO MAXILL SURG, V24, P360, DOI 10.1016/S1010-5182(96)80037-0
   Kusumoto K, 1997, BRIT J ORAL MAX SURG, V35, P433, DOI 10.1016/S0266-4356(97)90722-1
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   MISTRY AS, 2005, TISSUE ENG STRATEGIE, V2
   Nakagawa T, 2000, ORAL DIS, V6, P172
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shirai K, 2009, J PERIODONTAL RES, V44, P238, DOI 10.1111/j.1600-0765.2008.01140.x
   Spencer NJ, 2008, BIOMATERIALS, V29, P1028, DOI 10.1016/j.biomaterials.2007.11.006
   Takechi M, 2007, DENT MATER J, V26, P194, DOI 10.4012/dmj.26.194
   Tanaka T, 2009, J BIOMED MATER RES A, V91A, P428, DOI 10.1002/jbm.a.32253
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Yamazoe K, 2007, J VET MED SCI, V69, P835, DOI 10.1292/jvms.69.835
   Yoshida K, 1999, J DENT RES, V78, P1505, DOI 10.1177/00220345990780090401
   Yoshikawa T, 1998, J BIOMED MATER RES, V41, P568, DOI 10.1002/(SICI)1097-4636(19980915)41:4<568::AID-JBM8>3.3.CO;2-6
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhao XJ, 2004, TRENDS BIOTECHNOL, V22, P470, DOI 10.1016/j.tibech.2004.07.011
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
NR 40
TC 18
Z9 22
U1 4
U2 30
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2011
VL 25
IS 7
BP 663
EP 684
DI 10.1177/0885328209356328
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 744EP
UT WOS:000289077800002
PM 20089608
DA 2018-10-20
ER

PT J
AU Nieto-Aguilar, R
   Serrato, D
   Garzon, I
   Campos, A
   Alaminos, M
AF Nieto-Aguilar, R.
   Serrato, D.
   Garzon, I.
   Campos, A.
   Alaminos, M.
TI Pluripotential Differentiation Capability of Human Adipose-derived Stem
   Cells in a Novel Fibrin-agarose Scaffold
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE fibrin-agarose; biomaterials; scaffolds; adipose-derived stromal cells;
   transdifferentiation
ID BONE-MARROW; ENDOTHELIAL-CELLS; STROMAL CELLS; ORAL-MUCOSA; IN-VITRO;
   TISSUE; EXPRESSION; REGENERATION; CHONDROGENESIS; PATTERNS
AB The potentiality of adipose-derived stem cells (ASCs) cultured on 2D systems has been previously established. Nevertheless, very little is known so far about the differentiation potentiality of ASCs in 3D culture systems using biomaterials. In this work, we have evaluated the transdifferentiation capabilities of ASCs cultured within a novel fibrin-agarose biomaterial by histological analysis, histochemistry and immunofluorescence. Our results showed that 3D fibrin-agarose biomaterial is highly biocompatible and supports the transdifferentiation capabilities of ASCs to the osteogenic, chondrogenic, adipogenic, and neurogenic lineages.
C1 [Nieto-Aguilar, R.; Serrato, D.; Garzon, I.; Campos, A.; Alaminos, M.] Univ Granada, Fac Med, Dept Histol, Tissue Engn Grp, E-18012 Granada, Spain.
RP Alaminos, M (reprint author), Univ Granada, Fac Med, Dept Histol, Tissue Engn Grp, Ave Madrid 11, E-18012 Granada, Spain.
EM malaminos@ugr.es
RI ALAMINOS, MIGUEL/N-9960-2016
OI ALAMINOS, MIGUEL/0000-0003-4876-2672; serrato ochoa,
   Deyanira/0000-0001-7031-832X
FU Junta de Andalucia [P06-CTS-2191, SAS PI0135/2007]
FX This work was supported by grants P06-CTS-2191 and SAS PI0135/2007 of
   Junta de Andalucia. This study was approved by the local Research and
   Ethics committees of the University of Granada (number 2006/2191).
CR Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Alaminos M, 2007, J CELL PHYSIOL, V211, P692, DOI 10.1002/jcp.20976
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Atala A, 2008, CURR STEM CELL RES T, V3, P21, DOI 10.2174/157488808783489435
   Baillie DR, 2007, OSTOMY WOUND MANAG, V53, P30
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Chiu RCJ, 2008, SEMIN THORAC CARDIOV, V20, P115, DOI 10.1053/j.semtcvs.2008.03.004
   De Rosa A, 2009, TISSUE ENG PART C-ME, V15, P659, DOI [10.1089/ten.tec.2008.0674, 10.1089/ten.TEC.2008.0674]
   De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1
   Duggal S, 2009, TISSUE ENG PT A, V15, P1763, DOI 10.1089/ten.tea.2008.0306
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Holcomb J David, 2005, Facial Plast Surg, V21, P223, DOI 10.1055/s-2006-939501
   Housman TS, 2008, DERMATOL SURG, V34, P1
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim IK, 2008, TRANSPLANTATION, V86, P889, DOI 10.1097/TP.0b013e318186ac4a
   Kinikoglu B, 2009, BIOMATERIALS, V30, P6418, DOI 10.1016/j.biomaterials.2009.08.010
   Lin CS, 2008, ASIAN J ANDROL, V10, P171, DOI 10.1111/j.1745-7262.2008.00389.x
   Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Mehlhorn AT, 2009, TISSUE ENG PT A, V15, P1159, DOI 10.1089/ten.tea.2008.0069
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   NeunerJehle M, 1996, J NEUROSCI RES, V46, P138, DOI 10.1002/(SICI)1097-4547(19961015)46:2<138::AID-JNR2>3.0.CO;2-I
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Qi L, 2008, OBESITY, V16, P1061, DOI 10.1038/oby.2008.26
   Saadeh PB, 2001, J CRANIOFAC SURG, V12, P573, DOI 10.1097/00001665-200111000-00015
   Sanchez-Quevedo MC, 2007, HISTOL HISTOPATHOL, V22, P631, DOI 10.14670/HH-22.631
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Stevens B, 2008, J BIOMED MATER RES B, V85B, P573, DOI 10.1002/jbm.b.30962
   Suga H, 2009, BRIT J DERMATOL, V161, P819, DOI 10.1111/j.1365-2133.2009.09272.x
   Trubiani O, 2008, J BIOMED MATER RES A, V87A, P986, DOI 10.1002/jbm.a.31837
   Wei Y, 2007, CYTOTHERAPY, V9, P712, DOI 10.1080/14653240701620596
   Weinzierl K, 2006, J CRANIO MAXILL SURG, V34, P466, DOI 10.1016/j.jcms.2006.07.860
   Xu Y, 2005, CURR OPIN MOL THER, V7, P300
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 43
TC 14
Z9 14
U1 0
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2011
VL 25
IS 7
BP 743
EP 768
DI 10.1177/0885328209360425
PG 26
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 744EP
UT WOS:000289077800006
PM 20237181
DA 2018-10-20
ER

PT J
AU Kolettis, TM
   Vilaeti, A
   Dimos, K
   Tsitou, N
   Agathopoulos, S
AF Kolettis, T. M.
   Vilaeti, A.
   Dimos, K.
   Tsitou, N.
   Agathopoulos, S.
TI Tissue Engineering for Post-Myocardial Infarction Ventricular Remodeling
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Biomaterial scaffold; cardiac repair; heart failure; myocardial
   infarction; ventricular remodeling
ID ACUTE MYOCARDIAL-INFARCTION; ISCHEMIC MITRAL REGURGITATION; ASSEMBLING
   PEPTIDE NANOFIBERS; BIOENGINEERED CARDIAC GRAFTS; MESENCHYMAL
   STEM-CELLS; GROWTH-FACTOR DELIVERY; HEART-FAILURE; POSTEROLATERAL
   INFARCTION; SMECTITE CLAYS; MODEL
AB Myocardial tissue engineering involves the design of biomaterial scaffolds, aiming at regenerating necrotic myocardium after myocardial infarction. Biomaterials provide mechanical support to the infarct area and they can be used as vehicles for sustained and controlled local administration of cells and growth factors. Although promising results have been reported in experimental studies, many issues need to be addressed before human use.
C1 [Kolettis, T. M.; Vilaeti, A.; Tsitou, N.] Univ Ioannina, Sch Med, Dept Cardiol, GR-45110 Ioannina, Greece.
   [Dimos, K.; Agathopoulos, S.] Univ Ioannina, Dept Mat Sci & Engn, Lab Ceram & Composite Mat, GR-45110 Ioannina, Greece.
RP Kolettis, TM (reprint author), Univ Ioannina, Sch Med, Dept Cardiol, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM thkolet@cc.uoi.gr
RI Dimos, Konstantinos/G-4809-2014
OI Dimos, Konstantinos/0000-0001-7390-1289
CR Agathopoulos S, 2003, BIOMATERIALS, V24, P1317, DOI 10.1016/S0142-9612(02)00468-4
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02,003
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Bourlinos AB, 2001, CHEM COMMUN, P1518, DOI 10.1039/b104922b
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Disesa VJ, 2002, ANN THORAC SURG, V74, P449
   Elaiopoulos DA, 2007, CLIN SCI, V112, P385, DOI 10.1042/CS20060193
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x
   Gournis D, 2006, J AM CHEM SOC, V128, P6154, DOI 10.1021/ja0579661
   Gournis D, 2004, J AM CHEM SOC, V126, P8561, DOI 10.1021/ja049237b
   Gournis D, 2002, LANGMUIR, V18, P10024, DOI 10.1021/la026292u
   Hatzistergos KE, 2008, GROWTH HORM IGF RES, V18, P157, DOI 10.1016/j.ghir.2007.08.002
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li RK, 1999, CIRCULATION, V100, P63
   Li ZH, 2006, AM J PHYSIOL-HEART C, V291, pH1972, DOI 10.1152/ajpheart.00043.2006
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Mitsi AC, 2005, MED HYPOTHESES, V64, P582, DOI 10.1016/j.mehy.2004.07.028
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Pilla JJ, 2003, J THORAC CARDIOV SUR, V126, P1467, DOI 10.1016/S0022-5223(03)00739-6
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Serefoglou E, 2008, CHEM MATER, V20, P4106, DOI 10.1021/cm800486u
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   STJOHN SM, 2003, CIRCULATION, V107, P2577
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Yang SC, 2008, BIOCONJUGATE CHEM, V19, P1164, DOI 10.1021/bc700442g
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
NR 74
TC 10
Z9 10
U1 1
U2 10
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PD MAR
PY 2011
VL 11
IS 3
BP 263
EP 270
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 743AA
UT WOS:000288985900006
PM 21222573
DA 2018-10-20
ER

PT J
AU Galler, KM
   Cavender, AC
   Koeklue, U
   Suggs, LJ
   Schmalz, G
   D'Souza, RN
AF Galler, Kerstin M.
   Cavender, Adriana C.
   Koeklue, Umut
   Suggs, Laura J.
   Schmalz, Gottfried
   D'Souza, Rena N.
TI Bioengineering of dental stem cells in a PEGylated fibrin gel
SO REGENERATIVE MEDICINE
LA English
DT Article
DE dental stem cells; dental tissue engineering; fibrin; polyethylene
   glycol
ID IN-VITRO; PULP; TISSUE; DIFFERENTIATION; MATRIX; TEETH; VIVO
AB Aim: Postnatal stem cells can generate tooth-specific structures after transplantation in vivo, which makes them a valuable tool for dental tissue engineering. Scaffold materials that are compatible with dental stem cells, injectable and tunable for targeted regeneration are needed. A candidate material is fibrin, a biopolymer critical to hemostasis and wound healing. Rapid degradation of fibrin can be decelerated by modification with polyethylene glycol (PEG), thus creating a hybrid material for cell delivery. The aim of this study was to evaluate the suitability of PEGylated fibrin as a scaffold for dental stem cells. Methods: A PEGylated fibrin hydrogel was combined with stem cells derived from dental pulp or periodontal ligament. Cell proliferation was assessed over a 4-week period, and alkaline phosphatase activity and expression levels of mineralization-associated genes after osteogenic induction were analyzed. Cell morphology, matrix degradation, collagen production and mineral deposition were evaluated by histology. Constructs of PEGylated fibrin with dental pulp stem cells in dentin disks were transplanted in immunocompromised mice for 5 weeks and examined for new tissue formation. Results: All cell types proliferated in PEGylated fibrin. After osteogenic induction, alkaline phosphatase activity was higher and osteoblast-specific genes were upregulated. Dentin-specific markers increased in pulp-derived stem cells. Histologic analysis revealed degradation of fibrin, production of a collagenous matrix and mineral deposition. In vivo transplantation rendered a vascularized soft connective tissue similar to dental pulp. Conclusion: Fibrin allows for the growth and differentiation of dental stem cells, can be inserted into small defects and thus appears to be a promising biomaterial for tissue regeneration in the oral cavity.
C1 [Cavender, Adriana C.; Koeklue, Umut; D'Souza, Rena N.] Texas A&M, Baylor Coll Med, Dept Biomed Sci, Dallas, TX USA.
   [Galler, Kerstin M.; Koeklue, Umut; Schmalz, Gottfried] Univ Regensburg, Dept Restorat Dent & Periodontol, Regensburg, Germany.
   [Suggs, Laura J.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP D'Souza, RN (reprint author), Texas A&M, Baylor Coll Med, Dept Biomed Sci, Dallas, TX USA.
EM rdsouza@bad.tamhsc.edu
OI D'Souza, Rena/0000-0002-1505-5173
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Bohl KS, 1998, J BIOMAT SCI-POLYM E, V9, P749, DOI 10.1163/156856298X00127
   BRIGANTI E, 2010, J CONTROL RELEASE, V147, P14
   Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009
   Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026
   Gandia C, 2008, STEM CELLS, V26, P638, DOI 10.1634/stemcells.2007-0484
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Huang GTJ, 2006, CELL TISSUE RES, V324, P225, DOI 10.1007/s00441-005-0117-9
   Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034
   Liu H, 2006, BIOMATERIALS, V27, P6004, DOI 10.1016/j.biomaterials.2006.06.016
   MIURA M, 2003, P NATL ACAD SCI USA, V100, P5808
   Petersen PE, 2008, INT DENT J, V58, P115, DOI 10.1922/IDJ_1930Petersen07
   Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Ranly DM, 2000, J DENT, V28, P153, DOI 10.1016/S0300-5712(99)00065-2
   Sakai VT, 2010, J DENT RES, V89, P791, DOI 10.1177/0022034510368647
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shibata Yasuaki, 2000, Histochemistry and Cell Biology, V113, P153, DOI 10.1007/s004180050434
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Trubiani O, 2003, J DENT RES, V82, P742, DOI 10.1177/154405910308200916
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   MICROBIOLOGY IMMUNOL
NR 25
TC 61
Z9 62
U1 0
U2 39
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD MAR
PY 2011
VL 6
IS 2
BP 191
EP 200
DI 10.2217/RME.11.3
PG 10
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 743UD
UT WOS:000289043300011
PM 21391853
DA 2018-10-20
ER

PT J
AU Karajanagi, SS
   Lopez-Guerra, G
   Park, H
   Kobler, JB
   Galindo, M
   Aanestad, J
   Mehta, DD
   Kumai, Y
   Giordano, N
   d'Almeida, A
   Heaton, JT
   Langer, R
   Herrera, VLM
   Faquin, W
   Hillman, RE
   Zeitels, SM
AF Karajanagi, Sandeep S.
   Lopez-Guerra, Gerardo
   Park, Hyoungshin
   Kobler, James B.
   Galindo, Marilyn
   Aanestad, Jon
   Mehta, Daryush D.
   Kumai, Yoshihiko
   Giordano, Nicholas
   d'Almeida, Anthony
   Heaton, James T.
   Langer, Robert
   Herrera, Victoria L. M.
   Faquin, William
   Hillman, Robert E.
   Zeitels, Steven M.
TI Assessment of Canine Vocal Fold Function After Injection of a New
   Biomaterial Designed to Treat Phonatory Mucosal Scarring
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE hoarseness; hydrogel; polyethylene glycol; scar
ID EXTRACELLULAR-MATRIX; HYALURONIC-ACID; TISSUE-REPAIR; GROWTH-FACTOR;
   PHONOSURGERY; CORD
AB Objectives: Most cases of irresolvable hoarseness are due to deficiencies in the pliability and volume of the superficial lamina propria of the phonatory mucosa. By using a US Food and Drug Administration approved polymer, polyethylene glycol (PEG), we created a novel hydrogel (PEG30) and investigated its effects on multiple vocal fold structural and functional parameters.
   Methods: We injected PEG30 unilaterally into 16 normal canine vocal folds with survival times of I to 4 months. Highspeed videos of vocal fold vibration, induced by intratracheal airflow, and phonation threshold pressures were recorded at 4 time points per subject. Three-dimensional reconstruction analysis of 11.7 T magnetic resonance images and histologic analysis identified 3 cases wherein PEG30 injections were the most superficial, so as to maximally impact vibratory function. These cases were subjected to in-depth analyses.
   Results: High-speed video analysis of the 3 selected cases showed minimal to no reduction in the maximum vibratory amplitudes of vocal folds injected with PEG30 compared to the non-injected, contralateral vocal fold. All PEG30-injected vocal folds displayed mucosal wave activity with low average phonation threshold pressures. No significant inflammation was observed on microlaryngoscopic examination. Magnetic resonance imaging and histologic analyses revealed time-dependent resorption of the PEG30 hydrogel by phagocytosis with minimal tissue reaction or fibrosis.
   Conclusions: The PEG30 hydrogel is a promising biocompatible candidate biomaterial to restore form and function to deficient phonatory mucosa, while not mechanically impeding residual endogenous superficial lamina propria.
C1 [Kobler, James B.; Heaton, James T.; Langer, Robert; Hillman, Robert E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Karajanagi, Sandeep S.; Park, Hyoungshin; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Herrera, Victoria L. M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Karajanagi, Sandeep S.; Lopez-Guerra, Gerardo; Park, Hyoungshin; Kobler, James B.; Kumai, Yoshihiko; Heaton, James T.; Hillman, Robert E.; Zeitels, Steven M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.
   [Giordano, Nicholas] Boston Univ, Sch Engn, Boston, MA 02118 USA.
   [Mehta, Daryush D.] Harvard Univ, Sch Engn & Appl Sci, Boston, MA 02115 USA.
   [Faquin, William] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.
   [Karajanagi, Sandeep S.; Lopez-Guerra, Gerardo; Park, Hyoungshin; Kobler, James B.; Galindo, Marilyn; Aanestad, Jon; Mehta, Daryush D.; Kumai, Yoshihiko; d'Almeida, Anthony; Heaton, James T.; Hillman, Robert E.; Zeitels, Steven M.] Massachusetts Gen Hosp, Ctr Laryngeal Surg & Voice Rehabil, Boston, MA 02114 USA.
   [Faquin, William] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
RP Karajanagi, SS (reprint author), Massachusetts Gen Hosp, Ctr Laryngeal Surg & Voice Rehabil, Bartlett Hall Extens 413, Boston, MA 02114 USA.
FU Eugene B. Casey Foundation; Institute of Laryngology and Voice
   Restoration
FX From the Center for Laryngeal Surgery and Voice Rehabilitation
   (Karajanagi, Lopez-Guerra, Park, Kobler, Galindo, Aanestad, Mehta,
   Kumai, d'Almeida, Heaton, Hillman, Zeitels) and the Department of
   Pathology (Faquin), Massachusetts General Hospital, the Departments of
   Surgery (Karajanagi, Lopez-Guerra, Park, Kobler, Kumai, Heaton, Hillman,
   Zeitels) and Pathology (Faquin), Harvard Medical School, the Department
   of Medicine, Boston University School of Medicine (Herrera), the School
   of Engineering and Applied Sciences, Harvard University (Mehta), and the
   School of Engineering, Boston University (Giordano), Boston, and the
   Department of Chemical Engineering (Karajanagi, Park, Langer) and the
   Harvard-MIT Division of Health Sciences and Technology (Kobler, Heaton,
   Langer, Hillman), Massachusetts Institute of Technology, Cambridge,
   Massachusetts. This work was supported in part by the Eugene B. Casey
   Foundation and the Institute of Laryngology and Voice Restoration. Dr
   Zeitels has an equity interest in Endocraft LLC. This study was
   performed in accordance with the PHS Policy on Humane Care and Use of
   Laboratory Animals, the NIH Guide for the care and Use of Laboratory
   Animals, and the Animal Welfare Act (7 U.S.C. et seq.); the animal use
   protocol was approved by the Institutional Animal Care and Use Committee
   (IACUC) of the Massachusetts General Hospital.
CR ALLEN J, CURR OPIN O IN PRESS
   ARNOLD GE, 1955, ARCHIV OTOLARYNGOL, V62, P1
   BLESS DM, CURR OPIN O IN PRESS
   BRUNINGS W, 1912, TECHNIQUE AUTOSCOPIC, P118
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   CHHETRI DK, CURR OPIN O IN PRESS
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Finck C, 2005, LARYNGOSCOPE, V115, P1841, DOI 10.1097/01.mlg.0000173158.22274.8d
   Finck CL, 2010, J VOICE, V24, P626, DOI 10.1016/j.jvoice.2008.12.015
   Hansen JK, 2005, ANN OTO RHINOL LARYN, V114, P662, DOI 10.1177/000348940511400902
   Herrera VLM, 2009, LARYNGOSCOPE, V119, P2187, DOI 10.1002/lary.20643
   Hirano M, 1975, OTOLOGIA FUKUOKA  S1, V21, P239
   ISSHIKI N, 1978, ARCH OTOLARYNGOL, V104, P555
   ISSHIKI N, 1974, ACTA OTO-LARYNGOL, V78, P451, DOI 10.3109/00016487409126379
   Jahan-Parwar B, 2008, ANN OTO RHINOL LARYN, V117, P703, DOI 10.1177/000348940811700913
   KISHIMOTO Y, CURR OPIN O IN PRESS
   Kishimoto Y, 2010, LARYNGOSCOPE, V120, P108, DOI 10.1002/lary.20642
   LONG JL, CURR OPIN O IN PRESS
   Mehta DD, 2010, ANN OTO RHINOL LARYN, V119, P1
   Molteni G, 2010, OTOLARYNG HEAD NECK, V142, P547, DOI 10.1016/j.otohns.2009.12.035
   Payr E, 1915, DEUT MED WOCHENSCHR, V43, P1265
   Roy N, 2004, J SPEECH LANG HEAR R, V47, P281, DOI 10.1044/1092-4388(2004/023)
   SATALOFF RT, CURR OPIN O IN PRESS
   Suehiro A, 2010, ACTA OTO-LARYNGOL, V130, P844, DOI 10.3109/00016480903426618
   Zeitels S. M., 2007, ANN OTOL RHINOL S198, V116, P1
   Zeitels S.M., 1998, ANN OTOL RHINOL S173, V107, P1
   Zeitels SM, 2003, NEW ENGL J MED, V349, P882, DOI 10.1056/NEJMra035148
   ZEITELS SM, 1991, OTOLARYNG HEAD NECK, V105, P478
NR 28
TC 12
Z9 12
U1 1
U2 17
PU ANNALS PUBL CO
PI ST LOUIS
PA 4507 LACLEDE AVE, ST LOUIS, MO 63108 USA
SN 0003-4894
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD MAR
PY 2011
VL 120
IS 3
BP 175
EP 184
DI 10.1177/000348941112000306
PG 10
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 741BE
UT WOS:000288837300006
PM 21510143
DA 2018-10-20
ER

PT J
AU Zhu, YY
   Wu, GM
   Zhang, YH
   Zhao, Q
AF Zhu, Yanying
   Wu, Guangming
   Zhang, Yun-Hong
   Zhao, Qing
TI Growth and characterization of Mg(OH)(2) film on magnesium alloy AZ31
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Magnesium alloy; Hydrothermal; Magnesium hydroxide; Corrosion;
   Biomaterial
ID SIMULATED BODY-FLUIDS; HYDROTHERMAL CRYSTALLIZATION; BIODEGRADABLE
   IMPLANTS; CORROSION-RESISTANCE; HANKS SOLUTION; BIO-CORROSION; BONE;
   SCAFFOLDS; CYTOTOXICITY; COMPOSITES
AB Magnesium-based biomaterials have been proposed as potential candidates for biodegradable implant materials, such as bone screws, bone plates, intraluminal stents and so on. However, the poor corrosion resistance inhibits their applications in surgery. They collapse before the injured tissues are healed. In this paper, Mg(OH)(2) nonstructural film was synthesized on the substrate of AZ31 magnesium alloy by hydrothermal method with NaOH solution as mineralizer to reduce the corrosion rate of magnesium-based materials. The obtained films were characterized by XRD, SEM, and XPS. The results showed that a Mg(OH)(2) film with nanostructure surface can be synthesized by hydrothermal method. It was observed that the thickness of film increased with the holding time. Corrosion rates of the films were studied by immersing the samples in Hank's solution (37 degrees C). Surface deposits of samples with films soaked in Hank's solution for 31 days were investigated by XRD, SEM, EDS, XPS, and FTIR. It verified that the corrosion rate of the magnesium alloy with grown film was slowed down in the Hank's solution and the behavior of corrosion was inhibited effectively. Amorphous calcium apatite precursor was observed to deposit on the surface of the film during corrosion experiments in Hank's solution. And the tape test revealed a strong adhesion between the film and the substrate. (C) 2011 Elsevier B. V. All rights reserved.
C1 [Zhu, Yanying; Zhang, Yun-Hong; Zhao, Qing] Beijing Inst Technol, Sch Sci, Minist Educ, Key Lab Cluster Sci, Beijing 100081, Peoples R China.
   [Wu, Guangming] Beijing Inst Petrochem Technol, Beijing 102617, Peoples R China.
RP Zhao, Q (reprint author), Beijing Inst Technol, Sch Sci, Minist Educ, Key Lab Cluster Sci, Beijing 100081, Peoples R China.
EM qzhaoyuping@bit.edu.cn
FU Ministry of Science and Technology of China [2009IM033000]
FX This work was supported by the Ministry of Science and Technology of
   China (2009IM033000). Additional support was provided by the National
   Natural Science Foundation of China (50935001).
CR [Anonymous], 2002, D335902 ASTM
   Cowan J. A., 1995, BIOL CHEM MAGNESIUM
   De-Bao Liu, 2010, Frontiers of Materials Science in China, V4, P139, DOI 10.1007/s11706-010-0034-z
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   DUYGULU O, 2007, MATER SCI FORUM, V545, P421
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Guo XX, 2009, LANGMUIR, V25, P9894, DOI 10.1021/la901012w
   Haders DJ, 2008, CHEM MATER, V20, P7177, DOI 10.1021/cm071628c
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   HOFMANN G O, 1992, Clinical Materials, V10, P75, DOI 10.1016/0267-6605(92)90088-B
   Jiang WJ, 2009, POWDER TECHNOL, V191, P227, DOI 10.1016/j.powtec.2008.10.023
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Ma E, 2009, NAT MATER, V8, P855, DOI 10.1038/nmat2550
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Ng WF, 2010, SURF COAT TECH, V204, P1823, DOI 10.1016/j.surfcoat.2009.11.024
   Pekounov Y, 2008, J MATER SCI-MATER M, V19, P753, DOI 10.1007/s10856-007-3085-7
   Qiu LZ, 2003, COMPOS STRUCT, V62, P391, DOI 10.1016/j.compstruct.2003.09.010
   QUACH NC, 2007, EUROPEAN CELLS MA S3, V14, P3
   Ramirez CAO, 2009, KEY ENG MATER, V396-398, P611, DOI 10.4028/www.scientific.net/KEM.396-398.611
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang L, 2010, APPL SURF SCI, V256, P5807, DOI 10.1016/j.apsusc.2010.02.058
   Wen CE, 2003, MATER SCI FORUM, V419-4, P1001, DOI 10.4028/www.scientific.net/MSF.419-422.1001
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, MATERIALWISS WERKST, V37, P504, DOI 10.1002/mawe.200600027
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008
   Xin YC, 2007, J MATER RES, V22, P2004, DOI 10.1557/JMR.2007.0233
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zhou W, 2010, CORROS SCI, V52, P1035, DOI 10.1016/j.corsci.2009.11.030
NR 41
TC 78
Z9 86
U1 6
U2 82
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2011
VL 257
IS 14
BP 6129
EP 6137
DI 10.1016/j.apsusc.2011.02.017
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 738NQ
UT WOS:000288646900036
DA 2018-10-20
ER

PT J
AU Stavropoulos, A
   Chiantella, G
   Costa, D
   Steigmann, M
   Windisch, P
   Sculean, A
AF Stavropoulos, Andreas
   Chiantella, Giovanni
   Costa, Dinu
   Steigmann, Marius
   Windisch, Peter
   Sculean, Anton
TI Clinical and Histologic Evaluation of a Granular Bovine Bone Biomaterial
   Used as an Adjunct to GTR With a Bioresorbable Bovine Pericardium
   Collagen Membrane in the Treatment of Intrabony Defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Grafting; bone; guided tissue regeneration; histology; periodontitis;
   regeneration
ID GUIDED TISSUE REGENERATION; PERIODONTAL DEFECTS; OSSEOUS DEFECTS;
   NATURAL BONE; CASE SERIES; BIO-OSS; OUTCOMES; THERAPY; HUMANS; XENOGRAFT
AB Background: The aim of the present study is to evaluate the clinical and histologic healing of deep intrabony defects treated with guided tissue regeneration (GTR) with a collagen membrane from bovine pericardium and implantation of granular bovine bone biomaterial.
   Methods: Thirty patients with one deep, combined 1- and 2-wall intrabony defect exhibiting a probing depth mm and an associated intrabony defect mm were treated with GTR with a bioresorbable collagen membrane from bovine pericardium and adjunct implantation of a granular bovine bone biomaterial. The clinical results were evaluated 1 and 3 years after surgery. In addition, five teeth fulfilling the inclusion criteria but scheduled for extraction because of advanced periodontitis or restorative considerations were treated similarly and then extracted along with a portion of their surrounding periodontal tissues for histologic evaluation 6 months after surgery.
   Results: Healing was uneventful in all patients. Significant clinical improvements were observed at 1 and 3 years postoperatively (P<0.01; probing depth averaged 4.4 +/- 1.6 and 4.7 +/- 1.4 mm and clinical attachment level gain was 3.9 +/- 1.4 and 3.5 +/- 1.3 mm, respectively). The histologic evaluation revealed formation of new cellular cementum and new periodontal ligament in four of the five cases. In general, the xenograft particles seemed to be mostly embedded in connective tissue without any evidence of new bone formation.
   Conclusion: GTR treatment of intrabony defects with the collagen membrane from bovine pericardium and adjunct implantation of the new bovine bone biomaterial may result in significant clinical improvements that can be maintained over a period of 3 years, and regeneration of cementum and periodontal ligament, but without bone formation. J Periodontol 2011;82:462-470.
C1 [Stavropoulos, Andreas] Univ Aarhus, Dept Periodontol, Sch Dent, DK-8000 Aarhus C, Denmark.
   [Stavropoulos, Andreas] Ctr Expt & Preclin Res CEPBR, Athens, Greece.
   [Windisch, Peter] Semmelweis Univ, Dept Periodontol, Budapest, Hungary.
   [Sculean, Anton] Univ Bern, Dept Periodontol, Bern, Switzerland.
RP Stavropoulos, A (reprint author), Univ Aarhus, Dept Periodontol, Sch Dent, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.
EM stavropoulos@odont.au.dk
FU Tutogen Medical, Neunkirchen am Brand, Germany
FX This study was partially funded by Tutogen Medical, Neunkirchen am
   Brand, Germany, which manufactures the bovine pericardium collagen
   membrane and the particulate bovine bone graft used in this case series.
   The authors report no conflicts of interest related to any products used
   in this case series.
CR Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI [10.1902/jop.2008.060521, 10.1902/jop.2008.060521 ]
   Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Christgau M, 1997, J CLIN PERIODONTOL, V24, P17, DOI 10.1111/j.1600-051X.1997.tb01179.x
   Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672
   Cortellini P, 1999, J PROSTHET DENT, V81, P305, DOI 10.1016/S0022-3913(99)70274-X
   Gunther KP, 1996, OSTEOLOGIE, V5, P4
   Karring T, 2003, CLIN PERIODONTOLOGY, P650
   Kim TS, 2002, J PERIODONTOL, V73, P450, DOI 10.1902/jop.2002.73.4.450
   Laurell L, 2006, J CLIN PERIODONTOL, V33, P596, DOI 10.1111/j.1600-051X.2006.00951.x
   Machtei EE, 2001, J PERIODONTOL, V72, P512, DOI 10.1902/jop.2001.72.4.512
   Mellonig JT, 2000, INT J PERIODONT REST, V20, P19
   Meyer S, 2008, ARCH ORTHOP TRAUM SU, V128, P539, DOI 10.1007/s00402-007-0402-z
   Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266
   Needleman IG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001724.pub2
   Nevins ML, 2003, INT J PERIODONT REST, V23, P9
   Paolantonio M, 2001, INT J PERIODONT REST, V21, P505
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Schoepf C, 2006, INT MAGAZINE ORAL IM, V1, P10
   Schultheiss M, 2005, EUR SPINE J, V14, P192, DOI 10.1007/s00586-004-0764-7
   Schwarz F, 2006, CLIN ORAL IMPLAN RES, V17, P403, DOI 10.1111/j.1600-0501.2005.01225.x
   Sculean A, 2001, J PERIODONTOL, V72, P1695, DOI 10.1902/jop.2001.72.12.1695
   Sculean A, 2004, Clin Oral Investig, V8, P70
   Sculean A, 2003, J CLIN PERIODONTOL, V30, P73, DOI 10.1034/j.1600-051X.2003.10192.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P72, DOI 10.1111/j.1600-051X.2006.01007.x
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Slotte C, 2007, J CLIN PERIODONTOL, V34, P977, DOI 10.1111/j.1600-051X.2007.01138.x
   Stavropoulos A, 2004, J CLIN PERIODONTOL, V31, P939, DOI 10.1111/j.1600-051X.2004.00586.x
   STAVROPOULOS A, 2002, THESIS U AARHUS, P163
   Stavropoulos Andreas, 2004, Clin Oral Investig, V8, P226, DOI 10.1007/s00784-004-0277-0
   Stavropoulos A, 2010, J CLIN PERIODONTOL, V37, P200, DOI 10.1111/j.1600-051X.2009.01520.x
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P770, DOI 10.1111/j.1600-051X.2004.00562.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Tudor C, 2008, ORAL SURG ORAL MED O, V105, P430, DOI 10.1016/j.tripleo.2007.07.037
   WIKESJO UM, 2010, PERIODONTAL REGENERA, P25
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
NR 38
TC 16
Z9 19
U1 0
U2 3
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2011
VL 82
IS 3
BP 462
EP 470
DI 10.1902/jop.2010.100331
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 737RZ
UT WOS:000288587200015
PM 20932158
DA 2018-10-20
ER

PT J
AU Mohammadi, H
   Mequanint, K
AF Mohammadi, Hadi
   Mequanint, Kibret
TI Prosthetic aortic heart valves: Modeling and design
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Review
DE Mechanical heart valves; Bioprosthetic heart valve; Design of heart
   valves; Modeling and simulation; Nanocomposite biomaterials
ID FATIGUE-CRACK PROPAGATION; CARBON-COATED GRAPHITE; NUMERICAL-SIMULATION;
   ARTIFICIAL-HEART; PYROLYTIC CARBON; STRESS-ANALYSIS; CYCLIC FATIGUE;
   LEAFLET ESCAPE; DYNAMIC SIMULATION; LIFE PREDICTION
AB Although heart valve replacement is among the most common cardiovascular surgical procedures, their outcome is often difficult to predict. One of the reasons is the design and choice of the materials used for the fabrication of the prostheses. This review paper describes the use of modeling techniques in prosthetic heart valve (HV) design and aims at the justification and development of a polymer based trileaflet mechanical heart valve (MHV). The closing/opening phase behavior of the bileafiet MHV was investigated. The potential problem of valve failure due to crack propagation in the brittle pyrolytic carbon leaflet was also discussed. These studies suggest that although bileaflet MHV performs satisfactorily, there are justifications for improvement. Since the native aortic HV is trileaflet and made of anisotropic and hyperelastic tissue, one possible approach to a better MHV design is based on our ability to closely mimic the natural geometry and biomaterial properties. (C) 2010 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 [Mohammadi, Hadi] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
   [Mequanint, Kibret] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Mohammadi, H (reprint author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
EM hadim74@gmail.com
OI Mequanint, Kibret/0000-0002-7888-418X
CR ABE H, 1998, DATA BOOK MECH PROPE
   AKINS CW, 1991, ANN THORAC SURG, V52, P161, DOI 10.1016/0003-4975(91)91453-3
   Aluri S, 2001, ANN BIOMED ENG, V29, P665, DOI 10.1114/1.1385810
   ALVAREZ J, 1990, J THORAC CARDIOV SUR, V99, P372
   [Anonymous], 2004, GRAYS ANATOMY ANATOM
   Avanzini A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913235
   Baumgartner FJ, 1997, TEX HEART I J, V24, P122
   BEATTY MF, 1979, INT J ENG SCI, V17, P907, DOI 10.1016/0020-7225(79)90019-3
   Beck A, 2001, J HEART VALVE DIS, V10, P1
   BENJAMIN TB, 1966, PHILOS TR R SOC S-A, V260, P221, DOI 10.1098/rsta.1966.0046
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   BHUVANESHWAR GS, 2001, B MATER SCI, V14, P1361
   Birkhoff G., 1957, JETS WAKES CAVITIES
   BLAKE JR, 1982, J AUST MATH SOC B, V23, P383, DOI 10.1017/S0334270000000321
   BLAKE JR, 1986, J FLUID MECH, V170, P479, DOI 10.1017/S0022112086000988
   BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   BORKON AM, 1988, ANN THORAC SURG, V46, P270, DOI 10.1016/S0003-4975(10)65924-3
   BRAUNWALD NS, 1965, J THORAC CARDIOV SUR, V49, P485
   BREMER J, 1996, J BIOMECH, V29, P609
   BURRIESCI G, 1999, J BIOMECH, V10, P707
   CAMPBELL JM, 1950, J THORAC SURG, V19, P312
   Cao HC, 1996, J HEART VALVE DIS, V5, pS32
   Chahine G L, 1994, J Heart Valve Dis, V3 Suppl 1, pS102
   Cheng R, 2003, J HEART VALVE DIS, V12, P772
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Daebritz SH, 2003, CIRCULATION, V108, P134, DOI 10.1161/01.cir.0000087655.41288.dc
   DAHM M, 1995, ANN THORAC SURG, V60, pS348, DOI 10.1016/0003-4975(95)00291-R
   Dasi LP, 2009, CLIN EXP PHARMACOL P, V36, P225, DOI 10.1111/j.1440-1681.2008.05099.x
   DAUSKARDT RH, 1994, J BIOMED MATER RES, V28, P791, DOI 10.1002/jbm.820280706
   Davis H. E., 2008, TOPICS MULTIFUNCTION
   De Hart J, 2004, J BIOMECH, V37, P303, DOI 10.1016/S0021-9290(03)00293-8
   De Santis R, 2004, COMPOS SCI TECHNOL, V64, P861, DOI 10.1016/j.compscitech.2003.09.008
   DEHART J, 2002, THESIS EINDHOVEN U T
   DEUVAERT FE, 1989, ACTA CHIR BELG, V89, P15
   Edmunds LH, 1996, TEX HEART I J, V23, P24
   Elber W., 1971, ASTM STP, V486, P230
   EVAN AG, 1980, INT J FRACTURE, V108, P153
   Fisher J., 1988, P PROGR BIOENGINEERI, P238
   FREED D, 1981, T AM SOC ART INT ORG, V27, P105
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   GERALD F, 1993, CURVES SURFACES COMP
   Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   Graf T, 1992, J Heart Valve Dis, V1, P131
   Grande-Allen KJ, 2001, IEEE T BIO-MED ENG, V48, P647, DOI 10.1109/10.923783
   Gross JM, 1996, J HEART VALVE DIS, V5, P581
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   Haubold A D, 1994, J Heart Valve Dis, V3, P318
   He ZM, 2001, J HEART VALVE DIS, V10, P666
   Herold M, 1987, POLYURETHANES BIOMED, P231
   HUANG ZJ, 1994, J BIOMECH, V27, P391, DOI 10.1016/0021-9290(94)90015-9
   HUFNAGEL CA, 1954, SURGERY, V35, P673
   Hyde JAJ, 1999, J HEART VALVE DIS, V8, P331
   IONESCU MI, 1974, THORAX, V29, P56, DOI 10.1136/thx.29.1.56
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Johansen P, 2004, EXPERT REV MED DEVIC, V1, P95, DOI 10.1586/17434440.1.1.95
   Kim HG, 2008, ANN BIOMED ENG, V36, P262, DOI 10.1007/s10439-007-9409-4
   Kim H, 2006, J BIOMECH ENG-T ASME, V128, P717, DOI 10.1115/1.2244578
   King M. J., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P63, DOI 10.1243/PIME_PROC_1994_208_267_02
   King MJ, 1997, MED ENG PHYS, V19, P235, DOI 10.1016/S1350-4533(96)00066-5
   Kiris C, 1997, J BIOMECH ENG-T ASME, V119, P452, DOI 10.1115/1.2798293
   KLEPETKO W, 1989, J THORAC CARDIOV SUR, V97, P90
   Knapp R. T., 1970, CAVITATION
   KNIERBEIN B, 1992, J BIOMED ENG, V14, P275, DOI 10.1016/0141-5425(92)90001-2
   Krafczyk M, 1998, J BIOMECH, V31, P453, DOI 10.1016/S0021-9290(98)00036-0
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   Lai YG, 2002, J BIOMECH, V35, P881, DOI 10.1016/S0021-9290(02)00056-8
   LEAT ME, 1994, MED ENG PHYS, V16, P470, DOI 10.1016/1350-4533(94)90071-X
   LEAT ME, 1993, J BIOMED ENG, V15, P516, DOI 10.1016/0141-5425(93)90068-A
   Lee H, 2007, ARTIF ORGANS, V31, P532, DOI 10.1111/j.1525-1594.2007.00419.x
   LEE SC, 1996, J BIOMECHANICAL ENG, V118, P97
   Li J, 2001, J BIOMECH, V34, P1279, DOI 10.1016/S0021-9290(01)00092-6
   Lin HY, 2000, J BIOMECH ENG-T ASME, V122, P304, DOI 10.1115/1.1287171
   Luo XY, 2003, J BIOMECH ENG-T ASME, V125, P735, DOI 10.1115/1.1614821
   Mackay TG, 1996, BIOMATERIALS, V17, P1857, DOI 10.1016/0142-9612(95)00242-1
   Mastroroberto P, 2000, CAN J CARDIOL, V16, P1269
   McKelvey AL, 1999, J BIOMED MATER RES, V47, P301, DOI 10.1002/(SICI)1097-4636(19991205)47:3<301::AID-JBM3>3.0.CO;2-H
   McNaney JM, 1999, ACTA MATER, V47, P2809, DOI 10.1016/S1359-6454(99)00121-4
   *MEDTR, MOAS BIOPR MOAS AORT
   MERCER JL, 1973, J THORAC CARDIOV SUR, V65, P511
   Miranda ACO, 2003, ENG FRACT MECH, V70, P1259, DOI 10.1016/S0013-7944(02)00099-1
   Mohammadi H, 2006, MED ENG PHYS, V28, P122, DOI 10.1016/j.medengphy.2005.03.013
   Mohammadi H, 2009, P I MECH ENG H, V223, P697, DOI 10.1243/09544119JEIM493
   MOHAMMADI H, 2008, J ENG MED, V7, P1115
   MOHAMMADI H, 2009, THESIS U W ONTARIO
   Mohammadi H, 2009, MED ENG PHYS, V31, P1110, DOI 10.1016/j.medengphy.2009.07.012
   Moosavi MH, 2007, P ANN INT IEEE EMBS, P1027, DOI 10.1109/IEMBS.2007.4352469
   Morsi YS, 2004, INT J ARTIF ORGANS, V27, P445
   MURALEEDHARAN CV, 1995, 14 C BIOM ENG SOC IN
   Nicosia MA, 2003, J HEART VALVE DIS, V12, P781
   NISTAL F, 1990, J THORAC CARDIOVASC, V99, P1047
   Nobili M, 2008, J BIOMECH, V41, P2539, DOI 10.1016/j.jbiomech.2008.05.004
   Patterson EA, 1996, J MED ENG TECHNOL, V20, P95, DOI 10.3109/03091909609008387
   PEARSALL IS, 1972, CAVITATION
   PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4
   Ray S, 2006, EUR HEART J, V27, P2925, DOI 10.1093/eurheartj/ehl381
   RIBEIRO PA, 1986, J THORAC CARDIOV SUR, V91, P92
   RITCHIE RO, 1986, J BIOMECH ENG-T ASME, V108, P153, DOI 10.1115/1.3138595
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   Ritchie RO, 1996, J HEART VALVE DIS, V5, pS9
   ROBERTS WC, 1976, AM J CARDIOL, V38, P633, DOI 10.1016/S0002-9149(76)80014-8
   ROE B B, 1958, Exp Med Surg, V16, P177
   Rosenfeld M, 2002, J BIOMECH ENG-T ASME, V124, P21, DOI 10.1115/1.1427696
   ROUSSEAU EPM, 1983, J BIOMECH, V16, P339, DOI 10.1016/0021-9290(83)90017-9
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCHOEN FJ, 1985, HUM PATHOL, V16, P549, DOI 10.1016/S0046-8177(85)80103-9
   Shi YB, 2003, J HEART VALVE DIS, V12, P245
   Shim EB, 1997, J BIOMECH ENG-T ASME, V119, P45, DOI 10.1115/1.2796063
   Simionescu A, 1996, ASAIO J, V42, pM561, DOI 10.1097/00002480-199609000-00049
   Simionescu DT, 2004, EXPERT OPIN BIOL TH, V4, P1971, DOI 10.1517/14712598.4.12.1971
   Simionescu DT, 2003, J BIOMED MATER RES A, V66A, P755, DOI 10.1002/jbm.a.10066
   Sneckenberger DS, 1996, J HEART VALVE DIS, V5, P216
   Sripathi VC, 2004, ANN THORAC SURG, V77, P844, DOI 10.1016/S0003-4975(03)01518-2
   STARR A, 2007, NAT MED, V13, P6
   Subramanian A, 2000, J HEART VALVE DIS, V9, P721
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   *US DEP HHS, 1994, REPL HEART VALV GUID
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   VITALE N, 1995, EUR J CARDIO-THORAC, V9, P181, DOI 10.1016/S1010-7940(05)80142-3
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Vyavahare N, 1999, AM J PATHOL, V155, P973, DOI 10.1016/S0002-9440(10)65197-8
   Weinberg EJ, 2005, CARDIOVASCULAR ENG, V5, P37
   Weinberg EJ, 2007, J BIOMECH, V40, P705, DOI 10.1016/j.jbiomech.2006.01.003
   Weinberg EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005960
   Weinberg Eli J, 2007, Cardiovasc Eng, V7, P140, DOI 10.1007/s10558-007-9038-4
   Weinberg EJ, 2008, J BIOMECH, V41, P3482, DOI 10.1016/j.jbiomech.2008.08.006
   WIJSMULLER EG, 1990, INT J ARTIF ORGANS, V13, P503
   Wu Z J, 1994, ASAIO J, V40, pM702, DOI 10.1097/00002480-199407000-00089
   Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111
   YOGANATHAN AP, 1995, HDB BIOMEDICAL ENG, V123, P1847
   Yuan Q, 2003, J HEART VALVE DIS, V12, P102
   ZAPANTA CM, 1994, J BIOMECH ENG-T ASME, V116, P460, DOI 10.1115/1.2895797
NR 135
TC 39
Z9 45
U1 6
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
EI 1873-4030
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD MAR
PY 2011
VL 33
IS 2
BP 131
EP 147
DI 10.1016/j.medengphy.2010.09.017
PG 17
WC Engineering, Biomedical
SC Engineering
GA 737RQ
UT WOS:000288586300001
PM 20971672
DA 2018-10-20
ER

PT J
AU Calvo-Guirado, JL
   Mate-Sanchez, JE
   Delgado-Ruiz, R
   Ramirez-Fernandez, MP
AF Calvo-Guirado, Jose-Luis
   Mate-Sanchez, Jose-Eduardo
   Delgado-Ruiz, Rafael
   Ramirez-Fernandez, Maria-Piedad
TI Calculation of bone graft volume using 3D reconstruction system
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Stereolithography; biological models; xenograft
ID STEREOLITHOGRAPHIC MODELS; RESECTION; SURGERY
AB Objectives: To obtain bone "bioreplicas" for determining precisely the amount of biomaterial required for bone regeneration procedure. Study design: A case-control comparison with a total sample size of 20 cases, 10 control and 10 test samples. "Bioreplicas" were generated from helical CAT scans with 0.5 mm slices, without 3D reconstruction or image filters. Bone defects in premolar and molar areas were treated with titanium mesh and xenograft (MP3) combined with resorbable carriers. Time taken to carry out procedures with and without the use of "bioreplicas" (in minutes), discrepancies between the grafts performed with and without "bioreplicas" and bone defects (mm), and postoperative complications were registered. Results: No significant differences were recorded for measurements of width and length of bone defect between patient bone and the biological models. Conclusions: The use of "bioreplicas" obtained by rapid prototyping is effective in treatment planning.
C1 [Calvo-Guirado, Jose-Luis; Mate-Sanchez, Jose-Eduardo; Delgado-Ruiz, Rafael] Univ Murcia, E-30001 Murcia, Spain.
RP Mate-Sanchez, JE (reprint author), Paseo Alfonso 13 12 9B, Murcia 30201, Spain.
EM jmsodont@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; RAMIREZ FERNANDEZ,
   MARIA PIEDAD/0000-0003-1913-9902
CR Arias-Irimia O, 2010, MED ORAL PATOL ORAL, V15, pE512, DOI 10.4317/medoral.15.e512
   Barker T. M., 1993, Australasian Physical and Engineering Sciences in Medicine, V16, P79
   Bouyssie JF, 1997, SURG RADIOL ANAT, V19, P193, DOI 10.1007/BF01627975
   Cohen A, 2009, ORAL SURG ORAL MED O, V108, P661, DOI 10.1016/j.tripleo.2009.05.023
   Cunningham LL, 2005, J ORAL MAXIL SURG, V63, P873, DOI 10.1016/j.joms.2005.02.027
   Curcio R, 2007, ACTA CIR BRAS, V22, P387, DOI 10.1590/S0102-86502007000500011
   D'Urso PS, 1999, J CRANIO MAXILL SURG, V27, P30, DOI 10.1016/S1010-5182(99)80007-9
   Erickson DM, 1999, J ORAL MAXIL SURG, V57, P1040, DOI 10.1016/S0278-2391(99)90322-1
   Gateno J, 2003, J ORAL MAXIL SURG, V61, P814, DOI 10.1016/S078-239(03)00240-4
   Izatt MT, 2007, EUR SPINE J, V16, P1507, DOI 10.1007/s00586-006-0289-3
   Kernan BT, 2000, J ORAL MAXIL SURG, V58, P349, DOI 10.1016/S0278-2391(00)90071-5
   Lal Kunal, 2006, J Prosthodont, V15, P51, DOI 10.1111/j.1532-849X.2006.00069.x
   Lohfeld S, 2005, ANN BIOMED ENG, V33, P1295, DOI 10.1007/s10439-005-5873-x
   Sannomiya EK, 2008, ORAL SURG ORAL MED O, V106, pE36, DOI 10.1016/j.tripleo.2008.01.014
   Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001
   Spencer KR, 1999, INT J ORAL MAX SURG, V28, P288, DOI 10.1016/S0901-5027(99)80160-X
   Yi Z, 1999, INT J ORAL MAXILLOF, V28, P445
NR 17
TC 1
Z9 1
U1 0
U2 5
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-4447
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2011
VL 16
IS 2
BP E260
EP E264
AR 17004
DI 10.4317/medoral.16.e260
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 738ZV
UT WOS:000288682100024
PM 21196873
OA Bronze
DA 2018-10-20
ER

PT J
AU Frota, R
   Da Silva, VA
   Teixeira, M
   Sobral, APV
   Silva, EDDE
   Da Silveira, MMF
   Aragao-Neto, AC
AF Frota, Riedel
   Da Silva-Junior, Valdemiro-Amaro
   Teixeira, Marcelo
   Sobral, Ana-Paula-Veras
   Emanuel-Dias-de Oliveira e Silva
   Da Silveira, Marcia-Maria-Fonseca
   Aragao-Neto, Adelmo-Cavalcanti
TI Histological evaluation of bone repair using beta-tricalcium phosphate
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Tricalcium phosphate; bone substitutes; rats
ID SINUS FLOOR AUGMENTATION; DEFECTS; REGENERATION; IMPLANTATION;
   PARTICLES; MATRIX; RAT
AB Objectives: The aim of the present study was to evaluate bone repair in defects induced in the cranium of Wistar rats using beta-tricalcium phosphate. Study Design: In this research, we used 30 rats, randomly distributed in three groups of 10 animals (G1, G2 and G3), corresponding respectively to time of histological evaluation (7, 15 and 30 days). This was a paired study, a defect being induced in the parietal bone on either side of the median sagittal suture of the animals, being the left-hand side the experimental subgroup (filled by biomaterial) and the right control. The histological evaluation was performed by means of light microscopy. The collected data were submitted to the Fisher Exact test for comparison between the groups and to the McNemar test for comparison between the subgroups (P > 5%). Results: The results showed no statistically significant differences between the groups and bone regeneration was similar at the different times of evaluation. Conclusions: Therefore, we concluded that beta-tricalcium phosphate has not contributed significantly to repair process of defects induced in the cranium of Wistar rats.
C1 [Frota, Riedel; Sobral, Ana-Paula-Veras; Emanuel-Dias-de Oliveira e Silva; Da Silveira, Marcia-Maria-Fonseca] FOP UPE, Recife, PE, Brazil.
   [Da Silva-Junior, Valdemiro-Amaro; Teixeira, Marcelo] Univ Fed Rural Pernambuco, Recife, PE, Brazil.
   [Aragao-Neto, Adelmo-Cavalcanti] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Frota, R (reprint author), FOP UPE, Recife, PE, Brazil.
EM riedelfrota@uol.com.br
CR Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   FIGUEIREDO AS, 1997, ACTA CIR BRAS, V12, P84
   Kamakura S, 1999, J DENT RES, V78, P1682, DOI 10.1177/00220345990780110401
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   KONDO N, 2006, INT J ORAL MAXILLOF, V35, P708
   Kraal T, 2008, KNEE, V15, P201, DOI 10.1016/j.knee.2008.02.005
   LEUTENEGGER A, 1994, HELV CHIR ACTA, V60, P1061
   Lind M, 2001, BIOMATERIALS, V22, P189, DOI 10.1016/S0142-9612(00)00165-4
   Mardas N, 2002, J CRANIOFAC SURG, V13, P453, DOI 10.1097/00001665-200205000-00017
   Silva FMSE, 2006, J ORAL MAXIL SURG, V64, P931, DOI 10.1016/j.joms.2006.02.026
   Neo M, 1998, J BIOMED MATER RES, V39, P71, DOI 10.1002/(SICI)1097-4636(199801)39:1<71::AID-JBM9>3.0.CO;2-F
   Pripatnanont P, 2009, INT J ORAL MAX SURG, V38, P356, DOI 10.1016/j.ijom.2009.02.015
   Rios ALBB, 1996, REV ODONTOL U EST SA, V25, P87
   Rueger JM, 1998, ORTHOPADE, V27, P89
   Tudor C, 2008, ORAL SURG ORAL MED O, V105, P430, DOI 10.1016/j.tripleo.2007.07.037
NR 15
TC 2
Z9 3
U1 1
U2 2
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2011
VL 16
IS 2
BP E190
EP E194
AR 16874
DI 10.4317/medoral.16.e190
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 738ZV
UT WOS:000288682100012
PM 20711155
OA Bronze
DA 2018-10-20
ER

PT J
AU Noll, GA
   Muller, B
   Ernst, AM
   Ruping, B
   Twyman, RM
   Prufer, D
AF Noll, Gundula A.
   Mueller, Boje
   Ernst, Antonia M.
   Rueping, Boris
   Twyman, Richard M.
   Pruefer, Dirk
TI Native and artificial forisomes: functions and applications
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Artificial forisomes; Sieve element occlusion; Phloem; Recombinant
   production; Smart biomaterial; Mechanoprotein
ID PROTEIN AGGREGATES FORISOMES; BEAN PHASEOLUS-MULTIFLORUS; CRYSTALLINE
   P-PROTEIN; SIEVE ELEMENTS; MOTOR PROTEINS; SMART BIOMATERIALS; MOLECULAR
   MACHINE; ATP SYNTHASE; PHLOEM; WORK
AB Forisomes are remarkable protein bodies found exclusively in the phloem of the Fabaceae. When the phloem is wounded, forisomes are converted from a condensed to a dispersed state in an ATP-independent reaction triggered by Ca2+, thereby plugging the sieve tubes and preventing the loss of photoassimilates. Potentially, forisomes are ideal biomaterials for technical devices because the conformational changes can be replicated in vitro and are fully reversible over a large number of cycles. However, the development of technical devices based on forisomes has been hampered by the laborious and time-consuming process of purifying native forisomes from plants. More recently, the problem has been overcome by the production of recombinant artificial forisomes. This is a milestone in the development of forisome-based devices, not only because large quantities of homogeneous forisomes can be produced on demand, but also because their properties can be tailored for particular applications. In this review, we discuss the physical and molecular properties of native and artificial forisomes, focusing on their current applications in technical devices and potential developments in the future.
C1 [Mueller, Boje; Ernst, Antonia M.; Pruefer, Dirk] Fraunhofer Inst Mol Biol & Angewandte Okol, D-52074 Aachen, Germany.
   [Noll, Gundula A.; Rueping, Boris; Pruefer, Dirk] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48143 Munster, Germany.
   [Twyman, Richard M.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.
RP Prufer, D (reprint author), Fraunhofer Inst Mol Biol & Angewandte Okol, Forckenbeckstr 6, D-52074 Aachen, Germany.
EM dpruefer@uni-muenster.de
RI Twyman, Richard/M-5016-2018
OI Twyman, Richard/0000-0002-8764-3003
FU Fraunhofer MAVO; VolkswagenStiftung [I/82 075]
FX We gratefully acknowledge Lena Harig for critical reading of the
   manuscript and helpful discussion. The work was supported with grants
   from the Fraunhofer MAVO program "Smart Plastics" and the
   VolkswagenStiftung, contract no. I/82 075.
CR Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   BEHNKE HD, 1991, IAWA BULL, V12, P143, DOI 10.1163/22941932-90001231
   BERG HC, 1974, NATURE, V249, P77, DOI 10.1038/249077a0
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CRONSHAW J, 1968, J CELL BIOL, V38, P292, DOI 10.1083/jcb.38.2.292
   CRONSHAW J, 1968, J CELL BIOL, V38, P25, DOI 10.1083/jcb.38.1.25
   CRONSHAW J, 1967, J CELL BIOL, V34, P801, DOI 10.1083/jcb.34.3.801
   Dinant S, 2010, CR BIOL, V333, P307, DOI 10.1016/j.crvi.2010.01.006
   DUSCHL C, 2004, LAB ON CHIPS CELLOMI, P83
   ESAU K, 1967, VIROLOGY, V33, P26, DOI 10.1016/0042-6822(67)90090-6
   FISHER DB, 1975, PLANT PHYSIOL, V56, P555, DOI 10.1104/pp.56.5.555
   Focke M, 2010, LAB CHIP, V10, P1365, DOI 10.1039/c001195a
   Fontanellaz ME, 2006, THESIS RWTH GERMANY
   Fulga F, 2009, INTEGR BIOL-UK, V1, P150, DOI 10.1039/b814985b
   GIBBONS R, 1965, SCIENCE, V149, P424
   Glowacki J., 2007, BIOPOLYMERS, V89, P338, DOI DOI 10.1002/BIP.20871
   Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d
   Hackney DD, 1996, ANNU REV PHYSIOL, V58, P731
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hartig T., 1854, BOT Z, V12, P51
   Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176
   Huck WTS, 2008, MATER TODAY, V11, P24, DOI 10.1016/S1369-7021(08)70146-9
   Jaeger MS, 2008, BIOMATERIALS, V29, P247, DOI 10.1016/j.biomaterials.2007.09.020
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kinosita K, 2000, PHILOS T ROY SOC B, V355, P473, DOI 10.1098/rstb.2000.0589
   Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716
   Knoblauch M, 2003, NAT MATER, V2, P600, DOI 10.1038/nmat960
   Knoblauch M, 1998, PLANT CELL, V10, P35
   Knoblauch M, 2001, PLANT CELL, V13, P1221, DOI 10.1105/tpc.13.5.1221
   Korten T, 2010, CURR OPIN BIOTECH, V21, P477, DOI [10.1016/j.coPbio.2010.115.881, 10.1016/j.copbio.2010.05.001]
   LAFLECHE D, 1966, J MICROSC-OXFORD, V5, P493
   LAWTON DM, 1978, ANN BOT-LONDON, V42, P353, DOI 10.1093/oxfordjournals.aob.a085467
   LAWTON DM, 1978, PROTOPLASMA, V97, P1, DOI 10.1007/BF01276386
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu XH, 2010, BIOMATERIALS, V31, P259, DOI 10.1016/j.biomaterials.2009.09.046
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409
   Martin LM, 1995, STRUCTURE, V3, P245
   Mavroidis C, 2003, NAT MATER, V2, P573, DOI 10.1038/nmat973
   Mavroidis C, 2004, ANNU REV BIOMED ENG, V6, P363, DOI 10.1146/annurev.bioeng.6.040803.140143
   Mrazek A., 1910, OSTERR BOT Z, V60, P198
   Muller B, 2010, APPL MICROBIOL BIOT, V88, P689, DOI 10.1007/s00253-010-2771-4
   Ng AHC, 2010, ANAL BIOANAL CHEM, V397, P991, DOI 10.1007/s00216-010-3678-8
   NOLL GA, 2005, THESIS JUSTUSLIEBIG
   Noll GA, 2007, PLANT MOL BIOL, V65, P285, DOI 10.1007/s11103-007-9217-0
   Noll GA, 2009, PLANT MOL BIOL REP, V27, P526, DOI 10.1007/s11105-009-0120-5
   O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012
   PALEVITZ BA, 1971, PROTOPLASMA, V72, P399, DOI 10.1007/BF01289511
   Peters WS, 2007, ANN BOT-LONDON, V100, P101, DOI 10.1093/aob/mcm080
   Przybyla DE, 2010, BIOCHEMISTRY-US, V49, P4411, DOI 10.1021/bi902129p
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   Richter A, 2004, SENSOR ACTUAT B-CHEM, V99, P451, DOI 10.1016/j.snb.2003.12.014
   Ruping B, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-219
   Sabnis DD, 1995, CAMBIAL DERIVATIVES, P271
   Salieb-Beugelaar GB, 2010, ANAL CHEM, V82, P4848, DOI 10.1021/ac1009707
   Schwan S, 2009, BIOPHYS CHEM, V139, P99, DOI 10.1016/j.bpc.2008.10.008
   Schwan S, 2007, BIOPHYS CHEM, V125, P444, DOI 10.1016/j.bpc.2006.10.008
   SCHWAN S, 2007, P FALL M
   Shen AQ, 2006, SMART STRUCT SYST, V2, P225, DOI 10.12989/sss.2006.2.3.225
   STRASBURGER E, 1891, HISTOLOGISCHE BEITRA, V3
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Szent-Gyorgyi A., 1945, ACTA PHYSL SCAND S25, V9, P1
   Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045
   Tuteja N, 2010, PLANT SIGNAL BEHAV, V5, P1
   Tuteja N, 2010, TRENDS BIOTECHNOL, V28, P102, DOI 10.1016/j.tibtech.2009.11.005
   Uhlig K, 2008, J MICROELECTROMECH S, V17, P1322, DOI 10.1109/JMEMS.2008.2007241
   UMMAT A, 2005, BIOMEDICAL ENG HDB
   VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4
   Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x
   van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570
   Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476
   WERGIN WP, 1970, PROTOPLASMA, V71, P365, DOI 10.1007/BF01279682
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   WOOLFSON DN, 2009, BIOPOLYMERS, V94, P118
   Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 81
TC 7
Z9 7
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2011
VL 89
IS 6
BP 1675
EP 1682
DI 10.1007/s00253-011-3117-6
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 734KU
UT WOS:000288333800002
PM 21286708
DA 2018-10-20
ER

PT J
AU Hines, DJ
   Kaplan, DL
AF Hines, Daniel J.
   Kaplan, David L.
TI Mechanisms of Controlled Release from Silk Fibroin Films
SO BIOMACROMOLECULES
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; IN-VITRO; BIOMATERIAL COATINGS; SOLUTE RELEASE;
   SCAFFOLDS; VIVO; MICROSPHERES; DEGRADATION; RESPONSES; MATRICES
AB The controlled release of fluorescein-iso-thio-cyanate (FITC)-labeled dextrans from methanol-treated and untreated silk fibroin films was modeled to characterize the release kinetics and mechanisms. Silk films were prepared with FITC-dextrans of various molecular weights (4, 10, 20, 40 kDa). Methanol treatment was used to promote crystallinity. The release data were assessed with two different models, an empirical exponential equation commonly fit to release data and a mechanism-based semiempirical model derived from Fickian diffusion through a porous film. The FITC-dextran release kinetics were evaluated as a function of molecular weight and compared between the untreated- and methanol-treated films. For the empirical model, the estimated values of the model parameters decreased with the molecular weight of the analyte and showed no significant difference between untreated- and methanol-treated films. For the diffusion-based model, the estimated diffusion coefficient was smaller for the methanol-treated films than for the untreated films. Also, the diffusion coefficient was observed to decrease linearly with increasing molecular weight of the analyte. The percent of FITC-dextran loading entrapped and not released was less for the methanol-treated films than for untreated films and linearly increased with molecular weight. A linear regression was fit to the relationship between molecular weight and the percent of entrapped FITC-dextran particles. Using these defined linear relationships, we present an updated version of the diffusion model for simulating release of FITC-dextran of varied molecular weights from methanol-treated and untreated silk films.
C1 [Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU National Institute of Health [P41EB002520, R01NS05780]
FX This work was funded by grants P41EB002520 and R01NS05780 from the
   National Institute of Health.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   CUSSLER E, 2003, DIFFUDION MASS TRANS
   Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4
   Grathwohl P., 1998, DIFFUSION NATURAL PO
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   LANGER R, 1983, POLYM REV, V23, P61
   LEE P I, 1987, Journal of Controlled Release, V6, P207, DOI 10.1016/0168-3659(87)90077-0
   Lemaire V, 2003, INT J PHARM, V258, P95, DOI 10.1016/S0378-5173(03)00165-0
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   PEPPAS NA, 1989, INT J PHARM, V57, P169, DOI 10.1016/0378-5173(89)90306-2
   PRITCHARD E, 2010, J CONTROL RELEASE, V44, P159
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Saltzman W. M., 2001, DRUG DELIVERY ENG PR
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P229, DOI 10.1016/S0169-409X(01)00116-8
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 33
TC 36
Z9 37
U1 4
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2011
VL 12
IS 3
BP 804
EP 812
DI 10.1021/bm101421r
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 732KG
UT WOS:000288183100035
PM 21250666
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Atala, A
AF Atala, Anthony
TI Tissue engineering of human bladder
SO BRITISH MEDICAL BULLETIN
LA English
DT Article
DE bladder; tissue engineering; cystectomy; reconstruction; regenerative
   medicine; stem cells; biomaterials
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS;
   ACELLULAR MATRIX GRAFT; BIODEGRADABLE POLYMER SCAFFOLDS; HUMAN
   UROTHELIAL CELLS; IN-VITRO; VESICOURETERAL REFLUX; EXTRACELLULAR-MATRIX;
   URINARY-BLADDER
AB There are a number of conditions of the bladder that can lead to loss of function. Many of these require reconstructive procedures. However, current techniques may lead to a number of complications. Replacement of bladder tissues with functionally equivalent ones created in the laboratory could improve the outcome of reconstructive surgery. A review of the literature was conducted using PubMed to identify studies that provide evidence that tissue engineering techniques may be useful in the development of alternatives to current methods of bladder reconstruction. A number of animal studies and several clinical experiences show that it is possible to reconstruct the bladder using tissues and neo-organs produced in the laboratory. Materials that could be used to create functionally equivalent urologic tissues in the laboratory, especially non-autologous cells that have the potential to reject have many technical limitations. Current research suggests that the use of biomaterial-based, bladder-shaped scaffolds seeded with autologous urothelial and smooth muscle cells is currently the best option for bladder tissue engineering. Further research to develop novel biomaterials and cell sources, as well as information gained from developmental biology, signal transduction studies and studies of the wound healing response would be beneficial.
C1 Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Atala, A (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, 5th Floor,Watlington Hall,Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM aatala@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Adams MC, 1998, J UROLOGY, V160, P851, DOI 10.1016/S0022-5347(01)62819-2
   Alberts B., 1994, MOL BIOL CELL, P971
   Amiel GE, 1999, UROL CLIN N AM, V26, P235, DOI 10.1016/S0094-0143(99)80019-6
   Anumanthan G, 2008, J UROLOGY, V180, P1778, DOI 10.1016/j.juro.2008.04.076
   ATALA A, 1993, J UROLOGY, V149, P1099, DOI 10.1016/S0022-5347(17)36307-3
   Atala A, 1998, J UROLOGY, V159, P2, DOI 10.1016/S0022-5347(01)63994-6
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2003, CLIN PLAST SURG, V30, P649, DOI 10.1016/S0094-1298(03)00094-4
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P724, DOI 10.1016/S0022-5347(17)36704-6
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Atala A, 1995, J UROL, V153
   Atala A, 1995, J UROLOGY, V156, P338
   Atala A, 1994, DIALOGUES PEDIAT URO, V17, P11
   Atala Anthony, 1997, P149
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Atala A, 2006, CURR OPIN UROL, V16, P305, DOI 10.1097/01.mou.0000232055.20084.f6
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BAKER R, 1958, JAMA-J AM MED ASSOC, V168, P1178, DOI 10.1001/jama.1958.03000090008002
   Ballas CB, 2002, J CELL BIOCHEM, P20, DOI 10.1002/jcb.10127
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BELLINGER MF, 1993, J UROLOGY, V149, P811, DOI 10.1016/S0022-5347(17)36215-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Boccaccini AR, 2005, EXPERT REV MED DEVIC, V2, P303, DOI 10.1586/17434440.2.3.303
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   BUCKLEY JF, 1997, MINIM INVASIV THER, V1, P72
   Campbell PG, 2007, EXPERT OPIN BIOL TH, V7, P1123, DOI 10.1517/14712598.7.8.1123
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P505, DOI 10.1016/S0022-5347(17)38798-0
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P1050, DOI 10.1016/S0022-5347(17)38985-1
   Cartwright PC, 1989, J UROLOGY, V142, P520
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   CHURCHILL BM, 1993, J UROLOGY, V150, P716, DOI 10.1016/S0022-5347(17)35596-9
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Crisan M, 2008, STEM CELLS, V26, P2425, DOI 10.1634/stemcells.2008-0325
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   DEBOER WI, 1994, AM J PATHOL, V145, P1199
   DEUEL TF, 1997, PRINCIPLES TISSUE EN, P133
   Devine SM, 2002, J CELL BIOCHEM, P73, DOI 10.1002/jcb.10046
   Dozmorov Mikhail G., 2007, Journal of Smooth Muscle Research, V43, P55, DOI 10.1540/jsmr.43.55
   Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Farhat WA, 2008, WORLD J UROL, V26, P301, DOI 10.1007/s00345-008-0318-4
   Faris RA, 2001, ARTIF ORGANS, V25, P513, DOI 10.1046/j.1525-1594.2001.025007513.x
   Fauza DO, 1998, J PEDIATR SURG, V33, P357, DOI 10.1016/S0022-3468(98)90462-6
   Fauza DO, 1998, J PEDIATR SURG, V33, P7, DOI 10.1016/S0022-3468(98)90350-5
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   GORHAM SD, 1989, EUR UROL, V16, P440
   Haller H, 2005, KIDNEY INT, V68, P1932, DOI 10.1111/j.1523-1755.2005.00622.x
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   HARRISS DR, 1995, BRIT J UROL, V75, P18
   Hipp J, 2008, BJU INT, V101, P100, DOI 10.1111/j.1464-410X.2007.07211.x
   Hochedlinger K, 2004, HEMATOL J, V5, pS114, DOI 10.1038/sj.thj.6200435
   Hristov M, 2008, BIOL CHEM, V389, P837, DOI 10.1515/BC.2008.093
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ikeda E, 2008, DIFFERENTIATION, V76, P495, DOI 10.1111/j.1432-0436.2007.00245.x
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   in 't Anker Pieternella S., 2003, Haematologica, V88, P845
   INTVELD PJA, 1994, J POLYM SCI POL CHEM, V32, P1063, DOI 10.1002/pola.1994.080320608
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jiao J, 2008, STEM CELLS, V26, P1221, DOI 10.1634/stemcells.2007-0513
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kaefer M, 1997, J UROLOGY, V157, P1394, DOI 10.1016/S0022-5347(01)64998-X
   Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1
   Kikuno N, 2008, BJU INT, V103, P1424
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kolambkar YM, 2007, J MOL HISTOL, V38, P405, DOI 10.1007/s10735-007-9118-1
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007
   Kwon TG, 2008, J UROLOGY, V179, P2035, DOI 10.1016/j.juro.2008.01.005
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1097/01.ju.0000030040.76258.5a
   Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27
   Lee SJ, 2008, REJUV RES, V11, P747, DOI 10.1089/rej.2008.0691
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Lee SJ, 2008, BIOMATERIALS, V29, P1422, DOI 10.1016/j.biomaterials.2007.11.024
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Levesque PE, 1996, J UROLOGY, V156, P625, DOI 10.1016/S0022-5347(01)65767-7
   LI ST, 1995, BIOMEDICAL ENG HDB, P627
   Liebert M, 1997, DIFFERENTIATION, V61, P177, DOI 10.1046/j.1432-0436.1997.6130177.x
   Liebert M, 1991, Semin Urol, V9, P124
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4
   LUTTUN, 2006, CURR PROTOC IMMUNOL, V75, pCH22
   MACHLUF M, 1998, GRAFT, V1, P31
   MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1
   Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Mimeault M, 2008, STEM CELL REV, V4, P27, DOI 10.1007/s12015-008-9008-2
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Nguyen HT, 1999, IN VITRO CELL DEV-AN, V35, P371
   Nguyen MM, 2007, CELL PROLIFERAT, V40, P157, DOI 10.1111/j.1365-2184.2007.00424.x
   Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Puthenveettil JA, 1999, ADV EXP MED BIOL, V462, P83
   Rackley RR, 1999, J UROLOGY, V162, P1812, DOI 10.1016/S0022-5347(05)68243-2
   RIEHMANN M, 1993, J UROLOGY, V149, P1304, DOI 10.1016/S0022-5347(17)36375-9
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P47, DOI 10.1016/S1063-4584(05)80037-8
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P67
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Solomon LZ, 1998, J LAB CLIN MED, V132, P279, DOI 10.1016/S0022-2143(98)90040-3
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Taupin Philippe, 2006, Recent Pat CNS Drug Discov, V1, P299, DOI 10.2174/157488906778773670
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tobin Matthew S., 1994, Surgical Forum, V45, P786
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW
   Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7
   Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Xu T, 2009, TISSUE ENG PT A, V15, P95, DOI 10.1089/ten.tea.2008.0095
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Yoo JJ, 2007, J BIOMED MATER RES B, V83B, P189, DOI 10.1002/jbm.b.30783
   Yoo JJ, 1997, J UROLOGY, V158, P1066, DOI 10.1016/S0022-5347(01)64390-8
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   YU J, 2007, SCIENCE, P1151
   Zhang Y, 2008, J UROLOGY, V180, P10, DOI 10.1016/j.juro.2008.04.068
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
NR 158
TC 107
Z9 122
U1 0
U2 33
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-1420
J9 BRIT MED BULL
JI Br. Med. Bull.
PD MAR
PY 2011
VL 97
IS 1
BP 81
EP 104
DI 10.1093/bmb/ldr003
PG 24
WC Medicine, General & Internal
SC General & Internal Medicine
GA 733QY
UT WOS:000288279000006
PM 21324973
OA Bronze
DA 2018-10-20
ER

PT J
AU Bossini, PS
   Renno, ACM
   Ribeiro, DA
   Fangel, R
   Peitl, O
   Zanotto, ED
   Parizotto, NA
AF Bossini, Paulo Sergio
   Muniz Renno, Ana Claudia
   Ribeiro, Daniel Araki
   Fangel, Renan
   Peitl, Oscar
   Zanotto, Edgar Dutra
   Parizotto, Nivaldo Antonio
TI Biosilicate (R) and low-level laser therapy improve bone repair in
   osteoporotic rats
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Biosilicate (R); low level laser therapy; bone repair; osteoporotic rats
ID LOW-POWER LASER; IN-VITRO; MECHANICAL-PROPERTIES; GROWTH-FACTORS;
   IRRADIATION; DIFFERENTIATION; OSTEOBLAST; PROLIFERATION; OVARIECTOMY;
   DELIVERY
AB The aim of this study was to investigate the effects of a novel bioactive material (Biosilicate (R)) and low-level laser therapy (LLLT) on bone fracture consolidation in osteoporotic rats. Forty female Wistar rats were submitted to ovariectomy (OVX) to induce osteopenia. Eight weeks after surgery, the animals were randomly divided into four groups of 10 animals each: a bone defect control group (CG); a bone defect filled with Biosilicate group (BG); a bone defect filled with Biosilicate and irradiated with LLLT at 60 J/cm(2) group (BG60); and a bone defect filled with Biosilicate and irradiated with LLLT at 120 J/cm2 group (BG120). Bone defects were surgically performed on both tibias. The size of particle used for Biosilicate was 180-212 mu m. Histopathological analysis showed that bone defects were predominantly filled with the biomaterial in specimens treated with Biosilicate. LLLT with either 60 or 120 J/cm2 was able to increase collagen, Cbfa-1, VGEF and COX-2 expression in the circumjacent cells of the biomaterial. A morphometric analysis revealed that the Biosilicate + laser groups showed a higher amount of newly formed bone. Our results indicate that laser therapy improves bone repair process in contact with Biosilicate as a result of increasing bone formation, as well as COX-2 and Cbfa-1 immunoexpression, angiogenesis and collagen deposition in osteoporotic rats. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Bossini, Paulo Sergio; Fangel, Renan; Parizotto, Nivaldo Antonio] Univ Fed Sao Carlos, Dept Physiotherapy, BR-13560 Sao Carlos, SP, Brazil.
   [Muniz Renno, Ana Claudia; Ribeiro, Daniel Araki] Univ Fed Sao Paulo, Dept Biosci, Santos, SP, Brazil.
   [Peitl, Oscar; Zanotto, Edgar Dutra] Univ Fed Sao Carlos, Vitreous Mat Lab LaMaV, Dept Mat Engn, BR-13560 Sao Carlos, SP, Brazil.
RP Renno, ACM (reprint author), Ave Ana Costa 95, BR-11050240 Sao Paulo, Brazil.
EM a.renno@unifesp.br
RI Renno, Ana Claudia/C-1266-2015; Parizotto, Nivaldo/D-5347-2014; Zanotto,
   Edgar/A-7992-2011; Bossini, Paulo/G-2333-2014
OI Parizotto, Nivaldo/0000-0003-1774-9053; Zanotto,
   Edgar/0000-0003-4931-4505; 
CR Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Clupper DC, 2003, J BIOMED MATER RES A, V67A, P285, DOI 10.1002/jbm.a.10040
   da Silva RV, 2006, J CRANIOFAC SURG, V17, P297, DOI 10.1097/00001665-200603000-00017
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Forwood MR, 1996, J BONE MINER RES, V11, P1688
   GARAVELLOFREITA.V, 2009, J PHOTOCH PHOTOBIO B, V70, P81
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Li J, 2002, CALCIFIED TISSUE INT, V70, P320, DOI 10.1007/s00223-001-1025-y
   Lu HH, 2008, J BIOMED MATER RES A, V86A, P1128, DOI 10.1002/jbm.a.31740
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Matsumoto MA, 2009, LASER MED SCI, V24, P195, DOI 10.1007/s10103-008-0544-4
   Meyer RA, 2001, J ORTHOPAED RES, V19, P428, DOI 10.1016/S0736-0266(00)90034-2
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nicolau RA, 2003, LASER MED SCI, V18, P89, DOI 10.1007/s10103-003-0260-z
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   PANUSH RS, 1993, AM J MED, V95, P1, DOI 10.1016/0002-9343(93)90225-E
   Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456
   Renno ACM, 2007, PHOTOMED LASER SURG, V25, P275, DOI 10.1089/pho.2007.2055
   RENNO AC, 2010, PHOTOMED LA IN PRESS
   Renno ACM, 2006, PHOTOMED LASER SURG, V24, P202, DOI 10.1089/pho.2006.24.202
   Ribeiro DA, 2008, J ORAL REHABIL, V35, P925, DOI 10.1111/j.1365-2842.2008.01891.x
   Sato Yutaka, 1997, Journal of Medical and Dental Sciences, V44, P81
   Shakouri SK, 2010, LASER MED SCI, V25, P73, DOI 10.1007/s10103-009-0670-7
   Silva Oliveira M, 2007, PHOTOCHEM PHOTOBIOL, V83, P1379, DOI 10.1111/j.1751-1097.2007.00174.x
   Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963
   Sojo K, 2005, J CRANIO MAXILL SURG, V33, P238, DOI 10.1016/j.jcms.2005.02.004
   Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161
   Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002
   Thomas Mark V, 2005, J Long Term Eff Med Implants, V15, P585
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   ZANOTTO ED, 2004, Patent No. 2004074199
   Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681
NR 39
TC 29
Z9 29
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2011
VL 5
IS 3
BP 229
EP 237
DI 10.1002/term.309
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 734RY
UT WOS:000288355800007
PM 20925130
DA 2018-10-20
ER

PT J
AU Korompilias, AV
   Beris, AE
   Lykissas, MG
   Kostas-Agnantis, IP
   Soucacos, PN
AF Korompilias, Anastasios V.
   Beris, Alexandros E.
   Lykissas, Marios G.
   Kostas-Agnantis, Ioannis P.
   Soucacos, Panayiotis N.
TI FEMORAL HEAD OSTEONECROSIS: WHY CHOOSE FREE VASCULARIZED FIBULA GRAFTING
SO MICROSURGERY
LA English
DT Article
ID TERM-FOLLOW-UP; TOTAL HIP-ARTHROPLASTY; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
   POROUS TANTALUM BIOMATERIAL; CORE DECOMPRESSION; AVASCULAR NECROSIS;
   ASEPTIC NECROSIS; INTERTROCHANTERIC OSTEOTOMY; NONTRAUMATIC
   OSTEONECROSIS; SURVIVORSHIP ANALYSIS
AB Osteonecrosis of the femoral head is a disease in which bone death occurs and usually progresses to articular incongruity and subsequent osteoarthritis. To delay the process of the disease and the conversion to total hip arthroplasty, many surgical techniques have been described. Core decompression, nonvascularized autologous bone grafts, porous tantalum implant procedure, and various osteotomies have been used for the management of early precollapse stage osteonecrosis of the femoral head. However, none of these procedures is neither entirely effective nor can obtain predictable results. With the progress of microsurgery, the implantation of a free vascularized fibula graft to the necrotic femoral head has provided the most consistently successful results. Although the procedure is technically demanding, there is growing recognition that the use of free vascularized fibula graft may improve patient quality of life by functional improvement and pain alleviation. The success of the procedure is related to decompression of the femoral head, excision of the necrotic bone, and addition of cancellous bone graft with osteoinductive and osteoconductive properties, which augments revascularization and neoosteogenesis of the femoral head. Free vascularized fibula graft, especially in younger patients, is a salvaging procedure of the necrotic femoral head in early precollapse stages. In postcollapse osteonecrosis, the procedure appears to delay the need for total hip arthroplasty in the majority of patients. The purpose of this review article is to update knowledge about treatment strategies in femoral head osteonecrosis and to compare free vascularized fibula grafting to traditional and new treatment modalities. (C) 2010 Wiley-Liss, Inc. Microsurgery 31:223-228, 2011.
C1 [Korompilias, Anastasios V.; Beris, Alexandros E.; Lykissas, Marios G.; Kostas-Agnantis, Ioannis P.] Univ Ioannina, Sch Med, Dept Orthopaed Surg, GR-45110 Ioannina, Greece.
   [Soucacos, Panayiotis N.] Univ Athens, Sch Med, Dept Orthopaed Surg, GR-11527 Athens, Greece.
RP Korompilias, AV (reprint author), Univ Ioannina, Sch Med, Dept Orthopaed Surg, GR-45110 Ioannina, Greece.
EM koroban@otenet.gr
CR AARON RK, 1989, CLIN ORTHOP RELAT R, P209
   AMSTUTZ HC, 1994, J BONE JOINT SURG BR, V76B, P423
   BEAULE PE, 2001, CLIN ORTHOP RELAT R, V385, P104
   Berend KR, 2003, J BONE JOINT SURG AM, V85A, P987, DOI 10.2106/00004623-200306000-00001
   Beris AE, 2004, ORTHOP CLIN N AM, V35, P335, DOI 10.1016/j.ocl.2004.02.008
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bozic KJ, 1999, J BONE JOINT SURG AM, V81A, P200, DOI 10.2106/00004623-199902000-00007
   CAMP JF, 1986, J BONE JOINT SURG AM, V68A, P1313, DOI 10.2106/00004623-198668090-00002
   COOGAN PG, 1997, OSTEONECROSIS ETIOLO, P327
   CORNELL CN, 1985, ORTHOP CLIN N AM, V16, P757
   DEAN MT, 1993, J BONE JOINT SURG BR, V75, P597
   DUNN AW, 1977, CLIN ORTHOP RELAT R, P249
   FERGUSON GM, 1994, J BONE JOINT SURG BR, V76B, P252
   Gallinaro P, 2001, CLIN ORTHOP RELAT R, P79
   Garrigues GE, 2009, MICROSURG, V29, P342, DOI 10.1002/micr.20648
   GILBERT A, 1981, INT SURG, V66, P27
   Glueck CJ, 1999, CLIN ORTHOP RELAT R, P133
   Hadjigeorgiou GM, 2007, J ORTHOP RES, V25, P1087, DOI 10.1002/jor.20393
   HOPSON CN, 1988, J BONE JOINT SURG AM, V70A, P1048, DOI 10.2106/00004623-198870070-00013
   Hungeford DS, 2002, J ARTHROPLASTY, V17, P121, DOI 10.1054/arth.2002.33300
   Hungerford D S, 1988, J Bone Joint Surg Am, V70, P474
   HUNGERFORD DS, 1997, OSTEONECROSIS ETIOLO, P287
   Hungerford MW, 1998, J BONE JOINT SURG AM, V80A, P1656, DOI 10.2106/00004623-199811000-00013
   Huo M H, 1992, J Arthroplasty, V7, P51, DOI 10.1016/0883-5403(92)90032-L
   Inao S, 1999, CLIN ORTHOP RELAT R, P141
   Kane SM, 1996, ORTHOPEDICS, V19, P869
   Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2012, DOI 10.2106/JBJS.D.02593
   Koo KH, 2006, J ORTHOP RES, V24, P1722, DOI 10.1002/jor.20164
   Korompilias AV, 2009, J BONE JOINT SURG BR, V91B, P287, DOI 10.1302/0301-620X.91B3.21846
   KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9
   Lavernia CJ, 2000, J ARTHROPLASTY, V15, P171, DOI 10.1016/S0883-5403(00)90132-3
   Liu YF, 2005, NEW ENGL J MED, V352, P2294, DOI 10.1056/NEJMoa042480
   Louie BE, 1999, CAN J SURG, V42, P274
   Lowrie AG, 2010, MICROSURG, V30, P19, DOI 10.1002/micr.20695
   MALIZOS KN, 1995, CLIN ORTHOP RELAT R, P67
   MANKIN HJ, 1992, NEW ENGL J MED, V326, P1473
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Mont MA, 1996, J BONE JOINT SURG AM, V78A, P1032, DOI 10.2106/00004623-199607000-00007
   Nelson CL, 1997, J ARTHROPLASTY, V12, P736, DOI 10.1016/S0883-5403(97)90002-4
   Nelson L M, 1993, J Arthroplasty, V8, P253, DOI 10.1016/S0883-5403(06)80086-0
   PHEMISTER DB, 1992, CLIN ORTHOP RELAT R, P4
   Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001
   Poort SR, 1996, BLOOD, V88, P3698
   SCHER MA, 1993, J BONE JOINT SURG AM, V75A, P1119, DOI 10.2106/00004623-199308000-00001
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Shannon BD, 2004, CLIN ORTHOP RELAT R, P34
   Sotereanos DG, 1997, CLIN ORTHOP RELAT R, P243
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   SUGANO N, 1994, CLIN ORTHOP RELAT R, P190
   Tanzer M, 2008, J BONE JOINT SURG AM, V90A, P1282, DOI 10.2106/JBJS.F.00847
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004
   URBANIAK JR, 1987, MICROSURGERY MAJOR L, P178
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
NR 58
TC 31
Z9 40
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0738-1085
EI 1098-2752
J9 MICROSURG
JI Microsurgery
PD MAR
PY 2011
VL 31
IS 3
BP 223
EP 228
DI 10.1002/micr.20837
PG 6
WC Surgery
SC Surgery
GA 735FZ
UT WOS:000288400100010
PM 21400578
DA 2018-10-20
ER

PT J
AU Ananthanarayanan, A
   Narmada, BC
   Mo, XJ
   McMillian, M
   Yu, H
AF Ananthanarayanan, Abhishek
   Narmada, Balakrishnan Chakrapani
   Mo, Xuejun
   McMillian, Michael
   Yu, Henry
TI Purpose-driven biomaterials research in liver-tissue engineering
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID XENOGENEIC HEPATOCYTE TRANSPLANTATION; C VIRUS-INFECTION; IN-VITRO;
   CELL-CULTURE; ARTERIOVENOUS LOOP; ENZYME-INDUCTION; DRUG DEVELOPMENT;
   GENE-EXPRESSION; HEPATITIS-B; STEM-CELLS
AB Bottom-up engineering of microscale tissue ("microtissue") constructs to recapitulate partially the complex structure function relationships of liver parenchyma has been realized through the development of sophisticated biomaterial scaffolds, liver-cell sources, and in vitro culture techniques. With regard to in vivo applications, the long-lived stem/progenitor cell constructs can improve cell engraftment, whereas the short-lived, but highly functional hepatocyte constructs stimulate host liver regeneration. With regard to in vitro applications, microtissue constructs are being adapted or custom-engineered into cell-based assays for testing acute, chronic and idiosyncratic toxicities of drugs or pathogens. Systems-level methods and computational models that represent quantitative relationships between biomaterial scaffolds, cells and microtissue constructs will further enable their rational design for optimal integration into specific biomedical applications.
C1 [Ananthanarayanan, Abhishek; Narmada, Balakrishnan Chakrapani; Mo, Xuejun; Yu, Henry] Natl Univ Singapore, Singapore 117597, Singapore.
   [Ananthanarayanan, Abhishek; Mo, Xuejun; Yu, Henry] ASTAR, Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
   [McMillian, Michael] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ 08869 USA.
RP Yu, H (reprint author), Natl Univ Singapore, MD9 03-03,2 Med Dr, Singapore 117597, Singapore.
EM hanry_yu@nuhs.edu.sg
RI Yu, Hanry/C-1031-2013
OI Yu, Hanry/0000-0002-0339-3685; Narmada, Balakrishnan
   Chakrapani/0000-0002-9536-5015
FU Institute of Bioengineering and Nanotechnology; BMRC; A*STAR; National
   University of Singapore; Janssen-Cilag; SMART BioSyM; Mechanobiology
   Institute, Singapore
FX We thank colleagues of the Cell and Tissue Engineering Laboratory; and
   J&J PRD for stimulating scientific discussions; A/P Choon-Hong Tan for
   guiding XM as a NUS Graduate Research Scholar; and funding support in
   part by Institute of Bioengineering and Nanotechnology, BMRC, A*STAR,
   NGS, Janssen-Cilag, SMART BioSyM and Mechanobiology Institute,
   Singapore. AA and BCN are National University of Singapore scholars.
CR Allen JW, 2005, TOXICOL SCI, V84, P110, DOI 10.1093/toxsci.kfi052
   Arkudas A, 2007, TISSUE ENG, V13, P1549, DOI 10.1089/ten.2006.0387
   Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094
   Brophy CM, 2009, HEPATOLOGY, V49, P578, DOI 10.1002/hep.22674
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Calvert VS, 2007, HEPATOLOGY, V46, P166, DOI 10.1002/hep.21688
   Chao P, 2009, BIOCHEM PHARMACOL, V78, P625, DOI 10.1016/j.bcp.2009.05.013
   Chong TW, 2006, J SURG RES, V130, P52, DOI 10.1016/j.jss.2005.04.043
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   Cosgrove BD, 2009, TOXICOL APPL PHARM, V237, P317, DOI 10.1016/j.taap.2009.04.002
   Dash A, 2009, EXPERT OPIN DRUG MET, V5, P1159, DOI 10.1517/17425250903160664
   Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5
   Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127
   Du YA, 2008, P NATL ACAD SCI USA, V105, P9522, DOI 10.1073/pnas.0801866105
   Du YN, 2007, TISSUE ENG, V13, P1455, DOI 10.1089/ten.2006.0381
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   ESPEJEL S, 2010, J CLIN INVEST
   Feng ZQ, 2010, BIOMATERIALS, V31, P3604, DOI 10.1016/j.biomaterials.2010.01.080
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   GORAL YCH, 2010, MICRO TAS
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117
   Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07
   Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Howe K, 2009, DRUG METAB DISPOS, V37, P391, DOI 10.1124/dmd.108.022921
   Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104
   Janakiraman V, 2008, BIOMED MICRODEVICES, V10, P355, DOI 10.1007/s10544-007-9143-6
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Kawashita Y, 2008, J HEPATOL, V49, P99, DOI 10.1016/j.jhep.2008.02.020
   Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715
   Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kienhuis AS, 2007, TOXICOL IN VITRO, V21, P892, DOI 10.1016/j.tiv.2007.01.010
   Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721
   Kumashiro Y, 2005, TRANSPLANTATION, V79, P550, DOI 10.1097/01.TP.0000153637.44069.C6
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Lemon G, 2009, MATH BIOSCI, V221, P101, DOI 10.1016/j.mbs.2009.07.003
   Liu T, 2010, TISSUE ENG PT A, V16, P1115, DOI [10.1089/ten.tea.2009.0391, 10.1089/ten.TEA.2009.0391]
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   MAKOWKA L, 1981, TRANSPLANT P, V13, P855
   MAKOWKA L, 1980, SURGERY, V88, P244
   Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07
   Mo XJ, 2010, BIOMATERIALS, V31, P7455, DOI 10.1016/j.biomaterials.2010.06.020
   Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013
   NAUGHTON B, 3 DIMENSIONAL LIVER
   Ng S, 2006, TISSUE ENG, V12, P2181, DOI 10.1089/ten.2006.12.2181
   Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s
   OH SK, 2009, STEM CELL RES
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ong SM, 2008, BIOMATERIALS, V29, P3237, DOI 10.1016/j.biomaterials.2008.04.022
   Ong SM, 2007, BIOMATERIALS, V28, P3656, DOI 10.1016/j.biomaterials.2007.04.034
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   RASHID ST, 2010, J CLIN INVEST
   Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101
   Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396
   Sauer IM, 2001, ANN NY ACAD SCI, V944, P308
   Seidle T, 2010, TOXICOL SCI, V116, P382, DOI 10.1093/toxsci/kfq143
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Sicklick JK, 2006, AM J PHYSIOL-GASTR L, V290, pG859, DOI 10.1152/ajpgi.00456.2005
   Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632
   Smets F, 2008, PEDIATR TRANSPLANT, V12, P6, DOI 10.1111/j.1399-3046.2007.00788.x
   Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t
   Sung JH, 2010, EXPERT OPIN DRUG MET, V6, P1063, DOI 10.1517/17425255.2010.496251
   Szczurek E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.45
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Tsuda Y, 2005, BIOMATERIALS, V26, P1885, DOI 10.1016/j.biomaterials.2004.06.005
   Tsuda Y, 2010, LANGMUIR, V26, P2645, DOI [10.1021/la902827y, 10.1021/la002827y]
   Ueki T, 1999, NAT MED, V5, P226
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Venkatraman L, 2010, BIOCOMPUT-PAC SYM, P190
   Williams D. P., 2006, TOXICOLOGY, V226, P1
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599
   Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h
   Zhang SF, 2008, BIOMATERIALS, V29, P3993, DOI 10.1016/j.biomaterials.2008.06.024
   Zhang WX, 2010, ADV DRUG DELIVER REV, V62, P814, DOI 10.1016/j.addr.2010.02.005
   Zhao DQ, 2008, BIOMATERIALS, V29, P3693, DOI 10.1016/j.biomaterials.2008.05.019
NR 86
TC 37
Z9 41
U1 1
U2 37
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAR
PY 2011
VL 29
IS 3
BP 110
EP 118
DI 10.1016/j.tibtech.2010.10.006
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 735NF
UT WOS:000288421600002
PM 21129798
DA 2018-10-20
ER

PT J
AU May, BC
   Irvine, SM
   Cayzer, J
   Todd, E
   Negron, L
   Lun, S
   Floden, EW
   Dempsey, SG
   Alexander, A
   Gunningham, S
   Knight, C
   Davis, PF
   Ward, BR
AF May, B. C.
   Irvine, S. M.
   Cayzer, J.
   Todd, E.
   Negron, L.
   Lun, S.
   Floden, E. W.
   Dempsey, S. G.
   Alexander, A.
   Gunningham, S.
   Knight, C.
   Davis, P. F.
   Ward, B. R.
TI A FUNCTIONAL EXTRACELLULAR MATRIX BIOMATERIAL DERIVED FROM OVINE
   FORESTOMACH
SO WOUND REPAIR AND REGENERATION
LA English
DT Meeting Abstract
C1 [May, B. C.; Irvine, S. M.; Todd, E.; Negron, L.; Lun, S.; Floden, E. W.; Dempsey, S. G.; Ward, B. R.] Mesynthes Ltd, Lower Hutt, North Island, New Zealand.
   [Irvine, S. M.; Davis, P. F.] Univ Otago, Dept Med, Wellington, North Island, New Zealand.
   [Cayzer, J.; Alexander, A.] Estendart Ltd, Palmerston North, North Island, New Zealand.
   [Gunningham, S.] Univ Otago, Christchurch Angiogenesis & Canc Res Grp, Christchurch, South Island, New Zealand.
   [Knight, C.] Inst Vet Anim & Biomed Sci, Palmerston North, North Island, New Zealand.
   [Davis, P. F.] Trinity Bioact, Wellington, North Island, New Zealand.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAR-APR
PY 2011
VL 19
IS 2
BP A38
EP A38
PG 1
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 728ML
UT WOS:000287878100121
DA 2018-10-20
ER

PT J
AU Krebs, MD
   Alsberg, E
AF Krebs, Melissa D.
   Alsberg, Eben
TI Localized, Targeted, and Sustained siRNA Delivery
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE biomaterials; biotechnology; gene silencing; localized delivery; siRNA;
   therapeutics
ID ADULT-MOUSE BRAIN; IN-VIVO; RNA INTERFERENCE; OCULAR NEOVASCULARIZATION;
   ADMINISTERED SIRNA; SYSTEMIC DELIVERY; CATIONIC LIPIDS; GENE-EXPRESSION;
   CELLULAR UPTAKE; CELLS
AB Short interfering RNA (siRNA) functions directly in the cytoplasm, where it is assembled into an RNA-induced silencing complex (RISC). The localized delivery of siRNA to a specific site in vivo is highly challenging. There are many disease states in which a systemic effect of RNAi may be desirable; some examples include non-localized cancers, HIV, neurodegenerative diseases, respiratory viruses, and heart and vascular disease. In this Concept, we will focus on the localized delivery of siRNA to a target site using various delivery modalities. In certain tissues, such as the eye, central nervous system and lung, it has been demonstrated that a simple injection of naked siRNA will silence gene expression specifically in that tissue. To achieve local gene silencing in other tissues, a variety of approaches have been pursued to help stabilize the siRNA and facilitate uptake; they include chemical modification of the siRNA or complexation within liposomes or polymers to form nanoparticles. Recently, the use of macroscopic biomaterial scaffolds for siRNA delivery has been reported, and although there is still significant work to be done in this area to optimize the delivery systems, it is an important area of research that offers the potential for having great impact on the field of siRNA delivery.
C1 [Krebs, Melissa D.; Alsberg, Eben] Case Western Reserve Univ, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, 309 Wickenden,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
RI Krebs, Melissa/L-4878-2015
OI Krebs, Melissa/0000-0002-5170-7116; Alsberg, Eben/0000-0002-3487-4625
CR AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457
   Aigner A, 2007, APPL MICROBIOL BIOT, V76, P9, DOI 10.1007/s00253-007-0984-y
   Aigner A, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71659
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Alshamsan A, 2010, BIOMATERIALS, V31, P1420, DOI 10.1016/j.biomaterials.2009.11.003
   BEDI D, 2011, NANOMEDICIN IN PRESS
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164
   Chen QM, 2010, J CONTROL RELEASE, V144, P227, DOI 10.1016/j.jconrel.2010.02.011
   Chen YC, 2008, EXPERT OPIN DRUG DEL, V5, P1301, DOI 10.1517/17425240802568505 
   Collins RE, 2005, FEBS LETT, V579, P5841, DOI 10.1016/j.febslet.2005.07.072
   Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956
   De Fougerolles AR, 2008, HUM GENE THER, V19, P125, DOI 10.1089/hum.2008.928
   Deleavey GF, 2009, CURR PROTOC NUCL ACI
   Dickerson EB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-10
   DiFiglia M, 2007, P NATL ACAD SCI USA, V104, P17204, DOI 10.1073/pnas.0708285104
   Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044
   Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24
   Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007
   Dykxhoorn DM, 2006, GENE THER, V13, P541, DOI 10.1038/sj.gt.3302703
   Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Gao ZY, 2006, PLAST RECONSTR SURG, V118, P1328, DOI 10.1097/01.prs.0000239537.77870.2c
   Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021
   Hammond SM, 2000, NATURE, V404, P293
   Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010
   Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663
   Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609
   Kim SH, 2008, J CONTROL RELEASE, V129, P107, DOI 10.1016/j.jconrel.2008.03.008
   Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022
   Krebs MD, 2009, J AM CHEM SOC, V131, P9204, DOI 10.1021/ja9037615
   Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280
   Lomas-Neira JL, 2005, J LEUKOCYTE BIOL, V77, P846, DOI 10.1189/jlb.1004617
   Lorenz C, 2004, BIOORG MED CHEM LETT, V14, P4975, DOI 10.1016/j.bmcl.2004.07.018
   Lu W, 2010, CANCER RES, V70, P3177, DOI 10.1158/0008-5472.CAN-09-3379
   MAKIMURA H, 2002, BMC NEUROSCI, V3, pNIL1
   Merkel OM, 2009, MOL PHARMACEUT, V6, P1246, DOI 10.1021/mp900107v
   Murata N, 2008, J CONTROL RELEASE, V126, P246, DOI 10.1016/j.jconrel.2007.11.017
   Namiki Y, 2009, NAT NANOTECHNOL, V4, P598, DOI [10.1038/NNANO.2009.202, 10.1038/nnano.2009.202]
   Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27
   Noh SM, 2010, J CONTROL RELEASE, V145, P159, DOI 10.1016/j.jconrel.2010.04.005
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263
   Pardridge WM, 2004, EXPERT OPIN BIOL TH, V4, P1103, DOI 10.1517/14712598.4.7.1103
   Perkel JM, 2009, SCIENCE, V326, P454, DOI 10.1126/science.opms.p0900039
   Reich S, 2003, MOL VIS, V9, P210
   Rutz S, 2004, ARTHRITIS RES THER, V6, P78, DOI 10.1086/ar1168
   Ryther RCC, 2005, GENE THER, V12, P5, DOI 10.1038/sj.gt.3302356
   Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602
   Sepp-Lorenzino L, 2008, CLIN PHARMACOL THER, V84, P628, DOI 10.1038/clpt.2008.174
   Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a
   Suh MS, 2009, J CONTROL RELEASE, V140, P268, DOI 10.1016/j.jconrel.2009.06.017
   Taratula O, 2009, J CONTROL RELEASE, V140, P284, DOI 10.1016/j.jconrel.2009.06.019
   Thakker DR, 2005, MOL PSYCHIATR, V10, P782, DOI 10.1038/sj.mp.4001687
   Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101
   Vinas-Castells R, 2009, BIOCONJUGATE CHEM, V20, P2262, DOI 10.1021/bc900241w
   Wang Y, 2010, CURR DRUG METAB, V11, P182, DOI 10.2174/138920010791110863
   Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI [10.1016/j.drudis.2008.05.007, 10.1016/j.drudi5.2008.05.007]
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
   Wu YC, 2009, CELL HOST MICROBE, V5, P84, DOI 10.1016/j.chom.2008.12.003
   Yao YC, 2009, PHARM RES-DORD, V26, P263, DOI 10.1007/s11095-008-9772-3
   Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200
   Zhang YJ, 2006, MOL THER, V14, P336, DOI 10.1016/j.ymthe.2006.04.001
   Zhu L, 2010, BIOCONJUGATE CHEM, V21, P2119, DOI 10.1021/bc100346n
NR 68
TC 46
Z9 46
U1 0
U2 37
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR
PY 2011
VL 17
IS 11
BP 3054
EP 3062
DI 10.1002/chem.201003144
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 731IF
UT WOS:000288098800001
PM 21341332
DA 2018-10-20
ER

PT J
AU Park, D
   Lee, DS
   Park, JM
AF Park, Donghee
   Lee, Dae Sung
   Park, Jong Moon
TI Consideration of the methods for evaluating the Cr(VI)-removing capacity
   of biomaterial
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Biosorption; Hexavalent Chromium; Reduction; Langmuir; Freundlich
ID INDUSTRIAL WASTE-WATER; HEXAVALENT CHROMIUM; AQUEOUS-SOLUTION;
   CORYNEBACTERIUM-GLUTAMICUM; FUNGAL BIOMASS; BIOSORPTION; REMOVAL;
   ADSORPTION; CR(VI); REDUCTION
AB Over the last few decades, many researchers have tested various biomaterials for the removal of toxic Cr(VI) from aquatic systems. It is now widely accepted that the mechanism of Cr(VI) biosorption is not 'anionic adsorption' but 'adsorption-coupled reduction'. Unfortunately, however, many researchers have still used common equilibrium isotherm models, such as Langmuir and Freundlich ones, based on 'anionic adsorption' mechanism in order to evaluate the Cr(VD-removing capacity of biomaterial tested. In this study, a fermentation waste of Corynebacterium glutamicum, capable of removing Cr(VI) efficiently, was used as a model biomaterial to show why equilibrium isotherm models cannot be used to evaluate the Cr(VI)-removing capacity of biomaterial. Meanwhile, some alternative methods considering the mechanism of Cr(VI) biosorption were suggested; the maximum Cr(VI)-removing capacity of the biomaterial could be evaluated by a Cr(VI)-biosorption experiment under biomaterial-limited condition as well as by a simplified kinetic model based on the reduction mechanism of Cr(VI).
C1 [Lee, Dae Sung] Kyungpook Natl Univ, Dept Environm Engn, Taegu 702701, South Korea.
   [Park, Donghee] Yensei Univ, Dept Environm Engn, Wonju 220710, South Korea.
   [Park, Jong Moon] Pohang Univ Sci & Technol, Adv Environm Biotechnol Res Ctr, Div Adv Nucl Engn, Dept Chem Engn,Sch Environm Sci & Engn, Pohang 790784, South Korea.
RP Lee, DS (reprint author), Kyungpook Natl Univ, Dept Environm Engn, Taegu 702701, South Korea.
EM daesung@knu.ac.kr; jmpark@postech.ac.kr
FU Ministry of Education, Science and Technology [2010-0005198,
   2009-0093819, R31-30005]; Korea Ministry of Environment (MOE); Brain
   Korea 21 Program
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (2010-0005198) and by
   Korea Ministry of Environment (MOE) as "Human resource development
   Project for Energy from Waste & Recycling". This work was also
   financially supported by the second phase of the Brain Korea 21 Program
   in 2010 as well as by the Priority Research Centers Program through the
   National Research Foundation of Korea (NRF) funded by the MEST
   (2009-0093819). This research was supported by WCU (World Class
   University) program through the National Research Foundation of Korea
   funded by the Ministry of Education, Science and Technology (R31-30005).
CR Anderson RA, 1997, REGUL TOXICOL PHARM, V26, pS35, DOI 10.1006/rtph.1997.1136
   Bankar AV, 2009, J HAZARD MATER, V170, P487, DOI 10.1016/j.jhazmat.2009.04.070
   Baral SS, 2009, J HAZARD MATER, V171, P358, DOI 10.1016/j.jhazmat.2009.06.011
   Bingol A, 2009, J HAZARD MATER, V161, P747, DOI 10.1016/j.jhazmat.2008.04.018
   Chand R, 2009, J HAZARD MATER, V163, P245, DOI 10.1016/j.jhazmat.2008.06.084
   Choi J, 2008, KOREAN J CHEM ENG, V25, P764, DOI 10.1007/s11814-008-0125-z
   Choi SB, 2004, BIOTECHNOL LETT, V26, P331, DOI 10.1023/B:BILE.0000015453.20708.fc
   Clesceri LS, 1998, STANDARD METHODS EXA
   Costa M, 2006, CRIT REV TOXICOL, V36, P155, DOI 10.1080/10408440500534032
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   Elangovan R, 2008, CHEM ENG J, V141, P99, DOI 10.1016/j.cej.2007.10.026
   Freundlich H., 1906, PHYS CHEM SOC, V40, P1361
   Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013
   Kumar KV, 2006, J HAZARD MATER, V138, P633, DOI 10.1016/j.jhazmat.2006.06.078
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Moussavi G, 2010, CHEM ENG J, V162, P893, DOI 10.1016/j.cej.2010.06.032
   Nityanandi D, 2009, J HAZARD MATER, V170, P876, DOI 10.1016/j.jhazmat.2009.05.049
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Park D, 2008, CHEM ENG J, V136, P173, DOI 10.1016/j.cej.2007.03.039
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   Singh KK, 2009, CHEM ENG J, V151, P113, DOI 10.1016/j.cej.2009.02.003
   SRIVASTAVA HCP, 1986, ENVIRON TECHNOL LETT, V7, P55, DOI 10.1080/09593338609384391
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Wang XS, 2009, CHEM ENG J, V148, P217, DOI 10.1016/j.cej.2008.08.020
   Won SW, 2004, IND ENG CHEM RES, V43, P7865, DOI 10.1021/ie049559o
   Yoon J, 2009, KOREAN J CHEM ENG, V26, P1296, DOI 10.2478/s11814-009-0228-1
NR 32
TC 3
Z9 3
U1 1
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-1115
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD MAR
PY 2011
VL 28
IS 3
BP 831
EP 836
DI 10.1007/s11814-010-0453-7
PG 6
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 732KJ
UT WOS:000288183500027
DA 2018-10-20
ER

PT J
AU Yu-Song, P
AF Yu-song, Pan
TI Surface modification of nanocrystalline hydroxyapatite
SO MICRO & NANO LETTERS
LA English
DT Article
ID COMPOSITE; PARTICLES
AB Nanometre-scale hydroxyapatite (nano-HA) is the key component to manufacture biomaterial. In this work, the surface of nano-HA particle was modified by KH-550 silane coupling agent and the coupling mechanism was investigated. The results showed that the coupling treatment on the surface of nano-HA particle did not change its micromorphology and microstructure. The hydrolysis reaction of KH-550 is a multistage dissociation of the chemical equilibrium process and produces lots of Si-OH group. With the hydrolysis time prolonged, polycondensation reaction of parts of Si-OH group occurs and produces Si-O-Si groups. Furthermore, coupling mechanisms of KH-550 with nano-HA is mainly predominated by three mechanisms such as chemical bond theory, hydrogen bond theory and double electronic shell theory.
C1 Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
RP Yu-Song, P (reprint author), Hui Univ Sci & Technol, Dept Mat Sci & Engn, Huai Nan 232001, Peoples R China.
EM yusongpan@163.com
FU Natural Science Research of key projects of Anhui Provincial
   Universities [KJ2010A099]
FX Research reported in the Letter was funded by the Natural Science
   Research of key projects of Anhui Provincial Universities (project
   KJ2010A099).
CR Benmesli S, 2008, INT J POLYM MATER, V57, P1045, DOI 10.1080/00914030802257628
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Brandt J, 2008, KEY ENG MATER, V361-363, P35, DOI 10.4028/www.scientific.net/KEM.361-363.35
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   HAN MJ, 2005, FUNCT MAT, V35, P629
   Liu YK, 2004, MATER CHEM PHYS, V86, P69, DOI 10.1016/j.matchemphys.2004.02.009
   Ma ZL, 2008, J APPL POLYM SCI, V107, P1000, DOI 10.1002/app.27173
   MASSARU S, 2009, MAT T, V50, P1318
   Pan YS, 2010, J MATER ENG PERFORM, V19, P1037, DOI 10.1007/s11665-009-9569-5
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Panda RN, 2003, J PHYS CHEM SOLIDS, V64, P193, DOI 10.1016/S0022-3697(02)00257-3
   Ren J, 2008, J MATER SCI-MATER M, V19, P1075, DOI 10.1007/s10856-007-3181-8
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   WANG XM, 2007, J MAT ENG, V2, P26
   YANG Y, 2000, J MAT SCI ENG, V18, P52
   [尹志岚 Yin Zhilan], 2004, [功能高分子学报, Journal of Functional Polymer], V17, P298
NR 17
TC 10
Z9 10
U1 2
U2 18
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD MAR
PY 2011
VL 6
IS 3
BP 129
EP 132
DI 10.1049/mnl.2010.0187
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 732QF
UT WOS:000288202800009
DA 2018-10-20
ER

PT J
AU Qiu, YZ
   Lim, JJ
   Scott, L
   Adams, RC
   Bui, HT
   Temenoff, JS
AF Qiu, Yongzhi
   Lim, Jeremy J.
   Scott, Larry, Jr.
   Adams, Ryan C.
   Bui, Hieu T.
   Temenoff, Johnna S.
TI PEG-based hydrogels with tunable degradation characteristics to control
   delivery of marrow stromal cells for tendon overuse injuries
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Marrow stromal cells; Cell infiltration; Tendon/ligament;
   Tendinopathy
ID MESENCHYMAL STEM-CELLS; TENDINOPATHY; GLYCOL); REPAIR; MIGRATION;
   COLLAGEN; MODEL
AB Marrow stromal cells (MSCs) have been suggested as a means to improve healing in tendon overuse injuries (tendinopathy), but optimal delivery methods for these cells have yet to be determined. In this study novel degradable hydrogels based on oligo(poly(ethylene glycol) fumarate) (OPF) and acrylated poly(ethylene glycol)-dithiothreitol (Ac PEG-DTT) with tunable degradation times ranging from a few days to >1 month were synthesized as MSC carriers for tendon overuse injuries. The addition of higher amounts of OPF or higher dithiothreitol (DTT) concentrations resulted in enhanced fold swelling and degradation. Three formulations, including non-degrading, slower degrading (degraded in similar to 10 days) and faster degrading (degraded in similar to 5 days) hydrogels were selected for studies with MSCs in tendon tissue explants that had been treated with collagenase as a reproducible model of tendinopathy. Quantitative analysis of the resulting histology images indicated that cell delivery from the hydrogels was dependent on the degradation rate, with cells present in the tissue only after hydrogel dissolution. In addition, significantly more cells were found in the tendon after 14 days with the fast degrading (53 +/- 19) vs. slow degrading (20 +/- 6) hydrogels. Based on these results, OPF/Ac PEG-DTT hydrogels provide a versatile biomaterial platform to control cell delivery and thus better identify dosing regimens required for MSC-based therapies for tendinopathy. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Qiu, Yongzhi; Lim, Jeremy J.; Scott, Larry, Jr.; Adams, Ryan C.; Bui, Hieu T.; Temenoff, Johnna S.] Georgia Inst Technol, WH Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Qiu, Yongzhi; Lim, Jeremy J.; Scott, Larry, Jr.; Adams, Ryan C.; Bui, Hieu T.; Temenoff, Johnna S.] Emory Univ, Atlanta, GA 30332 USA.
   [Temenoff, Johnna S.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Inst Technol, WH Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
RI Bui, Hieu/J-4408-2014
OI Bui, Hieu/0000-0002-0038-8266
FU National Science Foundation; Georgia Tech Petit Undergraduate Research
   Scholars
FX This work is supported by a National Football League Charities Medical
   Grant, National Science Foundation Graduate Research Fellowship
   (J.J.L.), and the Georgia Tech Petit Undergraduate Research Scholars
   (U.R.S.) Program (LS.).
CR Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1
   Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347
   Asanuma H, 2010, J UROLOGY, V184, P26, DOI 10.1016/j.juro.2010.03.050
   Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230
   Brink KS, 2009, ACTA BIOMATER, V5, P570, DOI 10.1016/j.actbio.2008.09.015
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f
   Fu SC, 2002, ACTA ORTHOP SCAND, V73, P658, DOI 10.3109/17453670209178031
   Gimbel JA, 2004, J BIOMECH, V37, P739, DOI 10.1016/j.jbiomech.2003.09.019
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hammoudi TM, 2010, TISSUE ENG PART C-ME, V16, P1621, DOI [10.1089/ten.tec.2010.0146, 10.1089/ten.TEC.2010.0146]
   Hankemeier S, 2009, TISSUE ENG PT A, V15, P1019, DOI 10.1089/ten.tea.2008.0046
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004
   Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460
   Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   Magra M, 2005, BRIT J SPORT MED, V39, P789, DOI 10.1136/bjsm.2005.017855
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Peppas N. A., 1987, HYDROGELS MED PHARM
   Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2
   Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Shimode K, 2007, TISSUE ENG, V13, P333, DOI 10.1089/ten.2006.0079
   Shin H, 2003, BIOMACROMOLECULES, V4, P552, DOI 10.1021/bm020121m
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Smith RKW, 2008, DISABIL REHABIL, V30, P1752, DOI 10.1080/09638280701788241
   Stone D, 1999, J ORTHOPAED RES, V17, P168, DOI 10.1002/jor.1100170204
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4
   YOUNG NJ, 2010, 56 ORS ANN M NEW ORL
NR 39
TC 32
Z9 32
U1 3
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 959
EP 966
DI 10.1016/j.actbio.2010.11.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900006
PM 21056127
DA 2018-10-20
ER

PT J
AU Ruttermann, S
   Trellenkamp, T
   Bergmann, N
   Raab, WHM
   Ritter, H
   Janda, R
AF Ruettermann, Stefan
   Trellenkamp, Taina
   Bergmann, Nora
   Raab, Wolfgang H. -M.
   Ritter, Helmut
   Janda, Ralf
TI A new approach to influence contact angle and surface free energy of
   resin-based dental restorative materials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Resin-based dental restorative material; Physical properties; Bacterial
   adhesion; Plaque; Contact angle
ID STREPTOCOCCUS-MUTANS ADHESION; ANTIBACTERIAL ACTIVITY; BIOMATERIAL
   SURFACES; BACTERIAL ADHESION; BIOFILM FORMATION; IN-VITRO;
   PLAQUE-FORMATION; COMPOSITE RESIN; HUMAN-ENAMEL; ROUGHNESS
AB The purpose of the present study was to identify novel delivery systems and active agents which increase the water contact angle and reduce the surface free energy when added to resin-based dental restorative materials. Two delivery systems based on zeolite or novel polymeric hollow beads (Poly-Pore), loaded with two low surface tension active agents (hydroxy functional polydimethylsiloxane and polydimethylsiloxane) or a polymerizable active agent (silicone polyether acrylate) were used to modify commonly formulated experimental dental resin composites. The non-modified resin was used as a standard (ST). Flexural strength, flexural modulus, water sorption, solubility, polymerization shrinkage, surface roughness R(a), contact angle theta, total surface free energy gamma(S), and the apolar gamma(LW)(S), polar gamma(AB)(S), Lewis acid gamma(+)(S) and base gamma(-)(S) components, and the active agents surface tensions gamma(L) were determined (P < 0.05). The active agents did not differ in gamma(L). The modified materials had significantly higher theta but significantly lower gamma(S), gamma(AB)(S) and gamma(-)(S) than the ST. A Poly-Pore/polydimethyl siloxane delivery system yielded the highest theta (110.9 +/- 3.5 degrees) acceptable physical properties and the lowest values for gamma(LW)(S) and gamma(-)(S). Among the modified materials the polymerizable materials containing active agents had the lowest gamma(AB) and the highest gamma(+)(S) and gamma(-)(S). Although not significant, both of the zeolite delivery systems yielded higher gamma(LW)(S), gamma(+)(S) and gamma(-)(S) but lower gamma(AB)(S) than the Poly-Pore delivery systems. Poly-Pore based delivery systems highly loaded with low surface tension active agents were found not to influence the physical properties but to significantly increase the water contact angle and thus reduce surface free energy of dental resin composites. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ruettermann, Stefan; Bergmann, Nora; Raab, Wolfgang H. -M.; Janda, Ralf] Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat & Prevent Dent & Endodont, D-40225 Dusseldorf, Germany.
   [Trellenkamp, Taina; Ritter, Helmut] Univ Dusseldorf, Inst Organ Chem & Macromol Chem, D-40225 Dusseldorf, Germany.
RP Janda, R (reprint author), Univ Dusseldorf, Fac Med, Ctr Dent, Dept Operat & Prevent Dent & Endodont, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM ralf.janda@uni-duesseldorf.de
FU DFG Deutsche Forschungsgemeinschaft, Bonn, Germany [RU 825/3-1]
FX This study was supported by the DFG Deutsche Forschungsgemeinschaft,
   Bonn, Germany (project no. RU 825/3-1).
CR Ahn SJ, 2009, DENT MATER, V25, P206, DOI 10.1016/j.dental.2008.06.002
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Asmussen E, 1998, DENT MATER, V14, P51, DOI 10.1016/S0109-5641(98)00009-8
   Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003
   Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Buergers R, 2009, DENT MATER, V25, P269, DOI 10.1016/j.dental.2008.07.011
   CARLEN A, 2001, BIOMATERIALS, V22, P467
   Cejka J., 2007, INTRO ZEOLITE SCI PR
   Chutinan S, 2004, DENT MATER, V20, P345, DOI 10.1016/S0109-5641(03)00127-1
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Eick JD, 2007, DENT MATER, V23, P1011, DOI 10.1016/j.dental.2006.09.002
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gyo M, 2008, APPL ENVIRON MICROB, V74, P1428, DOI 10.1128/AEM.02039-07
   Hahnel S, 2008, J MATER SCI-MATER M, V19, P2619, DOI 10.1007/s10856-007-3352-7
   Hahnel S, 2009, DENT MATER, V25, P969, DOI 10.1016/j.dental.2009.02.003
   Hahnel S, 2008, J DENT, V36, P977, DOI 10.1016/j.jdent.2008.08.004
   Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005
   Hansel C, 1998, J DENT RES, V77, P60, DOI 10.1177/00220345980770010601
   Imazato S, 2003, BIOMATERIALS, V24, P3605, DOI 10.1016/S0142-9612(03)00217-5
   Imazato S, 2008, DENT MATER J, V27, P145, DOI 10.4012/dmj.27.145
   INDRANI DJ, 1995, DENT MATER, V11, P201, DOI 10.1016/0109-5641(95)80019-0
   *INT ORG STAND, 1998, 4288 ISO
   International Organization for Standardization, 2009, 4049 ISO
   Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056
   Knorr SD, 2005, DENT MATER, V21, P272, DOI 10.1016/j.dental.2004.06.002
   Konishi N, 2003, J ORAL REHABIL, V30, P790, DOI 10.1046/j.1365-2842.2003.01129.x
   Lee LH, 1996, LANGMUIR, V12, P1681, DOI 10.1021/la950725u
   Lee SP, 2009, ANGLE ORTHOD, V79, P353, DOI 10.2319/021308-88.1
   Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004
   MCBRIDE BC, 1984, INFECT IMMUN, V44, P68
   Mei L, 2009, EUR J ORAL SCI, V117, P419, DOI 10.1111/j.1600-0722.2009.00648.x
   Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x
   Namba N, 2009, DENT MATER, V25, P424, DOI 10.1016/j.dental.2008.08.012
   Ono M, 2007, DENT MATER J, V26, P613, DOI 10.4012/dmj.26.613
   Persson A, 2005, ACTA ODONTOL SCAND, V63, P21, DOI 10.1080/00016350510019649
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   QUIRYNEN M, 1989, J DENT RES, V68, P79
   ROSENBERG M, 1983, INFECT IMMUN, V42, P831
   Ruttermann S, 2007, J DENT, V35, P806, DOI 10.1016/j.jdent.2007.07.014
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   Shahal Y, 1998, J ORAL REHABIL, V25, P52
   Sipahi C, 2001, J DENT, V29, P197, DOI 10.1016/S0300-5712(01)00011-2
   Sojka MS, 1998, US Patent, Patent No. [US5830960, 5830960]
   Spori DM, 2008, LANGMUIR, V24, P5411, DOI 10.1021/la800215r
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   Weinmann W, 2005, DENT MATER, V21, P68, DOI 10.1016/j.dental.2004.10.007
   WEISS E, 1982, CURR MICROBIOL, V7, P125, DOI 10.1007/BF01568427
   WESTERGREN G, 1983, INFECT IMMUN, V40, P432
   Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022
   Yamanaka-Okada Ayumi, 2008, Bull Tokyo Dent Coll, V49, P107
NR 55
TC 19
Z9 19
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1160
EP 1165
DI 10.1016/j.actbio.2010.10.002
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900026
PM 20933616
DA 2018-10-20
ER

PT J
AU Zhao, RG
   Sider, KL
   Simmons, CA
AF Zhao, Ruogang
   Sider, Krista L.
   Simmons, Craig A.
TI Measurement of layer-specific mechanical properties in multilayered
   biomaterials by micropipette aspiration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Micropipette aspiration; Finite-element analysis; Micromechanical
   testing; Layered biomaterials; Heart valve
ID AORTIC-VALVE LEAFLET; SOFT-TISSUES; IN-VIVO; VISCOELASTIC PROPERTIES;
   THORACIC AORTAS; YOUNGS MODULUS; POISSONS RATIO; CARDIAC VALVES;
   ELASTIC-MODULI; HUMAN SKIN
AB Many biomaterials and tissues are complex multilayered structures in which the individual layers have distinct mechanical properties that influence the mechanical behavior and define the local cellular micro-environment. Characterization of the mechanical properties of individual layers in intact tissues is technically challenging. Micropipette aspiration (MA) is a proven method for the analysis of local mechanical properties of soft single-layer biomaterials, but its applicability for multilayer structures has not been demonstrated. We sought to determine and validate MA experimental parameters that would permit measurement of the mechanical properties of only the top layer of an intact multilayer biomaterial or tissue. To do so, we performed parametric nonlinear finite-element (FE) analyses and validation experiments using a multilayer gelatin system. The parametric FE analyses demonstrated that measurement of the properties of only the top layer of a multilayer structure is sensitive to the ratio of the pipette inner diameter (D) to top layer thickness (t(top)), and that accurate measurement of the top layer modulus requires D/t(top) < 1. These predictions were confirmed experimentally by MA of the gelatin system. Using this approach and an inverse FE method, the mean effective modulus of the fibrosa layer of intact porcine aortic valve leaflets was determined to be greater than that of the ventricularis layer (P<0.01), consistent with data obtained by tensile testing of dissected layers. This study provides practical guidelines for the use of MA to measure the mechanical properties of single layers in intact multilayer biomaterials and tissues. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Zhao, Ruogang; Sider, Krista L.; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Simmons, Craig A.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
EM c.simmons@utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772; Zhao, Ruogang/0000-0002-5351-0843
FU Natural Science and Engineering Research Council of Canada (NSERC)
   [RGPIN 327627-06]; Heart and Stroke Foundation (HSF) of Ontario [NA6047,
   NA6654]; Ontario Early Researcher Award; HSF of Canada; Canada Research
   Chair in Mechanobiology
FX This study was supported by the Natural Science and Engineering Research
   Council of Canada (NSERC; RGPIN 327627-06), the Heart and Stroke
   Foundation (HSF) of Ontario (NA6047 and NA6654), an Ontario Early
   Researcher Award (to C.A.S.), HSF of Canada Doctoral Research Awards (to
   R.Z. and K.L.S.), an NSERC Canada Graduate Scholarship (to K.L.S.), and
   the Canada Research Chair in Mechanobiology (to C.A.S.).
CR Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047
   ANSYS,Inc, 2006, ANSYS STRUCT AN GUID
   Aoki T, 1997, ANN BIOMED ENG, V25, P581, DOI 10.1007/BF02684197
   Boudou T, 2006, J BIOMECH, V39, P1677, DOI 10.1016/j.biomech.2005.04.026
   Boudou T, 2006, BIORHEOLOGY, V43, P721
   Boyer G, 2007, P ANN INT IEEE EMBS, P4584, DOI 10.1109/IEMBS.2007.4353360
   Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684
   Chaudhry B, 2009, J MATER SCI-MATER M, V20, P257, DOI 10.1007/s10856-008-3574-3
   Cox MAJ, 2006, J BIOMECH ENG-T ASME, V128, P428, DOI 10.1115/1.2187040
   Cox MAJ, 2008, J BIOMECH, V41, P422, DOI 10.1016/j.jbiomech.2007.08.006
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Diridollou S, 2000, SKIN RES TECHNOL, V6, P214, DOI 10.1034/j.1600-0846.2000.006004214.x
   FUNG YC, 1995, P NATL ACAD SCI USA, V92, P2169, DOI 10.1073/pnas.92.6.2169
   GOW BS, 1983, J BIOMECH, V16, P451, DOI 10.1016/0021-9290(83)90077-5
   Holzapfel G. A., 2006, MECH BIOL TISSUE
   Kauer M, 2002, MED IMAGE ANAL, V6, P275, DOI 10.1016/S1361-8415(02)00085-3
   Matsumoto T, 2004, J BIOMECH, V37, P807, DOI 10.1016/j.jbiomech.2003.08.014
   Matsumoto T, 2002, PHYSIOL MEAS, V23, P635, DOI 10.1088/0967-3334/23/4/304
   Merryman WD, 2007, CARDIOVASC PATHOL, V16, P268, DOI 10.1016/j.carpath.2007.03.006
   Merryman WD, 2006, J BIOMECH, V39, P88, DOI 10.1016/j.jbiomech.2004.11.008
   Ohashi T, 2005, J BIOMECH, V38, P2248, DOI 10.1016/j.jbiomech.2004.09.019
   Ohashi T, 1999, JSME INT J C-MECH SY, V42, P568, DOI 10.1299/jsmec.42.568
   Ozawa H, 2001, J NEUROSURG, V95, P221, DOI 10.3171/spi.2001.95.2.0221
   Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007
   Rabkin-Aikawa E, 2004, J HEART VALVE DIS, V13, P841
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Usyk TP, 2003, CISM COURSES LECT, P273
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
   Zhao RG, 2009, J BIOMECH, V42, P2768, DOI 10.1016/j.jbiomech.2009.07.035
   ZHOU EH, 2005, MECH ADV MATER STRUC, V12, P12
NR 32
TC 43
Z9 45
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1220
EP 1227
DI 10.1016/j.actbio.2010.11.004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900033
PM 21056128
DA 2018-10-20
ER

PT J
AU Mendoza-Novelo, B
   Avila, EE
   Cauich-Rodriguez, JV
   Jorge-Herrero, E
   Rojo, FJ
   Guinea, GV
   Mata-Mata, JL
AF Mendoza-Novelo, Birzabith
   Avila, Eva E.
   Cauich-Rodriguez, Juan V.
   Jorge-Herrero, Eduardo
   Rojo, Francisco J.
   Guinea, Gustavo V.
   Mata-Mata, Jose L.
TI Decellularization of pericardial tissue and its impact on tensile
   viscoelasticity and glycosaminoglycan content
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Tissue decellularization; Pericardium; Glycosaminoglycans; Tensile
   properties; Detergents
ID BOVINE PERICARDIUM; CANINE PERICARDIUM; HEART-VALVES;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; STABILIZATION;
   CALCIFICATION; CONSTRUCTION; BIOMATERIALS; COLLAGEN
AB Bovine pericardium is a collagenous tissue commonly used as a natural biomaterial in the fabrication of cardiovascular devices. For tissue engineering purposes, this xenogeneic biomaterial must be decellularized to remove cellular antigens. With this in mind, three decellularization protocols were compared in terms of their effectiveness to extract cellular materials, their effect on glycosaminoglycan (GAG) content and, finally, their effect on tensile biomechanical behavior. The tissue decellularization was achieved by treatment with t-octyl phenoxy polyethoxy ethanol (Triton X-100), tridecyl polyethoxy ethanol (ATE) and alkaline treatment and subsequent treatment with nucleases (DNase/RNase). The quantified residual DNA content (3.0 +/- 0.4%, 4.4 +/- 0.6% and 5.6 +/- 0.7% for Triton X-100, ATE and alkaline treatment, respectively) and the absence of nuclear structures (hematoxylin and eosin staining) were indicators of effective cell removal. In the same way, it was found that the native tissue GAG content decreased to 61.6 +/- 0.6%, 62.7 +/- 1.1% and 88.6 +/- 0.2% for Triton X-100, ATE and alkaline treatment, respectively. In addition, an alteration in the tissue stress relaxation characteristics was observed after alkaline treatment. We can conclude that the three decellularization agents preserved the collagen structural network, anisotropy and the tensile modulus, tensile strength and maximum strain at failure of native tissue. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mendoza-Novelo, Birzabith; Mata-Mata, Jose L.] Univ Guanajuato, Dept Quim, Guanajuato 36050, Mexico.
   [Avila, Eva E.] Univ Guanajuato, Dept Biol, Guanajuato 36050, Mexico.
   [Cauich-Rodriguez, Juan V.] Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico.
   [Jorge-Herrero, Eduardo] Hosp Univ Puerta Hierro, Serv Invest Quirurg, Madrid 28222, Spain.
   [Rojo, Francisco J.; Guinea, Gustavo V.] Univ Politecn Madrid, Dept Ciencia Mat, ETSI Caminos Canales & Puertos, E-28040 Madrid, Spain.
RP Mata-Mata, JL (reprint author), Univ Guanajuato, Dept Quim, Noria Alta S-N, Guanajuato 36050, Mexico.
EM matamm@quijote.ugto.mx
RI GUINEA TORTUERO, GUSTAVO VICTOR/N-1241-2014; Mendoza-Novelo,
   Birzabith/M-8588-2016; Rojo Perez, Francisco Javier/F-7710-2016
OI GUINEA TORTUERO, GUSTAVO VICTOR/0000-0002-4326-3746; Mendoza-Novelo,
   Birzabith/0000-0001-6604-395X; Rojo Perez, Francisco
   Javier/0000-0001-9517-0050; Avila, Eva E./0000-0003-2011-688X
FU Fundacion Carolina (Spain); FIS, Instituto de Salud Carlos III
   [PI050048]
FX This work was supported partly by a scholarship from the Fundacion
   Carolina (Spain) to B.M.N. We thank R.F. Vargas-Coronado (CICY) and E.
   Duran-Castro (UGTO) for their assistance with SEM and histology,
   respectively. B.M.N. also thanks Prof. G. Mendoza-Diaz (UGTO) for a
   critical review of this work and E.J.H. acknowledges the Spanish
   Government Grant No. PI050048 from the FIS, Instituto de Salud Carlos
   III. The authors also want to thank the referees' suggestions for
   improve this paper.
CR ALLEN DJ, 1984, ANAT REC, V208, pA7
   Arenaz B, 2004, BIOMATERIALS, V25, P3359, DOI 10.1016/j.biomaterials.2003.09.105
   ARGESE E, 1994, ENVIRON TOXICOL CHEM, V13, P737, DOI 10.1897/1552-8618(1994)13[737:SPRTLA]2.0.CO;2
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Duncan AC, 1998, BIOMATERIALS, V19, P777, DOI 10.1016/S0142-9612(97)00215-9
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FLANAGAN TC, 2003, CELLS MAT, V6, P28
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guinea GV, 2008, ANN BIOMED ENG, V36, P66, DOI 10.1007/s10439-007-9397-4
   JOBLING S, 1993, AQUAT TOXICOL, V27, P361, DOI 10.1016/0166-445X(93)90064-8
   Jorge-Herrero E, 2010, ARTIF ORGANS, V34, pE168, DOI 10.1111/j.1525-1594.2009.00978.x
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Lazarou G, 2005, INT UROGYNECOL J, V16, P242, DOI 10.1007/s00192-004-1230-0
   LEE JM, 1985, CIRC RES, V57, P475, DOI 10.1161/01.RES.57.3.475
   LEE JM, 1981, CIRC RES, V49, P533, DOI 10.1161/01.RES.49.2.533
   Liao J, 2008, BIOMATERIALS, V29, P1065, DOI 10.1016/j.biomaterials.2007.11.007
   Limpert Jonathan N, 2009, Am J Surg, V198, pe60, DOI 10.1016/j.amjsurg.2009.01.027
   Matsagas MI, 2006, ANN VASC SURG, V20, P614, DOI 10.1007/s10016-006-9102-3
   Mavrilas D, 2005, J BIOMECH, V38, P761, DOI 10.1016/j.jbiomech.2004.05.019
   Mendoza-Novelo B, 2009, J APPL BIOMATER BIOM, V7, P123
   Moon JJ, 2008, CURR TOP MED CHEM, V8, P300
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   Paez JMG, 2000, J MATER SCI-MATER M, V11, P273, DOI 10.1023/A:1008901128613
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shah SR, 2008, BIOMATERIALS, V29, P1645, DOI 10.1016/j.biomaterials.2007.12.009
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   SOTO AM, 1991, ENVIRON HEALTH PERSP, V92, P167, DOI 10.1289/ehp.9192167
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Wei HJ, 2005, BIOMATERIALS, V26, P1905, DOI 10.1016/j.biomaterials.2004.06.014
   WIEGNER AW, 1981, CIRC RES, V49, P807, DOI 10.1161/01.RES.49.3.807
   Xi-xun Y, 2008, J MATER SCI-MATER M, V19, P319, DOI 10.1007/s10856-007-3157-8
   Yeung Bryan K. S., 2001, P425, DOI 10.1201/9780585407500.ch12
   Zilla P, 2008, BIOMATERIALS, V29, P385, DOI 10.1016/j.biomaterials.2007.09.033
   ZIOUPOS P, 1994, BIOMATERIALS, V15, P366, DOI 10.1016/0142-9612(94)90249-6
NR 40
TC 52
Z9 53
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1241
EP 1248
DI 10.1016/j.actbio.2010.11.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900035
PM 21094703
DA 2018-10-20
ER

PT J
AU Berlind, T
   Tengvall, P
   Hultman, L
   Arwin, H
AF Berlind, T.
   Tengvall, P.
   Hultman, L.
   Arwin, H.
TI Protein adsorption on thin films of carbon and carbon nitride monitored
   with in situ ellipsometry
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Protein adsorption; Carbon nitride; Ellipsometry; Biomaterial; Antibody
   incubation
ID RAY PHOTOELECTRON-SPECTROSCOPY; CONTACT ACTIVATION; SILICON SURFACES;
   WATER-ADSORPTION; VITRO; TITANIUM; HEMOCOMPATIBILITY; FIBRINOGEN;
   COATINGS; ADHESION
AB Thin films of amorphous carbon and amorphous, graphitic and fullerene-like carbon nitride were deposited by reactive magnetron sputtering and optically characterized with spectroscopic ellipsometry. Complementary studies using scanning electron microscopy and atomic force microscopy were performed. The films were exposed to human serum albumin (HSA) and the adsorption was monitored in situ using dynamic ellipsometry. From the ellipsometric data the adsorbed amount of proteins was quantified in terms of surface mass density using de Feijter's model. The results indicate larger adsorption of proteins onto the amorphous films compared to the films with a more textured structure. Complementary studies with (125)I-labeled HSA showed an apparent protein adsorption up to six times larger compared to the ellipsometry measurement. In addition, the four types of films were incubated in blood plasma followed by exposure to anti-fibrinogen, anti-HMWK or anti-C3c, revealing the materials' response to complement and contact activation. The amorphous and graphitic carbon nitride exhibit rather high immune activity compared to a titanium reference, whereas the amorphous carbon and the fullerene-like CN(x) show less immune complement deposition. Compared to the reference, all films exhibit indications of a stronger ability to initiate the intrinsic pathway of coagulation. Finally, the surfaces' bone-bonding ability was investigated by examination of their ability to form calcium phosphate crystals in a simulated body fluid, with a-CN(x) depositing most calcium phosphate after 21 days of incubation. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Berlind, T.; Hultman, L.; Arwin, H.] Linkoping Univ, Dept Phys Chem & Biol IFM, S-58183 Linkoping, Sweden.
   [Tengvall, P.] Univ Gothenburg, Sahlgrenska Acad, Inst Surg Sci, Dept Biomat, S-40530 Gothenburg, Sweden.
RP Berlind, T (reprint author), Linkoping Univ, Dept Phys Chem & Biol IFM, S-58183 Linkoping, Sweden.
EM torun@ifm.liu.se
RI Hultman, Lars/H-4061-2018
OI Hultman, Lars/0000-0002-2837-3656
FU Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic
   Research; Swedish Government Strategic Faculty Grant in Materials
   Science (AFM); County Council of Ostergotland; Linkoping University,
   Sweden
FX Financial support from the Knut and Alice Wallenberg Foundation, Swedish
   Foundation for Strategic Research, Swedish Government Strategic Faculty
   Grant in Materials Science (AFM), and the local strategic research
   project Materials in Medicine, funded by County Council of Ostergotland
   and Linkoping University, Sweden, is appreciated. Agneta Askendal is
   gratefully acknowledged for assistance with radioactivity measurements
   and valuable information regarding the plasma incubation study.
CR Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   ARWIN H, 1992, APPL PHYS COMM, V11, P41
   Azzam R. M., 1987, ELLIPSOMETRY POLARIZ
   Ball V, 1998, BIOPOLYMERS, V46, P489
   Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Berlind T, 2008, PHYS STATUS SOLIDI C, V5, P1249, DOI 10.1002/pssc.200777897
   Berlind T, 2009, THIN SOLID FILMS, V517, P6652, DOI 10.1016/j.tsf.2009.04.065
   Broitman E, 2006, THIN SOLID FILMS, V515, P979, DOI 10.1016/j.tsf.2006.07.065
   Broitman E, 2002, J ELECTRON MATER, V31, pL11, DOI 10.1007/s11664-002-0190-8
   Broitman E, 2008, THIN SOLID FILMS, V517, P1106, DOI 10.1016/j.tsf.2008.07.022
   Broitman E, 2000, DIAM RELAT MATER, V9, P1984, DOI 10.1016/S0925-9635(00)00352-6
   Cui FZ, 2005, SURF COAT TECH, V200, P1009, DOI 10.1016/j.surfcoat.2005.02.157
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Gammon WJ, 2003, CARBON, V41, P1917, DOI 10.1016/S008-6223(03)00170-2
   GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hellgren N, 1999, PHYS REV B, V59, P5162, DOI 10.1103/PhysRevB.59.5162
   *JA WOOLL CO INC, 1999, GUID US WVASE 32
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Jarrendahl K, 1998, THIN SOLID FILMS, V313, P114, DOI 10.1016/S0040-6090(97)00781-5
   KERN W, 1970, RCA REV, V31, P187
   KLINTSTROM SW, 1993, J COLLOID INTERF SCI, V158, P188
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Logothetidis S, 2007, DIAM RELAT MATER, V16, P1847, DOI 10.1016/j.diamond.2007.05.012
   McCrackin F. L., 1969, 479 NBS
   Mora E, 2006, J POWER SOURCES, V156, P719, DOI 10.1016/j.jpowsour.2005.06.025
   Neidhardt J, 2004, CARBON, V42, P2729, DOI 10.1016/j.carbon.2004.06.011
   Neidhardt J, 2007, J VAC SCI TECHNOL A, V25, P633, DOI 10.1116/1.2738505
   Olivares R, 2004, SURF COAT TECH, V177, P758, DOI 10.1016/j.surfcoat.2003.08.018
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Ortega-Vinuesa JL, 1998, THIN SOLID FILMS, V324, P257, DOI 10.1016/S0040-6090(98)00363-0
   *PIERC BIOT, 2002, INSTR IODO BEADS IOD
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   SJOSTROM H, 1995, PHYS REV LETT, V75, P1336, DOI 10.1103/PhysRevLett.75.1336
   STEINBERG SM, 2004, IMMOBILIZATION FISSI
   Stenberg M., 1983, Journal de Physique Colloque, V44, P83, DOI 10.1051/jphyscol:19831017
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vinnichenko M, 2004, THIN SOLID FILMS, V455, P530, DOI 10.1016/j.tsf.2003.11.253
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wu ZR, 2007, SURF COAT TECH, V201, P5710, DOI 10.1016/j.surfcoat.2006.11.032
   Yang YQ, 1996, J HEART VALVE DIS, V5, P526
   Zhang MQ, 1997, BIOTECHNOL BIOENG, V56, P618, DOI 10.1002/(SICI)1097-0290(19971220)56:6<618::AID-BIT4>3.0.CO;2-Q
   Zheng CL, 2005, SURF COAT TECH, V193, P361, DOI 10.1016/j.surfcoat.2004.08.152
NR 46
TC 14
Z9 14
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1369
EP 1378
DI 10.1016/j.actbio.2010.10.024
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900049
PM 20977950
DA 2018-10-20
ER

PT J
AU Sjostrom, T
   Lalev, G
   Mansell, JP
   Su, B
AF Sjoestroem, Terje
   Lalev, Georgi
   Mansell, Jason Peter
   Su, Bo
TI Initial attachment and spreading of MG63 cells on nanopatterned titanium
   surfaces via through-mask anodization
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Nanotopography; Osteoblast; Cell attachment; Cell spreading; Titania
   nanopillars; Titanium surfaces; Through-mask anodization
ID OSTEOBLAST-LIKE CELLS; NANOSCALE TOPOGRAPHY; ADHESION FORMATION;
   STEM-CELLS; INTERFACES; ALIGNMENT; DIFFERENTIATION; DIAMETER; DISORDER;
   BEHAVIOR
AB It is well established that nanosized surface topography significantly affects cell response at a biomaterial surface. Here we used a through-mask anodization technique to fabricate well-defined titania nanopillars with tunable feature sizes from 15 to 100nm on bulk titanium (Ti) substrates and studied their effects on initial attachment and spreading of osteoblast-like cells (MG63). An increase of titania pillar height from 15 to 100nm resulted in reduced spreading of MG63 osteoblast-like cells and the higher pillar structures also gave rise to heavily elongated cells. By using a FIB/SEM dual beam microscope the interface between MG63 cells and nanopatterned Ti surfaces could be studied in more detail. It was found that the higher pillar structures prevented the cells to conform to the surface topography leaving voids in between the cells and the substrates. The results found in this study agree with previous studies that cells response better to surfaces with smaller (<20 nm) features. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Sjoestroem, Terje; Mansell, Jason Peter; Su, Bo] Univ Bristol, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   [Lalev, Georgi] Cardiff Univ, Mfg Engn Ctr, Cardiff CF24 3AA, S Glam, Wales.
RP Su, B (reprint author), Univ Bristol, Dept Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
EM b.su@bristol.ac.uk
FU Engineering and Physical Sciences Research Council [EP/F056745/1]
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Bittermann AG, 2009, ADV ENG MATER, V11, pB182, DOI 10.1002/adem.200900080
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Martinez E, 2008, MICRON, V39, P111, DOI 10.1016/j.micron.2006.12.003
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mills CA, 2007, SMALL, V3, P871, DOI 10.1002/smll.200600683
   Palin E, 2005, NANOTECHNOLOGY, V16, P1828, DOI 10.1088/0957-4484/16/9/069
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   Rausch-fan XH, 2008, DENT MATER, V24, P102, DOI 10.1016/j.dental.2007.03.001
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Sjostrom T, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135305
   Wood MA, 2008, EXP CELL RES, V314, P927, DOI 10.1016/j.yexcr.2007.10.003
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
NR 29
TC 22
Z9 22
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 1
PY 2011
VL 257
IS 10
BP 4552
EP 4558
DI 10.1016/j.apsusc.2010.11.064
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 714KK
UT WOS:000286808300002
DA 2018-10-20
ER

PT J
AU Liu, WE
   Ma, ML
   Bratlie, KM
   Dang, TT
   Langer, R
   Anderson, DG
AF Liu, Wendy E.
   Ma, Minglin
   Bratlie, Kaitlin M.
   Dang, Tram T.
   Langer, Robert
   Anderson, Daniel G.
TI Real-time in vivo detection of biomaterial-induced reactive oxygen
   species
SO BIOMATERIALS
LA English
DT Article
DE Biocompatibility; Immune response; Foreign body response; Free radical
ID HUMAN-NEUTROPHILS; PROTEASE ACTIVITY; OXIDATIVE STRESS; MECHANISMS;
   OXIDASE; INFLAMMATION; SUPEROXIDE; ACTIVATION; RESPONSES; CANCER
AB The non-specific host response to implanted biomaterials is often a key challenge of medical device design. To evaluate biocompatibility, measuring the release of reactive oxygen species (ROS) produced by inflammatory cells in response to biomaterial surfaces is a well-established method. However, the detection of ROS in response to materials implanted in vivo has not yet been demonstrated. Here, we develop a bioluminescence whole animal imaging approach to observe ROS released in response to subcutaneously-implanted materials in live animals. We compared the real-time generation of ROS in response to two representative materials, polystyrene and alginate, over the course of 28 days. High levels of ROS were observed near polystyrene, but not alginate implants, and persisted throughout the course of 28 days. Histological analysis revealed that high levels of ROS correlated not only with the presence of phagocytic cells at early timepoints, but also fibrosis at later timepoints, suggesting that ROS may be involved in both the acute and chronic phase of the foreign body response. These data are the first in vivo demonstration of ROS generation in response to implanted materials, and describe a novel technique to evaluate the host response. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Bratlie, Kaitlin M.; Dang, Tram T.; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Liu, Wendy E.; Ma, Minglin; Bratlie, Kaitlin M.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Liu, Wendy E.; Ma, Minglin; Bratlie, Kaitlin M.; Langer, Robert; Anderson, Daniel G.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA.
RP Anderson, DG (reprint author), MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM dgander@mit.edu
RI Dang, Tram/E-7966-2011
OI Dang, Tram/0000-0001-6464-0101
FU Juvenile Diabetes Research Foundation [17-2007-1063]; National
   Institutes of Health [2R01DE016516-06, F32 EB011580-01]; Agency for
   Science, Technology and Research of Singapore
FX We thank Mr. Chakib Boussahmain for preparation of histological samples,
   Dr. Rod Bronson and Dr. Scott Malstrom for assistance with data
   analysis, and Mr. Phillip Kim for technical assistance. This research
   was supported by the Juvenile Diabetes Research Foundation under grant
   17-2007-1063 and the National Institutes of Health under grant
   2R01DE016516-06. T.D. is grateful for support from the Agency for
   Science, Technology and Research of Singapore for the A*STAR National
   Science Graduate Fellowship. K.B. is grateful for the support from the
   National Institutes of Health Postdoctoral Fellowship F32 EB011580-01.
CR Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Daiber A, 2004, FREE RADICAL BIO MED, V36, P101, DOI 10.1016/j.freeradbiomed.2003.09.023
   DECHATELET LR, 1982, J IMMUNOL, V129, P1589
   Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeadbiomed.2006.09.030
   GINIS I, 1990, BLOOD, V76, P1233
   Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886
   Hallett Maurice B, 2003, Methods Mol Biol, V225, P61
   Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Huie RE, 2002, REACTIVE OXYGEN SPEC, P33
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/ncr1046
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898
   Kielland A, 2009, FREE RADICAL BIO MED, V47, P760, DOI 10.1016/j.freeradbiomed.2009.06.013
   Li Z, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S8
   Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334
   Thurber GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008053
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wunder A, 2004, ARTHRITIS RHEUM-US, V50, P2459, DOI 10.1002/art.20379
NR 35
TC 61
Z9 61
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2011
VL 32
IS 7
BP 1796
EP 1801
DI 10.1016/j.biomaterials.2010.11.029
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717TD
UT WOS:000287069400004
PM 21146868
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rahal, SC
   Teixeira, CR
   Vulcano, LC
   Aguiar, AJA
AF Rahal, Sheila C.
   Teixeira, Carlos R.
   Vulcano, Luiz C.
   Aguiar, Antonio J. A.
TI Use of an osteoconductive compound as an aid in the management of a
   maxillary fracture in a boa constrictor
SO CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE
LA English
DT Article
ID BONE-GRAFT SUBSTITUTES
AB A boa constrictor was presented with a short oblique compound fracture of the rostral third of the right maxilla. The fracture was reduced and biomaterial was placed around the fracture. A computed tomography scan at 1.5 mo post-surgery showed that the fracture had healed with slight displacement of the bone fragments.
C1 [Rahal, Sheila C.; Teixeira, Carlos R.; Vulcano, Luiz C.; Aguiar, Antonio J. A.] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, BR-18618000 Botucatu, SP, Brazil.
RP Rahal, SC (reprint author), Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, BR-18618000 Botucatu, SP, Brazil.
EM sheilacr@fmvz.unesp.br
RI Rahal, Sheila/E-9264-2012; Aguiar, Antonio/V-5843-2017
OI Rahal, Sheila/0000-0002-9211-4093; Aguiar, Antonio/0000-0001-6854-722X
CR Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   JACOBSON ER, 1993, VET CLIN N AM-SMALL, V23, P1179, DOI 10.1016/S0195-5616(93)50152-3
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9
   KOLESNIKOVAS C.K.M, 2007, TRATADO ANIMAIS SELV, P68
   Mader DR, 2006, REPTILE MED SURG, P581
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   OMALLEY B., 2005, CLIN ANATOMY PHYSL E, P77
   OSHEA M, 2002, REPTILES AMPHIBIANS, P104
   POUGH FH, 2004, HERPENTOLOGY, P385
   SCARTOZZONI R.R., 2004, REV ETOL, V6, P25
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
NR 12
TC 1
Z9 1
U1 0
U2 2
PU CANADIAN VET MED ASSOC
PI OTTAWA
PA 339 BOOTH ST ATTN: KIMBERLY ALLEN-MCGILL, OTTAWA, ONTARIO K1R 7K1,
   CANADA
SN 0008-5286
J9 CAN VET J
JI Can. Vet. J.-Rev. Vet. Can.
PD MAR
PY 2011
VL 52
IS 3
BP 300
EP 302
PG 3
WC Veterinary Sciences
SC Veterinary Sciences
GA 729ZH
UT WOS:000287992700013
PM 21629425
DA 2018-10-20
ER

PT J
AU Grandi, C
   Di Liddo, R
   Paganin, P
   Lora, S
   Dalzoppo, D
   Feltrin, G
   Giraudo, C
   Tommasini, M
   Conconi, MT
   Parnigotto, PP
AF Grandi, Claudio
   Di Liddo, Rosa
   Paganin, Piergiorgio
   Lora, Silvano
   Dalzoppo, Daniele
   Feltrin, Giampietro
   Giraudo, Chiara
   Tommasini, Mara
   Conconi, Maria Teresa
   Parnigotto, Pier Paolo
TI Porous alginate/poly(epsilon-caprolactone) scaffolds: preparation,
   characterization and in vitro biological activity
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE bone regeneration; scaffold porosity; poly(epsilon-caprolactone);
   calcium alginate threads; scaffold pore size
ID LIQUID PHASE-SEPARATION; BIODEGRADABLE POLYMER SCAFFOLDS; TISSUE
   ENGINEERING APPLICATIONS; POLY(L-LACTIC ACID) FOAMS; BMP-INDUCED
   OSTEOGENESIS; CREST BONE-GRAFT; ILIAC CREST; OSTEOBLASTIC
   DIFFERENTIATION; POLYCAPROLACTONE SCAFFOLD; MECHANICAL-PROPERTIES
AB In bone tissue engineering, scaffolds with controlled porosity are required to allow cell ingrowth, nutrient diffusion and sufficient formation of vascular networks. The physical properties of synthetic scaffolds are known to be dependent on the biomaterial type and its processing technique. In this study, we demonstrate that the separation phase technique is a useful method to process poly(epsilon-caprolactone) (PCL) into a desired shape and size. Moreover, using poly(ethylene glycol), sucrose, fructose and Ca2+ alginate as porogen agents, we obtained PCL scaffolds with three-dimensional porous structures characterized by different pore size and geometry. Scanning electron microscopy and porosity analysis indicated that PCL scaffolds prepared with Ca2+ alginate threads resemble the porosity and the homogeneous pore size distribution of native bone. In parallel, MicroCT analysis confirmed the presence of interconnected void spaces suitable to guarantee a biological environment for cellular growth, as demonstrated by a biocompatibility test with MC3T3-E1 murine preosteoblastic cells. In particular, scaffolds prepared with Ca2+ alginate threads increased adhesion and proliferation of MC3T3-E1 cells under basal culture conditions, and upon stimulation with a specific differentiation culture medium they enhanced the early and later differentiated cell functions, including alkaline phosphatase activity and mineralized extracellular matrix production. These results suggest that PCL scaffolds, obtained by separation phase technique and prepared with alginate threads, could be considered as candidates for bone tissue engineering applications, possessing the required physical and biological properties.
C1 [Grandi, Claudio; Di Liddo, Rosa; Paganin, Piergiorgio; Lora, Silvano; Dalzoppo, Daniele; Tommasini, Mara; Conconi, Maria Teresa; Parnigotto, Pier Paolo] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy.
   [Feltrin, Giampietro; Giraudo, Chiara] Univ Padua, Dept Med Diagnost Sci & Special Therapies, I-35131 Padua, Italy.
RP Di Liddo, R (reprint author), Univ Padua, Dept Pharmaceut Sci, Via Marzolo 5, I-35131 Padua, Italy.
EM rosa.diliddo@unipd.it
OI /0000-0003-0924-5883
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Aronin CEP, 2008, ACTA BIOMATER, V4, P1187, DOI 10.1016/j.actbio.2008.02.029
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BENOIT MA, 1999, INT J PHARMACEUT, V184, P105
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Ciardelli G, 2005, BIOMACROMOLECULES, V6, P1961, DOI 10.1021/bm0500805
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Currey JD, 1998, P I MECH ENG H, V212, P399, DOI 10.1243/0954411981534178
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   GOULET JA, 1997, CLIN ORTHOP RELAT R, V339, P76, DOI DOI 10.1097/00003086-199706000-00011
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hua FJ, 2002, J BIOMED MATER RES, V63, P161, DOI 10.1002/jbm.10121.abs
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   JOWSEY J, 1966, J ANAT, V100, P857
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lanza RP, 1997, SURGERY, V121, P1, DOI 10.1016/S0039-6060(97)90175-6
   Lebourg M, 2008, J MATER SCI-MATER M, V19, P2047, DOI 10.1007/s10856-007-3282-4
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Lewandrowski KU, 2003, TISSUE ENG, V9, P85, DOI 10.1089/107632703762687564
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15
   Ma GL, 2006, CONTRACEPTION, V74, P141, DOI 10.1016/j.contraception.2006.02.013
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marra KG, 1999, MATER RES SOC SYMP P, V550, P155
   Mikos A. G., 1998, FRONTIERS TISSUE ENG, P3
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mikos Antonios G., 2000, EJB Electronic Journal of Biotechnology, V3, P1
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   SHANG M, 2002, J POLYM SCI B, V41, P194
   Shin KC, 2005, POLYMER, V46, P3801, DOI 10.1016/j.polymer.2005.02.114
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Stylios G, 2007, INJURY, V38, pS63, DOI 10.1016/j.injury.2007.02.011
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Wei GB, 2006, J BIOMED MATER RES A, V78A, P306, DOI 10.1002/jbm.a.30704
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu HY, 2008, J BIOMED MATER RES B, V86B, P541, DOI 10.1002/jbm.b.31054
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 76
TC 8
Z9 8
U1 0
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD MAR
PY 2011
VL 27
IS 3
BP 455
EP 467
DI 10.3892/ijmm.2010.593
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 727FQ
UT WOS:000287783600021
PM 21206967
OA Bronze
DA 2018-10-20
ER

PT J
AU Rosskopfova, O
   Galambos, M
   Rajec, P
AF Rosskopfova, O.
   Galambos, M.
   Rajec, P.
TI Study of sorption processes of strontium on the synthetic hydroxyapatite
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
DE Sorption; Hydroxyapatite; Strontium; Langmuir isotherm
ID AQUEOUS-SOLUTIONS; ANIMAL BONES; IONS; PHOSPHATE; REMOVAL;
   HYDROXYLAPATITE; PRECIPITATION; TEMPERATURE; ADSORPTION; BENTONITE
AB The sorption of strontium on synthetic hydroxyapatite was investigated using batch method and radiotracer technique. The hydroxyapatite samples were prepared by a wet precipitation process followed by calcination of calcium phosphate that precipitated from aqueous solution. Also, commercial hydroxyapatites were used. The sorption of strontium on hydroxyapatite depended on the method of preparation and it was pH independent ranging from 4 to 9 as a result of buffering properties of hydroxyapatite. The distribution coefficient K (d) was significantly decreased with increasing concentration of Sr(2+) and Ca(2+) ions in solution with concentration above 1 x 10(-3) mol dm(-3). The percentage strontium sorption for commercial and by wet method prepared hydroxyapatite was in the range of 83-96%, while calcined hydroxyapatite was ranging from 10 to 30%. The experimental data for sorption of strontium have been interpreted in the term of Langmuir isotherm. The sorption of Sr(2+) ions was performed by ion-exchange with Ca(2+) cations on the crystal surface of hydroxyapatite. Although calcined hydroxyapatite is successfully used as biomaterial for hard tissues repair, it is not used for the treatment of liquid wastes.
C1 [Rosskopfova, O.; Galambos, M.; Rajec, P.] Comenius Univ, Fac Nat Sci, Dept Nucl Chem, Bratislava 84215, Slovakia.
RP Rosskopfova, O (reprint author), Comenius Univ, Fac Nat Sci, Dept Nucl Chem, Bratislava 84215, Slovakia.
EM rosskopfova@fns.uniba.sk
RI Galambos, Michal/M-8579-2015
CR Ashok M, 2007, J MATER SCI-MATER M, V18, P895, DOI 10.1007/s10856-006-0070-5
   Bailliez S, 2004, CHEM ENG J, V98, P141, DOI 10.1016/j.cej.2003.07.001
   Bengtsson A, 2009, GEOCHIM COSMOCHIM AC, V73, P257, DOI 10.1016/j.gca.2008.09.034
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Dimovic S, 2009, J HAZARD MATER, V164, P279, DOI 10.1016/j.jhazmat.2008.08.013
   Elouear Z, 2008, J HAZARD MATER, V156, P412, DOI 10.1016/j.jhazmat.2007.12.036
   Fernane F, 2008, MATER CHARACT, V59, P554, DOI 10.1016/j.matchar.2007.04.009
   Galambos M, 2009, J RADIOANAL NUCL CH, V281, P347, DOI 10.1007/s10967-009-0017-7
   Galambos M, 2010, J RADIOANAL NUCL CH, V283, P803, DOI 10.1007/s10967-009-0424-9
   Hollriegl V, 2006, RADIAT ENVIRON BIOPH, V45, P179, DOI 10.1007/s00411-006-0057-0
   Jeanjean J, 1995, J RADIOAN NUCL CH LE, V201, P529, DOI 10.1007/BF02162730
   Khan SA, 1995, WASTE MANAGE, V15, P641, DOI 10.1016/0956-053X(96)00049-9
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Krejzler J, 2003, NUKLEONIKA, V48, P171
   Krestou A, 2004, MINER ENG, V17, P373, DOI 10.1016/j.mineng.2003.11.019
   KRISTIN J, 1984, Patent No. 8300114
   LAZIC S, 1991, J RADIOAN NUCL CH AR, V149, P161, DOI 10.1007/BF02053724
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Luo P, 1996, BIOMATERIALS, V17, P1959, DOI 10.1016/0142-9612(96)00019-1
   Moore RC, 2005, J RADIOANAL NUCL CH, V263, P97, DOI 10.1007/s10967-005-0019-z
   Moore RC, 2004, RADIOCHIM ACTA, V92, P719, DOI 10.1524/ract.92.9.719.55000
   Moore RC, 2003, RADIOCHIM ACTA, V91, P721, DOI 10.1524/ract.91.12.721.23417
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Nzihou A, 2010, WASTE BIOMASS VALORI, V1, P163, DOI 10.1007/s12649-009-9006-x
   Parkman RH, 1998, GEOCHIM COSMOCHIM AC, V62, P1481, DOI 10.1016/S0016-7037(98)00072-6
   Raicevic S, 1996, J RADIOAN NUCL CH AR, V204, P363, DOI 10.1007/BF02060325
   Rajec P, 1998, J RADIOANAL NUCL CH, V229, P49, DOI 10.1007/BF02389445
   Raynaud S, 1998, J MATER SCI-MATER M, V9, P221, DOI 10.1023/A:1008840308094
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Sanosh KP, 2009, CURR APPL PHYS, V9, P1459, DOI 10.1016/j.cap.2009.03.024
   Simon FG, 2008, APPL GEOCHEM, V23, P2137, DOI 10.1016/j.apgeochem.2008.04.025
   Smiciklas I, 2006, WATER RES, V40, P2267, DOI 10.1016/j.watres.2006.04.031
   Smiciklas I, 2010, J NUCL MATER, V400, P15, DOI 10.1016/j.jnucmat.2010.02.004
   Smiciklas ID, 2000, SEP PURIF TECHNOL, V18, P185, DOI 10.1016/S1383-5866(99)00066-0
   SOMASUNDARAN P, 1985, COLLOID SURFACE, V15, P309, DOI 10.1016/0166-6622(85)80081-0
   Stotzel C, 2009, COLLOID SURFACE B, V74, P91, DOI 10.1016/j.colsurfb.2009.06.031
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Tsai SC, 2000, J RADIOANAL NUCL CH, V243, P741, DOI 10.1023/A:1010694910170
   Vucinic DR, 2010, J COLLOID INTERF SCI, V343, P239, DOI 10.1016/j.jcis.2009.11.024
   Wang AJ, 2009, POWDER TECHNOL, V191, P1, DOI 10.1016/j.powtec.2008.10.020
   Zhang ZZ, 2010, ENVIRON POLLUT, V158, P514, DOI 10.1016/j.envpol.2009.08.024
NR 42
TC 25
Z9 25
U1 1
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD MAR
PY 2011
VL 287
IS 3
BP 715
EP 722
DI 10.1007/s10967-010-0816-x
PG 8
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA 726WI
UT WOS:000287756900007
DA 2018-10-20
ER

PT J
AU Sakono, M
   Akiyama, S
   Zako, T
   Sakaki, S
   Waku, T
   Tanaka, N
   Maeda, M
AF Sakono, Masafumi
   Akiyama, Shigenori
   Zako, Tamotsu
   Sakaki, Shujiro
   Waku, Tomonori
   Tanaka, Naoki
   Maeda, Mizuo
TI Application of two morphologically different fibrillar and filamentous
   insulin amyloids as a biomaterial for cell culture surfaces
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Insulin amyloid; Self-assembly; Insulin filament; Biomaterial; Cell
   culture surface
ID BETA OLIGOMERS; BINDING-SITES; FABRICATION; PREFOLDIN; PROTEIN;
   CHAPERONIN; SUBSTRATE; TOXICITY
AB Synthetic biomaterials, such as polymers and self-assembling polypeptides have been developed for cell culture. The self-assembly of misfolded proteins, which is so-called 'amyloid', has also been demonstrated to work as a cell adhesive biomaterial. In this study, we demonstrated that two morphologically different insulin amyloids, fibrils and filaments, can be used as biomaterials for cell culture. We previously showed that the cytotoxicity of insulin filaments is markedly lower than that of fibrils. Both types of insulin amyloid-coated dishes showed higher cell adhesion and cell proliferation ability compared to non-coated dishes. Interestingly, insulin filaments showed higher cell adhesion and cell proliferation ability compared to insulin fibrils. These results strongly suggest that insulin amyloids, and insulin filaments in particular, can be used as a biomaterial for cell culture surfaces. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Sakono, Masafumi; Zako, Tamotsu; Maeda, Mizuo] Riken Inst Phys & Chem Res, Bioengn Lab, Wako, Saitama 3510198, Japan.
   [Akiyama, Shigenori; Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.
   [Sakaki, Shujiro] Akita Natl Coll Technol, Dept Appl Chem, Akita 0118511, Japan.
RP Zako, T (reprint author), Riken Inst Phys & Chem Res, Bioengn Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM zako@riken.jp; tanaka@kit.ac.jp
RI Zako, Tamotsu/C-3004-2012; Sakono, Masafumi/I-7547-2017; Maeda,
   Mizuo/I-3498-2014
OI Sakono, Masafumi/0000-0002-1892-7520; 
FU RIKEN (Nano-scale Science and Technology Research)
FX The authors are grateful for financial support from RIKEN (Nano-scale
   Science and Technology Research). We thank Piotr Gryko (Imperial College
   London) for helpful comments.
CR Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0
   Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   Okochi M, 2004, J BIOL CHEM, V279, P31788, DOI 10.1074/jbc.M402889200
   Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x
   Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008
   Vacanti JP, 1999, LANCET, V354, pSI32
   Zako T, 2005, FEBS LETT, V579, P3718, DOI 10.1016/j.febslet.2005.05.061
   Zako T, 2009, BIOPHYS J, V96, P3331, DOI 10.1016/j.bpj.2008.12.3957
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   ZHENG J, 1995, BIOTECHNOL PROGR, V11, P677, DOI 10.1021/bp00036a011
NR 25
TC 6
Z9 6
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAR
PY 2011
VL 71
IS 3
SI SI
BP 324
EP 328
DI 10.1016/j.reactfunctpolym.2010.10.012
PG 5
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 728UB
UT WOS:000287898900014
DA 2018-10-20
ER

PT J
AU Ellis, G
   Cano, P
   Jadraque, M
   Martin, M
   Lopez, L
   Nunez, T
   de la Pena, E
   Marco, C
   Garrido, L
AF Ellis, Gary
   Cano, Pilar
   Jadraque, Maria
   Martin, Margarita
   Lopez, Laura
   Nunez, Teresa
   de la Pena, Enrique
   Marco, Carlos
   Garrido, Leoncio
TI Laser microperforated biodegradable microbial polyhydroxyalkanoate
   substrates for tissue repair strategies: an infrared microspectroscopy
   study
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE FTIR microspectroscopy; Laser microfabrication;
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate); Biodegradable
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; X-RAY-DIFFRACTION;
   CORRELATION SPECTROSCOPY; SYNCHROTRON-RADIATION; ENZYMATIC DEGRADATION;
   THERMAL-DEGRADATION; HYDROGEN BONDINGS; MELTING BEHAVIOR; POLYMER
   SURFACES; MEDICAL DEVICES
AB Flexible and biodegradable film substrates prepared by solvent casting from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) solutions in chloroform were microperforated by ultraviolet laser ablation and subsequently characterized using infrared (IR) microspectroscopy and imaging techniques and scanning electron microscopy (SEM). Both transmission synchrotron IR microspectroscopy and attenuated total reflectance microspectroscopy measurements demonstrate variations in the polymer at the ablated pore rims, including evidence for changes in chemical structure and crystallinity. SEM results on microperforated PHBHV substrates after cell culture demonstrated that the physical and chemical changes observed in the biomaterial did not hinder cell migration through the pores.
C1 [Ellis, Gary; Cano, Pilar; Marco, Carlos; Garrido, Leoncio] CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
   [Jadraque, Maria; Martin, Margarita] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
   [Lopez, Laura; Nunez, Teresa; de la Pena, Enrique] Fdn Hosp Alcorcon, Alcorcon 28922, Spain.
RP Ellis, G (reprint author), CSIC, Inst Ciencia & Tecnol Polimeros, Juan de la Cierva 3, E-28006 Madrid, Spain.
EM gary@ictp.csic.es
RI Martin, Margarita/L-7758-2013; Garrido, Leoncio/K-3092-2014; Ellis,
   Gary/C-1617-2010
OI Garrido, Leoncio/0000-0002-7587-1260; Ellis, Gary/0000-0003-4851-6092
FU Ministerio de Ciencia e Innovacion (MICINN), Instituto de Salud Carlos
   III [FIS PI05/2087, PI08/1677]; US Department of Energy, Division of
   Materials Sciences, and Division of Chemical Sciences
   [DE-AC02-98CH10886]; European Union [RII3-CT-2004-506008]
FX Financial support was provided by the Ministerio de Ciencia e Innovacion
   (MICINN), Instituto de Salud Carlos III, projects FIS PI05/2087 and
   PI08/1677. Synchrotron measurements performed at the U10B Beamline of
   the National Synchrotron Light Source, Brookhaven National Laboratory
   were supported by the US Department of Energy, Division of Materials
   Sciences, and Division of Chemical Sciences under Contract No.
   DE-AC02-98CH10886, and those performed at the SMIS Beamline of
   Synchrotron Soleil were supported by the European Union Trans National
   Access I3/IA-SFS Program(RII3-CT-2004-506008). We wish to thank the
   Beamline staff of both installations for their helpful support and
   advice.
CR Aguilar CA, 2005, BIOMATERIALS, V26, P7642, DOI 10.1016/j.biomaterials.2005.04.053
   Bassan P, 2009, ANALYST, V134, P1586, DOI 10.1039/b904808a
   BAUERLE D, 2000, LASER PROCESSING CHE, P599
   Bayari S, 2005, J MOL STRUCT, V744, P529, DOI 10.1016/j.molstruc.2004.12.029
   Bettinger CJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P341, DOI 10.1016/B978-012370615-7/50028-7
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Cyras VP, 2000, J APPL POLYM SCI, V77, P2889, DOI 10.1002/1097-4628(20000923)77:13<2889::AID-APP11>3.0.CO;2-O
   De Bartolo L, 2001, J MATER SCI-MATER M, V12, P959, DOI 10.1023/A:1012857031409
   DUNCAN WD, 1983, APPL OPTICS, V22, P2914, DOI 10.1364/AO.22.002914
   Ellis G, 2004, INFRARED PHYS TECHN, V45, P349, DOI 10.1016/j.infrared.2004.01.015
   Ellis G, 2004, J MACROMOL SCI PHYS, VB43, P253, DOI [10.1081/MB-120027762, 10.1018/MB-120027762]
   Ellis G, 2002, MACROMOL SYMP, V184, P37, DOI 10.1002/1521-3900(200208)184:1<37::AID-MASY37>3.0.CO;2-4
   Freier T., 2006, ADV POLYM SCI, V203, P1, DOI DOI 10.1007/12_073
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   Garrido L, 2011, J APPL POLYM SCI, V119, P3286, DOI 10.1002/app.32920
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gonzalez A, 2005, POLYM DEGRAD STABIL, V87, P347, DOI 10.1016/j.polymdegradstab.2004.09.005
   Gu J, 2002, APPL PHYS A-MATER, V74, P487, DOI 10.1007/s003390101042
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   HONG SG, 2006, POLYMERS, V1, P1
   Hu Y, 2007, POLYMER, V48, P4777, DOI 10.1016/j.polymer.2007.06.016
   Jadraque M, 2011, PHOTOMED LASER SURG, V29, P75, DOI 10.1089/pho.2010.2769
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kansiz M, 2007, ANAL BIOANAL CHEM, V388, P1207, DOI 10.1007/s00216-007-1337-5
   Kazarian SG, 2006, BBA-BIOMEMBRANES, V1758, P858, DOI 10.1016/j.bbamem.2006.02.011
   Kohler A, 2008, APPL SPECTROSC, V62, P259, DOI 10.1366/000370208783759669
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Li SD, 2003, J APPL POLYM SCI, V89, P1530, DOI 10.1002/app.12249
   Lippert T, 2003, CHEM REV, V103, P453, DOI 10.1021/cr010460q
   MALYSHEV AY, 2006, QUANTUM ELECTRON, V3, P5825
   Martele Y, 2002, POLYM INT, V51, P1172, DOI 10.1002/pi.935
   Martin MC, 2010, TRAC-TREND ANAL CHEM, V29, P453, DOI 10.1016/j.trac.2010.03.002
   Martinez G, 2002, POLYM DEGRAD STABIL, V76, P205, DOI 10.1016/S0141-3910(02)00015-0
   Mohlenhoff B, 2005, BIOPHYS J, V88, P3635, DOI 10.1529/biophysj.104.057950
   MORIKAWA H, 1981, CAN J CHEM, V59, P2306, DOI 10.1139/v81-334
   Murphy MB, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P309, DOI 10.1016/B978-012370615-7/50026-3
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Numata K, 2005, BIOMACROMOLECULES, V6, P2008, DOI 10.1021/bm0501151
   Padermshoke A, 2004, VIB SPECTROSC, V36, P241, DOI 10.1016/j.vibspec.2003.11.016
   Padermshoke A, 2005, SPECTROCHIM ACTA A, V61, P541, DOI 10.1016/j.saa.2004.05.004
   Padermshoke A, 2004, POLYMER, V45, P6547, DOI 10.1016/j.polymer.2004.07.051
   Romeo M, 2005, VIB SPECTROSC, V38, P129, DOI 10.1016/j.vibspec.2005.04.003
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   Sato H, 2005, MACROMOL SYMP, V220, P123, DOI 10.1002/masy.200550210
   Sato H, 2004, MACROMOLECULES, V37, P7203, DOI 10.1021/ma049117o
   Sato H, 2008, MACROMOLECULES, V41, P4305, DOI 10.1021/ma7O2222a
   Sato H, 2009, VIB SPECTROSC, V51, P132, DOI 10.1016/j.vibspec.2008.11.010
   Serrano F, 2007, BIOMATERIALS, V28, P650, DOI 10.1016/j.biomaterials.2006.09.018
   SRINIVASAN R, 1987, POLYM DEGRAD STABIL, V17, P193, DOI 10.1016/0141-3910(87)90063-2
   Steiner G, 2009, ANAL BIOANAL CHEM, V394, P671, DOI 10.1007/s00216-009-2737-5
   Tomasi G, 1996, MACROMOLECULES, V29, P507, DOI 10.1021/ma951067n
   VANDEHULST HC, 1981, LIGHT SCATTERING SMA, P76
   Vogel C, 2008, MACROMOLECULES, V41, P2975, DOI 10.1021/ma800139u
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   Wu Q, 2001, J APPL POLYM SCI, V82, P934, DOI 10.1002/app.1925.abs
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
NR 59
TC 12
Z9 12
U1 5
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD MAR
PY 2011
VL 399
IS 7
BP 2379
EP 2388
DI 10.1007/s00216-011-4653-8
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 718QU
UT WOS:000287141700010
PM 21240671
DA 2018-10-20
ER

PT J
AU Talukdar, S
   Mandal, M
   Hutmacher, DW
   Russell, PJ
   Soekmadji, C
   Kundu, SC
AF Talukdar, Sarmistha
   Mandal, Mahitosh
   Hutmacher, Dietmar W.
   Russell, Pamela J.
   Soekmadji, Carolina
   Kundu, Subhas C.
TI Engineered silk fibroin protein 3D matrices for in vitro tumor model
SO BIOMATERIALS
LA English
DT Article
DE Silk; Fibroin; 3D; Cell culture; Tumour
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; SCAFFOLDS; BIOMATERIALS;
   MATRIX-METALLOPROTEINASE-9; CULTURE; CANCER; FIBROBLASTS; EXPRESSION;
   MULBERRY
AB 3D in vitro model systems that are able to mimic the in vivo microenvironment are now highly sought after in cancer research. Antheraea mylitta silk fibroin protein matrices were investigated as potential biomaterial for in vitro tumor modeling. We compared the characteristics of MDA-MB-231 cells on A. mylitta, Bombyx mori silk matrices, Matrigel, and tissue culture plates. The attachment and morphology of the MDA-MB-231 cell line on A. mylitta silk matrices was found to be better than on B. mori matrices and comparable to Matrigel and tissue culture plates. The cells grown in all 3D cultures showed more MMP-9 activity, indicating a more invasive potential. In comparison to B. mod fibroin, A. mylitta fibroin not only provided better cell adhesion, but also improved cell viability and proliferation. Yield coefficient of glucose consumed to lactate produced by cells on 3D A. mylitta fibroin was found to be similar to that of cancer cells in vivo. LNCaP prostate cancer cells were also cultured on 3D A. mylitta fibroin and they grew as clumps in long term culture. The results indicate that A. mylitta fibroin scaffold can provide an easily manipulated microenvironment system to investigate individual factors such as growth factors and signaling peptides, as well as evaluation of anticancer drugs. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Talukdar, Sarmistha; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Mandal, Mahitosh] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
   [Hutmacher, Dietmar W.; Russell, Pamela J.; Soekmadji, Carolina] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Hutmacher, Dietmar W.; Russell, Pamela J.; Soekmadji, Carolina] Australian Prostate Canc Res Ctr, Brisbane, Qld 4102, Australia.
RP Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM kundu@hijli.iitkgp.ernet.in
RI Russell, Pamela/G-1685-2010; Soekmadji, Carolina/M-2757-2016
OI Russell, Pamela/0000-0002-3995-1239; Soekmadji,
   Carolina/0000-0002-6920-6627; Kundu, Subhas C./0000-0002-7170-2291;
   Hutmacher, Dietmar Werner/0000-0001-5678-2134
FU Department of Biotechnology; Indo-Australia Biotechnology fund;
   Department of Science and Technology; Government of India Indo-US
   Science and Technology Forum (IUSSTF), New Delhi; Australian Prostate
   Cancer Foundation
FX This work is supported by Department of Biotechnology and its
   Bioinformatics facilities, Indo-Australia Biotechnology fund (DBT),
   Department of Science and Technology, Government of India Indo-US
   Science and Technology Forum (IUSSTF), New Delhi and by the Australian
   Prostate Cancer Foundation. We would like to thank Dr Christina
   Theodoropoulos (QUT) for her assistance in SEM for LNCaP cells.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Acharya C, 2008, BIOMATERIALS, V29, P4665, DOI 10.1016/j.biomaterials.2008.08.033
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bajzer Z., 1997, SURVEY MODELS TUMOR, P89
   Bergers G, 2000, NAT CELL BIOL, V2, P737
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Fingleton B, 2001, NEOPLASIA, V3, P459, DOI 10.1038/sj.neo.7900190
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Ghosh S, 2005, ANN SURG, V242, P851, DOI 10.1097/01.sla.0000189571.84213.b0
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1
   Kim JK, 2007, MACROMOL BIOSCI, V10, P643
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj/bjc/6600158
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015
   LENGYEL E, 1995, CANCER RES, V55, P963
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Manes S, 1999, J BIOL CHEM, V274, P6935, DOI 10.1074/jbc.274.11.6935
   Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706
   MARUSIC M, 1994, B MATH BIOL, V56, P617, DOI 10.1007/BF02460714
   McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202
   McQuibban GA, 2002, BLOOD, V100, P1160
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884
   Padron JM, 2000, CRIT REV ONCOL HEMAT, V36, P141, DOI 10.1016/S1040-8428(00)00083-4
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Tang X., 2008, J BIOMED MATER RES A, V91A, P166
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Ward JP, 1997, IMA J MATH APPL MED, V14, P39
   Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113
   Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1
   Yu Q, 2000, GENE DEV, V14, P163
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
NR 63
TC 76
Z9 77
U1 0
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2011
VL 32
IS 8
BP 2149
EP 2159
DI 10.1016/j.biomaterials.2010.11.052
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717QB
UT WOS:000287061400016
PM 21167597
DA 2018-10-20
ER

PT J
AU Sileri, P
   Franceschilli, L
   Blanco, GD
   Stolfi, VM
   Angelucci, GP
   Gaspari, AL
AF Sileri, Pierpaolo
   Franceschilli, Luana
   Blanco, Giovanna Del Vecchio
   Stolfi, Vito M.
   Angelucci, Giulio P.
   Gaspari, Achille L.
TI Porcine dermal collagen matrix injection may enhance flap repair surgery
   for complex anal fistula
SO INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
LA English
DT Article
DE Permacol; Complex anal fistula; Flap repair
ID FIBRIN GLUE; IN-ANO; ADVANCEMENT FLAP; FISTULECTOMY; MANAGEMENT;
   SEALANT; DISEASE
AB The use of biomaterials to treat anal fistula has drawn great interest. More recently, a porcine dermal matrix injection has been proposed as infill biomaterial to treat fistulas.
   We propose a novel approach consisting in non-cutting seton positioning followed by flap repair associated with dermal matrix injection into the fistula tracts after several weeks.
   We report our experience with this two-staged procedure on 11 consecutive patients with recurrent high trans-sphincteric fistulas with a minimum follow-up of 6 months.
   In our experience, this two-stage approach seems to be safe and effective.
C1 [Sileri, Pierpaolo; Franceschilli, Luana; Blanco, Giovanna Del Vecchio; Stolfi, Vito M.; Angelucci, Giulio P.; Gaspari, Achille L.] Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Surg Dir Achille L Gaspari, I-00133 Rome, Italy.
RP Sileri, P (reprint author), Univ Roma Tor Vergata, Policlin Tor Vergata, Dept Surg Dir Achille L Gaspari, Chirurg Gen 6B,Viale Oxford 81, I-00133 Rome, Italy.
EM piersileri@yahoo.com
OI STOLFI, VITO MARIA/0000-0001-6530-8063; STOLFI, VITO
   MARIA/0000-0002-3445-0830
CR Buchanan GN, 2003, DIS COLON RECTUM, V46, P1167, DOI 10.1097/01.DCR.0000084408.85802.A2
   Chung W, 2010, AM J SURG, V199, P609, DOI 10.1016/j.amjsurg.2010.01.007
   Chung W, 2009, AM J SURG, V197, P604, DOI 10.1016/j.amjsurg.2008.12.013
   Davies M, 2008, INT J COLORECTAL DIS, V23, P833, DOI 10.1007/s00384-008-0444-x
   Ellis C Neal, 2007, J Surg Educ, V64, P36, DOI 10.1016/j.cursur.2006.07.005
   Ellis CN, 2006, DIS COLON RECTUM, V49, P1736, DOI 10.1007/s10350-006-0718-8
   GarciaAguilar J, 1996, DIS COLON RECTUM, V39, P723, DOI 10.1007/BF02054434
   Hammond T M, 2004, Colorectal Dis, V6, P308, DOI 10.1111/j.1463-1318.2004.00676.x
   Himpson RC, 2009, DIS COLON RECTUM, V52, P602, DOI 10.1007/DCR.0b013e31819ece3e
   Lindsey I, 2002, COLORECTAL DIS, V4, P118
   Milito G, 2009, J AM COLL SURGEONS, V209, P542, DOI 10.1016/j.jamcollsurg.2009.07.012
   Miller GV, 1998, BRIT J SURG, V85, P108
   Ortiz H, 2008, BRIT J SURG, V95, P484, DOI 10.1002/bjs.6023
   Quah HM, 2006, INT J COLORECTAL DIS, V21, P602, DOI 10.1007/s00384-005-0060-y
   Sentovich SA, 2003, DIS COLON RECTUM, V46, P498, DOI 10.1097/01.DCR.0000059658.99412.3C
   Singer M, 2005, DIS COLON RECTUM, V48, P799, DOI 10.1007/s10350-004-0898-z
   Taxonera C, 2009, WORLD J GASTROENTERO, V15, P4263, DOI 10.3748/wjg.15.4263
   van Koperen PJ, 2008, INT J COLORECTAL DIS, V23, P697, DOI 10.1007/s00384-008-0460-x
   WILLIAMS JG, 1991, BRIT J SURG, V78, P1159, DOI 10.1002/bjs.1800781004
   Zmora O, 2003, DIS COLON RECTUM, V46, P584, DOI 10.1097/01.DCR.0000064697.21308.37
NR 20
TC 9
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-1958
J9 INT J COLORECTAL DIS
JI Int. J. Colorectal Dis.
PD MAR
PY 2011
VL 26
IS 3
BP 345
EP 349
DI 10.1007/s00384-010-1066-7
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 723UH
UT WOS:000287532200009
PM 20953873
DA 2018-10-20
ER

PT J
AU Abed, A
   Assoul, N
   Ba, M
   Derkaoui, SM
   Portes, P
   Louedec, L
   Flaud, P
   Bataille, I
   Letourneur, D
   Meddahi-Pelle, A
AF Abed, Aicha
   Assoul, Nabila
   Ba, Maguette
   Derkaoui, Sidi Mohamed
   Portes, Patrick
   Louedec, Liliane
   Flaud, Patrice
   Bataille, Isabelle
   Letourneur, Didier
   Meddahi-Pelle, Anne
TI Influence of polysaccharide composition on the biocompatibility of
   pullulan/dextran-based hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE pullulan; dextran; polysaccharides; hydrogel; in vivo; biocompatibility
ID DEXTRAN HYDROGELS; TISSUE-RESPONSE; IN-VIVO; SCAFFOLDS; DEGRADATION;
   BLENDS; FILMS; ACID); RAT; IMPLANTATION
AB The implantation of a biomaterial for tissue engineering requires the presence of a suitable scaffold on which the tissue repair and regeneration will take place. Polymers have been frequently used for that purpose because they show similar properties to that of the natural extracellular matrix. Scaffold properties and biocompatibility are modulated by the composition of the polymers used. In this work four polysaccharide-based hydrogels (PSH) made of dextran and pullulan were synthesized. Their in vitro properties were determined and then tested in vivo in a rat model. As pullulan concentration increased in dextran hydrogels, the glass transition temperature and the maximum modulus decreased. In vitro degradation studies for 30 days demonstrated no significant degradation of PSH except for 100% pullulan hydrogel. In vivo tissue response evaluated 30 days after PSH subcutaneous implantation in rats indicated that all PSH were surrounded by a fibrous capsule. Adding pullulan to dextran induced an increased inflammatory reaction compared to PSH-D (100% dextran) or PSH-D(75)P(25) (75% dextran). This in vitro and in vivo data can be used in the design of hydrogels appropriate for tissue engineering applications (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 535-542, 2011.
C1 [Abed, Aicha; Assoul, Nabila; Ba, Maguette; Derkaoui, Sidi Mohamed; Louedec, Liliane; Bataille, Isabelle; Letourneur, Didier; Meddahi-Pelle, Anne] CHU Xavier Bichat, INSERM, U698, F-75018 Paris, France.
   [Abed, Aicha; Assoul, Nabila; Ba, Maguette; Bataille, Isabelle; Letourneur, Didier] Univ Paris 13, BPC, Inst Galilee, F-93430 Villetaneuse, France.
   [Portes, Patrick] Univ Paris 13, LIMHP CNRS UPR 1311, F-93430 Villetaneuse, France.
   [Flaud, Patrice] Univ Paris 07, MSC Biofluid, F-75205 Paris, France.
RP Meddahi-Pelle, A (reprint author), CHU Xavier Bichat, INSERM, U698, Bat Inserm,46 Rue Henri Huchard, F-75018 Paris, France.
EM anne.pelle@inserm.fr
RI Didier, letourneur/H-5268-2012; Meddahi-Pelle, Anne/B-7821-2013
OI Didier, letourneur/0000-0003-2197-9468; Bataille,
   Isabelle/0000-0002-1204-8189
CR Abed A, 2008, TISSUE ENG PT A, V14, P519, DOI 10.1089/tea.2007.0134
   AGUILAR F, 2004, EFSA J, V85, P1
   Ahn HH, 2007, INT J BIOL MACROMOL, V41, P590, DOI 10.1016/j.ijbiomac.2007.07.019
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017
   Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998
   Autissier A, 2010, ACTA BIOMATER, V6, P3640, DOI 10.1016/j.actbio.2010.03.004
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Bumbu GG, 2003, J APPL POLYM SCI, V88, P2585, DOI 10.1002/app.11853
   Carvalho J, 2010, J BIOMED MATER RES A, V93A, P389, DOI 10.1002/jbm.a.32553
   Cascone MG, 1997, J APPL POLYM SCI, V66, P2089, DOI 10.1002/(SICI)1097-4628(19971219)66:11<2089::AID-APP4>3.0.CO;2-D
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   De Jong WH, 2007, J BIOMED MATER RES A, V83A, P538, DOI 10.1002/jbm.a.31302
   Ferreira L, 2004, J BIOMED MATER RES A, V68A, P584, DOI 10.1002/jm.a.20102
   FLAUD P, 1988, BIORHEOLOGY, V25, P95
   Gontard N, 1996, J AGR FOOD CHEM, V44, P1064, DOI 10.1021/jf9504327
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   HELEN HL, 2003, J BIOMED MATER RES A, V64, P465
   Hlawaty H, 2007, AM J PHYSIOL-HEART C, V293, pH3593, DOI 10.1152/ajpheart.00517.2007
   Kempen DHR, 2004, J BIOMED MATER RES A, V70A, P293, DOI 10.1002/jbm.a.30080
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kristo E, 2007, FOOD CHEM, V101, P753, DOI 10.1016/j.foodchem.2006.02.030
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Lee WJ, 2008, MACROMOL RES, V16, P247, DOI 10.1007/BF03218860
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054
   Levesque SG, 2007, BIOCONJUGATE CHEM, V18, P874, DOI 10.1021/bc0602127
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   MACHY D, 2006, Patent No. 62006991648
   Maire M, 2005, BIOMATERIALS, V26, P1771, DOI 10.1016/j.biomaterials.2004.06.003
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Prasad P, 2008, J APPL POLYM SCI, V110, P444, DOI 10.1002/app.28575
   Sakata Y, 2009, INT J PHARMACEUT, V374, P33, DOI 10.1016/j.ijpharm.2009.02.019
   San Juan A, 2007, J BIOMED MATER RES A, V83A, P819, DOI 10.1002/jbm.a.31413
   Sun G, 2009, J BIOMED MATER RES A, V93A, P1080
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Vachon DJ, 2006, J BIOMED MATER RES A, V76A, P35, DOI 10.1002/jbm.a.30440
   Wood KM, 2010, ACTA BIOMATER, V6, P48, DOI 10.1016/j.actbio.2009.05.032
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
NR 46
TC 22
Z9 22
U1 0
U2 28
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2011
VL 96A
IS 3
BP 535
EP 542
DI 10.1002/jbm.a.33007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 716EX
UT WOS:000286953000005
PM 21254385
DA 2018-10-20
ER

PT J
AU Edwards, FC
   Taheri, A
   Dann, SC
   Dye, JF
AF Edwards, Felicity C.
   Taheri, Amir
   Dann, Sophie C.
   Dye, Julian F.
TI Characterization of cytolytic neutrophil activation in vitro by
   amorphous hydrated calcium phosphate as a model of biomaterial
   inflammation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate; neutrophil; activation; inflammation; foreign body
   reaction
ID MONOSODIUM URATE; HUMAN-MONOCYTES; POLYMORPHONUCLEAR LEUKOCYTES;
   PYROPHOSPHATE DIHYDRATE; CRYSTAL PHAGOCYTOSIS; CERAMIC DEGRADATION;
   RESPIRATORY BURST; HYDROXYAPATITE; MACROPHAGE; MICROCRYSTALS
AB Calcium ions are utilized in biomolecular biomaterial design for osteomimetic scaffolds and as divalent cross-linking agents, typically for gelation of alginates, stabilisation of protein structure (e.g., fibrinogen) and enzyme activation (e.g., thrombin). Biological interactions with defined calcium phosphates (e.g., hydroxyapatite) are exploited for osteogenesis, although crystalline calcium phosphates (e.g., calcium pyrophosphate) stimulate inflammation. We found that the calcium concentration used in the manufacture of prototype dermal scaffolds made from fibrin/alginate composite was related to the inflammatory infiltration during in vivo integration. In investigating a cause for this inflammatory response, we have identified and characterized a cytolytic inflammatory effect of amorphous calcium phosphate (CaP) formed in physiological solutions, relevant to biomaterial biocompatibility. Isolated human neutrophils (N phi) were incubated in phosphate-buffered saline with CaCl2 ranging 2.5-20 mM total calcium. N phi activation was assessed by morphology and integrin-beta 2 (CD18a) expression. Mediator release (N phi-elastase, IL-8, and TNF alpha) was measured from both N phi and whole blood cultures plus CaCl2. CaP exposure increased CD18a expression over 1 h (maximal at 10 mM calcium/ phosphate) with concurrent phagocytosis, cytolysis, and N phi-elastase release. CaCl2 induced expression of IL-8 and TNF alpha in whole blood cultures. These results suggest that CaP formed from the resorption of calcium-containing biomaterials could induce inflammation and accelerate biomaterial degradation, driving further CaP release. This demonstrates a novel mechanism for biomaterial-induced inflammation. The in vitro system described could aid preclinical evaluation of novel biomaterial inflammatory potential. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 552-565, 2011.
C1 [Edwards, Felicity C.; Taheri, Amir; Dann, Sophie C.; Dye, Julian F.] Mt Vernon Hosp, RAFT Inst Plast Surg Res, Northwood, Middx, England.
RP Dye, JF (reprint author), Mt Vernon Hosp, RAFT Inst Plast Surg Res, Northwood, Middx, England.
EM dyej@raft.ac.uk
FU DoH HTD LINK
FX Contract grant sponsor: DoH HTD LINK
CR AMOR B, 1977, REV RHUM, V44, P309
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   BIRD J, 1984, AGENTS ACTIONS, V15, P349, DOI 10.1007/BF01972370
   Bloebaum RD, 1998, J BIOMED MATER RES, V40, P104, DOI 10.1002/(SICI)1097-4636(199804)40:1<104::AID-JBM12>3.3.CO;2-6
   Blomback B, 1996, THROMB RES, V83, P1, DOI 10.1016/0049-3848(96)00111-9
   Boyum A, 1968, SCAND J CLIN LAB I S, V97, P77
   BROOKS PM, 1987, BRIT J PHARMACOL, V90, P413, DOI 10.1111/j.1476-5381.1987.tb08971.x
   BURT HM, 1989, J RHEUMATOL, V16, P809
   Cairns CB, 1996, ACAD EMERG MED, V3, P1093, DOI 10.1111/j.1553-2712.1996.tb03366.x
   Cheung HS, 2005, CURR OPIN RHEUMATOL, V17, P336, DOI 10.1097/01.bor.0000155362.83990.80
   Dai YN, 2008, BIOPHARM DRUG DISPOS, V29, P173, DOI 10.1002/bdd.590
   Di Y, 2007, TISSUE ENG, V13, P1696
   Drbal K, 2001, BLOOD, V98, P1561, DOI 10.1182/blood.V98.5.1561
   Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6
   Edwards FC, 2008, TISSUE ENG PT A, V14, P816
   EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384
   Fukuchi N, 1995, BIO-MED MATER ENG, V5, P219
   GIROUD JP, 1983, BRIT J DERMATOL, V109, P41
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GREGOIRE M, 1987, BIOL CELL, V59, P255, DOI 10.1111/j.1768-322X.1987.tb00538.x
   HACHICHA M, 1995, J EXP MED, V182, P2019, DOI 10.1084/jem.182.6.2019
   Halverson PB, 1998, OSTEOARTHR CARTILAGE, V6, P324, DOI 10.1053/joca.1998.0131
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   HIGSON FK, 1985, ANN RHEUM DIS, V44, P54, DOI 10.1136/ard.44.1.54
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   ISHIKAWA H, 1987, RHEUMATOL INT, V7, P217, DOI 10.1007/BF00541380
   KANGESU T, 1993, BRIT J PLAST SURG, V46, P393, DOI 10.1016/0007-1226(93)90045-D
   Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9
   Longmore M, 2007, OXFORD HDB CLIN MED, P892
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Mohamadnia Z, 2008, J BIOMAT SCI-POLYM E, V19, P47, DOI 10.1163/156856208783227640
   Nunamaker EA, 2007, J BIOMED MATER RES A, V83A, P1128, DOI 10.1002/jbm.a.31275
   POUBELLE PE, 1987, BIOCHEM BIOPH RES CO, V149, P649, DOI 10.1016/0006-291X(87)90417-7
   Pritzker Kenneth P. H., 1994, Current Opinion in Rheumatology, V6, P442, DOI 10.1097/00002281-199407000-00016
   REGINATO A, 1982, ARCH PHYS MED REHAB, V63, P401
   ROBERGE CJ, 1991, AGENTS ACTIONS, V34, P38, DOI 10.1007/BF01993232
   SCHUMACHER HR, 1975, ARTHRITIS RHEUM, V18, P783, DOI 10.1002/art.1780180723
   SEMMELINK JM, 1986, BIOMATERIALS, V7, P152, DOI 10.1016/0142-9612(86)90074-8
   SIMCHOWITZ L, 1982, ARTHRITIS RHEUM, V25, P181, DOI 10.1002/art.1780250211
   SIMMS HH, 1995, CELL IMMUNOL, V166, P71, DOI 10.1006/cimm.1995.0009
   Tudan C, 2000, J RHEUMATOL, V27, P2463
   Vieira EFS, 2008, BIOMACROMOLECULES, V9, P1195, DOI 10.1021/bm7011983
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   WILLOUGHBY DA, 1975, AGENTS ACTIONS, V5, P35, DOI 10.1007/BF02027156
   Zhang LF, 2008, INT J PHARM, V353, P74, DOI 10.1016/j.ijpharm.2007.11.023
NR 46
TC 0
Z9 2
U1 3
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2011
VL 96A
IS 3
BP 552
EP 565
DI 10.1002/jbm.a.32937
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 716EX
UT WOS:000286953000007
PM 21254387
DA 2018-10-20
ER

PT J
AU Chun, YW
   Lim, H
   Webster, TJ
   Haberstroh, KM
AF Chun, Young Wook
   Lim, Hojean
   Webster, Thomas J.
   Haberstroh, Karen M.
TI Nanostructured bladder tissue replacements
SO WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
LA English
DT Review
ID SMALL-INTESTINAL SUBMUCOSA; FIBROBLAST-GROWTH-FACTOR;
   SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; NEUROPATHIC BLADDER;
   SURFACE-FEATURES; URINARY-BLADDER; SCAFFOLDS; ADHESION; PROLIFERATION
AB The interaction between cells or tissues and natural or synthetic materials which mimic the natural biological environment has been a matter of great interest in tissue engineering. In particular, surface properties of biomaterials (regardless of whether they are natural or synthetic) have been optimized using nanotechnology to improve interactions with cells for regenerative medicine applications. Specifically, in vivo and in vitro studies have demonstrated greater bladder tissue growth on polymeric surfaces with nanoscale to submicron surface features. Improved bladder cell responses on nanostructured polymers have been correlated to unique nanomaterial surface features leading to greater surface energy which influences initial protein interactions. Moreover, coupled with the observed greater in vitro and in vivo bladder cell adhesion as well as proliferation on nanostructured compared to conventional synthetic polymers, decreased calcium stone formation has also been measured. In this article, the importance of nanostructured biomaterial surface features for bladder tissue replacements are reviewed with thoughts on future directions for this emerging field. (C) 2010 John Wiley & Sons, Inc. WIREs Nanomed Nanobiotechnol 2011 3 134-145 DOI:10.1002/wnan.89
C1 [Chun, Young Wook; Webster, Thomas J.; Haberstroh, Karen M.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Lim, Hojean] Coll William & Mary, Dept Neurosci, Williamsburg, VA USA.
RP Haberstroh, KM (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
EM Karen_Haberstroh@Brown.edu
FU Coulter and Hermann Foundation
FX The authors would like to thank the Coulter and Hermann Foundation for
   funding portions of the studies mentioned here.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Beqaj SH, 2005, J UROLOGY, V174, P1699, DOI 10.1097/01.ju.0000176633.92150.4e
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   CARTZ L, 1995, NONDESTRUCTIVE TESTI, P135
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Chun YW, 2009, ANN BIOMED ENG, V37, P2034, DOI 10.1007/s10439-009-9722-1
   Chun YW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085104
   Cooke MJ, 2008, CYTOTECHNOLOGY, V56, P71, DOI 10.1007/s10616-007-9119-7
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   ENGELHARDT EM, 2009, J TISSUE ENG REGEN M, V4, P123
   Falke G, 2000, WORLD J UROL, V18, P36, DOI 10.1007/s003450050007
   Feng Zhonggang, 2003, J Artif Organs, V6, P192, DOI 10.1007/s10047-003-0230-z
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3
   Fleshner NE, 1996, CANCER, V78, P1505, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3
   Gonzalez R, 2009, J UROLOGY, V182, P1781, DOI 10.1016/j.juro.2009.02.062
   Harrington DA, 2008, WORLD J UROL, V26, P315, DOI 10.1007/s00345-008-0273-0
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hoque ME, 2009, TISSUE ENG PT A, V15, P3013, DOI [10.1089/ten.tea.2008.0355, 10.1089/ten.TEA.2008.0355]
   Hudson AE, 2007, TISSUE ENG, V13, P2219, DOI 10.1089/ten.2006.0337
   Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Kiddoo DA, 2004, UROL CLIN N AM, V31, P417, DOI 10.1016/j.ucl.2004.04.023
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   Mikos AG, 1994, POLYMER, V35, P1069
   Mitchell ME, 2003, BJU INT, V92, P29, DOI 10.1046/j.1464-410X.92.s1.6.x
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MOREY AF, 2007, CAMPBELLWALSH UROLOG
   Neel EAA, 2006, SOFT MATTER, V2, P986
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Sasmazel HT, 2008, BIO-MED MATER ENG, V18, P119, DOI 10.3233/BME-2008-0515
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Snodgrass WT, 2004, UROL CLIN N AM, V31, P427, DOI 10.1016/j.ucl.2004.04.001
   Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   TUGRUL AB, 1997, CAPILLARITY EFFECT A, V30
   Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110
   Walles T, 2004, EXPERT REV MED DEVIC, V1, P241, DOI 10.1586/14734440.1.2.241
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Webster TJ, 2006, INT J NANOMED, V1, P1, DOI 10.2147/nano.2006.1.1.1
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 54
TC 11
Z9 11
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5116
J9 WIRES NANOMED NANOBI
JI Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol.
PD MAR-APR
PY 2011
VL 3
IS 2
BP 134
EP 145
DI 10.1002/wnan.89
PG 12
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 724XG
UT WOS:000287609100003
PM 20730887
DA 2018-10-20
ER

PT J
AU Ishihara, K
   Goto, Y
   Takai, M
   Matsuno, R
   Inoue, Y
   Konno, T
AF Ishihara, Kazuhiko
   Goto, Yusuke
   Takai, Madoka
   Matsuno, Ryosuke
   Inoue, Yuuki
   Konno, Tomohiro
TI Novel polymer biomaterials and interfaces inspired from cell membrane
   functions
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Cell membrane; Phospholipid polymer; Biomaterial; Biointerface;
   Biocompatibility
ID PHOSPHOLIPID POLYMER; QUANTUM DOTS; PHOSPHORYLCHOLINE GROUPS; PROTEIN
   ADSORPTION; POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); FACILE
   SYNTHESIS; NANOPARTICLES; SURFACE; RESISTANCE; PLASMA
AB Background: Materials with excellent biocompatibility on interfaces between artificial system and biological system are needed to develop any equipments and devices in bioscience, bioengineering and medicinal science. Suppression of unfavorable biological response on the interface is most important for understanding real functions of biomolecules on the surface. So, we should design and prepare such biomaterials.
   Scoop of review: One of the best ways to design the biomaterials is generated from mimicking a cell membrane structure. It is composed of a phospholipid bilayered membrane and embedded proteins and polysaccharides. The surface of the cell membrane-like structure is constructed artificially by molecular integration of phospholipid polymer as platform and conjugated biomolecules. Here, it is introduced as the effectiveness of biointerface with highly biological functions observed on artificial cell membrane structure.
   Major conclusions: Reduction of nonspecific protein adsorption is essential for suppression of unfavorable bioresponse and achievement of versatile biomedical applications. Simultaneously, bioconjugation of biomolecules on the phospholipid polymer platform is crucial for a high-performance interface.
   General significance: The biointerfaces with both biocompatibility and biofunctionality based on biomolecules must be installed on advanced devices, which are applied in the fields of nanobioscience and nanomedicine.
   This article is part of a Special Issue entitled Nanotechnologies - Emerging Applications in Biomedicine. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ishihara, Kazuhiko; Goto, Yusuke; Takai, Madoka; Matsuno, Ryosuke; Inoue, Yuuki] Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko; Konno, Tomohiro] Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko; Goto, Yusuke; Takai, Madoka; Matsuno, Ryosuke; Konno, Tomohiro] Univ Tokyo, Ctr NanoBio Integrat CNBI, Tokyo 1138656, Japan.
   [Ishihara, Kazuhiko; Inoue, Yuuki; Konno, Tomohiro] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan.
RP Ishihara, K (reprint author), Sch Engn, Dept Mat Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.
EM ishihara@mpc.t.u-tolcyo.acjp
RI Konno, Tomohiro/E-5244-2011
OI Konno, Tomohiro/0000-0002-7814-3306
FU Ministry of Education, Culture, Sports, Science, and Technology, Japan
FX This research was partially supported by Special Coordination Funds for
   Promoting Science and Technology from the Ministry of Education,
   Culture, Sports, Science, and Technology, Japan.
CR Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Chiang YC, 2009, J MEMBRANE SCI, V339, P151, DOI 10.1016/j.memsci.2009.04.044
   Cho HM, 2010, COLLOID SURFACE B, V75, P209, DOI 10.1016/j.colsurfb.2009.08.033
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Goto Y, 2008, BIOMACROMOLECULES, V9, P3252, DOI 10.1021/bm800819r
   Goto Y, 2008, BIOMACROMOLECULES, V9, P828, DOI 10.1021/bm701161d
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Hezinger AFE, 2008, EUR J PHARM BIOPHARM, V68, P138, DOI 10.1016/j.ejpb.2007.05.013
   Huang XD, 2007, CLIN EXP OPHTHALMOL, V35, P462, DOI 10.1111/j.1442-9071.2007.01516.x
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, POLYM J, V31, P1231, DOI 10.1295/polymj.31.1231
   Ishihara K, 2003, MATER SCI FORUM, V426-4, P3171, DOI 10.4028/www.scientific.net/MSF.426-432.3171
   Ishihara Kazuhiko, 2008, Advances in Science and Technology, V57, P5, DOI 10.4028/www.scientific.net/AST.57.5
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Ishihara K, 2009, J R SOC INTERFACE, V6, pS279, DOI [10.1098/rsif.2008.0335.focus, 10.1098/rsif.2008.0335]
   Ito T, 2006, COLLOID SURFACE B, V50, P55, DOI 10.1016/j.colsurfb.2006.04.006
   Jamieson T, 2007, BIOMATERIALS, V28, P4717, DOI 10.1016/j.biomaterials.2007.07.014
   Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910
   Kharlampieva E, 2007, MACROMOLECULES, V40, P6967, DOI 10.1021/ma071152i
   Kinoshita K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl939
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Konno K, 2004, BIOMACROMOLECULES, V5, P342
   Kyomoto M, 2007, J BIOMED MATER RES A, V82A, P10, DOI 10.1002/jbm.a.31134
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Moro T, 2004, NAT MATER, V3, P829, DOI 10.1038/nmat1233
   Myers Gerard J, 2003, J Extra Corpor Technol, V35, P6
   Nishizawa K, 2008, BIOMACROMOLECULES, V9, P403, DOI 10.1021/bm7010246
   Nishizawa K, 2010, COLLOID SURFACE B, V77, P263, DOI 10.1016/j.colsurfb.2010.02.008
   Ramsden JJ, 1996, BIOSENS BIOELECTRON, V11, P523, DOI 10.1016/0956-5663(96)86789-3
   Rose SF, 2005, J MATER SCI-MATER M, V16, P1003, DOI 10.1007/s10856-005-4755-y
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Smith AM, 2008, ADV DRUG DELIVER REV, V60, P1226, DOI 10.1016/j.addr.2008.03.015
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Sun XL, 2004, TETRAHEDRON, V60, P11765, DOI 10.1016/j.tet.2004.09.110
   Takei K, 2004, BIOMACROMOLECULES, V5, P858, DOI 10.1021/bm0344250
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Vuppu A., 1999, BIOSEPARATION PROCES
   Watanabe J, 2006, BIOMACROMOLECULES, V7, P171, DOI 10.1021/bm050544z
   Watanabe J., 2008, NANOBIOTECHNOLOGY, V3, P76
   WATANABE J, 2005, NANOTECHNOLOGIES LIF, V1, P125
   Watanabe J., 2005, HDB NANOSTRUCTURED B, V1, P129
   Watanabe J, 2008, COLLOID SURFACE B, V65, P155, DOI 10.1016/j.colsurfb.2008.04.006
   Watanabe J, 2008, SENSOR ACTUAT B-CHEM, V129, P87, DOI 10.1016/j.snb.2007.07.100
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Yamasaki A, 2003, COLLOID SURFACE B, V28, P53, DOI 10.1016/S0927-7765(02)00130-3
   Yeagle PL, 1993, MEMBRANES CELLS
   Yuan JJ, 2006, LANGMUIR, V22, P11022, DOI 10.1021/la0616350
NR 59
TC 30
Z9 30
U1 5
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAR
PY 2011
VL 1810
IS 3
SI SI
BP 268
EP 275
DI 10.1016/j.bbagen.2010.04.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 722YJ
UT WOS:000287470900005
PM 20435095
DA 2018-10-20
ER

PT J
AU Bouta, EM
   McCarthy, CW
   Keim, A
   Wang, HB
   Gilbert, RJ
   Goldman, J
AF Bouta, Echoe M.
   McCarthy, Connor W.
   Keim, Alexander
   Wang, Han Bing
   Gilbert, Ryan J.
   Goldman, Jeremy
TI Biomaterial guides for lymphatic endothelial cell alignment and
   migration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Lymphatic regeneration; Endothelial cell; Aligned fibers; Biodegradable
   materials; Axillary lymph node dissection
ID GROWTH FACTOR-C; BREAST-CANCER; VEGF-C; NEURITE OUTGROWTH; MOUSE TAIL;
   LYMPHANGIOGENESIS; LYMPHEDEMA; SCAFFOLDS; HYPERPLASIA; SKIN
AB Axillary dissection during breast cancer surgery produces extensive lymphatic vessel damage that often leads to lifelong secondary lymphedema of the arm. We have developed a biodegradable material conduit for lymphatic vessel reconstruction where fibers electrospun along the conduit lumen promote endothelial cell alignment and migration in vitro. The diameter and density of the electrospun fibers were optimized for cell migration and direction on two-dimensional substrates by seeding human lymphatic endothelial cells (LECs) onto aligned fibers of varying diameters and densities, randomly oriented fibers, and film substrates with no fibers. We found that LECs became aligned in the fiber direction, with cells seeded on the randomly oriented fibers becoming oriented in random directions, whereas cells seeded on the highly aligned fibers became highly aligned. Cell migration was dependent upon fiber alignment and density, with optimal migration found on 1300 nm diameter aligned fibers of low density. Blood endothelial cells seeded on the fibers exhibited similar behavior as the LECs. Fiber alignment was preserved upon rolling the two-dimensional substrate into the tubular geometry of a lymphatic vessel. The data suggest that aligned electrospun fibers may promote endothelial migration across the conduit in a manner that is independent of lymphatic growth factors. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [McCarthy, Connor W.; Wang, Han Bing; Gilbert, Ryan J.; Goldman, Jeremy] Michigan Technol Univ, Dept Biomed Engn, Regenerat & Repair Lab, Houghton, MI 49931 USA.
RP Goldman, J (reprint author), Michigan Technol Univ, Dept Biomed Engn, Regenerat & Repair Lab, Houghton, MI 49931 USA.
EM jgoldman@mtu.edu
RI Zhou, Qinghui/C-8436-2011
FU National Institutes of Health [R21-HL-093568, R15-HL-093705]
FX This work was funded by National Institutes of Health Grants
   R21-HL-093568 and R15-HL-093705. We would like to thank Nils Bergman for
   his help with the FESEM. We would like to thank Nick Schaub for his help
   with Matlab.
CR Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X
   Avraham T, 2010, AM J PHYSIOL-CELL PH, V299, pC589, DOI 10.1152/ajpcell.00535.2009
   Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9
   Clark B, 2005, QJM-INT J MED, V98, P343, DOI 10.1093/qjmed/hci053
   Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008
   Daoud WA, 2010, J NANOSCI NANOTECHNO, V10, P1255, DOI 10.1166/jnn.2010.1847
   DEVOOGDT N, 2009, EUR J CANC CARE
   Enholm B, 2001, CIRC RES, V88, P623, DOI 10.1161/01.RES.88.6.623
   Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78
   Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com
   Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4
   Hamner JB, 2007, ANN SURG ONCOL, V14, P1904, DOI 10.1245/s10434-006-9332-1
   Hwang K, 2010, J CRANIOFAC SURG, V21, P847, DOI 10.1097/SCS.0b013e3181d7f2ff
   Inanc B, 2009, J BIOMED MATER RES A, V90A, P186, DOI 10.1002/jbm.a.32066
   Isaka N, 2004, CANCER RES, V64, P4400, DOI 10.1158/0008-5472.CAN-04-0752
   Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Karkkainen MJ, 2000, ONCOGENE, V19, P5598, DOI 10.1038/sj.onc.1203855
   Liu SQ, 1999, CRIT REV BIOMED ENG, V27, P75, DOI 10.1615/CritRevBiomedEng.v27.i1-2.30
   Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378
   Lumachi F, 2009, IN VIVO, V23, P1017
   Ongstad EL, 2010, AM J PHYSIOL-HEART C, V299, pH46, DOI 10.1152/ajpheart.00008.2010
   Pu FR, 2010, BIOMATERIALS, V31, P4330, DOI 10.1016/j.biomaterials.2010.02.010
   Pytowski B, 2005, J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003
   RAN S, 2009, PATHOSPHYSIOLOGY
   Rossi A, 2009, TISSUE ENG PT A, V15, P525, DOI 10.1089/ten.tea.2007.0421
   Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009
   Sagen A, 2009, ACTA ONCOL, V48, P1111, DOI 10.3109/02841860903061691
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Suami H, 2007, LYMPHOLOGY, V40, P122
   Szuba A, 2002, CANCER, V95, P2260, DOI 10.1002/cncr.10976
   Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069
   Uzarski J, 2008, AM J PHYSIOL-HEART C, V294, pH1326, DOI 10.1152/ajpheart.00900.2007
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   WIJDICKS CA, 2010, KNEE SURG SPORTS TRA
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Zhang DP, 2010, CANCER RES, V70, P2495, DOI 10.1158/0008-5472.CAN-09-3488
NR 42
TC 11
Z9 11
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1104
EP 1113
DI 10.1016/j.actbio.2010.10.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900020
PM 20974299
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kou, PM
   Schwartz, Z
   Boyan, BD
   Babensee, JE
AF Kou, Peng Meng
   Schwartz, Zvi
   Boyan, Barbara D.
   Babensee, Julia E.
TI Dendritic cell responses to surface properties of clinical titanium
   surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Dendritic cells; Titanium; Immune response; Inflammation; Principal
   component analysis
ID SELF-ASSEMBLED MONOLAYERS; OSTEOBLAST-LIKE CELLS;
   POLY(LACTIC-CO-GLYCOLIC ACID); OSTEOPROTEGERIN LIGAND;
   RHEUMATOID-ARTHRITIS; DEFINED CHEMISTRIES; PERIODONTAL-DISEASE;
   IMMUNE-RESPONSES; BONE DESTRUCTION; EXPRESSION
AB Dendritic cells (DCs) play pivotal roles in responding to foreign entities during the innate immune response and in initiating effective adaptive immunity as well as maintaining immune tolerance. The sensitivity of DCs to foreign stimuli also makes them useful cells to assess the inflammatory response to biomaterials. Elucidating material property-DC phenotype relationships using a well-defined biomaterial system is expected to provide criteria for immunomodulatory biomaterial design. Clinical titanium (Ti) substrates, including pretreatment (PT), sand blasted and acid etched (SLA), and modified SLA (modSLA), with different roughnesses and surface energies were used to treat DCs and resulted in differential DC responses. PT and SLA induced a mature DC (mDC) phenotype, while modSLA promoted a non-inflammatory environment by supporting an immature DC (iDC) phenotype, based on surface marker expression, cytokine production profiles and cell morphology. Principal component analysis (PCA) confirmed these experimental results, and also indicated that the non-stimulating property of modSLA covaried with certain surface properties, such as high surface hydrophilicity, percent oxygen and percent Ti of the substrates. In addition to previous research that demonstrated superior osteogenic properties of modSLA compared with PT and SLA, the results reported herein indicates that modSLA may further benefit implant osteointegration by reducing local inflammation and its associated osteoclastogenesis. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kou, Peng Meng; Schwartz, Zvi; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Boyan, Barbara D.; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn Georgia Tech, Atlanta, GA 30332 USA.
   [Boyan, Barbara D.; Babensee, Julia E.] Emory Univ, Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.
FU National Institutes of Health [EB004633, AR052102]
FX The authors thank the Institut Straumann AG (Basel, Switzerland) for
   providing the Ti disks used in this study, Dr Melissa L. Kemp of Georgia
   Institute of Technology for helpful discussion on PCA and critical
   review of the manuscript, and Dr Manu O. Platt of Georgia Institute of
   Technology for access to the Simca P<SUP>+</SUP> software. This research
   was supported by National Institutes of Health grants EB004633 (J.E.B.)
   and AR052102 (B.D.B.).
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   BABENSEE JE, 1992, J BIOMED MATER RES, V26, P1401, DOI 10.1002/jbm.820261102
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bornstein MM, 2010, J PERIODONTOL, V81, P809, DOI 10.1902/jop.2010.090727
   Bornstein MM, 2009, CLIN IMPLANT DENT R, V11, P338, DOI 10.1111/j.1708-8208.2009.00148.x
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103
   Cruikshank WW, 2000, J LEUKOCYTE BIOL, V67, P757
   Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84
   Hessel EM, 1998, J IMMUNOL, V160, P2998
   Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/cmb.2004.11.544
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Janeway CA, 1999, CURR BIOL, V9, pR342, DOI 10.1016/S0960-9822(99)80209-7
   Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200
   Klimiuk PA, 1999, J IMMUNOL, V162, P4293
   Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   NORTON LW, 2010, J CONTROL R IN PRESS
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211
   RAHIMI P, 1995, ENDOCRINOLOGY, V136, P2752, DOI 10.1210/en.136.6.2752
   Rollins BJ, 1997, BLOOD, V90, P909
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1487, DOI 10.1002/jbm.a.32487
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1329, DOI 10.1002/jbm.a.32457
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Taubman MA, 2001, CRIT REV ORAL BIOL M, V12, P125, DOI 10.1177/10454411010120020301
   Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763
   Teng YTA, 2003, CRIT REV ORAL BIOL M, V14, P237, DOI 10.1177/154411130301400402
   Theodore AC, 1996, J IMMUNOL, V157, P1958
   Thomas R, 1999, J LEUKOCYTE BIOL, V66, P286
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P789, DOI 10.1172/JCI112036
NR 49
TC 27
Z9 27
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2011
VL 7
IS 3
BP 1354
EP 1363
DI 10.1016/j.actbio.2010.10.020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725KP
UT WOS:000287643900047
PM 20977948
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Romano, NH
   Sengupta, D
   Chung, C
   Heilshorn, SC
AF Romano, Nicole H.
   Sengupta, Debanti
   Chung, Cindy
   Heilshorn, Sarah C.
TI Protein-engineered biomaterials: Nanoscale mimics of the extracellular
   matrix
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Biomaterial; Protein engineering; Stem cell niche; Extracellular matrix;
   Tissue engineering; Regenerative medicine
ID ELASTIN-LIKE POLYPEPTIDES; CELL-MIGRATION; CROSS-LINKING; POLYMERIC
   BIOMATERIALS; PHYSICAL-PROPERTIES; FUSION PROTEIN; DRUG-DELIVERY;
   TISSUE-REPAIR; IN-VITRO; HYDROGELS
AB Background: Traditional materials used as in vitro cell culture substrates are rigid and flat surfaces that lack the exquisite nano- and micro-scale features of the in vivo extracellular environment. While these surfaces can be coated with harvested extracellular matrix (ECM) proteins to partially recapitulate the bio-instructive nature of the ECM, these harvested proteins often exhibit large batch-to-batch variability and can be difficult to customize for specific biological studies. In contrast, recombinant protein technology can be utilized to synthesize families of 3 dimensional protein-engineered biomaterials that are cyto-compatible, reproducible, and fully customizable.
   Scope of Review: Here we describe a modular design strategy to synthesize protein-engineered biomaterials that fuse together multiple repeats of nanoscale peptide design motifs into full-length engineered ECM mimics.
   Major Conclusions: Due to the molecular-level precision of recombinant protein synthesis, these biomaterials can be tailored to include a variety of bio-instructional ligands at specified densities, to exhibit mechanical properties that match those of native tissue, and to include proteolytic target sites that enable cell-triggered scaffold remodeling. Furthermore, these biomaterials can be processed into forms that are injectable for minimally-invasive delivery or spatially patterned to enable the release of multiple drugs with distinct release kinetics.
   General significance: Given the reproducibility and flexibility of these protein-engineered biomaterials, they are ideal substrates for reductionist biological studies of cell-matrix interactions, for in vitro models of physiological processes, and for bio-instructive scaffolds in regenerative medicine therapies.
   This article is part of a Special Issue entitled Nanotechnologies - Emerging Applications in Biomedicine. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Romano, Nicole H.; Chung, Cindy; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Sengupta, Debanti] Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough 246, Stanford, CA 94305 USA.
EM Heilshorn@stanford.edu
OI Romano, Nicole/0000-0002-9541-8885
FU Stanford Graduate Fellowship; National Science Foundation; NIH [1DP2
   OD006477-01]; NSF [EFRI-CBE-0735551, DMR-0846363]; Stanford
   Cardiovascular Institute
FX N.R. acknowledges support from a Stanford Graduate Fellowship and a
   National Science Foundation Graduate Fellowship. The authors acknowledge
   funding from NIH 1DP2 OD006477-01, NSF EFRI-CBE-0735551, NSF
   DMR-0846363, and a Stanford Cardiovascular Institute Seed Grant.
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   Bao Qi-Bin, 2007, SAS J, V1, P36, DOI 10.1016/SASJ-2006-0007-RR
   Bidwell GL, 2010, PEPTIDES, V31, P834, DOI 10.1016/j.peptides.2010.02.007
   Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Chow DC, 2006, BIOTECHNOL PROGR, V22, P638, DOI 10.1021/bp0503742
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   ELLINGSWORTH LR, 1986, J IMMUNOL, V136, P877
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   FOO CWP, 2010, PROTEIN ENG DESIGN
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599
   Kiick KL, 2007, POLYM REV, V47, P1, DOI 10.1080/15583720601109545
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lee Y, 2010, BIOMED MICRODEVICES, V12, P207, DOI 10.1007/s10544-009-9376-7
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   LIU CY, 2003, NEUROSURGERY, V52, P1165
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091
   Munoz-Pinto DJ, 2009, J BIOMED MATER RES A, V90A, P303, DOI 10.1002/jbm.a.32492
   Nagaoka M, 2002, BIOTECHNOL LETT, V24, P1857, DOI 10.1023/A:1020905532227
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Park H, 2007, TISSUE ENG, V13, P1867, DOI 10.1089/ten.2006.0198
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reinhart-King CA, 2003, LANGMUIR, V19, P1573, DOI 10.1021/la026142j
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Sarig-Nadir O, 2009, BIOPHYS J, V96, P4743, DOI 10.1016/j.bpj.2009.03.019
   Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Straley K. S., 2009, FRONT NEUROENG, V2
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   STRALEY KS, 2009, ADV MATER, V21, P1
   Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Wheeldon IR, 2009, J MOL BIOL, V392, P129, DOI 10.1016/j.jmb.2009.06.075
   Woolfson DN, 2006, CURR OPIN CHEM BIOL, V10, P559, DOI 10.1016/j.cbpa.2006.09.019
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 106
TC 58
Z9 60
U1 3
U2 103
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAR
PY 2011
VL 1810
IS 3
SI SI
BP 339
EP 349
DI 10.1016/j.bbagen.2010.07.005
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 722YJ
UT WOS:000287470900012
PM 20647034
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shekaran, A
   Garcia, AJ
AF Shekaran, Asha
   Garcia, Andres J.
TI Nanoscale engineering of extracellular matrix-mimetic bioadhesive
   surfaces and implants for tissue engineering
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Review
DE Biomaterials; Nanotechnology; Cell adhesion; Regenerative medicine;
   Integrins
ID DIP-PEN NANOLITHOGRAPHY; PEPTIDE AMPHIPHILE NANOFIBERS; CALVARIAL
   OSTEOBLAST DIFFERENTIATION; RGD NANOPATTERNED HYDROGELS; SELF-ASSEMBLED
   MONOLAYERS; MESENCHYMAL STEM-CELLS; SER-ARG-ASN; HUMAN FIBRONECTIN;
   NANOIMPRINT LITHOGRAPHY; OSTEOGENIC DIFFERENTIATION
AB Background: The goal of tissue engineering is to restore tissue function using biomimetic scaffolds which direct desired cell fates such as attachment, proliferation and differentiation. Cell behavior in vivo is determined by a complex interaction of cells with extracellular biosignals, many of which exist on a nanoscale. Therefore, recent efforts in tissue engineering biomaterial development have focused on incorporating extracellular matrix- (ECM) derived peptides or proteins into biomaterials in order to mimic natural ECM. Concurrent advances in nanotechnology have also made it possible to manipulate protein and peptide presentation on surfaces on a nanoscale level.
   Scope of Review: This review discusses protein and peptide nanopatterning techniques and examples of how nanoscale engineering of bioadhesive materials may enhance outcomes for regenerative medicine.
   Major Conclusions: Synergy between ECM-mimetic tissue engineering and nanotechnology fields can be found in three major strategies: (1) Mimicking nanoscale orientation of ECM peptide domains to maintain native bioactivity, (2) Presenting adhesive peptides at unnaturally high densities, and (3) Engineering multivalent ECM-derived peptide constructs.
   General Significance: Combining bioadhesion and nanopatterning technologies to allow nanoscale control of adhesive motifs on the cell-material interface may result in exciting advances in tissue engineering.
   This article is part of a Special Issue entitled Nanotechnologies - Emerging Applications in Biomedicine. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Shekaran, Asha; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Shekaran, Asha] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Shekaran, Asha] Emory Univ, Atlanta, GA 30322 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
OI Shekaran, Asha/0000-0002-0978-6631
FU NIBIB NIH HHS [R01 EB004496, R01 EB004496-04]
CR Accardo A, 2008, J PEPT SCI, V14, P903, DOI 10.1002/psc.1024
   AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275
   Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   [Anonymous], 2002, MOL BIOL CELL
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Aplin AE, 2002, J CELL SCI, V115, P2781
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bano F, 2009, NANO LETT, V9, P2614, DOI 10.1021/nl9008869
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267
   Bull SR, 2005, NANO LETT, V5, P1, DOI 10.1021/nl0484898
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788
   CARRELL NA, 1985, J BIOL CHEM, V260, P1743
   Case MA, 2003, NANO LETT, V3, P425, DOI 10.1021/nl025795h
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   CHHABRA B, 2007, J AM CHEM SOC, V129, P10304
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Christman KL, 2006, SOFT MATTER, V2, P928, DOI 10.1039/b611000b
   CHRISTMAN KL, 2008, J AM CHEM SOC
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   Coussen F, 2002, J CELL SCI, V115, P2581
   Coyer SR, 2007, ANGEW CHEM INT EDIT, V46, P6837, DOI 10.1002/anie.200700989
   Craig JA, 2008, LANGMUIR, V24, P10282, DOI 10.1021/la702434p
   Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Duckworth BP, 2007, ANGEW CHEM INT EDIT, V46, P8819, DOI 10.1002/anie.200701942
   El-Amin SF, 2002, J ORTHOPAED RES, V20, P20, DOI 10.1016/S0736-0266(01)00062-6
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Erben CM, 2006, ANGEW CHEM INT EDIT, V45, P7414, DOI 10.1002/anie.200603392
   Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438
   Fernandes R, 2003, LANGMUIR, V19, P4058, DOI 10.1021/la027052h
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoff JD, 2004, NANO LETT, V4, P853, DOI 10.1021/nl049758x
   Hong Y, 2004, LANGMUIR, V20, P11123, DOI 10.1021/la048651m
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hu Y, 2005, LANGMUIR, V21, P9103, DOI 10.1021/la046857h
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jang SG, 2006, LANGMUIR, V22, P3326, DOI 10.1021/la0525170
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim JK, 2009, MOL PHARMACEUT, V6, P978, DOI 10.1021/mp900009n
   Kim TI, 2002, BIOTECHNOL LETT, V24, P2029, DOI 10.1023/A:1021368519336
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1989, ARCH BIOCHEM BIOPHYS, V272, P39, DOI 10.1016/0003-9861(89)90192-6
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KOMORIYA A, 1991, J BIOL CHEM, V266, P15075
   Koo LY, 2002, J CELL SCI, V115, P1423
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   KUSHWAHA M, 2009, BIOMATERIALS
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Lee M, 2006, PROTEOMICS, V6, P1094, DOI 10.1002/pmic.200500392
   Lee SA, 2009, LAB CHIP, V9, P1670, DOI 10.1039/b819999j
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   LIM JH, 2003, ANGEW CHEM, V115, P2411
   Liu GY, 2002, P NATL ACAD SCI USA, V99, P5165, DOI 10.1073/pnas.072695699
   Liu MZ, 2005, LANGMUIR, V21, P1972, DOI 10.1021/la047586d
   Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4333, DOI 10.1002/anie.200501089
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mardilovich A, 2006, LANGMUIR, V22, P3259, DOI 10.1021/la052756n
   Marques BF, 2005, LANGMUIR, V21, P2488, DOI 10.1021/la047962u
   Maury P, 2007, SMALL, V3, P1584, DOI 10.1002/smll.200700046
   MERCEY E, BIOMATERIALS, V31, P3156
   Mironov V, 2008, REGEN MED, V3, P93, DOI 10.2217/17460751.3.1.93
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Mrksich M, 2009, ACTA BIOMATER, V5, P832, DOI 10.1016/j.actbio.2009.01.016
   NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x
   Nuraje N, 2004, J AM CHEM SOC, V126, P8088, DOI 10.1021/ja048617u
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Park SH, 2005, NANO LETT, V5, P729, DOI 10.1021/nl050175c
   Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1
   PETRIE TA, 2008, J CELL MOL MED
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Powell T, 2006, BIOTECHNOL PROGR, V22, P106, DOI 10.1021/bp0501726
   Rao JH, 1998, SCIENCE, V280, P708, DOI 10.1126/science.280.5364.708
   Renault JP, 2003, J PHYS CHEM B, V107, P703, DOI 10.1021/jp0263424
   Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164
   ROBEY PG, 2002, PRINCIPLES BONE BIOL, P225
   ROSSERT J, 2002, PRINCIPLES BONE BIOL, P189
   Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v
   Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39
   Salazar RB, 2006, SMALL, V2, P1274, DOI 10.1002/smll.200600235
   Sancey L, 2009, MOL THER, V17, P837, DOI 10.1038/mt.2009.29
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Schvartzman M, 2009, J VAC SCI TECHNOL B, V27, P61, DOI 10.1116/1.3043472
   Senaratne W, 2006, J AM CHEM SOC, V128, P5594, DOI 10.1021/ja058701p
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Susuki Y, 2002, CHEM PHARM BULL, V50, P1229, DOI 10.1248/cpb.50.1229
   Taha H, 2003, APPL PHYS LETT, V83, P1041, DOI 10.1063/1.1594844
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Valiokas R, 2006, LANGMUIR, V22, P3456, DOI 10.1021/la053367w
   Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Wiradharma N, 2009, BIOMATERIALS, V30, P3100, DOI 10.1016/j.biomaterials.2009.03.006
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zhang H, 2003, OSTEOARTHR CARTILAGE, V11, P309, DOI 10.1016/S1063-4584(03)00032-3
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
NR 134
TC 68
Z9 69
U1 7
U2 108
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAR
PY 2011
VL 1810
IS 3
SI SI
BP 350
EP 360
DI 10.1016/j.bbagen.2010.04.006
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 722YJ
UT WOS:000287470900013
PM 20435097
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wang, YY
   Lu, LX
   Shi, JC
   Wang, HF
   Xiao, ZD
   Huang, NP
AF Wang, Yan-Yan
   Lue, Lan-Xin
   Shi, Jun-Cai
   Wang, Hai-Feng
   Xiao, Zhong-Dang
   Huang, Ning-Ping
TI Introducing RGD Peptides on PHBV Films through PEG-Containing
   Cross-Linkers to Improve the Biocompatibility
SO BIOMACROMOLECULES
LA English
DT Article
ID HUMAN-ENDOTHELIAL-CELLS; POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL);
   FIBRINOGEN ADSORPTION; SURFACE MODIFICATION; PROTEIN ADSORPTION; PLASMA
   TREATMENT; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); BIOMATERIALS;
   AMINOLYSIS; SCAFFOLDS
AB Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), a biodegradable polyester, has been a good candidate of biomaterial employed in tissue engineering. However, the PHBV film is hydrophobic and has no recognition sites for cell attachment. In this study, PHBV films are activated by ammonia plasma treatment to produce amino groups on the surface, followed by sequential reactions with a heterobifunctional cross-linker containing a segment of poly(ethylene glycol) (PEG) and further with RGD-containing peptides. XPS analyses of modified surfaces after each reaction step reveal that the RGD-containing peptides have been covalently grafted onto PHBV films. The result of cell viability assay indicates that the RGD-modified PHBV films exhibit a distinctly unproved cellular compatibility. Moreover, according to the results of serum adsorption tests by optical waveguide lightmode spectroscopy (OWLS) and fibrinogen adsorption tests by enzyme-linked immunosorbent assay (ELISA) on unmodified and modified PHBV surfaces, the introduced PEG chains can significantly decrease the nonspecific adsorption of proteins from serum and fibrinogen from plasma, thus decreasing the risk of thrombus formation and improving the blood compatibility of implanted materials.
C1 [Wang, Yan-Yan; Lue, Lan-Xin; Shi, Jun-Cai; Wang, Hai-Feng; Xiao, Zhong-Dang; Huang, Ning-Ping] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Xiao, ZD (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
EM zdxiao@seu.edu.cn; nphuang@seu.edu.cn
RI Zhou, Feng/E-9510-2011
FU National Science Foundation of China [30870626]; SRF for ROCS, SEM
FX This work is supported by the National Science Foundation of China
   (No.30870626) and the project sponsored by SRF for ROCS, SEM.
CR Alvarez-Barreto JF, 2007, MACROMOL BIOSCI, V7, P579, DOI 10.1002/mabi.200600280
   BEAMSON G, 1992, MOL PHYS, V76, P919, DOI 10.1080/00268979200101761
   Chang Y, 2008, J MEMBRANE SCI, V323, P77, DOI 10.1016/j.memsci.2008.06.023
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   GARTNER TK, 1985, J BIOL CHEM, V260, P1891
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huang NP, 2002, LANGMUIR, V18, P220, DOI 10.1021/la010913m
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Karrer L, 2005, INT J ARTIF ORGANS, V28, P993
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   LAM SCT, 1987, J BIOL CHEM, V262, P947
   Liao S, 2008, MAT SCI ENG C-BIO S, V28, P1189, DOI 10.1016/j.msec.2008.08.015
   Liu H, 2010, J BIOMED MATER RES A, V92A, P922, DOI 10.1002/jbm.a.32427
   Olivieri MP, 1999, J BIOMED MATER RES, V46, P355, DOI 10.1002/(SICI)1097-4636(19990905)46:3<355::AID-JBM7>3.0.CO;2-O
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Papra A, 2001, LANGMUIR, V17, P1457, DOI 10.1021/la000609d
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   RAMSDEN JJ, 1995, J AM CHEM SOC, V117, P8511, DOI 10.1021/ja00138a003
   Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003
   SLACK SM, 1991, J BIOMAT SCI-POLYM E, V3, P49
   Sombatmankhong K, 2007, POLYMER, V48, P1419, DOI 10.1016/j.polymer.2007.01.014
   STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tesema Y, 2004, J APPL POLYM SCI, V93, P2445, DOI 10.1002/app.20787
   Tigli RS, 2008, INT J BIOL MACROMOL, V43, P121, DOI 10.1016/j.ijbiomac.2008.04.003
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Wang YJ, 2009, J BIOMED MATER RES A, V88A, P616, DOI 10.1002/jbm.a.31858
   Wang YJ, 2006, J BIOMED MATER RES A, V76A, P589, DOI 10.1002/jbm.a.30575
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 43
TC 53
Z9 58
U1 5
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2011
VL 12
IS 3
BP 551
EP 559
DI 10.1021/bm100886w
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 732KG
UT WOS:000288183100005
PM 21294539
DA 2018-10-20
ER

PT J
AU Huey, DJ
   Athanasiou, KA
AF Huey, Daniel J.
   Athanasiou, Kyriacos A.
TI Maturational growth of self-assembled, functional menisci as a result of
   TGF-beta 1 and enzymatic chondroitinase-ABC stimulation
SO BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; Knee meniscus; TGF (transforming growth
   factor); C-ABC (chondroitinase-ABC); ECM; Mechanical properties
ID ARTICULAR-CARTILAGE CONSTRUCTS; IN-VITRO; SHAPED CONSTRUCTS; PORCINE
   MENISCUS; TISSUE; SURFACE; REPAIR; PROTEOGLYCAN; EXTRACTION; COCULTURE
AB Replacement of the knee meniscus requires a material possessing adequate geometrical and biomechanical properties. Meniscal tissue engineering attempts have been unable to produce tissue with collagen content and biomechanical properties, particularly tensile properties, mimicking native menisci. In an effort to obtain the geometric properties and the maturational growth necessary for the recapitulation of biochemical and, thus, biomechanical properties, a scaffoldless cell-based system, the self-assembly process, was used in conjunction with the catabolic enzyme chondroitinase-ABC and TGF-beta 1. We show that combinations of these agents resulted in maturational growth as evidenced by synergistic enhancement of the radial tensile modulus by 5-fold and the compressive relaxation modulus by 68%, and additive increases of the compressive instantaneous modulus by 136% and Col/WW by 196%. This study shows that tissue engineering can produce a biomaterial that is on par with the biochemical and biomechanical properties of native menisci. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Huey, Daniel J.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Athanasiou, KA (reprint author), Univ Calif Davis, Dept Biomed Engn, 1 Shields Ave, Davis, CA 95616 USA.
EM athanasiou@ucdavis.edu
FU NIH NIAMS [R01 AR047839]; NFL Charities
FX The authors would like to acknowledge NIH NIAMS, R01 AR047839 and NFL
   Charities for funding this work.
CR Adkisson HD, 2010, STEM CELL RES, V4, P57, DOI 10.1016/j.scr.2009.09.004
   Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298
   ATHANASIOU KA, 2009, ENG KNEE MENISCUS SY, P1
   Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291
   Bian LM, 2009, TISSUE ENG PT A, V15, P2065, DOI 10.1089/ten.tea.2008.0495
   Elder BD, 2009, OSTEOARTHR CARTILAGE, V17, P114, DOI 10.1016/j.joca.2008.05.006
   Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341
   Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012
   Giovannini S, 2010, EUR CELLS MATER, V20, P245
   Gunja NJ, 2009, J TISSUE ENG REGEN M, V3, P521, DOI 10.1002/term.191
   Gunja NJ, 2009, BIOMATERIALS, V30, P565, DOI 10.1016/j.biomaterials.2008.10.007
   HEATLEY FW, 1985, BIOMATERIALS, V6, P161, DOI 10.1016/0142-9612(85)90004-3
   Hennerbichler A, 2007, AM J SPORT MED, V35, P754, DOI 10.1177/0363546506296416
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Imler SM, 2004, OSTEOARTHR CARTILAGE, V12, P736, DOI 10.1016/j.joca.2004.05.007
   Jones RS, 1996, CLIN BIOMECH, V11, P295, DOI 10.1016/0268-0033(96)00003-4
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   Lietman SA, 2003, ORTHOPEDICS, V26, P799
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140
   Natoli RM, 2009, J ORTHOP RES, V27, P949, DOI 10.1002/jor.20821
   NG KW, 2008, T ORTHOP RES SOC, V33, P558
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   Pangborn CA, 2005, J ORTHOP RES, V23, P1184, DOI 10.1016/j.orthres.2005.01.019
   Prabhakar V, 2006, BIOCHEMISTRY-US, V45, P11130, DOI 10.1021/bi0605484
   SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307
   SCOTT GA, 1986, J BONE JOINT SURG AM, V68A, P847, DOI 10.2106/00004623-198668060-00006
   Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   YAMAGATA T, 1968, J BIOL CHEM, V243, P1523
NR 32
TC 50
Z9 52
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2011
VL 32
IS 8
BP 2052
EP 2058
DI 10.1016/j.biomaterials.2010.11.041
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717QB
UT WOS:000287061400005
PM 21145584
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Motta, A
   Barbato, B
   Foss, C
   Torricelli, P
   Migliaresi, C
AF Motta, Antonella
   Barbato, Beatrice
   Foss, Cristina
   Torricelli, Paola
   Migliaresi, Claudio
TI Stabilization of Bombyx mori silk fibroin/sericin films by crosslinking
   with PEG-DE 600 and genipin
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE crosslinking; fibroin/sericin films; genipin; PEG-DE; silk fibroin; silk
   sericin; tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO; ENDOTHELIAL-CELLS; PROTEIN SERICIN;
   FIBROIN; SCAFFOLDS; BIOMATERIALS; HYDROGELS; GELATIN; ABSORPTION
AB Silk fibroin and sericin have been widely used as a biomaterial for many different purposes. In this study, the properties of crosslinked fibroin/sericin 90/10 films have been investigated using two different crosslinkers poly(ethylene glycol) diglycidyl ether 600 (PEG-DE) and genipin. The films were characterized by molecular weight, fibroin conformation, crystallinity, and thermal stability. Both PEG-DE and genipin cross-linkers stabilized the random/alpha-helix structures in the fibroin and prevented phase separation between fibroin and sericin that occurs with non-crosslinked materials. The genipin crosslinked film displayed highest elongation at break and tensile strength. The in vitro cytotoxicity of the materials was assessed by lactate dehydrogenase activity and the viability was based on the tetrazolium salt and WST-1 tests. All films exhibited good biocompatibility and supported cell adhesion and proliferation.
C1 [Motta, Antonella; Barbato, Beatrice; Foss, Cristina; Migliaresi, Claudio] Univ Trento, Dept Mat Engn & Ind Technol, I-38123 Mattarello Trento, Italy.
   [Motta, Antonella; Barbato, Beatrice; Foss, Cristina; Migliaresi, Claudio] Univ Trento, Biotech Res Ctr, I-38123 Mattarello Trento, Italy.
   [Motta, Antonella; Foss, Cristina; Migliaresi, Claudio] European Inst Excellence Tissue Engn & Regenerat, Trento, Italy.
   [Torricelli, Paola] IOR, Bologna, Italy.
   [Motta, Antonella; Foss, Cristina; Migliaresi, Claudio] INSTM Consorzio Interuniv Nazl Sci & Tecnol Mat, Res Unit Trento, Trento, Italy.
RP Motta, A (reprint author), Univ Trento, Dept Mat Engn & Ind Technol, Via Regole 101, I-38123 Mattarello Trento, Italy.
EM antonella.motta@ing.unitn.it
RI TORRICELLI, PAOLA/J-5298-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Motta,
   Antonella/0000-0003-4893-6863
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Denkbas E, 2009, J BIOACT COMPAT POL, V21, P351
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Khurma JR, 2008, POLYM BULL, V59, P805, DOI 10.1007/s00289-007-0817-2
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Lien SM, 2008, MAT SCI ENG C-BIO S, V28, P36, DOI 10.1016/j.msec.2006.12.015
   Meena R, 2007, J APPL POLYM SCI, V104, P290, DOI 10.1002/app.25596
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MIYAIRI S, 1978, J FERMENT TECHNOL, V56, P303
   Moonsri P, 2008, J APPL POLYM SCI, V108, P1402, DOI 10.1002/app.27528
   Motta A, 2002, J BIOACT COMPAT POL, V17, P23, DOI 10.1106/088391102023195
   Motta A, 2009, J BIOMAT SCI-POLYM E, V20, P1875, DOI 10.1163/156856208X399936
   Murase M, 1994, Japan Patent, Patent No. [06-166850A, 06166850]
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakamura K., 2001, Japan Patent, Patent No. [2001106794, 2001-106794A]
   Padamwar MN, 2004, J SCI IND RES INDIA, V63, P323
   Peptu CA, 2009, J BIOACT COMPAT POL, V25, P98
   Santin M, 2002, J BIOACT COMPAT POL, V17, P195, DOI 10.1106/0883911`02026326
   Sarovart S, 2003, REV ADV MATER SCI, V5, P193
   Sasaki M, 2000, NUTR RES, V20, P1505, DOI 10.1016/S0271-5317(00)80031-7
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Takahashi M, 2003, BIOTECHNOL LETT, V25, P1805, DOI 10.1023/A:1026284620236
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Tsujimoto K, 2001, J BIOCHEM-TOKYO, V129, P979, DOI 10.1093/oxfordjournals.jbchem.a002946
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wei T, 2005, MACROMOL MATER ENG, V290, P188
   Xie RJ, 2007, KEY ENG MATER, V342-343, P241, DOI 10.4028/www.scientific.net/KEM.342-343.241
   Yao CH, 2004, MATER CHEM PHYS, V83, P204, DOI 10.1016/j.mathchemphys.2003.08.027
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2003, ONCOL REP, V10, P537
NR 50
TC 25
Z9 27
U1 1
U2 41
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2011
VL 26
IS 2
BP 130
EP 143
DI 10.1177/0883911511400251
PG 14
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 740HT
UT WOS:000288783600003
DA 2018-10-20
ER

PT J
AU Giovanini, AF
   Gonzaga, CC
   Zielak, JC
   Deliberador, TM
   Kuczera, J
   Goringher, I
   de Oliveira, MA
   Baratto, F
   Urban, CA
AF Giovanini, Allan Fernando
   Gonzaga, Carla Castiglia
   Zielak, Joao Cesar
   Deliberador, Tatiana Miranda
   Kuczera, Juliane
   Goeringher, Isabella
   de Oliveira Filho, Marco Antonio
   Baratto-Filho, Flares
   Urban, Cicero Andrade
TI Platelet-Rich Plasma (PRP) Impairs the Craniofacial Bone Repair
   Associated with Its Elevated TGF-beta Levels and Modulates the
   Co-Expression between Collagen III and alpha-Smooth Muscle Actin
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE platelet-rich plasma; bone regeneration; type III collagen; smooth
   muscle actin; fibrosis
ID GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; TRANSFORMING
   GROWTH-FACTOR-BETA-1; MOLECULAR-MECHANISMS; FIBROSIS; MYOFIBROBLAST;
   CELLS; TGF-BETA-1; DIFFERENTIATION; EXPRESSION
AB Transforming growth factor-beta (TGF-beta) is considered the main inducer of both the alpha-smooth muscle actin (alpha-SMA) phenotype and collagen synthesis and deposition and plays a significant role in the tissue repair and the development of fibrosis. Since the PRP constitutes an important source of TGF-beta and its efficacy on the craniofacial bone repair remains controversy, the aim of this study was to evaluate the effect of PRP in the presence of levels of TGF-beta on PRP samples, as well as in the presence of collagen III and alpha-SMA+ cells, while comparing these results by means of a histomorphornetric analysis of the bone matrix and fibrous deposition on the bone repair. Four bone defects of 16 mm(2) were created on the calvarium of 21 rabbits. The surgical defects were treated with either particulate autograft, particulate autograft mixed with PRP and PRP alone. Animals were euthanized at 15, 30, and 45 days postoperative. Histomorphometric and immunohistochemical analyses were performed to assess repair time, as well as the expression of collagen III, and alpha-SMA. The histomorphometric results demonstrated intensive deposition of fibrous tissue while hinder bone deposition occurred in PRP groups. These results coincided with higher values of the TGF-beta on the PRP sample, also larger occurrence of diffuse collagen III deposition and higher presence of alpha-SMA+ cells spread among the fibrous tissue. Thus, the higher levels of TGF-beta associated with the both expression of collagen III and beta-SMA on defect treated with PRP suggest that its biomaterial induce an effect that can be considered similarly to a fibroproliferative disorder. (C) 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:457-463, 2011
C1 [Giovanini, Allan Fernando; Kuczera, Juliane; Goeringher, Isabella] Positivo Univ, Sch Dent, BR-81280330 Curitiba, Parana, Brazil.
   [de Oliveira Filho, Marco Antonio] Evangelic Hosp, Head & Neck Surg Serv, Curitiba, Parana, Brazil.
RP Giovanini, AF (reprint author), Positivo Univ, Sch Dent, Rua Pedro Viriato Parigot de Souza 5300, BR-81280330 Curitiba, Parana, Brazil.
EM afgiovanini@gmail.com
RI Baratto Filho, Flares/O-2007-2015; Gonzaga, Carla/K-2997-2012;
   Giovanini, Allan/K-5215-2012; Deliberador, Tatiana/C-3022-2016
OI Gonzaga, Carla/0000-0001-6374-1605; Deliberador,
   Tatiana/0000-0003-4076-4905; Baratto Filho, Flares/0000-0002-5649-7234;
   Giovanini, Allan/0000-0002-1637-2955
FU Histopathology Laboratory of Positivo University
FX This work was supported by the Histopathology Laboratory of Positivo
   University. The authors would like to thank Mr. Andre Alex Antunes for
   the skilled technical assistance.
CR Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004
   Artaza JN, 2008, J ENDOCRINOL, V196, P235, DOI 10.1677/JOE-07-0408
   Baricos WH, 1999, J AM SOC NEPHROL, V10, P790
   Blakytny R, 2004, J CELL PHYSIOL, V199, P67, DOI 10.1002/jcp.10454
   Brenmoehl J, 2009, WORLD J GASTROENTERO, V15, P1431, DOI 10.3748/wjg.15.1431
   Chauhan H, 2003, J CLIN PATHOL, V56, P271, DOI 10.1136/jcp.56.4.271
   Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725
   DAS AM, 2004, DRUG DISCOV TODAY, V1, P361
   Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Freymiller EG, 2004, J ORAL MAXIL SURG, V62, P484, DOI 10.1016/j.joms.2003.08.021
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   GIOVANINI AF, 2010, BONE, V46, P1469
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   HINZ B, J BIOMECH, V43, P146
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412
   Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190
   Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR
   Kissin Eugene, 2002, Curr Rheumatol Rep, V4, P129, DOI 10.1007/s11926-002-0008-y
   Klongnoi B, 2006, J CLIN PERIODONTOL, V33, P500, DOI 10.1111/j.1600-051X.2006.00938.x
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Manetti M, 2007, ARTHRITIS RHEUM, V56, P3442, DOI 10.1002/art.22940
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033
   Nikolidakis D, 2008, TISSUE ENG PART B-RE, V14, P249, DOI 10.1089/ten.teb.2008.0062
   Peters H, 2004, KIDNEY INT, V65, P2238, DOI 10.1111/j.1523-1755.2004.00630.x
   Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S
   Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004
   Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009
   Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1
   Reinhold D, 1997, J IMMUNOL METHODS, V209, P203, DOI 10.1016/S0022-1759(97)00160-9
   Shehata M, 2004, J CLIN INVEST, V113, P676, DOI 10.1172/JCI200419540
   Simmons JG, 2002, AM J PHYSIOL-GASTR L, V283, pG809, DOI 10.1152/ajpgi.00057.2002
   Tang WW, 1997, KIDNEY INT, V51, P926, DOI 10.1038/ki.1997.131
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   Wells RG, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.110pe13, 10.1126/stke/110pe13]
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Xu QH, 2007, AM J PHYSIOL-RENAL, V293, pF631, DOI 10.1152/ajprenal.00379.2006
   Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200
NR 43
TC 24
Z9 30
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2011
VL 29
IS 3
BP 457
EP 463
DI 10.1002/jor.21263
PG 7
WC Orthopedics
SC Orthopedics
GA 719BF
UT WOS:000287173500023
PM 20922797
OA Bronze
DA 2018-10-20
ER

PT J
AU Vernon, BA
   Bollinger, AJ
   Garvin, KL
   McGarry, SV
AF Vernon, Brian A.
   Bollinger, Alexander J.
   Garvin, Kevin L.
   McGarry, Sean V.
TI Osteolytic Lesion of the Tibial Diaphysis After Cementless TKA
SO ORTHOPEDICS
LA English
DT Article
AB Biomaterial wear debris is a known contributing factor in aseptic loosening of total joint prostheses, particularly when cementless tibial trays are used in total knee arthroplasty (TKA). Local inflammatory response can lead to osteolysis and aseptic loosening of implants. The resulting lesions require careful clinical evaluation. This article presents a case of a 76-year old man with a remote history of prostate cancer and cigarette smoking who presented with acute onset left knee and tibia pain 15 years after TKA. Radiographs showed an osteolytic lesion in the distal tibial diaphysis and magnetic resonance imaging revealed a cystic lesion with evidence concerning for pathologic mid-shaft fracture. Biopsy of the lesion confirmed a foreign body reaction and revision TKA was performed. The patient was seen at 3-year follow-up without complication. The existing literature presents cases reporting osteolytic lesions of the distal femur and proximal tibial metaphysis due to polyethylene wear debris and foreign body reaction following TKA. We are unaware of case reports involving osteolysis of this etiology extending into the distal tibial diaphysis. We conclude that polyethylene wear debris with foreign body reaction should be considered in the differential diagnosis of an osteolytic lesion extending into the tibial diaphysis following TKA.
C1 [Vernon, Brian A.; Bollinger, Alexander J.; Garvin, Kevin L.; McGarry, Sean V.] Univ Nebraska Med Ctr, Dept Orthoped Surg & Rehabil, Omaha, NE 68198 USA.
RP Vernon, BA (reprint author), Univ Nebraska Med Ctr, Dept Orthoped Surg & Rehabil, 42nd & Emile, Omaha, NE 68198 USA.
EM bvernon@unmc.edu
CR Cottias P, 1997, INT ORTHOP, V21, P243, DOI 10.1007/s002640050159
   DAHLIN DC, 1956, J BONE JOINT SURG AM, V38, P1025, DOI 10.2106/00004623-195638050-00007
   ENGH GA, 1992, J BONE JOINT SURG BR, V74, P9
   ENGH GA, 1994, CLIN ORTHOP RELAT R, P33
   Frick Chris, 2006, J Long Term Eff Med Implants, V16, P423
   GOODMAN SB, 1991, ARCH ORTHOP TRAUM SU, V110, P123, DOI 10.1007/BF00395792
   GOODMAN SB, 1988, J ARTHROPLASTY S, pS41
   HARRIS WH, 1993, ORTHOP CLIN N AM, V24, P611
   HAYES CS, 1990, ORTHOPEDICS, V13, P363
   JUHN A, 1989, ORTHOPEDICS, V12, P245
   Kane K R, 1994, Orthop Rev, V23, P332
   Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21
   LINDENBAUM S, 1984, CLIN ORTHOP RELAT R, P193
   Lobo J, 2003, CAN J SURG, V46, P47
   Murphey MD, 1997, RADIOGRAPHICS, V17, P1205, DOI 10.1148/radiographics.17.5.9308111
   Rasool MN, 2001, J BONE JOINT SURG BR, V83B, P93, DOI 10.1302/0301-620X.83B1.11180
   Rogers LF, 1987, PAUL JUHLS ESSENTIAL, P85
   Sanchis-Alfonso V, 2001, KNEE SURG SPORT TR A, V9, P173, DOI 10.1007/s001670000178
   STEWART MJ, 1952, J BONE JOINT SURG AM, V34-A, P372, DOI 10.2106/00004623-195234020-00011
   Wasielewski RC, 1997, CLIN ORTHOP RELAT R, P53
NR 20
TC 1
Z9 1
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0147-7447
EI 1938-2367
J9 ORTHOPEDICS
JI Orthopedics
PD MAR
PY 2011
VL 34
IS 3
AR 224
DI 10.3928/01477447-20110124-30
PG 6
WC Orthopedics
SC Orthopedics
GA V33KC
UT WOS:000209016700015
PM 21410114
DA 2018-10-20
ER

PT J
AU Iwasaki, N
   Kasahara, Y
   Yamane, S
   Igarashi, T
   Minami, A
   Nisimura, S
AF Iwasaki, Norimasa
   Kasahara, Yasuhiko
   Yamane, Shintarou
   Igarashi, Tatsuya
   Minami, Akio
   Nisimura, Shin-ichiro
TI Chitosan-Based Hyaluronic Acid Hybrid Polymer Fibers as a Scaffold
   Biomaterial for Cartilage Tissue Engineering
SO POLYMERS
LA English
DT Review
DE chitosan; hyaluronic acid; hybrid polymer fiber; cartilage tissue
   engineering; scaffold
AB An ideal scaffold material is one that closely mimics the natural environment in the tissue-specific extracellular matrix (ECM). Therefore, we have applied hyaluronic acid (HA), which is a main component of the cartilage ECM, to chitosan as a fundamental material for cartilage regeneration. To mimic the structural environment of cartilage ECM, the fundamental structure of a scaffold should be a three-dimensional (3D) system with adequate mechanical strength. We structurally developed novel polymer chitosan-based HA hybrid fibers as a biomaterial to easily fabricate 3D scaffolds. This review presents the potential of a 3D fabricated scaffold based on these novel hybrid polymer fibers for cartilage tissue engineering.
C1 [Iwasaki, Norimasa; Kasahara, Yasuhiko; Yamane, Shintarou; Igarashi, Tatsuya; Minami, Akio] Hokkaido Univ, Dept Orthopaed Surg, Sch Med, Sapporo, Hokkaido 0608638, Japan.
   [Nisimura, Shin-ichiro] Hokkaido Univ, Grad Sch Adv Life Sci, Frontier Res Ctr Postgenom Sci & Technol, Sapporo, Hokkaido 0600810, Japan.
RP Iwasaki, N (reprint author), Hokkaido Univ, Dept Orthopaed Surg, Sch Med, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
EM niwasaki@med.hokudai.ac.jp; kasa14@rose.ocn.ne.jp;
   yamane629@yahoo.co.jp; iga@amber.plala.or.jp;
   a-minami@med.hokudai.ac.jp; shin@glyco.sci.hokudai.ac.jp
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Bhardwaj T, 2001, J BIOMED MATER RES, V57, P190, DOI 10.1002/1097-4636(200111)57:2<190::AID-JBM1158>3.0.CO;2-J
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HIRANO S, 1990, PROGRESS IN BIOMEDICAL POLYMERS, P283
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hynes RO, 1999, TRENDS BIOCHEM SCI, V24, pM33, DOI 10.1016/S0968-0004(99)01479-6
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Kasahara Y, 2008, J BIOMED MATER RES A, V86A, P127, DOI 10.1002/jbm.a.31259
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Murdoch A.D., 2003, P 49 ANN M ORTH RES
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nuernberger S., 2010, BIOMATERIALS, V32, P1032
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Otsuka Y, 1997, DEV GROWTH DIFFER, V39, P143
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   SHARPIO F, 1993, J BONE JOINT SURG AM, V75, P532
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tamura H, 2002, MAT SCI ENG C-BIO S, V20, P143, DOI 10.1016/S0928-4931(02)00024-3
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 42
TC 20
Z9 20
U1 2
U2 32
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD MAR
PY 2011
VL 3
IS 1
BP 100
EP 113
DI 10.3390/polym3010100
PG 14
WC Polymer Science
SC Polymer Science
GA V27GJ
UT WOS:000208601400006
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Van Vlierberghe, S
   Vanderleyden, E
   Boterberg, V
   Dubruel, P
AF Van Vlierberghe, Sandra
   Vanderleyden, Els
   Boterberg, Veerle
   Dubruel, Peter
TI Gelatin Functionalization of Biomaterial Surfaces: Strategies for
   Immobilization and Visualization
SO POLYMERS
LA English
DT Article
DE gelatin immobilization; polyimide; titanium; surface characterization
AB In the present work, the immobilization of gelatin as biopolymer on two types of implantable biomaterials, polyimide and titanium, was compared. Both materials are known for their biocompatibility while lacking cell-interactive behavior. For both materials, a pre-functionalization step was required to enable gelatin immobilization. For the polyimide foils, a reactive succinimidyl ester was introduced first on the surface, followed by covalent grafting of gelatin. For the titanium material, methacrylate groups were first introduced on the Ti surface through a silanization reaction. The applied functionalities enabled the subsequent immobilization of methacrylamide modified gelatin. Both surface modified materials were characterized in depth using atomic force microscopy, static contact angle measurements, confocal fluorescence microscopy, attenuated total reflection infrared spectroscopy and X-ray photo-electron spectroscopy. The results indicated that the strategies elaborated for both material classes are suitable to apply stable gelatin coatings. Interestingly, depending on the material class studied, not all surface analysis techniques are applicable.
C1 [Van Vlierberghe, Sandra; Vanderleyden, Els; Boterberg, Veerle; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
RP Dubruel, P (reprint author), Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281 S4 Bis, B-9000 Ghent, Belgium.
EM sandra.vanvlierberghe@ugent.be; els.vanderleyden@ugent.be;
   veerle.boterberg@ugent.be; Peter.Dubruel@UGent.be
FU EU 6th framework programme [019114]
FX The authors would like to acknowledge the PolExGene consortium.
   PolExGene is a STREP project (contract number 019114) funded under the
   EU 6th framework programme. Sandra Van Vlierberghe is post-doctoral
   fellow of the Research Foundation-Flanders (FWO, Belgium). Further
   acknowledgement goes to the Agency for Innovation by Science and
   Technology in Flanders (IWT). The authors would like to thank
   Christopher J. Guerin, leader of the microscopy core facility of the
   Flemish Institute of Biotechnology, Department of Molecular Biomedical
   Research, for the CFM images, and Raymond Kemps from the Flemish
   Institute for Technological Research (VITO) for the SEM images.
CR Bansiddhi A, 2008, ACTA BIOMATER, V4, P773, DOI 10.1016/j.actbio.2008.02.009
   Guerra NB, 2010, SOFT MATTER, V6, P4748, DOI 10.1039/c0sm00074d
   CAI SX, 1992, CHEM MATER, V4, P879, DOI 10.1021/cm00022a025
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Dubruel P, 2006, SURF SCI, V600, P2562, DOI 10.1016/j.susc.2006.04.021
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fiegel HC, 2008, J CELL MOL MED, V12, P56, DOI 10.1111/j.1582-4934.2007.00162.x
   HARMER MA, 1991, LANGMUIR, V7, P2010, DOI 10.1021/la00058a007
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Huang CY, 2003, SURF COAT TECH, V167, P1, DOI 10.1016/S0257-8972(02)00817-4
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   KUANGL HG, 2008, BIOCERAMICS 2, V361, P685
   LaNasa SM, 2009, ACTA BIOMATER, V5, P2929, DOI 10.1016/j.actbio.2009.05.011
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   Low BT, 2009, MACROMOLECULES, V42, P7042, DOI 10.1021/ma901251y
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Navarro X, 1998, J PERIPHER NERV SYST, V3, P91
   Navarro X, 2001, RESTOR NEUROL NEUROS, V18, P9
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Pritchard CD, 2010, BIOMATERIALS, V31, P2153, DOI 10.1016/j.biomaterials.2009.11.074
   Prystupa DA, 1996, POLYM GELS NETW, V4, P87, DOI 10.1016/0966-7822(96)00003-2
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Rodriguez FJ, 2000, J NEUROSCI METH, V98, P105, DOI 10.1016/S0165-0270(00)00192-8
   Roger P, 2010, EUR POLYM J, V46, P1594, DOI 10.1016/j.eurpolymj.2010.04.002
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Stendahl JC, 2004, BIOMATERIALS, V25, P5847, DOI 10.1016/j.biomaterials.2004.01.042
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van Vlierberghe S, 2008, J MATER SCI-MATER M, V19, P1459, DOI 10.1007/s10856-008-3375-8
   Van Vlierberghe S, 2010, BIOMACROMOLECULES, V11, P2731, DOI 10.1021/bm100783h
   Van Vlierberghe S, 2009, J BIOMAT SCI-POLYM E, V20, P1417, DOI 10.1163/092050609X12457418905508
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Van Vlierberghe S, 2009, MACROMOL BIOSCI, V9, P1105, DOI 10.1002/mabi.200900043
   Van Vlierberghe S, 2008, MACROMOL BIOSCI, V8, P1090, DOI 10.1002/mabi.200800074
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Weng YJ, 2008, MAT SCI ENG C-BIO S, V28, P1495, DOI 10.1016/j.msec.2008.04.004
   YAN MD, 1993, J AM CHEM SOC, V115, P814, DOI 10.1021/ja00055a078
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
   Zhu YB, 2006, BIOMATERIALS, V27, P68, DOI 10.1016/j.biomaterials.2005.05.069
NR 43
TC 15
Z9 15
U1 1
U2 32
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD MAR
PY 2011
VL 3
IS 1
BP 114
EP 130
DI 10.3390/polym3010114
PG 17
WC Polymer Science
SC Polymer Science
GA V27GJ
UT WOS:000208601400007
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Vavken, P
   Murray, MM
AF Vavken, Patrick
   Murray, Martha M.
TI The Potential for Primary Repair of the ACL
SO SPORTS MEDICINE AND ARTHROSCOPY REVIEW
LA English
DT Review
DE tissue engineering; ACL; regeneration; PRP; animal model; biomechanics
ID ANTERIOR CRUCIATE LIGAMENT; PLATELET-RICH PLASMA; SKELETALLY IMMATURE
   PATIENTS; ADOLESCENT PATIENTS; RECONSTRUCTION; COLLAGEN; PATIENT; KNEE;
   OSTEOARTHRITIS; PREPUBESCENT
AB The objective of this work is to assess the feasibility of successfully repairing the torn anterior cruciate ligament (ACL). Two major motivators for developing a new treatment for ACL injuries are the recently reported high rates of osteoarthritis, after conventional ACL reconstruction, and the problem of how to safely treat skeletally immature patients. A key factor in developing such a technique was the identification of the main inhibitor of intrinsic ACL healing-the lack of clot formation between the 2 torn ends of the ligament. A bioactive and biocompatible scaffold, which could be placed in the wound site to enhance cellular proliferation and biosynthesis, was developed. This biomaterial has shown promising functional outcomes in several large animal models of primary repair of partial and complete ACL transection over 4 to 14 weeks, suggesting potential for a successful, future clinical application.
C1 [Vavken, Patrick; Murray, Martha M.] Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med,Sports Med Res Lab, Boston, MA 02115 USA.
RP Murray, MM (reprint author), Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med,Sports Med Res Lab, 300 Longwood Ave,Enders 1016, Boston, MA 02115 USA.
EM Martha.murray@childrens.harvard.edu
FU NIAMS NIH HHS [R01 AR052772-04, R01 AR052772]
CR ANDRISH J, 1979, CLIN ORTHOP RELAT R, P279
   BROMMER EJP, 1992, THROMB HAEMOSTASIS, V68, P180
   Cabaud H E, 1979, Am J Sports Med, V7, P18, DOI 10.1177/036354657900700105
   DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511
   Edwards TB, 2001, J BONE JOINT SURG AM, V83A, P725, DOI 10.2106/00004623-200105000-00012
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Everts Peter A M, 2006, J Extra Corpor Technol, V38, P174
   Feagin J A Jr, 1976, Am J Sports Med, V4, P95, DOI 10.1177/036354657600400301
   Guzzanti V, 2003, AM J SPORT MED, V31, P941, DOI 10.1177/03635465030310063301
   Guzzanti V, 2003, AM J SPORT MED, V31, P949, DOI 10.1177/03635465030310063401
   Henry J, 2009, KNEE SURG SPORT TR A, V17, P748, DOI 10.1007/s00167-009-0741-0
   Houle JB, 2001, CLIN ORTHOP RELAT R, P275
   Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915
   Koman JD, 1999, J BONE JOINT SURG AM, V81A, P711, DOI 10.2106/00004623-199905000-00014
   Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396
   LOHMANDER LS, 1994, ACTA ORTHOP SCAND, V65, P605, DOI 10.3109/17453679408994613
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Magarian EM, 2010, AM J SPORT MED, V38, P2528, DOI 10.1177/0363546510377416
   MASTRANGELO A, 2009, J ORTHOP RES
   Mastrangelo AN, 2010, J ORTHOP RES, V28, P1100, DOI 10.1002/jor.21070
   Mastrangelo AN, 2010, J ORTHOP RES, V28, P644, DOI 10.1002/jor.21018
   McIntosh AL, 2006, ARTHROSCOPY, V22, P1325, DOI 10.1016/j.arthro.2006.07.014
   Micheli LJ, 1999, CLIN ORTHOP RELAT R, P40
   Mohtadi N, 2006, CLIN J SPORT MED, V16, P457, DOI 10.1097/01.jsm.0000248844.39498.1f
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2010, J BONE JOINT SURG AM, V92A, P2039, DOI 10.2106/JBJS.I.01368
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2000, J BONE JOINT SURG AM, V82A, P1387, DOI 10.2106/00004623-200010000-00004
   ODONOGHU.DH, 1971, J BONE JOINT SURG AM, VA 53, P710, DOI 10.2106/00004623-197153040-00010
   ODONOGHUE DH, 1963, J BONE JOINT SURG AM, V45, P905, DOI 10.2106/00004623-196345050-00002
   ODONOGHUE DH, 1966, J BONE JOINT SURG AM, VA 48, P503, DOI 10.2106/00004623-196648030-00009
   Robson AWM, 1903, ANN SURG, V37, P716
   Rosc D, 2002, MED SCI MONITOR, V8, pCR371
   SANDBERG R, 1987, J BONE JOINT SURG AM, V69A, P1120, DOI 10.2106/00004623-198769080-00002
   Seil R, 2008, ARTHROSCOPY, V24, P824, DOI 10.1016/j.arthro.2008.02.007
   Shea KG, 2007, KNEE SURG SPORT TR A, V15, P320, DOI 10.1007/s00167-006-0171-1
   Shea KG, 2003, SPORTS MED, V33, P455, DOI 10.2165/00007256-200333060-00006
   Streich NA, 2010, KNEE SURG SPORT TR A, V18, P1481, DOI 10.1007/s00167-010-1057-9
   Trentacosta NE, 2009, AM J SPORT MED, V37, P1684, DOI 10.1177/0363546509332507
   Vavken P, 2010, J ORTHOP RES, V28, P1107, DOI 10.1002/jor.21111
   Vavken P, 2010, TISSUE ENG PART B-RE, V16, P5, DOI 10.1089/ten.teb.2009.0147
   von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136
   Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jems.2002.0285
   WESTER W, 1994, J PEDIATR ORTHOPED, V14, P516, DOI 10.1097/01241398-199407000-00019
   WIIG ME, 1990, J ORTHOP RES, V8, P425, DOI 10.1002/jor.1100080314
NR 46
TC 37
Z9 37
U1 0
U2 15
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1062-8592
J9 SPORTS MED ARTHROSC
JI Sports Med. Arthrosc. Rev.
PD MAR
PY 2011
VL 19
IS 1
BP 44
EP 49
DI 10.1097/JSA.0b013e3182095e5d
PG 6
WC Sport Sciences
SC Sport Sciences
GA 716KS
UT WOS:000286968100007
PM 21293237
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Das, RK
   Sharma, P
   Nahar, P
   Bora, U
AF Das, Ratul Kumar
   Sharma, Pragya
   Nahar, Pradip
   Bora, Utpal
TI Synthesis of gold nanoparticles using aqueous extract of Calotropis
   procera latex
SO MATERIALS LETTERS
LA English
DT Article
DE Nanomaterials; Procera latex; Gold nanoparticles; Coagulation test;
   Cytotoxicity; Crystal structure
ID GREEN SYNTHESIS; GIGANTEA; PROTEIN
AB This is an account of the use of aqueous extract of the latex of Calotropis procera for the synthesis of gold nanoparticles. UV-Vis spectroscopic studies of the products resulting from reaction between the aqueous latex extract and chlorauric acid indicated the successful synthesis of gold nanoparticles. Reaction parameters viz, concentration of latex extract and reaction time were optimized for maximum yield of gold nanoparticles. Effect of reaction temperature on the synthesis rate of the particles and their optical properties was also studied. Transmission electron microscopic (TEM) studies of the particles revealed the dominance of spherical particles. Mean particle size distribution was found to be 22 +/- 10 nm. Crystalline nature of the particles was confirmed from X-ray diffractrograms. FT-IR analysis and protein coagulation test of the gold nanoparticles confirmed capping behaviour of the latex proteins that contributed to their long term stability (6 months) in aqueous medium. Toxicity of the particles was tested on three cell lines, HeLa. A549 and BHK21. The method exploits a cheap and easily available biomaterial not explored so far for the synthesis of metallic nanoparticles. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Das, Ratul Kumar; Bora, Utpal] Indian Inst Technol, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
   [Sharma, Pragya; Nahar, Pradip] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India.
RP Bora, U (reprint author), Indian Inst Technol, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
RI Ganju, Shahji/F-3409-2012
FU Department of Science & Technology, Government of India
FX We thank the Department of Science & Technology, Government of India for
   the financial support.
CR ABRAHAM KI, 1979, BIOCHIM BIOPHYS ACTA, V568, P120, DOI 10.1016/0005-2744(79)90279-1
   Alric C, 2008, J AM CHEM SOC, V130, P5908, DOI 10.1021/ja078176p
   Bar H, 2009, COLLOID SURFACE A, V339, P134, DOI 10.1016/j.colsurfa.2009.02.008
   Basset C, 2003, LIVER INT, V23, P89, DOI 10.1034/j.1600-0676.2003.00806.x
   Das RK, 2010, MATER LETT, V64, P1445, DOI 10.1016/j.matlet.2010.03.051
   Freitas CDT, 2007, PLANT PHYSIOL BIOCH, V45, P781, DOI 10.1016/j.plaphy.2007.07.020
   Hainfeld JF, 2006, BRIT J RADIOL, V79, P248, DOI 10.1259/bjr/13169882
   HORISBERGER M, 1984, HISTOCHEMISTRY, V80, P13, DOI 10.1007/BF00492765
   Jain S. C., 1996, Fitoterapia, V67, P275
   lqbal Z., 2005, ETHANOPHARMACOL, V14, P256
   MASCOLO N, 1988, J ETHNOPHARMACOL, V22, P211, DOI 10.1016/0378-8741(88)90129-8
   Mossman T., 1989, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4
   PAL G, 1980, ARCH BIOCHEM BIOPHYS, V202, P321, DOI 10.1016/0003-9861(80)90434-8
   Ravindra P, 2009, MATER SCI ENG B-ADV, V163, P93, DOI 10.1016/j.mseb.2009.05.013
   Roy S, 2005, J ETHNOPHARMACOL, V102, P470, DOI 10.1016/j.jep.2005.06.026
   SHAW CF, 1999, CHEM REV, V99
NR 16
TC 25
Z9 26
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 28
PY 2011
VL 65
IS 4
BP 610
EP 613
DI 10.1016/j.matlet.2010.11.040
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 724ZO
UT WOS:000287615200006
DA 2018-10-20
ER

PT J
AU Liu, B
   Zheng, YF
   Ruan, LQ
AF Liu, B.
   Zheng, Y. F.
   Ruan, Liquan
TI In vitro investigation of Fe30Mn6Si shape memory alloy as potential
   biodegradable metallic material
SO MATERIALS LETTERS
LA English
DT Article
DE Mechanical properties; Shape memory materials; Fe-Mn-Si alloy;
   Biodegradable; Biocompatibility
ID CORROSION BEHAVIOR; IRON; BIOCOMPATIBILITY; STENTS
AB Fe30Mn6Si alloy was investigated as a potential degradable biomaterial, with the recently well-developed biodegradable metals, pure iron and Fe30Mn alloy, as comparison. The microstructure, mechanical properties, shape memory effect, corrosion behavior and in vitro biocompatibilities were evaluated by X-ray diffraction, scanning electron microscopy, tensile tests, electrochemical tests, immersion tests in Hank's solution till 6 months, cytotoxicity and hemolysis tests. It's found that Fe30Mn6Si alloy consists of epsilon-martensite and gamma-austenite at room temperature, the mechanical property of Fe30Mn6Si alloy is higher than that of the pure iron, and the corrosion rate of Fe30Mn6Si alloy is higher than that of Fe30Mn alloy. Additionally. Fe30Mn6Si alloy shows good performance for blood vessel related cellular application and the hemolysis percentage is less than 2%. In conclusion, Fe30Mn6Si alloy is a promising biodegradable metallic material with a shape memory function. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Liu, B.; Zheng, Y. F.] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Liu, B.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
   [Zheng, Y. F.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   [Ruan, Liquan] Kumamoto Univ, Grad Sch Sci & Technol, Dept Mech Syst Engn, Kumamoto 8608555, Japan.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National Natural Science Foundation of China [30670560, 30770580];
   Research Funds for the Central Universities [PKUJC2009001]; Program for
   New Century Excellent Talents in University [NCET-07-0033]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 30670560 and 30770580), Research Funds for the Central
   Universities (PKUJC2009001) and Program for New Century Excellent
   Talents in University (NCET-07-0033).
CR Charfi A, 2009, CR CHIM, V12, P270, DOI 10.1016/j.crci.2007.11.008
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hermawan H., 2009, ACTA BIOMATER, V6, P1852
   Lin HC, 2002, CORROS SCI, V44, P2013, DOI 10.1016/S0010-938X(02)00027-6
   Meng GZ, 2008, CORROS SCI, V50, P3116, DOI 10.1016/j.corsci.2008.08.026
   Moravej M, 2010, ACTA BIOMATER, V6, P1843, DOI 10.1016/j.actbio.2010.01.008
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Schinhammer M, 2009, ACTA BIOMATER, V6, P1705
   Wada M, 2008, MAT SCI ENG A-STRUCT, V481, P178, DOI 10.1016/j.msea.2007.02.149
   Waksman R, 2008, J INTERV CARDIOL, V21, P15, DOI 10.1111/j.1540-8183.2007.00319.x
   Zhang EL, 2010, ACTA BIOMATER, V6, P1756, DOI 10.1016/j.actbio.2009.11.024
NR 11
TC 66
Z9 68
U1 2
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2011
VL 65
IS 3
BP 540
EP 543
DI 10.1016/j.matlet.2010.10.068
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 715UD
UT WOS:000286912500040
DA 2018-10-20
ER

PT J
AU Qiu, DL
   Yang, LJ
   Yin, YS
   Wang, AP
AF Qiu, Deliang
   Yang, Lejiao
   Yin, Yansheng
   Wang, Aiping
TI Preparation and characterization of hydroxyapatite/titania composite
   coating on NiTi alloy by electrochemical deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE NiTi; Hydroxyapatite; Titania; Coating; Corrosion
ID BIOMATERIAL APPLICATIONS; CORROSION BEHAVIOR; TITANIUM; KINETICS
AB NiTi alloy is used as biomaterial due to its unique properties, but the high content of Ni (about 50 at.%) in biomedical NiTi is of concern. Hydroxyapatite/titania composite coating was directly electrodeposited on the surface of NiTi alloy. The coated samples were characterized using X-ray diffraction, scanning electron microscopy, infrared spectroscopy. bonding strength test, polarization and electrochemical impedance spectroscopy (EIS). Results showed that addition of TiO(2) to the electrolyte changed the morphology of hydroxyapatite from thin flake-flower-like crystals to needle-flower-like crystals, and the coating was much denser. Besides, hydroxyapatite crystal grains in the coating were preferentially arranged in the [001] direction, which was perpendicular to the surface of NiTi alloy. The addition of TiO(2) improved the bonding strength between the coating and the substrate. Corrosion resistance of NiTi in the simulated body fluid at 37 degrees C was significantly improved by more than 50 times by electrodeposition of the hydroxyapatite/titania composite coating. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Yin, Yansheng] Shanghai Maritime Univ, Inst Marine Mat Sci & Engn, Shanghai 200135, Peoples R China.
   [Qiu, Deliang; Yang, Lejiao; Wang, Aiping] Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266100, Peoples R China.
RP Yin, YS (reprint author), Shanghai Maritime Univ, Inst Marine Mat Sci & Engn, Shanghai 200135, Peoples R China.
EM yys2006@ouc.edu.cn
FU National Natural Science Foundation of China [50672090, 50842061]; Key
   Foundation of Tsingtao [091338-jch]
FX This work was supported by the National Natural Science Foundation of
   China grant (Nos. 50672090 and 50842061) and the Key Foundation of
   Tsingtao (091338-jch).
CR *ASTM INT, 104405 ASTM INT
   Blackwood DJ, 2009, MAT SCI ENG C-BIO S, V29, P1233, DOI 10.1016/j.msec.2008.10.015
   Bonora PL, 1996, ELECTROCHIM ACTA, V41, P1073, DOI 10.1016/0013-4686(95)00440-8
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   GUGLIELMI N, 1972, J ELECTROCHEM SOC, V119, P1009, DOI 10.1149/1.2404383
   Heimann RB, 1998, J BIOMED MATER RES, V43, P441, DOI 10.1002/(SICI)1097-4636(199824)43:4<441::AID-JBM12>3.3.CO;2-N
   Heimann RB, 1999, J THERM SPRAY TECHN, V8, P597, DOI 10.1361/105996399770350304
   Hu R, 2007, J BIOMED MATER RES A, V80A, P687, DOI 10.1002/jbm.a.30891
   Huang LY, 2000, J MATER SCI-MATER M, V11, P667, DOI 10.1023/A:1008934522363
   Inagaki M, 2003, J MATER SCI-MATER M, V14, P919, DOI 10.1023/A:1025694929108
   INAGAKI M, 2001, THIN SOLID FILMS, V386, P221
   Jiao MJ, 2009, MATER LETT, V63, P2286, DOI 10.1016/j.matlet.2009.07.048
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   Kwok CT, 2009, APPL SURF SCI, V255, P6736, DOI 10.1016/j.apsusc.2009.02.086
   Li H, 2003, BIOMATERIALS, V24, P949, DOI 10.1016/S0142-9612(02)00431-3
   MacDonald J. R., 1986, IMPEDANCE SPECTROSCO
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Narayanan R, 2007, SCRIPTA MATER, V56, P229, DOI 10.1016/j.scriptamat.2006.10.004
   Ng KW, 2008, APPL SURF SCI, V254, P6725, DOI 10.1016/j.apsusc.2008.04.076
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Otsuka K., 1998, SHAPE MEMORY MAT
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Raja KS, 2005, MATER LETT, V59, P2137, DOI 10.1016/j.matlet.2005.01.084
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Yahia L., 2000, SHAPE MEMORY IMPLANT
NR 26
TC 38
Z9 40
U1 0
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 15
PY 2011
VL 205
IS 10
BP 3280
EP 3284
DI 10.1016/j.surfcoat.2010.11.049
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 715FQ
UT WOS:000286866400022
DA 2018-10-20
ER

PT J
AU Xu, FM
   Flanagan, CE
   Ruiz, A
   Crone, WC
   Masters, KS
AF Xu, Fangmin
   Flanagan, Claire E.
   Ruiz, Amaliris
   Crone, Wendy C.
   Masters, Kristyn S.
TI Polyurethane/Dermatan Sulfate Copolymers as Hemocompatible,
   Non-Biofouling Materials
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biological applications of polymers; cell adhesion; hemocompatibility;
   polysaccharides; polyurethanes
ID TISSUE ENGINEERING APPLICATIONS; VALVULAR INTERSTITIAL-CELLS;
   POLY(ETHYLENE GLYCOL); PLATELET-ADHESION; SURFACTANT POLYMERS; BYPASS
   GRAFTS; YIGSR PEPTIDE; CHAIN-LENGTH; HYALURONAN; BIOMATERIALS
AB The range of application of polyurethanes has been limited by their poor hemocompatibility and inability to resist non-specific binding of biomolecules and cells. In this work, a non-adhesive PU-based material was synthesized via the copolymerization of PU with dermatan sulfate. Incorporation of DS into the PU backbone dramatically increased material hydrophilicity and decreased protein adsorption. The in vitro adhesion of several cell types, including platelets, also significantly decreased with increasing DS content. Both the physical and biological properties of the DS contributed to the anti-adhesive properties of the PU/DS copolymer, and this anti-adhesive nature of PU/DS renders this new biomaterial attractive for blood-contacting or non-fouling applications.
C1 [Xu, Fangmin; Flanagan, Claire E.; Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Ruiz, Amaliris; Crone, Wendy C.; Masters, Kristyn S.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Crone, Wendy C.] Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA.
RP Masters, KS (reprint author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
EM kmasters@wisc.edu
FU Wallace H. Coulter Foundation
FX Funding for this study was provided by the Wallace H. Coulter
   Foundation.
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bandyopadhyay SK, 2008, AM J PATHOL, V173, P1361, DOI 10.2353/ajpath.2008.080444
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   Clark HR, 1999, BIOTECHNOL PROGR, V15, P259, DOI 10.1021/bp990003j
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du HY, 2007, THROMB RES, V119, P377, DOI 10.1016/j.thromres.2006.07.008
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Gong Ping, 2007, V381, P59
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jun HW, 2005, J BIOMED MATER RES B, V72B, P131, DOI 10.1002/jbm.b.30135
   Kim SW, 1996, BLOOD PURIFICAT, V14, P357
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Lamba N, 1997, POLYURETHANES BIOMED
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Luensmann Doerte, 2008, Cont Lens Anterior Eye, V31, P179, DOI 10.1016/j.clae.2008.05.004
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ofosu F. A., 1984, BLOOD, V64, P742
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Perrino C, 2008, LANGMUIR, V24, P8850, DOI 10.1021/la800947z
   Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001
   Salacinski HJ, 2001, FASEB J, V15, pA85
   Salim M, 2007, LAB CHIP, V7, P523, DOI 10.1039/b615328c
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thierry B, 2008, LANGMUIR, V24, P11834, DOI 10.1021/la801359w
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1
   Xu F, 2008, BIOMATERIALS, V29, P150, DOI 10.1016/j.biomaterials.2007.09.028
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   Zhu JM, 2006, BIOMACROMOLECULES, V7, P1036, DOI 10.1021/bm050611p
NR 48
TC 11
Z9 11
U1 0
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB 11
PY 2011
VL 11
IS 2
BP 257
EP 266
DI 10.1002/mabi.201000313
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 718YO
UT WOS:000287162800010
PM 21077227
DA 2018-10-20
ER

PT J
AU Rajkhowa, R
   Wang, LJ
   Kanwar, JR
   Wang, XG
AF Rajkhowa, Rangam
   Wang, Lijing
   Kanwar, Jagat R.
   Wang, Xungai
TI Molecular Weight and Secondary Structure Change in Eri Silk During
   Alkali Degumming and Powdering
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biopolymers; gelation; microstructure; silk; particles
ID FIBROIN FILMS; IN-VITRO; ENZYME IMMOBILIZATION; CONTROLLED-RELEASE;
   INDIAN SILK; BIOMATERIAL; FIBERS; MICROSPHERES; CONFORMATION; HYDROGELS
AB Changes in molecular weight and secondary structure of eri silk during alkali degumming and silk powdering were studied. An increase in silk degumming intensity, through increased alkali concentration, treatment temperature, and time, reduced the fibroin molecular weight and, therefore, the fiber tenacity, but at the same time, increased the beta-sheet fraction. These changes reduced the time required to mill the degummed silk fibers into fine powders. Mechanical forces used in wet attritor and air jet milling disturbed intermolecular packing along the direction of side chains, but the conformation remained essentially beta-sheet even in the sub-micron silk particles. Dry milling drastically reduced molecular weight and changed the conformation of the fibroin chains. The rate of the spontaneous conformation transition in regenerated fibroin solution prepared from fibers and powders increased with a decrease in fibroin molecular weight, affecting the time fibroin solutions could be stored before gelling. Overall, the study showed that molecular weight and secondary structure of silk powders could be manipulated by suitably changing the degumming and milling conditions. It also suggests that wet media milling and air jet milling are better than dry media milling to prepare less degraded and more crystalline ultrafine silk particles. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 119: 1339-1347, 2011
C1 [Rajkhowa, Rangam; Kanwar, Jagat R.; Wang, Xungai] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
   [Wang, Lijing] RMIT Univ, Sch Fash & Text, Brunswick, Vic 3056, Australia.
RP Wang, XG (reprint author), Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
EM xwang@deakin.edu.au
RI Wang, Lijing/O-3130-2018
OI Wang, Lijing/0000-0002-7300-9271
CR AKIYAMA D, 1994, POLYMER, V35, P2355, DOI 10.1016/0032-3861(94)90772-2
   AMNAT J, 2006, APPL MICROBIOL BIOT, V72, P726
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DHARMAPRAKASH MS, 2008, 7 INT C NUCL RAD BUD
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   FRUSHOUR BG, 1974, BIOPOLYMERS, V13, P455, DOI 10.1002/bip.1974.360130303
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Hidefumi T., 2000, MACROMOLECULAR MAT E, V283, P126
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Inoue S, 2003, NANO LETT, V3, P1329, DOI 10.1021/nl0340327
   Iridag Y, 2006, J APPL POLYM SCI, V100, P4260, DOI 10.1002/app.23810
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kweon HY, 1999, J APPL POLYM SCI, V73, P2887, DOI 10.1002/(SICI)1097-4628(19990929)73:14<2887::AID-APP12>3.0.CO;2-I
   Liang SB, 2002, CHEM ENG TECHNOL, V25, P401, DOI 10.1002/1521-4125(200204)25:4<401::AID-CEAT401>3.0.CO;2-S
   Mandelkern L, 2004, BIOPHYS CHEM, V112, P109, DOI 10.1016/j.bpc.2004.07.010
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Molina-Boisseau S, 2002, POWDER TECHNOL, V128, P99, DOI 10.1016/S0032-5910(02)00180-8
   MOORE WH, 1976, BIOPOLYMERS, V15, P2465, DOI 10.1002/bip.1976.360151211
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   RAJKHOWA R, 2009, 3 IND C BIOM IMPL TI
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   Rajkhowa R, 2009, POWDER TECHNOL, V191, P155, DOI 10.1016/j.powtec.2008.10.004
   Sen K, 2004, J APPL POLYM SCI, V92, P1098, DOI 10.1002/app.13610
   Smith AP, 2000, POLYMER, V41, P6271, DOI 10.1016/S0032-3861(99)00830-7
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Tao W, 2007, INT J BIOL MACROMOL, V40, P472, DOI 10.1016/j.ijbiomac.2006.11.006
   TSUBOUCHI K, 2004, Patent No. 2004123683
   TSUBOUCHI K, 2002, Patent No. 6440740
   TSUBOUCHI K, 1999, Patent No. 11104228
   Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Q, 1997, POLYM ENG SCI, V37, P1091, DOI 10.1002/pen.11754
   WANG X, 2008, BIOMATERIALS, V29, P1051
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0
   Xu WL, 2006, J APPL POLYM SCI, V101, P2967, DOI 10.1002/app.23529
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   YASUSHI T, 2005, BIOMACROMOLECULES, V6, P3100
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
   ZUO LLB, 2007, J APPL POLYM SCI, V106, P53
NR 56
TC 22
Z9 22
U1 1
U2 28
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 5
PY 2011
VL 119
IS 3
BP 1339
EP 1347
DI 10.1002/app.31981
PG 9
WC Polymer Science
SC Polymer Science
GA 680CM
UT WOS:000284210000011
DA 2018-10-20
ER

PT J
AU Sigley, JL
   Bahawdory, M
   Hantgan, R
   Van Dyke, M
   Guthold, M
AF Sigley, Justin L.
   Bahawdory, Maria
   Hantgan, Roy
   Van Dyke, Mark
   Guthold, Martin
TI Platelet Adhesion to Keratin Biomaterial Hydrogels under Physiologic
   Flow Conditions
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 55th Annual Meeting of the Biophysical-Society
CY MAR 05-09, 2011
CL Baltimore, MD
SP Biophys Soc
NR 0
TC 0
Z9 0
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2011
VL 100
IS 3
SU 1
BP 489
EP 489
PG 1
WC Biophysics
SC Biophysics
GA 972PF
UT WOS:000306288604175
DA 2018-10-20
ER

PT J
AU Tripathi, S
   Mehrotra, GK
   Dutta, PK
AF Tripathi, Shipra
   Mehrotra, G. K.
   Dutta, P. K.
TI Chitosan-silver oxide nanocomposite film: Preparation and antimicrobial
   activity
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Chitosan; silver oxide; nanocomposite; antibacterial; film; food
   packaging
ID DIFFERENT MOLECULAR-WEIGHTS; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI;
   BARRIER PROPERTIES; FOOD APPLICATIONS; SHRIMP CHITOSAN; OUTER-MEMBRANE;
   BLEND FILM; NANOPARTICLES; BACTERIA
AB The chitosan-silver oxide encapsulated nanocomposite film was prepared by solution casting method. The prepared film was characterized by FTIR, scanning electron microscopy (SEM), thermal studies, and UV-Vis spectroscopy. The elemental composition of the film was studied by energy dispersive X-ray analysis (EDAX). The antibacterial activity of the composite film against pathogenic bacteria viz. Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Pseudomonas aeruginosa was measured by agar diffusion method. Our observations suggest that chitosan as biomaterial based nanocomposite film containing silver oxide has an excellent antibacterial ability for food packaging applications.
C1 [Tripathi, Shipra; Mehrotra, G. K.; Dutta, P. K.] Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad 211004, Uttar Pradesh, India.
RP Dutta, PK (reprint author), Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad 211004, Uttar Pradesh, India.
EM pkd_437@yahoo.com
FU Motilal Nehru National Institute of Technology, Allahabad; UGC; CSIR,
   New Delhi
FX The authors wish to thank the Director, Motilal Nehru National Institute
   of Technology, Allahabad, for providing a Institute Research Fellowship
   to (ST) and UGC and CSIR, New Delhi, for research project grants to
   (PKD). Authors also like to thank SAIF, Kochi, for providing the EDAX,
   TGA and SEM facilities.
CR Ahmad Zahoor, 2006, Indian J Chest Dis Allied Sci, V48, P171
   BLACK JG, 1996, MICROBIOLOGY PRINCIP, P80
   Brody AL, 2001, ACTIVE PACKAGING FOO, P218
   Cagri A, 2001, J FOOD SCI, V66, P865, DOI 10.1111/j.1365-2621.2001.tb15188.x
   CHAN HH, 2004, ADV MATER, V16, P967
   Coma V, 2002, J FOOD SCI, V67, P1162, DOI 10.1111/j.1365-2621.2002.tb09470.x
   Coma V, 2003, J FOOD SCI, V68, P2788, DOI 10.1111/j.1365-2621.2003.tb05806.x
   DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7
   Dolgaev SI, 2002, APPL SURF SCI, V186, P546, DOI 10.1016/S0169-4332(01)00634-1
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Dutta PK, 2004, J POLYM MATER, V21, P321
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Friedman M, 2010, J FOOD PROTECT, V73, P1737, DOI 10.4315/0362-028X-73.9.1737
   Gerasimenko DV, 2004, APPL BIOCHEM MICRO+, V40, P253, DOI 10.1023/B:ABIM.0000025947.84650.b4
   Gogoi SK, 2006, LANGMUIR, V22, P9322, DOI 10.1021/la060661v
   Gong P., 2007, NANOTECHNOLOGY, V18, P604
   Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Helander IM, 1998, MICROBIOL-UK, V144, P385, DOI 10.1099/00221287-144-2-385
   Hernandez-Lauzardo AN, 2008, CARBOHYD POLYM, V73, P541, DOI 10.1016/j.carbpol.2007.12.020
   Herrera M, 2001, MICROBIOS, V104, P141
   Jin YD, 2003, J PHYS CHEM B, V107, P12902, DOI 10.1021/jp035400y
   Kim CH, 1998, J IND ENG CHEM, V4, P19
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Li Z, 2002, POLYMER, V43, P1541, DOI 10.1016/S0032-3861(01)00699-1
   Mathew S, 2008, FOOD HYDROCOLLOID, V22, P826, DOI 10.1016/j.foodhyd.2007.03.012
   Mi FL, 2006, J AGR FOOD CHEM, V54, P3290, DOI 10.1021/jf0529868
   Murugadoss A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015603
   Nigam N., 2009, ASIAN CHITIN J, V5, P97
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Nonaka T, 2000, J APPL POLYM SCI, V77, P1077, DOI 10.1002/1097-4628(20000801)77:5<1077::AID-APP15>3.3.CO;2-H
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Ouattara B, 2000, J FOOD SCI, V65, P768, DOI 10.1111/j.1365-2621.2000.tb13584.x
   Pranoto Y, 2005, LWT-FOOD SCI TECHNOL, V38, P859, DOI [10.1016/j.lwt.2004.09.014, 10.1016/j.lwt.2004.lwt.2004.09.014]
   Prescott L. M., 2002, MICROBIOLOGY, P46
   Retchkiman-Schabes P.S., 2006, OPT MATER, V29, P95
   Salleh E., 2007, ASIAN CHITIN J, V3, P55
   Savard T, 2002, J FOOD PROTECT, V65, P828, DOI 10.4315/0362-028X-65.5.828
   Schierholz JM, 1999, AM J MED, V107, P101
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   SIRAGUSA GR, 1992, J FOOD SCI, V57, P293, DOI 10.1111/j.1365-2621.1992.tb05479.x
   SPADARO JA, 1974, ANTIMICROB AGENTS CH, V6, P637, DOI 10.1128/AAC.6.5.637
   Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006
   Tripathi S, 2010, NAT SEM CONT RES MAT
   Tripathi S., 2008, E-POLYMERS, V093, P1
   TRIPATHI S, 2009, ADV CHEM ENG, P69
   Tripathi S., 2008, ASIAN CHITIN J, V4, P29
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Tsai GJ, 2000, J FOOD PROTECT, V63, P747, DOI 10.4315/0362-028X-63.6.747
   Turker M, 2004, MAT SCI ENG A-STRUCT, V367, P74, DOI 10.1016/j.msea.2003.10.290
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Yoshida K, 1999, J BIOMED MATER RES, V47, P516, DOI 10.1002/(SICI)1097-4636(19991215)47:4<516::AID-JBM7>3.0.CO;2-E
   Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055
NR 53
TC 75
Z9 78
U1 2
U2 39
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
J9 B MATER SCI
JI Bull. Mat. Sci.
PD FEB
PY 2011
VL 34
IS 1
BP 29
EP 35
DI 10.1007/s12034-011-0032-5
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 776MX
UT WOS:000291540500005
DA 2018-10-20
ER

PT J
AU Reiche, J
   Kratz, K
   Hofmann, D
   Lendlein, A
AF Reiche, Juergen
   Kratz, Karl
   Hofmann, Dieter
   Lendlein, Andreas
TI Current status of Langmuir monolayer degradation of polymeric
   biomaterials
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Monolayer; Hydrolytic degradation; Enzymatic degradation; Biomaterial;
   Degradable polymer
ID HYDROLYTIC DEGRADATION; MULTIBLOCK COPOLYMERS; BIODEGRADABLE POLYMERS;
   ENZYMATIC DEGRADATION; AIR/WATER INTERFACE; SHAPE-MEMORY;
   POLY(EPSILON-CAPROLACTONE); KINETICS; SCISSION; MODEL
AB Langmuir monolayer degradation (LMD) experiments with polymers possessing outstanding biomedical application potential yield information regarding the kinetics of their hydrolytic or enzymatic chain scission under well-defined and adjustable degradation conditions. A brief review is given of LMD investigations, including the author's own work on 2-dimensional (2D) polymer systems, providing chain scission data, which are not disturbed by simultaneously occurring transport phenomena, such as water penetration into the sample or transport of scission fragments out of the sample.
   A knowledge-based approach for the description and simulation of polymer hydrolytic and enzymatic degradation based on a combination of fast LMD experiments and computer simulation of the water penetration is briefly introduced. Finally, the advantages and disadvantages of this approach are discussed.
C1 [Reiche, Juergen] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany.
   [Kratz, Karl; Hofmann, Dieter; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Teltow, Germany.
   [Kratz, Karl; Hofmann, Dieter; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
RP Reiche, J (reprint author), Univ Potsdam, Inst Phys & Astron, Karl Liebknecht Str 24-25, D-14476 Potsdam, Germany.
EM jreiche@rz.uni-potsdam.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670
CR Entrialgo-Castano M, 2006, ADV ENG MATER, V8, P434, DOI 10.1002/adem.200600021
   Entrialgo-Castano M, 2008, MACROMOL SYMP, V269, P47, DOI 10.1002/masy.200850908
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Fosbinder RJ, 1933, P R SOC LOND A-CONTA, V143, P61, DOI 10.1098/rspa.1933.0203
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Grablowitz H, 2007, J MATER CHEM, V17, P4050, DOI 10.1039/b707104c
   Grozev N, 2002, COLLOID POLYM SCI, V280, P7, DOI 10.1007/s003960200001
   Han XX, 2009, BIOMATERIALS, V30, P423, DOI 10.1016/j.biomaterials.2008.10.001
   Hofmann D., 2010, ADV SCI TECHNOL, V76, P16
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Ivanova T, 2003, COLLOID SURFACE B, V32, P307, DOI 10.1016/j.colsurfb.2003.08.005
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kostoglou M, 2000, CHEM ENG SCI, V55, P2507, DOI 10.1016/S0009-2509(99)00471-6
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Kulkarni A, 2007, SURF INTERFACE ANAL, V39, P740, DOI 10.1002/sia.2580
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lebedeva NV, 2008, J AM CHEM SOC, V130, P4228, DOI 10.1021/ja7111806
   Lee WK, 2005, LANGMUIR, V21, P11180, DOI 10.1021/la051137b
   Lee WK, 2002, LANGMUIR, V18, P2309, DOI 10.1021/la011663c
   Lee WK, 2000, LANGMUIR, V16, P3401, DOI 10.1021/la990800r
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Li S, 1995, DEGRADABLE POLYM PRI, P43
   Numata K, 2008, BIOMACROMOLECULES, V9, P2180, DOI 10.1021/bm800281d
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reiche J, 2008, THIN SOLID FILMS, V516, P8821, DOI 10.1016/j.tsf.2007.11.053
   Richardson T. H., 2000, FUNCTIONAL ORGANIC P
   Shalaby S.W., 2003, ABSORBABLE BIODEGRAD
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673
   Tredgold R.H, 1994, ORDER THIN ORGANIC F
   ULMAN A, 1991, INTRO ULTRATHIN ORGA
   van Nostrum CF, 2004, POLYMER, V45, P6779, DOI 10.1016/j.polymer.2004.08.001
   VERGER R, 1973, CHEM PHYS LIPIDS, V10, P127, DOI 10.1016/0009-3084(73)90009-1
   Wang S., 1995, AICHE J, V41, P1521
NR 39
TC 7
Z9 7
U1 2
U2 18
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 123
EP 128
DI 10.5301/IJAO.2011.6401
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000008
PM 21374565
DA 2018-10-20
ER

PT J
AU Kratz, K
   Habermann, R
   Becker, T
   Richau, K
   Lendlein, A
AF Kratz, Karl
   Habermann, Ronny
   Becker, Tino
   Richau, Klaus
   Lendlein, Andreas
TI Shape-memory properties and degradation behavior of multifunctional
   electro-spun scaffolds
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomaterial; Degradation; Polymers
ID POLYMER NETWORKS; BIOMEDICAL APPLICATIONS; MULTIBLOCK COPOLYMERS;
   POLY(EPSILON-CAPROLACTONE); BIOMATERIALS
AB Multifunctional polymer-based biomaterials, which combine degradability and shape-memory capability, are promising candidate materials for the realization of active self-anchoring implants. In this work we explored the shape-memory capability as well as the hydrolytic and enzymatic in vitro degradation behavior of electro-spun scaffolds prepared from a multiblock copolymer, containing hydrolytically degradable poly(p-dioxanone) (PPDO) and poly(e-caprolactone) (PCL) segments, which we have named PDC.
   Electro-spun PDC scaffolds with an average deposit thickness of 80 +/- 20 mu m and a porosity in the range from 70% to 80% were prepared, where the single fiber diameter was around 3 mu m. Excellent shape-memory properties were achieved with high recovery rate (R-r) values in the range of R-r = 92% to 98% and a recovery stress of sigma(max) = 4.6 MPa to 5.0 MPa. The switching temperature (T-sw) and the characteristic temperature obtained under constant strain recovery conditions (T-sigma,T-max) were found in the range from 32 degrees C to 35 degrees C, which was close to the melting temperature (T-m,T-PCL) associated to the poly(epsilon-caprolactone) domains.
   A linear mass loss was observed in both hydrolytic and enzymatic degradation experiments. The mass loss was substantially accelerated, in enzymatic degradation when Pseudomonas cepacia lipase was added, which was reported to accelerate the degradation of PCL. During hydrolytic degradation a continuous decrease in elongation at break (epsilon(B)) from epsilon(B) = 800% to 15% was observed in a time period of 92 days, while in enzymatic degradation experiments a complete mechanical failure was obtained after 4 days.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Kratz, Karl/K-7115-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Kratz, Karl/0000-0002-9229-4266
CR Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447
   Behl M, 2009, SOFT MATTER, V5, P676, DOI 10.1039/b810583a
   Bellin I, 2007, J MATER CHEM, V17, P2885, DOI 10.1039/b702524f
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]
   Grablowitz H, 2007, J MATER CHEM, V17, P4050, DOI 10.1039/b707104c
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Kulkarni A, 2007, LANGMUIR, V23, P12202, DOI 10.1021/la701523e
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Reiche J, 2008, THIN SOLID FILMS, V516, P8821, DOI 10.1016/j.tsf.2007.11.053
   Wagermaier W, 2010, ADV POLYM SCI, V226, P97, DOI 10.1007/12_2009_25
NR 19
TC 26
Z9 26
U1 7
U2 48
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 225
EP 230
DI 10.5301/IJAO.2011.6404
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000021
PM 21374579
DA 2018-10-20
ER

PT J
AU Dubruel, P
   Schacht, E
   Van Vlierberghe, S
   Kirkpatrick, J
   Unger, R
   Fassina, L
   Visai, L
AF Dubruel, Peter
   Schacht, Etienne
   Van Vlierberghe, Sandra
   Kirkpatrick, James
   Unger, Ron
   Fassina, Lorenzo
   Visai, Livia
TI Gelatin as promising cell-interactive ECM mimicking biomaterial
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th Congress on Regenerative Biology and Medicine
CY OCT 13-15, 2010
CL Stuttgart, GERMANY
C1 [Dubruel, Peter; Schacht, Etienne; Van Vlierberghe, Sandra] Univ Ghent, Polymer Chem & Biomat Grp, B-9000 Ghent, Belgium.
   [Kirkpatrick, James; Unger, Ron] Johannes Gutenberg Univ Mainz, Mainz, Germany.
   [Fassina, Lorenzo; Visai, Livia] Univ Pavia, I-27100 Pavia, Italy.
EM Peter.Dubruel@UGent.be
RI Fassina, Lorenzo/K-9283-2015
OI Fassina, Lorenzo/0000-0002-5587-4632
NR 0
TC 1
Z9 1
U1 0
U2 18
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2011
VL 17
IS 3-4
BP 545
EP 545
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 712JB
UT WOS:000286661600060
DA 2018-10-20
ER

PT J
AU Novosel, E
   Meyer, W
   Wegener, M
   Kruger, H
   Borchers, K
   Kluger, P
   Tovar, G
   Walles, H
   Hirth, T
AF Novosel, Esther
   Meyer, Wolfdietrich
   Wegener, Michael
   Krueger, Hartmut
   Borchers, Kirsten
   Kluger, Petra
   Tovar, Guenter
   Walles, Heike
   Hirth, Thomas
TI Characterization of endothelial cell-biomaterial interaction on newly
   developed 3D-printable polymer surfaces for vascular grafts
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT 4th Congress on Regenerative Biology and Medicine
CY OCT 13-15, 2010
CL Stuttgart, GERMANY
C1 [Novosel, Esther; Borchers, Kirsten; Kluger, Petra] Fraunhofer IGB, Zellsyst, D-70569 Stuttgart, Germany.
   [Meyer, Wolfdietrich; Wegener, Michael; Krueger, Hartmut] Fraunhofer IAP, Potsdam, Germany.
   [Tovar, Guenter; Hirth, Thomas] Univ Stuttgart IGVT, Stuttgart, Germany.
   [Walles, Heike] Univ Wurzburg, Wurzburg, Germany.
EM esther.novosel@igb.fraunhofer.de
RI Walles, Prof. Dr. Heike/M-1289-2015
NR 0
TC 0
Z9 0
U1 0
U2 4
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2011
VL 17
IS 3-4
BP 568
EP 568
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 712JB
UT WOS:000286661600118
DA 2018-10-20
ER

PT J
AU Xia, Y
   Prawirasatya, M
   Heng, BC
   Boey, F
   Venkatraman, SS
AF Xia, Yun
   Prawirasatya, Melissa
   Heng, Boon Chin
   Boey, Freddy
   Venkatraman, Subbu S.
TI Seeding density matters: extensive intercellular contact masks the
   surface dependence of endothelial cell-biomaterial interactions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLY(L-LACTIC ACID); PLASMA TREATMENT; IN-VITRO; ADHESION; MATRIX;
   POLYTETRAFLUOROETHYLENE; CROSSTALK; JUNCTIONS; COATINGS; PTFE
AB The effects of seeding density have often been overlooked in evaluating endothelial cell-biomaterial interactions. This study compared the cell attachment and proliferation characteristics of endothelial cells on modified poly (l-lactic acid) (PLLA) films conjugated to gelatin and chitosan at low and high seeding densities (5,000 and 50,000 cells/cm(2)). During the early stage (2 h) of cell-biomaterial interaction, a low seeding density enabled us to observe the intrinsic surface-dependent differences in cell attachment capacity and morphogenesis, whereas extensive intercellular interactions at high seeding density masked differences between substrates and improved cell attachment on low-affinity substrates. During the later stage of cell-biomaterial interaction over 7-days of culture, the proliferation rate was found to be surface-dependent at low seeding density, whereas this surface-dependent difference was not apparent at high seeding density. It is recommended that low seeding density should be utilized for evaluating biomaterial applications where EC density is likely to be low, such as in situ endothelialization of blood-contacting devices.
C1 [Xia, Yun; Prawirasatya, Melissa; Heng, Boon Chin; Boey, Freddy; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Nanyang 639798, Singapore.
RP Venkatraman, SS (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Nanyang 639798, Singapore.
EM assubbu@ntu.edu.sg
RI Venkatraman, Subramanian/A-2228-2011; Heng, Boon Chin/E-5462-2016; Boey,
   Freddy Yin Chiang/G-2618-2017
OI Venkatraman, Subramanian/0000-0002-8693-1070; Heng, Boon
   Chin/0000-0003-2541-3699; 
FU National Research Foundation of Singapore
FX Authors would like to thank National Research Foundation of Singapore
   for funding the work with their Competitive Research Grant and Dr. Wong
   Yee Shan for critical reading.
CR Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Berard X, 2009, ACTA BIOMATER, V5, P1147, DOI 10.1016/j.actbio.2008.10.002
   BHATTACHARYA V, 2005, VASCULAR DIS PREVENT, V2, P21
   Boura C, 2006, BIO-MED MATER ENG, V16, pS115
   Brewster LP, 2007, BIOMATERIALS, V28, P5028, DOI 10.1016/j.biomaterials.2007.07.048
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Eisenbarth E, 2007, BIOMOL ENG, V24, P27, DOI 10.1016/j.bioeng.2006.05.016
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Huang YY, 2009, J INTERV CARDIOL, V22, P466, DOI 10.1111/j.1540-8183.2009.00489.x
   Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e
   LIN A, 2010, BIOMATERIALS, V31, P4017
   Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Nagahara S, 1996, J BIOMED MATER RES, V32, P677, DOI 10.1002/(SICI)1097-4636(199612)32:4<677::AID-JBM22>3.0.CO;2-9
   Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Xia Y, 2010, BIOINTERPHASES, V5, pFA32, DOI 10.1116/1.3467508
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 33
TC 8
Z9 9
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2011
VL 22
IS 2
BP 389
EP 396
DI 10.1007/s10856-010-4211-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 735ZG
UT WOS:000288458700021
PM 21221736
DA 2018-10-20
ER

PT J
AU Kawaguchi, Y
   Kondo, E
   Kitamura, N
   Arakaki, K
   Tanaka, Y
   Munekata, M
   Nagai, N
   Yasuda, K
AF Kawaguchi, Yasuyuki
   Kondo, Eiji
   Kitamura, Nobuto
   Arakaki, Kazunobu
   Tanaka, Yasuhito
   Munekata, Masanobu
   Nagai, Nobuhiro
   Yasuda, Kazunori
TI In vivo effects of isolated implantation of salmon-derived crosslinked
   atelocollagen sponge into an osteochondral defect
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COLLAGEN GEL; CELLS; FIBROBLASTS; SCAFFOLD; LINKING; MATRIX; REPAIR;
   VITRO
AB We have developed crosslinked salmon-derived atelocollagen (SC) sponge, which has a denaturation temperature of 47A degrees C. Sixty-four knees of 32 mature rabbits were randomly divided into 4 groups after creating an osteochondral defect in the femoral trochlea. Defects in Groups I, II, and III were filled with the crosslinked SC sponge, the crosslinked porcine collagen (PC) sponge, and the non-crosslinked PC sponge, respectively. In Group IV, defects were left untreated as the control. At 12 weeks after implantation, the histological score showed that Group I was significantly greater than Groups III (P = 0.0196) and IV (P = 0.0021). In addition, gene expression of type-2 collagen, aggrecan, and SOX9 was the greatest in Group I at 12 weeks. The fundamental in vivo properties of the crosslinked SC sponge showed that this is a promising biomaterial, specifically as a scaffold for cartilage tissue engineering.
C1 [Kawaguchi, Yasuyuki; Kondo, Eiji; Kitamura, Nobuto; Arakaki, Kazunobu; Yasuda, Kazunori] Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Kawaguchi, Yasuyuki; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Nara, Japan.
   [Munekata, Masanobu] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Sapporo, Hokkaido 0608638, Japan.
   [Nagai, Nobuhiro] Tohoku Univ, Grad Sch Med, Dept Translat Res, Ctr Translat & Adv Anim Res, Sendai, Miyagi 980, Japan.
RP Yasuda, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
EM yasukaz@med.hokudai.ac.jp
RI Kondo, Eiji/G-2004-2012; Yasuda, Kazunori/C-9998-2009; Kitamura,
   Nobuto/G-2646-2012
FU Ministry of Education, Culture, Sports, Science and Technology, Japan;
   Takeda Science Foundation, Japan
FX We thank Yuko Taniguro for assistance with the animal experiments, and
   Dr. Yoshie Tanabe for data collection. This work was financially
   supported by grants from the Ministry of Education, Culture, Sports,
   Science and Technology, Japan, and from Takeda Science Foundation,
   Japan.
CR Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Kuzuya M, 1998, DIABETOLOGIA, V41, P491, DOI 10.1007/s001250050937
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Yunoki S, 2003, J BIOSCI BIOENG, V96, P575, DOI 10.1016/S1389-1723(04)70152-8
NR 16
TC 15
Z9 21
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2011
VL 22
IS 2
BP 397
EP 404
DI 10.1007/s10856-010-4215-1
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 735ZG
UT WOS:000288458700022
PM 21259035
DA 2018-10-20
ER

PT J
AU White, JS
   Walker, GM
AF White, Jane S.
   Walker, Graeme M.
TI Influence of cell surface characteristics on adhesion of Saccharomyces
   cerevisiae to the biomaterial hydroxylapatite
SO ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR
   MICROBIOLOGY
LA English
DT Article
DE Hydroxylapatite; Cell adhesion; Saccharomyces; Surface properties;
   Hydrophobicity
ID ETHANOL-PRODUCTION; CANDIDA-ALBICANS; CONTACT ANGLES; SPENT GRAINS;
   YEAST; HYDROXYAPATITE; IMMOBILIZATION; HYDROPHOBICITY; FERMENTATION;
   ENERGY
AB The influence of the physicochemical properties of biomaterials on microbial cell adhesion is well known, with the extent of adhesion depending on hydrophobicity, surface charge, specific functional groups and acid-base properties. Regarding yeasts, the effect of cell surfaces is often overlooked, despite the fact that generalisations may not be made between closely related strains. The current investigation compared adhesion of three industrially relevant strains of Saccharomyces cerevisiae (M-type, NCYC 1681 and ALY, strains used in production of Scotch whisky, ale and lager, respectively) to the biomaterial hydroxylapatite (HAP). Adhesion of the whisky yeast was greatest, followed by the ale strain, while adhesion of the lager strain was approximately 10-times less. According to microbial adhesion to solvents (MATS) analysis, the ale strain was hydrophobic while the whisky and lager strains were moderately hydrophilic. This contrasted with analyses of water contact angles where all strains were characterised as hydrophilic. All yeast strains were electron donating, with low electron accepting potential, as indicated by both surface energy and MATS analysis. Overall, there was a linear correlation between adhesion to HAP and the overall surface free energy of the yeasts. This is the first time that the relationship between yeast cell surface energy and adherence to a biomaterial has been described.
C1 [Walker, Graeme M.] Univ Abertay Dundee, Yeast Res Grp, Sch Contemporary Sci, Dundee DD1 1HG, Scotland.
   [White, Jane S.] Edinburgh Napier Univ, Biofuel Res Ctr, Edinburgh EH10 5DT, Midlothian, Scotland.
RP Walker, GM (reprint author), Univ Abertay Dundee, Yeast Res Grp, Sch Contemporary Sci, Bell St, Dundee DD1 1HG, Scotland.
EM g.walker@abertay.ac.uk
FU European Commission [NMP3-CT-504937]
FX This work was funded by European Commission Project NMP3-CT-504937
   'PERCERAMICS'. The authors wish to thank Yun Liu and Qi Zhao, Division
   of Mechanical Engineering and Mechatronics, University of Dundee,
   Scotland for the contact angle measurements and surface energy
   calculations. The authors are grateful to the Institute of Silica
   Materials, Riga Technical University, Latvia for fabricating and
   supplying the HAP tablets.
CR Alsteens D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384005
   Aronov D, 2007, J MATER SCI-MATER M, V18, P865, DOI 10.1007/s10856-006-0080-3
   Baillez S., 2007, J HAZARD MATER, V139, P443, DOI DOI 10.1016/J.JHAZMAT.2006.02.039
   Baptista CMSG, 2006, ENZYME MICROB TECH, V40, P127, DOI 10.1016/j.enzmictec.2005.12.025
   BellonFontaine MN, 1996, COLLOID SURFACE B, V7, P47, DOI 10.1016/0927-7765(96)01272-6
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Branyik T, 2004, BIOTECHNOL BIOENG, V88, P84, DOI 10.1002/bit.20217
   del Rio JAG, 2004, J ENVIRON MANAGE, V71, P169, DOI 10.1016/j.jenvman.2004.02.004
   DEMUYAKOR B, 1992, APPL MICROBIOL BIOT, V36, P717
   Dengis PB, 1997, YEAST, V13, P931, DOI 10.1002/(SICI)1097-0061(199708)13:10<931::AID-YEA149>3.0.CO;2-T
   Dragone G, 2008, EUR FOOD RES TECHNOL, V228, P257, DOI 10.1007/s00217-008-0930-y
   Gross KA, 2002, REV MINERAL GEOCHEM, V48, P631, DOI 10.2138/rmg.2002.48.17
   Guillemot G, 2006, COLLOID SURFACE B, V49, P126, DOI 10.1016/j.colsurfb.2006.03.001
   Henriques M, 2004, COLLOID SURFACE B, V33, P235, DOI 10.1016/j.colsurfb.2003.10.012
   Itoh S, 2006, BIOMATERIALS, V27, P5572, DOI 10.1016/j.biomaterials.2006.07.007
   Kandori K, 2005, CALCIFIED TISSUE INT, V76, P194, DOI 10.1007/s00223-004-0102-4
   Kang S, 2005, COLLOID SURFACE B, V46, P70, DOI 10.1016/j.colsurfb.2005.08.017
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kourkoutas Y, 2004, FOOD MICROBIOL, V21, P377, DOI 10.1016/j.fm.2003.10.005
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Misra V, 2007, ENVIRON MONIT ASSESS, V133, P169, DOI 10.1007/s10661-006-9570-5
   Mortensen HD, 2005, FEMS MICROBIOL LETT, V249, P165, DOI 10.1016/j.femsle.2005.06.009
   Nakari-Setala T, 2002, APPL ENVIRON MICROB, V68, P3385, DOI 10.1128/AEM.68.7.3385-3391.2002
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Pereira-Cenci T, 2008, ARCH ORAL BIOL, V53, P755, DOI 10.1016/j.archoralbio.2008.02.015
   Powell CD, 2003, FEMS YEAST RES, V3, P149, DOI 10.1016/S1567-1356(03)00002-3
   Tata M, 1999, BIOTECHNOL PROGR, V15, P105, DOI 10.1021/bp980109z
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Verbelen PJ, 2006, BIOTECHNOL LETT, V28, P1515, DOI 10.1007/s10529-006-9132-5
   VERNHET A, 1995, COLLOID SURFACE B, V3, P255
   Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8
   Zhao Q, 2005, CHEM ENG SCI, V60, P4858, DOI 10.1016/j.ces.2005.04.006
NR 37
TC 15
Z9 15
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0003-6072
J9 ANTON LEEUW INT J G
JI Antonie Van Leeuwenhoek
PD FEB
PY 2011
VL 99
IS 2
BP 201
EP 209
DI 10.1007/s10482-010-9477-6
PG 9
WC Microbiology
SC Microbiology
GA 716AU
UT WOS:000286938100006
PM 20582470
DA 2018-10-20
ER

PT J
AU Zhu, HX
   Jia, SR
   Yang, HJ
   Jia, YY
   Yan, L
   Li, J
AF Zhu, Huixia
   Jia, Shiru
   Yang, Hongjiang
   Jia, Yuanyuan
   Yan, Lin
   Li, Jing
TI PREPARATION AND APPLICATION OF BACTERIAL CELLULOSE SPHERE: A NOVEL
   BIOMATERIAL
SO BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
LA English
DT Article
DE bacterial cellulose spheres; biomaterial; bioseparation; sewage
   treatment
ID MICROBIAL CELLULOSE; AQUEOUS-SOLUTIONS
AB This paper explores preparation of spherical bacterial cellulose (BC), a novel biomaterial, and its adsorption capacity is charaterized. The effect of shaking speed and culture duration on fermentation production of BC spheres is analyzed: BC spheres are produced after 72 h fermention at 30 degrees C with a shaking speed of 160 rpm. The spheres have a diameter range of 3-5 mm. The scanning electron micrograph photograph shows that BC spheres have a loose and porous structure. Repetition using tests on adsorption of Bovine serum albumin (BSA) and Pb(2+) had been carried out. The results indicated that BC spheres can be recovered from BSA-BC complex and Pb-BC complex by eluting with NaOH and sodium citrate solution, respectively. So BC spheres have a vast potential for application in the fields of biomaterial bioseparation and sewage treatment.
C1 [Zhu, Huixia; Jia, Shiru; Yang, Hongjiang; Jia, Yuanyuan; Yan, Lin; Li, Jing] Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Minist Educ, Tianjin, Peoples R China.
   [Zhu, Huixia] Heng Shui Univ, Dept Life Sci, Hengshui, Hebei, Peoples R China.
RP Jia, SR (reprint author), Tianjin Univ Sci & Technol, Key Lab Ind Microbiol, Minist Educ, Tianjin, Peoples R China.
EM jiashiru@tust.edu.cn
FU National Natural Science Foundation of China [20976133]; Foundation for
   Excellent Doctoral Dissertations of TianJin University of Science and
   Technology [B201002]
FX This work was funded by the National Natural Science Foundation of China
   under No.20976133 and the Foundation for Excellent Doctoral
   Dissertations of TianJin University of Science and Technology under No.
   B201002.
CR AMIR S, 2010, J CHEM TECHNOL BIOT, V84, P228
   Cheng HP, 2002, BIOTECHNOL APPL BIOC, V35, P125, DOI 10.1042/BA20010066
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Jia SR, 2004, BIOTECHNOL BIOPROC E, V9, P166, DOI 10.1007/BF02942287
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Kumar V, 2001, PHARM DEV TECHNOL, V6, P459, DOI 10.1081/PDT-100002254
   Lazaridis NK, 2005, WATER RES, V39, P4385, DOI 10.1016/j.watres.2005.09.013
   LIANG HX, 2007, CHEM RES APPL, V19, P933
   Liu MH, 2007, BIORESOURCE TECHNOL, V98, P1144, DOI 10.1016/j.biortech.2006.03.026
   Nagaoka S, 2002, J MOL CATAL A-CHEM, V177, P255, DOI 10.1016/S1381-1169(01)00271-0
   Rama K, 2005, J MICROENCAPSUL, V22, P863
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   Uraki Y, 2007, CARBOHYD POLYM, V69, P1, DOI 10.1016/j.carbpol.2006.08.021
   WATANABE K, 1995, BIOSCI BIOTECH BIOCH, V59, P65, DOI 10.1271/bbb.59.65
   Yamanaka S, 2000, CELLULOSE, V7, P213, DOI 10.1023/A:1009208022957
NR 17
TC 6
Z9 6
U1 1
U2 31
PU DIAGNOSIS PRESS LTD
PI SOFIA
PA 67 DONDUKOV BLVD, 1504 SOFIA, BULGARIA
SN 1310-2818
J9 BIOTECHNOL BIOTEC EQ
JI Biotechnol. Biotechnol. Equip.
PD FEB
PY 2011
VL 25
IS 1
BP 2233
EP 2236
DI 10.5504/BBEQ.2011.0010
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 729IZ
UT WOS:000287943500010
OA Bronze
DA 2018-10-20
ER

PT J
AU Boennelycke, M
   Christensen, L
   Nielsen, LF
   Everland, H
   Lose, G
AF Boennelycke, Marie
   Christensen, Lise
   Nielsen, Lene Feldskov
   Everland, Hanne
   Lose, Gunnar
TI Tissue response to a new type of biomaterial implanted subcutaneously in
   rats
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Histology; Implant; Pelvic reconstructive surgery; PLGA; Resorbable
ID PELVIC ORGAN PROLAPSE; RECONSTRUCTIVE SURGERY; RANDOMIZED TRIAL;
   ANIMAL-MODEL; IN-VIVO; MESH; REPAIR; AUGMENTATION; GRAFTS; IMPACT
AB A new type of resorbable biomaterial intended for pelvic reconstruction was tested with respect to tissue regeneration and biocompatibility in rats. The biomaterial consisted of methoxypolyethyleneglycol-poly(lactic-co-glycolic acid) (MPEG-PLGA). Implants were pure, enriched with extra-cellular matrix (ECM) or estrogen.
   Ten implants of each type were tested for 3 and 8 weeks, respectively. Histological assessment of connective tissue organization, inflammation, vascularization, and thickness of regenerated tissue was undertaken.
   All implants had a high degree of biocompatibility. ECM-enriched implants had significantly higher inflammatory scores compared to pure implants at 3 weeks. At 8 weeks, neither of the parameters differed significantly. No trace of the implants remained.
   The MPEG-PLGA is highly biocompatible, degrades quickly, and seems inert in the process of tissue regeneration. Thus, it is hardly a candidate per se in reinforcement of pelvic reconstruction, but it could have a future role as carrier for stem cells.
C1 [Boennelycke, Marie; Lose, Gunnar] Univ Copenhagen, Herlev Hosp, Dept Obstet & Gynecol, DK-2730 Herlev, Denmark.
   [Christensen, Lise] Univ Copenhagen, Bispebjerg Hosp, Dept Pathol, Copenhagen, Denmark.
   [Nielsen, Lene Feldskov; Everland, Hanne] Coloplast AS, Humlebaek, Denmark.
RP Boennelycke, M (reprint author), Univ Copenhagen, Herlev Hosp, Dept Obstet & Gynecol, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
EM mabn@heh.regionh.dk
FU Danish National Advanced Technology Foundation
FX This study was supported by the Danish National Advanced Technology
   Foundation.
CR Adekanmi OA, 2009, INT UROGYNECOL J, V20, P1369, DOI 10.1007/s00192-009-0962-2
   Allahdin S, 2008, J OBSTET GYNAECOL, V28, P427, DOI 10.1080/01443610802150077
   Altman D, 2005, OBSTET GYNECOL SURV, V60, P753, DOI 10.1097/01.ogx.0000182906.75926.cb
   Baessler K, 2006, CURR OPIN OBSTET GYN, V18, P560, DOI 10.1097/01.gco.0000242961.48114.b0
   Blandon RE, 2009, INT UROGYNECOL J, V20, P523, DOI 10.1007/s00192-009-0818-9
   Boulanger L, 2008, EUR J OBSTET GYN R B, V136, P254, DOI 10.1016/j.ejogrb.2007.08.021
   Chen CCG, 2007, CLIN OBSTET GYNECOL, V50, P383, DOI 10.1097/GRF.0b013e31804b184c
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Falconer C, 2001, INT UROGYNECOL J PEL, V12, pS19, DOI 10.1007/s001920170007
   Higgins EW, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.050
   Ho MH, 2009, OBSTET GYNECOL, V114, P300, DOI 10.1097/AOG.0b013e3181af6abd
   Huffaker RK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.029
   Jia X, 2008, BJOG-INT J OBSTET GY, V115, P1350, DOI 10.1111/j.1471-0528.2008.01845.x
   Jones KA, 2009, INT UROGYNECOL J, V20, P847, DOI 10.1007/s00192-008-0781-x
   Kavvadias T, 2009, INT UROGYNECOL J, V20, P1473, DOI 10.1007/s00192-009-0974-y
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y
   Krause HG, 2006, AUST NZ J OBSTET GYN, V46, P42, DOI 10.1111/j.1479-828X.2006.00513.x
   Lind M, 2008, KNEE SURG SPORT TR A, V16, P690, DOI 10.1007/s00167-008-0522-1
   Moalli PA, 2004, AM J OBSTET GYNECOL, V190, P620, DOI 10.1016/j.ajog.2003.08.040
   Moalli PA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.01.042
   Murphy M, 2009, OBSTET GYN CLIN N AM, V36, P615, DOI 10.1016/j.ogc.2009.08.007
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Pessina MA, 2006, ENDOCRINOLOGY, V147, P61, DOI 10.1210/en.2005-0870
   Pierce LM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.040
   Riccetto C, 2008, INT UROGYNECOL J, V19, P1117, DOI 10.1007/s00192-008-0582-2
   Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
   SMITH KPB, 1993, ACTA OBSTET GYN SCAN, V72, P1
   Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081
NR 30
TC 10
Z9 12
U1 0
U2 9
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD FEB
PY 2011
VL 22
IS 2
BP 191
EP 196
DI 10.1007/s00192-010-1257-3
PG 6
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 709UU
UT WOS:000286467700010
PM 20838988
DA 2018-10-20
ER

PT J
AU Hassan, A
   Swaminathan, D
AF Hassan, Akram
   Swaminathan, Dasan
TI An In Vitro Study to Evaluate the Genotoxicity of Value Added
   Hydroxyapatite as a Bone Replacement Material
SO SAINS MALAYSIANA
LA English
DT Article
DE Ames test; genotoxicity; hydroxyapatite
ID CALCIUM-PHOSPHATE; CERAMICS; ASSAY
AB Hydroxyapatite (HA) used for bone replacement is one of the most active areas of ceramic biomaterials research currently. It has been used clinically for the last 20 years due to its excellent biocompatibility, osseoconduction and osseointegration. Many modifications have been done to develop a stronger, tougher and biocompatible ceramic biomaterial because pure HA is brittle. Researchers in Universiti Sains Malaysia had developed this value added HA that is stronger and less brittle compared to pure HA. The objective of this in vitro study was to evaluate the genotoxic characteristic of the value added HA based material by using Bacterial Reverse Mutation Assay (Ames test). The Bacterial Reverse Mutation Assay of HA was performed on Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and Escherichia coli strain WP2 uvrA using the preincubation method in the presence and absence of an exogenous metabolic activation system. All the bacterial tester strains treated with and without S9 Mix showed no increase of revertant colonies with increase in concentration of test substance for both the dose finding test and the main test. The number of revertant colonies was less than twice that of the solvent control for all the jive bacterial strains and this was reproducible for both the dose finding test and the main test. The numbers of revertant colonies in the negative and positive controls were within the background data of our laboratory. In conclusion the results of the tests showed that the value added HA was considered to have no reverse mutagenic potential under the present test conditions.
C1 [Swaminathan, Dasan] Univ Malaya, Dept Oral Pathol Oral Med & Periodontol, Fac Dent, Kuala Lumpur 50603, Malaysia.
   [Hassan, Akram] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian 16150, Kelantan, Malaysia.
RP Swaminathan, D (reprint author), Univ Malaya, Dept Oral Pathol Oral Med & Periodontol, Fac Dent, Kuala Lumpur 50603, Malaysia.
EM dasans@um.edu.my
RI S SWAMINATHAN, DASAN/B-8426-2010; Management Center, Dental
   Research/C-2478-2013
CR ANDERSON JC, 1990, MAT SCI, P317
   BAJPAI PK, 1976, CLIN RES, V24, pA524
   Chauvel-Lebret DJ, 2001, BIOMATERIALS, V22, P1795, DOI 10.1016/S0142-9612(00)00351-3
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P634, DOI 10.1097/00006534-197905000-00005
   ISO International Organization for Standardization, 1992, BIOL EV MED DEV TEST, P1
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JOHNSON GJ, 1998, PREVALENCE INCIDENCE, P1
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6
   OECD, 1997, TOW SUST FISH, P1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SMITH WF, 1996, PRINCIPLES MAT SCI E, P633
   Williams DF, 1987, PROGR BIOMEDICAL ENG, V4, P54
NR 16
TC 3
Z9 3
U1 0
U2 7
PU UNIV KEBANGSAAN MALAYSIA
PI KUALA LUMPUR
PA FAC ALLIED HEALTH SCI, JALAN RAJA MUDA ABDUL AZIZ, KUALA LUMPUR, 50300,
   MALAYSIA
SN 0126-6039
J9 SAINS MALAYS
JI Sains Malays.
PD FEB
PY 2011
VL 40
IS 2
BP 163
EP 171
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 727SJ
UT WOS:000287821400012
DA 2018-10-20
ER

PT J
AU Shah, JS
   Girase, B
   Thein-Han, WW
   Misra, RDK
AF Shah, Jinesh S.
   Girase, Bhupinder
   Thein-Han, Wah Wah
   Misra, R. Devesh K.
TI Stimulated Cellular Response of Novel Hybrid Network Structure
   Elastomers with Inorganic Short Chain Cross-Links for Soft Tissue
   Reconstruction
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; CALCIUM-PHOSPHATE;
   IN-VITRO; TITANIUM; FIBRONECTIN; OSTEOBLASTS; SILICONE; ADHESION;
   IMPLANT
AB The flexible and highly ductile silicone elastomer widely used as a soft-tissue substitute for joint reconstruction and replacement fragments prematurely because of low tensile strength and inadequate bone build-up around the implants. In this regard, an excellent vehicle to favorably modulate cellular response and retain intrinsic elastic recovery of soft tissue implants is to consider hybrid network structure elastomers with inorganic short chain cross-links. The concept involves covalently linking nanocrystalline titania with a bi-functional agent, acrylic acid, which has a carboxylic group to coordinate with titania and a vinyl group to form short chain cross-links as an integral part of the silicone network during curing at elevated pressure. This approach provides high strength-at-break and undiminished intrinsic ductility of silicone elastomer and high cytocompatibility. Interestingly, cellular response is favorably modulated, as described here. The biologic response in terms of initial cell attachment, cell viability, and proliferation was consistently greater in relation to stand alone silicone elastomer such that cell spreading, morphology, and density were distinctly different. Pre-osteoblasts grown on hybrid network structure elastomers were widely spread on the surface as a sheet after a culture time of 24 h. In contrast, these features were less pronounced on the stand alone silicone elastomer. Furthermore, immunofluorescence study illustrated distinct fibronectin expression level, stronger vinculin focal adhesion contacts associated with abundant actin stress fibers in pre-osteoblasts grown on hybrid network structure elastomer compared to stand alone silicone elastomer, implying enhanced cell-substrate interactions. This finding was consistent with the observation of total protein content and sodium dodecyl sulfate polyacrylamide gel analysis. Based on the study described here, our hypothesis is that silicone-titania network structure elastomer with high strength-high ductility combination and favorable cellular response is a model hybrid network structure elastomer for joint reconstruction and soft tissue substitution. The integration of cellular and molecular biology with materials science and engineering aspects described here provides a new direction toward the development of new generation of hybrid network structure silicone elastomer. This subject is germane from the view point of fundamental understanding and from the view of hybrid elastomers as soft tissue reconstruction.
C1 [Shah, Jinesh S.; Girase, Bhupinder; Thein-Han, Wah Wah; Misra, R. Devesh K.] Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Shah, JS (reprint author), Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Catanese J, 1999, J BIOMED MATER RES, V48, P187, DOI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   Degidi Marco, 2003, J Oral Implantol, V29, P13, DOI 10.1563/1548-1336(2003)029<0013:BCAAIA>2.3.CO;2
   El Fray M, 2007, J MATER SCI-MATER M, V18, P501, DOI 10.1007/s10856-007-2010-4
   ELWARRAK AO, 2004, BMC MUSCULOSKEL DIS, P5
   Erlich Mark A, 2003, Facial Plast Surg, V19, P325
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Globus RK, 1998, J CELL SCI, V111, P1385
   Goldfarb CA, 2003, J BONE JOINT SURG AM, V85A, P1869, DOI 10.2106/00004623-200310000-00001
   Hukkanen M, 1998, CLIN ORTHOP RELAT R, P53
   HYNES RO, 1974, CELL, V3, P113, DOI 10.1016/0092-8674(74)90114-7
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Matrin-Granizo R., 1997, PLAST RECONSTR SURG, V99, P2100
   MEYER U, 1993, CELL MATER, V3, P129
   NORDAHL J, 1995, CALCIFIED TISSUE INT, V57, P442, DOI 10.1007/BF00301948
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Park S. H., 2000, BIOMEDICAL ENG HDB, V1, P44
   Polyzois G L, 1995, J Prosthodont, V4, P38, DOI 10.1111/j.1532-849X.1995.tb00313.x
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Shah J, 2009, MAT SCI ENG A-STRUCT, V523, P199, DOI 10.1016/j.msea.2009.05.059
   Starch MS, 2003, J COSMET SCI, V54, P193
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   SUZIKI R, 2000, CLIN ORTHOP RELAT R, V372, P280
   SUZIKI R, 2003, J BIOMED MATER RES A, V66, P396
   Takeuchi H, 1999, MACROMOLECULES, V32, P6792, DOI 10.1021/ma990218+
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Waris E, 2008, BIOMATERIALS, V29, P683, DOI 10.1016/j.biomaterials.2007.10.037
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Yuan Q, 2008, MAT SCI ENG A-STRUCT, V480, P181, DOI 10.1016/j.msea.2007.07.019
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 44
TC 7
Z9 7
U1 0
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD FEB
PY 2011
VL 13
IS 1-2
BP B41
EP B53
DI 10.1002/adem.201080051
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 717LC
UT WOS:000287044300006
DA 2018-10-20
ER

PT J
AU Dave, RN
   Joshi, HM
   Venugopalan, VP
AF Dave, Rachna N.
   Joshi, Hiren M.
   Venugopalan, Vayalam P.
TI Novel Biocatalytic Polymer-Based Antimicrobial Coatings as Potential
   Ureteral Biomaterial: Preparation and In Vitro Performance Evaluation
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID URETHRAL CATHETER; URINARY CATHETERS; PSEUDOMONAS-AERUGINOSA;
   TRACT-INFECTION; DEGRADATION; GENTAMICIN; EFFICACY; HYDROXYAPATITE;
   SURFACES; BIOFILMS
AB Catheters and other indwelling devices placed inside human body are prone to bacterial infection, causing serious risk to patients. Infections associated with implants are difficult to resolve, and hence the prevention of bacterial colonization of such surfaces is quite appropriate. In this context, the development of novel antimicrobial biomaterials is currently gaining momentum. We describe here the preparation and antibacterial properties of an enzyme-embedded polycaprolactone (PCL)-based coating, coimpregnated with the antibiotic gentamicin sulfate (GS). The enzyme uses PCL itself as substrate; as a result, the antibiotic gets released at a rate controlled by the degradation of the PCL base. In vitro drug release studies demonstrated sustained release of GS from the PCL film throughout its lifetime. By modulating the enzyme concentration in the PCL film, we were able to vary the lifetime of the coating from 33 h to 16 days. In the end, the polymer is completely degraded, delivering the entire load of the antibiotic. The polymer exhibited antibacterial properties against three test isolates: Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. Foley urinary catheters coated with the modified polymer exhibited sustained in vitro release of GS over a 60-h period. The results suggest that the antibiotic-plus-enzyme-loaded polymer can be used as tunable self-degrading antimicrobial biomaterial coating on catheters.
C1 [Dave, Rachna N.; Joshi, Hiren M.; Venugopalan, Vayalam P.] BARC Facil, Biofouling & Biofilm Proc Sect, Water & Steam Chem Div, Kalpakkam 603102, Tamil Nadu, India.
RP Venugopalan, VP (reprint author), BARC Facil, Biofouling & Biofilm Proc Sect, Water & Steam Chem Div, Kalpakkam 603102, Tamil Nadu, India.
EM vpv@igcar.gov.in
OI Joshi, Hiren/0000-0002-2774-7695
FU DST-FAST TRACK [SR/FT/LS-031/2007]; Department of Science and
   Technology, Government of India
FX This research was supported by DST-FAST TRACK grant (SR/FT/LS-031/2007).
   R.N.D. is the recipient the Young Scientist Fellowship from Department
   of Science and Technology, Government of India.
CR AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Chavanpatil MD, 2007, MOL PHARM, V4, P730, DOI 10.1021/mp070024d
   Cho YH, 2001, BJU INT, V87, P104, DOI 10.1046/j.1464-410x.2001.00978.x
   Cho YW, 2003, J BIOMAT SCI-POLYM E, V14, P963, DOI 10.1163/156856203322381447
   DeJong ES, 2001, J TRAUMA, V50, P1008
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   ELDASTER C, 2000, POLYMERS, V41, P1297
   Falk R, 1997, J CONTROL RELEASE, V44, P77, DOI 10.1016/S0168-3659(96)01508-8
   Ganesh M, 2009, MACROMOLECULES, V42, P6836, DOI 10.1021/ma901481h
   GUGGENBICHLER JP, 2004, INT J ANTIMICROB S1, V23, pS75
   Ha US, 2006, INT J ANTIMICROB AG, V28, P485, DOI 10.1016/j.ijantimicag.2006.08.020
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Joshi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006065
   Kister G, 2000, POLYMER, V41, P925, DOI 10.1016/S0032-3861(99)00223-2
   Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028
   Mader JT, 1997, ANTIMICROB AGENTS CH, V41, P415, DOI 10.1128/AAC.41.2.415
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Mcfee RB, 2009, DM-DIS MON, V55, P422, DOI 10.1016/j.disamonth.2009.03.014
   MEYER JD, 1995, BIOPOLYMERS, V35, P451, DOI 10.1002/bip.360350504
   *NAT COMM CLIN LAB, 1990, M7A2 NCCLS
   NICKEL JC, 1992, UROLOGY, V39, P93
   Parker D, 2009, J WOUND OSTOMY CONT, V36, P23, DOI 10.1097/01.WON.0000345173.05376.3e
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Regev-Shoshani G, 2010, ANTIMICROB AGENTS CH, V54, P273, DOI 10.1128/AAC.00511-09
   REID G, 1994, ANTIMICROB AGENTS CH, V38, P1490, DOI 10.1128/AAC.38.7.1490
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631
   Trotonda MP, 2005, J BACTERIOL, V187, P5790, DOI 10.1128/JB.187.16.5790-5798.2005
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 30
TC 21
Z9 21
U1 0
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2011
VL 55
IS 2
BP 845
EP 853
DI 10.1128/AAC.00477-10
PG 9
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 709FE
UT WOS:000286422500051
PM 21135190
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Patel, D
   Menon, R
   Taite, LJ
AF Patel, Dhaval
   Menon, Rohan
   Taite, Lakeshia J.
TI Self-Assembly of Elastin-Based Peptides into the ECM: the Importance of
   Integrins and the Elastin Binding Protein in Elastic Fiber Assembly
SO BIOMACROMOLECULES
LA English
DT Article
ID CROSS-LINKED ELASTIN; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX;
   IN-VITRO; VASCULAR GRAFTS; ALPHA-ELASTIN; LYSYL OXIDASE; TROPOELASTIN;
   HYDROGELS; COACERVATION
AB The formation of a suitable extracellular matrix (ECM) that promotes cell adhesion, organization, and proliferation is essential within biomaterial scaffolds for tissue engineering applications. In this work, short elastin mimetic peptide sequences, EM-19 and EM-23, were engineered to mimic the active motifs of human elastin in hopes that they can stimulate ECM development in synthetic polymer scaffolds. Each peptide was incubated with human aortic smooth muscle cells (SMCs) and elastin and desmosine production were quantified after 48 h. EM-19 inhibited elastin production through competitive binding phenomena with the elastin binding protein (EBP), whereas EM-23, which contains an RGDS domain, induces recovery of elastin production at higher concentrations, alluding to a higher binding affinity for the integrins than for the EBP and the involvement of integrins in elastin production. Colocalization of each peptide with the elastin matrix was confirmed using immunofluorescent techniques. Our data suggest that with appropriate cell-binding motifs, we can simulate the cross-linking of tropoelastin into the developing elastin matrix using short peptide sequences. The potential for increased cell adhesion and the incorporation of elastin chains into tissue engineering scaffolds make these peptides attractive bioactive moieties that can easily be incorporated into synthetic biomaterials to induce ECM formation.
C1 [Patel, Dhaval; Menon, Rohan; Taite, Lakeshia J.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
RP Taite, LJ (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, 311 Ferst Dr NW, Atlanta, GA 30332 USA.
EM lakeshia.taite@chbe.gatech.edu
FU Georgia Institute of Technology
FX The authors would like to thank Dr. Barry Starcher of the University of
   Texas Health Science Center at Tyler for assistance with the desmosine
   ELISA and Dr. Tsutomu Arakawa of Alliance Protein Laboratories for CD
   analysis. Funding for this project has been provided by the Georgia
   Institute of Technology.
CR Ayad S., 1998, EXTRACELLULAR MATRIX
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/1076327042500427
   BRESSAN GM, 1977, BIOCHEMISTRY-US, V16, P1406, DOI 10.1021/bi00626a026
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CHRZANOWSKI P, 1980, AM J MED, V69, P351, DOI 10.1016/0002-9343(80)90004-2
   COX BA, 1974, J BIOL CHEM, V249, P997
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   Floquet N, 2004, BIOPOLYMERS, V76, P266, DOI 10.1002/bip.20029
   GROSSO LE, 1988, BIOCHEM BIOPH RES CO, V153, P545, DOI 10.1016/S0006-291X(88)81129-X
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hem DL, 1998, J BIOMED MATER RES, V39, P266
   Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   Hinek A, 1996, BIOL CHEM, V377, P471
   HIROSHI SHW, 2004, J ATHEROSCLER THROMB, V11, P159
   Kaufmann D, 2008, MACROMOL BIOSCI, V8, P577, DOI 10.1002/mabi.200700234
   Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004
   Lee J, 2002, RRD POLYM SCI, V6, P27
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Li DY, 1998, J CLIN INVEST, V102, P1783, DOI 10.1172/JCI4487
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   LIAW L, 1994, CIRC RES, V74, P214, DOI 10.1161/01.RES.74.2.214
   LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718
   Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2
   MAMMI M, 1968, NATURE, V220, P371, DOI 10.1038/220371b0
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   POWELL T, 1992, ATHEROSCLEROSIS, V97, P201
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   ROSE JR, 1993, FASEB J, V7, pA1208
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Seyrantepe V, 2008, CIRCULATION, V117, P1973, DOI 10.1161/CIRCULATIONAHA.107.733212
   Sibon I, 2005, HEART, V91, DOI 10.1136/hrt.2004.053074
   TAMBURRO AM, 1982, INT J BIOL MACROMOL, V4, P111, DOI 10.1016/0141-8130(82)90035-6
   TAMBURRO AM, 1977, BIOCHIM BIOPHYS ACTA, V492, P370, DOI 10.1016/0005-2795(77)90088-5
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   URRY DW, 1983, ULTRASTRUCT PATHOL, V4, P227, DOI 10.3109/01913128309140793
   URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0
   Urry DW, 2002, J MUSCLE RES CELL M, V23, P543, DOI 10.1023/A:1023422925910
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Yamamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P630, DOI 10.1093/ndt/17.4.630
NR 57
TC 9
Z9 9
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2011
VL 12
IS 2
BP 432
EP 440
DI 10.1021/bm101214f
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 719BZ
UT WOS:000287175700019
PM 21192640
DA 2018-10-20
ER

PT J
AU Franz, S
   Forstreuter, I
   Hintze, V
   Moller, S
   Scharnweber, D
   Schnabelrauch, M
   Simon, JC
AF Franz, S.
   Forstreuter, I.
   Hintze, V.
   Moeller, S.
   Scharnweber, D.
   Schnabelrauch, M.
   Simon, J. C.
TI Immunomodulatory effects on dendritic cells of biomaterial coatings
   based on artificial extracellular matrices (aECM)
SO EXPERIMENTAL DERMATOLOGY
LA English
DT Meeting Abstract
CT 38th Annual Meeting of the
   Arbeitsgemeinschaft-Dermatologishche-Forschung
CY FEB 17-19, 2011
CL Tuebingen, GERMANY
SP Arbeitsgemeinsch Dermatol Forsch
C1 [Franz, S.; Forstreuter, I.; Simon, J. C.] Univ Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Germany.
   [Hintze, V.; Scharnweber, D.] Tech Univ Dresden, Max Bergmann Ctr Biomat, Dresden, Germany.
   [Moeller, S.; Schnabelrauch, M.] INNOVENT eV Jena, Biomat Dept, Jena, Germany.
RI Franz, Sandra/G-6730-2011
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0906-6705
J9 EXP DERMATOL
JI Exp. Dermatol.
PD FEB
PY 2011
VL 20
IS 2
MA P124
BP 182
EP 182
PG 1
WC Dermatology
SC Dermatology
GA 709UZ
UT WOS:000286468200142
DA 2018-10-20
ER

PT J
AU Athanassiou, G
   Koutsoukos, PG
   Jin, HB
   Agathopoulos, S
AF Athanassiou, George
   Koutsoukos, Petros George
   Jin, Hai-Bo
   Agathopoulos, Simeon
TI Attachment of blood erythrocytes on zirconium oxide under laminar flow
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Zirconia; Blood; Cell adhesion; Shear stress; Surface roughness
ID INTERFACIAL INTERACTIONS; RED-CELL; BIOCERAMICS; ADHESION; SURFACES;
   BIOMATERIAL; CULTURE; GLASS
AB The adhesion of human erythrocytes settled for different times (15, 30 and 45 min) onto opaque zirconia surfaces of different surface roughness (R-a 0.08, 0.8 and 1.0 mu m) was investigated with detachment experiments. The parallel plate/laminar flow experimental set up was employed, whereby the cells were subjected to increasing shear stress, applied via controlled flow of phosphate buffer solution (PBS), and gradually detached. The experimental results showed that the critical shear stress, tau(s,c), corresponding to 50% detachment, was about 15 dyn/cm(2). The distribution curves of attachment suggested that smoother surfaces and longer settling times favoured strengthening of cells adherence, but the influence of settling time was sounder in smoother than in rougher surfaces. Assuming that the cells' shape relaxes over prolonged settling time, a geometric model, providing satisfactory interpretation of the experimental results, is consistent with the prediction that the surface morphology precisely determines the maximum extent of erythrocyte/surface contacting area and consequently the adhesion strength. (C)2011 The Ceramic Society of Japan. All rights reserved.
C1 [Athanassiou, George] Univ Patras, Biomed Engn Lab, Dept Mech & Aeronaut Engn, GR-26500 Patras, Greece.
   [Koutsoukos, Petros George] Univ Patras, Dept Chem Engn, GR-26504 Patras, Greece.
   [Koutsoukos, Petros George] FORTH ICEHT, GR-26504 Patras, Greece.
   [Jin, Hai-Bo] Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
   [Agathopoulos, Simeon] Univ Ioannina, Dept Mat Sci & Engn, GR-45110 Ioannina, Greece.
RP Athanassiou, G (reprint author), Univ Patras, Biomed Engn Lab, Dept Mech & Aeronaut Engn, GR-26500 Patras, Greece.
EM gathan@mech.upatras.gr
CR Agathopoulos S, 2003, KEY ENG MAT, V240-2, P675, DOI 10.4028/www.scientific.net/KEM.240-242.675
   Agathopoulos S, 2002, KEY ENG MAT, V224-2, P417, DOI 10.4028/www.scientific.net/KEM.224-226.417
   Agathopoulos S, 1996, J MATER SCI-MATER M, V7, P629, DOI 10.1007/BF00058203
   AGATHOPOULOS S, 1995, J BIOMED MATER RES, V29, P421, DOI 10.1002/jbm.820290402
   BULL BS, 1973, BLOOD, V41, P833
   Dee K.C., 2002, TISSUE BIOMATERIAL I
   DIMILLA PA, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P490
   EVANS E, 1972, MICROVASC RES, V4, P335, DOI 10.1016/0026-2862(72)90069-6
   GARSIA AJ, 1997, BIOMETERIALS, V18, P1091
   GENTLE CR, 1995, BIOMATERIALS, V16, P245, DOI 10.1016/0142-9612(95)92124-O
   GEORGE JN, 1971, J CELL PHYSIOL, V77, P51, DOI 10.1002/jcp.1040770107
   HARMAND M F, 1992, Clinical Materials, V11, P145
   Hench L. L., 1993, ADV SERIES CERAMICS, V1, P1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1982, BIOMATERIALS INTERFA, P1
   HOCHMUTH RM, 1973, BIOPHYS J, V13, P747, DOI 10.1016/S0006-3495(73)86021-7
   *ISO TC, 1995, 150SC1 ISO TC
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   OWENS NF, 1988, J CELL SCI, V91, P269
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   PONDER E, 1965, BIOPHYSICAL MECHANIS, P53
   PRICE TC, 1985, Q J MECH APPL MATH, V38, P93, DOI 10.1093/qjmam/38.1.93
   Ridgway JS, 2001, J MATER PROCESS TECH, V109, P161, DOI 10.1016/S0924-0136(00)00791-3
   SCHOEN FJ, 2004, BIOMATERIALS SCI, P709
   SCHOENBEIN S, 1975, BLOOD CELLS, V1, P285
   Valerio P, 2005, KEY ENG MAT, V284-286, P671, DOI 10.4028/www.scientific.net/KEM.284-286.671
   WEISS L, 1961, EXP CELL RES, V25, P504, DOI 10.1016/0014-4827(61)90186-0
   WEISS L, 1970, J CELL PHYSL, V70, P23
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   XIA ZM, 1994, BIOPHYS J, V66, P1222, DOI 10.1016/S0006-3495(94)80906-3
   ZARDA PR, 1977, J BIOMECH, V10, P211, DOI 10.1016/0021-9290(77)90044-6
   ZHOU XB, 1995, J MATER RES, V10, P1984, DOI 10.1557/JMR.1995.1984
NR 32
TC 0
Z9 0
U1 0
U2 4
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD FEB
PY 2011
VL 119
IS 1386
BP 120
EP 124
DI 10.2109/jcersj2.119.120
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 726JL
UT WOS:000287716500007
OA Bronze
DA 2018-10-20
ER

PT J
AU Barnett, BP
   Gailloud, P
AF Barnett, Brad P.
   Gailloud, Philippe
TI Assessment of EmboGel-A Selectively Dissolvable Radiopaque Hydrogel for
   Embolic Applications
SO JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Article
ID CELLULOSE-ACETATE POLYMER; DETACHABLE PLATINUM COILS; CALCIUM ALGINATE
   GEL; SWINE RETE-MIRABILE; IN-VITRO ASSESSMENT; ENDOVASCULAR TREATMENT;
   CEREBRAL ANEURYSMS; ARTERIOVENOUS-MALFORMATIONS; EMBOLIZATION MODEL;
   DIRECT THROMBOSIS
AB Purpose: To evaluate the embolic properties of an alginate-based embolic biomaterial (EmboGel) and its solvent (EmboClear) in treatment of aneurysms.
   Materials and Methods: EmboGel is a mixture of iohexol and alginate that polymerizes into a hydrocoil when delivered through a coaxial catheter with a distal mixing tip, exposing alginate to a calcium chloride solution. In contrast to previously reported embolic agents, EmboGel can be selectively dissolved by EmboClear, a mixture of the enzyme alginate lyase and ethylenediaminetetraacetic acid (EDTA). The embolic and contrast properties of EmboGel were assessed in in vitro models of saccular aneurysm and an aortic aneurysm endoleak. The dissolvability of EmboGel with EmboClear was assessed further after endovascular delivery in the New Zealand white rabbit in the native aortoiliofemoral territory, a created saccular aneurysm, and the native carotid arteries.
   Results: EmboGel effectively filled aneurysm cavities in the case of stent excluded saccular and fusiform aneurysms. EmboGel was readily dissolved by EmboClear in vitro and after in vivo embolization. When the distal abdominal aorta and pelvic arteries were occluded with EmboGel, within I minute of EmboClear infusion, patency of the aorta and most of the pelvic circulation was regained as noted by angiography. Embolization in the subclavian artery and numerous distal branches was rapidly dissolved by EmboClear. Finally, the carotid artery occluded with EmboGel regained patency after administration of EmboClear.
   Conclusions: EmboGel is a dissolvable alginate-based biomaterial that can be used for numerous embolic applications. EmboGel can be selectively dissolved with EmboClear, a solution of alginate lyase and EDTA.
C1 [Barnett, Brad P.; Gailloud, Philippe] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA.
   [Barnett, Brad P.] Johns Hopkins Univ Hosp, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA.
   [Gailloud, Philippe] Johns Hopkins Univ Hosp, Intervent Neuroradiol Res Lab, Baltimore, MD 21287 USA.
RP Gailloud, P (reprint author), Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St, Baltimore, MD 21287 USA.
EM phg@jhmi.edu
FU SIR Foundation
FX B.P.B. conducted this research as a Howard Hughes Medical Institute
   Research Training Fellow and a Pfeiffer Foundation Fellow. This project
   was funded in part by the generous support of the SIR Foundation in the
   form of the Medical Student Research Grant to B.P.B.
CR Altes TA, 2000, AM J ROENTGENOL, V174, P349, DOI 10.2214/ajr.174.2.1740349
   Barnett BP, 2009, J VASC INTERV RADIOL, V20, P507, DOI 10.1016/j.jvir.2009.01.005
   BAYER AS, 1992, INFECT IMMUN, V60, P3979
   Becker TA, 2005, NEUROSURGERY, V56, P793, DOI 10.1227/01.NEU.0000156494.94675.BB
   Becker TA, 2002, NEUROSURGERY, V51, P453, DOI 10.1227/01.NEU.0000020083.33150.81
   Bosman WMPF, 2010, EUR J VASC ENDOVASC, V40, P65, DOI 10.1016/j.ejvs.2010.02.019
   Bosman WMPF, 2010, J VASC SURG, V51, P1230, DOI 10.1016/j.jvs.2009.08.093
   BROTHERS MF, 1989, AM J NEURORADIOL, V10, P777
   Cekirge HS, 2006, NEURORADIOLOGY, V48, P113, DOI 10.1007/s00234-005-0007-6
   CHALOUPKA JC, 1994, AM J NEURORADIOL, V15, P1107
   Chaloupka JC, 1999, AM J NEURORADIOL, V20, P401
   Dudeck O, 2006, AM J NEURORADIOL, V27, P1900
   Dudeck O, 2006, J NEUROSURG, V104, P290, DOI 10.3171/jns.2006.104.2.290
   Gailloud P, 2005, TECH VASC INTERV RAD, V8, P118, DOI 10.1053/j.tvir.2005.10.003
   Howington JU, 2005, NEUROSURG CLIN N AM, V16, P355, DOI 10.1016/j.nec.2004.08.013
   Jahan R, 2001, NEUROSURGERY, V48, P984, DOI 10.1097/00006123-200105000-00003
   KINUGASA K, 1992, J NEUROSURG, V77, P501, DOI 10.3171/jns.1992.77.4.0501
   MANDAI S, 1992, J NEUROSURG, V77, P497, DOI 10.3171/jns.1992.77.4.0497
   Molyneux AJ, 2004, AM J NEURORADIOL, V25, P39
   Mottu F, 2000, BIOMATERIALS, V21, P803, DOI 10.1016/S0142-9612(99)00243-4
   Murayama Y, 2000, AM J NEURORADIOL, V21, P1726
   *NBCA TRIAL INV, 2002, AJNR AM J NEUR, V23, P748
   Nishi S, 1996, ACTA NEUROCHIR, V138, P294, DOI 10.1007/BF01411740
   Norbash AM, 2001, AM J NEURORADIOL, V22, P334
   Piotin M, 2001, AM J ROENTGENOL, V176, P235, DOI 10.2214/ajr.176.1.1760235
   Piotin M, 2000, AM J NEURORADIOL, V21, P757
   Raymond J, 2003, AM J NEURORADIOL, V24, P1214
   Sakakibara H, 2002, J PHARM SCI, V91, P1191, DOI 10.1002/jps.10110
   Soga Y, 2004, NEUROSURGERY, V55, P1401, DOI 10.1227/01.NEU.0000143616.22174.67
   TAKI W, 1992, J NEUROSURG, V77, P37, DOI 10.3171/jns.1992.77.1.0037
   Weber W, 2005, AM J NEURORADIOL, V26, P1909
   Yang XJ, 2001, SURG NEUROL, V55, P116, DOI 10.1016/S0090-3019(00)00331-1
NR 32
TC 6
Z9 6
U1 0
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1051-0443
J9 J VASC INTERV RADIOL
JI J. Vasc. Interv. Radiol.
PD FEB
PY 2011
VL 22
IS 2
BP 203
EP 211
DI 10.1016/j.jvir.2010.10.010
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular
   Disease
SC Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System &
   Cardiology
GA 718ZU
UT WOS:000287166600013
PM 21185201
DA 2018-10-20
ER

PT J
AU Xu, M
   Peng, D
AF Xu, Min
   Peng, Dan
TI Mesenchymal stem cells cultured on tantalum used in early-stage
   avascular necrosis of the femoral head
SO MEDICAL HYPOTHESES
LA English
DT Article
ID OSTEONECROSIS; DIFFERENTIATION; BIOMATERIAL; IMPLANT; HIP
AB Avascular necrosis of the femoral head (ANFH) is a common ailment characterized by necrosis of bone trabecular and bone marrow. It's mainly caused by the destruction of the blood supply in the femoral head and high rate of morbidity and disability is involved. Many methods have been tried including conservative treatment as drugs, electric stimulus, shock wave and electromagnetic field therapy and surgeries as core compression, rotary osteotomy and vascularized bone graft, but neither of them has definitive effect. Recently mesenchymal stem cells (MSCs) and tantalum robust have been widely used in ANFH. They have definite cure effects but advantages and disadvantages should not be neglected. In this paper, we hypothesize that mesenchymal stem cells cultured on tantalum can be used to prevent collapse of the articular surface in patients with ANFH. Unlike current treatment modalities, it would promote the regeneration of femoral head, provide structural support and allow for bony substitution over time. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Xu, Min; Peng, Dan] Cent S Univ, Xiangya Hosp 2, Dept Orthopaed, Changsha 410011, Hunan, Peoples R China.
RP Peng, D (reprint author), Cent S Univ, Xiangya Hosp 2, Dept Orthopaed, 86 Ren Min Rd, Changsha 410013, Hunan, Peoples R China.
EM xyeypd@163.com
CR Aldegheri R, 2007, STRATEG TRAUMA LIMB, V2, P63, DOI 10.1007/s11751-007-0021-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BROWN TD, 1993, J BONE JOINT SURG AM, V75A, P1358, DOI 10.2106/00004623-199309000-00011
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   HERNIGOU P, 2002, J CLIN ORTHOP RELAT, V405, P14
   Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x
   KIM YM, 1991, ORTHOPEDICS, V14, P1111
   Petrigliano FA, 2007, CLIN ORTHOP RELAT R, P53, DOI 10.1097/BLO.0b013e3181591c92
   SCHILDHAUER TA, 2008, J BIOMED MAT RES A
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   STEINBERG ME, 2001, J CLIN ORTHOP RELAT, V386, P71
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   SUN W, 2005, J ZHONGGUO XIU FU CH, V19, P703
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
   Wen Qian, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1627
NR 17
TC 7
Z9 8
U1 0
U2 8
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD FEB
PY 2011
VL 76
IS 2
BP 199
EP 200
DI 10.1016/j.mehy.2010.09.028
PG 2
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 725WK
UT WOS:000287677400014
PM 20970260
DA 2018-10-20
ER

PT J
AU Bohner, M
   Loosli, Y
   Baroud, G
   Lacroix, D
AF Bohner, M.
   Loosli, Y.
   Baroud, G.
   Lacroix, D.
TI Commentary: Deciphering the link between architecture and biological
   response of a bone graft substitute
SO ACTA BIOMATERIALIA
LA English
DT Editorial Material
DE Biomaterial; Bone; Tissue engineering; Resorbable; Graft
ID CALCIUM-PHOSPHATE SCAFFOLDS; MICRO-COMPUTED TOMOGRAPHY; IN-VIVO; TISSUE;
   DESIGN; CELLS; MODEL; MICROTOMOGRAPHY; QUANTIFICATION; OSTEOGENESIS
AB Hundreds of studies have been devoted to the search for the ideal architecture for bone scaffold. Despite these efforts, results are often contradictory, and rules derived from these studies are accordingly vague. In fact, there is enough evidence to postulate that ideal scaffold architecture does not exist. The aim of this document is to explain this statement and review new approaches to decipher the existing but complex link between scaffold architecture and in vivo response. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bohner, M.; Loosli, Y.] RMS Fdn, CH-2544 Bettlach, Switzerland.
   [Baroud, G.] Univ Sherbrooke, Lab Biomecan, Dept Genie Mecan, Sherbrooke, PQ J1K 2R1, Canada.
   [Lacroix, D.] Inst Bioengn Catalonia, Barcelona 08028, Spain.
RP Bohner, M (reprint author), RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
EM actabio.bohner@bluewin.ch
RI Bohner, Marc/F-3828-2011; Lacroix, Damien/G-3230-2010
OI Bohner, Marc/0000-0002-5079-3286; Lacroix, Damien/0000-0002-5482-6006
CR Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   Bohner M, 2009, ACTA BIOMATER, V5, P3524, DOI 10.1016/j.actbio.2009.05.024
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KLEIN CPAT, 1985, BIOMATERIALS, V6, P189, DOI 10.1016/0142-9612(85)90008-0
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   KYRO A, 1993, ANN CHIR GYNAECOL FE, V82, P254
   Langer M, 2010, J MICROSC-OXFORD, V238, P230, DOI [10.1111/j.1365-2818.2009.03545.x, 10.1111/j.1365-2818.2009.03345.x]
   Levengood SKL, 2010, BIOMATERIALS, V31, P3552, DOI 10.1016/j.biomaterials.2010.01.052
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Liska R, 2007, J COAT TECHNOL RES, V4, P505, DOI 10.1007/s11998-007-9059-3
   Loosli Y, 2010, PHILOS T R SOC A, V368, P2629, DOI 10.1098/rsta.2010.0069
   Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Ludwig W, 2009, MAT SCI ENG A-STRUCT, V524, P69, DOI 10.1016/j.msea.2009.04.009
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026
   Mogilner A, 2006, DEV CELL, V11, P279, DOI 10.1016/j.devcel.2006.08.004
   MUENCH B, 2008, J AM CERAM SOC, V91, P4059
   Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   PASSERI LA, 1993, J ORAL MAXIL SURG, V51, P22, DOI 10.1016/S0278-2391(10)80383-0
   Potter K, 2006, BONE, V38, P350, DOI 10.1016/j.bone.2005.08.025
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Schneider P, 2009, MICROSC RES TECHNIQ, V72, P690, DOI 10.1002/jemt.20720
   Simon JL, 2007, J BIOMED MATER RES A, V83A, P747, DOI 10.1002/jbm.a.31329
   Sloan A, 2010, SURG-J R COLL SURG E, V8, P111, DOI 10.1016/j.surge.2009.10.014
   Stahli C, 2010, ACTA BIOMATER, V6, P2760, DOI 10.1016/j.actbio.2010.01.018
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Wehrli FW, 2008, J BONE MINER RES, V23, P730, DOI 10.1359/JBMR.080108
   Willbold E, 2010, ACTA BIOMATER, V6, P4447, DOI 10.1016/j.actbio.2010.06.022
   Wu XM, 2003, BBA-MOL CELL RES, V1641, P65, DOI 10.1016/S0167-4889(03)00065-X
   ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V163, P1461, DOI 10.1016/0006-291X(89)91143-1
NR 47
TC 71
Z9 71
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2011
VL 7
IS 2
BP 478
EP 484
DI 10.1016/j.actbio.2010.08.008
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 713AP
UT WOS:000286707700002
PM 20709195
DA 2018-10-20
ER

PT J
AU Padial-Molina, M
   Galindo-Moreno, P
   Fernandez-Barbero, JE
   O'Valle, F
   Jodar-Reyes, AB
   Ortega-Vinuesa, JL
   Ramon-Torregrosa, PJ
AF Padial-Molina, Miguel
   Galindo-Moreno, Pablo
   Emilio Fernandez-Barbero, Juan
   O'Valle, Francisco
   Belen Jodar-Reyes, Ana
   Luis Ortega-Vinuesa, Juan
   Ramon-Torregrosa, Pedro J.
TI Role of wettability and nanoroughness on interactions between osteoblast
   and modified silicon surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osteoblast; Silicon surface; Nanoroughness; Wettability; Cell
   immunophenotype
ID CELL-MATERIALS INTERACTIONS; IMPLANT SURFACES; PROTEIN ADSORPTION;
   CONTACT-ANGLE; TITANIUM; ROUGHNESS; ADHESION; BEHAVIOR; PROLIFERATION;
   GEL
AB Development of new biomaterials is a constant in regenerative medicine. A biomaterial's surface properties, such as wettability, roughness, surface energy, surface charge, chemical functionalities and composition, are determinants of cell adhesion and subsequent tissue behavior. Thus, the main aim of this study was to analyze the correlation between changes in wettability without topographical variation and the response of osteoblast-like cells. For this purpose oxidized silicon surfaces were methylated to different degrees. Additionally, the influence of nanoroughness, and the subsequent effect of hysteresis on cell behavior, was also analyzed. In this case oxidized silicon pieces were etched with caustic solutions to produce different degrees of nanoroughness. Axisymmetric drop-shape analysis and atomic force microscopy confirmed that the proposed surface treatments increased the nanometer roughness and/or the water contact angles. MG-63 osteoblast-like cells were cultured on the altered surfaces to study proliferation, and for ultrastructural analysis and immunocytochemical characterization. Increasing the nanometer surface roughness or water contact angle enhanced osteoblast behavior in terms of cell morphology, proliferation and immunophenotype, the effect provoked by methylation being more significant than that caused by nanoroughness. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Padial-Molina, Miguel; Galindo-Moreno, Pablo] Univ Granada, Sch Dent, Oral Surg & Implant Dent Dept, E-18071 Granada, Spain.
   [Padial-Molina, Miguel; Galindo-Moreno, Pablo] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
   [Emilio Fernandez-Barbero, Juan] Univ Granada, Sch Med, Human Anat & Embryol Dept, Granada 18012, Spain.
   [Emilio Fernandez-Barbero, Juan; O'Valle, Francisco] Univ Granada, IBIMER, Granada 18012, Spain.
   [O'Valle, Francisco] Univ Granada, Sch Med, Dept Pathol, Granada 18012, Spain.
   [Belen Jodar-Reyes, Ana; Luis Ortega-Vinuesa, Juan; Ramon-Torregrosa, Pedro J.] Univ Granada, Sch Sci, Dept Appl Phys, E-18071 Granada, Spain.
RP Galindo-Moreno, P (reprint author), Univ Granada, Sch Dent, Oral Surg & Implant Dent Dept, Campus Cartuja S-N, E-18071 Granada, Spain.
EM pgalindo@ugr.es
RI Galindo-Moreno, Pablo/F-5567-2015; Jodar Reyes, Ana Belen/I-3333-2016;
   Padial-Molina, Miguel/L-9882-2013
OI Galindo-Moreno, Pablo/0000-0002-6614-6470; Jodar Reyes, Ana
   Belen/0000-0002-6136-7477; Padial-Molina, Miguel/0000-0001-6222-1341
FU Ministerio de Ciencia e Innovacion de Espana [MAT2007-66662-C02-01,
   MAT2007-66117]; Junta de Andalucia (Spain) [P07-FQM3099, FQM392]; 
   [CTS-138];  [CTS-583]
FX This work was supported by the Ministerio de Ciencia e Innovacion de
   Espana (MAT2007-66662-C02-01 and MAT2007-66117) and by the Junta de
   Andalucia (Spain) (P07-FQM3099, FQM392 and Research Groups No. CTS-138
   and No. CTS-583). We wish to thank Professor M.A. Cabrerizo Vilchez for
   his accurate comments, suggestions and supervision.
CR AKHTER P, 1989, J PHYS D APPL PHYS, V22, P1924, DOI 10.1088/0022-3727/22/12/020
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Baum T, 1998, LANGMUIR, V14, P2925, DOI 10.1021/la9711950
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0
   DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912
   Dotto MER, 2001, PHYSICA A, V295, P149, DOI 10.1016/S0378-4371(01)00068-1
   Fernandez-Barbero JE, 2006, CLIN ORAL IMPLAN RES, V17, P687, DOI 10.1111/j.1600-0501.2006.01179.x
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Galindo-Moreno P, 2008, CLIN ORAL IMPLAN RES, V19, P755, DOI 10.1111/j.1600-0501.2008.01536.x
   Huntington ND, 2004, IMMUNOL LETT, V94, P167, DOI 10.1016/j.imlet.2004.05.01
   Ishino C, 2008, EUR PHYS J E, V25, P415, DOI 10.1140/epje/i2007-10308-y
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kim HM, 2000, J BIOMED MATER RES, V52, P553, DOI 10.1002/1097-4636(20001205)52:3<553::AID-JBM14>3.0.CO;2-X
   Kitchens RL, 2000, CHEM IMMUNOL, V74, P61
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Okada S, 2010, ACTA BIOMATER, V6, P591, DOI 10.1016/j.actbio.2009.07.037
   Oliva E, 2004, ADV ANAT PATHOL, V11, P310, DOI 10.1097/01.pap.0000138140.81139.46
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   ORTIZ GA, 2006, THESIS U GRANADA GRA
   Padial-Molina M, 2009, MINERVA BIOTECNOL, V21, P173
   Paital SR, 2009, ACTA BIOMATER, V5, P2763, DOI 10.1016/j.actbio.2009.03.004
   Rabinowitz JE, 1996, P NATL ACAD SCI USA, V93, P6421, DOI 10.1073/pnas.93.13.6421
   Ramon-Torregrosa PJ, 2008, COLLOID SURFACE A, V323, P83, DOI 10.1016/j.colsurfa.2007.10.032
   Rico P, 2009, TISSUE ENG PT A, V15, P3271, DOI [10.1089/ten.tea.2009.0141, 10.1089/ten.TEA.2009.0141]
   Rodriguez-Valverde MA, 2002, COLLOID SURFACE A, V206, P485, DOI 10.1016/S0927-7757(02)00054-7
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Sawase T, 2008, CLIN ORAL IMPLAN RES, V19, P491, DOI 10.1111/j.1600-0501.2007.01509.x
   Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Snyder ML, 1940, J INFECT DIS, V67, P113, DOI 10.1093/infdis/67.2.113
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   WARKENTIN P, 1994, BIOMATERIALS, V15, P786, DOI 10.1016/0142-9612(94)90033-7
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zahn W, 1999, FRESEN J ANAL CHEM, V365, P168, DOI 10.1007/s002160051466
   Zhou J, 2007, MACROMOL BIOSCI, V7, P804, DOI 10.1002/mabi.200700007
NR 52
TC 50
Z9 57
U1 4
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2011
VL 7
IS 2
BP 771
EP 778
DI 10.1016/j.actbio.2010.08.024
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 713AP
UT WOS:000286707700034
PM 20807595
DA 2018-10-20
ER

PT J
AU Amor, N
   Geris, L
   Vander Sloten, J
   Van Oostervvyck, H
AF Amor, N.
   Geris, L.
   Vander Sloten, J.
   Van Oostervvyck, H.
TI Computational modelling of biomaterial surface interactions with blood
   platelets and osteoblastic cells for the prediction of contact
   osteogenesis
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Modeling; Bone regeneration; Osseointegration; Oral implant; Blood
   platelet
ID MESENCHYMAL PROGENITOR CELLS; STIMULATE CHEMOTACTIC MIGRATION;
   BONE-FORMATION ADJACENT; GROWTH-FACTOR-BETA; PROTEIN-KINASE-A; TITANIUM
   IMPLANTS; ROUGHNESS; REGENERATION; MG63; DOG
AB Surface microroughness can induce contact osteogenesis (bone formation initiated at the implant surface) around oral implants, which may result from different mechanisms, such as blood platelet-biomaterial interactions and/or interaction with (pre-)osteoblast cells. We have developed a computational model of implant endosseous healing that takes into account these interactions. We hypothesized that the initial attachment and growth factor release from activated platelets is crucial in achieving contact osteogenesis. In order to investigate this, a computational model was applied to an animal experiment [7] that looked at the effect of surface microroughness on endosseous healing. Surface-specific model parameters were implemented based on in vitro data (Lincks et al. Biomaterials 1998;19:2219-32). The predicted spatio-temporal patterns of bone formation correlated with the histological data. It was found that contact osteogenesis could not be predicted if only the osteogenic response of cells was up-regulated by surface microroughness. This could only be achieved if platelet-biomaterial interactions were sufficiently up-regulated as well. These results confirmed our hypothesis and demonstrate the added value of the computational model to study the importance of surface-mediated events for peri-implant endosseous healing. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Amor, N.; Geris, L.; Vander Sloten, J.; Van Oostervvyck, H.] Katholieke Univ Leuven, Div Biomech & Engn Design, B-3001 Louvain, Belgium.
   [Geris, L.; Van Oostervvyck, H.] Katholieke Univ Leuven, Prometheus Div Skeletal Tissue Engn, B-3001 Louvain, Belgium.
   [Geris, L.] Univ Liege, Biomech Res Unit, B-4000 Liege 1, Belgium.
RP Van Oostervvyck, H (reprint author), Katholieke Univ Leuven, Div Biomech & Engn Design, B-3001 Louvain, Belgium.
EM hans.vanoosterwyck@mech.kuleuven.be
RI Van Oosterwyck, Hans/C-2528-2016
OI Van Oosterwyck, Hans/0000-0002-2142-9717; geris,
   liesbet/0000-0002-8180-1445
FU Research Council of Katholieke Universiteit Leuven [DB/09/001]
FX N.A. gratefully acknowledges the Research Council of Katholieke
   Universiteit Leuven for their financial support (DB/09/001). L.G. is a
   postdoctoral research fellow of the Research Foundation Flanders
   (FWO-Vlaanderen).
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   AMBARD D, 2006, EUR J MECH A-SOLID, V2, P927
   AMOR N, 2009, COMPUT METHOD BIOMEC, V4, P459
   ANDERSON JM, 2000, BONE ENG, P81
   Bailon-Plaza A, 2003, J BIOMECH, V36, P1069, DOI [10.1016/S0021-9290(03)00117-9, 10.1016/S0021-9290(03)001117-9]
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Boyan Barbara D, 2006, J Am Acad Orthop Surg, V14, pS157
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   COCHRAN DL, 2000, BONE ENG, P392
   COFFEY RJ, 1990, ANN NY ACAD SCI, V593, P285, DOI 10.1111/j.1749-6632.1990.tb16120.x
   DASCH JR, 1989, J IMMUNOL, V142, P1536
   Davies J.E., 2000, BONE ENG, P1
   Davies JE, 1996, ANAT REC, V245, P426
   Davies John E, 2003, J Dent Educ, V67, P932
   DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199
   Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   Fiedler J, 2006, BIOCHEM BIOPH RES CO, V345, P1177, DOI 10.1016/j.bbrc.2006.05.034
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Gemmell CH, 2000, BONE ENG, P108
   Geris L, 2009, PHILOS T R SOC A, V367, P2031, DOI 10.1098/rsta.2008.0293
   Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008
   Geris L, 2006, MED BIOL ENG COMPUT, V44, P280, DOI 10.1007/s11517-006-0040-6
   GERIS V, 2010, BIOMECH MODEL MECHAN, DOI DOI 10.1007/S10237-010-0208-8
   Gerisch A, 2006, MATH COMPUT MODEL, V43, P49, DOI 10.1016/j.mcm.2004.05.016
   GRULER H, 1984, BLOOD CELLS, V10, P61
   Hundsdorfer W., 2003, SPRINGER SERIES COMP, V33
   JONES SJ, 1977, CELL TISSUE RES, V184, P179
   JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Moreo P, 2008, J THEOR BIOL, V260, P1
   Olsen L, 1997, IMA J MATH APPL MED, V14, P261
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   PARK YJ, 2000, CLIN ORAL IMPLAN RES, V11, P530
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Schwartz Z, 2009, BIOMATERIALS, V30, P3390, DOI 10.1016/j.biomaterials.2009.03.047
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P136, DOI 10.1111/j.1708-8208.2005.tb00057.x
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Vandamme K, 2008, J PERIODONTOL, V79, P150, DOI [10.1902/jop.2008.060413, 10.1902/jop.2008.060413 ]
   Vandamme K, 2007, EUR J ORAL SCI, V115, P21, DOI 10.1111/j.1600-0722.2007.00416.x
   VANDER A, 1998, HUMAN PHYSL MECH BOD
   Weiner R, 1997, APPL NUMER MATH, V25, P303, DOI 10.1016/S0168-9274(97)00067-6
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 58
TC 8
Z9 8
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2011
VL 7
IS 2
BP 779
EP 790
DI 10.1016/j.actbio.2010.09.025
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 713AP
UT WOS:000286707700035
PM 20883839
DA 2018-10-20
ER

PT J
AU Kumar, GP
   Mathew, L
AF Kumar, Gideon P.
   Mathew, Lazar
TI Stent Biomaterial and Design Selection Using Finite Element Analysis for
   Percutaneous Aortic Valve Replacement
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Stent; Finite element analysis; Aorta; Coronaries; Biomaterials
AB Vascular support structures are important devices for treating valve stenosis. Large populations of patients are treated for valvular disease and the principal mode of treatment is the use of percutaneous valvuloplasty. Stent devices are proving to be imperative in minimally invasive cardiac surgery. This new technology provides highly effective results at minimal cost and short duration of hospitalization. This article discusses the finite element analysis (FEA) of various percutaneous aortic valve stent designs. The stent designs were modeled and subjected to FEA. Analysis was done on four models using three biomaterials, with loads ranging from 10 665.8 N/m2 to 26 664 N/m2. These pressures were selected as they are equivalent to human blood pressure, which ranges from 80 mm Hg to 200 mm Hg. They were also selected to understand the mechanical behavior of different stent designs under such high pressures. Four stent models were generated and their physical, mechanical, and behavioral properties were studied. FEA and simulation of these models encouraged the designer to select the geometry and the biomaterial suitable for performance during and after implantation. The analysis performed in this article may aid in understanding the stents' performance ranges when subjected to the physiological pressures exerted by the heart and cardiac blood flow during abnormal cardiovascular conditions. It may also help in finding the best design and the biomaterial that would be suitable under such conditions.
C1 [Kumar, Gideon P.; Mathew, Lazar] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.
RP Kumar, GP (reprint author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.
EM gidi99-5611@yahoo.co.in
CR Kumar Gideon Praveen, 2009, Health, V1, P2
   Kumar G V Praveen, 2009, Journal of Medical Devices, V3, DOI 10.1115/1.3135156
   Kumar GVP, 2008, IFMBE PROC, V21, P446
   Kumar GP, 2010, BIOMED ENG-APP BAS C, V22, P157, DOI 10.4015/S101623721000189X
   Kumar GVP, 2009, CARDIOVASC REVASCULA, V10, P247, DOI 10.1016/j.carrev.2008.12.003
   Kumar GVP, 2009, CARDIOVASC REVASCULA, V10, P121, DOI 10.1016/j.carrev.2008.09.002
   KUMAR GP, 2009, ARTIF ORGANS, DOI DOI 10.1111/J.1525-1594.2009.00973X
   KUMAR GP, 2009, TRENDS BIOMATER ARTI, V23, P16
   KUMAR GP, 2008, INT C BIOT INCOB P F, P139
   KUMAR GP, 2009, COMPUT METHODS BIOME
   KUMAR GP, 2008, IFMBE SERIES, V23, P1539
   KUMAR GP, 2010, INT J CARDIOVASC REV, V11, P101
NR 12
TC 2
Z9 2
U1 1
U2 15
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 2011
VL 35
IS 2
BP 166
EP 175
DI 10.1111/j.1525-1594.2010.01061.x
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 721ZQ
UT WOS:000287398100014
PM 21108649
DA 2018-10-20
ER

PT J
AU Wu, SF
   Liu, Y
   Bharadwaj, S
   Atala, A
   Zhang, YY
AF Wu, Shaofeng
   Liu, Yan
   Bharadwaj, Shantaram
   Atala, Anthony
   Zhang, Yuanyuan
TI Human urine-derived stem cells seeded in a modified 3D porous small
   intestinal submucosa scaffold for urethral tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Urine; Stem cells; Biomaterial; Urethral stricture; Tissue engineering
ID BIAXIAL MECHANICAL-BEHAVIOR; HUMAN UROTHELIAL CELLS;
   SMOOTH-MUSCLE-CELLS; BLADDER WASHINGS; COLLAGEN MATRIX; RABBIT URETHRA;
   BUCCAL MUCOSAL; RECONSTRUCTION; GRAFT; REPAIR
AB The goal of this study was to determine whether urothelial cells (UC) and smooth muscle cells (SMC) derived from the differentiation of urine-derived stem cells (USC) could be used to form engineered urethral tissue when seeded on a modified 3-D porous small intestinal submucosa (SIS) scaffold. Cells were obtained from 12 voided urine samples from 4 healthy individuals. USC were isolated, characterized and induced to differentiate into UC and SMC. Fresh SIS derived from pigs was decellularized with 5% peracetic acid (PAA). Differentiated UC and SMC derived from USC were seeded onto SIS scaffolds with highly porous microstructure in a layered co-culture fashion and cultured under dynamic conditions for one week. The seeded cells formed multiple uniform layers on the SIS and penetrated deeper into the porous matrix during dynamic culture. USC that were induced to differentiate also expressed UC markers (Uroplakin-III and AE1/AE3) or SMC markers (alpha-SM actin, desmin, and myosin) after implantation into athymic mice for one month, and the resulting tissues were similar to those formed when UC and SMC derived from native ureter were used. In conclusion, UC and SMC derived from USC could be maintained on 3-D porous SIS scaffold. The dynamic culture system promoted 3-D cell matrix ingrowth and development of a multilayer mucosal structure similar to that of native urinary tract tissue. USC may serve as an alternative cell source in cell-based tissue engineering for urethral reconstruction or other urological tissue repair. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Wu, Shaofeng; Liu, Yan; Bharadwaj, Shantaram; Atala, Anthony; Zhang, Yuanyuan] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Wu, Shaofeng] Shanghai Childrens Hosp, Shanghai 200040, Peoples R China.
RP Zhang, YY (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM yzhang@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   BHARADWAJ S, 2010, MULTIPOTENT STEM CEL, pE61
   Bharadwaj S, 2009, J TISSUE ENG REGEN M, V6, pS293
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen F, 2000, WORLD J UROL, V18, P67, DOI 10.1007/s003450050012
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Dabernig J, 2007, EUR UROL, V52, P547, DOI 10.1016/j.eururo.2007.01.004
   Djordjevic ML, 2008, EUR J PEDIATR SURG, V18, P427, DOI 10.1055/s-2008-1038929
   DUFFY PG, 1988, BRIT J UROL, V61, P505, DOI 10.1111/j.1464-410X.1988.tb05090.x
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Feng C, 2010, J BIOMED MATER RES A, V94A, P317, DOI 10.1002/jbm.a.32729
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Foroutan HR, 2006, PEDIATR SURG INT, V22, P259, DOI 10.1007/s00383-005-1627-y
   Fossum M, 2003, SCAND J PLAST RECONS, V37, P41, DOI 10.1080/alp.37.1.41.45
   Fu Q, 2007, BJU INT, V99, P1162, DOI 10.1111/j.1464-410X.2006.06691.x
   Fu WJ, 2009, BJU INT, V104, P263, DOI 10.1111/j.1464-410X.2009.08366.x
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hu YF, 2008, CHIN J TRAUMATOL, V11, P274, DOI 10.1016/S1008-1275(08)60055-3
   Kanatani I, 2007, TISSUE ENG, V13, P2933, DOI 10.1089/ten.2007.0052
   Koshima I, 1999, PLAST RECONSTR SURG, V103, P964, DOI 10.1097/00006534-199903000-00030
   Koziak Andrzej, 2004, Ann Transplant, V9, P21
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   MITCHELL ME, 1988, J UROLOGY, V139, P1282, DOI 10.1016/S0022-5347(17)42893-X
   Mungadi IA, 2009, ANN AFR MED, V8, P203, DOI 10.4103/1596-3519.59572
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Ozgok Y, 2000, INT J UROL, V7, P355, DOI 10.1046/j.1442-2042.2000.00210.x
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Rotariu P, 2002, J ENDOUROL, V16, P617, DOI 10.1089/089277902320913332
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Wang HJ, 2004, J FORMOS MED ASSOC, V103, P244
   Weiser AC, 2003, J UROLOGY, V170, P1593, DOI 10.1097/01.ju.0000083863.01634.e1
   Zhang Y, 2000, J UROLOGY, V164, P934
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2003, ADV EXP MED BIOL, V539, P907
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 40
TC 85
Z9 104
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 5
BP 1317
EP 1326
DI 10.1016/j.biomaterials.2010.10.006
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717UN
UT WOS:000287073000008
PM 21055807
DA 2018-10-20
ER

PT J
AU Nguyen, LH
   Kudva, AK
   Guckert, NL
   Linse, KD
   Roy, K
AF Nguyen, Lonnissa H.
   Kudva, Abhijit K.
   Guckert, Nicole L.
   Linse, Klaus D.
   Roy, Krishnendu
TI Unique biomaterial compositions direct bone marrow stem cells into
   specific chondrocytic phenotypes corresponding to the various zones of
   articular cartilage
SO BIOMATERIALS
LA English
DT Article
DE Bone marrow stromal cells; Degradable hydrogel; Chondroitin sulfate;
   Hyaluronic acid; MMP (matrix metalloproteinase); Articular cartilage
   tissue engineering
ID PEG HYDROGELS; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION;
   ENGINEERED CARTILAGE; CHONDROITIN SULFATE; MESENCHYMAL CELLS;
   GENE-EXPRESSION; REPAIR; SCAFFOLDS; CULTURE
AB Numerous studies have reported generation of cartilage-like tissue from chondrocytes and stem cells, using pellet cultures, bioreactors and various biomaterials, especially hydrogels. However, one of the primary unsolved challenges in the field has been the inability to produce tissue that mimics the highly organized zonal architecture of articular cartilage; specifically its spatially varying mechanical properties and extra-cellular matrix (ECM) composition. Here we show that different combinations of synthetic and natural biopolymers create unique niches that can "direct" a single marrow stem cell (MSC) population to differentiate into the superficial, transitional, or deep zones of articular cartilage. Specifically, incorporating chondroitin sulfate (CS) and matrix metalloproteinase-sensitive peptides (MMP-pep) into PEG hydrogels (PEG:CS:MMP-pep) induced high levels of collagen II and low levels of proteoglycan expression resulting in a low compressive modulus, similar to the superficial zone. PEG:CS hydrogels produced intermediate-levels of both collagen II and proteoglycans, like the transitional zone, while PEG:hyaluronic acid (HA) hydrogels induced high proteoglycan and low collagen II levels leading to high compressive modulus, similar to the deep zone. Additionally, the compressive moduli of these zone-specific matrices following cartilage generation showed similar trend as the corresponding zones of articular cartilage, with PEG:CS:MMP-pep having the lowest compressive modulus, followed by PEG:CS while PEG:HA had the highest modulus. These results underscore the potential for composite scaffold structures incorporating these biomaterial compositions such that a single stem-progenitor cell population can give rise to zonally-organized, functional articular cartilage-like tissue. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Nguyen, Lonnissa H.; Kudva, Abhijit K.; Guckert, Nicole L.; Linse, Klaus D.; Roy, Krishnendu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Roy, K (reprint author), Univ Texas Austin, Dept Biomed Engn, Biomed Engn Bldg 2-312, Austin, TX 78712 USA.
EM kroy@mail.utexas.edu
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Boschetti F, 2008, BIORHEOLOGY, V45, P337, DOI 10.3233/BIR-2008-0479
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   ButnariuEphrat M, 1996, CLIN ORTHOP RELAT R, P234
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91
   Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134
   Einhorn T.A., 2007, ORTHOPAEDIC BASIC SC
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   HALL BK, 2005, BONES CARTILAGE DEV
   Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460
   He XZ, 2007, BIOMACROMOLECULES, V8, P780, DOI 10.1021/bm060671a
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Klein TJ, 2010, SOFT MATTER, P1
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Leach BJ, 2003, BIOTECHNOL BIOENG, V82, P578
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   PACIFICI M, 1991, EXP CELL RES, V192, P266, DOI 10.1016/0014-4827(91)90185-W
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636
   Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Thirion S, 2004, METH MOLEC MED, V100, P1
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
NR 42
TC 90
Z9 90
U1 2
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 5
BP 1327
EP 1338
DI 10.1016/j.biomaterials.2010.10.009
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717UN
UT WOS:000287073000009
PM 21067807
DA 2018-10-20
ER

PT J
AU Kim, YH
   Anirban, JM
   Song, HY
   Seo, HS
   Lee, BT
AF Kim, Young-Hee
   Anirban, Jyoti M.
   Song, Ho-Yeon
   Seo, Hyung-Seok
   Lee, Byong-Taek
TI In Vitro and In Vivo Evaluations of 3D Porous TCP-coated and Non-coated
   Alumina Scaffolds
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE tricalcium phosphate; biocompatibility; cytotoxicity; ECMs; micro-CT;
   alumina scaffold
ID BONE TISSUE; BEHAVIOR; HYDROXYAPATITE; ACTIVATION; DEPOSITION; COLLAGEN;
   INVITRO; CARBON
AB Both tricalcium phosphate (TCP) and alumina have been extensively studied and shown to have high biocompatibility. Tricalcium phosphate has improved biodegradability and a higher solubility than hydroxyapatite. In contrast, alumina (Al(2)O(3)) is almost completely inert at physiological conditions and has been used as a biomaterial due to its wear resistance, high surface finish, and excellent hardness. Thus, the combination of these two implants would result in greater biocompatibility and phenotype maintenance. A polyurethane (PU) foam replica method was employed in this study to coat TCP on an alumina scaffold. The TCP-coated alumina scaffold was then sintered to generate a porous surface morphology. The pore sizes obtained using this approach ranged between 100-600 mu m, which is ideal for cellular proliferation. The cytotoxicity, cellular proliferation, differentiation, and ECM deposition on the coated scaffold resulted in longer-term viability of osteogenic markers compared to the non-coated scaffold. Moreover, the osteogenic properties of porous TCP-coated Al(2)O(3) scaffolds were reported in this study using rabbit models. The TCP/Al(2)O(3) scaffold and control Al(2)O(3) scaffolds were implanted in the rabbit femur. The bone tissue response was analyzed with micro-computed tomography (micro CT) at 12 and 24 weeks after implantation. The porous scaffolds exhibited favorable hard and soft tissue responses at both time points. At 24 weeks, a three-fold increase in bone tissue ingrowth was observed in defects containing TCP-coated Al(2)O(3) scaffolds compared to control Al(2)O(3) scaffolds.
C1 [Kim, Young-Hee; Anirban, Jyoti M.; Song, Ho-Yeon] Soonchunhyang Univ, Sch Med, Dept Immunol, Cheonan 330090, Chungnam, South Korea.
   [Seo, Hyung-Seok] Konyang Univ, Collage Hlth Ind, Nonsan 320711, Chungnam, South Korea.
   [Lee, Byong-Taek] Soonchunhyang Univ, Dept Biomed Engn & Mat, Cheonan 330090, Chungnam, South Korea.
RP Song, HY (reprint author), Soonchunhyang Univ, Sch Med, Dept Immunol, 366-1 Ssangyoung Dong, Cheonan 330090, Chungnam, South Korea.
EM songmic@sch.ac.kr
FU Ministry of Knowledge Economy (MKE), Republic of Korea
FX This research was supported by a grant from the Center for Advanced
   Materials Processing (CAMP) of the 21st Century Frontier R&D Program by
   the Ministry of Knowledge Economy (MKE), Republic of Korea.
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   BOHNER M, 2003, INJURY, V31, P37
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Gross KA, 2004, BIOMATERIALS, V25, P4955, DOI 10.1016/j.biomaterials.2004.01.046
   Han JK, 2006, MATER CHEM PHYS, V99, P235, DOI 10.1016/j.matchemphys.2005.10.017
   Hildebrand HF, 2006, SURF COAT TECH, V200, P6318, DOI 10.1016/j.surfcoat.2005.11.086
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Laffargue P, 1998, WIL SER BIOM SCI ENG, P467
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE JS, 2008, ENCY BIOMATERIALS BI, V1, P17
   MICKISCH G, 1990, UROL RES, V18, P131, DOI 10.1007/BF00302474
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Moreira EA, 2004, J EUR CERAM SOC, V24, P3209, DOI 10.1016/j.jeurceramsoc.2003.11.014
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   RAJARAMAN R, 1974, EXP CELL RES, V88, P327, DOI 10.1016/0014-4827(74)90248-1
   RISBUD M, 2001, BIOGERONTOLOGY, V2, P112
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   SILKAVITSAS VI, 2002, J BIOMED MATER RES, V62, P136
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
NR 30
TC 9
Z9 10
U1 1
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2011
VL 25
IS 6
BP 539
EP 558
DI 10.1177/0885328209356945
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 719VD
UT WOS:000287238600002
PM 20207781
DA 2018-10-20
ER

PT J
AU Clough, A
   Ball, J
   Smith, GS
   Leibman, S
AF Clough, Anthony
   Ball, Jonathon
   Smith, Garett S.
   Leibman, Steven
TI Porcine Small Intestine Submucosa Matrix (Surgisis) for Esophageal
   Perforation
SO ANNALS OF THORACIC SURGERY
LA English
DT Editorial Material
ID FISTULAS; REPAIR
AB We present a case of traumatic cervical esophageal perforation complicated by delayed diagnosis and foreign body presence successfully repaired with acellular matrix biomaterial made from porcine submucosa (Surgisis mesh [Wilson-Cook, Winston-Salem, NC]). With metal plating eroding into the esophagus from a spinal fixation procedure, the mesh was applied to the defect just under the cricopharyngeus. The patient re-commenced oral intake after 7 days, and an endoscopy at 4 weeks revealed a well-incorporated mesh in an intact esophagus with normal caliber. In this case, Surgisis mesh (Wilson-Cook) proved effective in providing temporary esophageal integrity to allow healing in an infected field where diversion was impossible. (Ann Thorac Surg 2011; 91: e15-6) (C) 2011 by The Society of Thoracic Surgeons
C1 Royal N Shore Hosp, Sydney, NSW, Australia.
   Univ Sydney, N Shore Private Hosp, Sydney, NSW 2006, Australia.
RP Clough, A (reprint author), Epworth Eastern Hosp, Suite 62,Level 6,1 Arnold St, Box Hill, Vic 3084, Australia.
EM adclough@optusnet.com.au
RI Ball, Jonathon/K-1076-2015
OI Ball, Jonathon/0000-0003-0594-8063
CR Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Bardaxoglou E, 1997, WORLD J SURG, V21, P618, DOI 10.1007/s002689900282
   Fumagalli U, 2008, SURG LAPARO ENDO PER, V18, P433, DOI 10.1097/SLE.0b013e3181802ca7
   Gonsalves S, 2009, DIS COLON RECTUM, V52, P1877, DOI 10.1007/DCR.0b013e3181b55560
   Maluf F, 2004, GASTROINTEST ENDOSC, V59, pAB151
   Maluf F, 2009, SURG ENDOSC, V23, P1541, DOI 10.1007/s00464-009-0440-4
   RICHARDSON JD, 1994, ARCH SURG-CHICAGO, V129, P1
   WEIMAN DS, 1995, ANN THORAC SURG, V59, P845, DOI 10.1016/0003-4975(95)00008-9
NR 8
TC 16
Z9 16
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD FEB
PY 2011
VL 91
IS 2
BP E99
EP E100
DI 10.1016/j.athoracsur.2010.10.011
PG 2
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 709QM
UT WOS:000286456400001
PM 21256256
DA 2018-10-20
ER

PT J
AU Yunoki, S
   Sugiura, H
   Ikoma, T
   Kondo, E
   Yasuda, K
   Tanaka, J
AF Yunoki, Shunji
   Sugiura, Hiroaki
   Ikoma, Toshiyuki
   Kondo, Eiji
   Yasuda, Kazunori
   Tanaka, Junzo
TI Effects of increased collagen-matrix density on the mechanical
   properties and in vivo absorbability of hydroxyapatite-collagen
   composites as artificial bone materials
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MINERALIZED COLLAGEN; TRABECULAR BONE; SCAFFOLDS; CERAMICS;
   NANOCOMPOSITES; REGENERATION; BIOCERAMICS; BIOMATERIAL; FABRICATION;
   STRENGTH
AB The aim of this study was to evaluate the effects of increased collagen-matrix density on the mechanical properties and in vivo absorbability of porous hydroxyapatite (HAp)-collagen composites as artificial bone materials. Seven types of porous HAp-collagen composites were prepared from HAp nanocrystals and dense collagen fibrils. Their densities and HAp/collagen weight ratios ranged from 122 to 331 mg cm(-3) and from 20/80 to 80/20, respectively. The flexural modulus and strength increased with an increase in density, reaching 2.46 +/- 0.48 and 0.651 +/- 0.103 MPa, respectively. The porous composites with a higher collagen-matrix density exhibited much higher mechanical properties at the same densities, suggesting that increasing the collagen-matrix density is an effective way of improving the mechanical properties. It was also suggested that other structural factors in addition to collagen-matrix density are required to achieve bone-like mechanical properties. The in vivo absorbability of the composites was investigated in bone defects of rabbit femurs, demonstrating that the absorption rate decreased with increases in the composite density. An exhaustive increase in density is probably limited by decreases in absorbability as artificial bones.
C1 [Yunoki, Shunji] Tokyo Metropolitan Ind Technol Res Inst, Life Sci Grp, Setagaya Ku, Tokyo 1580081, Japan.
   [Sugiura, Hiroaki; Kondo, Eiji; Yasuda, Kazunori] Hokkaido Univ, Grad Sch Med, Dept Sports Med & Joint Surg, Sapporo, Hokkaido 0608638, Japan.
   [Ikoma, Toshiyuki; Tanaka, Junzo] Dept Met & Ceram Sci, Meguro Ku, Tokyo 1528550, Japan.
RP Yunoki, S (reprint author), Tokyo Metropolitan Ind Technol Res Inst, Life Sci Grp, Setagaya Ku, 2-11-1 Fukazawa, Tokyo 1580081, Japan.
EM yunoki.shunji@iri-tokyo.jp
RI Yasuda, Kazunori/C-9998-2009; Ikoma, Toshiyuki/E-4288-2012; Kondo,
   Eiji/G-2004-2012
OI Ikoma, Toshiyuki/0000-0003-3154-1777; 
FU Japan Science and Technology Agency
FX This research was supported in part by the grant program 'Collaborative
   Development of Innovative Seeds' from the Japan Science and Technology
   Agency.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   AN HY, 2000, MECH TESTING BONE BO, P41
   Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Goldberg VM, 2000, CLIN ORTHOP RELAT R, P68
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KUHN JL, 1989, J BIOMECH, V22, P95, DOI 10.1016/0021-9290(89)90032-8
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Liao SS, 2004, TISSUE ENG, V10, P73, DOI 10.1089/107632704322791718
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Okamoto M, 2006, J MATER SCI-MATER M, V17, P327, DOI 10.1007/s10856-006-8232-z
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Sugiura H, 2009, J BIOMAT SCI-POLYM E, V20, P1353, DOI 10.1163/092050609X12457418396658
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Tonegawa T, 2007, J NANOSCI NANOTECHNO, V7, P839, DOI 10.1166/jnn.2007.526
   Wang Y, 2008, J BIOMED MATER RES B, V86B, P29, DOI 10.1002/jbm.b.30984
   Yunoki S, 2007, J BIOMAT SCI-POLYM E, V18, P393, DOI 10.1163/156856207780425077
   Yunoki S, 2010, MATER CHARACT, V61, P907, DOI 10.1016/j.matchar.2010.05.010
   Yunoki S, 2007, J BIOMED MATER RES B, V80B, P166, DOI 10.1002/jbm.b.30581
NR 34
TC 13
Z9 13
U1 0
U2 27
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2011
VL 6
IS 1
AR 015012
DI 10.1088/1748-6041/6/1/015012
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 711LO
UT WOS:000286593300001
PM 21242631
DA 2018-10-20
ER

PT J
AU George, SM
   Gaylor, JDS
   Leadbitter, J
   Grant, MH
AF George, Susan M.
   Gaylor, John D. S.
   Leadbitter, Jason
   Grant, M. Helen
TI The effect of betacyclodextrin and hydroxypropyl betacyclodextrin
   incorporation into plasticized poly(vinyl chloride) on its compatibility
   with human U937 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE plasticized PVC; biomaterial; biocompatibility; betacyclodextrin; U937
   cells
ID ALOE-VERA LINNE; IN-VITRO; POLYVINYL-CHLORIDE; CHROMIUM IONS; TNF-ALPHA;
   MACROPHAGES; PARTICLES; TOXICITY; COBALT; LINES
AB Di (2-ethyl hexyl) phthalate (DEHP) is one of the main plasticizers used in poly(vinyl chloride) (PVC) medical devices and is currently the only one listed for use in the European Pharmacopoeia Monograph. It leaches out of PVC when the material is in contact with lipophilic media, for example, blood and certain nutritional feeds. Consequently, concerns have been expressed since in certain animal species, DEHP has been shown to exhibit both carcinogenic and reproductive toxic effects. Incorporation of beta cyclodextrin (BCD) and hydroxypropyl betacyclodectrin (HPBCD) into plasticized materials has been reported to decrease the leaching of DEHP. We have investigated whether this results in improved in vitro biocompatibility by measuring the responses of U937 cells to plasticized PVC in the presence and absence of added BCD or HPBCD. Growth and viability of the U937 cells, as well as tumor necrosis factor-alpha (TNF-alpha) production in contact with these materials revealed no significant difference between unmodified plasticized PVC materials and those containing BCD or HPBCD. Lipopolysaccharide (LPS) was used to elicit TNF-alpha production, and the response of cells to LPS in the presence of the PVC materials was evaluated. When PVC was modified by addition of HPBCD there was a significant reduction in the TNF-alpha production in response to LPS. Modification of plasticized PVC biomaterials by adding cyclodextrins did not significantly improve their biocompatibility. However, the HPBCD modified plasticized PVC materials caused a reduction in the production in TNF-alpha induced by LPS which may have implications for the inflammatory potential of these biomaterials. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 310-315, 2011.
C1 [George, Susan M.; Gaylor, John D. S.; Grant, M. Helen] Univ Strathclyde, Wolfson Ctr, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Grant, MH (reprint author), Univ Strathclyde, Wolfson Ctr, Bioengn Unit, 106 Rottenrow, Glasgow G4 0NW, Lanark, Scotland.
EM m.h.grant@strath.ac.uk
CR BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Biwer A, 2002, APPL MICROBIOL BIOT, V59, P609, DOI 10.1007/s00253-002-1057-x
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   *COUNC EUR, 2008, EUR PHARM, V6
   Dagtekin G, 2003, BIOMATERIALS, V24, P3395, DOI 10.1016/S0142-9612(03)00201-1
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   FISHER FP, 1998, PERITONEAL DIALYSIS, V18, P620, DOI DOI 10.1016/S0142-9612(03)00201-1
   Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007
   Howling GI, 2003, J BIOMED MATER RES B, V67B, P758, DOI 10.1002/jbm.b.10068
   Ingham E, 2000, BIOMATERIALS, V21, P1005, DOI 10.1016/S0142-9612(99)00261-6
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011
   Lee KH, 2000, J PHARM PHARMACOL, V52, P593, DOI 10.1211/0022357001774246
   Lee KH, 2000, J PHARM PHARMACOL, V52, P1037, DOI 10.1211/0022357001774778
   Loftsson Thorsteinn, 2005, Expert Opin Drug Deliv, V2, P335, DOI 10.1517/17425247.2.1.335
   Luo L, 2005, BIOMATERIALS, V26, P5587, DOI 10.1016/j.biomaterials.2005.02.013
   MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69
   Matthews JB, 2001, J MATER SCI-MATER M, V12, P249, DOI 10.1023/A:1008967200706
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Petit A, 2006, J BIOMED MATER RES A, V79A, P599, DOI 10.1002/jbm.a.30884
   Rusyn I, 2001, MOL PHARMACOL, V59, P744
   SMITH MD, 1995, J BIOMAT SCI-POLYM E, V7, P453
   Sreenivasan K, 1996, J APPL POLYM SCI, V59, P2089
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H
   Wan R, 2008, TOXICOL APPL PHARM, V233, P276, DOI 10.1016/j.taap.2008.08.022
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   Xu HY, 2002, J TOXICOL ENV HEAL A, V65, P1141, DOI 10.1080/00984100290071153
   Yokoyama Y, 2003, TOXICOL LETT, V144, P371, DOI 10.1016/S0378-4274(03)00256-X
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
   Zhao XB, 2007, J BIOMED MATER RES A, V80A, P539, DOI 10.1002/jbm.a.30925
NR 30
TC 2
Z9 2
U1 2
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2011
VL 96B
IS 2
BP 310
EP 315
DI 10.1002/jbm.b.31767
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 705VU
UT WOS:000286169600015
PM 21210511
DA 2018-10-20
ER

PT J
AU Kirchhoff, M
   Lenz, S
   Henkel, KO
   Frerich, B
   Holzhuter, G
   Radefeldt, S
   Gerber, T
AF Kirchhoff, Mark
   Lenz, Solvig
   Henkel, Kai-Olaf
   Frerich, Bernhard
   Holzhueter, Gerd
   Radefeldt, Sven
   Gerber, Thomas
TI Lateral augmentation of the mandible in minipigs with a synthetic
   nanostructured hydroxyapatite block
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE allograft; absorbable; hydroxyapatite; nanomaterials; histomorphometry
ID VERTICAL RIDGE AUGMENTATION; NANOPHASE CERAMICS; ANIMAL-MODELS; BONE
   REPAIR; DOG-MODEL; OSTEOINDUCTION; BIOMATERIALS; SUBSTITUTES; GRAFT
AB The purpose of this study was to evaluate biomaterial degradation and new bone formation after implantation of a nanostructured hydroxyapatite (HA) grafting block. Furthermore, physical characteristics of the biomaterial were measured. The biomaterial consists of nanostructured HA embedded in a porous matrix of silica (SiO2) gel. The blocks with two different contents of silica (group A: 24 wt % and group B: 39 wt %) were fixed with titanium screws at the lateral aspect of the mandible of minipigs (n = 5). The specific surface areas of both blocks were measured using Brunauer-Emmett-Teller (BET) equation and mercury intrusion. In all animals, the wound healing was uneventful. After 5 weeks, the biomaterial percentage was 51.5% +/- 12.1% for group A and 33.2% +/- 5.9% for group B (p = 0.017). New bone formation accounted to 7.6% +/- 6.0% for group A and 15.3% +/- 8.3% for group B (p = 0.126) after 5 weeks. After 10 weeks, further resorption of the biomaterial led to percentages of 30.6% +/- 10.0% for group A and 12.1% +/- 6.7% for group B (p = 0.000). After 10 weeks, new bone formations were measured to be 34.1% +/- 10.8% in group A and 39.9% +/- 13.5% in group B (p = 0.383). The rate of degradation of the biomaterial is controlled by the composition of the material. A higher content of silica gel matrix leads to faster degradation of the biomaterial. The formation of new bone failed to show a significant difference between both groups. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 342-350, 2011.
C1 [Kirchhoff, Mark; Lenz, Solvig; Frerich, Bernhard] Univ Rostock, Dept Oral & Maxillofacial Plast Surg, Rostock, Germany.
   [Henkel, Kai-Olaf] Fed Army Hosp Hamburg Wandsbek, Dept Oral & Maxillofacial Surg, Hamburg, Germany.
   [Holzhueter, Gerd; Radefeldt, Sven; Gerber, Thomas] Univ Rostock, Inst Phys, Rostock, Germany.
RP Kirchhoff, M (reprint author), Univ Rostock, Dept Oral & Maxillofacial Plast Surg, Rostock, Germany.
EM mkirchhoff@gmx.com
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Block AS, 2005, J ORAL MAXIL SURG, V63, P291, DOI 10.1016/j.joms.2004.11.005
   Cestari TM, 2009, CLIN ORAL IMPLAN RES, V20, P340, DOI 10.1111/j.1600-0501.2008.01659.x
   Chen YP, 2009, J BIOMED MATER RES A, V91A, P296, DOI 10.1002/jbm.a.32246
   Chiapasco M, 2006, CLIN ORAL IMPLAN RES, V17, P136, DOI 10.1111/j.1600-0501.2006.01357.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Fontana F, 2008, INT J PERIODONT REST, V28, P601
   GERBER T, 2007, Patent No. 1624904
   Gerike W., 2006, Folia Morphologica, V65, P54
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Henkel KO, 2006, ORAL SURG ORAL MED O, V102, P606, DOI 10.1016/j.tripleo.2005.10.034
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Olsen ML, 2004, CLIN ORAL IMPLAN RES, V15, P333, DOI 10.1111/j.1600-0501.2004.01016.x
   Park BW, 2007, ARCH ORAL BIOL, V52, P983, DOI 10.1016/j.archoralbio.2007.04.007
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rothamel D, 2009, INT J ORAL MAX IMPL, V24, P243
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P642, DOI 10.1111/j.1600-0501.2008.01537.x
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   von Arx T, 2001, CLIN ORAL IMPLAN RES, V12, P260, DOI 10.1034/j.1600-0501.2001.012003260.x
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Xu WG, 2009, J BIOMED MATER RES B, V91B, P692, DOI 10.1002/jbm.b.31445
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 28
TC 7
Z9 7
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2011
VL 96B
IS 2
BP 342
EP 350
DI 10.1002/jbm.b.31775
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 705VU
UT WOS:000286169600019
PM 21210515
DA 2018-10-20
ER

PT J
AU Krishnaji, ST
   Huang, WW
   Rabotyagova, O
   Kharlampieva, E
   Choi, I
   Tsukruk, VV
   Naik, R
   Cebe, P
   Kaplan, DL
AF Krishnaji, Sreevidhya T.
   Huang, Wenwen
   Rabotyagova, Olena
   Kharlampieva, Eugenia
   Choi, Ikjun
   Tsukruk, Vladimir V.
   Naik, Rajesh
   Cebe, Peggy
   Kaplan, David L.
TI Thin Film Assembly of Spider Silk-like Block Copolymers
SO LANGMUIR
LA English
DT Article
ID AIR-WATER-INTERFACE; CLAVIPES DRAGLINE SILK; AIR/WATER INTERFACE;
   NEPHILA-CLAVIPES; DIBLOCK COPOLYMER; MECHANICAL-PROPERTIES; SECONDARY
   STRUCTURE; SURFACE; CONFORMATION; ORIENTATION
AB We report the self-assembly of monolayers of spider silk-like block copolymers. Langmuir isotherms were obtained for a series of bioengineered variants of the spider silks, and stable monolayers were generated. Langmuir-Blodgett films were prepared by transferring the monolayers onto silica substrates and were subsequently analyzed by atomic force microscopy (AFM). Static contact angle measurements were performed to characterize interactions across the interface (thin film, water, air), and molecular modeling was used to predict 3D conformation of spider silk-like block copolymers. The influence of molecular architecture and volume fraction of the proteins on the self-assembly process was assessed. At high surface pressure, spider silk-like block copolymers with minimal hydrophobic block (f(A) = 12%) formed oblate structures, whereas block copolymer with a 6-fold larger hydrophobic domain (f(A) = 46%) formed prolate structures. The varied morphologies obtained with increased hydrophobicity offer new options for biomaterials for coatings and related options. The design and use of bioengineered protein block copolymers assembled at air-water interfaces provides a promising approach to compare 2D microstructures and molecular architectures of these amphiphiles, leading to more rationale designs for a range of nanoengineered biomaterial needs as well as providing a basis of comparison to more traditional synthetic block copolymer systems.
C1 [Kharlampieva, Eugenia; Choi, Ikjun; Tsukruk, Vladimir V.] Georgia Inst Technol, Atlanta, GA 30332 USA.
   [Krishnaji, Sreevidhya T.; Rabotyagova, Olena; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Krishnaji, Sreevidhya T.; Rabotyagova, Olena; Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Huang, Wenwen; Cebe, Peggy] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   [Naik, Rajesh] USAF, Res Lab, Mat & Mfg Directorate, Biotechnol Grp, Wright Patterson AFB, OH 45433 USA.
RP Tsukruk, VV (reprint author), Georgia Inst Technol, 771 Ferst Dr NW, Atlanta, GA 30332 USA.
EM vladimir@mse.gatech.edu; david.kaplan@tufts.edu
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083; Cebe, Peggy/0000-0002-8721-644X
FU AFOSR; NSF
FX We thank the AFOSR and the NSF for financial support.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Azzam T, 2006, ANGEW CHEM INT EDIT, V45, P7443, DOI 10.1002/anie.200602897
   Beattie D, 2006, BIOMACROMOLECULES, V7, P1072, DOI 10.1021/bm050858m
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Borner HG, 2007, SOFT MATTER, V3, P394, DOI 10.1039/b615985k
   Castelletto V, 2004, CURR OPIN SOLID ST M, V8, P426, DOI 10.1016/j.cossms.2005.06.001
   Cox JK, 1999, PHYS CHEM CHEM PHYS, V1, P4417, DOI 10.1039/a905008f
   Cox JK, 1999, LANGMUIR, V15, P7714, DOI 10.1021/la9901940
   Deschenes L, 2008, LANGMUIR, V24, P3699, DOI 10.1021/la702141h
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Farmer RS, 2006, MACROMOLECULES, V39, P162, DOI 10.1021/ma051534t
   Faure MC, 1999, MACROMOLECULES, V32, P8538, DOI 10.1021/ma9900840
   Faure MC, 1998, EUR PHYS J B, V3, P365, DOI 10.1007/s100510050324
   Fraser R., 1973, CONFORMATION FIBROUS
   Goeden-Wood NL, 2003, MACROMOLECULES, V36, P2932, DOI 10.1021/ma025952z
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grason GM, 2006, PHYS REP, V433, P1, DOI 10.1016/j.physrep.2006.08.001
   Gupta MK, 2010, ADV MATER, V22, P115, DOI 10.1002/adma.200901275
   Hamley IW, 2009, PROG POLYM SCI, V34, P1161, DOI 10.1016/j.progpolymsci.2009.06.003
   HAMLEY JW, 1998, PHYS BLOCK COPOLYMER
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Kaplan David L., 1997, P103
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Kim YS, 2010, LANGMUIR, V26, P336, DOI 10.1021/la902052f
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Liivak O, 1997, MACROMOLECULES, V30, P7127, DOI 10.1021/ma970834a
   MCCONNEY ME, 2010, POLYM REV IN PRESS
   MULLER WS, 1993, LANGMUIR, V9, P1857, DOI 10.1021/la00031a038
   MULLER WS, 1993, MATER RES SOC SYMP P, V292, P181
   Pagac ES, 1997, LANGMUIR, V13, P2993, DOI 10.1021/la9608829
   Park JY, 2009, SOFT MATTER, V5, P747, DOI 10.1039/b810149c
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   Peleshanko S, 2008, PROG POLYM SCI, V33, P523, DOI 10.1016/j.progpolymsci.2008.01.003
   Rabotyagova ES, 2008, MAT SCI ENG C-BIO S, V28, P1420, DOI 10.1016/j.msec.2008.03.012
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Renault A, 2009, LANGMUIR, V25, P8170, DOI 10.1021/la900475q
   Seo Y, 2008, LANGMUIR, V24, P2381, DOI 10.1021/la702745w
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sharma N, 2009, ANGEW CHEM INT EDIT, V48, P7078, DOI 10.1002/anie.200901621
   SHNEK DR, 1994, LANGMUIR, V10, P2382, DOI 10.1021/la00019a058
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   SMALL DM, 1986, PHYS CHEM LIPIDS
   Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T
   Thompson DH, 2007, CHEM LETT, V36, P956, DOI 10.1246/cl.2007.956
   Trubetskoy VS, 1999, ADV DRUG DELIVER REV, V37, P81, DOI 10.1016/S0169-409X(98)00100-8
   Tsukruk VV, 1997, RUBBER CHEM TECHNOL, V70, P430, DOI 10.5254/1.3538437
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   XU C, 2008, PHARM RES, V3, P674
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yee Ka, 2008, ANN PHYS CHEM, V59, P771
   Zhang JL, 2008, LANGMUIR, V24, P796, DOI 10.1021/la702567w
   ZHANG W, 1993, P ANN M EL MICR SOC, P1216
NR 66
TC 29
Z9 30
U1 3
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 1
PY 2011
VL 27
IS 3
BP 1000
EP 1008
DI 10.1021/la102638j
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 710BL
UT WOS:000286485600021
PM 21207952
DA 2018-10-20
ER

PT J
AU Foster, LJR
   Butt, J
AF Foster, L. John R.
   Butt, Julian
TI Chitosan films are NOT antimicrobial
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Chitosan; Staphylococcus aureus; Staphylococcus epidermidis; Escherichia
   coli; Biomaterial
ID SPOILAGE BACTERIA; POLYHYDROXYALKANOATES; CHITIN
AB Chitosan is a promising biomaterial for biomedical applications and is currently applied as wound dressings. While chitosan solutions demonstrate strong bactericidal activity against a range of medically important bacteria, the study here reports a loss of this beneficial property in thin films cast from the same solutions. Chitosan films (20 mu m) showed no inhibitory effects against Escherichia coli, Staphylococcus aureus or S. epidermidis species. In contrast, solutions used to prepare the films showed almost complete inhibition (similar to 98 +/- A 2%) when tested on bacterial lawns and in liquid cultures. Increased acidity of the chitosan solutions (pH 5) was shown to promote the bactericidal effects of this biopolymer. The concept that devices fabricated from chitosan have an inherent antimicrobial activity is suggested as an important misconception.
C1 [Foster, L. John R.; Butt, Julian] Univ New S Wales, Bio Polymer Res Grp, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Bio Polymer Res Grp, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
EM J.Foster@unsw.edu.au
CR BIAGINI G, 1991, BIOMATERIALS, V12, P287, DOI 10.1016/0142-9612(91)90036-A
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Foster LJR, 2008, BIOMACROMOLECULES, V9, P314, DOI 10.1021/bm7006289
   Foster LJR, 2001, BIOTECHNOL LETT, V23, P893, DOI 10.1023/A:1010528229685
   Gil G, 2004, BIOTECHNOL LETT, V26, P569, DOI 10.1023/B:BILE.0000021957.37426.9b
   KHOR L, 2003, BIOMATERIALS, V24, P2339
   LEHR CM, 1992, INT J PHARM, V78, P43, DOI 10.1016/0378-5173(92)90353-4
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MUZZARELLI RAA, 1999, CHITIN CHITINASES, P251
   Ouattara B, 2000, INT J FOOD MICROBIOL, V62, P139, DOI 10.1016/S0168-1605(00)00407-4
   Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Wicken A. J., 1983, TOXICON S, V3, P501
   WILSON M, BACTERIAL DIS MECH I
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
NR 17
TC 24
Z9 24
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD FEB
PY 2011
VL 33
IS 2
BP 417
EP 421
DI 10.1007/s10529-010-0435-1
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 706DW
UT WOS:000286198700031
PM 20953663
DA 2018-10-20
ER

PT J
AU Kocun, M
   Grandbois, M
   Cuccia, LA
AF Kocun, Marta
   Grandbois, Michel
   Cuccia, Louis A.
TI Single molecule atomic force microscopy and force spectroscopy of
   chitosan
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Chitosan; Atomic force microscopy; Single molecule force spectroscopy;
   Biopolymer desorption
ID DEACETYLATION; IMPLANTS; MODE
AB Atomic force microscopy (AFM) and AFM-based force spectroscopy was used to study the desorption of individual chitosan polymer chains from substrates with varying chemical composition. AFM images of chitosan adsorbed onto a flat mica substrate show elongated single strands or aggregated bundles. The aggregated state of the polymer is consistent with the high level of flexibility and mobility expected for a highly positively charged polymer strand. Conversely, the visualization of elongated strands indicated the presence of stabilizing interactions with the substrate. Surfaces with varying chemical composition (glass, self-assembled monolayer of mercaptoundecanoic acid/decanethiol and polytetrafluoroethylene (PTFE)) were probed with chitosan modified AFM tips and the corresponding desorption energies, calculated from plateau-like features, were attributed to the desorption of individual polymer strands. Desorption energies of 2.0 +/- 0.3 x 10(-20) J, 1.8 +/- 0.3 x 10(-20) J and 3.5 +/- 0.3 x 10(-20) J were obtained for glass, SAM of mercaptoundecanoic/dodecanethiol and PTFE, respectively. These single molecule level results can be used as a basis for investigating chitosan and chitosan-based materials for biomaterial applications. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kocun, Marta; Cuccia, Louis A.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada.
   [Grandbois, Michel] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.
RP Cuccia, LA (reprint author), Concordia Univ, Dept Chem & Biochem, 7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada.
EM cuccial@alcor.concordia.ca
FU NSERC; FQRNT; CFI; Concordia University; Sigma Xi
FX We thank Dr. M. Buschmann for the chitosan samples, Dr. M. Tabrizian for
   PTFE samples, Dr. V. loader for the synthesis of dithiobis(succinimidyl
   undecanoate) used in AFM tip functionalization and Dr. Rolf Schmidt for
   useful discussions and technical expertise. Dr. Fiorenzo Vetrone is
   thanked for careful proofreading of the manuscript. NSERC (M.G.,
   L.A.C.), FQRNT (L.A.C.), CFI ((M.G., L.A.C.)), Concordia University and
   Sigma Xi (Grant-in-Aid of Research) are thanked for financial support.
   We also acknowledge our membership in the FQRNT-supported,
   multi-university Centre for Self-Assembled Chemical Structures (CSACS).
CR Abu-Lail NI, 2003, J MICROSC-OXFORD, V212, P217, DOI 10.1111/j.1365-2818.2003.01261.x
   ALEX R, 2008, J BIOMED MATER RES A, V87, P78
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m
   Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hugel T, 2001, MACROMOLECULES, V34, P1039, DOI 10.1021/ma0009404
   Kacher CM, 2000, EUR BIOPHYS J BIOPHY, V28, P611, DOI 10.1007/s002490050001
   Kuehner F., 2006, LANGMUIR, V22, P11180
   Kujawa P, 2007, BIOMACROMOLECULES, V8, P3169, DOI 10.1021/bm7006339
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Morris S, 2004, NANOTECHNOLOGY, V15, P1296, DOI 10.1088/0957-4484/15/9/031
   MUZZARELLI RAA, 1977, CHITIN
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   ROBYT JF, 1998, ESSENTIALS CARBOHYDR
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   Seitz M, 2003, CHEMPHYSCHEM, V4, P986, DOI 10.1002/cphc.200300760
   Sonnenberg L, 2007, LANGMUIR, V23, P6660, DOI 10.1021/la063682y
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
NR 26
TC 16
Z9 16
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD FEB 1
PY 2011
VL 82
IS 2
BP 470
EP 476
DI 10.1016/j.colsurfb.2010.10.004
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 701XJ
UT WOS:000285858200031
PM 21071189
DA 2018-10-20
ER

PT J
AU Anderson, JM
   Vines, JB
   Patterson, JL
   Chen, H
   Javed, A
   Jun, HW
AF Anderson, Joel M.
   Vines, Jeremy B.
   Patterson, Jessica L.
   Chen, Haiyan
   Javed, Amjad
   Jun, Ho-Wook
TI Osteogenic differentiation of human mesenchymal stem cells
   synergistically enhanced by biomimetic peptide amphiphiles combined with
   conditioned medium
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone tissue regeneration; Peptide amphiphile; Mesenchymal stem cell;
   Extracellular matrix; Osteogenic differentiation
ID MARROW STROMAL CELLS; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; BETA-GLYCEROL
   PHOSPHATE; BONE-MARROW; IN-VITRO; EXTRACELLULAR-MATRIX; OSTEOBLASTIC
   DIFFERENTIATION; GENE-EXPRESSION; ADHERENT CELLS; MINERALIZATION
AB An attractive strategy for bone tissue engineering is the use of extracellular matrix (ECM) analogous biomaterials capable of governing biological response based on synthetic cell-ECM interactions. In this study, peptide amphiphiles (PAs) were investigated as an ECM-mimicking biomaterial to provide an instructive microenvironment for human mesenchymal stem cells (hMSCs) in an effort to guide osteogenic differentiation. PAs were biologically functionalized with ECM isolated ligand sequences (i.e. RGDS, DGEA), and the osteoinductive potential was studied with or without conditioned medium, containing the supplemental factors of dexamethasone, beta-glycerol phosphate and ascorbic acid. It was hypothesized that the ligand-functionalized PAs would synergistically enhance osteogenic differentiation in combination with conditioned medium. Concurrently, comparative evaluations independent of osteogenic supplements investigated the differentiating potential of the functionalized PA scaffolds as promoted exclusively by the inscribed ligand signals, thus offering the potential for therapeutic effectiveness under physiological conditions. Osteoinductivity was assessed by histochemical staining for alkaline phosphatase (ALP) and quantitative real-time polymerase chain reaction analysis of key osteogenic markers. Both of the ligand-functionalized PAs were found to synergistically enhance the level of visualized ALP activity and osteogenic gene expression compared to the control surfaces lacking biofunctionality. Guided osteoinduction was also observed without supplemental aid on the PA scaffolds, but at a delayed response and not to the same phenotypic levels. Thus, the biomimetic PAs foster a symbiotic enhancement of osteogenic differentiation, demonstrating the potential of ligand-functionalized biomaterials for future bone tissue repair. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Anderson, Joel M.; Vines, Jeremy B.; Patterson, Jessica L.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Chen, Haiyan; Javed, Amjad] Univ Alabama Birmingham, Inst Oral Hlth Res, Sch Dent, Birmingham, AL 35294 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, Shelby Bldg 806,1825 Univ Blvd, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
OI Javed, Amjad/0000-0002-0847-8266
FU Wallace H. Coulter Foundation; NSF; NIH [EB004312-01]; Ruth L.
   Kirschstein National Research Service Award [1F31DE021286-01]
FX The authors wish to acknowledge the Mass Spectrometry/Proteomics Shared
   Facility at UAB for analyzing all the PA samples. Special thanks are
   also extended to Dr. Ralph Sanderson for use of his real-time PCR
   laboratory facilities, along with Dr. Vishnu Ramani and Dr. Anurag
   Purushothaman for invaluable help and discussion with all the PCR
   experiments. This work was supported by the Wallace H. Coulter
   Foundation and the NSF CAREER awarded to H.-W.J., along with funding
   from NIH 132 predoctoral training Grant (NIBIB #EB004312-01) and Ruth L.
   Kirschstein National Research Service Award Individual Fellowship
   (1F31DE021286-01) for J.M.A.
CR Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Bernhardt A, 2009, J BIOMED MATER RES A, V90A, P852, DOI 10.1002/jbm.a.32144
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Canalis E, 1996, J CLIN ENDOCR METAB, V81, P3441, DOI 10.1210/jcem.81.10.8855781
   Chen TL, 2004, BONE, V35, P83, DOI 10.1016/j.bone.2004.03.019
   Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   Hamada K, 2008, J BIOMED MATER RES A, V84A, P128, DOI 10.1002/jbm.a.31439
   Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Ishida Y, 1998, J BONE MINER RES, V13, P1822, DOI 10.1359/jbmr.1998.13.12.1822
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jun HW, 2006, SOFT MATTER, V2, P177, DOI 10.1039/b516805h
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kim JK, 2009, MOL PHARMACEUT, V6, P978, DOI 10.1021/mp900009n
   Kimelman N, 2007, TISSUE ENG, V13, P1135, DOI 10.1089/ten.2007.0096
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Lowik DWPM, 2004, CHEM SOC REV, V33, P234, DOI 10.1039/b212638a
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200
   PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Prockop D. J., 2008, MESENCHYMAL STEM CEL
   ROACH HI, 1992, CALCIFIED TISSUE INT, V50, P553, DOI 10.1007/BF00582172
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salasznyk RM, 2004, CELL COMMUN ADHES, V11, P137, DOI 10.1080/15419060500242836
   Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676
   Stendahl JC, 2006, ADV FUNCT MATER, V16, P499, DOI 10.1002/adfm.200500161
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001
   Tobias JH, 1999, RHEUMATOLOGY, V38, P198, DOI 10.1093/rheumatology/38.3.198
   Walsh S, 2001, RHEUMATOLOGY, V40, P74, DOI 10.1093/rheumatology/40.1.74
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zhou YF, 2007, BIOMATERIALS, V28, P814, DOI 10.1016/j.biomaterials.2006.09.032
NR 62
TC 38
Z9 41
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2011
VL 7
IS 2
BP 675
EP 682
DI 10.1016/j.actbio.2010.08.016
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 713AP
UT WOS:000286707700023
PM 20728586
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schnitzler, V
   Fayon, F
   Despas, C
   Khairoun, I
   Mellier, C
   Rouillon, T
   Massiot, D
   Walcarius, A
   Janvier, P
   Gauthier, O
   Montavon, G
   Bouler, JM
   Bujoli, B
AF Schnitzler, Verena
   Fayon, Franck
   Despas, Christelle
   Khairoun, Ibrahim
   Mellier, Charlotte
   Rouillon, Thierry
   Massiot, Dominique
   Walcarius, Alain
   Janvier, Pascal
   Gauthier, Olivier
   Montavon, Gilles
   Bouler, Jean-Michel
   Bujoli, Bruno
TI Investigation of alendronate-doped apatitic cements as a potential
   technology for the prevention of osteoporotic hip fractures: Critical
   influence of the drug introduction mode on the in vitro cement
   properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate cements; Drug delivery; Bisphosphonates; Biomedical
   applications; Osteoporosis
ID PHOSPHATE BONE CEMENTS; CALCIUM-DEFICIENT APATITE; QUANTUM
   NMR-SPECTROSCOPY; SOLID-STATE; BISPHOSPHONATE DELIVERY; HYDRATION
   INHIBITION; TITANIUM IMPLANTS; PROXIMAL FEMUR; HYDROXYAPATITE; SYSTEMS
AB Combination of a bisphosphonate (BP) anti-osteoporotic drug, alendronate, with an apatitic calcium phosphate cement does not significantly affect the main properties of the biomaterial, in terms of injectability and setting time, provided that the BP is introduced chemisorbed onto calcium-deficient apatite, one of the components of the cement. In contrast to other modes of introducing the BP into the cement formulation, this mode allows to minimize alendronate release in the cement paste, thus limiting the setting retardant effect of the BP. An original approach based on high frequency impedance measurements is found to be a convenient method for in situ monitoring of the cement setting reaction. The release profile of the drug from a cement block under continuous flow conditions can be well described using a coupled chemistry/transport model, under simulated in vivo conditions. The results show that the released alendronate concentration is expected to be much lower than the cytotoxic concentration. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Khairoun, Ibrahim; Rouillon, Thierry; Gauthier, Olivier; Bouler, Jean-Michel] Univ Nantes, INSERM, UMR 791, Fac Chirurg Dent,LIOAD, F-44042 Nantes 1, France.
   [Schnitzler, Verena; Mellier, Charlotte] Graftys SARL, F-13854 Aix En Provence 3, France.
   [Fayon, Franck; Massiot, Dominique] CNRS, UPR 3079, CEMHTI, F-45071 Orleans 02, France.
   [Despas, Christelle; Walcarius, Alain] Nancy Univ, CNRS, UMR 7564, LCPME, F-54600 Villers Les Nancy, France.
   [Janvier, Pascal; Bujoli, Bruno] Univ Nantes, CNRS, UMR 6230, CEISAM,UFR Sci & Tech, F-44322 Nantes 3, France.
   [Montavon, Gilles] SUBATECH, CNRS, UMR 6457, Ecole Mines Nantes, F-44307 Nantes 3, France.
RP Bouler, JM (reprint author), Univ Nantes, INSERM, UMR 791, Fac Chirurg Dent,LIOAD, BP 84215, F-44042 Nantes 1, France.
EM bruno.bujoli@univ-nantes.fr
RI Gauthier, Olivier/A-4639-2015; Fayon, Franck/C-1835-2008; Rouillon,
   Thierry/P-1587-2014; Massiot, Dominique/C-1287-2008; WALCARIUS,
   Alain/G-2727-2013; Montavon, Gilles/O-1225-2017
OI Massiot, Dominique/0000-0003-1207-7040; Montavon,
   Gilles/0000-0002-3049-0106; BOULER, Jean-Michel/0000-0001-9784-5584
FU Region Pays de la Loire (Bioregos I Program); ANR [5A0659]; Graftys Co.;
   TGE RMN THC [FR3050]
FX This work was partially supported by the Region Pays de la Loire
   (Bioregos I Program), ANR (RNTS 2005 Program, grant 5A0659) and Graftys
   Co. Financial support from the TGE RMN THC FR3050 to conduct the
   research is gratefully acknowledged. We thank S. Ribet (SUBATECH) who
   contributed to the simulation results on the release of BP from the
   cement block under dynamic conditions.
CR AMES BN, 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   *ASTM, 1966, C26689 ASTM
   Beckmann J, 2007, MED ENG PHYS, V29, P755, DOI 10.1016/j.medengphy.2006.08.006
   BESSIERE J, 1995, SENSOR ACTUAT B-CHEM, V27, P411, DOI 10.1016/0925-4005(94)01629-V
   Bishop M, 2003, CHEM MATER, V15, P3074, DOI 10.1021/cm0302431
   Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040
   Bobyn JD, 2009, J BONE JOINT SURG AM, V91A, P23, DOI 10.2106/JBJS.I.00518
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   Bradley JP, 2009, PHYS CHEM CHEM PHYS, V11, P6941, DOI 10.1039/b906400a
   Brenner G. S., 1991, Patent No. [EP 0449405.A2, 0449405]
   Brinkmann A, 2000, J CHEM PHYS, V112, P8539, DOI 10.1063/1.481458
   Brown SP, 2001, CHEM REV, V101, P4125, DOI 10.1021/cr990132e
   Cabanas MV, 2002, CHEM MATER, V14, P3550, DOI 10.1021/cm021121w
   Denissen H, 2000, J PERIODONTOL, V71, P272, DOI 10.1902/jop.2000.71.2.272
   Despas C, 1997, TALANTA, V45, P357, DOI 10.1016/S0039-9140(97)00138-0
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Elliott SN, 1997, LIFE SCI, V62, P77, DOI 10.1016/S0024-3205(97)01040-0
   Feike M, 1998, J NON-CRYST SOLIDS, V223, P200, DOI 10.1016/S0022-3093(97)00439-0
   Fernandez D, 2003, ACTA CRYSTALLOGR C, V59, pM543, DOI 10.1107/S0108270103025599
   GALLACHER SJ, 1989, LANCET, V2, P42
   Gallagher AM, 2008, J BONE MINER RES, V23, P1569, DOI [10.1359/jbmr.080510, 10.1359/JBMR.080510]
   Gao Y, 2009, BIOMATERIALS, V30, P1790, DOI 10.1016/j.biomaterials.2008.12.025
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5
   Gittings JP, 2009, ACTA BIOMATER, V5, P743, DOI 10.1016/j.actbio.2008.08.012
   GOTTWALD J, 1995, CHEM PHYS LETT, V243, P314, DOI 10.1016/0009-2614(95)00872-2
   GU P, 1995, ADV CEM BASED MATER, V2, P182, DOI 10.1016/1065-7355(95)90002-0
   Heini PF, 2004, CLIN BIOMECH, V19, P506, DOI 10.1016/j.clinbiomech.2004.01.014
   Hofmann MP, 2006, J BIOMED MATER RES B, V79B, P360, DOI 10.1002/jbm.b.30550
   HYLDSTRUP L, 1993, CALCIFIED TISSUE INT, V53, P297, DOI 10.1007/BF01351831
   Johnell O, 1997, AM J MED, V103, p25S
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Josse S, 2004, ADV MATER, V16, P1423, DOI 10.1002/adma.200306340
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   KHAIROUN I, 2008, Patent No. 2008023254
   LEGEROS R Z, 1982, Journal of Dental Research, V61, P343
   Lewis G, 2006, CLIN ORTHOP RELAT R, P233, DOI 10.1097/01.blo.0000201162.59819.28
   Liu CS, 1999, J AM CERAM SOC, V82, P1052, DOI 10.1111/j.1151-2916.1999.tb01872.x
   Lupu C, 2005, CHEM COMMUN, P2354, DOI 10.1039/b500192g
   Migliorati CA, 2003, J CLIN ONCOL, V21, P4253, DOI 10.1200/JCO.2003.99.132
   MUKHERJEE H, 2009, J AM CHEM SOC, V131, P8374
   Mukherjee S, 2008, J AM CHEM SOC, V130, P1264, DOI 10.1021/ja0759949
   Nancollas GH, 2006, BONE, V38, P617, DOI 10.1016/j.bone.2005.05.003
   Nilsson M, 2002, J MATER SCI-MATER M, V13, P1135, DOI 10.1023/A:1021181702807
   Obadia L, 2007, J BIOMED MATER RES B, V80B, P32, DOI 10.1002/jbm.b.30565
   Panzavolta S, 2009, J INORG BIOCHEM, V103, P101, DOI 10.1016/j.jinorgbio.2008.09.012
   Parkhurst DL, 1999, 994259 US GEOL SURV
   Parratte S, 2010, OSTEOPOROSIS INT, V21, P346
   Peter B, 2006, J BIOMED MATER RES A, V76A, P133, DOI 10.1002/jbm.a.30456
   PING X, 1993, CEMENT CONCRETE RES, V23, P359
   Purcell PM, 2005, MED J AUSTRALIA, V182, P417
   Robinson J, 2006, J MOL STRUCT, V825, P134, DOI 10.1016/j.molstruc.2006.04.032
   Roussiere H, 2005, J MATER CHEM, V15, P3869, DOI 10.1039/b503680a
   Roussiere H, 2008, CHEM MATER, V20, P182, DOI 10.1021/cm702584d
   Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8
   Russell RGG, 2007, BONE, V40, pS21, DOI 10.1016/j.bone.2007.03.002
   Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0
   Schnell I, 2001, J MAGN RESON, V151, P153, DOI 10.1006/jmre.2001.2336
   Taha EA, 2003, CHEM PHARM BULL, V51, P1444, DOI 10.1248/cpb.51.1444
   Tanaka Y, 2008, J CERAM SOC JPN, V116, P815, DOI 10.2109/jcersj2.116.815
   Tanzer M, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000194728.62996.2d
   Taylor HF, 1997, CEMENT CHEM
   Thiebaud D, 1997, CALCIFIED TISSUE INT, V61, P386, DOI 10.1007/s002239900353
   THIEBAUT JM, 1989, J ELECTROANAL CHEM, V262, P131, DOI 10.1016/0022-0728(89)80017-8
   Trtnik G, 2008, CEMENT CONCRETE RES, V38, P1336, DOI 10.1016/j.cemconres.2008.08.003
   Vachal P, 2006, J MED CHEM, V49, P3060, DOI 10.1021/jm060398v
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Verron E, 2010, DRUG DISCOV TODAY, V15, P547, DOI 10.1016/j.drudis.2010.05.003
   Walcarius A, 2006, LANGMUIR, V22, P1671, DOI 10.1021/la0522404
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Wang Q, 2009, PHYS CHEM CHEM PHYS, V11, P10391, DOI 10.1039/b914468d
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
NR 75
TC 33
Z9 34
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2011
VL 7
IS 2
BP 759
EP 770
DI 10.1016/j.actbio.2010.09.017
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 713AP
UT WOS:000286707700033
PM 20854940
DA 2018-10-20
ER

PT J
AU Johnsen, BO
   Ronning, EJ
   Onken, A
   Figved, W
   Jenum, PA
AF Johnsen, Bjorn Odd
   Ronning, Else Johanne
   Onken, Annette
   Figved, Wender
   Jenum, Pal A.
TI Dolosigranulum pigrum causing biomaterial-associated arthritis
SO APMIS
LA English
DT Article
DE Dolosigranulum pigrum; infectious arthritis; biomaterials
ID INFECTIONS; PNEUMONIA
AB Dolosigranulum pigrum is a gram-positive, catalase-negative bacteria rarely associated with disease. We report a case of biomaterial-associated arthritis in an immunocompetent patient caused by D. pigrum. The organism was isolated from a synovial biopsy specimen and its identity confirmed by 16S rRNA gene sequencing.
C1 [Johnsen, Bjorn Odd; Onken, Annette] Oslo Univ Hosp, Rikshosp, Dept Microbiol, N-0424 Oslo, Norway.
   [Johnsen, Bjorn Odd; Jenum, Pal A.] Asker & Baerum Hosp, Dept Microbiol, Baerum, Norway.
   [Ronning, Else Johanne] Asker & Baerum Hosp, Dept Internal Med, Baerum, Norway.
   [Figved, Wender] Asker & Baerum Hosp, Dept Orthopaed, Baerum, Norway.
RP Johnsen, BO (reprint author), Oslo Univ Hosp, Rikshosp, Dept Microbiol, PB 4950 Nydalen, N-0424 Oslo, Norway.
EM Bjorn.Odd.Johnsen@oslo-universitessykehus.no
OI Johnsen, Bjorn Odd/0000-0001-8044-2818
CR AGUIRRE M, 1993, J APPL BACTERIOL, V75, P608, DOI 10.1111/j.1365-2672.1993.tb01602.x
   Hall GS, 2001, J CLIN MICROBIOL, V39, P1202, DOI 10.1128/JCM.39.3.1202-1203.2001
   Hoedemaekers A, 2006, J CLIN MICROBIOL, V44, P3461, DOI 10.1128/JCM.01050-06
   LaClaire L, 2000, ANTIMICROB AGENTS CH, V44, P2001, DOI 10.1128/AAC.44.7.2001-2003.2000
   Lecuyer H, 2007, J CLIN MICROBIOL, V45, P3474, DOI 10.1128/JCM.01373-07
   Lin JC, 2006, J CLIN MICROBIOL, V44, P2298, DOI 10.1128/JCM.02520-05
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 7
TC 1
Z9 1
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0903-4641
J9 APMIS
JI APMIS
PD FEB
PY 2011
VL 119
IS 2
BP 85
EP 87
DI 10.1111/j.1600-0463.2010.02697.x
PG 3
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA 702WB
UT WOS:000285925500001
PM 21208274
DA 2018-10-20
ER

PT J
AU Zhang, XH
   Hu, J
   Li, YF
   Yin, GZ
   Luo, E
AF Zhang, Xiaohui
   Hu, Jing
   Li, Yunfeng
   Yin, Guozhu
   Luo, En
TI Effects of ibandronate-hydroxyapatite on resorptive activity of
   osteoclasts
SO ARCHIVES OF MEDICAL SCIENCE
LA English
DT Article
DE hydroxyapatite; bisphosphonate; osteoclast; biomaterial
ID OSTEOBLAST ADHESION; BONE TURNOVER; BISPHOSPHONATES; TITANIUM; SURFACE;
   PAMIDRONATE; CLODRONATE; CALCITONIN; BEHAVIOR
AB Introduction: Bisphosphonates (BPs) can be locally used to improve the osteogenesis around hydroxyapatite (HA) implants. However, there are almost no reports discussing the effects of BPs in the bound state with HA on osteoclasts. Ibandronate is a BP widely used in clinical practice. This study was designed to evaluate the effects of ibandronate combined with HA on the morphology and resorptive activity of osteoclasts.
   Material and methods: The HA and ibandronate-HA were prepared. Osteoclasts were isolated from Sprague-Dawley rats and then the cells were cultured with both HA and ibandronate-HA. Then the cell morphology was inspected by inverted phase contrast microscope and transmission electron microscopy observation. The resorptive activity was tested using the dyeing agent seminaphthofluorescein and bone resorption assay.
   Results: Compared with the control group, the osteoclasts demonstrated morphological alterations, and the hydrogen ion concentration was significantly lower in the ibandronate-HA group. Areas of the resorption pits formed by the osteoclasts were significantly smaller, the trabecula thickness appeared thicker, and concentration of CTx was also significantly lower in the experimental group.
   Conclusions: Resorptive activity of osteoclasts cultured with ibandronate-HA was weaker than that of the control group. Ibandronate on HA in the bound state could maintain its action as an inhibitor to osteoclasts.
C1 [Zhang, Xiaohui; Hu, Jing; Li, Yunfeng; Yin, Guozhu; Luo, En] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Sichuan Prov, Peoples R China.
RP Luo, E (reprint author), Sichuan Univ, State Key Lab Oral Dis, Renmin S Ave, Chengdu 610041, Sichuan Prov, Peoples R China.
EM luoen521125@sina.com
FU National Science Foundation of China [30700950, 30973346]; Doctoral
   Specialty Foundation of High School [20070610061]
FX This study was supported by grants from the financial support of the
   National Science Foundation of China (30700950 and 30973346), the
   Doctoral Specialty Foundation of High School (20070610061).
CR CHAMBERS TJ, 1982, J PATHOL, V136, P27, DOI 10.1002/path.1711360104
   Cukrowski I, 2007, BONE, V41, P668, DOI 10.1016/j.bone.2007.05.008
   David P, 1996, J BONE MINER RES, V11, P1498, DOI 10.1002/jbmr.5650111017
   EPKER BN, 1965, J DENT RES, V44, P33, DOI 10.1177/00220345650440012801
   Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80
   Frith JC, 1997, J BONE MINER RES, V12, P1358, DOI 10.1359/jbmr.1997.12.9.1358
   Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006
   He G, 2008, APPL SURF SCI, V255, P442, DOI 10.1016/j.apsusc.2008.06.088
   Kajiwara H, 2005, BIOMATERIALS, V26, P581, DOI 10.1016/j.biomaterials.2004.02.072
   Kandil ME, 2009, ARCH MED SCI, V5, P434
   Luo E, 2008, APPL SURF SCI, V255, P308, DOI 10.1016/j.apsusc.2008.06.090
   Luo E, 2007, KEY ENG MATER, V330-332, P885, DOI 10.4028/www.scientific.net/KEM.330-332.885
   LUO E, 2005, J WUHAN UNIV TECHNOL, V20, P98
   Makras P, 2009, BONE, V44, P766, DOI 10.1016/j.bone.2009.01.371
   Riihonen R, 2007, BONE, V40, P1021, DOI 10.1016/j.bone.2006.11.028
   Rogers Michael J., 2000, Cancer, V88, P2961, DOI 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.3.CO;2-C
   Rogers MJ, 1997, CANCER, V80, P1652, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1652::AID-CNCR15>3.0.CO;2-Z
   Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7
   SWAIN VM, 2009, INT J ORAL SCI, V4, P177
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Xie Z, 2006, J CHROMATOGR A, V1104, P173, DOI 10.1016/j.chroma.2005.11.113
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   ZIMOLO Z, 1995, J CLIN INVEST, V96, P2277, DOI 10.1172/JCI118283
NR 23
TC 3
Z9 4
U1 0
U2 8
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA WENEDOW ST 9-1, POZNAN, 61-614, POLAND
SN 1734-1922
J9 ARCH MED SCI
JI Arch. Med. Sci.
PD FEB
PY 2011
VL 7
IS 1
BP 53
EP 60
DI 10.5114/aoms.2011.20604
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 765ZL
UT WOS:000290747800009
PM 22291733
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Intranuovo, F
   Favia, P
   Sardella, E
   Ingrosso, C
   Nardulli, M
   d'Agostino, R
   Gristina, R
AF Intranuovo, Francesca
   Favia, Pietro
   Sardella, Eloisa
   Ingrosso, Chiara
   Nardulli, Marina
   d'Agostino, Riccardo
   Gristina, Roberto
TI Osteoblast-Like Cell Behavior on Plasma Deposited Micro/Nanopatterned
   Coatings
SO BIOMACROMOLECULES
LA English
DT Article
ID FLUOROCARBON COATINGS; HEXAFLUOROPROPYLENE OXIDE; SURFACE-MORPHOLOGY;
   THIN-FILMS; ADHESION; TOPOGRAPHY; ROUGHNESS; PROLIFERATION; ACTIVATION;
   MIGRATION
AB The behavior of cells in terms of cell-substrate and cell-cell interaction is dramatically affected by topographical characteristics as shape, height, and distance, encountered in their physiological environment. The combination of chemistry and topography of a biomaterial surface influences in turns, important biological responses as inflammatory events at tissue-implant interface, angiogenesis, and differentiation of cells. By disentangling the effect of material chemistry from the topographical one, the possibility of controlling the cell behavior can be provided. In this paper, surfaces with different roughness and morphology were produced by radiofrequency (RF, 13.56 MHz) glow discharges, fed with hexafluoropropylene oxide (C3F6O), in a single process. Coatings with different micro/nanopatterns and the same uppermost chemical composition were produced by combining two plasma deposition processes, with C3F6O and tetrafluoroethylene (C2F4), respectively. The behavior of osteoblast-like cells toward these substrates clearly shows a strict dependence of cell adhesion and proliferation on surface roughness and morphology.
C1 [Intranuovo, Francesca; Favia, Pietro; Nardulli, Marina; d'Agostino, Riccardo] Univ Bari, Dept Chem, I-70121 Bari, Italy.
   [Favia, Pietro; Sardella, Eloisa; d'Agostino, Riccardo; Gristina, Roberto] IMIP CNR, Inst Inorgan Methodol & Plasmas, Bari, Italy.
   [Ingrosso, Chiara] IPCF CNR, Inst Chem & Phys Proc, Bari, Italy.
RP Intranuovo, F (reprint author), Univ Bari, Dept Chem, I-70121 Bari, Italy.
EM intranuovo@chimica.uniba.it
RI Intranuovo, Francesca/A-3910-2013
OI SARDELLA, ELOISA/0000-0002-6776-8327
FU PRISMA INSTM [PRISMA05MADA1]; INTERREG, Italy-Greece regional [I
   2101003]
FX The authors thank the laboratory support of Mr. S. Cosmai (IMIP-CNR
   Bari, Italy), Mrs. P. Rossini (Plasma Solution Srl, Italy), Ms. G.
   Genchi, and Mrs. R. Giordano. This work has been funded by the PRISMA
   INSTM (PRISMA05MADA1 nanostructured surfaces having a specific
   biological response) project and the INTERREG (I 2101003) Italy-Greece
   regional (Apulia and Acaia regions) project.
CR Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Beamson G., 1992, HIGH RESOLUTION XPS
   Buttiglione M, 2007, BIOMATERIALS, V28, P2932, DOI 10.1016/j.biomaterials.2007.02.022
   d'Agostino R., 1990, PLASMA DEPOSITION TR, P95
   D'Aloia E., 2007, SURF SCI, V601, P1019
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   Denes FS, 2004, PROG POLYM SCI, V29, P815, DOI 10.1016/j.progpolymsci.2004.05.001
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Favia P, 2008, NATO SCI PEACE SEC A, P203
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gristina R, 2009, J BIOMED MATER RES B, V88B, P139, DOI 10.1002/jbm.b.31160
   Intranuovo F, 2009, CHEM VAPOR DEPOS, V15, P95, DOI 10.1002/cvde.200806755
   Jung HJ, 2008, ARTIF ORGANS, V32, P981
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Labelle CB, 1999, J APPL POLYM SCI, V74, P2439, DOI 10.1002/(SICI)1097-4628(19991205)74:10<2439::AID-APP12>3.0.CO;2-6
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lau KKS, 2000, CHEM MATER, V12, P3032, DOI 10.1021/cm000499w
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Martin IT, 2004, J VAC SCI TECHNOL A, V22, P227, DOI 10.1116/1.1638779
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Matsuda T, 1996, J BIOMED MATER RES, V32, P165
   Milella A, 2005, PURE APPL CHEM, V77, P399, DOI 10.1351/pac200577020399
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Pistillo BR, 2009, PLASMA PROCESS POLYM, V6, pS61, DOI 10.1002/ppap.200930308
   Ratner B.D., 2004, BIOMATERIALS SCI
   Riehle M., 2002, MATER RES SOC S P, V705, P107
   Rosso F, 2006, J CELL PHYSIOL, V207, P636, DOI 10.1002/jcp.20595
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Salerno S, 2009, BIOMATERIALS, V30, P4348, DOI 10.1016/j.biomaterials.2009.04.052
   Sardella E., 2009, PLASMA PROCESS POLYM, V6, pS57
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yuanbin L., 1999, PROG NEUROPSYCHOPHAR, V23, P377
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhu MF, 2006, J MATER SCI, V41, P3793, DOI 10.1007/s10853-005-5910-z
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 43
TC 18
Z9 18
U1 0
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2011
VL 12
IS 2
BP 380
EP 387
DI 10.1021/bm101136n
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 719BZ
UT WOS:000287175700013
PM 21190339
DA 2018-10-20
ER

PT J
AU Yeo, M
   Lee, H
   Kim, G
AF Yeo, MyungGu
   Lee, Hyeongjin
   Kim, GeunHyung
TI Three-Dimensional Hierarchical Composite Scaffolds Consisting of
   Polycaprolactone, beta-Tricalcium Phosphate, and Collagen Nanofibers:
   Fabrication, Physical Properties, and In Vitro Cell Activity for Bone
   Tissue Regeneration
SO BIOMACROMOLECULES
LA English
DT Article
ID NANOCOMPOSITE SCAFFOLDS; BEHAVIOR; PROLIFERATION; ATTACHMENT; DESIGN
AB beta-Tricalcium phosphate (beta-TCP) and collagen have been widely used to regenerate various hard tissues, but although Bioceramics and collagen have various biological advantages with respect to cellular activity, their usage has been limited due to beta-TCP's inherent brittleness and low mechanical properties, along with the low shape-ability of the three-dimensional collagen. To overcome these material deficiencies, we fabricated a new hierarchical scaffold that consisted of a melt-plotted polycaprolactone (PCL)/beta-TCP composite and embedded collagen nanofibers. The fabrication process was combined with general melt-plotting methods and electrospinning. To evaluate the capability of this hierarchical scaffold to act as a biomaterial for bone tissue regeneration, physical and biological assessments were performed. Scanning electron microscope (SEM) micrographs of the fabricated scaffolds indicated that the beta-TCP particles were uniformly embedded in PCL struts and that electrospun collagen nanofibers (diameter = 160 nm) were well layered between the composite struts. By accommodating the beta-TCP and collagen nanofibers, the hierarchical composite scaffolds showed dramatic water-absorption ability (100% increase), increased hydrophilic properties (20%), and good mechanical properties similar to PCL/beta-TCP composite. MTT assay and SEM images of cell-seeded scaffolds showed that the initial attachment of osteoblast-like cells (MG63) in the hierarchical scaffold was 2.2 times higher than that on the PCL/beta-TCP composite scaffold. Additionally, the proliferation rate of the cells was about two times higher than that of the composite scaffold after 7 days of cell culture. Based on these results, we conclude that the collagen nanofibers and beta-TCP particles in the scaffold provide good synergistic effects for cell activity.
C1 [Yeo, MyungGu; Lee, Hyeongjin; Kim, GeunHyung] Chosun Univ, Dept Mech Engn, Bio Nanofluid Lab, Kwangju 501759, South Korea.
   [Kim, GeunHyung] Chosun Univ, Coll Dent, Dept Dent Life Sci, Kwangju 501759, South Korea.
RP Kim, G (reprint author), Chosun Univ, Dept Mech Engn, Bio Nanofluid Lab, Kwangju 501759, South Korea.
EM gkim@chosun.ac.kr
CR Arafat M. T., 2010, ACTA BIOMATER, DOI [10.1016/j.actbio, DOI 10.1016/J.ACTBIO]
   BITTIGER H, 1970, ACTA CRYSTALL B-STRU, VB 26, P1923, DOI 10.1107/S0567740870005198
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Dalton PD, 2009, BIOMATERIALS, V30, P2420, DOI 10.1016/j.biomaterials.2009.01.049
   HALPIN JC, 1976, POLYM ENG SCI, V16, P344
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Kalbacova M, 2008, PHYS STATUS SOLIDI B, V245, P2124, DOI 10.1002/pssb.200879579
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim CH, 2006, J BIOMED MATER RES B, V78B, P283, DOI 10.1002/jbm.b.30484
   Kim GH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956416
   Kim G, 2008, MACROMOL RAPID COMM, V29, P1577, DOI 10.1002/marc.200800277
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li X, 2010, CARBOHYD POLYM, V79, P429, DOI 10.1016/j.carbpol.2009.08.032
   Liang JZ, 2001, J REINF PLAST COMP, V20, P630, DOI 10.1106/EJRE-YF61-YNY9-70X3
   Manson J. A., 1976, POLYM BLENDS COMPOSI
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nair KCM, 2000, COMPOS PART A-APPL S, V31, P1231, DOI 10.1016/S1359-835X(00)00083-X
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   UTRACKI LA, 1983, POLYM ENG SCI, V23, P602, DOI 10.1002/pen.760231103
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeo A, 2010, J BIOMED MATER RES A, V93A, P1358, DOI 10.1002/jbm.a.32633
   Zhou YF, 2007, POLYM INT, V56, P333, DOI 10.1002/pi.2138
NR 37
TC 66
Z9 68
U1 0
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2011
VL 12
IS 2
BP 502
EP 510
DI 10.1021/bm1013052
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 719BZ
UT WOS:000287175700027
PM 21189025
DA 2018-10-20
ER

PT J
AU Fernandez, ICS
   Busscher, HJ
   Metzger, SW
   Grainger, DW
   van der Mei, HC
AF Fernandez, Isabel C. Saldarriaga
   Busscher, Henk J.
   Metzger, Steve W.
   Grainger, David W.
   van der Mei, Henny C.
TI Competitive time- and density-dependent adhesion of staphylococci and
   osteoblasts on crosslinked poly(ethylene glycol)-based polymer coatings
   in co-culture flow chambers
SO BIOMATERIALS
LA English
DT Article
DE Staphylococcus epidermidis; U2OS osteoblasts; Biomaterial-associated
   infections; Co-culture; PEG coatings; Race for the surface
ID BACTERIAL ADHESION; TISSUE INTEGRATION; MICROBIAL ADHESION;
   SURFACE-PROPERTIES; BIOFILM FORMATION; SILICONE-RUBBER; CHEMISTRY;
   INFECTION; IMMOBILIZATION; TITANIUM
AB Biomaterial-associated infections (BAI) remain a serious clinical complication, often arising from an inability of host tissue-implant integration to out-compete bacterial adhesion and growth. A commercial polymer coating based on polyethylene glycol (PEG), available in both chemically inert and NHS-activated forms (OptiChem), was compared for simultaneous growth of staphylococci and osteoblasts. In the absence of staphylococci, osteoblasts adhered and proliferated well on glass controls and on the NHS-reactive PEG-based coating over 48 h, but not on the inert PEG coating. Staphylococcal growth was low on both PEG-based coatings. When staphylococci were pre-adhered on surfaces for 1.5 h to mimic peri-operative contamination, osteoblast growth and spreading was reduced on glass but virtually absent on both reactive and inert PEG-based coatings. Thus although NHS-reactive, PEG-based coatings stimulated tissue cell interactions in the absence of contaminating staphylococci, the presence of adhering staphylococci eliminated osteoblast adhesion advantages on the PEG surface. This study demonstrates the importance of using bacterial and cellular co-cultures compared to monocultures when assessing functionalized biomaterials coatings for infectious potential. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Fernandez, Isabel C. Saldarriaga; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Metzger, Steve W.] Accelr8 Technol Corp, Denver, CO 80221 USA.
   [Grainger, David W.] Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Coll Pharm, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn FB40, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
FU University of Groningen-University Medical Center Groningen, Groningen,
   The Netherlands
FX This research was funded by the University of Groningen-University
   Medical Center Groningen, Groningen, The Netherlands.
CR Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Currie EPK, 2003, ADV COLLOID INTERFAC, V100, P205, DOI 10.1016/S0001-8686(02)00061-1
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023
   Fernandez ICS, 2010, ACTA BIOMATER, V6, P1119, DOI 10.1016/j.actbio.2009.08.040
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Lavanant L, 2008, CHIMIA, V62, P793, DOI 10.2533/chimia.2008.793
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   MAO G, 2005, Patent No. 6844028
   Marsh LH, 2002, J BIOMED MATER RES, V61, P641, DOI 10.1002/jbm.10174
   Nejadnik MR, 2008, J ANTIMICROB CHEMOTH, V62, P1323, DOI 10.1093/jac/dkn395
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Takahashi H, 2008, ADV FUNCT MATER, V18, P2079, DOI 10.1002/adfm.200800105
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Whyte W, 1982, J Hosp Infect, V3, P123, DOI 10.1016/0195-6701(82)90004-4
NR 27
TC 19
Z9 19
U1 7
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 4
BP 979
EP 984
DI 10.1016/j.biomaterials.2010.10.011
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 699PL
UT WOS:000285675200004
PM 20980049
DA 2018-10-20
ER

PT J
AU Lu, QA
   Wang, XL
   Lu, SZ
   Li, MZ
   Kaplan, DL
   Zhu, HS
AF Lu, Qiang
   Wang, Xiuli
   Lu, Shenzhou
   Li, Mingzhong
   Kaplan, David L.
   Zhu, Hesun
TI Nanofibrous architecture of silk fibroin scaffolds prepared with a mild
   self-assembly process
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Scaffold; Silk; Nanofiber; Tissue engineering
ID GROWTH-FACTOR; IN-VITRO; FILMS; MATRIX; CELLS; DIFFERENTIATION;
   STABILIZATION; BIOMATERIAL; ATTACHMENT; DELIVERY
AB Besides excellent biocompatibility and biodegradability, a useful tissue engineering scaffold should provide suitable macropores and nanofibrous structure, similar to extracellular matrix (ECM), to induce desired cellular activities and to guide tissue regeneration. In the present study, a mild process to prepare porous and nanofibrous silk-based scaffolds from aqueous solution is described. Using collagen to control the self-assembly of silk, nanofibrous silk scaffolds were firstly achieved through lyophilization. Water annealing was used to generate insolubility in the silk-based scaffolds, thereby avoiding the use of organic solvents. The nano-fibrils formed in the silk-collagen scaffolds had diameters of 20-100 nm, similar with native collagen in ECM. The silk-collagen scaffolds dissolved slowly in PBS solution, with about a 28% mass lost after 4 weeks. Following the dissolution or degradation, the nanofibrous structure inside the macropore walls emerged and interacted with cells directly. During in vitro cell culture, the nanofibrous silk-collagen scaffolds containing 7.4% collagen demonstrated significantly improved cell compatibility when compared with salt-leached silk scaffolds and silk-collagen scaffolds containing 20% collagen that emerged less nano-fibrils. Therefore, this new process provides useful scaffolds for tissue engineering applications. Furthermore, the process involves all-aqueous, room temperature and pressure processing without the use of toxic chemicals or solvents, offering new green chemistry approaches, as well as options to load bioactive drugs or growth factors into process. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Lu, Qiang; Lu, Shenzhou; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Lu, Qiang; Wang, Xiuli; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, QA (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn
RI Lu, Shenzhou/P-6519-2015
OI Lu, Shenzhou/0000-0003-4188-2057
FU NIH [EB002520]; National Natural Science Foundation of China [30970714]
FX The authors thank the NIH (EB002520), and National Natural Science
   Foundation of China (30970714) for support of this research.
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Lv Q, 2008, J APPL POLYM SCI, V109, P1577, DOI 10.1002/app.24546
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Migliaresi C, 2008, TISSUE ENG PT A, V14, P775
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Phillips JE, 2006, BIOMATERIALS, V27, P5535, DOI 10.1016/j.biomaterials.2006.06.019
   Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004
   Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   UNGER RE, 2004, BIOMATERIALS, V25, P137
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wei GB, 2009, BIOMATERIALS, V30, P6426, DOI 10.1016/j.biomaterials.2009.08.012
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 39
TC 78
Z9 83
U1 11
U2 122
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 4
BP 1059
EP 1067
DI 10.1016/j.biomaterials.2010.09.072
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 699PL
UT WOS:000285675200013
PM 20970185
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Douglas, TA
   Tamburro, D
   Fredolini, C
   Espina, BH
   Lepene, BS
   Ilag, L
   Espina, V
   Petricoin, EF
   Liotta, LA
   Luchini, A
AF Douglas, Temple A.
   Tamburro, Davide
   Fredolini, Claudia
   Espina, Benjamin H.
   Lepene, Benjamin S.
   Ilag, Leopold
   Espina, Virginia
   Petricoin, Emanuel F., III
   Liotta, Lance A.
   Luchini, Alessandra
TI The use of hydrogel microparticles to sequester and concentrate
   bacterial antigens in a urine test for Lyme disease
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Microparticle; Affinity; Bacteria; Protein
ID ALLERGIC CONTACT-DERMATITIS; BORRELIA-BURGDORFERI; DIAGNOSIS; BLOOD;
   PARTICLES; MICROGELS; PROTEIN; HUMANS; GROWTH; TICKS
AB Hydrogel biomarker capturing microparticles were evaluated as a biomaterial to amplify the sensitivity of urine testing for infectious disease proteins. Lyme disease is a bacterial infection transmitted by ticks. Early diagnosis and prompt treatment of Lyme disease reduces complications including arthritis and cardiac involvement. While a urine test is highly desirable for Lyme disease screening, this has been difficult to accomplish because the antigen is present at extremely low concentrations, below the detection limit of clinical immunoassays. N-isopropylacrylamide (NIPAm) - acrylic acid (AAc) microparticles were covalently functionalized with amine containing dyes via arnidation of carboxylic groups present in the microparticles. The dyes act as affinity baits towards protein analytes in solution. NIPAm/AAc microparticles functionalized with acid black 48 (AB48) mixed with human urine, achieved close to one hundred percent capture and 100 percent extraction yield of the target antigen. In urine, microparticles sequestered and concentrated Lyme disease antigens 100 fold, compared to the absence of microparticles, achieving an immunoassay detection sensitivity of 700 pg/mL in 10 mL urine. Antigen present in a single infected tick could be readily detected following microparticle sequestration. Hydrogel microparticles functionalized with high affinity baits can dramatically increase the sensitivity of urinary antigen tests for infectious diseases such as Lyme disease. These findings justify controlled clinical studies evaluating the sensitivity and precision of Lyme antigen testing in urine. (c) 2010 Elsevier Ltd. All rights reserved.
C1 [Douglas, Temple A.; Tamburro, Davide; Fredolini, Claudia; Espina, Virginia; Petricoin, Emanuel F., III; Liotta, Lance A.; Luchini, Alessandra] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA.
   [Fredolini, Claudia] S Giovanni Bosco Hosp, Dept Urol, I-10154 Turin, Italy.
   [Fredolini, Claudia] Univ Turin, Dept Med & Expt Oncol, I-10126 Turin, Italy.
   [Espina, Benjamin H.; Lepene, Benjamin S.] Ceres Nanosci LLLP, Manassas, VA 20110 USA.
   [Ilag, Leopold] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden.
RP Luchini, A (reprint author), George Mason Univ, Ctr Appl Prote & Mol Med, 10900 Univ Blvd, Manassas, VA 20110 USA.
EM aluchini@gmu.edu
OI Espina, Virginia/0000-0001-5080-5972; Luchini,
   Alessandra/0000-0003-1599-0214
FU George Mason University; Italian Istituto Superiore di Sanita, U.S.
   Department of Health and Human Services, George Mason University, and
   the Italian Ministry of Public Health; U.S. Department of Energy
   [DE-FC52-04NA2545]; NIH, NCI [1R21CA137706-01]
FX This work was supported partially by 1) George Mason University, 2) the
   Italian Istituto Superiore di Sanita' in the framework of the Italy/USA
   cooperation agreement between the U.S. Department of Health and Human
   Services, George Mason University, and the Italian Ministry of Public
   Health, 3) U.S. Department of Energy DE-FC52-04NA2545, 4) NIH, NCI grant
   1R21CA137706-01. The funding organizations did not have any role in data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barr W B, 1999, Appl Neuropsychol, V6, P12, DOI 10.1207/s15324826an0601_2
   Cameron DJ, 2008, NEW ENGL J MED, V358, P429
   Coulter P, 2005, J CLIN MICROBIOL, V43, P5080, DOI 10.1128/JCM.43.10.5080-5084.2005
   DESILVA AM, 1995, AM J TROP MED HYG, V53, P397, DOI 10.4269/ajtmh.1995.53.397
   DORWARD DW, 1991, J CLIN MICROBIOL, V29, P1162
   Espina V, 2008, MOL CELL PROTEOMICS, V7, P1998, DOI 10.1074/mcp.M700596-MCP200
   Fallon BA, 2009, ARCH GEN PSYCHIAT, V66, P554, DOI 10.1001/archgenpsychiatry.2009.29
   Fredolini C, 2008, NANO RES, V1, P502, DOI 10.1007/s12274-008-8054-z
   Harris NS, 1995, J SPIROCHET TICK BOR, V2, P37
   Hatch KL, 1998, QUANT STRUCT-ACT REL, V17, P20, DOI 10.1002/(SICI)1521-3838(199801)17:01<20::AID-QSAR20>3.3.CO;2-6
   Hatch KL, 2000, CONTACT DERMATITIS, V42, P187, DOI 10.1034/j.1600-0536.2000.042004187.x
   Heckler AK, 2009, CLIN PEDIAT PHILA, V49, P82
   Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069
   HYDE FW, 1989, J CLIN MICROBIOL, V27, P58
   Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Longo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004763
   Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l
   Luchini A, 2009, J MATER CHEM, V19, P5071, DOI 10.1039/b822264a
   Lyon H. O., 2002, Biotechnic and Histochemistry, V77, P121, DOI 10.1080/714028187
   NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015
   Nau R, 2009, DTSCH ARZTEBL INT, V106, P72, DOI 10.3238/arztebl.2009.0072
   Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1
   Norman GL, 1996, J CLIN MICROBIOL, V34, P1732
   Pecora R., 1985, DYNAMIC LIGHT SCATTE
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rainczuk A, 2009, PROTEOMICS, V10, P332
   Rauter C, 2005, CLIN DIAGN LAB IMMUN, V12, P910, DOI 10.1128/CDLI.12.8.910-917.2005
   Vojdani A, 2009, EVID-BASED COMPL ALT, V6, P283, DOI 10.1093/ecam/nem138
   Wang CY, 2010, BIOMATERIALS, V31, P4944, DOI 10.1016/j.biomaterials.2010.02.073
   Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667
   Wu WT, 2010, BIOMATERIALS, V31, P7555, DOI 10.1016/j.biomaterials.2010.06.030
   Zhang S, 2009, J AM CHEM SOC, V131, P13072, DOI 10.1021/ja903733z
NR 35
TC 22
Z9 23
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 4
BP 1157
EP 1166
DI 10.1016/j.biomaterials.2010.10.004
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 699PL
UT WOS:000285675200023
PM 21035184
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rogers, TH
   Babensee, JE
AF Rogers, Todd H.
   Babensee, Julia E.
TI The role of integrins in the recognition and response of dendritic cells
   to biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Dendritic cells; Immune response; Integrin; Adhesion
ID POLY(LACTIC-CO-GLYCOLIC ACID); EXTRACELLULAR-MATRIX; INFLAMMATORY
   RESPONSES; IMMUNE-RESPONSES; LIGAND-BINDING; HUMAN BLOOD; ADHESION;
   MATURATION; PROTEINS; ALPHA(M)BETA(2)
AB Biomaterials have the potential to be utilized as immunostimulatory or immunosuppressive delivery agents for biologics. It is hypothesized that this is directed by the ability of a biomaterial to drive dendritic cells (DC) in situ toward an immunostimulatory or an immunosuppressive phenotype, respectively. However, the specific pattern recognition receptors (PRRs) that DCs use to recognize and respond to biomaterials are unknown. From among the many receptors that DCs use to recognize and respond to foreign entities, herein the focus is on integrins. A biomaterial that induces DC maturation, namely poly(lactic-co-glycolic) acid (PLGA), supported increased human monocyte-derived DC adhesion and up-regulation of integrin receptor gene expression, measured via RT-PCR, as compared to culture on tissue culture polystyrene (TCPS). This was not observed for a biomaterial that does not support DC maturation. Through antibody-blocking techniques, the adhesion to both TCPS and PLGA was found to be beta(2) integrin dependent and beta(1) independent. Significantly, inhibiting beta(2)-mediated adhesion to biomaterials via blocking antibodies also lowered the level of maturation of DCs (CD86 expression). beta(2) integrins (but not beta(1)) were found localized in biomaterial-adherent DC podosomes and also were found in direct contact with the PLGA surface. Therefore, it appeared that beta(2) integrin-mediated adhesion is involved in determining the state of DC maturation on the PLGA surface. DC adhesion to biomaterials may be engaged or avoided to manipulate an immune response to biological component delivered with a biomaterial carrier. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Parker H Petit Inst Bioengn & Biosci, Georgia Inst Technol, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Institutes of Health [2T32GM08433-11A1, 124000007, 1RO1
   EB004633-01A1]
FX The authors would like to thank Dr. Andres Garcia for his guidance in
   the cellular cross-linking and immunofluorescence work. Furthermore, the
   authors acknowledge the support of Todd Rogers with a Cell and Tissue
   Engineering National Institutes of Health Training Grant (TR,
   2T32GM08433-11A1) and Medtronic Supplement (TR, Award Number:
   124000007). This research was supported by the National Institutes of
   Health grant 1RO1 EB004633-01A1.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554
   Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x
   Andersen CAS, 2006, INT IMMUNOL, V18, P1295, DOI 10.1093/intimm/dxl062
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Annenkov A, 1996, EUR J IMMUNOL, V26, P207, DOI 10.1002/eji.1830260132
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Beals CR, 2001, J IMMUNOL, V167, P6113, DOI 10.4049/jimmunol.167.11.6113
   Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J
   Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163
   DAVIS GE, 1992, EXP CELL RES, V200, P242, DOI 10.1016/0014-4827(92)90170-D
   de Fougerolles AR, 2000, IMMUNITY, V13, P749, DOI 10.1016/S1074-7613(00)00073-X
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kohl K, 2007, EUR J CELL BIOL, V86, P719, DOI 10.1016/j.ejcb.2007.06.007
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   McCarthy DA, 1997, IMMUNOLOGY, V92, P244, DOI 10.1046/j.1365-2567.1997.00346.x
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4
   Nerem RM, 2006, TISSUE ENG, V12, P1143, DOI 10.1089/ten.2006.12.1143
   Nerem RM, 2007, BIOMATERIALS, V28, P5074, DOI 10.1016/j.biomaterials.2007.07.032
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09
   Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845
   Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathol.3.121806.151456
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006
   Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
NR 56
TC 22
Z9 23
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 5
BP 1270
EP 1279
DI 10.1016/j.biomaterials.2010.10.014
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717UN
UT WOS:000287073000003
PM 21030075
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Miyagi, Y
   Chiu, LLY
   Cimini, M
   Weisel, RD
   Radisic, M
   Li, RK
AF Miyagi, Yasuo
   Chiu, Loraine L. Y.
   Cimini, Massimo
   Weisel, Richard D.
   Radisic, Milica
   Li, Ren-Ke
TI Biodegradable collagen patch with covalently immobilized VEGF for
   myocardial repair
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Cardiac tissue engineering; Collagen; Growth factors;
   Scaffold; Heart
ID ENDOTHELIAL GROWTH-FACTOR; CARDIAC TISSUE; CELL TRANSPLANTATION;
   SMALL-INTESTINE; HEART FUNCTION; STEM-CELLS; ANGIOGENESIS; INFARCTION;
   RELEASE; GRAFTS
AB Vascularization of engineered tissues in vitro and in vivo remains a key problem in translation of engineered tissues to clinical practice. Growth factor signalling can be prolonged by covalent tethering, thus we hypothesized that covalent immobilization of vascular endothelial growth factor (VEGF-165) to a porous collagen scaffold will enable rapid vascularization in vivo. Covalent immobilization may be preferred over controlled release or cell transfection if the effects are desired within the biomaterial rather than the surrounding tissue. Scaffolds were prepared with 14.5 +/- 1.4 ng (Low) or 97.2 +/- 8.0 ng (High) immobilized VEGF, or left untreated (control), and used to replace a full right ventricular free wall defect in rat hearts. In addition to rapid vascularization, an effective cardiac patch should exhibit neither thinning nor dilatation upon implantation. In vitro, VEGF enhanced the growth of endothelial and bone marrow cells seeded onto scaffolds. In vivo, High VEGF patches had greater blood vessel density (p < 0.01) than control at Day 7 and 28 due to increased cell recruitment and proliferation (p < 0.05 vs. control). At Day 28, VEGF-treated patches were significantly thicker (p < 0.05) than control, and thickness correlated positively with neovascularization (r = 0.67, p = 0.023). Importantly, angiogenesis in VEGF scaffolds contributed to improved cell survival and tissue formation. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Miyagi, Yasuo; Cimini, Massimo; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Dept Surg, Toronto, ON, Canada.
   [Miyagi, Yasuo; Cimini, Massimo; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Div Cardiovasc Surg, Toronto, ON, Canada.
   [Miyagi, Yasuo; Cimini, Massimo; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto, ON, Canada.
   [Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 3G9, Canada.
RP Li, RK (reprint author), MaRS Ctr, Toronto Med Discovery Tower,101 Coll St,Room 3-70, Toronto, ON M5G 1L7, Canada.
EM m.radisic@utoronto.ca; renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X
FU Canadian Institutes of Health Research [RMF82498]; Heart and Stroke
   Foundation of Ontario [NA6077, T6946]
FX This work was supported by the Canadian Institutes of Health Research
   (RMF82498 to RDW and RKL) and the Heart and Stroke Foundation of Ontario
   (NA6077 and T6946 to MR and RKL). RKL is a Career Investigator of the
   Heart and Stroke Foundation of Canada and holds a Canada Research Chair
   in Cardiac Regeneration. LC is a Natural Sciences and Engineering
   Research Council of Canada Alexander Graham Bell Canada Graduate
   Scholar. The authors thank Heather McDonald Kinkaid for writing and
   editing assistance.
CR Brown MA, 2008, BIOTECHNOL PROGR, V24, P907, DOI [10.1002/btpr.11, 10.1021/bp.11]
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Chiu LL, 2010, J TISSUE ENG REGEN M
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Garin G, 2005, CIRC RES, V97, P955, DOI 10.1161/01.RES.0000193566.65262.d8
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jiang F, 2008, J CELL MOL MED, V12, P2062, DOI 10.1111/j.1582-4934.2008.00199.x
   Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559
   Kutryk MJB, 2003, MICROSC RES TECHNIQ, V60, P138, DOI 10.1002/jemt.10252
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lee KY, 2000, NATURE, V408, P998
   Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882
   Liu J, 2009, CURR MOL MED, V9, P287, DOI 10.2174/156652409787847218
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Matsubayashi K, 2003, CIRCULATION, V108, P219, DOI 10.1161/01.cir.0000087450.34497.9a
   Menasche P, 2005, CORONARY ARTERY DIS, V16, P105, DOI 10.1097/00019501-200503000-00005
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa T, 2002, J THORAC CARDIOV SUR, V124, P1157, DOI 10.1067/mtc.2002.127449
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Schroeder JW, 2007, OTOLARYNG HEAD NECK, V137, P465, DOI 10.1016/j.otohns.2007.04.027
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shimizu T, 2009, CURR PHARM DESIGN, V15, P2807, DOI 10.2174/138161209788923822
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tomita S, 2002, J THORAC CARDIOV SUR, V123, P1132, DOI 10.1067/mtc.2002.120716
   Tucker OP, 2002, J THORAC CARDIOV SUR, V124, P1165, DOI 10.1067/mtc.2002.125818
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 41
TC 131
Z9 134
U1 1
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 5
BP 1280
EP 1290
DI 10.1016/j.biomaterials.2010.10.007
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717UN
UT WOS:000287073000004
PM 21035179
DA 2018-10-20
ER

PT J
AU Chatterjee, K
   Sun, LM
   Chow, LC
   Young, MF
   Simon, CG
AF Chatterjee, Kaushik
   Sun, Limin
   Chow, Laurence C.
   Young, Marian F.
   Simon, Carl G., Jr.
TI Combinatorial screening of osteoblast response to 3D calcium
   phosphate/poly(is an element of-caprolactone) scaffolds using gradients
   and arrays
SO BIOMATERIALS
LA English
DT Article
DE 3D scaffolds; Calcium phosphate; Combinatorial screening; Nanoparticles;
   Osteoblast; Tissue engineering
ID STEM-CELLS; BONE REGENERATION; PHOSPHATE; DIFFERENTIATION; BIOMATERIALS;
   BIOCERAMICS; INTERFACES; COMPOSITE; CULTURE; MODEL
AB There is a need for combinatorial and high-throughput methods for screening cell-biomaterial interactions to maximize tissue generation in scaffolds. Current methods employ a flat two-dimensional (2D) format even though three-dimensional (3D) scaffolds are more representative of the tissue environment in vivo and cells are responsive to topographical differences of 2D substrates and 3D scaffolds. Thus, combinatorial libraries of 3D porous scaffolds were developed and used to screen the effect of nano-amorphous calcium phosphate (nACP) particles on osteoblast response. Increasing nACP content in poly (is an element of-caprolactone) (PCL) scaffolds promoted osteoblast adhesion and proliferation. The nACP-containing scaffolds released calcium and phosphate ions which are known to activate osteoblast function. Scaffold libraries were fabricated in two formats, gradients and arrays, and the magnitude of the effect of nACP on osteoblast proliferation was greater for arrays than gradients. The enhanced response in arrays can be explained by differences in cell culture designs, diffusional effects and differences in the ratio of "scaffold mass to culture medium". These results introduce a gradient library approach for screening large pore 3D scaffolds and demonstrate that inclusion of the nACP particles enhances osteoblast proliferation in 3D scaffolds. Further, comparison of gradients and arrays suggests that gradients were more sensitive for detecting effects of scaffold composition on cell adhesion (short time points, 1 day) whereas arrays were more sensitive at detecting effects on cell proliferation (longer time points, 14 day). Published by Elsevier Ltd.
C1 [Chatterjee, Kaushik; Simon, Carl G., Jr.] Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
   [Chatterjee, Kaushik; Young, Marian F.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA.
   [Sun, Limin; Chow, Laurence C.] Natl Inst Stand & Technol, Amer Dent Assoc Fdn, Paffenbarger Res Ctr, Gaithersburg, MD 20899 USA.
RP Simon, CG (reprint author), Natl Inst Stand & Technol, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
RI Sanders, Susan/G-1957-2011
OI Chatterjee, Kaushik/0000-0002-7204-2926
FU National Research Council of the National Academy of Sciences in the
   Joint NIH-NIBIB/NIST; NIST; NIH-NIDCR (National Institute of Dental and
   Craniofacial Research) [NIH-NIBIB R21 EB006497-01, NIH-NIDCR R01DE16416]
FX K.C. acknowledges support from a Research Associateship Award from the
   National Research Council of the National Academy of Sciences in the
   Joint NIH-NIBIB/NIST Postdoctoral Program (National Institutes of
   Health-National Institute of Biomedical Imaging and
   Bioengineering/National Institute of Standards and Technology). This
   work was supported by NIST, the Intramural Program of the NIH-NIDCR
   (National Institute of Dental and Craniofacial Research), NIH-NIBIB R21
   EB006497-01 and NIH-NIDCR R01DE16416. The standard deviation (S.D.) is
   the same as the "combined standard uncertainty of the mean" for the
   purposes of this work. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of NIH,
   NIBIB, NIDCR, NIST or ADA (American Dental Association). This article, a
   contribution of NIST and NIH, is not subject to US copyright. Certain
   equipment and instruments or materials are identified in the paper to
   adequately specify the experimental details. Such identification does
   not imply recommendation by NIST, nor does it imply the materials are
   necessarily the best available for the purpose.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   Bostrom Mathias P G, 2005, HSS J, V1, P9, DOI 10.1007/s11420-005-0111-5
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chow LC, 2004, J RES NATL INST STAN, V109, P543, DOI 10.6028/jres.109.041
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Khan F, 2010, BIOMATERIALS, V31, P2216, DOI 10.1016/j.biomaterials.2009.11.101
   Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004
   Lin NJ, 2009, BIOMATERIALS, V30, P4480, DOI 10.1016/j.biomaterials.2009.05.019
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Powell K, 2005, J CELL BIOL, V171, P409
   Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011
   Simon CG, 2009, COMB CHEM HIGH T SCR, V12, P544, DOI 10.2174/138620709788681961
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Simon CG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2755761
   Simon J, 2005, BIOMATERIALS, V26, P6906
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   VOGEL GL, 1983, CARIES RES, V17, P23, DOI 10.1159/000260645
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Xu HHK, 2007, J DENT RES, V86, P378, DOI 10.1177/154405910708600415
   Xu HHK, 2008, DENT MATER, V24, P1212, DOI 10.1016/j.dental.2008.02.001
   Yamaguchi T, 2000, BIOCHEM BIOPH RES CO, V279, P363, DOI 10.1006/bbrc.2000.3955
   Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
NR 40
TC 33
Z9 33
U1 0
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2011
VL 32
IS 5
BP 1361
EP 1369
DI 10.1016/j.biomaterials.2010.10.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717UN
UT WOS:000287073000012
PM 21074846
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bai, F
   Zhang, JK
   Wang, Z
   Lu, JX
   Chang, JA
   Liu, JA
   Meng, GL
   Dong, X
AF Bai Feng
   Zhang Jinkang
   Wang Zhen
   Lu Jianxi
   Chang Jiang
   Liu Jian
   Meng Guolin
   Dong Xin
TI The effect of pore size on tissue ingrowth and neovascularization in
   porous bioceramics of controlled architecture in vivo
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID BMP-INDUCED OSTEOGENESIS; MARROW STROMAL CELLS; BONE-FORMATION;
   TRICALCIUM PHOSPHATE; CORALLINE HYDROXYAPATITE; SCAFFOLDS; GROWTH;
   GEOMETRY; ANGIOGENESIS; IMPLANTS
AB The purpose of this study was to investigate the role of pore size on tissue ingrowth and neovascularization in porous bioceramics under the accurate control of the pore parameters. For that purpose, beta-tricalcium phosphate (beta-TCP) cylinders with four different macropore sizes (300-400, 400-500, 500-600 and 600-700 mu m) but the same interconnection size (120 mu m) and unchangeable porosity were implanted into fascia lumbodorsalis in rabbits. The fibrous tissues and blood vessels formed in scaffolds were observed histologically and histomorphometrically. The vascularization of the porous bioceramics was analyzed by single-photon emission computed tomography (SPECT). It is found that pore size as an important parameter of a porous structure plays an important role in tissue infiltration into porous biomaterial scaffolds. The amount of fibrous tissue ingrowth increases with the decrease of the pore size. In four kinds of scaffolds with different macropore sizes (300-400, 400-500, 500-600 and 600-700 mu m) and a constant interconnection size of 120 mu m, the areas of fibrous tissue (%) were 60.5%, 52.2%, 41.3% and 37.3%, respectively, representing a significant decrease at 4 weeks (P < 0.01). The pore size of a scaffold is closely related to neovascularization of macroporous biomaterials implanted in vivo. A large pore size is beneficial for the growth of blood vessels, and the diameter of a pore smaller than 400 mu m limits the growth of blood vessels and results in a smaller blood vessel diameter.
C1 [Bai Feng; Zhang Jinkang; Wang Zhen; Liu Jian; Meng Guolin; Dong Xin] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.
   [Lu Jianxi; Chang Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Wang, Z (reprint author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.
EM baifeng_fmmu@126.com
FU National Basic Research Program (Program) of China [2005CB522704];
   Natural Science Foundation of China [30730034, 30900299]
FX This work was supported by grants from the National Basic Research
   Program (Program) of China (grant no 2005CB522704) and the Natural
   Science Foundation of China (grant nos 30730034 and 30900299). We are
   grateful to Shanghai Institute of Ceramics, Chinese Academy of Sciences,
   for providing beta-TCP bioceramics. We thank all technicians at
   Institute of orthopedic of XiJing <SUP>P</SUP>hospital, Fourth Military
   Medical University in China for their contribution to the experiment.
CR Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Charriere E, 2003, BIOMATERIALS, V24, P809, DOI 10.1016/S0142-9612(02)00406-4
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   CIVELEK AC, 1995, CLIN NUCL MED, V20, P779, DOI 10.1097/00003072-199509000-00005
   Dard M, 2000, Clin Oral Investig, V4, P126, DOI 10.1007/s007840050128
   Davies N, 2008, BIOMATERIALS, V29, P3531, DOI 10.1016/j.biomaterials.2008.05.007
   Dawson JI, 2008, BIOMATERIALS, V29, P3105, DOI 10.1016/j.biomaterials.2008.03.040
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Elcin AE, 2006, TISSUE ENG, V12, P959, DOI 10.1089/ten.2006.12.959
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gogolewski S, 2000, INJURY, V31, pS28
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Henno S, 2003, BIOMATERIALS, V24, P3173, DOI 10.1016/S0142-9612(03)00149-2
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Mukherjee DP, 2009, J BIOMED MATER RES B, V88B, P92, DOI 10.1002/jbm.b.31155
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Ohsawa K, 2004, J MATER SCI-MATER M, V15, P859, DOI 10.1023/B:JMSM.0000036273.37843.0c
   OLIVEIRA JF, 2003, ARTIF ORGANS, V27, P406
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Park HK, 2001, NEUROL RES, V23, P267, DOI 10.1179/016164101101198424
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   WAKE MC, 1995, CELL TRANSPLANT, V4, P275, DOI 10.1177/096368979500400305
   WEILAND AJ, 1983, CLIN ORTHOP RELAT R, P87
   XUEMING W, 2006, CHIN J CLIN REHABIL, V37, P87
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 49
TC 70
Z9 76
U1 5
U2 52
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2011
VL 6
IS 1
AR 015007
DI 10.1088/1748-6041/6/1/015007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 706MA
UT WOS:000286221300008
PM 21206002
DA 2018-10-20
ER

PT J
AU Brodie, M
   Vollenweider, L
   Murphy, JL
   Xu, FM
   Lyman, A
   Lew, WD
   Lee, BP
AF Brodie, Michael
   Vollenweider, Laura
   Murphy, John L.
   Xu, Fangmin
   Lyman, Arinne
   Lew, William D.
   Lee, Bruce P.
TI Biomechanical properties of Achilles tendon repair augmented with a
   bioadhesive-coated scaffold
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SURGICAL REPAIR; SUTURE AUGMENTATION; WEIGHT-BEARING; HERNIA REPAIR;
   FIBRIN GLUE; RUPTURE; ADHESIVE; REHABILITATION; CYANOACRYLATE; STRENGTH
AB The Achilles tendon is the most frequently ruptured tendon. Both acute and chronic (neglected) tendon ruptures can dramatically affect a patient's quality of life, and require a prolonged period of recovery before return to pre-injury activity levels. This paper describes the use of an adhesive-coated biologic scaffold to augment primary suture repair of transected Achilles tendons. The adhesive portion consisted of a synthetic mimic of mussel adhesive proteins that can adhere to various surfaces in a wet environment, including biologic tissues. When combined with biologic scaffolds such as bovine pericardium or porcine dermal tissues, these adhesive constructs demonstrated lap shear adhesive strengths significantly greater than that of fibrin glue, while reaching up to 60% of the strength of a cyanoacrylate-based adhesive. These adhesive constructs were wrapped around transected cadaveric porcine Achilles tendons repaired with a combination of parallel and three-loop suture patterns. Tensile mechanical testing of the augmented repairs exhibited significantly higher stiffness (22-34%), failure load (24-44%), and energy to failure (27-63%) when compared to control tendons with suture repair alone. Potential clinical implications of this novel adhesive biomaterial are discussed.
C1 [Brodie, Michael; Vollenweider, Laura; Murphy, John L.; Xu, Fangmin; Lyman, Arinne; Lew, William D.; Lee, Bruce P.] Nerites Corp, Madison, WI 53719 USA.
RP Lee, BP (reprint author), Nerites Corp, 505 S Rosa Rd,Suite 123, Madison, WI 53719 USA.
EM b-lee@nerites.com
RI Lee, Bruce/H-5233-2011
OI Lee, Bruce/0000-0002-6529-0032
FU NIH [1R43AR056519-01A1, P41RR02301, P41GM66326, RR02781, RR08438]; NSF
   [DMB-8415048, OIA-9977486, BIR-9214394]; University of Wisconsin; U.S.
   Department of Agriculture
FX This work was supported by NIH grant 1R43AR056519-01A1. NMR was
   performed at the National Magnetic Resonance Facility at Madison
   (Madison, WI), which is supported by NIH (P41RR02301, P41GM66326,
   RR02781, RR08438), NSF (DMB-8415048, OIA-9977486, BIR-9214394), the
   University of Wisconsin, and the U.S. Department of Agriculture. The
   authors were employees of Nerites Corporation. They gratefully
   acknowledge Professor Ray Vanderby, Jr (Departments of Biomedical
   Engineering and Orthopedics and Rehabilitation, University of
   Wisconsin-Madison) for input related to mechanical testing and data
   analysis.
CR Bilic G, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.051
   BONUTTI PM, 1988, CLIN ORTHOP RELAT R, P241
   Boyer MI, 2001, J BONE JOINT SURG AM, V83A, P891, DOI 10.2106/00004623-200106000-00011
   Brubaker CE, 2010, BIOMATERIALS, V31, P420, DOI 10.1016/j.biomaterials.2009.09.062
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Costa ML, 2006, J BONE JOINT SURG BR, V88B, P69, DOI 10.1302/0301-620X.88B1.16549
   Evans CE, 1999, J HAND SURG-BRIT EUR, V24B, P658, DOI 10.1054/jhsb.1999.0279
   Fortelny RH, 2007, SURG ENDOSC, V21, P1781, DOI 10.1007/s00464-007-9243-7
   Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Guvendiren M, 2008, BIOMACROMOLECULES, V9, P122, DOI 10.1021/bm700886b
   Herbort M, 2008, ARCH ORTHOP TRAUM SU, V128, P1273, DOI 10.1007/s00402-008-0602-1
   Hohendorff B, 2008, J FOOT ANKLE SURG, V47, P392, DOI 10.1053/j.jfas.2008.05.006
   Hohendorff B, 2009, J FOOT ANKLE SURG, V48, P439, DOI 10.1053/j.jfas.2009.04.005
   Houshian S, 1998, INJURY, V29, P651, DOI 10.1016/S0020-1383(98)00147-8
   IKADA Y, 1997, TISSUE ADHESIVES WOU, P317
   Korenkov M, 2002, BRIT J SURG, V89, P50, DOI 10.1046/j.0007-1323.2001.01974.x
   Kummer FJ, 2005, J BIOMED MATER RES B, V74B, P789, DOI 10.1002/jbm.b.30296
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee DK, 2008, J FOOT ANKLE SURG, V47, P8, DOI 10.1053/j.jfas.2007.08.015
   Lee Daniel K, 2007, J Foot Ankle Surg, V46, P451, DOI 10.1053/j.jfas.2007.05.007
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee SJ, 2008, FOOT ANKLE INT, V29, P427, DOI 10.3113/FAI.2008.0427
   Lee SJ, 2009, AM J SPORT MED, V37, P786, DOI 10.1177/0363546508328595
   Leppilahti J, 1998, SPORTS MED, V25, P79, DOI 10.2165/00007256-199825020-00002
   Liden BA, 2009, J AM PODIAT MED ASSN, V99, P104, DOI 10.7547/0980104
   Lo Menzo E, 2008, AM J SURG, V196, P715, DOI 10.1016/j.amjsurg.2008.07.012
   Maffulli N, 1999, J BONE JOINT SURG AM, V81A, P1019, DOI 10.2106/00004623-199907000-00017
   Moores AP, 2004, VET SURG, V33, P131, DOI 10.1111/j.1532-950X.2004.04020.x
   Murphy JL, 2010, BIOMACROMOLECULES, V11, P2976, DOI 10.1021/bm1007794
   NISTOR L, 1981, J BONE JOINT SURG AM, V63, P394, DOI 10.2106/00004623-198163030-00012
   Pajala A, 2002, J BONE JOINT SURG AM, V84A, P2016, DOI 10.2106/00004623-200211000-00017
   Pasternak B, 2007, ACTA ORTHOP, V78, P680, DOI 10.1080/17453670710014392
   POWELL ES, 1989, J BIOMED ENG, V11, P215, DOI 10.1016/0141-5425(89)90144-1
   SantillanDoherty P, 1996, J INVEST SURG, V9, P45, DOI 10.3109/08941939609012459
   Shepard ME, 2007, FOOT ANKLE INT, V28, P1074, DOI 10.3113/FAI.2007.1074
   Sorrenti SJ, 2006, FOOT ANKLE INT, V27, P407, DOI 10.1177/107110070602700603
   Strauss EJ, 2007, INJURY, V38, P832, DOI 10.1016/j.injury.2006.06.005
   Strom AC, 2009, FOOT ANKLE CLIN, V14, P773, DOI 10.1016/j.fcl.2009.08.003
   Suchak AA, 2008, J BONE JOINT SURG AM, V90A, P1876, DOI 10.2106/JBJS.G.01242
   Suchak AA, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000203458.05135.74
   Thermann H, 2001, FOOT ANKLE INT, V22, P478, DOI 10.1177/107110070102200604
   Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049
   TURNER TM, 2009, AM COLL FOOT ANK SUR
   WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0
   White DW, 2007, AM J SPORT MED, V35, P1308, DOI 10.1177/0363546507301256
   Williams GR, 2004, J BONE JOINT SURG AM, V86A, P2764, DOI 10.2106/00004623-200412000-00027
   Winter E, 1998, ARCH ORTHOP TRAUM SU, V117, P364, DOI 10.1007/s004020050267
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
NR 49
TC 30
Z9 31
U1 4
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2011
VL 6
IS 1
AR 015014
DI 10.1088/1748-6041/6/1/015014
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 711LO
UT WOS:000286593300003
PM 21266745
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ghanaati, S
   Schlee, M
   Webber, MJ
   Willershausen, I
   Barbeck, M
   Balic, E
   Gorlach, C
   Stupp, SI
   Sader, RA
   Kirkpatrick, CJ
AF Ghanaati, Shahram
   Schlee, Markus
   Webber, Matthew J.
   Willershausen, Ines
   Barbeck, Mike
   Balic, Ela
   Goerlach, Christoph
   Stupp, Samuel I.
   Sader, Robert A.
   Kirkpatrick, C. James
TI Evaluation of the tissue reaction to a new bilayered collagen matrix in
   vivo and its translation to the clinic
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID OUTGROWTH ENDOTHELIAL-CELLS; GUIDED BONE REGENERATION; IMPLANT
   PLACEMENT; CROSS-LINKING; SILK FIBROIN; MEMBRANES; DEFECTS; RAT;
   BIOCOMPATIBILITY; VASCULARIZATION
AB This study evaluates a new collagen matrix that is designed with a bilayered structure in order to promote guided tissue regeneration and integration within the host tissue. This material induced a mild tissue reaction when assessed in a murine model and was well integrated within the host tissue, persisting in the implantation bed throughout the in vivo study. A more porous layer was rapidly infiltrated by host mesenchymal cells, while a layer designed to be a barrier allowed cell attachment and host tissue integration, but at the same time remained impermeable to invading cells for the first 30 days of the study. The tissue reaction was favorable, and unlike a typical foreign body response, did not include the presence of multinucleated giant cells, lymphocytes, or granulation tissue. In the context of translation, we show preliminary results from the clinical use of this biomaterial applied to soft tissue regeneration in the treatment of gingival tissue recession and exposed roots of human teeth. Such a condition would greatly benefit from guided tissue regeneration strategies. Our findings demonstrate that this material successfully promoted the ingrowth of gingival tissue and reversed gingival tissue recession. Of particular importance is the fact that the histological evidence from these human studies corroborates our findings in the murine model, with the barrier layer preventing unspecific tissue ingrowth, as the scaffold becomes infiltrated by mesenchymal cells from adjacent tissue into the porous layer. Also in the clinical situation no multinucleated giant cells, no granulation tissue and no evidence of a marked inflammatory response were observed. In conclusion, this bilayered matrix elicits a favorable tissue reaction, demonstrates potential as a barrier for preferential tissue ingrowth, and achieves a desirable therapeutic result when applied in humans for soft tissue regeneration.
C1 [Ghanaati, Shahram; Barbeck, Mike; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-6500 Mainz, Germany.
   [Ghanaati, Shahram; Sader, Robert A.] Goethe Univ Frankfurt, Clin Maxillofacial & Plast Surg, Frankfurt, Germany.
   [Webber, Matthew J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Willershausen, Ines] Johannes Gutenberg Univ Mainz, Inst Dent Mat Sci & Technol, Univ Med Ctr, Mainz, Germany.
   [Balic, Ela; Goerlach, Christoph] Geistlich Pharma AG, Wolhusen, Switzerland.
   [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn Chem & Med, Evanston, IL 60208 USA.
RP Ghanaati, S (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, D-6500 Mainz, Germany.
EM ghanaati@uni-mainz.de
RI Webber, Matthew/D-4847-2011; Stupp, Samuel/B-6737-2009
OI Webber, Matthew/0000-0003-3111-6228; Barbeck, Mike/0000-0002-3001-1347
CR Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Dahlin C, 1989, J ORAL MAXILLOFAC IM, V4, P19
   Eickholz P, 2001, J PERIODONTOL, V72, P35, DOI 10.1902/jop.2001.72.1.35
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/3/035005
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   GOTTLOW J, 1993, J PERIODONTOL, V64, P1157, DOI 10.1902/jop.1993.64.11s.1157
   Greenstein G, 1993, Periodontol 2000, V1, P36, DOI 10.1111/j.1600-0757.1993.tb00205.x
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x
   Hoffmann O, 2008, J PERIODONTOL, V79, P1355, DOI 10.1902/jop.2008.070502 
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Karring T, 1986, Orthod Fr, V57 Pt 2, P435
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   LANG NP, 1994, CLIN ORAL IMPLAN RES, V5, P92, DOI 10.1034/j.1600-0501.1994.050205.x
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   MINABE M, 1989, J PERIODONTOL, V60, P35, DOI 10.1902/jop.1989.60.1.35
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PITARU S, 1988, J PERIODONTOL, V59, P380, DOI 10.1902/jop.1988.59.6.380
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schwarz F, 2006, CLIN ORAL IMPLAN RES, V17, P403, DOI 10.1111/j.1600-0501.2005.01225.x
   Weng D, 2009, INT J ORAL MAX IMPL, V24, P31
   Zucchelli G, 2000, J PERIODONTOL, V71, P1506, DOI 10.1902/jop.2000.71.9.1506
NR 29
TC 50
Z9 53
U1 1
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2011
VL 6
IS 1
AR 015010
DI 10.1088/1748-6041/6/1/015010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 706MA
UT WOS:000286221300011
PM 21239849
DA 2018-10-20
ER

PT J
AU Khataee, AR
   Dehghan, G
   Zarei, M
   Ebadi, E
   Pourhassan, M
AF Khataee, A. R.
   Dehghan, G.
   Zarei, M.
   Ebadi, E.
   Pourhassan, M.
TI Neural network modeling of biotreatment of triphenylmethane dye solution
   by a green macroalgae
SO CHEMICAL ENGINEERING RESEARCH & DESIGN
LA English
DT Article
DE Bioremediation; Modeling; Decolorization; Macroalgae; Textile dye
ID MALACHITE-GREEN; AZO-DYE; BOTTOM ASH; PHOTOCATALYTIC DEGRADATION;
   BIOLOGICAL DECOLORIZATION; OPERATIONAL PARAMETERS; CHLORELLA-VULGARIS;
   TEXTILE EFFLUENT; FRESH-WATER; REMOVAL
AB The potential of a green macroalgae Cladophora species was investigated as a viable biomaterial for biotreatment of Malachite Green (MG) solution. The effects of operational parameters such as temperature, pH, initial dye concentration, reaction time and amount of algae on biological decolorization efficiency were studied. Biotreatment of MG solution by live and dead algae was compared. The reusability and efficiency of the live algae in long-term repetitive operations were also examined. COD and FT-IR analysis revealed the ability of algal species in biological degradation of the dye. An artificial neural network (ANN) model was developed to predict the biotreatment of MG solution. The findings indicated that the ANN provided reasonable predictive performance (R-2 = 0.987). The influence of each parameter on the variable studied was assessed, and reaction time and initial pH were found to be the most significant factors, followed by temperature, initial dye concentration and amount of algae. Simulations based on the developed ANN model can estimate the behavior of the biological biotreatment process under different conditions. (C) 2010 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Khataee, A. R.; Zarei, M.; Ebadi, E.] Univ Tabriz, Dept Appl Chem, Fac Chem, Tabriz, Iran.
   [Dehghan, G.; Ebadi, E.; Pourhassan, M.] Univ Tabriz, Dept Biol, Fac Sci, Tabriz, Iran.
RP Khataee, AR (reprint author), Univ Tabriz, Dept Appl Chem, Fac Chem, Tabriz, Iran.
EM a_khataee@tabrizu.ac.ir
RI Khataee, Alireza/E-2874-2015
OI Khataee, Alireza/0000-0002-4673-0223; Pourhassan shamchi,
   Minoo/0000-0003-1764-0453
FU University of Tabriz
FX The authors would like to thank the University of Tabriz for the
   financial support of this project.
CR Acuner E, 2004, PROCESS BIOCHEM, V39, P623, DOI 10.1016/S0032-9592(03)00138-9
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P1347, DOI 10.1016/j.procbio.2004.06.007
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014
   Bekci Z, 2009, J HAZARD MATER, V161, P1454, DOI 10.1016/j.jhazmat.2008.04.125
   Binupriya Arthur R., 2007, Biotechnology Journal, V2, P1014, DOI 10.1002/biot.200600238
   Chang JS, 2000, BIORESOURCE TECHNOL, V75, P107, DOI 10.1016/S0960-8524(00)00049-3
   CLESCERI LS, 1989, STANDARD METHODS EXA, P5
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Daneshvar N, 2007, J HAZARD MATER, V143, P214, DOI 10.1016/j.jhazmat.2006.09.016
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   ERTUGRUL S, 2009, ECOL ENG, V5, P128
   Faur C, 2008, CHEM ENG J, V145, P7, DOI 10.1016/j.cej.2008.02.015
   Garson D, 1991, AI EXPERT, V6, P47
   Gontarski CA, 2000, COMPUT CHEM ENG, V24, P1719, DOI 10.1016/S0098-1354(00)00449-X
   Gupta VK, 2005, IND ENG CHEM RES, V44, P3655, DOI 10.1021/ie0500220
   Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008
   Henderson R, 2008, WATER RES, V42, P1827, DOI 10.1016/j.watres.2007.11.039
   Jadhav JP, 2006, YEAST, V23, P315, DOI 10.1002/yea.1356
   JINQUI L, 1992, Environmental Pollution, V75, P273, DOI 10.1016/0269-7491(92)90127-V
   Khatace A. R., 2009, Chinese Journal of Applied and Environmental Biology, V15, P110, DOI 10.3724/SP.J.1145.2009.00110
   Khataee AR, 2010, BIORESOURCE TECHNOL, V101, P2252, DOI 10.1016/j.biortech.2009.11.079
   Khataee AR, 2010, DESALINATION, V251, P64, DOI 10.1016/j.desal.2009.09.142
   Khataee AR, 2009, J HAZARD MATER, V168, P451, DOI 10.1016/j.jhazmat.2009.02.052
   Khataee AR, 2010, CLEAN-SOIL AIR WATER, V38, P96, DOI 10.1002/clen.200900233
   Kumar KV, 2005, PROCESS BIOCHEM, V40, P2865, DOI 10.1016/j.procbio.2005.01.007
   Kumar KV, 2006, DYES PIGMENTS, V69, P74
   Mittal A, 2005, J HAZARD MATER, V117, P171, DOI 10.1016/j.jhazmat.2004.09.016
   Mohan SV, 2002, WASTE MANAGE, V22, P575
   Pareek VK, 2002, J PHOTOCH PHOTOBIO A, V149, P139, DOI 10.1016/S1010-6030(01)00640-2
   Parshetti G, 2006, ACTA CHIM SLOV, V53, P492
   Peta A., 2009, SCI TOTAL ENVIRON, V407, P1164
   Ramalho Patricia A., 2007, Biotechnology Journal, V2, P370, DOI 10.1002/biot.200600049
   Rani KY, 1999, BIOPROCESS ENG, V21, P77
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Couto SR, 2009, BIOTECHNOL ADV, V27, P227, DOI 10.1016/j.biotechadv.2008.12.001
   Salari D, 2005, J HAZARD MATER, V125, P205, DOI 10.1016/j.jhazmat.2005.05.030
   Salari D, 2009, J ELECTROANAL CHEM, V629, P117, DOI 10.1016/j.jelechem.2009.02.002
   Slokar YM, 1999, DYES PIGMENTS, V42, P123, DOI 10.1016/S0143-7208(99)00022-4
   Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026
   WALSH GE, 1980, ENVIRON POLLUT A, V21, P169, DOI 10.1016/0143-1471(80)90161-0
   Yan H, 2004, CHEMOSPHERE, V55, P1281, DOI 10.1016/j.chemosphere.2003.12.019
NR 44
TC 53
Z9 55
U1 0
U2 10
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0263-8762
EI 1744-3563
J9 CHEM ENG RES DES
JI Chem. Eng. Res. Des.
PD FEB
PY 2011
VL 89
IS 2A
BP 172
EP 178
DI 10.1016/j.cherd.2010.05.009
PG 7
WC Engineering, Chemical
SC Engineering
GA 731ZZ
UT WOS:000288151300006
DA 2018-10-20
ER

PT J
AU Pennesi, G
   Scaglione, S
   Giannoni, P
   Quarto, R
AF Pennesi, G.
   Scaglione, S.
   Giannoni, P.
   Quarto, R.
TI Regulatory Influence of Scaffolds on Cell Behavior: How Cells Decode
   Biomaterials
SO CURRENT PHARMACEUTICAL BIOTECHNOLOGY
LA English
DT Review
DE Stem cells; stem cell niche; bio-scaffold; bone; cartilage
ID MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CERAMICS; BETA-TRICALCIUM
   PHOSPHATE; MARROW STROMAL CELLS; TISSUE-ENGINEERED BONE; IN-VIVO
   EVALUATION; POROUS HYDROXYAPATITE; ARTICULAR-CARTILAGE; HYALURONIC-ACID;
   BIOMEDICAL APPLICATIONS
AB A stem cell is defined as a cell able to self-renew and at the same time to generate one or more specialized progenies. In the adult organism, stem cells need a specific microenvironment where to reside. This tissue-specific instructive microenvironment, hosting stem cells and governing their fate, is composed of extracellular matrix and soluble molecules. Cell-matrix and cell-cell interactions also contribute to the specifications of this milieu, regarded as a whole unitary system and referred to as "niche". For many stem cell systems a niche has been identified, but only partially defined. In regenerative medicine and tissue engineering, biomaterials are used to deliver stem cells in specific anatomical sites where a regenerative process is needed. In this context, biomaterials have to provide informative microenvironments mimicking a physiological niche. Stem cells may read and decode any biomaterial and modify their behavior and fate accordingly. Any material is therefore informative in the sense that its intrinsic nature and structure will anyway transmit a signal that will have to be decoded by colonizing cells. We still know very little of how to create local microenvironments, or artificial niches, that will govern stem cells behavior and their terminal fate. Here we will review some characteristics identifying specific niches and some of the requirements allowing stem cells differentiation processes. We will discuss on those biomaterials that are being projected/engineered/manufactured to gain the informative status necessary to drive proper molecular cross-talk and cell differentiation; specific examples will be proposed for bone and cartilage substitutes.
C1 [Pennesi, G.] MultiMed IRCCS, I-20138 Milan, Italy.
   [Scaglione, S.; Giannoni, P.] CBA, I-16132 Genoa, Italy.
   [Scaglione, S.] Univ Genoa, DIST, I-16145 Genoa, Italy.
   [Quarto, R.] Univ Genoa, DIMES, I-16132 Genoa, Italy.
RP Pennesi, G (reprint author), MultiMed IRCCS, Via Fantoli 16-15, I-20138 Milan, Italy.
EM giuseppina.pennesi@multimedica.it
RI Scaglione, Silvia/B-7124-2014
OI Scaglione, Silvia/0000-0002-9464-3554; Quarto,
   Rodolfo/0000-0002-1146-894X
FU Italian Ministry of the University and Research [RBPR05RSM2]
FX We acknowledge the Italian Ministry of the University and Research
   (project TISSUENET, prot. n. RBPR05RSM2) for partial funding of the
   work.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   ADKISSON HD, 2001, CLIN ORTHOP S, V391, pS280, DOI DOI 10.1097/00003086-200110001-00026
   Agneskirchner JD, 2002, KNEE SURG SPORT TR A, V10, P160, DOI 10.1007/s00167-001-0259-6
   Albertini G, 2009, TISSUE ENG PART C-ME, V15, P403, DOI 10.1089/ten.tec.2008.0270
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   BOO JS, 2002, J CRANIOFAC SURG, V13, P240
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Burkart A, 2001, Unfallchirurg, V104, P797, DOI 10.1007/s001130170048
   Butler DL, 2009, TISSUE ENG PART B-RE, V15, P477, DOI [10.1089/ten.teb.2009.0340, 10.1089/ten.TEB.2009.0340]
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Cheng L., 2009, ACTA BIOMATER, V6, P1569
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006
   COSTA D, 2001, CYTOKINE, V51, P47
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   De Oliveira JF, 2003, ARTIF ORGANS, V27, P406
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Eisenbarth E, 2007, BIOMOL ENG, V24, P27, DOI 10.1016/j.bioeng.2006.05.016
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Gabler F, 2007, BIOMOL ENG, V24, P515, DOI 10.1016/j.bioeng.2007.08.013
   Garbacz H, 2007, BIOMOL ENG, V24, P559, DOI 10.1016/j.bioeng.2007.08.007
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Guarino V, 2008, J BIOMED MATER RES B, V86B, P548, DOI 10.1002/jbm.b.31055
   Hall B., 2007, V180, P263
   Hamilton DW, 2005, CELL BIOL INT, V29, P605, DOI 10.1016/j.cellbi.2005.03.013
   Hamilton DW, 2005, CELL BIOL INT, V29, P408, DOI 10.1016/j.cellbi.2004.12.008
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hildebrand HF, 2007, BIOMOL ENG, V24, P423, DOI 10.1016/j.bioeng.2007.07.001
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang L, 2001, SCANNING, V23, P372
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188
   Karpowicz P, 2009, J NEUROSCI, V29, P3885, DOI 10.1523/JNEUROSCI.0037-09.2009
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khang D, 2008, J BIOMED MATER RES A, V86A, P253, DOI 10.1002/jbm.a.31803
   Klopcic SB, 2007, BIOMOL ENG, V24, P467, DOI 10.1016/j.bioeng.2007.07.009
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940
   Kwon IK, 2006, BIOMATERIALS, V27, P986, DOI 10.1016/j.biomaterials.2005.07.038
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   Leguen E, 2007, BIOMOL ENG, V24, P33, DOI 10.1016/j.bioeng.2006.05.023
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI [10.1089/ten.teb.2008.0575, 10.1089/ten.TEB.2008.0575]
   Lewandowska M, 2007, BIOMOL ENG, V24, P438, DOI 10.1016/j.bioeng.2007.07.002
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Luthen F, 2007, BIOMOL ENG, V24, P531, DOI 10.1016/j.bioeng.2007.08.003
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Muller L, 2007, BIOMOL ENG, V24, P462, DOI 10.1016/j.bioeng.2007.07.011
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Nakamura T, 2007, J ORTHOP SCI, V12, P111, DOI 10.1007/s00776-007-1109-2
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nicula R, 2007, BIOMOL ENG, V24, P564, DOI 10.1016/j.bioeng.2007.08.008
   Niemeyer P, 2003, Z ORTHOP GRENZGEB, V141, P712, DOI 10.1055/s-2003-812397
   Nilsson SK, 2003, BLOOD, V101, P856, DOI 10.1182/blood-2002-05-1344
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Pan YS, 2008, J MATER SCI-MATER M, V19, P1963, DOI 10.1007/s10856-007-3280-6
   PARK KH, 2008, BIOTECHNOL LETT, V31, P337
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   Schneider A, 2006, BIOMACROMOLECULES, V7, P2882, DOI 10.1021/bm0605208
   Setton L, 2008, NAT MATER, V7, P172, DOI 10.1038/nmat2130
   Sheehan PE, 2003, BIOSENS BIOELECTRON, V18, P1455, DOI 10.1016/S0956-5663(03)00078-2
   Tasso R, 2009, CARCINOGENESIS, V30, P150, DOI 10.1093/carcin/bgn234
   Tomkowicz B, 2007, P NATL ACAD SCI USA, V104, P17965, DOI 10.1073/pnas.0705647104
   Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3567, DOI 10.1007/s10856-008-3525-z
   Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wise JK, 2009, TISSUE ENG PT A, V15, P913, DOI 10.1089/ten.tea.2008.0109
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 122
TC 26
Z9 26
U1 1
U2 23
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-2010
J9 CURR PHARM BIOTECHNO
JI Curr. Pharm. Biotechnol.
PD FEB
PY 2011
VL 12
IS 2
BP 151
EP 159
DI 10.2174/138920111794295684
PG 9
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 715IG
UT WOS:000286876200003
PM 21044012
DA 2018-10-20
ER

PT J
AU Aviles, MO
   Shea, LD
AF Aviles, Misael O.
   Shea, Lonnie D.
TI Hydrogels to modulate lentivirus delivery in vivo from microporous
   tissue engineering scaffolds
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Biomaterial scaffolds; Hydrogels; Collagen; Fibrin; Alginate; Lentivirus
AB Numerous strategies to induce tissue regeneration employ scaffolds to create space and present biological cues that promote development. In this report, microporous scaffolds that provide structural support were filled with hydrogels to regulate cell adhesion and migration and were investigated as delivery vehicles for gene therapy vectors in vivo. Porous scaffolds were filled with either lentivirus-entrapped collagen or fibrin hydrogels, both of which support cell adhesion yet have varied rates for degradation and cell infiltration. Empty scaffolds and alginate hydrogels were employed as controls, with the latter not supporting cell infiltration. Hydrogel-filled scaffolds retained the lentivirus more effectively than empty scaffolds, and transgene expression was observed for all scaffold conditions. Empty and fibrin-filled scaffolds had maximal transgene expression in vivo, followed by collagen and alginate, with similar levels. Transduced macrophages and dendritic cells were initially present at the scaffold boundary and adjacent tissue and within the scaffold at later time points for all but the alginate condition. At days 3 and 7, expression was also imaged throughout the spleen and thymus, which may result from cell migration from the implant. These studies demonstrate that hydrogels can modulate gene delivery from scaffolds used in cell transplantation and regenerative medicine.
C1 [Aviles, Misael O.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Adv Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Inst BioNanotechnol Adv Med, 303 East Super St,Lurie Bldg, Chicago, IL 60611 USA.
EM l-shea@northwestern.edu
FU NIH [R01 EB005678, R21 EB006520]
FX Financial support for this research was provided by grants from NIH (R01
   EB005678 and R21 EB006520). The authors thank Ryan Boehler, Ariella
   Shikanov, and Taba Kheradmand (Northwestern University) for technical
   assistance with lentivirus, hydrogels, and organ dissection.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Chan AW, 2009, BIOMATERIALS, V30, P6119, DOI 10.1016/j.biomaterials.2009.07.034
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eyrich D., 2007, TISSUE ENG, V13, P379
   Gong YH, 2007, J BIOMED MATER RES B, V82B, P192, DOI 10.1002/jbm.b.30721
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nielsen LF, 1998, BIOTECH HISTOCHEM, V73, P71, DOI 10.3109/10520299809140509
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Petter-Puchner AH, 2010, J INVEST SURG, V23, P40, DOI 10.3109/08941930903469383
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Salvay DM, 2010, GENE THER, V17, P1134, DOI 10.1038/gt.2010.79
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shepard JA, 2010, J CONTROL RELEASE, V146, P128, DOI 10.1016/j.jconrel.2010.04.032
   Shin S, 2010, J BIOMED MATER RES A, V93A, P1252, DOI 10.1002/jbm.a.32619
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Shin S, 2010, MOL THER, V18, P700, DOI 10.1038/mt.2009.300
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Tsui LV, 2002, NAT BIOTECHNOL, V20, P53, DOI 10.1038/nbt0102-53
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
NR 40
TC 12
Z9 12
U1 0
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD FEB
PY 2011
VL 1
IS 1
BP 91
EP 101
DI 10.1007/s13346-010-0011-1
PG 11
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA V39PO
UT WOS:000209423100012
PM 22229129
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lippi, G
   Montagnana, M
   Franchini, M
AF Lippi, Giuseppe
   Montagnana, Martina
   Franchini, Massimo
TI Ex-vivo red blood cells generation: A step ahead in transfusion
   medicine?
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Review
DE Red blood cells; Transfusion; Blood
ID SYNTHETIC BIOMATERIAL PARTICLES; TASK-FORCE; GUIDELINES; THERAPY
AB Blood transfusion and especially red blood cell (RBC) transfusion is an essential therapeutic act because it might be life-saving in several situations such as massive bleeding or as prolonged quality-of-life therapies in patients with chronic anemic disorders. Although the need for blood is thereby widespread, there is however a major imbalance between demand and supply of donors, so that there is a mounting research to develop suitable surrogates for human donated blood. Functional RBCs have already been generated from a variety of cellular progenitors (i.e., somatic stem cells, human embryonic stem cells and induced pluripotent stem cells) and synthetic biomaterials. Although these types of "artificial blood" carry several advantages over donated blood, including larger supply, lower risk of blood-borne pathogens transmission, no risk of immune incompatibility using group O, RhD-negative RBCs, and extended survival of stored RBCs, their efficacy has not been extensively tested thus far in clinical trials. Therefore, while it seems premature at this point in time to conclude that ex-vivo manufacturing of blood might be the definitive solution to the current shortage of blood supply, it represents however a valuable starting point for translational research in transfusion medicine. (C) 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
C1 [Franchini, Massimo] Azienda Osped Univ Parma, Serv Immunoematol & Trasfus, I-43126 Parma, Italy.
   [Lippi, Giuseppe] Azienda Osped Univ Parma, UO Diagnost Ematochim, Dipartimento Patol & Med Lab, I-43126 Parma, Italy.
   [Montagnana, Martina] Azienda Osped Univ Verona, Sez Chim Clin, Verona, Italy.
RP Franchini, M (reprint author), Azienda Osped Univ Parma, Serv Immunoematol & Trasfus, Via Gramsci 14, I-43126 Parma, Italy.
EM mfranchini@ao.pr.it
CR ANSTEE DJ, 2010, TRANSFUS CLIN B 0722
   Bonig H, 2008, TRANSFUSION, V48, P1039, DOI 10.1111/j.1537-2995.2008.01706.x
   Chang TMS, 1957, HEMOGLOBIN CORPUSCLE
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Expert Work Group, 1997, CAN MED ASS J S11, V156, pS1
   Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544
   Kim HW, 2006, ARTIF CELL BLOOD SUB, V34, P537, DOI 10.1080/10731190600973725
   LAFOLIE P, BLOOD SUBSTITUTES
   LAPILLONNE H, 2010, HAEMATOLOGICA   0709
   Lippi G, 2010, INT J SPORTS MED, V31, P75, DOI 10.1055/s-0030-1247540
   Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313
   Lippi G, 2010, SEMIN THROMB HEMOST, V36, P471, DOI 10.1055/s-0030-1255440
   Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P49, DOI 10.2450/2008.0020-08
   Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198
   Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105
   Mountford J, 2010, BRIT J HAEMATOL, V149, P22, DOI 10.1111/j.1365-2141.2010.08079.x
   Murphy MF, 2001, BRIT J HAEMATOL, V113, P24
   Scholer M, 2010, DEUT MED WOCHENSCHR, V135, P575, DOI 10.1055/s-0030-1249214
   Seifinejad A, 2010, BIOCHEM BIOPH RES CO, V391, P329, DOI 10.1016/j.bbrc.2009.11.058
   Simon TL, 1998, ARCH PATHOL LAB MED, V122, P130
   Stehling LC, 1996, ANESTHESIOLOGY, V84, P732
NR 21
TC 9
Z9 11
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD FEB
PY 2011
VL 22
IS 1
BP 16
EP 19
DI 10.1016/j.ejim.2010.08.001
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 706BU
UT WOS:000286191400005
PM 21238887
DA 2018-10-20
ER

PT J
AU Vert, M
AF Vert, Michel
TI Degradable polymers in medicine: Updating strategies and terminology
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Degradable; Biodegradable; Polymer biomaterial; Bioresorbability;
   Terminology
ID HYDROLYTIC DEGRADATION
AB Today, the field of biodegradable materials and devices attracts polymer scientists and healthcare professionals in surgery, dentistry, pharmacology and regenerative medicine. More than one thousand papers are published per year in the literature, while the topic appears in the title of many patents. However, the number of devices or systems that have been successfully developed for clinical and commercial uses is still very small. A critical examination of the literature suggests two main reasons for this. Firstly, biodegradation is generally considered the main goal to reach, so that academic strategies do not take into account the criteria specific to targeted applications. Secondly, the term "biodegradable" is too often used inappropriately and creates confusion. This paper aims specifically to remind readers of the complexity of in vivo polymer degradation and the need for an enriched and universally recognized terminology in order to clearly distinguish between the various possible stages, and to enable clear communication between specialists when discussing related issues. It also emphasizes the need for any novel polymer to be well characterized and to include application-specific requirements in the research strategy from the very beginning, since these determine its potential clinical and commercial uses. Based on more than a decade of efforts, this would appear to be paramount in order to provide a chance for novel polymers to reach the market.
C1 Univ Montpellier 1, CNRS, IBMM, CRBA,Fac Pharm,UMR 5247, F-34093 Montpellier 5, France.
RP Vert, M (reprint author), Univ Montpellier 1, CNRS, IBMM, CRBA,Fac Pharm,UMR 5247, 15 Ave Charles Flahault,BP 14491, F-34093 Montpellier 5, France.
EM vertmichel@univ-montp1.fr
CR ALBERTSSON AC, 2002, BIOPOLYMERS POLYESTE, V3, P25
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   *BRIT STAND I, 2006, 15351 PD CENTR BRIT
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Li S., 2002, BIODEGRADABLE POLYM, P71
   SHALABY SW, 2003, ADV POLYM BIOMAT SER
   Tsuji H., 2002, BIOPOLYMERS, VIII, P129
   Vert M, 1997, ANGEW MAKROMOL CHEM, V247, P239, DOI 10.1002/apmc.1997.052470116
   Vert M., 2002, BIOPOLYMERS BIOL CHE, P179
   VERT M, 2005, E-POLYMERS, V8, P1
   VERT M, 2001, BIORELATED POLYM SUS, P63
   Vert M, 2009, J MATER SCI-MATER M, V20, P437, DOI 10.1007/s10856-008-3581-4
NR 12
TC 13
Z9 13
U1 3
U2 36
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 76
EP 83
DI 10.5301/IJAO.2011.6400
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000002
PM 21374558
DA 2018-10-20
ER

PT J
AU Pierce, BF
   Bellin, K
   Behl, M
   Lendlein, A
AF Pierce, Benjamin F.
   Bellin, Katja
   Behl, Marc
   Lendlein, Andreas
TI Demonstrating the influence of water on shape-memory polymer networks
   based on poly[(rac-lactide)-co-glycolide] segments in vitro
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Shape-memory polymer; Poly[(rac-dilactide)-co-glycolide];
   Copolyesterurethane; Degradable polymer; Biomaterial
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; URETHANE NETWORKS;
   DEGRADATION
AB Thermally-responsive shape-memory polymers (SMP) are highly promising implant materials for applications in minimally-invasive surgery since the shape-memory effect (SME) enables the implantation of a bulky device in a compressed temporary state through a small incision. When heated to a temperature exceeding the material switching temperature (T(sw)), the device recovers its original bulky shape. Therefore, SMP implants with T(sw) similar to 37 degrees C are required for such applications because the body cannot withstand excessive applications of heat. Here, T(sw) of networks based on poly[(rac-lactide)-co-glycolide] star-shaped macrotriol or macrotetrols with 19-22 wt% glycolide content, varying oligomer molecular weight (M(n)=3000-10000 g.mol(-1)), and netpoint functionality (f=3 or 4) were lowered from 55-66 degrees C to below body temperature via the uptake of water, which also induced SME at body temperature. Programmed samples kept their temporary shape at room temperature in water as well as at 37 degrees C under dry conditions but recovered in 37 degrees C water. Water uptake/swelling studies and FTIR analysis indicated that the mechanism of solvent-induced SME involved the plasticization of water in switching domains as opposed to changes in swelling or hydrogen bonding. This indirect actuation of SME by using a combination of solvent and heat could be exploited in easy-to-handle shape-memory implant with slower degradation kinetics.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geestacht, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   Helmholtz Zentrum Geestacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geestacht, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Behl, Marc/K-9429-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Behl, Marc/0000-0002-1507-0277
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447
   Behl M, 2010, ADV POLYM SCI, V226, P1, DOI 10.1007/12_2009_26
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Choi NY, 2006, ADV ENG MATER, V8, P439, DOI 10.1002/adem.200600020
   DAVIS FE, 1953, SCIENCE, V118, P276, DOI 10.1126/science.118.3062.276
   Du HY, 2010, SOFT MATTER, V6, P3370, DOI 10.1039/b922220k
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2010, ADV MATER, V22, P3344, DOI 10.1002/adma.201002520
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Lu HB, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/8/085003
   MA X, 2010, E POLYM, V76
   MONTON M, 1987, SOLUTION THEORY POLY
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Neffe AT, 2010, MACROMOL CHEM PHYS, V211, P182, DOI 10.1002/macp.200900441
   Su JF, 2007, POLYM BULL, V58, P913, DOI 10.1007/s00289-007-0731-7
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   TZONEVA R, 2010, J BIOMATER SCI POLYM
   Wischke C, 2010, EUR J PHARM SCI, V41, P136, DOI 10.1016/j.ejps.2010.06.003
   Wischke C, 2010, ADV POLYM SCI, V226, P177, DOI 10.1007/12_2009_29
   Zotzmann J, 2009, J MATER SCI-MATER M, V20, P1815, DOI 10.1007/s10856-009-3761-x
NR 27
TC 22
Z9 23
U1 3
U2 36
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 172
EP 179
DI 10.5301/IJAO.2011.6413
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000014
PM 21374570
DA 2018-10-20
ER

PT J
AU Niepel, MS
   Peschel, D
   Groth, T
AF Niepel, Marcus S.
   Peschel, Dieter
   Groth, Thomas
TI Controlling fibroblast adhesion with pH modified polyelectrolyte
   multilayers
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Surface modification; Heparin; Human fibroblasts; Polyelectrolyte
   multilayer
ID BIOMEDICAL APPLICATIONS; SUBSTRATUM CHEMISTRY; CELL-ADHESION; FILMS;
   ADSORPTION; SURFACE; LAYER; QCM
AB Tissue cells need to adhere to a biomaterial surface to promote their growth and differentiation and, thus, foster the integration of implants. As a result, surface features and their modification play an important role in biomedical applications. In this study, the layer-by-layer (LbL) technique was used to design self-assembled polyelectrolyte multilayer (PEM) coatings of polyethyleneimine (PEI) and heparin (HEP) on glass, which will control the adhesion of primary human dermal fibroblasts in a model system. The study showed that, among other surface features, the wettability of surfaces can be controlled by changing the conditions during multilayer self-assembly. Here, the pH value of the HEP solution was adjusted to acidic or alkaline values for terminal layers, which also led to a change in multilayer growth. Further, the study revealed that plain terminal layers were rather cytophobic. Upon pre-adsorption of fibronectin (FN), a clear effect on cell adhesion and morphology in dependence on the pH setup was evident. Proliferation studies clearly showed that terminal layers, which impaired cell adhesion, also inhibited growth of human fibroblasts under serum-conditions. On the other hand, on layers with pronounced cell adhesion an elevated cell growth was also observed. As a result, HEP terminated multilayers are interesting for applications requiring cell repellent properties, whereas PEI terminated multilayers could be used to promote cell adhesion and growth on implant surfaces.
C1 [Niepel, Marcus S.; Peschel, Dieter; Groth, Thomas] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Technol & Biopharm, Biomed Mat Grp, D-06099 Halle, Saale, Germany.
RP Groth, T (reprint author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Technol & Biopharm, Biomed Mat Grp, D-06099 Halle, Saale, Germany.
EM thomas.groth@pharmazie.uni-halle.de
RI Niepel, Marcus/G-2340-2011
OI Niepel, Marcus/0000-0002-4479-1225; Groth, Thomas/0000-0001-6647-9657
FU German Academic Exchange Service (DAAD) [D/08/45100]
FX This work was partly supported by the German Academic Exchange Service
   (DAAD) in the frame of a short-term stipend for Ph.D. students to M.S.N.
   (D/08/45100).
CR Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   Alves NM, 2009, MACROMOL BIOSCI, V9, P776, DOI 10.1002/mabi.200800336
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0
   Czeslik C, 2006, CHEM UNSERER ZEIT, V40, P238, DOI 10.1002/ciuz.200600352
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   Kirchhof K, 2009, J MATER SCI-MATER M, V20, P897, DOI 10.1007/s10856-008-3639-3
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Ngankam AP, 2004, LANGMUIR, V20, P3362, DOI 10.1021/la035479y
   NIEPEL M, 2008, AKTUELLES KLIN HAMOR, P42
   Niepel MS, 2009, BIOMATERIALS, V30, P4939, DOI 10.1016/j.biomaterials.2009.06.014
   Notley SM, 2005, J COLLOID INTERF SCI, V292, P29, DOI 10.1016/j.jcis.2005.05.057
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tomita S, 2008, J COLLOID INTERF SCI, V326, P35, DOI 10.1016/j.jcis.2008.06.054
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
NR 24
TC 6
Z9 6
U1 0
U2 17
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 185
EP 191
DI 10.5301/IJAO.2011.6395
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000016
PM 21374559
DA 2018-10-20
ER

PT J
AU Piluso, S
   Hiebl, B
   Gorb, SN
   Kovalev, A
   Lendlein, A
   Neffe, AT
AF Piluso, Susanna
   Hiebl, Bernhard
   Gorb, Stanislav N.
   Kovalev, Alexander
   Lendlein, Andreas
   Neffe, Axel T.
TI Hyaluronic acid-based hydrogels crosslinked by copper-catalyzed
   azide-alkyne cycloaddition with tailorable mechanical properties
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomaterial; Hydrogel; Hyaluronic acid; Microindentation; Rheology
ID CLICK CHEMISTRY; NETWORKS
AB Biopolymers of the extracellular matrix are attractive starting materials for providing degradable and biocompatible biomaterials. In this study, hyaluronic acid-based hydrogels with tunable mechanical properties were prepared by the use of copper-catalyzed azide-alkyne cycloaddition (known as "click chemistry"). Alkyne-functionalized hyaluronic acid was crosslinked with linkers having two terminal azide functionalities, varying crosslinker density as well as the lengths and rigidity of the linker molecules. By variation of the crosslinker density and crosslinker type, hydrogels with elastic moduli in the range of 0.5-4 kPa were prepared. The washed materials contained a maximum of 6.8 mg copper per kg dry weight and the eluate of the gel crosslinked with diazidostilbene did not show toxic effects on L929 cells. The hyaluronic acid-based hydrogels have potential as biomaterials for cell culture or soft tissue regeneration applications.
C1 [Piluso, Susanna; Hiebl, Bernhard; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Piluso, Susanna; Hiebl, Bernhard; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Polymer Res Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Piluso, Susanna; Lendlein, Andreas; Neffe, Axel T.] Univ Potsdam, Inst Chem, Potsdam Golm, Germany.
   [Gorb, Stanislav N.; Kovalev, Alexander] Univ Kiel, Dept Zool Funct Morphol & Biomech, D-24098 Kiel, Germany.
RP Neffe, AT (reprint author), Helmholtz Zentrum Geesthacht, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM axel.neffe@hzg.de
RI Lendlein, Andreas/K-9553-2013; Neffe, Axel/H-6997-2013; Kovalev,
   Alexander/B-3070-2012
OI Lendlein, Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990;
   Hiebl, Bernhard/0000-0002-6450-0675; Piluso, Susanna/0000-0003-0508-711X
FU Helmholtz Association [SO_036]; Federal Ministry of Education and
   Research, Germany (BMBF) [01RI0633D]
FX Financial support was provided by the Helmholtz Association (grant
   SO_036). AK and SG were supported from funds of the Federal Ministry of
   Education and Research, Germany (BMBF project Inspirat 01RI0633D).
CR Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Gribbon P, 1999, BIOPHYS J, V77, P2210, DOI 10.1016/S0006-3495(99)77061-X
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Malavaki CJ, 2007, CURR PHARM ANAL, V3, P117, DOI 10.2174/157341207780598940
   Ramamurthi A., 2002, J BIOMED MATER RES, V60, P195
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Vogel S., 1988, LIFES DEVICES PHYS W
NR 16
TC 13
Z9 13
U1 1
U2 21
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD FEB
PY 2011
VL 34
IS 2
BP 192
EP 197
DI 10.5301/IJAO.2011.6394
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 748FI
UT WOS:000289375000017
PM 21374560
OA Green Published
DA 2018-10-20
ER

PT J
AU Pulido, L
   Rachala, SR
   Cabanela, ME
AF Pulido, Luis
   Rachala, Sridhar R.
   Cabanela, Miguel E.
TI Cementless acetabular revision: past, present, and future
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; POROUS TANTALUM BIOMATERIAL; FOLLOW-UP; PELVIC
   DISCONTINUITY; BONE LOSS; RECONSTRUCTION RINGS; COMPONENT; FAILURE;
   10-YEAR; CUPS
AB Acetabular revision is probably the most difficult aspect of hip reconstructive surgery. Although the majority of acetabular revisions can be performed using an uncemented hemispherical acetabular device with ancillary fixation, patients with severe acetabular deficiencies and poor bone quality require more complex alternatives for revision. The limitations of traditional cementless acetabular implants has promoted the development of improved methods of fixation and revision techniques. Highly porous metals have been introduced for clinical use in arthroplasty surgery over the last decade. Their higher porosity and surface friction are ideal for acetabular revision, optimising biological fixation. The use of trabecular metal cups in acetabular revision has yielded excellent clinical results.
   This review focuses on the use of cementless implants for acetabular revision. The use of trabecular metal cups, augments, jumbo cups, oblong cups, cages, and structural grafting are also discussed.
C1 [Pulido, Luis; Cabanela, Miguel E.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Rachala, Sridhar R.] SUNY Buffalo, Dept Orthoped Surg, Buffalo, NY 14203 USA.
RP Cabanela, ME (reprint author), Mayo Clin, Dept Orthoped Surg, 200 1st St, Rochester, MN 55905 USA.
EM cabanela.miguel@mayo.edu
CR Berry DJ, 1999, J BONE JOINT SURG AM, V81A, P1692, DOI 10.2106/00004623-199912000-00006
   Berry DJ, 2000, CLIN ORTHOP RELAT R, P154
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bojescul JA, 2003, J BONE JOINT SURG AM, V85A, P1079, DOI 10.2106/00004623-200306000-00015
   Cabanela ME, 1998, ORTHOP CLIN N AM, V29, P255, DOI 10.1016/S0030-5898(05)70324-2
   CALLAGHAN JJ, 1985, J BONE JOINT SURG AM, V67A, P1074, DOI 10.2106/00004623-198567070-00011
   Chen WM, 2000, J BONE JOINT SURG AM, V82A, P197, DOI 10.2106/00004623-200002000-00005
   Civinini R, 2008, INT ORTHOP, V32, P189, DOI 10.1007/s00264-006-0307-4
   Clohisy JC, 2004, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000150126.73024.42
   DeBoer DK, 2007, J BONE JOINT SURG AM, V89A, P835, DOI 10.2106/JBJS.F.00313
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P91
   Fernandez-Fairen M, 2010, J ARTHROPLASTY, V25, P865, DOI 10.1016/j.arth.2009.07.027
   Goodman S, 2004, J ARTHROPLASTY, V19, P436, DOI 10.1016/j.arth.2003.11.015
   Hallstrom BR, 2004, J BONE JOINT SURG AM, V86A, P1007, DOI 10.2106/00004623-200405000-00018
   Hanssen AD, 2004, ORTHOPEDICS, V27, P830
   HEDLEY AK, 1988, CLIN ORTHOP RELAT R, P75
   Holt GE, 2004, CLIN ORTHOP RELAT R, P209, DOI 10.1097/01.blo.0000150252.19780.74
   JASTY M, 1990, J BONE JOINT SURG BR, V72, P63
   Katz RP, 1997, J BONE JOINT SURG BR, V79B, P322, DOI 10.1302/0301-620X.79B2.7245
   KAVANAGH BF, 1985, J BONE JOINT SURG AM, V67A, P517, DOI 10.2106/00004623-198567040-00003
   Kosashvili Y, 2009, J BONE JOINT SURG BR, V91B, P870, DOI 10.1302/0301-620X.91B7.22181
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lachiewicz PF, 1998, J BONE JOINT SURG AM, V80A, P980, DOI 10.2106/00004623-199807000-00006
   Lakstein D, 2009, CLIN ORTHOP RELAT R, V467, P2318, DOI 10.1007/s11999-009-0772-3
   Lazarinis S, 2010, ACTA ORTHOP, V81, P53, DOI 10.3109/17453670903413178
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Lee PTH, 2010, CLIN ORTHOP RELAT R, V468, P3295, DOI 10.1007/s11999-010-1591-2
   LEWALLEN DG, 2002, ANN M AAOS DALL TEX
   Lie SA, 2004, J BONE JOINT SURG BR, V86B, P504, DOI 10.1302/0301-620X.86B4.14799
   Manley MT, 1998, J BONE JOINT SURG AM, V80A, P1175, DOI 10.2106/00004623-199808000-00011
   Meneghini RM, 2010, J ARTHROPLASTY, V25, P337, DOI 10.1016/j.arth.2009.03.003
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Paprosky W G, 1994, J Arthroplasty, V9, P33, DOI 10.1016/0883-5403(94)90135-X
   Paprosky W, 2006, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000246530.52253.7b
   Peters CL, 2004, J ARTHROPLASTY, V19, P67, DOI 10.1016/j.arth.2004.06.015
   Sembrano JN, 2008, CLIN ORTHOP RELAT R, V466, P1657, DOI 10.1007/s11999-008-0183-x
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   Sporer SM, 2006, J ARTHROPLASTY, V21, P87, DOI 10.1016/j.arth.2006.05.015
   Sporer Scott M, 2006, Instr Course Lect, V55, P287
   Sporer SM, 2005, J BONE JOINT SURG AM, V87A, P760, DOI 10.2106/JBJS.D.02099
   Springer BD, 2005, J BONE JOINT SURG AM, V87A, P2626, DOI 10.2106/JBJS.E.00088
   TANZER M, 1992, J BONE JOINT SURG AM, V74A, P987, DOI 10.2106/00004623-199274070-00005
   Templeton JE, 2001, J BONE JOINT SURG AM, V83A, P1706, DOI 10.2106/00004623-200111000-00014
   Van Kleunen JP, 2009, J ARTHROPLASTY, V24, P64, DOI 10.1016/j.arth.2009.02.001
   Whaley AL, 2001, J BONE JOINT SURG AM, V83A, P1352, DOI 10.2106/00004623-200109000-00010
NR 46
TC 55
Z9 58
U1 2
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD FEB
PY 2011
VL 35
IS 2
BP 289
EP 298
DI 10.1007/s00264-010-1198-y
PG 10
WC Orthopedics
SC Orthopedics
GA 716DJ
UT WOS:000286945100021
PM 21234562
OA Green Published
DA 2018-10-20
ER

PT J
AU Kong, YM
   Dahlke, C
   Xiang, Q
   Qian, Y
   Karp, D
   Scheuermann, RH
AF Kong, Y. Megan
   Dahlke, Carl
   Xiang, Qun
   Qian, Yu
   Karp, David
   Scheuermann, Richard H.
TI Toward an ontology-based framework for clinical research databases
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE Ontology; Clinical trials; Biomaterial transformation; Assay; Data
   transformation; Conceptual model
ID BIOMEDICAL DATA; PROJECT; DOMAIN
AB Clinical research includes a wide range of study designs from focused observational studies to complex interventional studies with multiple study arms, treatment and assessment events, and specimen procurement procedures. Participant characteristics from case report forms need to be integrated with molecular characteristics from mechanistic experiments on procured specimens. In order to capture and manage this diverse array of data, we have developed the Ontology-Based eXtensible data model (OBX) to serve as a framework for clinical research data in the Immunology Database and Analysis Portal (ImmPort). By designing OBX around the logical structure of the Basic Formal Ontology (BFO) and the Ontology for Biomedical Investigations (OBI), we have found that a relatively simple conceptual model can represent the relatively complex domain of clinical research. In addition, the common framework provided by BFO makes it straightforward to develop data dictionaries based on reference and application ontologies from the OBO Foundry. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Scheuermann, Richard H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Div Biomed Informat, Div Translat Pathol, Dallas, TX 75390 USA.
   [Dahlke, Carl] Northrop Grumman Inc, Hlth Informat Syst, Rockville, MD USA.
   [Karp, David] Univ Texas SW Med Ctr Dallas, Div Rheumatol, Dallas, TX 75390 USA.
RP Scheuermann, RH (reprint author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Div Biomed Informat, Div Translat Pathol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
EM richard.scheuermann@utsouthwestern.edu
RI Qian, Yu/B-9547-2011
OI Scheuermann, Richard/0000-0003-1355-892X
FU NIH [N01A140076, U54RR023468]
FX We would like to thank the OBI consortium for helpful discussion about
   biomedical investigations that forms the basis for the described work.
   Supported by NIH N01A140076 and U54RR023468.
CR Califf RM, 2010, ACAD MED, V85, P457, DOI 10.1097/ACM.0b013e3181ccb74d
   Chute CG, 2010, J AM MED INFORM ASSN, V17, P131, DOI 10.1136/jamia.2009.002691
   *CLINICALTRIALS, 2009, PROT DAT EL IN PRESS
   *CLINICALTRIALS, 2009, BAS RES DAT IN PRESS
   Fridsma DB, 2008, J AM MED INFORM ASSN, V15, P130, DOI 10.1197/jamia.M2556
   Grenon P, 2004, ST HEAL T, V102, P20
   HAMMOND WE, 2009, J AHIMA, V80, P51
   Hammond William Edward, 2009, J AHIMA, V80, P44
   Kuchinke W, 2009, METHOD INFORM MED, V48, P408, DOI 10.3414/ME9236
   Kush R, 2007, J AM MED INFORM ASSN, V14, P662, DOI 10.1197/jamia.M2157
   Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623
   Nahm M, 2009, J BIOMED INFORM, V42, P327, DOI 10.1016/j.jbi.2008.10.004
   Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346
   Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411
   2009, BRIDG RELEASE 2 2 ST
NR 15
TC 16
Z9 16
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD FEB
PY 2011
VL 44
IS 1
SI SI
BP 48
EP 58
DI 10.1016/j.jbi.2010.05.001
PG 11
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA 733UW
UT WOS:000288289900006
PM 20460173
OA Bronze, Green Accepted
DA 2018-10-20
ER

PT J
AU Reichert, W
   Ratner, BD
   Anderson, J
   Coury, A
   Hoffman, AS
   Laurencin, CT
   Tirrell, D
AF Reichert, William (Monty)
   Ratner, Buddy D.
   Anderson, James
   Coury, Art
   Hoffman, Allan S.
   Laurencin, Cato T.
   Tirrell, David
TI 2010 Panel on the Biomaterials Grand Challenges
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; grand challenges; biocompatibility testing; smart polymers;
   regenerative medicine
ID SINTERED MICROSPHERE SCAFFOLDS; ANTERIOR CRUCIATE LIGAMENT;
   DELIVERY-SYSTEMS; BONE REPAIR; TISSUE; POLYMERS; MATRIX; REGENERATION;
   REPLACEMENT; DEGRADATION
AB In 2009, the National Academy for Engineering issued the Grand Challenges for Engineering in the 21st Century comprised of 14 technical challenges that must be addressed to build a healthy, profitable, sustainable, and secure global community (http://www.engineeringchallenges.org). Although crucial, none of the NEA Grand Challenges adequately addressed the challenges that face the biomaterials community. In response to the NAE Grand Challenges, Monty Reichert of Duke University organized a panel entitled Grand Challenges in Biomaterials at the at the 2010 Society for Biomaterials Annual Meeting in Seattle. Six members of the National Academies-Buddy Ratner, James Anderson, Allan Hoffman, Art Coury, Cato Laurencin, and David Tirrell-were asked to propose a grand challenge to the audience that, if met, would significantly impact the future of biomaterials and medical devices. Successfully meeting these challenges will speed the 60-plus year transition from commodity, off-the-shelf biomaterials to bioengineered chemistries, and biomaterial devices that will significantly advance our ability to address patient needs and also to create new market opportunities. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A:275-287, 2011.
C1 [Reichert, William (Monty)] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Ratner, Buddy D.] UWEB, Dept Pathol, Seattle, WA USA.
   [Ratner, Buddy D.] UWEB, Dept Macromol Sci, Seattle, WA USA.
   [Ratner, Buddy D.] UWEB, Dept Biomed Engn, Seattle, WA USA.
   [Anderson, James] Case Western Reserve Univ, Cleveland, OH 44106 USA.
   [Coury, Art] Coury Consulting Serv, Boston, MA USA.
   [Hoffman, Allan S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT USA.
   [Tirrell, David] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Reichert, W (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
EM reichert@duke.edu
FU NIBIB NIH HHS [R13 EB009294]
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380
   Cushnie EK, 2010, J BIOMED MATER RES A, V94A, P568, DOI 10.1002/jbm.a.32722
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Golden AL, 2010, BIOCONJUGATE CHEM, V21, P1820, DOI 10.1021/bc100169y
   Hoffman AS, 2007, PROG POLYM SCI, V32, P922, DOI 10.1016/j.progpolymsci.2007.05.005
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Jabbarzadeh E, 2007, BIOTECHNOL BIOENG, V98, P1094, DOI 10.1002/bit.21495
   Jabbarzadeh E, 2007, J BIOMAT SCI-POLYM E, V18, P1141, DOI 10.1163/156856207781554073
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Khan YM, 2007, J MATER SCI, V42, P4183, DOI 10.1007/s10853-006-0636-0
   Kofron MD, 2007, J BIOMED MATER RES A, V82A, P415, DOI 10.1002/jbm.a.31148
   Kofron MD, 2004, BIOMATERIALS, V25, P2637, DOI 10.1016/j.biomaterials.2003.09.042
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   LAI J, 2009, LAB CHIP, V4, P1997
   Lai JJ, 2007, LANGMUIR, V23, P7385, DOI 10.1021/la062527g
   Laurencin CT, 2006, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000194677.02506.45
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lu HH, 2003, BIOCHEM BIOPH RES CO, V305, P882, DOI 10.1016/S0006-291X(03)00858-1
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   MARSHALL AJ, 2004, THESIS U WASHINGTON
   MIYATA T, 2004, J BIOMAT SCI-POLYM E, V15, P1081
   MOHAMEDHASHEM IK, 2000, BR J ORTHODONTICS, V27, P198
   MONJI N, 1987, APPL BIOCHEM BIOTECH, V14, P107, DOI 10.1007/BF02798429
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nash MA, 2010, NANO LETT, V10, P85, DOI [10.1021/nl902865v, 10.1021/nl902865V]
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Roy D, 2010, PROG POLYM SCI, V35, P278, DOI 10.1016/j.progpolymsci.2009.10.008
   Shimoboji T, 2001, BIOCONJUGATE CHEM, V12, P314, DOI 10.1021/bc000107b
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
NR 37
TC 20
Z9 20
U1 0
U2 35
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2011
VL 96A
IS 2
BP 275
EP 287
DI 10.1002/jbm.a.32969
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 696GA
UT WOS:000285428700002
PM 21171147
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Safranski, DL
   Weiss, D
   Clark, JB
   Caspersen, BS
   Taylor, WR
   Gall, K
AF Safranski, David L.
   Weiss, Daiana
   Clark, J. Brian
   Caspersen, Birgitta S.
   Taylor, W. Robert
   Gall, Ken
TI Effect of poly(ethylene glycol) diacrylate concentration on network
   properties and in vivo response of poly(beta-amino ester) networks
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(beta-amino ester); degradation; modulus; inflammatory response;
   network
ID TISSUE ENGINEERING APPLICATIONS; BIOMATERIAL; DEGRADATION;
   PHOTOPOLYMERS; MACROPHAGES; FIXATION; DELIVERY; BEHAVIOR; LIBRARY;
   DEVICES
AB Poly(beta-amino ester) networks have shown promise as tissue scaffolds. The objective of this work was to examine the effect of changing poly(ethylene glycol) diacrylate concentration on poly(beta-amino ester) network properties and to assess the degradable polymers' in vivo response, using magnetic resonance imaging (MRI) and immunohistochemistry. The networks were synthesized from hexanediol diacrylate (HDDA), poly(ethylene glycol) diacrylate (PEGDA), and a primary amine, 3-methoxypropylamine (3-MOPA), with a fixed overall molar ratio of diacrylate to amine. Network properties were verified to insure that the networks possessed equivalent initial properties and structure other than chemistry. The effect of varying PEGDA concentration on water content, mass loss, and modulus was determined, where increasing the concentration of PEGDA increases both water content, mass loss rate, and decreases modulus. We also show that manipulating the network composition at ratios of 0: 100, 10: 90 and 25: 75 (PEGDA: HDDA) does not elicit a major inflammatory response to subcutaneous implantation of the networks in mice. This work provides a foundation for tailoring poly(b-amino ester) networks, based on degradation rate and modulus, as a means to tune the polymer properties for various biomedical applications. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 320-329, 2011.
C1 [Safranski, David L.; Gall, Ken] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Weiss, Daiana; Clark, J. Brian; Taylor, W. Robert] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.
   [Caspersen, Birgitta S.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Taylor, W. Robert] Atlanta Vet Affairs Med Ctr, Atlanta, GA 30033 USA.
   [Taylor, W. Robert] Georgia Tech & Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Gall, Ken] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Safranski, DL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM Safranski@gatech.edu
RI Library, Woodruff Health/A-6096-2012
FU Parker H. Petit Institute for Bioengineering and Bioscience
FX Contract grant sponsor: Parker H. Petit Institute for Bioengineering and
   Bioscience
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Barrows TH, 1986, CLIN MATER, V1, P233
   Baumgartner S, 2005, EUR J PHARM BIOPHARM, V59, P299, DOI 10.1016/j.ejpb.2004.08.010
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Brey DM, 2008, J BIOMED MATER RES A, V85A, P731, DOI 10.1002/jbm.a.31494
   Brey DM, 2008, ACTA BIOMATER, V4, P207, DOI 10.1016/j.actbio.2007.10.002
   BRITO LA, 2009, J BIOMED MATER RES A, V93, P325
   Burdick JA, 2001, J POLYM SCI POL CHEM, V39, P683, DOI 10.1002/1099-0518(20010301)39:5<683::AID-POLA1040>3.0.CO;2-Z
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Hiemenz P.C., 2007, POLYM CHEM
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kanerva L, 2001, ACTA ODONTOL SCAND, V59, P320, DOI 10.1080/000163501750541200
   Pascault J.-P., 2002, THERMOSETTING POLYM
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Peters R, 2007, J CHROMATOGR A, V1156, P111, DOI 10.1016/j.chroma.2006.10.071
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2006, BIOMACROMOLECULES, V7, P2827, DOI 10.1021/bm0603793
   Safranski DL, 2010, POLYMER, V51, P3130, DOI 10.1016/j.polymer.2010.05.029
   Senyurt AF, 2007, MACROMOLECULES, V40, P4901, DOI 10.1021/ma062534b
   Shen JY, 2007, BIOMACROMOLECULES, V8, P376, DOI 10.1021/bm060766c
   Shen YQ, 2009, NANOMED-NANOTECHNOL, V5, P192, DOI 10.1016/j.nano.2008.09.003
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132
NR 31
TC 8
Z9 8
U1 2
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2011
VL 96A
IS 2
BP 320
EP 329
DI 10.1002/jbm.a.32983
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 696GA
UT WOS:000285428700006
PM 21171151
DA 2018-10-20
ER

PT J
AU Nuryastuti, T
   Krom, BP
   Aman, AT
   Busscher, HJ
   van der Mei, HC
AF Nuryastuti, Titik
   Krom, Bastiaan P.
   Aman, Abu T.
   Busscher, Henk J.
   van der Mei, Henny C.
TI Ica-expression and gentamicin susceptibility of Staphylococcus
   epidermidis biofilm on orthopedic implant biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ica-expression; S. epidermidis; biofilm; infection;
   gentamicin-susceptibility; orthopedics
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; PSEUDOMONAS-AERUGINOSA;
   INFECTIONS; BACTERIA; CULTURE; ICAADBC; AUREUS; OPERON; SKIN; PIA
AB Ica-expression by Staphylococcus epidermidis and slime production depends on environmental conditions such as implant material and presence of antibiotics. Here, we evaluate biofilm formation and ica-expression of S. epidermidis strains on biomaterials involved in total hip-and knee arthroplasty [polyethylene (PE), polymethylmethacrylate (PMMA), stainless steel (SS)]. Ica-expression, assayed using real-time RT-PCR, was highest on PE as confirmed using confocal laser scanning microscopy. Yet biofilm formation by S. epidermidis was most extensive on SS, with less slime production. Ica-expression and slime production were minimal on PMMA. After 3 h of continued growth of 24 h old biofilms in the presence of gentamicin, biofilms on PE showed lower susceptibility to gentamicin, relative to the other materials, presumably as a result of the stronger ica-expression. A higher gentamicin concentration further decreased metabolic activity on all biomaterials. It is concluded that the level of biomaterial-induced ica-expression does not correlate with the amount of biofilm formed, but initially aids bacteria in surviving antibiotic attacks. Once antibiotic treatment has started however, also the antibiotic itself induces slime production and only if its concentration is high enough, killing results. Results suggest that biomaterial-associated infections in orthopedics by S. epidermidis on PE may be more difficult to eradicate than on PMMA or SS. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 365-371, 2011.
C1 [Nuryastuti, Titik; Krom, Bastiaan P.; Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Nuryastuti, Titik; Krom, Bastiaan P.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Dept Biomed Engn, Groningen, Netherlands.
   [Nuryastuti, Titik; Aman, Abu T.] Gadjah Mada Univ, Dept Microbiol, Fac Med, Yogyakarta, Indonesia.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
OI Aman, Abu Tholib/0000-0002-8634-7624; Krom, Bastiaan/0000-0002-1497-1161
CR Amsterdam D., 1996, ANTIBIOTICS LAB MED, P52
   Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cuckler JM, 2005, J ARTHROPLASTY, V20, P33, DOI 10.1016/j.arth.2005.03.004
   DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   KNOBLOCH JKM, 2008, INT J ARTIF ORGANS, V31, P749
   KUMON H, 1994, MICROBIOL IMMUNOL, V38, P615, DOI 10.1111/j.1348-0421.1994.tb01831.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mitchell G, 2010, MICROB PATHOGENESIS, V48, P18, DOI 10.1016/j.micpath.2009.10.003
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   NURYASTUTI T, 2010, ADHESION THERM UNPUB
   Nuryastuti T, 2008, ANTON LEEUW INT J G, V94, P317, DOI 10.1007/s10482-008-9249-8
   Nuryastuti T, 2009, APPL ENVIRON MICROB, V75, P6850, DOI 10.1128/AEM.00875-09
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rogers KL, 2008, APPL ENVIRON MICROB, V74, P6155, DOI 10.1128/AEM.01017-08
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stoodley LH, 2004, NAT REV, V2, P95
   TENCATEHOEDEMAK.HO, 1997, BIOMEDICAL MAT RES G, P109
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
NR 31
TC 18
Z9 24
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2011
VL 96A
IS 2
BP 365
EP 371
DI 10.1002/jbm.a.32984
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 696GA
UT WOS:000285428700011
PM 21171156
DA 2018-10-20
ER

PT J
AU Sang, T
AF Sang, Tao
TI Toward the Domestication of Lignocellulosic Energy Crops: Learning from
   Food Crop DomesticationFree Access
SO JOURNAL OF INTEGRATIVE PLANT BIOLOGY
LA English
DT Review
ID MISCANTHUS X GIGANTEUS; RICE DOMESTICATION; CLIMATE-CHANGE; PLANT
   DOMESTICATION; ATMOSPHERIC CO2; COLD TOLERANCE; INNER-MONGOLIA;
   WATER-USE; LAND-USE; CHINA
AB Domestication of cereal crops has provided a stable source of food for thousands of years. The extent to which lignocellulosic crops will contribute to the world's renewable energy depends largely on how the new crops will be domesticated. Growing miscanthus as biofuel feedstocks on marginal and degraded land in northern and northwestern China offers an example for developing theoretical framework and practical strategies for energy crop domestication. The domestication should incorporate the highest possible genetic diversity from wild species, focus on the improvement of drought and cold tolerance especially in the stage of crop establishment, increase the efficiencies of water and nutrient uses and photosynthesis, adjust vegetative growing season according to local temperature and precipitation, and reduce or prevent seed production. Positive ecological effects on soil conservation, landscape restoration, carbon sequestration, and hydrological cycles should be maximized, while negative impact on biodiversity needs to be minimized. With the development of other sources of renewable energy, the role of lignocellulosic crops may evolve from primarily energy production to increasingly ecological restoration and biomaterial development. The integration of this new cropping system into the existing agriculture may open a new avenue to the long-term sustainability of our society.
C1 Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.
RP Sang, T (reprint author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.
EM sang@msu.edu
CR Boehmel C, 2008, AGR SYST, V96, P224, DOI 10.1016/j.agsy.2007.08.004
   Bornke F, 2010, CURR OPIN PLANT BIOL, V13, P354, DOI 10.1016/j.pbi.2010.01.005
   BRANDAO M, 2010, BIOMASS BIOENERG, V35, P2323, DOI DOI 10.1016/J.BIOMBIOE.2009.10.019
   Buckler ES, 2001, GENET RES, V77, P213
   Burger JC, 2008, AM J BOT, V95, P113, DOI 10.3732/ajb.95.2.113
   Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597
   Cao SX, 2010, AMBIO, V39, P279, DOI 10.1007/s13280-010-0038-z
   Cao SX, 2009, J APPL ECOL, V46, P536, DOI 10.1111/j.1365-2664.2008.01605.x
   Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290
   Chen SL, 2006, FLORA CHINA, V22, P581
   Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x
   Clifton-Brown JC, 2000, ANN BOT-LONDON, V86, P191, DOI 10.1006/anbo.2000.1183
   Clifton-Brown John, 2008, P273, DOI 10.1007/978-0-387-70805-8_10
   Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x
   Cunniff J, 2008, GLOBAL CHANGE BIOL, V14, P576, DOI 10.1111/j.1365-2486.2007.01515.x
   Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019
   Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006
   Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162
   Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747
   Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605
   Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1
   Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x
   Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383
   Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008
   Harlan JR, 1992, CROPS MAN
   Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x
   Heaton EA, 2008, CURR OPIN BIOTECH, V19, P202, DOI 10.1016/j.copbio.2008.05.001
   Heaton EA, 2009, GCB BIOENERGY, V1, P297, DOI 10.1111/j.1757-1707.2009.01022.x
   Henry RJ, 2010, PLANT BIOTECHNOL J, V8, P288, DOI 10.1111/j.1467-7652.2009.00482.x
   Hodgson EM, 2010, BIOMASS BIOENERG, V34, P652, DOI 10.1016/j.biombioe.2010.01.008
   Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279
   Jansson C, 2010, BIOSCIENCE, V60, P685, DOI 10.1525/bio.2010.60.9.6
   Jiang GM, 2006, AMBIO, V35, P269, DOI 10.1579/06-S-158.1
   Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170
   Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x
   Kovach MJ, 2008, CURR OPIN PLANT BIOL, V11, P193, DOI 10.1016/j.pbi.2007.12.006
   Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5
   Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604
   Long SP, 1987, ENERGY BIOMASS, P95
   NILOLAU BJ, 2008, PLANT J, V54, P536
   Oliver RJ, 2009, GCB BIOENERGY, V1, P97, DOI 10.1111/j.1757-1707.2009.01011.x
   Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x
   Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364
   Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rajagopal D, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/044004
   Richerson PJ, 2001, AM ANTIQUITY, V66, P387, DOI 10.2307/2694241
   Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525
   Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104
   Rowe RL, 2009, RENEW SUST ENERG REV, V13, P271, DOI 10.1016/j.rser.2007.07.008
   SAGE RF, 1995, GLOB CHANGE BIOL, V1, P93, DOI 10.1111/j.1365-2486.1995.tb00009.x
   Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817
   Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827
   Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005
   Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1672.2007.00510.x
   Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x
   Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105
   Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861
   Smeets EMW, 2009, RENEW SUST ENERG REV, V13, P1230, DOI 10.1016/j.rser.2008.09.006
   Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765
   Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268
   Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133
   Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008
   Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063
   Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x
   Wang DF, 2008, PLANT PHYSIOL, V148, P557, DOI 10.1104/pp.108.120709
   Wilske B, 2009, J ENVIRON MANAGE, V90, P2762, DOI 10.1016/j.jenvman.2009.03.004
   Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426
   Zhang LB, 2009, NEW PHYTOL, V184, P708, DOI 10.1111/j.1469-8137.2009.02984.x
   Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104
   Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y
   Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005
   Zub HW, 2010, AGRON SUSTAIN DEV, V30, P201, DOI 10.1051/agro/2009034
NR 73
TC 28
Z9 30
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1672-9072
EI 1744-7909
J9 J INTEGR PLANT BIOL
JI J. Integr. Plant Biol.
PD FEB
PY 2011
VL 53
IS 2
BP 96
EP 104
DI 10.1111/j.1744-7909.2010.01006.x
PG 9
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA 712ND
UT WOS:000286672600002
PM 21261812
OA Bronze
DA 2018-10-20
ER

PT J
AU Manju, S
   Sreenivasan, K
AF Manju, S.
   Sreenivasan, K.
TI Synthesis and Characterization of a Cytotoxic Cationic
   Polyvinylpyrrolidone-Curcumin Conjugate
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE conjugation; FTIR; stabilization; micelle; polymeric drug carrier
ID NF-KAPPA-B; IN-VIVO; CELL-LINES; SURFACE MODIFICATION; BLOCK-COPOLYMER;
   NANOPARTICLES; POLYMERS; CANCER; DIFERULOYLMETHANE; BIODISTRIBUTION
AB Curcumin has been studied as a potential drug for many diseases including cancer. One of the serious limitations projected on curcumin is its poor water solubility and the substantially low bioavailability. With a view to enhance the aqueous solubility of curcumin, we synthesized polyvinylpyrrolidone curcumin conjugates. Polyvinylpyrrolidone was used for the conjugation considering its long history of safe usage as a biomaterial for various medical applications. The drug conjugates self-assembled in aqueous solution to form nanosized micellar aggregates. The formation of micellae stabilized curcumin against hydrolytic degradation. Another interesting feature of the conjugate was its cationic nature. The net zeta potential in the pH range from 3 to 7.4 was +25 to +20 mV, reflecting the potential stability of the conjugate micellae at physiological pH. We quantified cytotoxic potential of the conjugate by the MTT assay, using L929 fibroblast cells. The results showed that the conjugate had higher cytotoxicity than that of the free curcumin. It is expected that the relative enhanced cytotoxicities are the result of enhanced aqueous solubility and polymer-mediated drug internalization. The conjugate has the potential to circumvent limitations of curcumin and thereby to extrapolate further its applications as an effective anticancer drug. (C) 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:504-511, 2011
C1 [Manju, S.; Sreenivasan, K.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Polymer Anal, Trivandrum 695012, Kerala, India.
RP Sreenivasan, K (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Lab Polymer Anal, Trivandrum 695012, Kerala, India.
EM sreeni@sctimst.ac.in
OI saraswathy, manju/0000-0002-5889-0064
FU Department of Biotechnology, New Delhi, India
FX S. Manju thanks Department of Biotechnology, New Delhi, India, for
   financial assistance.
CR Aggarwal BB, 2003, ANTICANCER RES, V23, P363
   AGGARWAL BB, 2006, BIOCHEM PHARMACOL, V71, P397
   Alexis F, 2008, UROL ONCOL-SEMIN ORI, V26, P74, DOI 10.1016/j.urolonc.2007.03.017
   AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004
   AMMON HPT, 1992, PLANTA MED, V58, P26
   Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014
   Choi SH, 2006, LANGMUIR, V22, P1758, DOI 10.1021/la052549n
   Fang C, 2006, EUR J PHARM SCI, V27, P27, DOI 10.1016/j.ejps.2005.08.002
   Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011
   Fassas A, 2003, BRIT J HAEMATOL, V122, P161, DOI 10.1046/j.1365-2141.2003.04395_3.x
   Frank A., 2008, MOL PHARM, V5, P505, DOI DOI 10.1021/MP800051M
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X
   Ishita C., 2004, CURR SCI, V87, P44
   Kawamori T, 1999, CANCER RES, V59, P597
   Koon HK, 2006, J ENVIRON PATHOL TOX, V25, P205, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.120
   LE RAM, 1994, INT J PHARMACEUT, V106, P201
   Li SD, 2008, MOL PHARMACEUT, V5, P496, DOI 10.1021/mp800049w
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   Mandy H. M., 2008, LANGMUIR, V24, P5672
   Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749
   Mehta K, 1997, ANTI-CANCER DRUG, V8, P470, DOI 10.1097/00001813-199706000-00010
   Moghimi SM, 2003, FEBS LETT, V547, P177, DOI 10.1016/S0014-5793(03)00707-5
   Moghimi SM, 2000, TRENDS BIOTECHNOL, V18, P412, DOI 10.1016/S0167-7799(00)01485-2
   Mosqueira VCF, 2001, PHARMACEUT RES, V18, P1411, DOI 10.1023/A:1012248721523
   Park K, 2007, ONCOL REP, V17, P537
   Ramachandran C, 1999, BREAST CANCER RES TR, V54, P269, DOI 10.1023/A:1006170224414
   Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X
   Tomita M, 2006, INT J CANCER, V118, P765, DOI 10.1002/ijc.21389
   TORCHILIN VP, 1994, BBA-BIOMEMBRANES, V1195, P181, DOI 10.1016/0005-2736(94)90025-6
   TORCHILIN VP, 1995, J PHARM SCI, V84, P1049, DOI 10.1002/jps.2600840904
   Torchilin VP, 2001, BIOMATERIALS, V22, P3035, DOI 10.1016/S0142-9612(01)00050-3
   Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9
   Ward R A, 1988, ASAIO Trans, V34, P334
   Yamamoto Y, 2001, J CONTROL RELEASE, V77, P27, DOI 10.1016/S0168-3659(01)00451-5
   Yoo HS, 2001, J CONTROL RELEASE, V70, P63, DOI 10.1016/S0168-3659(00)00340-0
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
NR 39
TC 43
Z9 43
U1 1
U2 15
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-3549
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD FEB
PY 2011
VL 100
IS 2
BP 504
EP 511
DI 10.1002/jps.22278
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 726LW
UT WOS:000287724800014
PM 20848656
DA 2018-10-20
ER

PT J
AU Beg, S
   Rizwan, M
   Sheikh, AM
   Hasnain, MS
   Anwer, K
   Kohli, K
AF Beg, Sarwar
   Rizwan, Mohammad
   Sheikh, Asif M.
   Hasnain, M. Saquib
   Anwer, Khalid
   Kohli, Kanchan
TI Advancement in carbon nanotubes: basics, biomedical applications and
   toxicity
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
DE biomedical application; carbon nanotubes; nanocarrier; nanomedicine;
   targeted drug delivery
ID VAPOR-DEPOSITION METHOD; TARGETED DRUG-DELIVERY; IN-VIVO; SCANNING
   PROBE; CANCER-CELLS; ORGANIC FUNCTIONALIZATION; ELECTRONIC-STRUCTURE;
   RAMAN-SPECTROSCOPY; FLUID EXPERIMENTS; GRAPHITIC CARBON
AB Objectives
   Carbon nanotubes (CNTs) have attracted much attention by researchers worldwide in recent years for their small dimensions and unique architecture, and for having immense potential in nanomedicine as biocompatible and supportive substrates, as a novel tool for the delivery of therapeutic molecules including peptides, RNA and DNA, and also as sensors, actuators and composites.
   Key findings
   CNTs have been employed in the development of molecular electronic, composite materials and others due to their unique atomic structure, high surface area-to-volume ratio and excellent electronic, mechanical and thermal properties. Recently they have been exploited as novel nanocarriers in drug delivery systems and biomedical applications. Their larger inner volume as compared with the dimensions of the tube and easy immobilization of their outer surface with biocompatible materials make CNTs a superior nanomaterial for drug delivery. Literature reveals that CNTs are versatile carriers for controlled and targeted drug delivery, especially for cancer cells, because of their cell membrane penetrability.
   Summary
   This review enlightens the biomedical application of CNTs with special emphasis on utilization in controlled and targeted drug delivery, as a diagnostics tool and other possible uses in therapeutic systems. The review also focuses on the toxicity aspects of CNTs, and revealed that genotoxic potential, mutagenic and carcinogenic effects of different types of CNTs must be explored and overcome by formulating safe biomaterial for drug delivery. The review also describes the regulatory aspects and clinical and market status of CNTs.
C1 [Beg, Sarwar; Rizwan, Mohammad; Hasnain, M. Saquib; Kohli, Kanchan] Hamdard Univ, Dept Pharmaceut, Fac Pharm, New Delhi, India.
   [Sheikh, Asif M.] Wockhardt Res Ctr, Aurangabad, Maharashtra, India.
   [Anwer, Khalid] King Saud Univ, Riyadh, Saudi Arabia.
RP Beg, S (reprint author), Hamdard Univ, Dept Pharmaceut, Fac Pharm, New Delhi, India.
EM sarwar.beg@gmail.com
CR Abdulkareem AS, 2007, J NANOSCI NANOTECHNO, V7, P3233, DOI 10.1166/jnn.2007.685
   Ada G., 1997, NEW GENERATION VACCI, V2, P13
   ADRIAN P, 2003, SENS BUS DIG
   Ajayan PM, 2002, SCIENCE, V296, P705, DOI 10.1126/science.296.5568.705
   Ajima K, 2008, ACS NANO, V2, P2057, DOI 10.1021/nn800395t
   Ajima K, 2005, MOL PHARMACEUT, V2, P475, DOI 10.1021/mp0500566
   Akita S, 2001, APPL PHYS LETT, V79, P1691, DOI 10.1063/1.1403275
   Ashcroft JM, 2006, CHEM COMMUN, P3004, DOI 10.1039/b601717g
   Awasthi K, 2005, J NANOSCI NANOTECHNO, V5, P1616, DOI 10.1166/jnn.2005.407
   Baddour C, 2005, INT J CHEM REACT ENG, V3
   Bardi G, 2009, NANOMED-NANOTECHNOL, V5, P96, DOI 10.1016/j.nano.2008.06.008
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   BHARGAVA A, 1999, NANOROBOTS MED FUTUR
   Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   BIFENG P, 2007, CHINESE J CANCER RES, V19, P1
   Boczkowski J, 2007, NANOMEDICINE-UK, V2, P407, DOI 10.2217/17435889.2.4.407
   Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020
   BRIAN M, 2009, BASIC BIOTECHNOLOGY
   Bronikowski MJ, 2001, J VAC SCI TECHNOL A, V19, P1800, DOI 10.1116/1.1380721
   Burke A, 2009, P NATL ACAD SCI USA, V106, P12897, DOI 10.1073/pnas.0905195106
   Bystrzejewski M, 2007, BIOMOL ENG, V24, P555, DOI 10.1016/j.bioeng.2007.08.006
   Cavalcanti A, 2007, 6TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE, PROCEEDINGS, P738, DOI 10.1109/ICIS.2007.138
   Chen JY, 2008, J AM CHEM SOC, V130, P16778, DOI 10.1021/ja805570f
   Chiaretti M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/47/474203
   Choi EC, 2009, MICRON, V40, P612, DOI 10.1016/j.micron.2009.02.009
   CONCEICAO J, 1995, PHYS REV B, V51, P4668, DOI 10.1103/PhysRevB.51.4668
   Couvreur P, 2006, PHARM RES-DORDR, V23, P1417, DOI 10.1007/s11095-006-0284-8
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Danailov D, 2002, J NANOSCI NANOTECHNO, V2, P503, DOI 10.1166/jnn.2002.132
   Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007
   Dhar S, 2008, J AM CHEM SOC, V130, P11467, DOI 10.1021/ja803036e
   Dresselhaus MS, 2004, PHILOS T R SOC A, V362, P2065, DOI 10.1098/rsta.2004.1430
   Dresselhaus MS, 2002, ACCOUNTS CHEM RES, V35, P1070, DOI 10.1021/ar0101537
   DRESSELHAUS MS, 2009, CARBON NANOTUBES, P1761
   Dyke CA, 2004, CHEM-EUR J, V10, P813, DOI 10.1002/chem.200305534
   EKLUND P, 2004, CARBON, V33, P6905
   Emirov YN, 2003, P SOC PHOTO-OPT INS, V5038, P493, DOI 10.1117/12.483759
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Flahaut E, 2003, CHEM COMMUN, P1442, DOI 10.1039/b301514a
   Foldvari M, 2008, NANOMED-NANOTECHNOL, V4, P173, DOI 10.1016/j.nano.2008.04.002
   Fraczek A, 2008, ACTA BIOMATER, V4, P1593, DOI 10.1016/j.actbio.2008.05.018
   GALAASEN OP, 2002, MED TECHNOL
   GANNON CJ, 2007, CANCER, P2654
   Gao HJ, 2003, NANO LETT, V3, P471, DOI 10.1021/nl025967a
   Gao M, 2000, PROC SPIE, V3987, P18, DOI 10.1117/12.387798
   Gao Y, 2009, POLYMER, V50, P2572, DOI 10.1016/j.polymer.2009.04.018
   Gasparac R, 2004, NANO LETT, V4, P513, DOI 10.1021/nl0352494
   Georgakilas V, 2002, J AM CHEM SOC, V124, P760, DOI 10.1021/ja016954m
   Georgakilas V, 2002, J AM CHEM SOC, V124, P14318, DOI 10.1021/ja0260869
   Ghosh S, 2003, SCIENCE, V299, P1042, DOI 10.1126/science.1079080
   Gogotsi Y, 2001, APPL PHYS LETT, V79, P1021, DOI 10.1063/1.1391228
   GUENZEL JDN, 2009, EUREKA ALERT
   Guo Xiaotian, 2006, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V23, P438
   Hampel S, 2008, NANOMEDICINE-UK, V3, P175, DOI 10.2217/17435889.3.2.175
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Harutyunyan A R, 2002, EUR CELLS MATER, V3, P84
   He PG, 2004, CHEM COMMUN, P348, DOI 10.1039/b313030b
   Heller DA, 2004, J PHYS CHEM B, V108, P6905, DOI 10.1021/jp037690o
   Hilder TA, 2008, MICRO NANO LETT, V3, P18, DOI 10.1049/mnl:20070070
   Hilder TA, 2009, SMALL, V5, P300, DOI 10.1002/smll.200800321
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   HUI HW, 1987, CONTROLLED DRUG DELI, P373
   Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053
   Iijima S, 1999, CHEM PHYS LETT, V309, P165, DOI 10.1016/S0009-2614(99)00642-9
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Inami N, 2007, SCI TECHNOL ADV MAT, V8, P292, DOI 10.1016/j.stam.2007.02.009
   Inoue K, 2009, TOXICOL APPL PHARM, V237, P306, DOI 10.1016/j.taap.2009.04.003
   Itkis ME, 2005, J AM CHEM SOC, V127, P3439, DOI 10.1021/ja043061w
   Jia NQ, 2007, NANO LETT, V7, P2976, DOI 10.1021/nl071114c
   JINGYI C, 2008, J AM CHEM SOC, V130, P16778
   Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361
   Jose-Yacaman M., 1993, APPL PHYS LETT, V273, P483
   Joselevich E, 2004, CHEMPHYSCHEM, V5, P619, DOI 10.1002/cphc.200301049
   Joseph H., 1997, Sensors, V14, P47
   Kam NWS, 2005, J AM CHEM SOC, V127, P6021, DOI 10.1021/ja050062v
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Karajanagi SS, 2004, LANGMUIR, V20, P11594, DOI 10.1021/la047994h
   Kassab AC, 1997, J BIOMAT SCI-POLYM E, V8, P947, DOI 10.1163/156856297X00119
   Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078
   KIERNAN G, 2002, P SOC PHOTO-OPT INS, V4876, P775
   Kim BM, 2005, NANO LETT, V5, P873, DOI 10.1021/nl050278v
   Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148
   Kishore AS, 2009, TOXICOL LETT, V191, P268, DOI 10.1016/j.toxlet.2009.09.007
   Kisin ER, 2007, J TOXICOL ENV HEAL A, V70, P2071, DOI 10.1080/15287390701601251
   Kleinsorge B, 2004, CHEM COMMUN, P1416, DOI 10.1039/b401785d
   Klumpp C, 2006, BBA-BIOMEMBRANES, V1758, P404, DOI 10.1016/j.bbamem.2005.10.008
   Kramer K, 2007, UROLOGE, V46, P1248, DOI 10.1007/s00120-007-1489-0
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Kulamarva A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/2/025612
   Lanning C, 2003, MED BIOL ENG COMPUT, V41, P416, DOI 10.1007/BF02348084
   Lanone S, 2006, CURR MOL MED, V6, P651, DOI 10.2174/156652406778195026
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   LEONARD S, 2009, QMED BETA       0517
   Levi-Polyachenko NH, 2009, MOL PHARMACEUT, V6, P1092, DOI 10.1021/mp800250e
   LEWINSKI N, 2005, J ENG PUBLIC POLICY, V9, P1
   Li PH, 2006, J NANOSCI NANOTECHNO, V6, P990, DOI 10.1166/jnn.2006.167
   Liao K-J, 2003, MICROFAB TECHNOL, V4, P57
   LIMYT, 2003, MOL IMAGING, V2, P50
   LIU J, 2002, DESIGN FABRICATION T
   Liu L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.217206
   Liu Z, 2008, CANCER RES, V68, P6652, DOI 10.1158/0008-5472.CAN-08-1468
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Liz K., 2009, CARBON NANOTUBES PAS, P24233
   Mamalis AG, 2007, J MATER PROCESS TECH, V181, P52, DOI 10.1016/j.jmatprotec.2006.03.052
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   McDevitt MR, 2007, J NUCL MED, V48, P1180, DOI 10.2967/jnumed.106.039131
   McKee GSB, 2006, J PHYS CHEM B, V110, P1179, DOI 10.1021/jp054265h
   Megaridis CM, 2002, PHYS FLUIDS, V14, pL5, DOI 10.1063/1.1429249
   Mehra NK, 2008, CRIT REV THER DRUG, V25, P169, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i2.20
   Mitchell DT, 2002, J AM CHEM SOC, V124, P11864, DOI 10.1021/ja027247b
   MOHAPATRA SS, 2008, Patent No. 20080214494
   Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243
   Muller J, 2009, TOXICOL SCI, V110, P442, DOI 10.1093/toxsci/kfp100
   Murakami T, 2008, NANOMEDICINE-UK, V3, P453, DOI 10.2217/17435889.3.4.453
   Muralkami T, 2006, MOL PHARMACEUT, V3, P407, DOI 10.1021/mp060027a
   Muralkami T, 2004, MOL PHARMACEUT, V1, P399, DOI 10.1021/mp049928e
   Nagy JB, 2004, J NANOSCI NANOTECHNO, V4, P326, DOI 10.1166/jnn.2004.069
   Nasibulin AG, 2007, NAT NANOTECHNOL, V2, P156, DOI 10.1038/nnano.2007.37
   *NAT CANC RES I, 2010, NAN CLIN TRIALS
   Nguyen CV, 2004, J PHYS CHEM B, V108, P2816, DOI 10.1021/jp0361529
   Odom TW, 2002, ANN NY ACAD SCI, V960, P203, DOI 10.1111/j.1749-6632.2002.tb03035.x
   OSEYACAMAN M, 1993, APPL PHYS LETT, V62, P657
   Ou ZM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105102
   Pan BF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/12/125101
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Pantarotto D, 2003, J AM CHEM SOC, V125, P6160, DOI 10.1021/ja034342r
   Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013
   Pardridge William M, 2005, NeuroRx, V2, P3
   Park K., 1997, CONTROLLED DRUG DELI
   Park WI, 2009, CARBOHYD POLYM, V77, P457, DOI 10.1016/j.carbpol.2009.01.021
   Pastorin G, 2006, CHEM COMMUN, P1182, DOI 10.1039/b516309a
   Pelley J., 2009, INT APPROACHES REGUL
   PENMAN D, 2003, CARBON NANOTUBES SHO
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Polizu S, 2006, J NANOSCI NANOTECHNO, V6, P1883, DOI 10.1166/jnn.2006.197
   Popov AM, 2007, INT J NANOMED, V2, P361
   Prakash Satya, 2007, Recent Pat Drug Deliv Formul, V1, P214, DOI 10.2174/187221107782331601
   Pramanik M, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147407
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Pulskamp K, 2007, TOXICOL LETT, V168, P58, DOI 10.1016/j.toxlet.2006.11.001
   Qu GB, 2009, CARBON, V47, P2060, DOI 10.1016/j.carbon.2009.03.056
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187
   Rautio J, 2004, CURR PHARM DESIGN, V10, P1341, DOI 10.2174/1381612043384916
   Riggio C, 2009, NANOSCALE RES LETT, V4, P668, DOI 10.1007/s11671-009-9291-0
   ROMERO M, 2000, MED DEV DIAG IND MAG
   Rosen Y, 2009, EXPERT OPIN DRUG DEL, V6, P517, DOI [10.1517/17425240902865579, 10.1517/17425240902865579 ]
   Rotoli BM, 2008, TOXICOL LETT, V178, P95, DOI 10.1016/j.toxlet.2008.02.007
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Sakai K, 1997, J CHEM ENG JPN, V30, P587, DOI 10.1252/jcej.30.587
   Sakamoto Y, 2009, J TOXICOL SCI, V34, P65, DOI 10.2131/jts.34.65
   Sanchez S, 2007, BIOSENS BIOELECTRON, V23, P332, DOI 10.1016/j.bios.2007.04.021
   SCHONENBERGER C, 2000, MULTIWALL CARBON NAN
   SCHULZ MJ, 2007, NANOTECHNOLOGY, V18
   SCHULZ MJ, 2007, NANO WERK SPOTLIGHT
   Science Daily, 2009, SCI DAILY
   SHARON G, 2009, COMPUTER WORLD IDG
   Shiba Kiyotaka, 2006, Nihon Rinsho, V64, P239
   SHULTTS MC, 1994, MEEE T BIOMED ENG, V41, P937
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Sotiropoulou S, 2003, ANAL BIOANAL CHEM, V375, P103, DOI 10.1007/s00216-002-1617-z
   Soto K, 2007, ACTA BIOMATER, V3, P351, DOI 10.1016/j.actbio.2006.11.004
   SOTTO AD, 2009, TOXICOL LETT, V184, P192
   Stevens RM, 2004, IEEE T NANOBIOSCI, V3, P56, DOI 10.1109/TNB.2004.824275
   Stevens RMD, 2000, NANOTECHNOLOGY, V11, P1, DOI 10.1088/0957-4484/11/1/301
   Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004
   Szendi K, 2008, ANTICANCER RES, V28, P349
   Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105
   Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0
   Tasis D, 2003, CHEM-EUR J, V9, P4001, DOI 10.1002/chem.200304800
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
   Tong HY, 2009, TOXICOL APPL PHARM, V239, P224, DOI 10.1016/j.taap.2009.05.019
   Torti SV, 2007, INT J NANOMED, V2, P707
   Vajtai R, 2004, PHILOS T R SOC A, V362, P2143, DOI 10.1098/rsta.2004.1433
   VanHandel M, 2009, J NEUROIMMUNOL, V208, P3, DOI 10.1016/j.jneuroim.2008.12.006
   VINOGRADOV SV, 2008, CURCUMIN COMBRETASTA
   Vittorio O, 2009, NANOMED-NANOTECHNOL, V5, P424, DOI 10.1016/j.nano.2009.02.006
   VOHRER U, 2000, CARBON, V42, P316
   Wang HF, 2006, J AM CHEM SOC, V128, P13364, DOI 10.1021/ja065455o
   Wang J, 2004, J AM CHEM SOC, V126, P3010, DOI 10.1021/ja031723w
   Wang XH, 2008, CHEMMEDCHEM, V3, P940, DOI 10.1002/cmdc.200700329
   Wang YF, 2002, SPECTROCHIM ACTA A, V58, P2089, DOI 10.1016/S1386-1425(01)00691-6
   Welsher K, 2008, NANO LETT, V8, P586, DOI 10.1021/nl072949q
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613
   Wu YR, 2008, ACS NANO, V2, P2023, DOI 10.1021/nn800325a
   Xu Y, 2004, ANAL CHIM ACTA, V516, P19, DOI 10.1016/j.aca.2004.04.013
   Yacobi NR, 2007, TOXICOL IN VITRO, V21, P1373, DOI 10.1016/j.tiv.2007.04.003
   Yang F, 2008, MED HYPOTHESES, V70, P765, DOI 10.1016/j.mehy.2007.07.045
   Yang F, 2009, NANOMEDICINE-UK, V4, P317, DOI 10.2217/NNM.09.5
   Yang J, 2007, IET NANOBIOTECHNOL, V1, P10, DOI 10.1049/iet-nbt:20060017
   Yang R, 2006, GENE THER, V13, P1714, DOI 10.1038/sj.gt.3302808
   Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020
   Yang YJ, 2009, ACTA BIOMATER, V5, P3488, DOI 10.1016/j.actbio.2009.05.002
   ZACH Z, 2005, DISCOVER MAGAZINE
   Zeni O, 2008, SENSORS-BASEL, V8, P488, DOI 10.3390/s8010488
   Zhang CH, 2009, J BIOMAT SCI-POLYM E, V20, P1119, DOI 10.1163/156856209X444466
   Zhang MG, 2005, J AM CHEM SOC, V127, P2058, DOI 10.1021/ja044764g
   Zhang MG, 2005, ANAL CHEM, V77, P3960, DOI 10.1021/ac050059u
   Zhang XK, 2009, BIOMATERIALS, V30, P6041, DOI 10.1016/j.biomaterials.2009.07.025
   Zhang Y, 1999, SCIENCE, V285, P1719, DOI 10.1126/science.285.5434.1719
   Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831
   Zhao QC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105101
   Zheng LX, 2004, NAT MATER, V3, P673, DOI 10.1038/nmat1216
   Zhou FF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078803
   Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v
   2009, CARBON NANOTUBE SCI
   2010, NANO WERK       0611
   2009, INPHARMA WEEKLY
   2005, SCI DAILY       0803
   2010, MULTI WALL CARBON NA
   2010, NANO WERK       0602
   2004, CARBON NANOTUBES OFF
NR 223
TC 114
Z9 117
U1 1
U2 62
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD FEB
PY 2011
VL 63
IS 2
BP 141
EP 163
DI 10.1111/j.2042-7158.2010.01167.x
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 706IZ
UT WOS:000286212900001
PM 21235578
OA Bronze
DA 2018-10-20
ER

PT J
AU Lim, DJ
   Antipenko, SV
   Anderson, JM
   Jaimes, KF
   Viera, L
   Stephen, BR
   Bryant, SMJ
   Yancey, BD
   Hughes, KJ
   Cui, WX
   Thompson, JA
   Corbett, JA
   Jun, HW
AF Lim, Dong-Jin
   Antipenko, Sergey V.
   Anderson, Joel M.
   Jaimes, Kimberly F.
   Viera, Liliana
   Stephen, Bradley R.
   Bryant, Stacie M. J.
   Yancey, Brett D.
   Hughes, Katherine J.
   Cui, Wanxing
   Thompson, John A.
   Corbett, John A.
   Jun, Ho-Wook
TI Enhanced Rat Islet Function and Survival In Vitro Using a Biomimetic
   Self-Assembled Nanomatrix Gel
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID CELL-MATRIX INTERACTIONS; PANCREATIC-ISLETS; EXTRACELLULAR-MATRIX;
   INSULIN-SECRETION; TRANSPLANTATION; LANGERHANS; CULTURE; PEPTIDES;
   INTEGRIN; ADHESION
AB Peptide amphiphile (PA) is a peptide-based biomaterial that can self-assemble into a nanostructured gel-like scaffold, mimicking the chemical and biological complexity of natural extracellular matrix. To evaluate the capacity of the PA scaffold to improve islet function and survival in vitro, rat islets were cultured in three different groups-(1) bare group: isolated rat islets cultured in a 12-well nontissue culture-treated plate; (2) insert group: isolated rat islets cultured in modified insert chambers; (3) nanomatrix group: isolated rat islets encapsulated within the PA nanomatrix gel and cultured in modified insert chambers. Over 14 days, both the bare and insert groups showed a marked decrease in insulin secretion, whereas the nanomatrix group maintained glucose-stimulated insulin secretion. Moreover, entire islets in the nanomatrix gel stained positive for dithizone up to 14 days, indicating better maintained glucose-stimulated insulin production. Fluorescein diacetate/propidium iodide staining results also verified necrosis in the bare and insert groups after 7 days, whereas the PA nanomatrix gel maintained islet viability after 14 days. Thus, these results demonstrate the potential of PAs as an intermediary scaffold for increasing the efficacy of pancreatic islet transplantation.
C1 [Lim, Dong-Jin; Antipenko, Sergey V.; Anderson, Joel M.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Jaimes, Kimberly F.; Cui, Wanxing; Jun, Ho-Wook] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA.
   [Viera, Liliana; Stephen, Bradley R.; Bryant, Stacie M. J.; Yancey, Brett D.; Cui, Wanxing; Thompson, John A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA.
   [Hughes, Katherine J.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA.
   [Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, 806 Shelby,1825 Univ Blvd, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
OI Antipenko, Sergey/0000-0002-5079-6735
FU Wallace H. Coulter Foundation; UAB Diabetes Research Training Center
   Pilot; American Diabetes Association; NIH [EB004312-01, 1F31DE021286-01,
   DK 52194, AI 44458]
FX The authors are indebted to the many contributions of Dr. Juan L.
   Contreras, which include assistance with the experimental design, islet
   isolation, and methodologies for assessment of islet viability and
   function. Many thanks to Eun-Ha Lim as well, for expert graphical
   assistance. This study was supported in part by Wallace H. Coulter
   Foundation, the UAB Diabetes Research Training Center Pilot Grant, and
   the Innovation Award from the American Diabetes Association to H.W.J.,
   an NIH T32 predoctoral training grant (NIBIB # EB004312-01) and NIH Ruth
   L. Kirschstein National Research Service Award Individual Fellowship
   (1F31DE021286-01) to J.M.A., and NIH grants DK 52194 and AI 44458 to
   J.A.C.
CR Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   BEATTIE GM, 1991, J CLIN ENDOCR METAB, V73, P93, DOI 10.1210/jcem-73-1-93
   Biancamaria B., 2006, J CHEM TECHNOL BIOT, V81, P491
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   LATIF ZA, 1988, TRANSPLANTATION, V45, P827
   London NJM, 1998, DIABETES METAB, V24, P200
   Lutolf M. P., 2005, NAT BIOTECHNOL, V23, P45
   MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182
   Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827
   Nagata N, 2001, CELL TRANSPLANT, V10, P447
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187
   Park KH, 2005, J BIOSCI BIOENG, V99, P598, DOI 10.1263/jbb.99.598
   Pavlakis Martha, 2006, Curr Diab Rep, V6, P473, DOI 10.1007/s11892-006-0082-z
   Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654
NR 29
TC 18
Z9 20
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2011
VL 17
IS 3-4
BP 399
EP 406
DI 10.1089/ten.tea.2010.0151
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 712JB
UT WOS:000286661600014
PM 20807014
OA Green Published
DA 2018-10-20
ER

PT J
AU Filion, TM
   Li, XN
   Mason-Savas, A
   Kreider, JM
   Goldstein, SA
   Ayers, DC
   Song, J
AF Filion, Tera M.
   Li, Xinning
   Mason-Savas, April
   Kreider, Jaclynn M.
   Goldstein, Steven A.
   Ayers, David C.
   Song, Jie
TI Elastomeric Osteoconductive Synthetic Scaffolds with Acquired
   Osteoinductivity Expedite the Repair of Critical Femoral Defects in Rats
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BONE MORPHOGENETIC PROTEINS; CLINICAL-APPLICATIONS; CELL-ADHESION;
   GENE-THERAPY; IN-VITRO; HYDROXYAPATITE; LOCALIZATION; ALLOGRAFT; GRAFTS;
   RANKL
AB Regenerative medicine aspires to reduce reliance on or overcome limitations associated with donor tissue-mediated repair. Structural bone allografts are commonly used in orthopedic surgery, with a high percentage of graft failure due to poor tissue integration. This problem is aggravated among elderly, those suffering from metabolic conditions, or those undergoing cancer therapies that compromise graft healing. Toward this end, we developed a synthetic graft named FlexBone, in which nanocrystalline hydroxyapatite (50 wt%) was structurally integrated with crosslinked poly(hydroxyethyl methacrylate) hydrogel, which provides dimensional stability and elasticity. It recapitulates the essential role of nanocrystalline hydroxyapatite in defining the osteoconductivity and biochemical microenvironment of bone because of its affinity for biomolecules. Here, we demonstrate that FlexBone effectively absorbed endogenously secreted signaling molecules associated with the inflammation/graft healing cascade upon being press-fit into a 5-mm rat femoral segmental defect. Further, when preabsorbed with a single dose of 400 ng recombinant human (rh) bonemorphogenetic protein-2/7 heterodimer, it enabled the functional repair of the critical-sized defect by 8-12 weeks. FlexBone was stably encapsulated by the bridging bony callus and the FlexBone-callus interface was continuously remodeled. In summary, FlexBone combines the dimensional stability and osteoconductivity of structural bone allografts with desirable surgical compressibility and acquired osteoinductivity in an easy-to-fabricate and scalable synthetic biomaterial.
C1 [Filion, Tera M.; Li, Xinning; Mason-Savas, April; Ayers, David C.; Song, Jie] Univ Massachusetts, Sch Med, Dept Orthopaed & Phys Rehabil, Worcester, MA 01655 USA.
   [Filion, Tera M.; Song, Jie] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA.
   [Kreider, Jaclynn M.; Goldstein, Steven A.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.
RP Song, J (reprint author), Univ Massachusetts, Dept Orthoped, Sch Med, 55 Lake Ave N, Worcester, MA 01655 USA.
EM jie.song@umassmed.edu
FU National Institutes of Health [5R01AR055615, 5P30DK32520]; American
   Society for Bone and Mineral Research; Orthopaedic Research and
   Education Foundation; UMASS Diabetes Endocrinology Research Center
   [DK32520]
FX This work was supported by the National Institutes of Health grants
   5R01AR055615 (to J.S.) and 5P30DK32520, the American Society for Bone
   and Mineral Research Career Enhancement Award (to J.S.), and the
   Orthopaedic Research and Education Foundation Resident Clinician
   Scientist Training Grant (to X. L.). J. Song is a member of the UMASS
   Diabetes Endocrinology Research Center (DK32520). The authors thank
   James Potts for advising on the statistical analyses.
CR Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Blokhuis TJ, 2008, INJURY, V39, pS33, DOI 10.1016/S0020-1383(08)70013-5
   Cool SM, 2002, BONE, V30, P386, DOI 10.1016/S8756-3282(01)00686-X
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   GOLDBERG VM, 1994, ORTHOPEDICS, V17, P809
   Hsu WK, 2007, BONE, V40, P931, DOI 10.1016/j.bone.2006.10.030
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Kidder LS, 2009, CLIN ORTHOP RELAT R, V467, P3249, DOI 10.1007/s11999-008-0405-2
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305
   Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8
   PELKER RR, 1989, J ORTHOP RES, V7, P585, DOI 10.1002/jor.1100070417
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Reynolds DG, 2007, J BIOMECH, V40, P3178, DOI 10.1016/j.jbiomech.2007.04.004
   Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Song J, 2009, J BIOMED MATER RES A, V89A, P1098, DOI 10.1002/jbm.a.32110
   Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210
   Tang RK, 2001, LANGMUIR, V17, P3480, DOI 10.1021/la001730n
   Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916
   Wang FS, 2003, BONE, V32, P387, DOI 10.1016/S8756-3282(03)00029-2
   White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x
   Xu JW, 2009, J ORTHOP RES, V27, P1306, DOI 10.1002/jor.20890
   Zheng YN, 2010, TISSUE ENG PT A, V16, P879, DOI 10.1089/ten.TEA.2009.0312
NR 31
TC 24
Z9 24
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2011
VL 17
IS 3-4
BP 503
EP 511
DI 10.1089/ten.tea.2010.0274
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 712JB
UT WOS:000286661600024
PM 20818999
OA Green Published
DA 2018-10-20
ER

PT J
AU Liu, JR
   Mao, JJ
   Chen, LL
AF Liu, Jiarong
   Mao, Jeremy J.
   Chen, Lili
TI Epithelial-Mesenchymal Interactions as a Working Concept for Oral Mucosa
   Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID STEM-CELLS; BONE-MARROW; FIBROBLAST DIFFERENTIATION; TUMOR RESECTION;
   BUCCAL MUCOSA; FREE-FLAP; IN-VITRO; TISSUE; RECONSTRUCTION; SKIN
AB Oral mucosa consists of two tissue layers, the superficial epithelium and the underlying lamina propria. Together, oral mucosa functions as a barrier against exogenous substances and pathogens. In development, interactions of stem/progenitor cells of the epithelium and mesenchyme are crucial to the morphogenesis of oral mucosa. Previous work in oral mucosa regeneration has yielded important clues for several meritorious proof-of-concept approaches. Tissue engineering offers a broad array of novel tools for oral mucosa regeneration with reduced donor site trauma and accelerated clinical translation. However, the developmental concept of epithelial-mesenchymal interactions (EMIs) is rarely considered in oral mucosa regeneration. EMIs in postnatal oral mucosa regeneration likely will not be a simple recapitulation of prenatal oral mucosa development. Biomaterial scaffolds play an indispensible role for oral mucosa regeneration and should provide a conducive environment for pivotal EMIs. Autocrine and paracrine factors, either exogenously delivered or innately produced, have rarely been and should be harnessed to promote oral mucosa regeneration. This review focuses on a working concept of epithelial and mesenchymal interactions in oral mucosa regeneration.
C1 [Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA.
   [Liu, Jiarong; Chen, Lili] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Stomatol, Wuhan 430022, Peoples R China.
RP Mao, JJ (reprint author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, 630 W 168 St,PH7E CDM, New York, NY 10032 USA.
EM jmao@columbia.edu; chenlili@whuh.com
FU National Natural Science Foundation of China [30970740]; China Hubei
   Provincial Health Department [JX4B10]; NIH [RC2DE020767, R01EB006261]
FX The authors thank Michael Diggs and Kening Hua for administrative
   assistance. This work was supported by grants from the National Natural
   Science Foundation of China (No. 30970740 to L.C.) and the China Hubei
   Provincial Health Department (No. JX4B10 to L.C.). This work was
   supported by NIH grants RC2DE020767 and R01EB006261 (to J.J.M.).
CR Agostini T, 2008, J PLAST RECONSTR AES, V61, P1164, DOI 10.1016/j.bjps.2008.03.038
   Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100
   Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Bannasch H, 2008, BURNS, V34, P1015, DOI 10.1016/j.burns.2007.12.009
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bickenbach Jackie R, 2005, Methods Mol Biol, V289, P97
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a
   Bodner L, 2003, J ORAL MAXIL SURG, V61, P169, DOI 10.1053/joms.2003.50043
   Brouard M, 2003, CURR OPIN BIOTECH, V14, P520, DOI 10.1016/j.copbio.2003.09.005
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen HCJ, 2009, INVEST OPHTH VIS SCI, V50, P4660, DOI 10.1167/iovs.09-3377
   Chen WL, 2008, J ORAL MAXIL SURG, V66, P1145, DOI 10.1016/j.joms.2007.09.023
   Cho KH, 2000, J DERMATOL SCI, V22, P117, DOI 10.1016/S0923-1811(99)00056-0
   Chung JH, 1997, ARCH DERMATOL RES, V289, P677, DOI 10.1007/s004030050261
   Clark J Madison, 2003, Arch Facial Plast Surg, V5, P40
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   de Bree R, 2008, EUR ARCH OTO-RHINO-L, V265, P1, DOI 10.1007/s00405-007-0413-y
   Feinberg SE, 2005, J ORAL MAXIL SURG, V63, P1418, DOI 10.1016/j.joms.2005.07.004
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Grossman Nili, 2001, Cell and Tissue Banking, V2, P241, DOI 10.1023/A:1021197928136
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hitoshi O, 2004, J CRANIOFAC SURG, V15, P614, DOI 10.1097/00001665-200407000-00016
   Hotta Takeshi, 2007, Kobe J Med Sci, V53, P1
   Izumi K, 2007, J DENT RES, V86, P341, DOI 10.1177/154405910708600408
   Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0
   Izumi K, 2000, J DENT RES, V79, P798, DOI 10.1177/00220345000790030301
   Izumi K, 2003, INT J ORAL MAX SURG, V32, P188, DOI 10.1054/ijom.2002.0365
   Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014
   Janes SM, 2002, J PATHOL, V197, P479, DOI 10.1002/path.1156
   Jansen RG, 2008, ARCH ORAL BIOL, V53, P376, DOI 10.1016/j.archoralbio.2007.11.003
   Jaquet Y, 2004, ARCH OTOLARYNGOL, V130, P1185, DOI 10.1001/archotol.130.10.1185
   Kim WS, 2009, EXPERT OPIN BIOL TH, V9, P879, DOI 10.1517/14712590903039684
   Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Krimmel M, 2005, PLAST RECONSTR SURG, V116, P1870, DOI 10.1097/01.prs.0000191173.14154.ef
   Kuo CK, 2003, IEEE ENG MED BIOL, V22, P51, DOI 10.1109/MEMB.2003.1256272
   Laco F, 2009, J DERMATOL SCI, V55, P150, DOI 10.1016/j.jdermsci.2009.05.009
   Lai CC, 2007, LARYNGOSCOPE, V117, P1368, DOI 10.1097/MLG.0b013e318068b5ac
   LANGDON J, 1991, BRIT DENT J, V171, P87, DOI 10.1038/sj.bdj.4807616
   Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006
   Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee S, 2010, J ORAL MAXIL SURG, V68, P2169, DOI 10.1016/j.joms.2009.08.026
   Liu J, 2008, J DENT RES, V87, P788, DOI 10.1177/154405910808700806
   Liu J, 2010, ORTHOD CRANIOFAC RES, V13, P11, DOI 10.1111/j.1601-6343.2009.01475.x
   Lorimier S, 1998, J DENT RES, V77, P1717, DOI 10.1177/00220345980770090801
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8
   Markiewicz MR, 2007, J UROLOGY, V178, P387, DOI 10.1016/j.juro.2007.03.094
   Matsumoto Y, 2010, J BIOMAT SCI-POLYM E, V21, P83, DOI 10.1163/156856209X410247
   McGuire MK, 2008, J PERIODONTOL, V79, P1847, DOI [10.1902/jop.2008.080017, 10.1902/jop.2008.080017 ]
   Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200
   Mogford JE, 2009, WOUND REPAIR REGEN, V17, P405, DOI 10.1111/j.1524-475X.2009.00481.x
   Moharamzadeh K, 2008, J MATER SCI-MATER M, V19, P1793, DOI 10.1007/s10856-007-3321-1
   Mungadi IA, 2009, ANN AFR MED, V8, P203, DOI 10.4103/1596-3519.59572
   Nakamura T, 2007, STEM CELLS, V25, P628, DOI 10.1634/stemcells.2006-0494
   Omura S, 1997, BRIT J ORAL MAX SURG, V35, P85, DOI 10.1016/S0266-4356(97)90681-1
   Ophof R, 2002, BIOMATERIALS, V23, P3741, DOI 10.1016/S0142-9612(02)00108-4
   Pellegrini G, 2010, CELL STEM CELL, V6, P8, DOI 10.1016/j.stem.2009.12.002
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rhee PH, 1998, ARCH OTOLARYNGOL, V124, P1201, DOI 10.1001/archotol.124.11.1201
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Schrader S, 2009, CURR EYE RES, V34, P913, DOI 10.3109/02713680903198045
   Shannon DB, 2006, WOUND REPAIR REGEN, V14, P172, DOI 10.1111/j.1743-6109.2006.00107.x
   Song JH, 2004, J BIOMED MATER RES A, V71A, P143, DOI 10.1002/jbm.a.30144
   Squier C, 2003, 10 CATES ORAL HISTOL, P329
   Squier C A, 2001, J Natl Cancer Inst Monogr, P7
   Stein E, 2007, WIEN KLIN WOCHENSCHR, V119, P318, DOI 10.1007/s00508-007-0783-6
   Torikai K, 2009, J CRANIOFAC SURG, V20, P1729, DOI 10.1097/SCS.0b013e3181b3efda
   Tsao CK, 2010, J PLAST RECONSTR AES, V63, P1117, DOI 10.1016/j.bjps.2009.05.047
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681
   Valentini V, 2008, J CRANIOFAC SURG, V19, P1508, DOI 10.1097/SCS.0b013e318175f3df
   Wei RQ, 2009, EXP BIOL MED, V234, P453, DOI 10.3181/0901-RM-5
   Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526
NR 83
TC 18
Z9 22
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB
PY 2011
VL 17
IS 1
BP 25
EP 31
DI 10.1089/ten.teb.2010.0489
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 711IN
UT WOS:000286583500003
PM 21062224
OA Green Published
DA 2018-10-20
ER

PT J
AU Krishnamoorthy, G
   Krithica, N
   Sehgal, PK
   Mandal, AB
   Sadulla, S
AF Krishnamoorthy, Ganesan
   Krithica, Natarajan
   Sehgal, Praveen Kumar
   Mandal, Asit Baran
   Sadulla, Sayeed
TI Preparation and characterization of collagen coated cholesterol-free
   liposome nanoparticles matrix for drug carriers and tissue engineering
   application
SO TRANSACTIONS OF THE INDIAN INSTITUTE OF METALS
LA English
DT Article
DE biomaterial; collagen; liposome; CH-free LNP
ID DELIVERY-SYSTEMS; I COLLAGEN; STABILITY; CHITOSAN; PROTEIN; VITRO
AB The collagen coated cholesterol (CH)-free liposome nanoparticle (CCLNP) matrix has been prepared and characterized for use as therapeutic drug carriers, tissue engineering and regenerative medicinal applications. The CH-free liposome nanoparticle (LNP) was prepared by heating method under the N2 atmosphere and CCLNP matrix was prepared by incubation of bovine Achilles tendon collagen with preformed CH-free LNP. The results indicate that collagen stabilizes the original liposomal structure, and CCLNP are more stable in vitro than control liposome. This mineralized collagen composite matrix could be useful to bone and dental implants.
C1 [Krishnamoorthy, Ganesan; Krithica, Natarajan; Sehgal, Praveen Kumar] Cent Leather Res Inst, CSIR, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Mandal, Asit Baran] Cent Leather Res Inst, CSIR, Chem Lab, Madras 600020, Tamil Nadu, India.
   [Sadulla, Sayeed] Indian Shoe Federat, Madras 600008, Tamil Nadu, India.
RP Krishnamoorthy, G (reprint author), Cent Leather Res Inst, CSIR, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
RI Mandal, Asit Baran/B-9977-2009; Ganesan, Krishnamoorthy/A-1783-2012
FU Council of Scientific & Industrial Research (CSIR); Department of
   Science and Technology (DST), Government of India
FX The first author acknowledges the Council of Scientific & Industrial
   Research (CSIR) and Department of Science and Technology (DST),
   Government of India, for award of CSIR-SRF fellowship and financial
   support.
CR DELPOZO AM, 1989, MATRIX, V9, P405, DOI 10.1016/S0934-8832(89)80046-0
   ELFERINK MGL, 1992, BIOCHIM BIOPHYS ACTA, V1106, P23, DOI 10.1016/0005-2736(92)90217-A
   Filipovic-Grcic J, 2001, J MICROENCAPSUL, V18, P3, DOI 10.1080/026520401750038557
   Ghannam MM, 1999, BIOPHYS CHEM, V80, P31, DOI 10.1016/S0301-4622(99)00058-7
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   Gotoh T, 2004, BIOTECHNOL LETT, V26, P611, DOI 10.1023/B:BILE.0000021966.01506.5a
   Krishnamoorthy G, 2010, AIP CONF PROC, V1276, P163, DOI 10.1063/1.3504292
   Laye C, 2008, J FOOD SCI, V73, pN7, DOI 10.1111/j.1750-3841.2008.00747.x
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2007, PROG POLYM SCI, V32, P669, DOI 10.1016/j.progpolymsci.2007.04.001
   Madrigal-Carballo S, 2010, J FUNCT FOODS, V2, P99, DOI 10.1016/j.jff.2010.01.002
   Pederson AW, 2003, BIOMATERIALS, V24, P4881, DOI 10.1016/S0142-9162(03)00369-7
   POKORNY J, 1990, NAHRUNG, V34, P159, DOI 10.1002/food.19900340217
   Sehgal PK, 2001, Indian Patent. DEL, Patent No. [201, 2001201]
   Shabbits JA, 2002, J CONTROL RELEASE, V84, P161, DOI 10.1016/S0168-3659(02)00294-8
   SHAHUM E, 1989, CELL IMMUNOL, V123, P36, DOI 10.1016/0008-8749(89)90266-9
   Shi XY, 2001, BIOMATERIALS, V22, P1627, DOI 10.1016/S0142-9612(00)00320-3
   Singh C U, 2007, United States Patent, Patent No. 7179484
   SUNAMOTO J, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P117
   Velev O D, 1997, Adv Biophys, V34, P139, DOI 10.1016/S0065-227X(97)89637-2
   Venkatesan N, 2000, INT J PHARM, V203, P169, DOI 10.1016/S0378-5173(00)00442-7
   Wang P, 2010, BIOMATERIALS, V31, P8741
   Woolfson DN., 2010, PEPTIDE SCI, V94, P118
NR 23
TC 0
Z9 0
U1 1
U2 14
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0972-2815
EI 0975-1645
J9 T INDIAN I METALS
JI Trans. Indian Inst. Met.
PD FEB
PY 2011
VL 64
IS 1-2
BP 199
EP 204
DI 10.1007/s12666-011-0039-z
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 798EJ
UT WOS:000293185100039
DA 2018-10-20
ER

PT J
AU Singh, RK
   Srinivasan, A
AF Singh, Rajendra Kumar
   Srinivasan, A.
TI Magnetic properties of bioactive glass-ceramics containing
   nanocrystalline zinc ferrite
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Glass-ceramic; X-ray diffraction; Ferrimagnetism; Nanocrystalline
   magnetic material; Biomaterial
ID SYSTEM FEO-FE2O3-CAO-SIO2; HYPERTHERMIA; ZNFE2O4; CANCER; CELLS
AB Glass-ceramics with finely dispersed zinc ferrite (ZnFe2O4) nanocrystallites were obtained by heat treatment of x(ZnO, Fe2O3)(65-x)SiO(2)20( CaO, P2O5)15Na(2)O (6 <= x <= 21 mole%) glasses. X-ray diffraction patterns of the glass-ceramic samples revealed the presence of calcium sodium phosphate [NaCaPO4] and zinc ferrite [ZnFe2O4] as major crystalline phases. Zinc ferrite present in nanocrystalline form contributes to the magnetic properties of the glass-ceramic samples. Magnetic hysteresis cycles of the glass-ceramic samples were obtained with applied magnetic field sweeps of +/- 20 kOe and +/- 500 Oe, in order to evaluate the potential of these glass-ceramics for hyperthermia treatment of cancer. The evolution of magnetic properties in these samples, viz., from a partially paramagnetic to fully ferrimagnetic nature has been explored using magnetometry and X-ray diffraction studies. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Singh, Rajendra Kumar; Srinivasan, A.] Indian Inst Technol Guwahati, Dept Phys, Gauhati 781039, India.
RP Srinivasan, A (reprint author), Indian Inst Technol Guwahati, Dept Phys, Gauhati 781039, India.
EM k.rajendra@iitg.ernet.in; asrini@iitg.ernet.in
RI Singh, Rajendra K/O-9797-2016
OI Singh, Rajendra K/0000-0003-3127-3346
FU Department of Science and Technology, India [SR/S2/CMP-19/2006]
FX Financial assistance from the Department of Science and Technology,
   India vide Project no. SR/S2/CMP-19/2006 is gratefully acknowledged.
CR Anantharaman MR, 1998, J MAGN MAGN MATER, V189, P83, DOI 10.1016/S0304-8853(98)00171-1
   Arcos D, 2002, BIOMATERIALS, V23, P2151, DOI 10.1016/S0142-9612(01)00346-5
   Bretcanu O, 2006, J MAGN MAGN MATER, V305, P529, DOI 10.1016/j.jmmm.2006.02.264
   Bretcanu O, 2006, J MATER SCI, V41, P1029, DOI 10.1007/s10853-005-2636-x
   Bretcanu O, 2005, ACTA BIOMATER, V1, P421, DOI 10.1016/j.actbio.2005.04.007
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Cullity RD, 1972, INTRO MAGNETIC MAT
   EBISAWA Y, 1993, J MATER SCI-MATER M, V4, P225, DOI 10.1007/BF00122273
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   GORTER EW, 1950, NATURE, V165, P798, DOI 10.1038/165798a0
   Ikenaga M., 1991, BIOCERAMICS, V4, P255
   JEYADEVAN B, 1994, J APPL PHYS, V76, P6325, DOI 10.1063/1.358255
   JEYADEVAN B, 1994, J JAPAN SOC POWDER P, V41, P109
   KAMIYAMA T, 1992, SOLID STATE COMMUN, V81, P563, DOI 10.1016/0038-1098(92)90412-3
   Kawashita M, 2004, J CERAM SOC JPN, V112, P373, DOI 10.2109/jcersj.112.373
   Kawashita M, 2001, J CERAM SOC JPN, V109, P39, DOI 10.2109/jcersj.109.39
   KOKUBO T, 1992, BIOCERAMICS, V5, P213
   Lee YK, 2003, J MATER SCI, V38, P4221, DOI 10.1023/A:1026346109737
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Singh RK, 2008, J MAGN MAGN MATER, V320, P1352, DOI 10.1016/j.jmmm.2007.11.007
   Singh RK, 2010, MAT SCI ENG C-MATER, V30, P1100, DOI 10.1016/j.msec.2010.06.003
   Singh RK, 2010, CERAM INT, V36, P283, DOI 10.1016/j.ceramint.2009.07.028
   SUGIHARA T, 1986, GAN TO TATAKAU HYPER, P37
   Tanaka K, 1998, J PHYS CHEM SOLIDS, V59, P1611, DOI 10.1016/S0022-3697(98)00078-X
NR 28
TC 26
Z9 26
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD FEB
PY 2011
VL 323
IS 3-4
BP 330
EP 333
DI 10.1016/j.jmmm.2010.09.029
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 673FQ
UT WOS:000283644900014
DA 2018-10-20
ER

PT J
AU Garrain, PA
   Costa, D
   Marcus, P
AF Garrain, P-A
   Costa, D.
   Marcus, P.
TI Biomaterial-Biomolecule Interaction: DFT-D Study of Glycine Adsorption
   on Cr2O3
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID STAINLESS-STEEL SURFACE; DENSITY-FUNCTIONAL THEORY; BOVINE
   SERUM-ALBUMIN; CO-CR-MO; PSEUDO PHYSIOLOGICAL SOLUTION; AB-INITIO;
   PASSIVE FILMS; CORROSION-RESISTANCE; BETA-LACTOGLOBULIN; IMPLANT ALLOYS
AB The adsorption of glycine, the smallest amino acid and building block of proteins, on a Cr2O3 surface, taken as a model of stainless steel surfaces, was studied by means of GGA + U (on site Coulomb repulsion). The role of coverage on the adsorption mode and the self-assembly properties were explored. The dispersion contribution to the adsorption energies was also calculated. Glycine adsorbs at low and high coverage in the anionic form. The adsorption is driven by the formation of iono-covalent bonds with the Cr surface atoms. The most stable configurations correspond to maximization of the bonds (Cr-O and Cr-N), where the O or N atoms replace O atoms from the missing anionic plane above the terminal Cr plane. To maximize the bonds formation and minimize lateral repulsion, glycine lies parallel to the surface at low coverage and has a bent orientation at high coverage. The inclusion of dispersion forces strengthens this trend. At mean coverage under the ML, clusterization of high density domains may coexist with domains of lower coverage at the surface. At saturation, a glycinate monolayer with a 1:1 Gly:Cr ratio is formed.
C1 [Garrain, P-A; Costa, D.; Marcus, P.] Ecole Natl Super Chim Paris, CNRS ENSCP UMR 7045, Lab Physicochim Surfaces, F-75005 Paris, France.
RP Costa, D (reprint author), Ecole Natl Super Chim Paris, CNRS ENSCP UMR 7045, Lab Physicochim Surfaces, 11 Rue Pierre & Marie Curie, F-75005 Paris, France.
EM dominique-costa@chimie-paristech.fr
RI costa, dominique/G-5347-2011
CR Arrouvel C, 2007, J PHYS CHEM C, V111, P18164, DOI 10.1021/jp0741408
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Borck O, 2006, J PHYS-CONDENS MAT, V18, P10751, DOI 10.1088/0953-8984/18/48/003
   Borck O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035403
   Bredow T, 1998, SURF SCI, V401, P82, DOI 10.1016/S0039-6028(97)00913-8
   Brown GE, 1999, CHEM REV, V99, P77, DOI 10.1021/cr980011z
   Catti M, 1996, J PHYS CHEM SOLIDS, V57, P1735, DOI 10.1016/0022-3697(96)00034-0
   Chakarova-Kack SD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155402
   Compere C, 2001, BIOFOULING, V17, P129, DOI 10.1080/08927010109378472
   Compere C, 2000, NEW J CHEM, V24, P993, DOI 10.1039/b005313i
   Costa D, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212407
   Costa D, 2009, AIP CONF PROC, V1102, P251, DOI 10.1063/1.3108382
   COSTA D, 1995, MATER SCI FORUM, V325, P185
   Costa D, 2008, PHYS CHEM CHEM PHYS, V10, P6360, DOI 10.1039/b806501b
   Costa D, 2007, J MOL STRUC-THEOCHEM, V806, P253, DOI 10.1016/j.theochem.2006.12.006
   Costa D, 2010, SURF SCI, V604, P932, DOI 10.1016/j.susc.2010.02.023
   Costa D, 2009, SURF SCI, V603, P2484, DOI 10.1016/j.susc.2009.05.037
   Daff TD, 2009, J PHYS CHEM C, V113, P15714, DOI 10.1021/jp904054n
   Demetrescu I, 2008, MOL CRYST LIQ CRYST, V486, P1152, DOI 10.1080/15421400801917858
   Diawara B, 2009, SURF SCI, V603, P3025, DOI 10.1016/j.susc.2009.08.001
   Dobin AY, 2000, PHYS REV B, V62, P11997, DOI 10.1103/PhysRevB.62.11997
   Frateur I, 2006, ELECTROCHIM ACTA, V51, P1550, DOI 10.1016/j.electacta.2005.02.116
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344
   Hafner J, 2008, J COMPUT CHEM, V29, P2044, DOI 10.1002/jcc.21057
   Imamura K, 2003, J COLLOID INTERF SCI, V267, P294, DOI 10.1016/S0021-9797(03)00700-8
   Imamura K, 2002, J COLLOID INTERF SCI, V245, P50, DOI 10.1006/jcis.2001.7967
   Imamura K, 2000, J COLLOID INTERF SCI, V229, P237, DOI 10.1006/jcis.2000.7016
   Irrera S, 2009, SUPERLATTICE MICROST, V46, P19, DOI 10.1016/j.spmi.2008.11.021
   Irrera S, 2009, J MOL STRUC-THEOCHEM, V903, P49, DOI 10.1016/j.theochem.2009.01.023
   Ithurbide A, 2007, ELECTROCHIM ACTA, V53, P1336, DOI 10.1016/j.electacta.2007.04.109
   ITOH H, 1995, BIOSCI BIOTECH BIOCH, V59, P1648, DOI 10.1271/bbb.59.1648
   Kasprzyk-Hordern B, 2004, ADV COLLOID INTERFAC, V110, P19, DOI 10.1016/j.cis.2004.02.002
   KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251
   Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758
   Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0
   Lambert JF, 2008, ORIGINS LIFE EVOL B, V38, P211, DOI 10.1007/s11084-008-9128-3
   Lewis AC, 2006, J ORTHOP RES, V24, P1587, DOI 10.1002/jor.20198
   Li YS, 1999, J RAMAN SPECTROSC, V30, P97, DOI 10.1002/(SICI)1097-4555(199902)30:2<97::AID-JRS352>3.0.CO;2-X
   Liang CH, 2006, RARE METAL MAT ENG, V35, P528
   Liang CH, 2002, RARE METALS, V21, P266
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Lomenech C, 2005, CHEMPHYSCHEM, V6, P1061, DOI 10.1002/cphc.200400608
   Maurice V, 1996, J ELECTROCHEM SOC, V143, P1182, DOI 10.1149/1.1836616
   Mckee MA, 2009, SURF SCI, V603, P265, DOI 10.1016/j.susc.2008.11.016
   Mosey NJ, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155123
   Mosey NJ, 2009, J MECH PHYS SOLIDS, V57, P287, DOI 10.1016/j.jmps.2008.10.009
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   OKAZAKI Y, 1995, J JPN I MET, V59, P229, DOI 10.2320/jinstmet1952.59.2_229
   OUDAR J, 1995, CORROSION MECH THEOR
   PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244
   Pradier CM, 2002, SURF INTERFACE ANAL, V34, P50, DOI 10.1002/sia.1250
   Pradier CM, 2000, SURF INTERFACE ANAL, V30, P45, DOI 10.1002/1096-9918(200008)30:1<45::AID-SIA767>3.0.CO;2-G
   Premathilaka S, 2006, FOOD BIOPROD PROCESS, V84, P265, DOI 10.1205/fbp06026
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rehbein C, 1998, SURF REV LETT, V5, P337, DOI 10.1142/S0218625X98000621
   Rimola A, 2009, J PHYS CHEM C, V113, P5741, DOI 10.1021/jp811193f
   Rohrbach A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125426
   ROHRBACH A, 2004, PHYS REV B, V70
   Rubio C, 2002, COLLOID SURFACE B, V24, P193, DOI 10.1016/S0927-7765(01)00242-9
   Sakiyama T, 2004, COLLOID SURFACE B, V33, P77, DOI 10.1016/j.colsurfb.2003.08.010
   Sakiyama T, 1998, J CHEM ENG JPN, V31, P208, DOI 10.1252/jcej.31.208
   Sakiyama T, 1999, J BIOSCI BIOENG, V88, P536, DOI 10.1016/S1389-1723(00)87672-0
   Sakiyama T, 2006, J BIOSCI BIOENG, V101, P434, DOI 10.1263/jbb.101.434
   SAVIO L, ELECT CATAL IN PRESS
   Smerieri M, 2010, LANGMUIR, V26, P7208, DOI 10.1021/la904331d
   Sovar MM, 2008, MOL CRYST LIQ CRYST, V486, P1182, DOI 10.1080/15421400801917924
   Stievano L, 2007, EUR J MINERAL, V19, P321, DOI 10.1127/0935-1221/2007/0019-1731
   Stievano L, 2010, CRYST GROWTH DES, V10, P3657, DOI 10.1021/cg100525h
   Sun JZ, 2007, SURF SCI, V601, P5050, DOI 10.1016/j.susc.2007.09.004
   Sun JZ, 2006, SURF COAT TECH, V201, P4205, DOI 10.1016/j.surfcoat.2006.08.061
   Tanaka Y, 2009, J ARTIF ORGANS, V12, P182, DOI 10.1007/s10047-009-0468-1
   Tielens F, 2008, J PHYS CHEM C, V112, P182, DOI 10.1021/jp074023c
   Tkatchenko A, 2010, MRS BULL, V35, P435, DOI 10.1557/mrs2010.581
   Vinnichenko M, 2002, APPL SURF SCI, V201, P41, DOI 10.1016/S0169-4332(02)00290-8
   Wei C., 2010, J PHYS CHEM C, V114, P460
   YANG WP, 1994, J ELECTROCHEM SOC, V141, P2669, DOI 10.1149/1.2059166
   YUTA T, 2009, J ARTIF ORGANS, V12, P182
NR 81
TC 22
Z9 22
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD JAN 27
PY 2011
VL 115
IS 3
BP 719
EP 727
DI 10.1021/jp109704b
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 707SQ
UT WOS:000286306700018
DA 2018-10-20
ER

PT J
AU Tavangar, A
   Tan, B
   Venkatakrishnan, K
AF Tavangar, Amirhossein
   Tan, Bo
   Venkatakrishnan, Krishnan
TI Synthesis of three-dimensional calcium carbonate nanofibrous structure
   from eggshell using femtosecond laser ablation
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
AB Background: Natural biomaterials from bone-like minerals derived from avian eggshells have been considered as promising bone substitutes owing to their biodegradability, abundance, and lower price in comparison with synthetic biomaterials. However, cell adhesion to bulk biomaterials is poor and surface modifications are required to improve biomaterial-cell interaction. Three-dimensional (3D) nanostructures are preferred to act as growth support platforms for bone and stem cells. Although there have been several studies on generating nanoparticles from eggshells, no research has been reported on synthesizing 3D nanofibrous structures.
   Results: In this study, we propose a novel technique to synthesize 3D calcium carbonate interwoven nanofibrous platforms from eggshells using high repetition femtosecond laser irradiation. The eggshell waste is value engineered to calcium carbonate nanofibrous layer in a single step under ambient conditions. Our striking results demonstrate that by controlling the laser pulse repetition, nanostructures with different nanofiber density can be achieved. This approach presents an important step towards synthesizing 3D interwoven nanofibrous platforms from natural biomaterials.
   Conclusion: The synthesized 3D nanofibrous structures can promote biomaterial interfacial properties to improve cell-platform surface interaction and develop new functional biomaterials for a variety of biomedical applications.
C1 [Tavangar, Amirhossein; Venkatakrishnan, Krishnan] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Tan, Bo] Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
RP Venkatakrishnan, K (reprint author), Ryerson Univ, Dept Mech & Ind Engn, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM venkat@ryerson.ca
OI Tan, Bo/0000-0001-8141-4819; Tavangar, Amirhossein/0000-0003-3272-3679;
   Venkatakrishnan, Krishnan/0000-0002-6491-3971
FU Natural Science and Engineering Research Council of Canada
FX This research is funded by Natural Science and Engineering Research
   Council of Canada.
CR BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Coughlin MJ, 2006, FOOT ANKLE INT, V27, P19, DOI 10.1177/107110070602700104
   Dupoirieux L, 2001, J CRANIOFAC SURG, V12, P53, DOI 10.1097/00001665-200101000-00009
   DURMUS E, 2007, J BIOMEDICAL MAT R B, V86, P82
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Haque S, 2007, LANGMUIR, V23, P6671, DOI 10.1021/la063517i
   HJORTINGHANSEN E, 2002, ORAL MAXILLOFACIAL S, V6, P6
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Liang XH, 2010, LANGMUIR, V26, P5882, DOI 10.1021/la9037815
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Matsuya S, 2007, J MATER SCI-MATER M, V18, P1361, DOI 10.1007/s10856-007-0123-4
   Meijndert L, 2005, INT J ORAL MAX SURG, V34, P877, DOI 10.1016/j.ijom.2005.04.017
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Park JW, 2009, CLIN ORAL IMPLAN RES, V20, P372, DOI 10.1111/j.1600-0501.2008.01602.x
   PARK JW, 2007, J BIOMEDICAL MAT R A, V87, P203
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Siddharthan A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045010
   Tsai WT, 2008, MICROPOR MESOPOR MAT, V111, P379, DOI 10.1016/j.micromeso.2007.08.010
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Vuola J, 1996, BIOMATERIALS, V17, P1761, DOI 10.1016/0142-9612(95)00351-7
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 23
TC 7
Z9 8
U1 0
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD JAN 20
PY 2011
VL 9
AR 1
DI 10.1186/1477-3155-9-1
PG 6
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 721KY
UT WOS:000287354300001
PM 21251288
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lecuyer, S
   Rusconi, R
   Shen, Y
   Forsyth, A
   Vlamakis, H
   Kolter, R
   Stone, HA
AF Lecuyer, Sigolene
   Rusconi, Roberto
   Shen, Yi
   Forsyth, Alison
   Vlamakis, Hera
   Kolter, Roberto
   Stone, Howard A.
TI Shear Stress Increases the Residence Time of Adhesion of Pseudomonas
   aeruginosa
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PLATE FLOW CHAMBER; BACTERIAL ADHESION; BIOMATERIAL SURFACES; BIOFILM
   FORMATION; ESCHERICHIA-COLI; CELL-ADHESION; CATCH BONDS; FORCE;
   IDENTIFICATION; MECHANISMS
AB Although ubiquitous, the processes by which bacteria colonize surfaces remain poorly understood. Here we report results for the influence of the wall shear stress on the early-stage adhesion of Pseudomonas aeruginosa PA14 on glass and polydimethylsiloxane. surfaces. We use image analysis to measure the residence time of each adhering bacterium under flow. Our main finding is that, on either surface, the characteristic residence time of bacteria increases approximately linearly as the shear stress increases (similar to 0-3.5 Pa). To investigate this phenomenon, we used mutant strains defective in surface organelles (type I pili, type IV pili, or the flagellum) or extracellular matrix production. Our results show that, although these bacterial surface features influence the frequency of adhesion events and the early-stage detachment probability, none of them is responsible for the trend in the shear-enhanced adhesion time. These observations bring what we believe are new insights into the mechanism of bacterial attachment in shear flows, and suggest a role for other intrinsic features of the cell surface, or a dynamic cell response to shear stress.
C1 [Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
   [Lecuyer, Sigolene; Rusconi, Roberto; Shen, Yi; Forsyth, Alison] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Vlamakis, Hera; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.
RP Stone, HA (reprint author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
EM hastone@princeton.edu
RI Shen, Yi/N-9285-2017; lecuyer, sigolene/E-7626-2012; Rusconi,
   Roberto/D-9692-2011
OI Shen, Yi/0000-0002-0456-3850; Rusconi, Roberto/0000-0002-8385-9296
FU BASF Advanced Research Initiative at Harvard University; Fulbright
   foundation; National Institutes of Health [GM58213]
FX This work was supported by the BASF Advanced Research Initiative at
   Harvard University, a grant from the Fulbright foundation to S.L., and a
   grant from the National Institutes of Health to R.K. (No. GM58213).
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198
   Busscher HJ, 2008, LANGMUIR, V24, P10968, DOI 10.1021/la8016968
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   Ding AM, 2010, APPL ENVIRON MICROB, V76, P1294, DOI 10.1128/AEM.02083-09
   DOUGLAS JF, 1993, SCIENCE, V262, P2010, DOI 10.1126/science.262.5142.2010
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298
   Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x
   Katsikogianni MG, 2010, J MATER SCI-MATER M, V21, P963, DOI 10.1007/s10856-009-3975-y
   Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276
   Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103
   Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001
   Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605
   McClaine JW, 2002, BIOTECHNOL BIOENG, V78, P179, DOI 10.1002/bit.10192
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001
   Neu TR, 1996, MICROBIOL REV, V60, P151
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Paris T, 2007, BIOTECHNOL BIOENG, V97, P1550, DOI 10.1002/bit.21321
   Pierres A, 1996, P NATL ACAD SCI USA, V93, P15114, DOI 10.1073/pnas.93.26.15114
   Pierres A, 2002, BIOPHYS J, V82, P3214, DOI 10.1016/S0006-3495(02)75664-6
   Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002
   Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523
   SJOBLAD RD, 1982, CURR MICROBIOL, V7, P191, DOI 10.1007/BF01568974
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   Thomas W, 2008, ANNU REV BIOMED ENG, V10, P39, DOI 10.1146/annurev.bioeng.10.061807.160427
   Ubbink J, 2007, CURR OPIN COLLOID IN, V12, P263, DOI 10.1016/j.cocis.2007.08.004
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5
NR 39
TC 50
Z9 51
U1 3
U2 40
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 19
PY 2011
VL 100
IS 2
BP 341
EP 350
DI 10.1016/j.bpj.2010.11.078
PG 10
WC Biophysics
SC Biophysics
GA 710UX
UT WOS:000286543600011
PM 21244830
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Wang, YC
   Yuan, YY
   Wang, F
   Wang, J
AF Wang, Yu-Cai
   Yuan, You-Yong
   Wang, Feng
   Wang, Jun
TI Syntheses and Characterization of Block Copolymers of Poly(aliphatic
   ester) with Clickable Polyphosphoester
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE block copolymers; click chemistry; polyphosphoester; ring-opening
   polymerization
ID RING-OPENING POLYMERIZATION; FUNCTIONALIZED MICELLES; ALIPHATIC
   POLYESTERS; EPSILON-CAPROLACTONE; RAFT POLYMERIZATION; MATERIAL SCIENCE;
   CHEMISTRY; COMBINATION; POLYMERS; ATRP
AB We report a series of biocompatible and biodegradable block copolymers of poly(epsilon-caprolactone) with "clickable" polyphosphoester (PPE). The block copolymers are synthesized through controlled ring-opening polymerization of five-membered cyclic phosphoester monomer, propargyl ethylene phosphate (PAEP), initiated with poly(epsilon-caprolactone) macroinitiator. The polymerization followed first-order kinetics with living polymerization characteristics, thus the molecular weight and composition of copolymers are tunable by adjusting the feed ratio of PAEP monomer to macroinitiator. Azide-functionalized poly(ethylene glycol) has been grafted to the copolymer to demonstrate the reactive feasibility by Cu(I)-catalyzed "click" chemistry of azides and alkynes, generating "brush-coil" polymers. The mild conditions associated with the click reaction are shown to be compatible with poly(epsilon-caprolactone) and PPE backbones, rendering the click reaction a generally useful method for grafting numerous types of functionality onto the block copolymers. The block copolymers also show good biocompatibility to cells, suggesting their suitability for a range of biomaterial applications. (C) 2010 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 49: 487-494, 2011
C1 [Yuan, You-Yong; Wang, Feng; Wang, Jun] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.
   [Wang, Yu-Cai] Univ Sci & Technol China, Dept Polymer Sci & Engn, Hefei 230026, Anhui, Peoples R China.
   [Yuan, You-Yong; Wang, Feng; Wang, Jun] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.
RP Wang, J (reprint author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.
EM jwang699@ustc.edu.cn
RI wang, yucai/B-5388-2012; Wang, Yucai/G-9298-2011; Wang, Jun/F-9033-2011;
   Wang, Yucai/A-1098-2017; Yuan, Youyong/L-4466-2017
OI wang, yucai/0000-0001-6046-2934; Wang, Jun/0000-0001-9957-9208; Wang,
   Yucai/0000-0001-6046-2934; Yuan, Youyong/0000-0003-2784-3780
FU National Basic Research Program of China [2010CB934001, 2009CB930301];
   Fundamental Research Funds for the Central Universities [WK2070000008];
   National Natural Science Foundation of China [20974105, 50733003]
FX This work was supported by National Basic Research Program of China (973
   Program, 2010CB934001, 2009CB930301), Fundamental Research Funds for the
   Central Universities (WK2070000008) and National Natural Science
   Foundation of China (20974105, 50733003).
CR Becer CR, 2009, ANGEW CHEM INT EDIT, V48, P4900, DOI 10.1002/anie.200900755
   Binder WH, 2008, MACROMOL RAPID COMM, V29, P952, DOI 10.1002/marc.200800089
   Binder WH, 2007, MACROMOL RAPID COMM, V28, P15, DOI 10.1002/marc.200600625
   Binder WH, 2006, CURR ORG CHEM, V10, P1791, DOI 10.2174/138527206778249838
   Dedola S, 2007, ORG BIOMOL CHEM, V5, P1006, DOI 10.1039/b618048p
   Du JZ, 2006, BIOMACROMOLECULES, V7, P1898, DOI 10.1021/bm051003c
   Gauthier MA, 2009, ANGEW CHEM INT EDIT, V48, P48, DOI 10.1002/anie.200801951
   Golas PL, 2007, QSAR COMB SCI, V26, P1116, DOI 10.1002/qsar.200740059
   Iha RK, 2009, CHEM REV, V109, P5620, DOI 10.1021/cr900138t
   Jiang X, 2008, MACROMOLECULES, V41, P1937, DOI 10.1021/ma7027962
   Jubeli E, 2010, J POLYM SCI POL CHEM, V48, P3178, DOI 10.1002/pola.24105
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P702, DOI 10.1021/ma991181w
   Ladmiral V, 2006, J AM CHEM SOC, V128, P4823, DOI 10.1021/ja058364k
   LIBISZOWSKI J, 1978, J POLYM SCI POL CHEM, V16, P1275, DOI 10.1002/pol.1978.170160610
   Lutz JF, 2006, MACROMOLECULES, V39, P6376, DOI 10.1021/ma061557n
   O'Reilly RK, 2006, J POLYM SCI POL CHEM, V44, P5203, DOI 10.1002/pola.21602
   Opsteen JA, 2005, CHEM COMMUN, P57, DOI 10.1039/b412930j
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Riva R, 2005, CHEM COMMUN, P5334, DOI 10.1039/b5102182k
   Riva R, 2007, MACROMOLECULES, V40, P796, DOI 10.1021/ma0624090
   Sun TM, 2008, BIOMATERIALS, V29, P4348, DOI 10.1016/j.biomaterials.2008.07.036
   Topham PD, 2008, MACROMOLECULES, V41, P9542, DOI 10.1021/ma8019656
   Tsarevsky NV, 2007, MACROMOLECULES, V40, P4439, DOI 10.1021/ma070705m
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wang YC, 2006, MACROMOLECULES, V39, P8992, DOI 10.1021/ma061821c
   Wang YC, 2008, J CONTROL RELEASE, V128, P32, DOI 10.1016/j.jconrel.2008.01.021
   Wang YC, 2009, MACROMOLECULES, V42, P3026, DOI 10.1021/ma900288t
   Williams CK, 2007, CHEM SOC REV, V36, P1573, DOI 10.1039/b614342n
   Wu DX, 2010, J POLYM SCI POL CHEM, V48, P443, DOI 10.1002/pola.23804
   Xiao CS, 2006, MACROMOLECULES, V39, P6825, DOI 10.1021/ma0615396
   Xiong MH, 2009, MACROMOLECULES, V42, P893, DOI 10.1021/ma802688y
   Xu N, 2009, J POLYM SCI POL CHEM, V47, P3583, DOI 10.1002/pola.23443
   Yang XZ, 2008, J POLYM SCI POL CHEM, V46, P6425, DOI 10.1002/pola.22951
   Zhang XW, 2008, MACROMOLECULES, V41, P7863, DOI 10.1021/ma801405j
NR 35
TC 18
Z9 20
U1 4
U2 59
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JAN 15
PY 2011
VL 49
IS 2
BP 487
EP 494
DI 10.1002/pola.24462
PG 8
WC Polymer Science
SC Polymer Science
GA 708ZN
UT WOS:000286403100018
DA 2018-10-20
ER

PT J
AU Shi, K
   Huang, YP
   Yu, HL
   Lee, TC
   Huang, QR
AF Shi, Ke
   Huang, Yuping
   Yu, Hailong
   Lee, Tung-Ching
   Huang, Qingrong
TI Reducing the Brittleness of Zein Films through Chemical Modification
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Zein films; mechanical properties; chemical modification
ID WATER-VAPOR PERMEABILITY; MECHANICAL-PROPERTIES; OXYGEN PERMEABILITY;
   TENSILE PROPERTIES; DELIVERY-SYSTEMS; EDIBLE FILMS; CORN ZEIN; PROTEINS;
   MICROSTRUCTURE; ACIDS
AB Zein protein is a major coproduct of biofuel from corn. To reduce the brittleness of zein films, a new type of zein-based biomaterial, was synthesized by chemical modification of zein with lauryl chloride through an acylation reaction. The final products were confirmed by H-1 NMR, FT-IR analysis, and SDS-PAGE. Thermal analysis detected no microphase separation in the synthesized polymer matrix. As the content of lauryl moiety increased, the glass transition temperatures of modified zein decreased by as large as 25.8 degrees C due to the plasticization effect of the lauryl moiety. In addition, mechanical and surface properties of cast films from acylated zein were also investigated. The elongation at break of modified zein sheet was increased by about 7-fold at the high modification level with some loss of mechanical strength. The surfaces of modified zein films were as uniform as unmodified zein film but more hydrophobic, further suggesting that no microphase separation happened during the film formation process. This work indicated the potential of these new biomaterials in the development of biodegradable food packaging materials and delivery systems.
C1 [Shi, Ke; Huang, Yuping; Yu, Hailong; Lee, Tung-Ching; Huang, Qingrong] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
RP Huang, QR (reprint author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.
EM qhuang@aesop.rutgers.edu
RI yu, hailong/F-7716-2011
FU United States Department of Agriculture [2009-35603-05075]
FX Received for review August 15, 2010. Revised manuscript received
   November 2, 2010. Accepted November 5, 2010. This work was supported by
   United States Department of Agriculture National Research Initiative
   Program (#2009-35603-05075).
CR Ausubel F., 1987, CURRENT PROTOCOLS MO
   Brauer S, 2007, MACROMOL MATER ENG, V292, P176, DOI 10.1002/mame.200600364
   Chen LY, 2006, TRENDS FOOD SCI TECH, V17, P272, DOI 10.1016/j.tifs.2005.12.011
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Ghanbarzadeh B, 2007, PACKAG TECHNOL SCI, V20, P155, DOI 10.1002/pts.750
   Ghanbarzadeh B, 2007, LWT-FOOD SCI TECHNOL, V40, P1191, DOI 10.1016/j.lwt.2006.07.008
   GIANAZZA E, 1977, PHYTOCHEMISTRY, V16, P315, DOI 10.1016/0031-9422(77)80054-X
   Grandtner G, 2005, POLYM BULL, V55, P235, DOI 10.1007/s00289-005-0431-0
   Grant J, 2008, INT J PHARM, V360, P83, DOI 10.1016/j.ijpharm.2008.04.031
   Gudiksen KL, 2006, BIOPHYS J, V91, P298, DOI 10.1529/biophysj.106.081547
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   LEE KH, 1976, BIOCHEM GENET, V14, P641, DOI 10.1007/BF00485842
   Lesiak-Cyganowska E, 2001, ARCH IMMUNOL THER EX, V49, P247
   Liu Y, 2002, MACROMOL RAPID COMM, V23, P739, DOI 10.1002/1521-3927(20020901)23:13<739::AID-MARC739>3.0.CO;2-0
   Oh JH, 2004, INT J FOOD SCI TECH, V39, P287, DOI 10.1111/j.1365-2621.2004.00783.x
   Park JW, 1996, J FOOD SCI, V61, P401, DOI 10.1111/j.1365-2621.1996.tb14203.x
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Parris N, 2002, J AGR FOOD CHEM, V50, P3306, DOI 10.1021/jf011455q
   PAULIS JW, 1988, CEREAL CHEM, V65, P215
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   Selling G, 2007, IND CROP PROD, V25, P63, DOI 10.1016/j.indcrop.2006.07.003
   Sessa DJ, 2008, J AGR FOOD CHEM, V56, P7067, DOI 10.1021/jf800712k
   Sessa DJ, 2007, J APPL POLYM SCI, V105, P2877, DOI 10.1002/app.26272
   Shi K, 2009, J AGR FOOD CHEM, V57, P2186, DOI 10.1021/jf803559v
   Shirai A, 2008, J BIOL CHEM, V283, P10745, DOI 10.1074/jbc.M709211200
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Song SY, 2008, J PHYS CHEM C, V112, P3805, DOI 10.1021/jp7100144
   Stuart B. H., 2004, INFRARED SPECTROSCOP, P71, DOI DOI 10.1002/0470011149
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   Tomasik P, 2004, ADV CARBOHYD CHEM BI, V59, P175, DOI 10.1016/S0065-2318(04)59005-4
   Wu QX, 2003, POLYMER, V44, P3909, DOI 10.1016/S0032-3861(03)00314-8
   Wu QX, 2003, POLYMER, V44, P3901, DOI 10.1016/S0032-3861(03)00313-6
   Yamada K, 1995, INT J FOOD SCI TECH, V30, P599
   Yang YQ, 1996, J APPL POLYM SCI, V59, P433
   Zhong QX, 2008, FOOD BIOPHYS, V3, P186, DOI 10.1007/s11483-008-9059-6
NR 38
TC 26
Z9 29
U1 3
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JAN 12
PY 2011
VL 59
IS 1
BP 56
EP 61
DI 10.1021/jf103164r
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 700JP
UT WOS:000285735200005
PM 21126002
DA 2018-10-20
ER

PT J
AU Toppazzini, M
   Coslovi, A
   Boschelle, M
   Marsich, E
   Benincasa, M
   Gennaro, R
   Paoletti, S
AF Toppazzini, Mila
   Coslovi, Anna
   Boschelle, Manuela
   Marsich, Eleonora
   Benincasa, Monica
   Gennaro, Renato
   Paoletti, Sergio
TI Can the interaction between the antimicrobial peptide LL-37 and alginate
   be exploited for the formulation of new biomaterials with antimicrobial
   properties?
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Antimicrobial peptides; LL 37; Polysaccharides; Alginate; Circular
   dichroism; alpha Helix
ID HUMAN CATHELICIDIN LL-37; BACTERIAL POLYSACCHARIDES; CAPSULE
   POLYSACCHARIDE; INNATE IMMUNITY; ANTIBIOTICS; RESISTANCE; INHIBITION;
   STABILITY; PATHOGENS; MEMBRANE
AB in this study we took advantage of the strong interaction between the antimicrobial peptide LL-37 and anionic polysaccharides such as alginate to design and evaluate a new biomaterial with putative antibacterial properties
   To begin with we have investigated the effect of different biocompatible polysaccharides on both the cytotoxicity and the antimicrobial activity of LL-37 a powerful endogenous antimicrobial peptide of human origin whose use in therapy has been hampered by its toxicity to host cells Interactions of the peptide with polysaccharides were evaluated by circular dichroism analyses which revealed a different capacity of the polymers to induce the active helical conformation in the peptide Among the polysaccharides tested sodium alginate was the only one that significantly reduced the toxicity of LL-37 toward mammalian cells A sodium alginate/LL-37 preparation was then tested on four bacterial strains The Gram-negative bacteria resulted susceptible to the mixture while the growth of the Gram-positive ones was poorly affected and only at the highest peptide concentration tested Following the positive results with Gram-negative species the alginate/LL-37 binary system was used for the preparation of calcium alginate beads which were tested for peptide release (C) 2010 Elsevier Ltd All rights reserved
C1 [Toppazzini, Mila; Coslovi, Anna; Boschelle, Manuela; Marsich, Eleonora; Benincasa, Monica; Gennaro, Renato; Paoletti, Sergio] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy.
RP Toppazzini, M (reprint author), Univ Trieste, Dept Life Sci, Via L Giorgien 1, I-34127 Trieste, Italy.
RI Benincasa, Monica/R-6457-2016
OI Benincasa, Monica/0000-0001-6087-4461; MARSICH,
   ELEONORA/0000-0002-0700-4464; Paoletti, Sergio/0000-0001-5944-8182
FU EU [026279-2]; Friuli Venezia Giulia Region [LR 26/2005 art 23]
FX This work was supported by the EU-FP6 project NEWBONE contract no
   026279-2 and by the Friuli Venezia Giulia Region grant LR 26/2005 art 23
   for the R<SUP>3</SUP>A<SUP>2</SUP> network
CR Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x
   Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3
   Benincasa M, 2009, J PEPT SCI, V15, P595, DOI 10.1002/psc.1142
   BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
   Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004
   Chan C, 2005, J PEPT RES, V65, P343, DOI 10.1111/j.1399-3011.2005.0217.X
   Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005
   DOMENICO P, 1994, INFECT IMMUN, V62, P4495
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Donati I, 2004, BIOMACROMOLECULES, V5, P186, DOI 10.1021/bm030063k
   Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030
   Etrych T, 2005, EUR J PHARM SCI, V25, P281, DOI 10.1016/j.ejps.2005.03.005
   Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589, DOI 10.1046/j.1432-1033.2001.02494.x
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317
   Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020
   Hiemstra PS, 2007, EUR RESPIR J, V29, P617, DOI 10.1183/09031936.00017007
   HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824
   Izquierdo-Barba I, 2009, BIOMATERIALS, V30, P5729, DOI 10.1016/j.biomaterials.2009.07.003
   Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718
   Juban M. M., 1997, ANTIBACTERIAL PEPTID, P73
   Kuo HH, 2007, CHEM BIOL DRUG DES, V69, P405, DOI 10.1111/j.1747-0285.2007.00518.x
   LIVERMORE DM, 2004, CLIN MICROBIOL INFEC, V4, P1, DOI DOI 10.1111/J.1465-0691.2004.1004.X
   Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425
   Payne DJ, 2008, SCIENCE, V321, P1644, DOI 10.1126/science.1164586
   SCOTT JE, 1989, OBA FDN S, V143, P6
   Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891
   Statz AR, 2008, BIOFOULING, V24, P439, DOI 10.1080/08927010802331829
   Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91
   Tanida T, 2006, J ANTIMICROB CHEMOTH, V57, P94, DOI 10.1093/jac/dki402
   Theuretzbacher U, 2009, INT J ANTIMICROB AG, V34, P15, DOI 10.1016/j.ijantimicag.2009.02.005
   Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001
   Turco G, 2009, BIOMACROMOLECULES, V10, P1575, DOI 10.1021/bm900154b
   Vicente M, 2006, FEMS MICROBIOL REV, V30, P841, DOI 10.1111/j.1574-6976.2006.00038.x
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O
   Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147
NR 48
TC 8
Z9 8
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 10
PY 2011
VL 83
IS 2
BP 578
EP 585
DI 10.1016/j.carbpol.2010.08.020
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 696JF
UT WOS:000285437000035
DA 2018-10-20
ER

PT J
AU Vasconcellos, FC
   Goulart, GAS
   Beppu, MM
AF Vasconcellos, Fernando C.
   Goulart, Gilberto A. S.
   Beppu, Marisa M.
TI Production and characterization of chitosan microparticles containing
   papain for controlled release applications
SO POWDER TECHNOLOGY
LA English
DT Article
DE Chitosan; Microparticles; Papain; Controlled release; Biomaterial
ID DRUG-DELIVERY; CROSS-LINKING; MICROSPHERES; FILMS; BIOCOMPATIBILITY;
   COMPLEX; BEADS
AB The production and modification of chitosan microparticles using crosslinking agents and papain were evaluated for controlled release applications. Chitosan microparticles were produced and crosslinked with sodium tripolyphosphate (TPP) 10% (w/v) solution or glutaraldehyde (GLU) 0.75% (w/w), with subsequent papain sorption. Microparticles were characterized by Fourier transformed infrared spectroscopy (FTIR) for chemical modifications, scanning electron microscopy (SEM) for morphology and X-ray diffraction (XRD) for crystallographic analysis. Chemical composition and the thermal stability of the material were characterized by thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). It was observed that the presence of TPP and papain resulted in a decrease of the stability of the chitosan matrix. Papain release rates from the microparticles were also conducted in vitro. The amount of released papain in phosphate buffer (pH = 7.4) was analyzed with UV-spectroscopy, showing release profiles of enzymatic activity ranging from 0.006 to 0.011 mu mol.min(-1). The results indicate that both chitosan-TPP-papain and chitosan-GLU-papain microparticles can successfully be used for systems that aim at a controlled release of papain with potential use in the biomedical area. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Vasconcellos, Fernando C.; Goulart, Gilberto A. S.; Beppu, Marisa M.] State Univ Campinas UNICAMP, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
RP Beppu, MM (reprint author), State Univ Campinas UNICAMP, Sch Chem Engn, Cidade Univ Zeferino Vaz, BR-13083852 Campinas, SP, Brazil.
EM beppu@feq.unicamp.br
RI BEPPU, MARISA/E-1057-2012; Vasconcellos, Fernando/G-6327-2012
FU CAPES; CNPq; FAEPEX-UNICAMP
FX The authors gratefully acknowledge the financial support from CAPES,
   CNPq and FAEPEX-UNICAMP.
CR AIMOLI GG, 2006, MAT SCI ENG C, V26, P78
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Bhumkar DR, 2006, AAPS PHARMSCITECH, V7
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   Cardenas G, 2008, J MATER SCI-MATER M, V19, P2397, DOI 10.1007/s10856-007-3275-3
   Combadiere B, 2008, COMP IMMUNOL MICROB, V31, P293, DOI 10.1016/j.cimid.2007.07.015
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   EMERUWA AC, 1982, J NAT PROD, V45, P123, DOI 10.1021/np50020a002
   Falabella AF, 2006, DERMATOL THER, V19, P317, DOI 10.1111/j.1529-8019.2006.00090.x
   Garmise RJ, 2006, AAPS PHARMSCITECH, V7, pE1
   Gupta KC, 2007, CARBOHYD RES, V342, P2244, DOI 10.1016/j.carres.2007.06.009
   Gupta OP, 2000, PHYTOMEDICINE, V7, P21, DOI 10.1016/S0944-7113(00)80017-3
   He QR, 2009, J MATER SCI-MATER M, V20, P1457, DOI 10.1007/s10856-009-3702-8
   Hebda PA, 2001, WOUNDS, V13, P190
   Ko JA, 2002, INT J PHARM, V249, P165, DOI 10.1016/S0378-5173(02)00487-8
   Kumar S, 2009, INT J BIOL MACROMOL, V45, P330, DOI 10.1016/j.ijbiomac.2009.08.002
   Learoyd TP, 2008, POWDER TECHNOL, V187, P231, DOI 10.1016/j.powtec.2008.02.015
   Lim LY, 1997, DRUG DEV IND PHARM, V23, P981, DOI 10.3109/03639049709149150
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mi FL, 1999, J APPL POLYM SCI, V74, P1868, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
   Mi FL, 2001, J APPL POLYM SCI, V81, P1700, DOI 10.1002/app.1602.abs
   MUZZARELLI RAA, 1994, CARBOHYD POLYM, V25, P45, DOI 10.1016/0144-8617(94)90161-9
   PEPPAS LB, 2007, PHARM RES, V24, P618
   Rimbach G, 2000, ANTICANCER RES, V20, P2907
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   SHU X, 1999, 2 INT S HIGH TECH PO
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Telgenhoff D, 2007, WOUND REPAIR REGEN, V15, P727, DOI 10.1111/j.1524-475X.2007.00279.x
   Vasiliu S, 2008, EUR POLYM J, V44, P3894, DOI 10.1016/j.eurpolymj.2008.07.040
   Wei CZ, 2009, BIOMATERIALS, V30, P5534, DOI 10.1016/j.biomaterials.2009.05.084
NR 30
TC 31
Z9 35
U1 1
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD JAN 10
PY 2011
VL 205
IS 1-3
BP 65
EP 70
DI 10.1016/j.powtec.2010.08.066
PG 6
WC Engineering, Chemical
SC Engineering
GA 687ON
UT WOS:000284787900008
DA 2018-10-20
ER

PT J
AU Adewuyi, S
   Sanyaolu, N
   Ayedun, H
   Amolegbe, SA
AF Adewuyi, S.
   Sanyaolu, N.
   Ayedun, H.
   Amolegbe, S. A.
TI Synthesis of poly [beta-(1 -> 4)-2-amino-2-deoxy-D-glucopyranose]/lead
   nanocomposite
SO SCIENTIFIC RESEARCH AND ESSAYS
LA English
DT Article
DE Chitosan; lead ions; nanoparticles; complexation
ID GAMMA-GLUTAMIC ACID; SILVER NANOPARTICLES; CHITOSAN; IONS; COMPLEX; LEAD
AB Chitosan (poly [beta-(1 -> 4)-2-amino-2-deoxy-D-glucopyranose] beta-PADG) is a natural polymer with abundant primary amino groups in its molecular structure. Due to its excellent properties such as biocompatibility, biodegradability, nontoxicity, and adsorption properties, it is a potential polysaccharide resource. The present investigation describes the preparation and characterization of novel biodegradable nanocomposite based on complexation of beta-PADG with bivalent lead ion. The prepared nano-systems were stable in aqueous media at low pH. The particle size and the size of the complexes were identified by x-ray diffraction (XRD) and UV-vis spectra measurements. It was found that the size of the complexes depended on the concentrations of beta-PADG and lead ions. UV-vis spectra of the nanocomposites revealed the presence of metal nanoparticles. At low concentrations, nanosized particles were formed, however, at high concentrations, formation of large aggregates with a broad size distribution was promoted. The results from the XRD measurements showed that the high concentrations of chitosan and Pb2+ ions favored the growth of large complexes. The beta-PADG nanocomposite composed of a biodegradable biomaterial with high flocculating and heavy metal binding activity may be useful for various water treatment applications.
C1 [Adewuyi, S.] Rhodes Univ, Dept Chem, ZA-6140 Grahamstown, South Africa.
   [Adewuyi, S.; Sanyaolu, N.; Amolegbe, S. A.] Univ Agr Abeokuta, Dept Chem, Abeokuta, Ogun State, Nigeria.
   [Ayedun, H.] Fed Polytech Ilaro, Dept Sci Lab Technol, Ilaro, Ogun State, Nigeria.
RP Adewuyi, S (reprint author), Rhodes Univ, Dept Chem, POB 94, ZA-6140 Grahamstown, South Africa.
EM S.Adewuyi@ru.ac.za
CR Adewuyi S., 2008, J CHEM SOC NIG, V33, P46
   Bodnar M, 2008, J HAZARD MATER, V153, P1185, DOI 10.1016/j.jhazmat.2007.09.080
   Bodnar M, 2006, BIOMACROMOLECULES, V7, P3030, DOI 10.1021/bm0605053
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   CLERMOUNT B, 2005, J CHILE CHEM SOC, V51, P5
   Huang HZ, 2005, J COLLOID INTERF SCI, V282, P26, DOI 10.1016/j.jcis.2004.08.063
   Hudson S, 1998, BIOPOLYMERS RENEWABL, P96
   ILINA AV, 2005, REV APPL BIOCH MIC, V41, P5
   Murugadoss A, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/01/015603
   SAIFUDDIN MN, 2005, ENV BIOTECH, V8, P2
   Schmuhl R, 2001, WATER SA, V27, P1
   SEIICHI M, 1983, J APPL POLYM SCI, V28, P1909
   Solpan D, 2005, COLLOID SURFACE A, V268, P12, DOI 10.1016/j.colsurfa.2005.04.035
   TABOADA E, 2003, CHILE CHEM J, V48, P1
   Taniguchi M, 2005, J BIOSCI BIOENG, V99, P130, DOI 10.1263/jbb.99.130
   Twu YK, 2008, POWDER TECHNOL, V185, P251, DOI 10.1016/j.powtec.2007.10.025
   Yin XQ, 2004, ARKIVOC, P66
   Yokoi H, 1996, J FERMENT BIOENG, V82, P84, DOI 10.1016/0922-338X(96)89461-X
NR 18
TC 2
Z9 2
U1 0
U2 4
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1992-2248
J9 SCI RES ESSAYS
JI Sci. Res. Essays
PD JAN 4
PY 2011
VL 6
IS 1
BP 157
EP 161
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 729HO
UT WOS:000287939500020
DA 2018-10-20
ER

PT S
AU Xiao, XF
   Jiao, JJ
   Huang, QY
   Liu, RF
AF Xiao, Xiufeng
   Jiao, Jianjin
   Huang, Qiongyu
   Liu, Rongfang
BE Guo, ZN
TI Fabrication of Polycaprolactone/Chitosan Scaffolds by Freeze-solvent
   Extraction Method
SO ADVANCED MATERIALS AND PROCESSES, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Design and Manufacturing
   Engineering (ADME 2011)
CY SEP 16-18, 2011
CL Guangzhou, PEOPLES R CHINA
SP Guangdong Univ Technol, Huazhong Univ Sci & Technol, Hong Kong Univ Sci & Technol, Hong Kong Polytechn Univ, Univ Nottingham
DE Scaffold; Polycaprolactone; Chitsosan; Biomaterial
ID TISSUE ENGINEERING APPLICATIONS; PHASE-SEPARATION; CHITOSAN; BLENDS
AB The polycaprolactone (PCL)/chitosan (CS) scaffolds were prepared by the freeze-solvent extraction method using glacial acetic acid with little water as a common blend system. The effect of different solvents on the crystallinity, the morphology, the structure and the mechanical properties of the scaffolds was studied. The results indicate that alkaline solvent favors the deposition of CS, solvent extraction in the frozen condition perfects the crystal of PCL and improves the crystallinity of PCL/CS scaffolds, in the mean while, the compression property enhances. The porosity of PCL/CS reaches 81%, when immersed in water solvent.
C1 [Xiao, Xiufeng; Jiao, Jianjin; Huang, Qiongyu; Liu, Rongfang] Fujian Normal Univ, Fujian Key Lab Polymer Mat, Coll Chem & Mat Sci, Fuzhou 350007, Peoples R China.
RP Xiao, XF (reprint author), Fujian Normal Univ, Fujian Key Lab Polymer Mat, Coll Chem & Mat Sci, Fuzhou 350007, Peoples R China.
EM rfliu@vip.sina.com
CR CHATANI Y, 1970, POLYM J, V1, P555, DOI 10.1295/polymj.1.555
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Olabarrieta I, 2001, POLYMER, V42, P4401, DOI 10.1016/S0032-3861(00)00680-7
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   SEEFRIED CG, 1975, J POLYM SCI POL PHYS, V13, P851, DOI 10.1002/pol.1975.180130416
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Tanaka H, 2000, J PHYS-CONDENS MAT, V12, pR207, DOI 10.1088/0953-8984/12/15/201
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
NR 11
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-214-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 311-313
BP 1695
EP 1698
DI 10.4028/www.scientific.net/AMR.311-313.1695
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ31
UT WOS:000309144500340
DA 2018-10-20
ER

PT S
AU Huang, CF
   Yoshikawa, C
   Zhang, K
   Hattori, S
   Honda, T
   Zawadzak, E
   Kobayashi, H
AF Huang, Chih-Feng
   Yoshikawa, Chiaki
   Zhang, Kun
   Hattori, Shinya
   Honda, Takako
   Zawadzak, Ewelina
   Kobayashi, Hisatoshi
BE Liu, SQ
   Zuo, M
TI Fabrication of Shortened Electrospun Fibers with Concentrated Polymer
   Brush toward Biomaterial Applications
SO EMERGING FOCUS ON ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 1st International Congress on Advanced Materials
CY MAY 13-16, 2011
CL Univ Jinan, Jinan, PEOPLES R CHINA
SP Int Assoc Adv Mat, Univ Jinan, Journal Inorgan & Organometall Polymers & Mat, Adv Mat Letters, Chinese Ceram Soc, Shandong Univ, Minist Educ, Key Lab Liquid Solid Structural Evolut & Proc Mat
HO Univ Jinan
DE surface-initiated living radical polymerization; concentrated polymer
   brush; electrospinning
ID SUSPENSIONS
AB In this research, we aimed to develop a new type of core-shell electrospun fiber, possessing "short" length (core) and "concentrated" polymer brush (shell). We prepared electrospun fibers with initiating moiety for surface-initiated atom transfer radical polymerization (SI-ATRP), one of living radical polymerizations. Then we grafted poly(sodium styrene sulfonate) (PSSNa) on the fibers by SI-ATRP. After the polymerization, we mechanically cut the electrospun fibers with a homogenizer, yielding regulated shortened fibers. Our ultimate goal is to make a novel shortened nanofibril biomaterial with concentrated brush as cell growth scaffolds. Therefore we expect that this unprecedented short nanofiber can be broadly applied as a biomaterial owing to the unique structures and properties of the concentrated brush. The details will be discussed.
C1 [Huang, Chih-Feng; Yoshikawa, Chiaki; Zhang, Kun; Hattori, Shinya; Zawadzak, Ewelina] Natl Inst Mat Sci, World Premier Int Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.
   [Honda, Takako; Kobayashi, Hisatoshi] Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050047, Japan.
   [Kobayashi, Hisatoshi] JST CREST Sanbancho, Tokyo 1020075, Japan.
RP Huang, CF (reprint author), Natl Inst Mat Sci, World Premier Int Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.
EM YOSHIKAWA.Chiaki@nims.go.jp; KOBAYASHI.Hisatoshi@nims.go.jp
OI Huang, Chih-Feng/0000-0002-8062-8708
FU WPI, MEXT; JST-CREST
FX This work was supported by a Grant-in-Aid for Scientific Research, the
   Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan (Grant-in-Aids 19750095 and 20350108), and partially supported by
   WPI, MEXT and JST-CREST.
CR Kobayashi H., 2010, JP. Patent, Patent No. [2010-197279, 2010197279]
   Ohno K, 2006, MACROMOLECULES, V39, P1245, DOI 10.1021/ma0521708
   Ohno K, 2007, MACROMOLECULES, V40, P9143, DOI 10.1021/ma071770z
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
NR 5
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-204-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 306-307
BP 58
EP +
DI 10.4028/www.scientific.net/AMR.306-307.58
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ55
UT WOS:000309192200012
DA 2018-10-20
ER

PT S
AU Petchwattana, N
   Covavisaruch, S
   Euapanthasate, N
AF Petchwattana, Nawadon
   Covavisaruch, Sirijutaratana
   Euapanthasate, Nukul
BE Liu, SQ
   Zuo, M
TI Mechanical and thermal behaviors of the acrylic based core-shell rubber
   modified poly(lactic acid)
SO EMERGING FOCUS ON ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 1st International Congress on Advanced Materials
CY MAY 13-16, 2011
CL Univ Jinan, Jinan, PEOPLES R CHINA
SP Int Assoc Adv Mat, Univ Jinan, Journal Inorgan & Organometall Polymers & Mat, Adv Mat Letters, Chinese Ceram Soc, Shandong Univ, Minist Educ, Key Lab Liquid Solid Structural Evolut & Proc Mat
HO Univ Jinan
DE Biomaterial; Mechanical Properties; Thermal properties; Rubber-Toughened
   polymers.
ID BLENDS
AB Toughening of poly(lactic acid) (PLA) biopolymer by particles of acrylic based core-shell rubber (CSR) was conducted to observe the influences of the rubber contents on the properties of the modified PLA. A series of PLA specimens modified with the CSR by 0.1-10 wt% was prepared by twin screw extrusion and injection. Diminishing brittleness was reflected in the dramatic increment of both the impact strength by threefolds and the elongation at break by fifteenfolds when CSR was employed by 10 wt%. The toughening was also accompanied with a decrease in the tensile modulus and strength. At low loading, the added CSR by 0.5wt% also assisted crystallization of the PLA by slightly lowering the crystallization temperature, allowing decreased processing time and improving the degree of crystallinity of the generally difficult to crystallize PLA.
C1 [Petchwattana, Nawadon] Srinakharinwirot Univ, Fac Agr Prod Innovat & Echnol, Div Polymer Mat Technol, Bangkok 10110, Thailand.
   [Covavisaruch, Sirijutaratana] Chulalongkorn Univ, Fac Med, Dept Chem Engn, Bangkok 10330, Thailand.
   [Euapanthasate, Nukul] Minist Sci, Natl Sci & Technol Dev Agcy NSTDA, Natl Met & Mat Technol Ctr METC, Khlong Nueng 12120, Pathum Thani, Thailand.
RP Petchwattana, N (reprint author), Srinakharinwirot Univ, Fac Agr Prod Innovat & Echnol, Div Polymer Mat Technol, Bangkok 10110, Thailand.
EM nawadon@swu.ac.th; sirijutaratana.c@chula.ac.th; nukule@mtec.or.th
CR Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Hua Y., 2003, POLYMER, V44, P5701
   Huneault MA, 2007, POLYMER, V48, P270, DOI 10.1016/j.polymer.2006.11.023
   Oyama HI, 2009, POLYMER, V50, P747, DOI 10.1016/j.polymer.2008.12.025
   Petchwattana N., 2009, P 1 INT C MAT MET TE, P72
   Todo M, 2007, ENG FRACT MECH, V74, P1872, DOI 10.1016/j.engfracmech.2006.05.021
NR 7
TC 3
Z9 3
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-204-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 306-307
BP 340
EP +
DI 10.4028/www.scientific.net/AMR.306-307.340
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ55
UT WOS:000309192200070
DA 2018-10-20
ER

PT S
AU Wang, Q
   Qi, L
AF Wang, Qun
   Qi, Lu
BE Hu, J
   Luo, Q
TI Preparation and Properties of the Drug-loaded Films of Polyvinyl
   Alcohol-graft-Fibroin Peptides
SO KEY ENGINEERING MATERIALS AND COMPUTER SCIENCE
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Key Engineering Materials and Computer
   Science (KEMCS 2011)
CY AUG 06-07, 2011
CL Dalian, PEOPLES R CHINA
SP Hong Kong Educ Soc, Int Mat Sci Soc, Informat Engn Res Inst, Purdue Univ
DE polyvinyl alcohol; graft; fibroin peptide; drug; film; property
ID POLY(VINYL ALCOHOL); SILK FIBROIN; BIOMATERIAL COATINGS;
   CONTROLLED-RELEASE; PHASE-SEPARATION; BLEND FILMS; SCAFFOLDS
AB Research of biomaterials made from synthesized polymer and naturally occurring macromolecules is a promising subject. The paper reported a series of drug-loaded films manufactured by a method of solution casting, taking polyvinyl alcohol-graft-fibroin peptides (PVA-g-FP) obtained by a graft copolymerization of PVA with allyl fibroin peptides (AFP) as the polymer matrix and, the ornidazole as the model drug. The mechanical property, moisture content, dissolution degree, water absorption and water-vapor transmission rate of the films were determined respectively, and the crystalline of the films were characterized via X-ray diffraction, the morphology of the films and the dispersity profile of the drug ornidazole loaded in the matrix of PVA-g-FP were investigated via the scanning electronic microscopy (SEM). It was concluded that: with the increase of the graft efficiency of FP in the PVA-g-FP films, the mechanical property and the degree of crystalline reduced gradually; but the moisture content, dissolution degree and water-vapor transmission rate rised gradually, and especially, the dispersity of the drug loaded in the PVA-g-FP matrix improved evidently. The results may be useful in exploiting biomaterials such as artificial skin, drug delivery systems and wound dressings.
C1 [Wang, Qun; Qi, Lu] Tianjin Polytech Univ, Inst Biol & Spinning Mat, Tianjin 300160, Peoples R China.
RP Wang, Q (reprint author), Tianjin Polytech Univ, Inst Biol & Spinning Mat, Tianjin 300160, Peoples R China.
EM wangqun0910@126.com; luqi005@sina.com
CR ARRANZ F, 1994, MACROMOL CHEM PHYSIC, V195, P3789, DOI 10.1002/macp.1994.021951205
   Bayraktar O., 2005, EUR J PHARM BIOPHARM, V60, P373
   Dai LX, 2002, J APPL POLYM SCI, V86, P2342, DOI 10.1002/app.11260
   Hassan CM, 2000, POLYMER, V41, P6729, DOI 10.1016/S0032-3861(00)00031-8
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu YL, 2003, J POLYM SCI POL CHEM, V41, P1107, DOI 10.1002/pola.10654
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Pritchard J.G., 1970, POLY VINYL ALCOHOL
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Sanchez-Chaves M, 1998, POLYMER, V39, P2751, DOI 10.1016/S0032-3861(97)00601-0
   SCHACHT E, 1983, MACROMOLECULES, V16, P291, DOI 10.1021/ma00236a025
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tanaka T, 1999, POLYM INT, V48, P811, DOI 10.1002/(SICI)1097-0126(199909)48:9<811::AID-PI221>3.0.CO;2-V
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Wang Q, 2009, IRAN POLYM J, V18, P663
   Wang Q, 2009, DES MONOMERS POLYM, V12, P323, DOI 10.1163/156855509X448299
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Weska R. F., 2009, BIOCEREMICS, V21, P396
   Wu T. C., 1984, US Patent, Patent No. [4,463, 138, 4463138]
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 22
TC 1
Z9 1
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-211-8
J9 ADV MATER RES-SWITZ
PY 2011
VL 320
BP 202
EP 209
DI 10.4028/www.scientific.net/AMR.320.202
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ80
UT WOS:000309245200036
DA 2018-10-20
ER

PT S
AU Wang, BQ
   Yang, LL
AF Wang, Baoqiang
   Yang, Liangliang
BE Ai, ZJ
   Zhang, XD
   Kim, YH
   Yarlagadda, P
TI Design of Embedded Monitored Control System for Ultrasonic Reaction
   Kettle
SO ADVANCED MANUFACTURING SYSTEMS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials and Products Manufacturing
   Technology (ICMPMT 2011)
CY OCT 28-30, 2011
CL Chengdu, PEOPLES R CHINA
SP Minist Educ, Key Lab Oil & Nat Gas Equipment, SW Petroleum Univ, Korea Maritime Univ, Queensland Univ Technol
DE Ultrasonic reaction kettle; Embedded technology; CAN bus; Monitored
   control
AB Ultrasonic effect is widely applied in biomaterial treatment and this process will happen in ultrasonic reaction kettle of which physical parameters directly affect the treatment effect. This paper introduces a kind of monitored control system of ultrasonic reaction kettle and mainly presents the realization method of key units. Depending on embedded technology, this system includes three layers control unit: ARM central control layer, PC control layer and bottom CAN intelligent node layer which has sensors and actuators. Linux operating system has been transplanted on ARM processor as the software platform. Through the practical hardware arrangement and software design, it can be proved that this system can effectively and accurately monitored control the parameters of ultrasonic reaction kettle.
C1 [Wang, Baoqiang; Yang, Liangliang] CUIT, Inst Elect Engn, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), CUIT, Inst Elect Engn, Chengdu 610225, Peoples R China.
EM wbq@cuit.edu.cn; yangll1028@163.com
CR Doche ML, 2003, ULTRASON SONOCHEM, V10, P357, DOI 10.1016/S1350-4177(03)00099-3
   Feng Guojin, 2008, EMBEDDED LINUX DRIVE
   Neamen Donald A, 2000, ELECT CIRCUIT ANAL D, P120
   Rao yuntao, 2008, CAN BUS PRINCIPLES A
   Rubini Alessandro, 2002, LINUX DEVICE DRIVERS
   Wang Baoqiang, 2007, IEEE P ICEMI
   Yaghmour K., 2003, BUILDING EMBEDDED LI
NR 7
TC 0
Z9 0
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-249-1
J9 ADV MATER RES-SWITZ
PY 2011
VL 339
BP 219
EP 222
DI 10.4028/www.scientific.net/AMR.339.219
PG 4
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BCA21
UT WOS:000309383100045
DA 2018-10-20
ER

PT S
AU Akram, MA
   Khan, MB
   Hussain, R
   Iqbal, N
AF Akram, Muhammad Aftab
   Khan, Muhammad Bilal
   Hussain, Rafaqat
   Iqbal, Nida
BE Munir, A
   Khan, ZM
TI Microwave Augmented Fabrication and Evaluation of CNT-Reinforced
   Nanohydroxyapatite
SO ADVANCED MATERIALS FOR APPLIED SCIENCE AND TECHNOLOGY
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 8th International Bhurban Conference on Applied Science and Technology
   (IBCAST 2011)
CY JAN 10-13, 2011
CL Natl Ctr Phys, Islamabad, PAKISTAN
HO Natl Ctr Phys
DE Microwave Irradiation; Refluxing; CNT functionalization; Reinforcement
ID HYDROXYAPATITE COMPOSITES; CARBON NANOTUBES
AB Bioactive CNT reinforced hydroxyapatite nano-composite is synthesized by in-situ precipitation for use in load bearing orthopedic applications. Microwaves augment the synthesis, enhance the reaction rate, and institute energy savings. Heat and acid treated purified CNTs in microwaves are functionalized and dispersed in calcium nitrate tetrahydrate. Diammonium hydrogen phosphate is incorporated in calcium ion solution to furnish the required Ca:P ratio. Refluxing of the precursor solution is accomplished under microwaves. XRD shows the phase purity and crystallinity, FTIR spectroscopy indicates the fucntionalization of CNTs and SEM analysis depicts the nanoporous nanomorphology of synthesized powder. TGA measures the thermal endurance of product, showing good CNTs retention at high temperatures (1100 degrees C) in nitrogen ambient, otherwise they get oxidized in air in that temperature range. CNT reinforced sintered biomaterial exhibits excellent consolidation and a Vicker hardness increment of 30%. The relation of between mechanical properties and sintering time is correlated by SEM.
C1 [Akram, Muhammad Aftab; Khan, Muhammad Bilal] Natl Univ Sci & Technol, Sch Chem & Mat Engn, Sect H 12, Islamabad 44000, Pakistan.
   [Hussain, Rafaqat; Iqbal, Nida] COMSATS Inst Technol, Interdisciplinary Res Ctr Biomed Mat, Lahore 57000, Pakistan.
RP Akram, MA (reprint author), Natl Univ Sci & Technol, Sch Chem & Mat Engn, Sect H 12, Islamabad 44000, Pakistan.
EM aftabi101@gmail.com; bilalkhan-ccems@nust.edu.pk
RI Akram, Muhammad Aftab/A-6160-2015
OI Akram, Muhammad Aftab/0000-0002-1645-7852; Hussain,
   Rafaqat/0000-0003-4810-4776; iqbal, nida/0000-0002-8502-4954
CR Bajpai P. K., 1985, P 1 ANN SCI SESS AC, P50
   Balazsi C, 2003, MAT SCI ENG C-BIO S, V23, P1133, DOI 10.1016/j.msec.2003.09.085
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Guo YP, 2011, MATER LETT, V65, P1007, DOI 10.1016/j.matlet.2010.12.036
   Kealley C, 2006, PHYSICA B, V385, P496, DOI 10.1016/j.physb.2006.05.254
   Khan M B, 2011, SUPPLEMENTARY P TMS, V3
   Li J, 1996, BIOMATERIALS, V17, P1787, DOI 10.1016/0142-9612(95)00356-8
   Parhi P, 2004, MATER LETT, V58, P3610, DOI 10.1016/j.matlet.2004.06.056
   Park Joon B., 2003, PRINCIPLES APPL, P21
   Peigney A, 2003, NAT MATER, V2, P15, DOI 10.1038/nmat794
   PIATTELLI A, 1994, J BIOMED MATER RES, V28, P529, DOI 10.1002/jbm.820280502
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Siddharthan A, 2006, SCRIPTA MATER, V55, P175, DOI 10.1016/j.scriptamat.2006.03.044
   Thostenson ET, 1999, COMPOS PART A-APPL S, V30, P1055, DOI 10.1016/S1359-835X(99)00020-2
   White AA, 2007, INT J APPL CERAM TEC, V4, P1, DOI 10.1111/j.1744-7402.2007.02113.x
   Xia Z, 2004, ACTA MATER, V52, P931, DOI 10.1016/j.actamat.2003.10.050
   Xiao Y, 2010, BIOMATERIALS, V31, P5182, DOI 10.1016/j.biomaterials.2010.03.012
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 21
TC 1
Z9 1
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-227-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 326
BP 110
EP +
DI 10.4028/www.scientific.net/AMR.326.110
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BCA13
UT WOS:000309370200012
DA 2018-10-20
ER

PT S
AU Wang, Y
   Ban, LT
   Li, Z
AF Wang, Yu
   Ban, Litong
   Li, Zheng
BE Qian, XM
   Liu, HW
TI Optimization of simple medium for exopolysaccharide production by
   Agaricus brunnescens
SO ADVANCED TEXTILE MATERIALS, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Textile Engineering and Materials (ICTEM
   2011)
CY SEP 23-25, 2011
CL Tianjin, PEOPLES R CHINA
SP Tianjin Polytechn Univ
DE Agaricus brunnescens; Exopolysaccharide; Optimization; medium
AB The exopolysaccharide of Agaricus brunnescens is a novel biomaterial for various uses. In this paper, the optimization of simple media for the exopolysaccharide production by Agaricus brunnescens through orthogonal methods was reported. The optimal medium for enhancing production was (g/L): glucose 40, yeast extract 5, KH2PO4 0.5. This optimization strategy in shake flask culture lead to an exopolysaccharide production of 1.8 g/L, which was considerably higher than that obtained in preliminary studied.
C1 [Wang, Yu; Ban, Litong] Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China.
   [Li, Zheng] Tianjin Polytech Univ, Sch Text, Tianjin, Peoples R China.
RP Wang, Y (reprint author), Tianjin Agr Univ, Dept Agron, Tianjin, Peoples R China.
EM wytjac@163.com; banlitong@126.com; lizheng@tjpu.edu.cn
CR [Anonymous], 1990, BIOTECHNOL BIOENG, V36, P778
   CASTLE AJ, 1987, APPL ENVIRON MICROB, V53, P816
   Chang XW, 2010, CATAL TODAY, V158, P198, DOI 10.1016/j.cattod.2010.02.009
   Fang QH, 2002, BIOCHEM ENG J, V10, P61, DOI 10.1016/S1369-703X(01)00158-9
   Hao LM, 2010, APPL BIOCHEM BIOTECH, V160, P621, DOI 10.1007/s12010-008-8507-6
   JODON MH, 1982, CRYOBIOLOGY, V19, P602, DOI 10.1016/0011-2240(82)90189-4
   Liu C., 2000, EDIBLE FUNGI, V22, P24
   MAY B, 1982, EXP MYCOL, V6, P283, DOI 10.1016/0147-5975(82)90121-9
   ROYSE DJ, 1982, MYCOLOGIA, V74, P93, DOI 10.2307/3792632
   Wang Y., CHINA BREWING
NR 10
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-241-5
J9 ADV MATER RES-SWITZ
PY 2011
VL 332-334
BP 160
EP +
DI 10.4028/www.scientific.net/AMR.332-334.160
PG 2
WC Materials Science, Textiles
SC Materials Science
GA BBX70
UT WOS:000308573500035
DA 2018-10-20
ER

PT B
AU Radu, CD
   Hritcu, M
   Oproiu, LC
   Lupusoru, C
   Foia, L
   Ghiciuc, C
AF Radu, C. D.
   Hritcu, M.
   Oproiu, L. C.
   Lupusoru, C.
   Foia, L.
   Ghiciuc, C.
BE Rusu, C
TI SUSTAINABLE DEVELOPMENT FOR THE MEDICAL TEXTILES WITH ANTI-ALLERGIC
   PROPERTIES II. IN VIVO TESTS
SO MANAGEMENT OF TECHNOLOGICAL CHANGES, BOOK 2
LA English
DT Proceedings Paper
CT 7th International Conference on Management of Technological Changes
CY SEP 01-03, 2011
CL Alexandroupolis, GREECE
SP Democritus Univ Thrace, Gheorghe Asachi Tech Univ, Central & E European Management Dev Assoc, Ctr Continu Educ & Train, Region E Macedonia & Thrace
DE sustainable development; natural products; biomaterial; blood; enzymes;
   in vivo tests
AB Paper is a part from a study which process clothing with medical properties using a cleaner technology. In actual paper one determines the efficiency of medicines used to diminish any negative effects which could stop activity of chemical mediators which usually determine a severe evolution of an allergy episode. It focuses only on biological implications which have sounds in textiles and bring data on use efficiency. It represents the medical and textile base for an anti-allergy cloth. Substances used in conventional textile finishing chemicals are often accused of affecting human health and the environment. By using natural products on the textile support trying to improve consumer health and protect the environment. An appropriate answer of a body in an interference with some active principles can diminishes the anarchical evolution of mediators. One performs a system by means of a cyclodextrin compound which links a drug and then releases from surface of textile fabric to epidermis. Details linked on these aspects are presented in an another paper. In vivo tests determine anti-oxidative action in connection with natural active principles used in pathogeny of allergy episodes. One determines tests on toxicity of natural products to evaluate the effects of a dose used on a knitted fabric. The toxicity values are obtained by performing in vivo tests accomplished on white mice and Guinea pigs. One determines tests on toxicity of natural products to evaluate any possible harmful effect in the therapeutically use on a knitted fabric. One determined the effects of natural compounds on blood cells and anti-allergy efficiency. The paper becomes a useful instrument for medical and textile researchers from academic level or industrial area. The originality of this work consists in developing and obtaining textile fabrics using natural products to reduce environmental impacts on human health and environment. Work in pharmacological, dermatological and textile teams could offer solutions to medical cases with lower social costs.
C1 [Radu, C. D.; Hritcu, M.] Tech Univ, Iasi, Romania.
EM rcezar2010@yahoo.com; miha.hritcu@yahoo.com
CR [Anonymous], 2008, ALERGOLOGIE SI IMUNO, V4, P4
   [Anonymous], 2001, CLOTHING DERMATITIS
   Miller Freeman Inc, 1996, NONWOVEN MARKETS 199
   Miraftab M., 2007, ECOTEXTILES THE WAY
   Moldovan D., 2000, ALERGIA DIAGNOSTIC S, P105
   POPA A, 2003, MAT TEXTILE CARACTER, P114
   Schacher L., 2003, INT J HLTH CARE QUAL, V16, P261
NR 7
TC 0
Z9 0
U1 0
U2 3
PU DEMOCRITUS UNIV THRACE
PI KOMOTINI
PA UNIV CAMPUS, KOMOTINI, 69100, GREECE
BN 978-960-99486-3-0
PY 2011
BP 113
EP 116
PG 4
WC Economics; Management
SC Business & Economics
GA BBI19
UT WOS:000306940000029
DA 2018-10-20
ER

PT S
AU Singare, S
   Zhong, SY
   Sun, ZZ
AF Singare, Sekou
   Zhong Shouyan
   Sun Zhenzhong
BE Zhang, LC
   Zhang, CL
   Chen, Z
TI The Use of Rapid Prototyping to Fabricate Liver Tissue Engineering
   Scaffold
SO MECHATRONICS AND MATERIALS PROCESSING I, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Mechatronics and Materials Processing (ICMMP
   2011)
CY NOV 18-20, 2011
CL Guangzhou, PEOPLES R CHINA
SP Guangzhou Univ, Univ New S Wales, Zhejiang Univ, Xian Jiaotong Univ
DE Tissue engineering; Rapid prototyping; PDMS mould; Scaffolds;
   Biomaterial
ID BIODEGRADABLE POLYMER SCAFFOLDS; FREE-FORM FABRICATION;
   PHASE-SEPARATION; POLYURETHANE; DEPOSITION; SALT; MORPHOLOGY; MATRICES;
   SPONGES; BONE
AB In this papers, the authors described a rapid prototyping method to produce vascularized tissue such liver scaffold for tissue engineering applications. A scaffold with interconnected channel was designed using CAD environment. The data were transferred to a Polyjet 3D Printing machine (Eden 250, Object, Israel) to generate the models. Based on the 3D Printing model, a PDMS (polydimethyl-silicone) mould was created which can be used to cast the biodegradable poly (L-lactic-co-glycolic acid) (PLGA)material. The advantages and limitations of Rapid Prototyping (RP) techniques as well as the future direction of RP development in tissue engineering scaffold fabrication were reviewed.
C1 [Singare, Sekou; Zhong Shouyan; Sun Zhenzhong] Dongguan Univ Technol, Sch Mech Engn, Dongguan 523808, Peoples R China.
RP Singare, S (reprint author), Dongguan Univ Technol, Sch Mech Engn, Dongguan 523808, Peoples R China.
EM singarese@gmail.com
CR Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Budyanto L, 2009, J MATER SCI-MATER M, V20, P105, DOI 10.1007/s10856-008-3545-8
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heijkants RGJC, 2008, J BIOMED MATER RES A, V87A, P921, DOI 10.1002/jbm.a.31829
   Hou QP, 2003, J BIOMED MATER RES B, V67B, P732, DOI 10.1002/jbm.b.10066
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   Karamuk E, 1999, ARTIF ORGANS, V23, P881, DOI 10.1046/j.1525-1594.1999.06308.x
   Kim SS, 1998, ANN SURG, V228, P8, DOI 10.1097/00000658-199807000-00002
   Lorenzini S, 2007, STEM CELLS, V25, P2383, DOI 10.1634/stemcells.2007-0056
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   REUBER M, 1987, ARTIF ORGANS, V11, P323
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Schoof H, 2000, J CRYST GROWTH, V209, P122, DOI 10.1016/S0022-0248(99)00519-9
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Shin K, 2007, J BIOMED MATER RES A, V83A, P1076, DOI 10.1002/jbm.a.31437
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   vandeWitte P, 1996, J POLYM SCI POL PHYS, V34, P2553, DOI 10.1002/(SICI)1099-0488(19961115)34:15<2553::AID-POLB3>3.0.CO;2-U
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Wu BM, 1996, J CONTROL RELEASE, V40, P77, DOI 10.1016/0168-3659(95)00173-5
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 32
TC 0
Z9 0
U1 1
U2 22
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-238-5
J9 ADV MATER RES-SWITZ
PY 2011
VL 328-330
BP 658
EP 661
DI 10.4028/www.scientific.net/AMR.328-330.658
PG 4
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BBI73
UT WOS:000306989600139
DA 2018-10-20
ER

PT S
AU Cheema, U
   MacRobert, AJ
   Rong, Z
   Alekseeva, T
   Kirresh, O
   Vadgama, P
   Brown, RA
AF Cheema, U.
   MacRobert, A. J.
   Rong, Z.
   Alekseeva, T.
   Kirresh, O.
   Vadgama, P.
   Brown, R. A.
BE ElHaj, A
   Bader, D
TI O-2 Diffusion through Collagen Scaffolds at Defined Densities:
   Implications for Cell Survival and Angiogenic Signalling in Tissue
   Models
SO 8TH INTERNATIONAL CONFERENCE ON CELL & STEM CELL ENGINEERING (ICCE)
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 8th International Conference on Cell and Stem Cell Engineering
CY JUN 11-12, 2010
CL Trin Coll, Dublin, IRELAND
HO Trin Coll
DE Collagen Scaffold; Biomimetic; Oxygen Diffusion; Oxygen permeability;
   Photo-chemical crosslinking; Phosphate-based dissolving glass fibres;
   Angiogenic Factors; Tissue-Constructs
ID COMPRESSION; GEL
AB The success of any biomaterial for tissue engineering is dominated by its mechanical properties and ability to support nutrient diffusion. Collagen scaffolds are ideal candidates due to their ability to immerse cells in a biomimetic nano-fibrous matrix. We have established O-2 diffusion coefficients through native, dense collagen scaffolds at two tissue-like densities, with and without photo-chemical crosslinking, by adapting an optical fibre-based system for real-time core O-2 monitoring deep within collagen constructs. The high diffusion coefficients of these collagen scaffolds, as well as their material properties, render them viable tissue engineering matrices for tissue replacement. Due to this O-2 diffusion through cell-seeded collagen type I scaffolds, natural gradients of O-2 form and cells in different locations are subject to varying levels of O-2. These gradients were controlled by varying cell density, as it was found that cell consumption of O-2 played a greater role compared to material diffusion in formation of such O-2 gradients. Potent angiogenic signaling molecules were upregulated at both the gene and protein level, particularly within the core of 3D scaffolds, where O-2 was low, but remained within physiological hypoxia. By incorporating phosphate-based dissolving glass fibres into collagen constructs, as they are produced, it was possible to introduce channels throughout the construct in a gradual manner. Where channeled architecture was introduced to the 3D constructs, thus delivery of sustained O-2 to all cells even within the core, this upregulation of angiogenic factors was abolished. We can now engineer collagen type I scaffolds with varying density, varying degrees of crosslinking and various architectural features to control delivery of O-2 to all cells embedded within the construct.
C1 [Cheema, U.; Alekseeva, T.; Kirresh, O.; Brown, R. A.] UCL, Tissue Repair & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, London, England.
   [MacRobert, A. J.] UCL, Natl Med Laser Ctr, UCL Div Surg & Intervent Sci, London, England.
   [Rong, Z.; Vadgama, P.] Queen Mary Univ London, IRC Biomed Mat, London, England.
RP Cheema, U (reprint author), UCL, Tissue Repair & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, London, England.
OI Rong, Zimei/0000-0002-7642-3160
CR Abou Neel EA, 2006, SOFT MATTER, V2, P986, DOI 10.1039/b609784g
   Androjna C, 2008, TISSUE ENG PT A, V14, P559, DOI 10.1089/tea.2006.0361
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Cheema U, 2008, CELL MOL LIFE SCI, V65, P177, DOI 10.1007/s00018-007-7356-8
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f
NR 6
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-19043-8
J9 IFMBE PROC
PY 2011
VL 30
BP 13
EP +
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA BBQ35
UT WOS:000307851500004
DA 2018-10-20
ER

PT J
AU Chan, RTH
   Marcal, H
   Russell, RA
   Holden, PJ
   Foster, LJR
AF Chan, Rodman T. H.
   Marcal, Helder
   Russell, Robert A.
   Holden, Peter J.
   Foster, L. John R.
TI Application of Polyethylene Glycol to Promote Cellular Biocompatibility
   of Polyhydroxybutyrate Films
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID OLFACTORY ENSHEATHING CELLS; POLY(ETHYLENE GLYCOL); IN-VITRO;
   MECHANICAL-PROPERTIES; ACETATE BUTYRATE; PHB/PEG BLENDS;
   POLYHYDROXYALKANOATES; POLY(3-HYDROXYBUTYRATE); SURFACES;
   POLY(BETA-HYDROXYBUTYRATE)
AB Polyhydroxybutyrate (PHB) is a biomaterial with potential for applications in biomedical and tissue engineering; however, its brittle nature and high crystallinity limit its potential. Blending PHB with a variety of PEGs produced natural-synthetic composite films composed of FDA-approved polymers with significant reductions in crystallinity, from 70.1% for PHB films to 41.5% for its composite with a 30% (w/w) loading of PEG2000. Blending also enabled manipulation of the material properties, increasing film flexibility with an extension to break of 2.49 +/- 1.01% for PHB films and 8.32 +/- 1.06% for films containing 30% (w/w) PEG106. Significant changes in the film surface properties, as measured by porosity, contact angles, and water uptake, were also determined as a consequence of the blending process, and these supported greater adhesion and proliferation of neural-associated olfactory ensheathing cells (OECs). A growth rate of 7.2 x 10(5) cells per day for PHB films with 30% (w/w) PEG2000 loading compared to 2.5 x 10(5) for PHB films was observed. Furthermore, while cytotoxicity of the films as measured by lactate dehydrogenase release was unaffected, biocompatibility, as measured by mitochondrial activity, was found to increase. It is anticipated that fine control of PEG composition in PHB-based composite biomaterials can be utilised to support their applications in medicinal and tissue engineering applications.
C1 [Chan, Rodman T. H.; Marcal, Helder; Russell, Robert A.; Foster, L. John R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
   [Russell, Robert A.; Holden, Peter J.] Australian Nucl Sci & Technol Org, Sydney, NSW 2234, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
EM j.foster@unsw.edu.au
OI Russell, Robert/0000-0002-6819-8194
CR Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Arcana IM, 2006, POLYM INT, V55, P435, DOI 10.1002/pi.1994
   Ashby RD, 1997, TETRAHEDRON, V53, P15209, DOI 10.1016/S0040-4020(97)00958-7
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Chen C, 2005, J POLYM SCI POL PHYS, V43, P35, DOI 10.1002/polb.10742
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng GX, 2006, J APPL POLYM SCI, V100, P1471, DOI 10.1002/app.23135
   Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Foster LJR, 2007, APPL MICROBIOL BIOT, V75, P1241, DOI 10.1007/s00253-007-0976-y
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Foster LJR, 2005, POLYM DEGRAD STABIL, V87, P1, DOI 10.1016/j.polymdegradstab.2003.11.012
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Freier T, 2002, BIOMATERIALS, V23, P2649, DOI 10.1016/S0142-9612(01)00405-7
   Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527
   Hang XM, 2002, FEMS MICROBIOL LETT, V212, P71, DOI 10.1016/S0378-1097(02)00713-9
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hurrell BL, 1998, J MATER SCI, V33, P1709, DOI 10.1023/A:1004364112658
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kapritchkoff FM, 2006, J BIOTECHNOL, V122, P453, DOI 10.1016/j.jbiotec.2005.09.009
   Li X, 2006, BIOMACROMOLECULES, V7, P3112, DOI 10.1021/bm060675f
   Li X, 2009, ACTA BIOMATER, V5, P2002, DOI 10.1016/j.actbio.2009.01.035
   Marcal H, 2008, BIOMACROMOLECULES, V9, P2719, DOI 10.1021/bm800418e
   Mitomo H, 2001, POLYMER, V42, P3455, DOI 10.1016/S0032-3861(00)00678-9
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   Rodrigues JAFR, 2005, J THERM ANAL CALORIM, V79, P379, DOI 10.1007/s10973-005-0069-z
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sanguanchaipaiwong V, 2004, BIOMACROMOLECULES, V5, P643, DOI 10.1021/bm0344708
   Tan SM, 2006, J APPL POLYM SCI, V101, P2776, DOI 10.1002/app.21921
   Townsend KJ, 2005, BIOTECHNOL PROGR, V21, P959, DOI 10.1021/bp050044h
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0
   Wang TZ, 2003, J APPL POLYM SCI, V89, P2116, DOI 10.1002/app.12359
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   Xia CY, 2005, NEUROPEPTIDES, V39, P453, DOI 10.1016/j.npep.2005.07.004
   ZALIPSKY S, 1993, BIOCONJUGATE CHEM, V4, P296, DOI 10.1021/bc00022a008
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang QQ, 1998, J MATER SCI TECHNOL, V14, P95
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 44
TC 7
Z9 7
U1 1
U2 22
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-9422
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2011
AR 473045
DI 10.1155/2011/473045
PG 9
WC Polymer Science
SC Polymer Science
GA 990LW
UT WOS:000307633400018
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Chan, RTH
   Garvey, CJ
   Marcal, H
   Russell, RA
   Holden, PJ
   Foster, LJR
AF Chan, Rodman T. H.
   Garvey, Christopher J.
   Marcal, Helder
   Russell, Robert A.
   Holden, Peter J.
   Foster, L. John R.
TI Manipulation of Polyhydroxybutyrate Properties through Blending with
   Ethyl-Cellulose for a Composite Biomaterial
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
ID POLY(ETHYLENE GLYCOL); MECHANICAL-PROPERTIES; DRUG-RELEASE; IN-VITRO;
   POLY(3-HYDROXYBUTYRATE); POLYHYDROXYALKANOATES; CRYSTALLIZATION;
   COPOLYMER; BIODEGRADATION; BIOSYNTHESIS
AB Polyhydroxybutyrate (PHB) is widely used as a biomaterial in medical and tissue-engineering applications, a relatively high crystallinity limits its application. Blending PHB with ethyl-cellulose (EtC) was readily achieved to reduce PHB crystallinity and promote its degradation under physiological conditions without undue influence on biocompatibility. Material strength of composite films remained unchanged at 6.5 +/- 0.6 MPa with 40% (w/w) EtC loadings. Phase separation between the two biopolymers was determined with PHB crystallinity decreasing from 63% to 47% for films with the same loading. This reduction in crystallinity supported an increase in the degradation rates of composite films from 0.39 to 0.81% wk(-1) for PHB and its composite, respectively. No significant change in morphology and proliferation of olfactory ensheathing cells were observed with the composites despite significant increases in average surface roughness (R-a) of the films from 2.90 to 3.65 mu m for PHB and blends with 80% (w/w) EtC, respectively.
C1 [Chan, Rodman T. H.; Marcal, Helder; Russell, Robert A.; Foster, L. John R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
   [Garvey, Christopher J.; Russell, Robert A.; Holden, Peter J.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW 2234, Australia.
RP Foster, LJR (reprint author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Adv Macromol Design, Bio Polymer Res Grp, Sydney, NSW 2052, Australia.
EM j.foster@unsw.edu.au
RI Garvey, Christopher/E-6475-2010
OI Garvey, Christopher/0000-0001-6496-7008; Russell,
   Robert/0000-0002-6819-8194
CR BARHAM PJ, 1984, J MATER SCI, V19, P2781, DOI 10.1007/BF01026954
   Chen C, 2006, BIOMATERIALS, V27, P4804, DOI 10.1016/j.biomaterials.2006.04039
   Chen J, 1995, CARBOHYD POLYM, V28, P69, DOI 10.1016/0144-8617(95)00080-1
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y
   Crowley MM, 2004, INT J PHARMACEUT, V269, P509, DOI 10.1016/j.ijpharm.2003.09.037
   Dai ZW, 2009, BIOMATERIALS, V30, P3075, DOI 10.1016/j.biomaterials.2009.02.015
   Dong HQ, 2008, COLLOID SURFACE B, V66, P26, DOI 10.1016/j.colsurfb.2008.05.007
   Foster LJR, 2007, APPL MICROBIOL BIOT, V75, P1241, DOI 10.1007/s00253-007-0976-y
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Foster LJR, 2005, POLYMER, V46, P6587, DOI 10.1016/j.polymer.2005.05.012
   FOSTER LJR, 1995, BIOMATERIALS, V16, P341, DOI 10.1016/0142-9612(95)93263-D
   Freier T, 2006, ADV POLYM SCI, P1, DOI 10.1007/12_073
   Furukawa T, 2005, MACROMOLECULES, V38, P6445, DOI 10.1021/ma0504668
   Garvey C. J., 2009, SMALL ANGLE NEUTRON
   Hazer Baki, 2010, Energy and Power Engineering, V2, P31, DOI 10.4236/epe.2010.21006
   Hurrell BL, 1998, J MATER SCI, V33, P1709, DOI 10.1023/A:1004364112658
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kapritchkoff FM, 2006, J BIOTECHNOL, V122, P453, DOI 10.1016/j.jbiotec.2005.09.009
   KUMAGAI Y, 1992, MAKROMOL CHEM, V193, P53
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Marcal H, 2008, BIOMACROMOLECULES, V9, P2719, DOI 10.1021/bm800418e
   Muhamad II, 2006, MALAYSIAN POLYM J, V1, P39
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Rosa DS, 2004, POLYM TEST, V23, P3, DOI 10.1016/S0142-9418(03)00042-4
   SCANDOLA M, 1995, CAN J MICROBIOL, V41, P310, DOI 10.1139/m95-202
   Vogel C, 2008, BIOMACROMOLECULES, V9, P523, DOI 10.1021/bm701035p
   Wang TZ, 2003, J APPL POLYM SCI, V89, P2116, DOI 10.1002/app.12359
   Woolnough CA, 2008, POLYM INT, V57, P1042, DOI 10.1002/pi.2444
   You JW, 2003, POLYMER, V44, P4355, DOI 10.1016/S0032-3861(03)00348-3
   Zhang LL, 1997, POLYMER, V38, P5379, DOI 10.1016/S0032-3861(97)84642-3
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 32
TC 15
Z9 15
U1 0
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-9422
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2011
AR 651549
DI 10.1155/2011/651549
PG 8
WC Polymer Science
SC Polymer Science
GA 990LW
UT WOS:000307633400027
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Schneider, T
   Kohl, B
   Sauter, T
   Becker, T
   Kratz, K
   Schossig, M
   Hiebl, B
   Jung, F
   Lendlein, A
   Ertel, W
   Schulze-Tanzil, G
AF Schneider, Tobias
   Kohl, Benjamin
   Sauter, Tilman
   Becker, Tino
   Kratz, Karl
   Schossig, Michael
   Hiebl, Bernhard
   Jung, Friedrich
   Lendlein, Andreas
   Ertel, Wolfgang
   Schulze-Tanzil, Gundula
BE Lendlein, A
   Grijpma, DW
TI Viability, Adhesion and Differentiated Phenotype of Articular
   Chondrocytes on Degradable Polymers and Electro-Spun Structures Thereof
SO ADVANCED POLYMERS IN MEDICINE
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT Conference on Advanced Functional Polymers for Medicine (AFPM)
CY JUN 15-17, 2011
CL Univ Twente, Enschede, NETHERLANDS
SP Royal Netherlands Acad Arts & Sci (KNAW), Univ Twente, MIRA Inst Biomed Technol & Tech Med, PolyVat, DSM
HO Univ Twente
DE chondrocytes; degradable polymer; differentiation; electro-spinning;
   multiblock copolymer
ID SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; MULTIBLOCK COPOLYMERS;
   CARTILAGE
AB Degradable polymers are essential to enable biomaterial-based regenerative therapies, particularly, in articular cartilage defect healing, which remains a major clinical challenge. The aim of this study was to investigate the effect of two degradable polymers (as a film or scaffold) on primary articular chondrocytes vitality, adherence, differentiated phenotype and morphology. Films and electro-spun scaffolds were prepared from degradable poly(ether) ester urethane (PDC), which was synthesized via co-condensation of poly(p-dioxanone) diol and poly(epsilon-caprolactone)-diol with an aliphatic diisocyanate and poly(p-dioxanone) (PPDO). The thermal and mechanical properties and the surface roughness of the films and scaffolds were examined by differential scanning calorimetry, dynamic mechanical thermal analysis, tensile tests and optical profilometry. Primary porcine articular chondrocytes were seeded on the polymers and analysed for viability, ultrastructure (scanning electron microscopy) and immunolabelled for type II collagen. All films and scaffolds exhibited a low endotoxin load < 0.06 EU/ml and only moderate cytotoxic effects when tested with L929 cells. The results of the seeding experiments revealed that survival and adhesion of chondrocytes depended strongly on seeding density. Vital chondrocytes could be detected on both PPDO and PDC films and scaffolds. They produced the cartilage-specific protein type II collagen indicating differentiated functions. However, they exhibited a mixed morphology on the films and a more flattened cell shape on the scaffolds. The cell/biomaterial interaction in the PPDO scaffolds or films was more intense compared to that in PDC topologies.
   The polymer topology influences chondrocytes phenotype, whereby the scaffolds permitted a more continuous cell growth compared with the films.
C1 [Schneider, Tobias; Kohl, Benjamin; Ertel, Wolfgang; Schulze-Tanzil, Gundula] Charite, Dept Orthopaed Trauma & Reconstruct Surg, Campus Benjamin Franklin,Garystr 5, D-14195 Berlin, Germany.
   [Sauter, Tilman; Becker, Tino; Kratz, Karl; Schossig, Michael; Hiebl, Bernhard; Jung, Friedrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Polymer Res Inst, D-14513 Teltow, Germany.
   [Sauter, Tilman; Kratz, Karl; Jung, Friedrich; Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therap, D-13353 Berlin, Germany.
   [Schneider, Tobias] Univ Appl Sci, D-48149 Munster, Germany.
RP Schneider, T (reprint author), Charite, Dept Orthopaed Trauma & Reconstruct Surg, Campus Benjamin Franklin,Garystr 5, D-14195 Berlin, Germany.
EM gundula.schulze-tanzil@charite.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670
FU Freie Universita t Berlin
FX The present study was partially funded by a starting grant focus areas
   nanoscale, of the Freie Universita t Berlin.
CR Behl M, 2009, SOFT MATTER, V5, P676, DOI 10.1039/b810583a
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Ferreira T., 2011, IMAGEJ IMAGE PROCESS, P2011
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Kratz K, 2011, INT J ARTIF ORGANS, V34, P225, DOI 10.5301/IJAO.2011.6404
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Lohan A., 2011, HISTOCHEM CELL BIOL, DOI [10.1007/S00418, DOI 10.1007/S00418]
   Schlegel W, 2008, INT J MOL MED, V22, P691, DOI 10.3892/ijmm_00000074
   Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Spain TL, 1998, TISSUE ENG, V4, P343, DOI 10.1089/ten.1998.4.343
   Stoll C, 2011, BIOMATERIALS, V32, P4806, DOI 10.1016/j.biomaterials.2011.03.026
NR 18
TC 7
Z9 7
U1 4
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2011
VL 309-310
BP 28
EP 39
DI 10.1002/masy.201100057
PG 12
WC Engineering, Biomedical; Polymer Science
SC Engineering; Polymer Science
GA BAW44
UT WOS:000305740200005
DA 2018-10-20
ER

PT S
AU Wischke, C
   Lobler, M
   Neffe, AT
   Hanh, BD
   Zierke, M
   Sternberg, K
   Schmitz, KP
   Guthoff, R
   Lendlein, A
AF Wischke, Christian
   Loebler, Marian
   Neffe, Axel T.
   Bui Duc Hanh
   Zierke, Michael
   Sternberg, Katrin
   Schmitz, Klaus-Peter
   Guthoff, Rudolf
   Lendlein, Andreas
BE Lendlein, A
   Grijpma, DW
TI A Blend of Poly(epsilon-caprolactone) and
   Poly[(epsilon-caprolactone)-co-glycolide] with Remarkable Mechanical
   Features and Wide Applicability as Biomaterial
SO ADVANCED POLYMERS IN MEDICINE
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT Conference on Advanced Functional Polymers for Medicine (AFPM)
CY JUN 15-17, 2011
CL Univ Twente, Enschede, NETHERLANDS
SP Royal Netherlands Acad Arts & Sci (KNAW), Univ Twente, MIRA Inst Biomed Technol & Tech Med, PolyVat, DSM
HO Univ Twente
DE biomaterials; blends; mechanical properties; poly(epsilon-caprolactone);
   poly[(epsilon-caprolactone)-co-glycolide]
ID POLYMER-BASED BIOMATERIALS; HYDROLYTIC DEGRADATION; NETWORKS;
   COPOLYMERS; DEVICES
AB Hydrolytic degradation of poly(epsilon-caprolactone) [PCL] can be enhanced by introduction of 8 wt.% glycolide leading to poly[(epsilon-caprolactone)-co-glycolide] (PCG), which has a low elongation at break epsilon(B) of 4%. PCG/PCL blends (50/50 w/w) combined the advantageous features of its individual components such as mechanical properties similar to pure PCL (epsilon(B, Blend): 900 +/- 230%; epsilon(B, PCL): 730 +/- 50 at 20 degrees C), water uptake rates during degradation similar to pure PCG, and linear mass loss during bulk degradation independent from sample dimensions. The outcome of cytotoxicity studies was depending on the cell type with promising results, e. g., for Tenon fibroblasts. Easy processing of the blend was demonstrated by melt compression, foaming with CO2, and hot melt extrusion, suggesting a wide applicability as biomaterial, e. g., as drug carrier.
C1 [Wischke, Christian; Neffe, Axel T.; Bui Duc Hanh; Zierke, Michael; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14153 Teltow, Germany.
   [Wischke, Christian; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14153 Teltow, Germany.
   [Loebler, Marian; Sternberg, Katrin; Schmitz, Klaus-Peter] Univ Rostock, Inst Biomed Engn, D-18119 Rostock, Germany.
   [Guthoff, Rudolf] Univ Rostock, Dept Ophthalmol, D-18057 Rostock, Germany.
RP Wischke, C (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14153 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Wischke, Christian/K-9651-2013; Lendlein, Andreas/K-9553-2013; Neffe,
   Axel/H-6997-2013
OI Wischke, Christian/0000-0001-5531-9033; Lendlein,
   Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990
CR Behl M, 2009, SOFT MATTER, V5, P676, DOI 10.1039/b810583a
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   KHAW PT, 1992, INVEST OPHTH VIS SCI, V33, P2043
   Kulinski Z, 2006, BIOMACROMOLECULES, V7, P2128, DOI 10.1021/bm060089m
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lobler M, 2011, J BIOMED MATER RES B, V97B, P388, DOI 10.1002/jbm.b.31826
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Neffe AT, 2010, MACROMOL CHEM PHYS, V211, P182, DOI 10.1002/macp.200900441
   Ovsianikov A, 2011, ACTA BIOMATER, V7, P967, DOI 10.1016/j.actbio.2010.10.023
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Wischke C, 2010, EUR J PHARM SCI, V41, P136, DOI 10.1016/j.ejps.2010.06.003
NR 15
TC 2
Z9 2
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2011
VL 309-310
BP 59
EP 67
DI 10.1002/masy.201100050
PG 9
WC Engineering, Biomedical; Polymer Science
SC Engineering; Polymer Science
GA BAW44
UT WOS:000305740200008
DA 2018-10-20
ER

PT S
AU Roch, T
   Pierce, BF
   Zaupa, A
   Jung, F
   Neffe, AT
   Lendlein, A
AF Roch, Toralf
   Pierce, Benjamin F.
   Zaupa, Alessandro
   Jung, Friedrich
   Neffe, Axel T.
   Lendlein, Andreas
BE Lendlein, A
   Grijpma, DW
TI Reducing the Endotoxin Burden of Desaminotyrosine- and Desaminotyrosyl
   Tyrosine-Functionalized Gelatin
SO ADVANCED POLYMERS IN MEDICINE
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT Conference on Advanced Functional Polymers for Medicine (AFPM)
CY JUN 15-17, 2011
CL Univ Twente, Enschede, NETHERLANDS
SP Royal Netherlands Acad Arts & Sci (KNAW), Univ Twente, MIRA Inst Biomed Technol & Tech Med, PolyVat, DSM
HO Univ Twente
DE biocompatibility; biomaterial; gelatin; hydrogels; endotoxins
ID CELLS; CONTAMINATION; BIOMATERIALS; ACTIVATION; IMMUNITY; SEPSIS
AB Biomaterial-induced autoregeneration requires materials with distinct tailored mechanical and thermal properties, water uptake and swelling properties as well as degradation behavior. Furthermore, before any biomaterial can be applied in vivo, in vitro studies should be performed that confirm the suitability for such applications. One facet in this process is the evaluation of endotoxin loads and immunogenic response to the material to avoid an unspecific activation of the immune system, which otherwise might cause fever and could lead to life-threatening pathologies. In this study, gelatins functionalized with desaminotyrosine (DAT) or desaminotyrosyl tyrosine (DATT) were investigated in terms of their endotoxin content and their potential to induce an inflammatory cytokine response in macrophages. Using the Limulus amebocyte lysate (LAL) test it could be shown that the endotoxin content was substantially reduced by using certified low endotoxin containing gelatin and performing the gelatin functionalization under cleanroom conditions. Furthermore, production of inflammatory cytokines such as interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF alpha) of an immune relevant macrophage cell line was significantly reduced for these materials. The survival of the macrophage cell line in the presence of DAT(T)-functionalized gelatins was not influenced by both materials. Therefore, DAT- and DATT-functionalized gelatins were shown to have passed the tests concerning immunological responses important for their applicability in vivo.
C1 [Roch, Toralf; Pierce, Benjamin F.; Zaupa, Alessandro; Jung, Friedrich; Neffe, Axel T.; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Roch, Toralf/K-9531-2013; Neffe,
   Axel/H-6997-2013; Jung, Friedrich/L-1301-2013; Zaupa,
   Alessandro/I-2682-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Neffe, Axel/0000-0002-5056-3990;
   Jung, Friedrich/0000-0001-8098-7180; Zaupa,
   Alessandro/0000-0003-4062-403X; Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung for financing through
   project Poly4bio BB Forderkennzeichen [0315696A]
FX We thank the Bundesministerium fur Bildung und Forschung for financing
   through project Poly4bio BB (Forderkennzeichen 0315696A).
CR Brandenburg K, 2009, CURR MED CHEM, V16, P2653, DOI 10.2174/092986709788682001
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809
   Nakagawa Y, 2003, J BIOMED MATER RES B, V66B, P347, DOI 10.1002/jbm.b.10020
   Neffe AT, 2011, ACTA BIOMATER, V7, P1693, DOI 10.1016/j.actbio.2010.11.025
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016
   Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006
   Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Suri RM, 1998, J IMMUNOL METHODS, V214, P149, DOI 10.1016/S0022-1759(98)00048-9
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Van Ginderachter JA, 2006, IMMUNOBIOLOGY, V211, P487, DOI 10.1016/j.imbio.2006.06.002
   Williams K. L., 2007, ENDOTOXINS PYROGENS
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zaupa A, 2011, INT J ARTIF ORGANS, V34, P139, DOI 10.5301/IJAO.2010.6083
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
NR 26
TC 12
Z9 12
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2011
VL 309-310
BP 182
EP 189
DI 10.1002/masy.201100048
PG 8
WC Engineering, Biomedical; Polymer Science
SC Engineering; Polymer Science
GA BAW44
UT WOS:000305740200022
DA 2018-10-20
ER

PT S
AU Federico, S
   Lendlein, A
   Neffe, AT
AF Federico, Stefania
   Lendlein, Andreas
   Neffe, Axel T.
BE Lendlein, A
   Grijpma, DW
TI Synthesis and Characterization of a Telechelic Peptide as a Precursor
   for Supramolecular Networks
SO ADVANCED POLYMERS IN MEDICINE
SE Macromolecular Symposia
LA English
DT Proceedings Paper
CT Conference on Advanced Functional Polymers for Medicine (AFPM)
CY JUN 15-17, 2011
CL Univ Twente, Enschede, NETHERLANDS
SP Royal Netherlands Acad Arts & Sci (KNAW), Univ Twente, MIRA Inst Biomed Technol & Tech Med, PolyVat, DSM
HO Univ Twente
DE biomaterial; molecular recognition; peptides; supramolecular structures;
   telechelic precursor
ID SECONDARY STRUCTURE; PROTEINS; NMR
AB A peptide showing propensity for the adoption of beta-sheet conformation was synthesized in order to develop a defined molecular building block as part of a toolbox for the development of polymer networks based on supramolecular interactions. The peptide was synthesized by microwave-assisted solid phase peptide synthesis and the purification was performed by Reversed Phase-High Performance Liquid Chromatography (RP-HPLC), from which a purity higher than 95 mol-% was obtained. The calculated mass was confirmed by Matrix Assisted Laser Desorption Ionization-Time of Flight-Mass Spectrometry (MALDI-ToF-MS). Further characterization of the peptide was performed by IR and 2D TOCSY, NOESY, and HSQC NMR spectroscopy, which confirmed the identity and the sequence of the peptide.
C1 [Federico, Stefania; Lendlein, Andreas; Neffe, Axel T.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
RP Federico, S (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM axel.neffe@hzg.de
RI Neffe, Axel/H-6997-2013; Lendlein, Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Lendlein, Andreas/0000-0003-4126-4670
CR BAX A, 1989, ANNU REV BIOCHEM, V58, P223
   Bruckdorfer T, 2004, CURR PHARM BIOTECHNO, V5, P29, DOI 10.2174/1389201043489620
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   CARPINO LA, 1993, TETRAHEDRON LETT, V34, P7829, DOI 10.1016/S0040-4039(00)61487-9
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Elder AN, 2011, BIOMACROMOLECULES, V12, P2610, DOI 10.1021/bm200393k
   Feng YK, 2009, MACROMOL BIOSCI, V9, P45, DOI 10.1002/mabi.200800199
   Fort AG, 2009, BIOPOLYMERS, V92, P173, DOI 10.1002/bip.21166
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   LUO SQ, 1994, ANAL BIOCHEM, V216, P67, DOI 10.1006/abio.1994.1009
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maslovskis A, 2011, SOFT MATTER, V7, P6025, DOI 10.1039/c1sm05288h
   Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180
   Neffe AT, 2004, ANGEW CHEM INT EDIT, V43, P2937, DOI 10.1002/anie.200353271
   Neffe AT, 2006, ORG BIOMOL CHEM, V4, P3259, DOI 10.1039/b605380g
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Newcomb WS, 1998, BIOTECHNOL BIOENG, V61, P55, DOI 10.1002/(SICI)1097-0290(199824)61:1<55::AID-BIT10>3.0.CO;2-8
   Orain D, 2002, J COMB CHEM, V4, P1, DOI 10.1021/cc0001093
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Stewart JM, 2007, INT J PEPT RES THER, V13, P3, DOI 10.1007/s10989-006-9043-2
NR 22
TC 0
Z9 0
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
PY 2011
VL 309-310
BP 205
EP 212
DI 10.1002/masy.201100055
PG 8
WC Engineering, Biomedical; Polymer Science
SC Engineering; Polymer Science
GA BAW44
UT WOS:000305740200025
DA 2018-10-20
ER

PT S
AU Liu, ZW
   Huang, HY
   Yang, YX
   Wang, JN
AF Liu, Zhi-Wu
   Huang, Hai-Yan
   Yang, Yun-Xing
   Wang, Jian-Nan
BE Li, Y
   Liu, YF
   Luo, XN
   Li, JS
TI Construction and Analysis of Morphological Characteristics of a Novel
   Fabric-Based Silk Fibroin Vascular Prosthesis
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT Textile Bioengineering and Informatics Symposium
CY MAY 27-29, 2011
CL Textile Bioengneer & Informat  Soc, Beijing, PEOPLES R CHINA
SP Beijing Inst Fashion Technol, Mixmind Art & Design Co Ltd
HO Textile Bioengneer & Informat  Soc
DE Silk worm SF; Tubular braid; Vascular prosthesis; Morphological
   characteristics
AB Silk fibroin (SF) is a kind of natural protein and has excellent biocompatibility. In recent years, SF had been studied as an ideal biomaterial for a range of applications, including blood vessel tissue repair and induction of blood vessel tissue regeneration. Most of the researches on silk fibroin vascular scaffolds only focused on biocompatibility such as endothelialization and anticoagulation while the smooth muscle function of the middle layer of natural blood vessel was usually neglected. In this paper, a new strategy was developed in which a novel vascular prosthesis with three layers was designed and constructed especially from bionic techniques in accordance with natural blood vessels. A silk tubular braid (STB) was prepared as the middle layer that played the role of an analogue media, and was then coated with regenerated silk fibroin to construct an internal layer and external layer by freeze drying. Mass per unit area, wall thickness, and kinking diameter of the silk fibroin vascular prosthesises were analyzed. In addition, surface smoothness, porosity and pore size were observed by SEM. This study showed that the morphological characteristics of the fabric based silk fibroin vascular prosthesis can be controlled by controlling the silk fibroin concentration, freezing temperature, freezing time and cross-linking technique.
C1 [Liu, Zhi-Wu; Huang, Hai-Yan; Yang, Yun-Xing; Wang, Jian-Nan] Soochow Univ, Natl Engn Lab Modern Silk, Coll Text & Clothing Engn, Suzhou 215123, Jiangsu, Peoples R China.
RP Wang, JN (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Coll Text & Clothing Engn, 199 Ren Ai Rd,Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.
EM wangjn@suda.edu.cn
CR Agravval C.M, 2001, BIODEGRADABLE SCAFFO, P141
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   [高欣 GAO Xin], 2008, [纺织学报, Journal of Textile Research], V29, P132
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Li MZ, 2000, SILK, P37
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Min BM, 2004, INT J BIOL MACROMOL, V34, P223, DOI DOI 10.1016/J.IJBIOMAC.2004.08.004
   Petrini P, 2003, TISSUE ENG, V9, P1113
   [王璐 Wang Lu], 2003, [纺织学报, Journal of Textile Research], V24, P7
   [吴林波 Wu Linbo], 2003, [功能高分子学报, Journal of Functional Polymer], V16, P91
   Yu Tong-yin, 2003, Journal of Fudan University (Natural Science), V42, P828
NR 11
TC 3
Z9 3
U1 1
U2 5
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2011
BP 151
EP 154
DI 10.3993/tbis2011027
PG 4
WC Materials Science, Textiles
SC Materials Science
GA BAQ73
UT WOS:000305197600027
DA 2018-10-20
ER

PT S
AU Zhou, DX
   Zhang, J
   Wang, HX
   Gao, XL
   Han, YX
   Li, Y
AF Zhou, Dang-Xia
   Zhang, Jing
   Wang, Hai-Xu
   Gao, Xiao-Li
   Han, Yan-Xia
   Li, Yi
BE Li, Y
   Liu, YF
   Luo, XN
   Li, JS
TI Assessment of Genetic Toxicity of Neutral Wool Hydrolyzed Polypeptide
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT Textile Bioengineering and Informatics Symposium
CY MAY 27-29, 2011
CL Textile Bioengneer & Informat  Soc, Beijing, PEOPLES R CHINA
SP Beijing Inst Fashion Technol, Mixmind Art & Design Co Ltd
HO Textile Bioengneer & Informat  Soc
DE wool hydrolyzed polypeptide; safety evaluation; toxicology; biomaterials
ID ADULT RATS; KERATIN
AB Neutral Wool hydrolyzed polypeptide (NWHP) is a new biomaterial derived from natural wool. The genetic toxicity of NWHP was evaluated systematically by a series of toxicological tests. NWHP is not mutagenic according to the results of mouse bone marrow micronucleus test and mouse sperm abnormality test. In conclusion, NWHP can be considered as genetically safe at a maximum dose of 100mg/kg/day.
C1 [Zhou, Dang-Xia; Zhang, Jing; Wang, Hai-Xu; Gao, Xiao-Li] Xi An Jiao Tong Univ, Dept Pathol, Xian 710061, Shaanxi, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyk.edu.hk; tcliyi@polyk.edu.hk
RI LI, YI/G-4421-2012
OI LI, YI/0000-0002-2092-4505
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Ashammakhi N, 2008, REGEN MED, V3, P547, DOI 10.2217/17460751.3.4.547
   Barba C, 2008, SKIN RES TECHNOL, V14, P243, DOI 10.1111/j.1600-0846.2007.00280.x
   Barba C, 2007, J COSMET SCI, V58, P99
   Cardamnone JM, 2007, TEXT RES J, V77, P277, DOI 10.1177/004517507078788
   Chen AZ.ZhaoZ, 2009, TEXTILE BIOENGINEERI, V1-2, P122
   Chen LP, 2009, WOOL TEXTILE J, V37, P20
   Dart AJ, 2009, AUST VET J, V87, P215, DOI 10.1111/j.1751-0813.2009.00428.x
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Lode A, 2009, J TISSUE ENG REGEN M, V3, P149, DOI 10.1002/term.138
   Madsen J, 2008, BIOMACROMOLECULES, V9, P2265, DOI 10.1021/bm8005006
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Tung WS, 2009, ACTA BIOMATER, V5, P50, DOI 10.1016/j.actbio.2008.08.009
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Yamauchi A, 2002, PROTEIN-BASED FILMS AND COATINGS, P253
   Yang X, 2009, J COLLOID INTERF SCI, V336, P756, DOI 10.1016/j.jcis.2009.04.050
   Zhou DX, 2011, TOXICOL IND HEALTH, V27, P65, DOI 10.1177/0748233710381895
   Zhou DX, 2010, SYST BIOL REPROD MED, V56, P413, DOI 10.3109/19396368.2010.509902
   Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009
NR 19
TC 0
Z9 0
U1 0
U2 1
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2011
BP 176
EP 179
DI 10.3993/tbis2011032
PG 4
WC Materials Science, Textiles
SC Materials Science
GA BAQ73
UT WOS:000305197600032
DA 2018-10-20
ER

PT S
AU Liu, X
   Zhang, Y
   Li, Y
   Hu, JY
   Han, YX
   Zhao, Z
AF Liu, Xuan
   Zhang, Yu
   Li, Yi
   Hu, Jun-Yan
   Han, Yan-Xia
   Zhao, Zheng
BE Li, Y
   Liu, YF
   Luo, XN
   Li, JS
TI Biocompatibility of Alkaline Hydrolyzed Wool Polypeptides on Human
   Foreskin Fibroblasts
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT Textile Bioengineering and Informatics Symposium
CY MAY 27-29, 2011
CL Textile Bioengneer & Informat  Soc, Beijing, PEOPLES R CHINA
SP Beijing Inst Fashion Technol, Mixmind Art & Design Co Ltd
HO Textile Bioengneer & Informat  Soc
DE Biocompatibility; Cell morphology; Cell viability; Cell metabolism
ID KERATIN
AB The purpose of this preliminary study was to evaluate the biocompatibility of alkaline hydrolyzed wool polypeptides. The human foreskin fibroblasts, HFF-1, were incubated for 24 hours with the presence of cell culture medium contained different concentrations of alkaline hydrolyzed wool polypeptides. Then the morphology of the fibroblasts was observed. The living cell number was counted and the Alamar Blue assay was chosen to reveal the metabolism status of the cells for each treatment. The morphological changes of the human foreskin fibroblasts were hardly observed between different treatments. The acidic polypeptides showed negative effect to fibroblasts via Trypan Blue stained cell number counting at the highest concentration, 5 mg/mL (n=3, p<0.05). The metabolism effects of the fibroblasts incubated with the neutral polypeptides decreased slightly in the concentration 5 mg/mL (n=9, p<0.05) evaluated by Alamar Blue assay. The conclusion can be set that the alkaline hydrolyzed wool polypeptides are the good candidates in a range of proper concentrations as a part of biomaterial compensation or for tissue engineering.
C1 [Liu, Xuan; Zhang, Yu; Li, Yi; Hu, Jun-Yan; Han, Yan-Xia; Zhao, Zheng] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk; tcliyi@polyu.edu.hk
RI Liu, Xuan/J-7367-2012; LI, YI/G-4421-2012; Zhao, Zheng/K-7150-2012; HU,
   Junyan/J-7323-2012; HU, JUNYAN/G-8806-2012
OI LI, YI/0000-0002-2092-4505; 
CR Agrawal AA, 2010, BIOMATERIALS, V31, P5408, DOI 10.1016/j.biomaterials.2010.03.041
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Cardamone JM, 2010, J MOL STRUCT, V969, P97, DOI 10.1016/j.molstruc.2010.01.048
   Chen AZ, 2009, TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2, P122, DOI 10.3993/tbis2009023
   Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Iridag Y, 2006, J APPL POLYM SCI, V100, P4260, DOI 10.1002/app.23810
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Liao F, 2010, J MATER SCI-MATER M, V21, P489, DOI 10.1007/s10856-009-3931-x
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Misra SK, 2010, BIOMATERIALS, V31, P2806, DOI 10.1016/j.biomaterials.2009.12.045
   Nieto A, 2009, ACTA BIOMATER, V9, P3478
   Resende VTR, 2009, BIOMATERIALS, V30, P5251
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Terho P, 2006, CYTOM PART A, V69A, P552, DOI 10.1002/cyto.a.20261
   Travan A, 2011, ACTA BIOMATER, V7, P337, DOI 10.1016/j.actbio.2010.07.024
NR 17
TC 1
Z9 1
U1 0
U2 1
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2011
BP 346
EP 349
DI 10.3993/tbis2011060
PG 4
WC Materials Science, Textiles
SC Materials Science
GA BAQ73
UT WOS:000305197600059
DA 2018-10-20
ER

PT S
AU Potorac, S
   Popa, M
   Zagnat, M
   Verestiuc, L
AF Potorac, S.
   Popa, M.
   Zagnat, M.
   Verestiuc, L.
GP IEEE
TI Porous Hydrogels Based on Itaconic Anhydride Modified Collagen/HEMA for
   Skin Tissue Engineering
SO 2011 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB)
SE E-Health and Bioengineering Conference
LA English
DT Proceedings Paper
CT 3rd International Conference on E-Health and Bioengineering (EHB)
CY NOV 24-26, 2011
CL Univ Med & Pharm, Iasi, ROMANIA
SP Romania Sect, Romania Sect EMB Chapter, IEEE
HO Univ Med & Pharm
DE collagen; itaconic anhydride; poly(HEMA); skin tissue engineering;
   biomaterial
ID SCAFFOLDS
AB Porous scaffolds for skin tissue engineering were fabricated by radical copolymerization of 2-hydroxyethyl methacrylate (HEMA) and collagen (Coll) modified with itaconic anhydride (ITA). In order to participate in copolymerization reactions with the acrylic monomer, monoitacon-amide functional groups were added to the native collagen macromolecules. Ammonium persulfate (APS) and N,N,N',N'-tetramethylethylene diamine (TEMED) were used as a redox initiator system. Fourier Transform Infrared spectroscopy (FTIR) was used to study the structure of the obtained hydrogels and Scanning Electron Microscopy (SEM) data confirmed the homogeneous pore distribution of the new modified collagen (CIT) and the interconnected porous structure of the developed hydrogels. The biopolymer/monomer ratio has a considerably effect on the cross-section morphology of the matrices. The hemostatic properties of the matrices were studied.
C1 [Potorac, S.; Popa, M.] Gh Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron,71A, Iasi 700050, Romania.
   [Zagnat, M.; Verestiuc, L.] Gr T Popa Univ Med & Pharm, Fac Med Bioengn, Iasi 700454, Romania.
RP Potorac, S (reprint author), Gh Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron,71A, Iasi 700050, Romania.
EM liliana.verestiuc@bioinginerie.ro
RI Verestiuc, Liliana/C-4317-2011
OI Verestiuc, Liliana/0000-0002-3098-8406
FU BRAIN "Doctoral scholarships as an investment in intelligence" project;
   European Social Found; Romanian Government
FX This paper was realized with the support of BRAIN Doctoral scholarships
   as an investment in intelligence project, financed by the European
   Social Found and Romanian Government.
CR Baker MV, 2009, POLYMER, V50, P5918, DOI 10.1016/j.polymer.2009.10.047
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Kubinova S, 2009, BIOMATERIALS, V30, P4601, DOI 10.1016/j.biomaterials.2009.05.007
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Markowicz M., 2005, TOPICS TISSUE ENG, V2
   Nam K, 2007, BIOMATERIALS, V28, P3153, DOI 10.1016/j.biomaterials.2007.03.001
   Potorac S, 2012, MATER LETT, V67, P95, DOI 10.1016/j.matlet.2011.09.039
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
NR 11
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2575-5137
EI 2575-5145
BN 978-1-4577-0292-1
J9 E-HEALTH BIOENG CONF
PY 2011
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BAN05
UT WOS:000304806300019
DA 2018-10-20
ER

PT S
AU Zou, JP
AF Zou, Jianpeng
BE Cao, Z
   Cao, XQ
   Sun, L
   He, YH
TI Fabrication, stress relaxation behavior and bioactivity evaluation of
   HA/316L asymmetrical functionally gradient biomaterial
SO ADVANCED MATERIALS, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical Engineering and Advanced Materials
CY MAY 28-30, 2011
CL Changsha, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, James Cook Univ, Hunan Univ, S Central Univ China, Hunan Normal Univ, Xiangtan Univ
DE hot pressing; stress relaxation; bioactivity evaluation; asymmetrical;
   functionally gradient material (FGM)
ID APATITE FORMATION; STAINLESS-STEEL; HYDROXYAPATITE; COATINGS
AB HA/316L powder asymmetrical functionally gradient biomaterial (FGM) with varying 316L content at 100vol%, 80vol%, 60vol%, 40vol%, 20vol%, 0vol% throughout the thickness of the samples was successfully fabricated by hot pressing(HP) technique. The stress relaxation behavior indicates that gradient structure of the asymmetrical HA/316L FGM has prominent relaxation effect of thermal residual stress. The largest stress in the FGM is 246.13 MPa, which is belonging to tensile stress and at 316L-80vol%HA/ 316L interface. The surfaces of HA/316L FGM are covered with a layer of bone-like apatite after soaking in dynamic SBF, and the apatite increases with the increase of HA content. It reveals that HA/316L FGM with good bioactivity can be obtained with reasonable component design of gradient layers.
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Zou, JP (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM zoujp@mail.csu.edu.cn
CR Balamurugan A, 2007, CERAM INT, V33, P605, DOI 10.1016/j.ceramint.2005.11.011
   Becker J., 2002, ENG FRACT MECH, V69, P1521, DOI 10.1016/S0013-7944(02)00047-4
   Behnamghader A, 2008, J MATER SCI-MATER M, V19, P197, DOI 10.1007/s10856-007-3120-8
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Javidi M, 2008, MAT SCI ENG C-BIO S, V28, P1509, DOI 10.1016/j.msec.2008.04.003
   Kokubo T, 2004, BIOMATERIALS, V25, P4485, DOI 10.1016/j.biomaterials.2003.11.007
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Mohamed KR, 2008, MAT SCI ENG C-BIO S, V28, P1087, DOI 10.1016/j.msec.2007.04.040
   Okada M, 2008, J BIOMED MATER RES A, V86A, P589, DOI 10.1002/jbm.a.31668
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   Suwanprateeb J, 2009, J MATER SCI-MATER M, V20, P1281, DOI 10.1007/s10856-009-3697-1
   Teng SH, 2008, J MATER SCI-MATER M, V19, P2453, DOI 10.1007/s10856-008-3370-0
   [张其冀 Zhang Qiyi], 2002, [四川大学学报. 自然科学版, Journal of Sichuan University], V39, P1085
NR 15
TC 0
Z9 1
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-123-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 239-242
BP 1049
EP 1057
DI 10.4028/www.scientific.net/AMR.239-242.1049
PN 1-4
PG 9
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BAI75
UT WOS:000304284000224
DA 2018-10-20
ER

PT S
AU Zou, JP
AF Zou, Jianpeng
BE Cao, Z
   Cao, XQ
   Sun, L
   He, YH
TI Investigation of physico-chemical properties and microstructure of
   HA/316L asymmetrical functionally gradient biomaterial
SO ADVANCED MATERIALS, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical Engineering and Advanced Materials
CY MAY 28-30, 2011
CL Changsha, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, James Cook Univ, Hunan Univ, S Central Univ China, Hunan Normal Univ, Xiangtan Univ
DE hot pressing; physico-chemical properties; microstructure; asymmetrical;
   functionally gradient material (FGM)
ID GRADED DENTAL IMPLANT; DESIGN OPTIMIZATION; FABRICATION
AB By using of hot pressing(HP) technique, HA/316L powder asymmetrical functionally gradient biomaterial (FGM) with 316L's content changing as 100vol%-> 80vol%-> 60vol%-> 40vol%-> 20vol%-> 0vol% was prepared successfully. The results show obvious macroscopic gradient changes in the FGM. While the components change continuously in microcosmic, the interfaces among all gradient layers integrate tightly. The addition of 316L powder changes the fracture modes of the composites and improves their mechanical properties. HA contents in HA/316L biological FGM change regularly with different gradient layer, which is responding to the components design. Combining circumstance of phase interface is considerably well and both phase bite into each other at the interface. The two phases of HA and 316L powder dissolve into each other in some degree during hot pressing and the combining mechanism is dissolving behavior.
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Zou, JP (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM zoujp@mail.csu.edu.cn
CR Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Galusek D, 2007, J EUR CERAM SOC, V27, P2385, DOI 10.1016/j.jeurceramsoc.2006.09.007
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Hong LY, 2007, COMPOS SCI TECHNOL, V67, P1195, DOI 10.1016/j.compscitech.2006.05.025
   Hsu YH, 2008, KEY ENG MAT, V361-363, P123, DOI 10.4028/www.scientific.net/KEM.361-363.123
   Jia CL, 2006, ACTA MATER, V54, P2383, DOI 10.1016/j.actamat.2006.01.011
   Khor K.A., 1998, SURF ENG, V14, P159
   Lee CS, 2010, J EUR CERAM SOC, V30, P1743, DOI 10.1016/j.jeurceramsoc.2010.01.012
   Lin D, 2009, COMPOS PART B-ENG, V40, P668, DOI 10.1016/j.compositesb.2009.04.015
   Mohanty RM, 2008, MAT SCI ENG A-STRUCT, V498, P42, DOI 10.1016/j.msea.2007.11.154
   Shen HS, 2009, COMPOS STRUCT, V91, P375, DOI 10.1016/j.compstruct.2009.06.005
   Shodja HM, 2006, SURF COAT TECH, V200, P4050, DOI 10.1016/j.surfcoat.2004.11.005
   Zou J.P., 2005, CHINESE J MAT RES, V19, P261
   Zou JP, 2008, SCI CHINA SER E, V51, P957, DOI 10.1007/s11431-008-0078-9
   [邹俭鹏 ZOU Jianpeng], 2009, [复合材料学报, Acta Materiae Compositae Sinica], V26, P137
NR 15
TC 1
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-123-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 239-242
BP 1062
EP 1067
DI 10.4028/www.scientific.net/AMR.239-242.1062
PN 1-4
PG 6
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BAI75
UT WOS:000304284000226
DA 2018-10-20
ER

PT S
AU Zhao, J
   Yu, ZM
   Yu, K
   Chen, LJ
AF Zhao, Jun
   Yu, Zhiming
   Yu, Kun
   Chen, Liangjian
BE Cao, Z
   Cao, XQ
   Sun, L
   He, YH
TI Biodegradable Behaviors of Mg-6%Zn-5%Hydroxyapatite Biomaterial
SO ADVANCED MATERIALS, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical Engineering and Advanced Materials
CY MAY 28-30, 2011
CL Changsha, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, James Cook Univ, Hunan Univ, S Central Univ China, Hunan Normal Univ, Xiangtan Univ
DE Mg-Zn-Hydroxyapatite Biomaterial; Biodegradable behaviors; Composites
ID MAGNESIUM ALLOYS; IN-VITRO; BONE
AB The Mg-6%Zn-5%Hydroxyapatite (HA) biomaterial had been prepared through powder metallurgy method in this investigation. The mechanical properties and biodegradable behaviors of the Mg-Zn-HA composite in simulated body fluid were studied. The Mg-Zn-HA specimens obtained appropriate density, adjustable elastic modulus and compatible strength to natural bones. Immersion corrosion experiments revealed that 5wt% addition of HA in Mg-6%Zn alloy exhibited acceptable corrosion rates in simulated body fluid. The Mg matrix, Mg7Zn3 phase and HA are identified in the experimental composite. The Mg(OH)(2) and Hydroxyapatite were found on the corrosion products in the simulated body fluid.
C1 [Zhao, Jun; Yu, Zhiming; Yu, Kun] Cent S Univ, Sch Mat Sci & Engn, Changsha 410083, Hunan, Peoples R China.
   [Chen, Liangjian] Xiangya Hosp 3, Changsha 410083, Hunan, Peoples R China.
   [Yu, Kun; Chen, Liangjian] State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Zhao, J (reprint author), Cent S Univ, Sch Mat Sci & Engn, Changsha 410083, Hunan, Peoples R China.
EM junzhao2000@163.com; csuyzm@yahoo.com.cn; yukungroup@gmail.com;
   chen0313@xy3yy.com
CR Engin NO, 2000, J AM CERAM SOC, V83, P1581
   Fulmer MT, 2002, BIOMATERIALS, V23, P751, DOI 10.1016/S0142-9612(01)00180-6
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Muller D.W., 2007, MAT RES, V10, P1, DOI DOI 10.1590/S1516-14392007000100002
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 14
TC 3
Z9 3
U1 2
U2 15
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-123-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 239-242
BP 1287
EP +
DI 10.4028/www.scientific.net/AMR.239-242.1287
PN 1-4
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BAI75
UT WOS:000304284000273
DA 2018-10-20
ER

PT J
AU Radetzki, F
   Wohlrab, D
   Zeh, A
   Delank, KS
   Mendel, T
   Berger, G
   Syrowatka, F
   Mayr, O
   Bernstein, A
AF Radetzki, F.
   Wohlrab, D.
   Zeh, A.
   Delank, K. S.
   Mendel, T.
   Berger, G.
   Syrowatka, F.
   Mayr, O.
   Bernstein, A.
TI Cellular compatibility of highly degradable bioactive ceramics for
   coating of metal implants
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Calcium phosphate(s); biocompatility; MTT assay; environmental scanning
   electron microscopy; confocal laser scanning microscopy
ID CALCIUM-PHOSPHATE CERAMICS; IN-VITRO; TRICALCIUM-PHOSPHATE; BONE
   REGENERATION; HUMAN OSTEOBLASTS; TRABECULAR BONE; HYDROXYAPATITE;
   BIOMATERIALS; EXPRESSION; BIOCERAMICS
AB Resorbable ceramics can promote the bony integration of implants. Their rate of degradation should ideally be synchronized with bone regeneration.
   This study examined the effect of rapidly resorbable calcium phosphate ceramics 602020, GB14, 305020 on adherence, proliferation and morphology of human bone-derived cells (HBDC) in comparison to beta-TCP. The in vitro cytotoxicity was determined by the microculture tetrazolium (MTT) assay. HBDC were grown on the materials for 3, 7, 11, 15 and 19 days and counted. Cell morphology, cell attachment, cell spreading and the cytoskeletal organization of HBDC cultivated on the substrates were investigated using laser scanning microscopy and environmental scanning electron microscopy.
   All substrates supported sufficient cellular growth for 19 days and showed no cytotoxicity. On each material an identical cell colonisation of well communicating, polygonal, vital cells with strong focal contacts was verified. HBDC showed numerous well defined stress fibres which give proof of well spread and strongly anchored cells. Porous surfaces encouraged the attachment and spreading of HBDC. Further investigations regarding long term biomaterial/cell interactions in vitro and in vivo are required to confirm the utility of the new biomaterials.
C1 [Radetzki, F.; Wohlrab, D.; Zeh, A.; Delank, K. S.] Univ Halle Wittenberg, Dept Orthoped Surg, D-06112 Halle, Saale, Germany.
   [Mendel, T.] Employers Liabil Insurance Assoc Hosp Bergmannstr, Dept Trauma Surg, Halle, Saale, Germany.
   [Mendel, T.] Univ Jena, Dept Trauma Surg, Jena, Germany.
   [Berger, G.] Fed Inst Mat Res & Testing, Berlin, Germany.
   [Syrowatka, F.] Univ Halle Wittenberg, IZM, D-06112 Halle, Saale, Germany.
   [Mayr, O.; Bernstein, A.] Univ Freiburg, Dept Orthoped & Trauma Surg, D-79106 Freiburg, Germany.
RP Radetzki, F (reprint author), Univ Halle Wittenberg, Dept Orthoped Surg, Magdeburger Str 22, D-06112 Halle, Saale, Germany.
EM florian.radetzki@medizin.uni-halle.de
CR Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Anselme K, 2004, BIO-MED MATER ENG, V14, P545
   Barrere F, 2006, INT J NANOMED, V1, P317
   Behrens P, 2000, ORTHOPADE, V29, P129
   BERGER G, 1995, BIOMATERIALS, V16, P1241, DOI 10.1016/0142-9612(95)98131-W
   Berger G., 2005, Bundesrepublik Deutschland Patentschrift, Patent No. [DE 102 49 627 B4, 10249627]
   Berger G, 1995, BIOCERAMICS, P453
   Bernstein A, 2008, J BIOMED MATER RES B, V84B, P452, DOI 10.1002/jbm.b.30891
   BERSTEIN A, 1992, BIOMATERIALS, V13, P98, DOI 10.1016/0142-9612(92)90002-6
   Byers H.R., 1984, Cell and Muscle Motility, V5, P83
   Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   GREGOIRE M, 1987, BIOL CELL, V59, P255, DOI 10.1111/j.1768-322X.1987.tb00538.x
   HARMAND MF, 1990, ADV BIOMAT, V9, P19
   HEIMANN RB, 2004, Z TU CLAUSTHALZELLER, V15, P44
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hing KA, 1998, P I MECH ENG H, V212, P437, DOI 10.1243/0954411981534204
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius AA, 2001, J BIOMED MATER RES, V55, P285, DOI 10.1002/1097-4636(20010605)55:3<285::AID-JBM1016>3.3.CO;2-T
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]
   Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059
   Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8
   Langstaff S, 1999, BIOMATERIALS, V20, P1727, DOI 10.1016/S0142-9612(99)00086-1
   Lind M, 1999, BIOMATERIALS, V20, P803, DOI 10.1016/S0142-9612(98)00216-6
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   Mayer U., 1993, CELLS MAT, V3, P129
   Murphy S, 2010, J MATER SCI-MATER M, V21, P2827, DOI 10.1007/s10856-010-4139-9
   NAJI A, 1990, J BIOMED MATER RES, V24, P861, DOI 10.1002/jbm.820240706
   Navrotsky A, 2004, P NATL ACAD SCI USA, V101, P12096, DOI 10.1073/pnas.0404778101
   Overgaard S, 1997, J BONE JOINT SURG BR, V79B, P654, DOI 10.1302/0301-620X.79B4.7670
   Picker H., 1993, Z ZAHNARZTL IMPLANTO, VIX, P111
   PIZZOFERRATO A, 1985, BIOMATERIALS, V6, P346
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   PULEO DA, 1992, J BIOMED MATER RES, V26, P291, DOI 10.1002/jbm.820260303
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Sato M., 2007, CELLULAR MOL BIOMECH
   Schenk R.K., 1986, MAT SCI MONOGRAPHS, V33, P121
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   SCHNEIDER M, 1994, CRYST RES TECHNOL, V29, P671, DOI 10.1002/crat.2170290516
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035
   WATANABE H, 1993, ACTA ANAT, V147, P14
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 53
TC 1
Z9 1
U1 1
U2 8
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2011
VL 21
IS 5-6
BP 307
EP 321
DI 10.3233/BME-2012-0678
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 937PA
UT WOS:000303669200004
PM 22561250
DA 2018-10-20
ER

PT S
AU Chen, B
   Luo, J
   Yuan, Q
   Fan, JH
AF Chen, Bin
   Luo, Ji
   Yuan, Quan
   Fan, Jinghong
BE Zeng, D
TI Microstructure and Toughness Mechanism of Tooth
SO MATERIALS, MECHATRONICS AND AUTOMATION, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Materials, Mechatronics and Automation
   (ICMMA 2011)
CY JAN 15-16, 2011
CL Melbourne, AUSTRALIA
SP Natl Univ Singapore, Int Sci & Engn Ctr
DE Tooth; hydroxyapatite sheet; microstructure; pullout energy
ID DENTIN
AB Tooth is a kind of biomaterial in nature. It behaves favorable strength, stiffness and fracture toughness, which are closely related to its fine microstructure. The observation of scanning electron microscope (SEM) on a mature tooth shows that the tooth is a kind of natural bioceramic composite consisting of hydroxyapatite layers and collagen protein matrix. The observation also shows that the hydroxyapatite layers consist of long and thin hydroxyapatite sheets and that all the hydroxyapatite sheets are arranged in a kind of parallel distribution. The maximum pullout energy of the hydroxyapatite sheets, which is closely related to the fracture toughness of the tooth, is investigated based on the representative model of the parallel distribution. It shows that the long and thin shape as well as the parallel distribution of the hydroxyapatite sheets increase the maximum pullout energy and enhance the fracture toughness of the tooth.
C1 [Chen, Bin; Luo, Ji; Yuan, Quan] Chongqing Univ, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
   [Chen, Bin] Chongqing Univ, Minist Educ, Key Lab Exploitat Southwest Resources & Environm, Chongqing 40044, Peoples R China.
   [Fan, Jinghong] Alfred Univ, Div Mech Engn, Alfred, NY 14802 USA.
RP Chen, B (reprint author), Chongqing Univ, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn
FU Natural Science Foundations of China [10872221, 50621403]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant no. 10872221 and
   50621403).
CR CHONG KP, 1999, MECH AAM, V28, P1
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   Koester KJ, 2008, BIOMATERIALS, V29, P1318, DOI 10.1016/j.biomaterials.2007.12.008
   Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6
   SARIKAYA M, 1989, P AM COMP, P176
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 467-469
BP 567
EP +
DI 10.4028/www.scientific.net/KEM.467-469.567
PG 2
WC Automation & Control Systems; Engineering, Manufacturing; Materials
   Science, Multidisciplinary
SC Automation & Control Systems; Engineering; Materials Science
GA BZY38
UT WOS:000303364700107
DA 2018-10-20
ER

PT S
AU Chen, JJ
   Men, JY
AF Chen, Jianjun
   Men, Jiying
BE Kim, YH
   Yarlagadda, P
   Zhang, XD
   Ai, ZJ
TI Chemical Preparation and Characterizationof Polypyrrole-Polylactic Acid
   Conductive Composite Membranes
SO ADVANCED MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials and Products Manufacturing
   Technology (ICMPMT 2011)
CY OCT 28-30, 2011
CL Chengdu, PEOPLES R CHINA
SP Minist Educ, Key Lab Oil & Nat Gas Equipment, SW Petroleum Univ, Korea Maritime Univ, Queensland Univ Technol
DE Polypyrrole; Polylactic Acid; Electrical stability
AB Conductive polypyrrole(PPy)-polylactic Acid(PLA) composite membranes are prepared with chemical method. Membranes have been characterized by Fouier transform infrared spectroscopic(FT-IR) and scanning electron microscopy (SEM).The conductive stability of membranes has been measured by home-made multiwell direct current electrical stimulating system. The results show PPy nanparticals network embeds in PLA matrix and the conductive stability of membranes sustains in the range of 28 mu A similar to 35 mu A between the observation time of 560h to 1146h. The scaffold is vital one of three important factors in tissue engineering, which includes scaffold, cells and suitable biochemical factors. The scaffold provides a framework and initial support for the cells to attach, proliferate and differentiate, and form an extracellular matrix (ECM) ([1]). Bioelectricity presents in the human body and plays an integral role in maintaining normal biological functions in signaling in the nervous system,would healing, and skeletal muscle ,ect([2]). Electrical stimulation is highly significant in tissue engineering because it can regulate cell activities such as cell adhesion ([3]), cell migration ([4]),cell proliferation ([5]) and cell division([6]). An ideal electrically conductive materials therefore should be able to prepare to regulate in vitro or in vivo cells growth. Polypyrrole (PPy) is a synthetic easily conductive polymer and has frequently research interests because of its biocompatible([7]), long-term environment stability, good electrochemical properties, thermal stability ([8-9]) and high electrical conductivity in iodine-doped oxidize([10]). However, the principal problems with the practical utilization of polypyrrole are its poor mechanical properties like brittleness, insoluble and low processibility([11]). In order to optimize the advantages of PPy's electrical conductivity for biomedical, and particularly tissue engineering applications, it then becomes apparent that it must be transformed into a mechanically manageable and processable form.Blending polymers which is insulating and good mechanical properties is an attractive route. Polylactic acid (PLA) is at present one of the most promising biodegradable and biocompatible polymers.We hope to prepare biomaterial combining electrically conductive, biocompatible, largely biodegradable and easily processable.
   In this paper, the authors wish to report on the chemical preparation and characterizations of the composite films of PPy-PLA conducting polymer with a very low PPy content.
C1 [Chen, Jianjun] North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China.
   [Chen, Jianjun] North Univ China, Key Lab Instrumentat Sci & Dynam Measurement, Minist Educ, Taiyuan 030051, Peoples R China.
   [Men, Jiying] North Univ China, Chem Ind & Ecol Inst, Taiyuan 030051, Peoples R China.
RP Chen, JJ (reprint author), North Univ China, Natl Key Lab Elect Measurement Technol, Taiyuan 030051, Peoples R China.
EM cjj@nuc.edu.cn; menjiying@yahoo.com.cn
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCNEILL R, 1963, AUST J CHEM, V16, P1056, DOI 10.1071/CH9631056
   Migahed MD, 2004, POLYM TEST, V23, P361, DOI 10.1016/S0142-9418(03)00101-6
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Ugarte G, 2010, MATRIX BIOL, V29, P383, DOI 10.1016/j.matbio.2010.03.003
   Vishnuvardhan TK, 2006, B MATER SCI, V29, P77, DOI 10.1007/BF02709360
   Wang ET, 2003, FASEB J, V17, P458, DOI 10.1096/fj.02-0510fje
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Zhang LL, 2011, SYNTHETIC MET, V161, P724, DOI 10.1016/j.synthmet.2011.01.021
   Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942
   Zhao Min, 2009, SEMINARS CELL DEV BI, V20, P674
NR 12
TC 0
Z9 0
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-246-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 335-336
BP 187
EP +
DI 10.4028/www.scientific.net/AMR.335-336.187
PN 1-2
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BZZ73
UT WOS:000303423600038
DA 2018-10-20
ER

PT S
AU Zhang, WM
   Zhang, YC
   Zhao, DF
AF Zhang, Wenming
   Zhang, Yucang
   Zhao, Defeng
BE Cao, Z
   He, YH
   Sun, L
   Cao, XQ
TI Synthesis and characterization of liquefied corn barn-based epoxy resins
SO APPLICATION OF CHEMICAL ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical Engineering and Advanced Materials
CY MAY 28-30, 2011
CL Changsha, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, James Cook Univ, Hunan Univ, S Central Univ China, Hunan Normal Univ, Xiangtan Univ
DE liquefaction; corn barn; epoxy resins; biomaterial
AB The liquefied corn barn-based epoxy resin (LCBER) was synthesised through the glycidyl etherification reaction from liquefied corn barn (LCB) had having groups of bound phenol and epichlorohydrine under alkali conditions. The average molecular weights of LCBER in various reaction conditions were examined. The extreme high molecular weight portion of LCBER-30 was obtained using LCB at 30 min as raw materials. The epoxy functionality of LCBER was controlled by the amount of bound phenol in LCB. LCBER was cured with polyamide-650 (PA-650) and the thermal and mechanical properties were evaluated. Comparing to the petroleum-based bisphenol-A type epoxy resin (DGEBA), LCBER presented higher adhesive shear strength and good thermal stability. These suggested that LCBER would be more suitable to glue biomass materials.
C1 [Zhang, Wenming; Zhao, Defeng] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116012, Peoples R China.
   [Zhang, Wenming; Zhang, Yucang] Dalian Polytech Uinv, Inst Resources Recycling, Dalian 116034, Peoples R China.
RP Zhang, WM (reprint author), Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116012, Peoples R China.
EM zycdlcn@yahoo.com.cn
FU National Natural Science Foundation of China [30950008]; Ministry of
   Education of China [208030]
FX Thanks to the financially sponsor by National Natural Science Foundation
   of China (Project No. 30950008) and Ministry of Education of China
   (Project No. 208030).
CR FIERZDAVID HE, 1925, CHEM IND REV, V44, P942
   Kishi H, 2006, J APPL POLYM SCI, V102, P2285, DOI 10.1002/app.24433
   Kurimoto Y, 2001, BIORESOURCE TECHNOL, V77, P33, DOI 10.1016/S0960-8524(00)00136-X
   Ono H, 1996, J ADHESION, V59, P135, DOI 10.1080/00218469608011083
   Tymchyshyn M, 2010, BIORESOURCE TECHNOL, V101, P2483, DOI 10.1016/j.biortech.2009.11.091
   Yan YB, 2010, IND CROP PROD, V32, P349, DOI 10.1016/j.indcrop.2010.05.015
   Zhang YC, 2006, BIORESOURCE TECHNOL, V97, P313, DOI 10.1016/j.biortech.2005.02.019
NR 7
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-121-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 236-238
BP 116
EP +
DI 10.4028/www.scientific.net/AMR.236-238.116
PN 1-3
PG 2
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BZT82
UT WOS:000302924100023
DA 2018-10-20
ER

PT S
AU Chen, C
   Li, J
AF Chen, Cheng
   Li, Jian
BE Du, ZY
   Wang, Z
TI Preparation of Lignocellulose Aerogel from Wood-ionic liquid Solution
SO GREEN BUILDING MATERIALS AND ENERGY-SAVING CONSTRUCTION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference of Green Building Materials and Energy-saving
   Construction (GBMEC 2011)
CY AUG 06, 2011
CL Harbin, PEOPLES R CHINA
SP Informat Technol & Ind Engn Res Ctr, Harbin Inst Technol
DE ionic liquids; aerogel; wood powder; network structure; supercritical
   drying; FTIR
ID DISSOLUTION
AB This paper reports a new method to prepare a new lignocellulose aerogel that is made from two kinds of wood powder through dissolution/regeneration of cellulose in ionic liquids. The obtained gel was washed with ethanol, liquid carbon dioxide and finally dried by releasing the carbon dioxide from the net structure at supercritical temperature to obtain the aerogel wood. All aerogels were compressible and consisted of nanofibrillar biomaterial network with open-pore structure. The range of density meets a criterion with aerogel density. Infrared spectrum shows that the pre-and post-treatment characteristic absorption peak of wood powder remained unchanged, and the ionic liquid played a mesomeric role among the physical reaction.
C1 [Chen, Cheng; Li, Jian] NE Forestry Univ, Minist Educ, Key Lab Biobased Mat Sci & Technol, Harbin 150040, Peoples R China.
RP Chen, C (reprint author), NE Forestry Univ, Minist Educ, Key Lab Biobased Mat Sci & Technol, Harbin 150040, Peoples R China.
EM cc523@126.com; nefulijian@163.com
CR Aaltonen O, 2009, CARBOHYD POLYM, V75, P125, DOI 10.1016/j.carbpol.2008.07.008
   ARGYROPOULOS DS, 2008, Patent No. 2008098037
   Chen C, 2010, ADV MATER RES-SWITZ, V113-116, P407, DOI 10.4028/www.scientific.net/AMR.113-116.407
   Devi R. R., 2011, WOOD SCI TECHNOL
   Fasching M, 2008, HOLZFORSCHUNG, V62, P15, DOI 10.1515/HF.2008.003
   Innerlohinger J, 2006, MACROMOL SYMP, V244, P126, DOI 10.1002/masy.200651212
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Li Jian, 2008, J NE FORESTRY U, V36, P1
   Lucas M, 2010, ACS APPL MATER INTER, V2, P2198, DOI 10.1021/am100371q
   Michele LA, 2002, NANO LETT, V2, P235
   Qiu Jian, 2008, J NE FORESTRY U, V36, P74
   Sun N, 2009, GREEN CHEM, V11, P646, DOI 10.1039/b822702k
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
NR 13
TC 2
Z9 3
U1 1
U2 21
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-189-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 280
BP 191
EP 195
DI 10.4028/www.scientific.net/AMR.280.191
PG 5
WC Construction & Building Technology; Engineering, Civil
SC Construction & Building Technology; Engineering
GA BAA31
UT WOS:000303485900042
DA 2018-10-20
ER

PT S
AU Tank, KP
   Vasant, SR
   Chudasama, KS
   Thaker, VS
   Joshi, MJ
AF Tank, Kashmira P.
   Vasant, Sonal R.
   Chudasama, Kiran S.
   Thaker, Vrinda S.
   Joshi, Mihir J.
BE Garg, AB
   Mittal, R
   Mukhopadhyay, R
TI Pure and Strontium Doped Nano Hydroxyapatite: New Approach for Bone
   Implant and Drug Delivery System
SO SOLID STATE PHYSICS: PROCEEDINGS OF THE 55TH DAE SOLID STATE PHYSICS
   SYMPOSIUM 2010, PTS A AND B
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 55th Symposium on DAE Solid State Physics (SSPS)
CY DEC 26-30, 2010
CL Manipal Univ, Manipal, INDIA
SP Govt India, Dept Atom Energy (DAE), Board Res Nucl Sci (BRNS)
HO Manipal Univ
DE Biomaterial; Hydroxyapatite; XRD; TEM; Hemolytic properties
AB Hydroxyapatite, (Ca-10(PO4)(6)(OH)(2) - Hap), an excellent inorganic biomaterial, find various applications. The chemical composition of Hap is similar to that of the inorganic matrix of human bone and dental enamel. It is also used in drug delivery system and coating of bone implant. In the present study, pure nano Hap and Strontium doped nano-Hap (Sr-Hap) with different concentrations were synthesized by surfactant mediated approach. The samples were characterized by EDAX, XRD and TEM. The hemolytic properties were also studied and it proved that all the samples were non-hemolytic.
C1 [Tank, Kashmira P.; Vasant, Sonal R.; Joshi, Mihir J.] Saurashtra Univ, Dept Phys, Crystal Growth Lab, Rajkot 360005, Gujarat, India.
   [Chudasama, Kiran S.; Thaker, Vrinda S.] Saurashtra Univ, BioSci Dept, Rajkot 360005, Gujarat, India.
RP Tank, KP (reprint author), Saurashtra Univ, Dept Phys, Crystal Growth Lab, Rajkot 360005, Gujarat, India.
EM kashmira_physics@yahoo.co.in
CR Dutta T, 2007, J DRUG TARGET, V15, P89, DOI 10.1080/10611860600965914
   FERRARO EF, 1983, CALCIFIED TISSUE INT, V35, P258, DOI 10.1007/BF02405040
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Tank K. P., 2009, P 54 DAE SOL STAT PH, P335
NR 5
TC 0
Z9 0
U1 1
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0905-7
J9 AIP CONF PROC
PY 2011
VL 1349
BP 385
EP +
DI 10.1063/1.3605896
PG 2
WC Physics, Condensed Matter
SC Physics
GA BZT87
UT WOS:000302939900174
DA 2018-10-20
ER

PT S
AU Li, YP
   Gu, B
   Pi, XF
   Gong, YC
   Xiong, XY
   Wu, GJ
   Li, ZL
AF Li, Yuping
   Gu, Bing
   Pi, Xiaofang
   Gong, Yanchun
   Xiong, Xiangyuan
   Wu, Guangjie
   Li, Ziling
BE Bu, JL
   Wang, PC
   Ai, L
   Sang, XM
   Li, YG
TI Enhanced the insulin secretion of HIT-T15 cells by hyaluronic
   acid-coating involves cytosolic free [Ca2+](i) response
SO APPLICATIONS OF ENGINEERING MATERIALS, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Engineering Materials and
   Technology (AEMT2011)
CT International Conference on Civil Engineering and Building Materials
   (CEBM 2011)
CY JUL 29-31, 2011
CY JUL 29-31, 2011
CL Sanya, PEOPLES R CHINA
CL Kunming, PEOPLES R CHINA
SP Hebei United Univ, Inner Mongolia Univ Technol, Korea Maritime Univ
SP Kunming Univ Sci & Technol, Int Assoc Sci & High Technol
DE Hyaluronic acid; Bioartificial pancreas; Insulin; HIT-T15 cells;
   Calciumion
ID PANCREATIC BETA-CELLS; ISLETS
AB Hyaluronic acid (HA) is an extremely ubiquitous polysaccharide of extracellular matrix in body and plays various biological roles. In this study, cell viability, insulin secretion and cytosolic free Ca2+ concentration were investigated in HIT-T15 cells after HA-treatment. The cell viability was determined by the MTT assay while the insulin secretion was detected by ELISA technique. The Flou-3/AM was applied to probe intracellular free calcium concentration. HA (0.25, 0.5, 1.0 mg/dish) increase insulin secretion in the 3 or 25 mM glucose-stimulation for 4 h. Cytosolic Ca2+ fluorescent intensity in HA-treatment groups (0.25, 0.5, 1.0 mg/dish) is significantly higher than that in control group. This study implied that the increasing of insulin secretion of HIT-T15 cells by HA-coating result from the enhancement of cytosolic Ca2+. And these data also provide some information on design biocompatibility when HA used as a biomaterial for bioartificial pancreas.
C1 [Li, Yuping; Gu, Bing; Pi, Xiaofang; Gong, Yanchun; Xiong, Xiangyuan; Wu, Guangjie; Li, Ziling] Jiangxi Sci & Technol Normal Univ, Sch Life Sci, Nanchang 330013, Peoples R China.
RP Li, YP (reprint author), Jiangxi Sci & Technol Normal Univ, Sch Life Sci, Nanchang 330013, Peoples R China.
EM liyp20012000@yahoo.com.cn; bguemory@hotmail.com; pixiaofang0810@163.com;
   spoilming@163.com; xyxiong@gmail.com; wgjqil@yahoo.com.cn;
   lzlowen2010@gmail.com
CR Acharya JD, 2010, ISLETS, V2, P225, DOI 10.4161/isl.2.4.12219
   ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007
   Barton W., 2003, J BIOL CHEM, V278, P42080
   Bloomgarden ZT, 2004, DIABETES CARE, V27, P1506, DOI 10.2337/diacare.27.6.1506
   Chen B, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P233
   Cherr GN, 1999, ZYGOTE, V7, P211, DOI 10.1017/S0967199499000593
   David L.C., 1987, CALCIFIED TISSUE INT, V41, P79
   Dufer M, 2009, PFLUG ARCH EUR J PHY, V457, P1351, DOI 10.1007/s00424-008-0592-4
   Ilkka T.H., 2006, ARCH DERMATOL RES, V298, P207
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Li YP, 2006, BIOMATERIALS, V27, P1437, DOI [10.1016/j.biomaterials.2005.08.020, 10.1016/j.materials.2005.08.020]
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772
   Ricordi Camillo, 2004, Nat Rev Immunol, V4, P259, DOI 10.1038/nri1332
   Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025
   Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001
NR 17
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-192-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 287-290
BP 1960
EP 1965
DI 10.4028/www.scientific.net/AMR.287-290.1960
PN 1-4
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BZT44
UT WOS:000302894001075
DA 2018-10-20
ER

PT S
AU Wu, WT
   Liu, WS
AF Wu, Wen-Tung
   Liu, Wen-Sheng
BE Bu, JL
   Wang, PC
   Ai, L
   Sang, XM
   Li, YG
TI Anti-inflammatory property of biomaterial carotenoids production by
   Rhodobacter sphaeroides WL-APD911
SO APPLICATIONS OF ENGINEERING MATERIALS, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Engineering Materials and
   Technology (AEMT2011)
CT International Conference on Civil Engineering and Building Materials
   (CEBM)
CY JUL 29-31, 2011
CY JUL 29-31, 2011
CL Sanya, PEOPLES R CHINA
CL Kunming, PEOPLES R CHINA
SP Hebei United Univ, Inner Mongolia Univ Technol, Korea Maritime Univ
SP Kunming Univ Sci & Technol, Int Assoc Sci & High Technol
DE Rhodobacter sphaeroides WL-APD911; neurosporene; carotenoid;
   anti-inflammation
AB A Rhodobacter sphaeroides WL-APD911 with the capability of producing the end products of neurosporene and xi-carotene, rather than the normal end products of spheroidene, was isolated from hundreds of strains by using chemical mutagenesis. The strain WL-APD911 grew well in LB medium, and the colored carotenoids were produced within 3 days of incubation at 30 C. The Rs-M of colored carotenoid extracts obtained from strain WL-APD911 by using methanol extraction inhibited the NO production and iNOS expression by LPS-induced RAW 264.7 cells. This probability of reason for the Rs-M as the best source was to prompt the anti-inflammation and anti-oxidation in nutraceutical products. Finally, the carotenoid extracts (Rs-M) with neurosporene and xi-carotene was called lycogene to be a newly biomaterial.
C1 [Wu, Wen-Tung] Yung Ta Inst Technol & Commerce, Dept Biotechnol, Pingtung, Taiwan.
   [Liu, Wen-Sheng] Asia Pacific Biotech Dev Inc, Kaohsiung, Taiwan.
RP Wu, WT (reprint author), Yung Ta Inst Technol & Commerce, Dept Biotechnol, Pingtung, Taiwan.
EM gerrywu8769@yahoo.com.twl; tyw0718@gmail.com
FU Ministry of Education, Taipei; Asia-Pacific Biotech Developing, Inc. in
   Kaohsiung, Taiwan [98B-31-053]
FX This work was supported by the Ministry of Education, Taipei, and the
   Asia-Pacific Biotech Developing, Inc. in Kaohsiung, Taiwan (98B-31-053).
CR CLAYTON RK, 1960, BIOCHEM BIOPH RES CO, V3, P143, DOI 10.1016/0006-291X(60)90210-2
   Garcia-Asua G, 2002, MOL MICROBIOL, V44, P233, DOI 10.1046/j.1365-2958.2002.02871.x
   Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x
   Ouchane S, 1997, J BIOL CHEM, V272, P1670, DOI 10.1074/jbc.272.3.1670
   Rafi MM, 2007, J FOOD SCI, V72, pS69, DOI 10.1111/j.1750-3841.2006.00219.x
   Sieiro C, 2003, INT MICROBIOL, V6, P11, DOI 10.1007/s10123-003-0097-0
NR 6
TC 5
Z9 6
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-192-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 287-290
BP 2028
EP +
DI 10.4028/www.scientific.net/AMR.287-290.2028
PN 1-4
PG 3
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BZT44
UT WOS:000302894001087
DA 2018-10-20
ER

PT S
AU Soares, LGP
   Santos, NRS
   Correia, NA
   dos Santos, JN
   Pinheiro, ALB
AF Pinheiro Soares, Luiz Guilherme
   Silva Santos, Nicole Ribeiro
   Correia, Neandder A.
   dos Santos, Jean Nunes
   Barbosa Pinheiro, Antonio Luiz
BE Longo, L
TI Effects of LED Phototherapy on Bone Defects Grafted with MTA in a Rodent
   Model: A Description of the Bone Repair by Light Microscopy
SO ADVANCES IN LASEROLOGY - SELECTED PAPERS OF LASER FLORENCE 2010: THE
   50TH BIRTHDAY OF LASER MEDICINE WORLD
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT Annual Congress of the International-Academy-Laser-Medicine-and-Surgery
   (Laser Florence)
CY NOV 05-06, 2010
CL Florence, ITALY
SP Int Acad Laser Med & Surg (IALMS), Int Soc Laser Surg & Med (ISLSM), World Federat Laser Surg & Med Soc (WFLSMS), Int Photo Therapy Assoc (IPTA), Inst Laser Med (ILM), World Federat Laser Dent (WFLD), Soc Italiana Laser Odontostomatologia (SILO), New European Surg Acad (NESA), Amer Inst Phys (AIP)
DE Biomaterial; Light Emitting Diode; Mineral trioxide aggregate
ID MINERAL TRIOXIDE AGGREGATE; END FILLING MATERIALS; INFRARED-LASER LIGHT;
   MORPHOGENETIC PROTEINS; IN-VIVO; RAMAN-SPECTROSCOPY; DENTAL IMPLANTS;
   TISSUE REACTION; BOVINE BONE; GUINEA-PIGS
AB We carried out a histological analysis on bone defects grafted (MTA) treated or not with LED, BMPs and GBR. Benefits of the isolated or combined use these techniques on bone repair have been suggested, but there is no report on their association with LED light. 36 rats were divided into 4 groups each subdivided into 3. Defects on G II and I were filled with the blood clot. G II was further irradiated with LED. G III-IV were filled with MTA + Collagen gel; G IV was further irradiated. LED was applied over the defect at 48 h intervals and repeated for 15 days. Specimens were processed, cut and stained with H&E and Sirius red and underwent histological analysis. The results showed that MTA, due to its characteristics seemed not being directly affected by the LED light. But, the use of LED positively affect bone repair similarly to what was observed on different studies by our team using other biomaterials and laser. It is concluded that MTA seems not be directed affected by the LED light due to it characteristics. However, the beneficial results reported with its usage might be improved by the use of LED PT.
C1 [Pinheiro Soares, Luiz Guilherme; Silva Santos, Nicole Ribeiro; Correia, Neandder A.; Barbosa Pinheiro, Antonio Luiz] Univ Fed Bahia, Sch Dent, Ctr Biophoton, 62 Araujo Pinho Ave, BR-40110150 Salvador, BA, Brazil.
   [Barbosa Pinheiro, Antonio Luiz] Univ Camilo Castelo Branco, Ctr Engn Biomed, BR-12247004 Sao Paulo, Brazil.
   Inst Nacl Ciencia Tecnol Opt Foton, BR-13560970 Sao Paulo, Brazil.
   [dos Santos, Jean Nunes] Univ Fed Bahia, Lab Patologia Cirurg, BR-41170290 Salvador, BA, Brazil.
RP Soares, LGP (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, 62 Araujo Pinho Ave, BR-40110150 Salvador, BA, Brazil.
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003
   BIBIKOVA A, 1995, ANAT REC, V241, P123, DOI 10.1002/ar.1092410116
   Bystrom A., 1995, ENDOD DENT TRAUMATOL, P170
   Economides N, 2003, INT ENDOD J, V36, P44, DOI 10.1046/j.0143-2885.2003.00611.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   Holland R, 1999, J ENDODONT, V25, P728, DOI 10.1016/S0099-2399(99)80118-6
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   Pastori C.M., 1996, REV BRAS CIENC ESTOM, P51
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   Schwartz RS, 1999, J AM DENT ASSOC, V130, P967, DOI 10.14219/jada.archive.1999.0337
   Segundo T., 2000, RGO, V48, P217
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   Torabinejad M, 1998, J ENDODONT, V24, P468, DOI 10.1016/S0099-2399(98)80048-4
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
   Zhu Q, 2000, J ENDODONT, V26, P404, DOI 10.1097/00004770-200007000-00006
NR 44
TC 0
Z9 0
U1 0
U2 2
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0922-4
J9 AIP CONF PROC
PY 2011
VL 1364
BP 43
EP 50
DI 10.1063/1.3626910
PG 8
WC Physics, Applied
SC Physics
GA BZT54
UT WOS:000302911600005
DA 2018-10-20
ER

PT S
AU Shevchenko, RV
   Sibbons, PD
   Sharpe, JR
   James, SE
AF Shevchenko, R. V.
   Sibbons, P. D.
   Sharpe, J. R.
   James, S. E.
BE Mikhalovsky, S
   Khajibaev, A
TI A Novel Skin Substitute Biomaterial to Treat Full-Thickness Wounds in a
   Burns Emergency Care
SO BIODEFENCE: ADVANCED MATERIALS AND METHODS FOR HEALTH PROTECTION
SE NATO Science for Peace and Security Series A-Chemistry and Biology
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Biodefense - Advanced
   Materials and Methods for Health Protection
CY JUN 01-10, 2009
CL Republican Specialised Sci Ctr Emergency Med, Bukhara, UZBEKISTAN
SP NATO Sci Affairs Comm, Univ Brighton, Republican Sci Ctr Emergency Med, Samarkand Branch Ctr Emergency Med, Arterium Ltd, NATO Adv Study Inst
HO Republican Specialised Sci Ctr Emergency Med
DE Permacol; Integra; Skin substitute; Dermal substitute; Cultured
   keratinocytes; Collagen; Animal model
ID CULTURED EPITHELIAL AUTOGRAFT; ENGINEERED SKIN; KERATINOCYTES; INJURIES;
   CLOSURE
AB A novel porcine collagen-based paste dermal substitute to treat full-thickness wounds has been investigated. A thin split-thickness skin graft or autologous cultured keratinocytes have been combined with dermal replacement biomaterial and applied to full-thickness wounds in a porcine wound chamber preclinical experimental model. The data obtained suggest that: ( I) dermal substitute biomaterials may improve wound re-epithelialisation when combined with cultured autologous keratinocytes and (2) porcine collagen paste is able to support split-thickness skin graft survival as well as autologous cultured keratinocyte proliferation. These results demonstrate that the novel porcine collagen paste has a potential as a dermal substitute to treat acute full-thickness wounds and an application for the burns emergency care treatment.
C1 [Shevchenko, R. V.; James, S. E.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Sharpe, J. R.] Blond McIndoe Res Fdn, Queen Victoria Hosp, E Grinstead, E Sussex RH19 3DZ, England.
   [Sibbons, P. D.] Northwick Pk Inst Med Res, Harrow HA1 3UJ, Middx, England.
RP Shevchenko, RV (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
EM R.V.Shevchenko@brighton.ac.uk
FU Blond McIndoe Research Foundation; Mark Hanna Fellowship
FX We would like to thank the Blond McIndoe Research Foundation and the
   Mark Hanna Fellowship for funding this research; staff at the Blond
   McIndoe Research Foundation, Northwick Park Institute for Medical
   Research and the University of Brighton for their support; Ms. C. Gray
   at NPIMR for technical operative assistance, and Dr P. Sibbons for
   providing the Permacol Injectable material used in this study.
CR Anthony ET, 2006, DRUG DISCOV TODAY TH, V3, P81, DOI DOI 10.1016/J.DDSTR.2006.03.001
   Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002
   Bannasch H, 2005, PANMINERVA MED, V47, P53
   Bar-Meir E, 2006, ISRAEL MED ASSOC J, V8, P188
   Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc
   Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x
   Cubison TCS, 2006, BURNS, V32, P992, DOI 10.1016/j.burns.2006.02.007
   Currie LJ, 2003, BURNS, V29, P677, DOI 10.1016/S0305-4179(03)00155-4
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   Hansen S L, 2001, Adv Skin Wound Care, V14, P37, DOI 10.1097/00129334-200101000-00016
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   KANGESU T, 1993, BRIT J PLAST SURG, V46, P393, DOI 10.1016/0007-1226(93)90045-D
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Micali G, 2001, BIOLOGY OF THE SKIN, P219
   Orgill DP, 1998, PLAST RECONSTR SURG, V102, P423, DOI 10.1097/00006534-199808000-00020
   Papini R, 2004, BRIT MED J, V329, P158, DOI 10.1136/bmj.329.7458.158
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Shevchenko RV, 2008, WOUND REPAIR REGEN, V16, P198, DOI 10.1111/j.1524-475X.2008.00360.x
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Wood FM, 2006, BURNS, V32, P395, DOI 10.1016/j.burns.2006.01.008
   Wood FM, 2006, BURNS, V32, P538, DOI 10.1016/j.burns.2006.02.025
   Woodley DT, 2001, BIOLOGY OF THE SKIN, P133
NR 24
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6489
BN 978-94-007-0216-5
J9 NATO SCI PEACE SEC A
JI NATO Sci. Peace Secur. Ser. A-Chem. Biol.
PY 2011
BP 247
EP +
DI 10.1007/978-94-007-0217-2_25
PG 3
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental;
   Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine;
   Science & Technology - Other Topics
GA BZS67
UT WOS:000302836800025
DA 2018-10-20
ER

PT S
AU Fu, XL
   Tan, MJ
   Jarfors, AEW
   Gupta, M
AF Fu, X. L.
   Tan, M. J.
   Jarfors, A. E. W.
   Gupta, M.
BE Kim, HS
   Yang, JF
   Han, CH
   Thongtem, SC
   Lee, SW
TI Processing and Properties of Amorphous Magnesium-Based Eco-Materials
SO ECO-MATERIALS PROCESSING AND DESIGN XII
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 12th International Symposium on Eco-Materials Processing and Design
CY JAN 08-11, 2011
CL Chiang Mai, THAILAND
SP JSPS, NSFC, NRF, A3 Foresight Program, Thailands Off Higher Educ Commiss, Chiang Mai Univ, Mat Sci Res Ctr, Fac Sci, Chiang Mai Univ, Nanoscience & Nanotechnol Res Ctr, Fac Sci
DE Magnesium; Amorphous; Mechanical properties; Ductility; Eco-materials
ID MECHANICAL-PROPERTIES; METALLIC GLASSES; VOLUME FRACTION; ALLOYS;
   REINFORCEMENT; COMPOSITES
AB Magnesium alloys are the lightest known structural material and have been very attractive for usage in marine and transportation industry (for its weight savings and payload increase), and also for its portability in hand-held devices. It is recyclable and one of the most abundant metal. Lately, it has gained attention for its biocompatibility, and also its biodegradable properties depending on the alloying elements. They can be used as a biomaterial in various applications from heart stents to implant screws and fixtures. In this work, amorphous magnesium alloys have been processed, based on its glass forming ability, by various techniques in order to obtain its amorphous state, and the microstructure are characterized by thermal analysis, X-ray diffraction and electron microscopy. Their mechanical properties are also presented. High temperature tensile tests show similar strength to room temperature strength, while the total failure strain is significantly increased from around 0.5% to 10%.
C1 [Fu, X. L.] Nanyang Technol Univ, Sch Mech & Aerosp Eng, Singapore 639798, Singapore.
   [Jarfors, A. E. W.] Singapore Inst Mfg Technol, Singapore 638075, Singapore.
RP Fu, XL (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Eng, Singapore 639798, Singapore.
EM xlfu@ntu.edu.sg; mmjtan@ntu.edu.sg; andersj@SIMTech.a-star.edu.sg;
   mpegm@nus.edu.sg
RI Tan, Ming-Jen/A-3862-2011
OI Tan, Ming-Jen/0000-0002-3583-1723; Jarfors, Anders/0000-0002-0101-0062
FU Nanyang Technological University; Agency for Science, Technology and
   Research (ASTAR) [092 137 0018]; assistance of Magnequench Singapore Pte
   Ltd
FX Authors wish to acknowledge Nanyang Technological University for funding
   this research through grants and Agency for Science, Technology and
   Research (ASTAR) Grant No. 092 137 0018 and the support and assistance
   of Magnequench Singapore Pte Ltd.
CR Amiya K, 2000, MATER T JIM, V41, P1460, DOI 10.2320/matertrans1989.41.1460
   Fu XL, 2007, J MATER RES, V22, P1564, DOI [10.1557/jmr.2007.0191, 10.1557/JMR.2007.0191]
   Fu XL, 2007, ACTA MATER, V55, P3059, DOI 10.1016/j.actamat.2007.01.009
   Fukai Y., 1993, SPRINGER SERIES MAT
   Gupta M., 2010, MAT SCI ENG A UNPUB
   Hassan SF, 2002, MATER RES BULL, V37, P377, DOI 10.1016/S0025-5408(01)00772-3
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1993, MAT SCI ENG A-STRUCT, V173, P1, DOI 10.1016/0921-5093(93)90175-E
   INOUE A, 1992, MATER T JIM, V33, P937, DOI 10.2320/matertrans1989.33.937
   JOHNSON WL, 1986, PROG MATER SCI, V30, P81, DOI 10.1016/0079-6425(86)90005-8
   Ma H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2126794
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   Wiswall R., 1978, HYDROGEN MET 2, V29, P209
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
NR 15
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2011
VL 695
BP 186
EP +
DI 10.4028/www.scientific.net/MSF.695.186
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BZR67
UT WOS:000302594800046
DA 2018-10-20
ER

PT S
AU Xu, SL
   Wang, RH
   Li, RQ
   Xu, RP
AF Xu, Shilian
   Wang, Ruihong
   Li, Ruoqi
   Xu, Renping
BE Chen, R
TI The Experiment for the Fracture Toughness of the Compound Bioceramic and
   the Analysis for the Confidence Level of Its Reliability
SO FRONTIERS OF MANUFACTURING AND DESIGN SCIENCE, PTS 1-4
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Frontiers of Manufacturing and Design
   Science (ICFMD2010)
CY DEC 11-12, 2010
CL Chongqing, PEOPLES R CHINA
SP Control Engn & Informat Sci Res Assoc, Int Frontiers of Sci & Technol Res Assoc, Trans Tech Publicat, Chongqing Xueya Conf Cater Co Ltd, Chongqing Univ Technol
DE Bioceramic; Fracture toughness; Statistics distribution; Confidence
   level; Reliability; Fitting test
AB The brittle is crippling the application of bioceramic. The compound bioceramic is a new biomaterial being widely applied in medical treatments and its fracture toughness is an important mechanical behaviors. In this paper, we introduce the manufacturing method of the compound bioceramic and experiment facilities for its fracture toughness, investigate its probability distribution for the experimental data and conduct the test for fit. We conclude that the experimental data for the toughness fracture of the compound bioceramic obey the two-parameter Weibull distribution, introduce the analyzing method for the upper confidence limit curve and lower confidence limit curve and study the reliability and confidence level of the fracture toughness of the compound bioceramic.
C1 [Xu, Renping] Kunming Univ Sci & Technol, Fac Mech & Elect Engn, Kunming 650093, Yunnan, Peoples R China.
   [Xu, Shilian; Wang, Ruihong] Agr Univ Hebei, Coll Sci, Baoding 071001, Hebei, Peoples R China.
   [Li, Ruoqi] Agr Univ Hebei, Coll Business & Management, Baoding 071001, Hebei, Peoples R China.
RP Xu, RP (reprint author), Kunming Univ Sci & Technol, Fac Mech & Elect Engn, Kunming 650093, Yunnan, Peoples R China.
EM nashduan@gmail.com; sxdonglianjie@hebau.edu.cn; ruoqilee@yahoo.com.cn;
   xurenp@gmail.com
CR Deeb ME, 1991, J MAXILLOFAC SURG, V49, P257
   Fu H, 1992, ACTA AERONAUTICA AST, V13, P153
   Fu Huiming, 1991, BHB4034
   Hiroshige Suzuki, 1989, ENG CERAMICS
   Osborn J F, 1985, Quintessenz, V36, P239
   The Department of Mathematics and Mechanics in Sun Yat-sen University, 1980, PROB STAT
   Wen Hongguang, 1994, MECH ENG, V12, P145
   Wu Enge, 1992, CHINESE J DENT MAT D, V1, P55
   Zhang Qingchun, 1987, MECH PERFORMANCE CER
   Zhao S, 1989, STOMATOLOGY, V9, P174
   Zhao S, 1992, CHIN J DENT MAT DEVI, V1, P68
NR 11
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03785-004-6
J9 APPL MECH MATER
PY 2011
VL 44-47
BP 3003
EP +
DI 10.4028/www.scientific.net/AMM.44-47.3003
PN 1-4
PG 2
WC Engineering, Multidisciplinary; Engineering, Manufacturing
SC Engineering
GA BZR61
UT WOS:000302594201181
DA 2018-10-20
ER

PT S
AU Chen, B
   Yin, DG
   Yuan, Q
   Fan, JH
AF Chen, Bin
   Yin, Dagang
   Yuan, Quan
   Fan, Jinghong
BE Han, E
   Lu, GH
   Shu, XL
TI Correlation between Microstructure and Toughness of Crab Carapace
SO MATERIALS MODELING, SIMULATION, AND CHARACTERIZATION
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 11th International Conference in Asia of the
   International-Union-of-Materials-Research-Societies
CY SEP 25-28, 2010
CL Qingdao, PEOPLES R CHINA
SP Int Union Mat Res Soc (IUMRS), Chinese Mat Res Soc, Mat Res Soc Taiwan, Mat Res Soc Japan, Govt Qingdao City
DE Crab carapace; calcite crystal sheet; microstructure; pullout energy
ID MECHANICAL-PROPERTIES; DENTIN
AB Crab carapace is a kind of biomaterial in nature. It behaves favorable strength, stiffness and fracture toughness, which are closely related to its fine microstructure. The observation of scanning electron microscope (SEM) on the carapace of a Cyclodorippoidea crab shows that the carapace is a kind of natural bioceramic composite consisting of calcite crystal layers and collagen protein matrix. The observation also shows that the calcite crystal layers consist further of long and thin calcite crystal sheets and that all the calcite crystal sheets are arranged in a kind of parallel distribution. The maximum pullout energy of the calcite crystal sheets, which is closely related to the fracture toughness of the carapace, is investigated based on the representative model of the parallel distribution. It shows that the long and thin shape as well as the parallel distribution of the calcite crystal sheets enhance the maximum pullout energy and ensure the high fracture toughness of the carapace.
C1 [Chen, Bin; Yin, Dagang; Yuan, Quan] Chongqing Univ, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
   [Chen, Bin] Chongqing Univ, Minist Educ, Key Lab Explotat S W Resources & Enivron Disaster, Chongqing 400044, Peoples R China.
   [Fan, Jinghong] Alfred Univ, Div Mech Engn, Alfred, NY 14802 USA.
RP Chen, B (reprint author), Chongqing Univ, Coll Resource & Environm Sci, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn; ydgczn3512122@126.com; yuanquan82619@sina.com;
   fanjing@alfred.edu
FU Natural Science Foundations of China [10872221, 50921063]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant nos. 10872221 and
   50921063).
CR Bobelmann F, 2007, THERMOCHIM ACTA, V463, P65, DOI 10.1016/j.tca.2007.07.018
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   CHONG KP, 1999, MECH AAM, V28, P1
   Fong H, 2000, MAT SCI ENG C-BIO S, V7, P119, DOI 10.1016/S0928-4931(99)00133-2
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   Koester KJ, 2008, BIOMATERIALS, V29, P1318, DOI 10.1016/j.biomaterials.2007.12.008
   Paine ML, 2001, MATRIX BIOL, V20, P273, DOI 10.1016/S0945-053X(01)00153-6
   SARIKAYA M, 1989, P AM COMP, P176
   Zhou F, 2010, J MECH BEHAV BIOMED, V3, P454, DOI 10.1016/j.jmbbm.2010.05.001
NR 9
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2011
VL 689
BP 395
EP +
DI 10.4028/www.scientific.net/MSF.689.395
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BZR83
UT WOS:000302643800061
DA 2018-10-20
ER

PT S
AU Li, N
   Wang, YN
   Nie, HS
   Yu, HQ
   Xu, H
AF Li, Nan
   Wang, Yinan
   Nie, Hongshan
   Yu, Hongqi
   Xu, Hui
BE Li, YG
   Wang, PC
   Ai, LQ
   Sang, XM
   Bu, JL
TI Biomaterial Impedance Analyzer Based on Digital Auto Balancing Bridge
SO MATERIALS PROCESSING TECHNOLOGY, PTS 1-4
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advanced Engineering Materials and
   Technology (AEMT2011)
CY JUL 29-31, 2011
CL Sanya, PEOPLES R CHINA
SP Hebei United Univ, Inner Mongolia Univ Technol, Korea Maritime Univ
DE Biomaterial impedance analyzer; FPGA; DABB; auto balancing bridge; EIS
AB This paper presents the design method of a novel biomaterial impedance analyzer based on digital auto balancing bridge method. The system hardware mainly consists of FPGA, ADC, DACs and operational amplifiers. Many DSP algorithms such as direct digital frequency synthesis (DDS), digital phase sensitive demodulation (DPSD), digital modulation and digital filter are implemented in FPGA to realize the auto balancing function of the bridge circuit. Simulation results show that the system has good performance from low frequency to 10MHz. It is suitable for EIS application in biomaterial analysis.
C1 [Li, Nan; Wang, Yinan; Nie, Hongshan; Yu, Hongqi; Xu, Hui] Natl Univ Def Technol, Sch Elect Sci & Engn, ESSS Ctr, Changsha 410073, Hunan, Peoples R China.
RP Li, N (reprint author), Natl Univ Def Technol, Sch Elect Sci & Engn, ESSS Ctr, Changsha 410073, Hunan, Peoples R China.
EM linanc@nudt-esss.com; wangyinan@nudt-esss.com; nhs@nudt-esss.com;
   yhq@nudt-esss.com; xuhui@nudt-esss.com
CR Agilent Technologies, 2009, IMP MEAS HDB
   BANDYK DF, 1992, INFECT DIS CLIN N AM, V6, P719
   Hill David, 1998, DESIGN ENG BIOMATERI, P480
   Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7
   Silver F.H., 1993, BIOMATERIALS MED DEV
   West AR, 1997, J ELECTROCERAM, V1, P65, DOI 10.1023/A:1009950415758
NR 6
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-193-7
J9 ADV MATER RES-SWITZ
PY 2011
VL 291-294
BP 1259
EP 1262
DI 10.4028/www.scientific.net/AMR.291-294.1259
PN 1-4
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BZQ26
UT WOS:000302382700244
DA 2018-10-20
ER

PT B
AU Sheng, XY
   Fan, LP
   Cui, CJ
   Li, J
   Wu, JL
   Mo, XM
   He, CL
   Wang, HS
AF Sheng Xiao-yue
   Fan Lin-peng
   Cui Cheng-jun
   Li Jun
   Wu Jing-lei
   Mo Xiu-mei
   He Chuang-long
   Wang Hong-sheng
GP Donghua Univ, Coll Textiles
TI Novel Vitamin E-Loaded Silk Fibroin Nanofiber Mats Fabricated by
   Electrospinning
SO 2011 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY JUN 07-08, 2011
CL Donghua Univ, Shanghai, PEOPLES R CHINA
HO Donghua Univ
DE electrospinning; composite nanofiber; silk fibroin; TPGS
ID POLYETHYLENE GLYCOL-1000 SUCCINATE; HUMAN SKIN; WATER; BIOMATERIALS;
   CHOLESTASIS; FORMS
AB Vitamin E is widely used in personal care and cosmetic products because of its potent antioxidant ability. However, most forms of vitamin E are fat-soluble, which limits the bio-availability of the vitamin E. In this study, electrospun silk fibroin (SF) nanofibers were fabricated as carriers for delivery of a water-soluble derivative of vitamin E (TPGS). Comparing with the pure silk solution, the surface tension of SF/vitamin E mixture sightly decreased, which makes the electrospinning process more smoothly. The fabricated fibers were then treated with 75% ethanol vapor and then immersed in the acetate buffer for 4 days, the morphology of the vitamin E loaded SF nanofibers observed by scanning electronic microscope (SEM) showed no obvious change. Meanwhile, Fourier Transform Infrared (FTIR) spectra demonstrated that the conformation of silk fibroin transformed from silk I form to silk II form. Therefore, electrospun vitamin E loaded nanofiber mats appear to be a promising biomaterial for skin care, wound dressing and skin tissue engineering.
C1 [Sheng Xiao-yue; Mo Xiu-mei; He Chuang-long; Wang Hong-sheng] Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
RP Wang, HS (reprint author), Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
EM whs@dhu.edu.cn
RI He, Chuanglong/C-2976-2011; mo, xiumei/C-9340-2013
OI He, Chuanglong/0000-0001-8330-8542; 
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aydemir Orhan, 2004, International Ophthalmology, V25, P283, DOI 10.1007/s10792-005-2034-z
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Fan LP, 2010, COLL TEXT DONGH U 20, P96
   Fathi-Azarbayjani A, 2010, AAPS PHARMSCITECH, V11, P1164, DOI 10.1208/s12249-010-9475-z
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatious F., 2001, PCT/U. S. Pat., Patent No. [PCT/US 01/02399, 0102399]
   Krasavage Terhaar C, 1977, J AGR FOOD CHEM, V25, P273
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   Opanasopit P., 2009, INT J COSMETIC SCI, V31, P240
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Ping L., 2008, RECENT PAT NANOTECH, V2, P169
   SOKOL RJ, 1987, GASTROENTEROLOGY, V93, P975, DOI 10.1016/0016-5085(87)90559-2
   Somavarapu S., 2005, INT J PHARMACEUT, V298, P334
   Thiele JJ, 2007, MOL ASPECTS MED, V28, P646, DOI 10.1016/j.mam.2007.06.001
   TRABER MG, 1986, AM J CLIN NUTR, V44, P914
   TRABER MG, 1988, AM J CLIN NUTR, V48, P605
   TRIVEDI JS, 1995, EUR J PHARM SCI, V3, P241, DOI 10.1016/0928-0987(95)00014-5
   Xiong SY, 2010, TEXT BIOENG INF S P, V1-3, P322
   Xu WL, 2006, J APPL POLYM SCI, V101, P2967, DOI 10.1002/app.23529
   Yao JR, 2003, J FUDAN U NAT SCI, V42, P828
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   You Y, 2005, J APPL POLYM SCI, V95, P193, DOI 10.1002/app.21116
   Zhang KH, 2010, COLL TEXT DONGH U 20, p175~179
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 29
TC 0
Z9 0
U1 0
U2 7
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
PY 2011
BP 411
EP 415
PG 5
WC Materials Science, Biomaterials; Materials Science, Textiles
SC Materials Science
GA BZQ38
UT WOS:000302389200081
DA 2018-10-20
ER

PT S
AU Otsuka, Y
   Nagaoka, S
   Mutoh, Y
AF Otsuka, Yuichi
   Nagaoka, Satoshi
   Mutoh, Yoshiharu
BE Guagliano, M
   Vergani, L
TI Effects of dissolved oxygen on fatigue characteristics of austenitic
   stainless steel in 0.9wt% sodium chloride solutions
SO 11TH INTERNATIONAL CONFERENCE ON THE MECHANICAL BEHAVIOR OF MATERIALS
   (ICM11)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 11th International Conference on the Mechanical Behavior of Materials
   (ICM)
CY 2011
CL Como, ITALY
DE biomaterial; Iron and Steel; Biomechanics; Life prediction; corrosion
   fatigue
AB Fatigue life evaluations in low dissolved oxygen conditions have been considered as conservative in predicting fatigue strengths of biomaterials. However, dissolved oxygen is considered to increase crack propagation rates. It is necessary to observe whether the strength in low dissolved oxygen conditions becomes higher. In this paper, authors observed effects of dissolved gas on corrosion fatigue characteristics of austenitic stainless steels. Fatigue strength becomes higher in low dissolved O2 NaCl aq. at stress ratio R=0.1. However, fatigue strength did not change in low dissolved O2 NaCl aq. at stress ratio R=0.5 because of the effect of work hardening. Cycles to crack initiations became longer and crack growth rates became lower in low dissolved O2 NaCl aq.. In conclusion, dissolved oxygen has effects of accelerating crack propagation processes. (C) 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of ICM11
C1 [Otsuka, Yuichi] Nagaoka Univ Technol, Top Runner Incubat Ctr Acad Ind Fus, 1603-1 Kamitomioka Cho, Nagaoka, Niigata 9402188, Japan.
   [Nagaoka, Satoshi] Nagaoka Univ Technol, Grad Sch Mech Engn, Nagaoka, Niigata 9402188, Japan.
   [Mutoh, Yoshiharu] Nagaoka Univ Technol, Dept Syst Safety, Nagaoka, Niigata 9402188, Japan.
RP Otsuka, Y (reprint author), Nagaoka Univ Technol, Top Runner Incubat Ctr Acad Ind Fus, 1603-1 Kamitomioka Cho, Nagaoka, Niigata 9402188, Japan.
EM otsuka@vos.nagaokaut.ac.jp
OI Otsuka, Yuichi/0000-0003-4671-4861
FU Top Runner Incubation System through the Academia-Industry Fusion
   Training in the Promotion of Independent Research Environment for Young
   Researchers, MEXT, Japan
FX One of the authors was partially supported by the Top Runner Incubation
   System through the Academia-Industry Fusion Training in the Promotion of
   Independent Research Environment for Young Researchers, MEXT, Japan. The
   authors also appreciate the critical advice of Assoc. Prof. Yukio
   Miyashita at Nagaoka University of Technology.
CR Amano K., 1998, RELATIONSHIP T JAPAN, V64, P1831
   Hayashi K., 1990, METHODS T JAPAN SO A, V56, P681
   Japanese Standards Association, 2009, JIS HDB, P992
   MORITA M, 1992, ANN BIOMED ENG, V20, P505, DOI 10.1007/BF02368170
   Morita M., 1990, BIOMECHANISMS JAPAN, V19, P219
   Society of Materials Science, 2005, FAT DES HDB, P254
   Tokaji K., 1985, FATIGUE SOC MAT SCI, V34, P816
NR 7
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2011
VL 10
BP 1333
EP 1338
DI 10.1016/j.proeng.2011.04.222
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BYU61
UT WOS:000300451301059
OA Other Gold
DA 2018-10-20
ER

PT S
AU Kazakeviciute-Makovska, R
   Steeb, H
AF Kazakeviciute-Makovska, R.
   Steeb, H.
BE Guagliano, M
   Vergani, L
TI Superelasticity and Self-Healing of Proteinaceous Biomaterials
SO 11TH INTERNATIONAL CONFERENCE ON THE MECHANICAL BEHAVIOR OF MATERIALS
   (ICM11)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 11th International Conference on the Mechanical Behavior of Materials
   (ICM)
CY 2011
CL Como, ITALY
DE proteinaceous biomaterials; superelasticity; self-healing
ID MARINE SNAILS; DEFORMATION
AB Using experimental data from literature and general concepts of thermodynamics of materials, we propose a macroscopic continuum model to describe the nonlinear mechanical behavior of proteinaceous biomaterials such as the whelk egg capsule biopolymer (WECB). This model provides a relationship between macroscopically observed mechanical properties of WECB and physical mechanisms of phase transition in this biomaterial from the alpha-helix in the native (unstrained) state to the beta-sheet in the deformed state. The extent of this phase transition is represented by a scalar variable whose evolution during straining and relaxation is determined from the macroscopically measured stress-strain data. The proposed theory models the complete recovery of deformation (superelasticity) and the complete recovery of stiffness (self-healing) observed for WECB in cyclic tensile tests. (C) 2011 Published by Elsevier Ltd. Selection and peer-review under responsibility of ICM11
C1 [Kazakeviciute-Makovska, R.; Steeb, H.] Ruhr Univ Bochum, Bochum, Germany.
RP Kazakeviciute-Makovska, R (reprint author), Ruhr Univ Bochum, Bochum, Germany.
EM Rasa.Kazakeviciute-Makovska@rub.de
RI Steeb, Holger/E-2572-2011
OI Steeb, Holger/0000-0001-7602-4920
CR Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002
   FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025
   Fung Y.C., 1993, BIOMECHANICS MECH PR
   Miserez A, 2009, NAT MATER, V8, P910, DOI [10.1038/NMAT2547, 10.1038/nmat2547]
   R Kazakeviciute-Makovska, 2010, MECH GEN CO IN PRESS, P175
   Rapoport HS, 2007, J EXP BIOL, V210, P12, DOI 10.1242/jeb.02613
   Rapoport HS, 2002, BIOMACROMOLECULES, V3, P42, DOI 10.1021/bm0155470
   SS Wasko, 2010, THESIS U CALIFORNIA
NR 8
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2011
VL 10
DI 10.1016/j.proeng.2011.04.432
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BYU61
UT WOS:000300451302102
OA Other Gold
DA 2018-10-20
ER

PT S
AU Chiappini, C
   Tasciotti, E
   Serda, RE
   Brousseau, L
   Liu, XW
   Ferrari, M
AF Chiappini, Ciro
   Tasciotti, Ennio
   Serda, Rita E.
   Brousseau, Lou
   Liu, Xuewu
   Ferrari, M.
BE Cantarero, A
   Sailor, M
   Nassiopoulou, A
   Schmuki, P
   Canham, L
TI Mesoporous silicon particles as intravascular drug delivery vectors:
   fabrication, in-vitro, and in-vivo assessments
SO PHYSICA STATUS SOLIDI C: CURRENT TOPICS IN SOLID STATE PHYSICS, VOL 8,
   NO 6
SE Physica Status Solidi C-Current Topics in Solid State Physics
LA English
DT Proceedings Paper
CT 7th International Conference on Porous Semiconductors - Science and
   Technology (PSST)
CY MAR 14-19, 2010
CL Valencia, SPAIN
SP Univ Valencia, Minist Sci & Technol, Generalitat Valenciana
DE drug delivery; porous silicon; multi-stage vector; biomaterial
ID INTERFERING RNA DELIVERY; POROUS SILICON; MICROPARTICLES; NANOMEDICINE;
   GENE; BIODISTRIBUTION; PHAGOCYTOSIS; CHALLENGES; MECHANICS; RELEASE
AB Porous silicon is an attractive biomaterial for drug delivery thanks to its biocompatibility, biodegradability, ease of fabrication, tunable nanostructure, and porous network. Herein we briefly present the development of a multi-stage delivery vector that leverages these advantages to enhance delivery of systemically administered therapeutic agents. We illustrate the rational design, objective-oriented fabrication and geometric control of first stage porous silicon microparticles. We describe how geometry affects the biodistribution of first stage vectors and how their porous structure affects the loading and release of second stage theranostic payloads. We describe the mechanism of cellular internalization and intracellular trafficking of particles. Finally we present two multi-stage vector prototypes for the delivery of magnetic resonance imaging contrast agents and small interfering RNA. (C) 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Chiappini, Ciro; Ferrari, M.] Univ Texas Austin, Dept Biomed Engn, 1 Univ Stn, Austin, TX 78712 USA.
   [Tasciotti, Ennio; Serda, Rita E.; Brousseau, Lou; Liu, Xuewu; Ferrari, M.] Mehtodist Hosp Res Inst, Dept Nanomedicine & Biomed Engn, Houston, TX 77030 USA.
   [Ferrari, M.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.
   [Ferrari, M.] Rice Univ, Dept Bioengn, Houston, TX 77030 USA.
   [Tasciotti, Ennio; Serda, Rita E.; Brousseau, Lou; Liu, Xuewu; Ferrari, M.] UT Hlth Sci Ctr, Dept Nanomedicine & Biomed Engn, Houston, TX 77030 USA.
RP Ferrari, M (reprint author), Univ Texas Austin, Dept Biomed Engn, 1 Univ Stn, Austin, TX 78712 USA.
EM Mauro.ferrari@uth.tmc.edu
RI Chiappini, Ciro/A-6382-2013
OI Chiappini, Ciro/0000-0002-9893-4359; Tasciotti,
   Ennio/0000-0003-1187-3205
FU Texas's Emerging Technology Fund; NASA [NNJ06HE06A]; Department of
   Defense [W81XWH-07-2-0101, W91INF-09-1-0044, W81XWH-09-1-0212]; National
   Institute of Health [R01CA128797, U54CA143837]; Alliance for NanoHealth
   (ANH)
FX We acknowledge Prof. Paolo Decuzzi and Prof Takemi Tanaka for their
   fundamental contribution to the work presented in this manuscript and
   for the prolific discussions. We acknowledge the entire department of
   NanoMedicine and Biomedical Engineering at UT-Houston. We acknowledge
   support from the State of Texass Emerging Technology Fund, NASA
   (NNJ06HE06A), Department of Defense (W81XWH-07-2-0101, W91INF-09-1-0044,
   W81XWH-09-1-0212), National Institute of Health (R01CA128797,
   U54CA143837) and the Alliance for NanoHealth (ANH). Commercialization
   rights on intellectual property presented in this paper have been
   acquired by Leonardo Biosystems Inc. MF is the founding scientist of
   Leonardo Biosystems. ET, XL and MF are stockholders of Leonardo
   Biosystems. All authors hold intellectual property rights licensed to
   Leonardo Biosystems.
CR Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Bjorkqvist M, 2003, PHYS STATUS SOLIDI A, V197, P374, DOI 10.1002/pssa.200306528
   Blanchette J, 2005, J BIOMED MATER RES A, V72A, P381, DOI 10.1002/jbm.a.30243
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chiappini C., 2010, ADV FUNCT M IN PRESS
   Chiappini C, 2010, CHEMPHYSCHEM, V11, P1029, DOI 10.1002/cphc.200900914
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Fan D., J CONTROL RELE UNPUB
   Fenske DB, 2008, TOXICOL PATHOL, V36, P21, DOI 10.1177/0192623307310960
   Ferrari M, 2005, CURR OPIN CHEM BIOL, V9, P343, DOI 10.1016/j.cbpa.2005.06.001
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Ferrari M, 2008, NAT NANOTECHNOL, V3, P131, DOI 10.1038/nnano.2008.46
   Ferrari M, 2010, TRENDS BIOTECHNOL, V28, P181, DOI 10.1016/j.tibtech.2009.12.007
   Ferrati S., 2010, NANOSCALE IN PRESS
   Gentile F, 2008, J BIOMECH, V41, P2312, DOI 10.1016/j.jbiomech.2008.03.021
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Gratton SEA, 2007, J CONTROL RELEASE, V121, P10, DOI 10.1016/j.jconrel.2007.05.027
   Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639
   Herant M, 2006, J CELL SCI, V119, P1903, DOI 10.1242/jcs.02876
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Kojic M., 2008, BIOENGINEERING THEOR
   Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585
   Salonen J, 2005, J CONTROL RELEASE, V108, P362, DOI 10.1016/j.jconrel.2005.08.017
   Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114
   Serda R., 2009, NANOSTRUCTURED OXIDE, V2
   Serda R.E., 2010, SMALL IN PRESS
   Serda RE, 2009, NANOSCALE, V1, P250, DOI 10.1039/b9nr00138g
   Serda RE, 2009, CYTOM PART A, V75A, P752, DOI 10.1002/cyto.a.20769
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931
   Tasciotti E., 2009, NANOSCALE BIOENGINEE
   Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34
NR 39
TC 10
Z9 10
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
SN 1862-6351
J9 PHYS STATUS SOLIDI C
PY 2011
VL 8
IS 6
DI 10.1002/pssc.201000344
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA BZG93
UT WOS:000301574800023
DA 2018-10-20
ER

PT B
AU Kipshidze, N
   Archvadze, A
   Kipiani, V
   Kaloiani, V
   Kantaria, M
   Gunjua, T
   Khurtsidze, S
   Erbel, R
AF Kipshidze, N.
   Archvadze, A.
   Kipiani, V
   Kaloiani, V
   Kantaria, M.
   Gunjua, T.
   Khurtsidze, S.
   Erbel, R.
BE Lewis, BS
   Flugelman, MY
   Halon, DA
TI y New Polymeric Biomaterial accelerate (TM)-AT Coated Stent:
   First-In-Man Clinical Study-2 Year Results
SO CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION
LA English
DT Proceedings Paper
CT 9th International Congress on Coronary Artery Disease (ICCAD)
CY OCT 23-26, 2011
CL Venice, ITALY
ID SIROLIMUS-ELUTING STENT
AB HARTS I - a single-centre, prospective, first-in-man clinical study to evaluate the safety and performance of the Biomer Technology accelerate-AT coated stent, which in previous in-vitro and animal studies was shown to accelerate vascular healing and reduce smooth muscle cell growth, thus reducing the risk of restenosis and acute and late stent thrombosis.
   There were 2 cases of MACE during 2 years clinical follow-up. 6-month control coronary angiography and IVUS showed low late loss.
   The trial has shown that use of the Biomer Technology accelerate (TM)-AT coated stent is safe and associated with a sustained clinical and angiographic benefit.
C1 [Kipshidze, N.] Lenox Hill Heart & Vasc Inst, New York, NY 10075 USA.
   [Kipshidze, N.; Archvadze, A.; Kipiani, V; Kaloiani, V; Kantaria, M.; Gunjua, T.; Khurtsidze, S.] N Kipshidze Cent Univ Hosp, Tbilisi, Rep of Georgia.
   [Khurtsidze, S.; Erbel, R.] German Heart Ctr, Essen, Germany.
RP Kipshidze, N (reprint author), Lenox Hill Heart & Vasc Inst, New York, NY 10075 USA.
CR Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062
NR 5
TC 0
Z9 0
U1 0
U2 1
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-619-7
PY 2011
BP 391
EP 394
PG 4
WC Biochemistry & Molecular Biology; Cardiac & Cardiovascular Systems;
   Peripheral Vascular Disease
SC Biochemistry & Molecular Biology; Cardiovascular System & Cardiology
GA BYT85
UT WOS:000300222000075
DA 2018-10-20
ER

PT S
AU Antoniadou, EV
   Ahmad, RK
   Jackman, RB
   Seifalian, AM
AF Antoniadou, Eleni V.
   Ahmad, Rezal K.
   Jackman, Richard B.
   Seifalian, Alexander M.
GP IEEE
TI Next generation brain implant coatings and nerve regeneration via novel
   conductive nanocomposite development
SO 2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 33rd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBS)
CY AUG 30-SEP 03, 2011
CL Boston, MA
SP IEEE, Engn Med & Biol Soc (EMBS)
DE carbon nanotubes; nanomaterials; coated brain microelectrodes
ID POLYMER
AB Composite materials based on the coupling of conductive organic polymers and carbon nanotubes have shown that they possess properties of the individual components with a synergistic effect. Multi-wall carbon nanotube (MWCNT)/polymer composites are hybrid materials that combine numerous mechanical, electrical and chemical properties and thus, constitute ideal biomaterials for a wide range of regenerative medicine applications. Although, complete dispersion of CNT in a polymer matrix has rarely been achieved, in this study we have succeeded high dispersibility of CNT in POSS-PCU and POSS-PCL, novel polymers based on polyprolactone and polycarbonate polyurethane (PCU) and poly(caprolactone-urea) urethane both having incorporated polyhedral oligomeric silsesquioxane (POSS). We report the synthesis and characterization of a novel biomaterial that possesses unique properties of being electrically conducting and thus being capable of electronic interfacing with tissue. To this end, POSS-PCU/MWCNT composite can be used as a biomaterial for the development of nerve guidance channels to promote nerve regeneration and POSS-PCL/MWCNT as a substrate to increase electronic interfacing between neurons and micro-machined electrodes for potential applications in neural probes, prosthetic devices and brain implants.
C1 [Antoniadou, Eleni V.; Seifalian, Alexander M.] UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Interv Sci, Royal Free Hosp,Med Sch, London, England.
   [Ahmad, Rezal K.; Jackman, Richard B.] UCL Imperial Coll, London Ctr Nanotechnol, Dept Elect & Elect Engn, London, England.
RP Antoniadou, EV (reprint author), UCL, Ctr Nanotechnol & Regenerat Med, Div Surg & Interv Sci, Royal Free Hosp,Med Sch, London, England.
EM eleni.antoniadou.09@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Antoniadou EV, 2010, IEEE ENG MED BIO, P815, DOI 10.1109/IEMBS.2010.5626760
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BOYCE MC, 2008, FILLER ENHANCED POLY
   De Mattei M, 2007, OSTEOARTHR CARTILAGE, V15, P163, DOI 10.1016/j.joca.2006.06.019
   GOLDMAN JA, 1995, J CLIN EPIDEMIOL, V48, P571, DOI 10.1016/0895-4356(94)00215-C
   Mendonca AC, 2003, J NEUROSCI METH, V129, P183, DOI 10.1016/S0165-0270(03)00207-3
   MIYASAKA K, 1982, J MATER SCI, P1610
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   SEIFALIAN AM, Patent No. 0005000089
   Sisken BF, 1995, ADV CHEM SER, V250, P277
   WASSERSCHAFF M, 1990, BRAIN RES, V515, P241, DOI 10.1016/0006-8993(90)90602-8
NR 11
TC 6
Z9 7
U1 2
U2 17
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4122-8
J9 IEEE ENG MED BIO
PY 2011
BP 3253
EP 3257
PG 5
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BYH52
UT WOS:000298810002244
PM 22255033
DA 2018-10-20
ER

PT S
AU Holmes, H
   Tan, EL
   Ong, KG
   Rajachar, RM
AF Holmes, Hallie
   Tan, Ee Lim
   Ong, Keat Ghee
   Rajachar, Rupak M.
GP IEEE
TI Real-time, In vivo Investigation of Mechanical Stimulus on Cells with
   Remotely Activated, Vibrational Magnetoelastic Layers
SO 2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 33rd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBS)
CY AUG 30-SEP 03, 2011
CL Boston, MA
SP IEEE, Engn Med & Biol Soc (EMBS)
ID SURFACE
AB A system was developed for real-time, in vivo investigation of the relationship between local cell-level nano-mechanical perturbation and cell response to chemical-physical biomaterial surface properties. The system consisted of a magnetoelastic (ME) layer that could be remotely set to vibrate, at submicron levels, at a predetermined amplitude and profile. Experiments result indicated that submicron localized vibrations coupled with tailored biomaterial surface properties could selectively control cellular adhesion and possibly guide phenotypic gene expression. Practical application of this system includes modulation and monitoring of the surface of implantable biomaterials. The ME based vibrational system is the first of its kind for use in vitro for culture based mechanical testing, which could be readily deployed in situ as an in vivo system to apply local mechanical loads. It could be applied to specific implant surface sites and then subsequently sealed prior to long-term implantation. The potential advantage of this system over other similar approaches is that the system is translatable - the functional layer can serve as a "cellular workbench" material but could also be adapted and applied to the surface of implantable biomaterials and devices.
C1 [Holmes, Hallie; Ong, Keat Ghee; Rajachar, Rupak M.] Michigan Technol Univ, Houghton, MI 49931 USA.
RP Holmes, H (reprint author), Michigan Technol Univ, Houghton, MI 49931 USA.
EM eltan@mtu.edu; kgong@mtu.edu; rupakr@mtu.edu
CR Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Grimes CA, 2002, SENSORS, V2, P294, DOI 10.3390/s20700294
   Khang G, 1999, BIO-MED MATER ENG, V9, P179
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ong K.G., 2008, SENSORS, V8, P6396
   Vlaisavljevich E., 2011, BIOMEDICAL ENG IEEE, V58, P698
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
NR 9
TC 2
Z9 2
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4122-8
J9 IEEE ENG MED BIO
PY 2011
BP 3979
EP 3982
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BYH52
UT WOS:000298810003080
PM 22255211
DA 2018-10-20
ER

PT S
AU Sano, I
   Mukai, S
   Nakata, M
   Holben, BN
   Kikuchi, N
AF Sano, Itaru
   Mukai, Sonoyo
   Nakata, Makiko
   Holben, Brent N.
   Kikuchi, Nobuyuki
GP IEEE
TI RETRIEVAL OF BIOMASS BURING AEROSOLS WITH COMBINATION OF NEAR-UV
   RADIANCE AND NEAR-IR POLARIZATION
SO 2011 IEEE INTERNATIONAL GEOSCIENCE AND REMOTE SENSING SYMPOSIUM (IGARSS)
SE IEEE International Symposium on Geoscience and Remote Sensing IGARSS
LA English
DT Proceedings Paper
CT IEEE International Geoscience and Remote Sensing Symposium (IGARSS)
CY JUL 24-29, 2011
CL Vancouver, CANADA
SP IEEE, Inst Elect & Elect Engineers Geosci & Remote Sensing Soc (IEEE GRSS)
DE AOT; Angstrom exponent; SSA; GOSAT / CAI; POLDER
ID OPTICAL-PROPERTIES
AB Carbonaceous aerosol plays an important role not only in climate but also in aerosol study. It is, however, difficult to make models of biomass burning aerosols because their properties are changable due to strongly dependce on the biomaterial itself, and on the stage of burning, and/or transportation process.
   This work intends to estimate the optical properties of biomass burning aerosols based on the combined use of the satellite data by CAI (Cloud Aerosol Imager) on GOSAT and by POLDER (POLarization and Directionality of Earth's Reflectances) on PARASOL. As a result, aerosol optical thickness (AOT), Angstrom exponent, and single scattering albedo (SSA) are retrieved. The retrieved values of AOT and Angstrom exponent are partially validated with the ground-based measurements of AERONET.
C1 [Sano, Itaru; Mukai, Sonoyo; Nakata, Makiko] Kinki Univ, Fac Sci & Technol, Higashiosaka, Osaka 577, Japan.
   [Holben, Brent N.] NASA, Goddard Space Flight Ctr, Washington, DC 20546 USA.
   [Kikuchi, Nobuyuki] Natl Inst Environm Studies, Tokyo, Japan.
RP Sano, I (reprint author), Kinki Univ, Fac Sci & Technol, Higashiosaka, Osaka 577, Japan.
FU Greenhouse Gases Observing Satellite (GOSAT) Science Project of the
   National Institute of Environmental Studies (NIES), Tsukuba, Japan;
   GCOM-C1 SGLI project by JAXA [JX-PSPC- 308878]
FX The authors thank to NIES GOSAT team, CNES PARASOL team, Dr. Natalia
   Chubarova, and NASA AERONET team for operations of their instrument and
   data distributions. This work was supported by the Greenhouse Gases
   Observing Satellite (GOSAT) Science Project of the National Institute of
   Environmental Studies (NIES), Tsukuba, Japan, and GCOM-C1 SGLI project
   (JX-PSPC- 308878) by JAXA.
CR BOHREN CF, 1977, ASTROPHYS SPACE SCI, V50, P461, DOI 10.1007/BF00641750
   DESCHAMPS PY, 1994, IEEE T GEOSCI REMOTE, V32, P598, DOI 10.1109/36.297978
   Dubovik O, 2002, J ATMOS SCI, V59, P590, DOI 10.1175/1520-0469(2002)059<0590:VOAAOP>2.0.CO;2
   Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5
   Hungershoefer K, 2008, ATMOS CHEM PHYS, V8, P3427, DOI 10.5194/acp-8-3427-2008
   IPCC 2007, 2007, CLIM CHANG 2007 WORK
   Nadal F, 1999, IEEE T GEOSCI REMOTE, V37, P1709, DOI 10.1109/36.763292
   Nakajima T., 2008, J REMOTE SENS SOC JP, V28, P178
   Sano I, 1998, EARTH PLANETS SPACE, V50, P513, DOI 10.1186/BF03352143
   Sano I, 2004, ADV SPACE RES, V34, P833, DOI 10.1016/j.asr.2003.06.039
   Sano I., 2010, P SOC PHOTO-OPT INS, V7859, P7859
   Schkolnik G, 2007, ATMOS ENVIRON, V41, P1107, DOI 10.1016/j.atmosenv.2006.09.035
   UNEP and WMO, 2011, INT ASS BALCK CARB T
NR 13
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2153-6996
BN 978-1-4577-1005-6
J9 INT GEOSCI REMOTE SE
PY 2011
BP 4164
EP 4167
DI 10.1109/IGARSS.2011.6050048
PG 4
WC Engineering, Electrical & Electronic; Geosciences, Multidisciplinary;
   Remote Sensing
SC Engineering; Geology; Remote Sensing
GA BXX72
UT WOS:000297496304033
DA 2018-10-20
ER

PT S
AU Manners, JM
AF Manners, John M.
BE Kader, JC
   Delseny, M
TI Functional Genomics of Sugarcane
SO ADVANCES IN BOTANICAL RESEARCH, VOL 60
SE Advances in Botanical Research
LA English
DT Review; Book Chapter
ID SUCROSE-PHOSPHATE SYNTHASE; BICOLOR L. MOENCH; FESCUE
   FESTUCA-ARUNDINACEA; SACCHARUM-OFFICINARUM L.; EXPRESSED SEQUENCE TAGS;
   ZINC-FINGER NUCLEASES; AGROBACTERIUM-MEDIATED TRANSFORMATION; CINNAMYL
   ALCOHOL-DEHYDROGENASE; TRANSGENIC DOWN-REGULATION; NEUTRAL INVERTASE
   ACTIVITY
AB Sugarcane is an established source of sugar and is the current benchmark first-generation feedstock for efficient biofuel production. Sugarcane improvement has traditionally focused on sucrose-yield traits. In the future, energycanes with higher yields of fermentable sugars and fibre (bagasse) for biofuel and electricity applications will be developed. Commercial sugarcane cultivars are poly-aneuploid interspecific hybrids and contain in excess of a hundred chromosomes. Genetic maps linking DNA markers and traits have been developed, but marker-assisted breeding is in its infancy in sugarcane, and genome sequencing has just commenced. Substantial resources are available for the sugarcane transcriptome, and both specific and overlapping gene expression patterns for many traits have been established. Gene silencing and over-expression show promise as tests for gene function in sugarcane, and progress has been made in dissecting sucrose accumulation pathways. Commercial interest in genetically modified sugarcane will initially exploit input traits proven in GM maize but is also stimulating research into novel traits, and molecular tools, from sugarcane. Understanding the unique biological attributes of sugarcane through functional genomics will provide innovative plant improvement applications that can underpin future, carbon-neutral, bioenergy and biomaterial industries.
C1 CSIRO Plant Ind, Queensland Biosci Precinct, Brisbane, Qld, Australia.
RP Manners, JM (reprint author), CSIRO Plant Ind, Queensland Biosci Precinct, Brisbane, Qld, Australia.
EM john.manners@csiro.au
RI Manners, John/A-4922-2008
CR Aitken K, 2007, GENET RESOUR CROP EV, V54, P1395, DOI 10.1007/s10722-006-9124-2
   Aitken K, 2005, THEOR APPL GENET, V110, P789, DOI 10.1007/s00122-004-1813-7
   Aitken K., 2010, GENETICS GENOMICS BR, P419
   Aitken KS, 2008, THEOR APPL GENET, V117, P1191, DOI 10.1007/s00122-008-0856-6
   Aitken KS, 2007, GENOME, V50, P742, DOI 10.1139/G07-056
   Aitken KS, 2006, THEOR APPL GENET, V112, P1306, DOI 10.1007/s00122-006-0233-2
   Alexander AG, 1985, ENERGY CANE ALTERNAT
   Alwala S., 2010, Genetics, genomics and breeding of sugarcane, P69
   Amalraj RS, 2010, ELECTROPHORESIS, V31, P1959, DOI 10.1002/elps.200900779
   Andru S, 2011, THEOR APPL GENET, V123, P77, DOI 10.1007/s00122-011-1568-x
   Archer CT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-9
   Arencibia A, 1997, MOL BREEDING, V3, P247, DOI 10.1023/A:1009616318854
   Arencibia AD, 1998, TRANSGENIC RES, V7, P213, DOI 10.1023/A:1008845114531
   Arruda P., 2011, Tropical Plant Biology, V4, P3, DOI 10.1007/s12042-011-9074-5
   Arvinth S, 2010, PLANT CELL REP, V29, P383, DOI 10.1007/s00299-010-0829-5
   Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93
   Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800
   Baker P, 2010, THEOR APPL GENET, V120, P1653, DOI 10.1007/s00122-010-1283-z
   Basnayake SWV, 2012, PLANT BIOTECHNOL J, V10, P217, DOI 10.1111/j.1467-7652.2011.00655.x
   Basnayake SWV, 2011, PLANT CELL REP, V30, P439, DOI 10.1007/s00299-010-0927-4
   Begcy K., 2011, 10 GERMPL BREED 7 MO, P85
   Bekker JPL, 2007, THESIS U STELLENBOSC
   Berding N., 1997, P189
   Berkman P. J., PLANT BIOTE IN PRESS, V9, P768
   Beyene G, 2011, PLANT CELL REP, V30, P13, DOI 10.1007/s00299-010-0936-3
   Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107
   Birch R. G., 2010, Tropical Plant Biology, V3, P88, DOI 10.1007/s12042-010-9047-0
   Bohmert K, 2000, PLANTA, V211, P841, DOI 10.1007/s004250000350
   Bohmert-Tatarev K, 2011, PLANT PHYSIOL, V155, P1690, DOI 10.1104/pp.110.169581
   Borecky J, 2006, J EXP BOT, V57, P849, DOI 10.1093/jxb/erj070
   Borras-Hidalgo O, 2005, PLANT PHYSIOL BIOCH, V43, P1115, DOI 10.1016/j.plaphy.2005.07.011
   Bosch S., 2003, P S AFR SUGAR TECHNO, V7, P129
   Botha F., 2001, P INT SOC SUG CAN TE, V24, p[2001, 588]
   Botha F., 2009, P AUSTR SOC SUGAR CA, P1
   Botha F. C., 2007, P INT SOC SUGAR CANE, V26, P35
   Bower NI, 2005, PLANT SCI, V168, P761, DOI 10.1016/j.plantsci.2004.10.006
   BOWER R, 1992, PLANT J, V2, P409, DOI 10.1111/j.1365-313X.1992.00409.x
   Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102
   Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151
   Buanafina MMDO, 2008, PLANT BIOTECHNOL J, V6, P264, DOI 10.1111/j.1467-7652.2007.00317.x
   Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x
   Burnquist W.L, 2010, P INT SOC SUGAR CANE, V27, P1
   Cai Q, 2005, PLANT BREEDING, V124, P322, DOI 10.1111/j.1439-0523.2005.01099.x
   Calsa T, 2007, PLANT MOL BIOL, V63, P745, DOI 10.1007/s11103-006-9121-z
   Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356
   Calvino M, 2009, RICE, V2, P129, DOI 10.1007/s12284-009-9029-8
   Calvino M, 2008, RICE, V1, P166, DOI 10.1007/s12284-008-9012-9
   Camargo SR, 2007, PLANT CELL REP, V26, P2119, DOI 10.1007/s00299-007-0430-8
   Carlson SR, 2007, PLOS GENET, V3, P1965, DOI 10.1371/journal.pgen.0030179
   Carmona E, 2004, PLANT BREEDING, V123, P499, DOI 10.1111/j.1439-0523.2004.00935.x
   Carson D. L., 2002, South African Journal of Botany, V68, P434
   Carson DL, 2000, CROP SCI, V40, P1769, DOI 10.2135/cropsci2000.4061769x
   Casu R. E., 2010, Genetics, genomics and breeding of sugarcane, P229
   Casu R. E., 2010, Genetics, genomics and breeding of sugarcane, P167
   Casu R. E., 2009, P BIOEN WORKSH SUG I
   Casu RE, 2005, FIELD CROP RES, V92, P137, DOI 10.1016/j.fcr.2005.01.029
   Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41
   Casu RE, 2003, PLANT MOL BIOL, V52, P371, DOI 10.1023/A:1023957214644
   Casu RE, 2007, FUNCT INTEGR GENOMIC, V7, P153, DOI 10.1007/s10142-006-0038-z
   Cheavegatti-Gianotto A., 2011, Tropical Plant Biology, V4, P62, DOI 10.1007/s12042-011-9068-3
   Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316
   Chen L, 2004, FUNCT PLANT BIOL, V31, P235, DOI 10.1071/FP03254
   Chen L, 2003, PLANT BIOTECHNOL J, V1, P437, DOI 10.1046/j.14670-7652.2003.00040.x
   Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003
   Cho JI, 2010, NEW PHYTOL, V186, P657, DOI 10.1111/j.1469-8137.2010.03194.x
   Chong BF, 2007, PLANT BIOTECHNOL J, V5, P240, DOI 10.1111/j.1467-7652.2006.00235.x
   Chong BF, 2010, J PLANT GROWTH REGUL, V29, P149, DOI 10.1007/s00344-009-9118-3
   Chong BF, 2010, PHYTOCHEMISTRY, V71, P736, DOI 10.1016/j.phytochem.2010.01.014
   Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712
   Clarke JL, 2011, PLANT MOL BIOL, V76, P211, DOI 10.1007/s11103-011-9767-z
   Colombo R, 2006, J CHROMATOGR A, V1103, P118, DOI 10.1016/j.chroma.2005.11.007
   Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006
   Cordeiro GM, 2006, THEOR APPL GENET, V113, P331, DOI 10.1007/s00122-006-0300-8
   Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X
   Molinari HBC, 2007, PHYSIOL PLANTARUM, V130, P218, DOI 10.1111/j.1399-3054.2007.00909.x
   Cox M. C., 2005, P AUSTR SOC SUGAR CA, V27, P124
   Craveiro KIC, 2010, J BIOTECHNOL, V145, P215, DOI 10.1016/j.jbiotec.2009.11.011
   Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981
   D'Hont A., 2008, Genomics of tropical crop plants, P483
   D'Hont A, 2002, CHROMOSOME RES, V10, P253, DOI 10.1023/A:1015204424287
   D'Hont A., 1993, SUGAR CANE, V1, P12
   da Silva J. A., 2011, 10 GERMPL BREED 7 MO, P21
   da Silva JA, 2005, GENET MOL BIOL, V28, P294, DOI 10.1590/S1415-47572005000200020
   da Silva JAG, 2001, GENET MOL BIOL, V24, P155, DOI 10.1590/S1415-47572001000100021
   Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488
   Damaj MB, 2009, IN VITRO CELL DEV-AN, V45, pS81
   Damaj MB, 2010, GENOME, V53, P840, DOI [10.1139/G10-064, 10.1139/g10-064]
   Damaj MB, 2010, PLANTA, V231, P1439, DOI 10.1007/s00425-010-1138-5
   DASILVA JAG, 1993, GENOME, V36, P782, DOI 10.1139/g93-103
   Daugrois JH, 1996, THEOR APPL GENET, V92, P1059, DOI 10.1007/BF00224049
   de Araujo PG, 2005, PLANT J, V44, P707, DOI 10.1111/j.1365-313X.2005.02579.x
   De Souza AP, 2008, PLANT CELL ENVIRON, V31, P1116, DOI 10.1111/j.1365-3040.2008.01822.x
   DHont A, 1996, MOL GEN GENET, V250, P405, DOI 10.1007/s004380050092
   Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2
   Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x
   Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627
   Du JF, 2010, CHINESE SCI BULL, V55, P1263, DOI 10.1007/s11434-010-0035-4
   Dufour P, 1997, THEOR APPL GENET, V94, P409, DOI 10.1007/s001220050430
   Elliott AR, 1998, AUST J PLANT PHYSIOL, V25, P739, DOI 10.1071/PP98066
   Enoki H., 2011, 10 GERMPL BREED 7 MO, P57
   Fairley P, 2011, NATURE, V474, pS2, DOI 10.1038/474S02a
   Felix JDM, 2009, TROPICAL PLANT BIOL, V2, P98
   Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005
   Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459
   Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001
   Finn TE, 2011, GENETICS, V187, P409, DOI 10.1534/genetics.110.124370
   Fitzgerald T. L., 2011, CRITICAL RE IN PRESS
   Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108
   Furumizu C, 2010, RNA, V16, P1809, DOI 10.1261/rna.2265710
   Garsmeur O, 2011, NEW PHYTOL, V189, P629, DOI 10.1111/j.1469-8137.2010.03497.x
   Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106
   Gilbert RA, 2009, FIELD CROP RES, V111, P39, DOI 10.1016/j.fcr.2008.10.009
   Glassop D., 2010, Tropical Plant Biology, V3, P110, DOI 10.1007/s12042-010-9049-y
   Glassop D, 2007, PLANT CELL PHYSIOL, V48, P573, DOI 10.1093/pcp/pcm027
   Glynn NC, 2010, FIELD CROP RES, V119, P308, DOI 10.1016/j.fcr.2010.07.022
   Gnanasambandam A, 2008, FUNCT PLANT BIOL, V35, P166, DOI 10.1071/FP07277
   Goldemberg J, 2008, ENERG POLICY, V36, P2086, DOI 10.1016/j.enpol.2008.02.028
   GRIVET L, 1994, HEREDITY, V73, P500, DOI 10.1038/hdy.1994.148
   Grivet L, 2003, THEOR APPL GENET, V106, P190, DOI 10.1007/s00122-002-1075-1
   Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0
   Grivet L., 2006, DARWINS HARVEST NEW, P49
   Groenewald JH, 2008, TRANSGENIC RES, V17, P85, DOI 10.1007/s11248-007-9079-x
   Grof CPL, 2007, CROP SCI, V47, P1530, DOI 10.2135/cropsci2006.12.0825
   Grof CPL, 2006, FUNCT PLANT BIOL, V33, P605, DOI 10.1071/FP05283
   Grof CPL, 1996, SUGARCANE: RESEARCH TOWARDS EFFICIENT AND SUSTAINABLE PRODUCTION, P124
   Guimaraes CT, 1999, GENET MOL BIOL, V22, P125, DOI 10.1590/S1415-47571999000100024
   Guimaraes CT, 1997, P NATL ACAD SCI USA, V94, P14261, DOI 10.1073/pnas.94.26.14261
   Gupta V, 2010, FUNCT INTEGR GENOMIC, V10, P207, DOI 10.1007/s10142-009-0144-9
   Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421
   Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038
   Hamerli D, 2011, PLANT BIOTECHNOL J, V9, P32, DOI 10.1111/j.1467-7652.2010.00528.x
   Hansom S., 1999, P INT SOC SUG CAN TE, V22, P278
   Harrison MD, 2011, PLANT BIOTECHNOL J, V9, P884, DOI 10.1111/j.1467-7652.2011.00597.x
   Hatch MD, 2002, PHOTOSYNTH RES, V73, P251, DOI 10.1023/A:1020471718805
   Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8
   Heller-Uszynska K, 2011, MOL BREEDING, V28, P37, DOI 10.1007/s11032-010-9460-y
   Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103
   Hoarau JY, 2001, THEOR APPL GENET, V103, P84, DOI 10.1007/s001220000390
   Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3
   Hodnett GL, 2010, CROP SCI, V50, P1188, DOI 10.2135/cropsci2009.09.0486
   Hotta C. T., 2010, Tropical Plant Biology, V3, P75, DOI 10.1007/s12042-010-9050-5
   Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475
   Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695
   Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039
   Inman-Bamber G., 2011, P AUSTR ASS SUGAR CA, V33, P1
   Inman-Bamber NG, 2009, CROP PASTURE SCI, V60, P316, DOI 10.1071/CP08272
   Iskandar HM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-12
   Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676
   Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25
   Jackson MA, 2007, FUNCT PLANT BIOL, V34, P633, DOI 10.1071/FP07024
   Jackson MA, 2010, FUNCT PLANT BIOL, V37, P785, DOI 10.1071/FP09243
   JACKSON P, 2000, P AUSTR SOC SUGAR CA, V22, P23
   Jackson PA, 2005, FIELD CROP RES, V92, P277, DOI 10.1016/j.fcr.2005.01.024
   Jackson PA, 2003, AUST J AGR RES, V54, P389, DOI 10.1071/AR02110
   Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004
   Jain M, 2007, PLANT CELL REP, V26, P581, DOI 10.1007/s00299-006-0244-0
   Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x
   Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218
   Joosen RVL, 2009, CURR GENOMICS, V10, P540, DOI 10.2174/138920209789503914
   Joyce P., 2010, P AUSTR SOC SUGAR CA, V32, P703
   Joyce P, 2010, PLANT CELL REP, V29, P173, DOI 10.1007/s00299-009-0810-3
   Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4
   Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885
   Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990
   Kenan-Eichler M, 2011, GENETICS, V188, P263, DOI 10.1534/genetics.111.128348
   Khan MS, 2011, MOL BIOL REP, V38, P2359, DOI 10.1007/s11033-010-0369-7
   Krishnan C, 2010, BIOTECHNOL BIOENG, V107, P441, DOI 10.1002/bit.22824
   Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643
   Lakshmanan P, 2006, PLANT CELL REP, V25, P1007, DOI 10.1007/s00299-006-0154-1
   Lawrence RJ, 2003, PLANT J, V36, P114, DOI 10.1046/j.1365-313X.2003.01857.x
   Le Cunff L, 2008, GENETICS, V180, P649, DOI 10.1534/genetics.108.091355
   Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x
   Lingle S. E., 2008, 30 S BIOT FUELS CHEM
   Lingle SE, 2009, FIELD CROP RES, V113, P306, DOI 10.1016/j.fcr.2009.06.015
   Liu HJ, 2010, PLANT CELL PHYSIOL, V51, P1173, DOI 10.1093/pcp/pcq080
   Liu HJ, 2010, BIOTECHNOL J, V5, P1137, DOI 10.1002/biot.201000140
   LOOMIS R. S., 1963, CROP SCI, V3, P67
   LU YH, 1994, EUPHYTICA, V78, P7
   Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169
   Ma HM, 2000, AUST J PLANT PHYSIOL, V27, P1021
   Ma HM, 2004, THEOR APPL GENET, V108, P851, DOI 10.1007/s00122-003-1510-y
   Mace ES, 2011, THEOR APPL GENET, V123, P169, DOI 10.1007/s00122-011-1575-y
   Mace ES, 2010, THEOR APPL GENET, V121, P1339, DOI 10.1007/s00122-010-1392-8
   Macedo IC, 2008, BIOMASS BIOENERG, V32, P582, DOI 10.1016/j.biombioe.2007.12.006
   Manners J. M., 2011, Tropical Plant Biology, V4, P9, DOI 10.1007/s12042-011-9066-5
   Mathews L., 2009, AUSTR SUGARCANE, V13, P20
   Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895
   Matsuoka S, 2009, IN VITRO CELL DEV-PL, V45, P372, DOI 10.1007/s11627-009-9220-z
   McCormick AJ, 2008, ANN BOT-LONDON, V101, P89, DOI 10.1093/aob/mcm258
   McCormick A. J., 2008, Tropical Plant Biology, V1, P142, DOI 10.1007/s12042-008-9013-2
   McCormick AJ, 2009, J EXP BOT, V60, P357, DOI 10.1093/jxb/ern310
   McGinnis EE, 2010, PLANT CELL, V22, P1653, DOI 10.1105/tpc.110.077198
   McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544
   McIntyre CL, 2006, MOL BREEDING, V18, P39, DOI 10.1007/s11032-006-9012-7
   McIntyre C. L., 2009, Tropical Plant Biology, V2, P133, DOI 10.1007/s12042-009-9035-4
   Mcintyre CL, 2005, GENOME, V48, P391, DOI 10.1139/G05-006
   McIntyre CL, 2004, THEOR APPL GENET, V109, P875, DOI 10.1007/s00122-004-1702-0
   McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320
   McNeil MD, 2011, MOL BREEDING, V27, P395, DOI 10.1007/s11032-010-9441-1
   McQualter RB, 2005, PLANT BIOTECHNOL J, V3, P29, DOI 10.1111/j.1467-7652.2004.00095.x
   Melkus G., 2011, PLANT BIOTE IN PRESS, DOI DOI 10.1111/J.1467-7652.2011.00618X
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Mihara M., 2009, NUCLEIC ACIDS RES, V38, pD835
   Mingossi FB, 2010, PLANT MOL BIOL, V73, P271, DOI 10.1007/s11103-010-9613-8
   Moore P. H., 1997, P141
   Mudge SR, 2009, PLANTA, V229, P549, DOI 10.1007/s00425-008-0852-8
   Nebo J. F., 2011, 10 GERMPL BREED 7 MO, P9
   Nell JS, 2007, THESIS U STELLENBOSC
   Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104
   NEUHAUS HE, 1991, PLANT SCI, V76, P49
   Ngara R, 2011, AFR J BIOTECHNOL, V10, P253
   Nogueira FTS, 2005, PLANT SCI, V169, P93, DOI 10.1016/j.plantsci.2005.03.008
   Nogueira FTS, 2003, PLANT PHYSIOL, V132, P1811, DOI 10.1104/pp.102.017483
   O'Connell A., 2011, 10 GERMPL BREED 7 MO, P64
   Oliveira KM, 2009, GENOME, V52, P191, DOI [10.1139/G08-105, 10.1139/g08-105]
   Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1
   Osabe K., 2009, Tropical Plant Biology, V2, P143, DOI 10.1007/s12042-009-9036-3
   Papini-Terzi FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-120
   Park Y. W., 2011, P PLANT AN GEN C 19, VXIX, pW319
   Pastina M. M., 2010, Genetics, genomics and breeding of sugarcane, P117
   Patade VY, 2012, MOL BIOL REP, V39, P3311, DOI 10.1007/s11033-011-1100-z
   Patade VY, 2011, PROTOPLASMA, V248, P613, DOI 10.1007/s00709-010-0207-8
   Paterson A. H., 2010, Genetics, genomics and breeding of sugarcane, P149
   Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723
   Pennisi E, 2011, SCIENCE, V332, P1372, DOI 10.1126/science.332.6036.1372
   Petrasovits LA, 2007, PLANT BIOTECHNOL J, V5, P162, DOI 10.1111/j.1467-7652.2006.00229.x
   Pimentel D, 2007, NAT RESOUR RES, V16, P235
   Pinto LR, 2010, EUPHYTICA, V172, P313, DOI 10.1007/s10681-009-9988-2
   Piperidis G, 2010, MOL GENET GENOMICS, V284, P65, DOI 10.1007/s00438-010-0546-3
   Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]
   Prabu G, 2011, PLANT MOL BIOL REP, V29, P291, DOI 10.1007/s11105-010-0230-0
   Preuss D., 2011, Patent Application # WO/2011/011685, Patent No. [WO/2011/011685, 2011011685]
   Purnell MP, 2007, PLANT BIOTECHNOL J, V5, P173, DOI 10.1111/j.1467-7652.2006.00230.x
   Que Qiudeng, 2010, GM Crops, V1, P220, DOI 10.4161/gmcr.1.4.13439
   Rae A. L., 2009, Tropical Plant Biology, V2, P13, DOI 10.1007/s12042-008-9019-9
   Rae A. L., 2011, P AUSTR SOC SUGAR CA, V33, P27
   Rae AL, 2005, FIELD CROP RES, V92, P159, DOI 10.1016/j.fcr.2005.01.027
   Rae AL, 2005, PLANTA, V220, P817, DOI 10.1007/s00425-004-1399-y
   Rae AL, 2001, AUST J PLANT PHYSIOL, V28, P289, DOI 10.1071/PP00093
   Rae AL, 2011, J PLANT PHYSIOL, V168, P983, DOI 10.1016/j.jplph.2010.11.003
   Rattey AR, 2009, CROP PASTURE SCI, V60, P1165, DOI 10.1071/CP09136
   Reinders A, 2006, PLANT CELL ENVIRON, V29, P1871, DOI 10.1111/j.1365-3040.2006.01563.x
   Renewable Fuels Association, 2011, ETH IND STAT
   Renouf MA, 2008, BIOMASS BIOENERG, V32, P1144, DOI 10.1016/j.biombioe.2008.02.012
   Ribeiro CW, 2008, BIOTECHNOL PROGR, V24, P1060, DOI 10.1021/bp.45
   Ritter KB, 2008, MOL BREEDING, V22, P367, DOI 10.1007/s11032-008-9182-6
   Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71
   Rodrigues FA, 2011, BIOL PLANTARUM, V55, P43, DOI 10.1007/s10535-011-0006-x
   Rohwer JM, 2001, BIOCHEM J, V358, P437, DOI 10.1042/0264-6021:3580437
   Rossi M, 2003, MOL GENET GENOMICS, V269, P406, DOI 10.1007/s00438-003-0849-8
   Rossouw D, 2007, FUNCT PLANT BIOL, V34, P490, DOI 10.1071/FP06214
   Rossouw D, 2010, FUNCT PLANT BIOL, V37, P22, DOI 10.1071/FP08210
   Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190
   Ruelland E, 2003, PHYSIOL PLANTARUM, V117, P93, DOI 10.1034/j.1399-3054.2003.1170112.x
   Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416
   Sainz MB, 2009, IN VITRO CELL DEV-PL, V45, P314, DOI 10.1007/s11627-009-9210-1
   Salter B, 2008, AUST J AGR RES, V59, P149, DOI 10.1071/AR07049
   Sanderson K, 2011, NATURE, V474, pS12, DOI 10.1038/474S012a
   Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]
   Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001
   Scheepers I., 2005, THESIS U STELLENBOSC
   Schenk PM, 2008, PLANT BIOLOGY, V10, P539, DOI 10.1111/j.1438-8677.2008.00056.x
   Schenk PM, 2001, PLANT MOL BIOL, V47, P399, DOI 10.1023/A:1011680008868
   Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534
   Schulz A, 2011, PLANT J, V68, P129, DOI 10.1111/j.1365-313X.2011.04672.x
   Selman-Housein G, 1999, PLANT SCI, V143, P163, DOI 10.1016/S0168-9452(99)00041-2
   Setamou M, 2002, J ECON ENTOMOL, V95, P469, DOI 10.1603/0022-0493-95.2.469
   Shiringani AL, 2010, THEOR APPL GENET, V121, P323, DOI 10.1007/s00122-010-1312-y
   Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992
   Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032
   Smeets E, 2008, BIOMASS BIOENERG, V32, P781, DOI 10.1016/j.biombioe.2008.01.005
   Snyman SJ, 2006, PLANT CELL REP, V25, P1016, DOI 10.1007/s00299-006-0148-z
   SOBRAL BWS, 1994, THEOR APPL GENET, V87, P843, DOI 10.1007/BF00221137
   Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268
   Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]
   Souza G. M., 2011, Tropical Plant Biology, V4, P145
   Souza G. M., 2010, BIOENERGY RES INTEGR
   Srikanth J., 2011, Tropical Plant Biology, V4, P52, DOI 10.1007/s12042-011-9077-2
   Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR
   Swami AK, 2011, ENVIRON EXP BOT, V71, P321, DOI 10.1016/j.envexpbot.2010.12.017
   Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12
   Teetor VH, 2011, IND CROP PROD, V34, P1293, DOI 10.1016/j.indcrop.2010.09.010
   Thompson G. D., 1986, SA SUGAR J, V60, P593
   Tilbrook K, 2011, PLANT BIOTECHNOL J, V9, P958, DOI 10.1111/j.1467-7652.2011.00600.x
   Tilbrook K, 2010, J PLANT PHYSIOL, V167, P329, DOI 10.1016/j.jplph.2009.10.001
   Tomkins JP, 1999, THEOR APPL GENET, V99, P419, DOI 10.1007/s001220051252
   Travella S, 2006, PLANT PHYSIOL, V142, P6, DOI 10.1104/pp.106.084517
   Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025
   Urbanchuk J., 2009, AgBioForum, V12, P149
   Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842
   Uys L, 2007, PHYTOCHEMISTRY, V68, P2375, DOI 10.1016/j.phytochem.2007.04.023
   van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x
   Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600
   van der Merwe MJ, 2010, PLANTA, V231, P595, DOI 10.1007/s00425-009-1069-1
   Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Verma AK, 2011, PLANT BIOLOGY, V13, P325, DOI 10.1111/j.1438-8677.2010.00379.x
   Verma AK, 2011, ACTA PHYSIOL PLANT, V33, P1749, DOI 10.1007/s11738-011-0711-2
   Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103
   Vicentini R, 2009, PLANT CELL REP, V28, P481, DOI 10.1007/s00299-008-0656-0
   Vicentini R, 2009, FUNCT PLANT BIOL, V36, P242, DOI 10.1071/FP08252
   Vicentz M., 2004, PLANT PHYSIOL, V134, P951
   Vickers JE, 2005, AUST J AGR RES, V56, P57, DOI 10.1071/AR04159
   Vickers JE, 2005, CROP SCI, V45, P354, DOI 10.2135/cropsci2005.0354
   Voelker SL, 2011, PLANT CELL ENVIRON, V34, P655, DOI 10.1111/j.1365-3040.2010.02270.x
   Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747
   Vu JCV, 2006, PLANT SCI, V171, P123, DOI 10.1016/j.plantsci.2006.03.003
   Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x
   Waltz E, 2011, NAT BIOTECHNOL, V29, P294
   Wang J., 2011, 10 GERMPL BREED 7 MO, P63
   Wang LP, 2008, CROP SCI, V48, P951, DOI 10.2135/cropsci2007.10.0555
   Wang ML, 2005, TRANSGENIC RES, V14, P167, DOI 10.1007/s11248-004-5415-6
   Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622
   Wang ZZ, 2010, PLANT GROWTH REGUL, V61, P85, DOI 10.1007/s10725-010-9453-1
   Watt D., 2010, Genetics, genomics and breeding of sugarcane, P193
   Wei X, 2006, P AUSTR SOC SUGAR CA, V28, P181
   Wei XM, 2006, THEOR APPL GENET, V114, P155, DOI 10.1007/s00122-006-0418-8
   Wei XM, 2010, GENOME, V53, P973, DOI 10.1139/G10-050
   Weng LX, 2011, TRANSGENIC RES, V20, P759, DOI 10.1007/s11248-010-9456-8
   Weng LX, 2006, PEST MANAG SCI, V62, P178, DOI 10.1002/ps.1144
   Whittaker A, 1997, PLANT PHYSIOL, V115, P1651, DOI 10.1104/pp.115.4.1651
   Whittaker A, 1999, PHYSIOL PLANTARUM, V107, P379, DOI 10.1034/j.1399-3054.1999.100402.x
   Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007
   Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1
   Wu LG, 2007, PLANT BIOTECHNOL J, V5, P109, DOI 10.1111/j.1467-7652.2006.00224.x
   Wu LG, 2010, FUNCT PLANT BIOL, V37, P1161, DOI 10.1071/FP10055
   YE ZH, 1994, PLANT CELL, V6, P1427, DOI 10.1105/tpc.6.10.1427
   Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579
   Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260
   Zhang JM, 2006, J INTEGR PLANT BIOL, V48, P1450, DOI 10.1111/j.1672-9072.2006.00403.x
   Zhang LH, 1999, NAT BIOTECHNOL, V17, P1021, DOI 10.1038/13721
   Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716
   Zhang SZ, 2006, J INTEGR PLANT BIOL, V48, P453, DOI 10.1111/j.1744-7909.2006.00246.x
   Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818
   Zhangsun D, 2007, BIOLOGIA, V62, P386, DOI 10.2478/s11756-007-0096-2
   Zhou M, 2011, FEBS J, V278, P929, DOI 10.1111/j.1742-4658.2011.08008.x
   Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107
   Zhu YJ, 1997, PLANT PHYSIOL, V115, P609, DOI 10.1104/pp.115.2.609
   Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003
NR 339
TC 9
Z9 10
U1 1
U2 34
PU ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL ROAD, LONDON NW1 7DX, ENGLAND
SN 0065-2296
BN 978-0-12-385851-1
J9 ADV BOT RES
JI Adv. Bot. Res.
PY 2011
VL 60
BP 89
EP 168
DI 10.1016/B978-0-12-385851-1.00003-2
PG 80
WC Plant Sciences
SC Plant Sciences
GA BYN09
UT WOS:000299397200003
DA 2018-10-20
ER

PT J
AU Basu, J
   Genheimer, CW
   Rivera, EA
   Payne, R
   Mihalko, K
   Guthrie, K
   Bruce, AT
   Robbins, N
   McCoy, D
   Sangha, N
   Ilagan, R
   Knight, T
   Spencer, T
   Wagner, BJ
   Jayo, MJ
   Jain, D
   Ludlow, JW
   Halberstadt, C
AF Basu, Joydeep
   Genheimer, Christopher W.
   Rivera, Elias A.
   Payne, Richard
   Mihalko, Kim
   Guthrie, Kelly
   Bruce, Andrew T.
   Robbins, Neil
   McCoy, Darell
   Sangha, Namrata
   Ilagan, Roger
   Knight, Toyin
   Spencer, Thomas
   Wagner, Belinda J.
   Jayo, Manuel J.
   Jain, Deepak
   Ludlow, John W.
   Halberstadt, Craig
TI Functional Evaluation of Primary Renal Cell/Biomaterial Neo-Kidney
   Augment Prototypes for Renal Tissue Engineering
SO CELL TRANSPLANTATION
LA English
DT Article
DE Kidney; Renal tissue engineering; Biomaterials; Regeneration; Neo-kidney
   augment
ID TUBULAR EPITHELIAL-CELLS; IN-VIVO; HYDROGEL MATERIAL; REGENERATION;
   REPAIR; MIGRATION; FIBROSIS; DISEASE; GROWTH; BRAIN
AB Development of a tissue-engineered neo-kidney augment (NKA) requires evaluation of defined, therapeutically relevant cell and cell/biomaterial composites (NKA constructs) for regenerative potential in mammalian kidney. Previous work identified primary renal cell populations that extended survival and improved renal function in a rodent model of chronic kidney disease (CKD). This study extends that work toward the goal of developing NKA by (i) screening in vivo inflammatory and fibrotic responses to acellular biomaterials delivered to healthy rodent renal parenchyma, (ii) evaluating the functionality of renal cell/biomaterial combinations in vitro, (iii) generating NKA constructs by combining therapeutically relevant cell populations with biocompatible biomaterial, and (iv) evaluating in vivo neokidney tissue development in response to NKA constructs delivered to healthy rodent renal parenchyma. Gelatin and hyaluronic acid (HA)-based hydrogels elicited the least inflammatory and fibrotic responses in renal parenchyma relative to polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA) beads or particles and were associated with neovascularization and cellular infiltration by 4 weeks postimplantation. Renal cell populations seeded onto gelatin or HA-based hydrogels were viable and maintained a tubular epithelial functional phenotype during an in vitro maturation of 3 days as measured by transcriptomic, proteomic, secretomic, and confocal immunofluorescence assays. In vivo delivery of cell-seeded NKA constructs (bioactive renal cells + gelatin hydrogels) to healthy rodent renal parenchyma elicited neokidney tissue formation at 1 week postimplantation. To investigate a potential mechanism by which NKA constructs could impact a disease state, the effect of conditioned media on TGF-beta signaling pathways related to tubulo-interstitial fibrosis associated with CKD progression was evaluated. Conditioned medium was observed to attenuate TGF-beta-induced epithelial mesenchymal transition (EMT) in vitro in a human proximal tubular cell line (HK2).
C1 [Basu, Joydeep; Genheimer, Christopher W.; Rivera, Elias A.; Payne, Richard; Guthrie, Kelly; Bruce, Andrew T.; Robbins, Neil; McCoy, Darell; Sangha, Namrata; Ilagan, Roger; Knight, Toyin; Spencer, Thomas; Wagner, Belinda J.; Jayo, Manuel J.; Jain, Deepak; Ludlow, John W.; Halberstadt, Craig] Tengion Inc, Winston Salem, NC 27103 USA.
   [Mihalko, Kim] Carolinas Med Ctr, Charlotte, NC 28203 USA.
RP Basu, J (reprint author), Tengion Inc, 3929 Westpoint Blvd, Winston Salem, NC 27103 USA.
EM joydeep.basu@tengion.com
CR Aboushwareb T, 2008, WORLD J UROL, V26, P295, DOI 10.1007/s00345-008-0301-0
   Anand A, 2009, INDIAN J PHARM SCI, V71, P377, DOI 10.4103/0250-474X.57285
   Basu J., 2010, FASEB J, V24, pLB35
   Basu J, 2010, TRENDS BIOTECHNOL, V28, P526, DOI 10.1016/j.tibtech.2010.07.007
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   BORDER WA, 1994, NEW ENGL J MED, V331, P1286
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Dudas PL, 2009, NEPHROL DIAL TRANSPL, V24, P1406, DOI 10.1093/ndt/gfn662
   Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731
   Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Kelley R, 2010, AM J PHYSIOL-RENAL, V299, pF1026, DOI 10.1152/ajprenal.00221.2010
   Li WJ, 2009, J TISSUE ENG REGEN M, V3, P1, DOI 10.1002/term.127
   Lim SM, 2009, J BIOMED MATER RES B, V90B, P521, DOI 10.1002/jbm.b.31313
   Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Low SW, 2009, SINGAP MED J, V50, P777
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Natarajan V, 2011, J PHARM SCI-US, V100, P195, DOI 10.1002/jps.22266
   Okada H, 2000, NEPHROL DIAL TRANSPL, V15, P44, DOI 10.1093/ndt/15.suppl_6.44
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Powe NR, 2009, AM J KIDNEY DIS, V53, pS37, DOI 10.1053/j.ajkd.2008.07.056
   Presnell SC, 2011, TISSUE ENG PART C-ME, V17, P261, DOI 10.1089/ten.TEC.2010.0399
   PROPHET EB, 1992, ARMED FORCES I PATHO
   Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001
   Rosines E, 2007, BIOMATERIALS, V28, P4806, DOI 10.1016/j.biomaterials.2007.07.034
   Shackelford C, 2002, TOXICOL PATHOL, V30, P93, DOI 10.1080/01926230252824761
   Silva-Cunha A, 2009, INVEST OPHTH VIS SCI, V50, P2312, DOI 10.1167/iovs.08-2969
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   SUGGS LJ, 1996, PHYSICAL PROPERTIES, P615
   TATE SS, 1985, METHOD ENZYMOL, V113, P400
   U.S. Renal Data System, 2007, 2007 USRDS ANN DAT R, P223
   Vidal BC, 2005, CLIN SCI, V109, P421, DOI 10.1042/CS20050085
   VIZE PD, 2003, KIDNEY NORMAL DEV CO
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796
   Zeisberg M, 2002, AM J PATHOL, V160, P2001, DOI 10.1016/S0002-9440(10)61150-9
NR 43
TC 17
Z9 17
U1 0
U2 15
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2011
VL 20
IS 11-12
BP 1771
EP 1790
DI 10.3727/096368911X566172
PG 20
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 901JE
UT WOS:000300962400009
PM 21439130
OA Bronze
DA 2018-10-20
ER

PT J
AU Cavas, L
   Gokoglu, M
AF Cavas, Levent
   Gokoglu, Mehmet
TI Caulerpa scalpelliformis as an antibiotic carrier
SO TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
LA English
DT Article
DE Antibiotics; biosorption; Caulerpa scalpelliformis; tetracycline; waste
   water treatment
ID METHYLENE-BLUE; IRON-OXIDES; ADSORPTION; SORPTION; TETRACYCLINE;
   REMOVAL; BIOSORPTION; SEAWEED; CARBON; WATER
AB Aim: Excreted tetracycline via urine and feces of animals is an important ecological problem since microorganisms in soils can change their genetic structures to be resistant against tetracycline. Therefore, uncontrolled release of this antibiotic to environment should be prevented. Biosorption of tetracycline by Caulerpa scalpelliformis, alien seaweed for Turkish coastlines, was studied in the present study.
   Methods: Kinetics (pseudo first order, pseudo second order), isotherm (Langmuir, Freundlich and Dubinin-Radushkevich) and thermodynamics models were applied to the biosorption data.
   Results: Pseudo-second-order model was fitted well with the sorption data compared to pseudo-first-order model. Langmuir, Freundlich and Dubinin-Radushkevich (DR) isotherm models were also investigated. The energy values related to DR at 293, 308 and 323 K were found as 0.224, 0.845 and 1.291 kj/mol, respectively. These values revealed that biosorption process is in physical nature. According to DR model, the maximum adsorption capacity was found as 3.171 mg/g at 308 K. Thermodynamic parameters such as entropy, enthalpy and free energy values showed that biosorption process was endothermic and was not spontaneous.
   Conclusion: C. scalpelliformis could be used as a low-cost biomaterial for biosorption of tetracycline from aqueous solutions and also its tetracycline immobilised form could be evaluated as an animal food.
C1 [Cavas, Levent] Dokuz Eylul Univ, Fac Sci, Dept Chem, Div Biochem, TR-35160 Izmir, Turkey.
   [Gokoglu, Mehmet] Akdeniz Univ, Fac Fisheries, TR-07058 Antalya, Turkey.
RP Cavas, L (reprint author), Dokuz Eylul Univ, Fac Sci, Dept Chem, Div Biochem, Kaynaklar Campus, TR-35160 Izmir, Turkey.
EM lcavas@deu.edu.tr
RI Gokoglu, mehmet/C-3048-2016
CR ANTBURSALI E, 2009, CHEM ENG J, V150, P385
   Basha S, 2008, CHEM ENG J, V137, P480, DOI 10.1016/j.cej.2007.04.038
   Benhammou A, 2005, J COLLOID INTERF SCI, V282, P320, DOI 10.1016/j.jcis.2004.08.168
   Caparkaya D, 2008, ACTA CHIM SLOV, V55, P547
   Cavas L, 2010, CELL ORIG LIFE EXTRE, V15, P385, DOI 10.1007/978-90-481-8569-6_22
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Chang PH, 2009, COLLOID SURFACE A, V339, P94, DOI 10.1016/j.colsurfa.2009.02.002
   Chang PH, 2009, J HAZARD MATER, V165, P148, DOI 10.1016/j.jhazmat.2008.09.113
   Chen WR, 2010, CHEMOSPHERE, V79, P779, DOI 10.1016/j.chemosphere.2010.03.020
   Choi KJ, 2008, ENVIRON TECHNOL, V29, P333, DOI 10.1080/09593330802102223
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Figueroa RA, 2005, ENVIRON SCI TECHNOL, V39, P6664, DOI 10.1021/es048044l
   Figueroa RA, 2004, ENVIRON SCI TECHNOL, V38, P476, DOI 10.1021/es0342087
   Freundlich H. M. F., 1907, J PHYS CHEM-US, V57, P385, DOI DOI 10.1021/JE900585T
   Gokoglu M, 2010, TURKEY RAPP COMM INT, V39, P531
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Gurboga G, 2005, J HAZARD MAT B, VB120, P135
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Hu J, 2005, WATER RES, V39, P4528, DOI 10.1016/j.watres.2005.05.051
   Ji LL, 2010, ENVIRON SCI TECHNOL, V44, P6429, DOI 10.1021/es1014828
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Tanis E, 2008, COLLOID SURFACE A, V327, P57, DOI 10.1016/j.colsurfa.2008.06.013
   Turku I, 2007, ENVIRON CHEM LETT, V5, P225, DOI 10.1007/s10311-007-0106-1
   Vu BK, 2010, ENVIRON TECHNOL, V31, P233, DOI 10.1080/09593330903453210
   Wan Y, 2010, CHEMOSPHERE, V80, P807, DOI 10.1016/j.chemosphere.2010.04.066
   Wang JT, 2010, J COLLOID INTERF SCI, V349, P578, DOI 10.1016/j.jcis.2010.04.081
   Wu CX, 2009, J ENVIRON SCI HEAL A, V44, P454, DOI 10.1080/10934520902719779
   Yuan X, 2009, MICROPOR MESOPOR MAT, V117, P678, DOI 10.1016/j.micromeso.2008.07.039
NR 32
TC 3
Z9 3
U1 1
U2 6
PU TURKISH BIOCHEM SOC
PI ANKARA
PA HIRFANLI SOKAK BANU, APT 9-3 GAZIOSMANPASA, ANKARA, 06700, TURKEY
SN 0250-4685
J9 TURK J BIOCHEM
JI Turk. J. Biochem.
PY 2011
VL 36
IS 2
BP 93
EP 101
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 901NP
UT WOS:000300974200002
DA 2018-10-20
ER

PT S
AU Dumont, CM
   Karande, P
   Thompson, DM
AF Dumont, C. M.
   Karande, P.
   Thompson, D. M.
GP IEEE
TI High-throughput Analysis of 3D Schwann Cell Arrays for use in Neural
   Tissue Engineering
SO 2011 IEEE 37TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 37th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 01-03, 2011
CL Rensselaer Polytechn Inst (RPI), Troy, NY
SP IEEE
HO Rensselaer Polytechn Inst (RPI)
AB These results demonstrate the use of a high resolution scanner for rapid screening of cellular responses (number and morphology) to 3D biomaterials for neural tissue engineering applications. Limited axonal re-growth through the injury site has been linked to poor Schwann cell (SC) migration and re-population [1]. An optimal biomaterial that promotes neurite outgrowth and SC migration may improve functionality [2]. In this work, a fluorescence flatbed scanner was used to rapidly assess cells in 3D, using SC as a model cell. Assay sensitivity to size, cell number, and material was examined using primary SCs cultured for 1-3days. The cultured arrays were fixed, immunostained, and scanned. Increased spot intensities on the scanned arrays were identified as 'hits', which were confirmed with traditional fluorescence microscopy. There were no differences in scanning for constructs 2-4mm. Significant differences were detected in cell number for 250-1000cells/mu l. More subtle differences in cell spreading were detected below 1000cells/mu l, confirmed by traditional fluorescence microscopy. Morphological differences were detected using the scanner between the two model biomaterials (collagen-Matrigel (TM) and collagen-only materials) These results demonstrate the feasibility of using a scanner to rapidly assess complex protein arrays to screen large libraries of biomaterials in 3D for use in tissue engineering.
C1 [Dumont, C. M.; Karande, P.; Thompson, D. M.] Rensselaer Polytech Inst, Troy, NY 12180 USA.
RP Dumont, CM (reprint author), Rensselaer Polytech Inst, 110 8th St, Troy, NY 12180 USA.
CR Cimetta E, 2010, BIOTECHNOL PROGR, V26, P220, DOI 10.1002/btpr.300
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   L Baier, 2003, J ANN REV BIOMED ENG, V57, P293
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
NR 6
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-61284-826-6
J9 NORTHEAST BIOENGIN C
PY 2011
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials
SC Cell Biology; Engineering; Materials Science
GA BXV68
UT WOS:000297284900066
DA 2018-10-20
ER

PT S
AU Johnson, CD
   Zudiema, J
   Gilbert, RJ
AF Johnson, C. D.
   Zudiema, J.
   Gilbert, R. J.
GP IEEE
TI Decreasing the Gelation Time of Fibrin Hydrogels
SO 2011 IEEE 37TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 37th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 01-03, 2011
CL Rensselaer Polytechn Inst (RPI), Troy, NY
SP IEEE
HO Rensselaer Polytechn Inst (RPI)
AB Spinal cord injury (SCI) is a debilitating problem that often results in paraplegia or quadriplegia. Fibrin hydrogels can be injected into the injured cavity and fill the irregular space. Current techniques require 60 minutes to form a hydrogel. The purpose of this study was to design a fibrin biomaterial that would solidify at a faster rate. By augmenting the existing fabrication procedure, a novel biomaterial was created that formed in 5-7 minutes but lost much of its mechanical stability. Further studies will be performed to improve the mechanical properties while maintaining the faster rate of formation observed here.
C1 [Johnson, C. D.; Zudiema, J.; Gilbert, R. J.] Rensselaer Polytech Inst, Troy, NY 12180 USA.
RP Johnson, CD (reprint author), Rensselaer Polytech Inst, 110 8th St, Troy, NY 12180 USA.
CR Janmey P. A., 2008, J ROYAL SOC INTERFAC, V6, P1
   MCG Web Development, 2010, SPIN CORD INJ FACTS
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Weisel J. W., 2005, FIBRINOGEN FIBRIN FI, P247
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-61284-826-6
J9 NORTHEAST BIOENGIN C
PY 2011
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials
SC Cell Biology; Engineering; Materials Science
GA BXV68
UT WOS:000297284900140
DA 2018-10-20
ER

PT S
AU McKay, CA
   Gilbert, RJ
AF McKay, C. A.
   Gilbert, R. J.
GP IEEE
TI Using Cerebrospinal Fluid for in situ Fabrication of Injectable Alginate
   Hydrogels for Spinal Cord Repair
SO 2011 IEEE 37TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 37th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 01-03, 2011
CL Rensselaer Polytechn Inst (RPI), Troy, NY
SP IEEE
HO Rensselaer Polytechn Inst (RPI)
ID INJURY
AB Severe mechanical trauma of the spinal cord induces a secondary injury response that contributes to post injury cell death and the formation of barriers inhibitory to neuronal regeneration. It is believed that engineered scaffolds produce favorable results when they mimic the properties of the tissue that they are aiming to replicate. Alginate hydrogels have been shown to be beneficial in a number of biomaterial applications and this study shows that alginate hydrogels formed in the presence of an artificial cerebrospinal fluid are able to form hydrogels with mechanical properties similar to those exhibited by neural tissue in the CNS. Extracellular concentration of calcium is increased in the cerebrospinal fluid after spinal cord injury and has been linked to the apoptosis of surviving cells. The use of in situ forming alginate hydrogels is a novel approach that may aid in the regeneration of neurons after spinal cord injury and in the reduction of the effects of secondary injury.
C1 [McKay, C. A.; Gilbert, R. J.] Rensselaer Polytech Inst, New York, NY 12280 USA.
RP McKay, CA (reprint author), Rensselaer Polytech Inst, 110 8th St, New York, NY 12280 USA.
CR Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   Ma P. X., 2001, BIOMATERIALS, V22, P511
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-61284-826-6
J9 NORTHEAST BIOENGIN C
PY 2011
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials
SC Cell Biology; Engineering; Materials Science
GA BXV68
UT WOS:000297284900068
DA 2018-10-20
ER

PT S
AU Zhang, LJ
   Webster, TJ
AF Zhang, Lijuan
   Webster, Thomas J.
GP IEEE
TI Decreased breast adenocarcinoma cell functions on select polymer
   nanometer surface features
SO 2011 IEEE 37TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 37th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 01-03, 2011
CL Rensselaer Polytechn Inst (RPI), Troy, NY
SP IEEE
HO Rensselaer Polytechn Inst (RPI)
AB Biomaterial nanotopographies have been proposed as a means to significantly influence cell functions (including osteoblasts, fibroblasts, endothelial cells, chondrocytes, immune cells, bacteria, etc.). In this study, vascular endothelial growth factor (VEGF) synthesis by breast adenocarcinoma cells on poly-lactic-co-glycolic acid (PLGA) films with various nanotopographies was investigated. Importantly, this study created PLGA films with various nanotopographies but similar surface chemistry in order to focus only on the effect of topography on cancer cell functions. Simple and effective cast-molding and solvent evaporation methods were used to accomplish this. Atomic force microscopy (AFM), electron spectroscopy for chemical analysis (ESCA) and water contact angle measurements verified similar surface chemistry but varied topographies for all of the PLGA films prepared in this study. Cell experiment results demonstrated decreased breast carcinoma cell VEGF (a key growth factor secreted for vascularization of tumors) synthesis on the 23 nm surface featured PLGA compared to the nano-smooth substrates for up to 5 days. This result matches lung carcinoma cell VEGF synthesis in prior research. In summary, these results provided useful insights into understanding of the role nanotopography may play in mediating breast adenocarcinoma cell functions for a wide range of applications in regenerative medicine.
C1 [Zhang, Lijuan] Brown Univ, Dept Chem, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Sch Engn, Dept Orthopaed, Providence, RI 02912 USA.
RP Zhang, LJ (reprint author), Brown Univ, Dept Chem, Providence, RI 02912 USA.
CR Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Zhang LJ, 2010, INT J NANOMED, V5, P269
NR 2
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-61284-826-6
J9 NORTHEAST BIOENGIN C
PY 2011
PG 2
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials
SC Cell Biology; Engineering; Materials Science
GA BXV68
UT WOS:000297284900070
DA 2018-10-20
ER

PT S
AU Liu, Q
   Zhang, BJ
AF Liu, Qiang
   Zhang, Bingjian
BE Tan, Y
   Ju, DY
TI Synthesis and characterization of a novel biomaterial for the
   conservation of historic stone buildings and sculptures
SO ADVANCED MATERIAL SCIENCE AND TECHNOLOGY, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Forum on Advanced Material Science and Technology
CY JUN 26-28, 2011
CL Dalian, PEOPLES R CHINA
SP Natl Nat Sci Fdn China, KC Wong Educ Fdn, Dalian Univ Technol, Changchun Res Inst Mech Sci Co Ltd
DE Stone conservation; Consolidation; Surface protection; Biomimetic
   synthesis; Apatite
AB The conservation of historic stone sculptures and buildings is a focus of research. But there are no completely satisfying protective materials until now. In this paper, a conservative film of apatite has been prepared on the surface-modified marble stone by using a solution of CaCl2 and (NH4)(2)HPO4 as the precursor through a biomimetic method. The prepared material was characterized by some instruments. Its performances were also evaluated by its ability to consolidate, resist soil and acid. The obtained results indicate that the conservative effects are satisfying and the biomimetic synthesis should represent a new prospective in stone conservation.
C1 [Liu, Qiang] Yunnan Univ, Yunnan Key Lab Nanomat & Nanotechnol, Dept Mat Sci & Technol, Kunming 650091, Peoples R China.
   [Zhang, Bingjian] Zhejiang Univ, Dept Chem, Hangzhou 310027, Peoples R China.
RP Liu, Q (reprint author), Yunnan Univ, Yunnan Key Lab Nanomat & Nanotechnol, Dept Mat Sci & Technol, Kunming 650091, Peoples R China.
EM yusosliu@yahoo.com.cn; zbj@mail.hz.zj.cn
RI zhang, bingjian/F-1127-2014
FU National Natural Science Foundation of China [50963005, 20671080]; Youth
   Foundation on Humanities and Social Sciences of Chinese Education
   Ministry [07JC850006]; Provincial Natural Science Foundation of Yunnan
   [2007E160M, 08Z0008]; Scholastic Natural Science Foundation of Yunnan
   University [2009E26Q]
FX This work was supported by the National Natural Science Foundation of
   China (No. 50963005 and No. 20671080), the Youth Foundation on
   Humanities and Social Sciences of Chinese Education Ministry
   (07JC850006), the Provincial Natural Science Foundation of Yunnan
   (2007E160M and 08Z0008), and the Scholastic Natural Science Foundation
   of Yunnan University (2009E26Q).
CR Al-Turaif H, 2004, PROG ORG COAT, V49, P62, DOI 10.1016/j.progcoat.2003.08.008
   Liu Q, 2007, MATER LETT, V61, P4976, DOI 10.1016/j.matlet.2007.03.104
   Liu Q, 2006, APPL SURF SCI, V253, P2625, DOI 10.1016/j.apsusc.2006.05.032
   Price C., 1996, STONE CONSERVATION
   Song J, 2003, J AM CHEM SOC, V125, P1236, DOI 10.1021/ja028559h
   Striegel MF, 2003, PROG ORG COAT, V48, P281, DOI 10.1016/j.porgcoat.2003.05.001
   Sugawara A, 2002, J BIOMED MATER RES, V61, P47, DOI 10.1002/jbm.10010
NR 7
TC 9
Z9 9
U1 3
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2011
VL 675-677
BP 317
EP +
DI 10.4028/www.scientific.net/MSF.675-677.317
PG 2
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BXT82
UT WOS:000297036200075
DA 2018-10-20
ER

PT S
AU Malathi, S
   Mangal, N
   Samad, SA
   Honnungar, RV
   Srinivas, T
AF Malathi, Sathish
   Mangal, Nivesh
   Samad, Shafeek A.
   Honnungar, Rajini V.
   Srinivas, T.
BE Koshel, RJ
   Gregory, GG
TI SOI strip waveguide microring resonator for homogeneous biosensing
SO NOVEL OPTICAL SYSTEMS DESIGN AND OPTIMIZATION XIV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Novel Optical Systems Design and Optimization XIV
CY AUG 22, 2011
CL San Diego, CA
SP SPIE
DE Integrated optics; strip waveguides; silicon-on-insulator; biosensors;
   homogeneous sensing; microring resonators
AB We report the simulation and analytical results obtained for homogenous or bulk sensing of protein on Siliconon-insulator strip waveguide based microring resonator. The radii of the rings considered are 5 mu m and 20 mu m; the waveguide dimensions are 300 x 300 nm. A gap of (i) 200 nm and (ii) 300 nm exists between the ring and the bus waveguide. The biomaterial is uniformly distributed over a thickness which exceeds the evanescent field penetration depth of 150 nm. The sensitivities of the resonators are 32.5 nm/RIU and 17.5 nm/RIU (RIU - Refractive index unit) respectively.
C1 [Malathi, Sathish; Mangal, Nivesh; Honnungar, Rajini V.; Srinivas, T.] Indian Inst Sci, Appl Photon Lab, ECE Dept, Bangalore 560012, Karnataka, India.
   [Samad, Shafeek A.] Cochin Univ Sci & Technol, Cochin 682002, Kerala, India.
RP Malathi, S (reprint author), Indian Inst Sci, Appl Photon Lab, ECE Dept, Bangalore 560012, Karnataka, India.
EM sathishvac@gmail.com; niveshm@gmail.com; tsrinu.iisc@gmail.com
RI Talabattula, Srinivas/L-3819-2013
CR Borges Ben-Hur V., 1999, P SBMO IEEE MTT S IM
   De Vos K, 2007, OPT EXPRESS, V15, P7610, DOI 10.1364/OE.15.007610
   Densmore A, 2006, IEEE PHOTONIC TECH L, V18, P2520, DOI 10.1109/LPT.2006.887374
   Heebner J, 2008, OPTICAL MICRORESONAT
   Hiremath K.R., 2005, THESIS U TWENTE NETH
   Lockwood D. J., 2010, SILICON PHOTONICS, VII
   Luff BJ, 1998, J LIGHTWAVE TECHNOL, V16, P583, DOI 10.1109/50.664067
   Malathi S., 2010, P IEEE ICP2010 51 MA
   Malathi S., 2010, P PHOT GLOB C SING
   Parriaux O, 1998, J LIGHTWAVE TECHNOL, V16, P573, DOI 10.1109/50.664066
   Reed G. T., 2008, SILICON PHOTONICS ST
   Selvaraja SK, 2009, J LIGHTWAVE TECHNOL, V27, P4076, DOI 10.1109/JLT.2009.2022282
   YARIV A, 1973, IEEE J QUANTUM ELECT, VQE 9, P919, DOI 10.1109/JQE.1973.1077767
NR 13
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-81948-739-1
J9 PROC SPIE
PY 2011
VL 8129
AR UNSP 81290B
DI 10.1117/12.899476
PG 7
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BXL72
UT WOS:000296319100010
DA 2018-10-20
ER

PT J
AU Estarlich, FMF
   Eaton, PJ
   Fletcher, RL
   Lewey, SA
   Nevell, TG
   Smith, JR
   Tsibouklis, J
AF Estarlich, Francisca M. Fernandez
   Eaton, Peter J.
   Fletcher, Robert L.
   Lewey, Susan A.
   Nevell, Thomas G.
   Smith, James R.
   Tsibouklis, John
TI The Effects of Incorporated Silicone Oils and Calcium Carbonate on the
   Resistance to Settlement and the Antifouling Performance of a Silicone
   Elastomer
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Poly(dimethylsiloxane); silicone; calcium carbonate filler; marine
   antifouling
ID ATOMIC-FORCE MICROSCOPE; BACTERIAL ADHESION; PROTEIN ADSORPTION;
   BIOMATERIAL SURFACES; POLYMERS; COATINGS; POLYDIMETHYLSILOXANE;
   MECHANISMS; MONOLAYERS; DEXTRAN
AB The surfaces of elastomeric coatings based on poly(dimethylsiloxane), unfilled or containing calcium carbonate filler or with filler and silicone oils, have been characterised from topographic and surface indentation measurements by atomic force microscopy. The resistance of the coatings to marine biofouling has been assessed in a sea-exposure trial, in which the strengths of attachment of some barnacles and tubeworms have been measured. In laboratory experiments, the materials have been challenged with oyster larvae (Crassotrea gigas), barnacle cyprids (Balanus amphitrite) and brown algal embryos (Sargassum muticum). Using a linear stress flow cell, the stresses required to detach settled larvae and embryos by fluid flow have been measured.
   The attachment of barnacles to the coatings was promoted by the microscopic surface roughness produced by protruding particles of filler. Oyster larvae and algal embryos were more readily displaced from surfaces that had been characterised as relatively soft, or from oil-bloomed surfaces. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Estarlich, Francisca M. Fernandez; Eaton, Peter J.; Nevell, Thomas G.; Smith, James R.; Tsibouklis, John] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   [Estarlich, Francisca M. Fernandez; Lewey, Susan A.] Southampton Inst, Maritime Res Ctr, Southampton SO14 0RP, Hants, England.
   [Fletcher, Robert L.] Univ Portsmouth, Inst Marine Sci, Eastney PO4 9LY, Hants, England.
RP Nevell, TG (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM tom.nevell@port.ac.uk
RI REQUIMTE, FMN/M-5611-2013; Smith, James/F-1108-2014; REQUIMTE,
   UCIBIO/N-9846-2013; Smith, James/D-2350-2011; Eaton, Peter/B-4906-2008
OI Smith, James/0000-0001-8805-3788; Smith, James/0000-0001-8805-3788;
   Eaton, Peter/0000-0003-1821-1992; Tsibouklis, John/0000-0001-5300-357X
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   [Anonymous], 1993, D362378A ASTM
   Aranguren MI, 1997, J COLLOID INTERF SCI, V195, P329, DOI 10.1006/jcis.1997.5143
   *ASTM, D561894 ASTM
   Barnes H.A., 2000, HDB ELEMENTARY RHEOL
   Berglin M, 1999, J ADHES SCI TECHNOL, V13, P713, DOI 10.1163/156856199X00956
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brady RF, 1997, CHEM IND-LONDON, P219
   Brady RF, 1999, PROG ORG COAT, V35, P31, DOI 10.1016/S0300-9440(99)00005-3
   Bullock S, 1999, J COLLOID INTERF SCI, V210, P18, DOI 10.1006/jcis.1998.5856
   Burnell T, 2000, ACS SYM SER, V729, P180
   CLARE AS, 1992, INVERTEBR REPROD DEV, V22, P67, DOI 10.1080/07924259.1992.9672258
   Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276
   Cunliffe D, 2000, BIOTECHNOL LETT, V22, P141, DOI 10.1023/A:1005622424821
   Eaton P, 2002, LANGMUIR, V18, P10011, DOI 10.1021/la0110747
   Eaton PJ, 2000, LANGMUIR, V16, P7887, DOI 10.1021/la000159p
   EDWARDS DP, 1994, INT BIODETER BIODEGR, V34, P333
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   ESTARLICH FF, 2000, BIOFOULING, V16, P245
   EVANS LV, 1993, J APPL BACTERIOL, V74, pS119, DOI 10.1111/j.1365-2672.1993.tb04348.x
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Graham PD, 2000, BIOFOULING, V16, P289, DOI 10.1080/08927010009378452
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Griffith J. R., 1997, Patent No. [US5593732, 5593732]
   Griffith JR, 1995, US Patent, Patent No. [5,449,553, 5449553]
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Holland NB, 1998, NATURE, V392, P799
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   LEE JH, 1988, POLYM SURFACE DYNAMI, P119
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   MORTON LHG, 1994, INT BIODETER BIODEGR, V34, P203, DOI 10.1016/0964-8305(94)90083-3
   Nevell TG, 1996, BIOFOULING, V10, P199, DOI 10.1080/08927019609386280
   NEWBY J, 1995, SCIENCE, V269, P1407
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Schrader M. E., 1988, Marine biodeterioration., P261
   Swain GW, 1996, BIOFOULING, V10, P187, DOI 10.1080/08927019609386279
   Tsibouklis J, 1999, LANGMUIR, V15, P7076, DOI 10.1021/la990411x
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   Tsibouklis J., 2006, CONTACT ANGLE WETTAB, V4, P461
   USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vrolijk N.H., 1990, Biofouling, V2, P39
NR 48
TC 1
Z9 1
U1 1
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2011
VL 25
IS 17
BP 2183
EP 2198
DI 10.1163/016942411X574907
PG 16
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 842VE
UT WOS:000296628600006
DA 2018-10-20
ER

PT J
AU Carnazza, S
   Marletta, G
   Frasca, M
   Fortuna, L
   Guglielmino, S
AF Carnazza, S.
   Marletta, G.
   Frasca, M.
   Fortuna, L.
   Guglielmino, S.
TI Spatial Patterns of Microbial Retention on Polymer Surfaces
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Microbial retention; bacteria; yeast; polymer surfaces; surface free
   energy; cell physiological state; fractal distribution
ID PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; BACTERIAL ADHESION;
   CANDIDA-ALBICANS; CELL-ADHESION; BIOMATERIAL SURFACES; SUBSTRATUM
   SURFACE; CHEMICAL-REACTIONS; EPITHELIAL-CELLS; BIOFILM
AB Microbial adhesion and retention on surfaces are complex phenomena, critical to the formation and development of biofilms. Recently, the focus of research has been more and more on the importance of retention of bacteria under fluctuating high shear forces in biofilm formation. The aim of the present work was to carry out a comparative study of the retention process of different bacterial and yeast species using: (1) a range of surfaces with different surface free energy properties and (2) a number of different bacterial cell physiological states. It was found for the first time that once a threshold cell number is retained on the surface, microbial retention patterns are formed following a power law, i.e., not stochastic. Our results demonstrated that the overall spatial patterns of microbial retention observed for the different substrates are similar for the all investigated cell types and that the drastic modification of the surface free energy does not affect this spatial organization. On the other hand, the microbial retention patterns appear to be significantly affected by the physiological state of the cells. Finally, the experimental retention patterns have been well simulated by a general agent-based model, confirming that the typical fractal distribution of retained cells is the result of a self-organization process. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Carnazza, S.; Guglielmino, S.] Univ Messina, Dipartimento Sci Vita M Malpighi, Sez Sci Microbiol Genet & Mol, I-98166 Messina, Italy.
   [Marletta, G.] Univ Catania, Dipartimento Sci Chim, Lab Mol Surfaces & Nanotechnol LAMSUN, I-95127 Catania, Italy.
   [Frasca, M.; Fortuna, L.] Univ Catania, Dipartimento Ingn Elettr Elettron & Sistemi, I-95127 Catania, Italy.
RP Guglielmino, S (reprint author), Univ Messina, Dipartimento Sci Vita M Malpighi, Sez Sci Microbiol Genet & Mol, Via Ferdinando Stagno dAlcontres 31, I-98166 Messina, Italy.
EM sguglielm@unime.it
RI Marletta, Giovanni/F-3154-2012
OI Marletta, Giovanni/0000-0002-6929-9499; Frasca,
   Mattia/0000-0002-4361-0576
FU CSGI (Interuniversity Consortium for Large Interphase Systems); ITS-LEIF
   (EU); University of Messina [PRA 2005]
FX S.C. acknowledges fellowship support from CSGI (Interuniversity
   Consortium for Large Interphase Systems). G. M. acknowledges the partial
   financial support of ITS-LEIF Program (EU contract). This work was
   partially supported by the Athenaeum project of the University of
   Messina (PRA 2005).
CR Amato I, 2007, BIOMATERIALS, V28, P3668, DOI 10.1016/j.biomaterials.2007.04.038
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ARCIOLA CR, 1995, BIOMATERIALS, V16, P681, DOI 10.1016/0142-9612(95)99694-H
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V3, P195
   Assero G, 2004, MICROVASC RES, V68, P209, DOI 10.1016/j.mvr.2004.08.003
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Bedard DL, 2008, ANNU REV MICROBIOL, V62, P253, DOI 10.1146/annurev.micro.62.081307.162733
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   Blackman IC, 1996, J FOOD PROTECT, V59, P827, DOI 10.4315/0362-028X-59.8.827
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Bos R, 2000, FEMS MICROBIOL LETT, V189, P311, DOI 10.1016/S0378-1097(00)00298-6
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Brewer Susan Crouch, 1996, Chest, V109, P1019, DOI 10.1378/chest.109.4.1019
   Buchanan M., 2000, UBIQUITY
   Bucolo M., 2004, P INT S CIRC SYST IS
   BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   Caratozzolo M, 2008, MATH BIOSCI ENG, V5, P75
   Carnazza S, 2006, J PHYS-CONDENS MAT, V18, pS2221, DOI 10.1088/0953-8984/18/33/S36
   Carnazza S, 2005, J COLLOID INTERF SCI, V289, P386, DOI 10.1016/j.jcis.2005.03.089
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   COOKSEY KE, 1995, AQUAT MICROB ECOL, V9, P87, DOI 10.3354/ame009087
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   DAVIES DG, 1995, APPL ENVIRON MICROB, V61, P860
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Dhanasekaran D, 2009, INT J ENVIRON SCI TE, V6, P197
   Dornieden T, 2000, INT BIODETER BIODEGR, V46, P261, DOI 10.1016/S0964-8305(00)00107-4
   FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001
   Garrett ES, 1999, J BACTERIOL, V181, P7401
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Grasso D, 1996, ENVIRON SCI TECHNOL, V30, P3604, DOI 10.1021/es960332x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAZEN KC, 1989, INFECT IMMUN, V57, P1894
   Kiers PJM, 2001, MICROBIOL-UK, V147, P757, DOI 10.1099/00221287-147-3-757
   Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002
   Landa AS, 1998, CORNEA, V17, P293, DOI 10.1097/00003226-199805000-00007
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   Marletta G, 2007, BIOMATERIALS, V28, P1132, DOI 10.1016/j.biomaterials.2006.10.027
   MARLETTA G, 1990, NUCL INSTRUM METH B, V46, P295, DOI 10.1016/0168-583X(90)90716-8
   Marletta G, 2010, TOP APPL PHYS, V116, P345, DOI 10.1007/978-3-540-88789-8_12
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   MARLETTA G, 1995, NATO ASI SERIES E, V290, P597
   Oshima H., 1995, COLLOID SURF A, V103, P249
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993
   RAMSEY AJ, 1978, NEW ZEAL J MAR FRESH, V12, P365
   RATNER BD, 2004, BIOMATERIALS SCI INT, P201
   Rawlings DE, 2002, ANNU REV MICROBIOL, V56, P65, DOI 10.1146/annurev.micro.56.012302.161052
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P5, DOI DOI 10.1016/0927-7765(94)01146-V
   Satriano C, 2002, LANGMUIR, V18, P9469, DOI 10.1021/la025800x
   Satriano C., 2006, CONTACT ANGLE WETTAB, V4, P1
   Sauer K, 2001, J BACTERIOL, V183, P6579, DOI 10.1128/JB.183.22.6579-6589.2001
   Shabala L, 2006, FEMS MICROBIOL REV, V30, P472, DOI 10.1111/j.1574-6976.2006.00019.x
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Suzuki N, 1997, SURF INTERFACE ANAL, V25, P650
   Templeton A, 2009, ANNU REV EARTH PL SC, V37, P367, DOI 10.1146/annurev.earth.36.031207.124346
   Tompkin R. B., 1999, Dairy, Food and Environmental Sanitation, V19, P551
   Toth A, 1996, NUCL INSTRUM METH B, V116, P299, DOI 10.1016/0168-583X(96)00064-X
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Tuccitto N, 2011, SURF INTERFACE ANAL, V43, P370, DOI 10.1002/sia.3555
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001
   Wilensky U, 1999, NETLOGO
   Woteki CE, 2003, ANNU REV NUTR, V23, P315, DOI 10.1146/annurev.nutr.23.011702.073327
   ZIEGLER JF, 1996, STOPPING RANGE IONS, V1
NR 71
TC 4
Z9 4
U1 0
U2 11
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2011
VL 25
IS 17
BP 2255
EP 2280
DI 10.1163/016942411X574943
PG 26
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 842VE
UT WOS:000296628600010
DA 2018-10-20
ER

PT J
AU Jin, G
   Kim, GH
AF Jin, Gyuhyun
   Kim, Geun Hyung
TI Rapid-prototyped PCL/fucoidan composite scaffolds for bone tissue
   regeneration: design, fabrication, and physical/biological properties
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID POLYMER BLENDS; FUCOIDAN; MORPHOLOGY; RELEASE
AB Biomedical composite scaffolds consisting of poly(epsilon-caprolactone) (PCL) and fucoidan (Fu) fabricated by a melt-plotting system can be applied as a potential scaffold for bone tissue regeneration. In this study, the pore size and strut diameter of the layer-by-layer composite scaffolds were fixed at 305 mm and 300 +/- 15 mu m, respectively, and the effect of various compositions (3, 5, 10, 20 wt%) of fucoidan on the morphology, hydrophilic properties, water-absorption ability, and mechanical characterization of the scaffolds was evaluated. Through the water-contact angle and water-absorption abilities, the composite scaffolds complemented with fucoidan displayed dramatically increased hydrophilic properties and higher mechanical properties (22% increase of Young's modulus at 10 wt% of fucoidan) under limited compositions of fucoidan compared to the pure PCL scaffold. The in vitro biocompatibility of the scaffolds was examined using osteoblast-like-cells (MG63). Specifically, cellular proliferation and mineralization were assessed. Based on scanning electron microscope (SEM) images, the cells more easily adhered and grew on the surface of the PCL/Fu scaffolds, showing a 30% enhanced mineral deposition compared to the pure PCL scaffold after 14 days of cell culture. This result was due to the continuous release of fucoidan from the composite scaffold. These physical and biological results demonstrate that composite PCL/Fu scaffolds represent a potential biomaterial for enhancing bone tissue regeneration.
C1 [Jin, Gyuhyun; Kim, Geun Hyung] Chosun Univ, Dept Mech Engn, Biolnanofluid Lab, Kwangju 501759, South Korea.
RP Kim, GH (reprint author), Chosun Univ, Dept Mech Engn, Biolnanofluid Lab, Kwangju 501759, South Korea.
EM gkim@chosun.ac.kr
FU Ministry of Education, Science Technology (MEST); National Research
   Foundation of Korea (NRF); Ministry of Education, Science and Technology
   [2011-0004097]
FX This research was financially supported by the Ministry of Education,
   Science Technology (MEST) and National Research Foundation of Korea
   (NRF) through the Human Resource Training Project for Regional
   Innovation and was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (grant no. 2011-0004097).
CR Arinstein A, 2007, NAT NANOTECHNOL, V2, P59, DOI 10.1038/nnano.2006.172
   Chandrasekaran AR, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015001
   Changotade SIT, 2008, J BIOMED MATER RES A, V87A, P666, DOI 10.1002/jbm.a.31819
   Chen HL, 1998, MACROMOLECULES, V31, P2255, DOI 10.1021/ma9715740
   Cho YS, 2009, FOOD CHEM, V116, P990, DOI 10.1016/j.foodchem.2009.03.051
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Duarte MER, 2001, CARBOHYD RES, V333, P281, DOI 10.1016/S0008-6215(01)00149-5
   Frohlich M, 2008, CURR STEM CELL RES T, V3, P254, DOI 10.2174/157488808786733962
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   GOTOH Y, 1990, BONE MINER, V8, P239, DOI 10.1016/0169-6009(90)90109-S
   HALPIN JC, 1968, J COMPOS MATER, V2, P488, DOI 10.1177/002199836800200409
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Honma T, 2003, POLYM INT, V52, P1839, DOI 10.1002/pi.1380
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   PATANKAR MS, 1993, J BIOL CHEM, V268, P21770
   ROOSA SM, 2009, J BIOMED MATER RES A, V92, P359
   SENNI K, 2003, Patent No. 6559131
   Synytsya A, 2010, CARBOHYD POLYM, V81, P41, DOI 10.1016/j.carbpol.2010.01.052
   UTRACKI LA, 1983, POLYM ENG SCI, V23, P602, DOI 10.1002/pen.760231103
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
NR 27
TC 16
Z9 16
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 44
BP 17710
EP 17718
DI 10.1039/c1jm12915e
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 839SX
UT WOS:000296390600027
DA 2018-10-20
ER

PT J
AU Wang, WB
   Zhao, ZY
   Gao, ZH
   Guo, MR
AF Wang, Wenbo
   Zhao, Zongyan
   Gao, Zhenhua
   Guo, Mingruo
TI WHEY PROTEIN-BASED WATER-RESISTANT AND ENVIRONMENTALLY SAFE ADHESIVES
   FOR PLYWOOD
SO BIORESOURCES
LA English
DT Article
DE Wood adhesive; Whey protein; Plywood; Water resistance; Environmental
   safety
ID PHENOLIC RESIN; FORMALDEHYDE; WOOD; LIQUEFACTION; OPTIMIZATION;
   PRODUCTS; STRENGTH; TANNIN
AB Whey protein is a renewable and environmentally safe biomaterial, a by-product of cheese production. It can be utilized for non-food applications for value-added products. The substances glyoxal (GO), glutaraldehyde (GA), polymeric methylene biphenyl diisocyanate (p-MDI), urea-formaldehyde (UF) resin, and phenol-formaldehyde oligomer (PFO) that contain reactive groups were applied together with whey protein as modifier in order to increase crosslinking density and molecular weight for improving the bond strength and water resistance of whey protein. A water-resistant and environmentally safe whey protein-based wood adhesive for plywood was developed by evaluating the effects of these modifiers on the bond strength, bond durability, and free formaldehyde emission of the resulting plywood panels. Results of FTIR and SEM analyses and bond evaluation indicated that GO, GA, and p-MDI were not suitable to modify whey proteins due to their high reactivity with whey proteins, causing phase separation. UF resin was not a good modifier for whey proteins because of either its poor water-resistance or higher emission of hazardous formaldehyde. Whey protein adhesives modified with PFO had a dry shear bond strength of 1.98 MPa and a 28h-boiling-dry-boiling wet shear strength of 1.73 MPa, which were both much higher than the required values for structural use according to standard JIS K6806-2003, while its formaldehyde emission was 0.067mg/L, much lower than the required value for green plywood according to standard JIS A5908.
C1 [Wang, Wenbo; Guo, Mingruo] Univ Vermont, Coll Agr & Life Sci, Burlington, VT 05405 USA.
   Jilin Univ, Changchun 130012, Peoples R China.
   NE Forestry Univ, Coll Mat Sci & Engn, Harbin 150040, Peoples R China.
EM gao_zhenhua@yahoo.com; mguo@uvm.edu
FU USDA-NIFA; Northeast Forestry University [STIP10]
FX The authors are grateful for the supports by a grant from USDA-NIFA and
   the Graduate Research Fund of the Northeast Forestry University
   (STIP10).
CR Gao ZH, 2011, PIGM RESIN TECHNOL, V40, P42, DOI 10.1108/03699421111095937
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   Hojilla-Evangelista MP, 2002, J AM OIL CHEM SOC, V79, P1145, DOI 10.1007/s11746-002-0618-z
   Khan MA, 2004, J APPL POLYM SCI, V92, P3514, DOI 10.1002/app.20374
   KIM MG, 1994, HOLZFORSCHUNG, V48, P262, DOI 10.1515/hfsg.1994.48.3.262
   Kim S, 2009, BIORESOURCE TECHNOL, V100, P744, DOI 10.1016/j.biortech.2008.06.062
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Lee SH, 2000, J APPL POLYM SCI, V77, P2901, DOI 10.1002/1097-4628(20000923)77:13<2901::AID-APP12>3.3.CO;2-6
   Lee SH, 2002, J APPL POLYM SCI, V83, P1473, DOI 10.1002/app.10038.abs
   Lee WJ, 2008, BIORESOURCE TECHNOL, V99, P7247, DOI 10.1016/j.biortech.2007.12.060
   MCDONOUGH FE, 1974, J DAIRY SCI, V57, P1438
   NORDE W, 1992, COLLOID SURFACE, V64, P87, DOI 10.1016/0166-6622(92)80164-W
   Onwulata C., 2008, WHEY PROCESSING FUNC
   PARRIS N, 1991, J DAIRY SCI, V74, P58, DOI 10.3168/jds.S0022-0302(91)78143-5
   Qi XL, 1997, BIOCHEM J, V324, P341, DOI 10.1042/bj3240341
   SANTANA MAE, 1995, HOLZFORSCHUNG, V49, P146, DOI 10.1515/hfsg.1995.49.2.146
   Sarkar S, 2000, J ADHES SCI TECHNOL, V14, P1179, DOI 10.1163/156856100743167
   Sellers T, 2001, FOREST PROD J, V51, P12
   SHIMADA K, 1989, J AGR FOOD CHEM, V37, P161, DOI 10.1021/jf00085a038
   Smithers GW, 2008, INT DAIRY J, V18, P695, DOI 10.1016/j.idairyj.2008.03.008
   Tunick M. H, 2008, WHEY PROCESSING FUNC
   van der Leeden MC, 2000, J BIOTECHNOL, V79, P211, DOI 10.1016/S0168-1656(00)00238-8
   Vazquez G, 2009, IND CROP PROD, V29, P364, DOI 10.1016/j.indcrop.2008.07.004
   Walstra P., 1999, DAIRY TECHNOLOGY PRI
   Wang Y, 2007, J APPL POLYM SCI, V104, P130, DOI 10.1002/app.24675
   YAO YG, 1995, MOKUZAI GAKKAISHI, V41, P659
   Yip J, 2009, BIORESOURCE TECHNOL, V100, P6674, DOI 10.1016/j.biortech.2009.07.045
   Yuan JL, 2009, PIGM RESIN TECHNOL, V38, P290, DOI 10.1108/03699420910988769
   Zhang T.C, 2003, THESIS U TOKYO TOKYO
   Zhong ZK, 2003, J POLYM ENVIRON, V11, P137, DOI 10.1023/A:1026048213787
NR 30
TC 16
Z9 17
U1 1
U2 14
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2011
VL 6
IS 3
BP 3339
EP 3351
PG 13
WC Materials Science, Paper & Wood
SC Materials Science
GA 833EL
UT WOS:000295864500083
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, YY
   Tang, ZW
   Wang, J
   Wu, H
   Lin, CT
   Lin, YH
AF Zhang, Youyu
   Tang, Zhiwen
   Wang, Jun
   Wu, Hong
   Lin, Chiann-Tso
   Lin, Yuehe
TI Apoferritin nanoparticle: a novel and biocompatible carrier for enzyme
   immobilization with enhanced activity and stability
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID HORSE SPLEEN APOFERRITIN; GLUCOSE-OXIDASE; CONFORMATIONAL FLEXIBILITY;
   ALGINATE MICROSPHERES; FOREST ELECTRODES; ASPERGILLUS-NIGER;
   AMPLIFICATION; PROTEIN; FILM; GOLD
AB Apoferritin is a uniform spherical nano-size biomaterial with excellent bio-compatibility. In this work, we report the use of apoferritin as a novel biocompatible carrier for stabilizing enzymes and enhancing their activities. We used glucose oxidase (GOx) as a model enzyme in this study. GOx was immobilized on the surface of the apoferritin through a green synthetic approach, taking advantage of bioaffinity binding between streptavidin and biotin. As a result, a glucose oxidase-biotin/streptavidin/biotin-apoferritin conjugate (Apo-GOx) was prepared using streptavidin as the bridge. The synthesized Apo-GOx was characterized by transmission electron microscopy, ultraviolet and fluorescence spectroscopy. The activity and stability of GOx on the surface of the apoferritin were investigated and challenged by different environmental factors, such as the temperature, chemicals and pH, in comparison with the biotinylated GOx (B-GOx). The results demonstrate that the activity of Apo-GOx is significantly enhanced while the thermal and chemical stabilities of Apo-GOx are also greatly improved compared to free B-GOx. For instance, the activity of the Apo-GOx only lost 30% after 2 h incubation at 50 oC in comparison to a 70% loss of free B-GOx. The activity of Apo-GOx remains intact after 30 min incubation in 5 M urea solution while B-GOx lost 80% activity after the same treatment. Furthermore, glucose detection was used as a model application for the enzyme immobilization method developed in this work. The GOx immobilized apoferritin nanoparticles exhibited high sensitivity for glucose detection with a detection limit of 3 nM glucose. This work offers a novel approach for immobilizing enzymes with enhanced stability and activity, thus holds the promising advantage for a number of applications, such as in enzyme catalysis, DNA assays and immunoassays.
C1 [Zhang, Youyu; Tang, Zhiwen; Wang, Jun; Wu, Hong; Lin, Chiann-Tso; Lin, Yuehe] Pacific NW Natl Lab, Richland, WA 99352 USA.
   [Zhang, Youyu] Hunan Normal Univ, Coll Chem & Chem Engn, Minist Educ, Key Lab Chem Biol & Tradit Chinese Med Res, Changsha 410081, Hunan, Peoples R China.
RP Lin, YH (reprint author), Pacific NW Natl Lab, Richland, WA 99352 USA.
EM yuehe.lin@pnl.gov
RI Lin, Yuehe/D-9762-2011; Zhang, Youyu/D-9617-2013
OI Lin, Yuehe/0000-0003-3791-7587; Zhang, Youyu/0000-0002-7502-6817
FU National Institute of Environmental Health Sciences [U54 ES16015];
   National Institute of Health (NIH); NIH through the National Institute
   of Neurological Disorders and Stroke [U01 NS058161-01]; U.S. Department
   of Energy (DOE) [DE-AC05-76RL01830]; Department of Energy's Office of
   Biological and Environmental Research; National Natural Science
   Foundation of China [20975037]
FX The work was done at Pacific Northwest National Laboratory (PNNL) and
   was supported partially by Grant U54 ES16015 from the National Institute
   of Environmental Health Sciences, the National Institute of Health
   (NIH), and Grant U01 NS058161-01 from the NIH Counter ACT Program
   through the National Institute of Neurological Disorders and Stroke. Its
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the federal government.;
   PNNL is operated for the U.S. Department of Energy (DOE) by Battelle
   under Contract DE-AC05-76RL01830. The characterization was performed
   using EMSL, a national scientific user facility sponsored by the
   Department of Energy's Office of Biological and Environmental Research
   and located at PNNL. Y. Zhang acknowledges the support from the National
   Natural Science Foundation of China (20975037). The authors would like
   to acknowledge Ms. Alice Dohnalkova for her help in TEM measurement.
CR Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Bousalem S, 2004, COLLOID POLYM SCI, V282, P1301, DOI 10.1007/s00396-004-1065-8
   BRYCE CFA, 1973, BIOCHEM J, V133, P301, DOI 10.1042/bj1330301
   Cai WY, 2006, CHEM MATER, V18, P279, DOI 10.1021/cm051442i
   Chen XJ, 2009, SCI CHINA SER B, V52, P1999, DOI 10.1007/s11426-009-0249-y
   Clemente-Leon M, 2007, J MATER CHEM, V17, P49, DOI 10.1039/b614592b
   CRICHTON RR, 1973, BIOCHEM J, V133, P289, DOI 10.1042/bj1330289
   DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54
   DU D, 2010, ANAL CHEM, V83, P746
   Du D, 2011, BIOSENS BIOELECTRON, V26, P3857, DOI 10.1016/j.bios.2011.02.047
   Du D, 2010, ANAL CHEM, V82, P2989, DOI 10.1021/ac100036p
   Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003
   Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097
   FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046
   FREDERICK KR, 1990, J BIOL CHEM, V265, P3793
   Galvez N, 2006, J MATER CHEM, V16, P2757, DOI 10.1039/b604860a
   Hegedus I, 2009, CHEM ENG SCI, V64, P1053, DOI 10.1016/j.ces.2008.10.063
   Kim J, 2003, NANO LETT, V3, P1219, DOI 10.1021/nl034404b
   Lai GS, 2011, BIOSENS BIOELECTRON, V26, P3782, DOI 10.1016/j.bios.2011.02.032
   Lei CH, 2007, NANO LETT, V7, P1050, DOI 10.1021/nl070255b
   Li J, 2007, BIOSENS BIOELECTRON, V22, P2898, DOI 10.1016/j.bios.2006.12.004
   Li LM, 2010, BIOSENS BIOELECTRON, V25, P2436, DOI 10.1016/j.bios.2010.03.037
   Lin X, 2011, NANO LETT, V11, P814, DOI 10.1021/nl104141g
   Liu G, 2008, J AM CHEM SOC, V130, P6820, DOI 10.1021/ja800554t
   Liu GD, 2007, ANAL CHEM, V79, P5614, DOI 10.1021/ac070086f
   Liu GD, 2006, ANAL CHEM, V78, P7417, DOI 10.1021/ac060653j
   Liu GD, 2006, CHEMBIOCHEM, V7, P1315, DOI 10.1002/cbic.200600225
   Liu GD, 2006, SMALL, V2, P1139, DOI 10.1002/smll.200600206
   Luo DB, 2009, ACS NANO, V3, P2121, DOI 10.1021/nn9003154
   MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602
   Malhotra R, 2010, ANAL CHEM, V82, P3118, DOI 10.1021/ac902802b
   Mani V, 2009, ACS NANO, V3, P585, DOI 10.1021/nn800863w
   Minten IJ, 2011, SMALL, V7, P911, DOI 10.1002/smll.201001777
   MOZHAEV VV, 1993, TRENDS BIOTECHNOL, V11, P88, DOI 10.1016/0167-7799(93)90057-G
   Napoli A, 2004, LANGMUIR, V20, P3487, DOI 10.1021/la0357054
   OHARA TJ, 1994, ANAL CHEM, V66, P2451, DOI 10.1021/ac00087a008
   Ohnuki H, 2007, LANGMUIR, V23, P4675, DOI 10.1021/la063175g
   Okuda M, 2010, CHEM COMMUN, V46, P8797, DOI 10.1039/c0cc03298k
   Palocci C, 2007, BIOMACROMOLECULES, V8, P3047, DOI 10.1021/bm0703741
   Pandey P, 2007, LANGMUIR, V23, P3333, DOI 10.1021/la062901c
   Pescador P, 2008, LANGMUIR, V24, P14108, DOI 10.1021/la8027435
   Zhou QM, 2007, J PHYS CHEM B, V111, P11276, DOI 10.1021/jp073884i
   Qiu HJ, 2008, J PHYS CHEM C, V112, P14781, DOI 10.1021/jp805600k
   Srivastava R, 2005, MACROMOL BIOSCI, V5, P717, DOI 10.1002/mabi.200500061
   SWOBODA BEP, 1965, J BIOL CHEM, V240, P2209
   TAKAHASHI H, 2008, BIOMOLECULAR CATALYS, V986, P61
   Topoglidis E, 2001, LANGMUIR, V17, P7899, DOI 10.1021/la010309b
   Tsai YC, 2006, BIOSENS BIOELECTRON, V22, P495, DOI 10.1016/j.bios.2006.06.009
   TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158
   Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114
   Wu YF, 2009, ANAL CHEM, V81, P1600, DOI 10.1021/ac802345z
   Yu X, 2006, J AM CHEM SOC, V128, P11199, DOI 10.1021/ja062117e
   Zeng QO, 2010, ADV FUNCT MATER, V20, P3366, DOI 10.1002/adfm.201000540
   Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301
   Zhao J, 2011, BIOSENS BIOELECTRON, V26, P2297, DOI 10.1016/j.bios.2010.09.056
   Zhu HG, 2005, BIOCONJUGATE CHEM, V16, P1451, DOI 10.1021/bc050171z
NR 56
TC 15
Z9 17
U1 3
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 43
BP 17468
EP 17475
DI 10.1039/c1jm11598g
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 837MG
UT WOS:000296207300062
DA 2018-10-20
ER

PT J
AU Cazalbou, S
   Cavalie, S
   Brouillet, F
   Tourrette, A
   Rodriguez, F
AF Cazalbou, S.
   Cavalie, S.
   Brouillet, F.
   Tourrette, A.
   Rodriguez, F.
TI Use of Percolation Threshold as Element of Preformulation of Orthopaedic
   Cements Used as Drug Delivery Systems
SO JOURNAL OF THE AUSTRALIAN CERAMIC SOCIETY
LA English
DT Article
DE formulation; percolation; cement; biomaterials; porosity; calcium
   phosphate; drug delivery system
AB The theory of the percolation has been proposed to solve the following problem: "What is the probability that the center of a porous material immersed in a fluid is wet?" This theory used in biomaterial domain permit to determine the percolation threshold of orthopaedic cement associated with porogenic agent containing drug. Porogenic agent containing Ibuprofen is introduced into phosphocalcic cement in order to ensure a sustained release as well as an interconnecting porosity. The granulometry and rate of introduced active agent are modified in order to study the influence of such parameters on the kinetic release.
   The knowledge of the percolation threshold of this "drug delivery system" permits to establish the link between dissolution profile of the drug, porous, network and characteristics of the system. It can be used as element of pre-formulation and make it possible to predict the behaviour of the drug delivery system according to the characteristics of component constituting the system.
C1 [Cazalbou, S.; Cavalie, S.; Brouillet, F.; Tourrette, A.; Rodriguez, F.] Univ Toulouse, CIRIMAT, UPS INPT CNRS, Fac Pharm, F-31062 Toulouse 4, France.
RP Cazalbou, S (reprint author), Univ Toulouse, CIRIMAT, UPS INPT CNRS, Fac Pharm, 118 Route Narbonne, F-31062 Toulouse 4, France.
EM cazalbou@cict.fr
RI CAZALBOU, sophie/G-5683-2012; Tourrette, Audrey/R-2763-2017
OI Tourrette, Audrey/0000-0003-1107-2176; BROUILLET,
   Fabien/0000-0002-8860-9069
CR Bonny J.D., 1993, PHARM ACTA HELV, V68, P25, DOI DOI 10.1016/0031-6865(93)90005-Q
   BONNY JD, 1991, PHARM ACTA HELV, V66, P160
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 4
TC 0
Z9 0
U1 0
U2 4
PU AUSTRALIAN CERAMIC SOCIETY
PI PERTH
PA C/O CURTIN UNIV TECHNOLOGY, GPO BOX U1987, PERTH, 6845 W A, AUSTRALIA
SN 0004-881X
J9 J AUST CERAM SOC
JI J. Aust. Ceram. Soc.
PY 2011
VL 47
IS 2
BP 13
EP 15
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 833UJ
UT WOS:000295910100003
DA 2018-10-20
ER

PT S
AU Babilotte, P
   Dubreuil, M
   Rivet, S
   Lijour, Y
   Sevrain, D
   Martin, L
   Le, BG
   Le Grand, Y
   Le Jeune, B
AF Babilotte, P.
   Dubreuil, M.
   Rivet, S.
   Lijour, Y.
   Sevrain, D.
   Martin, L.
   Le, Brun G.
   Le Grand, Y.
   Le Jeune, B.
BE Berginc, G
TI Snapshot Mueller polarimetry for biomedical diagnostic related to human
   liver fibrosis: evaluation of the method for biomedical assessments
SO OPTICAL COMPLEX SYSTEMS: OCS11
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optical Complex Systems (OCS)
CY SEP 05-08, 2011
CL Marseille, FRANCE
SP SPIE, POPsud - Optitec, Communaute Urbaine Marseille Provence Metropole, Ville de Marseille
DE Mueller polarimetry; liver fibrosis; fibrillar collagen; depolarisation;
   retardance; scoring
ID MATRIX IMAGING POLARIMETRY; 2ND-HARMONIC MICROSCOPY; CONFOCAL
   MICROSCOPY; LIQUID-CRYSTALS; OPTIMIZATION; ELLIPSOMETRY; FORMALISM;
   SECTIONS; LIGHT; ANGLE
AB Human liver biopsy samples, consisting into a 16 mu m thickness biomaterial chemically fixed into a formaldehyde matrix, and stained by red picrosirius dye, are analysed for different states of fibrosis degeneration. Polarimetric methods, and specially Mueller polarimetry based on wavelength coding, have been qualified as an efficient tool to describe many different biological aspects. The polarimetric characteristics of the media, extracted from a Lu and Chipman decomposition(1,) (2) of their Mueller Matrix (MM), are correlated with the degeneracy level of tissue. Different works and results linked to the clinical analysis will be presented and compared to previous performed works.(3) Polarimetric imaging will be presented and compared with SHG measurements. A statistical analysis of the distribution of polarimetric parameters (such as the retardance R and depolarisation P-d) will be presented too, in order to characterise the liver fibrosis level into the biomaterial under study.
C1 [Babilotte, P.; Dubreuil, M.; Rivet, S.; Sevrain, D.; Martin, L.; Le, Brun G.; Le Grand, Y.; Le Jeune, B.] Univ Bretagne Occidentale, Lab Spectrometrie Opt & Laser, LSOL EA 938, Ave Gorgeu, F-29238 Brest 03, France.
   [Lijour, Y.] Univ Bretagne Occidentale, CNRS, UMR 6521, F-29238 Brest, France.
   [Babilotte, P.; Dubreuil, M.; Rivet, S.; Lijour, Y.; Sevrain, D.; Martin, L.; Le, Brun G.; Le Grand, Y.; Le Jeune, B.] UEB, Rennes, France.
RP Babilotte, P (reprint author), Univ Bretagne Occidentale, Lab Spectrometrie Opt & Laser, LSOL EA 938, Ave Gorgeu, F-29238 Brest 03, France.
EM philippe.babilotte@univ-brest.fr
FU Conseil General du Finistere (Kuzul-Departamant Penn Ar Bed)
FX The autors would like to thanks G. Zion and X. Mignot for technical
   ideas and specific technological realisations, and Conseil General du
   Finistere (Kuzul-Departamant Penn Ar Bed) for financial support.
CR ANASTASIADOU M, 2007, THESIS PARIS
   Aspnes DE, 2004, THIN SOLID FILMS, V455, P3, DOI 10.1016/j.tsf.2003.12.038
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022
   Boulvert F, 2005, J OPT A-PURE APPL OP, V7, P21, DOI 10.1088/1464-4258/7/1/003
   Bueno JM, 2009, J MICROSC-OXFORD, V235, P84, DOI 10.1111/j.1365-2818.2009.03185.x
   Bueno JM, 2002, OPT LETT, V27, P830, DOI 10.1364/OL.27.000830
   De Martino A, 2004, THIN SOLID FILMS, V455, P112, DOI 10.1016/j.tsf.2003.12.052
   De Martino A, 2003, OPT LETT, V28, P616, DOI 10.1364/OL.28.000616
   DUBREUIL M, 2010, P SOC PHOTO-OPT INS, V10, P7787
   Dubreuil M, 2007, OPT EXPRESS, V15, P13660, DOI 10.1364/OE.15.013660
   Dubreuil M, 2009, APPL OPTICS, V48, P6501, DOI 10.1364/AO.48.006501
   Dubreuil M, 2009, APPL OPTICS, V48, P1135, DOI 10.1364/AO.48.001135
   Fanjul-Velez F, 2010, OPT LETT, V35, P1163, DOI 10.1364/OL.35.001163
   Foldyna M, 2009, OPT COMMUN, V282, P735, DOI 10.1016/j.optcom.2008.11.036
   FOLDYNA M, 2009, EUR J PHYS, V5, pP34
   Gailhouste L, 2010, J HEPATOL, V52, P398, DOI 10.1016/j.jhep.2009.12.009
   Garcia-Caurel E, 2004, THIN SOLID FILMS, V455, P120, DOI 10.1016/j.tsf.2003.12.056
   Ghassemi P, 2009, J ZHEJIANG UNIV-SC B, V10, P602, DOI 10.1631/jzus.B0920068
   Ghosh N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960934
   Gil J J, 1986, J MOD OPTIC, V33, P185
   Guilbert T, 2010, OPT EXPRESS, V18, P25794, DOI 10.1364/OE.18.025794
   Huss S, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-10
   JIAO S, 2003, THESIS TEXAS A M U U
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kaplan B, 2004, APPL OPTICS, V43, P1233, DOI 10.1364/AO.43.001233
   Kiraly K, 1997, HISTOCHEM J, V29, P317, DOI 10.1023/A:1020802631968
   KOVIKOVA T, 2005, EUR J PHYS APPL PHYS, V31, pP4
   Lara D, 2006, APPL OPTICS, V45, P1917, DOI 10.1364/AO.45.001917
   Laude B, 2002, APPL OPTICS, V41, P6637, DOI 10.1364/AO.41.006637
   Laude-Boulesteix B, 2004, APPL OPTICS, V43, P2824, DOI 10.1364/AO.43.002824
   LAUDEBOULESTEIX B, 2004, THESIS PARIS
   Lemaillet P, 2008, OPT LETT, V33, P144, DOI 10.1364/OL.33.000144
   Lu SY, 1996, J OPT SOC AM A, V13, P1106, DOI 10.1364/JOSAA.13.001106
   Morgan JE, 1998, BRIT J OPHTHALMOL, V82, P684, DOI 10.1136/bjo.82.6.684
   Olivard P, 1999, J PHYS D APPL PHYS, V32, P1618, DOI 10.1088/0022-3727/32/14/312
   Ossikovski R, 2008, OPT COMMUN, V281, P2406, DOI 10.1016/j.optcom.2007.12.076
   PEZZANITI JL, 1995, OPT ENG, V34, P1558, DOI 10.1117/12.206161
   TAI CS, 2009, J BIOMED OPT, V14, P10
   Toma O, 2008, ROM REP PHYS, V60, P1065
   Twietmeyer KM, 2008, OPT EXPRESS, V16, P11589, DOI 10.1364/OE.16.011589
   Twietmeyer KM, 2008, OPT EXPRESS, V16, P21339, DOI 10.1364/OE.16.021339
   WANG L, 2000, P OSA TRENDS OPTICS, V38
NR 43
TC 1
Z9 1
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-81948-798-8
J9 PROC SPIE
PY 2011
VL 8172
AR UNSP 817206
DI 10.1117/12.896615
PG 13
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BXL84
UT WOS:000296324900005
DA 2018-10-20
ER

PT J
AU Aoyagi, S
   Inoue, M
   Mitsuoka, T
AF Aoyagi, Satoka
   Inoue, Masae
   Mitsuoka, Takuya
TI The effect of thin oxide film on protein sample measurement with
   TOF-SIMS
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT SIMS XVII Conference
CY SEP, 2009
CL Toronto, CANADA
DE TOF-SIMS; protein evaluation; thin oxide film; indium-tin oxide
ID ION MASS-SPECTROMETRY; INFORMATION; GOLD
AB Recently, the biomaterial field has become one of the most important applications of time of flight (TOF) SIMS time-of-flight secondary ion mass specmetry (TOF-SIMS). Although TOF-SIMS can be applied to insulating samples, electrically conductive substrates such as Si, Auplates and indium-tin oxide (ITO) glass plates are more useful to detect fragment ions from biomaterials. ITO glass and silicon substrates are often employed for the preparation of biomaterial samples instead of glass plates. In this study, an ITO glass plate and silicon plates with various thicknesses of silicon oxide thin film were compared to investigate the most suitable sample preparation conditions for evaluating protein samples using TOF-SIMS. Four kinds of substrates, an ITO glass plate, a silicon plate, a silicon plate with an oxide film of 50 nm, and another of 250 nm, were employed as substrates to adsorb a model protein, egg white lysozyme. Each sample was measured five times with TOF-SIMS with a gallium ion source under static conditions. The TOF-SIMS spectra of each sample were compared to evaluate the effect of thin oxide films on protein measurement with TOF-SIMS. The specific peaks of each sample related to lysozyme in the positive ion spectra were selected in comparison to their control samples. As a result, TOF-SIMS spectra of the silicon plate with a 50 nm silicon oxide film showed the most specific peaks related to lysozyme. In addition, TOF-SIMS spectra of the ITO sample showed many peaks of fragment ions related to lysozyme in a high-mass range at which the other samples do not show adequate peaks. Thus, both substrates with the oxide films, silicon oxide and ITO, displayed better results than the silicon plate sample. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Aoyagi, Satoka] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan.
   [Inoue, Masae; Mitsuoka, Takuya] Toyota Cent Res & Dev Labs Inc, Aichi 4801192, Japan.
RP Aoyagi, S (reprint author), Shimane Univ, Fac Life & Environm Sci, 1060 Matsue Shi, Matsue, Shimane 6908504, Japan.
EM aoyagi@life.shimane-u.ac.jp
CR Aoyagi S, 2005, NUCL INSTRUM METH B, V232, P146, DOI 10.1016/j.nimb.2005.03.037
   Aoyagi S., 2003, SURF SCI NANOTECH, V1, P67
   Aoyagi S, 2008, APPL SURF SCI, V255, P1071, DOI 10.1016/j.apsusc.2008.05.086
   Aoyagi S, 2009, SURF INTERFACE ANAL, V41, P136, DOI 10.1002/sia.2989
   Eckschlager K, 1990, J CHEMOMETR, V4, P195, DOI 10.1002/cem.1180040303
   Kim YP, 2007, ANAL CHEM, V79, P1377, DOI 10.1021/ac0616005
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382
   Shannon C. E., 1947, MATH THEORY INFORM
   Sohn S, 2004, SURF INTERFACE ANAL, V36, P1222, DOI 10.1002/sia.1881
   Sugiura Y, 2006, ANAL CHEM, V78, P8227, DOI 10.1021/ac060974v
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
NR 12
TC 2
Z9 2
U1 3
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JAN-FEB
PY 2011
VL 43
IS 1-2
BP 272
EP 276
DI 10.1002/sia.3443
PG 5
WC Chemistry, Physical
SC Chemistry
GA 725TR
UT WOS:000287669500069
DA 2018-10-20
ER

PT S
AU Hashimoto, Y
   Hanasaki, I
   Isono, Y
AF Hashimoto, Yoshihiko
   Hanasaki, Itsuo
   Isono, Yoshitada
GP IEEE
TI A NOVEL DFM CANTILEVER WITH TUNING FUNCTION OF RESONANT FREQUENCY FOR
   BIOMATERIAL IMAGING
SO 2011 IEEE 24TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL
   SYSTEMS (MEMS)
SE PROCEEDINGS: IEEE MICRO ELECTRO MECHANICAL SYSTEMS
LA English
DT Proceedings Paper
CT 24th IEEE International Conference on Micro Electro Mechanical Systems
   (MEMS)
CY JAN 23-27, 2011
CL Cancun, MEXICO
SP IEEE
AB We have developed a novel dynamic force microscope (DFM) cantilever with a function of tuning resonant frequency for measuring the topography of biomaterials with a single cantilever. We have integrated the electrostatic driving, clamping, and the lever motion amplification systems into the cantilever to change the cantilever length for varying the spring constant and resonant frequency. The resonant frequency is tunable in the range from 12 to 998 kHz, corresponding to the spring constant of 0.6 to 458 N/m. The system enables the imaging of biomolecule under a suitable condition by tuning the resonant frequency.
C1 [Hashimoto, Yoshihiko; Hanasaki, Itsuo; Isono, Yoshitada] Kobe Univ, Grad Sch Engn, Kobe, Hyogo, Japan.
RP Hashimoto, Y (reprint author), Kobe Univ, Grad Sch Engn, Kobe, Hyogo, Japan.
RI Kobe Univ, Engineering/D-2028-2017; Isono, Yoshitada/Q-8990-2016
CR ANSELMETTI D, 1994, NANOTECHNOLOGY, V5, P87, DOI 10.1088/0957-4484/5/2/004
   Hayashi T, 2006, NANO LETT, V6, P515, DOI 10.1021/nl050050n
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1084-6999
BN 978-1-4244-9634-1
J9 PROC IEEE MICR ELECT
PY 2011
BP 1217
EP 1220
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BXE03
UT WOS:000295841200304
DA 2018-10-20
ER

PT J
AU Yeh, CC
   Chen, CN
   Li, YT
   Chang, CW
   Cheng, MY
   Chang, HI
AF Yeh, Chih-Chang
   Chen, Cheng-Nan
   Li, Yun-Ting
   Chang, Chao-Wei
   Cheng, Ming-Yan
   Chang, Hsin-I
TI The Effect of Polymer Molecular Weight and UV Radiation on Physical
   Properties and Bioactivities of PCL Films
SO CELLULAR POLYMERS
LA English
DT Article
DE polycaprolactone; cytocompatibility; fibroblasts; myoblasts; polymer
   molecular weight
ID POLYCAPROLACTONE PCL; SURFACE MODIFICATION; CELL; TISSUE; ADHESION;
   POLY(EPSILON-CAPROLACTONE); BIOMATERIALS; ELASTICITY; STIFFNESS; BONE
AB Biodegradable polymers, such as polycaprolactone (PCL), have been well studied in the application of tissue engineering and drug delivery systems due to their favourable biocompatibility profiles. However, little research has discussed the influence of the molecular weight of these polymers on cell behaviours. Here, PCL films were synthesized using polymers with various molecular weight and the physical characteristics of these films and their effect on cell growth were evaluated. Results showed that the tensile strength and elongation rate of PCL films increased from 1.82 MPa and 95.3% to 2.01 MPa and 741.6% when the molecular weight (Mn) of polymers increased from 40,000 to 80,000. A significant difference in polymer crystallinity was also observed between these formulations. Moreover, we found that prolonged exposure to UV radiation of these films could lead to the breakdown of polymer chains and consequently increased the crystallinity of PCL films with a corresponding reduction in the tensile strength. Using Hs68 human foreskin fibroblasts, PCL films prepared using high molecular weight polymers (CAPA 6800) displayed a higher cell proliferation rate compared to ones prepared using low molecular weight polymers (CAPA 6400 and 6500). In contrast, a higher cell proliferation rate was observed for PCL films made of low molecular weight polymers, especially CAPA 6500, when H9c2 rat heart myoblasts were used. In conclusion, polymer molecular weight can alter the physical properties and surface morphology of PCL films, resulting in changes in cell behaviours in biomaterial scaffolds.
C1 [Chen, Cheng-Nan; Li, Yun-Ting; Chang, Chao-Wei; Cheng, Ming-Yan; Chang, Hsin-I] Natl Chia Yi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan.
   [Yeh, Chih-Chang] Taichung Vet Gen Hosp, Dept Orthopaed, Chiayi Branch, Chiayi 60090, Taiwan.
RP Chang, HI (reprint author), Natl Chia Yi Univ, Dept Biochem Sci & Technol, 300 Syuefu Rd, Chiayi 60004, Taiwan.
EM hchang@mail.ncyu.edu.tw
FU Veterans Affairs Commission, Executive Yuan (Taiwan) [RVHCY99001];
   National Science Council (Taiwan) [NSC 98-2320-B-415-001-MY3]
FX This work was supported by a Geriatric Medicine Research Project in
   Veterans Affairs Commission, Executive Yuan (Taiwan) (grant no:
   RVHCY99001) and the National Science Council (Taiwan) (grant no: NSC
   98-2320-B-415-001-MY3).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   He DM, 2009, PROG POLYM SCI, V34, P62, DOI 10.1016/j.progpolymsci.2008.08.004
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   PITT CG, 1980, CONTROLLED RELEASE B, P19
   Situma C, 2005, ANAL BIOCHEM, V340, P123, DOI 10.1016/j.ab.2005.01.044
   Skoglund P, 1996, J APPL POLYM SCI, V61, P2455, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2455::AID-APP25>3.0.CO;2-1
   Tan PS, 2007, MAT SCI ENG C-BIO S, V27, P304, DOI 10.1016/j.msec.2006.03.010
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 22
TC 8
Z9 8
U1 1
U2 15
PU ISMITHERS-IRAPRA TECHNOLOGY LTD
PI SHREWSBURY
PA SHAWBURY, SHREWSBURY SY4 4NR, SHROPS, ENGLAND
SN 0262-4893
J9 CELL POLYM
JI Cell Polym.
PY 2011
VL 30
IS 5
BP 261
EP 276
DI 10.1177/026248931103000503
PG 16
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA 837OL
UT WOS:000296213000003
DA 2018-10-20
ER

PT J
AU Hedia, HS
AF Hedia, Hassan S.
TI Numerical Optimization of Dental Implant Through the Concept of
   Functionally Graded Materials
SO MATERIALS TESTING
LA English
DT Article
ID STRAIN DISTRIBUTION; STRESS; BONE; BIOMATERIALS; MODULUS; DESIGN
AB The merge of materials science with the biological sciences has produced some advanced materials which are called functionally graded materials (FGMs) in order to provide the desired material characteristics. The FGMs concept originates in Japan in 1984 during the space plan project. FGMs are materials or structures in which the material properties vary with location in such a way as to optimize some functions of the overall FGMs.
   It is well known that the main inorganic component of natural bone is hydroxyapatite (HAP) and that the main organic component is collagen (Col). Hydroxyapatite HAP implants are not bioabsorbable, and because induction of bone into and around the artificially made HAP is not always satisfactory, loosening or breakage of HAP implants may occur after implantation in the clinical application. The development of a new material which is bioabsorbable and which has osteoconductive activity is needed. Therefore, the aim of the current investigation is to design an implant, in the presence of cancellous bone as a thin layer around it, from functionally graded material. In this study, a novel biomaterial, collagen/hydroxyapatite (Col/HAP) as a functionally graded material (FGM), was developed using the finite element and optimization techniques which are available in the ANSYS package. These materials have a self-organized character similar to that of natural bone. The investigations have shown that the maximum stress in the cortical bone and cancellous bone for the Col/HAP functionally graded implant has been reduced by about 40% and 19 % respectively compared to currently used titanium dental implants.
C1 King Abdulaziz Univ, Jeddah, Saudi Arabia.
RP Hedia, HS (reprint author), King Abdulaziz Univ, Jeddah, Saudi Arabia.
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 5
   Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BOUGHTON P, CERAMIC POLYM FUNCTI
   Brear K, 1988, Eng Med, V17, P163
   Choi HJ, 1996, J APPL MECH-T ASME, V63, P479, DOI 10.1115/1.2788893
   Clift S E, 1993, Proc Inst Mech Eng H, V207, P133, DOI 10.1243/PIME_PROC_1993_207_285_02
   Clift S E, 1992, Proc Inst Mech Eng H, V206, P233, DOI 10.1243/PIME_PROC_1992_206_295_02
   Erdogan F, 1997, J APPL MECH-T ASME, V64, P449, DOI 10.1115/1.2788914
   FUCHIYAMA T, 1993, CERAMIC T FUNCTIONAL, V34, P425
   FUJIMOTO T, 2001, P 4 INT C THERM STRE, P121
   HAYES WC, 1986, FRONTIERS BIOMECHANI, P196
   Hedia H. S., 2007, Journal of Medical Engineering & Technology, V31, P280, DOI 10.1080/03091900600861616
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Hedia HS, 2002, BIO-MED MATER ENG, V12, P111
   HEDIA HS, 2005, INT J MECH MAT DES, P329
   HUISKES R, 1986, FRONTIERS BIOMECHANI, P245
   Huiskes R, 1984, CALCIFIED TISSUE INT, V36, P110
   ITOH S, 2000, J BIOMEDICAL MAT RES, V52, P445
   Jallot E, 1998, MED ENG PHYS, V20, P697, DOI 10.1016/S1350-4533(98)00073-3
   Katti K., 2002, P 15 ASCE ENG MECH C
   KAYA F, 1991, J APPL MECH, V58, P410
   KERNER EH, 1956, P PHYS SOC LOND B, V69, P808, DOI 10.1088/0370-1301/69/8/305
   Kingery W. D., 1976, INTRO CERAMICS
   Miyao R, 2001, J DENT MAT, V20, P344
   Nemat-Alla M, 2003, INT J SOLIDS STRUCT, V40, P7339, DOI 10.1016/j.ijsolstr.2003.08.017
   RUI LR, 2001, MATER RES INNOV, P263
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suresh S., 1998, FUNDAMENTALS FUNCTIO
   ZIENKIEWICZ OC, 1977, FINITE ELEMENT METHO
NR 29
TC 1
Z9 1
U1 0
U2 8
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATER TEST
JI Mater. Test.
PY 2011
VL 53
IS 9
BP 556
EP 563
DI 10.3139/120.110263
PG 8
WC Materials Science, Characterization & Testing
SC Materials Science
GA 836AH
UT WOS:000296077900009
DA 2018-10-20
ER

PT J
AU Hodzhaoglu, FV
   Stanoeva, LN
   Nanev, CN
AF Hodzhaoglu, F. V.
   Stanoeva, L. N.
   Nanev, C. N.
TI Lysozyme crystal nucleation in solution layers
SO BULGARIAN CHEMICAL COMMUNICATIONS
LA English
DT Article
DE protein crystal nucleation; thin protein solution layers; heterogeneous
   vs. homogeneous nucleation; crystal nucleants of biological origin
ID PROTEIN CRYSTALS; HETEROGENEOUS NUCLEATION; HYDROSTATIC-PRESSURE;
   CRYSTALLIZATION; SOLUBILITY; GROWTH; ADHESION; KINETICS
AB By using the classical approach of separation in time of nucleation and growth stages, protein crystal nucleation was investigated in thin protein solution layers confined between two glass plates of custom made quasi two-dimensional all-glass cells. Solution layer thickness was varied from 0.05 down to 0.01, 0.0065 and 0.002 cm. Two commercial samples of hen-egg-white lysozyme, HEWL, Seikagaku 6 times crystallized and Sigma 3 times crystallized, were used as model proteins. The number. of HEWL crystal nuclei decreased with diminishing solution layer thickness but the crystal nuclei reduction was considerably lesser than proportional to solution layer diminish. Heterogeneous (on-glass) protein crystal nucleation was separated from bulk one in 0.05 cm solution layers,. the corresponding nucleation rates being measured separately. Up to 80% of the crystal nuclei were formed heterogeneously, on the glass, from 0.05 cm protein solution layers of Seikagaku HEWL. On the contrary, only 10 to 13% of the nuclei were observed on glass under the same conditions in Sigma solution; bulk nucleated crystals represented the main crystal fraction in this case. A plausible explanation of the experimental results was suggested. It is that the bulk crystal nucleation occurs on rests of source biomaterial that are always present in the protein solutions. Moreover, they may be even more active nucleants than the glass.
C1 [Hodzhaoglu, F. V.; Stanoeva, L. N.; Nanev, C. N.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, BU-1113 Sofia, Bulgaria.
RP Nanev, CN (reprint author), Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, Acad G Bonchev Str Bl 11, BU-1113 Sofia, Bulgaria.
EM nanev@ipc.bas.bg
FU Committee for Science, Ministry of Education and Science of Bulgaria
   [X-1520/05]
FX This project has been completed with the financial support of the
   Committee for Science, Ministry of Education and Science of Bulgaria,
   under contract X-1520/05.
CR Chayen NE, 1997, STRUCTURE, V5, P1269, DOI 10.1016/S0969-2126(97)00279-7
   D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430
   Galkin O, 2000, J AM CHEM SOC, V122, P156, DOI 10.1021/ja9930869
   Galkin O, 1999, J PHYS CHEM B, V103, P10965, DOI 10.1021/jp992786x
   Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810
   Kadowaki A, 2004, J SYNCHROTRON RADIAT, V11, P38, DOI 10.1107/S0909049503023574
   Lorber B, 1996, J CRYST GROWTH, V158, P103, DOI 10.1016/0022-0248(95)00399-1
   Nanev CN, 2006, CRYST RES TECHNOL, V41, P505, DOI 10.1002/crat.200510613
   OSTWALD W, 1897, Z PHYS CHEM, V22, P302
   ROSENBERGER F, 1988, J CRYST GROWTH, V90, P74, DOI 10.1016/0022-0248(88)90300-4
   Rosenberger F, 1996, J CRYST GROWTH, V168, P1, DOI 10.1016/0022-0248(96)00358-2
   Rosenberger F, 1996, J CRYST GROWTH, V166, P40, DOI 10.1016/0022-0248(95)00921-3
   Sazaki G, 1996, J CRYST GROWTH, V169, P355, DOI 10.1016/S0022-0248(96)00442-3
   Suzuki Y, 2000, J CRYST GROWTH, V209, P1018, DOI 10.1016/S0022-0248(99)00746-0
   Suzuki Y, 2000, J CRYST GROWTH, V208, P638, DOI 10.1016/S0022-0248(99)00537-0
   Takano KJ, 1997, J CRYST GROWTH, V171, P554, DOI 10.1016/S0022-0248(96)00702-6
   Tammann G., 1923, AGGREGATZUSTAENDE ZU, P222
   Tsekova D, 1999, J CRYST GROWTH, V196, P226, DOI 10.1016/S0022-0248(98)00827-6
   Webb JN, 1999, J CRYST GROWTH, V205, P563, DOI 10.1016/S0022-0248(99)00305-X
   Yin DC, 2008, CRYST RES TECHNOL, V43, P447, DOI 10.1002/crat.200710998
NR 20
TC 0
Z9 0
U1 0
U2 1
PU BULGARIAN ACAD SCIENCE
PI SOFIA
PA CENTRAL LIBRARY 7 NOEMVRI NO 1, SOFIA, 00000, BULGARIA
SN 0324-1130
J9 BULG CHEM COMMUN
JI Bulg. Chem. Commun.
PY 2011
VL 43
IS 3
BP 361
EP 369
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 831DY
UT WOS:000295710100001
DA 2018-10-20
ER

PT J
AU Huang, YL
   Gan, JH
   Zhu, R
   Wang, XG
   Seo, HJ
AF Huang, Yanlin
   Gan, Jiuhui
   Zhu, Rui
   Wang, Xigang
   Seo, Hyo Jin
TI Structural Phase Formation and Tunable Luminescence of Eu2+-Activated
   Apatite-Type (Ca,Sr,Ba)(5)(PO4)(2)(SiO4)
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article
ID PHOSPHORS; EU2+; OXYAPATITES; SITES; GREEN; HOST; LEDS
AB The samples on the base of the substitutions on Sr-cation in apatite Sr-5(PO4)(2)(SiO4) were prepared by conventional solid-state reaction method: I) Sr4.75-5xCa5x(PO4)(2)(SiO4):Eu-0.25(2+) (0.01 <= x <= 0.95) and II) Sr4.75-5yBa5y(PO4)2(SiO4):Eu0.252+ (0.01 <= z <= 0.5). The crystal phase formations were investigated by the X-ray powder diffraction patterns. The tunable green-yellow color was detected due to the substitution of cation Sr2+ in the host lattice by either Ca2+ or Ba2+. The relationship between the structure and luminescence properties was reported. The site-occupation of Eu2+ ions and energy transfer were discussed on the base of crystal structure. Partial substitution of Sr2+ by either Ca2+ or Ba2+ all results in a blue-shifted Eu2+ emission. The luminescence blue-shift is a common phenomenon in Ba2+-substition for Sr2+ due to a decreased crystal field splitting for Eu2+ on the bigger Ba2+ cation site. However, in the Ca2+-substitution for Sr2+, the luminescence blue-shifted Eu2+ emission is unusual. The detailed luminescence spectra of Eu2+ ions in relation with the micro-structure were first reported in one of the end compound Ca-5(PO4)(2)(SiO4). This is helpful to improve this series of materials for a potential application as a biomaterial or a phosphor for the lighting. (C) 2011 The Electrochemical Society. [DOI: 10.1149/2.026111jes] All rights reserved.
C1 [Huang, Yanlin; Gan, Jiuhui; Zhu, Rui; Wang, Xigang] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
   [Seo, Hyo Jin] Pukyong Natl Univ, Dept Phys, Pusan 608737, South Korea.
RP Huang, YL (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM hjseo@pknu.ac.kr
FU National Research Foundation of Korea (NRF); Ministry of Education,
   Science and Technology (MEST) [2009-0078682]; Jiangsu Higher Education
   Institutions
FX This work was supported by the Mid-career Researcher Program through
   National Research Foundation of Korea (NRF) grant funded by the Ministry
   of Education, Science and Technology (MEST) (Project No. 2009-0078682)
   and by A Project Funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD).
CR Al-Kattan A, 2010, J PHYS CHEM C, V114, P2918, DOI 10.1021/jp910923g
   Bachmann V, 2009, CHEM MATER, V21, P316, DOI 10.1021/cm802394w
   BLASSE G, 1969, PHYS LETT A, VA 28, P572, DOI 10.1016/0375-9601(69)90113-3
   Boyer L, 2000, J ALLOY COMPD, V311, P143, DOI 10.1016/S0925-8388(00)01085-9
   Chen L, 2010, MATERIALS, V3, P2172, DOI 10.3390/ma3032172
   Demirkiran H, 2010, MAT SCI ENG C-MATER, V30, P263, DOI 10.1016/j.msec.2009.10.011
   DICKENS B, 1971, TSCHERMAKS MINERALOG, V0016
   Gan JH, 2009, MATER LETT, V63, P2160, DOI 10.1016/j.matlet.2009.07.017
   Gong XH, 2005, CHEM MATER, V17, P1135, DOI 10.1021/cm0481401
   Huang CH, 2011, J LUMIN, V131, P1346, DOI 10.1016/j.jlumin.2011.02.034
   Huang YL, 2011, J AM CERAM SOC, V94, P1143, DOI 10.1111/j.1551-2916.2010.04190.x
   Jagannathan R, 1997, J LUMIN, V71, P115, DOI 10.1016/S0022-2313(96)00127-5
   Kim JS, 2005, SOLID STATE COMMUN, V133, P445, DOI 10.1016/j.ssc.2004.12.002
   Lu WH, 2012, J BIOMATER APPL, V26, P637, DOI 10.1177/0885328210383599
   Mikhailik VB, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.205110
   NOTZOLD D, 1995, PHYS STATUS SOLIDI B, V191, P21, DOI 10.1002/pssb.2221910103
   Olivia A. G., 2010, BIOMATERIALS, V31, P4259
   Ouenzerfi R., 2001, OPT MATER, V16, P301
   Parmentier AB, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/8/085401
   POORT SHM, 1995, CHEM MATER, V7, P1547, DOI 10.1021/cm00056a022
   Poort SHM, 1996, J ALLOY COMPD, V241, P75, DOI 10.1016/0925-8388(96)02324-9
   SATO M, 1994, J ELECTROCHEM SOC, V141, P1851, DOI 10.1149/1.2055016
   Setlur AA, 2006, CHEM MATER, V18, P3314, DOI 10.1021/cm060898c
   TAITAI A, 1987, J PHYS CHEM SOLIDS, V48, P629, DOI 10.1016/0022-3697(87)90151-X
   Ternane R, 2001, OPT MATER, V16, P291, DOI 10.1016/S0925-3467(00)00089-6
   VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6
   Wang FK, 2010, CHEM MATER, V22, P3630, DOI 10.1021/cm902727s
   Wang WN, 2008, ADV MATER, V20, P3422, DOI 10.1002/adma.200800415
   WELKER T, 1991, J LUMIN, V48-9, P49, DOI 10.1016/0022-2313(91)90075-7
   Whited BM, 2011, BIOMATERIALS, V32, P2294, DOI 10.1016/j.biomaterials.2010.12.003
NR 30
TC 21
Z9 21
U1 1
U2 22
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2011
VL 158
IS 11
BP J334
EP J340
DI 10.1149/2.026111jes
PG 7
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA 829ZL
UT WOS:000295626000072
DA 2018-10-20
ER

PT S
AU Mateus, CP
   Chierice, GO
   Okamoto, T
AF Mateus, Christiano Pavan
   Chierice, Gilberto Orivaldo
   Okamoto, Tetuo
BE Rocha, D
TI Histomorphological evaluation of Compound bone of Granulated Ricinus in
   bone regeneration in rabbits
SO XVII ARGENTINE CONGRESS OF BIOENGINEERING: CLINICAL ENGINEERING
   CONFERENCE VI
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 17th Biennial Congress of the Argentinean-Bioengineering-Society/6th
   Clinical Engineering Conference
CY OCT 14-16, 2009
CL Rosario, ARGENTINA
SP Argentinean Bioengn Soc
ID CALCIUM PHOSPHATES; HYDROXYAPATITE; AUGMENTATION
AB Histological evaluation is an effective method in the behavioral description of the qualitative and quantitative implanted materials. The research validated the performance of Compound bone of Granulated Ricinus on bone regeneration with the histomorphological analysis results. Were selected 30 rabbits, females, divided into 3 groups of 10 animals (G1, G2, G3) with a postoperative time of 45, 70 and 120 days respectively. Each animal is undergone 2 bone lesions in the ilium, one implemented in the material: Compound bone of Granulated Ricinus and the other for control. After the euthanasia, the iliac bone was removed, identified and subjected to histological procedure. The evaluation histological, histomorphological results were interpreted and described by quantitative and qualitative analysis based facts verified in the three experimental groups evaluating the rate of absorption of the material in the tissue regeneration, based on the neo-bone formation. The histomorphologic results classified as a material biocompatible and biologically active. Action in regeneration by bone resorption occurs slowly and gradually. Knowing the time and rate of absorption and neo-formation bone biomaterial, which can be determined in the bone segment applicable in the clinical surgical area.
C1 [Mateus, Christiano Pavan; Chierice, Gilberto Orivaldo; Okamoto, Tetuo] Univ Sao Paulo, IQSC, FMRP, Interunits Program Bioengn,EESC, Sao Carlos, SP, Brazil.
RP Mateus, CP (reprint author), Univ Sao Paulo, IQSC, FMRP, Interunits Program Bioengn,EESC, Sao Carlos, SP, Brazil.
EM christiano@sc.usp.br
RI Chierice, Gilberto Orivaldo/G-2185-2012
CR Artzi Z, 2003, INT J PERIODONT REST, V23, P381
   Boeck-Neto R, 2002, J PERIODONTOL, V73, P266, DOI 10.1902/jop.2002.73.3.266
   BORGES APB, 1998, THESIS U FEDERAL MIN, pF112
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   CAMPOS LEC, 2007, THESIS U VEIGA ALMEI, pF138
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Franco KL, 2001, ARQ BRAS MED VET ZOO, V53, P431, DOI 10.1590/S0102-09352001000400007
   HELMUS MN, 1995, ENCY HDB BIOMATERI A
   Ignacio H, 2002, REV BRAS ORTOP, V37, P187
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   MORAES PC, 2002, THESIS U ESTADUAL PA, pF73
   RIPAMONTI U, 1996, MRS B, V21
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Tsonis PA, 2002, DIFFERENTIATION, V70, P397, DOI 10.1046/j.1432-0436.2002.700802.x
   Zheng L, 2001, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V18, P470
NR 16
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2011
VL 313
AR 012005
DI 10.1088/1742-6596/313/1/012005
PG 7
WC Engineering, Biomedical; Physics, Multidisciplinary
SC Engineering; Physics
GA BXD44
UT WOS:000295800300005
OA Bronze
DA 2018-10-20
ER

PT S
AU Al Helou, M
   Boudeville, MAG
   Sanson, N
   Gerardin, C
   Mourchid, A
AF Al Helou, M.
   Boudeville, M-A. Guedeau
   Sanson, N.
   Gerardin, C.
   Mourchid, A.
BE Starov, V
   Prochazka, K
TI A Soft Method for Developing Nanostructured Organic Biomaterials
SO TRENDS IN COLLOID AND INTERFACE SCIENCE XXIV
SE Progress in Colloid and Polymer Science
LA English
DT Proceedings Paper
CT 24th Meeting of the European-Colloid-and-Interface-Society (ECIS)
CY SEP 05-10, 2010
CL Prague, CZECH REPUBLIC
SP European Colloid & Interface Soc
DE Biomaterial; Biopolymer; Micelle; Micellization; Complexes
ID IN-VITRO EVALUATION; BLOCK-COPOLYMERS; MICROSPHERES; SCATTERING
AB We study new methods for the elaboration of nanoporous biomaterials intended to deliver encapsulated molecules via diffusion. The strategy consists of casting a polylactide biopolymer around templating micelles strictly using soft preparation methods. The micelles are polyion complex micelles prepared from double hydrophilic block copolymers and hydrosoluble polyamines in aqueous solution. We show that when the aqueous solvent is switched to an organic one, the complexes remain stable, although dynamic light scattering measurements show a larger micellar size. The data is compatible with a much extended brush of the micelles in the organic solvent. The study is in progress with the aim to produce porous structures on a nanometric scale by casting biopolymer films around the micellar entities in chloroform.
C1 [Al Helou, M.; Boudeville, M-A. Guedeau; Mourchid, A.] Univ Paris Diderot, CNRS, UMR 7057, Paris, France.
   [Sanson, N.] ESPCI, CNRS, UPMC,UMR 7615, Phys chim Polymeres & Milieux Disperse, Paris, France.
   [Gerardin, C.] ENSCM, CNRS, UM2,UM1,UMR 5253, Inst Charles Gerhardt, Montpellier, France.
RP Al Helou, M (reprint author), Univ Paris Diderot, CNRS, UMR 7057, Paris, France.
EM milad.al-helou@univ-paris-diderot.fr
FU CNRS/CEA Leon Brillouin laboratory; CNRS/CEA
FX We acknowledge the support of the CNRS/CEA Leon Brillouin laboratory in
   providing the neutron facilities used in this study. We especially thank
   Dr A. Lapp for his assistance with the SANS measurements.
CR Al Helou M, 2010, POLYMER, V51, P5440, DOI 10.1016/j.polymer.2010.09.023
   Baccile N, [No title captured], Patent No. [WO2009081000, 2009081000]
   Baccile N, 2008, ANGEW CHEM INT EDIT, V47, P8433, DOI 10.1002/anie.200802431
   Dhanaraju MD, 2003, INT J BIOMED MAT R A, V66A, P441
   Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414
   Grandjean J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041503
   Guinier A, 1955, SMALL ANGLE SCATTERI
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   KOPSWERKHOVEN MM, 1981, J CHEM PHYS, V74, P1618, DOI 10.1063/1.441302
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Pedersen JS, 1996, MACROMOLECULES, V29, P1363, DOI 10.1021/ma9512115
   Pispas S, 2003, LANGMUIR, V19, P48, DOI 10.1021/la020561z
   Reboul J, 2009, THESIS U MONTPELLIER
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Senuma Y, 2000, BIOMATERIALS, V21, P1135, DOI 10.1016/S0142-9612(99)00276-8
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865
   Wang L, 2004, BIOMATERIALS, V25, P3275, DOI 10.1016/j.biomaterials.2003.09.099
   Zhao CS, 2004, J COLLOID INTERF SCI, V275, P470, DOI 10.1016/j.jcis.2004.02.079
NR 20
TC 0
Z9 0
U1 0
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-255X
BN 978-3-642-19038-4; 978-3-642-19037-7
J9 PROG COLL POL SCI S
PY 2011
VL 138
BP 173
EP 178
DI 10.1007/978-3-642-19038-4_31
PG 6
WC Polymer Science; Spectroscopy
SC Polymer Science; Spectroscopy
GA BWV82
UT WOS:000295091800031
DA 2018-10-20
ER

PT J
AU Gross, D
   Schmitz, AA
   Vonk, R
   Igney, FH
   Docke, WD
   Schoepe, S
   Sterry, W
   Asadullah, K
AF Gross, Durdana
   Schmitz, Arndt A.
   Vonk, Richardus
   Igney, Frederik H.
   Doecke, Wolf-Dietrich
   Schoepe, Stefanie
   Sterry, Wolfram
   Asadullah, Khusru
TI Willingness to Donate Human Samples for Establishing a Dermatology
   Research Biobank: Results of a Survey
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
ID LEGAL
AB There is a rising need for biomaterial in dermatological research with regard to both quality and quantity. Research biobanks as organized collections of biological material with associated personal and clinical data are of increasing importance. Besides technological/methodological and legal aspects, the willingness to donate samples by patients and healthy volunteers is a key success factor. To analyze the theoretical willingness to donate blood and skin samples, we developed and distributed a questionnaire. Six hundred nineteen questionnaires were returned and analyzed. The willingness to donate samples of blood (82.5%) and skin (58.7%) is high among the population analyzed and seems to be largely independent of any expense allowance. People working in the healthcare system, dermatological patients, and higher qualified individuals seem to be in particular willing to donate material. An adequate patient insurance as well as an extensive education about risks and benefits is requested. In summary, there is a high willingness to donate biological samples for dermatological research. This theoretical awareness fits well with our own experiences in establishing such a biobank.
C1 [Schmitz, Arndt A.; Vonk, Richardus; Doecke, Wolf-Dietrich; Schoepe, Stefanie; Asadullah, Khusru] Bayer Schering Pharma AG, Global Drug Discovery, D-13342 Berlin, Germany.
   [Gross, Durdana; Sterry, Wolfram] Charite, Dept Dermatol Venerol & Allergol, Berlin, Germany.
   [Igney, Frederik H.] Novartis Inst Biomed Res, Basel, Switzerland.
   [Sterry, Wolfram; Asadullah, Khusru] German Skin Res Ctr, Berlin, Germany.
RP Asadullah, K (reprint author), Bayer Schering Pharma AG, Global Drug Discovery, D-13342 Berlin, Germany.
EM khusru.asadullah@bayer.com
CR Asadullah K, 1997, DEUT MED WOCHENSCHR, V122, P1424, DOI 10.1055/s-2008-1047782
   Asadullah Khusru, 2007, J Dtsch Dermatol Ges, V5, P1085, DOI 10.1111/j.1610-0387.2007.06598.x
   Cambon-Thomsen A, 2007, EUR RESPIR J, V30, P373, DOI 10.1183/09031936.00165006
   Guerin JS, 2010, BIOPRESERV BIOBANK, V8, P3, DOI 10.1089/bio.2010.8101
   Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X
   Igney FH, 2004, TRENDS PHARMACOL SCI, V25, P543, DOI 10.1016/j.tips.2004.08.004
   Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106
   Vaught J, 2009, BIOPRESERV BIOBANK, V7, P143, DOI 10.1089/bio.2010.0003
   Yuille M, 2010, BIOPRESERV BIOBANK, V8, P65, DOI 10.1089/bio.2010.8102
NR 9
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PY 2011
VL 9
IS 3
BP 265
EP 271
DI 10.1089/bio.2011.0009
PG 7
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA 827ST
UT WOS:000295449200009
OA Green Published
DA 2018-10-20
ER

PT J
AU Bajpai, AK
   Kankane, S
   Singh, SK
AF Bajpai, A. K.
   Kankane, Sanjana
   Singh, Sunil K.
TI Designing Gelatin Based Blood Compatible Materials with Hydrophilic and
   Hydrophobic Macromolecular Chains
SO JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Acrylonitrile; biocompatibility; gelatin; hydrogel; water sorption
ID SWELLING BEHAVIOR; IN-VITRO; HYDROGELS; TISSUE; BIOMATERIAL; ADSORPTION;
   COPOLYMERS; SCAFFOLDS; NETWORKS; DELIVERY
AB Polymer matrices based on poly 2-hydroxyethyl methacrylate (PHEMA) have emerged as promising materials for developing applications in biomedical and tissue engineering fields. The major criteria of a material to be used as a support matrix in tissue engineering application rests on its biocompatible, hydrophilic, and mechanically strong nature. Although a great deal of research efforts have been put into designing such materials, achieving these properties together for such a material still remains a challenge. Thus, by a judicious combination of natural and synthetic polymers, such as gelatin and copolymers of PHEMA and PAN, respectively, it has been attempted to synthesize a polymer material by redox polymerization method. The prepared polymer matrix was characterized by FTIR, scanning electron microscopy (SEM), and differential scanning calorimetry (DSC) techniques. The prepared polymeric biomaterials were assessed for their water sorption potential under varying experimental conditions such as chemical composition, pH, and temperature of the swelling bath. The diffusion mechanism of transport of water molecules arising due to solvent-polymer interaction was analyzed to predict the behavior of continuously relaxing macromolecular chains. The in vitro blood compatibility of the prepared polymeric materials was determined by methods such as blood clot formation, platelet adhesion, percent hemolysis assay, and protein-adsorption on the surface of the prepared biomaterials.
C1 [Bajpai, A. K.; Kankane, Sanjana] Govt Autonomous Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur 482001, MP, India.
   [Singh, Sunil K.] Guru Ghasidas Univ, Dept Chem, Inst Technol, Bilaspur, Chhattisgarh, India.
RP Bajpai, AK (reprint author), Govt Autonomous Sci Coll, Bose Mem Res Lab, Dept Chem, Jabalpur 482001, MP, India.
EM akbmrl@yahoo.co.in
CR Abraham S, 2005, BIOMATERIALS, V26, P4767, DOI 10.1016/j.biomaterials.2005.01.031
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Bajpai AK, 2005, POLYM INT, V54, P304, DOI 10.1002/pi.1673
   Bajpai AK, 2001, J MACROMOL SCI PURE, V38, P1123, DOI 10.1081/MA-100107133
   BAJPAI AK, 2005, J MACROMOL SCI CHEM, V42, P1271
   Baker R W, 1974, CONTROLLED RELEASE M
   Balakrishnan B, 2005, POLYM INT, V54, P1304, DOI 10.1002/pi.1847
   Cascone MG, 2002, J MATER SCI-MATER M, V13, P523, DOI 10.1023/A:1014791327253
   Crespo J, 1995, J MATER SCI, V30, P6145, DOI 10.1007/BF00369660
   DOUMIT ME, 1992, TISSUE CELL, V24, P253, DOI 10.1016/0040-8166(92)90098-R
   Eichenbaum KD, 2005, MACROMOLECULES, V38, P10757, DOI 10.1021/ma0518306
   GRAINGER D, 1987, ADV BIOMEDICAL POLYM, P229
   Huang YB, 2002, MACROMOLECULES, V35, P1373, DOI 10.1021/ma011294r
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   Ju HK, 2002, J APPL POLYM SCI, V83, P1128, DOI 10.1002/app.10137
   KAPLAN A, 1967, CLIN CHEM INTERPRETA
   Kavitha A, 2005, J MACROMOL SCI PURE, VA42, P1703, DOI 10.1080/10601320500247154
   Kim JH, 2002, POLYMER, V43, P7549, DOI 10.1016/S0032-3861(02)00675-4
   Kiritoshi Y, 2002, J BIOMAT SCI-POLYM E, V13, P213, DOI 10.1163/156856202317414384
   Krishnan LK, 2004, BIOMATERIALS, V25, P5557, DOI 10.1016/j.biomaterials.2004.01.013
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   MAKARAND V, 2001, J BIOMAT SCI-POLYM E, V12, P125
   MICHAELI D, 1971, IMMUNOCHEMISTRY, V8, P1, DOI 10.1016/0019-2791(71)90416-2
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   PEPPAS NA, 1975, MAKROMOL CHEM, V176, P3433
   PEPPAS NA, 1983, J POLYM SCI POL PHYS, V21, P983, DOI 10.1002/pol.1983.180210614
   Ramseyer P, 2007, BIOMATERIALS, V28, P1185, DOI 10.1016/j.biomaterials.2006.09.019
   RAVINDRA BP, 1996, J APPL POLYM SCI, V65, P555
   Rosso F, 2004, J MATER SCI-MATER M, V15, P679, DOI 10.1023/B:JMSM.0000030209.61226.a1
   Savina IN, 2005, POLYMER, V46, P9596, DOI 10.1016/j.polymer.2005.07.091
   Serizawa T, 2002, MACROMOLECULES, V35, P10, DOI 10.1021/ma011362+
   Shukla S, 2003, MACROMOL RES, V11, P273, DOI 10.1007/BF03218364
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   Sun JY, 2005, EUR POLYM J, V41, P2443, DOI 10.1016/j.europolymj.2005.04.039
   Sun YM, 1995, J POLYM RES, V2, P71
   XIAODING X, 2005, COLLOID POLYM SCI, V285, P75
   Yang MC, 2002, J POLYM RES-TAIWAN, V9, P201, DOI 10.1023/A:1021347810130
   Zheng JP, 2005, J MATER SCI, V40, P4029, DOI 10.1007/s10853-005-0019-y
NR 40
TC 1
Z9 1
U1 0
U2 21
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0193-2691
J9 J DISPER SCI TECHNOL
JI J. Dispersion Sci. Technol.
PY 2011
VL 32
IS 7
BP 1032
EP 1040
DI 10.1080/01932691.2010.497463
PG 9
WC Chemistry, Physical
SC Chemistry
GA 824RC
UT WOS:000295218700016
DA 2018-10-20
ER

PT S
AU Klocke, D
   Schmitz, H
AF Klocke, D.
   Schmitz, H.
BE MartinPalma, RJ
   Lakhtakia, A
TI The importance of water for the mechanical properties of insect cuticle
SO BIOINSPIRATION, BIOMIMETICS, AND BIOREPLICATION
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Bioinspiration, Biomimetics, and Bioreplication
CY MAR 07-09, 2011
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers
DE elastic modulus; hardness; mechanical property; nano-indentation; insect
   cuticle; water content; biomaterial
ID PACHNODA-MARGINATA COLEOPTERA; LOBSTER HOMARUS-AMERICANUS; HARDNESS;
   SCARABAEIDAE; SURFACES; LIPIDS; DRY
AB Insect cuticle has a broad range of mechanical properties. As it has to provide a very efficient and lightweight skeleton, cuticle is a highly interesting composite-material and may serve as a natural model for new biomimetic materials.
   However, the water content of insect cuticle is of great importance for its material properties. Here, we present a new method to perform nano-indentation experiments in cuticle which has its full water content. Parts of the exoskeleton of Locusta migratoria were investigated to determine the elastic modulus (E-r) and hardness (H) of the cuticle. Cuticle sections were measured in air and then submerged and measured in water. As insect cuticle is an anisotropic material, we performed nano-indentation in the normal as well as in the transverse direction and also tested different cuticle layers within each sample (exo-, meso-and endo-cuticle).
   It turned out that a change of the water content has a dramatic impact on the material properties of the cuticle. For example, the Er of submerged endo-cuticle turned out to be 75% lower than of endo-cuticle samples measured in air. Further, the proportion of material property values between different cuticle layers within a sample change dramatically after addition of water.
C1 [Klocke, D.; Schmitz, H.] Univ Bonn, Inst Zool, D-53115 Bonn, Germany.
RP Klocke, D (reprint author), Univ Bonn, Inst Zool, D-53115 Bonn, Germany.
CR Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6
   Barbakadze N, 2006, J EXP BIOL, V209, P722, DOI 10.1242/jeb.02065
   Bhushan B, 2003, INT MATER REV, V48, P125, DOI 10.1179/095066003225010227
   CUSACK S, 1979, J MOL BIOL, V135, P39, DOI 10.1016/0022-2836(79)90339-5
   Enders S, 2004, J MATER RES, V19, P880, DOI 10.1557/jmr.2004.19.3.880
   Gibbs AG, 1998, AM ZOOL, V38, P471
   HADLEY NF, 1982, J EXP ZOOL, V222, P239, DOI 10.1002/jez.1402220306
   HEPBURN HR, 1976, J COMP PHYSIOL, V109, P177, DOI 10.1007/BF00689417
   HILLERTON JE, 1982, J EXP BIOL, V96, P45
   HILLERTON JE, 1979, J INSECT PHYSIOL, V25, P957, DOI 10.1016/0022-1910(79)90109-4
   Lin HT, 2009, J THEOR BIOL, V256, P447, DOI 10.1016/j.jtbi.2008.10.018
   LOCKE M, 1965, SCIENCE, V147, P295, DOI 10.1126/science.147.3655.295
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   Muller M, 2008, J EXP BIOL, V211, P2576, DOI 10.1242/jeb.020164
   Neville A. C., 1975, BIOL ARTHROPOD CUTIC
   NISSAN AH, 1976, MACROMOLECULES, V9, P840, DOI 10.1021/ma60053a026
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   REYNOLDS SE, 1975, J EXP BIOL, V62, P69
   Romano P, 2007, ACTA BIOMATER, V3, P301, DOI 10.1016/j.actbio.2006.10.003
   Sachs C, 2008, J STRUCT BIOL, V161, P120, DOI 10.1016/j.jsb.2007.09.022
   Schoberl T, 2006, ADV ENG MATER, V8, P1164, DOI 10.1002/adem.200600143
   Thompson J.I., 1995, BIOMED MAT ENG, V53, P7
   Vincent J, 2004, J COMMUN NETW-UK, V3, P4
   Vincent J.F.V., 1980, Symposia of the Society for Experimental Biology, P183
   Vincent J. F. V., 1990, STRUCTURAL BIOMATERI
   Vincent J.F.V., 2004, DEVELOPMENT, V33, P187
   VINCENT JFV, 1979, J INSECT PHYSIOL, V25, P653, DOI 10.1016/0022-1910(79)90115-X
   VINCENT JFV, 1987, J INSECT PHYSIOL, V33, P973, DOI 10.1016/0022-1910(87)90010-2
   Vincent JFV, 2009, J ADHESION, V85, P755, DOI 10.1080/00218460903291296
   WEYDA F, 1982, Z MIKROSK ANAT FORSC, V96, P79
NR 30
TC 0
Z9 0
U1 0
U2 7
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-81948-537-3
J9 PROC SPIE
PY 2011
VL 7975
AR 79750B
DI 10.1117/12.879889
PG 7
WC Engineering, Multidisciplinary; Optics
SC Engineering; Optics
GA BWT18
UT WOS:000294773800008
DA 2018-10-20
ER

PT J
AU Yang, DY
   Wang, ZH
   Huang, XL
   Xiao, ZF
   Liu, XD
AF Yang, Deyong
   Wang, Zhenhua
   Huang, Xiaoli
   Xiao, Zhifeng
   Liu, Xiangdong
TI Numerical Simulation on Superheated Steam Fluidized Bed Drying: I. Model
   Construction
SO DRYING TECHNOLOGY
LA English
DT Article
DE Condensation; Drag force; Eulerian-Eulerian model; Heat and mass
   transfer
ID KINETIC-THEORY; MATHEMATICAL-MODEL; GRANULAR FLOW; REDUCED PRESSURE;
   PARBOILED RICE; SPOUTED BED; HYDRODYNAMICS; BIOMATERIAL; PARTICLES;
   EQUATIONS
AB An unsteady axisymmetric two-dimensional mathematical model for a superheated steam fluidized bed drying process is established by using the Eulerian-Eulerian model to describe the turbulent flow of vapor and solid phases. The mathematical model consists of governing equations, a dynamic model of particles, a turbulent flow model, a drag force model, and a heat and mass transfer model. The model takes the effects of initial steam condensation and interaction of vapor and particles into account and can be used to describe the drying process and predict the distribution of various thermodynamic parameters in a normal atmosphere.
C1 [Yang, Deyong; Wang, Zhenhua; Huang, Xiaoli; Xiao, Zhifeng; Liu, Xiangdong] China Agr Univ, Coll Engn, Beijing 100083, Peoples R China.
RP Liu, XD (reprint author), China Agr Univ, Coll Engn, 17 Qinghua Eastern Rd, Beijing 100083, Peoples R China.
EM xdliu@cau.edu.cn
FU National Natural Science Foundation of China [51076163]
FX This research work was supported by the National Natural Science
   Foundation of China under Grant No. 51076163.
CR Benyahia S, 2000, POWDER TECHNOL, V112, P24, DOI 10.1016/S0032-5910(99)00302-2
   Chen Z, 2001, FUEL, V80, P209, DOI 10.1016/S0016-2361(00)00081-8
   Chen Z, 2000, FUEL, V79, P961, DOI 10.1016/S0016-2361(99)00217-3
   Devahastin S, 2000, DRY TECHNOL, V18, P1055, DOI 10.1080/07373930008917753
   Deventer H. C. van, 2001, Drying Technology, V19, P2033, DOI 10.1081/DRT-100107287
   DING J, 1990, AICHE J, V36, P523, DOI 10.1002/aic.690360404
   Du W, 2006, CHEM ENG SCI, V61, P1401, DOI 10.1016/j.ces.2005.08.013
   Erriguible A, 2006, DRY TECHNOL, V24, P941, DOI 10.1080/07373930600776019
   Gidaspow D, 1992, FLUIDIZATION, P75
   Gomez JE, 2009, DRY TECHNOL, V27, P1171, DOI 10.1080/07373930903262998
   Heinrich S, 1999, CHEM ENG PROCESS, V38, P131, DOI 10.1016/S0255-2701(98)00082-8
   Hinze J., 1975, TURBULENCE
   Kittiworrawatt S, 2009, CHEM ENG SCI, V64, P2644, DOI 10.1016/j.ces.2009.02.036
   LUN CKK, 1984, J FLUID MECH, V140, P223, DOI 10.1017/S0022112084000586
   Namsanguan Y, 2005, DRY TECHNOL, V23, P225, DOI 10.1081/DRT-200047883
   Neri A, 2000, AICHE J, V46, P52, DOI 10.1002/aic.690460108
   NIENWLAND JJ, 1996, CHEM ENG SCI, V51, P4087
   OGAWA S, 1980, Z ANGEW MATH PHYS, V31, P483, DOI 10.1007/BF01590859
   SCHAEFFER DG, 1987, J DIFFER EQUATIONS, V66, P19, DOI 10.1016/0022-0396(87)90038-6
   Schmidt E., 1981, PROPERTIES WATER STE
   SHIBATA H, 1994, DRY TECHNOL, V12, P1485, DOI 10.1080/07373939408961017
   Soponronnarit S, 2006, DRY TECHNOL, V24, P1457, DOI 10.1080/07373930600952800
   Suvarnakuta P, 2007, CHEM ENG PROCESS, V46, P675, DOI 10.1016/j.cep.2006.09.002
   Taechapairoj C, 2006, J FOOD ENG, V76, P411, DOI 10.1016/j.jfoodeng.2005.05.040
   Tao W. Q., 2001, NUMERICAL HEAT TRANS
   Tatemoto Y, 2008, DRY TECHNOL, V26, P168, DOI 10.1080/07373930701831267
   Tatemoto Y, 2007, CHEM ENG SCI, V62, P471, DOI 10.1016/j.ces.2006.09.016
   Wu ZH, 2007, DRY TECHNOL, V25, P59, DOI 10.1080/07373930601160775
   Zhou LX, 1994, THEORY NUMERICAL MOD
NR 29
TC 8
Z9 10
U1 1
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 2011
VL 29
IS 11
SI SI
BP 1325
EP 1331
DI 10.1080/07373937.2011.592047
PG 7
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 819DC
UT WOS:000294804600011
DA 2018-10-20
ER

PT J
AU Shi, YC
   Xiao, ZF
   Wang, ZH
   Liu, XD
   Yang, DY
AF Shi, Yongchun
   Xiao, Zhifeng
   Wang, Zhenhua
   Liu, Xiangdong
   Yang, Deyong
TI Numerical Simulation on Superheated Steam Fluidized Bed Drying: II.
   Experiments and Numerical Simulation
SO DRYING TECHNOLOGY
LA English
DT Article
DE Condensation; Inhomogeneous distribution; Negative drying rate;
   Thermodynamic parameter
ID REDUCED PRESSURE; MATHEMATICAL-MODEL; HOT-AIR; RICE; BIOMATERIAL
AB Based on the established axisymmetric two-dimensional superheated steam fluidized bed drying model, some required physical parameters and parametric models are measured and determined by experiments. The model can simulate the drying process and inhomogeneous spatial distribution of some thermodynamic and hydrodynamic parameters of rapeseed and superheated steam under normal pressure. The simulated drying dynamic curves are in agreement with the experimental curves. In the short condensing and heating period, a negative drying rate appears and rapeseed cannot be fully fluidized. The simulated and experimental results show that rapeseed is dried evenly without local overheating.
C1 [Xiao, Zhifeng; Wang, Zhenhua; Liu, Xiangdong; Yang, Deyong] China Agr Univ, Coll Engn, Beijing 100083, Peoples R China.
   [Shi, Yongchun] Shandong Univ, Sch Energy & Power Engn, Jinan, Shandong, Peoples R China.
RP Yang, DY (reprint author), China Agr Univ, Coll Engn, 17 Qinghua E Rd, Beijing 100083, Peoples R China.
EM ydy@cau.edu.cn
FU National Natural Science Foundation of China [51076163]
FX This research work was supported by the National Natural Science
   Foundation of China under Grant No. 51076163.
CR Chen Z, 2001, FUEL, V80, P209, DOI 10.1016/S0016-2361(00)00081-8
   Devahastin S, 2004, DRY TECHNOL, V22, P1845, DOI [10.1081/DRT-200032818, 10.1081/LDRT-200032818]
   Devahastin S, 2000, DRY TECHNOL, V18, P1055, DOI 10.1080/07373930008917753
   Heinrich S, 1999, CHEM ENG PROCESS, V38, P131, DOI 10.1016/S0255-2701(98)00082-8
   Iyota H, 2001, DRY TECHNOL, V19, P1425, DOI 10.1081/DRT-100105298
   Iyota H, 2008, DRY TECHNOL, V26, P211, DOI 10.1080/07373930701831598
   Kittiworrawatt S, 2009, CHEM ENG SCI, V64, P2644, DOI 10.1016/j.ces.2009.02.036
   Kozanoglu B, 2006, J FOOD ENG, V75, P383, DOI 10.1016/jjfoodeng.2005.03.063
   Kozanoglu B, 2005, POWDER TECHNOL, V150, P168, DOI 10.1016/j.powtec.2005.01.008
   Looi AY, 2002, INT J HEAT MASS TRAN, V45, P255
   NIENWLAND JJ, 1996, CHEM ENG SCI, V51, P4087
   Prachayawarakorn S, 2006, LWT-FOOD SCI TECHNOL, V39, P770, DOI 10.1016/j.lwt.2005.05.013
   Rordprapat W, 2005, J FOOD ENG, V71, P28, DOI 10.1016/j.jfoodeng.2004.10.014
   Soponronnarit S, 2006, J FOOD ENG, V75, P423, DOI 10.1016/j.jfoodeng.2005.04.058
   Suvarnakuta P, 2007, CHEM ENG PROCESS, V46, P675, DOI 10.1016/j.cep.2006.09.002
   Taechapairoj C, 2004, DRY TECHNOL, V22, P719, DOI 10.1081/DRT-120034259
   Taechapairoj C, 2003, J FOOD ENG, V58, P67, DOI 10.1016/S0260-8774(02)00335-7
   Taechapairoj C, 2006, J FOOD ENG, V76, P411, DOI 10.1016/j.jfoodeng.2005.05.040
   TANG Z, 2000, CANADIAN AGR ENG, V42
   Tatemoto Y, 2008, DRY TECHNOL, V26, P168, DOI 10.1080/07373930701831267
   Tatemoto Y, 2007, CHEM ENG SCI, V62, P2187, DOI 10.1016/j.ces.2007.01.022
   Tatemoto Y, 2007, CHEM ENG SCI, V62, P471, DOI 10.1016/j.ces.2006.09.016
   Yamsaengsung R, 2008, DRY TECHNOL, V26, P798, DOI 10.1080/07373930802046518
NR 23
TC 7
Z9 9
U1 0
U2 10
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 2011
VL 29
IS 11
SI SI
BP 1332
EP 1342
DI 10.1080/07373937.2011.592050
PG 11
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 819DC
UT WOS:000294804600012
DA 2018-10-20
ER

PT S
AU Husin, MR
   Wahit, MU
   Kadir, MRA
   Rahman, WAWA
AF Husin, Muhamad Rasyidi
   Wahit, Mat Uzir
   Kadir, Mohammed Rafiq Abdul
   Rahman, Wan Aizan Wan Abd
BE Sapuan, SM
   Mustapha, F
   Majid, DL
   Leman, Z
   Ariff, AHM
   Ariffin, MKA
   Zuhri, MYM
   Ishak, MR
   Sahari, J
TI Effect of Hydroxyapatite Reinforced High Density Polyethylene Composites
   on Mechanical and Bioactivity Properties
SO COMPOSITE SCIENCE AND TECHNOLOGY, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 8th International Conference on Composite Science and Technology
CY MAR 22-24, 2011
CL Kuala Lumpur, MALAYSIA
SP Dept Mech & Mfg Engn, Dept Aerosp Engn, Engn Composite Res Grp Fac Engn, Univ Putra Malaysia, Minist Higher Educ Malaysia, Minist Sci, Technol & Innovat, Minist Agr & Agro-Based Ind, Econom Plann Unit, UN Ind Dev Org
DE High density polyethylene; hydroxyapatite; composites; mechanical
   properties; bioactivity properties
ID IN-VITRO
AB The biomaterial composites consisting of a polymer with a matrix addition of particulate bioactive phase that analogous to the bone microstructure had been extensively studied as a substitute for human's hard and soft tissues. In this work, HA reinforced HDPE composite (HDPE/HA) was made, with HA contents being up to 50 phr using single screw extruder nanomixer for the compounding process, and later followed by the injection moulding. These characteristics of the HDPE/HA composites were examined using various techniques including differential scanning calorimetry (DSC), scanning electron microscopy (S EM), tensile testing. Mechanical and thermal properties of the composite are differed when the amount of HA incorporated into the composite were varied. It is shown that HA particles were well dispersed and homogeneously distributed within the HDPE matrix. The elastic modulus and tensile strength were increased when the HA volume percentage increased from 10 phr to 50 phr with corresponding decreases in elongation at break. However no significant influence on thermal stability was found with increasing HA loadings. The enhancement of bioactivity has been proved while incorporation of HA into HDPE composite. SEM-EDX image showed the bulk formation of apatite layers on the composite surface with 30 wt% HA after 7 days immersed in simulated body fluid (SBF) solution. These results suggest the great potential of the composites for a range of temporary application in which bone bonding ability is a desired property.
C1 [Husin, Muhamad Rasyidi; Wahit, Mat Uzir; Rahman, Wan Aizan Wan Abd] Univ Teknol Malaysia, Fac Chem Engn, Skudai 81310, Johor, Malaysia.
   [Kadir, Mohammed Rafiq Abdul] Univ Teknol Malaysia, Fac Biomed & Hlth Sci Engn, Skudai 81310, Johor, Malaysia.
RP Husin, MR (reprint author), Univ Teknol Malaysia, Fac Chem Engn, Skudai 81310, Johor, Malaysia.
EM hmrasyidi@gmail.com; mat.uzir@cheme.utm.my; rafiq@biomedical.utm.my;
   w.aizan@cheme.utm.my
CR BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Fathi M.H., 2008, DENT RES JURNAL, V5, P2
   Gu YW, 2003, BIOMATERIALS, V24, P1603, DOI 10.1016/S0142-9612(02)00573-2
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X
   WANG M, 1994, BRIT CERAM T, V93, P91
   Zhao WY, 2007, J MATER SCI-MATER M, V18, P917, DOI 10.1007/s10856-006-0069-y
NR 8
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 471-472
BP 303
EP +
DI 10.4028/www.scientific.net/KEM.471-472.303
PN 1,2
PG 3
WC Materials Science, Composites
SC Materials Science
GA BVY42
UT WOS:000293146200052
DA 2018-10-20
ER

PT S
AU Hakim, L
   Yaakob, Z
   Ismail, M
   Daud, WRW
   Majlan, EH
AF Hakim, Lukman
   Yaakob, Zahira
   Ismail, Manal
   Daud, Wan Ramli Wan
   Majlan, Edy Herianto
BE Sapuan, SM
   Mustapha, F
   Majid, DL
   Leman, Z
   Ariff, AHM
   Ariffin, MKA
   Zuhri, MYM
   Ishak, MR
   Sahari, J
TI Effect of Nickel Composition and Preparation Method for Production of
   Hydrogen via Glycerol Steam Reforming
SO COMPOSITE SCIENCE AND TECHNOLOGY, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 8th International Conference on Composite Science and Technology
CY MAR 22-24, 2011
CL Kuala Lumpur, MALAYSIA
SP Dept Mech & Mfg Engn, Dept Aerosp Engn, Engn Composite Res Grp Fac Engn, Univ Putra Malaysia, Minist Higher Educ Malaysia, Minist Sci Technol & Innovat, Minist Agr & Agro-Based Ind, Econom Plann Unit, UN Ind Dev Org
DE Glycerol; steam reforming; nickel /hydroxyapatite catalyst;
   impregnation; sol-gel; hydrogen production; surface area
ID CATALYSTS; HYDROXYAPATITE
AB The need and development of cleaner and greener alternative technologies using the heterogeneous catalytic system in the synthesis of fuel is very important. In this work hydrogen production via steam reforming of glycerol (C(3)H(8)O(3)) was carried out over nickel supported on hydroxyapatite [Ca(5)(PO(4))(3)(OH)] as a biomaterial catalyst. The time reaction is carried out for 240 minutes in a fixed-bed reactor fixed at 600 degrees C and atmospheric pressure with the water-to-glycerol feed ratio of 8:1. Catalysts were prepared by mean of impregnation and sol-gel method with varied nickel loadings (3, 6, 9, 12 %) on hydroxyapatite. The catalysts were characterized by BET surface area, X-ray diffraction, and SEM-EDX techniques. It is found that 3 wt% of nickel loading prepared via sol-gel method exhibit the higher hydrogen production rates (63.62 % - 74.16 %) in comparison to the other nickel loadings.
C1 [Hakim, Lukman; Yaakob, Zahira; Ismail, Manal; Daud, Wan Ramli Wan; Majlan, Edy Herianto] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43600, Selangor, Malaysia.
RP Hakim, L (reprint author), Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43600, Selangor, Malaysia.
EM hakim@eng.ukm.my; zahira@eng.ukm.my; manal@eng.ukm.my;
   wramli@eng.ukm.my; edy@ukm.my
RI Daud, Wan Ramli/B-3635-2013
OI Daud, Wan Ramli/0000-0002-1023-456X
CR ADIKAHRI S, 2008, RENEW ENERG, V33, P2097
   Ashok J, 2008, CATAL LETT, V121, P283, DOI 10.1007/s10562-007-9334-z
   Atir R, 2006, SYNTHETIC COMMUN, V36, P111, DOI 10.1080/00397910500330619
   *C RES SERV, 2004, CRS REP C
   Campanati M, 2003, CATAL TODAY, V77, P299, DOI 10.1016/S0920-5861(02)00375-9
   Esteban AS, 2010, INT J HYDROGEN ENERG, V35, P5902
   Iriondo A, 2008, TOP CATAL, V49, P46, DOI 10.1007/s11244-008-9060-9
   Sehested J, 2003, J CATAL, V217, P417, DOI 10.1016/S0021-9517(03)00075-7
   Zhang BC, 2007, INT J HYDROGEN ENERG, V32, P2367, DOI 10.1016/j.ijhydene.2006.11.003
NR 9
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 471-472
BP 1046
EP 1051
DI 10.4028/www.scientific.net/KEM.471-472.1046
PN 1,2
PG 6
WC Materials Science, Composites
SC Materials Science
GA BVY42
UT WOS:000293146200180
DA 2018-10-20
ER

PT J
AU Joddar, B
   Ito, Y
AF Joddar, Binata
   Ito, Yoshihiro
TI Biological modifications of materials surfaces with proteins for
   regenerative medicine
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-2; FACTOR FUSION
   PROTEIN; MESENCHYMAL STEM-CELLS; IMMOBILIZED CONCENTRATION GRADIENTS;
   POLY(METHYL METHACRYLATE) MEMBRANE; ARTIFICIAL JUXTACRINE STIMULATION;
   COLLAGEN-BINDING ACTIVITY; COILED-COIL INTERACTIONS; GUIDE NEURITE
   OUTGROWTH
AB It is very important to modify the surfaces of biomaterials for regulation of cells in the development of regenerative medicine or tissue engineering. Biomaterials are categorized into three primary types, metallic, ceramic, and polymers. Here the biological modification of biomaterial surfaces such as metals, ceramics, and polymers and the effects of such biological modifications are discussed. It is well known that cellular compatibility is regulated by three interactions: one is with extracellular matrices (ECM), second with neighboring cells, and third with soluble biosignals such as growth factors. Biomaterial researchers have immobilized ECM, cell adhesion factors, and growth factors on various materials to regulate cellular functions. Herein, biosignaling of ECM, cell adhesion factors, and growth factors are reviewed and biomaterial designs to activate biosignaling mechanisms are discussed.
C1 [Joddar, Binata; Ito, Yoshihiro] RIKEN, Adv Sci Inst, Nano Med Engn Lab, Wako, Saitama 10198, Japan.
RP Ito, Y (reprint author), RIKEN, Adv Sci Inst, Nano Med Engn Lab, 2-1 Hirosawa, Wako, Saitama 10198, Japan.
EM y-ito@riken.jp
RI Ito, Yoshihiro/F-4370-2012
CR Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   Achyuta AKH, 2009, BIOTECHNOL PROGR, V25, P227, DOI [10.1002/btpr.58, 10.1021/bp.58]
   Albuquerque ML, 2000, AM J PHYSIOL-HEART C, V279, P293
   anchez-Cortes J. S, 2010, J AM CHEM SOC, P9733
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Azuma K, 2010, BIOMATERIALS, V31, P802, DOI 10.1016/j.biomaterials.2009.09.105
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Bergeron E, 2007, J MATER SCI-MATER M, V18, P255, DOI 10.1007/s10856-006-0687-4
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Boucher C, 2010, BIOMATERIALS, V31, P7021, DOI 10.1016/j.biomaterials.2010.05.072
   Boucher C, 2009, BIOCONJUGATE CHEM, V20, P1569, DOI 10.1021/bc9001147
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Bramfeldt H., 2008, J BIOMED MATER RES A, V88, P520
   Brose C, 2009, ANN ANAT, V191, P83, DOI 10.1016/j.aanat.2008.09.004
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GP, 1997, BIOTECHNOL BIOENG, V53, P339
   Chen H, 2006, BIOCONJUGATE CHEM, V17, P21, DOI 10.1021/bc050174b
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Chevalier S, 2010, LANGMUIR, V26, P14707, DOI 10.1021/la103086b
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   CUATRECASAS P, 1969, P NATL ACAD SCI USA, V63, P450, DOI 10.1073/pnas.63.2.450
   Culpepper BK, 2010, BIOMATERIALS, V31, P9586, DOI 10.1016/j.biomaterials.2010.08.020
   DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g
   DSOUZA SE, 1991, NATURE, V350, P66, DOI 10.1038/350066a0
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x
   Edlund U., 2010, POLYM ADV TECHNOL, V22
   Edlund U, 2008, BIOMACROMOLECULES, V9, P901, DOI 10.1021/bm701267u
   Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Garty S, 2010, BIOMACROMOLECULES, V11, P1516, DOI 10.1021/bm100157s
   GHISO J, 1992, BIOCHEM J, V288, P1053, DOI 10.1042/bj2881053
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Goncalves R, 2010, J BIOMED MATER RES A, V94A, P576, DOI 10.1002/jbm.a.32723
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Guan JL, 1996, INT REV CYTOL, V168, P81, DOI 10.1016/S0074-7696(08)60883-9
   Guan YQ, 2010, BIOMATERIALS, V31, P9074, DOI 10.1016/j.biomaterials.2010.08.044
   Hall FL, 2000, INT J MOL MED, V6, P635
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   HASHI H, 1994, CELL STRUCT FUNCT, V19, P37, DOI 10.1247/csf.19.37
   Hatakeyama H, 2005, BIOMATERIALS, V26, P5167, DOI 10.1016/j.biomaterials.2004.11.061
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   Hong S, 2007, LANGMUIR, V23, P12261, DOI 10.1021/la7014397
   Horie M, 2010, J BIOSCI BIOENG, V110, P582, DOI 10.1016/j.jbiosc.2010.06.002
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Huang NF, 2010, ACTA BIOMATER, V6, P4614, DOI 10.1016/j.actbio.2010.06.033
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Imen EH, 2009, J BIOTECHNOL, V139, P19, DOI 10.1016/j.jbiotec.2008.09.011
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   Ishikawa T, 2001, J BIOCHEM-TOKYO, V129, P627, DOI 10.1093/oxfordjournals.jbchem.a002900
   ITO Y, 1992, BIOMATERIALS, V13, P789, DOI 10.1016/0142-9612(92)90019-K
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   ITO Y, 1991, BIOMATERIALS, V12, P449, DOI 10.1016/0142-9612(91)90141-V
   ITO Y, 1998, JPN J ARTIF ORGANS, V27, P383
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Ito Y, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P173, DOI 10.1007/978-0-387-98161-1_9
   Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z
   James AW, 2010, TISSUE ENG PT A, V16, P2605, DOI [10.1089/ten.tea.2010.0048, 10.1089/ten.TEA.2010.0048]
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   KAWASE Y, 1992, FEBS LETT, V298, P126, DOI 10.1016/0014-5793(92)80037-H
   Kertesz Z, 2006, CELL BIOL INT, V30, P401, DOI 10.1016/j.cellbi.2005.11.011
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim MH, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P157, DOI 10.1007/978-0-387-98161-1_8
   Kitajima T., 2011, HDB INTELLI IN PRESS
   Kitajima T, 2009, ACTA BIOMATER, V5, P2623, DOI 10.1016/j.actbio.2009.03.022
   Klenkler BJ, 2006, BIOTECHNOL BIOENG, V95, P1158, DOI 10.1002/bit.21083
   KLOCZEWIAK M, 1989, BIOCHEMISTRY-US, V28, P2915, DOI 10.1021/bi00433a025
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0
   Koike J, 2000, FEBS LETT, V477, P84, DOI 10.1016/S0014-5793(00)01765-8
   KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265
   Konagaya S, 2011, BIOMATERIALS, V32, P992, DOI 10.1016/j.biomaterials.2010.10.008
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lazarinis S, 2008, ACTA ORTHOP, V79, P763, DOI 10.1080/17453670810016821
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Li C, 2005, J BIOMAT SCI-POLYM E, V16, P875, DOI 10.1163/1568562054255754
   Liang WB, 2010, BIOMATERIALS, V31, P8634, DOI 10.1016/j.biomaterials.2010.07.084
   Liberelle B, 2010, BIOCONJUGATE CHEM, V21, P2257, DOI 10.1021/bc1002604
   Lim TY, 2009, J MATER SCI-MATER M, V20, P1, DOI 10.1007/s10856-008-3528-9
   Lin H, 2008, BIOMATERIALS, V29, P1189, DOI 10.1016/j.biomaterials.2007.11.032
   Liu HN, 2009, JOM-US, V61, P67, DOI 10.1007/s11837-009-0137-0
   LIU SQ, 1992, J BIOCHEM BIOPH METH, V25, P139
   LIU SQ, 1992, BIOMATERIALS, V13, P50, DOI 10.1016/0142-9612(92)90095-6
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Lutolf M. P., 2010, BIOTECHNIQUES, V48, pix
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Marcantonio NA, 2009, BIOMATERIALS, V30, P4629, DOI 10.1016/j.biomaterials.2009.05.061
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Mehta G, 2010, BIOMATERIALS, V31, P4657, DOI 10.1016/j.biomaterials.2010.01.138
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Meyers S. R., 2009, BIOMATERIALS, P277
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nagaoka M., 2008, J BIOL CHEM, V39, P26468
   Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015
   Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Ogiwara K, 2006, BIOCHEM BIOPH RES CO, V345, P255, DOI 10.1016/j.bbrc.2006.04.001
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Ohkawara N, 2007, J ATHEROSCLER THROMB, V14, P185, DOI 10.5551/jat.E503
   Okiyama N, 2011, J DERMATOL SCI, V61, P215, DOI 10.1016/j.jdermsci.2011.01.001
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   Paiva André Oliveira, 2006, Mat. Res., V9, P417, DOI 10.1590/S1516-14392006000400013
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Petrie TA, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P133, DOI 10.1007/978-0-387-98161-1_7
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Price N, 1997, J BIOMED MATER RES, V37, P394, DOI 10.1002/(SICI)1097-4636(19971205)37:3<394::AID-JBM10>3.0.CO;2-C
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   RAJ PA, 1992, J BIOL CHEM, V267, P5968
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Rexeisen EL, 2010, LANGMUIR, V26, P1953, DOI 10.1021/la902571q
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Sakuragi M., 2011, BIOTECHNOL LETT, P1
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schnettler R, 2009, J BIOMED MATER RES B, V90B, P75, DOI 10.1002/jbm.b.31255
   Shah SS, 2009, ACS APPL MATER INTER, V1, P2592, DOI 10.1021/am900508m
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Smith CM, 2004, TISSUE ENG, V10, P1566, DOI 10.1089/1076327042500274
   Sogo Y, 2007, BIOMED MATER, V2, P116, DOI 10.1088/1748-6041/2/2/009
   Sordel T, 2007, BIOMATERIALS, V28, P1572, DOI 10.1016/j.biomaterials.2006.10.032
   STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616
   Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945
   Sun W., 2009, BIOMATERIALS, V30, P4679
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   UNDERWOOD PA, 1995, BIOCHEM J, V309, P765, DOI 10.1042/bj3090765
   Van Lonkhuyzen DR, 2007, GROWTH FACTORS, V25, P295, DOI 10.1080/08977190701803752
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   VONDERHEIDE RH, 1994, J CELL BIOL, V125, P215, DOI 10.1083/jcb.125.1.215
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023
   Yue XS, 2010, BIOMATERIALS, V31, P5287, DOI 10.1016/j.biomaterials.2010.03.035
   Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025
   Zhang Y, 2007, MAT SCI ENG C-BIO S, V27, P213, DOI 10.1016/j.msec.2006.03.013
NR 180
TC 37
Z9 37
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 36
BP 13737
EP 13755
DI 10.1039/c1jm10984g
PG 19
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 814IG
UT WOS:000294441300003
DA 2018-10-20
ER

PT J
AU Cristache, CM
   Burlibasa, M
   Cristache, G
   Drafta, S
   Popovici, IA
   Iliescu, AA
   Zisi, S
   Burlibasa, L
AF Cristache, Corina Marilena
   Burlibasa, Mihai
   Cristache, Gheorghe
   Drafta, Sergiu
   Popovici, Ion Alexandru
   Iliescu, Alexandru Andrei
   Zisi, Sonila
   Burlibasa, Liliana
TI ZIRCONIA AND ITS BIOMEDICAL APPLICATIONS
SO METALURGIA INTERNATIONAL
LA English
DT Article
DE zirconia; ceramic; biomaterial; medicine; dentistry; aging
ID PARTIALLY-STABILIZED ZIRCONIA; COMMERCIALLY PURE TITANIUM; IN-VITRO
   EVALUATION; Y-TZP; MARTENSITIC-TRANSFORMATION; CERAMICS; OSTEOBLAST;
   OXIDE; DEGRADATION; VIVO
AB Zirconia (ZrO2), the oxidized form of zirconium is a ceramic material, existing in several phases, depending on the temperature. Due to its outstanding mechanical properties, in particular high bending strength, fracture toughness, and a Young's-modulus comparable to that of steel, zirconia has a been used over 40 years for industrial purposes and in 1990 its the biocompatibility was evaluated and ISO standard (13356) was established. With the continuous development of the CAD/CAM technique, zirconia became widely used in dentistry especially for manufacturing high strength frameworks, endodontic posts, pins, crowns, bridges, implants, implant abutments, veneers, orthodontic brackets, cutting instruments, etc. Despite the extended use of zircon a in many technical and biomedical applications, some questions concerning its properties have not yet fully answered and a large controversy exists among scientists, clinicians and industry. The aim of our review is to point out some of these questions and reveal solutions proposed in the literature.
C1 [Cristache, Corina Marilena; Cristache, Gheorghe] SC Concordia Dent SRL, Iasi, Romania.
   [Burlibasa, Mihai; Drafta, Sergiu; Popovici, Ion Alexandru; Iliescu, Alexandru Andrei; Zisi, Sonila] Univ Med & Pharm Carol Davila Bucharest, Bucharest, Romania.
   [Burlibasa, Liliana] Univ Bucharest, Fac Biol, Bucharest, Romania.
RP Cristache, CM (reprint author), SC Concordia Dent SRL, Iasi, Romania.
EM mburlibasa@gmail.com
RI CRISTACHE, CORINA MARILENA/B-1249-2011; Burlibasa, Liliana/G-2148-2014;
   Burlibasa, Liliana/S-7557-2017
OI CRISTACHE, CORINA MARILENA/0000-0001-6635-6091; Burlibasa,
   Liliana/0000-0003-0596-9331; 
CR BUKAT A, 1990, 3 SYMP CER MED
   CAPANNESI G, 1992, BIOCERAMICS AND THE HUMAN BODY, P211
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Deville S, 2004, ACTA MATER, V52, P5709, DOI 10.1016/j.actamat.2004.08.036
   Deville S, 2004, ACTA MATER, V52, P5697, DOI 10.1016/j.actamat.2004.08.034
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   GARVIE RC, 1972, J AM CERAM SOC, V55, P152, DOI 10.1111/j.1151-2916.1972.tb11241.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   GRECO F, 1993, MINERVA ORTOP TRAUMA, V44, P913
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Helmer J, 1969, S US CER SURG IMPL S
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   *ISO, 1997, 150SC1 ISO
   Kim DJ, 1997, J EUR CERAM SOC, V17, P897, DOI 10.1016/S0955-2219(96)00205-1
   Kohal RJ, 2002, INT J PROSTHODONT, V15, P189
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Koutayas SO, 2009, INT J ESTHET DENT, V4, P348
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   Lohmann CH, 2002, BIOMATERIALS, V23, P1855, DOI 10.1016/S0142-9612(01)00312-X
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   MACCAURO G, 1992, BIOL RESPONSE CALCIA, P110
   Manicone P F, 2007, Int J Immunopathol Pharmacol, V20, P9
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Sadi AY, 2008, J MATER SCI-MATER M, V19, P2359, DOI 10.1007/s10856-007-3336-7
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   SATO T, 1988, ADV CERAM, V24, P501
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Schultze-Mosgau S, 1995, Fortschr Kiefer Gesichtschir, V40, P144
   Silva VV, 2002, J BIOMED MATER RES, V63, P583, DOI 10.1002/jbm.10308
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
   UMERI A, 2009, THESIS U STUDY TRIES
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Wagner W, 1986, BIOL BIOMECHANICAL P, P129
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 49
TC 2
Z9 2
U1 0
U2 38
PU EDITURA STIINTIFICA FMR
PI BUCHAREST
PA CALEA GRIVITEI, NR 83, SECTOR 1, O P 12, BUCHAREST, 010705, ROMANIA
SN 1582-2214
J9 METAL INT
JI Metal. Int.
PY 2011
VL 16
IS 7
BP 18
EP 23
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 815HG
UT WOS:000294516100003
DA 2018-10-20
ER

PT J
AU Yu, JH
   Fan, HL
   Huang, J
   Chen, JH
AF Yu, Jiahui
   Fan, Honglei
   Huang, Jin
   Chen, Jinghua
TI Fabrication and evaluation of reduction-sensitive supramolecular
   hydrogel based on cyclodextrin/polymer inclusion for injectable
   drug-carrier application
SO SOFT MATTER
LA English
DT Article
ID PEO TRIBLOCK COPOLYMERS; ALPHA-CYCLODEXTRIN; GENE DELIVERY;
   COMPLEXATION; POLYMERIZATION; CHEMISTRY; POLYMERS; DEXTRAN; OXIDE)
AB Supramolecular hydrogels based on cyclodextrin/polymer inclusion are an emerging injectable biomaterial for drug controlled-release and cell capsulation. Although the pH- and temperature-sensitivity has been focused on contributing to intelligence, the system sensitive to physiological reduction condition caused by glutathione tripepetide (GSH) has not been reported so far. In this work, novel reduction-sensitive supramolecular hydrogels were, for the first time, fabricated by the inclusion of [poly(ethylene glycol) monomethyl ether]-graft-[disulfide-linked poly(amido amine)] (mPEG-g-SS-PAA) with alpha-cyclodextrin (alpha-CD) in aqueous solution. The reduction-sensitivity was ascribed to the disulfide linker in the SS-PAA main chain while various physical conjugations contributed to a reversible gel-sol transition under shearing as a key of injectable function. The drug release from such a supramolecular hydrogel showed a prominent sustained release profile, and the release rate could further be regulated depending upon the reduction condition. It is worth noting that incorporating a low loading-level of reducing agent did not inhibit the formation of hydrogel. As a result, it became possible to use the reduction-sensitivity to regulate the drug release profile in extracellular milieus and normal tissue. Combined with acceptable cytotoxicity, this kind of reduction-sensitive supramolecular hydrogel based on cyclodextrin/polymer inclusion showed a great potential as an injectable smart biomaterial for the application of drug controlled-release.
C1 [Yu, Jiahui; Huang, Jin] E China Normal Univ, Inst Drug Discovery & Dev, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
   [Fan, Honglei; Huang, Jin; Chen, Jinghua] Wuhan Univ Technol, Coll Chem Engn, Wuhan 430070, Peoples R China.
   [Chen, Jinghua] Jiangnan Univ, Sch Med & Pharmaceut, Wuxi 214122, Peoples R China.
RP Huang, J (reprint author), E China Normal Univ, Inst Drug Discovery & Dev, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
EM huangjin@iccas.ac.cn
RI Yu, Jiahui/A-8382-2015; Huang, Jin/E-4537-2011
FU Chinese Ministry of Science and Technology [2009CB930300]; Foundation of
   Shanghai Municipality Commission [10410710000, 09540709000]; Fundamental
   Research Funds for the Central Universities [2010-II-022]; Chinese
   Academy of Sciences Key Laboratory of Biological Effects of
   Nanomaterials and Nanosafety
FX The research work was financially supported by 973 Projects of Chinese
   Ministry of Science and Technology (2009CB930300); Foundation of
   Shanghai Municipality Commission (10410710000, 09540709000); Fundamental
   Research Funds for the Central Universities (Self-Determined and
   Innovative Research Funds of WUT 2010-II-022); and Open Project of
   Chinese Academy of Sciences Key Laboratory of Biological Effects of
   Nanomaterials and Nanosafety.
CR Abu Hashim II, 2010, INT J PHARMACEUT, V392, P83, DOI 10.1016/j.ijpharm.2010.03.026
   Chen Y, 2010, ADV FUNCT MATER, V20, P579, DOI 10.1002/adfm.200901400
   Choi HS, 2005, CHEMPHYSCHEM, V6, P1081, DOI 10.1002/cphc.200400598
   Choi HS, 2002, MACROMOL BIOSCI, V2, P298, DOI 10.1002/1616-5195(200208)2:6<298::AID-MABI298>3.0.CO;2-#
   Debouzy JC, 1998, J PHARM SCI, V87, P59, DOI 10.1021/js970180j
   Fan HL, 2010, POLYMER, V51, P5107, DOI 10.1016/j.polymer.2010.09.004
   He LH, 2005, MACROMOLECULES, V38, P3845, DOI 10.1021/ma0475333
   Hua C, 2008, MACROMOLECULES, V41, P6686, DOI 10.1021/ma800857d
   Huh KM, 2004, MACROMOL BIOSCI, V4, P92, DOI 10.1002/mabi.200300037
   Huh KM, 2001, MACROMOLECULES, V34, P8657, DOI 10.1021/ma0106649
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011
   Li J, 2009, ADV POLYM SCI, V222, P79, DOI 10.1007/12_2008_9
   Li X, 2008, J BIOMED MATER RES A, V86A, P1055, DOI 10.1002/jbm.a.31710
   Lin C, 2008, J CONTROL RELEASE, V126, P166, DOI 10.1016/j.jconrel.2007.11.012
   Liu KL, 2010, SOFT MATTER, V6, P2300, DOI 10.1039/b923472a
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Ni XP, 2009, J BIOMED MATER RES A, V88A, P1031, DOI 10.1002/jbm.a.31906
   Parrish B, 2007, BIOCONJUGATE CHEM, V18, P263, DOI 10.1021/bc060201d
   Ren LX, 2009, MACROMOL BIOSCI, V9, P902, DOI 10.1002/mabi.200900021
   Sun Y, 2010, BIOMATERIALS, V31, P7124, DOI 10.1016/j.biomaterials.2010.06.011
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P9009, DOI 10.1021/ma021061f
   van de Manakker F, 2009, BIOMACROMOLECULES, V10, P3157, DOI 10.1021/bm901065f
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   YU H, 1994, MACROMOLECULES, V27, P4554, DOI 10.1021/ma00094a019
   Yuan RX, 2008, J POLYM SCI POL PHYS, V46, P782, DOI 10.1002/polb.21412
   Zhang XL, 2010, POLYMER, V51, P4398, DOI 10.1016/j.polymer.2010.07.025
   Zhao SP, 2006, J PHYS CHEM B, V110, P12225, DOI 10.1021/jp057506u
   Zhao SP, 2006, J PHYS CHEM B, V110, P16503, DOI 10.1021/jp063005c
   Zhao SP, 2009, CARBOHYD RES, V344, P2201, DOI 10.1016/j.carres.2009.08.017
NR 33
TC 36
Z9 36
U1 3
U2 87
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 16
BP 7386
EP 7394
DI 10.1039/c1sm05426k
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 801CB
UT WOS:000293412900034
DA 2018-10-20
ER

PT J
AU Neupane, MP
   Park, IS
   Bae, TS
   Yi, HK
   Uo, M
   Watari, F
   Lee, MH
AF Neupane, Madhav Prasad
   Park, Il Song
   Bae, Tae Sung
   Yi, Ho Keun
   Uo, Motohiro
   Watari, Fumio
   Lee, Min Ho
TI Titania nanotubes supported gelatin stabilized gold nanoparticles for
   medical implants
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TIO2 NANOTUBES; OXIDE NANOTUBE; WATER; ARRAYS; PHOTOCATALYSIS;
   ELECTRODE; SURFACES; ADHESION; GROWTH; SCALE
AB TiO(2) nanotube (TN) arrays produced by electrochemical anodization have been studied extensively in recent years as a new biomaterial for implants, drug delivery systems, immuno-isolation, biosensors, cell growth, bioartifical organs and tissue engineering. A bare TiO(2) nanotube implant has many weaknesses when placed in contact with biological systems and surface modification is a possible solution for this problem. The aim of this study is to develop a very simple method for surface modification of TiO(2) nanotubes to tailor new interfacial properties important in many biomedical applications. TiO(2) nanotubes were fabricated by electrochemical anodization of titanium plate using 70 wt% glycerol in deionized water with 1 wt% NH(4)F as an electrolyte. The lyophilization method has been applied to impregnate gelatin stabilized gold nanoparticles into the TiO(2) nanotubes followed by vacuum drying. This approach for tailoring different surface chemistry of TiO(2) nanotubes develops a new platform for biomedical applications.
C1 [Neupane, Madhav Prasad; Park, Il Song; Bae, Tae Sung; Lee, Min Ho] Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Brain Korea Project 21, Jeonju 561756, South Korea.
   [Neupane, Madhav Prasad; Park, Il Song; Bae, Tae Sung; Lee, Min Ho] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Brain Korea Project 21, Jeonju 561756, South Korea.
   [Neupane, Madhav Prasad; Yi, Ho Keun] Chonbuk Natl Univ, Sch Dent, Dept Oral Biochem, Program BK21, Jeonju 561756, South Korea.
   [Neupane, Madhav Prasad; Yi, Ho Keun] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Program BK21, Jeonju 561756, South Korea.
   [Uo, Motohiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Adv Biomat Sect, Tokyo 1138549, Japan.
   [Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan.
RP Park, IS (reprint author), Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Brain Korea Project 21, Jeonju 561756, South Korea.
EM ilsong@jbnu.ac.kr; mh@jbnu.ac.kr
RI Neupane, Madhav/M-7151-2014
FU Ministry of Education, Science and Technology [2010-0023901]; Ministry
   of Knowledge Economy (MKE) of Korea [2010-H-004-00020000-2010]
FX This study was supported by the grant of 2010 Post-Doctoral Fellowship
   Program, Chonbuk National University, Basic Science and Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science and Technology (2010-0023901) and
   'Research & Commercialization for Green-Components with High Specific
   Hardness Materials Project (2010-H-004-00020000-2010) funded by the
   Ministry of Knowledge Economy (MKE) of Korea.
CR Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Funk S, 2007, NANO LETT, V7, P1091, DOI 10.1021/nl062797j
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Kalbacova M, 2008, PHYS STATUS SOLIDI-R, V2, P194, DOI 10.1002/pssr.200802080
   Kasuga T, 1998, LANGMUIR, V14, P3160, DOI 10.1021/la9713816
   Korotcenkov G, 2007, MAT SCI ENG B-SOLID, V139, P1, DOI 10.1016/j.mseb.2007.01.044
   Li N, 2006, J PHYS CHEM B, V110, P11561, DOI 10.1021/jp060653n
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Mohapatra SK, 2007, J CATAL, V246, P362, DOI 10.1016/j.jcat.2006.12.020
   Mohapatra SK, 2007, J PHYS CHEM C, V111, P11506, DOI 10.1021/jp0728712
   Mor GK, 2005, NANO LETT, V5, P191, DOI 10.1021/nl048301k
   Neupane MP, 2011, J NANOPART RES, V13, P491, DOI 10.1007/s11051-010-9971-9
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Prakasam HE, 2007, J PHYS CHEM C, V111, P7235, DOI 10.1021/jp070273h
   Regan BO, 1991, NATURE, V353, P737, DOI DOI 10.1038/353737A0
   Shrestha NK, 2009, ANGEW CHEM INT EDIT, V48, P969, DOI 10.1002/anie.200804429
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Yao H, 2007, TALANTA, V71, P550, DOI 10.1016/j.talanta.2006.04.025
   Zayat M, 2007, CHEM SOC REV, V36, P1270, DOI 10.1039/b608888k
   Zhang JJ, 2009, ANAL CHEM, V81, P6641, DOI 10.1021/ac900628y
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 30
TC 22
Z9 22
U1 0
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 32
BP 12078
EP 12082
DI 10.1039/c1jm10297d
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 802IY
UT WOS:000293504500056
DA 2018-10-20
ER

PT J
AU Park, SH
   Choi, BG
   Moon, HJ
   Cho, SH
   Jeong, B
AF Park, Soo Hyun
   Choi, Bo Gyu
   Moon, Hyo Jung
   Cho, So-Hye
   Jeong, Byeongmoon
TI Block sequence affects thermosensitivity and nano-assembly:
   PEG-L-PA-DL-PA and PEG-DL-PA-L-PA block copolymers
SO SOFT MATTER
LA English
DT Article
ID DRUG-DELIVERY; IN-SITU; SECONDARY STRUCTURE; THERMAL GELATION;
   HYDROGELS; POLYPEPTIDE; GELS; POLY(ALANINE); DEGRADATION; NANOFIBERS
AB We are reporting triblock copolymers of (ethylene glycol)(44)-(L-alanine)(9)-(DL-alanine)(9) (PEG-L-PA-DL-PA) with alpha-helical L-PA localized between flexible PEG and DL-PA, and (ethylene glycol)(44)-(DL-alanine) (9)-(L-alanine)(9) (PEG-DL-PA-L-PA) with gradient flexibility in water. Aqueous solutions of PEG-L-PA-DL-PA underwent only sol-to-gel transition, whereas those of PEG-DL-PA-L-PA underwent sol-to-gel-to-squeezed gel transitions as the temperature increased. The L-PAs of both polymers have an a-helical secondary structure in water at low temperature. However, the alpha-helical structure of the PEG-DL-PA-L-PA changed into a random coil structure as the temperature increased above 40 degrees C, whereas the PEG-L-PA-DL-PA kept the alpha-helical secondary structure over the same investigated temperature range of 4 degrees C to 50 degrees C. Cryo-transmission electron microscopy images and dynamic light scattering suggested that the PEG-L-PA-DL-PA develops spherical micelles, whereas the PEG-DL-PA-L-PA develops cylindrical bundles as well as spherical micelles in water. Even though both block copolymers have a similar composition of (ethylene glycol)(44), (L-alanine)(9), and (DL-alanine)(9), they showed significantly different temperature-sensitivities as well as different nano-assemblies in water. This report suggests that the block sequence of a polymer is very important in developing a specific nano-structure as well as in controlling thermosensitivity of the polymer, thus providing useful molecular information in designing a biomaterial.
C1 [Park, Soo Hyun; Choi, Bo Gyu; Moon, Hyo Jung; Jeong, Byeongmoon] Ewha Womans Univ, Dept Bioinspired Sci WCU, Dept Chem & Nano Sci, Seoul 120750, South Korea.
   [Cho, So-Hye] Korea Inst Sci & Technol, Nanomat Ctr, Seoul 130650, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Bioinspired Sci WCU, Dept Chem & Nano Sci, 52 Ewhayeodae Gil, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU MEST of Korea [2011-0000376, 2011-0001340, R31-2008-000-10010-0]
FX This work was supported by the National Research Foundation grant funded
   by the MEST of Korea (Grant number: 2011-0000376, 2011-0001340, and
   R31-2008-000-10010-0).
CR Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Choi BG, 2005, CHEM COMMUN, P2960, DOI 10.1039/b501515
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi YY, 2010, J MATER CHEM, V20, P3416, DOI 10.1039/b922956f
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Floudas G, 2003, MACROMOLECULES, V36, P3673, DOI 10.1021/ma025918k
   Han JO, 2009, MACROMOLECULES, V42, P6710, DOI 10.1021/ma901089s
   Han WS, 2005, J PHYS CHEM B, V109, P20661, DOI 10.1021/jp0547156
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kaneko Y, 1998, MACROMOLECULES, V31, P6099, DOI 10.1021/ma971899g
   Kim HJ, 2011, ACCOUNTS CHEM RES, V44, P72, DOI 10.1021/ar100111n
   Kim JY, 2009, MACROMOLECULES, V42, P3147, DOI 10.1021/ma900341m
   Kim SY, 2008, J PHYS CHEM B, V112, P7420, DOI 10.1021/jp711291x
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Lu H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1209
   Moon KS, 2007, ANGEW CHEM INT EDIT, V46, P6807, DOI 10.1002/anie.200702136
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   O'Lenick TG, 2010, LANGMUIR, V26, P8787, DOI 10.1021/la9045308
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Shklyarevskiy IO, 2005, LANGMUIR, V21, P2108, DOI 10.1021/la047166o
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Vernon B, 2000, J BIOMED MATER RES, V51, P69
   Vintiloiu A, 2008, J CONTROL RELEASE, V125, P179, DOI 10.1016/j.jconrel.2007.09.014
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 38
TC 27
Z9 27
U1 0
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 14
BP 6515
EP 6521
DI 10.1039/c1sm05505d
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 795PG
UT WOS:000292985500020
DA 2018-10-20
ER

PT J
AU Diaferia, GR
   Biunno, I
   DeBlasio, P
AF Diaferia, Giuseppe R.
   Biunno, Ida
   DeBlasio, Pasquale
TI Comprehensive Outsourcing Biobanking Facility to Serve the International
   Research Community
SO BIOPRESERVATION AND BIOBANKING
LA English
DT Article
ID PERSONALIZED MEDICINE
AB The validity of results from biomarker studies using archived specimens depends on the integrity of the specimens and the manner in which they are collected, processed, and stored. The management of a huge amount of biomaterial generated from research studies and clinical trials is becoming a very demanding task and many organizations are facing the choice between in-house storage and processing and outsourcing some activities. Storage and logistic functions are the prime targets for outsourcing, because to sustain these critical assets organizations must have the expertise, the dedicated qualified personnel, the proper quality control programs, and available resources to fulfill the mandatory requirements to maintain the integrity of the samples. External biobanks are dedicated and certified infrastructures (ISO, GMP, etc.) that apply efficient logistic and shipping activities, use validated standard operating procedures, install appropriate monitoring back-up systems, and, most of all, have room for expansion. Thus, the choice between in-house biobanking and outsourcing cannot be exclusively based on a financial decision; it must also consider (i) type of collection/project, (ii) logistic complexity (number and locations of collection sites), (iii) safety requirements, (iv) functional expertise, and (v) business priorities.
C1 [DeBlasio, Pasquale] BioRep Srl, I-20138 Milan, Italy.
   [Biunno, Ida] IRGB CNR, Milan, Italy.
   [Diaferia, Giuseppe R.; Biunno, Ida; DeBlasio, Pasquale] Integrated Syst Engn Srl, Milan, Italy.
RP DeBlasio, P (reprint author), BioRep Srl, Via Pantoli 16-15, I-20138 Milan, Italy.
EM p.deblasio@biorep.it
FU European Community [HEALTH-2008-B-222943]
FX The authors acknowledge the support of NeuroStemcell (European
   Community's Seventh Framework Programme grant agreement nr.
   HEALTH-2008-B-222943) and are grateful to Marble Arch Working Group on
   International Biobanking and the European Middle Eastern and African
   Society for Biopreservation and Biobanking who provided additional
   knowledge.
CR BENNER J, 2010, BIOPROCESS INT, V8, P10
   Beskow LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013302
   *BUS INS, 2009, MARKET RES REP, V1, P1
   CHALMERS D, 2008, METHODS BIOBANKING, V675, P1
   Clark BJ, 2010, BIOPRESERV BIOBANK, V8, P179, DOI 10.1089/bio.2010.8415
   HANSSON MG, 2008, METHODS BIOBANKING, V675, P39
   Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8
   MARCUM J, 2007, BIOPROCESS INT, V5, P1
   Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004
   Zatloukal K, 2010, BIOMARK MED, V4, P895, DOI 10.2217/BMM.10.104
   ZIKA E, 2011, GENOMICS, V14, P96
NR 11
TC 2
Z9 2
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1947-5535
J9 BIOPRESERV BIOBANK
JI Biopreserv. Biobank.
PY 2011
VL 9
IS 2
SI SI
BP 191
EP 194
DI 10.1089/bio.2011.0002
PG 4
WC Cell Biology; Chemistry, Applied; Medical Laboratory Technology
SC Cell Biology; Chemistry; Medical Laboratory Technology
GA 793FU
UT WOS:000292806600012
PM 24846267
DA 2018-10-20
ER

PT S
AU Zhou, ZY
   Zou, LI
   Li, HS
   Bunger, C
   Zou, XN
AF Zhou, Zhiyu
   Zou, Lijin
   Li, Haisheng
   Bunger, Cody
   Zou, Xuenong
BE Zhou, M
TI The Extraction Processes and Biological Characteristics of a New
   Generation Demineralized Bone Matrixes
SO HIGH PERFORMANCE STRUCTURES AND MATERIALS ENGINEERING, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 1st International Conference on High Performance Structures and
   Materials Engineering
CY MAY 05-06, 2011
CL Beijing, PEOPLES R CHINA
SP Int Ind Elect Ctr, Shenzhen Univ, ACM Hong Kong Chapter
DE Demineralizated bone matrix; Bone protein extracts; COLLOSS (R) E;
   Osteogenesis
ID LUMBAR INTERBODY FUSION; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS;
   PROTEIN EXTRACT; IN-VITRO; SPINAL-FUSION; COLLOSS(R) E; BOVINE BONE;
   OSTEOINDUCTIVE BIOMATERIAL; SCAFFOLDING MATERIAL
AB An ideal bone graft material should have osteocondutive, osteroindurctive, and osteogenic features. Scientists and doctors have been trying to develop this kind of material for over one century. However, all the features of few materials used in clinic now have been qualified. Recently, COLLOSS, as the new generation bone graft material of demineralized bone matrix, almost achieved this height. The paper presents a general survey of COLLOSS including its extraction processes, biological characteristics, and application prospects.
C1 [Zhou, Zhiyu; Zou, Xuenong] Sun Yat Sen Univ, Hosp Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthpaed Surg, Guangzhou 510080, Guangdong, Peoples R China.
   [Zou, Lijin] Nanchang Univ, Affilated Hosp 1, Dept Burn Surg, Nanchang 330031, Jiangxi, Peoples R China.
   [Li, Haisheng; Bunger, Cody] Aarhus Univ Hosp, Dept Orthopaed Surg, Orthopaed Res Lab, DK-8000 Aarhus, Denmark.
RP Zhou, ZY (reprint author), Sun Yat Sen Univ, Hosp Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthpaed Surg, Guangzhou 510080, Guangdong, Peoples R China.
EM zxnong@hotmail.com
CR Alanay A, 2008, SPINE J, V8, P789, DOI 10.1016/j.spinee.2007.06.009
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Baas J, 2006, ACTA ORTHOP, V77, P791, DOI 10.1080/17453670610013015
   Baas J, 2008, ACTA ORTHOP, V79, P841, DOI 10.1080/17453670810016948
   BACHRA BN, 1972, CALC TISS RES, V8, P287
   Bae H. W, 2006, SPINE, V31, P1307, DOI [DOI 10.1097/01.BRS.0000218581.92992.B7, 10.1097/01brs.0000218581,92992.b7]
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   Becerra J, 1996, J BONE MINER RES, V11, P1703
   Bertagnoli R., 2002, EUR SPINE J, V11, P189
   Boraiah S, 2009, CLIN ORTHOP RELAT R, V467, P3257, DOI 10.1007/s11999-009-1039-8
   Breitbart EA, 2010, J ORTHOP RES, V28, P942, DOI 10.1002/jor.21065
   Brower RS, 2008, SPINE, V33, pE653, DOI 10.1097/BRS.0b013e31817c4f1c
   Camargo Paulo M, 2002, Compend Contin Educ Dent, V23, P1023
   Camargo PM, 2002, COMPEND CONTIN ED DE, V23, P1030
   Camargo PM, 2002, COMPEND CONTIN ED DE, V23, P1032
   Camargo PM, 2002, COMPEND CONTIN ED DE, V23, P1042
   Chen WJ, 2007, J CRANIOFAC SURG, V18, P43, DOI 10.1097/SCS.0b013e31802ccf54
   DELMAS PD, 1984, CALCIFIED TISSUE INT, V36, P308, DOI 10.1007/BF02405335
   Deutsch H, 2010, SPINE J, V10, pE1, DOI 10.1016/j.spinee.2009.10.016
   Dodds R.A., 2009, J BIOMATER APPL
   Donati D, 2008, CLIN ORTHOP RELAT R, V466, P459, DOI 10.1007/s11999-007-0055-9
   El-Sabban ME, 2007, REGEN MED, V2, P383, DOI 10.2217/17460751.2.4.383
   Foldager C, 2009, BONE, V45, P267, DOI 10.1016/j.bone.2009.04.240
   Foldager C, 2008, SPINE, V33, P2683, DOI 10.1097/BRS.0b013e31817fce91
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Gurevitch O, 2003, STEM CELLS, V21, P588, DOI 10.1634/stemcells.21-5-588
   Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508
   HONSAWEK, 2005, CELL TISSUE BANK, V6, P13
   Honsawek Sittisak, 2006, J Med Assoc Thai, V89 Suppl 3, pS189
   Huffer WE, 2006, ADV EXP MED BIOL, V585, P87
   Huffer WE, 2007, J BIOMED MATER RES B, V82B, P460, DOI 10.1002/jbm.b.30751
   Jensen Jonas, 2010, Open Orthop J, V4, P181, DOI 10.2174/1874325001004010181
   Joseph V, 2007, SPINE, V32, P2885, DOI 10.1097/BRS.0b013e31815b7596
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Katz JM, 2009, J BIOMED MATER RES B, V89B, P127, DOI 10.1002/jbm.b.31195
   Khan MT, 1998, ANN ROY COLL SURG, V80, P150
   Kloss F R, 2004, Mund Kiefer Gesichtschir, V8, P12, DOI 10.1007/s10006-003-0518-4
   Krugliakov P V, 2005, Tsitologiia, V47, P466
   Kruglyakov PV, 2006, B EXP BIOL MED+, V142, P534, DOI 10.1007/s10517-006-0410-y
   Kuvat SV, 2009, J PLAST RECONSTR AES, V62, P639, DOI 10.1016/j.bjps.2007.09.043
   Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006
   Lee YP, 2005, J SPINAL DISORD TECH, V18, P439, DOI 10.1097/01.bsd.0000175696.66049.f7
   Li HS, 2007, J BIOMED MATER RES B, V81B, P194, DOI 10.1002/jbm.b.30653
   Li HS, 2007, SPINE, V32, pE126, DOI 10.1097/01.brs.0000255210.67616.2b
   Li HS, 2006, ADV EXP MED BIOL, V585, P393
   Li HS, 2005, SPINE, V30, P890, DOI 10.1097/01.brs.0000159097.74426.ea
   Li HS, 2004, EUR SPINE J, V13, P354, DOI 10.1007/s00586-003-0647-3
   Li HS, 2002, EUR SPINE J, V11, P476, DOI 10.1007/s00586-002-0455-1
   Liu GP, 2008, CALCIFIED TISSUE INT, V83, P176, DOI 10.1007/s00223-008-9159-9
   Liu GP, 2008, CRYOBIOLOGY, V56, P209, DOI 10.1016/j.cryobiol.2008.02.008
   Liu GP, 2010, TISSUE ENG PT A, V16, P971, DOI [10.1089/ten.tea.2009.0516, 10.1089/ten.TEA.2009.0516]
   Lode A, 2009, J TISSUE ENG REGEN M, V3, P149, DOI 10.1002/term.138
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Nienhuijs M.E., 2010, TISSUE ENG A
   Nienhuijs MEL, 2010, J BIOMED MATER RES B, V92B, P517, DOI 10.1002/jbm.b.31546
   Nienhuijs MEL, 2009, J BIOMED MATER RES B, V89B, P300, DOI 10.1002/jbm.b.31216
   Nienhuijs MEL, 2006, BIOMATERIALS, V27, P3109, DOI 10.1016/j.biomaterials.2006.01.021
   Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72
   Pietrzak WS, 2006, J CRANIOFAC SURG, V17, P84, DOI 10.1097/01.scs.0000179745.91165.73
   Price CT, 2003, SPINE, V28, P793, DOI 10.1097/00007632-200304150-00012
   Qiu QQ, 2007, J BIOMED MATER RES B, V82B, P239, DOI 10.1002/jbm.b.30726
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Rupprecht S, 2007, J BIOMED MATER RES B, V83B, P314, DOI 10.1002/jbm.b.30797
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P505
   Schlegel KA, 2006, CLIN ORAL IMPLAN RES, V17, P666, DOI 10.1111/j.1600-0501.2006.01214.x
   Sundar S, 2009, J BIOMED MATER RES B, V88B, P115, DOI 10.1002/jbm.b.31157
   TERMINE JD, 1981, J BIOL CHEM, V256, P403
   Tsiridis E, 2007, J ORTHOP RES, V25, P1425, DOI 10.1002/jor.20387
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Urrutia J, 2008, J NEUROSURG-SPINE, V9, P84, DOI 10.3171/SPI/2008/9/7/084
   Vilalta M, 2009, BIOMATERIALS, V30, P4986, DOI 10.1016/j.biomaterials.2009.05.056
   Walboomers XF, 2005, BIOMATERIALS, V26, P4779, DOI 10.1016/j.biomaterials.2004.11.029
   Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x
   Wildemann B., 2007, Cell and Tissue Banking, V8, P107, DOI 10.1007/s10561-006-9021-0
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Woo C, 2006, J BIOMED MATER RES A, V79A, P552, DOI 10.1002/jbm.a.30892
   Yoshida Y, 2000, J Orthop Sci, V5, P198, DOI 10.1007/s007760050151
   Zhukauskas R, 2010, J BIOMATER APPL, V24, P639, DOI 10.1177/0885328209335101
   Zou XN, 2009, BIOMATERIALS, V30, P991, DOI 10.1016/j.biomaterials.2008.10.061
NR 79
TC 0
Z9 0
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-075-6
J9 ADV MATER RES-SWITZ
PY 2011
VL 217-218
BP 1006
EP +
DI 10.4028/www.scientific.net/AMR.217-218.1006
PN 1-2
PG 4
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BVQ13
UT WOS:000292278900184
DA 2018-10-20
ER

PT S
AU Stach, S
AF Stach, Sebastian
BE Sandera, P
TI The simulation and modelling of the crack path of biomaterials
SO MATERIALS STRUCTURE & MICROMECHANICS OF FRACTURE
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 6th International Conference on Materials Structure and Micromechanics
   of Fracture
CY JUN 28-30, 2010
CL Brno, CZECH REPUBLIC
DE simulation; modeling; cracking; path; fracture; surface; biomaterial
AB Analysis of issues related to the cracking process of materials requires a quantitative description of the problem which frequently, due to its complexity, is difficult or impossible to solve. In a number of cases, the deficiencies of a quantitative description made using classical methods are compensated for by such unconventional tools as percolation, which requires creating an appropriate model. The aim of the study was to use a three-dimensional minimal spanning tree (3DMST) to create a model of the crack path, based on an example of a metallic biomaterial. For this purpose, a stereometric file, obtained as a result of measuring its fracture surface, was applied.
C1 Univ Silesia, Fac Comp Sci & Mat Sci, PL-41205 Sosnowiec, Poland.
RP Stach, S (reprint author), Univ Silesia, Fac Comp Sci & Mat Sci, Ul Bedzinska 39, PL-41205 Sosnowiec, Poland.
EM sebastian.stach@us.edu.pl
RI Stach, Sebastian/E-5798-2011
OI Stach, Sebastian/0000-0001-7054-700X
CR AUSTIN D, 2008, PERCOLATION SLIPPING
   Bollobas B, 2006, PERCOLATION
   HEERMAN DW, 2007, COMPUTER SIMULATION
   NEIMITZ A, 1998, CRACK MECH
   PAWLUS P, 2001, SURFACE TOPOGRAPHY
   Smith D. M., 2009, ENG COMPUTATION MATL
   STACH S, 2010, ADV SOFT CO IN PRESS
   VANDEWEYGAERT R, 1992, PHYS LETT A, V169, P145, DOI 10.1016/0375-9601(92)90584-9
   WEISMAN S, 1986, ANN N Y SCI, V1, P80
   WOLOSZYN J, 2006, ZESZYTY NAUKOWE, V724
NR 10
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 465
BP 141
EP 144
DI 10.4028/www.scientific.net/KEM.465.141
PG 4
WC Engineering, Mechanical; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BVK41
UT WOS:000291704700029
DA 2018-10-20
ER

PT S
AU Stach, S
AF Stach, Sebastian
BE Sandera, P
TI Comparative studies of fracture surfaces of a biomaterial with the use
   of a profilographometer and confocal microscope
SO MATERIALS STRUCTURE & MICROMECHANICS OF FRACTURE
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 6th International Conference on Materials Structure and Micromechanics
   of Fracture
CY JUN 28-30, 2010
CL Brno, CZECH REPUBLIC
DE confocal microscopy; profilometry; surface; fracture; biomaterial
AB The aim of the paper is to present comparative studies of the parameters of the fracture surface topography of titanium alloy, obtained by means of two techniques. The research equipment consisted of a Taylor Hobson profilographometer, Talysurf, and a confocal microscope, LEXT OLS 3000 by Olympus. By means of a contact and non-contact method, files of coordinates of the investigated surfaces were obtained, based on which some chosen stereometric parameters were calculated. The tests carried out as part of the study confirmed the usefulness and the possibility of using a confocal microscope as a modern instrument for evaluating the topography of non-planar surfaces. In the case of statistical parameters representing the whole surface under examination, very high convergence of the stereometric structure parameters was obtained, described by means of profilographometry and confocal microscopy methods.
C1 Univ Silesia, Fac Comp Sci & Mat Sci, PL-41205 Sosnowiec, Poland.
RP Stach, S (reprint author), Univ Silesia, Fac Comp Sci & Mat Sci, Ul Bedzinska 39, PL-41205 Sosnowiec, Poland.
EM sebastian.stach@us.edu.pl
RI Stach, Sebastian/E-5798-2011
OI Stach, Sebastian/0000-0001-7054-700X
CR Blunt L, 2003, ADV TECHNIQUES ASSES
   *ISO DIS, 2007, 251781 ISODIS
   *ISO DIS, 2008, 251782 ISODIS
   *ISO DIS, 2007, 251783 ISODIS
   PAWLUS P, 2001, SURFACE TOPOGRAPHY
   Stout K., 2000, 3 DIMENSIONAL SURFAC
NR 6
TC 1
Z9 1
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 465
BP 271
EP 275
DI 10.4028/www.scientific.net/KEM.465.271
PG 5
WC Engineering, Mechanical; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BVK41
UT WOS:000291704700061
DA 2018-10-20
ER

PT S
AU Stach, S
AF Stach, Sebastian
BE Sandera, P
TI New methods of EDC and 3DMST fractal analysis in the examination of
   biomaterial surface fractures
SO MATERIALS STRUCTURE & MICROMECHANICS OF FRACTURE
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 6th International Conference on Materials Structure and Micromechanics
   of Fracture
CY JUN 28-30, 2010
CL Brno, CZECH REPUBLIC
DE fracture; surface; fractal; dimension; biomaterial
AB The aim of this study was to gather methodological clues in the scope of a fractal description of non-planar surfaces, which clues can be used for testing biomaterials. The fundamentals of a few most popular fractal methods of surface analysis are discussed here and two new methods are proposed by presenting their basic assumptions. On this basis, appropriate programs for numerical calculations have been developed, while simultaneously using measuring files from instruments which enable stereometric measurement of surfaces (profilographometers, confocal microscopes, etc.).
C1 Univ Silesia, Fac Comp Sci & Mat Sci, PL-41205 Sosnowiec, Poland.
RP Stach, S (reprint author), Univ Silesia, Fac Comp Sci & Mat Sci, Ul Bedzinska 39, PL-41205 Sosnowiec, Poland.
EM sebastian.stach@us.edu.pl
RI Stach, Sebastian/E-5798-2011
OI Stach, Sebastian/0000-0001-7054-700X
CR CLARKE KC, 1986, COMPUT GEOSCI, V12, P713, DOI 10.1016/0098-3004(86)90047-6
   LUNG CW, 1998, PHYS REV B, V38, P11781
   Russ J.C, 1994, FRACTAL SURFACES
   Smith D. M., 2009, ENG COMPUTATION MATL
   VANDEWEYGAERT R, 1992, PHYS LETT A, V169, P145, DOI 10.1016/0375-9601(92)90584-9
   Xie HP, 1999, INT J SOLIDS STRUCT, V36, P3073, DOI 10.1016/S0020-7683(98)00141-3
NR 6
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 465
BP 276
EP 281
DI 10.4028/www.scientific.net/KEM.465.276
PG 6
WC Engineering, Mechanical; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Engineering; Science & Technology - Other Topics; Materials Science
GA BVK41
UT WOS:000291704700062
DA 2018-10-20
ER

PT J
AU Daud, WRW
   Kassim, MHM
   Seeni, A
AF Daud, Wan Rosli Wan
   Kassim, Mohamad Haafiz Mohamad
   Seeni, Azman
TI CELLULOSE PHOSPHATE FROM OIL PALM BIOMASS AS POTENTIAL BIOMATERIALS
SO BIORESOURCES
LA English
DT Article
DE Oil Palm biomass; Cellulose phosphate; Biomaterial; In vitro
   Biocompatibility; Cytotoxicity; Bioactivity; Simulated Body Fluid (SBF)
ID SIMULATED BODY-FLUID; CALCIUM-PHOSPHATE; PHOSPHORYLATED CHITIN;
   BIOCOMPATIBILITY; POLYMERS; FIBERS; BAMBOO; BONE
AB The present study investigates cellulose phosphate from oil palm biomass (OPEFB-CP) as a potential biomaterial. To this effect, oil palm biomass microcrystalline cellulose (OPEFB-MCC) was phosphorylated using the H3PO4/P2O5/Et3PO4/hexanol method. Characterization of OPEFB-CP was performed using Scanning Electron Microscopy (SEM), Energy Dispersive X-ray (EDX), Fourier Transform Infrared (FTIR) spectroscopy, thermogravimetry (TG), and X-ray diffraction (XRD). The cytotoxicity evaluation of OPEFB-CP was conducted on mouse connective tissue fibroblast cells (L929) using MTS Assay analysis, and the proliferation rate of OPEFB-CP on L929 was assessed by the indirect extraction method, whilst mineralization assessment was carried out by immersion of the material in Simulated Body Fluid (SBF) for 30 days. Disruption of the crystalline structure of OPEFB-MCC, changes in surface morphology of OPEFB-CP, the presence of new FTIR peaks on OPEFB-CP at 2380 cm(-1) and 1380 cm(-1), and a smaller rate of mass loss of OPEFB-CP are indications of a successful grafting of phosphate groups. OPEFB-CP showed non-cytotoxic in vitro biocompatibility after 72h exposure with an IC-50 value 45mg/mL and a proliferation rate of up to 8 days with no change in cells morphology below the IC-50 concentration. Apatite formation was observed on OPEFB-CP surfaces after 30 days in SBF with a Ca:P ratio of 1.85.
C1 [Daud, Wan Rosli Wan; Kassim, Mohamad Haafiz Mohamad] Univ Sains Malaysia, Sch Ind Technol, Bioresources Paper & Coating Div, George Town 11800, Malaysia.
   [Seeni, Azman] Univ Sains Malaysia, Adv Med & Dent Inst, Bertam 13200, Penang, Malaysia.
RP Daud, WRW (reprint author), Univ Sains Malaysia, Sch Ind Technol, Bioresources Paper & Coating Div, George Town 11800, Malaysia.
EM wanrosli@usm.my
RI M.K, Mohamad Haafiz/J-8883-2015; Seeni, Azman/I-3837-2012
OI M.K, Mohamad Haafiz/0000-0002-4344-0554; Seeni,
   Azman/0000-0002-3680-4006
FU Universiti Sains Malaysia [1001/PTEKIND 8141051]
FX The authors would like to thank Universiti Sains Malaysia for its
   financial support under research grant 1001/PTEKIND 8141051, Ministry of
   Higher Education Malaysia (KPT) for sponsoring postgraduate studies of
   M. K Mohamad Haafiz, and Craniofacial Lab Staff member Eda Binti Sarip
   PPSG USMKK for her help and discussion.
CR ALTMAN SA, 1999, BIOTECHNOL RAG, V9, P871
   Ardizzone S, 1999, CELLULOSE, V6, P57, DOI 10.1023/A:1009204309120
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CORRELO VM, 2008, J BIOMED MATER RES A, P489
   Ekholm E, 2005, ACTA BIOMATER, V1, P535, DOI 10.1016/j.actbio.2005.05.003
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gao C, 2010, CELLULOSE, V17, P365, DOI 10.1007/s10570-009-9371-4
   Gonzalez Alriols M, 2009, CHEM ENG J, V148, P106, DOI 10.1016/j.cej.2008.08.008
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Hayashi S, 2009, MACROMOL MATER ENG, V294, P315, DOI 10.1002/mame.200800335
   *INT STAND OFF, 1996, 1099312 ISO
   Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1
   Jayakumar R, 2009, POLYM ENG SCI, V49, P844, DOI 10.1002/pen.21306
   Kaputskii FN, 2007, RUSS J APPL CHEM+, V80, P1135, DOI 10.1134/S1070427207070245
   Kawashita M, 2003, BIOMATERIALS, V24, P2477, DOI 10.1016/S0142-9612(03)00050-4
   Leh CP, 2008, IND CROP PROD, V28, P260, DOI 10.1016/j.indcrop.2008.02.016
   Li SH, 1997, J MATER SCI-MATER M, V8, P543, DOI 10.1023/A:1018546730925
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   Lin Q, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045005
   Martins AM, 2009, ACTA BIOMATER, V5, P3328, DOI 10.1016/j.actbio.2009.05.027
   MATTHEW HWT, 2002, POLYM BIOMATERIAL PO, pCH8
   MELO AD, 2009, J BRAZIL CHEM SOC, V20, P1753
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Muzzarelli RAA, 2005, BIOMATERIALS, V26, P5844, DOI 10.1016/j.biomaterials.2005.03.006
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Rodrigues G, 2007, POLYM DEGRAD STABIL, V92, P205, DOI 10.1016/j.polymdegradstab.2006.11.008
   Rosli W. D. Wan, 1998, CELL CHEM TECHNOL, V32, P133
   Rosli WDW, 2004, J TROP FOR SCI, V16, P343
   Rosli WDW, 2003, HOLZFORSCHUNG, V57, P106, DOI 10.1515/HF.2003.017
   ROSLI WWD, 2011, CARBOHYD POLYM, V84, P262
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Suflet DM, 2006, REACT FUNCT POLYM, V66, P1240, DOI 10.1016/j.reactfunctpolym.2006.03.006
   TOWLE GA, 1972, METHODS CARBOHYDRATE, V6, P408
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VIGO TL, 1974, CARBOHYD RES, V32, P331, DOI 10.1016/S0008-6215(00)82109-6
   Wan Rosli W.D., 2007, IND CROP PROD, V25, P89
   WIESLANDER AP, 1993, BIOINFO BANK LIB, P31
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
NR 47
TC 10
Z9 10
U1 0
U2 9
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2011
VL 6
IS 2
BP 1719
EP 1740
PG 22
WC Materials Science, Paper & Wood
SC Materials Science
GA 776TA
UT WOS:000291559600062
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Geisler, CG
   Li, HL
   Wootton, DM
   Lelkes, PI
   Zhou, JG
AF Geisler, Chris G.
   Li, Ho-Lung
   Wootton, David M.
   Lelkes, Peter I.
   Zhou, Jack G.
GP ASME
TI SOFT BIOMATERIAL STUDY FOR 3-D TISSUE SCAFFOLD PRINTING
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE 2010, VOL 1
LA English
DT Proceedings Paper
CT ASME International Manufacturing Science and Engineering Conference
CY OCT 12-15, 2010
CL Penn State Erie, Erie, PA
SP Behrend Coll, ASME, Manufactur Engn
HO Penn State Erie
ID PHOTOCROSSLINKABLE CHITOSAN HYDROGEL; BIOMEDICAL APPLICATIONS;
   DRUG-DELIVERY; ALGINATE HYDROGELS; CONTROLLED-RELEASE; GEL BEADS;
   GENIPIN; FILMS; MICROSPHERES; SENSITIVITY
AB In 3-D scaffold printing, it is critical to find a material that is suitable for your printing method, printing speed, and ease of use. For a biomaterial to best suit solid freeform fabrication techniques, it must: 1) be a low-viscous solution before being printed, 2) involve easily joined on-substrate mixing to form a homogenous gel, 3) have a short solution to gel transition time, 4) be a mechanically strong gel, and 5) have an irreversible gelation processes.
   Ionic crosslinkable, photocrosslinkable, and thermosensitive hydrogels have all been investigated and found to not fully satisfy our every requirement for SFF printing. Ionic crosslinking hydrogels can gel rapidly but tend to involve additional steps for crosslinking like freeze drying, stirring, and shaking, while some form beads, not homogenous gels. Some photocrosslinkable hydrogels would not work due to the concern for viability of cells in initial gel layers receiving copious amount of UV light. Thermosensitive hydrogels meet most of the requirements except that they are reversible gels.
   A new type of gel that obtains the qualities of a photocrosslinkable and thermosensitive hydrogel satisfies every requirement. A PEG-PLGA-PEG thermosensitive triblock copolymer additionally crosslinked with photocrosslinkable Irgacure 2959 allows for quick transition from solution to gel with a post-processing step utilizing UV light would add additional crosslinks to the gel structure resulting in an irreversible hydrogel.
C1 [Geisler, Chris G.; Li, Ho-Lung; Zhou, Jack G.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Geisler, CG (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM CGeisler@drexel.edu
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BHUMKAR D, 2006, AAPS PHARMSCITECH, V17, pE143
   Boland T, 2003, ANAT REC PART A, V272A, P497, DOI 10.1002/ar.a.10059
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Desai KGH, 2005, DRUG DEVELOP RES, V64, P114, DOI 10.1002/ddr.10416
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Fujita M, 2004, J SURG RES, V121, P135, DOI 10.1016/j.jss.2004.04.010
   Gang Z, 2007, J MATER SCI, V42, P2591, DOI DOI 10.1007/S10853-006-1337-4
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grinberg VY, 2000, MACROMOLECULES, V33, P8685, DOI 10.1021/ma000527w
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Hwang J. K., 2000, KOREA-AUST RHEOL J, V12, P175
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jin J, 2004, BIOMACROMOLECULES, V5, P162, DOI 10.1021/bm034286m
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kumbar SG, 2003, J APPL POLYM SCI, V87, P1525, DOI 10.1002/app.11552
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lin YH, 2005, BIOMATERIALS, V26, P2105, DOI 10.1016/j.biomaterials.2004.06.011
   Mi FL, 1999, J POLYM SCI POL PHYS, V37, P1551, DOI 10.1002/(SICI)1099-0488(19990715)37:14<1551::AID-POLB1>3.3.CO;2-8
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Mi FL, 2003, POLYMER, V44, P6521, DOI 10.1016/S0032-3861(03)00620-7
   Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Schmaljohann D, 2003, BIOMACROMOLECULES, V4, P1733, DOI 10.1021/bm034160p
   Shantha KL, 2000, INT J PHARM, V207, P65, DOI 10.1016/S0378-5173(00)00533-0
   Shu X, 2000, INT J PHARM, V201, P51, DOI 10.1016/S0378-5173(00)00403-8
   Vernengo J, 2008, J BIOMED MATER RES B, V84B, P64, DOI 10.1002/jbm.b.30844
   XIN AX, 2006, ENG MED BIOL SOC 200, P2091
   Zhang XZ, 2004, BIOMATERIALS, V25, P3793, DOI 10.1016/j.biomaterials.2003.10.065
   Zhou J, 2007, VIRTUAL PHYS PROTOTY, V2, P217, DOI 10.1080/17452750701747278
NR 42
TC 0
Z9 0
U1 1
U2 15
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4946-0
PY 2011
BP 19
EP 26
PG 8
WC Engineering, Manufacturing
SC Engineering
GA BVE99
UT WOS:000291337100004
DA 2018-10-20
ER

PT J
AU Neelakandeswari, N
   Sangami, G
   Dharmaraj, N
AF Neelakandeswari, N.
   Sangami, G.
   Dharmaraj, N.
TI Preparation and Characterization of Nanostructured Hydroxyapatite Using
   a Biomaterial
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article
DE eggshell membrane; electron microscopy; hydroxyapatite; infrared
   spectroscopy; x-ray diffraction
ID SOLID-STATE SYNTHESIS; CATALYST; METAL; TEMPERATURE; TEMPLATES;
   EFFICIENT; NICKEL; TUBES
AB Nanostructured needle like, hydroxyapatite (HAp) samples were prepared by a simple approach using biomaterial (egg shell membrane) and characterized by Fourier transform infra-red spectroscopy (FT-IR), powder X-ray diffraction (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM) techniques. The elemental composition of one of the samples determined by EDAX showed the ratio of Ca/P as 1.425, as expected for the HAp. XRD shows the presence of hexagonal phase for all the samples prepared under various pH conditions. Crystallite size and cell parameters were calculated based on the XRD data.
C1 [Neelakandeswari, N.; Sangami, G.; Dharmaraj, N.] Bharathiar Univ, Dept Chem, Coimbatore 641046, Tamil Nadu, India.
RP Dharmaraj, N (reprint author), Bharathiar Univ, Dept Chem, Coimbatore 641046, Tamil Nadu, India.
EM dharmaraj@buc.edu.in
CR ARYAL KCS, 2006, SCRIPTA MATER, V54, P131
   Cai S, 2005, CERAM INT, V31, P135, DOI 10.1016/j.ceramint.2004.04.012
   Cao JM, 2005, J MATER SCI, V40, P6311, DOI 10.1007/s10853-005-4221-8
   Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Darr JA, 2004, CHEM COMMUN, P696, DOI 10.1039/b312855p
   Dong AG, 2002, ADV MATER, V14, P926, DOI 10.1002/1521-4095(20020618)14:12<926::AID-ADMA926>3.0.CO;2-1
   Fan Y., 2008, FRONT MAT SCI CHINA, V2, P91
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Huang JG, 2003, J AM CHEM SOC, V125, P11834, DOI 10.1021/ja037419k
   Jun JH, 2006, APPL CATAL A-GEN, V312, P27, DOI 10.1016/j.apcata.2006.06.020
   Kim W, 2001, ULTRASON SONOCHEM, V8, P85, DOI 10.1016/S1350-4177(00)00034-1
   Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545
   Li YB, 2009, J MATER SCI, V44, P1258, DOI 10.1007/s10853-008-3239-0
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   Liu JK, 2005, CRYST GROWTH DES, V5, P445, DOI 10.1021/cg0498002
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Sebti S, 2002, APPL CATAL A-GEN, V235, P273, DOI 10.1016/S0926-860X(02)00273-9
   Seshadri R, 2000, ADV MATER, V12, P1149, DOI 10.1002/1521-4095(200008)12:15<1149::AID-ADMA1149>3.3.CO;2-Y
   Smiciklas I, 2008, J HAZARD MATER, V152, P876, DOI 10.1016/jjhazmat.2007.07.056
   Su HL, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015045
   Tahir R, 2006, J MOL CATAL A-CHEM, V246, P39, DOI 10.1016/j.molcata.2005.10.012
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Tsuchida T, 2008, J CATAL, V259, P183, DOI 10.1016/j.jcat.2008.08.005
   Wang Q, 2006, J MATER SCI-MATER M, V17, P641, DOI 10.1007/s10856-006-9227-5
   Wuyts S, 2003, J CATAL, V219, P417, DOI 10.1016/S0021-9517(03)00217-3
   Xiao XF, 2008, J MATER SCI-MATER M, V19, P3429, DOI 10.1007/s10856-008-3499-x
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yang D, 2003, J MATER CHEM, V13, P1119, DOI 10.1039/b301077e
   Zhang W, 2006, NANOTECHNOLOGY, V17, P840, DOI 10.1088/0957-4484/17/3/038
NR 31
TC 7
Z9 7
U1 2
U2 18
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1553-3174
J9 SYNTH REACT INORG M
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PY 2011
VL 41
IS 5
BP 513
EP 516
AR PII 938025265
DI 10.1080/15533174.2011.568434
PG 4
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 772XR
UT WOS:000291272000013
DA 2018-10-20
ER

PT J
AU Zhu, JY
   Sabo, R
   Luo, XL
AF Zhu, J. Y.
   Sabo, Ronald
   Luo, Xiaolin
TI Integrated production of nano-fibrillated cellulose and cellulosic
   biofuel (ethanol) by enzymatic fractionation of wood fibers
SO GREEN CHEMISTRY
LA English
DT Article
ID TEMPO-MEDIATED OXIDATION; NATIVE CELLULOSE; MICROFIBRILLATED CELLULOSE;
   HYDROLYSIS; PULP; NANOCOMPOSITES; NANOFIBERS; CRYSTALLINITY;
   RECALCITRANCE; NANOSCALE
AB This study demonstrates the feasibility of integrating the production of nano-fibrillated cellulose (NFC), a potentially highly valuable biomaterial, with sugar/biofuel (ethanol) from wood fibers. Commercial cellulase enzymes were used to fractionate the less recalcitrant amorphous cellulose from a bleached Kraft eucalyptus pulp, resulting in a highly crystalline and recalcitrant cellulose (RC). The RC is difficult to hydrolyze to sugars but very suitable for producing biobased nanomaterials through mechanical homogenization. A range of fractionation yields of RC from 10-70% can be achieved by varying fractionation duration and enzyme dosage. The crystallinity of the RC was found to be as much as 24% higher than that of the original bleached pulp. The cellulase fractionation process facilitated mechanical homogenization by significantly reducing the degree of polymerization (DP) to about 400 and the length of the fibers to about 200 mm. The hydrolyzed sugars were found to be easily converted to ethanol through yeast fermentation with excellent efficiency of 92%. Films made from nano-fibrillated cellulose were found to be optically transparent, with opacity as low as 12%. The NFC films were mechanically strong and stiff, with tensile strengths and moduli approximately 10 and 6 times higher than film made from fibers that had not been nano-fibrillated.
C1 [Zhu, J. Y.; Sabo, Ronald; Luo, Xiaolin] US Forest Serv, USDA, Forest Prod Lab, Madison, WI 53726 USA.
RP Zhu, JY (reprint author), US Forest Serv, USDA, Forest Prod Lab, 1 Gifford Pinchot Dr, Madison, WI 53726 USA.
EM jzhu@fs.fed.us
OI Luo, Xiaolin/0000-0002-3110-0552
FU U.S. Forest Service; Kimberly-Clark Corporation (Appleton, WI)
FX This work was supported by the U.S. Forest Service through the Woody
   Biomass, Biofuel and Bioproducts (WBBB) program (2009) and
   Kimberly-Clark Corporation (Appleton, WI). We also acknowledge the
   following people from the U.S. Forest Service, Forest Products
   Laboratory: Jim Beecher and Tom Kuster of the Analytical Chemistry and
   Microscopy laboratory for the TEM and SEM imaging, Nancy Ross Sutherland
   of the Paper Test Laboratory for testing the NFC films, Diane Dietrich
   for ethanol analysis, and Rick Reiner and Umesh Agarwal for measuring
   the substrate crystallinities.
CR ADEN A, 2002, NRELTP51032438
   Agarwal UP, 2010, CELLULOSE, V17, P721, DOI 10.1007/s10570-010-9420-z
   AGARWAL UP, 2010, 2010 TAPPI INT C NAN
   Alemdar A, 2008, BIORESOURCE TECHNOL, V99, P1664, DOI 10.1016/j.biortech.2007.04.029
   Andresen M, 2006, CELLULOSE, V13, P665, DOI 10.1007/s10570-006-9072-1
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Chen Y, 2009, CARBOHYD POLYM, V76, P607, DOI 10.1016/j.carbpol.2008.11.030
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Dufresne A, 1997, J APPL POLYM SCI, V64, P1185
   Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0
   Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416
   FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053
   Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x
   Hayashi N, 2005, CARBOHYD POLYM, V61, P191, DOI 10.1016/j.carbpol.2005.04.018
   Henriksson M, 2007, EUR POLYM J, V43, P3434, DOI 10.1016/j.eurpolymj.2007.05.038
   Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Iwamoto S, 2007, APPL PHYS A-MATER, V89, P461, DOI 10.1007/s00339-007-4175-6
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   MARCHESSAULT R, 1961, J COLL SCI IMP U TOK, V16, P327, DOI 10.1016/0095-8522(61)90033-2
   Mazumder BB, 2000, J WOOD SCI, V46, P364, DOI 10.1007/BF00776397
   Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9
   Nakagaito AN, 2004, APPL PHYS A-MATER, V78, P547, DOI 10.1007/s00339-003-2453-5
   NICKERSON RF, 1947, IND ENG CHEM, V39, P1507, DOI 10.1021/ie50455a024
   Okita Y, 2009, HOLZFORSCHUNG, V63, P529, DOI 10.1515/HF.2009.096
   Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p
   Regalbuto JR, 2009, SCIENCE, V325, P822, DOI 10.1126/science.1174581
   Saito T, 2006, CARBOHYD POLYM, V65, P435, DOI 10.1016/j.carbpol.2006.01.034
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Scharlemann JPW, 2008, SCIENCE, V319, P43, DOI 10.1126/science.1153103
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   TAPPI, 2009, TAPPI TEST METH
   Wang B, 2007, APPL COMPOS MATER, V14, P89, DOI 10.1007/s10443-006-9032-9
   Wegner T. H., 2009, The nanoscience and technology of renewable biomaterials, P1, DOI 10.1002/9781444307474.ch1
   Zhang X, 2009, BIORESOURCE TECHNOL, V100, P5890, DOI 10.1016/j.biortech.2009.06.082
   Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282
   Zhu JY, 2010, APPL MICROBIOL BIOT, V87, P847, DOI 10.1007/s00253-010-2654-8
NR 39
TC 94
Z9 95
U1 5
U2 87
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9262
J9 GREEN CHEM
JI Green Chem.
PY 2011
VL 13
IS 5
BP 1339
EP 1344
DI 10.1039/c1gc15103g
PG 6
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY
SC Chemistry; Science & Technology - Other Topics
GA 759GD
UT WOS:000290227800043
DA 2018-10-20
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI SURFACE INTEGRITY OF BIODEGRADABLE MAGNESIUM-CALCIUM (MG-CA) ALLOY BY
   LOW PLASTICITY BURNISHING
SO PROCEEDINGS OF THE STLE/ASME INTERNATIONAL JOINT TRIBOLOGY CONFERENCE,
   2010
LA English
DT Proceedings Paper
CT STLE/ASME International Joint Tribology Conference
CY OCT 17-20, 2010
CL San Francisco, CA
SP ASME, Tribol Div, STLE, Soc Tribologists & Lubrication Engn
ID BONE-RESORPTION
AB When a device is implanted into the body, into either hard or soft tissue, the body will respond. While the bulk material of the device is often important for integrity and mechanical success, the device surface is at the interface with biology. Major effort has been spent modifying a biomaterial surface in order to elicit or inhibit a biological response. Metallic biodegradable Magnesium-Calcium (Mg-Ca) alloys have attracted an increased attention for orthopedic fixation applications. This research focuses on low plasticity burnishing (LPB) as a novel surface modification technique that is added to the surface to control biodegradation as a biological response. The effects of burnishing pressure as an important process parameter on surface integrity characteristics such as surface roughness, surface topography, and residual stresses are investigated. Burnished surface roughness is smaller than the machined ones. However, some amount of waviness is observed which might be due to large diameter of the burnishing ball and sever plastic deformation. High compressive residual stresses are measured on the burnished surface.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Salahshoor, M (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
CR Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
NR 8
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4419-9
PY 2011
BP 61
EP 63
PG 3
WC Engineering, Mechanical
SC Engineering
GA BUX06
UT WOS:000290556400017
DA 2018-10-20
ER

PT S
AU Ning, L
   Tao, L
AF Ning, Liu
   Tao, Liu
BE Shi, YG
   Zuo, JL
TI Adsorption and Decoloration of Nitroso Dye Based on Eggshell Membrane
SO ENVIRONMENTAL BIOTECHNOLOGY AND MATERIALS ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Environmental Biotechnology and Materials
   Engineering
CY MAR 26-28, 2011
CL Harbin Univ Commerce, Harbin, PEOPLES R CHINA
SP Heilongjiang Province Inst Food Sci & Technol, Harbin Univ Commerce
HO Harbin Univ Commerce
DE eggshell membrane; nitroso dye; alpha-naphthol green B; adsorption and
   decolorization
AB Eggshell membrane is a natural biomaterial with macropores lattice and high surface area. The bio-sorption and decolorization of organic dye eosin B was investigated based on eggshell membrane. The effect of adsorption time, pH value and temperature of eggshell membrane on the decolorization of eosin B was studied. Time for adsorption to reach equilibrium is 100 min. Optimum pH value is 2.0 for the adsorption. And the amount of dye removed by egg shell membrane was increasing as temperature ascending. At room temperature and optimum conditions, 95% of eosin B could be removed and maximum adsorption of 40.9 mg/g had been achieved. The adsorption behavior of eggshell membrane towards eosin B fit well with Freundlich isotherm.
C1 [Ning, Liu; Tao, Liu] Harbin Commercial Univ, Coll Food Engn, Harbin 150076, Heilongjiang, Peoples R China.
RP Ning, L (reprint author), Harbin Commercial Univ, Coll Food Engn, Harbin 150076, Heilongjiang, Peoples R China.
EM wendingzi666@163.com
CR Li XD, 2005, EGG SCI TECHNOLOGY
   LI YP, 2008, GRAIN FOOD IND, V5, P27
   YANG L, 2009, AGR PRODUCT PROCESSI, V10, P136
   ZHAO FL, 2006, FOOD SCI, V12, P798
NR 4
TC 3
Z9 4
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-022-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 183-185
BP 963
EP 966
DI 10.4028/www.scientific.net/AMR.183-185.963
PN 1-3
PG 4
WC Biotechnology & Applied Microbiology; Engineering, Environmental;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA BUT38
UT WOS:000290280600193
DA 2018-10-20
ER

PT S
AU Sui, CX
   Yu, GP
   Jiang, LZ
   Bao, YH
   Mei, DJ
   Wang, S
   Zhang, ZH
AF Sui, Chun-Xia
   Yu, Guo-Ping
   Jiang, Lian-Zhou
   Bao, Yi-Hong
   Mei, De-Jun
   Wang, Shu
   Zhang, Zhi-Hui
BE Shi, YG
   Zuo, JL
TI Research on soluble protein surface hydrophobicity of biomaterial
   solution from soy protein isolate - polysaccharide system
SO ENVIRONMENTAL BIOTECHNOLOGY AND MATERIALS ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Environmental Biotechnology and Materials
   Engineering
CY MAR 26-28, 2011
CL Harbin Univ Commerce, Harbin, PEOPLES R CHINA
SP Heilongjiang Province Inst Food Sci & Technol, Harbin Univ Commerce
HO Harbin Univ Commerce
DE soy protein isolate; guar gum; hydrophobicity; Box-Behnken Design method
ID MECHANICAL-PROPERTIES; FOOD PROTEINS; VICIA-FABA; PLASTICS; COMPOSITES
AB The work attempts to study the surface hydrophobicity (S-0) of soy protein isolate (SPI) -guar gum(GG) systems for biomaterial. Effect of four factors on the So values of the mixtures were studied. A response surface analysis was carried out using the Box-Behnken Design (BBD)method in order to determine the effects and interactions of pH (6.0, 8.0, 10.0), salt(0.05, 0.15, 0.25M), guar gum(0.10, 0.30, 0.50% w/v) and SPI concentrations (3, 4, 5% w/v) on the So values of mixtures. The datas were fitted into second order quadratic model. Salt concentration, pH and SPI concentration, interactions between pH and salt concentration, pH and GG concentration, pH and SPI concentration, GG and SPI concentrations were significant(P<0.05).
C1 [Yu, Guo-Ping; Jiang, Lian-Zhou; Mei, De-Jun; Wang, Shu; Zhang, Zhi-Hui] Northeast Agr Univ, Coll Food Sci, Harbin 150030, Heilongjiang, Peoples R China.
   [Sui, Chun-Xia] Northeast Agr Univ, Chengdong Coll, Harbin 150030, Heilongjiang, Peoples R China.
   [Bao, Yi-Hong] Northeast Forestry Univ, Coll Forestry, Harbin 150040, Heilongjiang, Peoples R China.
RP Yu, GP (reprint author), Northeast Agr Univ, Coll Food Sci, Harbin 150030, Heilongjiang, Peoples R China.
EM suichunxia1979@126.com; yuguopingneau@hotmail.com
FU National Natural Science Foundation Item of China; Harbin Special Funds
   for Technological Innovation
FX The financial supports from the National Natural Science Foundation Item
   of China and Harbin Special Funds for Technological Innovation talents
   are gratefully acknowledged.
CR ARNTFIELD SD, 1990, J AGR FOOD CHEM, V38, P1335, DOI 10.1021/jf00096a008
   ARNTFIELD SD, 1986, J FOOD SCI, V51, P371, DOI 10.1111/j.1365-2621.1986.tb11133.x
   ARNTFIELD SD, 1998, J AM OIL CHEM SOC, P108
   Chiellini E, 2004, MACROMOL BIOSCI, V4, P218, DOI 10.1002/mabi.200300126
   ISMOND MAH, 1986, FOOD CHEM, V21, P27, DOI 10.1016/0308-8146(86)90139-1
   KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2
   Kokoszka S, 2010, INNOV FOOD SCI EMERG, V11, P503, DOI 10.1016/j.ifset.2010.01.006
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Lodha P, 2005, COMPOS SCI TECHNOL, V65, P1211, DOI 10.1016/j.compscitech.2004.12.036
   Lodha P, 2005, IND CROP PROD, V21, P49, DOI 10.1016/j.indcrop.2003.12.006
   NAKAI S, 1983, J AGR FOOD CHEM, V31, P676, DOI 10.1021/jf00118a001
   PAULSON AT, 1989, J AGR FOOD CHEM, V37, P319, DOI 10.1021/jf00086a010
   SAMANT SK, 1993, FOOD SCI TECHNOL INT, V28, P547
   TOLSTOGUZOV VB, 1998, FUNCTIONAL PROPERTIE, pCH6
   Uruakpa FO, 2006, FOOD CHEM, V95, P255, DOI 10.1016/j.foodchem.2005.01.030
   Vaz CM, 2003, POLYM DEGRAD STABIL, V81, P65, DOI 10.1016/S0141-3910(03)00063-6
   VOUTSINAS LP, 1983, CAN I FOOD SC TECH J, V16, P185, DOI 10.1016/S0315-5463(83)72205-4
   Wang S, 1996, J MACROMOL SCI PURE, VA33, P557, DOI 10.1080/10601329608010878
   Wu QX, 2001, IND ENG CHEM RES, V40, P1879, DOI 10.1021/ie000694k
NR 19
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-022-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 183-185
BP 1094
EP +
DI 10.4028/www.scientific.net/AMR.183-185.1094
PN 1-3
PG 2
WC Biotechnology & Applied Microbiology; Engineering, Environmental;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA BUT38
UT WOS:000290280600220
DA 2018-10-20
ER

PT J
AU Aragon, J
   Gonzalez, R
   Fuentes, G
   Palin, L
   Croce, G
   Viterbo, D
AF Aragon, Javier
   Gonzalez, Ramon
   Fuentes, Gaston
   Palin, Luca
   Croce, Gianluca
   Viterbo, Davide
TI Development and Characterization of a Novel Bioresorbable and Bioactive
   Biomaterial Based on Polyvinyl Acetate, Calcium Carbonate and Coralline
   Hydroxyapatite
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE polyvinyl acetate; hydroxyapatite coralline; calcium carbonate;
   composite
ID LIQUID PHASE-SEPARATION; CELL TRANSPLANTATION; BONE; SCAFFOLDS;
   MICROSPHERES; COMPOSITES; IMPLANTS
AB Coralina (R) HAP-200 (coralline hydroxyapatite obtained by hydrothermal treatment of marine corals) and POVIAC (R) (polymeric matrix based on PVAc), commercial trade marks were mixed with a natural product from the Cuban sea costs, i.e. calcium carbonate from Porites Porites coral, to obtain a novel bioactive composite with potential use as bone restoration material. The samples were characterized by physical-chemical (FTIR, XRD, SEM, EDS) and mechanical studies. It was shown that there is no chemical interaction between the inorganic filler and the polymer matrix, each conserving the original properties of the raw materials. The studied formulation had a compressive strength similar to that reported for trabecular bone. Scanning electron microscopy examination revealed that the addition of CaCO(3) induces a change on the morphologic structure of the composite obtained after 30 days of SBF immersion. These composites generate novel biomaterials capable of promoting the deposition of a new phase, a Ca-P layer due to the bioactivity of a Ca(2+) precursors.
C1 [Aragon, Javier; Gonzalez, Ramon] Natl Ctr Sci Res, Havana, Cuba.
   [Fuentes, Gaston] Univ Havana, Ctr Biomat, Havana, Cuba.
   [Palin, Luca; Croce, Gianluca; Viterbo, Davide] Univ Piemonte Orientale, Dept Adv Sci & Technol, A Avogadro, Alessandria, Italy.
RP Aragon, J (reprint author), Natl Ctr Sci Res, Havana, Cuba.
EM javier.aragon@cnic.edu.cu
RI Croce, Gianluca/G-2804-2011; Aragon, Javier/M-9783-2017
OI Aragon, Javier/0000-0003-0505-2435; Palin, Luca/0000-0001-5347-7409
FU FONDAZIONE ISI
FX We thank FONDAZIONE ISI for the financial support for this scientific
   project.
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   ALLARD R, 1991, Patent No. 5071436
   Aragon J, 2009, REV IBEROAMERICANA P, V10, P119
   ARAGON JF, 2006, REV CENIC CIENCIAS Q, V37, P179
   Aragon JF, 2009, ANALES REAL ACAD NAC, V75, P345
   ARIAS D, 2004, REV CENIC CIENCIAS Q, V35, P101
   Comin M., 1999, BIOMECANICA FRACTURA
   Cowin S., 2001, BONE MECH HDB
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   Fernández Haney Castro, 2010, Quím. Nova, V33, P891, DOI 10.1590/S0100-40422010000400024
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Gen-Tao Z., 2009, AM MINERAL, V94, P293
   GOMEZ A, 2007, THESIS U GRANADA
   GONZALEZ R, 1993, QUIM NOVA, V16, P513
   Gonzalez R., 2007, United State Patent, Patent No. 0053951
   Green D, 2004, J MATER CHEM, V14, P2206, DOI 10.1039/b400486h
   Green DW, 2009, BIOMATERIALS, V30, P1918, DOI 10.1016/j.biomaterials.2008.12.052
   Guerra Nayrim B., 2010, Polímeros, V20, P98
   Iglesias G, 2009, United State Patent No, Patent No. 0306226
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lopez M, 2008, LAT AM APPL RES, V38, P227
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Paul W, 2003, J BIOMATER APPL, V17, P253, DOI 10.1177/088532803030571
   Piskin E, 1997, MATER SCI FORUM, V250, P1
   Ripamonti U, 2009, BIOMATERIALS, V30, P1428, DOI 10.1016/j.biomaterials.2008.10.065
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P57, DOI 10.1016/0278-2391(94)90016-7
   Schugens C, 1996, J BIOMED MATER RES, V30, P449, DOI 10.1002/(SICI)1097-4636(199604)30:4<449::AID-JBM3>3.0.CO;2-P
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 34
TC 8
Z9 8
U1 2
U2 24
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-MAR
PY 2011
VL 14
IS 1
BP 25
EP 30
DI 10.1590/S1516-14392011005000012
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 754LP
UT WOS:000289856400007
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Martins, JRS
   Nogueira, RA
   de Araujo, RO
   Donato, TAG
   Arana-Chavez, VE
   Claro, APRA
   Moraes, JCS
   Buzalaf, MAR
   Grandini, CR
AF Severino Martins Junior, Jose Roberto
   Nogueira, Renata Abdallah
   de Araujo, Raul Oliveira
   Goto Donato, Tatiani Ayako
   Arana-Chavez, Vitor Elias
   Rosifini Alves Claro, Ana Paula
   Silos Moraes, Joao Carlos
   Rabelo Buzalaf, Marilia Afonso
   Grandini, Carlos Roberto
TI Preparation and Characterization of Ti-15Mo Alloy used as Biomaterial
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE Ti-Mo alloys; elasticity modulus; biomaterials; vacuum melting
ID BIOMEDICAL TITANIUM-ALLOYS; TI-MO ALLOYS; CORROSION BEHAVIOR;
   CYTOTOXICITY; FRACTURE
AB With the increase in life expectancy, biomaterials have become an increasingly important focus of research because they are used to replace parts and functions of the human body, thus contributing to improved quality of life. In the development of new biomaterials, the Ti-15Mo alloy is particularly significant. In this study, the Ti-15Mo alloy was produced using an arc-melting furnace and then characterized by density, X-ray diffraction, optical microscopy, hardness and dynamic elasticity modulus measurements, and cytotoxicity tests. The microstructure was obtained with beta predominance. Microhardness, elasticity modulus, and cytotoxicity testing results showed that this material has great potential for use as biomaterial, mainly in orthopedic applications.
C1 [Severino Martins Junior, Jose Roberto; Nogueira, Renata Abdallah; de Araujo, Raul Oliveira; Grandini, Carlos Roberto] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Goto Donato, Tatiani Ayako; Arana-Chavez, Vitor Elias] Univ Sao Paulo, Dept Oral Biol, BR-05508900 Sao Paulo, Brazil.
   [Rosifini Alves Claro, Ana Paula] UNESP Univ Estadual Paulista, Dept Mat & Tecnol, BR-12516410 Guaratingueta, SP, Brazil.
   [Silos Moraes, Joao Carlos] UNESP Univ Estadual Paulista, Fac Engn, Dept Fis & Quim, BR-15385000 Ilha Solteira, SP, Brazil.
   [Rabelo Buzalaf, Marilia Afonso] USP, Fac Odontol, Dept Ciencias Biol, BR-17012901 Bauru, SP, Brazil.
RP Martins, JRS (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Moraes, Joao/C-3406-2012; ROSIFII ALVES CLARO, ANA PAULA/J-5215-2014;
   Buzalaf, Marilia/C-5228-2012; Grandini, Carlos Roberto/A-3790-2008;
   Martins Junior, Jose Roberto/E-2190-2014; Arana-Chavez,
   Victor/G-4948-2012
OI Moraes, Joao/0000-0002-7043-3157; Grandini, Carlos
   Roberto/0000-0002-3336-309X; Arana-Chavez, Victor/0000-0002-6767-7812;
   ROSIFINI ALVES CLARO, ANA PAULA/0000-0003-3353-4247
FU FAPESP; CNPq
FX The authors thank Brazilian agencies FAPESP and CNPq for their financial
   support.
CR [Anonymous], 2008, F206608 ASTM
   [Anonymous], 1994, 67212 ISO
   ATALA A, 2002, METHODS TISSUE ENG
   Bania P. J., 1993, TITANIUM ALLOYS 1990
   Callister WD, 2007, MAT SCI ENG INTRO
   Chen YY, 2006, T NONFERR METAL SOC, V16, pS824, DOI 10.1016/S1003-6326(06)60308-7
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   HOWARD CJ, 1987, J APPL CRYSTALLOGR, V20, P467
   *ISO, 1994, 109935 ISO
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Lide D. R., 2004, CRC HDB CHEM PHYS RE, P7
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Nasab M.B., 2010, TRENDS BIOMATER ARTI, V24, P69
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Pintao C.A.F., 2006, REV BRASILEIRA APLIC, V25, P189
   Rao S, 1996, BIO-MED MATER ENG, V6, P79
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Sugano M, 1998, MAT SCI ENG A-STRUCT, V243, P163, DOI 10.1016/S0921-5093(97)00795-8
   WALKER PR, 1989, BIOCHEMISTRY-US, V28, P3911, DOI 10.1021/bi00435a043
NR 27
TC 16
Z9 17
U1 1
U2 30
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JAN-MAR
PY 2011
VL 14
IS 1
BP 107
EP 112
DI 10.1590/S1516-14392011005000013
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 754LP
UT WOS:000289856400018
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kim, G
   Ahn, S
   Kim, Y
   Cho, Y
   Chun, W
AF Kim, GeunHyung
   Ahn, Seunghyun
   Kim, YunYoung
   Cho, Youngseok
   Chun, Wook
TI Coaxial structured collagen-alginate scaffolds: fabrication, physical
   properties, and biomedical application for skin tissue regeneration
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID 3-DIMENSIONAL FREEFORM FABRICATION; FULL-THICKNESS BURNS; POROUS
   SCAFFOLDS; MECHANICAL-PROPERTIES; IN-VIVO; SUBSTITUTES; CULTURE; DESIGN;
   MORPHOLOGY; NANOFIBERS
AB Collagen is the most promising natural biomaterial and has been used in various tissue engineering applications for skin, bone, and cartilage because it provides good biocompatibility and low antigenicity. Although collagen is an excellent candidate material for various biomedical applications, its difficult processability and mechanical properties have remained important limitations. To overcome the problems, several methods including indirect printing combined with a sacrificing mold and low-temperature printing were suggested. However, it is difficult to fabricate precisely controlled 3D pore structure using the methods. In a previous study, we introduced a three-dimensional (3D) pore-structure-controlled collagen scaffold fabricated by a 3D dispensing system supplemented with a cryogenic and freeze-drying system. The fabricated scaffold had remarkably good cellular behaviour (cell migration and differentiation) but poor mechanical stability due to the highly porous structure consisting of micro-sized strands and poor mechanical nature of collagen. To overcome this deficiency, we designed a hybrid (core/shell) scaffold composed of an outer collagen and an inner alginate. The collagen/alginate scaffolds exhibited good structural stability (core-shell structure), increased Young's modulus about seven times compared to pure collagen scaffold under a similar pore-structure, and resulted in good cell viability, similar to a pure collagen scaffold. In an in vivo test, the hybrid scaffold was used as a dermal substitute and provided good granulation tissue formation and rapid vascularisation.
C1 [Kim, GeunHyung; Ahn, Seunghyun] Chosun Univ, Dept Mech Engn, Bionanofluid Lab, Kwangju 501759, South Korea.
   [Kim, YunYoung] Modern Cell & Tissue Technol Inc, Seoul 137743, South Korea.
   [Cho, Youngseok; Chun, Wook] Hallym Univ, Coll Med, Hangang Sacred Heart Hosp, Dept Surg,Burn Ctr, Seoul 150719, South Korea.
RP Kim, G (reprint author), Chosun Univ, Dept Mech Engn, Bionanofluid Lab, 375 Seosok Dong, Kwangju 501759, South Korea.
EM gkim@chosun.ac.kr; chun0414@hallym.ac.kr
FU Ministry for Health, Welfare and Family Affairs, Republic of Korea
   [A084589]
FX This study was supported by a grant from the Korea Healthcare Technology
   R&D Project, Ministry for Health, Welfare and Family Affairs, Republic
   of Korea (Grant no. A084589).
CR Ahmad Z, 2010, MACROMOL MATER ENG, V295, P315, DOI 10.1002/mame.200900396
   Ahn S, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065015
   AHN SH, 2010, TISSUE ENG PART C-ME, V10, P813
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Choi SW, 2009, ADV MATER, V21, P2997, DOI 10.1002/adma.200803504
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   Cui WG, 2009, MAT SCI ENG C-MATER, V29, P1869, DOI 10.1016/j.msec.2009.02.013
   Drexler JW, 2011, TISSUE ENG PART C-ME, V17, P9, DOI [10.1089/ten.tec.2009.0754, 10.1089/ten.TEC.2009.0754]
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI [10.1089/ten.tec.2008.0703, 10.1089/ten.TEC.2008.0703]
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang S, 2008, ACTA BIOMATER, V4, P1057, DOI 10.1016/j.actbio.2008.02.007
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Iozzo RV, 1996, FASEB J, V10, P598
   Jamal M, 2010, BIOMATERIALS, V31, P1683, DOI 10.1016/j.biomaterials.2009.11.056
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim G, 2009, J MATER CHEM, V19, P8817, DOI 10.1039/b914187a
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lee W, 2010, BIOTECHNOL BIOENG, V105, P1178, DOI 10.1002/bit.22613
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liu XH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095501
   Ma L, 2004, J BIOMED MATER RES A, V71A, P334, DOI 10.1002/jbm.a.30170
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Pu FR, 2010, BIOMATERIALS, V31, P4330, DOI 10.1016/j.biomaterials.2010.02.010
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Srivastava RK, 2006, BIOMACROMOLECULES, V7, P2531, DOI 10.1021/bm060309w
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Zorlutuna P, 2009, BIOMACROMOLECULES, V10, P814, DOI 10.1021/bm801307y
NR 55
TC 49
Z9 51
U1 4
U2 81
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 17
BP 6165
EP 6172
DI 10.1039/c0jm03452e
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 750DG
UT WOS:000289524300010
DA 2018-10-20
ER

PT J
AU Heredia-Guerrero, JA
   San-Miguel, MA
   Luna, M
   Dominguez, E
   Heredia, A
   Benitez, JJ
AF Heredia-Guerrero, J. A.
   San-Miguel, M. A.
   Luna, M.
   Dominguez, E.
   Heredia, A.
   Benitez, J. J.
TI Structure and support induced structure disruption of soft nanoparticles
   obtained from hydroxylated fatty acids
SO SOFT MATTER
LA English
DT Article
ID SCANNING FORCE MICROSCOPY; TIP-SAMPLE INTERACTION; CARBOXYLIC-ACIDS;
   GOLD ELECTRODES; SIMULATION; CUTIN; WATER; MICA; SPECTROSCOPY;
   DERIVATIVES
AB Soft and spherical nanoparticles, named as cutinsomes, have been prepared from concentrated 9(10), 16-dihydroxypalmitic acid (diHPA) in aqueous solution. After isolation, cutinsomes have been chemically and structurally characterized by ATR-FTIR, TEM and dynamic atomic force microscopy (dynamic AFM). The nanoparticle can be described as a lipidic, liquid-like and mostly esterified core surrounded by a polar shell of carboxylate/carboxylic acid molecules. Molecular dynamic (MD) simulations have been used to support this model. The structural stability of soft cutinsomes has been tested by deposition on both non-polar (HOPG) and polar (mica) flat substrates. It has been found that the magnitude of the interaction between the polar shell of cutinsomes and the support determines their structure conservation or its spreading or rupture and spill out of the liquid-like content. The structural consistence of these nanoparticles as a function of the polarity of substrate is of interest in elucidating the formation mechanism of cutin, the most abundant biopolyester in nature and a very interesting biomaterial to be mimetized.
C1 [Heredia-Guerrero, J. A.; Benitez, J. J.] Univ Seville, CSIC, Inst Ciencia Mat Sevilla, Ctr Mixto, Seville 41092, Spain.
   [San-Miguel, M. A.] Univ Seville, Dept Quim Fis, Fac Quim, E-41012 Seville, Spain.
   [Luna, M.] CSIC, IMM, Madrid 28760, Spain.
   [Dominguez, E.] CSIC, Estn Expt La Mayora, Malaga 29750, Spain.
   [Heredia, A.] Univ Malaga, Dept Biol Mol & Bioquim, E-29071 Malaga, Spain.
RP Benitez, JJ (reprint author), Univ Seville, CSIC, Inst Ciencia Mat Sevilla, Ctr Mixto, Avda Amer Vespuccio 49, Seville 41092, Spain.
EM benitez@icmse.csic.es
RI Heredia-Guerrero, Jose/H-8822-2012; Dominguez, Eva/D-6137-2014; Luna,
   Monica/M-1792-2014; Micro y Nanotecnologia, Instituto de/D-5173-2013;
   Heredia, Antonio/H-4366-2015; San-Miguel, Miguel/A-8082-2008; Benitez,
   Jose J/K-5662-2014
OI Heredia-Guerrero, Jose/0000-0002-8251-7577; Luna,
   Monica/0000-0002-7104-0726; Micro y Nanotecnologia, Instituto
   de/0000-0003-4211-9045; San-Miguel, Miguel/0000-0002-6650-7432; Benitez,
   Jose J/0000-0002-3222-0564
FU Consejeria de Innovacion Ciencia y Empresa (Junta de Andalucia)
   [TEP-02550]; EPSRC; BBSRC
FX This research work has been funded by the Consejeria de Innovacion
   Ciencia y Empresa (Junta de Andalucia) through the TEP-02550 project and
   the EPSRC and BBSRC (via the Bionanotechnology IRC).
CR Heredia-Guerrero JA, 2010, PHYS CHEM CHEM PHYS, V12, P10423, DOI 10.1039/c0cp00163e
   Anczykowski B, 1996, ULTRAMICROSCOPY, V66, P251, DOI 10.1016/S0304-3991(97)00002-8
   Apel CL, 2002, BBA-BIOMEMBRANES, V1559, P1, DOI 10.1016/S0005-2736(01)00400-X
   Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   Benitez JJ, 2008, J PHYS CHEM C, V112, P16968, DOI 10.1021/jp805445z
   Benitez JJ, 2007, J PHYS CHEM C, V111, P9465, DOI 10.1021/jp070563y
   de Pablo PJ, 2000, PHYS REV B, V61, P14179, DOI 10.1103/PhysRevB.61.14179
   Dominguez E, 2010, MOL BIOSYST, V6, P948, DOI 10.1039/b927186d
   Douliez JP, 2005, BIOMACROMOLECULES, V6, P30, DOI 10.1021/bm049325o
   Fartaria RPS, 2005, J ELECTROANAL CHEM, V574, P321, DOI 10.1016/j.jelechem.2004.08.015
   Fuss M, 2008, J PHYS CHEM B, V112, P11595, DOI 10.1021/jp804191j
   Gil A, 2000, LANGMUIR, V16, P5086, DOI 10.1021/la9913304
   HAUTMAN J, 1992, MOL PHYS, V75, P379, DOI 10.1080/00268979200100301
   HAUTMAN J, 1989, J CHEM PHYS, V91, P4994, DOI 10.1063/1.457621
   Heredia A, 2003, BBA-GEN SUBJECTS, V1620, P1, DOI 10.1016/S0304-4165(02)00510-X
   HEREDIA A, 2008, BIOINTERPHASES, V4, P1
   Heredia-Guerrero JA, 2009, LANGMUIR, V25, P6869, DOI 10.1021/la9001412
   Heredia-Guerrero JA, 2008, BIOESSAYS, V30, P273, DOI 10.1002/bies.20716
   Heredia-Guerrero JA, 2010, CHEM PHYS LIPIDS, V163, P329, DOI 10.1016/j.chemphyslip.2010.01.006
   Heredia-Guerrero JA, 2009, POLYMER, V50, P5633, DOI 10.1016/j.polymer.2009.10.018
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Kober M, 2008, PHYS STATUS SOLIDI-R, V2, P138, DOI 10.1002/pssr.200802033
   Kuhle A, 1997, J APPL PHYS, V81, P6562, DOI 10.1063/1.365194
   KUHN LP, 1952, J AM CHEM SOC, V74, P2492, DOI 10.1021/ja01130a013
   Luna M, 1999, J PHYS CHEM B, V103, P9576, DOI 10.1021/jp991256y
   Luna M, 1998, APPL PHYS LETT, V72, P3461, DOI 10.1063/1.121666
   Luna M, 2000, APPL SURF SCI, V157, P285, DOI 10.1016/S0169-4332(99)00540-1
   LUQUE P, 1995, ARCH BIOCHEM BIOPHYS, V317, P417, DOI 10.1006/abbi.1995.1183
   Neves RS, 2004, J BRAZIL CHEM SOC, V15, P224, DOI 10.1590/S0103-50532004000200011
   NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   RIEDERER M, 2005, BIOL PLANT CUTICLE
   Roberts K., 2007, HDB PLANT SCI, V1
   Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769
   Velkova V, 2002, CHEM PHYS LIPIDS, V117, P63, DOI 10.1016/S0009-3084(02)00042-7
NR 35
TC 10
Z9 10
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 9
BP 4357
EP 4363
DI 10.1039/c0sm01545h
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 751QZ
UT WOS:000289634000037
DA 2018-10-20
ER

PT S
AU Zhu, JJ
   Quan, XJ
   Wang, YL
   Zou, SS
AF Zhu Jiu-jin
   Quan Xue-jun
   Wang Yuan-liang
   Zou Shu-shu
BE Luo, Q
   Wang, YZ
TI Preparation of beta-cyclodextrin Modified Poly(d,l-lactic acid) and Its
   Blood Compatibility
SO ADVANCED MATERIALS SCIENCE AND TECHNOLOGY, PTS 1-2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Materials Science and Technology
CY DEC 27-28, 2010
CL Jeju Island, SOUTH KOREA
SP Univ Kentucky, Huazhong Univ Sci & Technol
DE polylactic acid; beta-cyclodextrin modified polylactic acid; platelet
   adhesion
AB Aiming to develop a biomaterial with excellent biocompability, a novel beta-cyclodextrin modified polylactic acid (PLA-beta-CD) was synthesized by N-acylation reaction of MPLA (maleic anhydride modified poly(d,l-lactic acid)) using hydrophilic mono(6-(2-aminoethyl)-amino-6-deoxy)-beta-cyclodextrin(beta-CD-6-E) as acylating agent. Surface wettability and blood biocompatibility of PLA-beta-CD were investigated. The tests indicated that the static water contact angle of PLA-beta-CD was decreased from 76.7 degrees to 72.1 degrees comparing with PLA. The morphology of blood platelets adhered on the surface of PLA-beta-CD was observed by scanning, and only a few platelets, round and not aggregated. The results revealed that the blood compatibility of PLA-beta-CD was better than PLA.
C1 [Zhu Jiu-jin; Quan Xue-jun; Zou Shu-shu] Chongqing Univ Technol, Sch Chem & Biol Engn, Chongqing 400050, Peoples R China.
   [Zhu Jiu-jin; Wang Yuan-liang] Chongqing Univ, Res Ctr Bioinspired Mat Sci & Engn, Coll Bioengineering, Chongqing 400044, Peoples R China.
RP Zhu, JJ (reprint author), Chongqing Univ Technol, Sch Chem & Biol Engn, Chongqing 400050, Peoples R China.
EM zhujiujin@163.com
FU Scientific Research Foundation in Tianjin University of Science
   Technology [0200064]
FX The authors sincerely thank the financial support from the Scientific
   Research Foundation in Tianjin University of Science & Technology (No.
   0200064).
CR Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9
   Fu X. C., 1990, PHYS CHEM
   Gao H, 2006, J CONTROL RELEASE, V112, P301, DOI 10.1016/j.jconrel.2006.02.016
   Pan T, 2006, ACTA POLYM SIN, P330
   Wang W, 2008, CHEM J CHINESE U, V29, P433
   ZHAO MM, 2007, POLYM MATERIALCIENCE, V3, P231
   ZHU JJ, 2009, PREPARATION BETA CYC
NR 8
TC 0
Z9 0
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-015-2
J9 ADV MATER RES-SWITZ
PY 2011
VL 181-182
BP 429
EP +
DI 10.4028/www.scientific.net/AMR.181-182.429
PN 1, 2
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA BUA94
UT WOS:000288693000078
DA 2018-10-20
ER

PT J
AU Iddou, A
   Youcef, MH
   Aziz, A
   Ouali, MS
AF Iddou, Abdelkader
   Youcef, Mohamed Hadj
   Aziz, Abdallah
   Ouali, Mohand Said
TI Biosorptive removal of lead (II) ions from aqueous solutions using
   Cystoseira stricta biomass: Study of the surface modification effect
SO JOURNAL OF SAUDI CHEMICAL SOCIETY
LA English
DT Article
DE Lead (II); Biosorption; Cystoseira stricta biomass; Removal; Surface
   modification
ID HEAVY-METALS; BY-PRODUCTS; EQUILIBRIUM; ENHANCEMENT; NICKEL(II);
   ADSORPTION; PARAMETERS; EFFLUENTS; ALGAE; SOILS
AB A brown marine alga. Cystoseira stricta, has been studied for its biosorption capacities of the heavy metallic ion, the Pb(II), in aqueous solutions. The brown alga (C) has been used without previous treatment and with chemical treatment to acid (H(2)SO(4) 1 M: CS) and to sodium hydroxide (NaOH 1 M: CB). The results have shown the influence of the particle size of the biomaterial on the extraction-removal of Pb(II). The application of the Langmuir adsorption model revealed the maximum capacities of adsorption of each material (C, CS, CB). The one specific to C. stricta treated by a solution of sodium hydroxide 1 M (CB) was the most important (65 mg g(-1)). The established isotherms at different temperatures showed that this parameter affects the adsorption. The best results are obtained for a temperature of 25 degrees C, in comparison with those recorded at 50 degrees C. Finally, the results of this study showed that C. stricta can be a good potential biosorbent of heavy metals, in particular, when it is treated by a basic solution. (C) 2010 King Saud University. All rights reserved.
C1 [Iddou, Abdelkader; Youcef, Mohamed Hadj] Univ Sci Sand Technol Oran Mohamed Boudiaf, Fac Sci, Dept Chem, El Mnaouer 31000, Oran, Algeria.
   [Iddou, Abdelkader; Aziz, Abdallah; Ouali, Mohand Said] Univ Mostaganem, Lab Valorisat Mat & Traitement Nuisances, Dept Chim, Fac Sci & Sci Ingenieur, Mostaganem, Algeria.
RP Youcef, MH (reprint author), Univ Sci Sand Technol Oran Mohamed Boudiaf, Fac Sci, Dept Chem, POB 1505, El Mnaouer 31000, Oran, Algeria.
EM iddouaek@yahoo.fr; hadjyoucef_med@yahoo.com; ouali@univ-mosta.dz
CR Abu Al-Rub FA, 2006, PROCESS BIOCHEM, V41, P457
   Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1
   Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Blazquez G, 2005, PROCESS BIOCHEM, V40, P2649, DOI 10.1016/j.procbio.2004.11.007
   Bleuel C, 2005, SCI TOTAL ENVIRON, V345, P13, DOI 10.1016/j.scitotenv.2004.11.015
   Chen JP, 2003, CARBON, V41, P1979, DOI 10.1016/S0008-6223(03)00197-0
   FOUREST E, 1992, APPL MICROBIOL BIOT, V37, P399, DOI 10.1007/BF00211001
   Ho YS, 2001, SEPAR SCI TECHNOL, V36, P241, DOI 10.1081/SS-100001077
   Hursthouse AS, 2001, J ENVIRON MONITOR, V3, P49, DOI 10.1039/b006132h
   Iddou A, 2005, WATER QUAL RES J CAN, V40, P184
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   Kaewsarn P, 2001, ENVIRON POLLUT, V112, P209, DOI 10.1016/S0269-7491(00)00114-7
   Kalbitz K, 1998, SCI TOTAL ENVIRON, V209, P27, DOI 10.1016/S0048-9697(97)00302-1
   Khurshid S.J., 1984, NUCLEUS, V21, P3
   Rahmani GNH, 1999, BIORESOURCE TECHNOL, V70, P225, DOI 10.1016/S0960-8524(99)00050-4
   Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001
   Tien CJ, 2002, PROCESS BIOCHEM, V38, P605, DOI 10.1016/S0032-9592(02)00183-8
   Vijayaraghavan K, 2005, SEP PURIF TECHNOL, V44, P53, DOI 10.1016/j.seppur.2004.12.003
   VULLO D, 2003, REV QUIM VIVA, V2, P1
   Wang L, 2003, WATER RES, V37, P561, DOI 10.1016/S0043-1354(02)00350-0
   WHO, 1984, GUID VAL DRINK WAT Q
NR 24
TC 5
Z9 6
U1 0
U2 10
PU KING SAUD UNIV PRESS, KING SAUD UNIV
PI RIYADH
PA PO BOX 68953, RIYADH, 11537, SAUDI ARABIA
SN 1319-6103
J9 J SAUDI CHEM SOC
JI J. Saudi Chem. Soc.
PD JAN
PY 2011
VL 15
IS 1
BP 83
EP 88
DI 10.1016/j.jscs.2010.10.007
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 741DY
UT WOS:000288844500012
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Xiong, SL
   Li, AL
   Huang, N
AF Xiong, Shuangli
   Li, Anlin
   Huang, Ni
BE Jiang, ZY
   Han, JT
   Liu, XH
TI Recent Advances in the Bioactivities and Structural Analysis of
   Chondroitin Sulfate
SO NEW MATERIALS AND ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advances in Materials and Manufacturing
   Processes
CY NOV 06-08, 2010
CL Shenzhen, PEOPLES R CHINA
SP Univ Wollongong, NE Univ, Univ Sci & Technol Beijing, Hebei Polytechn Univ, Hong Kong Ind Technol Res Ctr
DE Chondroitin sulfate; bioactivity; structure analysis; spectrum
ID PERFORMANCE CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY;
   PERIODATE-OXIDATION; MASS-SPECTROMETRY; URONIC-ACIDS;
   GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES; PROTEOGLYCANS; DISACCHARIDES;
   POLYSACCHARIDES
AB Recent research data on chondroitin sulfate have suggested that they have many new biological functions such as anti-atherogenesis, anticoagulation, prevention and cure of arthritis, protection and repair of neuron during CNS development, morphogenesis and cell division. They are widely applied to functional food, clinical medicine and biomaterial. However, these bioactivities and applications are dependent on their fine structure with different monosaccharide unit and sulfation patterns. This review provides information on intimate relationship between these biological functions and the structure. Moreover, we overviewed the newly analytical methods about the composition and fine structure of them, including chromatometry, high performance liquid chromatography, mass spectrum and nuclear magnetic resonance before and after enzymolysis.
C1 [Xiong, Shuangli; Li, Anlin; Huang, Ni] SW Univ Sci & Technol, Coll Life Sci & Engn, Mianyang 621010, Sichuan Provinc, Peoples R China.
RP Xiong, SL (reprint author), SW Univ Sci & Technol, Coll Life Sci & Engn, Mianyang 621010, Sichuan Provinc, Peoples R China.
EM lxberry225@yahoo.com.cn; lianlin@swust.edu.cn; huangni@swust.edu.cn
CR Abuja PM, 2002, FEBS LETT, V512, P245, DOI 10.1016/S0014-5793(02)02273-1
   Albertini R, 1999, ARCH BIOCHEM BIOPHYS, V365, P143, DOI 10.1006/abbi.1999.1150
   ALHAKIM A, 1991, ANAL BIOCHEM, V195, P68, DOI 10.1016/0003-2697(91)90296-6
   Amarasekara AS, 2007, CARBOHYD POLYM, V68, P116, DOI 10.1016/j.carbpol.2006.07.019
   Balakrishnan B, 2005, CARBOHYD RES, V340, P1425, DOI 10.1016/j.carres.2005.05.028
   Benedict M. S., 2010, CARBOHYD RES, V345, P291
   Campo GM, 2009, J CELL BIOCHEM, V106, P83, DOI 10.1002/jcb.21981
   Campo GM, 2003, ARTHRITIS RES THER, V5, pR122, DOI 10.1186/ar748
   Cheng X., 2003, J CHROMATOGRAPHIC SC, V41, P1
   Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2
   DIERCKXSENS GC, 1983, ANAL BIOCHEM, V130, P120, DOI 10.1016/0003-2697(83)90658-9
   ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490
   Eun S.L., 2007, BIOMATERIALS, V28, P2754
   Falshaw R, 2000, CARBOHYD POLYM, V41, P357, DOI 10.1016/S0144-8617(99)00103-4
   Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510
   Gu Wen-Li, 2007, Sheng Li Ke Xue Jin Zhan, V38, P101
   Guo T., 2004, CHINA J ORTHOP TRAUM, V17, P574
   Hayashi K, 2001, GLYCOCONJUGATE J, V18, P401, DOI 10.1023/A:1014864131288
   Huang WJ, 2003, J MOL BIOL, V328, P623, DOI 10.1016/S0022-2836(03)00345-0
   Hung CC, 2001, ANAL CHIM ACTA, V427, P111, DOI 10.1016/S0003-2670(00)01196-X
   Iossif S., 2010, BIOMATERIALS, V31, P2788
   [姜瑞芝 Jiang Ruizhi], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P991
   Joon-Soo S., 2005, J CHROMATOGR B, V818, P133
   Juliana F. P., 2010, CARBOHYD POLYM, V80, P934
   KARAMANOS NK, 1995, J CHROMATOGR A, V696, P295, DOI 10.1016/0021-9673(94)01294-O
   Kim JS, 2006, CARBOHYD RES, V341, P1061, DOI 10.1016/j.carres.2006.03.008
   Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014
   [李波 Li Bo], 2004, [色谱, Chinese Journal of Chromatography], V22, P560
   LIU Yu-ying, 2005, CHIN J ANAL LAB, V24, P59
   Maccari F, 2004, CARBOHYD POLYM, V56, P55, DOI 10.1016/j.carbpol.2003.12.002
   Mazumder S, 2005, CARBOHYD POLYM, V59, P231, DOI 10.1016/j.carbpol.2004.09.014
   Minamisawa T, 2005, RAPID COMMUN MASS SP, V19, P1788, DOI 10.1002/rcm.1985
   Mourao PAS, 2001, THROMB RES, V102, P167, DOI 10.1016/S0049-3848(01)00230-4
   Mucci A, 2000, CARBOHYD POLYM, V41, P37, DOI 10.1016/S0144-8617(99)00075-2
   POOLE AR, 1986, BIOCHEM J, V236, P1
   Rachmilewitz J, 1998, BLOOD, V92, P223
   RUGGIERO J, 1994, CARBOHYD RES, V256, P275, DOI 10.1016/0008-6215(94)84213-2
   Sakai S, 2002, IMMUNOL LETT, V84, P211, DOI 10.1016/S0165-2478(02)00181-5
   Sakai S, 2006, J BIOL CHEM, V281, P19872, DOI 10.1074/jbc.M509058200
   Salama RHM, 2006, CANCER LETT, V233, P16, DOI 10.1016/j.canlet.2005.02.047
   SCOTT JE, 1978, BIOCHEM J, V173, P103, DOI 10.1042/bj1730103
   Sim JS, 2007, FOOD CHEM, V101, P532, DOI 10.1016/j.foodchem.2006.02.011
   Tamura J, 2009, BIOSCI BIOTECH BIOCH, V73, P1387, DOI 10.1271/bbb.90037
   Theocharis AD, 2002, BIOCHIMIE, V84, P667, DOI 10.1016/S0300-9084(02)01428-1
   Tircol M, 2006, CENT EUR J BIOL, V1, P150, DOI 10.2478/s11535-006-0010-x
   TOFFANIN R, 1994, CARBOHYD RES, V265, P151, DOI 10.1016/0008-6215(94)80085-5
   Volpi N, 2004, CARBOHYD POLYM, V55, P273, DOI 10.1016/j.carbpol.2003.09.010
   Wang SH, 2004, J CHROMATOGR A, V1039, P51, DOI 10.1016/j.chroma.2004.02.014
   WHITE CA, 1983, CARBOHYD RES, V114, P201, DOI 10.1016/0008-6215(83)88187-7
   Wu S F, 2005, J FOOD SCI BIOTECHNO, V24, P86
   Xiong SL, 2007, J FOOD BIOCHEM, V31, P356, DOI 10.1111/j.1745-4514.2007.00115.x
   Zaia J, 2001, ANAL CHEM, V73, P6030, DOI 10.1021/ac015577t
   Zamfir A, 2002, RAPID COMMUN MASS SP, V16, P2015, DOI 10.1002/rcm.820
   Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453
NR 54
TC 1
Z9 1
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-203-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 152-153
BP 399
EP 407
DI 10.4028/www.scientific.net/AMR.152-153.399
PN 1, 2
PG 9
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BTU54
UT WOS:000288114200075
DA 2018-10-20
ER

PT S
AU Guo, YJ
   Wang, YR
   Wang, GJ
   Yang, ZX
   Ji, WW
AF Guo, Yajie
   Wang, Yuran
   Wang, Guangjian
   Yang, Zhenxing
   Ji, Wenwen
BE Jiang, ZY
   Han, JT
   Liu, XH
TI Morphological control synthesis and characterization of hydroxyapatite
   with star-shaped
SO NEW MATERIALS AND ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advances in Materials and Manufacturing
   Processes
CY NOV 06-08, 2010
CL Shenzhen, PEOPLES R CHINA
SP Univ Wollongong, NE Univ, Univ Sci & Technol Beijing, Hebei Polytechn Univ, Hong Kong Ind Technol Res Ctr
DE Hydrixyapatite; Morphology; Ionic Liquid; Microwave; characterization
ID NANOCRYSTALLINE HYDROXYAPATITE; MICROWAVE IRRADIATION; IONIC LIQUIDS;
   SIZE
AB The aim of the present work was to study the feasibility of wet synthesizing hydroxyapatite (HAP) with star-like and high specific surface area. HAP was synthesized by one-step self-assembly process in ionic liquid media under microwave irradiation, and treated at 300, 600, 900 degrees C, respectively. X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) analysis revealed that HAP was pure crystal phase. Nitrogen adsorption and desorption isotherms (NADI) with a characteristic hysteresis loop further confirmed the existence of uniform micropores or channels of HAP. The BET surface area, pore volume, and pore size distribution were calculated to be 324m(2)g(-1), 0.39cm(3)g(-1), and 3.28 nm, respectively. Scanning electron microscopy (SEM) results indicated that the HAP was of star-shaped morphology. The formation of HAP could be explained by functional ionic liquid as structure-directing template. Well-ordered mesostructure of HAP with star-like might be therefore used as a potential biomaterial for preparation of bone implant materials.
C1 [Guo, Yajie; Wang, Guangjian; Yang, Zhenxing; Ji, Wenwen] Huaibei Normal Univ, Sch Chem & Mat Sci, Anhua, Peoples R China.
   [Wang, Yuran] Shanghai Jiao Tong Univ, Sch Chem & Chem Sci, Shanghai, Peoples R China.
RP Guo, YJ (reprint author), Huaibei Normal Univ, Sch Chem & Mat Sci, Anhua, Peoples R China.
EM chem@chnu.edu.cn; wyr2260@eyou.com; wgj2260@yahoo.com.cn
FU National Natural Foundation of Anhui Office of Education [2006KJ129b]
FX Financial supports from the National Natural Foundation of Anhui Office
   of Education (No. 2006KJ129b).
CR Aizawa M, 2005, BIOMATERIALS, V26, P3427, DOI 10.1016/j.biomaterials.2004.09.044
   Chen X., 2000, BIOCERAMICS, V292-1, P239
   Han YC, 2007, MATER RES BULL, V42, P1169, DOI 10.1016/j.materresbull.2006.09.003
   Kappe CO, 2004, ANGEW CHEM INT EDIT, V43, P6250, DOI 10.1002/anie.200400655
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Li JG, 2006, J AM CERAM SOC, V89, P3544, DOI [10.1111/j.1551-2916.2006.01149.x, 10.1111/j.1552-2916.2006.01149.x]
   Lin KL, 2007, ACTA BIOMATER, V3, P271, DOI 10.1016/j.actbio.2006.11.003
   Lopez I, 2007, TETRAHEDRON, V63, P2901, DOI 10.1016/j.tet.2007.01.031
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Nilce C.C., 2002, ENVIRON SCI TECHNOL, V36, P1630
   Okada M, 2007, J NANOSCI NANOTECHNO, V7, P848, DOI 10.1166/jnn.2007.505
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   Silva CC, 2007, J MATER SCI, V42, P3851, DOI 10.1007/s10853-006-0474-0
   Spanos N, 2006, J MATER SCI, V41, P1805, DOI 10.1007/s10853-006-2953-9
   Suarez PAZ, 1996, POLYHEDRON, V15, P1217, DOI 10.1016/0277-5387(95)00365-7
   Suljovrujica E., 2003, CHEMISTRY, V67, P375
   Wang AL, 2007, APPL SURF SCI, V253, P3311, DOI 10.1016/j.apsusc.2006.07.025
   Wu YJ, 2005, LANGMUIR, V21, P3232, DOI 10.1021/la046754z
   Xia M, 2007, J MOL CATAL A-CHEM, V265, P205, DOI 10.1016/j.molcata.2006.10.004
   Zhu RH, 2008, J ALLOY COMPD, V457, P555, DOI 10.1016/j.jallcom.2007.03.081
NR 21
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-203-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 152-153
BP 1603
EP +
DI 10.4028/www.scientific.net/AMR.152-153.1603
PN 1, 2
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BTU54
UT WOS:000288114200318
DA 2018-10-20
ER

PT S
AU Wang, HX
   Xue, ZX
   Wei, MH
   Chen, DL
   Li, M
AF Wang, Hongxin
   Xue, Zhengxiang
   Wei, Meihong
   Chen, Denglong
   Li, Min
BE Jiang, ZY
   Han, JT
   Liu, XH
TI A novel scaffold from recombinant spider silk protein in tissue
   engineering
SO NEW MATERIALS AND ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Advances in Materials and Manufacturing
   Processes
CY NOV 06-08, 2010
CL Shenzhen, PEOPLES R CHINA
SP Univ Wollongong, NE Univ, Univ Sci & Technol Beijing, Hebei Polytechn Univ, Hong Kong Ind Technol Res Ctr
DE Recombinant spider silk protein with RGD; Scaffold of tissue
   engineering; Cytocompatibility
ID MESENCHYMAL STEM-CELLS; DRAGLINE SILK; FIBROIN; OPTIMIZATION; ACID
AB As a new biomaterial, recombinant spider silk protein has attracted much attention in tissue engineering. The pNSR-16/ BL21(DE3)pLysS strains fermented and produced the recombinant spider silk protein, which was then cast into scaffolds. NIH-3T3 cells were cultivated with extractions of the scaffolds in vitro. The cytotoxicity of scaffolds was analyzed with a MTT assay. The performances of cells adhesion, growth and expression on the scaffolds were observed with SEM, HE staining and immunohistochemistry. Compared with the control, the extract fluid of materials culturing the NIH-3T3 cells was not apparently different. NIH-3T3 cells could adhere and grow on the scaffolds and secret FGF-2. The pNSR-16 recombinant spider silk protein scaffolds has satisfactory cytocompatibility and the scaffolds are ideal scaffold material for tissue engineering.
C1 [Wang, Hongxin; Xue, Zhengxiang; Wei, Meihong; Chen, Denglong; Li, Min] Fujian Normal Univ, Coll Life Sci, Fuzhou 350108, Fujian Province, Peoples R China.
RP Wang, HX (reprint author), Fujian Normal Univ, Coll Life Sci, Fuzhou 350108, Fujian Province, Peoples R China.
EM whxml12@163.com; xzxfly@163.com; mhwei_2006@163.com;
   chendenglong@163.com; mli@fjnu.edu.cn
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   CHEN BL, 2000, J HULUNBEI ER COLL, V8, P80
   CHEN BL, 1998, J HULUNBEIER COLL, V6, P56
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee MH, 2006, J BIOSCI BIOENG, V101, P127, DOI 10.1263/jbb.101.127
   LI M, 2004, J BIOMEDICAL ENG, V12, P1006
   Li Min, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P1206
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Takezawa T, 2003, BIOMATERIALS, V24, P2267, DOI 10.1016/S0142-9612(03)00038-3
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Teixeira AP, 2006, BIOTECHNOL PROGR, V22, P247, DOI 10.1021/bp0502328
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   YANG ZM, 2000, BASIC CLIN RES TISSU, V14, P215
   [张秋轩 ZHANG Qiuxuan], 2007, [福建师范大学学报. 自然科学版, Journal of Fujian Normal University. Natural Science], V23, P80
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
NR 26
TC 2
Z9 3
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-203-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 152-153
BP 1734
EP 1744
DI 10.4028/www.scientific.net/AMR.152-153.1734
PN 1, 2
PG 11
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BTU54
UT WOS:000288114200345
DA 2018-10-20
ER

PT S
AU Zhao, H
   Li, M
AF Zhao, Huijing
   Li, Mingzhong
BE Bai, L
   Chen, GQ
TI Preparation of braided silk as a tubular tissue engineering scaffold
SO SILK: INHERITANCE AND INNOVATION - MODERN SILK ROAD
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 7th China International Silk Conference on Inheritance and Innovation -
   Modern Silk Road
CY SEP 10-12, 2010
CL Suzhou, PEOPLES R CHINA
SP China Natl Silk Coordinating Off, China Natl Silk Assoc, Soochow Univ, Shinshu Univ Japan
DE silk; braiding; small diameter; tissue engineering scaffold; tube
AB Silkworm silk has been recognized as a satisfactory biomaterial for long time due to its exceptional biocompatibility, biodegradability, mechanical properties etc. For example, silk fibers in the form of sutures have been used for centuries. The aim of this study is to discuss the potential usage of silk as the novel biomedical devices, such as blood vessels. In this study, cuit silks prepared from degummed raw silks were twisted as threads with four different yarn linear densities. A specific braiding machine was used to weave those threads into a tube. Subsequently two different groups of silk tubes were prepared. One was treated by ethanol and the other without. Thickness, porosity, mass per unit area of two groups of braided tubes were measured. Its mechanical properties were also studied. The influence of ethanol treatment and various yarn linear densities on its structural and mechanical properties was also studied. Results indicated that structural and mechanical properties of the tubes were significatly changed by the yarn linear densities and ethanol treatment. Conclusively, braided silk tube could be a potential blood vessel tissue engineering scaffold.
C1 [Zhao, Huijing; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Zhao, H (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM zhhj@suda.edu.cn; mzli@suda.edu.cn
CR Brewster LP, 2007, BIOMATERIALS, V28, P5028, DOI 10.1016/j.biomaterials.2007.07.048
   Chung SW, 2010, ACTA BIOMATER, V6, P1958, DOI 10.1016/j.actbio.2009.12.007
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   NEREM RM, 2004, INT C SERIES, V1262, P122
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zhao HJ, 2010, J BIOMATER APPL, V24, P579, DOI 10.1177/0885328208099437
NR 7
TC 1
Z9 1
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-011-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 175-176
BP 95
EP 99
DI 10.4028/www.scientific.net/AMR.175-176.95
PG 5
WC Materials Science, Textiles
SC Materials Science
GA BUC70
UT WOS:000288889100018
DA 2018-10-20
ER

PT S
AU Li, WL
   Wang, JJ
   Dai, LX
AF Li, Wen-li
   Wang, Jian-jun
   Dai, Li-xing
BE Bai, L
   Chen, GQ
TI Preparation and Antibacterial Activity of Poly (vinyl alcohol)/Silk
   Fibroin Composite Nanofibers Containing Silver Nanoparticles
SO SILK: INHERITANCE AND INNOVATION - MODERN SILK ROAD
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 7th China International Silk Conference on Inheritance and Innovation -
   Modern Silk Road
CY SEP 10-12, 2010
CL Suzhou, PEOPLES R CHINA
SP China Natl Silk Coordinating Off, China Natl Silk Assoc, Soochow Univ, Shinshu Univ Japan
DE poly (vinyl alcohol); silk fibroin; electrospinning; Ag nanoparticles;
   composite nanofibers
ID POLY(VINYL ALCOHOL); BIOMATERIAL; SILK
AB Silk fibroin (SF) and polyvinyl alcohol (PVA) solutions were prepared respectively by formic acid and deionized water as solvent, the solutions were then blended, and after that AgNO3 was added. The PVA/SF/AgNO3 solution was electrospun to form nanofibers. A number of particles were generated on the surface of nanofibers during electrospinning, which was confirmed by transmission electron microscopy (TEM). The diameter distribution of the nanofibers was narrow and the particles were nano-sized and well-dispersed. X-ray diffraction (XRD) patterns of the composite nanofibers indicated that the component of the nanoparticles was silver. By annealing the composite nanofibers at 155 degrees C for 5 minutes, the silver nanoparticles possibly clustered into the larger size. The size of Ag nanoparticles was 2.25nm without post treatment, and this value increased to 3.76nm after the heat treatment. The antibacterial activity of the heat-treated PVA/SF composite nanofibers containing Ag nanoparticles was evaluated and the resultant nanofibers showed strong antimicrobial activity on Staphylococcus aureus and Escherichia coli. Moreover, the antibacterial PVA/SF composite nanofibers containing Ag nanoparticles have the possibility to be used in wound dressing due to the electrospun PVA nanofibers could preserve the web structure in water after the heat treatment,.
C1 [Li, Wen-li; Wang, Jian-jun; Dai, Li-xing] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
RP Dai, LX (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Suzhou 215123, Peoples R China.
EM lwl198546@126.com; wangjianjun@suda.edu.cn; dailixing@suda.edu.cn
CR Chen C, 2006, NANOTECHNOLOGY, V17, P466, DOI 10.1088/0957-4484/17/2/021
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   Jin WJ, 2007, SYNTHETIC MET, V157, P454, DOI 10.1016/j.synthmet.2007.05.011
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 8
TC 5
Z9 5
U1 1
U2 25
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-011-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 175-176
BP 105
EP 109
DI 10.4028/www.scientific.net/AMR.175-176.105
PG 5
WC Materials Science, Textiles
SC Materials Science
GA BUC70
UT WOS:000288889100020
DA 2018-10-20
ER

PT S
AU Wang, YY
   Cheng, YD
   Liu, Y
   Zhao, HJ
   Li, MZ
AF Wang, Yi-Yu
   Cheng, Ying-Dong
   Liu, Yu
   Zhao, Hui-Jing
   Li, Ming-Zhong
BE Bai, L
   Chen, GQ
TI The Effect of Ultrasonication on the Gelation Velocity and Structure of
   Silk Fibroin
SO SILK: INHERITANCE AND INNOVATION - MODERN SILK ROAD
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 7th China International Silk Conference on Inheritance and Innovation -
   Modern Silk Road
CY SEP 10-12, 2010
CL Suzhou, PEOPLES R CHINA
SP China Natl Silk Coordinating Off, China Natl Silk Assoc, Soochow Univ, Shinshu Univ Japan
DE silk fibroin; hydrogels; ultrasonication; structure
ID BOMBYX-MORI SILK; POLY(ETHYLENE OXIDE); BIOMATERIAL; SCAFFOLDS;
   ULTRASOUND; HYDROGELS; MEMBRANE; EXPOSURE
AB Silk fibroin hydrogels is an important morphous of biomaterial. As a natural protein collosol, purified native silk fibroin solution can be gelatinized under certain conditions. The main mechanism of the gelation is that the fibroin molecules turn into the beta-sheet conformation from the random coils. This transformation of silk fibroin molecules would be influenced by various parameters such as the temperature, pH value, ion concentration and so on. In this paper, the effect of ultrasonication on the gelation velocity and structure of silk fibroin were discussed. It is believed that the cavitations caused by sonication could accelerate the process of gelation of silk fibroin. Our experiments demonstrated that the ultrasonic treatment could greatly reduce the silk fibroin gelation time, especially at a high sonication power exceeding 400W. The results of XRD, FTIR, and Raman spectra indicated that the ultrasonication had no significant effect on the final structure and composition of the silk fibroin gels except the acceleration for the molecular transition from random coil and a-structure to beta-sheet conformation of silk fibroin. The SEM images showed freeze-dried fibroin gels close to the ultrasonication source had, compact structure, while the structure was more loosening far away to the source.
C1 [Wang, Yi-Yu; Cheng, Ying-Dong; Liu, Yu; Zhao, Hui-Jing; Li, Ming-Zhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Wang, YY (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM yiyiyuyu.7@163.com; cyd998716@163.com; liuyu19850912@163.com;
   zhhj@suda.edu.cn; mzli@suda.edu.cn
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   CAREY PR, 1986, BIOCHIM BIOPHYS ACTA, V872, P169, DOI 10.1016/0167-4838(86)90268-2
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   HIRABAYASHI K, 1967, SEN-I GAKKAISHI, V23, P538
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kemmere ME, 2005, MACROMOL MATER ENG, V290, P302, DOI 10.1002/mame.200400255
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Li M., 2001, J DONG HUA U NATURE, V27, P12
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Opdahl A, 2003, J BIOMED MATER RES A, V67A, P350, DOI 10.1002/jbm.a.10054
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   SHIMIZU M, 1941, HOUKOKU, V10, P475
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
NR 27
TC 3
Z9 3
U1 0
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-011-4
J9 ADV MATER RES-SWITZ
PY 2011
VL 175-176
BP 143
EP 148
DI 10.4028/www.scientific.net/AMR.175-176.143
PG 6
WC Materials Science, Textiles
SC Materials Science
GA BUC70
UT WOS:000288889100027
DA 2018-10-20
ER

PT J
AU Chen, F
   Zhu, YJ
   Wang, KW
   Zhao, KL
AF Chen, Feng
   Zhu, Ying-Jie
   Wang, Ke-Wei
   Zhao, Kuai-Le
TI Surfactant-free solvothermal synthesis of hydroxyapatite
   nanowire/nanotube ordered arrays with biomimetic structures
SO CRYSTENGCOMM
LA English
DT Article
ID CALCIUM-PHOSPHATE NANOPARTICLES; HYDROTHERMAL METHOD; MIXED-SOLVENTS;
   BONE; BIOMATERIALS; ENAMEL; BIOMINERALIZATION; MINERALIZATION;
   CYTOTOXICITY; TEMPLATE
AB Hydroxyapatite (HAp), as the main inorganic constituent in vertebrate bones, is an important biomaterial. However, fabricating biomimetic HAp ordered arrays of one-dimensional nanostructures remains a challenge. Herein, we report a solvothermal method for the preparation of HAp nanowire/nanotube ordered arrays with biomimetic structures using CaCl2 and NaH2PO4 center dot H2O in ternary solvents of water, ethylene glycol (EG) and N,N-dimethylformamide (DMF) without using any surfactant. The effects of the solvents on the morphology and crystal phase of the product as well as the formation mechanism of HAp nanowire/nanotube ordered arrays are investigated. This method does not need any hard template or surfactant, avoiding the procedures and cost for their removal in the product. The products are characterized with X-ray powder diffraction (XRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM), differential scanning calorimetric analysis (DSC) and thermogravimetric analysis (TG). The cytotoxicity of the as-prepared HAp samples with different morphologies are also tested.
C1 [Chen, Feng; Zhu, Ying-Jie; Wang, Ke-Wei] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Zhao, Kuai-Le] Fudan Univ, Canc Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI Chen, Feng/D-6406-2012; CHEN, Feng/E-4310-2016; Wang, Kewei/L-4460-2017
OI Chen, Feng/0000-0002-1162-1684; CHEN, Feng/0000-0002-1162-1684; Wang,
   Kewei/0000-0003-1611-7804
FU National Natural Science Foundation of China [50772124, 50821004];
   Science and Technology Commission of Shanghai [1052nm06200];
   Shanghai-Unilever Research and Development Fund [09520715200]
FX Financial support from the National Natural Science Foundation of China
   (50772124, 50821004), the Science and Technology Commission of Shanghai
   (1052nm06200), and Shanghai-Unilever Research and Development Fund
   (09520715200) is gratefully acknowledged.
CR Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Chen FP, 2009, ASIA-PAC J CHEM ENG, V4, P522, DOI 10.1002/apj.271
   Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002
   Dong LF, 2009, NANOSCALE RES LETT, V4, P1517, DOI 10.1007/s11671-009-9429-0
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Furuichi K, 2006, CHEM MATER, V18, P229, DOI 10.1021/cm052213z
   Habibovic P, 2010, ADV MATER, V22, P1858, DOI 10.1002/adma.200902778
   He QJ, 2007, MATER LETT, V61, P141, DOI 10.1016/j.matlet.2006.04.082
   Jayasuriya A. C., 2009, J MATER SCI-MATER M, V21, P393
   Jevtic M, 2008, CRYST GROWTH DES, V8, P2217, DOI 10.1021/cg7007304
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   Kumar R, 2008, J R SOC INTERFACE, V5, P427, DOI 10.1098/rsif.2007.1141
   Lai C, 2005, MATER LETT, V59, P210, DOI 10.1016/j.matlet.2004.08.037
   Lin KL, 2009, CRYST GROWTH DES, V9, P177, DOI 10.1021/cg800129u
   Lowenstam HA, 1989, BIOMINERALIZATION
   Ma MG, 2008, MATER LETT, V62, P1642, DOI 10.1016/j.matlet.2007.09.050
   Ma MG, 2006, J PHYS CHEM B, V110, P14226, DOI 10.1021/jp061738r
   Ma MY, 2008, J MATER CHEM, V18, P2722, DOI 10.1039/b800389k
   Maitra A, 2005, EXPERT REV MOL DIAGN, V5, P893, DOI 10.1586/14737159.5.6.893
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Oyama TM, 2010, TOXICOL IN VITRO, V24, P737, DOI 10.1016/j.tiv.2010.01.004
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Peytcheva A, 2002, COLLOID POLYM SCI, V280, P218, DOI 10.1007/s00396-001-0600-0
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Vlachy N, 2009, COLLOID SURFACE B, V70, P278, DOI 10.1016/j.colsurfb.2008.12.038
   Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yao X, 2010, J MATER SCI, V45, P1930, DOI 10.1007/s10853-009-4182-4
   Yuan Y, 2008, MATER CHEM PHYS, V112, P275, DOI 10.1016/j.matchemphys.2008.05.068
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang HB, 2009, J PHYS CHEM SOLIDS, V70, P243, DOI 10.1016/j.jpcs.2008.10.011
   Zhang JL, 2010, LANGMUIR, V26, P2989, DOI 10.1021/la9043649
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
NR 36
TC 59
Z9 61
U1 8
U2 98
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1466-8033
J9 CRYSTENGCOMM
JI Crystengcomm
PY 2011
VL 13
IS 6
BP 1858
EP 1863
DI 10.1039/c0ce00574f
PG 6
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA 729BV
UT WOS:000287923800024
DA 2018-10-20
ER

PT J
AU Firdous, S
   Fuzail, M
   Atif, M
   Nawaz, M
AF Firdous, S.
   Fuzail, M.
   Atif, M.
   Nawaz, M.
TI Polarimetric characterization of ultra-high molecular weight
   polyethylene (UHMWPE) for bone substitute biomaterials
SO OPTIK
LA English
DT Article
DE Biomaterial; UHMWPE; Polarization; Scattering; Depolarization; Mueller
   matrix
ID MUELLER MATRIX; ARTHROPLASTY; KNEE
AB In this work the UHMWPE is characterized for their optical properties with Mueller matrix polarimeter. The transmittance birefringence, retardance, polarizance, linear and circular polarization and absorbance of polarized light at different wavelengths ranging 400-800 nm are measured. The presented Mueller matrix elements along with depth resolve polarization decrease in intensity with the change in the wavelength. Linear retardance increases compared to circular through highly scattering polyethylene. High refractive index and low mean free path; and close bonding of particles of material rotates the incoming photons and circular polarization which is dominant as compared to the linear one. Therefore the average intensity increases with both the optical depth and the scattered concentration in UHMWPE, which would accordingly decrease the apparent degree of polarization.
   The extracted results in terms of linear and circular retardances prove that UHMWPE is compatible, strong, and compact. This research work provides an optical characterization technique for bone substitute biomaterial in the health care industry. (C) 2010 Elsevier GmbH. All rights reserved.
C1 [Firdous, S.; Atif, M.; Nawaz, M.] Natl Inst Lasers & Optron NILOP, Photon Div, Biophoton Lab, Islamabad, Pakistan.
   [Fuzail, M.] Appl Chem Lab ACL, Islamabad, Pakistan.
RP Firdous, S (reprint author), Natl Inst Lasers & Optron NILOP, Photon Div, Biophoton Lab, PO Nilore 45650, Islamabad, Pakistan.
EM shamaraz@gmail.com
RI Firdous, Shamaraz/I-8028-2015; atif, Muhammad/F-5873-2015; Atif,
   Muhammad/C-4789-2013
OI Atif, Muhammad/0000-0002-7356-4275
CR Barron D, 2008, POLYMER, V49, P3111, DOI 10.1016/j.polymer.2008.05.004
   Brosseau C., 1998, FUNDAMENTALS POLARIZ
   Collett E., 2003, POLARIZED LIGHT FIBE
   Crowley J, 2008, BIO-MED MATER ENG, V18, P149, DOI 10.3233/BME-2008-0518
   Eyerer P., 1990, CONCISE ENCY MED DEN, P271
   Firdous S, 2005, APPL OPTICS, V44, P1171, DOI 10.1364/AO.44.001171
   FIRDOUS S, 2005, P SOC PHOTO-OPT INS, V5867, P25
   Firdous S., 2006, ANN BIOMEDICAL RES E, V5, P55
   Firdous S, 2007, PROC SPIE, V6632, DOI 10.1117/12.729229
   Fisher J, 2004, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000148783.20469.4c
   Fuzail M., 2008, P 8 INT S ION RAD PO, P64
   GSELL RA, 1999, CHARACTERIZATION PRO, V27
   Ho SP, 2002, WEAR, V253, P1145, DOI 10.1016/S0043-1648(02)00220-X
   Kucklick T., 2005, MED DEVICE R D HDB
   Kurtz S. M., 2004, UHMWPE HDB ULTRA HIG
   Laurent MP, 2008, J ARTHROPLASTY, V23, P751, DOI 10.1016/j.arth.2007.06.006
   Ma T, 2008, BIOMATERIALS, V29, P3738, DOI 10.1016/j.biomaterials.2008.05.031
   Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002
   Moore J., 2003, BIOMEDICAL TECHNOLOG
   Niemz M.H., 2002, LASER TISSUE INTERAC
   Peacock A. J., 2000, HDB POLYETHYLENE
   Rice W., 2008, BIOMATERIALS, V29, P2014
   Tomasetti E, 1999, SURF INTERFACE ANAL, V27, P735, DOI 10.1002/(SICI)1096-9918(199908)27:8<735::AID-SIA567>3.3.CO;2-D
   Torrisi L, 2004, APPL SURF SCI, V227, P164, DOI 10.1016/j.apsusc.2003.11.078
   Tuchin V.V., 2007, OPTICAL POLARIZATION
   Twietmeyer KM, 2008, OPT EXPRESS, V16, P11589, DOI 10.1364/OE.16.011589
   Wang YP, 2005, COMPOS SCI TECHNOL, V65, P793, DOI 10.1016/j.compscitech.2004.10.012
   Wright TM, 2005, CLIN ORTHOP RELAT R, P141, DOI 10.1097/01.blo.0000187811.48717.9d
NR 28
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0030-4026
J9 OPTIK
JI Optik
PY 2011
VL 122
IS 2
BP 99
EP 104
DI 10.1016/j.ijleo.2009.10.008
PG 6
WC Optics
SC Optics
GA 736XI
UT WOS:000288527900004
DA 2018-10-20
ER

PT J
AU Lee, HS
   Kwon, SY
   Seo, EM
   Kim, YH
   Kim, SS
AF Lee, Hwa Sung
   Kwon, Soon Yong
   Seo, Eun Mi
   Kim, Yong-Hee
   Kim, Sung Soo
TI Preparation and characterization of alpha-tricalcium phosphate cements
   incorporated with polyamino acids
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE bone cement; calcium phosphate; polyaspartic acid; polyamino acid;
   biomaterial
ID CANAL SEALER-FILLER; CALCIUM-PHOSPHATE; HYDROXYAPATITE CEMENT;
   HYDROLYSIS; RECONSTRUCTION; BIOMATERIALS; IMPROVEMENT; AGENTS
AB Polymeric calcium phosphate cements (PCPCs) derived from biodegradable polyamino acids, such as polyaspartic acid (PAA) and poly-gamma-glutamic acid (gamma-PGA), were prepared in an attempt to improve their cohesion strength and injectability. The characteristics of the calcium phosphate cements (CPCs), such as dynamic viscosity, paste injectability, initial setting time, compressive strength and cell compatibility, were assessed. The dynamic viscosity increased significantly with gamma-PGA incorporation but decreased with PAA incorporation. The injectability increased with the concentration of polyamino acids and that of the CPCs mixed with gamma-PGA reached 94%. The initial setting time decreased with the gamma-PGA concentration in the cement liquid and reached approximately 10-15 min when the gamma-PGA concentration was 1-2 wt%. The compressive strength (CS) of CPCs after 1 week-incubation decreased with the incorporation of PAA and gamma-PGA. gamma-PGA incorporation deteriorated the CS more than PAA incorporation because the dissolution of alpha-tricalcium phosphate (alpha-TCP) was retarded. Saos-2 cells grown on CPCs with polyamino acids spread more than those grown on the CPC without them.
C1 [Kim, Sung Soo] Korea Res Inst Chem Technol, Adv Mat Div, Taejon 305600, South Korea.
   [Lee, Hwa Sung; Kwon, Soon Yong] Catholic Univ Korea, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Seo, Eun Mi; Kim, Yong-Hee] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.
RP Kim, SS (reprint author), Korea Res Inst Chem Technol, Adv Mat Div, Taejon 305600, South Korea.
EM sskim@krict.re.kr
FU Ministry for Health, Welfare & Family Affairs, Republic of Korea
   [A080739, A100451]
FX This study was supported by grants of the Korean Health Technology R&D
   Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A080739 and A100451).
CR Bigi A, 2002, BIOMATERIALS, V23, P1849, DOI 10.1016/S0142-9612(01)00311-8
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   BROWN WE, 1983, J DENT RES, V62, P672
   Chen GX, 2009, J MATER SCI, V44, P828, DOI [10.1007/s10853-008-3126-8, 10.1007/s10853-008-3126-1]
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   CHOHAYEB AA, 1987, J ENDODONT, V13, P384, DOI 10.1016/S0099-2399(87)80198-X
   Chow LC, 2009, DENT MATER J, V28, P1
   Gbureck U, 2004, BIOMATERIALS, V25, P2187, DOI 10.1016/j.biomaterials.2003.08.066
   Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5
   ISHIKAWA K, 1993, J DENT RES, V72, P474, DOI 10.1177/00220345930720020101
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Kim SS, 2009, J APPL POLYM SCI, V113, P1223, DOI 10.1002/app.30037
   KVETON JF, 1995, AM J OTOL, V16, P465
   Li YB, 1997, BIOMATERIALS, V18, P737
   Liu CS, 1997, J BIOMED MATER RES, V35, P75, DOI 10.1002/(SICI)1097-4636(199704)35:1<75::AID-JBM7>3.0.CO;2-J
   Matsuya S, 1996, J MATER SCI, V31, P3263, DOI 10.1007/BF00354678
   Matsuya Y, 1996, DENT MATER, V12, P2, DOI 10.1016/S0109-5641(96)80056-X
   MIYAZAKI K, 1993, DENT MATER, V9, P41, DOI 10.1016/0109-5641(93)90104-X
   SUGAWARA A, 1990, J ENDODONT, V16, P162, DOI 10.1016/S0099-2399(06)81963-1
   TENHUISEN KS, 1994, J MATER SCI-MATER M, V5, P291, DOI 10.1007/BF00122399
   Wang XP, 2007, J BIOMED MATER RES B, V81B, P410, DOI 10.1002/jbm.b.30678
NR 22
TC 5
Z9 6
U1 2
U2 27
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD JAN
PY 2011
VL 19
IS 1
BP 90
EP 96
DI 10.1007/s13233-011-0113-8
PG 7
WC Polymer Science
SC Polymer Science
GA 730IP
UT WOS:000288027300015
DA 2018-10-20
ER

PT J
AU Marangon, M
   Lucchetta, M
   Waters, EJ
AF Marangon, M.
   Lucchetta, M.
   Waters, E. J.
TI Protein stabilisation of white wines using zirconium dioxide enclosed in
   a metallic cage
SO AUSTRALIAN JOURNAL OF GRAPE AND WINE RESEARCH
LA English
DT Article
DE zirconium dioxide; protein; wine; haze; Sauvignon Blanc; Riesling;
   Chardonnay
ID PACKED-COLUMN; ADSORPTION; REMOVAL; GRAPE; IDENTIFICATION;
   CLARIFICATION; BIOMATERIAL; CHARDONNAY; STABILITY; BENTONITE
AB Backgrounds and Aims: White wines are stabilised by removing the heat unstable proteins through adsorption by bentonite. Bentonite fining is not an efficient wine processing step and can also remove other wine components. Alternative absorbents are thus sought; zirconium dioxide (zirconia) is recognised as a promising candidate. The aim of this work was to assess the viability of zirconia treatments to stabilise white wines, with particular attention on process development.
   Methods and Results: Effective treatment was achieved by enclosing zirconia pellets into a metallic cage submerged in the wine. With this method, the wine could be treated with the adsorbent for the time required for protein stabilisation, and then removed without further manipulation. Zirconia treatments of three unstable wines partially or fully stabilised them without detectable modifications of their physicochemical parameters and colours, apart from the removal of metals and some acids, particularly when wines were treated for long times and with high dosages of the adsorbent. A simple and inexpensive zirconia regeneration method was also developed.
   Conclusions: The zirconia application to wine was very effective in removing proteins, and the proposed regeneration procedure could facilitate the uptake and development of zirconia-based solutions for the wine industry.
   Significance of the Study: This study confirmed the effectiveness of zirconia in removing wine proteins and demonstrated that the proposed method of application has the potential to become a viable alternative to bentonite.
C1 [Marangon, M.; Waters, E. J.] Australian Wine Res Inst, Glen Osmond, SA 5064, Australia.
   [Lucchetta, M.] Univ Padua, Dipartimento Biotecnol Agr, CIRVE, I-35020 Legnaro, PD, Italy.
RP Waters, EJ (reprint author), Australian Wine Res Inst, POB 197, Glen Osmond, SA 5064, Australia.
EM elizabeth.waters@awri.com.au
RI Marangon, Matteo/N-2430-2016
OI Marangon, Matteo/0000-0001-5358-2428
FU Australia's grapegrowers and winemakers; Australian Government;
   Provincia di Treviso (Italy); Fondazione Ing.
FX This work was supported financially by Australia's grapegrowers and
   winemakers through their investment body the Grape and Wine Research and
   Development Corporation, with matching funds from the Australian
   Government. The AWRI is a member of the Wine Innovation Cluster located
   in Adelaide. The work of Marco Lucchetta is part of the research
   activity of the 'Dottorato di Ricerca in Viticoltura, Enologia e
   Marketing delle imprese vitivinicole' supported by Provincia di Treviso
   (Italy) and it has been supported in part by the Fondazione Ing. Aldo
   Gini. Leigh Francis, Patricia Osidacz and Belinda Bramley are thanked
   for their help with the sensory evaluation and the sensory panellists
   for assessing the wines. We thank Maurizio Ugliano and Tracey Siebert
   for sulphur compounds analysis, Steve Van Sluyter for helpful
   discussions regarding this work and Antonio Garcia Cordente and Cristian
   Varela for assistance with organic acid analysis. Francisco Lopez,
   Universitat Rovira i Virgili (Spain) is thanked for donating the
   zirconia and Vanessa Stockdale, Foster's Group, Australia for donating
   wines.
CR BAYLY FRANCIS, 1967, AMER J ENOL VITICULT, V18, P18
   Cabello-Pasini A, 2005, AM J ENOL VITICULT, V56, P52
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   de Bruijn J, 2009, INT J FOOD SCI TECH, V44, P330, DOI 10.1111/j.1365-2621.2008.01720.x
   de Bruijn J, 2009, CHIL J AGR RES, V69, P54, DOI 10.4067/S0718-58392009000100007
   HSU JC, 1987, AM J ENOL VITICULT, V38, P17
   Kwiatkowski MJ, 2007, AUST J GRAPE WINE R, V13, P81, DOI 10.1111/j.1755-0238.2007.tb00238.x
   Liu AG, 2005, J COLLOID INTERF SCI, V284, P66, DOI 10.1016/j.jcis.2004.09.034
   Lopes P, 2009, J AGR FOOD CHEM, V57, P10261, DOI 10.1021/jf9023257
   Lubbers S., 1993, Journal International des Sciences de la Vigne et du Vin, V27, P13
   Mallik S, 2006, J COLLOID INTERF SCI, V300, P237, DOI 10.1016/j.jcis.2006.03.047
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Marangon M, 2009, J AGR FOOD CHEM, V57, P4415, DOI 10.1021/jf9000742
   Mesquita PR, 2001, AM J ENOL VITICULT, V52, P324
   Miller GC, 1985, AUSTR GRAPEGROWER WI, V256, P49
   Pachova V, 2002, J FOOD SCI, V67, P2118, DOI 10.1111/j.1365-2621.2002.tb09511.x
   Pashova V, 2004, AM J ENOL VITICULT, V55, P195
   Pashova V, 2004, J AGR FOOD CHEM, V52, P1558, DOI 10.1021/jf034966g
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pocock K. F., 1973, Australian Wine Brewing and Spirit Review, V91, P42
   POWERS JR, 1988, AM J ENOL VITICULT, V39, P117
   Rankine B. C., 1970, Australian Wine, Brewing and Spirit Review, V88, P44
   RIBEREAUGAYON P, 2000, HDB ENOLOGY, V2, P272
   Rovira-Bru M, 2001, J COLLOID INTERF SCI, V235, P70, DOI 10.1006/jcis.2000.7355
   Salazar FN, 2007, J FOOD ENG, V79, P1329, DOI 10.1016/j.jfoodeng.2006.04.035
   Salazar F. N., 2007, THESIS U ROVIRA VIRG
   Salazar FN, 2006, J AGR FOOD CHEM, V54, P9955, DOI 10.1021/jf062632w
   Sarmento MR, 2000, INT J FOOD SCI TECH, V35, P41, DOI 10.1046/j.1365-2621.2000.00340.x
   Saywell LG, 1934, IND ENG CHEM, V26, P981, DOI 10.1021/ie50297a018
   Stichert W, 1998, CHEM MATER, V10, P2020, DOI 10.1021/cm980705o
   Van Sluyter SC, 2009, J AGR FOOD CHEM, V57, P11376, DOI 10.1021/jf902365r
   Vincenzi S, 2005, AM J ENOL VITICULT, V56, P246
   VOILLEY A, 1990, J AGR FOOD CHEM, V38, P248, DOI 10.1021/jf00091a054
   Waters EJ, 2005, AUST J GRAPE WINE R, V11, P215, DOI 10.1111/j.1755-0238.2005.tb00289.x
   WATERS EJ, 1992, J AGR FOOD CHEM, V40, P1514, DOI 10.1021/jf00021a008
   WEETALL HH, 1984, AM J ENOL VITICULT, V35, P212
NR 36
TC 11
Z9 11
U1 1
U2 28
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1322-7130
J9 AUST J GRAPE WINE R
JI Aust. J. Grape Wine Res.
PY 2011
VL 17
IS 1
BP 28
EP 35
DI 10.1111/j.1755-0238.2010.00112.x
PG 8
WC Food Science & Technology; Horticulture
SC Food Science & Technology; Agriculture
GA 711XU
UT WOS:000286626100004
DA 2018-10-20
ER

PT J
AU Heng, BC
   Xia, Y
   Shang, XB
   Preiser, PR
   Law, SKA
   Boey, FYC
   Venkatraman, SS
AF Heng, Boon Chin
   Xia, Yun
   Shang, Xiaobo
   Preiser, Peter Rainer
   Law, S. K. Alex
   Boey, Freddy Yin-Chiang
   Venkatraman, Subbu S.
TI Comparison of the Adhesion and Proliferation Characteristics of HUVEC
   and Two Endothelial Cell Lines (CRL 2922 and CRL 2873) on Various
   Substrata
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE adhesion; CRL 2873; CRL 2922; endothelial; HUVEC; proliferation
ID VASCULAR BIOLOGY; LIVER-TISSUE; INTEGRINS; SCAFFOLDS; ECV304; GROWTH;
   IMMORTALIZATION; POLYMERS; SURFACES; MODEL
AB Endothelial cell coverage of blood-contacting devices is crucial to their eventual success in the clinic. Two established human cell lines derived from HUVEC (human umbilical vascular endothelial cells), CRL 2922 and CRL 2873, have been widely utilized to study and model endothelial cell biology. However, it is not clear if these two cell lines would be useful for modeling primary endothelial cell interaction with newly-formulated biomaterials in tissue engineering applications. Hence, this study was conducted to compare the adhesion and proliferation characteristics of HUVEC grown on seven different substrata, tissue culture polystyrene (TCPS), gelatin, chitosan, poly-L-lysine, hyaluronan, poly-L-lactic acid (PLLA), and polylactic-co-glycolic acid (PLGA). The short-term adhesive behavior (2 h) of HUVEC on the various substrata was not closely-replicated by either CRL 2873 or CRL 2922. This was likely because the 2 h time-frame is too short for identification of differences in the interaction among the three cell types grown on various substrata. There was much faster proliferation of CRL 2922 on all seven substrata when compared to HUVEC and CRL 2873. Moreover, the proliferation rates of CRL 2922 on the various substrata showed little variation. In contrast, HUVEC and CRL 2873 displayed similar trends in proliferation rates, with gelatin and TCPS yielding the highest rates, and PLLA and PLGA yielding the lowest rates. Hence, CRL 2873 is better suited fix modeling primary endothelial cell interaction with newly-formulated biomaterials than CRL 2922. The advantage of using CRL 2873 over HUVEC for biomaterial screening is that it is immortalized and displays much less inter-batch variability than primary culture.
C1 [Heng, Boon Chin; Xia, Yun; Shang, Xiaobo; Boey, Freddy Yin-Chiang; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Preiser, Peter Rainer; Law, S. K. Alex; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
RP Heng, BC (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM alexishengbc@ntu.edu.sg
RI Boey, Freddy Yin Chiang/G-2618-2017; Heng, Boon Chin/E-5462-2016; Law,
   Alex/A-2212-2011; Preiser, Peter/A-2201-2011; Venkatraman,
   Subramanian/A-2228-2011
OI Heng, Boon Chin/0000-0003-2541-3699; Venkatraman,
   Subramanian/0000-0002-8693-1070; , Peter/0000-0003-4331-7000
CR AHN K, 1995, LIFE SCI, V56, P2331, DOI 10.1016/0024-3205(95)00227-W
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006
   Byzova TV, 1998, THROMB HAEMOSTASIS, V80, P726
   Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263
   Campillo-Fernandez AJ, 2009, TISSUE ENG PT A, V15, P1331, DOI 10.1089/ten.tea.2008.0146
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Consigny PM, 2000, J LONG-TERM EFF MED, V10, P79
   Denis CV, 2002, INT J HEMATOL, V75, P3, DOI 10.1007/BF02981972
   Eliceiri BP, 2000, CANCER J, V6, pS245
   FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025
   Gao CY, 2003, J BIOMAT SCI-POLYM E, V14, P937, DOI 10.1163/156856203322381429
   Gifford SM, 2004, J ENDOCRINOL, V182, P485, DOI 10.1677/joe.0.1820485
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Inamori M, 2009, TISSUE ENG PT A, V15, P2029, DOI 10.1089/ten.tea.2008.0403
   Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9
   Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379
   Kiessling F, 1999, CELL TISSUE RES, V297, P131, DOI 10.1007/s004410051340
   Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2
   MacLeod RAF, 1999, INT J CANCER, V83, P555
   Merx MW, 2005, BASIC RES CARDIOL, V100, P208, DOI 10.1007/s00395-005-0516-9
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127
   Risbud MV, 2002, CELL TRANSPLANT, V11, P369, DOI 10.3727/000000002783985837
   SHATTIL SJ, 1995, THROMB HAEMOSTASIS, V74, P149
   Suda K, 2001, IN VITRO CELL DEV-AN, V37, P505
   TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265
   Tanabe H, 1999, TISSUE CULT RES COMM, V18, P329
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456
   Zutter MM, 2007, ADV EXP MED BIOL, V608, P87
NR 32
TC 2
Z9 2
U1 2
U2 13
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD JAN-FEB
PY 2011
VL 16
IS 1
BP 127
EP 135
DI 10.1007/s12257-010-0141-9
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 729OF
UT WOS:000287959500016
DA 2018-10-20
ER

PT J
AU Saraydin, SU
   Bulut, HE
   Ozum, U
   Inan, ZDS
   Polat, ZA
   Yalman, Y
   Saraydin, D
AF Saraydin, Serpil Unver
   Bulut, H. Eray
   Ozum, Unal
   Inan, Z. Deniz Sahin
   Polat, Zubeyde Akin
   Yalman, Yucel
   Saraydin, Dursun
TI Evaluation of the Cytotoxic effects of various monomers In vitro also
   their effects on Apoptosis and GFAP immunolocalization in rat spinal
   cord In vivo
SO HEALTHMED
LA English
DT Article
DE biomaterials; spinal cord; apoptosis; GFAP; TUNEL
ID FIBRILLARY ACIDIC PROTEIN; ACRYLAMIDE TOXICITY; ADDUCT FORMATION;
   DNA-DAMAGE; CELL-DEATH; MALE-MICE; ASTROCYTES; BIOCOMPATIBILITY;
   METABOLISM; EXPRESSION
AB Biomaterials are mostly polymers made by monomers, and are used in artificial organ production in contemporary medicine. They are prepared by the polimerization reaction of certain monomers. The aim of the present study was to investigate whether acrylamide, methacrylamide, N-isopropylacrylamid, acrylic acid, 2-hydroxyethyl methacrylat, 1-vinyl-2-pyrrolidone and ethylene glycol had cytotoxic effects and induce apoptosis or not in spinal cord. Immunolocalization of glial fibrillary acidic protein (GFAP) was also determined, and it was evaluated by using semi-quantitative morphometrical techniques. The cellular process of apoptosis is an important component of tissue and organ development as well as the natural response to disease and injury. Therefore the positive immunohistochemical staining for apoptosis was also examined by TUNEL staining technique. Following the intramuscular injection of aqueous monomer solutions that are prepared in certain concentration, appropriate tissue samples obtained at certain time intervals were fixed in 10% buffered neutral formaline. The cytotoxicity of monomers on cultured fibroblastic cell lines was examined in vitro. Acrylic acid had the most cytotoxic effect when compared to the methacrylamide and the ethylene glycol groups. GFAP immunoreactivity was found to be rather stronger in the methacrylamide than the other monomers application groups. TUNEL positive cell were observed in the methacrylamide, acrylic acid, N-vynil pyrrolidine, acrylamide, N-isopropylacrilamid and 2-hydroxyethyl metacrylad application groups than the other groups. In conclusion, while some monomers used in biomaterial production seemed not to affect the cell viability and GFAP immunoreactivity, some other monomers had adverse effects on those features. This in turn may contribute to the pathological changes associated to the monomer type.
C1 [Saraydin, Serpil Unver; Bulut, H. Eray; Inan, Z. Deniz Sahin] Cumhuriyet Univ, Dept Histol & Embryol, Fac Med, Sivas, Turkey.
   [Ozum, Unal] Cumhuriyet Univ, Dept Neurosurg, Fac Med, Sivas, Turkey.
   [Polat, Zubeyde Akin] Cumhuriyet Univ, Res Ctr, Fac Med, Sivas, Turkey.
   [Yalman, Yucel] Cumhuriyet Univ, Anim Expt Lab, Sivas, Turkey.
   [Saraydin, Dursun] Cumhuriyet Univ, Dept Chem, Sivas, Turkey.
RP Saraydin, SU (reprint author), Cumhuriyet Univ, Fac Med, Dept Histol Embryol, Sivas, Turkey.
EM usaraydin@cumhuriyet.edu.tr
CR Adler ID, 2000, MUTAGENESIS, V15, P133, DOI 10.1093/mutage/15.2.133
   Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054
   Barber DS, 2001, NEUROTOXICOLOGY, V22, P341, DOI 10.1016/S0161-813X(01)00024-9
   Carneiro J., 2003, BASIC HISTOLOGY TEXT
   Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   Gold BG, 2000, EXPT CLIN NEUROTOXIC, P124
   GOODISON KL, 1993, J NEUROPATH EXP NEUR, V52, P192, DOI 10.1097/00005072-199305000-00002
   Kim David H, 2003, Spine J, V3, P510, DOI 10.1016/S1529-9430(03)00117-7
   Lamigeon C, 2001, J NEUROCHEM, V77, P598, DOI 10.1046/j.1471-4159.2001.00278.x
   Lee KY, 2005, ARCH TOXICOL, V79, P531, DOI 10.1007/s00204-005-0656-6
   LEQUESNE PM, 1985, NEUROTOXICOLOGY, V6, P17
   LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247
   MCLENDON RE, 1994, BRAIN PATHOL, V4, P221, DOI 10.1111/j.1750-3639.1994.tb00837.x
   Mendonca JEF, 2004, NUTR NEUROSCI, V7, P223, DOI 10.1080/10284150400010038
   MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201
   Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103
   Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063
   Okuno T, 2006, ARCH TOXICOL, V80, P146, DOI 10.1007/s00204-005-0022-8
   Samuelsen JT, 2008, DENT MATER, V24, P134, DOI 10.1016/j.dental.2007.08.006
   Saraydin D, 2004, NUCL INSTRUM METH B, V217, P281, DOI 10.1016/j.nimb.2003.09.035
   Saraydin D, 2001, J MATER SCI, V36, P2473, DOI 10.1023/A:1017934116229
   SEGA GA, 1990, ENVIRON MOL MUTAGEN, V16, P137, DOI 10.1002/em.2850160302
   Spencer P S, 1974, Can J Neurol Sci, V1, P152
   Sumizawa T, 2007, ARCH TOXICOL, V81, P279, DOI 10.1007/s00204-006-0145-6
   Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k
   TSUDA H, 1993, MUTAGENESIS, V8, P23, DOI 10.1093/mutage/8.1.23
NR 27
TC 3
Z9 3
U1 0
U2 7
PU DRUNPP-SARAJEVO
PI SARAJEVO
PA BOLNICKA BB, SARAJEVO, 71000, BOSNIA & HERCEG
SN 1840-2291
J9 HEALTHMED
JI HealthMED
PY 2011
VL 5
IS 1
BP 17
EP 28
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 727RT
UT WOS:000287819600002
DA 2018-10-20
ER

PT J
AU Schricker, SR
   Palacio, MLB
   Bhushan, B
AF Schricker, Scott R.
   Palacio, Manuel L. B.
   Bhushan, Bharat
TI Protein adhesion of block copolymer surfaces
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE Block copolymers; Atomic force microscopy; Protein adhesion
ID SILICON-BASED SURFACES; ALBUMIN ADSORPTION; BLOOD-PLASMA; BIOMOLECULES;
   MORPHOLOGY; HYDROGELS
AB Atomic force microscopy studies on the adhesion between various novel poly(methyl methacrylate)/poly(acrylic acid)-based block copolymers and the proteins fibronectin and bovine serum albumin are presented for the first time. Random, diblock, and triblock copolymers exhibit distinct adhesion profiles although their chemical compositions are identical, implying that biomaterial nanomorphology can be used to control protein-polymer interactions and potentially cell adhesion.
C1 [Palacio, Manuel L. B.; Bhushan, Bharat] Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
   [Schricker, Scott R.] Ohio State Univ, Restorat & Prosthet Dent Sect, Coll Dent, Columbus, OH 43210 USA.
RP Bhushan, B (reprint author), Ohio State Univ, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
EM Schricker.1@osu.edu; Palacio.1@osu.edu; Bhushan.2@osu.edu
RI Schricker, Scott/A-3957-2008; Bhushan, Bharat/A-9684-2013
OI Schricker, Scott/0000-0003-1982-1282; Bhushan,
   Bharat/0000-0001-7161-6601
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2006, ACTA BIOMATER, V2, P39, DOI 10.1016/j.actbio.2005.08.010
   Bhushan B., 2008, NANOTRIBOLOGY NANOME
   Bhushan B, 2008, J R SOC INTERFACE, V6, P719
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   BOISSONVIDAL C, 1991, J BIOMED MATER RES, V25, P67, DOI 10.1002/jbm.820250106
   BOUGHTON BJ, 1984, BIOCHEM BIOPH RES CO, V119, P1174, DOI 10.1016/0006-291X(84)90899-4
   Bromberg L, 2004, INT J PHARM, V282, P45, DOI 10.1016/j.ijpharm.2004.05.030
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Ibrahim S, 2010, LANGMUIR, V26, P2119, DOI 10.1021/la902677e
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   McFarland CD, 1998, J BIOMAT SCI-POLYM E, V9, P1227, DOI 10.1163/156856298X00749
   MILLER DC, 2006, J BIOMED MATER RES A, V81, P678, DOI DOI 10.1002/JBM.A.31093
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Palacio M, 2010, J MICROSC-OXFORD, V240, P239, DOI 10.1111/j.1365-2818.2010.03420.x
   SANDERS KJ, 1988, ORGANIC POLYM CHEM
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   SMITH BAH, 1993, J BIOMED MATER RES, V27, P89, DOI 10.1002/jbm.820270112
   Snellings GMBF, 2000, ADV MATER, V12, P1959, DOI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Veiseh M, 2002, LANGMUIR, V18, P6671, DOI 10.1021/la025529j
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Yang X., 1998, BIORELATED POLYM GEL
NR 27
TC 4
Z9 4
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD JAN
PY 2011
VL 289
IS 2
BP 219
EP 225
DI 10.1007/s00396-010-2352-1
PG 7
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 718CA
UT WOS:000287096300012
DA 2018-10-20
ER

PT J
AU Fernandez, ICS
   Domingues, JFD
   van Kooten, TG
   Metzger, S
   Grainger, DW
   Busscher, HJ
   van der Mei, HC
AF Fernandez, Isabel C. Saldarriaga
   Domingues, Joana F. Da Silva
   van Kooten, Theo G.
   Metzger, Steve
   Grainger, David W.
   Busscher, Henk J.
   van der Mei, Henny C.
TI MACROPHAGE RESPONSE TO STAPHYLOCOCCAL BIOFILMS ON CROSSLINKED
   POLY(ETHYLENE) GLYCOL POLYMER COATINGS AND COMMON BIOMATERIALS IN VITRO
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE S. epidermidis; macrophages J774; cross-linked poly(ethylene) glycol;
   polymer coatings; biomaterial associated infection; bacteria; adhesion
ID MICROBIAL ADHESION; SERUM-ALBUMIN; INFECTION; BACTERIAL; EPIDERMIDIS;
   IMMOBILIZATION; ATTACHMENT; CHEMISTRY; HYDROGELS; SURFACES
AB Biomaterial-associated-infections (BAI) are serious clinical complications that threaten the longevity of implanted devices and lead to high morbidity and mortality. Poly(ethylene) glycol (PEG) coatings have been studied as a strategy to reduce the incidence of BAI by reducing protein deposition that promotes pathogen adhesion and growth on device surfaces. Despite their effectiveness to reduce protein adsorption and a hundred-fold reduction in bacterial adhesion, PEG-based coatings still facilitate weak bacterial adhesion that can form an initial basis for biofilms. Here, we describe a methodology enabling direct, quantitative and detailed qualitative in situ observation of macrophage morphology, migration and phagocytosis of bacteria. In vitro interaction of macrophages with Staphylococcus epidermidis 3399 adhering to commercial, crosslinked PEG-based coatings (OptiChem (R)) was compared with fluorinated ethylene propylene, silicone rubber and glass. Adhesion, phagocytosis and migration were studied real-time in a parallel-plate-flow-chamber. Macrophages cultured on OptiChem (R) coatings showed enhanced migration and phagocytosis of bacteria compared to common biomaterials. Bacterial clearance per macrophage on both inert and reactive OptiChem (R) coatings were about three times higher than on the common biomaterials studied, corresponding with up to 70% reduction in bacterial numbers on OptiChem (R), whereas on the biomaterials less than 40% bacterial reduction was obtained. These findings show that bacterial clearance from cross-linked PEG-based coatings by macrophages is more effective than from common biomaterials, possibly resulting from weak adhesion of bacteria on Optichem (R). Moreover, macrophages exhibit higher mobility on Optichem (R) retaining an improved capability to clear bacteria from larger areas than from other common biomaterials, where they appear more immobilized.
C1 [Fernandez, Isabel C. Saldarriaga; Domingues, Joana F. Da Silva; van Kooten, Theo G.; Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Fernandez, Isabel C. Saldarriaga; Domingues, Joana F. Da Silva; van Kooten, Theo G.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [Metzger, Steve] Accelr8 Technol Corp, Denver, CO USA.
   [Grainger, David W.] Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Coll Pharm, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn FB 40, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   BUSSCHER HJ, 2009, BIOMATERIALS, V25, P4247
   Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029
   Fernandez ICS, 2007, BIOMATERIALS, V28, P4105, DOI 10.1016/j.biomaterials.2007.05.023
   Fernandez ICS, 2010, ACTA BIOMATER, V6, P1119, DOI 10.1016/j.actbio.2009.08.040
   FITZGERALD RH, 1979, COLLOID SURFACE B, V19, P127
   Godek ML, 2009, J BIOMED MATER RES A, V88A, P503, DOI 10.1002/jbm.a.31886
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Leid J.G., 2009, MICROBE MAGAZINE, V4, P66
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   MAO G, 2005, Patent No. 6844028
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   NELSON CL, 1979, ARCH SURG-CHICAGO, V114, P778
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   OAKES JA, 1986, N ENGL J, V315, P1129
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Takahashi H, 2008, ADV FUNCT MATER, V18, P2079, DOI 10.1002/adfm.200800105
   Wagner VE, 2004, J BIOMED MATER RES A, V69A, P79, DOI 10.1002/jbm.a.20115
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
NR 31
TC 10
Z9 10
U1 4
U2 17
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2011
VL 21
BP 73
EP 79
DI 10.22203/eCM.v021a06
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 725UP
UT WOS:000287671900006
PM 21240846
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Tarafa, PJ
   Williams, E
   Panvelker, S
   Zhang, JZ
   Matthews, MA
AF Tarafa, Pedro J.
   Williams, Eve
   Panvelker, Samir
   Zhang, Jian
   Matthews, Michael A.
TI Removing endotoxin from metallic biomaterials with compressed carbon
   dioxide-based mixtures
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE Endotoxin; Carbon dioxide; Microemulsion; Cleaning; Biomaterial;
   Surfactant
ID FLUORINATED SURFACTANTS; MICROEMULSION FORMATION; SUPERCRITICAL-FLUID;
   CO2 MICROEMULSION; LIPOPOLYSACCHARIDE; WATER; EXTRACTION; STABILITY;
   PRESSURE; AFFINITY
AB Bacterial endotoxins have strong affinity for metallic biomaterials because of surface energy effects. Conventional depyrogenation methods may not eradicate endotoxins and may compromise biological properties and functionality of metallic instruments and implants. We evaluated the solubilization and removal of Escherichia coli endotoxin from smooth and porous titanium (Ti) surfaces and stainless steel lumens using compressed CO(2)-based mixtures having water and/or surfactant Ls-54. The CO(2)/water/Ls-54 ternary mixture in the liquid CO(2) region (25 degrees C and 27.6 MPa) with strong mixing removed endotoxin below detection levels. This suggests that the ternary mixture penetrates and dissolves endotoxins from all the tested substrates. The successful removal of endotoxins from metallic biomaterials with compressed CO(2) is a promising cleaning technology for biomaterials and reusable medical devices. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Williams, Eve; Zhang, Jian; Matthews, Michael A.] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
   [Panvelker, Samir] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.
   [Tarafa, Pedro J.] Univ Puerto Rico, Dept Engn Sci & Mat, Mayaguez, PR 00681 USA.
RP Matthews, MA (reprint author), Swearingen Engn Ctr, 301 Main St, Columbia, SC 29208 USA.
EM matthews@cec.sc.edu
FU National Institutes of Health (NIH) [R01EB55201]; Alfred P. Sloan
   Foundation; South East Alliance for Graduate Education and the
   Professoriate (SEAGEP)
FX The authors acknowledge the National Institutes of Health (NIH) for
   partially supporting this work under a Bioengineering Research
   Partnership grant (R01EB55201). Financial assistance for Pedro J. Tarafa
   was provided by the Alfred P. Sloan Foundation and the South East
   Alliance for Graduate Education and the Professoriate (SEAGEP). The
   helpful comments of Professor James Blanchette and the reviewers are
   greatly appreciated.
CR Adkins SS, 2010, LANGMUIR, V26, P5335, DOI 10.1021/la903663v
   Casas L, 2007, J SUPERCRIT FLUID, V41, P43, DOI 10.1016/j.supflu.2006.09.001
   Eastoe J, 2002, LANGMUIR, V18, P3014, DOI 10.1021/la015576w
   Fukushima Y, 1999, J PHYS CHEM B, V103, P3062, DOI 10.1021/jp984649q
   HAGMAN DE, 2005, REMINGTON SCI PRACTI, P776
   HANK M, 2001, HDB SOLVENTS, P897
   ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1
   JOSLYN L, 1983, DISINFECTION STERILI, P27
   Jung JM, 2009, MICROELECTRON ENG, V86, P165, DOI 10.1016/j.mee.2008.09.006
   Keiper JS, 2004, LANGMUIR, V20, P1065, DOI 10.1021/la034742s
   KUNDSIN RB, 1980, J CLIN MICROBIOL, V11, P209
   Liu JC, 2002, CHEM-EUR J, V8, P1356, DOI 10.1002/1521-3765(20020315)8:6<1356::AID-CHEM1356>3.0.CO;2-N
   Lorinczy D, 2001, THERMOCHIM ACTA, V372, P19, DOI 10.1016/S0040-6031(01)00439-7
   Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.0.CO;2-1
   Maspero FA, 2002, J BIOMED MATER RES, V62, P89, DOI 10.1002/jbm.10212
   Mawson S, 1997, LANGMUIR, V13, P1519, DOI 10.1021/la961017r
   Mukhopadhyay M, 2009, J CHEM TECHNOL BIOT, V84, P6, DOI 10.1002/jctb.2072
   Nagai T, 2003, CHEM LETT, V32, P384, DOI 10.1246/cl.2003.384
   Nagai T, 2007, CHEM LETT, V36, P92, DOI 10.1246/cl.2007.92
   Nelson SK, 1997, J PROSTHET DENT, V77, P76, DOI 10.1016/S0022-3913(97)70210-5
   NIWA M, 1969, J BACTERIOL, V97, P1069
   NOVITSKY TJ, 1985, PDA TECHNICAL REPORT, V7, P93
   OHNO N, 1989, J BIOL CHEM, V264, P4434
   PETERSON KI, 1991, J CHEM PHYS, V94, P106, DOI 10.1063/1.460384
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rybka J, 2008, J SUPERCRIT FLUID, V45, P51, DOI 10.1016/j.supflu.2007.11.011
   Sagisaka M, 2004, LANGMUIR, V20, P2560, DOI 10.1021/la036074g
   Sagisaka M, 2003, LANGMUIR, V19, P220, DOI 10.1021/la020340t
   Sato H, 2000, CHEM PHYS LETT, V323, P257, DOI 10.1016/S0009-2614(00)00508-X
   SWEADNER KJ, 1977, APPL ENVIRON MICROB, V34, P382
   TSUJI K, 1978, APPL ENVIRON MICROB, V36, P710
   TWOHY C W, 1986, Journal of Parenteral Science and Technology, V40, P287
   van Roosmalen MJE, 2003, J SUPERCRIT FLUID, V27, P337, DOI 10.1016/S0896-8446(02)00266-8
   Wiebe R, 1941, CHEM REV, V29, P475, DOI 10.1021/cr60094a004
   WISSBRUN KF, 1954, J PHYS CHEM-US, V58, P693, DOI 10.1021/j150519a004
   Zhang XG, 2007, CLEAN-SOIL AIR WATER, V35, P223, DOI 10.1002/clen.200700007
NR 37
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2011
VL 55
IS 3
BP 1052
EP 1058
DI 10.1016/j.supflu.2010.09.010
PG 7
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 716HF
UT WOS:000286959000024
PM 21499532
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kannan, S
   Goetz-Neunhoeffer, F
   Neubauer, J
   Ferreira, JMF
AF Kannan, Sanjeevi
   Goetz-Neunhoeffer, Friedlinde
   Neubauer, Juergen
   Ferreira, Jose M. F.
TI Cosubstitution of Zinc and Strontium in beta-Tricalcium Phosphate:
   Synthesis and Characterization
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID NEUTRON POWDER DIFFRACTION; CRYSTAL-STRUCTURE ANALYSIS;
   THERMAL-STABILITY; BONE-FORMATION; HYDROXYAPATITES; APATITES; SODIUM;
   RATS
AB The present study aimed at investigating the cosubstitution of two biologically important cations, namely Zn2+ and Sr2+, in the structure of beta-tricalcium phosphate (beta-TCP), a well-known resorbable biomaterial. The formation Zn2+ and Sr2+ cosubstituted beta-Ca(3)(PO(4))(2) has been ensured through aqueous coprecipitation technique that involves the addition of Zn2+ and Sr2+ containing precursors to partially replace Ca2+ in a calcium-deficient apatite composition during the synthesis, followed by heat treating the resultant apatites at 800 degrees C to form single-phase beta-Ca(3)(PO(4))(2). Five different concentrations of single or combined substitution of elements have been investigated and the results were compared with those of pure beta-TCP without any substituted Zn2+ and Sr2+. The obtained materials were characterized by X-ray diffraction, FT-IR, elemental analysis, and Rietveld refinement techniques. The transformation of deficient apatites to Zn2+ and Sr2+ cosubstituted beta-TCP occurred at 800 degrees C and well crystalline beta-TCP materials were formed at 1000 degrees C with the typical rhombohedral structure at hexagonal setting (space group R3c). The Rietveld refinement results revealed gradual decreases in the a-axis and c-axis lattice parameters with increasing concentration levels of Zn2+ and Sr2+ substituted in the lattice of beta-TCP. Zn2+ prefers to occupy the sixfold coordinated Ca (5) site whereas Sr2+ preferentially occupies the ninefold coordinated Ca (4) site of beta-TCP structure.
C1 [Kannan, Sanjeevi; Ferreira, Jose M. F.] Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
   [Goetz-Neunhoeffer, Friedlinde; Neubauer, Juergen] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, D-91054 Erlangen, Germany.
RP Ferreira, JMF (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
EM jmf@ua.pt
OI Ferreira, Jose/0000-0002-7520-2809; Sanjeevi,
   Kannan/0000-0003-2285-4907; Goetz-Neunhoeffer,
   Friedlinde/0000-0002-1163-3271; Neubauer, Juergen/0000-0002-7997-1007
FU CICECO, University of Aveiro; GRICES-DAAD
FX This work was financially supported by CICECO, University of Aveiro and
   GRICES-DAAD.
CR Bandyopadhyay A, 2006, J AM CERAM SOC, V89, P2675, DOI 10.1111/j.1551-2916.2006.01207.x
   Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   DICKENS B, 1974, J SOLID STATE CHEM, V10, P232, DOI 10.1016/0022-4596(74)90030-9
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Gibson I.R., 2000, J MATER SCI-MATER M, V12, P799, DOI DOI 10.1023/A:1008905613182
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   HENCH L, 1993, INTRO BIOCERAMICS
   Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7
   Jumpei A., 1958, B CHEM SOC JPN, V31, P196
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Kannan S, 2006, J AM CERAM SOC, V89, P3277, DOI 10.1111/j.1551-2916.2006.01203.x
   Kannan S, 2006, J MATER CHEM, V16, P286, DOI 10.1039/b511867k
   Kannan S, 2010, ACTA BIOMATER, V6, P571, DOI 10.1016/j.actbio.2009.08.009
   Kannan S, 2009, J AM CERAM SOC, V92, P1592, DOI 10.1111/j.1551-2916.2009.03093.x
   KAY JF, 1988, J BIOMED MATER RES, V22, P1127, DOI 10.1002/jbm.820221206
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   LEMONS LE, 1988, CLIN ORTHOP RELAT R, V235, P220
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Obadia L, 2006, CHEM MATER, V18, P1425, DOI 10.1021/cm052135f
   Otsuka M, 2004, J BIOMED MATER RES A, V69A, P552, DOI 10.1002/jbm.a.30040
   Rawal A, 2008, CHEM MATER, V20, P2583, DOI 10.1021/cm702928h
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Ren FZ, 2009, ACTA BIOMATER, V5, P3141, DOI 10.1016/j.actbio.2009.04.014
   Tas AC, 2007, MAT SCI ENG C-BIO S, V27, P394, DOI 10.1016/j.msec.2006.05.051
   Wei X, 2007, J AM CERAM SOC, V90, P2709, DOI 10.1111/j.1551-2916.2007.01764.x
   Yashima M, 2003, J SOLID STATE CHEM, V175, P272, DOI 10.1016/S0022-4596(03)00279-2
   Young R. A., 1982, BIOL MINERALIZATION, P101
NR 31
TC 20
Z9 20
U1 1
U2 12
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD JAN
PY 2011
VL 94
IS 1
BP 231
EP 236
DI 10.1111/j.1551-2916.2010.04070.x
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 703IR
UT WOS:000285972100033
DA 2018-10-20
ER

PT J
AU Kumar, S
   Narayanan, TSNS
AF Kumar, Satendra
   Narayanan, T. S. N. Sankara
TI Evaluation of corrosion behaviour of Ti-25Mo alloy in chloride medium
SO JOURNAL OF APPLIED ELECTROCHEMISTRY
LA English
DT Article
DE Ti-25Mo alloy; Corrosion; Polarization; Electrochemical impedance
   spectroscopy (EIS)
ID TI-MO ALLOYS; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; TI-15MO
   BIOCOMPATIBLE ALLOYS; MICROSTRUCTURAL EVOLUTION; BIOMEDICAL
   APPLICATIONS; IMPLANT APPLICATION; ZR-FE; TITANIUM; RESISTANCE;
   BIOMATERIAL
AB The corrosion behaviour of Ti-25Mo alloy in 0.9 wt% NaCl was evaluated by potentiodynamic polarization, electrochemical impedance spectroscopy (EIS) and compared with that of commercially pure titanium (CP-Ti). The corrosion behaviour of Ti-25Mo alloy has been reported for the first time in this paper. The microstructure and structural characteristics were also examined using optical microscopy and X-ray diffraction (XRD), respectively. The study reveals that Ti-25Mo alloy possesses a beta-phase microstructure. The Ti-25Mo alloy exhibits higher passivation range, lower average passive current density (i(pass)) and higher charge transfer resistance (R-ct) compared to that of CP-Ti. Based on the corrosion protection ability, Ti-25Mo alloy can be a suitable alternative material for orthopaedic implant applications.
C1 [Kumar, Satendra; Narayanan, T. S. N. Sankara] Natl Met Lab, Madras 600113, Tamil Nadu, India.
RP Narayanan, TSNS (reprint author), Natl Met Lab, CSIR Madras Complex, Madras 600113, Tamil Nadu, India.
EM tsnsn@rediffmail.com
RI Sahu, Anjani/E-7590-2015; TSN, Sankara Narayanan/F-3671-2010
CR Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   BANIA PJ, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P3
   Capela MV, 2008, J ALLOY COMPD, V465, P479, DOI 10.1016/j.jallcom.2007.10.115
   DAVIS R, 1979, J MATER SCI, V14, P712
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Habazaki H, 2003, SURF COAT TECH, V169, P151, DOI 10.1016/S0257-8972(03)00216-0
   Habazaki H, 2002, ELECTROCHIM ACTA, V47, P3837, DOI 10.1016/S0013-4686(02)00319-5
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009
   KOVACS P, 1996, ASTM STP, V1272, P163
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Kumar S, 2009, J ALLOY COMPD, V479, P699, DOI 10.1016/j.jallcom.2009.01.036
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nag S, 2005, J MATER SCI-MATER M, V16, P679, DOI 10.1007/s10856-005-2540-6
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Ramires I, 2002, QUIM NOVA, V25, P10, DOI 10.1590/S0100-40422002000100003
NR 21
TC 8
Z9 8
U1 1
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0021-891X
J9 J APPL ELECTROCHEM
JI J. Appl. Electrochem.
PD JAN
PY 2011
VL 41
IS 1
BP 123
EP 127
DI 10.1007/s10800-010-0210-y
PG 5
WC Electrochemistry
SC Electrochemistry
GA 719YX
UT WOS:000287248500015
DA 2018-10-20
ER

PT J
AU Camilleri, J
AF Camilleri, Josette
TI Characterization of modified calcium-silicate cements exposed to acidic
   environment
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE Calcium silicate cement; Accelerated cements; Acid susceptibility
ID MINERAL TRIOXIDE AGGREGATE; ACCELERATED PORTLAND-CEMENT; END FILLING
   MATERIAL; CARIES-LIKE LESIONS; SEALING ABILITY; PHYSICAL-PROPERTIES;
   MECHANICAL-PROPERTIES; ENDODONTIC USE; PH; MTA
AB Portland cement which is used as a binder in concrete in the construction industry has been developed into a biomaterial. It is marketed as mineral trioxide aggregate and is used in dentistry. This material has been reported to be very biocompatible and thus its use has diversified. The extended use of this material has led to developments of newer versions with improved physical properties. The aim of this study was to evaluate the effect of acidic environments found in the oral cavity on fast setting calcium silicate cements with improved physical properties using a combination of techniques. Two fast setting calcium silicate cements (CSA and CFA) and two cement composites (CSAG and CFAG) were assessed by subjecting the materials to lactic acid/sodium lactate buffer gel for a period of 28 days. At weekly intervals the materials were viewed under the tandem scanning confocal microscope (TSM), and scanning electron microscope (SEM). The two prototype cements exhibited changes in their internal chemistry with no changes in surface characteristics. Since the changes observed were mostly sub-surface evaluation of surface characteristics of cement may not be sufficient in the determination of chemical changes occurring. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Camilleri, Josette] Univ Malta, Fac Built Environm, Dept Bldg & Civil Engn, Msida Msd 2080, Malta.
   [Camilleri, Josette] Univ Malta, Fac Dent Surg, Msida Msd 2080, Malta.
RP Camilleri, J (reprint author), Univ Malta, Fac Built Environm, Dept Bldg & Civil Engn, Msida Msd 2080, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365
FU Commonwealth Scholarship Commission
FX The author gratefully acknowledged the following The Commonwealth
   Scholarship Commission for funding. The late Professor T.R. Pitt Ford
   for his support and guidance. Mr. Gavin Gartshore at Lafarge Special
   Cements section, Nottingham, UK and Dr. Umberto Costa of Italcementi SPA
   Italy for providing the cement samples. Mr. Peter Pilecki of the
   Microscopy Section at the Biomaterials Department at King's College
   London Dental Institute at Guy's, King's and St Thomas' Hospitals,
   London, Mr. Ken Brady and Ms. Fiona Winning of the Center for
   Ultrastructural Imaging King's College, London for their assistance.
CR ABDULLAH D, 2002, BIOMATER, V23, P2001
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   BEYEROLSEN EM, 1981, ORAL SURG ORAL MED O, V51, P320, DOI 10.1016/0030-4220(81)90062-1
   *BRIT STAND I, 2007, 99171 BS EN ISO
   Camilleri J, 2008, INT ENDOD J, V41, P843, DOI 10.1111/j.1365-2591.2008.01435.x
   Camilleri J, 2008, INT ENDOD J, V41, P791, DOI 10.1111/j.1365-2591.2008.01439.x
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2008, INT ENDOD J, V41, P151
   Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x
   Camilleri J, 2008, J MATER SCI-MATER M, V19, P2941, DOI 10.1007/s10856-008-3429-y
   Camilleri J, 2008, DENT MATER, V24, P341, DOI 10.1016/j.dental.2007.06.004
   Dewar J. D., 1999, COMPUTER MODELING CO
   FORD TRP, 1995, ORAL SURG ORAL MED O, V79, P756
   HICKS MJ, 1985, J DENT RES, V64, P1296, DOI 10.1177/00220345850640110901
   HICKS MJ, 1983, J DENT RES, V62, P783, DOI 10.1177/00220345830620070101
   Huang TH, 2008, J ENDODONT, V34, P590, DOI 10.1016/j.joen.2008.02.002
   Islam I, 2006, J ENDODONT, V32, P193, DOI 10.1016/j.joen.2005.10.043
   KIDD EAM, 1979, BRIT DENT J, V147, P39, DOI 10.1038/sj.bdj.4804278
   KIDD EAM, 1986, BRIT DENT J, V160, P345, DOI 10.1038/sj.bdj.4805861
   Kogan P, 2006, J ENDODONT, V32, P569, DOI 10.1016/j.joen.2005.08.006
   LEE SJ, 1993, J ENDODONT, V19, P541, DOI 10.1016/S0099-2399(06)81282-3
   Lee YL, 2007, J DENT RES, V86, P534, DOI 10.1177/154405910708600609
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   Namazikhah MS, 2008, INT ENDOD J, V41, P108
   Odler I, 1999, CEMENT CONCRETE RES, V29, P731, DOI 10.1016/S0008-8846(99)00048-4
   Roy CO, 2001, J ENDODONT, V27, P7, DOI 10.1097/00004770-200101000-00002
   Saghiri MA, 2008, J ENDODONT, V34, P1226, DOI 10.1016/j.joen.2008.07.017
   Santos AD, 2005, INT ENDOD J, V38, P443, DOI 10.1111/j.1365-2591.2005.00963.x
   Saunders WP, 2008, J ENDODONT, V34, P660, DOI 10.1016/j.joen.2008.03.002
   Shie MY, 2009, J ENDODONT, V35, P98, DOI 10.1016/j.joen.2008.09.015
   Silverstone L M, 1988, Quintessence Int, V19, P773
   SILVERSTONE LM, 1967, CARIES RES, V1, P262
   Smith JB, 2007, J ENDODONT, V33, P463, DOI 10.1016/j.joen.2006.12.002
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   TORABINEJAD M, 1997, J ENDODONT, V23, P25
   Torabinejad M., 1995, US Patent, Patent No. [5769638, 5,769,638]
   Watts JD, 2007, J ENDODONT, V33, P970, DOI 10.1016/j.joen.2007.01.024
   Wiltbank KB, 2007, J ENDODONT, V33, P1235, DOI 10.1016/j.joen.2007.06.016
NR 39
TC 6
Z9 6
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD JAN
PY 2011
VL 62
IS 1
BP 70
EP 75
DI 10.1016/j.matchar.2010.10.014
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 722UJ
UT WOS:000287460200009
DA 2018-10-20
ER

PT J
AU Sripriya, R
   Kumar, R
   Balaji, S
   Kumar, MS
   Sehgal, PK
AF Sripriya, R.
   Kumar, Ramadhar
   Balaji, S.
   Kumar, M. Senthil
   Sehgal, P. K.
TI Characterizations of polyanionic collagen prepared by linking additional
   carboxylic groups
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Polyanionic collagen; Succinylation; Amino groups; Transparency;
   Cytoproliferation
ID INFRARED SPECTRUM; AMINO-GROUPS; WATER
AB We have successfully attempted to characterize the polyanionic collagen (PAC) intended for biomaterial and tissue engineering applications. PAC was obtained from type I collagen by chemically linking additional carboxylic groups to the reactive free amino groups. These changes do not affect the a chains morphology and conformation in collagen. Pure type I collagen obtained from bovine Achilles tendons was allowed to react slowly at pH 9 with succinic anhydride to attain 96% conversion into PAC confirmed by trinitrobenzenesulfonic acid (TNBS) assay. Electrophoretic mobility pattern of alpha, beta and gamma components of PAC shifted to higher molecular weight by 16,300 Da indicating modification of collagen. Similarly, FTIR, CD and DSC indicated retention of triple helical conformation of PAC. Novelty of PAC lies in its swelling behavior resulting in dissolution thus offering transparency in neutral pH buffer. The results obtained here give us an opportunity to use PAC as an injectable device for tissue engineering applications as its up-regulatory efficiency for cytoproliferation validates its biocompatibile potentials. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Sripriya, R.; Kumar, Ramadhar; Balaji, S.; Kumar, M. Senthil; Sehgal, P. K.] CSIR, Cent Leather Res Inst, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Sehgal, PK (reprint author), CSIR, Cent Leather Res Inst, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
FU CSIR
FX We are grateful to Dr. A.B. Mandel, Director, CLRI, Chennai for his kind
   permission to publish this work. The authors R.S.P., R.K. and S.B.
   acknowledge the CSIR for financial support in the form of Senior
   Research Associate and Senior Research Fellow.
CR Arnoczky S P, 2000, J Am Acad Orthop Surg, V8, P305
   Bailey AJ, 1999, P INDIAN AS-CHEM SCI, V111, P57
   BELLO J, 1967, BIOCHIM BIOPHYS ACTA, V147, P272, DOI 10.1016/0005-2795(67)90405-9
   Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   BLOOMFIELD SE, 1977, ARCH OPHTHALMOL-CHIC, V95, P247
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   BUCHAIM RL, 2007, CIENC ODONTOL BRAS, V10, P2
   Chrishan SS, 2009, ENDOCRINOLOGY, V145, P4125
   CUNHA EMR, 2008, J MATER SCI-MATER M, V19, P1341
   DEVORE DP, 1989, Patent No. 4851513
   DEVORE DP, 1993, REFRACT CORNEAL SURG, V9, P208
   GORDON PL, 1974, MACROMOLECULES, V7, P954, DOI 10.1021/ma60042a052
   Hadassah J, 2008, OPHTHALMIC RES, V40, P257, DOI 10.1159/000127833
   HADASSAH J, 2010, OPHTHALMIC RES, V43, P85
   HOLLECKER M, 1980, FEBS LETT, V119, P187, DOI 10.1016/0014-5793(80)81027-1
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   Kim SY, 2000, FASEB J, V14, pA519
   Klapper M H, 1972, Methods Enzymol, V25, P531, DOI 10.1016/S0076-6879(72)25050-9
   KOPP J, 1989, Matrix, V9, P443
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU YS, 1992, Patent No. 5163956
   Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2
   MIYATA T, 1976, T AM SOC ART INT ORG, V22, P261
   MIYATA T, 1988, Patent No. 4748152
   MIYATA T, 1970, Patent No. 4164559
   Mossman T. J., 1983, IMMUNOL METHODS, V65, P55
   NEUMAN RE, 1950, J BIOL CHEM, V186, P549
   Noishiki Y, 1998, ARTIF ORGANS, V22, P672, DOI 10.1046/j.1525-1594.1998.06066.x
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   PRAKASH D, 2003, 6 INT M WOUND HEAL W
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Rocha LB, 2004, J BIOMED MATER RES B, V71B, P355, DOI 10.1002/jbm.b.30102
   Sawhney S.K., 2000, INTRO PRACTICAL BIOC
   SILVESTER MF, 1989, THROMB RES, V55, P35
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   SRINIVAS SS, 2001, J BIOMAT SCI-POLYM E, V12, P37
   Sripriya R, 2004, J BIOMED MATER RES B, V70B, P389, DOI 10.1002/jbm.b.30051
   Sripriya R, 2003, J APPL POLYM SCI, V87, P2186, DOI 10.1002/app.11651
   SUSI H, 1971, BIOPOLYMERS, V10, P1597, DOI 10.1002/bip.360100913
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Turel I, 2003, ANAL SCI, V19, P329, DOI 10.2116/analsci.19.329
   Yamazaki M, 1998, ARTIF ORGANS, V22, P873, DOI 10.1046/j.1525-1594.1998.06074.x
NR 43
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD JAN
PY 2011
VL 71
IS 1
BP 62
EP 69
DI 10.1016/j.reactfunctpolym.2010.11.005
PG 8
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 710XX
UT WOS:000286551400008
DA 2018-10-20
ER

PT J
AU Srokowski, EM
   Blit, PH
   McClung, WG
   Brash, JL
   Santerre, JP
   Woodhouse, KA
AF Srokowski, E. M.
   Blit, P. H.
   McClung, W. G.
   Brash, J. L.
   Santerre, J. P.
   Woodhouse, K. A.
TI Platelet Adhesion and Fibrinogen Accretion on a Family of Elastin-Like
   Polypeptides
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Elastin-like polypeptides; blood compatibility; fibrinogen adsorption;
   platelet adhesion
ID SURFACE-MODIFYING MACROMOLECULES; ENDOTHELIAL-CELL ADHESION; PROTEIN
   ADSORPTION; BLOOD COMPATIBILITY; SELF-AGGREGATION; POLYURETHANE;
   HEPARIN; BIOCOMPATIBILITY; THROMBOMODULIN; BIOMATERIAL
AB Previous work in our laboratory showed the potential of using a human recombinant elastin-like polypeptide (ELP) as a thromboresistant coating. In this work we investigate the use of three particular ELPs (ELP1, ELP2 and ELP4), that differ by molecular weight and number of repeating hydrophobic and cross-linking domains, as coatings to improve blood-contacting properties. All three ELPs were passively adsorbed on Mylar surfaces. Differences in water contact angle and surface concentration were found among the three ELP coatings, with the shortest polypeptide, ELP1, being the most hydrophilic and abundant on the surface (55 degrees, 0.76 mu g/cm(2)), followed by ELP2 (55 degrees, 0.35 mu g/cm(2)) and ELP4, the longest of the three (66 degrees, 0.25 mu g/cm(2)), respectively. The blood interactions of the ELP coatings were investigated by measuring fibrinogen adsorption and platelet adhesion in whole blood under laminar flow in a cone and plate viscometer configuration. In general, platelet adhesion to the ELP-coated surfaces was found to correlate with fibrinogen adsorption. Decreases in fibrinogen accretion and platelet adhesion were observed for ELP-coated compared to uncoated surfaces. The magnitude of the decreases was found to depend on the ELP sequence length, with ELP4 exhibiting the lowest levels of fibrinogen adsorption and platelet adhesion at 43 +/- 24 ng/cm(2) and 113 +/- 77 platelets/mm(2), respectively. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Srokowski, E. M.; Blit, P. H.; Santerre, J. P.; Woodhouse, K. A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Srokowski, E. M.; Blit, P. H.; Santerre, J. P.; Woodhouse, K. A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [McClung, W. G.; Brash, J. L.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   [McClung, W. G.; Brash, J. L.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
   [Brash, J. L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L7, Canada.
   [Santerre, J. P.] Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON, Canada.
   [Woodhouse, K. A.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Woodhouse, KA (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
EM dean@appsci.queensu.ca
FU Canadian Institutes of Health Research (CIHR); ARTEC; Province of
   Ontario
FX The authors gratefully acknowledge the supply of the ELPs by Elastin
   Specialties Inc., under a collaborative research initiative through the
   Advanced Regenerative Tissue Engineering Centre (ARTEC) at the
   University of Toronto and Sunnybrook Health Sciences Centre. Funding for
   this research was provided by the Canadian Institutes of Health Research
   (CIHR), ARTEC and the Province of Ontario.
CR Anamelechi CC, 2005, BIOMATERIALS, V26, P6887, DOI 10.1016/.biomaterials.2005.04.027
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BARNES MJ, 1979, HAEMOSTASIS, V8, P158
   BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   CHEN VW, 1999, THESIS U TORONTO TOR
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Dutoya S, 1998, BIOMATERIALS, V19, P147, DOI 10.1016/S0142-9612(97)00214-7
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   Erbil HY, 2006, SURFACE CHEM SOLID L
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Ito S, 1998, ASAIO J, V44, pM501, DOI 10.1097/00002480-199809000-00036
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kielty CM, 2007, PHILOS T R SOC B, V362, P1293, DOI 10.1098/rstb.2007.2134
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Mecham RP, 2008, METHODS, V45, P32, DOI 10.1016/j.ymeth.2008.01.007
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x
   Nakabayashi N, 2003, BIOMATERIALS, V24, P2431, DOI 10.1016/S0142-9612(03)00113-3
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Pham VA, 1999, J APPL POLYM SCI, V73, P1363
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Simnick AJ, 2007, POLYM REV, V47, P121, DOI 10.1080/15583720601109594
   Skarja GA, 1998, BIOMATERIALS, V19, P2129, DOI 10.1016/S0142-9612(98)00045-3
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Stevens KNJ, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/29464
   Tan J, 2008, J BIOMED MATER RES A, V85A, P873, DOI 10.1002/jbm.a.31554
   Tanzi MC, 2005, EXPERT REV MED DEVIC, V2, P473, DOI 10.1586/17434440.2.4.473
   Tieche C, 2004, FRONT BIOSCI, V9, P2205, DOI 10.2741/1391
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Tseng PY, 2006, BIOMATERIALS, V27, P2637, DOI 10.1016/j.biomaterials.2005.10.025
   Werner C, 2007, J MATER CHEM, V17, P3373
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
NR 49
TC 16
Z9 16
U1 3
U2 12
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 1-3
BP 41
EP 57
DI 10.1163/092050609X12578498935594
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 699DO
UT WOS:000285644300003
PM 20546675
DA 2018-10-20
ER

PT J
AU Khurshid, SS
   Schmidt, CE
   Peppas, NA
AF Khurshid, Shahana S.
   Schmidt, Christine E.
   Peppas, Nicholas A.
TI Optimization of Molecularly Imprinted Polymers of Serotonin for
   Biomaterial Applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Molecularly imprinted polymers; methacrylic acid; serotonin;
   cytocompatibility; hyaluronic acid; biomaterial
ID TISSUE ENGINEERING SCAFFOLDS; HYALURONIC-ACID HYDROGELS; RECOGNITIVE
   HYDROGELS; DRUG-DELIVERY; POLYMERIZATION; BEHAVIOR; SYSTEMS; PLASMA
AB We prepared molecularly imprinted polymers (MIPs) of serotonin (5-hydroxytryptamine or 5-HT), a neurotransmitter and mood modulator, using a combination of neutral (methacrylamide or acrylamide) and positively charged (methacrylic acid) functional monomers. Water, PBS, acidified methanol and sodium dodecyl sulfate were compared as rinsing solvents for the removal of serotonin from the MIPs. Methacrylamide MIPs rinsed in acidified methanol (92% serotonin removal) produced the highest imprinting factor (3.1) in equilibrium batch rebinding experiments using a combination of 2% water and 98% MeCN as the rebinding solvent. For the first time, these MIPs were assessed for cytocompatibility using mouse mesencephalon neural progenitor cells (NPC) and NIH 3T3 fibroblasts. Although MIP particles decreased NPC viability to <70%, MIP particles did not significantly reduce fibroblast viability when incorporated into a hyaluronic acid biomaterial. MIP microparticles were incorporated into a cross-linked hyaluronic acid biomaterial to present one way in which molecularly imprinted polymers may be used in vivo in future biomaterials or biosensors applications. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Khurshid, Shahana S.; Schmidt, Christine E.; Peppas, Nicholas A.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Schmidt, Christine E.; Peppas, Nicholas A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Pharmaceut, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas Austin, Dept Biomed Engn, C0800, Austin, TX 78712 USA.
EM peppas@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
FU National Science Foundation [DGE-03-33080]; University of Texas
FX This work was supported in part by a National Science Foundation
   Integrative Graduate Education and Research Traineeship (IGERT)
   fellowship DGE-03-33080 and a University of Texas Thrust Fellowship (to
   S.S.K.).
CR ARSHADY R, 1981, MACROMOL CHEM PHYS, V182, P687
   Baier Leach J, 2004, ENCY BIOMATERIALS BI, P779
   Bereczki A, 2001, J CHROMATOGR A, V930, P31, DOI 10.1016/S0021-9673(01)01190-6
   Bergmann NM, 2008, IND ENG CHEM RES, V47, P9099, DOI 10.1021/ie071270u
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P2
   Dirion B, 2003, J AM CHEM SOC, V125, P15101, DOI 10.1021/ja0355473
   Haupt K, 2000, CHEM REV, V100, P2495, DOI 10.1021/cr990099w
   Hawkins DM, 2005, ANAL CHIM ACTA, V542, P61, DOI 10.1016/j.aca.2005.01.052
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1599, DOI 10.1016/j.addr.2004.04.002
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   KHAING ZZ, 2009, RESTOR NEUROL NEUROS, V27, P1
   Kitade T, 2004, ANAL CHEM, V76, P6802, DOI 10.1021/ac040098q
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Manuck SB, 1999, BIOL PSYCHIAT, V45, P603, DOI 10.1016/S0006-3223(98)00375-8
   Meneses A, 1998, REV NEUROSCIENCE, V9, P275
   Okutucu B, 2008, TALANTA, V76, P1153, DOI 10.1016/j.talanta.2008.05.033
   Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624
   Oral E, 2004, J BIOMED MATER RES A, V68A, P439, DOI 10.1002/jbm.a.20076
   Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201
   Schneider F, 2005, J APPL POLYM SCI, V98, P362, DOI 10.1002/app.22112
   Sellergren B, 2005, ADV DRUG DELIVER REV, V57, P1733, DOI 10.1016/j.addr.2005.07.010
   Spizzirri UG, 2005, CHEM MATER, V17, P6719, DOI 10.1021/cm0478531
   WULFF G, 1982, PURE APPL CHEM, V54, P2093, DOI 10.1351/pac198254112093
NR 28
TC 5
Z9 5
U1 0
U2 20
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 1-3
BP 343
EP 362
DI 10.1163/092050610X486955
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 699DO
UT WOS:000285644300023
PM 20557718
DA 2018-10-20
ER

PT J
AU Sunny, MC
   Vincy, PV
   Kumar, PRA
   Ramesh, P
AF Sunny, M. C.
   Vincy, P. V.
   Kumar, P. R. Anil
   Ramesh, P.
TI Porous composites of hydroxyapatite-filled poly[ethylene-co-(vinyl
   acetate)] for tissue engineering
SO POLYMER INTERNATIONAL
LA English
DT Article
DE bone tissue formation; biomaterial; regeneration;
   poly[ethylene-co-(vinyl acetate)]; hydroxyapatite; cell viability
ID BIODEGRADABLE POLYMER SCAFFOLDS; IN-VITRO; MECHANICAL-PROPERTIES; BONE;
   DEPOSITION; CARTILAGE; OSTEOGENESIS; BIOCERAMICS; FABRICATION;
   MORPHOLOGY
AB A novel porous composite of hydroxyapatite/poly[ethylene-co-vinyl acetate)] (HAP/EVA) having better osteointegration was fabricated by gas foaming technique using a non toxic gas blowing agent intended for bone replacement applications. Combined techniques of scanning electronic microscopy (SEM) and X-ray microcomputed tomography (mu CT) analysis showed that the pore size and pore volume of the porous composite decrease with the increase of HAP content. The gravimetric analysis evidenced for good pore interconnectivity within the porous composites. Energy dispersive X-ray analysis (EDX) studies inveterated the even scattering of Ca ions which in turn indicate the uniform dispersion of HAP particles in the composites. The significant gradation in Ca ion concentration seen in EDX studies is well accordance with the amount of HAP loading in the sample. Mechanical properties of the porous composite having different HAP content were measured to have the compressive strength varying from 1.06 to 2.2 MPa. Non-cytotoxic character of the material was observed by the cytocompatibility studies. The metabolic activity of L929 cells seeded on the material assessed by [3-(4,5-dimethylthiazol)-2-yl]-2,5-diphenyltertrazolium bromide (MTT) assay was found to be 91.8%. The adhesion and migration of the cells inside the pore walls were visualized by confocal microscopy. (C) 2010 Society of Chemical Industry
C1 [Sunny, M. C.; Vincy, P. V.; Ramesh, P.] Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Proc Lab, Thiruvananthapuram 695012, Kerala, India.
   [Kumar, P. R. Anil] Sree Chitra Tirunal Inst Med Sci & Technol, Div Implant Biol, Thiruvananthapuram 695012, Kerala, India.
RP Ramesh, P (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Polymer Proc Lab, Thiruvananthapuram 695012, Kerala, India.
EM rameshsct@yahoo.com
CR Armour AD, 2008, TISSUE ENG PT C-METH, V14, P89, DOI 10.1089/tec.2007.0228
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   Berkland C, 2004, BIOMATERIALS, V25, P5649, DOI 10.1016/j.biomaterials.2004.01.018
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Ducheyne P., 1984, FUNCTIONAL BEHAV ORT
   Gratson GM, 2004, NATURE, V428, P386, DOI 10.1038/428386a
   Hedberg EL, 2005, BIOMATERIALS, V26, P3215, DOI 10.1016/j.biomaterials.2004.09.012
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jhonson HJ, 1983, J BIOMED MATER RES, V17, P571
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Loeser E, ACUTE ORAL TOX UNPUB
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   MB Research Laboratories Inc, AC DERM TOX RA UNPUB
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Oleva A, 1998, BIOMATERIALS, V19, P1019
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Ravaglioli A, 1997, MATER SCI FORUM, V250, P221, DOI 10.4028/www.scientific.net/MSF.250.221
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   SPECTOR M, 1988, CLIN ORTHOP RELAT R, P207
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Velayudhan S, 2000, MATER LETT, V46, P142, DOI 10.1016/S0167-577X(00)00157-9
   Velayudhan S, 2002, J MATER SCI-MATER M, V13, P517, DOI 10.1023/A:1014739326345
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Yen HJ, 2009, TISSUE ENG PT A, V15, P965, DOI 10.1089/ten.tea.2008.0090
   Yeo LY, 2005, BIOMATERIALS, V26, P6122, DOI 10.1016/j.biomaterials.2005.03.033
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 5
Z9 5
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD JAN
PY 2011
VL 60
IS 1
BP 51
EP 58
DI 10.1002/pi.2973
PG 8
WC Polymer Science
SC Polymer Science
GA 702HU
UT WOS:000285886000007
DA 2018-10-20
ER

PT B
AU Xiao, LP
   Shi, ZJ
   Xu, F
   Sun, RC
AF Xiao, Lingping
   Shi, Zhengjun
   Xu, Feng
   Sun, Runcang
BE Wang, L
   Kuang, S
   Hou, Q
   Cao, C
   Si, CL
   Zhang, HJ
TI CHARACTERIZATION AND COMPARISON OF ETHANOL ORGANOSOLV AND ALKALINE
   ORGANOSOLV LIGNINS ISOLATED FROM CARAGANA SINICA
SO 16TH INTERNATIONAL SYMPOSIUM ON WOOD, FIBER AND PULPING CHEMISTRY,
   PROCEEDINGS, VOLS I & II
LA English
DT Proceedings Paper
CT 16th International Symposium on Wood, Fibre and Pulping Chemistry
   (ISWFPC)
CY JUN 08-10, 2011
CL Tianjin, PEOPLES R CHINA
DE caragana sinica; lignin; GPC; HSQC; TGA
ID EUCALYPTUS-GLOBULUS
AB Waste forest products are important sources for bioethanol and biomaterial production. Shrubs of Caragana sinica, planted in the desert region of China to prevent wind erosion and control desertification, generate a large amount of residues. In this study, the ethanol organosolv lignin (EOL) and alkaline organosolv lignin (AOL) were isolated from extractive-free C. sinica. GPC analysis indicated that AOL had a relatively lower molecular weight, but had a higher polydispersity. Results obtained from HSQC NMR spectroscopy showed that AOL had almost three times the abundance of syringyl/guaiacyl ratio when compared to EOL. In addition, AOL possessed a higher amount of beta-O-4' aryl ether linkages (77% against 61%), a higher acylation degree (31% against 9%), and a more stable thermal stability than those of EOL. These results suggested that refinement of C. sinica via alkaline organosolv processes provided a pathway for biorefining of biomass with a high predominance of the syringyl lignin units, together with a higher proportion of beta-O-4' aryl ether linkages, which could potentially contribute to a relatively high reactivity of C. sinica lignin during alkaline pulping.
C1 [Xiao, Lingping; Shi, Zhengjun; Xu, Feng; Sun, Runcang] Beijing Forestry Univ, Inst Biomass Chem & Technol, Beijing 100083, Peoples R China.
   [Sun, Runcang] South China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou 510640, Guangdong, Peoples R China.
RP Sun, RC (reprint author), Beijing Forestry Univ, Inst Biomass Chem & Technol, Beijing 100083, Peoples R China.
EM rcsun3@bjfu.edu.cn
FU Major State Basic Research Projects of China (973) [2010CB732204];
   National Natural Science Foundation of China [30930073]
FX This work was supported by the Major State Basic Research Projects of
   China (973-2010CB732204), and the National Natural Science Foundation of
   China for a key project (30930073).
CR Bose SK, 2009, BIORESOURCE TECHNOL, V100, P1628, DOI 10.1016/j.biortech.2008.08.046
   del Rio JC, 2005, J ANAL APPL PYROL, V74, P110, DOI 10.1016/j.jaap.2004.10.010
   Dominguez JC, 2008, IND CROP PROD, V27, P150, DOI 10.1016/j.indcrop.2007.07.006
   Alriols MG, 2010, CHEM ENG J, V157, P113, DOI 10.1016/j.cej.2009.10.058
   Ibarra D, 2007, J AGR FOOD CHEM, V55, P3477, DOI 10.1021/jf063728t
   Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005
   Oliveira L, 2009, IND CROP PROD, V29, P86, DOI 10.1016/j.indcrop.2008.04.012
   Rencoret J, 2009, HOLZFORSCHUNG, V63, P691, DOI 10.1515/HF.2009.070
   Rencoret J, 2009, IND CROP PROD, V30, P137, DOI 10.1016/j.indcrop.2009.03.004
   Villaverde JJ, 2009, J AGR FOOD CHEM, V57, P6262, DOI 10.1021/jf900483t
NR 10
TC 1
Z9 1
U1 1
U2 1
PU CHINA LIGHT INDUSTRY PRESS
PI BEIJING
PA NO 6 E CHANGAN ST, BEIJING, 100740, PEOPLES R CHINA
BN 978-7-5019-8206-6
PY 2011
BP 204
EP 207
PG 4
WC Chemistry, Multidisciplinary; Materials Science, Paper & Wood
SC Chemistry; Materials Science
GA BH0AD
UT WOS:000394407800042
DA 2018-10-20
ER

PT S
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
BE Brinksmeier, E
   Jawahir, IS
   Meyer, D
TI Surface integrity of magnesium-calcium implants processed by synergistic
   dry cutting-finish burnishing
SO 1ST CIRP CONFERENCE ON SURFACE INTEGRITY (CSI)
SE Procedia Engineering
LA English
DT Proceedings Paper
CT 1st CIRP Conference on Surface Integrity (CSI)
CY JAN 30-FEB 01, 2012
CL Bremen, GERMANY
SP Int Acad Prod Engn (CIRP)
DE Surface integrity; Biomedical; Burnishing; Cutting
ID ALLOYS
AB Biodegradable magnesium-calcium (MgCa) alloy is a very attractive orthopedic biomaterial compared to permanent metallic alloys. However, the critical issue is that MgCa alloy corrodes too fast in the human organism. It is expected that surface integrity of an MgCa implant has significant impact on the corrosion performance. Compared to dry cutting, the synergistic dry cutting-finish burnishing of MgCa0.8 alloy is capable of producing superior surface integrity including good surface finish, high compressive hook-shaped residual stress profile, extended strain hardening in subsurface, and little change of grain size. (C) 2012 Published by Elsevier Ltd. Selection and peer-review under responsibility of Prof. E. Brinksmeier
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Salahshoor, M (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, ADV MATER RES-SWITZ, V22, P67, DOI 10.4028/www.scientific.net/AMR.22.67
   Denkena B., 2004, P 7 INT C MG ALL THE, P895
   Friemuth T, 1999, ADV ENG MATER, V1, P183, DOI 10.1002/(SICI)1527-2648(199912)1:3/4<183::AID-ADEM183>3.3.CO;2-M
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Hassel T, 2007, P 7 INT C MG ALL THE, P789
   Nikitin I, 2008, SCRIPTA MATER, V58, P239, DOI 10.1016/j.scriptamat.2007.09.045
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Pu Z, 2011, SCRIPTA MATER, V65, P520, DOI 10.1016/j.scriptamat.2011.06.013
   Tomac N., 1991, ANN CIRP, V40, P79
   Tonshoff HK, 1997, SURF COAT TECH, V94-5, P610, DOI 10.1016/S0257-8972(97)00505-7
   Tonshoff HK, 2000, MG ALLOYS THEIR APP, P406
   Von Der Hoh N., 2007, ADV ENG MATER, V11, pB47
   Witte F., 2000, CURRENT OPINION SOLI, V12, P63
NR 15
TC 10
Z9 10
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1877-7058
J9 PROCEDIA ENGINEER
PY 2011
VL 19
DI 10.1016/j.proeng.2011.11.114
PG 6
WC Engineering, Mechanical
SC Engineering
GA BYU48
UT WOS:000300398200044
OA Other Gold
DA 2018-10-20
ER

PT S
AU Pegard, NC
   Fleischer, JW
AF Pegard, Nicolas C.
   Fleischer, Jason W.
GP IEEE
TI Contrast Enhancement by Multi-Pass Phase-Conjugation Microscopy
SO 2011 CONFERENCE ON LASERS AND ELECTRO-OPTICS (CLEO)
SE Conference on Lasers and Electro-Optics
LA English
DT Proceedings Paper
CT Conference on Lasers and Electro-Optics (CLEO)
CY MAY 01-06, 2011
CL Baltimore, MD
AB We demonstrate a non-invasive bright field imaging technique that optically enhances contrast for any weakly absorbing object. Results are shown on microscopic biomaterial. All-optical image processing and other filtering capabilities are discussed. (C) 2010 Optical Society of America
C1 [Pegard, Nicolas C.; Fleischer, Jason W.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA.
RP Fleischer, JW (reprint author), Princeton Univ, Dept Elect Engn, Olden St, Princeton, NJ 08544 USA.
EM jasonf@princeton.edu
CR Barsi C, 2009, NAT PHOTONICS, V3, P211, DOI 10.1038/NPHOTON.2009.29
   Dylov DV, 2010, NAT PHOTONICS, V4, P323, DOI 10.1038/NPHOTON.2010.31
   FEINBERG J, 1980, OPT LETT, V5, P330, DOI 10.1364/OL.5.000330
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Scotto P, 2003, OPT LETT, V28, P1695, DOI 10.1364/OL.28.001695
   YARIV A, 1977, OPT COMMUN, V21, P49, DOI 10.1016/0030-4018(77)90075-X
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2160-9020
BN 978-1-55752-910-7
J9 CONF LASER ELECTR
PY 2011
PG 2
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BXB77
UT WOS:000295612401417
DA 2018-10-20
ER

PT B
AU Ambati, BC
   Devery, SM
   Higginbotham, LC
AF Ambati, B. C.
   Devery, S. M.
   Higginbotham, L. C.
GP MEDIMOND
TI Vitamin enriched hydrogels for the Sweet Disease: Type I Diabetes
SO 24TH EUROPEAN CONFERENCE ON BIOMATERIALS
LA English
DT Proceedings Paper
CT 24th Annual European Conference on Biomaterials of the
   European-Society-for-Biomaterials (ESB)
CY SEP 04-08, 2011
CL Network Excellence Funct Biomat (NFB), Dublin, IRELAND
SP European Soc Biomat (ESB), Nanotechnol & Integrated Bioengn Ctr (NIBEC)
HO Network Excellence Funct Biomat (NFB)
AB The aim of this study was to develop a collagen based hydrogel system for the delivery of insulin for type I diabetic patients. Collagen is an attractive biomaterial for tissue engineering and drug delivery. It is highly biocompatible and less immunogenic because of its close resemblance to the extracellular matrix. However non crosslinked collagen exhibits poor mechanical properties, hence the hydrogels were synthesized by photochemical crosslinking technology using the vitamin riboflavin as a photoinitiator. The resulted hydrogels were fully characterized to understand their physico chemical and mechanical properties for delivery of insulin. The results obtained clearly confirms that the riboflavin acts as a good photoinitiator and the cell morphology and viability studies proves that it is non toxic and highly biocompatible.
C1 [Ambati, B. C.; Devery, S. M.; Higginbotham, L. C.] Athlone Inst Technol, Ctr Biopolymer & Biomol Res, Athlone, Westmeath, Ireland.
RP Ambati, BC (reprint author), Athlone Inst Technol, Ctr Biopolymer & Biomol Res, Dublin Rd, Athlone, Westmeath, Ireland.
CR OWENS DAVID R., 2002, NAT REV DRUG DISCOV, V1, P52
   PING L., 2007, DIABETES RES CLIN PR, V78, P1
   Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V82, P9, DOI 10.1016/j.photobiol.2005.08.003
   Varshosaz J, 2007, RECENT PATENTS ENDOC, V1, P25, DOI 10.2174/187221407779814624
NR 4
TC 0
Z9 0
U1 0
U2 3
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-630-2
PY 2011
BP 1
EP 8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFC19
UT WOS:000319162200001
DA 2018-10-20
ER

PT B
AU Rapoport, HS
   Sardon, H
   Herrero-Mendez, A
   Granado, MH
   Castro, B
AF Rapoport, H. S.
   Sardon, H.
   Herrero-Mendez, A.
   Granado, M. H.
   Castro, B.
GP MEDIMOND
TI Assessment of Histogel, a biomaterial derived from Wharton's jelly for
   tissue engineering product applications
SO 24TH EUROPEAN CONFERENCE ON BIOMATERIALS
LA English
DT Proceedings Paper
CT 24th Annual European Conference on Biomaterials of the
   European-Society-for-Biomaterials (ESB)
CY SEP 04-08, 2011
CL Network Excellence Funct Biomat (NFB), Dublin, IRELAND
SP European Soc Biomat (ESB), Nanotechnol & Integrated Bioengn Ctr (NIBEC)
HO Network Excellence Funct Biomat (NFB)
ID COLLAGEN; GLYCOSAMINOGLYCANS
AB Bottom-up approaches in the rational design of synthetic scaffolds rely on understandings of the biological information present in naturally-occurring complex biological materials such as extracellular matrix. Since this is an area not yet fully explored, the naturally occurring scaffolds themselves hold advantages over their synthetic counterparts. The putative utility of a purified Wharton jelly scaffold stems from its complex assemblage of naturally-occurring glycosaminoglycans including hyaluronic acid (HA) and chondroitin sulfate (CS), as well as others. In this simple study we have begun the process of characterizing this interesting biomaterial with potential applications in tissue engineering and regenerative medicine. In addition to strong compositional contributions from HA and CS, we have found a material tunable to a wide range of mechanical properties as well as a substrate favorable to cell growth.
C1 [Rapoport, H. S.; Sardon, H.; Herrero-Mendez, A.; Granado, M. H.; Castro, B.] Histocell SL, Derio, Spain.
RP Rapoport, HS (reprint author), Histocell SL, Derio, Spain.
RI Sardon, Haritz/C-4044-2015
OI Sardon, Haritz/0000-0002-6268-0916
CR Bankowski E, 1996, EUR J OBSTET GYN R B, V66, P109, DOI 10.1016/0301-2115(96)02390-1
   EDMONDS M, DIABETES METAB RE S1, V16, pS51
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Ratner B.D., 2004, BIOMATERIALS SCI
   ROPER-HALL MJ, 1983, T OPHTHAL SOC UK, V103, P275
   Sobolewski K, 1997, BIOL NEONATE, V71, P11
   2002, NURSING, V32, P24
NR 8
TC 0
Z9 0
U1 0
U2 6
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-630-2
PY 2011
BP 15
EP 20
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFC19
UT WOS:000319162200003
DA 2018-10-20
ER

PT B
AU Skagers, A
   Salma, I
   Salms, G
   Pilmane, M
   Vetra, J
   Feldmane, L
   Berzina-Cimdina, L
AF Skagers, A.
   Salma, I
   Salms, G.
   Pilmane, M.
   Vetra, J.
   Feldmane, L.
   Berzina-Cimdina, L.
GP MEDIMOND
TI Reactogenicity of synthetic porous HAp bioceramic materials after
   intraossal and subperiosteal implantation in rabbits
SO 24TH EUROPEAN CONFERENCE ON BIOMATERIALS
LA English
DT Proceedings Paper
CT 24th Annual European Conference on Biomaterials of the
   European-Society-for-Biomaterials (ESB)
CY SEP 04-08, 2011
CL Network Excellence Funct Biomat (NFB), Dublin, IRELAND
SP European Soc Biomat (ESB), Nanotechnol & Integrated Bioengn Ctr (NIBEC)
HO Network Excellence Funct Biomat (NFB)
ID IN-VIVO; BONE; CERAMICS; CELLS
AB For the evaluation of tissue response to intraossal and subperiosteal implantation of Hap porous (porosity average 50 %) ceramic biomaterial produced by the wet precipitation reaction from Ca (OH)(2) and H3PO4, calcinated at the temperature 800 degrees C, pressed in blocks and sintered at 1150 degrees C, and grinded in 0,2 - 0,4 mm granules, was implanted intraossaly and subperiostealy in rabbits. Samples were taken out after two weeks, three and six months. For histologic and immunohistochemical investigation granules in trabecular bone environment mainly was integrated through osseointegration while in subperiosteal site fibrous, cartilage and bone tissue formation around granules mainly as chondrogenesis with enchondral ossification. Higher expression of TGF beta in bone cells surrounding Hap implants and biodegradation of granules by activity of osteoclast like cells was observed.
C1 [Skagers, A.; Salma, I; Salms, G.] Riga Stradins Univ, Dept Oral & Maxillofacial Surg, Riga, Latvia.
   [Vetra, J.] Riga Stradins Univ, Inst Anat & Anthropol, Riga, Latvia.
   [Feldmane, L.] Riga Stradins Univ, Dept Pathol, Riga, Latvia.
   [Berzina-Cimdina, L.] Riga Tech Univ, Ctr Innovat & Dev Biomaterials, Riga, Latvia.
RP Skagers, A (reprint author), Riga Stradins Univ, Dept Oral & Maxillofacial Surg, Riga, Latvia.
EM askagers@latnet.lv
FU European Social Fund within project; Multidisciplinary Research in
   Biomaterials Technology of New Scientist Group [2009/0199/1DP/
   1.1.1.2.0/ 09/APIA/VIAA/090]; RTU [ZP-2010]
FX The work has been supported by the European Social Fund within project,
   Multidisciplinary Research in Biomaterials Technology of New Scientist
   Group", No. 2009/0199/1DP/ 1.1.1.2.0/ 09/APIA/VIAA/090, by the Latvian
   State programm's project VPP 4.5 "New materials and technologies for
   evaluation and substitution of biological tissue" and RTU project No.
   ZP-2010.
CR Annaz B, 2004, J MICROSC-OXFORD, V216, P97, DOI 10.1111/j.0022-2720.2004.01403.x
   Barrere F, 2006, INT J NANOMED, V1, P317
   EYREBROOK AL, 1984, CLIN ORTHOP RELAT R, P300
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Mahajan A, 2012, INT J DENT, V2012
   Manley MT, 2004, 15 YEARS CLIN EXPERI
   Slutskii LI, CELLS MAT, V6, P137
   Ye F, 2007, J MATER SCI-MATER M, V18, P2173, DOI 10.1007/s10856-007-3215-2
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
NR 11
TC 0
Z9 0
U1 0
U2 3
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-630-2
PY 2011
BP 151
EP 155
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFC19
UT WOS:000319162200027
DA 2018-10-20
ER

PT J
AU Li, X
   Petersen, L
   Broderick, S
   Narasimhan, B
   Rajan, K
AF Li, Xue
   Petersen, Latrisha
   Broderick, Scott
   Narasimhan, Balaji
   Rajan, Krishna
TI Identifying Factors Controlling Protein Release from Combinatorial
   Biomaterial Libraries via Hybrid Data Mining Methods
SO ACS COMBINATORIAL SCIENCE
LA English
DT Article
DE polyanhydrides; degradable biomaterials; drug delivery; vaccine
   delivery; drug release kinetics
ID CONTROLLED DRUG-DELIVERY; AIDED DECISION SYSTEMS; NEURAL-NETWORK;
   BIOERODIBLE POLYANHYDRIDES; GENETIC ALGORITHMS; MODEL; MICROSPHERES;
   EROSION; DEVICES; STABILIZATION
AB Polyanhydrides are a class of degradable biomaterials that have shown much promise for applications in drug and vaccine delivery. Their properties can be tailored for controlled drug release, drug/protein stability, and immune regulation (adjuvant effect). Identifying the relationship between the molecular structures of the polymers and the drug release kinetics profiles would help understand the release mechanism and aid in the accurate prediction of drug release and the rational design of polymer-based drug carrier systems. The molecular structure descriptors that had the most impact on the release kinetics were identified using a prediction/optimization data mining approach. Using this new approach for modeling nonlinear release kinetics behavior, we determined that the descriptors which had the greatest effect on the release kinetics were the number of backbone -COO- nonconjugated bonds, the number of aromatic rings, and the number of -CH2- bonds.
C1 [Li, Xue; Petersen, Latrisha; Broderick, Scott; Narasimhan, Balaji; Rajan, Krishna] Iowa State Univ, Inst Combinatorial Discovery, Ames, IA 50011 USA.
   [Li, Xue; Broderick, Scott; Rajan, Krishna] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   [Petersen, Latrisha; Narasimhan, Balaji] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
RP Rajan, K (reprint author), Iowa State Univ, Inst Combinatorial Discovery, 2240 Hoover Hall, Ames, IA 50011 USA.
EM krajan@iastate.edu
RI Narasimhan, Balaji/A-5487-2008
OI Narasimhan, Balaji/0000-0002-7955-5353
FU Office of Naval Research [N00014-06-1-1176]; National Science Foundation
   [CCF-AF:0917202, EEC 0552584, 0851519]
FX The authors acknowledge financial support from the Office of Naval
   Research MURI program for Novel Vaccines: Targeting and Exploiting the
   Bacterial Quorum Sensing Pathway, award number N00014-06-1-1176, and the
   National Science Foundation, under award number CCF-AF:0917202 (K.R.),
   EEC 0552584, and 0851519 (B.N.).
CR Abu Hammad AM, 2009, J CHEM INF MODEL, V49, P978, DOI 10.1021/ci8003682
   Adler AF, 2009, COMB CHEM HIGH T SCR, V12, P634, DOI 10.2174/138620709788923764
   AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Alnajjar F, 2006, INT J NEURAL SYST, V16, P229, DOI 10.1142/S0129065706000640
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Bicerano J., 1996, PREDICTION POLYM PRO
   Carrillo-Conde B, 2010, ACTA BIOMATER, V6, P3110, DOI 10.1016/j.actbio.2010.01.040
   Corbeil CR, 2009, J CHEM INF MODEL, V49, P997, DOI 10.1021/ci8004176
   Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006
   Husseini GA, 2007, TECHNOL CANCER RES T, V6, P49, DOI 10.1177/153303460700600107
   Ibric S, 2003, AAPS PHARMSCITECH, V4, P62
   Kakar M, 2009, COMPUT MED IMAG GRAP, V33, P72, DOI 10.1016/j.compmedimag.2008.10.009
   Kang L, 2009, J COMPUT AID MOL DES, V23, P1, DOI 10.1007/s10822-008-9232-5
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kipper MJ, 2005, MACROMOLECULES, V38, P1989, DOI 10.1021/ma047661r
   Larobina D., 2004, BIOENG FOOD NAT PROD, V48, P2960
   Li BB, 2007, IEEE T SYST MAN CY B, V37, P576, DOI 10.1109/TSMCB.2006.887946
   Lin T, 2009, PHYS MED BIOL, V54, P981, DOI 10.1088/0031-9155/54/4/011
   Lopac SK, 2009, J BIOMED MATER RES B, V91B, P938, DOI 10.1002/jbm.b.31478
   Masotti M, 2009, MED PHYS, V36, P311, DOI 10.1118/1.3049588
   Mazurowski MA, 2008, PHYS MED BIOL, V53, P6079, DOI 10.1088/0031-9155/53/21/013
   Mazurowski MA, 2008, PHYS MED BIOL, V53, P895, DOI 10.1088/0031-9155/53/4/005
   Petersen LK, 2010, ACTA BIOMATER, V6, P3873, DOI 10.1016/j.actbio.2010.04.004
   Petersen LK, 2010, J COMB CHEM, V12, P51, DOI 10.1021/cc900116c
   Petersen LK, 2009, BIOMATERIALS, V30, P5131, DOI 10.1016/j.biomaterials.2009.05.069
   ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6
   Shen E, 2002, J CONTROL RELEASE, V82, P115, DOI 10.1016/S0168-3659(02)00125-6
   Stoica P, 2004, IEEE SIGNAL PROC MAG, V21, P36, DOI 10.1109/MSP.2004.1311138
   Takayama K, 2003, ADV DRUG DELIVER REV, V55, P1217, DOI 10.1016/S0169-409X(03)00120-0
   THOMBRE AG, 1984, BIOMATERIALS, V5, P250, DOI 10.1016/0142-9612(84)90068-1
   Torres M. P., 2006, J BIOMED MATER RES A, P76102
   Torres MP, 2007, BIOMATERIALS, V28, P108, DOI 10.1016/j.biomaterials.2006.08.047
   ul-Haq Z, 2008, J CHEM INF MODEL, V48, P1092, DOI 10.1021/ci8000056
   van der Lee JH, 2008, ISA T, V47, P53, DOI 10.1016/j.isatra.2007.06.003
   Vogel BM, 2005, BIOMATERIALS, V26, P721, DOI 10.1016/j.biomaterials.2004.03.024
   Xi LL, 2010, J COMPUT CHEM, V31, P24, DOI 10.1002/jcc.21279
   Xu Q, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S47
   Yuan XF, 2008, NEURAL PROCESS LETT, V27, P125, DOI 10.1007/s11063-007-9064-7
   Zervakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-53
   Zhang MP, 2003, J PHARM SCI, V92, P2040, DOI 10.1002/jps.10463
   Zhou Y, 2008, IEEE T SYST MAN CY B, V38, P963, DOI 10.1109/TSMCB.2008.922053
   Zou AM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S49
   ZYGOURAKIS K, 1990, CHEM ENG SCI, V45, P2359, DOI 10.1016/0009-2509(90)80116-V
   Zygourakis K, 1996, BIOMATERIALS, V17, P125, DOI 10.1016/0142-9612(96)85757-7
NR 44
TC 14
Z9 15
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2156-8952
EI 2156-8944
J9 ACS COMB SCI
JI ACS Comb. Sci.
PD JAN-FEB
PY 2011
VL 13
IS 1
BP 50
EP 58
DI 10.1021/co100019d
PG 9
WC Chemistry, Applied; Chemistry, Medicinal; Chemistry, Multidisciplinary
SC Chemistry; Pharmacology & Pharmacy
GA 730VH
UT WOS:000288062600009
PM 21247125
OA Green Published
DA 2018-10-20
ER

PT J
AU Nelson, DM
   Ma, ZW
   Fujimoto, KL
   Hashizume, R
   Wagner, WR
AF Nelson, Devin M.
   Ma, Zuwei
   Fujimoto, Kazuro L.
   Hashizume, Ryotaro
   Wagner, William R.
TI Intra-myocardial biomaterial injection therapy in the treatment of heart
   failure: Materials, outcomes and challenges
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Injectable biomaterial; Myocardial infarction; Cardiac tissue
   engineering; Hydrogels; Thermoresponsive polymer
ID LEFT-VENTRICULAR FUNCTION; CARDIAC-SUPPORT DEVICE; RAT INFARCT MODEL;
   ASSEMBLING PEPTIDE NANOFIBERS; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR
   DELIVERY; LONG-TERM OUTCOMES; MYOCARDIAL-INFARCTION; ALGINATE HYDROGELS;
   EXTRACELLULAR-MATRIX
AB Heart failure initiated by coronary artery disease and myocardial infarction (MI) is a widespread, debilitating condition for which there are a limited number of options to prevent disease progression. Intra-myocardial biomaterial injection following MI theoretically provides a means to reduce the stresses experienced by the infarcted ventricular wall, which may alter the pathological remodeling process in a positive manner. Furthermore, biomaterial injection provides an opportunity to concurrently introduce cellular components and depots of bioactive agents. Biologically derived, synthetic and hybrid materials have been applied, as well as materials designed expressly for this purpose, although optimal design parameters, including degradation rate and profile, injectability, elastic modulus and various possible bioactivities, largely remain to be elucidated. This review seeks to summarize the current body of growing literature where biomaterial injection, with and without concurrent pharmaceutical or cellular delivery, has been pursued to improve functional outcomes following MI. The literature to date generally demonstrates acute functional benefits associated with biomaterial injection therapy across a broad variety of animal models and material compositions. Further functional improvements have been reported when cellular or pharmaceutical agents have been incorporated into the delivery system. Despite these encouraging early results, the specific mechanisms behind the observed functional improvements remain to be fully explored and future studies employing hypothesis-driven material design and selection may increase the potential of this approach to alleviate the morbidity and mortality of heart failure. (c) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ma, Zuwei; Fujimoto, Kazuro L.; Hashizume, Ryotaro; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Ma, Zuwei; Fujimoto, Kazuro L.; Hashizume, Ryotaro; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Nelson, Devin M.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
FU National Institutes of Health (NIH) [HL069368, T32-HL076124];
   Commonwealth of Pennsylvania
FX This work was supported by the National Institutes of Health (NIH),
   Grant No. HL069368 and the Commonwealth of Pennsylvania. Mr Nelson was
   supported by NIH training Grant No. T32-HL076124.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   AUGER FA, 1993, BRIT J PLAST SURG, V46, P136, DOI 10.1016/0007-1226(93)90145-2
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998
   Batista R, 1999, Eur J Cardiothorac Surg, V15 Suppl 1, pS12
   BATISTA R, 1999, EUR J CARDIO-THORAC, V15, pS39
   Blom AS, 2005, HEART FAIL REV, V10, P125, DOI 10.1007/s10741-005-4640-2
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2009, REGEN MED, V4, P387, DOI 10.2217/RME.09.2
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dib N, 2010, JACC-CARDIOVASC INTE, V3, P265, DOI 10.1016/j.jcin.2009.12.013
   Dobaczewski M., 2009, J MOL CELL CARDIOL, V48, P504, DOI [10.1016/j.yjmcc.2009.07.015, DOI 10.1016/J.YJMCC.2009.07.015]
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukamachi K, 2005, J CARDIAC SURG, V20, pS43, DOI 10.1111/j.1540-8191.2005.00157.x
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107
   Guan JJ, 2008, BIOMACROMOLECULES, V9, P1283, DOI 10.1021/bm701265j
   Gummert JF, 2004, Z KARDIOL, V93, P849, DOI 10.1007/s00392-004-0160-7
   GUPTA KB, 1994, CIRCULATION, V89, P2315, DOI 10.1161/01.CIR.89.5.2315
   Hale SL, 2008, LIFE SCI, V83, P511, DOI 10.1016/j.lfs.2008.07.020
   Hannan EL, 1999, J AM COLL CARDIOL, V33, P63, DOI 10.1016/S0735-1097(98)00540-3
   Hannan EL, 2005, NEW ENGL J MED, V352, P2174, DOI 10.1056/NEJMoa040316
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hayakawa K, 2003, CIRCULATION, V108, P104, DOI 10.1161/01.CIR.0000074225.62168.68
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jacovella PF, 2008, CLIN INTERV AGING, V3, P161, DOI 10.2147/CIA.S2065
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   John R, 2001, ANN THORAC SURG, V72, P440, DOI 10.1016/S0003-4975(01)02784-9
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kashem A, 2003, J HEART LUNG TRANSPL, V22, P1046, DOI 10.1016/S1053-2498(02)01162-2
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Klodell CT, 2008, J THORAC CARDIOV SUR, V135, P188, DOI 10.1016/j.jtcvs.2007.09.034
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kong HJ, 2002, POLYMER, V43, P6239, DOI 10.1016/S0032-3861(02)00559-1
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Menasche P, 2004, CURR OPIN CARDIOL, V19, P154, DOI 10.1097/00001573-200403000-00016
   Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Muller-Ehmsen J, 2006, J MOL CELL CARDIOL, V41, P876, DOI 10.1016/j.yjmcc.2006.07.023
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Nelson GS, 2000, CIRCULATION, V102, P3053
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Ota T, 2008, CIRCULATION, V118, pS115, DOI 10.1161/CIRCULATIONAHA.107.756049
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   PFEFFER MA, 1987, CIRCULATION, V75, P93
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Sartipy U, 2005, EUR J CARDIO-THORAC, V27, P1005, DOI 10.1016/j.ejcts.2005.01.055
   SCHWINGER RHG, 1994, CIRC RES, V74, P959, DOI 10.1161/01.RES.74.5.959
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   SEIFNARAGHI SB, 2010, TISSUE ENG PART A, V16, P1017
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   Shao ZQ, 2006, CIRC J, V70, P471, DOI 10.1253/circj.70.471
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Sierra DH, 2002, J BIOMED MATER RES, V59, P1
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Simon MA, 2008, ANNU REV BIOMED ENG, V10, P59, DOI 10.1146/annurev.bioeng.9.060906.151856
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Starling RC, 2007, ANN THORAC SURG, V84, P1236, DOI 10.1016/j.athoracsur.2007.03.096
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   TISCHLER MD, 1993, J AM COLL CARDIOL, V22, P751, DOI 10.1016/0735-1097(93)90187-6
   Tomihata K., 1993, POLYM BIOL BIOMEDICA, P275
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Tonnessen T, 2005, EUR J HEART FAIL, V7, P704, DOI 10.1016/j.ejheart.2005.07.005
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   vanZwieten PA, 1997, CARDIOVASC DRUG THER, V10, P693, DOI 10.1007/BF00053026
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang CC, 2008, CARDIOVASC RES, V77, P515, DOI 10.1093/cvr/cvm46
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Wollert KC, 2005, CIRC RES, V96, P151, DOI 10.1161/01.RES.0000155333.69009.63
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhang H, 2007, J THORAC CARDIOV SUR, V134, P1234, DOI 10.1016/j.jtcvs.2007.07.019
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 126
TC 105
Z9 107
U1 3
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 1
EP 15
DI 10.1016/j.actbio.2010.06.039
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300001
PM 20619368
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lynn, AD
   Bryant, SJ
AF Lynn, Aaron D.
   Bryant, Stephanie J.
TI Phenotypic changes in bone marrow-derived murine macrophages cultured on
   PEG-based hydrogels activated or not by lipopolysaccharide
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Macrophage; Phenotype; In vitro; Poly(ethylene glycol); RGD motif
ID POLYETHYLENE-GLYCOL HYDROGELS; FOREIGN-BODY REACTION; IN-VITRO; CELLS;
   EXPRESSION; CYTOKINE; BIOCOMPATIBILITY; BIOMATERIALS; INHIBITION;
   MONOCYTES
AB Macrophages are phenotypically diverse cells performing a number of functions involved in immunity, inflammation, wound healing, tissue homeostasis and the foreign body reaction. In the latter, the type of biomaterial and the surrounding environment likely have an impact on macrophage phenotype and, subsequently, the severity of the reaction. The objectives for this study were to characterize the phenotype of bone marrow-derived murine macrophages in response to poly(ethylene glycol) (PEG)-based hydrogels, a promising class of materials for cell delivery. Gene expression was used as a measure of phenotype and characterized by IL-1 beta, TNF-alpha, iNOS, IL-12 beta, arginase, VEGF-A, and IL-10. Macrophages were cultured on PEG hydrogels, PEG hydrogels with RGD tethers, and medical grade silicone rubber, a well-characterized biomaterial, up to 96 h in the absence and presence of lipopolysaccharide (LPS) to simulate an inflammatory environment. Macrophage interrogation led to immediate up-regulation (10x) of IL-1 beta and TNF-alpha within 4 h, followed by an increase in IL-10/1L-12 beta and a subsequent concomitant decrease in the pro-inflammatory genes by 96 h, suggesting a shift from classically activated to a regulatory phenotype. LPS stimulation led to a stronger early up-regulation of pro-inflammatory genes (e.g. 20-30x for IL-1 beta and TNF-alpha), followed by upregulation (4-6x) of arginase, suggesting a shift from an elevated classically activated to a wound healing phenotype. Material type played a significant role in regulating pro-inflammatory genes, which was most pronounced with PEG alone. Overall, our findings indicate that macrophages undergo similar phenotypic changes for the materials tested, but the magnitudes of these responses are highly material dependent. (c) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lynn, Aaron D.; Bryant, Stephanie J.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
RP Bryant, SJ (reprint author), Univ Colorado, Dept Chem & Biol Engn, 1111 Engn Dr,ECCH 111,UCB 424, Boulder, CO 80309 USA.
EM stephanie.bryant@colorado.edu
FU National Institutes of Health [1R03DE019505]; Department of Education
FX This project was supported by award no. 1R03DE019505 from the National
   Institutes of Health. Additional financial support was provided by a
   Department of Education Graduate Assistant-ships in Areas of National
   Need fellowship to A.D.L.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   ANDERSON JM, 1983, ABSTR PAP AM CHEM S, V185, P99
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   ERICKSON C, 1989, CLIN IMMUNOLOGY, P27
   Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   HAMILTON TA, 2002, MACROPHAGE, P73
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Kim JB, 2007, BIOL PHARM BULL, V30, P2345, DOI 10.1248/bpb.30.2345
   Kumar V., 2005, ROBBINS COTRAN PATHO
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Ma WY, 2010, IMMUNOLOGY, V130, P399, DOI 10.1111/j.1365-2567.2009.03239.x
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mason MN, 2009, TISSUE ENG PT A, V15, P1343, DOI 10.1089/ten.tea.2008.0290
   Moon C, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-18
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Naim JO, 1998, COLLOID SURFACE B, V11, P79, DOI 10.1016/S0927-7765(98)00023-X
   Nicodemus GD, 2008, J BIOMECH, V41, P1528, DOI 10.1016/j.jbiomech.2008.02.034
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Shi HP, 2001, SURGERY, V130, P225, DOI 10.1067/msy.2001.115837
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 36
TC 21
Z9 21
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 123
EP 132
DI 10.1016/j.actbio.2010.07.033
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300011
PM 20674808
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Greulich, C
   Diendorf, J
   Simon, T
   Eggeler, G
   Epple, M
   Koller, M
AF Greulich, C.
   Diendorf, J.
   Simon, T.
   Eggeler, G.
   Epple, M.
   Koeller, M.
TI Uptake and intracellular distribution of silver nanoparticles in human
   mesenchymal stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silver nanoparticles; Human mesenchymal stem cells; Cellular uptake;
   Focused ion beam; Fluorescence microscopy
ID GOLD NANOPARTICLES; UPTAKE MECHANISM; MAMMALIAN-CELLS; GENE DELIVERY;
   ENDOCYTOSIS; PATHWAYS; RELEASE; FATE
AB Silver nanoparticles (Ag-NP) are widely used due to their well-known antibacterial effects. In medicine Ag-NP have found applications as wound dressings, surgical instruments and bone substitute biomaterials, e.g. silver-containing calcium phosphate cements. Depending on the coating technique, during resorption of a biomaterial Ag-NP may come into close contact with body tissues, including human mesenchymal stem cells (hMSC). Despite the widespread uses of Ag-NP, there is a serious lack of information concerning their biological effects on human cells. In this study the uptake of Ag-NP into hMSC has been analyzed and the intracellular distribution of Ag-NP after exposure determined. Non-agglomerated (dispersed) Ag-NP from the cell culture medium were detected as agglomerates of nanoparticles within the hMSC by combined focused ion beam/scanning electron microscopy. The silver agglomerates were typically located in the perinuclear region, as determined by light microscopy. Specific staining of cellular structures (endo-lysosomes, nuclei, Golgi complex and endoplasmatic reticulum) using fluorescent probes showed that the silver nanoparticles occurred mainly within endo-lysosomal structures, not in the cell nucleus, endoplasmic reticulum or Golgi complex. Quantitative determination of the uptake of Ag-NP by flow cytometry (scattergram analysis) revealed a concentration-dependent uptake of the particles which was significantly inhibited by chlorpromazine and wortmannin but not by nystatin, indicating clathrin-dependent endocytosis and macropinocytosis as the primary uptake mechanisms. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Greulich, C.; Koeller, M.] Ruhr Univ Bochum, Bergmannsheil Univ Hosp Surg Res, D-44789 Bochum, Germany.
   [Diendorf, J.; Epple, M.] Univ Duisburg Essen, Ctr Narointegrat Duisburg Essen, D-45117 Essen, Germany.
   [Simon, T.; Eggeler, G.] Ruhr Univ Bochum, Fac Mech Engn, Inst Mat, D-44789 Bochum, Germany.
RP Greulich, C (reprint author), Ruhr Univ Bochum, Bergmannsheil Univ Hosp Surg Res, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
EM christina.greulich@rub.de
RI Eggeler, Gunther/R-9833-2016
OI Eggeler, Gunther/0000-0002-6671-4618
FU Deutsche Forschungsgemeinschaft [SPP1313]
FX We thank the Deutsche Forschungsgemeinschaft for financial support of
   this project within the Priority Program NanoBioResponses (SPP1313). We
   thank Prof. R. Zellner and Dr. L. Treuel for helpful discussions.
   Moreover, we would like to thank Dr. T. Habijan for helpful assistance
   with the FIB/SEM experiments.
CR Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015
   Alberts B, 2002, MOL BIOL CELL
   AshaRani PV, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-65
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Berry CC, 2007, IEEE T NANOBIOSCI, V6, P262, DOI 10.1109/TNB.2007.908973
   Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057
   Chang MY, 2008, CANCER SCI, V99, P1479, DOI 10.1111/j.1349-7006.2008.00827.x
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123
   Frohlich E, 2009, J TOXICOL SCI, V34, P363
   Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135
   Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005
   Hu L, 2009, J MATER CHEM, V19, P3108, DOI 10.1039/b815958k
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Kittler S, 2010, J MATER CHEM, V20, P512, DOI 10.1039/b914875b
   Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018
   Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com
   Panyam J, 2003, PHARMACEUT RES, V20, P212, DOI 10.1023/A:1022219003551
   Pelka J, 2009, CHEM RES TOXICOL, V22, P649, DOI 10.1021/tx800354g
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034
   Suzuki H, 2007, ENVIRON SCI TECHNOL, V41, P3018, DOI 10.1021/es0625632
   Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269
   Wang HS, 2005, COLLOID SURFACE A, V256, P111, DOI 10.1016/j.colsurfa.2004.12.058
NR 32
TC 187
Z9 190
U1 6
U2 147
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 347
EP 354
DI 10.1016/j.actbio.2010.08.003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300033
PM 20709196
DA 2018-10-20
ER

PT J
AU Hindie, M
   Degat, MC
   Gaudiere, F
   Gallet, O
   Van Tassel, PR
   Pauthe, E
AF Hindie, Mathilde
   Degat, Marie-Christelle
   Gaudiere, Fabien
   Gallet, Olivier
   Van Tassel, Paul R.
   Pauthe, Emmanuel
TI Pre-osteoblasts on poly(L-lactic acid) and silicon oxide: Influence of
   fibronectin and albumin adsorption
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibronectin; Protein adsorption; Pre-osteoblasts; Cell adhesion; Cell
   differentiation
ID QUARTZ-CRYSTAL MICROBALANCE; IN-VITRO BEHAVIOR; PROTEIN ADSORPTION;
   CELL-ADHESION; PLASMA FIBRONECTIN; SURFACE MODIFICATION; BIOACTIVE
   GLASS; FILMS; CONFORMATION; ATTACHMENT
AB Cell adhesion and subsequent viability are critical initial steps in biomaterial-tissue integration and are strongly dependent on the material properties and the presence of matrix proteins. In the present study MC3T3-E1 osteoblast-like cell behavior on silicon oxide (SO) and poly(L-lactic acid) (PLLA) substrates has been examined, with a focus on the influence of the adhesive protein fibronectin and the non-adhesive protein albumin adsorbed on the substrates. Quartz crystal microgravimetry showed adsorption of fibronectin and albumin to be nearly identical on SO and PLLA. Subsequent exposure a previously adsorbed fibronectin layer to albumin decreased the rigidity of the adsorbed layer without any measurable increase in adsorbed mass. Cell adhesion and spreading were significantly enhanced on both SO and PLLA substrates coated with fibronectin or with fibronectin and albumin, compared with uncoated or albumin-coated substrates. The only statistically significant difference between the two substrates in these assays was increased spreading on PLLA compared with SO in the presence of fibronectin and albumin. Cell proliferation was significantly higher on SO compared with PLLA after 7 days culture, but depended on the presence of fibronectin only in the PLLA system. In contrast, mitochondrial activity was higher on PLLA than on SO, and was enhanced by fibronectin on both substrates. PLLA substrates coated with fibronectin and subsequently exposed to albumin exhibited the highest level of cell differentiation, as assayed via alkaline phosphatase activity. These results demonstrate the importance of adsorbed proteins on osteoblast-like cell-surface interactions. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Van Tassel, Paul R.; Pauthe, Emmanuel] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
   [Hindie, Mathilde; Degat, Marie-Christelle; Gaudiere, Fabien; Gallet, Olivier; Van Tassel, Paul R.; Pauthe, Emmanuel] Univ Cergy Pontoise, ERRMECe, F-95302 Cergy Pontoise, France.
RP Pauthe, E (reprint author), Yale Univ, Dept Chem & Environm Engn, 9 Hillhouse Ave, New Haven, CT 06520 USA.
EM emmanuel.pauthe@yale.edu
RI Van Tassel, Paul/D-1087-2017
OI Gaudiere, Fabien/0000-0002-4932-3439
CR Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Balasundaram G, 2006, J MATER CHEM, V16, P3737, DOI 10.1039/b604966b
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Chen Y, 2008, J MATER SCI-MATER M, V19, P2261, DOI 10.1007/s10856-007-3335-8
   Martinez EC, 2008, TISSUE ENG PT A, V14, P1751, DOI 10.1089/ten.tea.2007.0270
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ikarashi Y, 2000, BIOMATERIALS, V21, P1259, DOI 10.1016/S0142-9612(00)00008-9
   Ikarashi Y, 2000, BIOL PHARM BULL, V23, P1470
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Jadlowiec JA, 2003, EXPERT OPIN BIOL TH, V3, P409, DOI 10.1517/14712598.3.3.409
   Joukainen A, 2007, J ORTHOP SCI, V12, P28, DOI 10.1007/s00776-006-1077-y
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Koblinski JE, 2005, J CELL SCI, V118, P2965, DOI 10.1242/jcs.02411
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Lubarsky GV, 2007, BIOSENS BIOELECTRON, V22, P1275, DOI 10.1016/j.bios.2006.05.024
   Lubarsky GV, 2005, COLLOID SURFACE B, V44, P56, DOI 10.1016/j.colsurfb.2005.05.010
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Meseguer-Olmo L, 2008, ACTA BIOMATER, V4, P1104, DOI 10.1016/j.actbio.2007.11.001
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Nelea V, 2010, J STRUCT BIOL, V170, P50, DOI 10.1016/j.jsb.2010.01.009
   Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104
   Patel S, 2006, INT J BIOCHEM CELL B, V38, P1547, DOI 10.1016/j.biocel.2006.03.005
   Pauthe E, 2002, BBA-PROTEIN STRUCT M, V1597, P12, DOI 10.1016/S0167-4838(02)00271-6
   Pellenc D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051904
   Pellenc D, 2006, J COLLOID INTERF SCI, V298, P132, DOI 10.1016/j.jcis.2005.11.059
   Pelta J, 2000, BIOCHEMISTRY-US, V39, P5146, DOI 10.1021/bi992770x
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Tanaka Y, 2010, BIOMATERIALS, V31, P4506, DOI 10.1016/j.biomaterials.2010.02.028
   Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Vallet-Regi M, 2003, J BIOMED MATER RES A, V67A, P674, DOI 10.1002/jbm.a.10159
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
NR 64
TC 16
Z9 16
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 387
EP 394
DI 10.1016/j.actbio.2010.08.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300037
PM 20692384
DA 2018-10-20
ER

PT J
AU Huang, L
   Cao, Z
   Meyer, HM
   Liaw, PK
   Garlea, E
   Dunlap, JR
   Zhang, T
   He, W
AF Huang, L.
   Cao, Z.
   Meyer, H. M.
   Liaw, P. K.
   Garlea, E.
   Dunlap, J. R.
   Zhang, T.
   He, W.
TI Responses of bone-forming cells on pre-immersed Zr-based bulk metallic
   glasses: Effects of composition and roughness
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bulk metallic glass; Biocompatibility; Pre-immersion; Surface roughness;
   Osteoblast
ID OSTEOBLAST-LIKE CELLS; BIOMATERIAL SURFACES; PROTEIN ADSORPTION;
   AMORPHOUS-ALLOYS; TITANIUM-ALLOY; BEHAVIOR; CORROSION; CYTOTOXICITY;
   RESISTANCE; CHEMISTRY
AB Bulk metallic glasses (BMGs) demonstrate attractive properties for potential biomedical applications, owing to their amorphous structure. The present work has investigated the biocompatibility of Zr-based BMGs by studying the cellular behavior of bone-forming mouse MC3T3-E1 pre-osteoblast cells. A Ti-6Al-4V alloy was used as a reference material. Pre-immersion treatment was performed on BMG samples in phosphate-buffered saline prior to cell experiments. The effects of 1 at.% yttrium alloying and surface roughness on cellular behavior were examined. The general biosafety of Zr-based BMGs for MC3T3-E1 cells was revealed as normal cell responses. Pre-immersion treatment was found to effectively reduce the surface concentrations of alloying elements. Micro-alloying with 1 at.% yttrium did not significantly affect cell adhesion and proliferation, but slightly decreased alkaline phosphatase (ALP) activity on rough surfaces. Lower cell adhesion and proliferation were found on smooth surfaces of Zr-based BMGs compared to their rougher counterparts. Higher ALP activity was detected on rougher surfaces. To obtain a mechanistic understanding surface free energy was correlated with cell adhesion. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Huang, L.; Zhang, T.] Beijing Univ Aeronaut & Astronaut, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
   [Huang, L.; Cao, Z.; Liaw, P. K.; Garlea, E.; He, W.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   [Meyer, H. M.] Oak Ridge Natl Lab, Microscopy Grp, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA.
   [Dunlap, J. R.] Univ Tennessee, Div Biol Sci, Knoxville, TN 37996 USA.
   [He, W.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
RP Zhang, T (reprint author), Beijing Univ Aeronaut & Astronaut, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
EM zhangtao@buaa.edu.cn; whe5@utk.edu
RI Meyer, Harry/G-6949-2017; Zhang, Tao/O-4911-2014; Huang, Lu/L-4643-2013;
   BAI, JIE/D-7448-2016; Huang, Lu/H-5325-2012; He, Wei/K-7218-2013
OI Meyer, Harry/0000-0003-4994-1664; Huang, Lu/0000-0001-8318-2687; Huang,
   Lu/0000-0001-8318-2687; He, Wei/0000-0002-6638-9691
FU National Science Foundation [DMR-0231320]; National Nature Science
   Foundation of China [50771005, 50631010]; Scientific User Facilities
   Division, Office of Basic Energy Sciences, US Department of Energy
FX The authors are grateful to Drs. Scott C. Lenaghan and David A. Gerard
   for their kind suggestions on SEM fixation procedures and Mr. Sameer
   Paital for his assistance in contact angle tests. This work was
   financially supported by the National Science Foundation International
   Materials Institutes Program (DMR-0231320) and National Nature Science
   Foundation of China (Grants Nos. 50771005 and 50631010). Research at the
   Oak Ridge National Laboratory SHaRE User Facility was sponsored by the
   Scientific User Facilities Division, Office of Basic Energy Sciences, US
   Department of Energy.
CR Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chrzanowski W, 2008, ACTA BIOMATER, V4, P1969, DOI 10.1016/j.actbio.2008.05.010
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Demetriou MD, 2010, JOM-US, V62, P83, DOI 10.1007/s11837-010-0038-2
   Gebert A, 1999, MAT SCI ENG A-STRUCT, V267, P294, DOI 10.1016/S0921-5093(99)00105-7
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hiromoto S, 2002, J ELECTROCHEM SOC, V149, pB117, DOI 10.1149/1.1456921
   Huang L, 2009, INTERMETALLICS, V17, P195, DOI 10.1016/j.intermet.2008.07.020
   Inoue A, 2008, REV ADV MATER SCI, V18, P1
   Johnson WL, 1999, MRS BULL, V24, P42, DOI 10.1557/S0883769400053252
   KHRUSCHOV MM, 1974, WEAR, V28, P69, DOI 10.1016/0043-1648(74)90102-1
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2009, INTERMETALLICS, V17, P235, DOI 10.1016/j.intermet.2008.07.022
   Liu YH, 2007, SCIENCE, V315, P1385, DOI 10.1126/science.1136726
   Loffler JF, 2003, INTERMETALLICS, V11, P529, DOI 10.1016/S0966-9795(03)00046-3
   Luo J, 2006, MATER TRANS, V47, P450, DOI 10.2320/matertrans.47.450
   Ma MZ, 2004, MAT SCI ENG A-STRUCT, V386, P326, DOI 10.1016/j.msea.2004.07.054
   Miller M. K., 2008, BULK METALLIC GLASSE
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Mudali UK, 2004, J ALLOY COMPD, V377, P290, DOI 10.1016/j.jallcom.2004.01.043
   Ochsenbein A, 2008, ACTA BIOMATER, V4, P1506, DOI 10.1016/j.actbio.2008.03.012
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Sato M, 2006, BIOMATERIALS, V27, P2358, DOI 10.1016/j.biomaterials.2005.10.041
   Schroers J, 2004, J APPL PHYS, V96, P7723, DOI 10.1063/1.1818355
   Schroers J, 2008, ACTA MATER, V56, P471, DOI 10.1016/j.actamat.2007.10.008
   Schroers J, 2010, ADV MATER, V22, P1566, DOI 10.1002/adma.200902776
   Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1
   Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052
   SERRO AP, 1999, J BIOMED MATER RES, V46, P376
   Stansbury E. E., 2000, FUNDAMENTALS ELECTRO
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang GY, 2009, INTERMETALLICS, V17, P579, DOI 10.1016/j.intermet.2009.01.017
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wise D.L., 1996, HUMAN BIOMATERIALS A
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Yaszemsk M.J., 2004, BIOMATERIALS ORTHOPE
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhang ZY, 2007, J MATER RES, V22, P364, DOI 10.1557/JMR.2007.0040
NR 50
TC 70
Z9 73
U1 4
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 395
EP 405
DI 10.1016/j.actbio.2010.08.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300038
PM 20709197
DA 2018-10-20
ER

PT J
AU Dong, Y
   Li, X
   Tian, L
   Bell, T
   Sammons, RL
   Dong, H
AF Dong, Y.
   Li, X.
   Tian, L.
   Bell, T.
   Sammons, R. L.
   Dong, H.
TI Towards long-lasting antibacterial stainless steel surfaces by combining
   double glow plasma silvering with active screen plasma nitriding
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wear resistance; Silver; Antimicrobial; Surface free energy; Attachment
   and adhesion
ID RESISTANT STAPHYLOCOCCUS-AUREUS; CO-CR; ADHESION; COPPER; FILMS;
   MICROORGANISMS; ENVIRONMENT; MECHANISMS; DRESSINGS; ADHERENCE
AB Antibacterial surface modification of biomedical materials has evolved as a potentially effective method for preventing bacterial proliferation on the surfaces of devices. However, thin antibacterial coatings or modified layers can be easily worn down when interacting with other surfaces in relative motion, thus leading to a low durability of the antibacterial surface. To this end, novel biomaterial surfaces with antibacterial Ag agents and a wear-resistant S-phase have been generated on stainless steel by duplex plasma silvering-nitriding techniques for application to load-bearing medical devices. The chemical composition, microstructure, surface topography, roughness and wettability of SS surfaces were characterised using glow discharge optical emission spectroscopy, energy-dispersive spectroscopy/wavelength dispersive spectrometry (WDS), X-ray diffraction, atomic force microscopy and a contact angle goniometer. Optimal surface design for high antimicrobial activity and prolonged durability has been achieved, as evidenced by rapid bacterial killing rates (within 6 h), an ultra hard matrix (875 +/- 25 Hv), high load-bearing capacity (critical load 37 N) and excellent wear resistance (wear rate 4.9 x 10(-6) mm(3) m(-1)). Ag embedded in the hard substrate of fcc compounds M4N (M = Fe, Cr, Ag, etc.) and the expanded fcc nitrogen S-phase shows deep infiltration of 6 +/- 1 mu m, and provides bactericidal activity against both Gram-negative Escherichia coli NCTC 10418 and Gram-positive Staphylococcus epidermidis NCTC 11047 of over 97% and 90%, respectively, within 6 h. The presence of silver in the surface before and after scratching under a progressive load applied up to 60 N using a diamond stylus was confirmed by WDS. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dong, Y.; Li, X.; Bell, T.; Dong, H.] Univ Birmingham, Sch Met & Mat, Birmingham B15 2TT, W Midlands, England.
   [Tian, L.] Taiyuan Univ Technol, Inst Surface Engn, Taiyuan 030024, Peoples R China.
   [Sammons, R. L.] Univ Birmingham, Sch Dent, Birmingham B4 6NN, W Midlands, England.
RP Dong, Y (reprint author), Univ Birmingham, Sch Met & Mat, Birmingham B15 2TT, W Midlands, England.
EM dongyangchun@hotmail.com
OI Sammons, Rachel/0000-0002-4787-048X; Li, Xiaoying/0000-0001-6449-1505
FU EPSRC UK [EP/F006926/1]; ORSAS award; School of Metallurgy and
   Materials, University of Birmingham; Engineering and Physical Sciences
   Research Council [EP/F006926/1]
FX This project was sponsored by the EPSRC UK (EP/F006926/1). H.D.
   gratefully acknowledges an ORSAS award and a School of Metallurgy and
   Materials, University of Birmingham studentship.
CR Bai XA, 2010, ACTA BIOMATER, V6, P2264, DOI 10.1016/j.actbio.2009.12.002
   Bowden F. P., 1950, FRICTION LUBRICATION
   BUHAGIAR J, 2007, SURFACE MODIFICATION, V21, P509
   BULL SJ, 1988, SURF COAT TECH, V36, P503, DOI 10.1016/0257-8972(88)90178-8
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005
   Davies RL, 1997, CATAL TODAY, V36, P107, DOI 10.1016/S0920-5861(96)00203-9
   Ding XG, 2005, KEY ENG MAT, V280-283, P801, DOI 10.4028/www.scientific.net/KEM.280-283.801
   Dong H, 2010, INT MATER REV, V55, P65, DOI 10.1179/095066009X12572530170589
   Dong YC, 2010, J BIOMED MATER RES B, V93B, P185, DOI 10.1002/jbm.b.31573
   Francolini I, 2010, ACTA BIOMATER, V6, P3482, DOI 10.1016/j.actbio.2010.03.042
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Gallo SC, 2009, VACUUM, V84, P321, DOI 10.1016/j.vacuum.2009.07.002
   Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Holmberg K, 1998, TRIBOL INT, V31, P107, DOI 10.1016/S0301-679X(98)00013-9
   Hood SK, 1997, INT J FOOD MICROBIOL, V37, P145, DOI 10.1016/S0168-1605(97)00071-8
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Kui XY, 2007, SURF COAT TECH, V201, P5302, DOI 10.1016/j.surfcoat.2006.07.125
   Lansdown A B G, 2002, J Wound Care, V11, P125
   Li XY, 2007, SURF ENG, V23, P45, DOI 10.1179/174329407X161564
   Marciano FR, 2009, APPL SURF SCI, V255, P8377, DOI 10.1016/j.apsusc.2009.05.091
   Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008
   OWEN CH, 1987, AORN, V45, P806
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   SPALVINS T, 1994, SURF COAT TECH, V68, P482, DOI 10.1016/0257-8972(94)90205-4
   Sreekumari KR, 2004, ISIJ INT, V44, P858, DOI 10.2355/isijinternational.44.858
   Strohal R, 2005, J HOSP INFECT, V60, P226, DOI 10.1016/j.jhin.2005.04.001
   Suzuki Shouji, 2006, Biocontrol Science, V11, P135
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Xu JY, 2007, SURF COAT TECH, V201, P5093, DOI 10.1016/j.surfcoat.2006.07.221
   Xu Z, 2007, SURF COAT TECH, V201, P4822, DOI 10.1016/j.surfcoat.2006.07.187
   XU Z, 1988, METHOD APPARATUS INT
   XU Z, 1990, SURF COAT TECH, V43, P1065
   Yuan WY, 2008, J BIOMED MATER RES B, V85B, P556, DOI 10.1002/jbm.b.30979
   Zhang W, 2007, J BIOMED MATER RES A, V83A, P838, DOI 10.1002/jbm.a.31436
NR 39
TC 49
Z9 57
U1 3
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2011
VL 7
IS 1
BP 447
EP 457
DI 10.1016/j.actbio.2010.08.009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687RJ
UT WOS:000284795300044
PM 20727993
DA 2018-10-20
ER

PT J
AU Silva, TSN
   Primo, BT
   Silva, AN
   Machado, DC
   Viezzer, C
   Santos, LA
AF Novaes Silva, Tais Somacal
   Primo, Bruno Tochetto
   Silva Junior, Aurelicio Novaes
   Machado, Denise Cantarelli
   Viezzer, Christian
   Santos, Luis Alberto
TI Use of calcium phosphate cement scaffolds for bone tissue engineering:
   in vitro study
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Biocompatible Materials; Stem Cells; Bioengineering; Bone Cements
ID MESENCHYMAL STEM-CELLS; HYDROXYAPATITE; CERAMICS; DIFFERENTIATION;
   CULTURE
AB Purpose: To evaluate the ability of macroporous tricalcium phosphate cement (CPC) scaffolds to enable the adhesion, proliferation, and differentiation of mesenchymal stem cells derived from human bone marrow. Methods: Cells from the iliac crest of an adult human donor were processed and cultured on macroporous CPC discs. Paraffin spheres sized between 100 and 250 mu m were used as porogens. Cells were cultured for 5, 10, and 15 days. Next, we assessed cells' behavior and morphology on the biomaterial by scanning electron microscopy. The expression levels of the BGLA and SSP1 genes and the alkaline phosphatase (ALP) activity were quantified by the quantitative real-time polymerase chain reaction technique (QT-PCR) using the fluorophore SYBR GREEN (R). Results: QT-PCR detected the expression of the BGLA and SSP1 genes and the ALP activity in the periods of 10 and 15 days of culture. Thus, we found out that there was cell proliferation and differentiation in osteogenic cells. Conclusion: Macroporous CPC, with pore sized between 100 and 250 mu m and developed using paraffin spheres, enables adhesion, proliferation, and differentiation of mesenchymal stem cells in osteogenic cells and can be used as a scaffold for bone tissue engineering.
C1 Pontificia Univ Catolica Rio Grande do Sul, Sao Lucas Hosp, Inst Biomed Res, Porto Alegre, RS, Brazil.
RP Silva, TSN (reprint author), Av Visconde do Herval 915-604, BR-91450151 Porto Alegre, RS, Brazil.
EM tais.somacal@hotmail.com
RI Machado, Denise/G-2852-2014
OI Machado, Denise/0000-0002-9371-5886; Viezzer,
   Christian/0000-0003-2800-7418
FU CAPES
FX Financial source: CAPES
CR Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chouteau J, 2003, REV CHIR ORTHOP, V89, P44
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P223, DOI 10.1023/A:1008958112257
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   KIM K, 2010, TISSUE ENG B    0526
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   Turhani D, 2005, J ORAL MAXIL SURG, V63, P673, DOI 10.1016/j.joms.2005.01.006
NR 14
TC 13
Z9 14
U1 1
U2 9
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD JAN-FEB
PY 2011
VL 26
IS 1
BP 7
EP 11
DI 10.1590/S0102-86502011000100003
PG 5
WC Surgery
SC Surgery
GA 711OM
UT WOS:000286601300003
PM 21271197
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Manso, JEF
   Mourao, CFDB
   Pinheiro, FAL
   Ferreira, ML
   Silva, PC
   Schanaider, A
AF Ferreira Manso, Jose Eduardo
   de Almeida Barros Mourao, Carlos Fernando
   Lima Pinheiro, Flavio Alexandre
   Ferreira, Manoel Luiz
   Silva, Paulo Cesar
   Schanaider, Alberto
TI Molars extraction for bone graft study in rabbits
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article; Proceedings Paper
CT 12th National Congress of Experimental Surgery/9th Forum of Scientific
   Initiation in Clinical Surgery and Experimental
   Surgery/Multidisciplinary Workshop on Organ Transplantation
CY OCT 26, 2011
CL Ribeirao Preto, BRAZIL
DE Animal Experimentation; Dental Models; Rabbits
ID CRITICAL-SIZE DEFECT; EXPERIMENTAL-MODEL; SOCKETS
AB PURPOSE: The aim of this study was to describe an experimental surgical technique to be used in the evaluation of bone grafts in rabbits.
   METHODS: The operative technique was performed in jaws, with external approach from the labial commissure to the last molar tooth. An incision about 1cm extended forward to the alveolar ridge, followed by a exposing the cervical region of the alveolar bone and dental elements was done. Thus, after extraction of first molar with forceps, the tooth socket left was filled with hydroxyapatite. The bone gain was analyzed by histopathological studies.
   RESULTS: The histological analyses indicated formed bone surrounding the biomaterial.
   CONCLUSION: The experimental model using the tooth socket of the rabbit molar is a feasible procedure for studies of bone grafts.
C1 [Ferreira Manso, Jose Eduardo] Univ Fed Rio de Janeiro, Fac Med, Expt Surg Ctr, BR-21941913 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Med, Postgrad Program, Dept Surg, BR-21941913 Rio De Janeiro, Brazil.
RP Manso, JEF (reprint author), Univ Fed Rio de Janeiro, Fac Med, Expt Surg Ctr, Av Prof Rodolpho Paulo Rocco 225, BR-21941913 Rio De Janeiro, Brazil.
OI Mourao, Carlos Fernando/0000-0001-5775-0222
CR AMLER MH, 1960, J AM DENT ASSOC, V61, P46
   Andersson L, 2009, DENT TRAUMATOL, V25, P78, DOI 10.1111/j.1600-9657.2008.00703.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Becker W., 1994, J PERIODONTOL, V65, P1028
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   COSTA OR, 1994, REV ASOC ODONTOL ARG, V82, P117
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Gosain AK, 2000, PLAST RECONSTR SURG, V106, P360, DOI 10.1097/00006534-200008000-00018
   Lalani Z, 2005, J ORAL MAXIL SURG, V63, P1500, DOI 10.1016/j.joms.2005.03.032
   Li Z, 2005, ANZ J SURG, V75, P1017, DOI 10.1111/j.1445-2197.2005.03586.x
   Marei MK, 2005, TISSUE ENG, V11, P751, DOI 10.1089/ten.2005.11.751
   MELLONIG JT, 1993, INT J PERIODONT REST, V13, P109
   Rabie ABM, 1996, J DENT RES, V75, P1045, DOI 10.1177/00220345960750040701
   Sarahrudi K, 2008, J ORTHOP RES, V26, P759, DOI 10.1002/jor.20527
   Schanaider Alberto, 2004, Acta Cir. Bras., V19, P441, DOI 10.1590/S0102-86502004000400014
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Wei H, 2011, INT J ORAL MAX SURG, V40, P413, DOI 10.1016/j.ijom.2010.10.015
NR 19
TC 4
Z9 4
U1 0
U2 1
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PY 2011
VL 26
SU 2
BP 66
EP 69
DI 10.1590/S0102-86502011000800012
PG 4
WC Surgery
SC Surgery
GA 855NT
UT WOS:000297572000012
PM 22030817
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Simoes, MJ
   Gartner, A
   Shirosaki, Y
   Da Costa, RMG
   Cortez, PP
   Gartner, F
   Santos, JD
   Lopes, MA
   Geuna, S
   Varejao, ASP
   Mauricio, AC
AF Simoes, M. J.
   Gartner, A.
   Shirosaki, Y.
   Gil Da Costa, R. M.
   Cortez, P. P.
   Gartner, F.
   Santos, J. D.
   Lopes, M. A.
   Geuna, S.
   Varejao, A. S. P.
   Mauricio, A. Colette
TI IN VITRO AND IN VIVO CHITOSAN MEMBRANES TESTING For Peripheral Nerve
   Reconstruction
SO ACTA MEDICA PORTUGUESA
LA English
DT Article
ID SCHWANN-CELL; REGENERATION; REPAIR; CONDUITS; CYTOTOXICITY; BIOMATERIAL;
   DEGRADATION; INJURY
AB Tissue regeneration over a large defect with a subsequent satisfactory functional recovery still stands as a major problem in areas such as nerve regeneration or bone healing. The routine technique for the reconstruction of a nerve gap is the use of autologous nerve grafting, but still with severe complications. Over the last decades several attempts have been made to overcome this problem by using biomaterials as scaffolds for guided tissue regeneration. Despite the wide range of biomaterials available, functional recovery after a serious nerve injury is still far from acceptable. Prior to the use of a new biomaterial on healing tissues, an evaluation of the host's inflammatory response is mandatory. In this study, three chitosan membranes were tested in vitro and in vivo for later use as nerve guides for the reconstruction of peripheral nerves submitted to axonotmesis or neurotmesis lesions. Chitosan membranes, with different compositions, were tested in vitro, with a nerve growth factor cellular producing system, N1E-115 cell line, cultured over each of the three membranes and differentiated for 48h in the presence of 1.5% of DMSO. The intracellular calcium concentrations of the non-differentiated and of the 48h-differentiated cells cultured on the three types of the chitosan membranes were measured to determine the cell culture viability. In vivo, the chitosan membranes were implanted subcutaneously in a rat model, and histological evaluations were performed from material retrieved on weeks 1, 2, 4 and 8 after implantation. The three types of chitosan membranes were a viable substrate for the N1E-115 cell multiplication, survival and differentiation. Furthermore, the in vivo studies suggested that these chitosan membranes are promising candidates as a supporting material for tissue engineering applications on the peripheral nerve, possibly owing to their porous structure, their chemical modifications and high affinity to cellular systems.
C1 [Simoes, M. J.; Gartner, A.; Gil Da Costa, R. M.; Cortez, P. P.; Gartner, F.; Mauricio, A. Colette] Univ Porto, Inst Ciencias & Tecnol Agrarias & Agro Alimentare, Ctr Estudos Ciencia Anim, P-4100 Oporto, Portugal.
   [Simoes, M. J.; Gartner, A.; Gil Da Costa, R. M.; Cortez, P. P.; Gartner, F.; Mauricio, A. Colette] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal.
   [Shirosaki, Y.; Santos, J. D.; Lopes, M. A.] Univ Porto, Fac Engn, Seccao Mat, P-4100 Oporto, Portugal.
   [Shirosaki, Y.] Okayama Univ, Grad Sch Nat Sci & Technol, Res Ctr Biomed Engn, Div Funct Mol Chem, Okayama, Japan.
   [Geuna, S.] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy.
   [Gartner, F.] Univ Porto, Inst Patol & Imunol Mol, P-4100 Oporto, Portugal.
   [Varejao, A. S. P.] Univ Tras Os Montes & Alto Douro, Dept Ciencias Vet, Vila Real, Portugal.
RP Simoes, MJ (reprint author), Univ Porto, Inst Ciencias & Tecnol Agrarias & Agro Alimentare, Ctr Estudos Ciencia Anim, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
RI Lopes, Cristina/A-4241-2010; Gartner, Fatima/A-3530-2010; Lopes, Maria
   A./P-4442-2014; SHIROSAKI, Yuki/B-2601-2011
OI Gartner, Fatima/0000-0002-5302-0086; Lopes, Maria
   A./0000-0003-4105-8148; Varejao, Artur/0000-0002-0736-3635; Santos, Jose
   Domingos/0000-0002-6871-9850; Cortez, Paulo/0000-0001-7132-6786; Geuna,
   Stefano/0000-0002-6962-831X; Gil da Costa, Rui/0000-0002-2151-2449;
   Mauricio, Ana Colette/0000-0002-0018-9363
FU Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/CVT/64220/2006]
FX This work was supported by the Fundacao para a Ciencia e Tecnologia
   (FCT) through the financing of the research project PTDC/CVT/64220/2006
CR Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235
   Cao WL, 2005, J BIOMAT SCI-POLYM E, V16, P791, DOI 10.1163/1568562053992496
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   Cortez PP, 2008, KEY ENG MATER, V361-363, P1265, DOI 10.4028/www.scientific.net/KEM.361-363.1265
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Geuna S, 2006, BRAIN RES REV, V52, P381, DOI 10.1016/j.brainresrev.2006.05.002
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   HENCH LL, 1982, BIOMATERIALS INTERFA, P10
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jensen JN, 2004, MICROSURG, V24, P309, DOI 10.1002/micr.20028
   Kline DG, 2000, J NEUROSURG, V93, P336
   Luis AL, 2007, MICROSURG, V27, P125, DOI 10.1002/micr.20317
   Lundborg G, 2004, Handchir Mikrochir Plast Chir, V36, P1
   Lundborg G, 2002, J PERIPHER NERV SYST, V7, P139, DOI 10.1046/j.1529-8027.2002.02019.x
   LUNDBORG G, 2003, BRIDGING NERVE DEFEC, P153
   MADISON RD, 1992, PERIPHERAL NERVE INJ, P450
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   MAY M, 1983, OTOLARYNG CLIN N AM, V16, P661
   MILLESI H, 1990, WORLD J SURG, V14, P733, DOI 10.1007/BF01670520
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Rodrigues JM, 2005, BIO-MED MATER ENG, V15, P455
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   SHIROSAKI Y, CHEM ENG J UNPUB
   SHIROSAKY Y, 2005, THESIS OKAYAMA U
   SIMOES MJ, 2007, 10 M PORT SOC NEUR O
   SUEMATSU N, 1989, MICROSURG, V10, P71, DOI 10.1002/micr.1920100112
   TATEISHI T, 2002, J ARTIF ORGANS, V5, P77, DOI DOI 10.1007/S100470200014
   TRUMP BF, 1995, FASEB J, V9, P219
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
NR 37
TC 15
Z9 15
U1 0
U2 8
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD JAN-FEB
PY 2011
VL 24
IS 1
BP 43
EP 52
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 740BF
UT WOS:000288765900006
PM 21672441
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Liu, X
   Guo, HM
   Meng, CG
AF Liu, Xin
   Guo, Huimin
   Meng, Changgong
BE Tan, Y
   Ju, DY
TI TiOx Film formation on NiTi alloy (100) Surface: Density Functional
   Theory Investigation
SO ADVANCED MATERIAL SCIENCE AND TECHNOLOGY, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Forum on Advanced Material Science and Technology
CY JUN 26-28, 2011
CL Dalian, PEOPLES R CHINA
SP Natl Nat Sci Fdn China, KC Wong Educ Fdn, Dalian Univ Technol, Changchun Res Inst Mech Sci Co Ltd
DE NiTi shape memory alloy; surface oxidation; biocompatibility
ID SHAPE-MEMORY ALLOY; O-2 ADSORPTION; MEDICAL APPLICATIONS; OXIDATION;
   NICKEL; TINI
AB NiTi shape memory alloy is widely used as biomaterial for its superior mechanical properties and good biocompatibility. Effective protocols based on the surface oxidation mechanisms, which would precisely control the formation of surface oxide, should be designed and implemented to improve the biocompatibility of NiTi alloy based biomaterials. To shed light on the TiOx species formation mechanism on NiTi surface, density functional theory (OFT) based calculations were carried out to study the adsorption and reactions of O-2 on the NiTi alloy (100) surface. O-2 is found activated and will decompose upon adsorption. At higher O-2 coverage, the reconstructed bridge configuration will generate (110) surface of TiO2, and the hollow configuration will evolve to (100) surface of TiO. The formation of TiO2 phase is thermodynamically favored, but only feasible when the temperature is enough high. At lower temperature, the atomic diffusion is slowed down, and the surface reconstruction will be limited. This explains why TiO2 will be dominant TiOx at higher temperature, and TiO will exist at lower temperature. Our current work provides more insights on the initial oxidation of NiTi surface, and these findings would be beneficial to improve NiTi alloy based biomaterials, and might guide the design of new functional materials.
C1 [Liu, Xin; Guo, Huimin; Meng, Changgong] Dalian Univ Technol, Sch Chem, Dalian 116024, Peoples R China.
RP Liu, X (reprint author), Dalian Univ Technol, Sch Chem, Dalian 116024, Peoples R China.
EM xliu@dlut.edu.cn; guohm@dlut.edu.cn; cgmeng@dlut.edu.cn
CR Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Firstov GS, 2002, BIOMATERIALS, V23, P4863, DOI 10.1016/S0142-9612(02)00244-2
   Gu YW, 2005, APPL SURF SCI, V252, P2038, DOI 10.1016/j.apsusc.2005.03.207
   Hammer B, 1999, PHYS REV B, V59, P7413, DOI 10.1103/PhysRevB.59.7413
   Hua YJ, 2004, J MATER SCI TECHNOL, V20, P182
   Hua YJ, 2003, J WUHAN UNIV TECHNOL, V18, P6
   Kulkova SE, 2004, PHYSICA B, V349, P342, DOI 10.1016/j.physb.2004.04.047
   Lelatko J., 2009, J MIRCOSCOPY, V237, P435
   Liu X, 2006, ACTA METALL SIN, V42, P421
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P468, DOI 10.1016/j.biomaterials.2008.10.014
   Vojtech D, 2008, APPL SURF SCI, V254, P5664, DOI 10.1016/j.apsusc.2008.03.014
   Wang RM, 2007, APPL SURF SCI, V253, P8507, DOI 10.1016/j.apsusc.2007.04.018
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Wong MH, 2007, MATER LETT, V61, P3391, DOI 10.1016/j.matlet.2006.11.081
   Xu CH, 2004, MAT SCI ENG A-STRUCT, V371, P45, DOI 10.1016/S0921-5093(103)00287-9
NR 16
TC 2
Z9 2
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2011
VL 675-677
BP 353
EP 356
DI 10.4028/www.scientific.net/MSF.675-677.353
PG 4
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BXT82
UT WOS:000297036200084
DA 2018-10-20
ER

PT B
AU Hollister, SJ
   Jeong, CG
   Schwiedrzik, JJ
   Mitsak, AG
   Kang, H
   Migneco, F
AF Hollister, Scott J.
   Jeong, Claire G.
   Schwiedrzik, J. Jakob
   Mitsak, Anna G.
   Kang, Heesuk
   Migneco, Francesco
BE Fernandes, PR
   Bartolo, PJ
TI Nonlinear Elastic Scaffold Design, Modeling and Fabrication for Soft
   Tissue Engineering
SO ADVANCES ON MODELING IN TISSUE ENGINEERING
SE Computational Methods in Applied Sciences
LA English
DT Proceedings Paper
CT 1st International ECCOMAS Thematic Conference on Tissue Engineering
CY JUL 09-11, 2009
CL Polytechn Inst Leiria, Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev, European Community on Computat Methods Appl Sci, Portuguese Assoc Theoret Appl & Computat Mech, Portuguese Fdn Sci & Technol, Ins Mech Engn
HO Polytechn Inst Leiria
ID PASSIVE MYOCARDIUM; CONSTITUTIVE RELATION; DEFORMATION; COMPOSITES;
   FRAMEWORK; SOLIDS
AB Biologic soft tissues exhibit nonlinear elastic behavior under physiologic forces. It is widely postulated that within tissue engineering, biomaterial scaffolds should be designed to replicate native tissue behavior. For soft tissue engineering, this implies that scaffolds should be designed to exhibit nonlinear elasticity. However, unlike linear elasticity, there is no single constitutive model for nonlinear elasticity. In this chapter, we discuss candidate strain energy functions that can be used to both model soft tissue behavior and biodegradable elastomer behavior. We further demonstrate how designed pore architecture not only reduces the tangent stiffness of nonlinear elastic biomaterials, but decreases the non linearity of such materials in accordance with known upper bounds on effective nonlinear elastic properties. Finally, we demonstrate that nonlinear elastic finite element analysis on porous scaffold unit cell models can be used to predict the effective nonlinear elastic properties of elastomeric scaffolds.
C1 [Hollister, Scott J.; Jeong, Claire G.; Schwiedrzik, J. Jakob; Mitsak, Anna G.; Kang, Heesuk; Migneco, Francesco] Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
   [Hollister, Scott J.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Hollister, Scott J.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
FU National Institutes of Health NIH [RO1 DE13608, RO1 DE016129, RO1
   DE13416, RO1 AR 053379]
FX Research reported in this chapter was supported by funding from the
   National Institutes of Health NIH RO1 DE13608, RO1 DE016129, RO1
   DE13416, and RO1 AR 053379.
CR Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044
   Cheng G, 2009, BIOPHYS J, V97, P401, DOI 10.1016/j.bpj.2009.03.067
   FUNG YC, 1981, J BIOMECH ENG-T ASME, V103, P91, DOI 10.1115/1.3138266
   FUNG YC, 1979, AM J PHYSIOL, V237, pH620
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   HASHIN Z, 1985, INT J SOLIDS STRUCT, V21, P711, DOI 10.1016/0020-7683(85)90074-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hollister SJ, 2009, FUNDAMENTAL TISSUE E
   Holzapfel GA, 2004, J BIOMECH ENG-T ASME, V126, P264, DOI 10.1115/1.1695572
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Holzapfel GA, 2009, PHILOS T R SOC A, V367, P3445, DOI 10.1098/rsta.2009.0091
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P340, DOI 10.1115/1.2891194
   Humphrey JD, 2002, CARDIOVASCULAR SOLID
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jeong CG, 2010, BIOMATERIALS, V31, P4304, DOI 10.1016/j.biomaterials.2010.01.145
   Jeong CG, 2010, J BIOMED MATER RES B, V93B, P141, DOI 10.1002/jbm.b.31568
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Khayyeri H, 2009, J MAT SCI MAT MED
   LIPTON R, 1994, P ROY SOC LOND A MAT, V444, P399, DOI 10.1098/rspa.1994.0028
   Lopez-Pamies O, 2009, J ELASTICITY, V95, P99, DOI 10.1007/s10659-009-9193-5
   Migneco F, 2009, BIOMATERIALS, V30, P6479, DOI 10.1016/j.biomaterials.2009.08.021
   OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026
   OGDEN RW, 1978, INT J SOLIDS STRUCT, V14, P265, DOI 10.1016/0020-7683(78)90037-9
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 29
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-94-007-1253-9
J9 COMPUT METH APPL SCI
PY 2011
VL 20
BP 35
EP 53
DI 10.1007/978-94-007-1254-6_3
PG 19
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA BH0JM
UT WOS:000395360100003
DA 2018-10-20
ER

PT B
AU Checa, S
   Sandino, C
   Byrne, DP
   Kelly, DJ
   Lacroix, D
   Prendergast, PJ
AF Checa, S.
   Sandino, C.
   Byrne, D. P.
   Kelly, D. J.
   Lacroix, D.
   Prendergast, P. J.
BE Fernandes, PR
   Bartolo, PJ
TI Computational techniques for selection of biomaterial scaffolds for
   tissue engineering
SO ADVANCES ON MODELING IN TISSUE ENGINEERING
SE Computational Methods in Applied Sciences
LA English
DT Proceedings Paper
CT 1st International ECCOMAS Thematic Conference on Tissue Engineering
CY JUL 09-11, 2009
CL Polytechn Inst Leiria, Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev, European Community on Computat Methods Appl Sci, Portuguese Assoc Theoret Appl & Computat Mech, Portuguese Fdn Sci & Technol, Ins Mech Engn
HO Polytechn Inst Leiria
ID MECHANO-REGULATION; DISTRACTION OSTEOGENESIS; BONE REGENERATION;
   FINITE-ELEMENT; DIFFERENTIATION; MODELS; SIMULATION; STIMULI; CHAMBER;
   STRAIN
AB Computational tools are nowadays an indispensable tool for engineering design. Tissue engineering is an interdisciplinary field which so far has been mainly limited to experimental investigations. Here we present several examples of how computer models can be used in the design of tissue engineering scaffolds. Investigations of the effect of scaffold porosity, dissolution rate and/or scaffold material properties on processes such as cell differentiation, migration and angiogenesis are presented. Current limitations and future perspectives in the development and potential application of these models are described.
C1 [Checa, S.; Byrne, D. P.; Kelly, D. J.; Prendergast, P. J.] Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin, Ireland.
   [Sandino, C.; Lacroix, D.] Inst Bioengn Catalonia, Barcelona, Spain.
RP Checa, S (reprint author), Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin, Ireland.
EM sara.checa@gmail.com; clara.sandino@upc.edu; dbyrne24@tcd.ie;
   kellyd9@tcd.ie; dlacroix@ibec.pcb.ub.es; pprender@tcd.ie
OI Kelly, Daniel/0000-0003-4091-0992
FU Science Foundation Ireland
FX The research reported here is funded by a Science Foundation Ireland
   Principal Investigator grant to P.J. Prendergast.
CR Andreykiv A, 2008, BIOMECH MODEL MECHAN, V7, P443, DOI 10.1007/s10237-007-0108-8
   Andreykiv A, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2970057
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1
   Boccaccio A, 2007, ANN BIOMED ENG, V35, P1940, DOI 10.1007/s10439-007-9367-x
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5
   Geris L, 2004, J BIOMECH, V37, P763, DOI 10.1016/j.jbiomech.2003.09.026
   Geris L, 2008, J THEOR BIOL, V251, P137, DOI 10.1016/j.jtbi.2007.11.008
   Geris L, 2008, J BIOMECH, V41, P145, DOI 10.1016/j.jbiomech.2007.07.008
   Gomez-Benito MJ, 2005, J THEOR BIOL, V235, P105, DOI 10.1016/j.jtbi.2004.12.023
   GREEN WT, 1977, CLIN ORTHOP RELAT R, P237
   Hayward LNM, 2009, BIOMECH MODEL MECHAN, V8, P447, DOI 10.1007/s10237-009-0148-3
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037
   Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030
   Isaksson H, 2007, J BIOMECH, V40, P2002, DOI 10.1016/j.jbiomech.2006.09.028
   Kelly DJ, 2006, TISSUE ENG, V12, P2509, DOI 10.1089/ten.2006.12.2509
   Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026
   Khayyeri H, 2009, J ORTHOP RES, V27, P1659, DOI 10.1002/jor.20926
   Lacroix D, 2002, Comput Methods Biomech Biomed Engin, V5, P369, DOI 10.1080/1025584021000025014
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu XY, 2008, BIOMECH MODEL MECHAN, V7, P335, DOI 10.1007/s10237-007-0100-3
   Loboa EG, 2001, J ORTHOPAED RES, V19, P1067, DOI 10.1016/S0736-0266(01)00028-6
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026
   Palsson B.O., 2004, TISSUE ENG
   PAUWELS F, 1973, ATLAS BIOMECHANIK GE
   Perez MA, 2007, J BIOMECH, V40, P2244, DOI 10.1016/j.jbiomech.2006.10.020
   Prendergast P, 1996, MECH COMPOSITE MAT, V32, P209, DOI [10.1007/BF02254782, DOI 10.1007/BF02254782]
   Prendergast P. J., 2001, Engineering Transactions, V49, P117
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Prendergast PJ, 2009, COMPUTATIONAL METHOD
   Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   von Neumann J, 1966, THEORY SELF REPRODUC
NR 41
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-94-007-1253-9
J9 COMPUT METH APPL SCI
PY 2011
VL 20
BP 55
EP 69
DI 10.1007/978-94-007-1254-6_4
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA BH0JM
UT WOS:000395360100004
DA 2018-10-20
ER

PT J
AU Borie, E
   Fuentes, R
   del Sol, M
   Oporto, G
   Engelke, W
AF Borie, Eduardo
   Fuentes, Ramon
   del Sol, Mariano
   Oporto, Gonzalo
   Engelke, Wilfried
TI The influence of FDBA and autogenous bone particles on regeneration of
   calvaria defects in the rabbit: A pilot study
SO ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER
LA English
DT Article
DE Bone regeneration; Rabbits; Critical size defect; Freeze dried bone
   allograft; Autogenous bone
ID CRITICAL-SIZE DEFECTS; HISTOMORPHOMETRIC EVALUATION; EXPERIMENTAL-MODEL;
   GROWTH-FACTOR; RAT CALVARIA; RICH PLASMA; IN-VIVO; GRAFTS; ALLOGRAFT
AB The histological behavior of bone formation using three biomaterials was examined including whether an 8 mm rabbit calvarial defect would behave as a critical size defect. Four trephine defects of 8 mm diameter in were created six rabbit parietal bones. A control defect was maintained only with coagulum and others were filled with autologous bone, FDBA (freeze dried bone allograft) and a mixture of autologous bone with FDBA, respectively. The animals were sacrificed after between 15 and 90 days at intervals of two weeks and the extracted samples were processed for histological evaluation. All control defects showed incomplete bone formation during 90 days of observation. The defects filled with FDBA and mixture of FDBA-autologous bone exhibited a higher regeneration degree than autologous bone after 60 days; however, the only biomaterial revealing complete mineralization of the original defect at 90 days was FDBA. In conclusion, 8 mm defects can be considered as critical size defects and only FDBA showed mature lamellar bone at 90 days. (C) 2011 Elsevier GmbH. All rights reserved.
C1 [Borie, Eduardo] Univ La Frontera, Fac Med, Dept Odontol Integral, Temuco, Chile.
   [del Sol, Mariano] Univ La Frontera, Dept Ciencias Basicas, Temuco, Chile.
   [Engelke, Wilfried] Univ Gottingen, Dept Maxillofacial Surg, Dent Ctr, Gottingen, Germany.
RP Borie, E (reprint author), Univ La Frontera, Fac Med, Dept Odontol Integral, Manuel Montt 112, Temuco, Chile.
EM eduardoborie@ufro.cl
RI Borie, Eduardo/J-8290-2012; del Sol, Mariano/I-4746-2018
OI del Sol, Mariano/0000-0003-3686-6757
FU DIUFRO [DI11-0069]
FX We acknowledge the financial support by DIUFRO project (DI11-0069).
CR Acocella A, 2011, J CRANIO MAXILL SURG, V39, P192, DOI 10.1016/j.jcms.2010.03.019
   Adeyemo WL, 2008, INT J ORAL MAX SURG, V37, P651, DOI 10.1016/j.ijom.2008.02.005
   Aghaloo TL, 2005, CLIN ORAL IMPLAN RES, V16, P250, DOI 10.1111/j.1600-0501.2004.01075.x
   Anitua E., 2000, NUEVO ENFOQUE REGENE, P49
   Artzi Z, 2008, INT J ORAL MAX IMPL, V23, P1063
   Butterfield K, 2004, J ORAL MAXILLOFAC SU, V63, P370
   Choi Jung-Yoo, 2010, J Periodontal Implant Sci, V40, P11, DOI 10.5051/jpis.2010.40.1.11
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Costa AD, 2010, ACTA CIR BRAS, V25, P264, DOI 10.1590/S0102-86502010000300008
   Cruz Gabriela Alessandra da, 2007, Braz. Dent. J., V18, P129, DOI 10.1590/S0103-64402007000200008
   de Vicente JC, 2006, INT J ORAL MAX SURG, V35, P1047, DOI 10.1016/j.ijom.2006.06.008
   Dodde R, 2000, J CRANIOFAC SURG, V11, P346, DOI 10.1097/00001665-200011040-00013
   Fok TCO, 2008, ORAL SURG ORAL MED O, V105, P417, DOI 10.1016/j.tripleo.2007.07.015
   Galia CR, 2008, CLINICS, V63, P801, DOI 10.1590/S1807-59322008000600016
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Haddad A.J., 2006, J CRANIOFAC SURG, V17, P926
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   He H, 2008, J ORAL PATHOL MED, V37, P378, DOI 10.1111/j.1600-0714.2008.00651.x
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Huh JY, 2005, ORAL SURG ORAL MED O, V100, P296, DOI 10.1016/j.tripleo.2004.12.015
   Jan AMA, 2006, ORAL SURG ORAL MED O, V101, P146, DOI 10.1016/j.tripleo.2005.08.032
   Kochi G, 2009, ORAL SURG ORAL MED O, V107, pE42, DOI 10.1016/j.tripleo.2009.02.010
   Lasanianos N, 2008, INJURY, V39, P1106, DOI 10.1016/j.injury.2008.04.005
   Lee DW, 2011, J PERIODONTAL IMPLAN, V41, P131, DOI 10.5051/jpis.2011.41.3.131
   Lee HJ, 2008, ORAL SURG ORAL MED O, V105, P27, DOI 10.1016/j.tripleo.2006.06.003
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Lu M, 2004, INT J ORAL MAX SURG, V33, P369, DOI 10.1016/j.ijom.2003.09.009
   Lu M, 2002, ARCH ORAL BIOL, V47, P831, DOI 10.1016/S0003-9969(02)00119-X
   Malinin Theodore I, 2007, Open Orthop J, V1, P19, DOI 10.2174/1874325000701010019
   Mariano R, 2010, ORAL SURG ORAL MED O, V109, P72, DOI 10.1016/j.tripleo.2009.08.003
   Nagata MJ, 2010, J ORTHOP RES, V28, P468, DOI 10.1002/jor.21027
   Olate S., 2007, INT J MORPHOL, V25, P649
   Oporto Venegas Gonzalo, 2008, Int. J. Morphol., V26, P853, DOI 10.4067/S0717-95022008000400013
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Ruehe B, 2009, ORAL SURG ORAL MED O, V108, P699, DOI 10.1016/j.tripleo.2009.06.037
   Schlegel KA, 2006, ORAL SURG ORAL MED O, V102, P7, DOI 10.1016/j.tripleo.2005.09.011
   Schmidmaier G, 2009, INJURY, V40, P39
   Schmitz J.P., 2009, ACTA ANAT, V138, P185
   Andrade MGS, 2010, ORAL SURG ORAL MED O, V110, P713, DOI 10.1016/j.tripleo.2010.03.019
   Tang TT, 2002, MAT SCI ENG C-BIO S, V20, P57, DOI 10.1016/S0928-4931(02)00013-9
   Wong RWK, 2005, J ORAL MAXIL SURG, V63, P1515, DOI 10.1016/j.joms.2005.06.009
   Wu Z, 2008, INT J ORAL MAX SURG, V37, P170, DOI 10.1016/j.ijom.2007.06.018
   Cavalcanti SCSXB, 2008, J CRANIO MAXILL SURG, V36, P354, DOI 10.1016/j.jcms.2008.02.005
NR 44
TC 16
Z9 18
U1 1
U2 7
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0940-9602
EI 1618-0402
J9 ANN ANAT
JI Ann. Anat.-Anat. Anz.
PY 2011
VL 193
IS 5
BP 412
EP 417
DI 10.1016/j.aanat.2011.06.003
PG 6
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 847DY
UT WOS:000296953300004
PM 21802915
DA 2018-10-20
ER

PT J
AU Pabittei, DR
   Heger, M
   Beek, JF
   van Tuijl, S
   Simonet, M
   van der Wal, AC
   de Mol, BA
   Balm, R
AF Pabittei, Dara R.
   Heger, Michal
   Beek, Johan F.
   van Tuijl, Sjoerd
   Simonet, Marc
   van der Wal, Allard C.
   de Mol, Bas A.
   Balm, Ron
TI Optimization of Suture-Free Laser-Assisted Vessel Repair by Solder-Doped
   Electrospun Poly(epsilon-caprolactone) Scaffold
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Adhesive and cohesive strength; Anastomosis; Medium-sized vessels;
   Polymeric biomaterial; Tissue welding
ID DIODE-LASER; MICROVASCULAR ANASTOMOSIS; ALBUMIN SOLDER; TISSUE-REPAIR;
   ARTERY; FILM; DIAMETER; DISEASE; SIZE; MEN
AB Poor welding strength constitutes an obstacle in the clinical employment of laser-assisted vascular repair (LAVR) and anastomosis. We therefore investigated the feasibility of using electrospun poly(epsilon-caprolactone) (PCL) scaffold as reinforcement material in LAVR of medium-sized vessels. In vitro solder-doped scaffold LAVR (ssLAVR) was performed on porcine carotid arteries or abdominal aortas using a 670-nm diode laser, a solder composed of 50% bovine serum albumin and 0.5% methylene blue, and electrospun PCL scaffolds. The correlation between leaking point pressures (LPPs) and arterial diameter, the extent of thermal damage, structural and mechanical alterations of the scaffold following ssLAVR, and the weak point were investigated. A strong negative correlation existed between LPP and vessel diameter, albeit LPP (484 +/- 111 mmHg) remained well above pathophysiological pressures. Histological analysis revealed that thermal damage extended into the medial layer with a well-preserved internal elastic lamina and endothelial cells. Laser irradiation of PCL fibers and coagulation of solder material resulted in a strong and stiff scaffold. The weak point of the ssLAVR modality was predominantly characterized by cohesive failure. In conclusion, ssLAVR produced supraphysiological LPPs and limited tissue damage. Despite heat-induced structural/mechanical alterations of the scaffold, PCL is a suitable polymer for weld reinforcement in medium-sized vessel ssLAVR.
C1 [Pabittei, Dara R.; Balm, Ron] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Pabittei, Dara R.; de Mol, Bas A.] Univ Amsterdam, Acad Med Ctr, Dept Cardiothorac Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Heger, Michal] Univ Amsterdam, Acad Med Ctr, Dept Expt Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Beek, Johan F.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands.
   [van Tuijl, Sjoerd; de Mol, Bas A.] HemoLab, NL-5612 AZ Eindhoven, Netherlands.
   [Simonet, Marc; de Mol, Bas A.] Tech Univ Eindhoven, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands.
   [van der Wal, Allard C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
RP Balm, R (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM R.Balm@amc.uva.nl
RI Simonet, Marc/B-8490-2009
OI Simonet, Marc/0000-0002-4926-0677
CR Aytac SK, 2003, J ULTRAS MED, V22, P433, DOI 10.7863/jum.2003.22.5.433
   Balguid A, 2008, TISSUE ENG PART A, V11, P437
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   BASU S, 1998, J VASC SURG, V7, P420
   Bleustein CB, 2000, LASER SURG MED, V27, P140, DOI 10.1002/1096-9101(2000)27:2<140::AID-LSM5>3.0.CO;2-C
   Bregy A, 2008, LASER SURG MED, V40, P716, DOI 10.1002/lsm.20710
   DALSING MC, 1992, LASER SURG MED, V12, P190, DOI 10.1002/lsm.1900120213
   Demaria RG, 2000, LASER MED SCI, V15, P207, DOI 10.1007/PL00011319
   Fahner PJ, 2004, INT J ARTIF ORGANS, V27, P979
   Giannattasio C, 1997, EUR HEART J, V18, P1492
   GODLEWSKI G, 1995, J RECONSTR MICROSURG, V11, P37, DOI 10.1055/s-2007-1006509
   GODLEWSKI G, 1993, LASER MED SCI, V8, P33, DOI 10.1007/BF02559753
   KAKIVAYA SR, 1975, BIOPHYSICS-USSR, V72, P3505
   Krejza J, 2006, STROKE, V37, P1103, DOI 10.1161/01.STR.0000206440.48756.f7
   Lauto A, 2004, LASER SURG MED, V35, P140, DOI 10.1002/lsm.20081
   Lauto A, 1999, LASER SURG MED, V25, P250, DOI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
   LEMOLE GM, 1991, P SOC PHOTO-OPT INS, V422, P116
   McNally KM, 1999, PHYS MED BIOL, V44, P983, DOI 10.1088/0031-9155/44/4/013
   McNally KM, 2000, LASER SURG MED, V27, P147, DOI 10.1002/1096-9101(2000)27:2<147::AID-LSM6>3.0.CO;2-P
   McNally KM, 2000, LASER SURG MED, V26, P346, DOI 10.1002/(SICI)1096-9101(2000)26:4<346::AID-LSM2>3.0.CO;2-V
   McNally KM, 2001, J BIOMED OPT, V6, P68, DOI 10.1117/1.1332776
   Ott B, 2004, LASER SURG MED, V35, P312, DOI 10.1002/lsm.20096
   Pabittei DR, 2011, PHOTOMED LASER SURG, V29, P19, DOI 10.1089/pho.2010.2779
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Riley J N, 2001, Biomed Sci Instrum, V37, P451
   Sorg BS, 2001, LASER SURG MED, V28, P297, DOI 10.1002/lsm.1053
   Sorg BS, 2000, LASER SURG MED, V27, P73, DOI 10.1002/1096-9101(2000)27:1<73::AID-LSM10>3.0.CO;2-7
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Tang J, 1997, LASER SURG MED, V21, P438, DOI 10.1002/(SICI)1096-9101(1997)21:5<438::AID-LSM5>3.3.CO;2-E
   Theodossiou T, 2002, LASER MED SCI, V17, P34, DOI 10.1007/s10103-002-8264-7
   UNNO N, 1989, LASER SURG MED, V9, P160, DOI 10.1002/lsm.1900090212
   White AJ, 2009, ATHEROSCLEROSIS, V206, P179, DOI 10.1016/j.atherosclerosis.2009.02.025
   Wolf -de Jonge ICD, 2004, EUR J VASC ENDOVASC, V27, P466, DOI 10.1016/j.ejvs.2004.02.021
   Wolf-de Jonge ICDYM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2953531
   Zindrou D, 2006, EUR J CARDIO-THORAC, V29, P492, DOI 10.1016/j.ejcts.2006.01.008
   Zubilewicz T, 2001, MED SCI MONITOR, V7, P316
NR 36
TC 7
Z9 9
U1 0
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JAN
PY 2011
VL 39
IS 1
BP 223
EP 234
DI 10.1007/s10439-010-0157-5
PG 12
WC Engineering, Biomedical
SC Engineering
GA 719OB
UT WOS:000287213100020
PM 20835847
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kitani, Y
   Kanemaru, S
   Umeda, H
   Suehiro, A
   Kishimoto, Y
   Hirano, S
   Nakamura, T
   Ito, J
AF Kitani, Yoshiharu
   Kanemaru, Shin-ichi
   Umeda, Hiroo
   Suehiro, Atsushi
   Kishimoto, Yo
   Hirano, Shigeru
   Nakamura, Tatsuo
   Ito, Juichi
TI Laryngeal Regeneration Using Tissue Engineering Techniques in a Canine
   Model
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article; Proceedings Paper
CT 89th Annual Meeting of the American-Broncho-Esophagological-Association
CY MAY 28-29, 2009
CL Phoenix, AZ
SP Amer Broncho Esophagol Assoc
DE fascia; laryngeal regeneration; polypropylene; scaffold; tissue
   engineering
ID GLOTTIC RECONSTRUCTION; STEM-CELLS; TRACHEA; FLAP; HEMILARYNGECTOMY;
   SCAFFOLD; ISLAND; MESH
AB Objectives: We previously reported that polypropylene mesh covered with collagen sponge is a useful material for the regeneration of the trachea and the cricoid cartilage. The aim of this study was to regenerate larynges after partial hemilaryngectomy with this new biomaterial.
   Methods: A left partial hemilaryngectomy was performed on 12 adult beagles. The defect size was about 1.8 x 1.0 cm. Both sides of polypropylene mesh were coated with either 1% or 3% collagen sponge. This scaffold was wrapped in fascia lata harvested from the left thigh and then fixed in place over the defect. Endoscopic examinations were performed periodically. Six months after treatment, 3-dimensional computed tomographic scanning was performed. Vibratory examinations were also performed with excised larynges.
   Results: In the 1% collagen group, exposure or dislocation of the mesh was found in 3 of 6 cases, but in the 3% group, no exposure of the mesh was seen. The morphological findings in the vocal fold were better in the 3% group than in the 1% group, but a difference in the vertical levels of the vocal folds was found in both groups.
   Conclusions: This study suggests that 3% collagen coated polypropylene mesh wrapped with autologous fascia is a useful material for laryngeal regeneration.
C1 [Kitani, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.
   [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto 6068507, Japan.
   [Kanemaru, Shin-ichi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Otolaryngol Head & Neck Surg, Osaka, Japan.
RP Kitani, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
OI Kishimoto, Yo/0000-0002-3583-0165
CR Andrews RJ, 2001, ANN OTO RHINOL LARYN, V110, P543, DOI 10.1177/000348940111000608
   AUBRY M, 1951, Ann Otolaryngol, V68, P129
   BAILEY BJ, 1975, LARYNGOSCOPE, V85, P960, DOI 10.1288/00005537-197506000-00005
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   BLAUGRUND SM, 1975, LARYNGOSCOPE, V85, P935, DOI 10.1288/00005537-197506000-00002
   Delaere P, 2007, LARYNGOSCOPE, V117, P1764, DOI 10.1097/MLG.0b013e3181238397
   Hori Y, 2003, INT J ARTIF ORGANS, V26, P241
   Hori Y, 2001, ASAIO J, V47, P206, DOI 10.1097/00002480-200105000-00008
   Huber JE, 2003, ANN OTO RHINOL LARYN, V112, P428, DOI 10.1177/000348940311200508
   Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915, DOI 10.1177/000348940311201101
   KOJIMA H, 1990, AM J OTOLARYNG, V11, P328, DOI 10.1016/0196-0709(90)90063-2
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627
   Nakamura T, 2000, INT J ARTIF ORGANS, V23, P718
   OKUMURA N, 1994, J THORAC CARDIOV SUR, V108, P337
   Omori K, 2008, ANN OTO RHINOL LARYN, V117, P673, DOI 10.1177/000348940811700908
   Omori K, 2008, ANN OTO RHINOL LARYN, V117, P609, DOI 10.1177/000348940811700811
   Papakosta V, 2007, ORAL SURG ORAL MED O, V103, pE13, DOI 10.1016/j.tripleo.2006.11.040
   WINEK TG, 1988, AM J SURG, V156, P235, DOI 10.1016/S0002-9610(88)80281-2
   YAMASHITA M, 2007, ACTA OTO-LARYNGOL, V557, P66
NR 20
TC 4
Z9 4
U1 0
U2 9
PU ANNALS PUBL CO
PI ST LOUIS
PA 4507 LACLEDE AVE, ST LOUIS, MO 63108 USA
SN 0003-4894
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD JAN
PY 2011
VL 120
IS 1
BP 49
EP 56
DI 10.1177/000348941112000107
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 712DS
UT WOS:000286645500007
PM 21370680
DA 2018-10-20
ER

PT J
AU Yuan, SM
   Jing, H
AF Yuan, Shi-Min
   Jing, Hua
TI A Reappraisal of Saphenous Vein Grafting
SO ANNALS OF SAUDI MEDICINE
LA English
DT Review
ID SUPERIOR VENA-CAVA; CORONARY-ARTERY BYPASS; KNEE FEMOROPOPLITEAL BYPASS;
   FREE-FLAP RECONSTRUCTION; VENOUS PATCH GRAFT; PEYRONIES-DISEASE;
   VASCULAR ACCESS; SURGICAL-TREATMENT; LIVER-TRANSPLANTATION; AORTORENAL
   BYPASS
AB Autologous saphenous vein grafting has been broadly used as a bypass conduit, interposition graft, and patch graft in a variety of operations in cardiac, thoracic, neurovascular, general vascular, vascular access, and urology surgeries, since they are superior to prosthetic veins. Modified saphenous vein grafts (SVG), including spiral and cylindrical grafts, and vein cuffs or patches, are employed in vascular revascularization to satisfy the large size of the receipt vessels or to obtain a better patency. A loop SVG helps flap survival in a muscle flap transfer in plastic and reconstructive surgery. For dialysis or transfusion purposes, a straight or loop arteriovenous fistula created in the forearm or the thigh with an SVG has acceptable patency. The saphenous vein has even been used as a stent cover to minimize the potential complications of standard angioplasty technique. However, the use of saphenous vein grafting is now largely diminished in treating cerebrovascular disorders, superior vena cava syndrome, and visceral revascularization due to the introduction of angioplasty and stenting techniques. The SVG remains the preferable biomaterial in coronary artery bypass, coronary ostioplasty, free flap transfer, and surgical treatment of Peyronie disease. Implications associated with saphenous vein grafting in vascular access surgery for the purpose of dialysis and chemotherapy are considerable. Vascular cuffs and patches have been developed as an important and effective means of enhancing the patency rates of the grafts by linking the synthetic material to the receipt vessel. In addition, saphenous veins can be a cell source for tissue engineering. We review the versatile roles that saphenous vein grafting has played as well as its current status in therapy.
C1 [Yuan, Shi-Min; Jing, Hua] Nanjing Univ, Jinling Hosp, Dept Cardiothorac Surg, Sch Clin Med, Nanjing, Jiangsu, Peoples R China.
RP Yuan, SM (reprint author), 305 Zhongshan E Rd, Nanjing 210002, Peoples R China.
EM dr.jing@163.com
CR ADAMSONS RJ, 1978, SURG GYNECOL OBSTET, V146, P869
   Adeniyi AA, 2002, BJU INT, V89, P404, DOI 10.1046/j.1464-4096.2001.01896.x
   Ahuja S, 2005, INT J GYNECOL CANCER, V15, P175, DOI 10.1111/j.1048-891X.2005.15017.x
   Anandbabu S, 2006, ACTA CHIR BELG, V106, P372
   Anderson J H, 1992, Eur J Surg Oncol, V18, P484
   Askerkhanov R P, 1975, Phlebologie, V28, P603
   Auguste KI, 2001, SURG NEUROL, V56, P164, DOI 10.1016/S0090-3019(01)00484-0
   Bastounis E, 1999, EUR J VASC ENDOVASC, V18, P127, DOI 10.1053/ejvs.1999.0880
   BATSON RC, 1984, ANN SURG, V199, P684, DOI 10.1097/00000658-198406000-00006
   BEEBE HG, 1988, AM J SURG, V155, P647, DOI 10.1016/S0002-9610(88)80135-1
   Beghi C, 2002, CHEST, V122, P2075, DOI 10.1378/chest.122.6.2075
   BENVENUTO R, 1962, ARCH SURG-CHICAGO, V84, P570
   Bogats G, 1996, ANN THORAC SURG, V61, P58, DOI 10.1016/0003-4975(95)00931-0
   Bortolotti U, 1997, TEX HEART I J, V24, P366
   Briguori C, 2000, CIRCULATION, V102, P3028
   BRUNNER U, 1978, LANGENBECK ARCH CHIR, V347, P239, DOI 10.1007/BF01579336
   Buckley CJ, 2000, J VASC SURG, V32, P731, DOI 10.1067/mva.2000.110049
   CHANG C H, 1964, Chin Med J, V83, P125
   Chang JA, 2002, INT J IMPOT RES, V14, P375, DOI 10.1038/sj.ijir.3900862
   Chang KP, 2007, HEAD NECK-J SCI SPEC, V29, P412, DOI 10.1002/hed.20508
   CHEANVECHAI C, 1975, J THORAC CARDIOV SUR, V70, P63
   CIMOCHOWSKI GE, 1991, AM J NEPHROL, V11, P64, DOI 10.1159/000168275
   CITRIN P, 1988, SURG GYNECOL OBSTET, V167, P79
   CLEVELAND JC, 1980, ANN THORAC SURG, V30, P336, DOI 10.1016/S0003-4975(10)61271-4
   COLE CW, 1988, CAN MED ASSOC J, V139, P517
   Colombo A, 1996, CATHETER CARDIO DIAG, V38, P172, DOI 10.1002/(SICI)1097-0304(199606)38:2<172::AID-CCD10>3.0.CO;2-L
   DANILOWICZ D, 1984, PEDIATR CARDIOL, V5, P13, DOI 10.1007/BF02306742
   DAVIDSON JT, 1993, ANN SURG, V217, P699, DOI 10.1097/00000658-199306000-00012
   De Stefani S, 2000, INT J IMPOT RES, V12, P299, DOI 10.1038/sj.ijir.3900633
   Deen KI, 2001, AM J SURG, V181, P145, DOI 10.1016/S0002-9610(00)00565-1
   Depprich Rita A, 2008, Head Face Med, V4, P27, DOI 10.1186/1746-160X-4-27
   DIHMIS WC, 1995, J THORAC CARDIOV SUR, V109, P600, DOI 10.1016/S0022-5223(95)70302-0
   DOHI K, 1993, SURGERY, V113, P574
   DOTY DB, 1976, ANN THORAC SURG, V22, P490, DOI 10.1016/S0003-4975(10)64459-1
   DOTY DB, 1990, J THORAC CARDIOV SUR, V99, P889
   EARLE A S, 1990, Journal of Reconstructive Microsurgery, V6, P165, DOI 10.1055/s-2007-1006818
   El-Sakka AI, 1998, J UROLOGY, V160, P2050, DOI 10.1016/S0022-5347(01)62240-7
   English WP, 2004, J VASC SURG, V40, P53, DOI 10.1016/j.jvs.2004.03.024
   Friedman Jonathan A, 2003, Neurosurg Focus, V14, pe1
   Gagne PJ, 2000, J VASC SURG, V32, P1149, DOI 10.1067/mva.2000.109204
   GARCIAVALDECASAS JC, 1990, TRANSPLANT P, V22, P2376
   GUBA AM, 1979, ANN SURG, V190, P72, DOI 10.1097/00000658-197907000-00016
   Gurbel PA, 1997, CATHETER CARDIO DIAG, V40, P75, DOI 10.1002/(SICI)1097-0304(199701)40:1<75::AID-CCD13>3.0.CO;2-T
   HAIMOV M, 1974, SURGERY, V75, P447
   Haridas K K, 2001, Indian Heart J, V53, P490
   HIEMER W, 1993, J CARDIOVASC SURG, V34, P303
   IAFFALDANO RA, 1995, CHEST, V108, P725, DOI 10.1378/chest.108.3.725
   IWABUCHI T, 1979, SURG NEUROL, V12, P463
   IWAI Y, 1993, ACTA NEUROCHIR, V120, P81, DOI 10.1007/BF02001474
   Jafar JJ, 2002, NEUROSURGERY, V51, P138, DOI 10.1227/01.NEU.0000017194.72280.D6
   JEGADEN O, 1994, CORONARY ARTERY DIS, V5, P519
   John LCH, 1996, ANN THORAC SURG, V62, P598, DOI 10.1016/0003-4975(96)00423-7
   Joseph D, 1997, CATHETER CARDIO DIAG, V42, P427, DOI 10.1002/(SICI)1097-0304(199712)42:4<427::AID-CCD21>3.0.CO;2-F
   Kadioglu A, 2007, J SEX MED, V4, P581, DOI 10.1111/j.1743-6109.2007.00461.x
   Kalra M, 2003, J VASC SURG, V38, P215, DOI 10.1016/S0741-5214(03)00331-8
   Kalsi J, 2005, BJU INT, V95, P1029, DOI 10.1111/j.1464-410X.2005.05459.x
   Karanas YL, 1998, PLAST RECONSTR SURG, V101, P1262, DOI 10.1097/00006534-199804050-00015
   KATZ SG, 1993, AM J SURG, V165, P312, DOI 10.1016/S0002-9610(05)80832-3
   Kavanagh EG, 1998, IRISH J MED SCI, V167, P221, DOI 10.1007/BF02937416
   Kereiakes DJ, 2002, CATHETER CARDIO INTE, V55, P100, DOI 10.1002/ccd.10064
   Kim JS, 2008, SCAND J PLAST RECONS, V42, P218, DOI 10.1080/02844310601140436
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Kuwaki  K, 2000, Ann Thorac Cardiovasc Surg, V6, P342
   Kvasha A, 2006, EJVES EXTRA, V11, P1
   LAUB GW, 1992, ANN THORAC SURG, V54, P826, DOI 10.1016/0003-4975(92)90632-E
   LAWTON RL, 1972, SURG GYNECOL OBSTETR, V135, P279
   LEAFSTEDT SW, 1985, ANGIOLOGY, V36, P827, DOI 10.1177/000331978503601111
   Lee KW, 2004, TRANSPLANT P, V36, P2261, DOI 10.1016/j.transproceed.2004.08.079
   Lee SK, 2008, J KOREAN VASC SURG S, V24, P45
   LEVEY RH, 1978, J PEDIATR SURG, V13, P724, DOI 10.1016/S0022-3468(78)80122-5
   LIANG MD, 1992, MICROSURG, V13, P59, DOI 10.1002/micr.1920130202
   LIBERTINO JA, 1976, J UROLOGY, V115, P369, DOI 10.1016/S0022-5347(17)59207-1
   Loubani M, 2004, ANN THORAC SURG, V78, P1838, DOI 10.1016/j.athorascur.2003.09.020
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   Lue TF, 1999, J UROLOGY, V161, P1141, DOI 10.1016/S0022-5347(01)61613-6
   MAILLARD JN, 1974, ARCH SURG-CHICAGO, V108, P315
   MANABE T, 1991, PANCREAS, V6, P368, DOI 10.1097/00006676-199105000-00014
   MARTIN RS, 1994, ANN SURG, V219, P664, DOI 10.1097/00000658-199406000-00009
   MATTINGLY WT, 1984, TEX HEART I J, V11, P302
   Menyhei Gabor, 1995, Orvosi Hetilap, V136, P1713
   Metin Ahmet, 2002, International Urology and Nephrology, V34, P223, DOI 10.1023/A:1023290705439
   MILLER JH, 1984, AUST NZ J SURG, V54, P283, DOI 10.1111/j.1445-2197.1984.tb05318.x
   MOLINA JE, 1989, ANN THORAC SURG, V48, P624, DOI 10.1016/0003-4975(89)90775-3
   Moon IS, 2005, TRANSPLANT P, V37, P1117, DOI 10.1016/j.transproceed.2004.11.040
   Morgan MK, 2002, J CLIN NEUROSCI, V9, P418, DOI 10.1054/jocn.2002.1127
   Moriyama Y, 1998, ANN THORAC SURG, V65, P561, DOI 10.1016/S0003-4975(97)01333-7
   MORSHUIS WJ, 1991, J THORAC CARDIOV SUR, V101, P369
   NAHAI F, 1986, PLAST RECONSTR SURG, V77, P312, DOI 10.1097/00006534-198602000-00028
   NAKAMURA S, 1990, ARCH SURG-CHICAGO, V125, P1455
   Okamoto Hideki, 2003, J Hepatobiliary Pancreat Surg, V10, P109
   PALMA E C, 1960, J Cardiovasc Surg (Torino), V1, P94
   Panneton JM, 2001, J VASC SURG, V34, P360, DOI 10.1067/mva.2001.115800
   Paz Yosef, 2002, Interact Cardiovasc Thorac Surg, V1, P93, DOI 10.1016/S1569-9293(02)00062-2
   Pfeiffer T, 2003, J VASC SURG, V37, P293, DOI 10.1067/mva.2003.117
   Piercy KT, 2005, J VASC SURG, V41, P973, DOI 10.1016/j.jvs.2005.03.007
   Raja Shahzad G, 2006, Expert Rev Cardiovasc Ther, V4, P523, DOI 10.1586/14779072.4.4.523
   Ramina R, 2000, ARQ NEURO-PSIQUIAT, V58, P162, DOI 10.1590/S0004-282X2000000100025
   Rechnic M, 1997, PLAST RECONSTR SURG, V99, P242, DOI 10.1097/00006534-199701000-00038
   REILLY LM, 1991, J VASC SURG, V14, P468, DOI 10.1016/0741-5214(91)90240-U
   Ridley PD, 1996, ANN THORAC SURG, V62, P293, DOI 10.1016/0003-4975(96)00266-4
   Rudich SM, 1998, LIVER TRANSPLANT SUR, V4, P91, DOI 10.1002/lt.500040113
   RUTLEDGE RH, 1983, SURGERY, V93, P333
   RUTTEN APM, 1971, BRIT J SURG, V58, P262, DOI 10.1002/bjs.1800580407
   Sakamoto Y, 2004, LANGENBECK ARCH SURG, V389, P110, DOI 10.1007/s00423-003-0452-9
   SALIBIAN AH, 1983, PLAST RECONSTR SURG, V71, P543, DOI 10.1097/00006534-198304000-00018
   Salim A S, 1992, HPB Surg, V5, P195, DOI 10.1155/1992/75089
   SAMSON DS, 1981, ARCH SURG-CHICAGO, V116, P1578
   Santoro A, 1999, J Neurosurg Sci, V43, P237
   Sasso F, 2007, UROL INT, V78, P1, DOI 10.1159/000096927
   Schaefermeier PK, 2009, ASAIO J, V55, P86, DOI 10.1097/MAT.0b013e31818f54e4
   Scholz H, 2009, United States Patent, Patent No. 6273912
   SCHRAMEL R, 1961, J THORAC CARDIOV SUR, V41, P375
   Sekhar LN, 2002, NEUROSURGERY, V50, P321, DOI 10.1097/00006123-200202000-00014
   SELLKE FW, 1991, J CARDIOVASC SURG, V32, P820
   SIEGMAN FA, 1979, SURG GYNECOL OBSTET, V148, P930
   STANTON PE, 1986, J VASC SURG, V4, P338, DOI 10.1067/mva.1986.avs0040338
   Stefanadis C, 2001, J Invasive Cardiol, V13, P143
   STEIGER HJ, 1989, ACTA NEUROCHIR, V100, P108, DOI 10.1007/BF01403595
   Stonebridge PA, 1997, J VASC SURG, V26, P543, DOI 10.1016/S0741-5214(97)70051-X
   Storey GS, 1996, J NEUROSURG, V84, P883, DOI 10.3171/jns.1996.84.5.0883
   STREEM SB, 1982, SURG GYNECOL OBSTET, V155, P855
   SUNDT TM, 1986, J NEUROSURG, V65, P439, DOI 10.3171/jns.1986.65.4.0439
   Tam VKH, 2001, ANN THORAC SURG, V71, P1537, DOI 10.1016/S0003-4975(01)02467-5
   Taniai N, 2004, HEPATO-GASTROENTEROL, V51, P589
   TAYLOR RS, 1992, BRIT J SURG, V79, P348
   Tetik O, 2005, TEX HEART I J, V32, P186
   Tyrrell MR, 1997, EUR J VASC ENDOVASC, V14, P33, DOI 10.1016/S1078-5884(97)80222-5
   URAYAMA H, 1993, SURG TODAY, V23, P936, DOI 10.1007/BF00311377
   Vazquez MA, 2009, CURR OPIN NEPHROL HY, V18, P116, DOI 10.1097/MNH.0b013e328325d635
   Vesely TM, 2002, ADV RENAL REPLACE TH, V9, P99, DOI 10.1053/jarr.2002.33521
   VLASTOU C, 1988, Journal of Reconstructive Microsurgery, V4, P145, DOI 10.1055/s-2007-1006913
   WINDUS DW, 1993, AM J KIDNEY DIS, V21, P457, DOI 10.1016/S0272-6386(12)80391-X
   WOBBES T, 1983, CANCER-AM CANCER SOC, V52, P978, DOI 10.1002/1097-0142(19830915)52:6<978::AID-CNCR2820520608>3.0.CO;2-L
   YEH TJ, 1979, ANN THORAC SURG, V27, P409, DOI 10.1016/S0003-4975(10)63336-X
   Yetkin U, 2003, TEX HEART I J, V30, P293
   Yuan SM, 2007, INT J CARDIOL, V121, P196, DOI 10.1016/j.ijcard.2006.08.066
NR 136
TC 3
Z9 3
U1 0
U2 5
PU K FAISAL SPEC HOSP RES CENTRE
PI RIYADH
PA PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
SN 0256-4947
J9 ANN SAUDI MED
JI Ann. Saudi Med.
PD JAN-FEB
PY 2011
VL 31
IS 1
BP 62
EP 71
DI 10.4103/0256-4947.75781
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA 711RN
UT WOS:000286609200012
PM 21245602
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Melin, P
   Schnurer, J
   Hakansson, S
AF Melin, Petter
   Schnurer, Johan
   Hakansson, Sebastian
TI Formulation and stabilisation of the biocontrol yeast Pichia anomala
SO ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR
   MICROBIOLOGY
LA English
DT Article
DE Formulation; Freeze-drying; Fluidised bed drying; Vacuum drying;
   Biopreservation
ID CANDIDA-SAKE CPA-1; SPRAY-DRYING PROCESS; LONG-TERM STORAGE;
   BIOLOGICAL-CONTROL; CRYPTOCOCCUS-LAURENTII; POSTHARVEST PATHOGENS;
   RHODOTORULA-GLUTINIS; LIQUID FORMULATION; GREY MOLD; BLUE MOLD
AB The yeast Pichia anomala has antifungal activities and its potential in biocontrol and biopreservation has previously been demonstrated. To practically use an organism in such applications on a larger scale the microbe has to be formulated and stabilised. In this review we give an overview of our experience of formulating and stabilising P. anomala strain J121 in a wider perspective. The stabilisation techniques we have evaluated were liquid formulations, fluidised bed drying, lyophilisation (freeze-drying) and vacuum drying. With all methods tested it was possible to obtain yeast cells with shelf lives of at least a few months and in all cases the biocontrol activity was retained. Fluidised bed drying was dependent on the addition of cottonseed flour as a carrier during the drying process. In liquid formulations a sugar, preferentially trehalose, was a required additive. These two kinds of microbial stabilisation are easily performed and relatively inexpensive but in order to keep the cells viable the biomaterial has to be stored at cool temperatures. However, there is room for optimization, such as improving the growth conditions, or include preconditioning steps to enable the cells to produce more compatible solutes necessary to survive formulation, desiccation and storage. In contrast, lyophilisation and vacuum drying require a lot of energy and are thus expensive. On the other hand, the dried cells were mostly intact after one year of storage at 30A degrees C. Inevitably, the choice of formulation and stabilisation techniques will be dependent also on the intended use.
C1 [Melin, Petter; Schnurer, Johan; Hakansson, Sebastian] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden.
RP Hakansson, S (reprint author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, POB 7025, S-75007 Uppsala, Sweden.
EM sebastian.hakansson@mikrob.slu.se
RI Hakansson, Sebastian/B-1048-2008
FU Foundation for Strategic Environmental Research-MISTRA, Sweden
FX The authors would like to acknowledge the Foundation for Strategic
   Environmental Research-MISTRA, Sweden for financing the research
   programme DOM-Domestication of microorganisms.
CR Abadias M, 2005, BIOCONTROL SCI TECHN, V15, P835, DOI 10.1080/09583150500187041
   Abadias M, 2003, PHYTOPATHOLOGY, V93, P436, DOI 10.1094/PHYTO.2003.93.4.436
   Abadias M, 2000, J APPL MICROBIOL, V89, P1009, DOI 10.1046/j.1365-2672.2000.01207.x
   Bayrock D, 1997, FOOD RES INT, V30, P417, DOI 10.1016/S0963-9969(97)00072-0
   BJORNBERG A, 1993, CAN J MICROBIOL, V39, P623
   Canamas TP, 2008, J APPL MICROBIOL, V104, P767, DOI 10.1111/j.1365-2672.2007.03590.x
   Costa E, 2002, J FOOD PROTECT, V65, P185, DOI 10.4315/0362-028X-65.1.185
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   da Costa M S, 1998, Adv Biochem Eng Biotechnol, V61, P117
   Droby S, 1998, BIOL CONTROL, V12, P97, DOI 10.1006/bcon.1998.0615
   DROBY S, 1993, BIOL CONTROL, V3, P47, DOI 10.1006/bcon.1993.1008
   Druvefors U, 2002, FEMS YEAST RES, V2, P389, DOI 10.1016/S1567-1356(02)00091-0
   Druvefors UA, 2005, FEMS YEAST RES, V5, P373, DOI 10.1016/j.femsyr.2004.10.006
   Fan Q, 2001, POSTHARVEST BIOL TEC, V21, P341, DOI 10.1016/S0925-5214(00)00182-4
   Filonow AB, 1998, BIOCONTROL SCI TECHN, V8, P243, DOI 10.1080/09583159830315
   Fonseca F, 2004, BIOTECHNOL PROGR, V20, P229, DOI 10.1021/bp034136n
   HOHMANN S, 2003, YEAST STRESS REPONSE
   Janisiewicz WJ, 2001, PHYTOPATHOLOGY, V91, P1098, DOI 10.1094/PHYTO.2001.91.11.1098
   Jijakli MH, 1998, PHYTOPATHOLOGY, V88, P335, DOI 10.1094/PHYTO.1998.88.4.335
   Li BQ, 2006, J APPL MICROBIOL, V100, P854, DOI 10.1111/j.1365-2672.2006.02852.x
   Lima G, 1998, BIOCONTROL SCI TECHN, V8, P257, DOI 10.1080/09583159830324
   Luna-Solano G, 2005, J FOOD ENG, V68, P9, DOI 10.1016/j.jfoodeng.2004.05.019
   Manzanera M, 2004, FEMS MICROBIOL LETT, V233, P347, DOI 10.1016/j.femsle.2004.03.005
   Manzanera M, 2002, APPL ENVIRON MICROB, V68, P4328, DOI 10.1128/AEM.68.9.4328-4333.2002
   Masih EI, 2000, FEMS MICROBIOL LETT, V189, P233, DOI 10.1016/S0378-1097(00)00290-1
   Melin P, 2006, J APPL MICROBIOL, V100, P264, DOI 10.1111/j.1365-2672.2005.02778.x
   Melin P, 2007, APPL MICROBIOL BIOT, V73, P1008, DOI 10.1007/s00253-006-0552-x
   Mokiou S, 2008, BIOCONTROL SCI TECHN, V18, P1063, DOI 10.1080/09583150802585769
   PFAMMATTER N, 1989, BIOCHEM BIOPH RES CO, V161, P1244, DOI 10.1016/0006-291X(89)91376-4
   Schisler DA, 2004, PHYTOPATHOLOGY, V94, P1267, DOI 10.1094/PHYTO.2004.94.11.1267
   Schoug A, 2006, CRYOBIOLOGY, V53, P119, DOI 10.1016/j.cryobiol.2006.04.003
   Slininger PJ, 1996, APPL MICROBIOL BIOT, V45, P391, DOI 10.1007/s002530050701
   Spadaro D, 2002, POSTHARVEST BIOL TEC, V24, P123, DOI 10.1016/S0925-5214(01)00172-7
   Torres R, 2003, J APPL MICROBIOL, V94, P330, DOI 10.1046/j.1365-2672.2003.01843.x
   Zhang HY, 2009, BIOL CONTROL, V48, P79, DOI 10.1016/j.biocontrol.2008.09.004
   Zhang SA, 2005, PHYTOPATHOLOGY, V95, P626, DOI 10.1094/PHYTO-95-0626
NR 36
TC 17
Z9 19
U1 1
U2 36
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0003-6072
J9 ANTON LEEUW INT J G
JI Antonie Van Leeuwenhoek
PD JAN
PY 2011
VL 99
IS 1
BP 107
EP 112
DI 10.1007/s10482-010-9522-5
PG 6
WC Microbiology
SC Microbiology
GA 709TB
UT WOS:000286463200013
PM 20981571
DA 2018-10-20
ER

PT J
AU Vanea, E
   Simon, V
AF Vanea, E.
   Simon, V.
TI XPS study of protein adsorption onto nanocrystalline aluminosilicate
   microparticles
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Aluminosilicates; Nanostructured microparticles; Protein adsorption; XPS
ID INFLAMMATORY RESPONSES; POLYMERIC BIOMATERIALS; GLASS-CERAMICS; SURFACE;
   HYPERTHERMIA; MULLITE; ALBUMIN; NANOPARTICLES; SPECTROSCOPY; FILMS
AB X-ray photoelectron spectroscopy (XPS) was used to study the interaction of two different sized proteins, bovine serum albumin (BSA) and fibrinogen, with an aluminosilicate system containing yttrium and iron that is a potential biomaterial. Serum albumin and fibrinogen are two major plasma proteins and the most relevant proteins adsorbed on the surface of biomaterials in blood contact.
   The aluminosilicate samples were incubated for several exposure times, up to 24 h, in simulated body fluid enriched with BSA, and in buffered fibrinogen solution. Time dependence of proteins adsorption onto surface of the investigated samples is reflected by the evolution of the new N 1s photoelectron peak and by the modification of C 1s core-level spectra recorded from the samples immersed in protein solution. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Simon, V.] Univ Babes Bolyai, Fac Phys, R-3400 Cluj Napoca, Romania.
   Univ Babes Bolyai, Inst Interdisciplinary Res Bio Nanosci, R-3400 Cluj Napoca, Romania.
RP Simon, V (reprint author), Univ Babes Bolyai, Fac Phys, M Kogalniceanu 1, R-3400 Cluj Napoca, Romania.
EM viosimon@phys.ubbcluj.ro
RI Vanea, Emilia Sabina/D-8274-2013
FU CNCSIS Romania [PN II IDEI - PCCE 312/2008]
FX The authors acknowledge support under PN II IDEI - PCCE 312/2008 project
   of CNCSIS Romania. They also like to thank Monica Tamasan for X-ray
   diffraction results.
CR Abou Neel EA, 2009, J R SOC INTERFACE, V6, P435, DOI 10.1098/rsif.2008.0348
   Advincula M, 2005, COLLOID SURFACE B, V42, P29, DOI 10.1016/j.colsurfb.2004.12.009
   Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Arvidsson A, 2009, J MATER SCI-MATER M, V20, P1869, DOI 10.1007/s10856-009-3755-8
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   BALZAR D, 1993, AM MINERAL, V78, P1192
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Bibby JK, 2005, J MATER SCI-MATER M, V16, P379, DOI 10.1007/s10856-005-6975-6
   Borza Virginia Nazarica, 2009, International Journal of Nano and Biomaterials, V2, P540, DOI 10.1504/IJNBM.2009.028342
   Branda F, 2002, BIOMATERIALS, V23, P711, DOI 10.1016/S0142-9612(01)00173-9
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Chen TH, 2005, EARTH PLANET SC LETT, V240, P790, DOI 10.1016/j.epsl.2005.09.026
   DAY D, 1995, AM CERAM SOC BULL, V74, P64
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Eniu D, 2005, J MAGN MAGN MATER, V293, P310, DOI 10.1016/j.jmmm.2005.02.025
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   Gandhi Y, 2010, J APPL PHYS, V108, DOI 10.1063/1.3464257
   He F, 2009, MATER LETT, V63, P2631, DOI 10.1016/j.matlet.2009.09.014
   Hench LL, 2010, INT J APPL GLASS SCI, V1, P104, DOI 10.1111/j.2041-1294.2010.00001.x
   Hofer K.G., 2002, EUR CELLS MATER, V3, P67
   Hou P, 1999, J MATER RES, V14, P2952, DOI 10.1557/JMR.1999.0395
   Hyun SH, 1996, J MATER SCI LETT, V15, P1384, DOI 10.1007/BF00275283
   Iucci G, 2004, SURF INTERFACE ANAL, V36, P724, DOI 10.1002/sia.1747
   Kawashita M, 2001, J CERAM SOC JPN, V109, P39, DOI 10.2109/jcersj.109.39
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Lewandowski RJ, 2009, J VASC INTERV RADIOL, V20, P1557, DOI 10.1016/j.jvir.2009.08.021
   McArthur SL, 2006, SURF INTERFACE ANAL, V38, P1380, DOI 10.1002/sia.2498
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z
   Overgaard J, 2009, INT J HYPERTHER, V25, P323, DOI 10.1080/02656730903091986
   PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Serra J, 2003, J NON-CRYST SOLIDS, V332, P20, DOI 10.1016/j.jnoncrysol.2003.09.013
   Serro AP, 2006, J BIOMED MATER RES A, V78A, P581, DOI 10.1002/jbm.a.30754
   Simon V, 2007, J OPTOELECTRON ADV M, V9, P3368
   Simon V, 2009, SOLID STATE IONICS, V180, P764, DOI 10.1016/j.ssi.2009.02.011
   Speranza G, 1999, PHILOS MAG B, V79, P2145, DOI 10.1080/13642819908223104
   Sun YK, 2005, J MAGN MAGN MATER, V285, P65, DOI 10.1016/j.jmmm.2004.07.016
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   WHITE JE, 1994, KEY ENG MAT, V94-9, P181, DOI 10.4028/www.scientific.net/KEM.94-95.181
NR 44
TC 44
Z9 45
U1 2
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 1
PY 2011
VL 257
IS 6
BP 2346
EP 2352
DI 10.1016/j.apsusc.2010.09.101
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 695YK
UT WOS:000285408700090
DA 2018-10-20
ER

PT J
AU Miranda, SCCC
   Silva, GAB
   Hell, RCR
   Martins, MD
   Alves, JB
   Goes, AM
AF Miranda, Suzana C. C. C.
   Silva, Gerluza A. B.
   Hell, Rafaela C. R.
   Martins, Maximiliano D.
   Alves, Jose B.
   Goes, Alfredo M.
TI Three-dimensional culture of rat BMMSCs in a porous chitosan-gelatin
   scaffold: A promising association for bone tissue engineering in oral
   reconstruction
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Review
DE Chitosan-gelatin scaffold; Bone marrow mesenchymal stem cells; Tissue
   engineering; Tooth sockets
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BETA-TRICALCIUM PHOSPHATE;
   IN-VITRO; OSTEOGENIC DIFFERENTIATION; COMPOSITE SCAFFOLDS; CARTILAGE
   TISSUE; BIOMATERIALS; MATRIX; BIOCOMPATIBILITY
AB Objective: This study investigated the in vitro effects of a chitosan-gelatin scaffold on growth and osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMMSCs) in three-dimensional (3D) cultures and evaluated the biomaterial biocompatibility and degradability after its grafting into tooth sockets of rats.
   Design: A porous chitosan-gelatin scaffold cross-linked by glutaraldehyde was synthesised and characterised by light (LM), scanning electronic microscopy (SEM), energy dispersion spectroscopy (EDs) and X-ray diffraction (XRD). Rat BMMSCs were isolated, expanded and seeded onto scaffold using Dulbecco's Modified Eagle's Medium (DMEM) with or without an osteogenic supplement. Cell viability by MTT assay, alkaline phosphatase (ALP) activity and morphological LM and SEM analysis were performed after 1, 3, 8 and 14 days in culture. Free-cell scaffolds were implanted into tooth sockets of Lewis rats after upper first molars extraction. Fifteen male recipient rats were sacrificed after 5, 21 and 35 days for histological analysis.
   Results: Scaffold characterisation revealed the porous structure, organic and amorphous content. This biomaterial promoted the adhesion, spreading and in vitro viability of the BMMSCs. Osteogenic-supplemented media did not improve the cellular response compared to DMEM. The biomaterial presented high biocompatibility and slow biodegradation in vivo. Remains of biomaterial were still observed at 21 and 35 days after implantation. However, on the 21st day, alveolar bone and epithelial healing were completely established.
   Conclusions: These results indicate that chitosan-gelatin support the adhesion and osteogenic differentiation of rat BMMSCs and offer adequate physico-chemical and biological properties for use as scaffolds in bone tissue engineering-related strategies. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Alves, Jose B.] Univ Uberaba, Lab Biopathol & Mol Biol, BR-38055500 Uberaba, MG, Brazil.
   [Miranda, Suzana C. C. C.; Silva, Gerluza A. B.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Hell, Rafaela C. R.; Goes, Alfredo M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Martins, Maximiliano D.] Univ Fed Minas Gerais, Nucl Energy Natl Commiss, Nucl Technol Dev Ctr, Nanotechnol Serv, BR-31270901 Belo Horizonte, MG, Brazil.
RP Alves, JB (reprint author), Univ Uberaba, Lab Biopathol & Mol Biol, Nene Sabino Ave 1801, BR-38055500 Uberaba, MG, Brazil.
EM propg.pr@uniube.br
RI Martins, Maximiliano/G-6144-2010
OI Martins, Maximiliano/0000-0003-4010-8043
FU FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais/Brazil); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/Brazil)
FX This work was financially supported by FAPEMIG (Fundacao de Amparo a
   Pesquisa de Minas Gerais/Brazil) and CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/Brazil). The authors would like
   to thank Hello Chiarini-Garcia Ph.D. for assisting in the SEM studies
   and Estefane Lorraine Martins Vasconcelos for histological assistance.
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Ge ZG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/022001
   Healy K. E., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P328
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kanyama M, 2003, ARCH ORAL BIOL, V48, P723, DOI 10.1016/S0003-9969(03)00153-5
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009
   Kruyt MC, 2004, J BIOMED MATER RES B, V69B, P113, DOI 10.1002/jbm.b.10073
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   LIU SQ, 2007, BIOREGENERATIVE EN 2, P468
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Mello A, 2007, BIOMED MATER, V2, P67, DOI 10.1088/1748-6041/2/2/003
   Mendes RM, 2008, ARCH ORAL BIOL, V53, P1155, DOI 10.1016/j.archoralbio.2008.07.001
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rosenbaum Andrew J, 2008, Organogenesis, V4, P23
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Smejkal GB, 2001, J HISTOCHEM CYTOCHEM, V49, P1189, DOI 10.1177/002215540104900914
   Stanford Clark M, 2004, Gerodontology, V21, P71, DOI 10.1111/j.1741-2358.2004.00006.x
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun LP, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055008
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Valerio P, 2005, J MATER SCI-MATER M, V16, P851, DOI 10.1007/s10856-005-3582-5
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   WEINSTEINOPPENH.CR, 2010, J TRANSL MED, V8, P2
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
NR 53
TC 41
Z9 45
U1 3
U2 54
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JAN
PY 2011
VL 56
IS 1
BP 1
EP 15
DI 10.1016/j.archoralbio.2010.08.018
PG 15
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 710WT
UT WOS:000286548400001
PM 20887975
DA 2018-10-20
ER

PT J
AU Ibanez, A
   Trinidad, A
   Garcia-Berrocal, JR
   Gomez, D
   Roman, JS
   Ramirez-Camacho, R
AF Ibanez, A.
   Trinidad, A.
   Garcia-Berrocal, J. R.
   Gomez, D.
   Roman, J. San
   Ramirez-Camacho, R.
TI Biofilm colonisation in nasolacrimal stents
SO B-ENT
LA English
DT Article
DE Biofilms; lacrimal duct obstruction; epiphora; dacryocystitis;
   environmental scanning electron microscopy
ID POLYURETHANE STENT; DUCT OBSTRUCTION; DACRYOCYSTORHINOSTOMY; EPIPHORA;
   SYSTEM; TUBES
AB Biofilm colonisation in nasolacrimal stents. Problem/Objective: Nasolacrimal duct obstruction is a common problem. A Song stent is a useful and simple treatment with low morbidity. However, the success rate is limited, especially in long-term follow-up. The aim of the present study is to determine the presence of biofilms in failing nasolacrimal stents.
   Methodology: Thirty-three polyurethane nasolacrimal stents were implanted between January 2006 and December 2007 using Song's technique. Patients were followed for a mean of 21.5 months (range 11-30 months). Removed nasolacrimal stents were preserved in saline and examined using environmental scanning electron microscopy (ESEM).
   Results: Eighteen nasolacrimal stents were removed because of the failure of the device (follow-up range 11-30 months). Seven stents were recovered for this study. Biofilms were identified in all the specimens studied. Five prostheses showed occlusion caused by mucus or granulation tissue.
   Conclusions: Biofilm colonisation of nasolacrimal stents could play a major role in prosthetic failure leading to stent occlusion. Mucus, granulation tissue and irregularities of the biomaterial are factors that facilitate biofilm colonisation. Non-stick material for newly developed stents or drugs capable of destroying the polysaccharide matrix should be considered as future therapeutic options.
C1 [Ibanez, A.; Trinidad, A.; Garcia-Berrocal, J. R.; Ramirez-Camacho, R.] Hosp Univ Puerta Hierro Majadahonda, Dept Otorhinolaryngol, Madrid 28222, Spain.
   [Gomez, D.; Roman, J. San] Spanish Natl Res Council CSIC, Organ Chem Inst Lora Tamayo, Madrid, Spain.
RP Trinidad, A (reprint author), Hosp Univ Puerta Hierro Majadahonda, Dept Otorhinolaryngol, Manuel de Falla 1, Madrid 28222, Spain.
EM atrinid@yahoo.es
CR Backman S, 2009, LARYNGOSCOPE, V119, P657, DOI 10.1002/lary.20048
   Barakate M, 2007, J LARYNGOL OTOL, V121, P993, DOI 10.1017/S0022215107008870
   Bin Abdulhak AA, 2009, DIAGN MICR INFEC DIS, V63, P330, DOI 10.1016/j.diagmicrobio.2008.11.003
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Eloy P., 2009, B-ENT, V5, P179
   Falappa P, 2006, RADIOL MED, V111, P116, DOI 10.1007/s11547-006-0012-9
   Lanciego C, 2003, J VASC INTERV RADIOL, V14, P1417, DOI 10.1097/01.RVI.0000096763.74047.EF
   Lee JS, 2000, OPHTHALMOLOGY, V107, P1666, DOI 10.1016/S0161-6420(00)00225-6
   Leong SC, 2010, AMJ RHINOL ALLERGY, V24, P81, DOI 10.2500/ajra.2010.24.3393
   Muscariello L, 2005, J CELL PHYSIOL, V205, P328, DOI 10.1002/jcp.20444
   Nazaret S, 2009, J MICROBIOL METH, V76, P58, DOI 10.1016/j.mimet.2008.09.019
   Ozturk S, 2004, OPHTHAL PLAST RECONS, V20, P130, DOI 10.1097/01.IOP.0000115597.92546.D5
   Paul L, 2002, J VASC INTERV RADIOL, V13, P83, DOI 10.1016/S1051-0443(07)60013-X
   Quickert M H, 1970, Trans Am Acad Ophthalmol Otolaryngol, V74, P431
   Ramirez-Camacho R, 2008, ACTA OTORRINOLAR ESP, V59, P16, DOI 10.1016/S0001-6519(08)73252-7
   Song HY, 1998, RADIOLOGY, V208, P689, DOI 10.1148/radiology.208.3.9722847
   SONG HY, 1994, RADIOLOGY, V190, P535, DOI 10.1148/radiology.190.2.8284412
   SONG HY, 1993, RADIOLOGY, V186, P372, DOI 10.1148/radiology.186.2.8421737
   Tsirbas A, 2005, AM J RHINOL, V19, P322, DOI 10.1177/194589240501900319
   Watkins LM, 2003, SURV OPHTHALMOL, V48, P73, DOI 10.1016/S0039-6257(02)00397-1
   Yazici Z, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.2.1790491
NR 21
TC 8
Z9 8
U1 1
U2 2
PU ROYAL BELGIAN SOC EAR, NOSE, THROAT, HEAD & NECK SURGERY
PI LEUVEN
PA PO BOX 1248, LEUVEN, 00000, BELGIUM
SN 0001-6497
J9 B-ENT
JI B-ENT
PY 2011
VL 7
IS 1
BP 7
EP 10
PG 4
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 743SB
UT WOS:000289037900002
PM 21563550
DA 2018-10-20
ER

PT S
AU Rodrigues, LR
AF Rodrigues, Ligia R.
BE Linke, D
   Goldman, A
TI Inhibition of Bacterial Adhesion on Medical Devices
SO BACTERIAL ADHESION: CHEMISTRY, BIOLOGY AND PHYSICS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID CENTRAL VENOUS CATHETERS; SILICONE-RUBBER; VOICE PROSTHESES; BIOFILM
   FORMATION; PSEUDOMONAS-AERUGINOSA; MICROBIAL ADHESION; IN-VITRO;
   STREPTOCOCCUS-THERMOPHILUS; BIOSURFACTANT PRODUCTION;
   INFECTIOUS-DISEASES
AB Microbial infections resulting from bacterial adhesion to biomaterial surfaces have been observed on almost all medical devices. Biofilm infections pose a number of clinical challenges clue to their resistance to immune defence mechanisms and antimicrobials, and, regardless of the sophistication of the implant, all medical devices are susceptible to microbial colonisation and infection. Research efforts are currently directed towards eliminating or reducing infection of medical devices. Strategies to prevent biofilm formation include physiochemical modification of the biomaterial surface to create anti-adhesive surfaces, incorporation of antimicrobial agents into medical device polymers, mechanical design alternatives, and release of antibiotics. Nevertheless, the success of these alternatives has been modest, mainly due to the various environments into which devices are placed and the diversity of ways in which organisms can colonise surfaces. Biosurfactants have been reported as a promising strategy as they effectively inhibit bacterial adhesion and retard biofilm formation, and are thus potentially useful as a new generation of anti-adhesive and antimicrobial coatings for medical devices.
C1 Univ Minho, IBB Inst Biotechnol & Bioengn, Ctr Biol Engn, P-4710057 Braga, Portugal.
RP Rodrigues, LR (reprint author), Univ Minho, IBB Inst Biotechnol & Bioengn, Ctr Biol Engn, P-4710057 Braga, Portugal.
EM lrmr@deb.uminho.pt
OI Rodrigues, Ligia/0000-0001-9265-0630
CR ANDERSON JM, 2001, ANTIMICROB AGENTS CH, V31, P1175
   Blanchemain N, 2005, EUR J VASC ENDOVASC, V29, P628, DOI 10.1016/j.ejvs.2005.02.020
   Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x
   Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Busscher HJ, 1997, APPL ENVIRON MICROB, V63, P3810
   Cachia PJ, 2003, BIOPOLYMERS, V71, P141, DOI 10.1002/bip.10395
   Carratala J, 1999, ANTIMICROB AGENTS CH, V43, P2200, DOI 10.1128/AAC.43.9.2200
   Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974
   Castelli Patrizio, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS45
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5
   DEVER LL, 2000, INFECT ASSOCIATED EN, P307
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Eggiman P, 2000, INFECT ASS INDWELLIN, P247
   Falagas ME, 2007, J ANTIMICROB CHEMOTH, V59, P359, DOI 10.1093/jac/dkl522
   Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007
   Free RH, 2001, ANN OTO RHINOL LARYN, V110, P946, DOI 10.1177/000348940111001010
   Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667
   GOEAUBRISSONNIE.OA, 2000, INFECT ASS INDWELLIN, P127
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GOTTENBOS B, 2004, J MATER SCI-MATER M, V13, P717
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gudina EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x
   Gudina EJ, 2010, COLLOID SURFACE B, V76, P298, DOI 10.1016/j.colsurfb.2009.11.008
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   HANCOCK EW, 1994, HEART ARTERIES VEINS, P1539
   Heinemann C, 2000, FEMS MICROBIOL LETT, V190, P177, DOI 10.1016/S0378-1097(00)00331-1
   Heldman AW, 1996, AM J MED, V101, P68, DOI 10.1016/S0002-9343(96)00070-8
   HESSEN MT, 2000, INFECT ASS INDWELLIN, P325
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001
   JOLY V, 1987, ANTIMICROB AGENTS CH, V31, P1632, DOI 10.1128/AAC.31.10.1632
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847
   KARCHMER AW, 2000, INFECT ASS INDWELLIN, P145
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   LOPEZLOPEZ G, 1991, J MED MICROBIOL, V34, P349, DOI 10.1099/00222615-34-6-349
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   Manierski C, 2006, ADV CHRONIC KIDNEY D, V13, P245, DOI 10.1053/j.ackd.2006.04.003
   Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001
   Muthusamy K, 2008, CURR SCI INDIA, V94, P736
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Neu TR, 1996, MICROBIOL REV, V60, P151
   OLIVER MJ, 2000, INFECT ASS INDWELLIN, P345
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   PERDIGON G, 1986, INFECT IMMUN, V53, P404
   Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Raad I, 2002, ANTIMICROB AGENTS CH, V46, P327, DOI 10.1128/AAC.46.2.327-332.2002
   Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5
   Reid G, 2000, INT DAIRY J, V10, P415, DOI 10.1016/S0958-6946(00)00059-5
   Rivardo F, 2009, APPL MICROBIOL BIOT, V83, P541, DOI 10.1007/s00253-009-1987-7
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Rodrigues L, 2006, BIOCHEM ENG J, V28, P109, DOI 10.1016/j.bej.2005.06.001
   Rodrigues L, 2006, FEMS IMMUNOL MED MIC, V46, P107, DOI 10.1111/j.1574-695X.2005.00006.x
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Rodrigues L, 2004, APPL ENVIRON MICROB, V70, P4408, DOI 10.1128/AEM.70.7.4408-4410.2004
   Rodrigues LR, 2006, BIOCHEM ENG J, V32, P135, DOI 10.1016/j.bej.2006.09.012
   Rodrigues L, 2007, J BIOMED MATER RES B, V81B, P358, DOI 10.1002/jbm.b.30673
   Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Shenkman B, 2002, J MED MICROBIOL, V51, P747, DOI 10.1099/0022-1317-51-9-747
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001
   Teller M, 2007, J BIOMED MATER RES B, V81B, P23, DOI 10.1002/jbm.b.30631
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261
   Velraeds MMC, 1998, J MED MICROBIOL, V47, P1081, DOI 10.1099/00222615-47-12-1081
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   YOGEV R, 2000, INFECT ASS INDWELLIN, P231
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 77
TC 51
Z9 52
U1 2
U2 53
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-94-007-0939-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2011
VL 715
BP 351
EP 367
DI 10.1007/978-94-007-0940-9_22
D2 10.1007/978-94-007-0940-9
PG 17
WC Biochemistry & Molecular Biology; Biology; Medicine, Research &
   Experimental; Microbiology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Research & Experimental Medicine; Microbiology
GA BVF19
UT WOS:000291365200022
PM 21557075
DA 2018-10-20
ER

PT S
AU Gentile, P
   Chiono, V
   Tonda-Turo, C
   Sartori, S
   Ciardelli, G
AF Gentile, Piergiorgio
   Chiono, Valeria
   Tonda-Turo, Chiara
   Sartori, Susanna
   Ciardelli, Gianluca
BE Nyanhongo, GS
   Steiner, W
   Gubitz, GM
TI Biomimetic Materials for Medical Application Through Enzymatic
   Modification
SO BIOFUNCTIONALIZATION OF POLYMERS AND THEIR APPLICATIONS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Biomimetic; Tissue engineering; Transglutaminase; Tyrosinase
ID POLY(ETHYLENE GLYCOL) HYDROGELS; MICHAEL-TYPE ADDITION; MICROBIAL
   TRANSGLUTAMINASE; CROSS-LINKING; IN-VITRO; TISSUE ADHESIVE;
   CELL-MIGRATION; MUSSEL GLUE; FIBRIN GELS; FACTOR-XIII
AB Living organisms synthesize functional materials, based on proteins and polysaccharides, using enzyme-catalyzed reactions. According to the biomimetic approach, biomaterial matrices for tissue engineering are designed to be able to mimic the properties and the functions of the extracellular matrix (ECM). In this chapter, the most significant research efforts dedicated to the study and the preparation of biomimetic materials through enzymatic modifications were reviewed. The functionalizations of different polymeric matrices obtained through the catalytic activity of two enzymes (Transglutaminase, TGase and Tyrosinase, TYRase) were discussed. Specifically, the biomimetic applications of TGase and TYRase to confer appropriate biomimetic properties to the biomaterials, such as the possibility to obtain in situ gelling hydrogels and the incorporation of bioactive molecules (growth factors) and cell-binding peptides into the scaffolds, were reviewed.
C1 [Gentile, Piergiorgio; Chiono, Valeria; Tonda-Turo, Chiara; Sartori, Susanna; Ciardelli, Gianluca] Politecn Torino, Dept Mech, I-10129 Turin, Italy.
RP Ciardelli, G (reprint author), Politecn Torino, Dept Mech, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM gianluca.ciardelli@polito.it
RI Chiono, Valeria/G-3631-2014; Gentile, Piergiorgio/C-8664-2014
OI Gentile, Piergiorgio/0000-0002-3036-6594; Ciardelli,
   Gianluca/0000-0003-0199-1427
CR Aberg CM, 2004, J AGR FOOD CHEM, V52, P788, DOI 10.1021/jf034626v
   Aeschlimann Daniel, 1996, Seminars in Thrombosis and Hemostasis, V22, P437
   ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Barber TA, 2003, J BIOMED MATER RES A, V64A, P38, DOI 10.1002/jbm.a.10321
   Barbetta A, 2006, BIOMACROMOLECULES, V7, P3059, DOI 10.1021/bm060533l
   Biran R, 2001, J BIOMED MATER RES, V55, P1
   Bowness JM, 1998, BIOCHIM BIOPHYS ACTA, V967, P234
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Burke SA, 2007, BIOMED MATER, V2, P203, DOI 10.1088/1748-6041/2/4/001
   BURTON SG, 1994, CATAL TODAY, V22, P459, DOI 10.1016/0920-5861(94)80118-5
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chen TH, 2006, J BIOMED MATER RES B, V77B, P416, DOI 10.1002/jbm.b.30439
   Chen TH, 2003, BIOMACROMOLECULES, V4, P1558, DOI 10.1021/bm034145k
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196
   Chen TH, 2001, BIOMACROMOLECULES, V2, P456, DOI 10.1021/bm000125w
   Chiono V, 2008, ENG LIFE SCI, V8, P226, DOI 10.1002/elsc.200700069
   CHUNG SI, 1972, ANN NY ACAD SCI, V202, P240, DOI 10.1111/j.1749-6632.1972.tb16338.x
   Ciardelli G, 2007, P EPF EUR POL C 2 6, P140
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Damodaran G, 2009, ACTA BIOMATER, V5, P2441, DOI 10.1016/j.actbio.2009.03.018
   DE Jong GAH, 2002, J FOOD SCI, V67, P2798, DOI 10.1111/j.1365-2621.2002.tb08819.x
   Deacon MP, 1998, BIOCHEMISTRY-US, V37, P14108, DOI 10.1021/bi9806192
   Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H
   Demolliens A, 2008, BIOCONJUGATE CHEM, V19, P1849, DOI 10.1021/bc800066b
   Dinh SM, 1999, INTELLIGENT MAT CONT, V1, P13
   Dubbink HJ, 1998, GENOMICS, V51, P434, DOI 10.1006/geno.1998.5393
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fenoll LG, 2000, BIOL CHEM, V381, P313, DOI 10.1515/BC.2000.041
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053
   Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gentile P, 2010, J BIOMAT SCI-POLYM E, V21, P1207, DOI 10.1163/092050609X12481751806213
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200
   Hansen DC, 1998, LANGMUIR, V14, P1139, DOI 10.1021/la970881w
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1999, CURR OPIN SOLID ST M, V4, P381, DOI 10.1016/S1359-0286(99)00038-8
   Heggli M, 2003, BIOCONJUGATE CHEM, V14, P967, DOI 10.1021/bc0340621
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2
   ISAACS BS, 1989, BIOCHEMISTRY-US, V28, P842, DOI 10.1021/bi00428a065
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Jaros D, 2006, J TEXTURE STUD, V37, P113, DOI 10.1111/j.1745-4603.2006.00042.x
   Jee JG, 2000, RAPID COMMUN MASS SP, V14, P1563, DOI 10.1002/1097-0231(20000830)14:16<1563::AID-RCM45>3.0.CO;2-4
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   KANAJI T, 1993, J BIOL CHEM, V268, P11565
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kim SM, 2003, BIOCHEM BIOPH RES CO, V312, P642, DOI 10.1016/j.bbrc.2003.10.173
   Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lewis KB, 1997, BIOCHEMISTRY-US, V36, P995, DOI 10.1021/bi961636z
   Liu Y, 2009, J BIOMED MATER RES B, V91B, P5, DOI 10.1002/jbm.b.31368
   LORAND L, 1950, NATURE, V166, P694, DOI 10.1038/166694a0
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200
   Mayo KH, 1996, BIOPOLYMERS, V40, P359, DOI 10.1002/(SICI)1097-0282(1996)40:4<359::AID-BIP2>3.3.CO;2-K
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   McGuirl MA, 1999, CURR OPIN CHEM BIOL, V3, P138, DOI 10.1016/S1367-5931(99)80025-8
   Motoki M, 1998, TRENDS FOOD SCI TECH, V9, P204, DOI 10.1016/S0924-2244(98)00038-7
   Muzzarelli C, 2002, TRENDS GLYCOSCI GLYC, V14, P223, DOI 10.4052/tigg.14.223
   O Halloran DM, 2006, TISSUE ENG, V12, P1467, DOI 10.1089/ten.2006.12.1467
   Paguirigan AL, 2007, NAT PROTOC, V2, P1782, DOI 10.1038/nprot.2007.256
   Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892
   PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1
   SARKAR NK, 1957, BIOCHIM BIOPHYS ACTA, V25, P451, DOI 10.1016/0006-3002(57)90512-7
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   Shao LH, 1999, ENZYME MICROB TECH, V25, P660, DOI 10.1016/S0141-0229(99)00111-8
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   SIERRA DH, 1990, LARYNGOSCOPE, V100, P360
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   SINGH RN, 1994, EUR J BIOCHEM, V225, P625, DOI 10.1111/j.1432-1033.1994.00625.x
   SOBEL E, 1989, NEUROLOGY, V39, P669
   Sperinde JJ, 2000, MACROMOLECULES, V33, P5476, DOI 10.1021/ma000459d
   Sugumaran M., 1988, Advances in Insect Physiology, V21, P179, DOI 10.1016/S0065-2806(08)60124-1
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Takai O, 2006, ANN NY ACAD SCI, V1093, P84, DOI 10.1196/annals.1382.006
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Villalobos E, 2004, GENE, V336, P93, DOI 10.1016/j.gene.2004.03.025
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Westhaus E, 2001, BIOMATERIALS, V22, P453, DOI 10.1016/S0142-9612(00)00200-3
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
   Yamada K, 2008, J APPL POLYM SCI, V107, P2723, DOI 10.1002/app.27339
   Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L
   YASUEDA H, 1994, BIOSCI BIOTECH BIOCH, V58, P2041, DOI 10.1271/bbb.58.2041
   Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5
   Zhang JS, 1997, MOL REPROD DEV, V47, P302, DOI 10.1002/(SICI)1098-2795(199707)47:3<302::AID-MRD9>3.0.CO;2-P
   Zhao WX, 2009, TISSUE ENG PT A, V15, P991, DOI 10.1089/ten.tea.2008.0240
   Zhu Y, 1995, APPL MICROBIOL BIOT, V44, P277, DOI 10.1007/s002530050554
NR 115
TC 5
Z9 5
U1 1
U2 32
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
EI 1616-8542
BN 978-3-642-21949-8; 978-3-642-21948-1
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2011
VL 125
BP 181
EP 205
DI 10.1007/10_2010_85
D2 10.1007/978-3-642-21949-8
PG 25
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA BFR28
UT WOS:000321040500009
PM 21072699
DA 2018-10-20
ER

PT J
AU Bratt-Leal, AM
   Carpenedo, RL
   Ungrin, MD
   Zandstra, PW
   McDevitt, TC
AF Bratt-Leal, Andres M.
   Carpenedo, Richard L.
   Ungrin, Mark D.
   Zandstra, Peter W.
   McDevitt, Todd C.
TI Incorporation of biomaterials in multicellular aggregates modulates
   pluripotent stem cell differentiation
SO BIOMATERIALS
LA English
DT Article
DE Pluripotent stem cells; Microparticles; Spheroids; Aggregates;
   Differentiation
ID FIBROBLAST-GROWTH-FACTOR; ENHANCED NEURITE EXTENSION; EMBRYOID BODIES;
   IN-VITRO; EXTRACELLULAR-MATRIX; PRIMITIVE ENDODERM; PLGA MICROSPHERES;
   ENVIRONMENT; AGAROSE; BLASTOCYSTS
AB Biomaterials are increasingly being used to engineer the biochemical and biophysical properties of the extracellular stem cell microenvironment in order to tailor niche characteristics and direct cell phenotype. To date, stem cell-biomaterial interactions have largely been studied by introducing stem cells into artificial environments, such as 2D cell culture on biomaterial surfaces, encapsulation of cell suspensions within hydrogel materials, or cell seeding on 3D polymeric scaffolds. In this study, microparticles fabricated from different materials, such as agarose, PLGA and gelatin, were stably integrated, in a dose-dependent manner, within aggregates of pluripotent stem cells (PSCs) prior to differentiation as a means to directly examine stem cell-biomaterial interactions in 3D. Interestingly, the presence of the materials within the stem cell aggregates differentially modulated the gene and protein expression patterns of several differentiation markers without adversely affecting cell viability. Microparticle incorporation within 3D stem cell aggregates can control the spatial presentation of extracellular environmental cues (i.e. soluble factors, extracellular matrix and intercellular adhesion molecules) as a means to direct the differentiation of stem cells for tissue engineering and regenerative medicine applications. In addition, these results suggest that the physical presence of microparticles within stem cell aggregates does not compromise PSC differentiation, but in fact the choice of biomaterials can impact the propensity of stem cells to adopt particular differentiated cell phenotypes. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Bratt-Leal, Andres M.; Carpenedo, Richard L.; McDevitt, Todd C.] Emory Univ, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.
   [Ungrin, Mark D.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [McDevitt, Todd C.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP McDevitt, TC (reprint author), 313 Ferst Dr,Suite 2102, Atlanta, GA 30332 USA.
EM todd.mcdevitt@bme.gatech.edu
RI McDevitt, Todd/C-7323-2008
OI Ungrin, Mark/0000-0002-7410-1491
FU National Science Foundation [CBET 0651739]; National Institutes of
   Health [R01, GM088291]; Canadian Institutes of Health Research (CIHR)
   [MOP57885]; NIH [GM008433]; Goizueta Foundation; St. George's Society;
   Center of Drug Design, Development and Delivery
FX Financial support was provided by funding from the National Science
   Foundation (CBET 0651739), the National Institutes of Health R01
   (GM088291) and the Canadian Institutes of Health Research (CIHR;
   MOP57885). ABL is supported by a NIH training grant (GM008433) as well
   as funding from the Goizueta Foundation. MU is supported by a St.
   George's Society Fellowship at the McEwen Centre for Regenerative
   Medicine. PWZ is a Canada Research Chair in Stem Cell Bioengineering.
   RLC was supported by a GAANN fellowship from the Center of Drug Design,
   Development and Delivery. We are grateful for electron microscopy
   training and facilities provided by The Center for Nanostructure
   Characterization at Georgia Tech as well as use of core facilities
   provided by the Parker H. Petit Institute of Bioengineering and
   Bioscience.
CR ADAMS JC, 1993, DEVELOPMENT, V117, P1183
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bratt-Leal AM, 2009, BIOTECHNOL PROGR, V25, P43, DOI [10.1021/bp.139, 10.1002/btpr.139]
   Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523
   Carpenedo RL, 2010, J BIOMED MATER RES A, V94A, P466, DOI 10.1002/jbm.a.32710
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Chaudhry MA, 2009, BIOCHEM ENG J, V45, P126, DOI 10.1016/j.bej.2009.03.005
   Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020
   Chen Y, 2000, J INFRARED MILLIM W, V19, P19
   Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747
   DOETSCHMAN IC, 1985, J EMBRYO EXP MORPHOL, V87, P27
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esner M, 2002, INT J DEV BIOL, V46, P817
   Ferreira L, 2008, ADV MATER, V20, P2285, DOI 10.1002/adma.200702404
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   LEVENBERG H, 2003, P NATL ACAD SCI USA, V100, P12741
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560
   Moribe K, 2008, PHARM DEV TECHNOL, V13, P541, DOI 10.1080/10837450802309661 
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Rula ME, 2007, GENESIS, V45, P327, DOI 10.1002/dvg.20298
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   Wang N, 1997, Pharm Dev Technol, V2, P135, DOI 10.3109/10837459709022618
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 41
TC 96
Z9 96
U1 3
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 1
BP 48
EP 56
DI 10.1016/j.biomaterials.2010.08.113
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693IK
UT WOS:000285217600007
PM 20864164
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Leipzig, ND
   Wylie, RG
   Kim, H
   Shoichet, MS
AF Leipzig, Nic D.
   Wylie, Ryan G.
   Kim, Howard
   Shoichet, Molly S.
TI Differentiation of neural stem cells in three-dimensional growth
   factor-immobilized chitosan hydrogel scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cells; Hydrogel scaffolds; Chitosan; Neurons; Neurogenesis;
   IFN-gamma
ID TISSUE ENGINEERING APPLICATIONS; INTERFERON-GAMMA; PROGENITOR CELLS;
   FUSION PROTEIN; NERVE GROWTH; SPINAL-CORD; FUNCTIONAL IMMOBILIZATION;
   NEURONAL DIFFERENTIATION; MAMMALIAN FOREBRAIN; COLLAGEN SCAFFOLDS
AB The adult central nervous system (CNS) contains adult neural stem/progenitor cells (NSPCs) that possess the ability to differentiate into the primary cell types found in the CNS and to regenerate lost or damaged tissue. The ability to specifically and spatially control differentiation is vital to enable cell-based CNS regenerative strategies. Here we describe the development of a protein-biomaterial system that allows rapid, stable and homogenous linking of a growth factor to a photocrosslinkable material. A bioactive recombinant fusion protein incorporating pro-neural rat interferon-gamma (rIFN-gamma) and the AviTag for bio-tinylation was successfully expressed in Escherichia coli and purified. The photocrosslinkable biopolymer, methacrylamide chitosan (MAC), was thiolated, allowing conjugation of maleimide-strepatavidin via Michael-type addition. We demonstrated that biotin-rIFN-gamma binds specifically to MAC-streptavidin in stoichiometric yields at 100 and 200 ng/mL in photocrosslinked hydrogels. For cell studies. NSPCs were photo-encapsulated in 100 ng/mL biotin-rIFN-gamma immobilized MAC based scaffolds and compared to similar NSPC-seeded scaffolds combining 100 ng/mL soluble biotin-rIFN-gamma vs. no growth factor. Cells were cultured for 8 days after which differentiation was assayed using immunohistochemistry for lineage specific markers. Quantification showed that immobilized biotin-rIFN-gamma promoted neuronal differentiation (72.8 +/- 16.0%) similar to soluble biotin-rIFN-gamma (71.8 +/- 13.2%). The percentage of nestin-positive (stem/progenitor) cells as well as RIP-positive (oligodendrocyte) cells were significantly higher in scaffolds with soluble vs. immobilized biotin-rIFN-gamma suggesting that 3-D immobilization results in a more committed lineage specification. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Leipzig, Nic D.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada.
   [Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Wylie, Ryan G.; Shoichet, Molly S.] Univ Toronto, Dept Chem, Toronto, ON M5S 3E1, Canada.
   [Kim, Howard; Shoichet, Molly S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 160 Coll St,Room 514, Toronto, ON M5S 3E1, Canada.
EM molly.shoichet@utoronto.ca
FU NSERC; Ontario Ministry of Research and Innovation; Fonds Quebecois de
   la Recherche sur la Nature et les Technologies (FRQRNT); Vision Science
   Research Program; Ontario Neurotrauma Foundation; Advanced Food and
   Materials Network (AFM-Net)
FX We are grateful to partial funding from NSERC (Discovery grant to MSS),
   Ontario Ministry of Research and Innovation postdoctoral fellowship
   (NDL), Fonds Quebecois de la Recherche sur la Nature et les Technologies
   (FRQRNT) and Vision Science Research Program to RGW, Ontario Neurotrauma
   Foundation (HK) and the Advanced Food and Materials Network (AFM-Net to
   MSS). The authors would like to thank Dr. Tasneem Zahir for assistance
   with neural stem cell culture and assays, Dr. Ying Fang Chen for
   assistance with cell culture, Dr. Karen Maxwell for help and advice with
   recombinant protein production and Dr. Henry Krause for use of the AKTA
   FPLC.
CR AHMED S, 1995, J NEUROSCI, V15, P5765
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Andrades JA, 2001, GROWTH FACTORS, V18, P261, DOI 10.3109/08977190109029115
   Ayuso-Sacido A, 2008, NEUROSURGERY, V62, P223, DOI [10.1227/01.NEU.0000280154.19237.36, 10.1227/01.NEU.0000311081.50648.4C]
   Benoit BO, 2001, J NEUROBIOL, V46, P265, DOI 10.1002/1097-4695(200103)46:4<265::AID-NEU1007>3.0.CO;2-B
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916
   Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891
   Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9
   Gotz M, 2003, NEUROSCIENTIST, V9, P379, DOI 10.1177/1073858403257138
   HASHI H, 1994, CELL STRUCT FUNCT, V19, P37, DOI 10.1247/csf.19.37
   Hayashi M, 2001, BBA-GEN SUBJECTS, V1528, P187, DOI 10.1016/S0304-4165(01)00187-8
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Kazanis I, 2009, BRAIN, V132, P2909, DOI 10.1093/brain/awp237
   Kim SJ, 2007, NEUROCHEM RES, V32, P1399, DOI 10.1007/s11064-007-9323-z
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nakayama T, 2003, NEUROSCI RES, V46, P241, DOI 10.1016/S0168-0102(03)00063-4
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ota T, 2008, J THORAC CARDIOV SUR, V136, P1309, DOI 10.1016/j.jtcvs.2008.07.008
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shetty AK, 1998, J NEUROBIOL, V35, P395, DOI 10.1002/(SICI)1097-4695(19980615)35:4<395::AID-NEU7>3.0.CO;2-U
   Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891
   Walker PA, 2009, STEM CELL REV REP, V5, P283, DOI 10.1007/s12015-009-9081-1
   Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k
   Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d
   WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722
   Weiss S, 1996, J NEUROSCI, V16, P7599
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009
   YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069
   Yu LMY, 2010, BIOMATERIALS, V31, P6987, DOI 10.1016/j.biomaterials.2010.05.070
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412
   ZHANG ZH, 1993, J CELL BIOL, V122, P235, DOI 10.1083/jcb.122.1.235
NR 55
TC 106
Z9 110
U1 7
U2 107
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 1
BP 57
EP 64
DI 10.1016/j.biomaterials.2010.09.031
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693IK
UT WOS:000285217600008
PM 20934216
DA 2018-10-20
ER

PT J
AU Zhang, QW
   Mochalin, VN
   Neitzel, I
   Knoke, IY
   Han, JJ
   Klug, CA
   Zhou, JG
   Lelkes, PI
   Gogotsi, Y
AF Zhang, Qingwei
   Mochalin, Vadym N.
   Neitzel, Ioannis
   Knoke, Isabel Y.
   Han, Jingjia
   Klug, Christopher A.
   Zhou, Jack G.
   Lelkes, Peter I.
   Gogotsi, Yury
TI Fluorescent PLLA-nanodiamond composites for bone tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE Functionalized nanodiamond; Fixation devices; Nanocomposite; Fluorescent
   nanoparticle; Bone tissue engineering
ID WALLED CARBON NANOTUBES; MECHANICAL-PROPERTIES; POLY(LACTIC ACID);
   POLYMER COMPOSITE; FIBERS; NANOINDENTATION; PLA; NANOCOMPOSITES;
   NANOPARTICLES; NANOMATERIALS
AB Superior mechanical properties, rich surface chemistry, and good biocompatibility of diamond nanoparticles make them attractive in biomaterial applications. A multifunctional fluorescent composite bone scaffold material has been produced utilizing a biodegradable polymer, poly(L-lactic acid) (PLLA), and octadecylamine-functionalized nanodiamond (ND-ODA). The uniform dispersion of nanoparticles in the polymer led to significant increase in hardness and Young's modulus of the composites. Addition of 10% wt of ND-ODA resulted in more than 200% increase in Young's modulus and 800% increase in hardness, bringing the nanocomposite properties close to that of the human cortical bone. Testing of ND-ODA/PLLA as a matrix supporting murine osteoblast (7F2) cell growth for up to 1 week showed that the addition of ND-ODA had no negative effects on cell proliferation. ND-ODA serves as a multifunctional additive providing improved mechanical properties, bright fluorescence, and options for drug loading and delivery via surface modification. Thus ND-ODA/PLLA composites open up numerous avenues for their use as components of bone scaffolds and smart surgical tools such as fixation devices in musculoskeletal tissue engineering and regenerative medicine. Intense fluorescence of ND-ODA/PLLA scaffolds can be used to monitor bone re-growth replacing the implant in vivo. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Zhang, Qingwei; Lelkes, Peter I.] Drexel Univ, Coll Med, Philadelphia, PA 19102 USA.
   [Zhang, Qingwei; Zhou, Jack G.; Gogotsi, Yury] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19102 USA.
   [Zhang, Qingwei; Han, Jingjia; Lelkes, Peter I.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   [Mochalin, Vadym N.; Neitzel, Ioannis; Knoke, Isabel Y.; Gogotsi, Yury] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19102 USA.
   [Klug, Christopher A.] USN, Res Lab, Div Chem, Washington, DC 20375 USA.
RP Lelkes, PI (reprint author), Drexel Univ, Coll Med, Philadelphia, PA 19102 USA.
EM pilelkes@drexel.edu; gogotsi@drexel.edu
RI Gogotsi, Yury/B-2167-2008
OI Gogotsi, Yury/0000-0001-9423-4032; Knoke, Isabel/0000-0001-6261-9819;
   Mochalin, Vadym/0000-0001-7403-1043
FU NSF [CMMI-0927963]; Surgical Engineering Enterprise of the Drexel
   College of Medicine Strategic Initiative
FX We acknowledge support from NSF under the grant number CMMI-0927963 and
   by the Surgical Engineering Enterprise of the Drexel College of Medicine
   Strategic Initiative. Additionally, the authors are grateful to NanoBlox
   Inc. for providing the samples of nanodiamond used in this study. The
   Centralized Research Facility (CRF) of the College of Engineering,
   Drexel University provided access to nanoindenter and electron
   microscopes used in this work. We would also like to thank Shraddha
   Vachhani for her help in analyzing nanoindentation data and Teresa
   Ubieto for her help with XRD analysis.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Behler KD, 2009, ACS NANO, V3, P363, DOI 10.1021/nn800445z
   Bourmaud A, 2008, COMPOS PART A-APPL S, V39, P1444, DOI 10.1016/j.compositesa.2008.05.023
   Bradac C, 2010, NAT NANOTECHNOL, V5, P345, DOI [10.1038/NNANO.2010.56, 10.1038/nnano.2010.56]
   Chao JI, 2007, BIOPHYS J, V93, P2199, DOI 10.1529/biophysj.107.108134
   d'Almeida JRM, 2007, J REINF PLAST COMP, V26, P321, DOI 10.1177/0731684407072516
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   HENGSBERGER S, 2001, CELL MAT, V1, P12
   HOOGSTEEN W, 1990, MACROMOLECULES, V23, P634, DOI 10.1021/ma00204a041
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Kalidindi SR, 2008, ACTA MATER, V56, P3523, DOI 10.1016/j.actamat.2008.03.036
   Kruger A, 2005, CARBON, V43, P1722, DOI 10.1016/j.carbon.2005.02.020
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu IC, 2004, MACROMOLECULES, V37, P283, DOI 10.1021/ma0304168
   Lovell CS, 2009, POLYMER, V50, P1925, DOI 10.1016/j.polymer.2009.02.016
   Maitra U, 2009, SOLID STATE COMMUN, V149, P1693, DOI 10.1016/j.ssc.2009.06.017
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mochalin VN, 2009, J AM CHEM SOC, V131, P4594, DOI 10.1021/ja9004514
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Oksman K, 2003, COMPOS SCI TECHNOL, V63, P1317, DOI 10.1016/S0266-3538(03)00103-9
   Osswald S, 2006, J AM CHEM SOC, V128, P11635, DOI 10.1021/ja063303n
   Rettenbacher AS, 2005, CHEM-EUR J, V12, P376, DOI 10.1002/chem.200500517
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v
   Schrand Amanda M., 2009, P159, DOI 10.1007/978-0-387-78608-7_8
   Shenderova O, 2009, NANOMATERIALS HDB, P203
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shimkunas RA, 2009, BIOMATERIALS, V30, P5720, DOI 10.1016/j.biomaterials.2009.07.004
   Sui XM, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272012
   Wang ZG, 2001, POLYMER, V42, P8965, DOI 10.1016/S0032-3861(01)00374-3
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Wright-Charlesworth DD, 2005, J BIOMED MATER RES A, V74A, P388, DOI 10.1002/jbm.a.30353
   Xu M, 2003, CHEM PHYS LETT, V375, P598, DOI 10.1016/S0009-2614(03)00923-0
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 37
TC 188
Z9 192
U1 2
U2 147
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 1
BP 87
EP 94
DI 10.1016/j.biomaterials.2010.08.090
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693IK
UT WOS:000285217600011
PM 20869765
DA 2018-10-20
ER

PT J
AU Teo, EY
   Ong, SY
   Chong, MSK
   Zhang, ZY
   Lu, J
   Moochhala, S
   Ho, B
   Teoh, SH
AF Teo, Erin Yiling
   Ong, Shin-Yeu
   Chong, Mark Seow Khoon
   Zhang, Zhiyong
   Lu, Jia
   Moochhala, Shabbir
   Ho, Bow
   Teoh, Swee-Hin
TI Polycaprolactone-based fused deposition modeled mesh for delivery of
   antibacterial agents to infected wounds
SO BIOMATERIALS
LA English
DT Article
DE Polycaprolactone-tricalcium phosphate; Fused deposition modeling;
   Antibiotic delivery system; Infection control
ID IN-VITRO; GENTAMICIN SULFATE; COMPOSITES; RELEASE;
   POLY(EPSILON-CAPROLACTONE); OSTEOMYELITIS; DRESSINGS; SYSTEMS; VIVO;
   IMPLANTS
AB Infections represent a significant source of site morbidity following tissue trauma. Scarring and tissue adhesion remain the challenging issues yet to be solved. Prolonged inflammation and morphology of the re-epithelisated layer are important considerations. We hypothesized that the solution lies not only in the biochemistry of biomaterial but also the micro-architecture of the scaffold used as the matrix for wound healing. Targeted delivery of antibiotics may provide an efficacious means of infection control through adequate release. Here, we study the use of 3-dimensional polycaprolactone tricalcium phosphate (PCL-TCP) mesh for the delivery of gentamicin sulphate (GS) fabricated using a solvent-free method. PCL-TCP meshes incorporated with varying loads of GS were evaluated in vitro for elution profile, antimicrobial efficacy and cytotoxicity. Results showed that PCL-TCP meshes incorporated with 15wt% GS (PT15) efficiently eliminate bacteria within 2 h and demonstrate low cytotoxicity. Subsequently, PT15 meshes were evaluated using an infected full thickness wound mice model, and observed to eliminate bacteria in the wounds effectively. Additionally, mice from the PT15 treatment group (TG) showed no observable signs of overall infection through neutrophil count by day 7 and displayed efficient wound healing (94.2% wound area reduction) by day 14. Histology also showed significantly faster healing in TG through neo-collagen deposition and wound re-epithelisation. The meshes from TG were also observed to be expelled from wounds while gauze fibers from CG were integrated into wounds during healing. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Teo, Erin Yiling; Zhang, Zhiyong; Teoh, Swee-Hin] Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol BIOMAT, Dept Mech Engn, Fac Engn, Singapore 117548, Singapore.
   [Ong, Shin-Yeu; Lu, Jia; Moochhala, Shabbir] DSO Natl Labs, Combat Care Lab, Def Med & Environm Res Inst, Singapore, Singapore.
   [Chong, Mark Seow Khoon] Natl Univ Singapore, Yong Loo Lin Sch Med, Expt Fetal Med Grp, Dept Obstet & Gynaecol, Singapore 117595, Singapore.
   [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.
   [Teoh, Swee-Hin] Natl Univ Singapore, Tissue Engn Programme, Singapore 117548, Singapore.
RP Teoh, SH (reprint author), Natl Univ Singapore, Ctr Biomed Mat Applicat & Technol BIOMAT, Dept Mech Engn, Fac Engn, Singapore 117548, Singapore.
EM mpetsh@nus.edu.sg
RI Chong, Mark/D-2678-2013; zhang, zhiyong/G-3227-2010
OI Chong, Mark/0000-0002-9586-6303; zhang, zhiyong/0000-0001-7903-1544
CR Aronson NE, 2006, CLIN INFECT DIS, V43, P1045, DOI 10.1086/507539
   Aviv M, 2007, J BIOMED MATER RES A, V83A, P10, DOI 10.1002/jbm.a.31184
   Benoit MA, 1999, INT J PHARMACEUT, V184, P73, DOI 10.1016/S0378-5173(99)00109-X
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Chang HI, 2006, J CONTROL RELEASE, V110, P414, DOI 10.1016/j.jconrel.2005.10.028
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   Dow G, 1999, Ostomy Wound Manage, V45, P23
   Dow G, 1999, OSTOMY WOUND MANAG, P29
   Dow G, 1999, OSTOMY WOUND MANAG, V45, P41
   DREGHORN CR, 1989, BRIT MED J, V298, P648, DOI 10.1136/bmj.298.6674.648
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   Fraser JF, 2004, BURNS, V30, P35, DOI 10.1016/j.burns.2003.09.008
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Griffis CD, 2009, EXPERT OPIN DRUG DEL, V6, P639, DOI 10.1517/17425240902997919
   Haas A F, 1995, Dermatol Nurs, V7, P28
   HAAS AF, 1995, DERMATOL NURS, V7, P74
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Kingsley Andrew, 2003, Ostomy Wound Manage, V49, P1
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   Murray CK, 2006, MIL MED, V171, P826, DOI 10.7205/MILMED.171.9.826
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   PITT CG, 1979, J BIOMED MATER RES, V13, P497, DOI 10.1002/jbm.820130313
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   Rai B, 2005, J CONTROL RELEASE, V107, P330, DOI 10.1016/j.jconrel.2005.07.002
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   ROBSON M, 1994, EUR J CLIN MICROBIOL, V13, pS41, DOI 10.1007/BF01973601
   Selkon J B, 1981, J R Nav Med Serv, V67, P160
   Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   SHIOZUKA M, 2009, J BIOCH         1111
   Stallmann HP, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-18
   Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366
   Strodtbeck F., 2001, NEWBORN INFANT NURS, V1, P43, DOI DOI 10.1053/NBIN.2001.23176
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   WALDROP J, 1991, WOUND HEALING PHYSL
NR 48
TC 77
Z9 78
U1 6
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 1
BP 279
EP 287
DI 10.1016/j.biomaterials.2010.08.089
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693IK
UT WOS:000285217600032
PM 20870283
DA 2018-10-20
ER

PT J
AU Ariganello, MB
   Simionescu, DT
   Labow, RS
   Lee, JM
AF Ariganello, Marianne B.
   Simionescu, Dan T.
   Labow, Rosalind S.
   Lee, J. Michael
TI Macrophage differentiation and polarization on a decellularized
   pericardial biomaterial
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Acid phosphatase; Collagen; Matrix metalloproteinase;
   Cytokine; Biocompatibility
ID MONOCYTE-DERIVED MACROPHAGES; MULTINUCLEATED GIANT-CELLS; MATRIX
   METALLOPROTEINASES; EXTRACELLULAR-MATRIX; IN-VIVO; COMPLEMENT
   ACTIVATION; HEART-VALVES; TISSUE; EXPRESSION; U937
AB The monocyte-derived macrophage (MDM) present at biomaterial implantations can Increase decrease or redirect the inflammatory and subsequent wound healing process associated with the presence of a biomaterial Understanding MDM responses to biomaterials is important for improved prediction and design of biomaterials for tissue engineering This study analyzed the direct differentiation of monocytes on intact native collagen Human monocytes were differentiated on decellularized bovine pericardium (DBP) polydimethylsiloxane (PDMS) or polystyrene (TCPS) for 14 d MDMs on all surfaces released high amounts of MMP-9 compared to MMP-2 and relatively little MMP-1 MDMs differentiated on DBP released more MMP-2 but less acid phosphatase activity MDMs on all three surfaces released low amounts of cytokines although substrate differences were found MDMs on DBP released higher amounts of IL-6 IL-8 and MCP-1 but lower amounts of IL-10 and IL-1ra This research provides evidence that MDMs on decellularized matrices may not be stimulated towards an activated inflammatory phenotype supporting the potential of decellularized matrices for tissue engineering This study also demonstrated that the differentiation surface affects MDM phenotype and therefore study design of macrophage interactions with biomaterials should scrutinize the specific macrophage culture method utilized and its effects on macrophage phenotype (C) 2010 Elsevier Ltd All rights reserved
C1 [Ariganello, Marianne B.; Labow, Rosalind S.; Lee, J. Michael] Dalhousie Univ, Sch Biomed Engn, Halifax, NS B3H 1W2, Canada.
   [Simionescu, Dan T.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
   [Labow, Rosalind S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
RP Ariganello, MB (reprint author), Dalhousie Univ, Sch Biomed Engn, 5981 Univ Ave, Halifax, NS B3H 1W2, Canada.
FU NSERC (Natural Sciences and Engineering Research Council of Canada);
   Institute for Musculoskeletal Health and Arthritis (IMHA); Canadian
   Federation of University Women (CFUW); CIHR [STP53877]
FX Contract grant sponsor NSERC (Natural Sciences and Engineering Research
   Council of Canada); The authors would like to thank the Taichman
   Laboratory University of Ottawa Heart Institute for use of their
   facilities and Dr Heidi McBride at the University of Ottawa Heart
   Institute for use of the confocal microscope Ms Tanya McCarthy and Dr
   Chris Sinai were instrumental for QPCR analysis Special thanks go to Ms
   Sarah Connolly for her help with trouble-shooting immunoblotting and Ms
   Jiasi Chen for assistance with enzyme assays Pat Scallion provided
   valuable assistance with scanning electron microscopy made available at
   the Institute for Research and Materials (IRM) Dalhousie University Paul
   Briggs was invaluable as the phlebotomist for our blood volunteers The
   advice and technical assistance of Maxine Langman Faculty of Dentistry
   is also gratefully acknowledged M B Ariganello was funded through the
   generous support of the Natural Science and Engineering Research Council
   (NSERC) the Institute for Musculoskeletal Health and Arthritis (IMHA)
   the Canadian Federation of University Women (CFUW) and a CIHR Strategic
   Training Fellowship in Cell Signaling in Mucosal Inflammation and Pain
   STP53877 These studies were funded by a grant from the Natural Sciences
   and Engineering Research Council of Canada to J M Lee
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baldwin L, 2008, CYTOKINE, V41, P217, DOI 10.1016/j.cyto.2007.11.015
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   DONALDSON K, 1984, IMMUNOL COMMUN, V13, P229, DOI 10.3109/08820138409025464
   DREXLER HG, 1985, EUR J CANCER CLIN ON, V21, P1485, DOI 10.1016/0277-5379(85)90243-3
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kasimir MT, 2006, J HEART VALVE DIS, V15, P278
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LASSER A, 1983, HUM PATHOL, V14, P108, DOI 10.1016/S0046-8177(83)80239-1
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Matheson LA, 2006, BIOCHEM CELL BIOL, V84, P763, DOI 10.1139/O06-093
   McBane JE, 2009, J BIOMAT SCI-POLYM E, V20, P437, DOI 10.1163/156856209X416467
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McQuibban GA, 2002, BLOOD, V100, P1160
   Nishise S, 2006, DIGEST DIS SCI, V51, P934, DOI 10.1007/s10620-005-9050-8
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   POMARES LM, 1996, IMMUNOBIOLOGY, V195, P407
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Rogers PD, 2000, J INFECT DIS, V182, P1280, DOI 10.1086/315835
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Speidl WS, 2004, FASEB J, V18, P603, DOI 10.1096/fj.03-0454fje
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Wang X, 2008, CYTOKINE, V43, P15, DOI 10.1016/j.cyto.2008.04.009
   Williams TN, 2004, ARTERIOSCL THROM VAS, V24, P61, DOI 10.1161/01.ATV.0000104014.24367.16
NR 46
TC 46
Z9 48
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 2
BP 439
EP 449
DI 10.1016/j.biomaterials.2010.09.004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 695VU
UT WOS:000285401500012
PM 20933269
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ruvinov, E
   Leor, J
   Cohen, S
AF Ruvinov, Emil
   Leor, Jonathan
   Cohen, Smadar
TI The promotion of myocardial repair by the sequential delivery of IGF-1
   and HGF from an injectable alginate biomaterial in a model of acute
   myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Affinity binding; Alginate hydrogel; Hepatocyte growth factor; Insulin
   like growth factor 1; Myocardial regeneration
ID HEPATOCYTE GROWTH-FACTOR; FACTOR-I; VENTRICULAR-FUNCTION; TRANSCRIPTION
   FACTOR; WALL STRESS; CELL-CYCLE; RAT MODEL; HEART; BINDING; ANGIOGENESIS
AB Proper spatio-temporal delivery of multiple therapeutic proteins represents a major challenge in therapy strategies aimed at inducing myocardial regeneration after myocardial infarction (MI) We hypothesized that the dual delivery of insulin-like growth factor-1 (IGF-1) and hepatocyte growth factor (HGF) by injectable affinity-binding alginate biomaterial would maximize their therapeutic effects leading to a more favorable course of tissue restoration after acute MI A sequential release of IGF-1 followed by HGF was attained from affinity-binding alginate Immaterial which also protected the proteins from proteolysis (shown by mass spectroscopy) The released factors retained bioactivity as judged by their capability to activate their respective signaling pathways and to prevent cardiomyocyte apoptosis in vitro In a rat model of acute MI an intramyocardial injection of the dual IGF-1/HGF affinity-bound alginate biomaterial preserved scar thickness attenuated infarct expansion and reduced scar fibrosis after 4 weeks concomitantly with increased angiogenesis and mature blood vessel formation at the infarct Furthermore this treatment prevented cell apoptosis induced cardiomyocyte cell cycle re-entry and Increased the incidence of GATA-4-positive cell clusters The dual delivery of IGF-1 and HGF from affinity-binding alginate Immaterial represents a useful strategy to treat MI It showed a marked therapeutic efficacy at various tissue levels as well as potential to induce endogenous regeneration of cardiac muscle (C) 2010 Elsevier Ltd All rights reserved
C1 [Ruvinov, Emil; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Leor, Jonathan] Tel Aviv Univ, Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-84105 Beer Sheva, Israel.
RI Leor, Jonathan/O-2930-2017; COHEN, SMADAR/F-1901-2012
FU Israel Science Foundation [793/04, 1368/08]; European Union
FX The research was supported by grants from the Israel Science Foundation
   (793/04 to SC and 1368/08) and European Union FWP7 (INELPY) We thank
   Radka Holbova for excellent technical assistance This work was performed
   in partial fulfillment of the requirements of Emil Ruvinov for a PhD
   degree in the Department of Biotechnology Engineering Ben-Gurion
   University of the Negev Prof Cohen holds the Claire and Harold Oshry
   Professor Chair in Biotechnology
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Ausoni S, 2009, J CELL BIOL, V184, P357, DOI 10.1083/jcb.200810094
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Ebelt H, 2007, STEM CELLS, V25, P236, DOI 10.1634/stemcells.2006-0374
   Etzion S, 2001, J MOL CELL CARDIOL, V33, P1321, DOI 10.1006/jmcc.2001.1391
   Forrester JS, 2009, JACC-CARDIOVASC INTE, V2, P1, DOI 10.1016/j.jcin.2008.10.010
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   GANG OT, 2009, BIOMATERIALS, V30, P189
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Hao XQ, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.037501
   Harris WA, 2002, RAPID COMMUN MASS SP, V16, P1714, DOI 10.1002/rcm.775
   Hausenloy DJ, 2009, CARDIOVASC RES, V83, P179, DOI 10.1093/cvr/cvp062
   Hwang H, 2010, LIFE SCI, V86, P461, DOI 10.1016/j.lfs.2010.01.004
   Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899
   KARDAMI E, 1990, MOL CELL BIOCHEM, V92, P129
   Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lesman A, 2010, ANN NY ACAD SCI, V1188, P46, DOI 10.1111/j.1749-6632.2009.05082.x
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Liu Y, 2004, GEOCHIM COSMOCHIM AC, V68, pA688
   Loennechen JP, 2001, AM J PHYSIOL-HEART C, V280, pH2902
   Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104
   Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133
   Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003
   Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67
   Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025
   Reiss K, 1997, EXP CELL RES, V235, P198, DOI 10.1006/excr.1997.3669
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez M, 2005, J MOL CELL CARDIOL, V38, P15, DOI 10.1016/j.yjmcc.2004.11.002
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Ruvinov E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-7
   Rysa J, 2010, CIRC-HEART FAIL, V3, P440, DOI 10.1161/CIRCHEARTFAILURE.109.889642
   Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097
   Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809
   Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001
   Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA
   Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004
NR 43
TC 152
Z9 157
U1 2
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 2
BP 565
EP 578
DI 10.1016/j.biomaterials.2010.08.097
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 695VU
UT WOS:000285401500025
PM 20889201
DA 2018-10-20
ER

PT J
AU Chung, TW
   Yang, MC
   Tseng, CC
   Sheu, SH
   Wang, SS
   Huang, YY
   Chen, SD
AF Chung, Tze-Wen
   Yang, Ming-Chia
   Tseng, Chih-Chung
   Sheu, Sung-Hau
   Wang, Shoei-Shen
   Huang, Yi-You
   Chen, Shin-Der
TI Promoting regeneration of peripheral nerves in-vivo using new
   PCL-NGF/Tirofiban nerve conduits
SO BIOMATERIALS
LA English
DT Article
DE PCL nerve conduit; NGF/Tirofiban; Surface modification; Peripheral nerve
   regeneration; Beta III tubulin (TB)
ID HUMAN ENDOTHELIAL-CELLS; SPINAL-CORD-INJURY; RAT SCIATIC-NERVE;
   GROWTH-FACTOR; NEURITE OUTGROWTH; REPAIR; PROTEIN; STRATEGIES; RECOVERY;
   GUIDANCE
AB Poly(epsilon-caprolactone) (PCL) scaffolds were modified by grafting nerve growth factor (NGF) and Tirofiban (TF) a clinical anti-thrombosis drug as a new biomaterial for producing nerve conduits to promote the regeneration of sciatic nerves The successful grafting of NGF and TF onto PCL scaffolds was confirmed by FTIR and ESCA spectra In vitro growths of the PC12 cells in PCL-NGF and PCL-NGF/TF scaffolds determined by MTS were significantly higher (P < 005 n = 4) than those in the PCL scaffolds following three days of cultivation Interestingly this study evaluation of the PCL, PCL-NGF and PCL-NGF/TF nerve conduits in a 12 mm long gap of the rat sciatic nerve defect model that the gastrocnemius muscle mass of the tested rats in the PCL-NGF/TF groups significantly exceeded those in the PCL-NGF and PCL group In the rats that had been Implanted with PCL-NGF/TF conduits the generated nerves passed through those conduits expressing beta-III tubulin (TB) growth association protein-43 (GAP-43) and myelin basic protein (MBP) along their longitudinal axis and the proximal and distal nerve ends of the rats were successfully connected Those that had been implanted with PCL and PCL-NGF conduits did not exhibit these effects as revealed by an immunochemical study of the expressions of the proteins in the conduits Moreover counting within the dorsal horn of the spinal cord (C(5)) demonstrated that the numbers of CTB-HRP-labeled neurons in the rats that had been implanted with PCL-NGF/TF conduits were significantly higher than those in the other groups In this study in-vivo examinations of the use of newly designed PCL-NGF/TF conduits to promote the generation of nerves in a defective rat model significantly increased the gastrocnemius muscle mass and led to the successful regeneration of nerves that bridged a 12 mm long defected gap of nerves in rats However more rats must be tested to confirm the efficacy the newly designed nerve conduits (C) 2010 Elsevier Ltd All rights reserved
C1 [Chung, Tze-Wen; Chen, Shin-Der] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Lui 640, Yun Lin, Taiwan.
   [Yang, Ming-Chia; Tseng, Chih-Chung; Wang, Shoei-Shen] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.
   [Sheu, Sung-Hau] Natl Taiwan Univ, Coll Life Sci, Inst Zool, Taipei 106, Taiwan.
   [Huang, Yi-You] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Huang, Yi-You] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Lui 640, Yun Lin, Taiwan.
OI Wang, Shoei-Shen/0000-0003-3201-4143
FU National Science Council of the Republic of China Taiwan
FX The authors would like to thank the National Science Council of the
   Republic of China Taiwan for financially supporting this research Ted
   Knoy is appreciated for his editorial assistance The staffs at the
   seventh core lab department of medical research national Taiwan
   university hospital are appreciated for their technical support
CR Bednar RA, 1998, J PHARMACOL EXP THER, V285, P1317
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   BENOWITZ LI, 1988, J NEUROSCI, V8, P339
   Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7
   Chang CJ, 2006, BIOMATERIALS, V27, P1035, DOI 10.1016/j.biomaterials.2005.07.003
   Chen YS, 2004, BIOMATERIALS, V25, P509, DOI 10.1016/S0142-9612(03)00548-9
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2010, J MICROENCAPSUL, V27, P514, DOI 10.3109/02652048.2010.484104
   Chung TW, 2010, J MATER SCI-MATER M, V21, P1343, DOI 10.1007/s10856-009-3876-0
   Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427
   CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Howe CL, 2003, NEUROSCI LETT, V351, P41, DOI 10.1016/S0304-3940(03)00915-7
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huang MC, 2007, SURG NEUROL, V68, pS17, DOI 10.1016/j.sumeu.2006.09.031
   Jiang J, 2001, BIOORG CHEM, V29, P357, DOI 10.1006/bioo.2001.1227
   KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549
   Kokai LE, 2009, ACTA BIOMATER, V5, P2540, DOI 10.1016/j.actbio.2009.03.009
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Malushte TS, 2004, MUSCLE NERVE, V30, P609, DOI 10.1002/mus.20152
   Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Patel M, 2008, TISSUE ENG PART C-ME, V14, P365, DOI 10.1089/ten.tec.2008.0166
   ROSE NR, 1991, AM J EPIDEMIOL, V134, P1073, DOI 10.1093/oxfordjournals.aje.a116010
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9
   Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Wang SS, 2008, DRUG DELIV, V15, P149, DOI [10.1080/10717540801952456, 10.1080/10717540801952456 ]
   Weisman GA, 2005, MOL NEUROBIOL, V31, P169, DOI 10.1385/MN:31:1-3:169
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
NR 39
TC 38
Z9 40
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 3
BP 734
EP 743
DI 10.1016/j.biomaterials.2010.09.023
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 694TT
UT WOS:000285322600008
PM 20888633
DA 2018-10-20
ER

PT J
AU Shi, CY
   Chen, W
   Zhao, YN
   Chen, B
   Xiao, ZF
   Wei, ZL
   Hou, XL
   Tang, J
   Wang, ZX
   Dai, JW
AF Shi, Chunying
   Chen, Wei
   Zhao, Yannan
   Chen, Bing
   Xiao, Zhifeng
   Wei, Zhenliang
   Hou, Xianglin
   Tang, Jinglong
   Wang, Zhaoxu
   Dai, Jianwu
TI Regeneration of full-thickness abdominal wall defects in rats using
   collagen scaffolds loaded with collagen-binding basic fibroblast growth
   factor
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Basic fibroblast growth factor; Abdominal wall; Full thickness
   defect; Regeneration
ID IN-VIVO; POLYPROPYLENE MESHES; EXPERIMENTAL-MODEL; CONTROLLED-RELEASE;
   VENTRAL HERNIA; REPAIR; BFGF; VASCULARIZATION; HYDROGEL; MATRIX
AB Biomaterials are increasingly used in the repair of tissue defects The aim of the present study was to evaluate a new composite biomaterial for reconstruction of a 2 x 2 5 cm full-thickness abdominal wall defect In this study the collagen membrane was activated with the engineered human basic fibroblast growth factor ( bFGF) To enhance the binding of bFGF to collagen membranes a specific peptide of collagen-binding domain (CBD) was fused to the N-terminal of bFGF After implantation little adhesion was caused in collagen/CBD-bFGF collagen/NAT-bFGF and collagen/PBS groups Moreover collagen/CBD-bFGF group could effectively promote the vascularization at 30 d after surgery and significantly accelerate the integration of myofibers Into the collagen material at 90 d after surgery compared to the other two groups Due to the replacement of the myofibers in materials the mechanical strength of Implanted biomaterials in collagen/CBD-bFGF group was also greater than the other two groups at 90 d after surgery Thus the collagen/CBD-bFGF composite biomaterial was promising for the treatment of full-thickness abdominal wall defect (C) 2010 Elsevier Ltd All rights reserved
C1 [Shi, Chunying; Zhao, Yannan; Chen, Bing; Xiao, Zhifeng; Wei, Zhenliang; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
   [Shi, Chunying] Chinese Acad Sci, Grad Sch, Beijing 100090, Peoples R China.
   [Chen, Wei] Third Mil Med Univ, Xinqiao Hosp, Dept Urol, Chongqing 400037, Peoples R China.
   [Hou, Xianglin] Zhenghai Biotechnol Co Ltd, Yanta 264006, Shangdong, Peoples R China.
   [Tang, Jinglong; Wang, Zhaoxu] Natl Inst Control Pharmaceut & Biol Prod, Beijing 100050, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, 3 Nanyitiao, Beijing 100190, Peoples R China.
FU NSFC [30688002, 30930032]; Chinese Academy of Sciences [KSCX2-YW-R-133,
   KSCX2-YW-G-047, KJCX2-YW-108]; K C Wang Education Foundation
FX The authors thank Prof Jay Tang from Brown University for his comments
   This work was supported by grants from NSFC (30688002 30930032) Chinese
   Academy of Sciences (KSCX2-YW-R-133 KSCX2-YW-G-047 KJCX2-YW-108) and K C
   Wang Education Foundation
CR Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Baillie DR, 2007, OSTOMY WOUND MANAG, V53, P30
   Bellon JM, 2009, J BIOMED MATER RES B, V89B, P448, DOI 10.1002/jbm.b.31234
   Butler CE, 2006, CLIN PLAST SURG, V33, P199, DOI 10.1016/j.cps.2005.12.009
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen W, 2010, J UROLOGY, V183, P2432, DOI 10.1016/j.juro.2010.02.042
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Demir U, 2005, SURG TODAY, V35, P223, DOI 10.1007/s00595-004-2907-1
   Dubay DA, 2004, ANN SURG, V240, P179, DOI 10.1097/01.sla.0000131576.12153.ab
   Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Holton Luther H 3rd, 2005, J Long Term Eff Med Implants, V15, P547
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Lin H, 2006, BIOMATERIALS, V27, P5708, DOI 10.1016/j.biomaterials.2006.07.023
   Losi P, 2007, J MATER SCI-MATER M, V18, P1939, DOI 10.1007/s10856-007-3101-y
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   Pascual G, 2008, SURGERY, V144, P427, DOI 10.1016/j.surg.2008.04.005
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215
   Unger EF, 2000, AM J CARDIOL, V85, P1414, DOI 10.1016/S0002-9149(00)00787-6
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Wasserberg N, 2007, J SURG RES, V141, P294, DOI 10.1016/j.jss.2006.12.541
   Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565
   Zhao WX, 2007, J BIOMED MATER RES A, V82A, P630, DOI 10.1002/bjm.a.31179
   Zhao WX, 2009, TISSUE ENG PT A, V15, P991, DOI 10.1089/ten.tea.2008.0240
NR 36
TC 35
Z9 43
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 3
BP 753
EP 759
DI 10.1016/j.biomaterials.2010.09.038
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 694TT
UT WOS:000285322600010
PM 20937527
DA 2018-10-20
ER

PT J
AU Pritchard, EM
   Valentin, T
   Boison, D
   Kaplan, DL
AF Pritchard, Eleanor M.
   Valentin, Thomas
   Boison, Detlev
   Kaplan, David L.
TI Incorporation of proteinase inhibitors into silk-based delivery devices
   for enhanced control of degradation and drug release
SO BIOMATERIALS
LA English
DT Article
DE Controlled drug release; Silk; Biomaterials; Protease; Biodegradation
ID IN-VITRO; PLGA MICROSPHERES; ADENOSINE RELEASE; SUSTAINED-RELEASE;
   BOMBYX-MORI; FIBROIN; BIOMATERIALS; EDTA; SYSTEMS; BIODEGRADATION
AB Controlling the rate of silk degradation is critical to its potential use in biomedical applications including drug delivery and tissue engineering The effect of protease concentration on accelerating degradation and the use of ethylenediamine tetraacetic acid (EDTA) on reducing rates of degradation and on drug release from silk-based drug carriers was studied Increased rates of proteolysis resulted in increased dye release from silk carriers while EDTA release from the silk carriers inhibited proteolysis The sustained release of EDTA from silk carriers in combination with the release of the small molecule anti-convulsant adenosine was investigated in vitro This combination of factors resulted in delayed release of adenosine by inhibiting proteolytic activity These results introduce a promising strategy to control drug delivery through the regulation of silk degradation rate achieved via manipulation of local proteolytic activity This ability to modulate enzyme function could be applicable to a range of silk Immaterial formats as well as other biodegradable polymers where enzymatic functions control biomaterial degradation and drug release rates (C) 2010 Elsevier Ltd All rights reserved
C1 [Pritchard, Eleanor M.; Valentin, Thomas; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Boison, Detlev] Legacy Res, Robert S Dow Neurobiol Labs, Portland, OR 97232 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
OI Boison, Detlev/0000-0002-7740-5781
FU National Institute of Neurological Disorders and Stroke [R01NS058780]
FX This project was supported by grant R01NS058780 from the National
   Institute of Neurological Disorders and Stroke and by the Epilepsy
   Research Foundation through the generous support of the Arlene and
   Arnold Goldstein Family Foundation
CR Aigner T, 2003, ADV DRUG DELIVER REV, V55, P1569, DOI 10.1016/j.addr.2003.08.009
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bernstein HG, 2005, PROTEASES BRAIN
   Beynon R., 2001, PROTEOLYTIC ENZYMES
   Burrell MM, 1994, ENZYMES MOL BIOL, P271
   Cacchio A, 2009, ARTHRIT RHEUM-ARTHR, V61, P84, DOI 10.1002/art.24370
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Chau Y, 2004, BIOCONJUGATE CHEM, V15, P931, DOI 10.1021/bc0499174
   Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6
   DANCKWERTS M, 1991, DRUG DEV IND PHARM, V17, P1465, DOI 10.3109/03639049109026629
   Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011
   Dorta MJ, 2002, INT J PHARM, V248, P149, DOI 10.1016/S0378-5173(02)00431-3
   Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559
   EE Sterchi, 1999, PROTEOLYTIC ENZYMES
   Ellis MR, 2000, AM FAM PHYSICIAN, V62, P545
   Evans DAP, 2001, DIABETES OBES METAB, V3, P417, DOI 10.1046/j.1463-1326.2001.00154.x
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1996, PHARM SCI, V2, P1
   FURIA TE, 1964, FOOD TECHNOL-CHICAGO, V18, P1874
   Girish KS, 2006, LIFE SCI, V78, P1433, DOI 10.1016/j.lfs.2005.07.015
   Gracia RC, 2007, AM J HEALTH-SYST PH, V64, P45, DOI 10.2146/ajhp060175
   Hewitt CW, 1996, TRANSPLANT P, V28, P922
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Ihedioha JI, 2007, J COMP PATHOL, V136, P206, DOI 10.1016/j.jcpa.2007.01.003
   Jeong J, 2010, J CHROMATOGR B, V878, P836, DOI 10.1016/j.jchromb.2010.01.034
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KINCL FA, 1980, ENDOCRINOL EXP, V14, P27
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Lacerda SHD, 2005, BIOMATERIALS, V26, P7164, DOI 10.1016/j.biomaterials.2005.05.032
   Lamas Gervasio A, 2006, Complement Ther Clin Pract, V12, P213, DOI 10.1016/j.ctcp.2006.04.002
   Lambert RJW, 2004, J APPL MICROBIOL, V96, P244, DOI 10.1046/j.1365-2672.2004.02135.x
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Law B, 2006, BIOMACROMOLECULES, V7, P1261, DOI 10.1021/bm050920f
   LEBOVITS AH, 1990, CANCER, V65, P17, DOI 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I
   Lesniak MS, 2005, ANTICANCER RES, V25, P3825
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LICASTRO F, 1994, ALZ DIS ASSOC DIS, V8, P241, DOI 10.1097/00002093-199408040-00003
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   Maniscalco Benedict S., 2004, Pathophysiology, V11, P95, DOI 10.1016/j.pathophys.2004.06.001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537
   Nuanchai K., 2009, BIOTECHNOLOGY, V8, P468, DOI [10.3923/biotech.2009.468.472, DOI 10.3923/BIOTECH.2009.468.472]
   Numata K, 2010, ADV DRUG DE IN PRESS
   Numata K, 2010, BIOCHEMISTR IN PRESS
   OHARA TM, 1995, J VET DIAGN INVEST, V7, P531, DOI 10.1177/104063879500700419
   Ostergaard J, 2005, EUR J PHARM SCI, V26, P280, DOI 10.1016/j.ejps.2005.06.008
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   PUTNAM D, 1995, BIOCONJUGATE CHEM, V6, P483, DOI 10.1021/bc00034a019
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roberts MH, 2002, ADV DRUG DELIV REV, V54, P439
   Rucavado A, 2000, AM J TROP MED HYG, V63, P313, DOI 10.4269/ajtmh.2000.63.313
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   SCHMITT EA, 1994, MACROMOLECULES, V27, P743, DOI 10.1021/ma00081a019
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SORENSEN K, 1992, ANAL BIOCHEM, V206, P210, DOI 10.1016/S0003-2697(05)80037-5
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WARD DR, 1969, J PHARM SCI, V58, P1464, DOI 10.1002/jps.2600581208
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   WOOLEY RE, 1983, VET MICROBIOL, V8, P271, DOI 10.1016/0378-1135(83)90079-2
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Yoshioka T, 2008, BIOMATERIALS, V29, P3438, DOI 10.1016/j.biomaterials.2008.04.011
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   ZHANG XC, 1995, J CONTROL RELEASE, V34, P175, DOI 10.1016/0168-3659(94)00124-D
   Zhou SB, 2004, J APPL POLYM SCI, V91, P1848, DOI 10.1002/app.13385
   Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034
   Zolnik BS, 2006, J CONTROL RELEASE, V112, P293, DOI 10.1016/j.jconrel.2006.02.015
NR 82
TC 34
Z9 37
U1 4
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2011
VL 32
IS 3
BP 909
EP 918
DI 10.1016/j.biomaterials.2010.09.055
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 694TT
UT WOS:000285322600026
PM 20950854
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yamada, Y
   Nomizu, M
AF Yamada, Y.
   Nomizu, M.
TI Peptide/agarose Matrices as a New Biomaterial
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 22nd American Peptide Symposium
CY JUN 25-30, 2011
CL San Diego, CA
SP Amer Peptide Soc
C1 [Yamada, Y.; Nomizu, M.] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Tokyo 1920392, Japan.
CR Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Yamada Y., 2011, BIOMATERIAL IN PRESS
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
NR 3
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2011
VL 96
IS 4
BP 456
EP 456
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 779FL
UT WOS:000291763400191
DA 2018-10-20
ER

PT J
AU Zakhama, S
   Dhaouadi, H
   M'Henni, F
AF Zakhama, S.
   Dhaouadi, H.
   M'Henni, F.
TI Nonlinear modelisation of heavy metal removal from aqueous solution
   using Ulva lactuca algae
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Ulva lactuca; Heavy metals; Adsorption; Kinetic data modeling; Isotherm
ID MARINE MACROALGA; BIOMASS; BIOSORPTION; ADSORPTION; EQUILIBRIUM;
   SORPTION; CU(II); GREEN; IONS; BIOSORBENT
AB After extensive analysis, Ulva lactuca dried algae, collected from the Monastir coastal zone, was proven to be successful as an adsorbent for the removal of certain inorganic pollutants. The main objective of this study was the nonlinear modeling of heavy metal removal from an aqueous solution, using a freely available and well analyzed biomaterial, as well as the evaluation of its efficacy on various metal ion sorptions. Although relatively low specific surface area, compared to more conventional adsorbents, the selected biomaterial displays very interesting retention capacities when used with aqueous inorganic pollutants. The pseudo, first and second-order kinetic models were used to investigate the kinetic retention mechanism. Assuming the nonlinear form, the results indicate that the retention mechanism is diffusion controlled. Concerning the heavy metal uptake capacity, it was found that the selected biomaterial has a retention capacity of 67 mg g(-1) of Ni(II), 112 mg g(-1) of Cu(II), 127 mg g(-1) of Cd(II) and 230 mg g(-1) of Pb(II). (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Zakhama, S.; Dhaouadi, H.; M'Henni, F.] Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl, Monastir, Tunisia.
RP Dhaouadi, H (reprint author), Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl, Monastir, Tunisia.
EM hatem.dhaouadi@fsm.rnu.tn
RI Dhaouadi, Hatem/J-2055-2015
OI Dhaouadi, Hatem/0000-0002-5833-0518
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Ahmady-Asbchin S, 2008, BIORESOURCE TECHNOL, V99, P6150, DOI 10.1016/j.biortech.2007.12.040
   Bhatnagar A, 2010, COLLOID SURFACE B, V76, P544, DOI 10.1016/j.colsurfb.2009.12.016
   BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   Boehm HP, 2002, CARBON, V40, P145, DOI 10.1016/S0008-6223(01)00165-8
   BRADY JM, 1995, ENZYME MICROB TECH, V17, P791, DOI 10.1016/0141-0229(95)00142-R
   Contescu A, 1997, CARBON, V35, P83, DOI 10.1016/S0008-6223(96)00125-X
   Dhaouadi H, 2009, J HAZARD MATER, V164, P448, DOI 10.1016/j.jhazmat.2008.08.029
   EI-Sikaily A, 2007, J HAZARD MATER, V148, P216, DOI 10.1016/j.jhazmat.2007.01.146
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Gupta N, 2010, BIORESOURCE TECHNOL, V101, P3355, DOI 10.1016/j.biortech.2009.12.024
   Haario H., 1994, MODEST USERS GUIDE
   Han RP, 2006, J HAZARD MATER, V137, P480, DOI 10.1016/j.jhazmat.2006.02.018
   Hanif A, 2009, ECOL ENG, V35, P1427, DOI 10.1016/j.ecoleng.2009.05.013
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   LASZLO K, 2001, ANAL SCI, V17, P1741
   Martin-Lara MA, 2009, BIOCHEM ENG J, V44, P151, DOI 10.1016/j.bej.2008.11.012
   Masakorala K, 2008, ENVIRON POLLUT, V156, P897, DOI 10.1016/j.envpol.2008.05.030
   Miretzky P, 2010, BIORESOURCE TECHNOL, V101, P2637, DOI 10.1016/j.biortech.2009.10.067
   Monier M, 2010, J HAZARD MATER, V176, P348, DOI 10.1016/j.jhazmat.2009.11.034
   Murphy V, 2007, WATER RES, V41, P731, DOI 10.1016/j.watres.2006.11.032
   Ofomaja AE, 2010, BIORESOURCE TECHNOL, V101, P3844, DOI 10.1016/j.biortech.2009.10.064
   Raungsomboon S, 2008, BIORESOURCE TECHNOL, V99, P5650, DOI 10.1016/j.biortech.2007.10.056
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Romera E, 2006, CRIT REV BIOTECHNOL, V26, P223, DOI 10.1080/07388550600972153
   Saeed A, 2005, SEP PURIF TECHNOL, V45, P25, DOI 10.1016/j.seppur.2005.02.004
   Sari A, 2008, J HAZARD MATER, V152, P302, DOI 10.1016/j.jhazmat.2007.06.097
   Singh V, 2009, BIORESOURCE TECHNOL, V100, P1977, DOI 10.1016/j.biortech.2008.10.034
   TOBIN JM, 1984, APPL ENVIRON MICROB, V47, P821
   Turner A, 2008, MAR CHEM, V110, P176, DOI 10.1016/j.marchem.2008.04.003
   Turner A, 2007, MAR CHEM, V105, P271, DOI 10.1016/j.marchem.2007.02.009
   Vijayaraghavan K, 2005, CHEMOSPHERE, V60, P419, DOI 10.1016/j.chemosphere.2004.12.016
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Wu J, 2010, J HAZARD MATER, V176, P697, DOI 10.1016/j.jhazmat.2009.11.088
   Zeroual Y, 2003, BIORESOURCE TECHNOL, V90, P349, DOI 10.1016/S0960-8524(03)00122-6
   Zheng LC, 2010, J HAZARD MATER, V176, P650, DOI 10.1016/j.jhazmat.2009.11.081
NR 37
TC 35
Z9 36
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD JAN
PY 2011
VL 102
IS 2
BP 786
EP 796
DI 10.1016/j.biortech.2010.08.107
PG 11
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 714BU
UT WOS:000286782700052
PM 20855200
DA 2018-10-20
ER

PT J
AU Subramanian, P
   Sampathrajan, A
   Venkatachalam, P
AF Subramanian, P.
   Sampathrajan, A.
   Venkatachalam, P.
TI Fluidized bed gasification of select granular biomaterials
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Granular biomaterials; Fluidized bed gasification; Equivalence ratio;
   Bed temperature; Hot gas efficiency
ID STEAM-GASIFICATION; BIOMASS; GASIFIER
AB Biomaterials can be converted into solid, liquid and gaseous fuels through thermochemical or biochemical conversion processes. Thermochemical conversion of granular biomaterials is difficult because of its physical nature and one of the suitable processes is fluidized bed gasification. In this study, coir pith, rice husk and saw dust were selected and synthetic gas was generated using a fluidized bed gasifier. Gas compositions of product gas were analyzed and the percentage of carbon monoxide and carbon dioxide was in the range of 8.24-19.55 and 10.21-17.14, respectively. The effect of equivalence ratio (0.3, 0.4 and 0.5) and reaction time (at 10 min interval) on gas constituents was studied. The gas yield for coir pith, rice husk and sawdust were found to be in the range of 1.98-3.24, 1.79-2.81 and 2.18-3.70 Nm(3) kg(-1), respectively. Models were developed to study the influence of biomaterial properties and operating conditions on molar concentration of gas constituents and energy output. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Subramanian, P.] Tamil Nadu Agr Univ, Dept Bioenergy, Agr Engn Coll, Coimbatore 641003, Tamil Nadu, India.
   Tamil Nadu Agr Univ, Res Inst, Coimbatore 641003, Tamil Nadu, India.
RP Subramanian, P (reprint author), Tamil Nadu Agr Univ, Dept Bioenergy, Agr Engn Coll, Coimbatore 641003, Tamil Nadu, India.
EM manianpasu@yahoo.com
FU Indian Council of Agricultural Research, New Delhi; Tamil Nadu
   Agricultural University, Coimbatore
FX The authors acknowledge the infrastructural, technical and financial
   help rendered by Indian Council of Agricultural Research, New Delhi and
   Tamil Nadu Agricultural University, Coimbatore.
CR Altafini CR, 2003, ENERG CONVERS MANAGE, V44, P2763, DOI 10.1016/S0196-8904(03)00025-6
   Bala B. K., 1997, DRYING STORAGE CEREA
   BINGYAN X, 1985, ENERGY BIOMASS WASTE, V9
   CZERNIK S, 1992, BIOMASS ENERGY IN 10, V423, P37
   Franco C, 2003, FUEL, V82, P835, DOI 10.1016/S0016-2361(02)00313-7
   Hanb J., 2008, BIORESOURCE TECHNOL, V99, P3782
   Henderson S. M., 1966, SIZE REDUCTION AGR P, P128
   Li XT, 2004, BIOMASS BIOENERG, V26, P171, DOI 10.1016/S0961-9534(03)00084-9
   Lin CL, 2002, POWDER TECHNOL, V126, P297, DOI 10.1016/S0032-5910(02)00074-8
   LUOA S, 2010, BIORESOURCE TECHNOL, V101, P6517
   Mansaray KG, 1999, BIOMASS BIOENERG, V17, P315, DOI 10.1016/S0961-9534(99)00046-X
   Mathieu P, 2002, ENERG CONVERS MANAGE, V43, P1291, DOI 10.1016/S0196-8904(02)00015-8
   RAMJANI SA, 2000, THESIS TAMIL NADU AG
   Rapagna S, 2000, BIOMASS BIOENERG, V19, P187, DOI 10.1016/S0961-9534(00)00031-3
   van Der Drift A., 2001, BIOMASS BIOENERG, V20, P45
   Weerachanchai P, 2009, BIORESOURCE TECHNOL, V100, P1419, DOI 10.1016/j.biortech.2008.08.002
   Yan HM, 1998, FUEL, V77, P1067, DOI 10.1016/S0016-2361(98)00003-9
NR 17
TC 21
Z9 22
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD JAN
PY 2011
VL 102
IS 2
BP 1914
EP 1920
DI 10.1016/j.biortech.2010.08.022
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 714BU
UT WOS:000286782700207
PM 20817445
DA 2018-10-20
ER

PT J
AU He, JK
   Du, YA
   Guo, YQ
   Hancock, MJ
   Wang, B
   Shin, H
   Wu, JH
   Li, DC
   Khademhosseini, A
AF He, Jiankang
   Du, Yanan
   Guo, Yuqi
   Hancock, Matthew J.
   Wang, Ben
   Shin, Hyeongho
   Wu, Jinhui
   Li, Dichen
   Khademhosseini, Ali
TI Microfluidic Synthesis of Composite Cross-Gradient Materials for
   Investigating Cell-Biomaterial Interactions
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE cross gradient; microfluidics; cell-biomaterial interactions
ID GELATIN SCAFFOLDS; COMBINATORIAL; CHITOSAN; GENERATION; HYDROGELS;
   BLENDS
AB Combinatorial material synthesis is a powerful approach for creating composite material libraries for the high-throughput screening of cell-material interactions. Although current combinatorial screening platforms have been tremendously successful in identifying target (termed "hit") materials from composite material libraries, new material synthesis approaches are needed to further optimize the concentrations and blending ratios of the component materials. Here we employed a microfluidic platform to rapidly synthesize composite materials containing cross-gradients of gelatin and chitosan for investigating cell-biomaterial interactions. The microfluidic synthesis of the cross-gradient was optimized experimentally and theoretically to produce quantitatively controllable variations in the concentrations and blending ratios of the two components. The anisotropic chemical compositions of the gelatin/chitosan cross-gradients were characterized by Fourier transform infrared spectrometry and X-ray photoelectron spectrometry. The three-dimensional (3D) porous gelatin/chitosan cross-gradient materials were shown to regulate the cellular morphology and proliferation of smooth muscle cells (SMCs) in a gradient-dependent manner. We envision that our microfluidic cross-gradient platform may accelerate the material development processes involved in a wide range of biomedical applications. Biotechnol. Bioeng. 2011;108: 175-185. (C) 2010 Wiley Periodicals, Inc.
C1 [He, Jiankang; Du, Yanan; Guo, Yuqi; Hancock, Matthew J.; Wang, Ben; Shin, Hyeongho; Wu, Jinhui; Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA.
   [He, Jiankang; Du, Yanan; Guo, Yuqi; Hancock, Matthew J.; Wang, Ben; Wu, Jinhui; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [He, Jiankang; Li, Dichen] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Shaanxi, Peoples R China.
   [Guo, Yuqi] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Henan, Peoples R China.
RP Khademhosseini, A (reprint author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA.
EM alik@rics.bwh.harvard.edu
RI Hancock, Matthew/G-3859-2010; Khademhosseini, Ali/A-9435-2010; Wang,
   Ben/P-4732-2017; Wang, Ben/B-6488-2011; Wu, Jinhui/J-9476-2012
OI Hancock, Matthew/0000-0001-9820-3620; Khademhosseini,
   Ali/0000-0002-2692-1524; Wang, Ben/0000-0002-4134-1835; Wang,
   Ben/0000-0002-4134-1835; Wu, Jinhui/0000-0001-8809-1290; Khademhosseini,
   Ali/0000-0001-6322-8852
FU US Army Engineer Research and Development Center; Institute for Soldier
   Nanotechnology; NIH [HL092836, DE019024]; China Scholarship Council;
   Program for Changjiang Scholars and Innovative Research Team in
   University [IRT0646]; National Science Foundation of China [50575170];
   National High Technology Research and Development Program, China
   [2009AA043801]
FX This research was funded by the US Army Engineer Research and
   Development Center, the Institute for Soldier Nanotechnology, and the
   NIH (HL092836 and DE019024). J. He was partially sponsored by the China
   Scholarship Council, the Program for Changjiang Scholars and Innovative
   Research Team in University (IRT0646), National Science Foundation of
   China (50575170), and National High Technology Research and Development
   Program (2009AA043801), China. We would like to thank Dr. Feng Xu, Dr.
   Lianyong Wang, Dr. Ian Wheeldon, and Dr. Shilpa Sant for scientific
   discussions and technical support. Author contributions: JH, YD, DL, and
   AK designed the study; JH, YD, and YG performed the experiments; MJH
   developed the theoretical model and simulations; BW performed SEM and HS
   performed FTIR; JH, YD, and JW analyzed the data. JH and YD contributed
   equally as lead authors. JH, YD, MJH, and AK wrote the article. All
   authors discussed the results and commented on the manuscript.
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gomez-Romero P, 2001, ADV MATER, V13, P163, DOI 10.1002/1521-4095(200102)13:3<163::AID-ADMA163>3.3.CO;2-L
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   He JK, 2010, ADV FUNCT MATER, V20, P131, DOI 10.1002/adfm.200901311
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Huang Y, 2006, BIOTECHNOL BIOENG, V93, P64, DOI 10.1002/bit.20703
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Lopez-Perez PM, 2007, J MATER CHEM, V17, P4064, DOI 10.1039/b707326g
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Potyrailo R. A., 2003, MACROMOL RAPID COMM, V24, P123
   Simon CG, 2004, MACROMOL RAPID COMM, V25, P2003, DOI 10.1002/marc.200400395
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P3453, DOI 10.1016/j.actbio.2009.05.012
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
NR 26
TC 18
Z9 18
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2011
VL 108
IS 1
BP 175
EP 185
DI 10.1002/bit.22901
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 686SY
UT WOS:000284717200017
PM 20721897
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kundu, AK
   Gelman, J
   Tyson, DR
AF Kundu, Anup K.
   Gelman, Joel
   Tyson, Darren R.
TI Composite Thin Film and Electrospun Biomaterials for Urologic Tissue
   Reconstruction
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE polycaprolactone; proliferation; cell morphology; urothelial cell;
   permeability; electrospinning
ID SMALL-INTESTINAL SUBMUCOSA; MESENCHYMAL STEM-CELLS;
   EXTRACELLULAR-MATRIX; UROTHELIAL CELLS; BLADDER MUCOSA; OSTEOGENIC
   DIFFERENTIATION; URETHRAL RECONSTRUCTION; NANOFIBER SCAFFOLD;
   EPITHELIAL-CELLS; PORCINE MODEL
AB A replacement material for autologous grafts for urinary tract reconstruction would dramatically reduce the complications of surgery for these procedures. However, acellular materials have not proven to work sufficiently well, and cell-seeded materials are technically challenging and time consuming to generate. An important function of the urinary tract is to prevent urine leakage into the surrounding tissue-a function usually performed by the urothelium. We hypothesize that by providing an impermeable barrier in the acellular graft material, urine leakage would be minimized, as the urothelium forms in vivo. However, since urothelial cells require access to nutrients from the supporting vasculature, the impermeable barrier must degrade over time. Here we present the development of a novel biomaterial composed of the common degradable polymers, poly(epsilon-caprolactone) and poly(L-lactic acid) and generated by electrospinning directly onto spin-coated thin films. The composite scaffolds with thin films on the luminal surface were compared to their electrospun counterparts and commercially available small intestinal submucosa by surface analysis using scanning electron microscopy and by analysis of permeability to small molecules. In addition, the materials were examined for their ability to support urothelial cell adhesion, proliferation, and multilayered urothelium formation. We provide evidence that these unique composite scaffolds provide significant benefit over commonly used acellular materials in vitro and suggest that they be further examined in vivo. Biotechnol. Bioeng. 2011;108: 207-215. (C) 2010 Wiley Periodicals, Inc.
C1 [Kundu, Anup K.; Gelman, Joel; Tyson, Darren R.] Univ Calif Irvine, Dept Urol, Orange, CA 92868 USA.
RP Kundu, AK (reprint author), Xavier Univ, Coll Pharm, Ctr Nanomed & Drug Delivery, 1 Drexel Dr, New Orleans, LA 70125 USA.
EM akundu@xula.edu
OI Tyson, Darren/0000-0002-3272-4308
FU Hefni Foundation
FX We gratefully acknowledge financial support from the Hefni Foundation,
   Dr. Joel Gelman, Dr. Ralph Clayman and Mr. Stuart Hayes. We would like
   to thank Alice Lau and Nahid Haghighi for technical assistance, Dr.
   Zhibin Guan and Hiromitsu Urakami in the Department of Chemistry for
   help with spin coating, to Dr. Jian-Guo Zheng and Chung Je Chien in the
   Material Characterization Center for help with SEM analysis and Lee
   Sutherland in the Department of Pathology for help in histochemical
   analysis. We are also grateful to Dr. Clayman for critically reviewing
   the manuscript and to Cook Biotech, Inc. for providing SIS.
CR Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x
   Atala A, 2002, UROL CLIN N AM, V29, pXIII, DOI 10.1016/S0094-0143(02)00051-4
   Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   DEVINE CJ, 1961, J UROLOGY, V85, P166, DOI 10.1016/S0022-5347(17)65301-1
   DEVINE PC, 1963, J UROLOGY, V90, P67, DOI 10.1016/S0022-5347(17)64362-3
   DUCKETT JW, 1995, J UROLOGY, V153, P1660, DOI 10.1016/S0022-5347(01)67497-4
   EHRLICH RM, 1989, J UROLOGY, V142, P626, DOI 10.1016/S0022-5347(17)38837-7
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526
   FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0
   Hauser S, 2006, UROLOGY, V68, P263, DOI 10.1016/j.urology.2006.02.044
   HENDREN WH, 1986, J PEDIATR SURG, V21, P189, DOI 10.1016/S0022-3468(86)80828-4
   John T, 2006, J UROLOGY, V176, P1025, DOI 10.1016/j.juro.2006.04.039
   Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x
   RANSLEY PG, 1987, J UROLOGY, V138, P1096, DOI 10.1016/S0022-5347(17)43512-9
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Shalhav AL, 1999, J ENDOUROL, V13, P241, DOI 10.1089/end.1999.13.241
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   TAMMELA T, 1993, NEUROUROL URODYNAM, V12, P39, DOI 10.1002/nau.1930120106
   Wunsch L, 2005, EUR J PEDIATR SURG, V15, P164, DOI 10.1055/s-2004-830356
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
   Zhu YB, 2007, BIOMATERIALS, V28, P861, DOI 10.1016/j.biomaterials.2006.09.051
NR 44
TC 7
Z9 9
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JAN
PY 2011
VL 108
IS 1
BP 207
EP 215
DI 10.1002/bit.22912
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 686SY
UT WOS:000284717200020
PM 20830673
DA 2018-10-20
ER

PT J
AU Handley-Sidhu, S
   Renshaw, JC
   Yong, P
   Kerley, R
   Macaskie, LE
AF Handley-Sidhu, Stephanie
   Renshaw, Joanna C.
   Yong, Ping
   Kerley, Robert
   Macaskie, Lynne E.
TI Nano-crystalline hydroxyapatite bio-mineral for the treatment of
   strontium from aqueous solutions
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Biomineralisation; Hydroxyapatite; Nanoparticles; Strontium removal;
   Bioremediation
ID REMOVAL; BIOFILM; METALS; CELLS
AB Hydroxyapatites were analysed using electron microscopy, X-ray diffraction (XRD) and X-ray fluorescence (XRF) analysis. Examination of a bacterially produced hydroxyapatite (Bio-HA) by scanning electron microscopy showed agglomerated nano-sized particles; XRD analysis confirmed that the Bio-HA was hydroxyapatite, with an organic matter content of 7.6%; XRF analysis gave a Ca/P ratio of 1.55, also indicative of HA. The size of the Bio-HA crystals was calculated as similar to 25 nm from XRD data using the Scherrer equation, whereas Comm-HA powder size was measured as <= 50 mu m. The nano-crystalline Bio-HA was similar to 7 times more efficient in removing Sr(2+) from synthetic groundwater than Comm-HA. Dissolution of HA as indicated by the release of phosphate into the solution phase was higher in the Comm-HA than the Bio-HA, indicating a more stable biomaterial which has a potential for the remediation of contaminated sites.
C1 [Yong, Ping; Macaskie, Lynne E.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Handley-Sidhu, Stephanie; Renshaw, Joanna C.; Kerley, Robert] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England.
RP Macaskie, LE (reprint author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM l.e.macaskie@bham.ac.uk
RI Handley-Sidhu, Stephanie/G-7882-2012
FU EPSRC [EP/E012213/1, EP/G063699/1]; BBSRC; Engineering and Physical
   Sciences Research Council [EP/E012213/1, EP/G063699/1]
FX This work was supported by the EPSRC (grants EP/E012213/1 and
   EP/G063699/1). The authors thank Dr. Louise Male and Mr. Colin Slater
   for supporting XRD and XRF analysis, and Professor Keiko Sasaki and Ms.
   Sayo Moriyama for useful discussions. The latter collaboration was
   supported by the BBSRC (Japan Partnering Award).
CR [Anonymous], 2002, TECHN REP SER IAEA, V408
   Benhayoune H, 2001, J PHYS D APPL PHYS, V34, P141, DOI 10.1088/0022-3727/34/1/321
   Cecille L., 1991, NEW SEPARATION CHEM
   Finlay JA, 1999, BIOTECHNOL BIOENG, V63, P87, DOI 10.1002/(SICI)1097-0290(19990405)63:1<87::AID-BIT9>3.0.CO;2-0
   LANGFORD JI, 1992, NIST SPEC PUBL, V846, P110
   LAZIC S, 1991, J RADIOAN NUCL CH AR, V149, P161, DOI 10.1007/BF02053724
   Ledo HM, 2008, J MATER SCI-MATER M, V19, P3419, DOI 10.1007/s10856-008-3485-3
   MACASKIE LE, 1995, INT BIODETER BIODEGR, V35, P73, DOI 10.1016/0964-8305(95)00050-F
   Macaskie LE, 2005, J BIOTECHNOL, V118, P187, DOI 10.1016/j.jbiotec.2005.03.006
   MENNAN C, 2010, BIOTECHNOL IN PRESS
   Paterson-Beedle M, 2006, HYDROMETALLURGY, V83, P141, DOI 10.1016/j.hydromet.2006.03.020
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   RAHMAN H, 2006, THESIS U BIRMINGHAM
   SAMMONS RL, 2007, J PHYS C SER, V93, P4
   Simon FG, 2008, APPL GEOCHEM, V23, P2137, DOI 10.1016/j.apgeochem.2008.04.025
   Smiciklas I, 2006, WATER RES, V40, P2267, DOI 10.1016/j.watres.2006.04.031
   Thackray AC, 2004, J MATER SCI-MATER M, V15, P403, DOI 10.1023/B:JMSM.0000021110.07796.6e
   Thomson BM, 2003, J ENVIRON ENG-ASCE, V129, P492, DOI 10.1061/(ASCE)0733-9372(2003)129:6(492)
   Yong P, 2002, J CHEM TECHNOL BIOT, V77, P593, DOI 10.1002/jctb.606
   YONG P, 2003, BIOHYDROMETALLURGY S, P1205
NR 20
TC 20
Z9 20
U1 2
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD JAN
PY 2011
VL 33
IS 1
BP 79
EP 87
DI 10.1007/s10529-010-0391-9
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 702SB
UT WOS:000285914500010
PM 20824306
DA 2018-10-20
ER

PT S
AU Ali, OA
   Mooney, DJ
AF Ali, Omar A.
   Mooney, David J.
BE Dranoff, G
TI Immunologically Active Biomaterials for Cancer Therapy
SO CANCER IMMUNOLOGY AND IMMUNOTHERAPY
SE Current Topics in Microbiology and Immunology
LA English
DT Review; Book Chapter
ID PULSED DENDRITIC CELLS; SYNTHETIC EXTRACELLULAR MATRICES; ANTITUMOR
   IMMUNITY; DRUG-DELIVERY; BIODEGRADABLE MICROSPHERES;
   TUMOR-IMMUNOTHERAPY; ALGINATE HYDROGELS; VACCINE DELIVERY; T-CELLS;
   IN-VIVO
AB Our understanding of immunological regulation has progressed tremendously alongside the development of materials science, and at their intersection emerges the possibility to employ immunologically active biomaterials for cancer immunotherapy. Strong and sustained anticancer, immune responses are required to clear large tumor burdens in patients, but current approaches for immunotherapy are formulated as products for delivery in bolus, which may be indiscriminate and/or shortlived. Multifunctional biomaterial particles are now being developed to target and sustain antigen and adjuvant delivery to dendritic cells in vivo, and these have the potential to direct and prolong antigen-specific T cell responses. Three-dimensional immune cell niches are also being developed to regulate the recruitment, activation and deployment of immune cells in situ to promote potent antitumor responses. Recent studies demonstrate that materials with immune targeting and stimulatory capabilities can enhance the magnitude and duration of immune responses to cancer antigens, and preclinical results utilizing material-based immunotherapy in tumor models show a strong therapeutic benefit, justifying translation to and future testing in the clinic.
C1 [Ali, Omar A.; Mooney, David J.] Harvard Univ, Harvard Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Ali, Omar A.; Mooney, David J.] Wyss Inst Biol Inspired Engn, Cambridge, MA USA.
   [Ali, Omar A.] InCytu Inc, Lincoln, RI 02865 USA.
RP Ali, OA (reprint author), Harvard Univ, Harvard Sch Engn & Appl Sci, 58 Oxford St,415, Cambridge, MA 02138 USA.
EM alio@seas.harvard.edu
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   ALI OA, 2006, CELL TRANSPLANT, P591
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Audran R, 2003, VACCINE, V21, P1250, DOI 10.1016/S0264-410X(02)00521-2
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bodnar M, 2005, BIOMACROMOLECULES, V6, P2521, DOI 10.1021/bm0502258
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Borzacchiello A, 2001, J MATER SCI-MATER M, V12, P861, DOI 10.1023/A:1012851402759
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Celluzzi CM, 1996, J EXP MED, V183, P283, DOI 10.1084/jem.183.1.283
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Cohen JA, 2009, BIOCONJUGATE CHEM, V20, P111, DOI 10.1021/bc800338n
   Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716
   Curiel TJ, 2002, J CLIN INVEST, V109, P311, DOI 10.1172/JCI200215042
   DIBRA A, 2010, CLIN RES CARDIOL
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DOH J, 1990, P NATL ACAD SCI USA, V15, P5700
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3
   GOMBOTZ WR, 1995, BIOCONJUGATE CHEM, V6, P332, DOI 10.1021/bc00034a002
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020
   Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Hinrichs CS, 2009, P NATL ACAD SCI USA, V106, P17469, DOI 10.1073/pnas.0907448106
   HOLGER K, 2007, NAT MED, V13, P552
   Hor Y, 2009, BIOMATERIALS, V30, P6757, DOI 10.1016/j.biomaterials.2009.08.037
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x
   Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545
   Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Langer R, 1998, NATURE, V392, P5
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2000, NATURE, V408, P998
   Li G. Y., 2005, International Journal of Cosmetic Science, V27, P101, DOI 10.1111/j.1467-2494.2004.00251.x
   Li JJ, 2002, J PHARM SCI-US, V91, P1669, DOI 10.1002/jps.10157
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lofthouse S, 2001, VACCINE, V19, P4318, DOI 10.1016/S0264-410X(01)00153-0
   MANMOHAN S, 2005, EXPERT OPIN BIOL TH, V4, P483
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9
   Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4
   Meyer Martin, 2006, Expert Opin Drug Deliv, V3, P563, DOI 10.1517/17425247.3.5.563
   Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Nair RE, 2006, J IMMUNOTHER, V29, P10, DOI 10.1097/01.cji.0000175489.19314.d2
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Neelapu SS, 2004, CLIN CANCER RES, V10, P8309, DOI 10.1158/1078-0432.CCR-04-1071
   Nemunaitis J, 2006, CANCER GENE THER, V13, P555, DOI 10.1038/sj.cgt.7700922
   Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328
   Nishioka Y, 2001, ADV DRUG DELIVER REV, V47, P55, DOI 10.1016/S0169-409X(00)00121-6
   Oussoren C, 2001, ADV DRUG DELIVER REV, V50, P143, DOI 10.1016/S0169-409X(01)00154-5
   Oussoren C, 1997, BBA-BIOMEMBRANES, V1328, P261, DOI 10.1016/S0005-2736(97)00122-3
   Paramonov SE, 2008, BIOCONJUGATE CHEM, V19, P911, DOI 10.1021/bc7004472
   Plautz GE, 1998, J NEUROSURG, V89, P42, DOI 10.3171/jns.1998.89.1.0042
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420
   Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3
   Silva EA, 2004, CURR TOP DEV BIOL, V64, P181, DOI 10.1016/S0070-2153(04)64008-7
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sozzani S, 1998, J IMMUNOL, V161, P1083
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   SUCKOW MA, 1999, POLYSACCHARIDE APPL, V737, P1
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   Thomasin C, 1996, J CONTROL RELEASE, V41, P131, DOI 10.1016/0168-3659(96)01363-6
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Waeckerie-Men Y, 2005, METH MOLEC MED, V109, P35
   Waeckerle-Men Y, 2006, VACCINE, V24, P1847, DOI 10.1016/j.vaccine.2005.10.032
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wischke C, 2009, INT J PHARMACEUT, V365, P61, DOI 10.1016/j.ijpharm.2008.08.039
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505
   Zaharoff DA, 2009, CANCER RES, V69, P6192, DOI 10.1158/0008-5472.CAN-09-1114
NR 87
TC 8
Z9 8
U1 0
U2 34
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
EI 2196-9965
BN 978-3-642-14135-5
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2011
VL 344
BP 279
EP 297
DI 10.1007/82_2010_69
D2 10.1007/978-3-642-14136-2
PG 19
WC Oncology; Immunology; Medicine, Research & Experimental; Microbiology
SC Oncology; Immunology; Research & Experimental Medicine; Microbiology
GA BVE69
UT WOS:000291324100013
PM 20556594
DA 2018-10-20
ER

PT J
AU Kuang, J
   Yuk, KY
   Huh, KM
AF Kuang, Jia
   Yuk, Kun Young
   Huh, Kang Moo
TI Polysaccharide-based superporous hydrogels with fast swelling and
   superabsorbent properties
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Superporous hydrogel; Superabsorbent; Polysaccharide; Fast swelling;
   Biodegradable
ID DRUG-DELIVERY; CORN STARCHES; POTATO STARCH; GELATINIZATION; CHITOSAN;
   ALGINATE
AB Most dried hydrogels (xerogels) require a long time to reach equilibrium swelling due to the slow absorption of water by diffusion. Superporous hydrogels (SPHs) have been developed to demonstrate fast swelling and superabsorbent properties, and thus attracted much attention for various biomedical applications. In this study, we have developed and evaluated a new polysaccharide-based SPH that can absorb a significant amount of water instantaneously by a capillary mechanism and swell to equilibrium quickly, regardless of their dimension and size. Here, starch was chemically modified to have hydrophilic sulfate groups and reactive vinyl groups and used as a water-soluble, biodegradable building block for making three-dimensional networks. Starch-based SPHs were prepared by a radical crosslinking reaction and gas-blowing foaming process to generate an interconnected pore structure. These new biodegradable, starch-based, superabsorbent SPHs with fast swelling could be useful for pharmaceutical and biomaterial applications. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Kuang, Jia; Yuk, Kun Young; Huh, Kang Moo] Chungnam Natl Univ, Dept Polymer Sci & Engn, Taejon 305764, South Korea.
RP Huh, KM (reprint author), Chungnam Natl Univ, Dept Polymer Sci & Engn, Taejon 305764, South Korea.
EM khuh@cnu.ac.kr
FU Korean Government [2009-0064258]; Korean Ministry of Education, Science,
   and Technology
FX This work was supported by a National Research Foundation of Korea Grant
   funded by the Korean Government (2009-0064258) and supported in part by
   a Grant of the Korean Ministry of Education, Science, and Technology
   (The Regional Core Research Program/Anti-aging and Well-being Research
   Center).
CR Berger J, 2005, INT J PHARM, V288, P17, DOI 10.1016/j.ijpharm.2004.07.036
   Bhuniya SP, 2003, J POLYM SCI POL CHEM, V41, P1650, DOI 10.1002/pola.10711
   Chen J, 1999, J MACROMOL SCI PURE, VA36, P917
   Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Choi YM, 2007, KEY ENG MATER, V342-343, P717, DOI 10.4028/www.scientific.net/KEM.342-343.717
   Coviello T, 2005, INT J PHARM, V289, P97, DOI 10.1016/j.ijpharm.2004.10.025
   Cui DP, 2009, INT J BIOL MACROMOL, V44, P294, DOI 10.1016/j.ijbiomac.2009.01.003
   Fang JM, 2005, J APPL POLYM SCI, V96, P452, DOI 10.1002/app.21464
   Graaf R. A. de, 1995, Starch/Staerke, V47, P469, DOI 10.1002/star.19950471205
   Karlsson ME, 2007, FOOD CHEM, V100, P136, DOI 10.1016/j.foodchem.2005.09.032
   Kim D, 2004, POLYMER, V45, P189, DOI 10.1016/j.polymer.2003.10.047
   Kuakpetoon D, 2007, CARBOHYD RES, V342, P2253, DOI 10.1016/j.carres.2007.06.010
   Omidian H, 2005, J CONTROL RELEASE, V102, P3, DOI 10.1016/j.jconrel.2004.09.028
   Omidian H, 2006, MACROMOL BIOSCI, V6, P703, DOI 10.1002/mabi.200600062
   Park K, 2002, DRUG DELIVERY TECHNO, V2, P5
   Reis AV, 2008, J POLYM SCI POL CHEM, V46, P2567, DOI 10.1002/pola.22588
   Sandhu KS, 2007, FOOD CHEM, V101, P1499, DOI 10.1016/j.foodchem.2006.01.060
   Spiridon I, 2008, POLYM DEGRAD STABIL, V93, P1884, DOI 10.1016/j.polymdegradstab.2008.07.017
   STAWSKI D, 2003, AUTEX RES J, V3, P2
NR 20
TC 55
Z9 58
U1 1
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 1
PY 2011
VL 83
IS 1
BP 284
EP 290
DI 10.1016/j.carbpol.2010.07.052
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 675DH
UT WOS:000283805600038
DA 2018-10-20
ER

PT S
AU McNally, AK
   Anderson, JM
AF McNally, Amy K.
   Anderson, James M.
BE Dittmar, T
   Zanker, KS
TI Macrophage Fusion and Multinucleated Giant Cells of Inflammation
SO CELL FUSION IN HEALTH AND DISEASE: I: CELL FUSION IN HEALTH
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID PROTEIN-KINASE-C; FOREIGN-BODY REACTION; BIOMATERIAL-ADHERENT
   MACROPHAGES; MANNOSE RECEPTOR-ACTIVITY; UREA) IN-VIVO; ALPHA-TOCOPHEROL;
   VITAMIN-E; MONOCYTES MACROPHAGES; INTERFERON-GAMMA; BLOOD MONOCYTES
AB Macrophages undergo fusion with other macrophages to form the hallmark multinucleated giant cells of chronic inflammation. However, neither the existence of distinct morphological types of giant cells, the signaling pathways that induce their formation, the molecular mechanism(s) of macrophage fusion, nor the significance of macrophage multinucleation at chronic inflammatory sites are well understood. Our efforts have been focused on these unknowns, particularly as they relate to the foreign body-type giant cells that form on implanted biomaterials and biomedical devices. We have pursued the discoveries of human macrophage fusion factors (interleukin-4, interleukin-13, alpha-tocopherol) with emphasis on foreign body giant cells, and identified adhesion receptors and signaling intermediates, as well as an adhesion protein substrate (vitronectin) that supports macrophage fusion. Studies on the molecular mechanism of macrophage fusion have revealed it to be a mannose receptor-mediated phagocytic process with participation of the endoplasmic reticulum. Further phenotypic and functional investigations will foster new perspectives on these remarkable multinucleated cells and their physiological significances in multiple inflammatory processes.
C1 [McNally, Amy K.; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP McNally, AK (reprint author), Case Western Reserve Univ, Dept Pathol, Wolstein Res Bldg, Cleveland, OH 44106 USA.
EM akm2@case.edu; jma6@case.edu
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0
   Brigelius-Flohe R, 1999, FASEB J, V13, P1145
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003
   Carnevale KA, 2003, J BIOL CHEM, V278, P25317, DOI 10.1074/jbc.M304182200
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Chan SS, 2001, FREE RADICAL RES, V35, P843, DOI 10.1080/10715760100301341
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N
   ELLIOTT MJ, 1991, BLOOD, V77, P2739
   ENELOW RI, 1992, AM J RESP CELL MOL, V6, P57
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063
   Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x
   Harsh DM, 2001, BIOCHEM BIOPH RES CO, V282, P480, DOI 10.1006/bbrc.2001.4601
   Henson PM, 1988, INFLAMMATION BASIC P
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Kirk JT, 2010, J BIOMED MATER RES A, V94A, P683, DOI 10.1002/jbm.a.32682
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002
   Langhans T., 1868, ARCH PATHOL ANAT, V42, P382
   Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809
   Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010
   Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x
   Lee IK, 1999, DIABETES RES CLIN PR, V45, P183, DOI 10.1016/S0168-8227(99)00048-0
   Liu Q, 1998, J IMMUNOL, V160, P1393
   MacEwan SR, 2007, SOC BIOM ANN M CHIC, P703
   Malefyt RW, 1999, INFLAMMATION BASIC P
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   Marx J, 2006, SCIENCE, V312, P1868, DOI 10.1126/science.312.5782.1868
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171
   Moreno JL, 2003, BLOOD, V102, P1078, DOI 10.1182/blood-2002-11-3437
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x
   ORENTAS RJ, 1992, J LEUKOCYTE BIOL, V51, P199
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Ratnikov BI, 2005, J THROMB HAEMOST, V3, P1783, DOI 10.1111/j.1538-7836.2005.01362.x
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schubert MA, 1996, J BIOMED MATER RES, V32, P493, DOI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
   Shive MS, 2002, J BIOMED MATER RES, V62, P163, DOI 10.1002/jbm.10225
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   TAKASHIMA T, 1993, J IMMUNOL, V150, P3002
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   WEINBERG JB, 1984, P NATL ACAD SCI-BIOL, V81, P4554, DOI 10.1073/pnas.81.14.4554
   Zhao O H, 1992, J Biomed Mater Res, V26, P1019
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 76
TC 66
Z9 68
U1 0
U2 17
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-94-007-0763-4; 978-94-007-0762-7
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2011
VL 713
BP 97
EP 111
DI 10.1007/978-94-007-0763-4_7
D2 10.1007/978-94-007-0763-4
PG 15
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA BC1UA
UT WOS:000350423400008
PM 21432016
DA 2018-10-20
ER

PT J
AU Hung, HS
   Chen, HC
   Tsai, CH
   Lin, SZ
AF Hung, Huey-Shan
   Chen, Hui-Chen
   Tsai, Chang-Hai
   Lin, Shinn-Zong
TI Novel Approach by Nanobiomaterials in Vascular Tissue Engineering
SO CELL TRANSPLANTATION
LA English
DT Article
DE Nanobiomaterials; Vascular endothelial cells (ECs); Tissue engineering;
   Nanotechnology
ID ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM/PROGENITOR CELLS;
   STEM-CELLS; BLOOD-VESSEL; POLY(LACTIC-CO-GLYCOLIC ACID);
   EXTRACELLULAR-MATRIX; INTIMAL HYPERPLASIA; PERIPHERAL-BLOOD;
   GROWTH-FACTOR; NANOFIBERS
AB Interactions between vascular endothelial cells (ECs) and biomaterials are important for engineered tissue substitute. The modification of biomaterial surfaces are designed to modulate EC adhesion and responses in order to improve implantation success rate. Specifically, it has now been well established that increased vascular tissue regeneration can be achieved on almost any surface by employing novel nanofabricated surface features. To enhance EC adhesion and growth, material surfaces have been modified with physicochemical and mechanical properties, such as bioactive molecules from the matrix, peptides, and/or growth factors to control EC behavior. The advances in nanotechnology can bring additional functionality to vascular tissue engineering, optimize internal vascular graft surface, help to direct the differentiation of stem cells into the vascular cell phenotype, and, most importantly, also provide a biomaterials-based cellularization process. Nanomaterials could promote in situ endothelialization by mobilizing endothelial progenitor cells (EPCs) from the bone marrow, by encouraging cell-specific adhesion to the vascular graft, and, once attached, by controlling the proliferation and differentiation of these cells. Interaction between different cell types and extracellular matrix continue to be a principal source of inspiration for material biological function and, therefore, the understanding of the molecular mechanism trigger by the interaction is discussed.
C1 [Hung, Huey-Shan; Lin, Shinn-Zong] China Med Univ & Hosp, Ctr Ncuropsychiat, Taichung, Taiwan.
   [Hung, Huey-Shan; Chen, Hui-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.
   [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan.
   [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan.
   [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan.
   [Lin, Shinn-Zong] China Med Univ Beigang Hosp, Yunlin, Taiwan.
RP Lin, SZ (reprint author), China Med Univ & Hosp, Ctr Ncuropsychiat, Taichung, Taiwan.
EM shinnzong@yahoo.com.tw
RI Chen, Hui-Chen/L-8149-2013
OI Chen, Hui-Chen/0000-0001-9751-5729
CR Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Calzi SL, 2009, MICROVASC RES, V78, P132, DOI 10.1016/j.mvr.2009.03.007
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen L, 2008, J NEUROIMMUNE PHARM, V3, P286, DOI 10.1007/s11481-008-9131-5
   Chua KN, 2007, EXP HEMATOL, V35, P771, DOI 10.1016/j.exphem.2007.02.002
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Chung S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015019
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI 10.1089/ten.TEA.2009.0089
   Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Divya P, 2007, BIOMOL ENG, V24, P593, DOI 10.1016/j.bioeng.2007.07.010
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Gafni Y, 2006, TISSUE ENG, V12, P3021, DOI 10.1089/ten.2006.12.3021
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Han Ben-song, 2006, Zhonghua Yi Xue Za Zhi, V86, P2065
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hung HS, 2009, NEW BIOTECHNOL, V25, P235, DOI 10.1016/j.nbt.2009.01.003
   Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003
   Igarashi S, 2007, J NANOSCI NANOTECHNO, V7, P814, DOI 10.1166/jnn.2007.516
   Kim JA, 2009, BIOMED MICRODEVICES, V11, P287, DOI 10.1007/s10544-008-9235-y
   Kofidis Theo, 2007, V140, P273
   Kothapalli CR, 2009, ACTA BIOMATER, V5, P541, DOI 10.1016/j.actbio.2008.09.004
   Kyrtatos PG, 2009, JACC-CARDIOVASC INTE, V2, P794, DOI 10.1016/j.jcin.2009.05.014
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   Lu HJ, 2009, J MATER SCI-MATER M, V20, P1937, DOI 10.1007/s10856-009-3744-y
   Luo ZY, 1998, J VASC SURG, V27, P167, DOI 10.1016/S0741-5214(98)70304-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Mai XL, 2009, CELL TRANSPLANT, V18, P171, DOI 10.3727/096368909788341306
   Miki A, 2006, CELL TRANSPLANT, V15, P893, DOI 10.3727/000000006783981378
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nurkiewicz TR, 2009, TOXICOL SCI, V110, P191, DOI 10.1093/toxsci/kfp051
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016
   Punshon G, 2008, CELL PROLIFERAT, V41, P321, DOI 10.1111/j.1365-2184.2008.00523.x
   Radomski A, 2005, BRIT J PHARMACOL, V146, P882, DOI 10.1038/sj.bjp.0706386
   Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407
   Ruhparwar A, 2006, THORAC CARDIOV SURG, V54, P447, DOI 10.1055/s-2006-924325
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Sengupta S, 2005, NATURE, V436, P568, DOI 10.1038/nature03794
   Solanki A, 2008, NANOMEDICINE-UK, V3, P567, DOI 10.2217/17435889.3.4.567
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   Vara DS, 2008, ARTIF ORGANS, V32, P978, DOI 10.1111/j.1525-1594.2008.00659.x
   Wary Kishore K, 2003, Mol Cancer, V2, P27, DOI 10.1186/1476-4598-2-27
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Weber A, 2004, EUR J CARDIO-THORAC, V26, P137, DOI 10.1016/j.ejcts.2004.03.024
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044
NR 58
TC 16
Z9 16
U1 1
U2 35
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2011
VL 20
IS 1
SI SI
BP 63
EP 70
DI 10.3727/096368910X532864
PG 8
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 743JP
UT WOS:000289014900007
PM 20887685
OA Bronze
DA 2018-10-20
ER

PT J
AU Yamashita, T
   Deguchi, K
   Nagotani, S
   Abe, K
AF Yamashita, Toru
   Deguchi, Kentaro
   Nagotani, Shoko
   Abe, Koji
TI Vascular Protection and Restorative Therapy in Ischemic Stroke
SO CELL TRANSPLANTATION
LA English
DT Article
DE Cerebral ischemia; Tissue plasminogen activator (tPA); Free radicals;
   Neural stem cells; Scaffold
ID FREE-RADICAL SCAVENGER; ENDOTHELIAL GROWTH-FACTOR; BRAIN-LESION;
   RAT-BRAIN; IMPLANTATION; EDARAVONE; SCAFFOLD; NXY-059; INJURY; HYBRID
AB Possible strategies for treating stroke include: I) thrombolytic therapy with tissue plasminogen activator (tPA): restoring cerebral blood flow in the acute phase of ischemic stroke but sometimes causing hemorrhagic transformation (HT); 2) stem cell therapy: the repair of disrupted neuronal networks with newly born neurons in the chronic phase of ischemic stroke. Firstly, we estimated the vascular protective effect of a free radical scavenger, edaravone, in the tPA-treated rat model of middle cerebral artery occlusion. Edaravone prevented dramatically decreased the hemorrhagic transformation and improved the neurologic score and survival rate of tPA-treated rats. Secondly, we attempted to restore brain tissue using a novel biomaterial, polydimethysiloxane-tetraethoxysilane (PDMS-TEOS) hybrid with or without vascular endothelial growth factor (VEGF), and we could show that implantation of a PDMS-TEOS scaffold with VEGF might be effective for treating old brain infarction or trauma. In the future, we will combine these strategies to develop more effective therapies for treatment of strokes.
C1 [Yamashita, Toru; Deguchi, Kentaro; Nagotani, Shoko; Abe, Koji] Okayama Univ, Dept Neurol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan.
RP Abe, K (reprint author), Okayama Univ, Dept Neurol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM abekabek@cc.okayama-u.ac.jp
CR ABE K, 1988, STROKE, V19, P480, DOI 10.1161/01.STR.19.4.480
   Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Kim BG, 2007, CELL TRANSPLANT, V16, P355, DOI 10.3727/000000007783464885
   Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980
   Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086
   Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240
   Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576
   Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164
   Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058
NR 15
TC 14
Z9 14
U1 1
U2 5
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2011
VL 20
IS 1
SI SI
BP 95
EP 97
DI 10.3727/096368910X532800
PG 3
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 743JP
UT WOS:000289014900010
PM 20887680
OA Bronze
DA 2018-10-20
ER

PT J
AU Rising, A
   Widhe, M
   Johansson, J
   Hedhammar, M
AF Rising, Anna
   Widhe, Mona
   Johansson, Jan
   Hedhammar, My
TI Spider silk proteins: recent advances in recombinant production,
   structure-function relationships and biomedical applications
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Review
DE Spidroin; Protein structure; Recombinant protein production;
   Biomaterial; Protein self-assembly; Biocompatibility
ID MAJOR AMPULLATE SILK; EGG CASE SILK; CLAVIPES DRAGLINE SILK; FIBROIN
   GENE FAMILY; CONSERVED C-TERMINI; BLACK-WIDOW SPIDER;
   MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; LATRODECTUS-HESPERUS; FIBER
   FORMATION
AB Spider dragline silk is an outstanding material made up of unique proteins-spidroins. Analysis of the amino acid sequences of full-length spidroins reveals a tripartite composition: an N-terminal non-repetitive domain, a highly repetitive central part composed of approximately 100 polyalanine/glycine rich co-segments and a C-terminal non-repetitive domain. Recent molecular data on the terminal domains suggest that these have different functions. The composite nature of spidroins allows for recombinant production of individual and combined regions. Miniaturized spidroins designed by linking the terminal domains with a limited number of repetitive segments recapitulate the properties of native spidroins to a surprisingly large extent, provided that they are produced and isolated in a manner that retains water solubility until fibre formation is triggered. Biocompatibility studies in cell culture or in vivo of native and recombinant spider silk indicate that they are surprisingly well tolerated, suggesting that recombinant spider silk has potential for biomedical applications.
C1 [Rising, Anna; Widhe, Mona; Johansson, Jan; Hedhammar, My] Swedish Univ Agr Sci, Ctr Biomed, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
RP Johansson, J (reprint author), Swedish Univ Agr Sci, Ctr Biomed, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
EM jan.johansson@afb.slu.se
OI Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council; Formas; Vinnova; Spiber Technologies AB; EU
   Commission
FX We are grateful to Prof. Wilhelm Engstrom for introducing spidroin
   research at our department. Financial support from the Swedish Research
   Council, Formas, Vinnova, Spiber Technologies AB, and the EU Commission
   is gratefully acknowledged.
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Augsten K, 2000, SCANNING, V22, P12
   Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013
   Blasingame E, 2009, J BIOL CHEM, V284, P29097, DOI 10.1074/jbc.M109.021378
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Bon Monsieur, 1710, PHIL T, V27, P2
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   CANDELAS GC, 1981, J EXP ZOOL, V216, P1, DOI 10.1002/jez.1402160102
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126
   Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315
   Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c
   Eisoldt L, 2010, J STRUCT BIOL, V170, P413, DOI 10.1016/j.jsb.2009.12.027
   Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946
   Geisler M, 2008, LANGMUIR, V24, P1350, DOI 10.1021/la702341j
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070
   Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111
   Grip Stefan, 2006, Cancer Genomics & Proteomics, V3, P83
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Heim M, 2010, J STRUCT BIOL, V170, P420, DOI 10.1016/j.jsb.2009.12.025
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XY, 2007, BIOCHEMISTRY-US, V46, P3294, DOI 10.1021/bi602507e
   Hu XY, 2006, BIOCHEMISTRY-US, V45, P3506, DOI 10.1021/bi052105q
   Hu XY, 2005, BIOCHEMISTRY-US, V44, P10020, DOI 10.1021/bi050494i
   Hu XY, 2005, J BIOL CHEM, V280, P21220, DOI 10.1074/jbc.M412316200
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Ittah S, 2010, BIOPOLYMERS, V93, P458, DOI 10.1002/bip.21362
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220
   Kovoor J., 1987, P160
   Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Lee KS, 2007, J BIOSCIENCES, V32, P705, DOI 10.1007/s12038-007-0070-8
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Liebmann B, 2008, COLLOID SURFACE A, V331, P126, DOI 10.1016/j.colsurfa.2008.04.005
   Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   Luan XY, 2009, CELL BIOL INT, V33, P1127, DOI 10.1016/j.cellbi.2009.07.005
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Metwalli E, 2007, APPL PHYS A-MATER, V89, P655, DOI 10.1007/s00339-007-4265-5
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Michal CA, 1996, BIOPHYS J, V70, P489, DOI 10.1016/S0006-3495(96)79594-2
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Patel J, 2007, TRANSGENIC RES, V16, P239, DOI 10.1007/s11248-006-9026-2
   PLAZAOLA A, 1991, TISSUE CELL, V23, P277, DOI 10.1016/0040-8166(91)90082-5
   Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schmidt M, 2007, BIOTECHNOL LETT, V29, P1741, DOI 10.1007/s10529-007-9461-z
   Schulz S, 2001, LIPIDS, V36, P637, DOI 10.1007/s11745-001-0768-7
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shao ZZ, 2003, MACROMOLECULES, V36, P1157, DOI 10.1021/ma0214660
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493
   Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T
   Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vollrath F, 2002, IN VIVO, V16, P229
   Wang Hongxin, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P747
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   Werten MWT, 2008, BIOMACROMOLECULES, V9, P1705, DOI 10.1021/bm701111z
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Williams David, 2003, Med Device Technol, V14, P9
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P14002, DOI 10.1021/bi005119z
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   WORK RW, 1977, T AM MICROSC SOC, V96, P170, DOI 10.2307/3226094
   Xu HT, 2007, ANIM BIOTECHNOL, V18, P1, DOI 10.1080/10495390601091024
   Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5
   Yang MY, 2005, J BIOCHEM, V137, P721, DOI 10.1093/jb/mvi090
   Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6
   Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g
   Zhao AC, 2005, J BIOCHEM, V138, P593, DOI 10.1093/jbchem/mvi155
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
   Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126
NR 137
TC 82
Z9 89
U1 5
U2 112
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
EI 1420-9071
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD JAN
PY 2011
VL 68
IS 2
BP 169
EP 184
DI 10.1007/s00018-010-0462-z
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 703IA
UT WOS:000285970400001
PM 20668909
DA 2018-10-20
ER

PT J
AU Hendler, N
   Fadeev, L
   Mentovich, ED
   Belgorodsky, B
   Gozin, M
   Richter, S
AF Hendler, Netta
   Fadeev, Ludmila
   Mentovich, Elad D.
   Belgorodsky, Bogdan
   Gozin, Michael
   Richter, Shachar
TI Bio-inspired synthesis of chiral silver nanoparticles in mucin
   glycoprotein-the natural choice
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID CIRCULAR-DICHROISM; METAL NANOPARTICLES; OPTICAL-ACTIVITY; AU
   NANOPARTICLES; GREEN SYNTHESIS; GOLD; DNA; NANOMATERIALS; NANOCRYSTALS;
   PARTICLES
AB A method of synthesizing stable chiral Ag nanoparticles inside a natural mucin glycoprotein is demonstrated. The reaction is carried out without the help of an external reducing agent, by utilizing the reducing properties of the host mucin. A chiral spectrum is detected in the visible range, indicating the formation of a new type of chiral Ag nanoparticles-containing biomaterial.
C1 [Hendler, Netta; Fadeev, Ludmila; Mentovich, Elad D.; Belgorodsky, Bogdan; Gozin, Michael] Tel Aviv Univ, Sch Chem, Fac Exact Sci, IL-69978 Tel Aviv, Israel.
   [Hendler, Netta; Mentovich, Elad D.; Richter, Shachar] Tel Aviv Univ, Ctr NanoSci & NanoTechnol, IL-69978 Tel Aviv, Israel.
RP Gozin, M (reprint author), Tel Aviv Univ, Sch Chem, Fac Exact Sci, IL-69978 Tel Aviv, Israel.
EM cogozin@mgchem.tau.ac.il; srichter@post.tau.ac.il
RI Gozin, Michael/E-2824-2014; Gozin, Michael/A-9863-2011; Richter,
   shachar/F-1562-2010
OI Gozin, Michael/0000-0003-0897-1760; 
CR Belgorodsky B, 2010, SMALL, V6, P262, DOI 10.1002/smll.200900637
   Berti L, 2008, NAT NANOTECHNOL, V3, P81, DOI 10.1038/nnano.2007.460
   Brause R, 2002, APPL PHYS B-LASERS O, V75, P711, DOI 10.1007/s00340-002-1024-3
   Carmeli I, 2010, NANO LETT, V10, P2069, DOI 10.1021/nl100254j
   Chen CL, 2008, J AM CHEM SOC, V130, P13555, DOI 10.1021/ja805683r
   Crookes-Goodson WJ, 2008, CHEM SOC REV, V37, P2403, DOI 10.1039/b702825n
   Emory SR, 1998, J PHYS CHEM B, V102, P493, DOI 10.1021/jp9734033
   Fan ZY, 2010, NANO LETT, V10, P2580, DOI 10.1021/nl101231b
   Gautier C, 2008, J AM CHEM SOC, V130, P7077, DOI 10.1021/ja800256r
   George J, 2010, J AM CHEM SOC, V132, P2502, DOI 10.1021/ja908574j
   Govorov AO, 2010, NANO LETT, V10, P1374, DOI 10.1021/nl100010v
   Hidalgo F, 2010, PHYS STATUS SOLIDI B, V247, P1889, DOI 10.1002/pssb.200983923
   Huang HZ, 2004, CARBOHYD RES, V339, P2627, DOI 10.1016/j.carres.2004.08.005
   Kang YJ, 2010, CHEM COMMUN, V46, P5665, DOI 10.1039/c0cc01071e
   Lee JS, 2007, NANO LETT, V7, P2112, DOI 10.1021/nl071108g
   LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025
   Li YG, 2008, CHEM COMMUN, P5571, DOI 10.1039/b812567h
   Liu JH, 2005, J PHYS CHEM B, V109, P40, DOI 10.1021/jp044938g
   Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g
   Mehta SK, 2010, J COLLOID INTERF SCI, V343, P447, DOI 10.1016/j.jcis.2009.11.053
   Nakashima T, 2009, J AM CHEM SOC, V131, P10342, DOI 10.1021/ja902800f
   Noguez C, 2009, CHEM SOC REV, V38, P757, DOI 10.1039/b800404h
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Perelaer J, 2006, ADV MATER, V18, P2101, DOI 10.1002/adma.200502422
   Petty JT, 2004, J AM CHEM SOC, V126, P5207, DOI 10.1021/ja031931o
   Pittelkow M, 2008, CHEM COMMUN, P2358, DOI 10.1039/b801215f
   Provorse MR, 2010, J AM CHEM SOC, V132, P1302, DOI 10.1021/ja906884m
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Roman-Velazquez CE, 2003, J PHYS CHEM B, V107, P12035, DOI 10.1021/jp0356315
   Schaaff TG, 2000, J PHYS CHEM B, V104, P2630, DOI 10.1021/jp993691y
   Shemer G, 2006, J AM CHEM SOC, V128, P11006, DOI 10.1021/ja0637021
   Shraga N, 2009, J AM CHEM SOC, V131, P12074, DOI 10.1021/ja9040626
   Shukla N, 2010, J AM CHEM SOC, V132, P8575, DOI 10.1021/ja908219h
   Singh M, 2009, MATER LETT, V63, P425, DOI 10.1016/j.matlet.2008.10.067
   Sotiropoulou S, 2008, CHEM MATER, V20, P821, DOI 10.1021/cm702152a
   Van Hyning DL, 1998, LANGMUIR, V14, P7034, DOI 10.1021/la980325h
   Yao H, 2005, J AM CHEM SOC, V127, P15536, DOI 10.1021/ja053504b
   Zheng J, 2002, J AM CHEM SOC, V124, P13982, DOI 10.1021/ja028282l
NR 38
TC 22
Z9 22
U1 1
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
J9 CHEM COMMUN
JI Chem. Commun.
PY 2011
VL 47
IS 26
BP 7419
EP 7421
DI 10.1039/c1cc11228g
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 780AM
UT WOS:000291823400037
PM 21584292
DA 2018-10-20
ER

PT S
AU Dutta, PK
   Rinki, K
   Dutta, J
AF Dutta, P. K.
   Rinki, Kumari
   Dutta, Joydeep
BE Jayakumar, R
   Prabaharan, M
   Muzzarelli, RAA
TI Chitosan: A Promising Biomaterial for Tissue Engineering Scaffolds
SO CHITOSAN FOR BIOMATERIALS II
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE Bone; Chitosan; Nerve; Scaffolds; Skin; Tissue engineering
ID HYDROXYAPATITE COMPOSITE SCAFFOLDS; PERIPHERAL-NERVE REGENERATION;
   SUPERCRITICAL CARBON-DIOXIDE; N-ACETYLATED CHITOSANS; IN-VITRO; BONE
   REGENERATION; NANOFIBROUS SCAFFOLDS; GALACTOSYLATED CHITOSAN; INORGANIC
   COMPOSITES; NEURITE EXTENSION
AB The contribution of chitosan as a scaffold material is quite significant in the field of tissue engineering, which is a multidisciplinary field of research and technology development requiring the involvement of chemists, physicists, chemical engineers, biologists, cell-biologists etc. to regenerate injured or damaged tissue. The advantages of using chitosan as a three-dimensional scaffold for tissue engineering applications are due to its versatile physicochemical and biological properties. Further, owing to its easy processability, it can be molded into the desired shape and size. Therefore, it is no exaggeration to say that chitosan is a promising biomaterial for tissue engineering scaffolds. There is an enormous body of work already published in various journals on chitosan as a tissue engineering scaffold but, to our knowledge, this work has not yet been brought together in one chapter. We have used our best efforts to accumulate the research work already done on chitosan in a single place so that chitosan researchers can easily find information and can therefore escalate their research activities. This chapter highlights different methods for the fabrication of scaffolds, the suitability of chitosan as a good scaffolding material, and its application as a scaffold for tissue engineering of bone, cartilage, skin, liver, corneal, vascular, nerve, and cardiac tissue.
C1 [Dutta, P. K.; Rinki, Kumari] Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad 211004, Uttar Pradesh, India.
   [Dutta, Joydeep] Disha Inst Management & Technol, Dept Chem, Raipur 492101, Madhya Pradesh, India.
RP Dutta, PK (reprint author), Motilal Nehru Natl Inst Technol, Dept Chem, Allahabad 211004, Uttar Pradesh, India.
EM pkd_437@yahoo.com
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Archana D, 2010, ASIAN CHITIN J, V6, P45
   Archana D, 2010, ASIAN CHITIN J, V6, P26
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Birla RK, 2008, IN VITRO CELL DEV-AN, V44, P340, DOI 10.1007/s11626-008-9098-9
   Blan NR, 2008, J BIOMED MATER RES A, V86A, P195, DOI 10.1002/jbm.a.31642
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen JS, 2005, ARTIF ORGANS, V29, P104, DOI 10.1111/j.1525-1594.2005.29021.x
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng MY, 2003, J BIOMAT SCI-POLYM E, V14, P1155, DOI 10.1163/156856203769231628
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Cuy JL, 2003, J BIOMED MATER RES A, V67A, P538, DOI 10.1002/jbm.a.10095
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Du LQ, 2008, OPHTHALMIC RES, V40, P282, DOI 10.1159/000131503
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Duarte ARC, 2009, J BIOACT COMPAT POL, V24, P385, DOI 10.1177/0883911509105796
   Dutta J, 2008, CURRENT RES DEV CHIT
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   Dutta PK, 2004, J POLYM MATER, V21, P321
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   Dutta PK, 2008, P NATL A SCI INDIA A, V78A, P255
   Ehrenfreund-Kleinman T, 2006, SCAFFOLDING TISSUE E
   Enescu D, 2008, CHEM ENG COMMUN, V195, P1269, DOI 10.1080/00986440801958808
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Freed L., 2000, PRINCIPLES TISSUE EN
   Frier T, 2005, BIOMATERIALS, V26, P5872
   Frier T, 2005, BIOMATERIALS, V26, P4624
   Gao XS, 2008, J MATER SCI-MATER M, V19, P3611, DOI 10.1007/s10856-008-3508-0
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   He Q, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055001
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   Hoerstrup SP, 2004, BIOMATERIAL SCI
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Hu XB, 2006, J CELL PLAST, V42, P517, DOI 10.1177/0021955X06066993
   HUTADILOK N, 1995, CARBOHYD RES, V268, P143, DOI 10.1016/0008-6215(94)00301-U
   Ingber D, 1993, PHYS FORCES MAMMALIA
   Ishikawa N, 2007, J BIOMED MATER RES A, V83A, P33, DOI 10.1002/jbm.a.31126
   Ishikawa N, 2009, J BIOMED MATER RES A, V89A, P1118, DOI 10.1002/jbm.a.32389
   Jagur-Grodzinski J, 2003, E-POLYMERS
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jayakumar R, 2009, ASIAN CHITIN J, V5, P63
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Jiang T., 2006, ASIAN CHITIN J, V2, P1
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kalayoglu MV, SEARCH ARTIFICIAL CO
   Kang YM, 2010, INT J MOL SCI, V11, P4140, DOI 10.3390/ijms11104140
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Kharande TS, 2008, NANOTECHNOLOGY TISSU
   KHNOR E, 2003, BIOMATERIALS, V24, P2339
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lao LH, 2008, COLLOID SURFACE B, V66, P218, DOI 10.1016/j.colsurfb.2008.06.014
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   LEE JE, 2005, TISSUE ENG REGEN MED, V2, P41
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu HF, 2007, BIOMACROMOLECULES, V8, P1446, DOI 10.1021/bm061025e
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Lu G, 2008, ASIAN CHITIN J, V4, P49
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Manjubala I, 2008, J BIOMED MATER RES B, V84B, P7, DOI 10.1002/jbm.b.30838
   Manjubala I, 2004, EURO CELLS MAT, V7, P64
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Martins AM, 2010, J MATER CHEM, V20, P1638, DOI 10.1039/b916259n
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Midha R, 2001, TRANSPLANT P, V33, P612, DOI 10.1016/S0041-1345(00)02167-9
   Mo Xiumei, 2007, Frontiers of Materials Science in China, V1, P20, DOI 10.1007/s11706-007-0004-2
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X
   Partap S, 2007, POLYM BULL, V58, P849, DOI 10.1007/s00289-006-0724-y
   Peng L, 2006, J BIOACT COMPAT POL, V21, P207, DOI 10.1177/0883911506065100
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pillai CKS, 2009, TRENDS BIOMATER ARTI, V22, P175
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Radisic M, 2006, SCAFFOLDING TISSUE E
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Rinki K., 2008, ASIAN CHITIN J, V4, P43
   Rinki K, 2011, INT J POLYM MATER
   Rinki K, 2007, ASIAN CHITIN J, V3, P69
   Rinki K, 2010, J MACROMOL SCI A, V47, P429, DOI 10.1080/10601321003659630
   Rinki K, 2010, INT J BIOL MACROMOL, V46, P261, DOI 10.1016/j.ijbiomac.2009.12.009
   Rinki K, 2009, J MATER CHEM, V19, P8651, DOI 10.1039/b910842d
   Rinki K, 2009, MACROMOL SYMP, V277, P36, DOI 10.1002/masy.200950305
   Sachlos E, 2008, ACTA BIOMATER, V4, P1322, DOI 10.1016/j.actbio.2008.03.016
   Sahai N, 2010, THESIS MNNIT ALLAHAB
   Sailaja GS, 2006, ACTA BIOMATER, V2, P651, DOI 10.1016/j.actbio.2006.05.011
   Sathirakul K, 1996, P 1 INT C EUR CHIT S, V1
   Scanga VI, 2010, CAN J CHEM, V88, P277, DOI 10.1139/V09-171
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SEGLEN PO, 1972, EXP CELL RES, V74, P450, DOI 10.1016/0014-4827(72)90400-4
   Sendemir-Urkmez A, 2006, J BIOMED MATER RES A, V81A, P624
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sivakumar R, 2007, J CELL ANIMAL BIOL, V1, P71
   Smentana K., 1993, BIOMATERIALS, V14, P1046
   Tan HP, 2009, ACTA BIOMATER, V5, P328, DOI 10.1016/j.actbio.2008.07.030
   Tessmar J. K. V., 2006, SCAFFOLDING TISSUE E
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thein-Han WW, 2007, J BIOMED MATER RES B, V80B, P92, DOI 10.1002/jbm.b.30573
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Verma P, 2005, CHITIN CHITOSAN OPPO
   Wang AJ, 2006, ASIAN CHITIN J, V2, P69
   Wang AJ, 2006, ASIAN CHITIN J, V2, P53
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang Y, 2009, BIOMED MATER, V4, P1
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Wei XA, 2011, PROG CHEM, V23, P42
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Wu LB, 2006, BIOMATERIALS, V27, P185, DOI 10.1016/j.biomaterials.2005.05.105
   Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s
   Xiangmei W., 2009, J APPL POLYM SCI, V112, P3652
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang J, 2001, BIOTECHNOL LETT, V23, P1385, DOI 10.1023/A:1011600414225
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 155
TC 17
Z9 17
U1 2
U2 60
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-642-24061-4; 978-3-642-24060-7
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2011
VL 244
BP 45
EP 79
DI 10.1007/12_2011_112
D2 10.1007/978-3-642-24061-4
PG 35
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA BYI44
UT WOS:000298919200004
DA 2018-10-20
ER

PT J
AU Wischke, C
   Lendlein, A
AF Wischke, Christian
   Lendlein, Andreas
TI Designing multifunctional polymers for cardiovascular implants
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 16th Conference of the
   European-Society-for-Clinical-Hemorheology-and-Microcirculation (ESCHM)
CY JUN 18-21, 2011
CL Munich, GERMANY
DE Degradable biomaterial; cardiovascular implants; shape-memory polymers;
   stents; vascular prosthesis
ID SHAPE-MEMORY POLYMERS; CONTROLLED DRUG-RELEASE; HYDROLYTIC DEGRADATION;
   IN-VITRO; ELUTING STENTS; NETWORKS; BIOMATERIALS; MATRIX;
   HEMOCOMPATIBILITY; CAPABILITY
AB Polymer-based biomaterials are extensively used in all disciplines of clinical medicine and innovations in biomaterial science are building a product pipeline, e. g., of future cardiovascular implants. Still, cardiovascular applications demand a number of extensive requirements of properties and functions to be fulfilled by the polymer matrix. This report provides an overview on some of these issues and how they can be addressed by a tailored design of novel polymer-based biomaterials. Multifunctional shape-memory polymers are highlighted as a class of materials that combine biocompatibility and the capability for stimuli-induced active movements for anchoring of implants with a controlled degradation and drug release profile to enable a functional regeneration of the tissue at the application site.
C1 [Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
   Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Wischke, Christian/K-9651-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Wischke,
   Christian/0000-0001-5531-9033
CR Alobaid N, 2005, CLIN HEMORHEOL MICRO, V33, P209
   Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447
   Behl M, 2010, J MATER CHEM, V20, P3335, DOI 10.1039/b922992b
   Behl M, 2010, ADV POLYM SCI, V226, P1, DOI 10.1007/12_2009_26
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Braune S, 2011, CLIN HEMORHEOL MICRO, V49, P375, DOI 10.3233/CH-2011-1487
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Frost&Sullivan, 2008, N39F 54 20 MED DEV T
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Hiebl B, 2009, MATER RES SOC SYMP P, V1140, P143
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kahovec J, 2002, PURE APPL CHEM, V74, P1921, DOI 10.1351/pac200274101921
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kumar UN, 2010, J MATER CHEM, V20, P3404, DOI 10.1039/b923000a
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Matschke K, 2004, HERZ, V29, P201, DOI 10.1007/s00059-004-2561-9
   Mayer A, 2010, CLIN HEMORHEOL MICRO, V46, P217, DOI 10.3233/CH-2010-1348
   Mrowietz C, 2005, CLIN HEMORHEOL MICRO, V32, P89
   Neffe AT, 2009, MATER RES SOC SYMP P, V1190, P105
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Neffe AT, 2010, MACROMOL CHEM PHYS, V211, P182, DOI 10.1002/macp.200900441
   Pierce BF, 2011, INT J ARTIF ORGANS, V34, P172, DOI 10.5301/IJAO.2011.6413
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Sisson AL, 2011, HANDBOOK OF BIODEGRADABLE POLYMERS: SYNTHESIS, CHARACTERIZATION AND APPLICATIONS, P1
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Tzoneva R, 2008, J MATER SCI-MATER M, V19, P3203, DOI 10.1007/s10856-008-3456-8
   Weigel T, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/2/025011
   Wessely R, 2010, NAT REV CARDIOL, V7, P194, DOI 10.1038/nrcardio.2010.14
   Wischke C, 2011, MACROMOL BIOSCI, V11, P1637, DOI 10.1002/mabi.201100226
   Wischke C, 2010, PHARM RES-DORDR, V27, P2063, DOI 10.1007/s11095-010-0202-y
   Wischke C, 2010, MACROMOL BIOSCI, V10, P1063, DOI 10.1002/mabi.201000089
   Wischke C, 2010, EUR J PHARM SCI, V41, P136, DOI 10.1016/j.ejps.2010.06.003
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wykrzykowska JJ, 2009, EXPERT OPIN DRUG DEL, V6, P113, DOI [10.1517/17425240802668495 , 10.1517/17425240802668495]
   Zotzmann J, 2010, ADV MATER, V22, P3424, DOI 10.1002/adma.200904202
NR 47
TC 9
Z9 9
U1 1
U2 28
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2011
VL 49
IS 1-4
BP 347
EP 355
DI 10.3233/CH-2011-1485
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 873CL
UT WOS:000298858400035
PM 22214706
DA 2018-10-20
ER

PT J
AU Braune, S
   Honow, A
   Mrowietz, C
   Cui, J
   Kratz, K
   Hellwig, J
   Uzum, C
   Klitzing, RV
   Lendlein, A
   Jung, F
AF Braune, S.
   Hoenow, A.
   Mrowietz, C.
   Cui, J.
   Kratz, K.
   Hellwig, J.
   Uezuem, C.
   Klitzing, R. V.
   Lendlein, A.
   Jung, F.
TI Hemocompatibility of soft hydrophobic poly(n-butyl acrylate) networks
   with elastic moduli adapted to the elasticity of human arteries
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 16th Conference of the
   European-Society-for-Clinical-Hemorheology-and-Microcirculation (ESCHM)
CY JUN 18-21, 2011
CL Munich, GERMANY
DE Haemocompatibility; platelets; polymer networks; elastic modulus;
   biomaterial
ID SELF-ASSEMBLED MONOLAYERS; COMMON CAROTID-ARTERY; PLATELET-ADHESION;
   PROTEIN ADSORPTION; BLOOD COMPATIBILITY; SURFACE-ROUGHNESS; IMPLANT
   BIOCOMPATIBILITY; FIBRINOGEN ADSORPTION; ADSORBED FIBRINOGEN;
   FUNCTIONAL-GROUPS
AB Small calibre vascular prostheses (<6 mm) still lack medium and long term patency. Inelasticity of the prosthesis is one of the characteristics, which is involved in the mechanisms of failure (e. g. the development of neointimal hyperplasia at the distal anastomosis). Here we report about covalently crosslinked poly(n-butyl acrylate) networks (cPnBA) with adjustable elastic moduli, which can be tailored to values of human arteries (between 100 and 1000 kPa). Motivated by the potential application of such polymer networks as cardiovascular prosthesis, adhesion, activation and thrombus formation of human platelets on cPnBA networks were evaluated. All cPnBA-samples displayed a high thrombogenicity compared to the control (silicone). Significantly less platelets adhered on the surface of the soft cPnBA04 than on cPnBA73. All cPnBA samples displayed a higher number of platelet aggregates and a lower number of inactivated platelets in comparison to the control. While the elastic modulus of cPnBA networks could be successfully adjusted to that of human arteries, the tested polymers did not show an optimal hemocompatibility. Future studies aim at improving the biofunctionality by surface modification of these polymer networks.
C1 [Braune, S.; Hoenow, A.; Mrowietz, C.; Cui, J.; Kratz, K.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Ctr Biomaterial Dev, Teltow, Germany.
   [Braune, S.; Hoenow, A.; Mrowietz, C.; Cui, J.; Kratz, K.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Polymer Res Inst, Teltow, Germany.
   [Hellwig, J.; Uezuem, C.; Klitzing, R. V.] Tech Univ Berlin, Stranski Lab Phys & Tech Chem, Berlin, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomaterial Dev, Teltow, Germany.
EM friedrich.jung@hzg.de
RI Braune, Steffen/D-2315-2015; Jung, Friedrich/L-1301-2013; Uzum,
   Cagri/B-6800-2012; Kratz, Karl/K-7115-2013; Lendlein,
   Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Kratz, Karl/0000-0002-9229-4266;
   Lendlein, Andreas/0000-0003-4126-4670
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   American National Standard, 2009, BIOL EV 4
   Andrade J. D., 1986, BIOPOLYMERS NONEXCLU, P1, DOI DOI 10.1007/3-540-16422-7_6
   [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1
   Authi K.S., 1997, PLATELETS THEIR FACT
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   BANTJES A, 1978, BRIT POLYM J, V10, P267, DOI 10.1002/pi.4980100410
   Barrias CC, 2005, BIOMATERIALS, V26, P2695, DOI 10.1016/j.biomaterials.2004.07.033
   Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202
   Beaglehole R, 2004, WORLD HLTH REPORT 20
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   BERG B, 1981, REFERENCE VALUES LAB, P55
   BERG JC, 1986, COMPOSITE SYSTEMS NA, P23
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Breddin HK, 2003, VASA-J VASCULAR DIS, V32, P123, DOI 10.1024/0301-1526.32.3.123
   BREDDIN K, 1980, THROMB RES, V19, P621, DOI 10.1016/0049-3848(80)90034-1
   BRYNDA E, 1978, J BIOENG, V2, P411
   CAHILL M, 1992, BRIT J CLIN PHARMACO, V33, P3, DOI 10.1111/j.1365-2125.1992.tb03993.x
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chinn J.A., 2000, BIOMEDICAL ENG HDB, P1
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P126, DOI 10.1002/pat.1816
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   FENG L, 1994, J BIOMED MATER RES, V28, P735, DOI 10.1002/jbm.820280611
   Feng L., 1995, PROTEINS INTERFACES
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Gawaz M, 1999, CIRCULATION, V99, P2
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Grunkemeier J, 1996, J BIOMAT SCI-POLYM E, V8, P189, DOI 10.1163/156856296X00246
   HANSON M, 1993, ANAL CHEM, V65, P2249, DOI 10.1021/ac00065a014
   Hayashi T, 2007, BIOINTERPHASES, V2, P119, DOI 10.1116/1.2794712
   HECKER JF, 1985, J BIOMED MATER RES, V19, P381, DOI 10.1002/jbm.820190404
   Henschen A., 1986, NEW COMPREHENSIVE BI, P171
   Hertz H, 1882, J REINE ANGEW MATH, P156
   Hiebl B, 2012, J BIOMAT SCI-POLYM E, V23, P901, DOI 10.1163/092050611X566144
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   LEE RG, 1974, J BIOMED MATER RES, V8, P393, DOI 10.1002/jbm.820080607
   Lendlein A, 2011, EXPERT REV MED DEVIC, V8, P533, DOI [10.1586/erd.11.39, 10.1586/ERD.11.39]
   LINDON JN, 1986, BLOOD, V68, P355
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   Nurnberger J, 2004, DEUT MED WOCHENSCHR, V129, P97, DOI 10.1055/s-2004-816293
   OGATA N, 1981, J APPL POLYM SCI, V26, P2293, DOI 10.1002/app.1981.070260716
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   PATEL DJ, 1970, CIRC RES, V27, P149, DOI 10.1161/01.RES.27.2.149
   Poussard L, 2004, BIOMATERIALS, V25, P3473, DOI 10.1016/j.biomaterials.2003.10.069
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952
   Roch T, 2012, CLIN HEMORHEOL MICRO, V50, P131, DOI 10.3233/CH-2010-1449
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   SEKIYA K, 1984, BIOCHIM BIOPHYS ACTA, V797, P348, DOI 10.1016/0304-4165(84)90256-3
   Shadwick RE, 1999, J EXP BIOL, V202, P3305
   Sheiko SS, 2001, MACROMOLECULES, V34, P8354, DOI 10.1021/ma010746x
   SHIBA E, 1991, AM J PHYSIOL, V260, pC965
   Silin V, 1997, J COLLOID INTERF SCI, V185, P94, DOI 10.1006/jcis.1996.4586
   Sitti M, 2009, ACS APPL MATER INTER, V1, P2277, DOI 10.1021/am9004368
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Stadler H, 2003, ANAL BIOANAL CHEM, V375, P53, DOI 10.1007/s00216-002-1664-5
   Tang LP, 1999, BIOMATERIALS, V20, P1365, DOI 10.1016/S0142-9612(99)00034-4
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Tsyganov I, 2005, SURF COAT TECH, V200, P1041, DOI 10.1016/j.surfcoat.2005.02.093
   Tzoneva R, 2008, J MATER SCI-MATER M, V19, P3203, DOI 10.1007/s10856-008-3456-8
   Vyas SP, 2009, EXPERT OPIN DRUG DEL, V6, P499, DOI [10.1517/17425240902878002 , 10.1517/17425240902878002]
   WARD CA, 1977, AM J PHYSIOL, V233, pH100
   Waterhouse A., 2011, REVIEWS, V17, P93
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Yamasaki F, 2005, J HUM HYPERTENS, V19, P527, DOI 10.1038/sj.jhh.1001861
   YOUNG BR, 1982, ADV CHEM SER, P317
   Zaidi TN, 1996, BLOOD, V88, P2967
   Zhang M, 2008, J BIOMAT SCI-POLYM E, V19, P1383, DOI 10.1163/156856208786052353
   ZINGG W, 1982, CAN J SURG, V25, P16
NR 90
TC 19
Z9 19
U1 1
U2 11
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2011
VL 49
IS 1-4
BP 375
EP 390
DI 10.3233/CH-2011-1487
PG 16
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 873CL
UT WOS:000298858400037
PM 22214708
DA 2018-10-20
ER

PT J
AU Scarano, A
   Piattelli, A
   Perrotti, V
   Manzon, L
   Iezzi, G
AF Scarano, Antonio
   Piattelli, Adriano
   Perrotti, Vittoria
   Manzon, Licia
   Iezzi, Giovanna
TI Maxillary Sinus Augmentation in Humans Using Cortical Porcine Bone: A
   Histological and Histomorphometrical Evaluation After 4 and 6 Months
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bone regeneration; porcine bone-derived biomaterial; sinus augmentation
   procedures
ID ANORGANIC BOVINE BONE; IMPLANT PLACEMENT; FLOOR ELEVATION; BIO-OSS;
   AUTOGENOUS BONE; DENTAL IMPLANTS; HYDROXYAPATITE; COMBINATION;
   BIO-OSS(R); SURVIVAL
AB Background:
   Bone substitutes, such as allografts, xenografts, and alloplasts, have been proposed in several augmentation procedures.
   Purpose:
   The aim of the present study was a histologic and histomorphometric evaluation of specimens retrieved 4 or 6 months after sinus augmentation using cortical porcine bone augmentation material.
   Materials and Methods:
   A total of 77 specimens, retrieved after 4 and 6 months from augmented sinuses, were used in this study. The specimens were processed to be observed under light microscopy. Histomorphometric measurements were presented as means +/- standard deviations.
   Results:
   Most of the particles were surrounded by newly formed bone with large osteocyte lacunae. Histomorphometry showed that, after 4 months, the newly formed bone represented 28%, marrow spaces 36%, the residual graft material 37%, while, after 6 months, the newly formed bone represented 31%, marrow spaces 34%, while the residual graft material was 37%.
   Conclusion:
   The present results show that cortical porcine bone is a biocompatible, osteoconductive biomaterial that can be used for maxillary sinus augmentation procedures without interfering with the normal reparative bone processes.
C1 [Scarano, Antonio; Piattelli, Adriano; Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Sch Dent, Chieti, Italy.
   [Manzon, Licia] Univ Roma La Sapienza, Dept Dent Mat, Rome, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146; MANZON, Licia/0000-0002-7727-7652
FU Ministry of the Education, University and Research, Rome, Italy
FX This work was partially supported by the Ministry of the Education,
   University and Research, Rome, Italy.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Iezzi G, 2008, J PERIODONTOL, V79, P192, DOI 10.1902/jop.2008.070105 
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Karabuda C, 2001, J PERIODONTOL, V72, P1436, DOI 10.1902/jop.2001.72.10.1436
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Orsini G, 2007, ORAL DIS, V13, P586, DOI 10.1111/j.1601-0825.2006.01343.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   PERROTTI V, 2008, J BIOMED MAT RES A
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Rosenlicht J L, 1999, J Oral Implantol, V25, P7, DOI 10.1563/1548-1336(1999)025<0007:HHEOIO>2.3.CO;2
   Scarano A, 2004, J PERIODONTOL, V75, P1161, DOI 10.1902/jop.2004.75.8.1161
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Yamamichi N, 2008, INT J PERIODONT REST, V28, P163
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 27
TC 33
Z9 33
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2011
VL 13
IS 1
BP 13
EP 18
DI 10.1111/j.1708-8208.2009.00176.x
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 716BW
UT WOS:000286940900002
PM 19438954
DA 2018-10-20
ER

PT J
AU Araujo, MG
   Linder, E
   Lindhe, J
AF Araujo, Mauricio G.
   Linder, Elena
   Lindhe, Jan
TI Bio-Oss (R) Collagen in the buccal gap at immediate implants: a 6-month
   study in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; dogs; extraction socket; grafting; implants
ID FRESH EXTRACTION SOCKETS; SINUS AUGMENTATION PROCEDURES; BONE TISSUE
   FORMATION; TOOTH EXTRACTION; PART 1; PLACEMENT; HUMANS; ADJACENT; TEETH
AB Background
   Following tooth extraction and immediate implant installation, the edentulous site of the alveolar process undergoes substantial bone modeling and the ridge dimensions are reduced.
   Objective
   The objective of the present experiment was to determine whether the process of bone modeling following tooth extraction and immediate implant placement was influenced by the placement of a xenogenic graft in the void that occurred between the implant and the walls of the fresh extraction socket.
   Material and methods
   Five beagle dogs about 1 year old were used. The 4th premolar in both quadrants of the mandible ((4)P(4)) were selected and used as experimental sites. The premolars were hemi-sected and the distal roots removed and, subsequently, implants were inserted in the distal sockets. In one side of the jaw, the marginal buccal-approximal void that consistently occurred between the implant and the socket walls was grafted with Bio-Oss (R) Collagen while no grafting was performed in the contra-lateral sites. After 6 months of healing, biopsies from each experimental site were obtained and prepared for histological analyses.
   Results
   The outline of the marginal hard tissue of the control sites was markedly different from that of the grafted sites. Thus, while the buccal bone crest in the grafted sites was comparatively thick and located at or close to the SLA border, the corresponding crest at the control sites was thinner and located a varying distance below SLA border.
   Conclusions
   It was demonstrated that the placement of Bio-Oss (R) Collagen in the void between the implant and the buccal-approximal bone walls of fresh extraction sockets modified the process of hard tissue healing, provided additional amounts of hard tissue at the entrance of the previous socket and improved the level of marginal bone-to-implant contact.
   To cite this article:Araujo MG, Linder E, Lindhe J. Bio-Oss (R) Collagen in the buccal gap at immediate implants: a 6-month study in the dog.Clin. Oral Impl. Res. 22, 2011; 1-8.doi: 10.1111/j.1600-0501.2010.01920.x.
C1 [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Linder, Elena; Lindhe, Jan] Univ Gothenburg, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim 15,Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Blanco J, 2008, J CLIN PERIODONTOL, V35, P640, DOI 10.1111/j.1600-051X.2008.01237.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   BOTTICELLI D, 2006, THESIS GOTEBORG U SW
   Botticelli D, 2006, CLIN ORAL IMPLAN RES, V17, P351, DOI 10.1111/j.1600-0501.2006.01270.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K, 1993, PREPARATION HISTOLOG
   DONATH K, 1988, PRAPARATOR, V34, P97
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Frost HM, 1964, MATH ELEMENTS LAMELL
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   KUBOKI Y, 1988, J DENT RES, V67, P944, DOI 10.1177/00220345880670061101
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Pietrokovski J., 2007, J PROSTHODONTICS, V15, P141
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 33
TC 122
Z9 125
U1 1
U2 18
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2011
VL 22
IS 1
BP 1
EP 8
DI 10.1111/j.1600-0501.2010.01920.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 695RQ
UT WOS:000285390700001
PM 21091538
DA 2018-10-20
ER

PT J
AU MacDonald, DE
   Rapuano, BE
   Schniepp, HC
AF MacDonald, Daniel E.
   Rapuano, Bruce E.
   Schniepp, Hannes C.
TI Surface oxide net charge of a titanium alloy Comparison between effects
   of treatment with heat or radiofrequency plasma glow discharge
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Titanium alloy; Oxides; Surface treatments; Net surface charge;
   Wettability
ID ATOMIC-FORCE MICROSCOPY; OSTEOBLAST-LIKE CELLS;
   PHOTOELECTRON-SPECTROSCOPY; PHYSIOLOGICAL SOLUTION; THIN-FILMS;
   ADSORPTION; BEHAVIOR; BIOMATERIAL; FIBRONECTIN; ROUGHNESS
AB In the current study we have compared the effects of heat and radiofrequency plasma glow discharge (RFGD) treatment of a Ti6Al4V alloy on the physico chemical properties of the alloys surface oxide Titanium alloy (Ti6Al4V) disks were passivated alone heated to 600 C or RFGD plasma treated in pure oxygen RFGD treatment did not alter the roughness topography elemental composition or thickness of the alloys surface oxide layer In contrast heat treatment altered oxide topography by creating a pattern of oxide elevations approximately 50-100 nm in diameter These nanostructures exhibited a three fold increase in roughness compared to untreated surfaces when RMS roughness was calculated after applying a spatial high-pass filter with a 200 nm cutoff wavelength Heat treatment also produced a surface enrichment in aluminum and vanadium oxides Both RFGD and heat treatment produced similar increases in oxide wettability Atomic force microscopy (AFM) measurements of metal surface oxide net charge signified by a long-range force of attraction to or repulsion from a (negatively charged) silicon nitride AFM probe were also obtained for all three experimental groups Force measurements showed that the RFGD treated Ti6Al4V samples demonstrated a higher net positive surface charge at pH values below 6 and a higher net negative surface charge at physiological pH (pH values between 7 and 8) compared to control and heat treated samples These findings suggest that RFGD treatment of metallic implant materials can be used to study the role of negatively charged surface oxide functional groups in protein bioactivity osteogenic cell behavior and osseointegration independently of oxide topography Published by Elsevier B V
C1 [MacDonald, Daniel E.; Rapuano, Bruce E.] Cornell Univ, Weill Med Coll, Hosp Special Surg, New York, NY 10021 USA.
   [MacDonald, Daniel E.] Gen Med Res James Peters VA Med Ctr, Bronx, NY 10468 USA.
   [MacDonald, Daniel E.] Columbia Univ, Langmuir Ctr Colloids & Interfaces, New York, NY 10027 USA.
   [Schniepp, Hannes C.] Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA.
RP MacDonald, DE (reprint author), Cornell Univ, Weill Med Coll, Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
RI Schniepp, Hannes/B-8368-2008
OI Schniepp, Hannes/0000-0003-4645-9469
FU NIH [RO1 DE017695]; National Center for Research Resources NIH
   [C06-RR12538-01]
FX The project described was supported by Grant number NIH RO1 DE017695
   (Awarded to DEM) The sponsor did not have any role in the study design
   the collection analysis and interpretation of data the writing of the
   report or the decision to submit the paper for publication This material
   is also the result of work supported with resources and the use of
   facilities at the James J Peters VA Medical Center Bronx New York This
   investigation was also conducted at the HSS research facility
   constructed with support of Grant C06-RR12538-01 from the National
   Center for Research Resources NIH We would like to acknowledge Michael
   Stranick of Colgate Palmolive Inc for assistance with the ESCA
   measurements Special thanks goes to Ryan Jeong and Dana McCloskey for
   their help in preparing and treating the alloy disks
CR Adamson A. W., 1990, PHYS CHEM SURFACE
   ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   ARONSSON BO, 1997, MAT RES, V35, P49
   ASTM, 1996, ANN BOOK ASTM STAND, V03.01
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chapman B., 1980, GLOW DISCHARGE PROCE
   Deng F, 1997, SOLID STATE NUCL MAG, V7, P281, DOI 10.1016/S0926-2040(96)01281-7
   DOUNDOULAKIS JH, 1987, J PROSTHET DENT, V58, P471, DOI 10.1016/0022-3913(87)90279-4
   GARINO J, 1999, REVISION TOTAL HIP A, P1
   GOLANDER CG, 1990, CHARACTERIZATION, V11, P32
   Han JB, 2006, SURF COAT TECH, V200, P4876, DOI 10.1016/j.surfcoat.2005.04.036
   Hardt CRE, 2002, CLIN ORAL IMPLAN RES, V13, P488, DOI 10.1034/j.1600-0501.2002.130507.x
   Hartley PG, 1997, LANGMUIR, V13, P2207, DOI 10.1021/la960997c
   HERBERTS PG, 1995, BRIS MYER Z, P1
   Hopwood J, 1992, PLASMA SOURCES SCI T, V1, P109, DOI 10.1088/0963-0252/1/2/006
   JENNISSEN HP, 2001, BIOMATERIALIEN, V2, P45
   Johansson P, 1994, INT J ORAL MAXILLOF, V9, P279
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Larsson G, 1996, BIOMATERIALS, V17, P605
   Li ZY, 2003, SURF SCI, V529, P410, DOI 10.1016/S0039-6028(03)00015-3
   LIM LJ, 2001, BIOMED MAT ENG, V11, P325
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mezzasalma SA, 1997, J COLLOID INTERF SCI, V190, P302, DOI 10.1006/jcis.1997.4839
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Morris H F, 2001, J Oral Implantol, V27, P180, DOI 10.1563/1548-1336(2001)027<0180:AMCIID>2.3.CO;2
   MOULDER JF, 1992, HDB PHOTOELECTIONS S
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   OLTHOFF JK, 1995, APPL PHYS LETT, V67, P473, DOI 10.1063/1.114540
   OLTHOFF JK, 1995, J RES NATL INST STAN, V100, pU3, DOI 10.6028/jres.100.001
   Ozden N, 1997, DENT MATER, V13, P174
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   Pavlik J., 1999, SUPERFICIES VACIO, V9, P131
   Pham MT, 1997, THIN SOLID FILMS, V310, P251, DOI 10.1016/S0040-6090(97)00330-1
   RAO CNR, 1979, P ROY SOC LOND A MAT, V367, P239, DOI 10.1098/rspa.1979.0085
   Rapuano BE, 2011, COLLOID SURFACE B, V82, P95, DOI 10.1016/j.colsurfb.2010.08.023
   RATNER BD, 1990, J VAC SCI TECHNOL A, V8, P2306, DOI 10.1116/1.576755
   Rossetti FF, 2003, LANGMUIR, V19, P10116, DOI 10.1021/la034280i
   Roth J. R., 1995, IND PLASMA ENG, V1
   SCHWARTZ A, 2008, J BONE JOINT SURG AM, V90, P2485
   SENDEN TJ, 1995, COLLOID SURFACE A, V94, P29, DOI 10.1016/0927-7757(94)02954-Q
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   SODHI RNS, 1991, J VAC SCI TECHNOL A, V9, P1329, DOI 10.1116/1.577621
   Sun TL, 2005, CHEM COMMUN, P1723, DOI 10.1039/b417670g
   Swart K M, 1992, J Oral Implantol, V18, P130
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P149, DOI 10.1002/jbm.820170112
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   VOGLER EA, 1993, INTERFACIAL CHEM BIO, P184
   Woodward JT, 2000, LANGMUIR, V16, P2957, DOI 10.1021/1a991068z
   Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 62
TC 19
Z9 20
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2011
VL 82
IS 1
BP 173
EP 181
DI 10.1016/j.colsurfb.2010.08.031
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 673YH
UT WOS:000283699600025
PM 20880672
OA Green Accepted
DA 2018-10-20
ER

PT B
AU Alexiou, TS
   Kapellos, GE
   Pavlou, S
AF Alexiou, Terpsichori S.
   Kapellos, George E.
   Pavlou, Stavros
BE Papadrakakis, M
   Onate, E
   Schrefler, B
TI COMPUTATIONAL STUDY OF THE INTERACTION BETWEEN A NEWTONIAN FLUID AND A
   CELLULAR BIOLOGICAL MEDIUM IN A STRAIGHT VESSEL
SO COMPUTATIONAL METHODS FOR COUPLED PROBLEMS IN SCIENCE AND ENGINEERING IV
LA English
DT Proceedings Paper
CT 4th International Conference on Computational Methods for Coupled
   Problems in Science and Engineering (COUPLED PROBLEMS)
CY JUN 20-22, 2011
CL Kos, GREECE
SP Natl Tech Univ Athens, Int Ctr Numer Methods Engn (CIMNE), Tech Univ Catalonia (UPC), Univ Padova
DE Fluid-Biomaterial Interactions; Navier-Stokes equations; Mixture Theory;
   Finite Element Method
ID INTERSTITIAL FLOW; CARTILAGE
AB In this work, we solve numerically the governing equations for quasi-steady Newtonian flow past and through a cellular biological medium, which is attached to the surface of a straight vessel. The flow past the cellular biological medium is described by the Navier-Stokes equations. For the modeling of momentum transfer within the cellular biological medium, we consider that the cellular biological medium constitutes a biphasic fluid-solid mixture with poroelastic behaviour. The system of governing equations is solved numerically with the mixed finite element method. The computational domain is discretized using an unstructured, variable density triangular element mesh. From the numerical solution we obtain the spatial distributions of: (i) the fluid velocity and pressure, and (ii) the displacement and stresses of the solid matrix within the cellular biological medium. Also, the components of the overall hydrodynamic force exerted by the flowing fluid on the cellular biological medium are calculated. A parametric analysis is performed with regard to the Reynolds and Darcy numbers that characterize the flow past and through the cellular biological medium.
C1 [Alexiou, Terpsichori S.; Kapellos, George E.; Pavlou, Stavros] Univ Patras, Dept Chem Engn, GR-26504 Patras, Greece.
RP Alexiou, TS (reprint author), Univ Patras, Dept Chem Engn, Karatheodori Str 1, GR-26504 Patras, Greece.
EM xalexiou@chemeng.upatras.gr; gek222@chemeng.upatras.gr;
   sp@chemeng.upatras.gr
RI Pavlou, Stavros/F-5771-2013
OI Pavlou, Stavros/0000-0002-5146-2390; Kapellos,
   George/0000-0002-8464-7893
CR BEDFORD A, 1983, INT J ENG SCI, V21, P863, DOI 10.1016/0020-7225(83)90071-X
   Evans RC, 2006, J BIOMECH, V39, P1048, DOI 10.1016/j.jbiomech.2005.02.017
   HOU JS, 1989, J BIOMECH ENG-T ASME, V111, P78, DOI 10.1115/1.3168343
   Kapellos GE, 2010, MATH BIOSCI, V225, P83, DOI 10.1016/j.mbs.2010.03.003
   Ng CP, 2006, ANN BIOMED ENG, V34, P446, DOI 10.1007/s10439-005-9067-3
   RAJAGOPAL KR, 1995, MECH MIXTURES
   Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007
NR 7
TC 0
Z9 0
U1 0
U2 2
PU INT CENTER NUMERICAL METHODS ENGINEERING
PI 08034 BARCELONA
PA GRAN CAPITAN, S-N, CAMPUS NORTE UPC, MODULO C1, 08034 BARCELONA, SPAIN
BN 978-84-89925-78-6
PY 2011
BP 1120
EP 1127
PG 8
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications
SC Engineering; Mathematics
GA BDJ78
UT WOS:000313559700099
DA 2018-10-20
ER

PT J
AU Esseku, F
   Adeyeye, MC
AF Esseku, Fredrick
   Adeyeye, Moji Christianah
TI Bacteria and pH-Sensitive Polysaccharide-Polymer Films for Colon
   Targeted Delivery
SO CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
LA English
DT Review
DE Biomaterial; gastrointestinal insoluble polymer; microflora; glycosidic
   enzymes; oral delivery; delayed release
ID INFLAMMATORY-BOWEL-DISEASE; IN-VIVO EVALUATION; DRY-COATED TABLETS;
   5-AMINOSALICYLIC ACID PELLETS; DIFFERENT WATER SOLUBILITY; DRIED
   CHITOSAN ACETATE; HIGH-AMYLOSE STARCH; DRUG-DELIVERY; VITRO EVALUATION;
   CROHNS-DISEASE
AB The colon provides drug delivery opportunities for colon-specific and systemic delivery of various therapeutic agents. Different strategies have been utilized in targeting drugs to the colon. Recently, integrated systems which incorporate dual mechanisms in colon targeted delivery have received a lot of attention. Of particular interest is bacteria-aided biomaterials and pH-sensitive polymeric film (BPSF) coating for colon targeted drug delivery. The major constituents of these films are polysaccharides and pH-sensitive polymers. The pH-sensitive polymer retards drug release in the stomach and small intestine, while the polysaccharide is digested by colonic enzymes. Digestion of the polysaccharides by bacterial glycosidic enzymes increases the pore density in the film to facilitate drug release. Generally, bacteria-aided biomaterials and pH-sensitive films can be applied to the delivery of most small organic molecules to the colon. The review encompasses the pharmaceutical design parameters such as film digestibility, swelling index and dry mass loss (that provide molecular mechanistic analysis of film permeability) as well as tensile strength, elastic modulus, and elongation at break (that describe the desirable mechanical properties of the films). A critical analysis of formulation, techniques for characterization of film properties and drug-release kinetics from these systems are emphasized.
C1 [Adeyeye, Moji Christianah] Roosevelt Univ, Coll Pharm, Dept Biopharmaceut Sci, Schaumburg, IL 60173 USA.
   [Esseku, Fredrick] Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15282 USA.
   [Esseku, Fredrick] Aptuit Inc, Kansas City, MO 64137 USA.
RP Adeyeye, MC (reprint author), Roosevelt Univ, Coll Pharm, Dept Biopharmaceut Sci, 1400 N Roosevelt Blvd, Schaumburg, IL 60173 USA.
EM madeyeye@roosevelt.edu
OI Adeyeye, Moji Christianah/0000-0003-3808-3166
CR Ahmed IS, 2005, DRUG DEV IND PHARM, V31, P465, DOI 10.1080/03639040500214704
   Akhgari A, 2006, EUR J PHARM SCI, V28, P307, DOI 10.1016/j.ejps.2006.03.005
   Akhgari A, 2010, DARU, V18, P91
   Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   [Anonymous], 2009, STUD COLAL PRED TREA
   ASHFORD M, 1994, J CONTROL RELEASE, V30, P225, DOI 10.1016/0168-3659(94)90028-0
   Basit AW, 2009, J DRUG TARGET, V17, P64, DOI [10.1080/10611860802455805, 10.1080/10611860802455805 ]
   Basit AW, 2007, School of Pharmacy University of London, assignee. Colonic drug delivery formulation. World Intellectual Property Organization, Patent No. [WO/2007/122374, 2007122374]
   Bauer K, 1998, COATED PHARM DOSAGE
   Bourgeois S, 2005, J DRUG TARGET, V13, P277, DOI 10.1080/10611860500206583
   Carrette O, 1995, DIGEST DIS SCI, V40, P2641, DOI 10.1007/BF02220454
   Cavalcanti Osvaldo Albuquerque, 2004, Acta Farmaceutica Bonaerense, V23, P53
   Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33
   COONEY DO, 1972, AICHE J, V18, P446, DOI 10.1002/aic.690180234
   Crohn's and Colitis Foundation of America, EP IBD
   Cummings JH, 1996, J CONTROL RELEASE, V40, P123, DOI 10.1016/0168-3659(95)00186-7
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   Dahan A, 2010, EXPERT REV CLIN IMMU, V6, P543, DOI 10.1586/ECI.10.30
   Coimbra CGD, 2010, BIORESOURCE TECHNOL, V101, P4725, DOI 10.1016/j.biortech.2010.01.091
   De Vos M, 2000, CLIN PHARMACOKINET, V39, P85, DOI 10.2165/00003088-200039020-00001
   Duda J. L., 1996, DIFFUSION POLYM, P143
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Edsbacker S, 2004, CLIN PHARMACOKINET, V43, P803, DOI 10.2165/00003088-200443120-00003
   Edwards CA, 1993, COLONIC DRUG ABSORPT, P1
   El-Kamel AH, 2008, INT J PHARM, V358, P248, DOI 10.1016/j.ijpharm.2008.04.021
   ENCK P, 1989, GUT, V30, P455, DOI 10.1136/gut.30.4.455
   ENGLYST HN, 1986, J SCI FOOD AGR, V37, P699, DOI 10.1002/jsfa.2740370717
   Englyst HN, 2006, FEMS MICROBIOL LETT, V45, P163
   Fadda HM, 2009, PHARM RES-DORD, V26, P356, DOI 10.1007/s11095-008-9749-2
   Faigle JW, 1993, COLONIC DRUG ABSORPT, P29
   Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369
   Fan LF, 2008, CHEM PHARM BULL, V56, P1118, DOI 10.1248/cpb.56.1118
   Fan LF, 2009, INT J PHARMACEUT, V375, P8, DOI 10.1016/j.ijpharm.2009.03.023
   Favier C, 1997, DIGEST DIS SCI, V42, P817, DOI 10.1023/A:1018876400528
   Fetzner A, 2004, EUR J PHARM BIOPHARM, V58, P91, DOI 10.1016/j.ejpb.2004.02.001
   Food and Drug Administration Center for Drug Evaluation and Research, 2003, BIOAV BIOEQ STUD OR
   Freire AC, 2009, EUR J PHARM BIOPHARM, V72, P574, DOI 10.1016/j.ejpb.2009.02.008
   Freire C, 2009, EUR J PHARM BIOPHARM, V72, P587, DOI 10.1016/j.ejpb.2009.02.010
   Freire C, 2010, J PHARM PHARMACOL, V62, P55, DOI [10.1211/jpp/62.01.0005, 10.1211/jpp.62.01.0005]
   Freire C, 2010, DRUG DEV IND PHARM, V36, P161, DOI 10.3109/03639040903124617
   Frieri G, 2000, GUT, V47, P410, DOI 10.1136/gut.47.3.410
   Frohoff-Hulsmann MA, 1999, EUR J PHARM BIOPHARM, V48, P67, DOI 10.1016/S0939-6411(99)00023-5
   Frohoff-Hulsmann MA, 1999, INT J PHARM, V177, P69, DOI 10.1016/S0378-5173(98)00327-5
   Ghaffari A, 2008, DRUG DEV IND PHARM, V34, P390, DOI 10.1080/03639040701662453 
   Ghaffari Alireza, 2006, Acta Pharmaceutica (Zagreb), V56, P299
   Ghaffari A, 2007, EUR J PHARM BIOPHARM, V67, P175, DOI 10.1016/j.ejpb.2007.01.013
   Gibson GR, 1999, J NUTR, V129, p1438S, DOI 10.1093/jn/129.7.1438S
   Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479
   GORBACH SL, 1971, GASTROENTEROLOGY, V60, P1110
   GORDON M, 1952, J APPL CHEM, V2, P493
   Han M, 2009, J PHARM SCI-US, V98, P2626, DOI 10.1002/jps.21627
   Hanauer SB, 2006, INFLAMM BOWEL DIS, V12, pS3, DOI 10.1097/01.MIB.0000195385.19268.68
   HARDY JG, 1985, J PHARM PHARMACOL, V37, P874, DOI 10.1111/j.2042-7158.1985.tb04992.x
   He W, 2009, EUR J PHARM BIOPHARM, V72, P266, DOI 10.1016/j.ejpb.2008.10.017
   He W, 2009, J PHARM PHARMACOL, V61, P167, DOI 10.1211/jpp/61.02.0005
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hodges LA, 2009, INT J PHARMACEUT, V370, P144, DOI 10.1016/j.ijpharm.2008.12.002
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   HOSEL W, 1978, EUR J BIOCHEM, V84, P487, DOI 10.1111/j.1432-1033.1978.tb12190.x
   Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190
   Hu ZP, 2000, J PHARM PHARMACOL, V52, P1187, DOI 10.1211/0022357001777315
   Ibekwe VC, 2008, ALIMENT PHARM THER, V28, P911, DOI 10.1111/j.1365-2036.2008.03810.x
   Ibekwe VC, 2008, PHARM RES-DORDR, V25, P1828, DOI 10.1007/s11095-008-9580-9
   Iwaya A, 2006, HEPATO-GASTROENTEROL, V53, P55
   Jain A, 2007, J PHARM PHARM SCI, V10, P86
   Kagan L, 2008, EXPERT OPIN DRUG DEL, V5, P681, DOI [10.1517/17425247.5.6.681 , 10.1517/17425240802182281]
   KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502
   Karp SM, 2006, DM-DIS MON, V52, P211, DOI 10.1016/j.disamonth.2006.05.008
   Karrout Y, 2010, J PHARM PHARMACOL, V62, P1676, DOI 10.1111/j.2042-7158.2010.01165.x
   Karrout Y, 2009, DRUG DEV IND PHARM, V35, P1190, DOI 10.1080/03639040902858868
   Karrout Y, 2009, EUR J PHARM BIOPHARM, V73, P74, DOI 10.1016/j.ejpb.2009.04.003
   Karrout Y, 2009, EUR J PHARM SCI, V37, P427, DOI 10.1016/j.ejps.2009.03.014
   Karrout Y, 2009, INT J PHARMACEUT, V371, P64, DOI 10.1016/j.ijpharm.2008.12.014
   Kasim NA, 2004, MOL PHARMACEUT, V1, P85, DOI 10.1021/mp034006h
   Katsuma M, 2006, INT J PHARM, V307, P156, DOI 10.1016/j.ijpharm.2005.09.028
   Katsuma M, 2004, J PHARM SCI-US, V93, P1287, DOI 10.1002/jps.20063
   Kaur Gurpreet, 2007, Recent Pat Drug Deliv Formul, V1, P222, DOI 10.2174/187221107782331665
   Kaur K, 2009, INT J PHARM, V366, P140, DOI 10.1016/j.ijpharm.2008.09.006
   Kendall RA, 2009, EUR J PHARM SCI, V37, P284, DOI 10.1016/j.ejps.2009.02.015
   Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269
   Klotz U, 2005, ADV DRUG DELIVER REV, V57, P267, DOI 10.1016/j.addr.2004.08.007
   Kosaraju SL, 2005, CRIT REV FOOD SCI, V45, P251, DOI 10.1080/10408690490478091
   Krishnaiah YSR, 2003, DRUG DELIV, V10, P263, DOI 10.1080/10717540390235634
   Krishnaiah YSR, 2003, EUR J PHARM SCI, V19, P355, DOI 10.1016/S0928-0987(03)00139-8
   Krishnamachari Y, 2007, INT J PHARM, V338, P238, DOI 10.1016/j.ijpharm.2007.02.015
   Kumar P., 2008, Current Drug Delivery, V5, P186, DOI 10.2174/156720108784911712
   Kumar P, 2008, CHEM PHARM BULL, V56, P1234, DOI 10.1248/cpb.56.1234
   Lai HM, 2010, DRUG DEV IND PHARM, V36, P81, DOI 10.3109/03639040903092335
   Lecomte F, 2004, J CONTROL RELEASE, V99, P1, DOI 10.1016/j.jconrel.2004.05.011
   Lecomte F, 2004, PHARM RES, V21, P882, DOI 10.1023/B:PHAM.0000026443.71935.cb
   LEE PI, 1980, J MEMBRANE SCI, V7, P255
   Leong CW, 2002, EUR J PHARM BIOPHARM, V54, P291, DOI 10.1016/S0939-6411(02)00121-2
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/nature4441022a
   Linskens RK, 2001, SCAND J GASTROENTERO, V36, P29, DOI 10.1080/003655201753265082
   Liu H, 2007, INT J PHARM, V332, P115, DOI 10.1016/j.ijpharm.2006.09.038
   Lu Q, 1998, PHARMACEUT RES, V15, P1202, DOI 10.1023/A:1011983606606
   Macleod GS, 1997, INT J PHARM, V157, P53, DOI 10.1016/S0378-5173(97)00216-0
   Makhof A, 2009, EUR J PHARM BIOPHARM, V72, P1, DOI 10.1016/j.ejpb.2008.12.013
   Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288
   Maroni A, 2009, EUR J PHARM BIOPHARM, V72, P246, DOI 10.1016/j.ejpb.2008.12.002
   Martin A. N., 2006, MARTINS PHYS PHARM P
   McConnell EL, 2008, MODIFIED RELEASE DRU, P343
   McConnell EL, 2008, INT J PHARMACEUT, V364, P213, DOI 10.1016/j.ijpharm.2008.05.012
   McConnell EL, 2008, J CONTROL RELEASE, V130, P154, DOI 10.1016/j.jconrel.2008.05.022
   Mcconnell EL, 2008, J PHARM SCI-US, V97, P3820, DOI 10.1002/jps.21271
   McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008
   McConnell EL, 2007, CELLULOSE, V14, P25, DOI 10.1007/s10570-006-9078-8
   McConnell EL, 2009, J DRUG TARGET, V17, P335, DOI 10.1080/10611860902839502
   Meissner Y, 2008, J PHARM SCI-US, V97, P2878, DOI 10.1002/jps.21216
   Milojevic S, 1996, J CONTROL RELEASE, V38, P75, DOI 10.1016/0168-3659(95)00112-3
   Milojevic S, 1996, J CONTROL RELEASE, V38, P85, DOI 10.1016/0168-3659(95)00113-1
   Milojevic S, 1993, P INT S CONTROL REL, V20, P288
   Milojevic S, 1993, THESIS U LONDON
   Morris V. J., 1990, TRENDS FOOD SCI TECH, V1, P2
   Nair HB, 2010, BIOCHEM PHARMACOL, V80, P1833, DOI 10.1016/j.bcp.2010.07.021
   Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571
   Nunthanid J, 2009, EUR J PHARM BIOPHARM, V71, P356, DOI 10.1016/j.ejpb.2008.08.002
   Nunthanid J, 2008, EUR J PHARM BIOPHARM, V68, P253, DOI 10.1016/j.ejpb.2007.05.017
   Ofori-Kwakye K, 2004, INT J PHARM, V270, P307, DOI 10.1016/ijpharm.2003.11.009
   Olano-Martin E, 2002, J APPL MICROBIOL, V93, P505, DOI 10.1046/j.1365-2672.2002.01719.x
   Omar S, 2007, J DRUG TARGET, V15, P691, DOI 10.1080/10611860701603281
   Orlu M, 2006, INT J PHARMACEUT, V318, P103, DOI 10.1016/j.ijpharm.2006.03.025
   Ozeki Y, 2004, J CONTROL RELEASE, V95, P51, DOI 10.1016/j.jconrel.2003.10.028
   Pal CM, 2000, P INT S CONTR REL BI, V27
   PANalytical BV, 2010, XRAY MIRR
   Pasman W, 2006, EUR J CLIN NUTR, V60, P1024, DOI 10.1038/sj.ejcn.1602418
   Patel M, 2007, CRIT REV THER DRUG, V24, P147, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i2.20
   patel Nirav, 2008, J PHARM RES, V1, P2
   Patel NV, 2010, ACTA PHARMACEUT, V60, P39, DOI 10.2478/v10007-010-0008-9
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Podczeck GF, 2008, Coating composition comprising starch. World Intellectual Property Organization, Patent No. [WO/2008/012573, 2008012573]
   Prakash S, 2008, BIOL-TARGETS THER, V2, P355
   Raghavan V, 2007, ERCIYES MED J, V29, P175
   Rahman Z, 2008, J PHARM PHARMACOL, V60, P615, DOI 10.1211/jpp.60.5.0007
   Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005
   Rowe R. C., 2006, HDB PHARM EXCIPIENTS
   Rubinstein Abraham, 2005, Drug Discov Today Technol, V2, P33, DOI 10.1016/j.ddtec.2005.05.021
   Safdi AV, 2005, AM J GASTROENTEROL, V100, pS159
   Sakurai M, 2008, YAKUGAKU ZASSHI, V128, P951, DOI 10.1248/yakushi.128.951
   Sakurai M, 2007, YAKUGAKU ZASSHI, V127, P2057, DOI 10.1248/yakushi.127.2057
   Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059
   Schellekens RCA, 2010, J CONTROL RELEASE, V146, P334, DOI 10.1016/j.jconrel.2010.05.028
   Schellekens RCA, 2009, BRIT J PHARMACOL, V158, P532, DOI 10.1111/j.1476-5381.2009.00302.x
   Schiller C, 2005, ALIMENT PHARM THERAP, V22, P971, DOI 10.1111/j.1365-2036.2005.02683.x
   SCHNEIDER HA, 1989, POLYMER, V30, P771, DOI 10.1016/0032-3861(89)90172-9
   Schwab M, 2001, CLIN PHARMACOKINET, V40, P723, DOI 10.2165/00003088-200140100-00003
   Schwartz D, 2007, CURR MED RES OPIN, V23, P2715, DOI 10.1185/030079907X233241
   Seidegard J, 2008, EUR J PHARM SCI, V35, P264, DOI 10.1016/j.ejps.2008.07.005
   Semde R, 2000, INT J PHARM, V197, P181, DOI 10.1016/S0378-5173(99)00467-6
   Semde R, 1998, INT J PHARM, V174, P233, DOI 10.1016/S0378-5173(98)00269-5
   Seow CH, 2009, EXPERT OPIN DRUG MET, V5, P971, DOI 10.1517/17425250903124355
   Shimono N, 2003, CHEM PHARM BULL, V51, P620
   Siepmann F, 2008, J CONTROL RELEASE, V125, P1, DOI 10.1016/j.jconrel.2007.09.012
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Siepmann J, 2000, PHARMACEUT RES, V17, P1290, DOI 10.1023/A:1026455822595
   Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004
   Siew L., 2000, AAPS PHARMSCITECH, V1, P53
   Siew LF, 2000, EUR J PHARM SCI, V11, P133, DOI 10.1016/S0928-0987(00)00098-1
   Siew LF, 2004, INT J PHARM, V273, P129, DOI 10.1016/j.ijpharm.2003.12.015
   Silva I, 2009, CARBOHYD POLYM, V76, P593, DOI 10.1016/j.carbpol.2008.11.026
   SIMHA R, 1962, J CHEM PHYS, V37, P1003, DOI 10.1063/1.1733201
   Simonsen L, 1995, EUR J PHARM SCI, V3, P329, DOI 10.1016/0928-0987(95)00023-6
   Sinha VR, 2005, INT J PHARM, V289, P79, DOI 10.1016/j.ijpharm.2004.10.019
   Sinko P.J., 2006, MARTINS PHYS PHARM P, P585
   Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005
   Sriamornsak P, 2003, PHARM DEV TECHNOL, V8, P311, DOI 10.1081/PDT-120022159
   THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735
   Torrado JJ, 2008, PHARM DOSAGE FORMS T, P509
   Tugcu-Demiroz F, 2004, J DRUG TARGET, V12, P105, DOI 10.1080/10611860410001693751
   Tuleu C, 2002, ALIMENT PHARM THERAP, V16, P1771, DOI 10.1046/j.0269-2813.2002.01327.x
   Tuohy KM, 2001, BRIT J NUTR, V86, P341, DOI 10.1079/BJN2001394
   Turkoglu M, 2002, EUR J PHARM BIOPHARM, V53, P65, DOI 10.1016/S0939-6411(01)00225-9
   Ugurlu T, 2007, EUR J PHARM BIOPHARM, V67, P202, DOI 10.1016/j.ejpb.2007.01.016
   United States Pharmacopoeia, 2009, USP32NF27 US PHARM
   van den Heuvel EGHM, 2005, EUR J NUTR, V44, P445, DOI 10.1007/s00394-005-0552-0
   van den Heuvel EGHM, 2004, EUR J CLIN NUTR, V58, P1046, DOI 10.1038/sj.ejcn.1601930
   Verbeke K, 2005, ALIMENT PHARM THERAP, V21, P187, DOI 10.1111/j.1365-2036.2005.02323.x
   Vermorel M, 2004, EUR J NUTR, V43, P344, DOI 10.1007/s00394-004-0477-z
   Wakerly Z, 1996, PHARMACEUT RES, V13, P1210, DOI 10.1023/A:1016016404404
   Wakerly Z, 1997, INT J PHARM, V153, P219, DOI 10.1016/S0378-5173(97)00110-5
   Wang QW, 2007, MED CHEM RES, V16, P370, DOI 10.1007/s00044-007-9049-0
   Warren RAJ, 1996, ANNU REV MICROBIOL, V50, P183, DOI 10.1146/annurev.micro.50.1.183
   WATTS PJ, 1992, INT J PHARMACEUT, V87, P215, DOI 10.1016/0378-5173(92)90245-W
   Wei H, 2008, J PHARM PHARMACOL, V60, P35, DOI 10.1211/jpp.60.1.0005
   Wei H, 2008, INT J PHARM, V348, P35, DOI 10.1016/j.ijpharm.2007.07.005
   Wei H, 2010, J PHARM SCI-US, V99, P186, DOI 10.1002/jps.21810
   Wils D, 2008, FOOD CHEM TOXICOL, V46, P3254, DOI 10.1016/j.fct.2008.06.092
   Wilson CG, 2008, MODIFIED RELEASE DRU, P287
   Wilson CG, 2008, MODIFIED RELEASE DRU, P295
   Wilson PJ, 2005, INT J PHARM, V300, P89, DOI 10.1016/j.ijpharm.2005.05.010
   Yang LB, 2003, PHARMACEUT RES, V20, P429, DOI 10.1023/A:1022660305931
   Yang LB, 2002, INT J PHARM, V235, P1, DOI 10.1016/S0378-5173(02)00004-2
   Yang L, 2008, J CONTROL RELEASE, V125, P77, DOI 10.1016/j.jconrel.2007.10.026
   Yu HQ, 2006, J APPL POLYM SCI, V100, P1561, DOI 10.1002/app.23634
   Zhang SQ, 2008, EUR J PHARM BIOPHARM, V69, P247, DOI 10.1016/j.ejpb.2007.10.010
   Zhang Yu, 2006, Zhongguo Zhong Yao Za Zhi, V31, P642
   Zou MJ, 2009, DRUG DEV IND PHARM, V35, P224, DOI 10.1080/03639040802258854 
NR 197
TC 7
Z9 8
U1 4
U2 37
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0743-4863
EI 2162-660X
J9 CRIT REV THER DRUG
JI Crit. Rev. Ther. Drug Carr. Syst.
PY 2011
VL 28
IS 5
BP 395
EP 445
DI 10.1615/CritRevTherDrugCarrierSyst.v28.i5.10
PG 51
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 851OC
UT WOS:000297279400001
PM 22077200
DA 2018-10-20
ER

PT J
AU Pietrzak, A
   Janowski, K
   Chodorowska, G
   Trela, K
   Szymanek, M
   Krasowska, D
AF Pietrzak, Aldona
   Janowski, Konrad
   Chodorowska, Grazyna
   Trela, Krystyna
   Szymanek, Magdalena
   Krasowska, Dorota
TI Candida parapsilosis infection following the electrosurgery procedure
SO DERMATOLOGIC THERAPY
LA English
DT Article
DE Candida parapsilosis; electrocoagulation complications; iatrogenic
   infection
ID SURVEILLANCE
AB Subcutaneous mycoses are fungal infections that predominantly affect the dermis and subcutaneous tissue. The most common pathogen responsible for these infections is Candida albicans; however, another yeast from this group, Candida parapsilosis, becomes the cause of increasing numbers of mycotic infections. Recent reports suggested that this microorganism may be particularly resistant to disinfectants, which can facilitate its spread through the medical staff, instruments, and biomaterial. We report a case of a patient in whom a C. parapsilosis infection occurred as a complication following a minor electrocoagulation procedure. Because all obtained laboratory findings were nonspecific, the infection could be properly diagnosed only through cultures from the skin lesion.
C1 [Janowski, Konrad] Univ Finance & Management, Dept Psychol, PL-01030 Warsaw, Poland.
   [Pietrzak, Aldona; Chodorowska, Grazyna; Trela, Krystyna; Szymanek, Magdalena; Krasowska, Dorota] Med Univ Lublin, Dept Dermatol Venereol & Pediat Dermatol, Warsaw, Poland.
RP Janowski, K (reprint author), Univ Finance & Management, Dept Psychol, 55 Pawia St, PL-01030 Warsaw, Poland.
EM janowski@kul.pl
OI Janowski, Konrad/0000-0003-0838-9754
CR Almirante B, 2006, J CLIN MICROBIOL, V44, P1681, DOI 10.1128/JCM.44.5.1681-1865.2006
   Dorocka-Bobkowska B., 2003, DENT MED PROBL, V40, P405
   MENDLING W, 2006, VAGINOSE VAGINITIS Z, P69
   Pang Katie R, 2004, Dermatol Ther, V17, P523, DOI 10.1111/j.1396-0296.2004.04056.x
   Pfaller MA, 2008, J CLIN MICROBIOL, V46, P842, DOI 10.1128/JCM.02122-07
   Rigo M, 2004, FOLIA MICROBIOL, V49, P41, DOI 10.1007/BF02931644
   Szymankiewicz M., 2007, MIKOL LEK, V14, P37
   van Asbeck EC, 2007, MYCOPATHOLOGIA, V164, P287, DOI 10.1007/s11046-007-9054-3
NR 8
TC 2
Z9 2
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1396-0296
J9 DERMATOL THER
JI Dermatol. Ther.
PD JAN-FEB
PY 2011
VL 24
IS 1
BP 131
EP 133
DI 10.1111/j.1529-8019.2010.01386.x
PG 3
WC Dermatology
SC Dermatology
GA 713WV
UT WOS:000286769000013
PM 21276166
DA 2018-10-20
ER

PT J
AU Miculescu, F
   Ciocan, LT
   Miculescu, M
   Ernuteanu, A
AF Miculescu, F.
   Ciocan, L. T.
   Miculescu, M.
   Ernuteanu, A.
TI EFFECT OF HEATING PROCESS ON MICRO STRUCTURE LEVEL OF CORTICAL BONE
   PREPARED FOR COMPOSITIONAL ANALYSIS
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE human bone; tissue modification; organic matrix; SEM; EDS
ID MECHANICAL-PROPERTIES; HIERARCHICAL STRUCTURE; TRABECULAR BONE;
   HYDROXYAPATITE; TOUGHNESS; TEMPERATURE; STRENGTH; COLLAGEN; IMAGES; SEM
AB At the structural level, the bones are composed of inorganic and organic compounds and water, actually being considered a composite biomaterial, each component contributing to the bone remarkable mechanical properties. The investigation presented in this paper aims to highlight the morphological and compositional changes that occur in human bone structure during the preparation of bulk samples for subsequent analysis by X-ray fluorescence spectrometry and atomic absorption methods. We applied a method for hard tissue (cortical bone) processing by thermal treatment, in order to obtain homogenous particles (concerning both their shape and size) having elemental compositions as close as possible to the "real" physiological values. This homogeneous material will be used for in vitro XRF analyses, in order to avoid the artefacts induced by the in situ matrix effect. Using scanning electron microscopy techniques we characterized the morphological changes occurring during samples processing. By heat treatment, below 300 degrees C, the Ca/P stoichiometric ratio was maintained between 1.65 and 1.69 for all investigated samples. Above this temperature, the Ca/P ratio decreased below its physiological value.
C1 [Miculescu, F.; Ciocan, L. T.; Miculescu, M.; Ernuteanu, A.] Univ Politehn, Bucharest, Romania.
   [Ciocan, L. T.] Carol Davila Univ Med & Pharm, Bucharest, Romania.
RP Miculescu, F (reprint author), Univ Politehn, Bucharest, Romania.
EM f_miculescu@yahoo.com
RI Miculescu, Marian/D-8857-2011; Miculescu, Florin/A-4524-2011
OI Miculescu, Marian/0000-0002-2723-6713; Miculescu,
   Florin/0000-0001-6757-5616
FU CNCSIS-UEFISCSU (UEFISCDI) [PN II-RU 114/2010]
FX This work was supported by CNCSIS-UEFISCSU (UEFISCDI), project number PN
   II-RU 114/2010.
CR Benezra V., 2002, BIOMATERIALS, V23, P921
   BOYDE, 1996, MICROSC RES TECHNIQ, V33, P92
   BURR B, 2002, BONE, V31, P8
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027
   GOUVEA, 2009, CERAM INT, V35, P3043
   Gross KA, 2004, BIOMATERIALS, V25, P1395, DOI 10.1016/j.biomaterials.2003.08.051
   GUIZZARDI S, 1995, BIOMATERIALS, V16, P931, DOI 10.1016/0142-9612(95)93118-W
   Herliansyah MK, 2009, MAT SCI ENG C-BIO S, V29, P1674, DOI 10.1016/j.msec.2009.01.007
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kotula PG, 2003, MICROSC MICROANAL, V9, P1, DOI [10.1017/S1431927603030058, 10.1017/S14131927603030058]
   KUHNSPEARING L, 1996, SYNTHESIS PROCESSING
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   RAIF M, 1993, BIOMATERIALS, V14, P978
   Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RIMMAC M, 1993, J BIOMECH, V26, P219
   Rubin MA, 2004, BONE, V35, P11, DOI 10.1016/j.bone.2004.02.008
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108
   TADIC, 2004, BIOMATERIALS, V25, P987
   Wang XD, 2000, CLIN ORTHOP RELAT R, P228
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wierzchos J, 2008, MICRON, V39, P1363, DOI 10.1016/j.micron.2008.01.022
   YANA J, 2007, J BIOMECH, V40, P1641
   Yeni YN, 2000, BONE, V26, P499, DOI 10.1016/S8756-3282(00)00258-1
   Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.0.CO;2-A
   ZIV V, 1994, CONNECT TISSUE RES, V30, P165, DOI 10.3109/03008209409061969
NR 29
TC 14
Z9 14
U1 1
U2 9
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD JAN-MAR
PY 2011
VL 6
IS 1
BP 225
EP 233
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 752TD
UT WOS:000289716200028
DA 2018-10-20
ER

PT B
AU Yanez, M
   De Maria, C
   Rincon, J
   Boland, T
AF Yanez, Maria
   De Maria, Carmelo
   Rincon, Julio
   Boland, Thomas
BE Benning, P
   Silence, S
TI Printable Biodegradable Hydrogel with Self-Crosslinking Agents for Wound
   Dressings
SO DIGITAL FABRICATION 2011/ NIP27- 27TH INTERNATIONAL CONFERENCE ON
   DIGITAL PRINTING TECHNOLOGIES: TECHNICAL PROGRAMS AND PROCEEDINGS, 2011
LA English
DT Proceedings Paper
CT 27th International Conference on Digital Printing Technologies (NIP27) /
   7th International Conference on Digital Fabrication
CY OCT 02-06, 2011
CL Minneapolis, MN
SP Soc Imag Sci & Technol, Imag Soc Japan, hp invent, xerox, TRek, esprix technol, INGEDE, 7-SIGMA, CABOT, RICOH, XAAR
DE Alginate; wound dressing; inject printing; printable hydrogel
ID ALGINATE; GELATIN
AB The printed Biomaterial Laboratory at UTEP does research a printable hydrogel which can have appropriate properties for tissue engineering of the skin. Skin is the largest organ in our body which protects us from the environment and pathogens. Skin can be affected by burns and also by diabetic foot ulcers. The current tissue engineered skin substitutes for treatment of diabetic foot ulcers have many shortcomings including difficulty of handling, little if any host integration and not being customizable. The goal of this research is to create a wound care material that helps by integrating with the host tissue. We have been investigating a biodegradable hydrogel which is derived from natural proteins and carbohydrates creating a scaffold to use as a substrate to grow cells. The main components of this hydrogel are gelatin and alginate, both materials with very high biocompatibility and promoting cell proliferation and vascularization. Here we have been studying the oxidation of sodium alginate to generate aldehyde groups that can crosslink the amino group of gelatin and form the biodegradable hydrogel. We also have been investigating the viscosity, gelling time and degree of crosslinking of alginate as a function of pH, degree of oxidation, concentration and temperature. Viscosities for 10% alginate solutions in the range of 5-10cp are obtained, making this material printable. For printable testing we modified an inkjet printer to control the temperature of the cartridge and of the deposition plate. In general, control over the concentrations of alginate as well as the spatial dispensing via printing in a temperature-controlled environment should allow us to generate wound dressings of tunable properties. For future work we will include testing viscosity and printability of alginate adding different types of cells, as fibroblast, keratinocytes and endothelial cell, varying cell concentration. We will also include testing the wound dressing in a small animal model on healing and wound contraction.
C1 [Yanez, Maria; Rincon, Julio; Boland, Thomas] Univ Texas El Paso, Engn Coll, Dept Met & Mat Engn, Printed Biomat Lab, 500 W Univ Ave, El Paso, TX 79968 USA.
   [De Maria, Carmelo] Univ Pisa, Interdept Res Ctr E Piaggio, I-56126 Pisa, Italy.
RP Yanez, M (reprint author), Univ Texas El Paso, Engn Coll, Dept Met & Mat Engn, Printed Biomat Lab, 500 W Univ Ave, El Paso, TX 79968 USA.
OI De Maria, Carmelo/0000-0002-1368-3571
CR ASPINALL GO, 1982, MOL BIOL POLYSACCHAR, V1
   Balakrishnan B, 2005, CARBOHYD RES, V340, P1425, DOI 10.1016/j.carres.2005.05.028
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Boanini E, 2010, ACTA BIOMATER, V6, P383, DOI 10.1016/j.actbio.2009.06.015
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Buddy D, 2004, BIOMATERIALS SCI INT
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Gomez CG, 2007, CARBOHYD POLYM, V67, P296, DOI 10.1016/j.carbpol.2006.05.025
   Kang HA, 2002, J CHEM TECHNOL BIOT, V77, P205, DOI 10.1002/jctb.550
   Liao HJ, 2009, J MATER SCI-MATER M, V20, P1263, DOI 10.1007/s10856-009-3694-4
   Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742
   Tao Xu, 2005, BIOMATERIALS, V26, P93
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 14
TC 0
Z9 0
U1 0
U2 7
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 978-0-89208-296-4
PY 2011
BP 632
EP 635
PG 4
WC Computer Science, Hardware & Architecture; Imaging Science &
   Photographic Technology
SC Computer Science; Imaging Science & Photographic Technology
GA BG9BS
UT WOS:000393009600165
DA 2018-10-20
ER

PT S
AU Zhou, ZH
   Gao, YY
   Yi, QF
   Liu, QQ
   Liu, LH
AF Zhou, Zhihua
   Gao, Yongyi
   Yi, Qingfeng
   Liu, Qingquan
   Liu, Lihua
BE Gao, KY
   Zhou, SX
   Zhao, XQ
TI Study on the Cytotoxicity In-vitro of Composite Materials Based on
   Poly(L-lactide-co-glycolide) and Bioactive Glass
SO ENERGY, ENVIRONMENT AND BIOLOGICAL MATERIALS
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 11th IUMRS International Conference in Asia (IUMRS-ICA 2010)
CY SEP 25-28, 2010
CL Qingdao, PEOPLES R CHINA
SP Govt Qingdao City
DE cytotoxicity; in-vitro; bioactive glass; poly (L-lactide-co-glycolide)
ID OSTEOBLAST ADHESION; PROLIFERATION; SCAFFOLDS; GROWTH
AB The effect of poly(L-lactide-co-glycolide)/bioactive glass (PLGA/BG) on cell attachment, proliferation and differentiation of L929 fibroblastic cells was investigated. The results of in-vitro cytotoxicity test indicated that the cells cultured in extract of PLGA/BG and on the surface of composite showed normal growth and proliferation. The cell proliferation and alkaline phosphatase (ALP) activity of fibroblast were significantly improved after 3 and 7 days of culture on PLGA/BG films in comparison with PLGA films. It can be concluded that the addition of bioactive glass into PLGA stimulates the proliferation and differentiation of fibroblastic cells. Therefore, PLGA/BG composites have a promising biological response as a potential biomaterial in medical field.
C1 [Zhou, Zhihua; Yi, Qingfeng; Liu, Qingquan; Liu, Lihua] Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Key Lab Theoret Chem & Mol Simulat, Minist Educ, Xiangtan 411201, Peoples R China.
   [Gao, Yongyi] Hunan Univ Sci & Technol, Sch Phys, Xiangtan 411201, Peoples R China.
RP Zhou, ZH (reprint author), Hunan Univ Sci & Technol, Sch Chem & Chem Engn, Key Lab Theoret Chem & Mol Simulat, Minist Educ, Xiangtan 411201, Peoples R China.
EM zhou7381@126.com
FU Planning Science and Technology Project of Hunan Province, P. R. China
   [2010SK3060]
FX This work was financially supported by the Planning Science and
   Technology Project of Hunan Province, P. R. China (No. 2010SK3060).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   He ZQ, 2010, J MACROMOL SCI B, V49, P66, DOI 10.1080/00222340903343731
   He ZQ, 2009, J MACROMOL SCI B, V48, P789, DOI 10.1080/00222340902959693
   Karakecli AG, 2008, ACTA BIOMATER, V4, P989, DOI 10.1016/j.actbio.2008.02.003
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Rovshandeh J.M., 2001, IRAN POLYM J, V10, P1026
   Zhou Z, 2008, MATER SCI-POLAND, V26, P505
   Zhou ZH, 2007, T NONFERR METAL SOC, V17, P394, DOI 10.1016/S1003-6326(07)60105-8
   Zhou ZH, 2008, POLYM-PLAST TECHNOL, V47, P451, DOI 10.1080/03602550801946278
   Zhou ZH, 2009, POLYM BULL, V63, P575, DOI 10.1007/s00289-009-0149-5
NR 14
TC 2
Z9 2
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2011
VL 685
BP 384
EP +
DI 10.4028/www.scientific.net/MSF.685.384
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BZZ80
UT WOS:000303432500062
DA 2018-10-20
ER

PT J
AU Heinemann, C
   Heinemann, S
   Worch, H
   Hanke, T
AF Heinemann, C.
   Heinemann, S.
   Worch, H.
   Hanke, T.
TI DEVELOPMENT OF AN OSTEOBLAST/OSTEOCLAST CO-CULTURE DERIVED BY HUMAN BONE
   MARROW STROMAL CELLS AND HUMAN MONOCYTES FOR BIOMATERIALS TESTING
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE human bone marrow stromal cells; osteoblasts; human monocytes;
   osteoclasts; osteoclastogenesis; co-cultivation; biocompatibility; bone
   remodelling; cross talk; biomaterial; xerogel
ID MESENCHYMAL STEM-CELLS; ACID-PHOSPHATASE 5B; IN-VITRO; OSTEOCLAST
   DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; SUBSTITUTED HYDROXYAPATITE;
   OSTEOPROTEGERIN LIGAND; DEXAMETHASONE; EXPRESSION; OSTEOBLAST
AB The communication of bone-forming osteoblasts and bone-resorbing osteoclasts is a fundamental requirement for balanced bone remodelling. For biomaterial research, development of in vitro models is necessary to investigate this communication. In the present study human bone marrow stromal cells and human monocytes were cultivated in order to differentiate into osteoblasts and osteoclasts, respectively. Finally, a cultivation regime was identified which firstly induces the differentiation of the human bone marrow stromal cells followed by the induction of osteoclastogenesis through the osteoblasts formed - without the external addition of the factors RANKL and M-CSF. As a feedback on osteoblasts enhanced gene expression of BSP II was detected for modifications which facilitated the formation of large multinuclear osteoclasts. Phenotype characterization was performed by biochemical methods (DNA, LDH, ALP, TRAP 5b), gene expression analysis (ALP, BSP II, RANKL, IL-6, VTNR, CTSK, TRAP, OSCAR, CALCR) as well as light microscopy, confocal laser scanning microscopy, and scanning electron microscopy. After establishing this model on polystyrene, similar positive results were obtained for cultivation on a relevant bone substitution material - a composite xerogel of silica, collagen, and calcium phosphate.
C1 Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
RP Heinemann, C (reprint author), Budapester Str 27, D-01069 Dresden, Germany.
EM christiane.heinemann@tu-dresden.de
FU DFG [TRR79 TPM03, WO 494/18-1]
FX The study was partly supported by DFG Projects TRR79 TPM03 and WO
   494/18-1. We thank Prof. M. Bornhauser and co-workers (Medical Clinic I,
   University Hospital Carl Gustav Carus, Dresden) for providing hBMSC.
CR Bernhardt A, 2010, J BIOMED MATER RES A, V95A, P848, DOI 10.1002/jbm.a.32856
   Bloemen V, 2009, BIOCHEM BIOPH RES CO, V385, P640, DOI 10.1016/j.bbrc.2009.05.145
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011
   Detsch R, 2008, KEY ENG MATER, V361-363, P1123, DOI 10.4028/www.scientific.net/KEM.361-363.1123
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Fong JE, 2008, EUR CELLS MAT S4, V16, P22
   Greiner S, 2009, J BIOMED MATER RES A, V91A, P288, DOI 10.1002/jbm.a.32245
   Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035
   Halleen JM, 2002, CALCIFIED TISSUE INT, V71, P20, DOI 10.1007/s00223-001-2122-7
   Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337
   Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO;2-7
   Heinemann C, 2010, EUR CELLS MATER, V19, P96, DOI 10.22203/eCM.v019a10
   Heinemann S., 2010, NANOCOMPOSITES LIFE, P405
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Heinemann S, 2007, ADV ENG MATER, V9, P1061, DOI 10.1002/adem.200700219
   Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399
   Hozumi A, 2009, BIOCHEM BIOPH RES CO, V382, P780, DOI 10.1016/j.bbrc.2009.03.111
   Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540
   HUGHES FJ, 1997, CULTURE CELLS OSTEOB
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Janckila AJ, 2001, J BONE MINER RES, V16, P788, DOI 10.1359/jbmr.2001.16.4.788
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Kim YH, 2006, ARCH PHARM RES, V29, P691, DOI 10.1007/BF02968254
   Kondo T, 2008, J CELL BIOCHEM, V103, P335, DOI 10.1002/jcb.21414
   Kreja L, 2010, J CELL BIOCHEM, V109, P347, DOI 10.1002/jcb.22406
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1
   LAKKAKORPI P, 1989, J BONE MINER RES, V4, P817
   Majumdar MK, 2000, J HEMATOTH STEM CELL, V9, P841, DOI 10.1089/152581600750062264
   Mandelin J, 2006, BONE, V38, P769, DOI 10.1016/j.bone.2005.10.017
   Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027
   Mbalaviele G, 1999, ENDOCRINOLOGY, V140, P3736, DOI 10.1210/en.140.8.3736
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Mundy GR, 2004, TISSUE ENG, V10, P93
   Narducci P, 2009, ANN ANAT, V191, P349, DOI 10.1016/j.aanat.2009.02.009
   NIJWEIDE PJ, 1986, PHYSIOL REV, V66, P855
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   ROBINS SP, 1997, BIOCH MARKERS BONE T
   Silva WA, 2003, STEM CELLS, V21, P661, DOI 10.1634/stemcells.21-6-661
   Sivagurunathan S, 2005, J BONE MINER RES, V20, P390, DOI 10.1359/JBMR.041233
   Spence G, 2009, J BIOMED MATER RES A, V90A, P217, DOI 10.1002/jbm.a.32083
   SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66
   Takeyama S, 2001, BIOCHEM BIOPH RES CO, V282, P798, DOI 10.1006/bbrc.2001.4652
   Tortelli F, 2009, TISSUE ENG PT A, V15, P2373, DOI 10.1089/ten.tea.2008.0501
   Yam LT, 2003, J BONE MINER RES, V18, P1894, DOI 10.1359/jbmr.2003.18.10.1894
   YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0
NR 49
TC 44
Z9 44
U1 2
U2 20
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2011
VL 21
BP 80
EP 93
DI 10.22203/eCM.v021a07
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 725UP
UT WOS:000287671900007
PM 21267944
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sreejit, P
   Verma, RS
AF Sreejit, P.
   Verma, R. S.
TI CARDIOGEL SUPPORTS ADHESION, PROLIFERATION AND DIFFERENTIATION OF STEM
   CELLS WITH INCREASED OXIDATIVE STRESS PROTECTION
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Stem cells; proliferation; differentiation; cardiogel; oxidative stress
   protection; therapeutic biomaterial
ID MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; IN-VITRO; HEART-FAILURE;
   RAT HEARTS; CARDIOMYOCYTES; SURVIVAL; REPAIR; BIOMATERIALS; REGENERATION
AB Cultured murine bone marrow derived mesenchymal stem cells (BMSC) when grown along with cardiogel derived from mouse cardiac fibroblast, exhibited increased cell proliferation and differentiation and enhanced survival under oxidative stress induced by the exposure of H(2)O(2) in vitro (similar to in vivo ischemia like condition). Adhesion of BMSC to the cardiogel occurred at a faster rate when compared to the cells grown on normal surface. BMSC attached to cardiogel showed an increased resistance to proteolytic (enzymatic) disassociation. This is the first report on an attempt to use an in house biomaterial for the growth of BMSC that led to their heightened resistance towards oxidative stress. These studies support that cardiogel is an efficient biodegradable three-dimensional extracellular matrix which supports better growth of BMSC and can be used as a scaffold for stem cell delivery, with potential therapeutic applications in cardiac tissue regeneration.
C1 [Sreejit, P.; Verma, R. S.] Indian Inst Technol, Stem Cell & Mol Biol Lab, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Verma, RS (reprint author), Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Stem Cell & Mol Biol Lab 201, Madras 600036, Tamil Nadu, India.
EM vermars@iitm.ac.in
OI Verma, Rama/0000-0001-7287-7803
FU Department of Biotechnology, Govt. of India
   [BT/PR7951/MED/14/1193/2006]; Indian Council for Medical Research
   [3/1/3/JRF/37/MPD/2004(32402)]
FX This work was supported by grants to RSV by the Department of
   Biotechnology, Govt. of India (BT/PR7951/MED/14/1193/2006) and by
   fellowship to SP by the Indian Council for Medical Research (No.
   3/1/3/JRF/37/MPD/2004(32402)).
CR Abbate A, 2009, AM J PHYSIOL-HEART C, V296, pH563, DOI 10.1152/ajpheart.00066.2009
   Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Beqqali A, 2009, CELL MOL LIFE SCI, V66, P800, DOI 10.1007/s00018-009-8476-0
   Bettiol E, 2007, REV PHYSIOL BIOCH P, V157, P1, DOI 10.1007/s112_0508
   Biagioli B, 2000, Ital Heart J, V1 Suppl 3, pS43
   Bick RJ, 1998, CELL ADHES COMMUN, V6, P301, DOI 10.3109/15419069809010789
   CATHARINA N, 2008, J CELL MOL MED, V12, P1795
   CHANG W, 2006, TISSUE ENG REGEN MED, V3, P327
   Chang W, 2007, TISSUE ENG REGEN MED, V4, P370
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QM, 2000, ARCH BIOCHEM BIOPHYS, V373, P242, DOI 10.1006/abbi.1999.1558
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   COSTANZO MR, 1995, CIRCULATION, V92, P3593, DOI 10.1161/01.CIR.92.12.3593
   Davis RA, 2006, J BURNS WOUNDS, V5, P16
   Dimarakis I, 2005, EUR J CARDIO-THORAC, V28, P665, DOI 10.1016/j.ejcts.2005.08.013
   Dimarakis I., 2006, J CARDIOTHORAC RENAL, V1, P107
   Dimarakis I, 2006, J CARDIOTHORAC RENAL, V1, P115
   DONALD GP, 2007, STEM CELLS, V25, P2896
   Edwards GO, 2008, TOXICOLOGY, V253, P46, DOI 10.1016/j.tox.2008.08.010
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   JON SO, 2001, STEM CELLS, V19, P193
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kubo M, 2007, AM J PHYSIOL-HEART C, V292, pH2582, DOI 10.1152/ajpheart.00786.2006
   Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53
   Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   PERKINS S, 1990, BLOOD, V75, P620
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467
   Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302
   Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4
   Struthers AD, 2005, HEART, V91, P14, DOI 10.1136/hrt.2005.062034
   Tang Yao Liang, 2007, Ann Thorac Surg, V83, P1499, DOI 10.1016/j.athoracsur.2006.11.054
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   van Laake LW, 2006, J PHYSIOL-LONDON, V577, P467, DOI 10.1113/jphysiol.2006.115816
   VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3567, DOI 10.1007/s10856-008-3525-z
   Wang JS, 2001, J THORAC CARDIOV SUR, V122, P699, DOI 10.1067/mtc.2001.116317
   Zhu Wei-Zhong, 2009, Transplant Rev (Orlando), V23, P53, DOI 10.1016/j.trre.2008.05.005
NR 45
TC 18
Z9 18
U1 0
U2 1
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2011
VL 21
BP 107
EP 121
DI 10.22203/eCM.v021a09
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 725UP
UT WOS:000287671900009
PM 21267946
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Schek, RM
   Michalek, AJ
   Iatridis, JC
AF Schek, R. M.
   Michalek, A. J.
   Iatridis, J. C.
TI GENIPIN-CROSSLINKED FIBRIN HYDROGELS AS A POTENTIAL ADHESIVE TO AUGMENT
   INTERVERTEBRAL DISC ANNULUS REPAIR
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Fibrin; genipin; hydrogel; crosslinker; annular repair; biomaterial;
   sealant; adhesive; intervertebral disc
ID IN-VITRO EVALUATION; NUCLEUS PULPOSUS; FIBROSUS CELLS; ANULUS FIBROSUS;
   TISSUE FIXATION; LINKING REAGENT; STEM-CELLS; SCAFFOLD; MATRIX;
   DEGENERATION
AB Treatment of damaged intervertebral discs is a significant clinical problem and, despite advances in the repair and replacement of the nucleus pulposus, there are few effective strategies to restore defects in the annulus fibrosus. An annular repair material should meet three specifications: have a modulus similar to the native annulus tissue, support the growth of disc cells, and maintain adhesion to tissue under physiological strain levels. We hypothesized that a genipin crosslinked fibrin gel could meet these requirements. Our mechanical results showed that genipin crosslinked fibrin gels could be created with a modulus in the range of native annular tissue. We also demonstrated that this material is compatible with the in vitro growth of human disc cells, when genipin: fibrin ratios were 0.25:1 or less, although cell proliferation was slower and cell morphology more rounded than for fibrin alone. Finally, lap tests were performed to evaluate adhesion between fibrin gels and pieces of annular tissue. Specimens created without genipin had poor handling properties and readily delaminated, while genipin crosslinked fibrin gels remained adhered to the tissue pieces at strains exceeding physiological levels and failed at 15-30%. This study demonstrated that genipin crosslinked fibrin gels show promise as a gap-filling adhesive biomaterial with tunable material properties, yet the slow cell proliferation suggests this biomaterial may be best suited as a sealant for small annulus fibrosus defects or as an adhesive to augment large annulus repairs. Future studies will evaluate degradation rate, fatigue behaviors, and long-term biocompatibility.
C1 [Schek, R. M.; Michalek, A. J.; Iatridis, J. C.] Univ Vermont, Sch Engn, Burlington, VT USA.
RP Iatridis, JC (reprint author), Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, 1 Gustave L Levy Pl,Box 1188, New York, NY 10029 USA.
EM james.iatridis@mssm.edu
OI Iatridis, James/0000-0002-2186-0590
FU National Institutes of Health [R01AR051146]
FX This project was supported by the National Institutes of Health
   (R01AR051146). We gratefully acknowledge the assistance procuring
   surgical tissue samples from Dr. Robert Monsey, and the technical
   assistance on shear testing from Ms. Kristin Funabashi. A preliminary
   patent was submitted for this biomaterial.
CR AHMED TA, 2008, TISSUE EN B IN PRESS
   Alini M, 2002, EUR SPINE J, V11, pS215, DOI 10.1007/s00586-002-0485-8
   Allon AA, 2010, SPINE J, V10, P1089, DOI 10.1016/j.spinee.2010.09.014
   Attia M, 2011, BIOMATERIALS, V32, P450, DOI 10.1016/j.biomaterials.2010.09.010
   Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025
   Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593
   Bron JL, 2009, J ORTHOP RES, V27, P620, DOI 10.1002/jor.20789
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   BUSER Z, 2011, SPINE PHILA IN PRESS
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Connelly JT, 2004, BIORHEOLOGY, V41, P377
   Costi JJ, 2007, J BIOMECH, V40, P2457, DOI 10.1016/j.jbiomech.2006.11.006
   Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230
   Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd
   Di Martino A, 2005, SPINE, V30, pS16, DOI 10.1097/01.brs.0000174530.88585.32
   Errington RJ, 1998, J ANAT, V192, P369, DOI 10.1046/j.1469-7580.1998.19230369.x
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Hankemeier S, 2007, ARCH ORTHOP TRAUM SU, V127, P815, DOI 10.1007/s00402-007-0366-z
   Hecker L, 2005, AM J PHYSIOL-GASTR L, V289, pG188, DOI 10.1152/ajpgi.00335.2004
   Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777
   Helen W, 2008, ACTA BIOMATER, V4, P230, DOI 10.1016/j.actbio.2007.09.010
   Hojo M, 2003, PLAST RECONSTR SURG, V111, P1638, DOI 10.1097/01.PRS.0000053842.90564.26
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   Johnson TS, 2004, TISSUE ENG, V10, P1308, DOI 10.1089/1076327042500445
   Koepsell L, 2011, MACROMOL BIOSCI, V11, P391, DOI 10.1002/mabi.201000352
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Krismer M, 1996, SPINE, V21, P2551, DOI 10.1097/00007632-199611150-00004
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   MEKHAIL M, 2010, J BIOMATER IN PRESS
   Mesa JM, 2006, PLAST RECONSTR SURG, V118, P41, DOI 10.1097/01.prs.0000231929.37736.28
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   Nerurkar NL, 2009, NAT MATER, V8, P986, DOI [10.1038/NMAT2558, 10.1038/nmat2558]
   Nieponice A, 2007, J BIOMED MATER RES A, V81A, P523, DOI 10.1002/jbm.a.31041
   OCONNELL GD, 2010, J ORTHOP RE IN PRESS
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Peretti GM, 2006, TISSUE ENG, V12, P1151, DOI 10.1089/ten.2006.12.1151
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Sato Masato, 2003, J Biomed Mater Res A, V64, P248, DOI 10.1002/jbm.a.10287
   Schlegel JD, 1996, SPINE, V21, P970, DOI 10.1097/00007632-199604150-00013
   Sebastine IM, 2007, P ANN INT IEEE EMBS, P6401
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/bjm.a.31030
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Sun JH, 2010, J HUAZHONG U SCI-MED, V30, P173, DOI 10.1007/s11596-010-0208-z
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   Tsai CC, 2000, J BIOMED MATER RES, V52, P58, DOI 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
   Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031
   Wan YQ, 2007, MACROMOL BIOSCI, V7, P1217, DOI 10.1002/mabi.200700053
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Yamazaki M, 2009, BIOL PHARM BULL, V32, P1043, DOI 10.1248/bpb.32.1043
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   Yao CH, 2004, MATER CHEM PHYS, V83, P204, DOI 10.1016/j.mathchemphys.2003.08.027
   Zhang YH, 2011, MATRIX BIOL, V30, P135, DOI 10.1016/j.matbio.2010.10.008
NR 67
TC 59
Z9 63
U1 1
U2 12
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2011
VL 21
BP 373
EP 383
DI 10.22203/eCM.v021a28
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 754NF
UT WOS:000289861100001
PM 21503869
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sollazzo, V
   Fanali, S
   Masiero, E
   Girardi, A
   Farnella, F
   Melloni, E
   Pezzetti, F
   Iaccarino, C
   Zauli, G
   Carinci, F
AF Sollazzo, V.
   Fanali, S.
   Masiero, E.
   Girardi, A.
   Farnella, F.
   Melloni, E.
   Pezzetti, F.
   Iaccarino, C.
   Zauli, G.
   Carinci, F.
TI PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS
   DIFFERENTIATION
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE P15; stem cells; biomaterial; gene expression; differentiation
AB Peptide-15 (P-15) is a bone augmentation material analog to the cell binding domain of collagen. P-15 competes for cell surface sites for attachment of collagen and, when immobilized on surfaces, it promotes adhesion of cells and facilitates physiological process like binding, migration and differentiation of cells. To study how P15 can induce osteoblast differentiation and proliferation in mesenchymal stem cells, the expression levels of bone related genes (RUNX2, SP7, ALPL, SPP1, COL1A1, COL3A1 and FOSL1) and mesenchymal stem cells marker (ENG) were measured in Dental Pulp Stem Cells (DPSCs) and Normal Osteoblast (NO), after 15 and 30 days of treatment. Significantly, differentially expressed genes among DPSCs and NO were SP7, ENG, RUNX2, COL3A1, COL1A1, ALPL and SPP1 in the first 15 days of treatment and ENG, RUNX2, COL31A, COL1A1, SPP1 and ALPL after 30 days. The present study demonstrated that P15 influences the behavior of DPSCs in vitro by enhancing proliferation, differentiation and deposition of matrix.
C1 [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
   [Fanali, S.] Univ G DAnnunzio, Dept Oral Sci Nano & Biotechnol, Chieti, Italy.
   [Masiero, E.; Girardi, A.; Pezzetti, F.; Carinci, F.] Univ Bologna, CARISBO Fdn, Ctr Mol Genet, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Farnella, F.] Univ Ferrara, Sect Maxillofacial Surg, Dept DMCCC, I-44100 Ferrara, Italy.
   [Melloni, E.] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.
   [Iaccarino, C.] Univ Hosp Parma, Emergency Dept, Hub & Spoke Neurosurg Unit, Parma, Italy.
   [Zauli, G.] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Maxillofacial Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   DODDS RA, 1995, J BONE MINER RES, V10, P1666
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118
   Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192
   Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Lallier TE, 2001, J PERIODONTOL, V72, P990, DOI 10.1902/jop.2001.72.8.990
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Smiler D, 2007, IMPLANT DENT, V16, P42, DOI 10.1097/ID.0b013e3180335934
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
NR 26
TC 3
Z9 3
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD JAN-APR
PY 2011
VL 9
IS 1
SU S
BP 125
EP 130
PG 6
WC Immunology
SC Immunology
GA V37BI
UT WOS:000209250900023
DA 2018-10-20
ER

PT S
AU Zhao, CQ
   Chen, WY
   Teng, B
AF Zhao, Changqing
   Chen, Wuyong
   Teng, Bo
BE Cao, Z
   Sun, L
   Cao, XQ
   He, YH
TI Removal of Chromium (VI) in Tannery Wastewater by Immobilized Technology
SO FUNDAMENTAL OF CHEMICAL ENGINEERING, PTS 1-3
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference on Chemical Engineering and Advanced Materials
CY MAY 28-30, 2011
CL Changsha, PEOPLES R CHINA
SP Changsha Univ Sci & Technol, James Cook Univ, Hunan Univ, S Central Univ China, Hunan Normal Univ, Xiangtan Univ
DE tannery wastewater; chromium (VI); Bacillus cereus; immobilization
AB Bacillus cereus was embedded in powdered activated carbon to prepare immobilized granule. Then, the granules was used to treat the Cr((VI)) in tannery wastewater. The results showed the removal effect of Cr((VI)) removed by the immobilized Bacillus cereus was better than either the single powdered activated carbon or the single Bacillus cereus. SEM photograph showed that the Bacillus cereus in the granules grew well. After the total chromium and the Cr((VI)) in the solution and the granules were detected before and after treatment, it was found that the Cr((VI)) in the solution and the granules was decreased, but the total chromium was changeless, which indicated that the removal of Cr((VI)) with the granules was mainly as the results of both the chromate reductase produced by Bacillus cereus and the adsorption of activated carbon. The kinetics data of Cr((VI)) removed by immobilized Bacillus cereus could be well-described by pseudo-second-order rate model. The experiments demonstrated that the immobilized Bacillus cereus could be selected as a new biomaterial to remove Cr((VI)) in tannery wastewater.
C1 [Zhao, Changqing] Sichuan Univ Sci & Engn, Coll Bioengn, Zigong 643000, Peoples R China.
   [Zhao, Changqing; Chen, Wuyong; Teng, Bo] Sichuan Univ, Natl Engn Lab Clean Technol Leather Manfacture, Chengdu 610065, Peoples R China.
RP Zhao, CQ (reprint author), Sichuan Univ Sci & Engn, Coll Bioengn, Zigong 643000, Peoples R China.
EM zhaocq81@163.com; wuyong.chen@163.com; teng_boo@163.com
FU Sichuan University of Science and Engineering [2010XJKRL003]
FX This work was financially supported by the Startup Program of Scientific
   Research for Sichuan University of Science and Engineering (Item No.
   2010XJKRL003).
CR [Anonymous], 1995, J SOC LEATHER TECHNO, V79, P57
   Chirayu D., 2008, BIORESOURCE TECHNOLO, V99, P6059
   Garbisu C, 1998, BIODEGRADATION, V9, P133, DOI 10.1023/A:1008358816529
   Garza-Gonzalez MT, 2003, EMERGING FIELDS IN SOL-GEL SCIENCE AND TECHNOLOGY, P426
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   [瞿建国 Qu Jianguo], 2005, [化工环保, Environmental Protection of Chemical Industry], V25, P1
   Zhao C.Q., 2010, BIOL TREATMENT HEXAV
   Zhao C.Q., 2008, LEATHER SCI ENG, V18, P39
NR 8
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-119-7
J9 ADV MATER RES-SWITZ
PY 2011
VL 233-235
BP 545
EP +
DI 10.4028/www.scientific.net/AMR.233-235.545
PN 1-3
PG 2
WC Engineering, Chemical
SC Engineering
GA BZY29
UT WOS:000303359000114
DA 2018-10-20
ER

PT J
AU Gomes, CC
   Moreira, LM
   Santos, VJSV
   Ramos, AS
   Lyon, JP
   Soares, CP
   Santos, FV
AF Gomes, Cristiano C.
   Moreira, Leonardo M.
   Santos, Vanessa J. S. V.
   Ramos, Alfeu S.
   Lyon, Juliana P.
   Soares, Cristina P.
   Santos, Fabio V.
TI Assessment of the genetic risks of a metallic alloy used in medical
   implants
SO GENETICS AND MOLECULAR BIOLOGY
LA English
DT Article
DE biomaterial; cytotoxicity; micronucleus; mutagenicity; Ti-6Al-4V
ID PERIPHERAL-BLOOD LYMPHOCYTES; IN-VITRO; TITANIUM-DIOXIDE; DNA-DAMAGE;
   VANADIUM PENTOXIDE; COMET ASSAY; CELLS; INDUCTION; MICRONUCLEI;
   CYTOTOXICITY
AB The use of artificial implants provides a palliative or permanent solution for individuals who have lost some bodily function through disease, an accident or natural wear. This functional loss can be compensated for by the use of medical devices produced from special biomaterials. Titanium alloy (Ti-6Al-4V) is a well-established primary metallic biomaterial for orthopedic implants, but the toxicity of the chemical components of this alloy has become an issue of concern. In this work, we used the MTT assay and micronucleus assay to examine the cytotoxicity and genotoxicity, respectively, of an extract obtained from this alloy. The MTT assay indicated that the mitochondrial activity and cell viability of CHO-K1 cells were unaffected by exposure to the extract. However, the micronucleus assay revealed DNA damage and an increase in micronucleus frequency at all of the concentrations tested. These results show that ions released from Ti-6Al-4V alloy can cause DNA and nuclear damage and reinforce the importance of assessing the safety of metallic medical devices constructed from biomaterials.
C1 [Santos, Vanessa J. S. V.; Santos, Fabio V.] Univ Fed Sao Joao Del Rei, Divinopolis, MG, Brazil.
   [Gomes, Cristiano C.; Ramos, Alfeu S.; Soares, Cristina P.] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Sao Jose Dos Campos, Brazil.
   [Moreira, Leonardo M.] Univ Fed Sao Joao Del Rei, Dept Engn Biossistemas, Sao Joao Del Rei, MG, Brazil.
   [Lyon, Juliana P.] Univ Fed Sao Joao Del Rei, Dept Ciencias Nat, Sao Joao Del Rei, MG, Brazil.
RP Santos, FV (reprint author), Univ Fed Sao Joao Del Rei UFSJ, Campus Ctr Oeste Dona Lindu,Ave Sebastiao Goncalv, BR-35501296 Divinopolis, MG, Brazil.
EM santos_fv@yahoo.com.br
RI Santos, Fabio/G-4912-2011; SOARES, CRISTINA/O-4906-2015; SOARES,
   CRISTINA/B-8093-2012
OI Santos, Fabio/0000-0003-0389-1737; SOARES, CRISTINA/0000-0002-0572-074X;
   SOARES, CRISTINA/0000-0002-0572-074X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Secretaria de Educacao do Estado de Sao Paulo
FX This study was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP). C.C.G. was supported by a grant from the
   Secretaria de Educacao do Estado de Sao Paulo.
CR Altamirano-Lozano M, 1999, TERATOGEN CARCIN MUT, V19, P243, DOI 10.1002/(SICI)1520-6866(1999)19:4<243::AID-TCM1>3.0.CO;2-J
   Anastassopoulou J, 2003, J MOL STRUCT, V651, P19, DOI 10.1016/S0022-2860(02)00625-7
   Cadosch D, 2009, J BIOMED MATER RES A, V91A, P1252, DOI 10.1002/jbm.a.32625
   Chen F, 2002, CRIT REV ONCOL HEMAT, V42, P105, DOI 10.1016/S1040-8428(01)00211-6
   CIRANNI R, 1995, MUTAT RES-GENET TOX, V343, P53, DOI 10.1016/0165-1218(95)90061-6
   Crebelli R, 2002, MUTAT RES-GEN TOX EN, V516, P63, DOI 10.1016/S1383-5718(02)00028-1
   Doherty AT, 2001, J BONE JOINT SURG BR, V83B, P1075, DOI 10.1302/0301-620X.83B7.10102
   *EFSA, 2004, J EFSA, V33, P1
   Faria ACL, 2008, J BIOMED MATER RES B, V85B, P504, DOI 10.1002/jbm.b.30972
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Guillamet E, 2008, MUTAT RES-GEN TOX EN, V654, P22, DOI 10.1016/j.mrgentox.2008.04.005
   International Organization for Standardization, 2007, BIOL EV MED DEV 12
   Kordowiak Anna M., 2007, Polish Journal of Pathology, V58, P51
   Lankoff A, 2006, TOXICOL LETT, V161, P27, DOI 10.1016/j.toxlet.2005.07.012
   LEONARD A, 1994, MUTAT RES, V317, P81, DOI 10.1016/0165-1110(94)90013-2
   Lima PDL, 2007, FOOD CHEM TOXICOL, V45, P1154, DOI 10.1016/j.fct.2006.12.022
   Lin CW, 2005, BIOMATERIALS, V26, P2899, DOI 10.1016/j.biomaterials.2004.09.007
   Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216
   Lu PJ, 1998, MUTAT RES-GEN TOX EN, V414, P15, DOI 10.1016/S1383-5718(98)00034-5
   MIGLIORE L, 1993, MUTAT RES, V319, P205, DOI 10.1016/0165-1218(93)90080-W
   Morais L S, 2009, AM J ORTHOD DENTOFAC, V135, P522
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   OWUSUYAW J, 1990, TOXICOL LETT, V50, P327, DOI 10.1016/0378-4274(90)90026-I
   Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034
   Ramirez P, 1997, MUTAT RES-REV MUTAT, V386, P291, DOI 10.1016/S1383-5742(97)00018-5
   Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010
   Riley MR, 2003, TOXICOLOGY, V190, P171, DOI 10.1016/S0300-483X(03)00162-8
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Scheving LA, 1999, AM J PHYSIOL-CELL PH, V277, pC572, DOI 10.1152/ajpcell.1999.277.3.C572
   Sedarat C, 2001, J PERIODONTAL RES, V36, P269, DOI 10.1034/j.1600-0765.2001.360501.x
   Soares SS, 2008, CHEM RES TOXICOL, V21, P607, DOI 10.1021/tx700204r
   Stea S, 2000, J ARTHROPLASTY, V15, P772, DOI 10.1054/arth.2000.7108
   TitenkoHolland N, 1997, MUTAT RES-GEN TOX EN, V388, P85, DOI 10.1016/S1383-5718(96)00140-4
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Vendittoli PA, 2010, J ARTHROPLASTY
   WANG TS, 1994, MUTAGENESIS, V9, P253, DOI 10.1093/mutage/9.3.253
   Ziaee H, 2007, J BONE JOINT SURG BR, V89B, P301, DOI 10.1302/0301-620X.89B3.18520
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 39
TC 20
Z9 21
U1 1
U2 18
PU SOC BRASIL GENETICA
PI RIBEIRAO PRET
PA RUA CAP ADELMIO NORBET DA SILVA, 736, ALTO DA BOA VISTA, 14025-670
   RIBEIRAO PRET, BRAZIL
SN 1415-4757
J9 GENET MOL BIOL
JI Genet. Mol. Biol.
PY 2011
VL 34
IS 1
BP 116
EP 121
DI 10.1590/S1415-47572010005000118
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 718RI
UT WOS:000287143400020
PM 21637553
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Honsawek, S
   Bumrungpanichthaworn, P
   Thitiset, T
   Wolfinbarger, L
AF Honsawek, S.
   Bumrungpanichthaworn, P.
   Thitiset, T.
   Wolfinbarger, L., Jr.
TI Gene expression analysis of demineralized bone matrix-induced
   osteogenesis in human periosteal cells using cDNA array technology
SO GENETICS AND MOLECULAR RESEARCH
LA English
DT Article
DE cDNA array; Demineralized bone matrix; Osteogenesis; Gene expression;
   Human periosteal cells
ID OSTEOBLAST DIFFERENTIATION; BIGLYCAN
AB Demineralized bone matrix (DBM) has been widely investigated as a biomaterial to promote new bone formation and is utilized clinically for bone repair and regeneration. We investigated gene expression patterns of osteogenic differentiation in human periosteal (HPO) cells cultured with demineralized bone matrix, using cDNA array technology. Osteogenic differentiation of HPO cells was determined using alkaline phosphatase assay. In order to examine differential gene expression during osteogenic differentiation, total RNA was isolated from HPO cells in the absence or presence of DBM on day seven and analyzed using osteogenesis cDNA gene array. The selected genes were verified using reverse transcriptase (RT)-PCR analysis. Human periosteal cells differentiated along an osteogenic lineage after treatment of DBM. The alkaline phosphatase activity assay showed that HPO cells differentiated into an osteogenic lineage. Gene expression of HPO cells treated with DBM for seven days was analyzed with cDNA array and RT-PCR analyses. Expression of biglycan, TGF-beta 1, and TGF-beta R1 was upregulated, whereas collagen14A1 expression was downregulated, as confirmed by RT-PCR. Human periosteal cells expressed osteogenesis genes when treated with DBM. These findings provide new insight into the capability of demineralized bone matrix to modulate the osteogenic differentiation of human periosteal cells.
C1 [Honsawek, S.; Bumrungpanichthaworn, P.; Thitiset, T.] Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Thai Red Cross Soc,Fac Med, Bangkok, Thailand.
   [Wolfinbarger, L., Jr.] Old Domin Univ & BioSci Consultants, LLC, Norfolk, VA USA.
RP Honsawek, S (reprint author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp, Fac Med, Thai Red Cross Soc,Fac Med, Bangkok, Thailand.
EM Sittisak.H@chula.ac.th
FU National Nanotechnology Center (NANOTEC), National Science and
   Technology Development Agency (NSTDA), Thailand; Thailand Research Fund
   [DBG4980017]; National Research Council of Thailand; National Research
   University; Ratchada-phiseksomphot Endowment Fund [1155A]; LifeNet
   Research Fund
FX The authors acknowledge financial support from the Research, Development
   and Engineering (RD & E) Fund through the National Nanotechnology Center
   (NANOTEC), National Science and Technology Development Agency (NSTDA),
   Thailand. This investigation was also supported in part by the Thailand
   Research Fund (#DBG4980017), the National Research Council of Thailand,
   the National Research University Project of CHE and the
   Ratchada-phiseksomphot Endowment Fund (#HR 1155A) and LifeNet Research
   Fund. The authors also thank Chulalongkorn Medical Research Center
   (Chula MRC) and Research Core Facility at Department of Biochemistry for
   kindly providing facilities.
CR Beck GR, 2001, CELL GROWTH DIFFER, V12, P61
   Boskey AL, 1997, CALCIFIED TISSUE INT, V61, P298, DOI 10.1007/s002239900339
   Chen WB, 2002, J BIOL CHEM, V277, P36118, DOI 10.1074/jbc.M203709200
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Honsawek S, 2007, ASIAN BIOMED, V1, P383
   Honsawek Sittisak, 2006, J Med Assoc Thai, V89 Suppl 3, pS189
   Honsawek Sittisak, 2005, Cell and Tissue Banking, V6, P13, DOI 10.1007/s10561-005-1445-4
   Honsawek S, 2010, ASIAN BIOMED, V4, P913, DOI 10.2478/abm-2010-0119
   Hutmacher DW, 2003, TISSUE ENG, V9, pS45, DOI 10.1089/10763270360696978
   Locklin RM, 2001, J BONE MINER RES, V16, P2192, DOI 10.1359/jbmr.2001.16.12.2192
   Meirowitz NB, 2002, AM J OBSTET GYNECOL, V187, P1679, DOI 10.1067/mob.2002.127595
   Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614
   WALCHLI C, 1994, J CELL SCI, V107, P669
   WOLFINBARGER L, 1993, IN VITRO CELL DEV-AN, V29A, P914
   Xu TS, 1998, NAT GENET, V20, P78
   Zhang M, 1997, J PERIODONTOL, V68, P1076, DOI 10.1902/jop.1997.68.11.1076
NR 16
TC 4
Z9 5
U1 0
U2 3
PU FUNPEC-EDITORA
PI RIBEIRAO PRETO
PA RUA HUDSON 655, JARDIM CANADA, RIBEIRAO PRETO, SP, BRAZIL
SN 1676-5680
J9 GENET MOL RES
JI Genet. Mol. Res.
PY 2011
VL 10
IS 3
BP 2093
EP 2103
DI 10.4238/vol10-3gmr1329
PG 11
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 832RG
UT WOS:000295823500080
PM 21968678
DA 2018-10-20
ER

PT S
AU Laidani, Y
   Hanini, S
   Henini, G
AF Laidani, Ykhlef
   Hanini, Salah
   Henini, Ghania
BE Salame, C
   ElCharif, H
   Hassan, FE
   ElTahchi, M
TI Use of fiber Luffa Cylindrica for waters traitement charged in copper.
   Study of the possibility of its regeneration by desorption chemical
SO IMPACT OF INTEGRATED CLEAN ENERGY ON THE FUTURE OF THE MEDITERRANEAN
   ENVIRONMENT
SE Energy Procedia
LA English
DT Proceedings Paper
CT Conference on Impact of Integrated Clean Energy on the Future of the
   Mediterranean Environment
CY APR 14-16, 2011
CL Beirut, LEBANON
DE Fiber of Luffa cylindrica; treatment of wastewater; biosorption;
   desorption
ID LOOFA SPONGE
AB The accumulation of toxic industrial waste has become for man and his environment, a topical problem. Organic products come in a large share of this pollution, and their elimination is the subject of much research.
   It exists in the literature of many studies on plant fibers, but very few are devoted to the study of fibers of the luffa Cvlindrica, hence the idea of directing a study in this direction. Indeed, Luffa cylindrica is an annual herb of the family Cucurbitaceae fruit gives slightly angular cylindrical shape of variable size.
   In the first step, we studied the kinetics of adsorption system (copper / fiber of Luffa cylindrica) using copper pollution model and method of analysis as UV spectrophotometry, the estimation of specific surface area (0.082 m(2)/g) revealed a porous biomaterial too, although its maximum adsorption capacity (0.101 mg/g) under optimal conditions is low. In the second step two comparative models (Langmuir and Freundlich) were tested for the adsorption isotherms obtained.
   We completed this work by studying the possibility of regeneration (30.2 %) and reuse this material. For that several parameters were optimized: the nature of the desorbent, the pHi 1.5, and the content of Luffa cylindrica desorbing, hence the method and very promising for the treatment of water laden with heavy metals. It allows them to concentrate and recover in a smaller volume, making the process more economical. (C) 2010 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of [name organizer]
C1 [Laidani, Ykhlef; Henini, Ghania] Hassiba Ben Bouali Univ, BP 151, Hay Essalem 02000, Chlef, Algeria.
   [Hanini, Salah] Univ Medea, LBMPT, Medea 26000, Algeria.
RP Laidani, Y (reprint author), Hassiba Ben Bouali Univ, BP 151, Hay Essalem 02000, Chlef, Algeria.
EM l.ykhlef@gmail.com
CR Bal KE, 2004, TEXT RES J, V74, P241, DOI 10.1177/004051750407400310
   Belghit FT, 2006, USING ENCAPSULATED B
   Chen JP, 2005, BIOTECHNOL PROGR, V21, P315, DOI 10.1021/bp049684v
   Demir H, 2008, J HAZARD MATER, V153, P389, DOI 10.1016/j.jhazmat.2007.08.070
   Hanini S., 1988, THESIS USTHB
   Iqbal M, 2004, BIOTECHNOL LETT, V26, P165, DOI 10.1023/B:BILE.0000012899.76157.19
   Tassist A., 2003, THESIS USTHB ALGIERS
NR 7
TC 11
Z9 12
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2011
VL 6
BP 381
EP 388
DI 10.1016/j.egypro.2011.05.044
PG 8
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA BYE94
UT WOS:000298294900044
OA Other Gold
DA 2018-10-20
ER

PT S
AU Pavlova, A
   Reinis, A
   Berzina-Cimdina, L
   Kroica, J
   Burlakova, A
   Rubenis, K
AF Pavlova, Agnese
   Reinis, Aigars
   Berzina-Cimdina, Liga
   Kroica, Juta
   Burlakova, Aleksandra
   Rubenis, Kristaps
BE Medvids, A
TI Staphylococcus epidermidis and Pseudomonas aeruginosa adhesion intensity
   on a TiO2 ceramic in an in vitro study
SO INTER ACADEMIA 2010: GLOBAL RESEARCH AND EDUCATION
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 9th International Conference on Global Research and Education,
   Inter-Academia 2010
CY AUG 09-12, 2010
CL Riga Tech Univ, Riga, LATVIA
SP Riga Tech Univ, Shizuoka Univ, Comenius Univ, Budapest Univ Tech & Econ, Warsaw Univ Technol, Wuppertal Univ, Alexandru Ioan Cuza Univ, Gomel State Univ, MAsaryk Univ
HO Riga Tech Univ
DE TiO2 ceramic; in vitro; Staphylococcus epidermidis; Pseudomonas
   aeruginosa; adhesion and colonization
AB Extrusion is a perspective forming technology for obtaining objects with certain profile, important for the TiO2 application as biomaterial. Extruded samples were calcinated at 1100 degrees C, thermally treated in different atmospheres: at 1450 degrees C in air and at 1300 degrees C in vacuum. An approach was made to examine the adhesion and colonization intensity of Staphylococcus epidermidis and Pseudomonas aeruginosa on TiO2 ceramic in vitro. It was found that Ps.aeruginosa demonstrated higher adhesion and colonization intensity as S.epidermidis and TiO2 samples treated in vacuum demonstrated higher attachment of microorganisms as TiO2 samples treated in air. It was supposed that surface charge promoted the bacterial adhesion on the vacuum treated samples.
C1 [Pavlova, Agnese; Berzina-Cimdina, Liga; Burlakova, Aleksandra; Rubenis, Kristaps] Riga Tech Univ, Biomat Innovat & Dev Ctr, Riga, Latvia.
   [Reinis, Aigars; Kroica, Juta] Riga Stradins Univ, Dept Biol & Microbiol, Riga, Latvia.
RP Pavlova, A (reprint author), Riga Tech Univ, Biomat Innovat & Dev Ctr, Riga, Latvia.
EM agnese.pavlova@rtu.lv; areinis@apollo.lv; liga.berzina-cimdina@rtu.lv;
   juta.kroica@rsu.lv; aleksandra.burlakova@rtu.lv; kristaps.rubenis@rtu.lv
OI Rubenis, Kristaps/0000-0002-9044-8479
FU European Social Fund within the project "Multidisciplinary Research in
   Biomaterials Technology of New Scientist Group"
   [2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090]
FX This work has been partly supported by the European Social Fund within
   the project Multidisciplinary Research in Biomaterials Technology of New
   Scientist Group, No.2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090.
CR Ghanem H, 2007, J EUR CERAM SOC, V27, P3433, DOI 10.1016/j.jeurceramsoc.2007.02.197
   JAMES P, 2001, J MED MICROBIOL, V50, P582
   Manso M, 2002, BIOMATERIALS, V23, P349, DOI 10.1016/S0142-9612(01)00112-0
   Mather GC, 1999, J EUR CERAM SOC, V19, P887, DOI 10.1016/S0955-2219(98)00338-0
   Radecka M, 2007, J POWER SOURCES, V173, P816, DOI 10.1016/j.jpowsour.2007.05.065
   Reinis A, 2010, IFMBE PROC, V31, P1204, DOI 10.1007/978-3-642-14515-5_305
   Santos E, 2007, MATER CHEM PHYS, V102, P92, DOI 10.1016/j.matchemphys.2006.11.010
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   WANG YH, 2007, ENGINEERING, V445, P611
NR 9
TC 5
Z9 5
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-087-9
J9 ADV MATER RES-SWITZ
PY 2011
VL 222
BP 301
EP +
DI 10.4028/www.scientific.net/AMR.222.301
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BVS06
UT WOS:000292631500072
DA 2018-10-20
ER

PT S
AU Joughehdoust, S
   Behnamghader, A
   Imani, M
   Daliri, M
   Jabbari, E
AF Joughehdoust, Sedigheh
   Behnamghader, Aliasghar
   Imani, Mohammad
   Daliri, Morteza
   Jabbari, Esmaeil
BE Aslan, MH
   Oral, AY
   Ozer, M
   Caglar, SH
TI Surface Modification of High Porosity Alumina Scaffold by Silane
   Coupling Agent
SO INTERNATIONAL CONGRESS ON ADVANCES IN APPLIED PHYSICS AND MATERIALS
   SCIENCE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 1st International Congress on Advances in Applied Physics and Materials
   Science (APMAS)
CY MAY 12-15, 2011
CL Antalya, TURKEY
SP Istanbul Kultur Univ, Gebze Inst Technol, Doga Nanobiotech Inc, Terra Lab Inc, LOT Oriel Grp, PHYWE, Delta Elekt Inc
DE Alumina; Corundum; Surface Modification; Silanization
ID BONE; CARTILAGE
AB Alumina is a bioceramic with improved mechanical properties in comparison to hydroxyapatite. It is also an inert biomaterial in the human body environment of good biocompatible characteristics. Silane coupling agents are capable to form a durable bond between organic and inorganic materials. However, formation of hydroxyl functional groups may enhance coupling of silane molecules on the scaffolds surface and improves the bioactivity of inert alumina. In this research, alumina scaffolds were immersed in H2O2/H2SO4 solution. The hydrated scaffolds were then immersed in different concentrations of gamma-Methacryloxy propyl trimethoxy silane (MTMS)/methanol/distilled water solutions. X-ray diffraction pattern was used for evaluation of phase changes. The structural changes were characterized by Fourier transform infrared spectroscopy. Morphology of the resulting scaffolds was observed by scanning electron microscopy and showed a thin layer of MTMS were formed on the alumina scaffold. The results confirmed the surface modification of alumina scaffolds were performed successfully by MTMS. These scaffolds had properly interconnected porosities with appropriate pore size that can be useful for hard tissues regeneration.
C1 [Joughehdoust, Sedigheh] Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran.
   [Behnamghader, Aliasghar; Jabbari, Esmaeil] Mat & Energy Res Ctr, Dept Ceram, Tehran, Iran.
   [Imani, Mohammad] Iran Polymer & Petrchem Inst, Novel Drug Deliev Syst Dept, Tehran, Iran.
   [Daliri, Morteza] Natl Inst Biotechnol & Genet Engn, Tehran, Iran.
RP Joughehdoust, S (reprint author), Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran.
EM joughehdoust@gmail.com
CR Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Bren L., 2004, P 7 WORLD BIOM C SYD, P1121
   Fischer H, 2005, BIOMATERIALS, V26, P6151, DOI 10.1016/j.biomaterials.2005.04.038
   Gomes M. E., 1993, J COATING TECHNOL, V65, P57
   Hench L.L., 1993, INTRO BIOCERAMICS, P3
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   ISHIDA H, 1985, MOL CHARACTERIZATION, P25
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Sousa R. A., 2001, J MATER SCI-MATER M, V14, P475
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   WITUCKI GL, 1993, J COATING TECHNOL, V65, P57
   Yang YC, 2009, POWDER TECHNOL, V191, P117, DOI 10.1016/j.powtec.2008.09.010
NR 16
TC 0
Z9 0
U1 2
U2 9
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0971-2
J9 AIP CONF PROC
PY 2011
VL 1400
BP 480
EP 485
DI 10.1063/1.3663167
PG 6
WC Physics, Applied
SC Physics
GA BZB61
UT WOS:000301042000092
DA 2018-10-20
ER

PT J
AU Saino, E
   Fassina, L
   Van Vlierberghe, S
   Avanzini, MA
   Dubruel, P
   Magenes, G
   Visai, L
   Benazzo, F
AF Saino, E.
   Fassina, L.
   Van Vlierberghe, S.
   Avanzini, M. A.
   Dubruel, P.
   Magenes, G.
   Visai, L.
   Benazzo, F.
TI EFFECTS OF ELECTROMAGNETIC STIMULATION ON OSTEOGENIC DIFFERENTIATION OF
   HUMAN MESENCHYMAL STROMAL CELLS SEEDED ONTO GELATIN CRYOGEL
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE mesenchymal stromal cells; bovine gelatin cryogel; electromagnetic
   bioreactor; bone matrix proteins
AB Bone tissue engineering typically uses biomaterial scaffolds, osteoblasts or cells that can become osteoblasts, and biophysical stimulations to promote cell attachment and differentiation. In this study, we investigated the effects of an electromagnetic wave on mesenchymal stromal cells isolated from the bone marrow and seeded upon gelatin cryogel disks. In comparison with control conditions without electromagnetic stimulus, the electromagnetic treatment (magnetic field, 2 mT; frequency, 75 Hz) increased the cell proliferation and differentiation and enhanced the biomaterial surface coating with bone extracellular matrix proteins. Using this tissue-engineering approach, the gelatin biomaterial, coated with differentiated cells and their extracellular matrix proteins, may be used in clinical applications as an implant for bone defect repair.
C1 [Saino, E.; Visai, L.] Univ Pavia, Dipartimento Biochim, Sez Med Farm, I-27100 Pavia, Italy.
   [Fassina, L.; Magenes, G.] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   [Van Vlierberghe, S.; Dubruel, P.] Univ Ghent, Biomat Res Grp, B-9000 Ghent, Belgium.
   [Avanzini, M. A.] Univ Pavia, IRCCS San Matteo, Oncoematol Pediat, I-27100 Pavia, Italy.
   [Visai, L.] IRCCS Fdn Salvatore Maugeri, Pavia, Italy.
   [Visai, L.] Int Ctr Studies & Res Biomed ICB, Luxembourg, Luxembourg.
   [Benazzo, F.] Univ Pavia, Dipartimento SMEC, Sez Ortopedia & Traumatol, IRCCS San Matteo, I-27100 Pavia, Italy.
   [Saino, E.; Fassina, L.; Magenes, G.; Visai, L.; Benazzo, F.] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, CIT, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632
CR Aaron RK, 2006, ANN NY ACAD SCI, V1068, P513, DOI 10.1196/annals.1346.045
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911
   Ciombor Deborah McK, 2005, Foot Ankle Clin, V10, P579, DOI 10.1016/j.fcl.2005.06.006
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2008, J BIOMED MATER RES A, V87A, P750, DOI 10.1002/jbm.a.31827
   Fassina L, 2007, P ANN INT IEEE EMBS, P6415
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fassina L, 2010, IEEE ENG MED BIO, P247, DOI 10.1109/IEMBS.2010.5627475
   Fassina L, 2010, J BIOMED MATER RES A, V93A, P1272, DOI 10.1002/jbm.a.32620
   Fassina L, 2008, IEEE ENG MED BIO, P3582, DOI 10.1109/IEMBS.2008.4649980
   Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398
   Fini M, 2004, INT J ARTIF ORGANS, V27, P681
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Haddad JB, 2007, J ALTERN COMPLEM MED, V13, P485, DOI 10.1089/acm.2007.5270
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Li JKJ, 2007, ELECTROMAGN BIOL MED, V26, P153, DOI 10.1080/15368370701572837
   Martino CF, 2008, BIOELECTROMAGNETICS, V29, P125, DOI 10.1002/bem.20372
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Saino E, 2010, TISSUE ENG PT A, V16, P995, DOI [10.1089/ten.tea.2009.0051, 10.1089/ten.TEA.2009.0051]
   Van Vlierberghe S, 2009, J BIOMAT SCI-POLYM E, V20, P1417, DOI 10.1163/092050609X12457418905508
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 24
TC 22
Z9 23
U1 1
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD JAN-MAR
PY 2011
VL 24
IS 1
SU 2
BP 1
EP 6
PG 6
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V39KY
UT WOS:000209411100001
PM 21669129
DA 2018-10-20
ER

PT J
AU Fozdar, DY
   Lee, JY
   Schmidt, CE
   Chen, SC
AF Fozdar, David Y.
   Lee, Jae Y.
   Schmidt, Christine E.
   Chen, Shaochen
TI Selective axonal growth of embryonic hippocampal neurons according to
   topographic features of various sizes and shapes
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE axon guidance; micropatterning; polarization; surface topography; tissue
   engineering
ID CONTACT GUIDANCE; POLARITY; CELLS; POLARIZATION; CULTURE; ESTABLISHMENT;
   REGENERATION; CHANNELS; BEHAVIOR
AB Purpose: Understanding how surface features influence the establishment and outgrowth of the axon of developing neurons at the single cell level may aid in designing implantable scaffolds for the regeneration of damaged nerves. Past studies have shown that micropatterned ridge-groove structures not only instigate axon polarization, alignment, and extension, but are also preferred over smooth surfaces and even neurotrophic ligands.
   Methods: Here, we performed axonal-outgrowth competition assays using a proprietary four-quadrant topography grid to determine the capacity of various micropatterned topographies to act as stimuli sequestering axon extension. Each topography in the grid consisted of an array of microscale (approximately 2 mu m) or submicroscale (approximately 300 nm) holes or lines with variable dimensions. Individual rat embryonic hippocampal cells were positioned either between two juxtaposing topographies or at the borders of individual topographies juxtaposing unpatterned smooth surface, cultured for 24 hours, and analyzed with respect to axonal selection using conventional imaging techniques.
   Results: Topography was found to influence axon formation and extension relative to smooth surface, and the distance of neurons relative to topography was found to impact whether the topography could serve as an effective cue. Neurons were also found to prefer submicroscale over microscale features and holes over lines for a given feature size.
   Conclusion: The results suggest that implementing physical cues of various shapes and sizes on nerve guidance conduits and other advanced biomaterial scaffolds could help stimulate axon regeneration.
C1 [Schmidt, Christine E.; Chen, Shaochen] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Fozdar, David Y.; Chen, Shaochen] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
   [Lee, Jae Y.; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Schmidt, Christine E.; Chen, Shaochen] Univ Texas Austin, Ctr Nano Mol Sci & Technol, Austin, TX 78712 USA.
   [Schmidt, Christine E.; Chen, Shaochen] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA.
   [Schmidt, Christine E.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA.
   [Chen, Shaochen] Univ Texas Austin, Microelect Res Ctr, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas Austin, Dept Biomed Engn, BME 4-2021,MC C0800, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
FU National Institutes of Health [NIH R01EB004429]; National Science
   Foundation (NSF); Texas Materials Institute (TMI) at the University of
   Texas at Austin
FX The contribution of CES to this project was supported by the National
   Institutes of Health (NIH R01EB004429). Work was performed at the Center
   for Nano and Molecular Science and Technology (CNM), Microelectronics
   Research Center (MRC), a part of the National Nanofabrication
   Infrastructure Network supported by the National Science Foundation
   (NSF), and Texas Materials Institute (TMI) at the University of Texas at
   Austin.
CR ADAMSON AW, 1982, PHYS CHEM SURFACES
   Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007
   BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848
   Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Christensen R, 1991, ANAL VARIANCE DESIGN
   CHRISTENSEN RR, 1996, ANAL VARIANCE DESIGN
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Fozdar DY, 2008, BIOMED MICRODEVICES, V10, P839, DOI 10.1007/s10544-008-9198-z
   Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gomez N, 2007, J R SOC INTERFACE, V4, P223, DOI 10.1098/rsif.2006.0171
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174
   Lazic SE, 2003, J HEMATOTH STEM CELL, V12, P635, DOI 10.1089/15258160360732669
   Lee JY, 2010, J BIOMED MATER RES A, V92A, P1398, DOI 10.1002/jbm.a.32471
   Liu CY, 2003, J HEMATOTH STEM CELL, V12, P689, DOI 10.1089/15258160360732713
   Mattson MP, 1999, J NEUROSCI RES, V57, P577, DOI 10.1002/(SICI)1097-4547(19990901)57:5<577::AID-JNR1>3.3.CO;2-8
   NAGATA I, 1993, DEVELOPMENT, V117, P401
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8
   Teixeira AI, 2003, J VAC SCI TECHNOL B, V21, P683, DOI 10.1116/1.1545753
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
NR 33
TC 31
Z9 31
U1 0
U2 14
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 45
EP 57
DI 10.2147/IJN.S12376
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 733FP
UT WOS:000288248900006
PM 21289981
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Biazar, E
   Khorasani, MT
   Daliri, M
AF Biazar, Esmaeil
   Khorasani, M. T.
   Daliri, M.
TI Cell sheet engineering: solvent effect on nanometric grafting of
   poly-N-isopropylacrylamide onto polystyrene substrate under ultraviolet
   radiation
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanometric grafting; solvent effect; poly-N-isopropylacrylamide;
   polystyrene film; ultraviolet radiation
ID SURFACE MODIFICATION; PARYLENE-C; POLY(N-ISOPROPYLACRYLAMIDE);
   POLYMERIZATION; ACRYLAMIDE; FILM
AB Background: The best solvent type and ratio for grafting of poly-N-isopropylacrylamide-(PNIPAAm) on the surface of polystyrene is obtained under ultraviolet radiation. In this study, the effects of solvents, such as water, methanol, and their combinations, under ultraviolet radiation were investigated successfully.
   Method and results: Attenuated total reflection Fourier transform infrared analysis showed the existence of the graft PNIPAAm on the substrate for all samples resolved in solvents. The best solvent ratio and NIPAAm concentration for grafting was obtained with 40% NIPAAm concentrations resolved in a solvent of 9:1 (v/v) water/methanol (120%). Scanning electron microscopic and atomic force microscopic images clearly showed that a 10% increase of methanol to water would increase the amount of grafting. Surface topography and graft thickness in atomic force microscopic images of the grafted samples showed that the thickness of these grafts was about 600 nm. The drop water contact angles of the best grafted sample at 37 degrees C and 4 degrees C were 43.3 degrees and 60.4 degrees, respectively, which demonstrated the hydrophilicity and hydrophobicity of the grafted surfaces. Differential scanning calorimetric analysis also revealed the low critical solution temperature of the grafted sample to be 32 degrees C. Thermoresponsive polymers were grafted to dishes covalently, which allowed epithelial cells to attach and proliferate at 37 degrees C. The cells were also detached spontaneously without using enzymes when the temperature dropped below 4 degrees C.
   Conclusion: MTT analysis also showed good viability of cells on the grafted samples, suggesting that this type of grafted material had potential as a biomaterial for cell sheet engineering.
C1 [Biazar, Esmaeil] Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran.
   [Khorasani, M. T.] Iran Polymer & Petrochem Inst, Biomat Dept, Tehran, Iran.
   [Daliri, M.] Natl Res Ctr Genet Engn & Biotechnol, Tehran, Iran.
RP Biazar, E (reprint author), Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran.
EM kia_esm@yahoo.com
RI Heidari keshel, Saeed/M-5936-2016
CR Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Biazar E, 2010, INT J NANOMED, V5, P549
   BOUSQUET JA, 1983, EUR POLYM J, V19, P135, DOI 10.1016/0014-3057(83)90027-7
   Curti PS, 2002, J MATER SCI-MATER M, V13, P1175, DOI 10.1023/A:1021154424189
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   Delivopoulos E, 2010, J BIOMED MATER RES A, V94A, P47, DOI 10.1002/jbm.a.32662
   Delivopoulos E, 2009, BIOMATERIALS, V30, P2048, DOI 10.1016/j.biomaterials.2008.12.049
   Deng JP, 2009, PROG POLYM SCI, V34, P156, DOI 10.1016/j.progpolymsci.2008.06.002
   Galaev IY, 2003, LANDES BIOSCIENCE, V6, P116
   Geuskens G, 2000, EUR POLYM J, V36, P265, DOI 10.1016/S0014-3057(99)00192-5
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Joeng B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI DOI 10.1016/S0167-7799(02)01962-5
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   Lu J, 2001, RADIAT PHYS CHEM, V60, P625
   NANDI US, 1982, MAKROMOL CHEM, V183, P1467
   OGIWARA Y, 1982, J APPL POLYM SCI, V27, P3743, DOI 10.1002/app.1982.070271010
   Ranogajec F, 2004, RADIAT PHYS CHEM, V71, P229, DOI 10.1016/j.radphyschem.2004.03.045
   Sasaki T, 1976, ACS SYM SER, V3, P283
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
NR 19
TC 4
Z9 4
U1 2
U2 16
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 295
EP 302
DI 10.2147/IJN.S15371
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 733FP
UT WOS:000288248900031
PM 21383854
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chen, HL
   Fan, XQ
   Xia, J
   Chen, P
   Zhou, XJ
   Huang, J
   Yu, JH
   Gu, P
AF Chen, Honglin
   Fan, Xianqun
   Xia, Jing
   Chen, Ping
   Zhou, Xiaojian
   Huang, Jin
   Yu, Jiahui
   Gu, Ping
TI Electrospun chitosan-graft-poly (epsilon-caprolactone)/poly
   (epsilon-caprolactone) nanofibrous scaffolds for retinal tissue
   engineering
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE electrospun; retinal progenitor cells; proliferation; differentiation;
   tissue engineering
ID SURFACE MODIFICATION; ENDOTHELIAL-CELLS; POLYCAPROLACTONE; FABRICATION;
   POLY(EPSILON-CAPROLACTONE); DIFFERENTIATION; BIOMATERIAL; PROGENITORS;
   MORPHOLOGY; BLENDS
AB A promising therapy for retinal diseases is to employ biodegradable scaffolds to deliver retinal progenitor cells (RPCs) for repairing damaged or diseased retinal tissue. In the present study, cationic chitosan-graft-poly(epsilon-caprolactone)/polycaprolactone (CS-PCL/PCL) hybrid scaffolds were successfully prepared by electrospinning. Characterization of the obtained nanofibrous scaffolds indicated that zeta-potential, fiber diameter, and the content of amino groups on their surface were closely correlated with the amount of CS-PCL in CS-PCL/PCL scaffolds. To assess the cell-scaffold interaction, mice RPCs (mRPCs) were cultured on the electrospun scaffolds for 7 days. In-vitro proliferation assays revealed that mRPCs proliferated faster on the CS-PCL/PCL (20/80) scaffolds than the other electrospun scaffolds. Scanning electron microscopy and the real-time quantitative polymerase chain reaction results showed that mRPCs grown on CS-PCL/PCL (20/80) scaffolds were more likely to differentiate towards retinal neurons than those on PCL scaffolds. Taken together, these results suggest that CS-PCL/PCL(20/80) scaffolds have potential application in retinal tissue engineering.
C1 [Chen, Honglin; Fan, Xianqun; Xia, Jing; Chen, Ping; Zhou, Xiaojian; Gu, Ping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Ninth, Dept Ophthalmol, Shanghai 200011, Peoples R China.
   [Chen, Honglin; Huang, Jin; Yu, Jiahui] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
RP Gu, P (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Ninth, Dept Ophthalmol, Shanghai 200011, Peoples R China.
EM guping06@gmail.com
RI Yu, Jiahui/A-8382-2015
FU Shanghai Municipality Commission for Science and Technology
   [09PJ1407200, 0952nm05300]; International Corporation Project of
   Shanghai Municipality Commission [09540709000, 10410710000]; Education
   Commission of Shanghai [11YZ47]; National Natural Science Foundation of
   China [81070737]; Shanghai Leading Academic Discipline Project [S30205]
FX The authors are grateful to Dr Henry Klassen and Dr Michael J Young for
   original provenance of the murine RPCs. The research work was supported
   by Shanghai Municipality Commission for Science and Technology
   (09PJ1407200, 0952nm05300), International Corporation Project of
   Shanghai Municipality Commission (09540709000, 10410710000), Education
   Commission of Shanghai (11YZ47), National Natural Science Foundation of
   China (81070737), Shanghai Leading Academic Discipline Project (S30205).
CR Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)000304
   Chang KY, 2009, ACTA BIOMATER, V5, P1937, DOI 10.1016/j.actbio.2009.02.002
   Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Duan KR, 2010, CARBOHYD POLYM, V80, P498, DOI 10.1016/j.carbpol.2009.12.013
   Feng H, 2006, J POLYM SCI POL CHEM, V44, P5353, DOI 10.1002/pola.21625
   Gelain F, 2008, INT J NANOMED, V3, P415
   Gu P, 2009, MOL VIS, V15, P2111
   Gupta D, 2009, ACTA BIOMATER, V5, P2560, DOI 10.1016/j.actbio.2009.01.039
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Haider S, 2009, J MEMBRANE SCI, V328, P90, DOI 10.1016/j.memsci.2008.11.046
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Kim JH, 2009, MAT SCI ENG C-BIO S, V29, P1725, DOI 10.1016/j.msec.2009.01.023
   Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511
   Klossner RR, 2008, BIOMACROMOLECULES, V9, P2947, DOI 10.1021/bm800738u
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   Margalit E, 2003, ARTIF ORGANS, V27, P963, DOI 10.1046/j.1525-1594.2003.07304.x
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Paneva D, 2008, EUR POLYM J, V44, P566, DOI 10.1016/j.eurpolymj.2008.01.010
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Redenti Stephen, 2008, J Ocul Biol Dis Infor, V1, P19, DOI 10.1007/s12177-008-9005-3
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shalumon KT, 2010, CARBOHYD POLYM, V80, P413, DOI 10.1016/j.carbpol.2009.11.039
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499
   Vaquette C, 2008, MENDELEEV COMMUN, V18, P38, DOI 10.1016/j.mencom.2008.01.015
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Yang XC, 2009, BIOMACROMOLECULES, V10, P2772, DOI 10.1021/bm900623j
   Yu HJ, 2006, BIOPOLYMERS, V83, P233, DOI 10.1002/bip.20551
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zhang YZ, 2008, BIOMACROMOLECULES, V9, P136, DOI 10.1021/bm701130e
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 41
TC 56
Z9 61
U1 0
U2 33
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 453
EP 461
DI 10.2147/IJN.S17057
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 733FP
UT WOS:000288248900048
PM 21499434
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, ZY
   Wang, L
   Zhang, J
   Li, YT
   Zhang, DS
AF Wang, Zi-Yu
   Wang, Li
   Zhang, Jia
   Li, Yun-Tao
   Zhang, Dong-Sheng
TI A study on the preparation and characterization of plasmid DNA and
   drug-containing magnetic nanoliposomes for the treatment of tumors
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanoliposomes; magnetic fluid hyperthermia; As2O3; DNA
ID ARSENIC TRIOXIDE; EXPRESSION; MICE
AB Purpose: To explore the preparation and characterization of a novel nanosized magnetic liposome containing the PEI-As2O3/Mn0.5Zn0.5Fe2O4 complex.
   Methods: Mn0.5Zn0.5Fe2O4 and As2O3/Mn0.5Zn0.5Fe2O4 nanoparticles were prepared by chemical coprecipitation and loaded with PEI. The PEI-As2O3/Mn0.5Zn0.5Fe2O4 complex was characterized using transmission electron and scanning electron microscopy, X-ray diffraction, energy dispersive spectrometry, and Fourier transform infrared spectroscopy. Cell transfection experiments were performed to evaluate the transfect efficiency. Magnetic nanoliposomes were prepared by rotatory evaporation and their shape, diameter, and thermodynamic characteristics were observed.
   Results: Mn0.5Zn0.5Fe2O4 and PEI-As2O3/Mn0.5Zn0.5Fe2O4 nanoparticles were spherical, with an average diameter of 20-40 nm. PEI-As2O3/Mn0.5Zn0.5Fe2O4 was an appropriate carrier for the delivery of a foreign gene to HepG2 cells. Energy dispersive spectrometry results confirmed the presence of the elements nitrogen and arsenic. Nanoliposomes of approximately 100 nm were observed under a transmission electron microscope. Upon exposure to an alternating magnetic field, they also had good magnetic responsiveness, even though Mn0.5Zn0.5Fe2O4 was modified by PEI and encased in liposomes. Temperatures increased to 37 degrees C-54 degrees C depending on different concentrations of PEI-As2O3/Mn0.5Zn0.5Fe2O4 and remained stable thereafter.
   Conclusion: Our results suggest that PEI-As2O3/Mn0.5Zn0.5Fe2O4 magnetic nanoliposomes are an excellent biomaterial, which has multiple benefits in tumor thermotherapy, gene therapy, and chemotherapy.
C1 [Wang, Zi-Yu; Wang, Li; Zhang, Jia; Li, Yun-Tao; Zhang, Dong-Sheng] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China.
   [Wang, Zi-Yu] Nanjing Univ Tradit Chinese Med, Sch Basic Med Sci, Nanjing, Peoples R China.
RP Zhang, DS (reprint author), Southeast Univ, Sch Med, Nanjing 210009, Peoples R China.
EM b7712900@jlonline.com
FU Chinese National 863 Plan [2007 AA03Z356]; Chinese National Natural
   Science Foundation [30770584]
FX This work was supported by the Chinese National 863 Plan (No: 2007
   AA03Z356), and the Chinese National Natural Science Foundation (No:
   30770584).
CR Florea AM, 2007, TOXICOL APPL PHARM, V220, P292, DOI 10.1016/j.taap.2007.01.022
   Jing YK, 2002, BLOOD, V100, P1008, DOI 10.1182/blood.V100.3.1008
   Jordan A, 1996, INT J HYPERTHER, V12, P705, DOI 10.3109/02656739609027678
   Li ZY, 2009, J OCCUP HEALTH, V51, P169, DOI 10.1539/joh.L8038
   Luo LQ, 2006, INT J CANCER, V118, P1823, DOI 10.1002/ijc.21557
   Pathak A, 2008, INT J NANOMED, V3, P31
   Patrick Lyn, 2003, Altern Med Rev, V8, P106
   Tang QS, 2008, BIOMATERIALS, V29, P2673, DOI 10.1016/j.biomaterials.2008.01.038
   Tasci TO, 2009, MED PHYS, V36, P1906, DOI 10.1118/1.3106343
   Xiao YF, 2007, WORLD J GASTROENTERO, V13, P6498, DOI 10.3748/wjg.13.6498
   Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x
NR 11
TC 15
Z9 17
U1 0
U2 21
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 871
EP 875
DI 10.2147/IJN.S16485
PG 5
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 755MN
UT WOS:000289936200001
PM 21720500
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cunha, C
   Panseri, S
   Villa, O
   Silva, D
   Gelain, F
AF Cunha, Carla
   Panseri, Silvia
   Villa, Omar
   Silva, Diego
   Gelain, Fabrizio
TI 3D culture of adult mouse neural stem cells within functionalized
   self-assembling peptide scaffolds
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE biomaterials; tissue engineering; 3D in vitro model
ID CENTRAL-NERVOUS-SYSTEM; IN-VITRO; VISCOELASTIC PROPERTIES; NANOFIBER
   SCAFFOLDS; GROWTH-FACTOR; DIFFERENTIATION; MATRIX; NEURONS; DESIGN;
   BIOREACTOR
AB Three-dimensional (3D) in vitro models of cell culture aim to fill the gap between the standard two-dimensional cell studies and the in vivo environment. Especially for neural tissue regeneration approaches where there is little regenerative capacity, these models are important for mimicking the extracellular matrix in providing support, allowing the natural flow of oxygen, nutrients, and growth factors, and possibly favoring neural cell regrowth. We have previously demonstrated that a new self-assembling nanostructured biomaterial, based on matrigel, was able to support adult neural stem cell (NSC) culture. In this study, we developed a new 3D cell culture system that takes advantage of the nano-and microfiber assembling process, under physiologic conditions, of these biomaterials. The assembled scaffold forms an intricate and biologically active matrix that displays specifically designed functional motifs: RGD (Arg-Gly-Asp), BMHP1 (bone marrow homing peptide 1), and BMHP2, for the culture of adult NSCs. These scaffolds were prepared at different concentrations, and microscopic examination of the cell-embedded scaffolds showed that NSCs are viable and they proliferate and differentiate within the nanostructured environment of the scaffold. Such a model has the potential to be tailored to develop ad hoc designed peptides for specific cell lines.
C1 [Cunha, Carla; Villa, Omar; Silva, Diego; Gelain, Fabrizio] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy.
   [Cunha, Carla; Villa, Omar; Silva, Diego; Gelain, Fabrizio] Osped Niguarda Ca Granda, CNTE AO, Ctr Nanomed & Tissue Engn, Milan, Italy.
   [Panseri, Silvia] Rizzoli Orthopaed Inst, Lab Biomech & Technol Innovat, Bologna, Italy.
   [Panseri, Silvia] CNR, Lab Nanobiomagnetism, Inst Sci & Technol Ceram, Faenza, Italy.
RP Cunha, C (reprint author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, Italy.
EM c.cunha@garvan.org.au; fabrizio.gelain@unimib.it
RI Gelain, Fabrizio/K-5069-2012; Cunha, Carla/I-1884-2013
OI Gelain, Fabrizio/0000-0002-2624-5853; Panseri,
   Silvia/0000-0002-8099-7132; Cunha, Carla/0000-0002-9096-5644
FU CARIPLO Foundation; Regione Lombardia
FX The authors acknowledge CARIPLO Foundation and Regione Lombardia for
   providing financial resources to the project.
CR Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dalton PD, 2009, FRONT BIOSCI, V14, P769, DOI 10.2741/3277
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferrari Daniela, 2010, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02d06s15
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Gritti A, 1996, J NEUROSCI, V16, P1091
   Gurkan UA, 2011, TISSUE ENG PT A, V17, P417, DOI [10.1089/ten.tea.2010.0193, 10.1089/ten.TEA.2010.0193]
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F
   MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Taraballi F, 2009, SOFT MATTER, V5, P660, DOI 10.1039/b809236b
   Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998
   Vescovi AL, 2001, BIOMED PHARMACOTHER, V55, P201, DOI 10.1016/S0753-3322(01)00056-7
   Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3
NR 50
TC 65
Z9 69
U1 3
U2 40
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 943
EP 955
DI 10.2147/IJN.S17292
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 757VY
UT WOS:000290117500001
PM 21720506
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Taylor, E
   Webster, TJ
AF Taylor, Erik
   Webster, Thomas J.
TI Reducing infections through nanotechnology and nanoparticles
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Review
DE nanomaterials; medical device infection; antibacterial; antibiotic
   resistance; nanoparticle; biofilms
ID CATHETER-RELATED INFECTIONS; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIBACTERIAL
   ACTIVITY; CARBON NANOTUBES; BIOMEDICAL APPLICATIONS; MAGNETIC
   NANOPARTICLES; ANTIBIOTIC-RESISTANCE; OXIDE NANOPARTICLES;
   ESCHERICHIA-COLI; JOINT INFECTIONS
AB The expansion of bacterial antibiotic resistance is a growing problem today. When medical devices are inserted into the body, it becomes especially difficult for the body to clear robustly adherent antibiotic-resistant biofilm infections. In addition, concerns about the spread of bacterial genetic tolerance to antibiotics, such as that found in multiple drug-resistant Staphylococcus aureus (MRSA), have significantly increased of late. As a growing direction in biomaterial design, nanomaterials (materials with at least one dimension less than 100 nm) may potentially prevent bacterial functions that lead to infections. As a first step in this direction, various nanoparticles have been explored for improving bacteria and biofilm penetration, generating reactive oxygen species, and killing bacteria, potentially providing a novel method for fighting infections that is nondrug related. This review article will first examine in detail the mechanisms and applications of some of these nanoparticles, then follow with some recent material designs utilizing nanotechnology that are centered on fighting medical device infections.
C1 [Taylor, Erik; Webster, Thomas J.] Brown Univ, Sch Engn, Providence, RI 02917 USA.
   [Webster, Thomas J.] Brown Univ, Dept Orthoped, Providence, RI 02917 USA.
RP Webster, TJ (reprint author), Brown Univ, Sch Engn, Providence, RI 02917 USA.
EM thomas_webster@brown.edu
CR Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kq1051
   Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949
   Caballero L, 2010, DYES PIGMENTS, V86, P56, DOI 10.1016/j.dyepig.2009.12.001
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050
   Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P229, DOI 10.1001/archsurg.136.2.229
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   ELLIS JR, 2007, AM J INFECT CONTROL, V35, pE26
   Fayaz AM, 2011, PROCESS BIOCHEM, V46, P636, DOI 10.1016/j.procbio.2010.11.001
   French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0
   Frey NA, 2009, CHEM SOC REV, V38, P2532, DOI 10.1039/b815548h
   Gao JH, 2009, ACCOUNTS CHEM RES, V42, P1097, DOI 10.1021/ar9000026
   Gottlieb T, 2002, MED J AUSTRALIA, V176, P609
   Gu HW, 2003, NANO LETT, V3, P1261, DOI 10.1021/nl034396z
   Gupta A, 1998, NAT BIOTECHNOL, V16, P888, DOI 10.1038/nbt1098-888
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Jabra-Rizk MA, 2004, EMERG INFECT DIS, V10, P14, DOI 10.3201/eid1001.030119
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Kang S, 2009, ENVIRON SCI TECHNOL, V43, P2648, DOI 10.1021/es8031506
   Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Lipovsky A, 2009, J PHYS CHEM C, V113, P15997, DOI 10.1021/jp904864g
   Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/NNANO.2009.153, 10.1038/nnano.2009.153]
   Makhluf S, 2005, ADV FUNCT MATER, V15, P1708, DOI 10.1002/adfm.200500029
   Maki DG, 2009, NEW ENGL J MED, V360, P949, DOI 10.1056/NEJMp0806575
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   O'Grady Naomi P, 2002, MMWR Recomm Rep, V51, P1
   Oh J, 2006, NANOTECHNOLOGY, V17, P4183, DOI 10.1088/0957-4484/17/16/031
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Pfaller MA, 2008, J CLIN MICROBIOL, V46, P515, DOI 10.1128/JCM.01915-07
   Puckett S, 2008, INT J NANOMED, V3, P229
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Rello J, 2000, AM J RESP CRIT CARE, V162, P1027, DOI 10.1164/ajrccm.162.3.9911093
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004
   Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0
   Sawai J, 1997, J CHEM ENG JPN, V30, P1034, DOI 10.1252/jcej.30.1034
   Sawai J, 1998, J FERMENT BIOENG, V86, P521, DOI 10.1016/S0922-338X(98)80165-7
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Sirivisoot S, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/8/085101
   Stanton T, 2010, AAOS NOW
   Suci PA, 2007, CHEM BIOL, V14, P387, DOI 10.1016/j.chembiol.2007.02.006
   Sunada K, 1998, ENVIRON SCI TECHNOL, V32, P726, DOI 10.1021/es970860o
   Taylor EN, 2009, INT J NANOMED, V4, P145
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Tran N, 2010, J MATER CHEM, V20, P8760, DOI 10.1039/c0jm00994f
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Weinberg ED, 1999, EMERG INFECT DIS, V5, P346, DOI 10.3201/eid0503.990305
   Xing BG, 2003, CHEM COMMUN, P2224, DOI 10.1039/b305886g
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 66
TC 114
Z9 117
U1 2
U2 97
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 1463
EP 1473
DI 10.2147/IJN.S22021
PG 11
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 791BS
UT WOS:000292635700001
PM 21796248
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hulander, M
   Lundgren, A
   Berglin, M
   Ohrlander, M
   Lausmaa, J
   Elwing, H
AF Hulander, Mats
   Lundgren, Anders
   Berglin, Mattias
   Ohrlander, Mattias
   Lausmaa, Jukka
   Elwing, Hans
TI Immune complement activation is attenuated by surface nanotopography
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanostructure; protein adsorption; gold nanoparticles; QCM-D; IgG;
   innate immunity
ID GLOBULAR-HEAD; ARTIFICIAL SURFACES; PROTEIN ADSORPTION; ADSORBED
   PROTEINS; PLASMA-PROTEINS; QCM-D; C1Q; BIOCOMPATIBILITY; COAGULATION;
   BINDING
AB The immune complement (IC) is a cell-free protein cascade system, and the first part of the innate immune system to recognize foreign objects that enter the body. Elevated activation of the system from, for example, biomaterials or medical devices can result in both local and systemic adverse effects and eventually loss of function or rejection of the biomaterial. Here, the researchers have studied the effect of surface nanotopography on the activation of the IC system. By a simple nonlithographic process, gold nanoparticles with an average size of 58 nm were immobilized on a smooth gold substrate, creating surfaces where a nanostructure is introduced without changing the surface chemistry. The activation of the IC on smooth and nanostructured surfaces was viewed with fluorescence microscopy and quantified with quartz crystal microbalance with dissipation monitoring in human serum. Additionally, the ability of pre-adsorbed human immunoglobulin G (IgG) (a potent activator of the IC) to activate the IC after a change in surface hydrophobicity was studied. It was found that the activation of the IC was significantly attenuated on nanostructured surfaces with nearly a 50% reduction, even after pre-adsorption with IgG. An increase in surface hydrophobicity blunted this effect. The possible role of the curvature of the nanoparticles for the orientation of adsorbed IgG molecules, and how this can affect the subsequent activation of the IC, are discussed. The present findings are important for further understanding of how surface nanotopography affects complex protein adsorption, and for the future development of biomaterials and blood-contacting devices.
C1 [Hulander, Mats; Lundgren, Anders; Berglin, Mattias; Elwing, Hans] Univ Gothenburg, Dept Cell & Mol Biol Interface Biophys, SE-41390 Gothenburg, Sweden.
   [Ohrlander, Mattias] Bactiguard AB, Stockholm, Sweden.
   [Lausmaa, Jukka] SP Tech Res Inst, Boras, Sweden.
   [Lausmaa, Jukka] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.
RP Hulander, M (reprint author), Univ Gothenburg, Dept Cell & Mol Biol Interface Biophys, Medicinaregatan 9E, SE-41390 Gothenburg, Sweden.
EM mats.hulander@cmb.gu.se
OI Lundgren, Anders/0000-0002-8537-9974
FU Bactiguard AB
FX The authors acknowledge Bactiguard AB for financial support, Per
   Borchardt at SP technical research institute for his excellence in
   TOF-SIMS, Urban Jelvestam for XPS measurements, and Julia Hedlund for
   her skills in electrochemical measurements. They also thank Kristina
   Nilsson Ekdahl and Pentti Tengvall for helpful discussions.
CR Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Bard A. J, 2001, ELECTROCHEMICAL METH
   Buijs J, 1996, LANGMUIR, V12, P1605, DOI 10.1021/la950665s
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   ELWING H, 1986, EUR J BIOCHEM, V156, P359, DOI 10.1111/j.1432-1033.1986.tb09591.x
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaboriaud C, 2003, J BIOL CHEM, V278, P46974, DOI 10.1074/jbc.M307764200
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hedlund J, 2009, SENSOR ACTUAT B-CHEM, V142, P494, DOI 10.1016/j.snb.2009.08.037
   Hulander M, 2009, ACS APPL MATER INTER, V1, P1053, DOI 10.1021/am900028e
   Hwang HY, 2008, MOL IMMUNOL, V45, P2570, DOI 10.1016/j.molimm.2007.12.019
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Karmali PP, 2011, EXPERT OPIN DRUG DEL, V8, P343, DOI 10.1517/17425247.2011.554818
   KILCHHERR E, 1985, J MOL BIOL, V186, P403, DOI 10.1016/0022-2836(85)90114-7
   Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w
   Kishore U, 2002, IMMUNOBIOLOGY, V205, P355, DOI 10.1078/0171-2985-00138
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   Malmstrom J, 2007, LANGMUIR, V23, P9760, DOI 10.1021/la701233y
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Sauerbrey G., 1959, PHYSIK, V155, P206, DOI DOI 10.1021/AM505510M
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 38
TC 36
Z9 37
U1 3
U2 47
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2011
VL 6
BP 2653
EP 2666
DI 10.2147/IJN.S24578
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 856ZN
UT WOS:000297683500001
PM 22114496
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tuan, RS
AF Tuan, Rocky S.
TI Role of Adult Stem/Progenitor Cells in Osseointegration and Implant
   Loosening
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN TRABECULAR BONE; TOTAL HIP-REPLACEMENT;
   FOCAL ADHESION KINASE; TITANIUM PARTICLES; PROGENITOR CELLS; WEAR
   DEBRIS; DIFFERENTIATION; OSTEOBLASTS; OSTEOLYSIS
AB The long-term stability of prosthetic implants is ultimately a function of the integrity of the biologic interaction between the resident tissues and cells and the biomaterial. Connective tissues of the skeleton undergo constant remodeling and turnover, and the interface with the implant biomaterial is therefore a dynamic structure that results from ongoing differentiation of progenitor cells into functional cellular phenotypes. An understanding of the regulation of the mechanisms by which progenitor cells initiate and maintain their interactions with the biomaterial surface while undergoing the necessary differentiation processes is thus essential to optimizing the long-term stability of prosthetic implants. This review presents evidence that the interactions between adult mesenchymal stem cells, as the principal progenitor cell type of skeletal connective tissues, and the biomaterial surfaces are influenced by surface chemistry and topography and regulated by the extracellular matrix and growth factors. Mesenchymal stem cells are also the targets of the wear debris particles that are a by-product of implant biomaterials, resulting in direct and microenvironmental effects, including apoptosis, suppression of proliferation and osteogenic differentiation, and the production of proinflammatory cytokines, that compromise the long-term stability of the bone-implant interface. These effects are initiated by endocytosis of the submicron particles by the mesenchymal stem cells. These observations strongly suggest that optimization of the stability of implant osseointegration must address factors that enhance and promote the biologic activities of the stem/progenitor cells of skeletal connective tissues. INT J ORAL MAXILLOFAC IMPLANTS 2011;26(SUPPL):50-62
C1 Univ Pittsburgh, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Sch Med, Pittsburgh, PA 15219 USA.
RP Tuan, RS (reprint author), Univ Pittsburgh, Ctr Cellular & Mol Engn, Dept Orthopaed Surg, Sch Med, 450 Technol Dr,Room 221, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
FU Commonwealth of Pennsylvania Department of Health
FX The author acknowledges the work of previous and present members of his
   laboratory who have contributed to the research data presented here, and
   the funding support of the Commonwealth of Pennsylvania Department of
   Health in the preparation of this manuscript.
CR Avila G, 2009, IMPLANT DENT, V18, P17, DOI 10.1097/ID.0b013e318192cb7d
   BOBYN JD, 1984, ORTHOPEDICS, V7, P1410, DOI 10.3928/0147-7447-19840901-05
   Bostrom M, 2008, J AM ACAD ORTHOP SUR, V16, pS63, DOI 10.5435/00124635-200800001-00013
   Branemark PI, 1997, SCAND J PLAST RECO S, V16, P1
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen FH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2514
   Chiu R, 2006, J BIOMED MATER RES A, V77A, P850, DOI 10.1002/jbm.a.30697
   Chiu R, 2007, J ORTHOP RES, V25, P450, DOI 10.1002/jor.20328
   COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   DJOUAD F, 2007, ARTHRITIS RES THER, V9, pR1304
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Fritz EA, 2006, J BIOMED MATER RES A, V77A, P192, DOI 10.1002/jbm.a.30609
   GOLDRING SR, 1986, ARTHRITIS RHEUM-US, V29, P836, DOI 10.1002/art.1780290704
   Gordon A, 2007, J ORTHOP RES, V25, P1665, DOI 10.1002/jor.20446
   GROESSNERSCHREIBER B, 1992, J CELL SCI, V101, P209
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   Haynes DR, 2004, INFLAMM RES, V53, P596, DOI 10.1007/s00011-004-1303-z
   HICKOK NJ, 2002, OSTEOLOGIE, V11, P75
   Hiraoka K, 2006, BIORHEOLOGY, V43, P447
   HO JE, 2007, J BIOMED MATER RES A, V15, P1200
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Janjanin S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2459
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Konttinen YT, 2005, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000150451.50452.da
   Koreny T, 2006, ARTHRITIS RHEUM, V54, P3221, DOI 10.1002/art.22134
   Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940
   Kwon SY, 2001, BIORHEOLOGY, V38, P161
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Leibbrandt A, 2009, ADV EXP MED BIOL, V649, P100
   Lozito Thomas P., 2009, P185, DOI 10.1007/978-1-60327-227-8_17
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2015, DOI 10.1016/j.biomaterials.2009.11.071
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ramage SC, 2007, J BONE JOINT SURG AM, V89A, P841, DOI 10.2106/JBJS.F.00655
   Rzhaninova AA, 2005, B EXP BIOL MED+, V139, P134, DOI 10.1007/s10517-005-0231-4
   Santerre JP, 2000, CAN J SURG, V43, P173
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3
   Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220
   Seo SW, 2007, ANN NY ACAD SCI, V1117, P151, DOI 10.1196/annals.1402.027
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   Shanbhag AS, 2007, J BONE JOINT SURG AM, V89A, P1081, DOI 10.2106/JBJS.F.00330
   Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125
   SINHA RK, 1996, SEMIN ARTHROPLASTY, V7, P47
   SINHA RK, 1994, CLIN ORTHOP RELAT R, V305, P258
   Song L, 2005, STEM CELLS DEV, V14, P712, DOI 10.1089/scd.2005.14.712
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Wang ML, 2003, J ORTHOPAED RES, V21, P697, DOI 10.1016/S0736-0266(02)00241-3
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wilkinson JM, 2003, J BONE MINER RES, V18, P1995, DOI 10.1359/jbmr.2003.18.11.1995
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 73
TC 16
Z9 16
U1 0
U2 11
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PY 2011
VL 26
SU S
BP 50
EP 62
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 724HD
UT WOS:000287565800006
PM 21464999
DA 2018-10-20
ER

PT J
AU Schipke, CG
   Jessenb, F
   Teipel, S
   Luckhaus, C
   Wiltfang, J
   Esselmann, H
   Frolich, L
   Maier, W
   Ruther, E
   Heppner, FL
   Prokop, S
   Heuser, I
   Peters, O
AF Schipke, Carola G.
   Jessenb, Frank
   Teipel, Stefan
   Luckhaus, Christian
   Wiltfang, Jens
   Esselmann, Hermann
   Frolich, Lutz
   Maier, Wolfgang
   Ruther, Eckart
   Heppner, Frank L.
   Prokop, Stefan
   Heuser, Isabella
   Peters, Oliver
TI Long-Term Stability of Alzheimer's Disease Biomarker Proteins in
   Cerebrospinal Fluid
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE Alzheimer's disease; amyloid-beta protein; biomarkers; cerebrospinal
   fluid; protein stability; tau-protein
ID NEUROCHEMICAL DEMENTIA DIAGNOSTICS; TAU; CSF; CRITERIA; STORAGE; ASSAYS
AB The quantitative analysis of peptides in human cerebrospinal fluid (CSF) has become an important step in the early diagnosis of dementia, e. g., Alzheimer's disease. In search of new biomarkers for early detection and differential diagnosis of chronic neurodegenerative diseases, "biobanking" and long-term storage of human samples is increasingly important. The German Dementia Competence Network (DCN) has accomplished one of the largest biomaterial banks in this field, comprising CSF from several hundreds of patients. Since little is known about long-term stability of biomarker proteins in frozen CSF, we investigated the reliability of quantitative analysis in a total of 56 CSF samples that had been frozen for up to six years. Here, we compare a second quantitative analysis of A beta(40), A beta(42), and the total-tau protein after several years of storage at -80 degrees C with initial results obtained within six months after lumbar puncture. The second analysis was done using standard ELISAs or the newly developed Mesocale System. We found that regarding A beta(42) and total-tau, the results highly correlate with correlation coefficients of c = 0.73 and c = 0.82 respectively, while for A beta(40) the correlation coefficient was lower (c = 0.53), suggesting that A beta(40) is more vulnerable to degradation. We conclude that the quantitative analysis of the concentration of A beta(42), as well as for total-tau, in CSF in samples that have been stored for years is reliable. The determination of these biomarkers and potentially new biomarkers in CSF samples stored in large biomaterial banks assembled over many years is feasible.
C1 [Schipke, Carola G.; Heuser, Isabella; Peters, Oliver] CBF, Dept Psychiat Charite, Berlin, Germany.
   [Jessenb, Frank; Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany.
   [Teipel, Stefan] Univ Rostock, Dept Psychiat, Rostock, Germany.
   [Luckhaus, Christian] Univ Dusseldorf, Dept Psychiat, Dusseldorf, Germany.
   [Wiltfang, Jens; Esselmann, Hermann] Univ Essen Gesamthsch, Dept Psychiat, Essen, Germany.
   [Frolich, Lutz] Cent Inst Mental Hlth, Mannheim, Germany.
   [Ruther, Eckart] Univ Gottingen, Dept Psychiat, Gottingen, Germany.
   [Heppner, Frank L.; Prokop, Stefan] CCM, Dept Neuropathol Charite, Berlin, Germany.
   [Jessenb, Frank; Maier, Wolfgang] German Ctr Neurodegenerat Disorders, DZNE, Bonn, Germany.
   [Teipel, Stefan] German Ctr Neurodegenerat Disorders, DZNE, Rostock, Germany.
RP Peters, O (reprint author), Charite, CBF, Dept Psychiat & Psychotherapy, Eschenallee 3, D-14050 Berlin, Germany.
EM oliver.peters@charite.de
OI Prokop, Stefan/0000-0002-5633-2149; Wiltfang, Jens/0000-0003-1492-5330
FU German Federal Ministry of Education and Research (BMBF): Kompetenznetz
   Demenzen [01GI0420]; European Union; Janssen-Cilag; Merz Pharmaceuticals
FX This study has been supported by a grant from the German Federal
   Ministry of Education and Research (BMBF): Kompetenznetz Demenzen
   (01GI0420). This work was also supported by the European Union (FP7
   HEALTH, Project Lupas to FLH). Additional funding related to randomized
   clinical trials came from Janssen-Cilag and Merz Pharmaceuticals. The
   latter funds were exclusively used for personnel, pharmaceuticals,
   blistering and shipment of medication, monitoring and as capitation fees
   for recruiting centers. We wish to thank all patients and their
   caregivers, as well as all coworkers in the cooperating centers.
CR Anesi A, 1998, CLIN CHEM, V44, P2359
   Bibl M, 2007, MOL PSYCHIATR, V12, P671, DOI 10.1038/sj.mp.4001967
   Bjerke M, 2010, INT J ALZHEIMERS DIS, V2010
   Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3
   Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027
   Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555
   Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483
   Kornhuber J, 2009, DEMENT GERIATR COGN, V27, P404, DOI 10.1159/000210388
   Lewczuk P, 2006, J NEURAL TRANSM, V113, P1075, DOI 10.1007/s00702-006-0511-9
   Lewczuk P, 2006, NEUROSCI LETT, V409, P1, DOI 10.1016/j.neulet.2006.07.009
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003
   Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034
   Petzold A, 2010, EXP NEUROL, V223, P432, DOI 10.1016/j.expneurol.2009.11.010
   Schipke CG, 2011, DEMENT GERIATR COGN, V31, P139, DOI 10.1159/000322588
   Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735
   Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859
   Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2
   Verwey NA, 2009, ANN CLIN BIOCHEM, V46, P235, DOI 10.1258/acb.2009.008232
   Verwey NA, 2010, J ALZHEIMERS DIS, V20, P445, DOI 10.3233/JAD-2010-1392
   Visser PJ, 2008, NEUROEPIDEMIOLOGY, V30, P254, DOI 10.1159/000135644
   von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010
   Wiltfang J, 2007, J NEUROCHEM, V101, P1053, DOI 10.1111/j.1471-4159.2006.04404.x
NR 23
TC 13
Z9 13
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2011
VL 26
IS 2
BP 255
EP 262
DI 10.3233/JAD-2011-110329
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 818OR
UT WOS:000294763100007
PM 21606567
DA 2018-10-20
ER

PT J
AU Pollanen, R
   Tikkanen, AM
   Lammi, MJ
   Lappalainen, R
AF Pollanen, Raimo
   Tikkanen, Anna-Maria
   Lammi, Mikko J.
   Lappalainen, Reijo
TI The effect of loading and material on the biomechanical properties and
   vitality of bovine cartilage in vitro
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE Biomechanical testing; Polyurethane; Biomaterial; Cartilage; Vitality
ID ARTICULAR-CARTILAGE; UNCONFINED COMPRESSION; PROTEOGLYCAN SYNTHESIS;
   STIMULATION; APOPTOSIS; PRESSURE; CHONDROCYTES; EXPLANTS
AB Purpose: New methodology for long-term (270 h) biomechanical testing with living cartilage was developed. Polyurethane (PU) implant material was compared with stainless steel and reference samples in static unconfined compressive loading conditions on cartilage to provide a basis for dynamic testing of novel PU implant materials under conditions that simulate an articulating human knee joint.
   Methods: Custom-made tools and techniques were developed to prepare cylindrical samples from bovine patella with cartilage including subchondral bone. Specific incubator cups with static loading setups for a culture incubator were manufactured to keep bovine cartilage explants alive in cell culture conditions under unconfined static compressive loading (0.25 MPa) for 270 h (11.25 d). Four loading conditions of cartilage were studied: free (FREE), restrained minimal loading (RESTR), loading with a metal plate (MEW) and loading with polyurethane (PUW).
   Results: After static loading for 270 h, cartilage biomechanical tests indicated clear differences between the groups in frequency dependent dynamic stiffness curves. Surprisingly, the PU curves were closest to the FREE sample curves. Those with load and direct contact with metal (MEW) became significantly stiffer, while restrained samples became softer. Significant differences (p<0.05, Mann-Whitney's U test) in cell vitality between samples from various groups could be seen in fluorescein diacetate (FDA) and propidium iodide (PI) stained samples by confocal microscopic analysis. The approximate mean percentages of living cells after 270 hours cultivation were: FREE 87%, MEW 3%, PUW 35%, and RESTR 66%. Test results indicate that it is possible to keep cartilage cells alive in cell culture incubator conditions for two weeks period under a 0.25 MPa unconfined static loading. The FREE samples were most successful and cells loaded with PU were more vital than cells loaded with metal.
   Conclusions: Based on the results, PU seems to be more compatible material than surgical steel in contact with living cartilage. Because of a large variation in the quality of bovine cartilage material from different animals, special care is necessary when selecting specimens to guarantee reliable and reproducible results.
C1 [Pollanen, Raimo; Tikkanen, Anna-Maria; Lappalainen, Reijo] Univ Eastern Finland, BioMater Ctr, FIN-70211 Kuopio, Finland.
   [Lammi, Mikko J.] Univ Eastern Finland, Dept Biomed, FIN-70211 Kuopio, Finland.
   [Lammi, Mikko J.] Univ Eastern Finland, Dept Biosci, FIN-70211 Kuopio, Finland.
   [Lappalainen, Reijo] Univ Eastern Finland, Dept Appl Phys, FIN-70211 Kuopio, Finland.
RP Lappalainen, R (reprint author), Univ Eastern Finland, BioMater Ctr, Kuopio Campus,POB 1627, FIN-70211 Kuopio, Finland.
EM Reijo.Lappalainen@uef.fi
RI Lammi, Mikko/B-9291-2008
OI Lammi, Mikko/0000-0002-6181-9904
FU Active Implants Ltd Company; University of Eastern Finland, BioMater
   Center
FX This study was supported by the grants from the Active Implants Ltd
   Company and University of Eastern Finland, BioMater Center.
CR Bachrach NM, 1995, J BIOMECH, V28, P1561, DOI 10.1016/0021-9290(95)00103-4
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2
   Elders M J, 2000, J Rheumatol Suppl, V60, P6
   Frank EH, 2000, J BIOMECH, V33, P1523, DOI 10.1016/S0021-9290(00)00100-7
   GIORI NJ, 1993, J ORTHOP RES, V11, P581, DOI 10.1002/jor.1100110413
   GRODZINSKY AJ, 1997, BAILLIERES CLIN ORTH, V2, P109
   Heraud F, 2000, ANN RHEUM DIS, V59, P959, DOI 10.1136/ard.59.12.959
   LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M
   MAKELA M, 1993, J CLIN EPIDEMIOL, V46, P549, DOI 10.1016/0895-4356(93)90128-N
   Montin L, 2007, CHRONIC ILLN, V3, P219, DOI 10.1177/1742395307084405
   Morel V, 2006, J BIOMECH, V39, P924, DOI 10.1016/j.jbiomech.2005.01.026
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   PARKKINEN JJ, 1992, J ORTHOPAED RES, V10, P610, DOI 10.1002/jor.1100100503
   SCHNEIDERMAN R, 1986, J ORTHOPAED RES, V4, P393, DOI 10.1002/jor.1100040402
   Sharif M, 2004, ARTHRITIS RHEUM-US, V50, P507, DOI 10.1002/art.20020
   Smith RL, 1996, J ORTHOP RES, V14, P53, DOI 10.1002/jor.1100140110
   Soulhat J, 1999, J BIOMECH ENG-T ASME, V121, P340, DOI 10.1115/1.2798330
   Toyras J, 2001, J BIOMECH, V34, P251, DOI 10.1016/S0021-9290(00)00189-5
   Wong M, 1997, J ORTHOPAED RES, V15, P189, DOI 10.1002/jor.1100150206
   Yoshimura F, 2006, OSTEOARTHR CARTILAGE, V14, P435, DOI 10.1016/j.joca.2005.11.003
NR 21
TC 2
Z9 2
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD JAN-APR
PY 2011
VL 9
IS 1
BP 47
EP 53
DI 10.5301/JABB.2011.6472
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 761DB
UT WOS:000290374400008
PM 21445828
DA 2018-10-20
ER

PT J
AU Gregoric, M
   Agnarsson, I
   Blackledge, TA
   Kuntner, M
AF Gregoric, Matjaz
   Agnarsson, Ingi
   Blackledge, Todd A.
   Kuntner, Matjaz
TI Darwin's bark spider: giant prey in giant orb webs (Caerostris darwini,
   Araneae: Araneidae)?
SO JOURNAL OF ARACHNOLOGY
LA English
DT Article
DE Web gigantism; web architecture; web size; bridge line; kleptoparasite;
   silk; biomaterial; prey capture
ID WEAVING SPIDERS; FLYING DRAGONFLIES; NEPHILID SPIDERS; CAPTURE AREA;
   PHYLOGENY; ARANEOIDEA; THERIDIIDAE; EVOLUTION; BEHAVIOR; TELAPROCERA
AB Although the diversity of spider orb web architectures is impressive, few lineages have evolved orb webs larger than I m in diameter. Until recently, such web gigantism was reported only in a few nephilids and araneids. However, new studies on bark spiders (Caerostris) of Madagascar report a unique case of web gigantism: Darwin's bark spider (C darwini) casts its webs over substantial water bodies, and these webs are made from silk whose toughness outperforms all other known spider silks. Here we investigate C. darwini web architecture and provide data to begin to answer two intriguing questions to explain these extraordinary web characteristics: 1) Are C darwini webs specialized to subdue unusually large, perhaps even vertebrate, prey? 2) Do these large, riverine webs allow the spiders to capitalize on catching numerous small semi-aquatic insects? During fieldwork in Madagascar, we studied C darwini web architecture and ecology, as well as interactions with prey. We characterize C. darwini webs as having relatively simple capture areas with very open sticky spirals and few radial lines. We also compare web features in several sympatric Caerostris species, among which C. darwini represents the most extreme case of web gigantism, with the largest orbs up to 2.76 m(2) and longest bridge lines reaching 25.5 m. While preliminary, current data suggest that C darwini webs are effective snares for semi-aquatic insects such as mayflies and dragonflies, while vertebrate prey were never observed. We suggest that mass emergence of aquatic insects may function analogously to the capture of rare, large prey that recent studies suggest are critical for reproduction in orb weaving spiders.
C1 [Gregoric, Matjaz; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
   [Agnarsson, Ingi] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA.
   [Blackledge, Todd A.] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Blackledge, Todd A.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
RP Gregoric, M (reprint author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
EM matjaz.gregoric@gmail.com
FU National Geographic Society [8655-09]; Slovenian Research Agency
   [P1-0236, J1-2063]; NSF [IOS-0745379]
FX This is Contribution 1 resulting from the 2010 Madagascar expedition,
   funded by the National Geographic Society (grant 8655-09 to I.
   Agnarsson, M. Kuntner, and T. Blackledge). Additional funding came from
   the Slovenian Research Agency (grants P1-0236, J1-2063) and NSF
   (IOS-0745379). We thank the MICET crew in Antananarivo, and Sahondra
   Lalao Rahanitriniaina and Honore Rabarison for their help in the field.
   We also thank Dinesh Rao, William Eberhard, Sean Blamires and Wolfgang
   Nentwig for their help in getting web size data for other spider
   species.
CR Agnarsson I, 2004, ZOOL J LINN SOC-LOND, V141, P447, DOI 10.1111/j.1096-3642.2004.00120.x
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   ALEXANDER DE, 1986, J EXP BIOL, V122, P81
   ALEXANDER DE, 1984, J EXP BIOL, V109, P379
   AZUMA A, 1988, J EXP BIOL, V137, P221
   Black ledge T.A, 2011, ADV INSECT IN PRESS
   Blackledge TA, 2002, J ARACHNOL, V30, P70, DOI 10.1636/0161-8202(2002)030[0070:EOCAOS]2.0.CO;2
   Blackledge TA, 2007, BIOLOGY LETT, V3, P456, DOI 10.1098/rsb1.2007.0218
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blackledge TA, 2011, J ARACHNOL, V39, P205, DOI 10.1636/Chi10-52.1
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Blamires SJ, 2007, AUSTRAL ECOL, V32, P551, DOI 10.1111/j.1442-9993.2007.01727.x
   CARICO J E, 1986, P306
   Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29
   Coddington J., 1986, P319
   CODDINGTON J A, 1986, Cladistics, V2, P53, DOI 10.1111/j.1096-0031.1986.tb00442.x
   CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025
   CRAIG CL, 1994, BEHAV ECOL SOCIOBIOL, V35, P45, DOI 10.1007/BF00167059
   Eberhard W.G., 1989, Bulletin of the British Arachnological Society, V8, P45
   EBERHARD W G, 1986, P70
   EBERHARD WG, 1982, EVOLUTION, V36, P1067, DOI 10.1111/j.1558-5646.1982.tb05475.x
   EBERHARD WG, 1990, ANNU REV ECOL SYST, V21, P341, DOI 10.1146/annurev.es.21.110190.002013
   EBERHARD WG, 1975, J NAT HIST, V9, P93, DOI 10.1080/00222937500770071
   Eberhard WG, 2008, SYST BIODIVERS, V6, P415, DOI 10.1017/S1477200008002855
   Field A., 2005, DISCOVERING STAT USI
   Foelix R. F, 1996, BIOL SPIDERS
   Foelix RF, 2011, BIOL SPIDERS
   GILLESPIE RG, 1987, ECOLOGY, V68, P887, DOI 10.2307/1938360
   Graham DL, 1997, J FIELD ORNITHOL, V68, P98
   GRASSHOFF M, 1984, Revue de Zoologie Africaine, V98, P725
   Gregoric M, 2010, J ARACHNOL, V38, P319, DOI 10.1636/A09-80.1
   Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1
   Harmer AMT, 2008, ZOOTAXA, P59
   Harmer AMT, 2009, J ETHOL, V27, P453, DOI 10.1007/s10164-008-0142-8
   Herberstein Marie E., 2011, P57
   Herberstein ME, 2000, J ARACHNOL, V28, P180, DOI 10.1636/0161-8202(2000)028[0180:EOFTET]2.0.CO;2
   Jaeger Peter, 2007, Acta Arachnologica, V56, P29, DOI 10.2476/asjaa.56.29
   Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530
   Kuntner M, 2005, INVERTEBR SYST, V19, P391, DOI 10.1071/IS05024
   Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x
   Kuntner M, 2008, J ARACHNOL, V36, P583, DOI 10.1636/T07-54.1
   Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x
   Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x
   Kuntner M, 2010, NATURWISSENSCHAFTEN, V97, P1097, DOI 10.1007/s00114-010-0736-1
   Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1
   Kuntner M, 2010, BIOL J LINN SOC, V99, P849, DOI 10.1111/j.1095-8312.2010.01414.x
   Kuntner M, 2009, J ARACHNOL, V37, P266, DOI 10.1636/St08-67.1
   Kuntner M, 2009, INVERTEBR SYST, V23, P193, DOI 10.1071/IS09002
   Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x
   LEVI H W, 1970, Psyche (Cambridge), V77, P280, DOI 10.1155/1970/69275
   Nakata K, 2010, P ROY SOC B-BIOL SCI, V277, P3019, DOI 10.1098/rspb.2010.0729
   NENTWIG W, 1985, OECOLOGIA, V66, P580, DOI 10.1007/BF00379353
   Opell BD, 1999, EVOL ECOL RES, V1, P503
   Peloso PL, 2007, REV BRAS ORNITOL, V15, P461
   Peters H., 1937, MORPHOLOGIE OKOLOGIE, V33, P128
   PLATNICK N, 2010, WORLD SPIDER CATALOG
   Rao D, 2008, BEHAV ECOL SOCIOBIOL, V63, P209, DOI 10.1007/s00265-008-0651-z
   Rao D, 2009, J ETHOL, V27, P35, DOI 10.1007/s10164-007-0080-x
   RISCH P, 1977, BEHAV GENET, V7, P199, DOI 10.1007/BF01066276
   Robinson M.H, 1974, ZOOLOGICAL J LINNEAN, V54, P145
   ROBINSON MH, 1972, J NAT HIST, V6, P687, DOI 10.1080/00222937200770631
   ROBINSON MH, 1980, PAC INSECTS MONOGR, V36, P35
   Rodriguez-Girones MA, 2010, J THEOR BIOL, V266, P430, DOI 10.1016/j.jtbi.2010.06.031
   Sakai WH, 2007, ORNITOL NEOTROP, V18, P117
   SANDOVAL CP, 1994, FUNCT ECOL, V8, P701, DOI 10.2307/2390229
   Scharff N, 1997, ZOOL J LINN SOC-LOND, V120, P355, DOI 10.1111/j.1096-3642.1997.tb01281.x
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   SHERMAN PM, 1994, ANIM BEHAV, V48, P19, DOI 10.1006/anbe.1994.1208
   Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262
   Timm RM, 2007, CARIBB J SCI, V43, P282
   Uhl G, 1998, ZOOL-ANAL COMPLEX SY, V101, P101
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
   Wiehle H, 1928, Z MORPHOLOGIE OKOLOG, V8, P468
   WIEHLE HERMAN, 1927, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V8, P468, DOI 10.1007/BF00407450
   WIEHLE HERMANN, 1931, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V22, P349, DOI 10.1007/BF00408816
   WIEHLE HERMANN, 1929, ZEITSCHR WIS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V15, P262, DOI 10.1007/BF00403104
   Zschokke S, 2002, EUROPEAN ARACHNOLOGY 2000, P99
NR 77
TC 10
Z9 11
U1 2
U2 44
PU AMER ARACHNOLOGICAL SOC
PI COLLEGE PARK
PA UNIV MARYLAND, DEPT ENTOMOLOGY, 4112 PLANT SCIENCES BLDG, COLLEGE PARK,
   MD 20742-4454 USA
SN 0161-8202
EI 1937-2396
J9 J ARACHNOL
JI J. Arachnol.
PY 2011
VL 39
IS 2
BP 287
EP 295
DI 10.1636/CB10-95.1
PG 9
WC Entomology
SC Entomology
GA 848XV
UT WOS:000297089300012
DA 2018-10-20
ER

PT J
AU Naujoks, C
   Langenbach, F
   Berr, K
   Depprich, R
   Kubler, N
   Meyer, U
   Handschel, J
   Kogler, G
AF Naujoks, Christian
   Langenbach, Fabian
   Berr, Karin
   Depprich, Rita
   Kuebler, Norbert
   Meyer, Ulrich
   Handschel, Joerg
   Koegler, Gesine
TI Biocompatibility of Osteogenic Predifferentiated Human Cord Blood Stem
   Cells with Biomaterials and the Influence of the Biomaterial on the
   Process of Differentiation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biocompatibility; bone tissue engineering; gene expression; scaffold;
   scanning electron microscopy; stem cell
ID BONE RECONSTRUCTION THERAPIES; IN-VITRO; BIOPHYSICAL PRINCIPLES; TISSUE;
   OSTEOBLASTS; REPAIR; GRAFT; PROGENITORS; SCAFFOLDS; IMPLANTS
AB Modern cell-based bone reconstruction therapies offer new therapeutic opportunities and tissue engineering represents a more biological-oriented approach to heal bone defects of the skeleton. Human unrestricted somatic stem cells (USSCs) derived form umbilical cord blood offer new promising aspects e. g., can differentiate into osteogenetic cells. Furthermore these cells have fewer ethical and legal restrictions compared to embryonic stem cells (ESCs). The purpose of this study was to evaluate the compatibility of osteogenic pre-differentiated USSCs with various biomaterials and to address the question, whether biomaterials influence the process of differentiation of the USSCs. After osteogenic differentiation with DAG USSCs were cultivated with various biomaterials. To asses the biocompatibility of USSCs the attachment and the proliferation of the cells on the biomaterial were measured by a CyQUANT (R) assay, the morphology was analyzed by scanning electron microscopy and the influence of the gene expression was analyzed by real time PCR. Our results provide evidence that insoluble collagenous bone matrix followed by beta-tricalciumphosphate is highly suitable for bone tissue engineering regarding cell attachment and proliferation. The gene expression analysis indicates that biomaterials influence the gene expression of USSCs. These results are in concordance with our previous study with ESCs.
C1 [Naujoks, Christian; Langenbach, Fabian; Berr, Karin; Depprich, Rita; Kuebler, Norbert; Meyer, Ulrich; Handschel, Joerg] Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, D-40225 Dusseldorf, Germany.
   [Koegler, Gesine] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany.
RP Langenbach, F (reprint author), Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM fabian.langenbach@med.uni-duesseldorf.de
RI Langenbach, Fabian/F-4011-2012
OI Langenbach, Fabian/0000-0002-0836-6512
FU Deutsche Forschungsgemeinschaft (DFG) [HA 3228/2-1, KO2119/6-1]
FX Fabian Langenbach is supported by a grant of Deutsche
   Forschungsgemeinschaft (DFG) (HA 3228/2-1). The work of Prof. Kogler is
   supported by the DFG grant KO2119/6-1.
CR Bandyopadhyay-Ghosh S, 2007, J BIOMED MATER RES A, V80A, P175, DOI 10.1002/jbm.a.30878
   Benito AI, 2004, BONE MARROW TRANSPL, V33, P675, DOI 10.1038/sj.bmt.1704405
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   Chaudhry GR, 2004, J BIOMED BIOTECHNOL, P203, DOI 10.1155/S111072430431003X
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   Cohen Steven R, 2004, Neurosurg Focus, V16, pE12
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dalby MJ, 2000, J MATER SCI-MATER M, V11, P805, DOI 10.1023/A:1008957630020
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Dennis J E, 1992, Cell Transplant, V1, P23
   Depprich R, 2005, ORAL MAXILLOFAC SURG, V9, P363, DOI 10.1007/s10006-005-0644-2
   Depprich Rita, 2008, Head Face Med, V4, P25, DOI 10.1186/1746-160X-4-25
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   Handschel J, 2006, INT J ORAL MAX IMPL, V21, P890
   Handschel J, 2009, J BIOMATER APPL, V23, P549, DOI 10.1177/0885328208094305
   Handschel Jorg, 2008, Head Face Med, V4, P10, DOI 10.1186/1746-160X-4-10
   Handschel Jorg G K, 2007, Head Face Med, V3, P4, DOI 10.1186/1746-160X-3-4
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Holmes RE, 2004, CLIN PLAST SURG, V31, P393, DOI 10.1016/j.cps.2004.03.003
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   KAHLE M, 2009, INT J ARTIF IN PRESS
   Kasaj Adrian, 2008, Head Face Med, V4, P22, DOI 10.1186/1746-160X-4-22
   Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440
   Mahmood J, 2001, J BIOCHEM-TOKYO, V129, P163, DOI 10.1093/oxfordjournals.jbchem.a002828
   Meyer U, 1998, J MATER SCI-MATER M, V9, P301, DOI 10.1023/A:1008894612021
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P635, DOI 10.1016/j.ijom.2004.04.006
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P325, DOI 10.1016/S0901-5027(03)00199-1
   Meyer U, 2005, BONE CARTILAGE TISSU
   Meyer U, 2006, INT J ORAL MAX IMPL, V21, P899
   NAUJOKS C, 2008, ZAHNARZTLICHE MITTEI, V98, P2688
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Petrovic L, 2006, INT J ORAL MAX IMPL, V21, P225
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pretorius JA, 2005, INT J ORAL MAX IMPL, V20, P387
   Prott FJ, 2002, INT J RADIAT ONCOL, V54, P203, DOI 10.1016/S0360-3016(02)02867-5
   Puricelli Edela, 2006, Head Face Med, V2, P43, DOI 10.1186/1746-160X-2-43
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Suh JD, 2004, ARCH OTOLARYNGOL, V130, P962, DOI 10.1001/archotol.130.8.962
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   Velich N, 2004, J CRANIOFAC SURG, V15, P11, DOI 10.1097/00001665-200401000-00006
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   WOJCIAKSTOTHARD B, 1995, CELL MOTIL CYTOSKEL, V31, P147, DOI 10.1002/cm.970310207
   Yamaguchi M, 2002, CYTOTHERAPY, V4, P109, DOI 10.1080/146532402317381811
   YOUDAS JW, 1988, J ORTHOPAED RES, V6, P621, DOI 10.1002/jor.1100060502
   zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1
NR 51
TC 17
Z9 17
U1 0
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2011
VL 25
IS 5
BP 497
EP 512
DI 10.1177/0885328209358631
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 705YN
UT WOS:000286176800007
PM 20207776
DA 2018-10-20
ER

PT J
AU Yan, J
   Li, JM
   Runge, MB
   Dadsetan, M
   Chen, QS
   Lu, LC
   Yaszemski, MJ
AF Yan, Jun
   Li, Jianmin
   Runge, M. Brett
   Dadsetan, Mahrokh
   Chen, Qingshan
   Lu, Lichun
   Yaszemski, Michael J.
TI Cross-linking Characteristics and Mechanical Properties of an Injectable
   Biomaterial Composed of Polypropylene Fumarate and Polycaprolactone
   Co-polymer
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Polypropylene fumarate; polycaprolactone; injectable biomaterials; in
   situ polymerizable
ID VERTEBRAL COMPRESSION FRACTURES; IN-VITRO CYTOTOXICITY; POLY(PROPYLENE
   FUMARATE); BONE-CEMENT; PERCUTANEOUS VERTEBROPLASTY;
   DEGRADATION-PRODUCTS; PHOSPHATE; POLYMETHYLMETHACRYLATE; KYPHOPLASTY;
   NETWORKS
AB In this work, a series of co-polymers of polypropylene fumarate-co-polycaprolactone (PPF-co-PCL) were synthesized via a three-step polycondensation reaction of oligomeric polypropylene fumarate (PPF) with polycaprolactone (PCL). The effects of PPF precursor molecular weight, PCL precursor molecular weight and PCL fraction in the co-polymer (PCL feed ratio) on the maximum cross-linking temperature, gelation time and mechanical properties of the cross-linked co-polymers were investigated. The maximum cross-linking temperature fell between 38.2 +/- 0.3 and 47.2 +/- 0.4 degrees C, which increased with increasing PCL precursor molecular weight. The gelation time was between 4.2 +/- 0.2 and 8.5 +/- 0.7 min, and decreased with increasing PCL precursor molecular weight. The compressive moduli ranged from 44 +/- 1.8 to 142 +/- 7.4 MPa, with enhanced moduli at higher PPF precursor molecular weight and lower PCL feed ratio. The compressive toughness was in the range of 4.1 +/- 0.3 and 17.1 +/- 1.3 kJ/m(3). Our data suggest that the cross-linking and mechanical properties of PPF-co-PCL can be modulated by varying the composition. Therefore, the PPF-co-PCL co-polymers may offer increased versatility as an injectable, in situ polymerizable biomaterial than the individual polymers of PPF and PCL. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Yan, Jun; Runge, M. Brett; Dadsetan, Mahrokh; Lu, Lichun; Yaszemski, Michael J.] Mayo Clin, Tissue Engn & Biomat Lab, Dept Biomed Engn, Rochester, MN 55905 USA.
   [Yan, Jun; Runge, M. Brett; Dadsetan, Mahrokh; Lu, Lichun; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.
   [Yan, Jun; Li, Jianmin] Shandong Univ, Qilu Hosp, Dept Orthoped Surg, Jinan 250014, Shandong, Peoples R China.
   [Chen, Qingshan] Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA.
RP Yaszemski, MJ (reprint author), Mayo Clin, Tissue Engn & Biomat Lab, Dept Biomed Engn, 200 1st St SW, Rochester, MN 55905 USA.
EM yaszemski.michael@mayo.edu
FU National Institutes of Health [AR056212-01, 1T32AR056950]
FX This work was funded by the National Institutes of Health (AR056212-01)
   and 1T32AR056950. We thank Stephen Cha for his help in statistical
   analysis of the data.
CR BUCKWALTER JA, 2000, ORTHOPAEDIC BASIC SC
   Deramond H, 1998, RADIOL CLIN N AM, V36, P533, DOI 10.1016/S0033-8389(05)70042-7
   Deramond H, 1999, BONE, V25, p17S, DOI 10.1016/S8756-3282(99)00127-1
   Einhorn TA, 2000, SPINE, V25, P1051, DOI 10.1097/00007632-200005010-00002
   Elfick APD, 2002, BIOMATERIALS, V23, P4463, DOI 10.1016/S0142-9612(02)00163-1
   Grafe IA, 2008, SPINE, V33, P1284, DOI 10.1097/BRS.0b013e3181714a84
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Legroux-Gerot I, 2004, CLIN RHEUMATOL, V23, P310, DOI 10.1007/s10067-004-0914-7
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026
   Odian G., 2004, PRINCIPLES POLYM
   Pascual B, 1996, BIOMATERIALS, V17, P509, DOI 10.1016/0142-9612(96)82725-6
   Perez-Higueras A, 2002, NEURORADIOLOGY, V44, P950, DOI 10.1007/s00234-002-0856-1
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Tseng YY, 2009, SPINE, V34, P1917, DOI [10.1097/BRS.0b013e3181ac8107, 10.1097/BRS.0b013e3181ac8f07]
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Wu QX, 2003, POLYMER, V44, P3909, DOI 10.1016/S0032-3861(03)00314-8
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Zhang ZX, 2009, BIOCHEM BIOPH RES CO, V379, P557, DOI 10.1016/j.bbrc.2008.12.084
NR 29
TC 23
Z9 24
U1 2
U2 19
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 4-6
BP 489
EP 504
DI 10.1163/092050610X487765
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 699EA
UT WOS:000285645500006
PM 20566042
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Padavan, DT
   Hamilton, AM
   Boughner, DR
   Wan, WK
AF Padavan, Donna T.
   Hamilton, Amanda M.
   Boughner, Derek R.
   Wan, Wankei
TI Synthesis and In Vitro Biocompatibility Assessment of a Poly(amic acid)
   Derived from Ethylenediaminetetraacetic Dianhydride
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Poly(amic acid); ring-opening polymerization; nuclear magnetic
   resonance; confocal microscopy; cell viability
ID POLYIMIDES; POLYMERS
AB Poly(amic acid) (PAA) derived from ethylenediaminetetracetic dianhydride shows great potential as a biomaterial suitable for biomedical applications. To evaluate this polymer class further, in vitro cell toxicity (WST-1/ECS, ELISA based) and cell compatibility (cell adhesion and cell proliferation) tests were conducted to establish structure-toxicity relationships. PAAs with a number-average molecular weight ranging between 100 to 200 kg/mol were synthesized at 37 degrees C after 24 h. Porcine radial artery cells (RACs) and descending aorta endothelial cells (ECs) were seeded independently in a 96-well cell culture plate at a cell density of 5000 cells/cm(2) to observe toxic effects. Similarly, RACs and ECs were seeded independently onto PAA coated and uncoated cover slips at a cell density of 7000 cells/cm(2) to observe growth patterns. Our results showed no toxicity after 96 h of incubation and in addition, both RACs and ECs adhered and proliferated on the PAA films, preserving their phenotype during this time. The tested synthetic material seems promising as a future biomaterial and should elicit a desired cellular response upon implantation. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Padavan, Donna T.; Boughner, Derek R.; Wan, Wankei] Univ Western Ontario, Biomed Engn Grad Program, London, ON N6A 5B9, Canada.
   [Padavan, Donna T.; Wan, Wankei] Univ Western Ontario, Dept Chem & Biochem Engn, Fordham Ctr Biomed Engn, London, ON N6A 5B9, Canada.
   [Hamilton, Amanda M.; Boughner, Derek R.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5B9, Canada.
   [Hamilton, Amanda M.; Boughner, Derek R.; Wan, Wankei] Univ Western Ontario, Robarts Res Inst, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Biomed Engn Grad Program, London, ON N6A 5B9, Canada.
EM wkwan@eng.uwo.ca
RI Boughner, Derek/G-3282-2011
FU Canadian Institutes of Health Research (CIHR); Heart and Stroke
   Foundation of Ontario; Ontario Graduate Scholarship (OGS); Ontario
   Graduate Scholarship in Science and Technology (OGSST); Western Graduate
   Research Scholarship (WGRS)
FX Financial support provided by the Canadian Institutes of Health Research
   (CIHR), Heart and Stroke Foundation of Ontario, the Ontario Graduate
   Scholarship (OGS) funds, the Ontario Graduate Scholarship in Science and
   Technology (OGSST) funds, and the Western Graduate Research Scholarship
   (WGRS) is gratefully acknowledged. In addition we would like to thank
   the Canadian Institutes of Health Research Training Grant in Vascular
   Research (D. P. and A. H. were both CIHR Training Fellows). The authors
   thank Viscotek for GPC analysis, Kenneth Wong for his discussions on
   EDX, Darius Strike for EC isolations and Dr. Kem Rogers for the use of
   his cell-culture facilities.
CR ABADIE MJM, 1991, P 2 EUR TECHN S POL
   Chen BK, 2006, POLYM INT, V55, P93, DOI 10.1002/pi.1924
   Chen CF, 2008, J MACROMOL SCI B, V47, P783, DOI 10.1080/00222340802119273
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jiang X, 2008, MACROMOLECULES, V41, P1937, DOI 10.1021/ma7027962
   Johnston DE, 2006, J BIOMED MATER RES A, V78A, P383, DOI 10.1002/jbm.a.30640
   Kreuz JA, 1998, ADV MATER, V10, P1229, DOI 10.1002/(SICI)1521-4095(199810)10:15<1229::AID-ADMA1229>3.0.CO;2-B
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   MATSUURA T, 1991, MACROMOLECULES, V24, P5001, DOI 10.1021/ma00018a004
   *MILL, 2009, WST 1 CELL PROL ASS
   Pavia D. L., 2009, INTRO SPECTROSCOPY
   ROGERS KA, 1986, CELL TISSUE RES, V243, P223
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
NR 15
TC 3
Z9 3
U1 1
U2 9
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 4-6
BP 683
EP 700
DI 10.1163/092050610X490149
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 699EA
UT WOS:000285645500018
PM 20566052
DA 2018-10-20
ER

PT J
AU Sarukawa, J
   Takahashi, M
   Abe, M
   Suzuki, D
   Tokura, S
   Furuike, T
   Tamura, H
AF Sarukawa, Junichiro
   Takahashi, Masaaki
   Abe, Masashi
   Suzuki, Daisuke
   Tokura, Seiichi
   Furuike, Tetsuya
   Tamura, Hiroshi
TI Effects of Chitosan-Coated Fibers as a Scaffold for Three-Dimensional
   Cultures of Rabbit Fibroblasts for Ligament Tissue Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Chitosan; anterior cruciate ligament; fibroblast; extracellular matrix;
   surface modification; tissue scaffolds
ID PATELLAR TENDON AUTOGRAFT; HUMAN-ENDOTHELIAL-CELLS; IN-VITRO; SURFACE
   MODIFICATION; ARTICULAR-CARTILAGE; CROSS-LINKING; BIOMEDICAL
   APPLICATIONS; POLYMERS; IMMOBILIZATION; RECONSTRUCTION
AB Material selection in tissue-engineering scaffolds is one of the primary factors defining cellular response and matrix formation. In this study, we fabricated chitosan-coated poly(lactic acid) (PLA) fiber scaffolds to test our hypothesis that PLA fibers coated with chitosan highly promoted cell supporting properties compared to those without chitosan. Both PLA fibers (PLA group) and chitosan-coated PLA fibers (PLA-chitosan group) were fabricated for this study. Anterior cruciate ligament (ACL) fibroblasts were isolated from Japanese white rabbits and cultured on scaffolds consisting of each type of fiber. The effects of cell adhesivity, proliferation, and synthesis of the extracellular matrix (ECM) for each fiber were analyzed by cell counting, hydroxyproline assay, scanning electron microscopy and quantitative RT-PCR. Cell adhesivity, proliferation, hydroxyproline content and the expression of type-I collagen mRNA were significantly higher in the PLA-chitosan group than in the PLA group. Scanning electron microscopic observation showed that fibroblasts proliferated with a high level of ECM synthesis around the cells. Chitosan coating improved ACL fibroblast adhesion and proliferation, and had a positive effect on matrix production. Thus, the advantages of chitosan-coated PLA fibers show them to be a suitable biomaterial for ACL tissue-engineering scaffolds. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Sarukawa, Junichiro; Takahashi, Masaaki; Abe, Masashi; Suzuki, Daisuke] Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Higashi Ku, Shizuoka, Japan.
   [Tokura, Seiichi; Furuike, Tetsuya; Tamura, Hiroshi] Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, Osaka, Japan.
RP Sarukawa, J (reprint author), Hamamatsu Univ Sch Med, Dept Orthopaed Surg, Higashi Ku, 1-20-1 Handayama, Shizuoka, Japan.
EM j-saru@xj8.so-net.ne.jp
CR Abe M, 2004, TISSUE ENG, V10, P585, DOI 10.1089/107632704323061942
   Altman Greg, 2002, FASEB Journal, V16, P270
   ALVAREZBARRETO JF, 2007, MACROMOL BIOSCI, V10, P579
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   Bach BR, 1998, AM J SPORT MED, V26, P20, DOI 10.1177/03635465980260012101
   BALLOCK RT, 1989, J ORTHOP RES, V7, P474, DOI 10.1002/jor.1100070404
   Chen GP, 2004, TISSUE ENG, V10, P323, DOI 10.1089/107632704323061681
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Crawford C, 2005, CLIN INFECT DIS, V41, P195, DOI 10.1086/430911
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   De la Riva B, 2009, EUR J PHARM BIOPHARM, V73, P50, DOI 10.1016/j.ejpb.2009.04.014
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Kartus J, 2001, ARTHROSCOPY, V17, P971, DOI 10.1053/jars.2001.28979
   KAWAKAMI T, 1992, BIOMATERIALS, V13, P759, DOI 10.1016/0142-9612(92)90014-F
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Koski JA, 2000, ORTHOP CLIN N AM, V31, P437, DOI 10.1016/S0030-5898(05)70162-0
   Ku Y, 2009, J BIOMED MATER RES A, V90A, P766, DOI 10.1002/jbm.a.31846
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Mattioli-Belmonte M, 1999, MED BIOL ENG COMPUT, V37, P130, DOI 10.1007/BF02513279
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   ROSS SM, 1990, IN VITRO CELL DEV B, V26, P579
   Tamura H, 2002, MAT SCI ENG C-BIO S, V20, P143, DOI 10.1016/S0928-4931(02)00024-3
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   UCHIYAMA A, 1991, J BIOCHEM, V110, P714, DOI 10.1093/oxfordjournals.jbchem.a123646
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yagi K, 1997, BIOL PHARM BULL, V20, P1290
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 49
TC 8
Z9 9
U1 2
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 4-6
BP 717
EP 732
DI 10.1163/092050610X491067
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 699EA
UT WOS:000285645500020
PM 20566054
DA 2018-10-20
ER

PT J
AU Wang, XT
   Schmidt, DR
   Joyce, EJ
   Kao, WJ
AF Wang, Xintong
   Schmidt, David R.
   Joyce, Evan J.
   Kao, W. John
TI Application of MS-Based Proteomics to Study Serum Protein
   Adsorption/Absorption and Complement C3 Activation on Poly(ethylene
   glycol) Hydrogels
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Poly(ethylene glycol) hydrogel; mass spectrometry; vitronectin;
   thrombin; fibrinogen; complement C3
ID PLATELET-ADHESION; C5A ANAPHYLATOXINS; MASS-SPECTROMETRY; OXIDE
   SURFACES; HUMAN PLASMA; ADSORPTION; FIBRINOGEN; MEMBRANES; CELLS; C1Q
AB Although the interaction between cells and poly(ethylene glycol) (PEG) hydrogels is well documented, there lacks a thorough investigation into the adsorption of blood proteins on these surfaces which dictates the observed cellular and in vivo host response. Thus, a clear understanding of how surface-bound proteins mediate the unique biological property of PEG hydrogels is fundamentally important. The information obtained will also provide insights into future biomaterial design. In this study, several mass-spectrometry-based proteomic tools coupled with complementary immunoassays were employed to survey the complex surface-bound serum proteome. The adsorption of vitronectin, thrombin, fibrinogen and complement component C3 was significantly lower on PEG hydrogels than on tissue culture polystyrene (TCPS). Although PEG hydrogels mediated lower C3 adsorption than TCPS, the extent of C3 activation between the two surfaces was comparable. Adherent monocyte density was also significantly lower on PEG hydrogels as compared to TCPS. Taken together, these results support the critical role of the complement C3 in mediating monocyte adhesion on biomaterials. Thus we conclude that the biocompatibility of PEG hydrogels both in vitro and in vivo can be partly contributed to their limited C3 interaction and monocyte activity. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Wang, Xintong; Kao, W. John] Univ Wisconsin Madison, Sch Pharm, Madison, WI 53705 USA.
   [Schmidt, David R.; Joyce, Evan J.; Kao, W. John] Univ Wisconsin Madison, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
   [Kao, W. John] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin Madison, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
RI Wang, Xintong/I-8169-2013
FU NIH [R01 EB6613]
FX The authors thank Sean Zuckerman, Grzegorz Sabat and Yao Fu for their
   assistance in MALDI and FT-IR. This work was supported in part by NIH
   Grant R01 EB6613.
CR Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6
   Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   BRASH JL, 1987, ANN NY ACAD SCI, V516, P206, DOI 10.1111/j.1749-6632.1987.tb33043.x
   Chen H, 2005, BIOMATERIALS, V26, P7418, DOI 10.1016/j.biomaterials.2005.05.053
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Cheng XH, 2006, BIOINTERPHASES, V1, P61, DOI 10.1116/1.2187980
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Halle M, 1996, ARTERIOSCL THROM VAS, V16, P144, DOI 10.1161/01.ATV.16.1.144
   Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276
   HAO YL, 1980, METHODS PLASMA PROTE, P57
   Hartmann K, 1997, BLOOD, V89, P2863
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Ishikawa I, 2006, AM J NEPHROL, V26, P372, DOI 10.1159/000094779
   JOENG JH, 2000, COLLOID SURFACE B, V18, P371
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Mahmood TA, 2006, BIOMACROMOLECULES, V7, P3012, DOI 10.1021/bm060489+
   Malmsten M, 1996, J COLLOID INTERF SCI, V178, P123, DOI 10.1006/jcis.1996.0100
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102
   NILEHN JE, 1967, SCAND J CLIN LAB INV, V20, P113, DOI 10.3109/00365516709076931
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   NOGITA T, 1992, ARCH DERMATOL RES, V284, P315, DOI 10.1007/BF00372589
   PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Puchades M, 1999, RAPID COMMUN MASS SP, V13, P344
   Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057
   Sayah S, 1999, J NEUROCHEM, V72, P2426, DOI 10.1046/j.1471-4159.1999.0722426.x
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Svendsen IE, 2006, COLLOID SURFACE B, V53, P157, DOI 10.1016/j.colsurfb.2006.08.016
   Takabayashi T, 1996, J IMMUNOL, V156, P3455
   Tan J, 2009, J BIOMED MATER RES A, V90A, P196, DOI 10.1002/jbm.a.32074
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Vecchiarelli A, 1998, INFECT IMMUN, V66, P4324
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   YING SC, 1993, J IMMUNOL, V150, P169
   YONEMASU K, 1978, IMMUNOLOGY, V35, P523
   Zembala M, 1998, LANGMUIR, V14, P2167, DOI 10.1021/la971146n
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 48
TC 12
Z9 12
U1 1
U2 20
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 10
BP 1343
EP 1362
DI 10.1163/092050610X508400
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 741ZF
UT WOS:000288906800006
PM 20594411
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Willenberg, BJ
   Zheng, T
   Meng, FW
   Meneses, JC
   Rossignol, C
   Batich, CD
   Terada, N
   Steindler, DA
   Weiss, MD
AF Willenberg, Bradley Jay
   Zheng, Tong
   Meng, Fan-Wei
   Meneses, Juan Carlos
   Rossignol, Candace
   Batich, Christopher D.
   Terada, Naohiro
   Steindler, Dennis A.
   Weiss, Michael D.
TI Gelatinized Copper-Capillary Alginate Gel Functions as an Injectable
   Tissue Scaffolding System for Stem Cell Transplants
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Anisotropy; ionotropy; capillary; alginate; gelatin; tissue scaffold;
   biomaterial; stem cell; tissue engineering
ID PEPTIDE-AMPHIPHILE NANOFIBERS; OSTEOGENIC DIFFERENTIATION;
   CONTROLLED-RELEASE; BONE REGENERATION; HYBRID SCAFFOLD; STROMAL CELLS;
   PLGA SPHERES; RAT MODEL; BRAIN; PROLIFERATION
AB In severe hypoxic ischemic brain injury, cellular components such as neurons and astrocytes are injured or destroyed along with the supporting extracellular matrix. This presents a challenge to the field of regenerative medicine since the lack of extracellular matrix and supporting structures makes the transplant milieu inhospitable to the transplanted cells. A potential solution to this problem is the use of a biomaterial to provide the extracellular components needed to keep cells localized in cystic brain regions, allowing the cells to form connections and repair lost brain tissue. Ideally, this biomaterial would be combined with stem cells, which have been proven to have therapeutic potentials, and could be delivered via an injection. To study this approach, we derived a hydrogel biomaterial tissue scaffold from oligomeric gelatin and copper capillary alginate gel (GCCAG). We then demonstrated that our multipotent astrocytic stem cells (MASCs) could be maintained in GCCAG scaffolds for up to 2 weeks in vitro and that the cells retained their multipotency. We next performed a pilot transplant study in which GCCAG was mixed with MASCs and injected into the brain of a neonatal rat pup. After a week in vivo, our results showed that: the GCCAG biomaterial did not cause a significant reactive gliosis; viable cells were retained within the injected scaffolds; and some delivered cells migrated into the surrounding brain tissue. Therefore, GCCAG tissue scaffolds are a promising, novel injectable system for transplantation of stem cells to the brain. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Willenberg, Bradley Jay; Batich, Christopher D.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
   [Zheng, Tong; Steindler, Dennis A.; Weiss, Michael D.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA.
   [Meng, Fan-Wei] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Meneses, Juan Carlos; Rossignol, Candace; Weiss, Michael D.] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA.
   [Batich, Christopher D.] Univ Florida, J Crayton Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Terada, Naohiro] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
RP Willenberg, BJ (reprint author), Univ Florida, Dept Mat Sci & Engn, POB 116400, Gainesville, FL 32611 USA.
EM yoda@ufl.edu
RI Batich, Chris/H-3966-2017
FU NIH [NS052583-01A2]; AHA [0255435B]; NIH/NINDS [NS055165]
FX The authors thank Marda Jorgensen and the McKnight Brain Institute Cell
   & Tissue Analysis Core (MBI-CTAC) for help performing the
   immunofluorescence for the in vitro portion of this study, and the Major
   Analytical Instrumentation Center (MAIC) for assistance with the
   scanning electron microscope imaging and energy dispersive spectroscopy.
   This work was supported by NIH NS052583-01A2 (M.D.W.), AHA 0255435B
   (M.D.W.) and NIH/NINDS NS055165 (D.A.S.). B.J.W. and T.Z. share first
   authorship.
CR BATICH CD, 2005, Patent No. 7601525
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Choi YS, 2005, BIOMATERIALS, V26, P5855, DOI 10.1016/j.biomaterials.2005.02.022
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Despang F, 2005, MATERIALWISS WERKST, V36, P761, DOI 10.1002/mawe.200500961
   Dittrich R., 2006, Advances in Science and Technology, V49, P159, DOI 10.4028/www.scientific.net/AST.49.159
   Dittrich R, 2007, J AM CERAM SOC, V90, P1703, DOI [10.1111/j.1551-2916.2007.01598.x, 10.1111/j.1 551-2916.2007.01598.x]
   GIFFARD RG, 1990, BRAIN RES, V530, P138, DOI 10.1016/0006-8993(90)90670-7
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050
   Kang SW, 2005, TISSUE ENG, V11, P438, DOI 10.1089/ten.2005.11.438
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697
   Leibovici A, 2007, DEV NEUROSCI-BASEL, V29, P268, DOI 10.1159/000097410
   Low JA, 1997, AM J OBSTET GYNECOL, V177, P1391, DOI 10.1016/S0002-9378(97)70080-2
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   MULLIGAN JC, 1980, J PEDIATR-US, V96, P903, DOI 10.1016/S0022-3476(80)80575-0
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   RIEHLE M, 1998, EXP BIOL ONLINE, V3, P1
   Rubin JP, 2007, PLAST RECONSTR SURG, V120, P414, DOI 10.1097/01.prs.0000267699.99369.a8
   Thumbs J, 1996, CHEM PHYS, V208, P9, DOI 10.1016/0301-0104(96)00031-6
   Vannucci R., 1997, HYPOXIA ISCHEMIA PAT
   Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1
   Willenberg BJ, 2006, J BIOMED MATER RES A, V79A, P440, DOI 10.1002/jbm.a.30942
   Yamada Y, 2008, TISSUE ENG PT A, V14, P1699, DOI 10.1089/ten.tea.2007.0189
   Zheng T, 2006, BRAIN RES, V1112, P99, DOI 10.1016/j.brainres.2006.07.014
NR 42
TC 7
Z9 7
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 12
BP 1621
EP 1637
DI 10.1163/092050610X519453
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 780BR
UT WOS:000291826700006
PM 20699061
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Low, YKA
   Meenubharathi, N
   Niphadkar, ND
   Boey, FYC
   Ng, KW
AF Low, Y. K. A.
   Meenubharathi, N.
   Niphadkar, N. D.
   Boey, F. Y. C.
   Ng, K. W.
TI alpha- and beta-Poly(Vinylidene Fluoride) Evoke Different Cellular
   Behaviours
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Poly(vinylidene fluoride); polymorphs; film; cell metabolic activity;
   cell morphology
ID POLY(VINYLIDENE FLUORIDE); CRYSTALLINE PHASE; POLYVINYLIDENE FLUORIDE;
   BETA-CRYSTALLINE; PVDF FILMS; MORPHOLOGY; TEMPERATURE; POLYMORPHS;
   POLYMERS
AB alpha-Phase poly(vinylidene fluoride) (PVDF) has chains of zero dipole moments and is, therefore, non-piezoelectric, while beta-phase PVDF has the most significant piezoelectric properties among the polymorphs due to its polar chains. Although many reports describe PVDF as a suitable biomaterial due to its stability and biocompatibility, few considered the specific effects that the different polymorphs exert on cellular behaviour. We hypothesized that alpha- and beta-phase PVDF will exert direct but different influences on cell attachment and metabolic activity. PVDF films were fabricated using N,N-dimethylformamide (DMF) and hexamethylphosphoramide (HMPA) by solvent casting. Samples were characterized by differential scanning calorimetry, Fourier transform infrared spectroscopy and X-ray diffraction. Films containing 83.5% alpha-phase PVDF (DMF-PVDF alpha) and 91.4% of beta-phase PVDF (HMPA-PVDF beta within the crystalline regions were produced and used to evaluate in vitro attachment and metabolic activity of L929 cells. Cell metabolic activity on both PVDF conformations increased 3-fold over the 1-week culture period, with higher cell metabolic activity observed on DMF-PVDF alpha on day 5 of culture, compared to HMPA-PVDF beta. Cells grown on DMF-PVDF alpha were well-spread, flat and expressed spotted paxillin in focal adhesions that were mainly localized to perinuclear regions of the cells, while a high proportion of cells on HMPA-PVDF beta were bulging, round and expressed relatively fewer paxillin spots. Our results suggest that alpha-phase PVDF supports higher cell metabolic activity and better cell spreading compared to beta-phase PVDF. Such variations can potentially be exploited for different biomedical applications. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Low, Y. K. A.; Meenubharathi, N.; Niphadkar, N. D.; Boey, F. Y. C.; Ng, K. W.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Niphadkar, N. D.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.
RP Ng, KW (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM kwng@ntu.edu.sg
RI Ng, Kee Woei/B-7242-2008; Boey, Freddy Yin Chiang/G-2618-2017
OI Ng, Kee Woei/0000-0002-7276-3563; 
CR Benz M, 2003, J APPL POLYM SCI, V89, P1093, DOI 10.1002/app.12267
   Berger D, 2009, HERNIA, V13, P167, DOI 10.1007/s10029-008-0435-4
   Bouaziz A, 1997, BIOMATERIALS, V18, P107, DOI 10.1016/S0142-9612(96)00114-7
   CHEN LT, 1984, FERROELECTRICS, V57, P51, DOI 10.1080/00150198408012751
   Du CH, 2007, J APPL POLYM SCI, V104, P2254, DOI 10.1002/app.25635
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   GREGORIO R, 1994, J POLYM SCI POL PHYS, V32, P859
   Gregorio R, 2006, J APPL POLYM SCI, V100, P3272, DOI 10.1002/app.23137
   Gregorio R, 1999, J MATER SCI, V34, P4489
   GREGORIO R, 1995, J PHYS D APPL PHYS, V28, P432, DOI 10.1088/0022-3727/28/2/028
   Gregorio R, 2008, POLYMER, V49, P4009, DOI 10.1016/j.polymer.2008.07.010
   Imamura R, 2008, J APPL POLYM SCI, V110, P3242, DOI 10.1002/app.28851
   KIM KJ, 1995, VIB SPECTROSC, V9, P147
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Lin DJ, 2006, EUR POLYM J, V42, P1581, DOI 10.1016/j.eurpolymj.2006.01.027
   LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115
   Mohammadi B, 2007, POLYM TEST, V26, P42, DOI 10.1016/j.polymertesting.2006.08.003
   OSAKI S, 1975, J POLYM SCI POL PHYS, V13, P1071, DOI 10.1002/pol.1975.180130602
   Park A, 1996, J BIOMED MATER RES, V31, P117
   PREST WM, 1978, J APPL PHYS, V49, P5042, DOI 10.1063/1.324439
   Salimi A, 2004, J POLYM SCI POL PHYS, V42, P3487, DOI 10.1002/polb.20223
   Salimi A, 2003, POLYM TEST, V22, P699, DOI 10.1016/S0142-9418(03)00003-5
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Sencadas V, 2004, THERMOCHIM ACTA, V424, P201, DOI 10.1016/j.tca.2004.06.006
   Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Zhao M, 2009, SEMIN CELL DEV BIOL, V20, P674, DOI 10.1016/j.semcdb.2008.12.009
NR 29
TC 20
Z9 20
U1 4
U2 28
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 12
BP 1651
EP 1667
DI 10.1163/092050610X519471
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 780BR
UT WOS:000291826700008
PM 20699059
DA 2018-10-20
ER

PT J
AU Rodriguez, R
   Loske, AM
   Fernandez, F
   Estevez, M
   Vargas, S
   Fernandez, G
   Paredes, MI
AF Rodriguez, Rogelio
   Loske, Achim M.
   Fernandez, Francisco
   Estevez, Miriam
   Vargas, Susana
   Fernandez, Gilberto
   Paredes, Miguel I.
TI In Vivo Evaluation of Implant-Host Tissue Interaction using
   Morphology-Controlled Hydroxyapatite-Based Biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Porous material; biomaterial; hydroxyapatite; silica; implants; MEMS;
   rats
ID BIOACTIVE GLASS; BONE; MANUFACTURE; SCAFFOLDS; BIOCERAMICS; IMPROVEMENT;
   LOAD
AB In medicine, micro-electro-mechanical systems (MEMS) perform several specific functions. The design of bio-packages for MEMS to be implanted into the human body has been an increasing challenge in the last years. Mechanical, chemical and thermal resistance, as well as excellent bonding to silicon surfaces, are needed. Furthermore, ideal bio-packages should minimize post-operative complications and be well accepted by the host. To reach this goal, two different morphology-controlled hydroxyapatite-based porous biomaterials were synthesized, implanted in rats and evaluated mechanically and histologically. The novel biomaterials were prepared at room temperature using synthetic hydroxyapatite micro-particles, silica nanoparticles and water-based resin and compared with a standard hydroxyapatite biomaterial. The morphology (porosity) was controlled to obtain interconnected pores with appropriated pore size and pore volume fraction. All biomaterials were implanted in rats at the dorsal area near the third thoracic vertebra. The rats were killed 2, 7 and 21 days after surgery. Histological analysis revealed that the implants were well accepted by the host and minimal local inflammation was observed. The acute inflammatory response disappeared 21 days after surgery for both novel biomaterials. Additionally, organic matter (collagen) was produced in the interior of the porous biomaterial, indicating that an incipient vascularization process was in progress after 21 days of implantation. Both new biomaterials showed high abrasion resistance, high Young modulus, the appropriate porosity to allow possible vascularization, and good bonding to silicon surfaces. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Rodriguez, Rogelio; Loske, Achim M.; Fernandez, Francisco; Estevez, Miriam; Vargas, Susana] Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Mexico.
   [Fernandez, Gilberto; Paredes, Miguel I.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico.
   [Paredes, Miguel I.] Hosp Angeles Queretaro, Lab Anat Patol, Queretaro, Mexico.
RP Rodriguez, R (reprint author), Univ Nacl Autonoma Mexico, Ctr Fis Aplicada & Tecnol Avanzada, Queretaro 76230, Mexico.
EM rogelior@servidor.unam.mx
RI Rodriguez Talavera, Jose Rogelio/L-1709-2018; Estevez,
   Miriam/F-8864-2018
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; Estevez,
   Miriam/0000-0003-4749-7715; Loske, Achim/0000-0002-9873-5165; VARGAS
   MUNOZ, SUSANA/0000-0001-9031-4182
CR Benlidayi ME, 2009, J ORAL MAXIL SURG, V67, P1174, DOI 10.1016/j.joms.2008.12.015
   Bharati S, 2009, J EUR CERAM SOC, V29, P2527, DOI 10.1016/j.jeurceramsoc.2009.02.013
   DANIEL WW, 2002, BIOSTATISTICS FDN AN, pCH7
   Descamps M, 2008, J EUR CERAM SOC, V28, P149, DOI 10.1016/j.jeurceramsoc.2007.05.025
   Descamps M, 2009, J EUR CERAM SOC, V29, P369, DOI 10.1016/j.jeurceramsoc.2008.06.008
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   Fathi MH, 2009, J MATER PROCESS TECH, V209, P1385, DOI 10.1016/j.jmatprotec.2008.03.051
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Hammouda IM, 2009, J MECH BEHAV BIOMED, V2, P73, DOI 10.1016/j.jmbbm.2008.04.002
   Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003
   Karlsson KH, 2008, J NON-CRYST SOLIDS, V354, P717, DOI 10.1016/j.jnoncrysol.2007.06.100
   LIN K, 2009, J EUR CERAM SOC, V23, P1023
   Mardinger O, 2009, J ORAL MAXIL SURG, V67, P1294, DOI 10.1016/j.joms.2008.12.026
   MCINNES SJP, 2009, J COLLOID INTERF SCI, P336
   Nychka JA, 2008, J MECH BEHAV BIOMED, V1, P243, DOI 10.1016/j.jmbbm.2007.11.004
   Rivera-Munoz E, 2003, MATER SCI FORUM, V426-4, P4489, DOI 10.4028/www.scientific.net/MSF.426-432.4489
   Rodriguez R, 2008, J MATER SCI-MATER EL, V19, P646, DOI 10.1007/s10854-007-9413-3
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Sprio S, 2009, J MECH BEHAV BIOMED, V2, P147, DOI 10.1016/j.jmbbm.2008.05.006
   Stojanovic D, 2007, J EUR CERAM SOC, V27, P1595, DOI 10.1016/j.jeurceramsoc.2006.04.111
   Villacampa AI, 2000, J CRYST GROWTH, V211, P111, DOI 10.1016/S0022-0248(99)00793-9
   Viscioni A, 2009, J ORAL MAXIL SURG, V67, P387, DOI 10.1016/j.joms.2008.06.099
   Wang YW, 2009, EUR J PHARM SCI, V37, P387, DOI 10.1016/j.ejps.2009.03.010
NR 23
TC 2
Z9 2
U1 0
U2 13
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 13
BP 1799
EP 1810
DI 10.1163/092050610X523674
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 790OH
UT WOS:000292598300007
PM 20843435
DA 2018-10-20
ER

PT J
AU Tan, RW
   Feng, QL
   Jin, H
   Li, JY
   Yu, X
   She, ZD
   Wang, MB
   Liu, HY
AF Tan, Rongwei
   Feng, Qingling
   Jin, He
   Li, Jinyu
   Yu, Xing
   She, Zhending
   Wang, Mingbo
   Liu, Huanye
TI Structure and Biocompatibility of an Injectable Bone Regeneration
   Composite
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Structure; biocompatibility; injectable; bone regeneration
ID MOLECULAR-WEIGHT DISTRIBUTION; PORE-SIZE DISTRIBUTION; DRUG-DELIVERY
   SYSTEMS; ALGINATE GEL BEADS; X-RAY-EMISSION; CHITIN FIBERS; INFLAMMATORY
   RESPONSE; MECHANICAL-PROPERTIES; COLLAGEN COMPOSITE; OXIDIZED ALGINATE
AB With the development of minimally invasive techniques, injectable materials have become one of the major hotspots in the biomaterial field. We have developed an injectable bone regeneration composite ( IBRC) using calcium alginate hydrogel as matrix to carry nano-hydroxyapatite/collagen particles. In this work, we evaluated the homogeneity of IBRC by dry/wet weight ratio test. The results showed that the structural homogeneity was determined by controlling the molar ratios of trisodium phosphate to calcium sulfate rather than alginate concentration in the studied ranges. Pore sizes of wet IBRC samples were characterized by thermoporometry. The pore properties of dried IBRC were tested by mercury porosimetry. Average pore size and porosity of dried IBRC declined with increasing alginate concentration. In contrast, surprisingly, pore size of wet homogeneous IBRC increased with increasing alginate concentration. Meanwhile, the swelling ratio did not increase with varying alginate concentration, but the swelling degree increased with increasing alginate concentration. In vitro cell culture showed that IBRC had no obvious cytotoxic effect on the rat bone mesenchymal stem cells. The morphology and viability of cells were also related to MR value. IBRC had good histocompatibility with a mild short-term inflammatory response in rat dorsum muscle. In addition, the excellent ability of IBRC to promote bone healing was confirmed by 5-mm-diameter cranial defects using histological analysis and bone mineral density measurement. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Tan, Rongwei; Feng, Qingling; She, Zhending; Wang, Mingbo] Tsinghua Univ, Dept Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
   [Jin, He; Li, Jinyu; Yu, Xing] Beijing Univ Chinese Med, Dept Orthopaed, Dongzhimen Hosp Affiliated, Beijing 100700, Peoples R China.
   [She, Zhending] Tsinghua Univ Shenzhen, Res Inst, Ctr Adv Mat & Biotechnol, Shenzhen 518057, Peoples R China.
   [Liu, Huanye] China Med Univ, Dept Prosthodont, Sch Stomatol, Shenyang 110002, Peoples R China.
RP Feng, QL (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Feng, Qingling/0000-0003-1288-300X
FU National Natural Science Foundation of China [50772052]; Doctor Subject
   Foundation of the Ministry of Education of China [20070003004]
FX This study was supported by National Natural Science Foundation of China
   (50772052) and Doctor Subject Foundation of the Ministry of Education of
   China (20070003004). We thank Prof. Qiang Lu for helpful discussions.
CR AEBISCHER P, 1994, TRANSPLANTATION, V58, P1275, DOI 10.1097/00007890-199412150-00025
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Cho SH, 2005, J BIOMAT SCI-POLYM E, V16, P933, DOI 10.1163/1568562054414658
   Cosgriff-Hernandez E, 2008, PHARM RES-DORDR, V25, P2345, DOI 10.1007/s11095-008-9666-4
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Gao CM, 2009, POLYM DEGRAD STABIL, V94, P1405, DOI 10.1016/j.polymdegradstab.2009.05.011
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Ishikiriyama K, 1995, THERMOCHIM ACTA, V267, P169, DOI 10.1016/0040-6031(95)02476-X
   Iza M, 2000, POLYMER, V41, P5885, DOI 10.1016/S0032-3861(99)00776-4
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X
   Kishi T, 1998, BONE, V22, P515, DOI 10.1016/S8756-3282(98)00045-3
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li N, 2008, BRAIN RES, V1215, P11, DOI 10.1016/j.brainres.2007.09.095
   Li XX, 2010, CARBOHYD POLYM, V79, P660, DOI 10.1016/j.carbpol.2009.09.020
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Li XM, 2005, MATER SCI FORUM, V475-479, P2387, DOI 10.4028/www.scientific.net/MSF.475-479.2387
   Liao SS, 2004, J BIOACT COMPAT POL, V19, P117, DOI 10.1177/0883911504042643
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2
   Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MARTY GD, 1988, T AM FISH SOC, V117, P401, DOI 10.1577/1548-8659(1988)117<0401:IROCCT>2.3.CO;2
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Niu XF, 2009, J MICROENCAPSUL, V26, P297, DOI 10.1080/02652040802319742
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P179
   Qin YM, 2008, POLYM INT, V57, P171, DOI 10.1002/pi.2296
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   SAAL CJ, 1983, J DENT RES, V62, P221
   SKJAKBRAEK G, 1989, CARBOHYD POLYM, V10, P31, DOI 10.1016/0144-8617(89)90030-1
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Strand BL, 2000, MINERVA BIOTECNOL, V12, P223
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tan RW, 2009, J MATER SCI-MATER M, V20, P1245, DOI 10.1007/s10856-009-3692-6
   Thu B, 1997, CARBOHYD RES, V297, P101, DOI 10.1016/S0008-6215(96)00257-1
   Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Yu CY, 2008, INT J PHARMACEUT, V357, P15, DOI 10.1016/j.ijpharm.2008.01.030
   Yu GH, 2008, J BIOMAT SCI-POLYM E, V19, P87, DOI 10.1163/156856208783227703
   Zhang HW, 2009, J BIOMAT SCI-POLYM E, V20, P1915, DOI 10.1163/156856208X393202
   Zhao Y, 2009, J COLLOID INTERF SCI, V332, P345, DOI 10.1016/j.jcis.2008.12.048
NR 62
TC 9
Z9 9
U1 3
U2 26
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 14
BP 1861
EP 1879
DI 10.1163/092050610X528561
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 804YD
UT WOS:000293690400003
PM 20979688
DA 2018-10-20
ER

PT J
AU Mai-ngam, K
   Boonkitpattarakul, K
   Jaipaew, J
   Mai-ngam, B
AF Mai-ngam, Katanchalee
   Boonkitpattarakul, Kanhokthorn
   Jaipaew, Jirayut
   Mai-ngam, Bunpot
TI Evaluation of the Properties of Silk Fibroin Films from the Non-mulberry
   Silkworm Samia cynthia ricini for Biomaterial Design
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Silk fibroin; non-mulberry silkworm; cell proliferation; cell spreading
ID INDUCED CONFORMATIONAL-CHANGES; AMINO-ACID-COMPOSITION; FIBROBLAST
   ADHESION; DRUG-DELIVERY; C-13 NMR; INFRARED-SPECTROSCOPY; CELL
   ATTACHMENT; PROTEIN; FIBRONECTIN; CHARGE
AB Silk fibroin from a domesticated mulberry silkworm, Bombyx mori, is the most widely used in biomaterial design. We report for the first time the preparation of a relatively smooth (granule free) film of the non-mulberry Samia cynthia ricini fibroin for comparative evaluation of its cell-supporting properties against those of the B. mori fibroin film. The granule formation on the S. c. ricini fibroin film was successfully prevented by facilitating proper rearrangement of the protein molecules, as monitored by FT-IR, by dialysis through a stepwise decrease in the urea concentration in the dialysis media. The lower contact angle of the S. c. ricini fibroin film, compared to the B. mori fibroin film, corresponds well to its lower hydrophobic/hydrophilic amino-acid ratio and grand average of hydropathicity (GRAVY). L929 murine fibroblast cells on the granule-free S. c. ricini fibroin films exhibited greater proliferation and spreading rates than those on the B. mori fibroin films, possibly attributable to its higher content of hydrophilic and positively charged amino acids. It further suggests that fabrication, modification and/or engineering of S. c. ricini fibroin may provide a better biomaterial scaffold design than the more commonly used B. mori fibroin. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Mai-ngam, Katanchalee; Boonkitpattarakul, Kanhokthorn; Jaipaew, Jirayut; Mai-ngam, Bunpot] Natl Met & Mat Technol Ctr, Klongluang 12120, Pathumthani, Thailand.
RP Mai-ngam, K (reprint author), Natl Met & Mat Technol Ctr, Thailand Sci Pk,114 Paholyothin Rd,Klong 1, Klongluang 12120, Pathumthani, Thailand.
EM katancv@mtec.or.th
FU Thailand National Metal and Materials Technology Center
FX This work was financially supported by the Thailand National Metal and
   Materials Technology Center.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Das S., 2005, AUTEX RES J, V5, P81
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Fountoulakis M, 1998, J CHROMATOGR A, V826, P109, DOI 10.1016/S0021-9673(98)00721-3
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Georgi A., 1996, J BIOMED MATER RES, V30, P385
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/6480.2005.00028
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   HOLMBERG K, 2006, ENCY SURFACE COLLOID, V7, P5288
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   KARGERKOCSIS J, 2007, HDB ENG BIOPOLYMERS, P485
   Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033
   Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Lv Q, 2005, J APPL POLYM SCI, V96, P2168, DOI 10.1002/app.21682
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   MINOURA N, 1996, POLYM MAT ENCY, V10, P7749
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   Muguruma H, 2007, IEICE T ELECTRON, VE90C, P1844, DOI 10.1093/ietele/e90-c.9.1844
   Nakazawa Y, 2002, FEBS LETT, V529, P188, DOI 10.1016/S0014-5793(02)03332-X
   NARKKONG N, 2009, J BIOL SCI, V9, P499
   PENNISI CP, 2009, NANOTECHNOLOGY, V20, P1
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   SUGIMOTO Y, 1981, EXP CELL RES, V135, P39, DOI 10.1016/0014-4827(81)90297-4
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka C, 2008, MACROMOLECULES, V41, P796, DOI 10.1021/ma7021875
   Van Nimmen E, 2005, J ARACHNOL, V33, P629, DOI 10.1636/CS05-5.1
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   WANGA X, 2007, BIOMATERIALS, V29, P1054
   Xu Y, 2005, J MATER SCI, V40, P5355, DOI 10.1007/s10853-005-4301-9
   Yamauchi K, 2010, SOLID STATE NUCL MAG, V38, P27, DOI 10.1016/j.ssnmr.2010.06.002
   Yukuhiro K, 1997, INSECT MOL BIOL, V6, P89, DOI 10.1046/j.1365-2583.1997.00161.x
NR 50
TC 12
Z9 12
U1 1
U2 13
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 15
BP 2001
EP 2022
DI 10.1163/092050610X530964
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 823LQ
UT WOS:000295124200003
PM 21029516
DA 2018-10-20
ER

PT J
AU Reddy, N
   Jiang, QR
   Yang, YQ
AF Reddy, Narendra
   Jiang, Qiuran
   Yang, Yiqi
TI Novel Wheat Protein Films as Substrates for Tissue Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biomaterials; proteins; tissue engineering; wheat glutenin; gliadin
ID MECHANICAL-PROPERTIES; COLLAGEN-FIBERS; CROSS-LINKING; BIOCOMPATIBILITY;
   SCAFFOLDS; ZEIN; BIOMATERIALS; STRENGTH; GLUTEN
AB This paper demonstrates that gliadin-free wheat glutenin can be an excellent biomaterial for tissue-engineering applications, better than poly(lactic acid) (PLA). Although plant proteins are more readily available than collagen and silk, limited studies have been conducted on understanding the potential of using plant proteins as biomaterials. Wheat proteins have not been used for tissue engineering due to the cytotoxicity of gliadin. In this research, wheat gluten, glutenin and gliadin were used to develop films and the mechanical properties, water stability and ability of the films to promote the attachment, growth and viability of osteoblast cells was studied in comparison to PLA films. The wheat protein films have good strength ranging from 8 to 30 MPa. Gliadin films experience about 50% weight loss whereas glutenin films have about 90% weight loss after being in water (pH 7.2) for 15 days at 37 degrees C. Gliadin is cytotoxic and the presence of gliadin restricts the cell proliferation on wheat gluten films. However, gliadin-free glutenin films show a higher rate of proliferation of osteoblast cells than the PLA films. Wheat gluten promises to be a potential substrate for tissue engineering and other medical applications. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Reddy, Narendra; Jiang, Qiuran; Yang, Yiqi] Univ Nebraska, Dept Text Clothing & Design, Lincoln, NE 68583 USA.
   [Yang, Yiqi] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.
   [Yang, Yiqi] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68583 USA.
RP Yang, YQ (reprint author), Univ Nebraska, Dept Text Clothing & Design, 234 HECO Bldg,East Campus, Lincoln, NE 68583 USA.
EM yyang2@unl.edu
RI reddy, narendra/J-3794-2014; Yang, Yiqi/A-6900-2009
OI reddy, narendra/0000-0002-8053-4867; Yang, Yiqi/0000-0001-8153-4159
FU DOE [DE-FG36-02G012026]; Nebraska Wheat Board; USDA Hatch Act;
   Agricultural Research Division at the University of Nebraska-Lincoln
   [S-1026]
FX This research was partially supported with funds from The Consortium for
   Plant Biotechnology Research, Inc by DOE prime agreement No.
   DE-FG36-02G012026, The Nebraska Wheat Board, USDA Hatch Act, the
   Agricultural Research Division at the University of Nebraska-Lincoln and
   Multi-State Research Project S-1026. The financial sponsors do not
   endorse the views expressed in this publication.
CR Bellincampi LD, 1997, J APPL POLYM SCI, V63, P1493, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1493::AID-APP11>3.0.CO;2-3
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Elli L, 2003, TOXICOL LETT, V146, P1, DOI 10.1016/j.toxlet.2003.09.004
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   MUNOZ PH, 2004, FOOD HYDROCOLLOIDS, V18, P403
   MUNOZ PH, 2004, BIOMACROMOLECULES, V5, P415
   Reddy N, 2008, J MATER SCI-MATER M, V19, P2055, DOI 10.1007/s10856-007-3294-0
   Reddy N, 2007, BIOMACROMOLECULES, V8, P638, DOI 10.1021/bm0608840
   Reddy N, 2010, J POLYM ENVIRON, V18, P277, DOI 10.1007/s10924-010-0193-0
   Roy S, 1999, J FOOD SCI, V64, P57, DOI 10.1111/j.1365-2621.1999.tb09860.x
   Shi XD, 2009, MACROMOL BIOSCI, V9, P1211, DOI 10.1002/mabi.200900224
   Silva GA, 2003, J MATER SCI-MATER M, V14, P1055, DOI 10.1023/B:JMSM.0000004002.11278.30
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   Yang YQ, 1996, J APPL POLYM SCI, V59, P433
NR 24
TC 8
Z9 9
U1 2
U2 30
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 15
BP 2063
EP 2077
DI 10.1163/092050610X532638
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 823LQ
UT WOS:000295124200006
PM 21029519
DA 2018-10-20
ER

PT J
AU De Smet, N
   Rymarczyk-Machal, M
   Schacht, E
AF De Smet, Nele
   Rymarczyk-Machal, Monika
   Schacht, Etienne
TI Plasma-Induced Surface Modification of Polydimethylsiloxane Aimed at
   Reducing Salt and Protein Deposition
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Plasma polymerisation; PDMS; sulfobetaine; AMPS; adhesion
ID URETERAL STENT BIOMATERIAL; ACRYLIC-ACID; GRAFT-COPOLYMERIZATION;
   SILICONE-RUBBER; FILMS; PDMS; POLYMERIZATION; ENCRUSTATION; ACRYLAMIDE;
   MEMBRANE
AB Polydimethylsiloxane (PDMS) is an elastomer that is widely used in construction and for biological and biomedical applications. The biocompatibility of PDMS was improved by different surface treatment methods, i.e., plasma treatment or a combination of plasma treatment with UV-irradiation or redox initiator, to minimize the effects of deposition of salts and proteins. In this work we used the vinyl monomers sulfobetaine and AMPS which have good biocompatible properties. (C) Koninklijke Brill NV, Leiden, 2011
C1 [De Smet, Nele; Rymarczyk-Machal, Monika; Schacht, Etienne] Univ Ghent, Dept Organ Chem, B-9000 Ghent, Belgium.
RP Schacht, E (reprint author), Univ Ghent, Dept Organ Chem, Krijgslaan 281 S4Bis, B-9000 Ghent, Belgium.
EM Etienne.Schacht@UGent.be
FU IWT [SBO-bioflex 04101]; Scientific Research FWO-Flanders [G.0534.05]
FX This work was supported by IWT (SBO-bioflex 04101) and Fund for
   Scientific Research FWO-Flanders (G.0534.05). The authors are indebted
   to Bjorn Vandecasteele for his technical assistance in the profilometry
   measurements. Jan Goeman from the Research Group of Organic and
   Bioorganic synthesis of the Faculty of Science is acknowledged for the
   single ion detection mass spectrometry.
CR AKINS RE, 1992, BIOTECHNIQUES, V12, P496
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   BHATTARCHARYA S, 2005, IEEE ASME J MICROELE, V14, P590
   Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195
   Chen YS, 2004, J APPL POLYM SCI, V93, P2014, DOI 10.1002/app.20663
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   Chun HJ, 1999, J APPL POLYM SCI, V72, P251, DOI 10.1002/(SICI)1097-4628(19990411)72:2<251::AID-APP10>3.0.CO;2-V
   COURLY AJ, 1994, Patent No. 5278200
   De Smet N, 2009, J BIOMAT SCI-POLYM E, V20, P2039, DOI 10.1163/156856208X397901
   Efimenko K, 2002, J COLLOID INTERF SCI, V254, P306, DOI 10.1006/jcis.202.8594
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   ITO Y, 1992, MACROMOLECULES, V25, P7313, DOI 10.1021/ma00052a037
   Karkhaneh A, 2007, J APPL POLYM SCI, V105, P2208, DOI 10.1002/app.26216
   Lee SD, 1996, J POLYM SCI POL CHEM, V34, P141, DOI 10.1002/(SICI)1099-0518(19960115)34:1<141::AID-POLA15>3.0.CO;2-L
   Morent R, 2007, J PHYS D APPL PHYS, V40, P7392, DOI 10.1088/0022-3727/40/23/021
   MORROW GRANT, 1954, CALIFORNIA MED, V80, P21
   Ruckert D, 1996, EUR POLYM J, V32, P201, DOI 10.1016/0014-3057(95)00136-0
   Schnyder B, 2003, SURF SCI, V532, P1067, DOI 10.1016/S0039-6028(03)00148-1
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   West SL, 2004, BIOMATERIALS, V25, P1195, DOI 10.1016/j.biomaterials.2003.08.010
   Yao C, 2008, J MEMBRANE SCI, V320, P259, DOI 10.1016/j.memsci.2008.04.012
   Yuan JA, 2004, COLLOID SURFACE B, V36, P27, DOI [10.1016/j.colsurfc.2004.03.017, 10.1016/j.colsurfb.2004.03.017]
NR 26
TC 1
Z9 1
U1 2
U2 24
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 18
BP 2457
EP 2473
DI 10.1163/092050610X540666
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 853KD
UT WOS:000297423800006
PM 21176391
DA 2018-10-20
ER

PT J
AU Ciucurel, EC
   Sefton, MV
AF Ciucurel, Ema C.
   Sefton, Michael V.
TI A Poloxamine-Polylysine Acrylate Scaffold for Modular Tissue Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Modular tissue engineering; poloxamine; polylysine; hydrogels;
   photo-cross-linkable scaffolds
ID ENDOTHELIAL-CELLS; POLY(ETHYLENE GLYCOL); MULTILAYER FILMS; HYDROGELS;
   ATTACHMENT; ADHESION; CHEMISTRY; POLYCATIONS; EXPRESSION; PEGYLATION
AB A new polymer, poloxamine-polylysine acrylate (PPA), was synthesized for tissue-engineering applications. Polylysine was used to confer endothelial cell attachment properties to the poloxamine-based polymer, while the acrylate groups made it photo-cross-linkable. The PPA polymer was synthesized in three reaction steps. (1) Polylysine was acrylated using N-hydroxysuccinimide acrylic acid ester and the reaction product was characterised by (1)H-NMR. (2) The hydroxyl groups on poloxamine were activated by tresylation with tresyl chloride and the reaction product (tresylated poloxamine) was characterised by ICP-AES for sulphur content. (3) The acrylated polylysine was reacted with the activated poloxamine to obtain the final product, poloxamine-polylysine acrylate. The final product was characterised by CHN elemental analysis. Aqueous solutions containing a mixture of PPA and poloxamine methacrylate were photo-cross-linked by exposure to a 365 nm UV light source in the presence of a photoinitiator to obtain hydrogels. The synthesized PPA polymer enhanced endothelial cell adhesion on poloxamine-based, photo-cross-linked hydrogel scaffolds. The same synthesis methods can be used in the future to introduce other desired functions (through other peptides) into the scaffold biomaterial. (C) Koninklijke Brill NV, Leiden, 2011
C1 [Ciucurel, Ema C.; Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM michael.sefton@utoronto.ca
FU Canadian Institutes of Health Research; National Institutes of Health
   [EB006903]; Natural Sciences and Engineering Research Council of Canada;
   Fonds Quebecois de la Recherche sur la Nature et les Technologies
FX The authors acknowledge the financial support of the Canadian Institutes
   of Health Research and the National Institutes of Health (EB006903). E.
   C. was supported by a Natural Sciences and Engineering Research Council
   of Canada Postgraduate Scholarship and a Fonds Quebecois de la Recherche
   sur la Nature et les Technologies Doctoral Research Scholarship. We also
   thank the Analytical Laboratory for Environmental Science Research and
   Training (ANALEST) at the University of Toronto for all the elemental
   analysis and ICP-AES services.
CR Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   BRINKLEY M, 1992, BIOCONJUGATE CHEM, V3, P2, DOI 10.1021/bc00013a001
   Bruynzeel I, 1997, ARCH DERMATOL RES, V289, P189, DOI 10.1007/s004030050179
   BUDD JS, 1989, BRIT J SURG, V76, P1259, DOI 10.1002/bjs.1800761212
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   D'Alessio P, 1998, FREE RADICAL BIO MED, V24, P979, DOI 10.1016/S0891-5849(97)00396-1
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   HERMAN S, 1995, J BIOACT COMPAT POL, V10, P145, DOI 10.1177/088391159501000205
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Jones DA, 1996, BIOMATERIALS, V17, P337, DOI 10.1016/0142-9612(96)85572-4
   Mcguigan AP, 2007, TISSUE ENG, V13, P1069, DOI 10.1089/ten.2006.0253
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   MORGAN DML, 1989, J CELL SCI, V94, P553
   MORGAN DML, 1988, J CELL SCI, V91, P231
   Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Sosnik A, 2005, TISSUE ENG, V11, P1807, DOI 10.1089/ten.2005.11.1807
   Sosnik A, 2006, BIOMACROMOLECULES, V7, P331, DOI 10.1021/bm050693h
   Sosnik A, 2005, J BIOMED MATER RES A, V75A, P295, DOI 10.1002/jbm.a.30419
   Sosnik A, 2005, BIOMATERIALS, V26, P7425, DOI 10.1016/j.biomaterials.2005.05.086
   Sperinde JJ, 1997, MACROMOLECULES, V30, P5255, DOI 10.1021/ma970345a
   Sperinde JJ, 1999, BIOCONJUGATE CHEM, V10, P213, DOI 10.1021/bc980070j
   Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X
   Willam C, 1999, AM J PHYSIOL-HEART C, V276, pH2044, DOI 10.1152/ajpheart.1999.276.6.H2044
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Ye Q, 2000, ASAIO J, V46, P730, DOI 10.1097/00002480-200011000-00014
NR 32
TC 6
Z9 6
U1 1
U2 20
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2011
VL 22
IS 18
BP 2515
EP 2528
DI 10.1163/092050610X541133
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 853KD
UT WOS:000297423800009
PM 21144169
DA 2018-10-20
ER

PT J
AU Khoda, AKMB
   Ozbolat, IT
   Koc, B
AF Khoda, A. K. M. B.
   Ozbolat, Ibrahim T.
   Koc, Bahattin
TI Engineered Tissue Scaffolds With Variational Porous Architecture
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE tissue engineering; scaffolds; porosity gradient; interconnected porous
   architecture; optimum deposition-path planning
ID SILK FIBROIN; IN-VITRO; FABRICATION; POROSITY; DESIGN; DEPOSITION;
   BIOMATERIALS; MATRICES
AB This paper presents a novel computer-aided modeling of 3D tissue scaffolds with a controlled internal architecture. The complex internal architecture of scaffolds is biomimetically modeled with controlled micro-architecture to satisfy different and sometimes conflicting functional requirements. A functionally gradient porosity function is used to vary the porosity of the designed scaffolds spatially to mimic the functionality of tissues or organs. The three-dimensional porous structures of the scaffold are geometrically partition into functionally uniform porosity regions with a novel offsetting operation technique described in this paper. After determining the functionally uniform porous regions, an optimized deposition-path planning is presented to generate the variational internal porosity architecture with enhanced control of interconnected channel networks and continuous filament deposition. The presented methods are implemented, and illustrative examples are presented in this paper. Moreover, a sample optimized tool path for each example is fabricated layer-by-layer using a micronozzle biomaterial deposition system. [DOI: 10.1115/1.4002933]
C1 [Khoda, A. K. M. B.; Ozbolat, Ibrahim T.; Koc, Bahattin] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
   [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
RP Khoda, AKMB (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bahattinkoc@sabanciuniv.edu
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   [Anonymous], 2008, MIMICS
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Gomez C., 2007, COMPUT AIDED DESIGN, V4, P649
   GOMEZ C, 2007, THESIS DREXEL U PENN
   Hollister SJ, 2007, COMPUT METHOD APPL M, V196, P2991, DOI 10.1016/j.cma.2006.09.023
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2007, THESIS U TEXAS AUSTI
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   Koc B, 2002, COMPUT IND, V47, P1, DOI 10.1016/S0166-3615(01)00141-5
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Mardle S, 1999, COMPUTERS HIGHER ED, V13, P16
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ng KW, 2006, BIOMATERIALS, V27, P4591, DOI 10.1016/j.biomaterials.2006.04.020
   Ozbolat I. T., 2009, COMPUT AIDED DESIGN, V6, P661
   PALSSON BO, 2003, TISSUE ENG
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Park S, 2009, J MATER SCI-MATER M, V20, P229, DOI 10.1007/s10856-008-3573-4
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shin H, 2003, LECT NOTES COMPUT SC, V2669, P711
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Sogutlu S., 2007, COMPUT AIDED DESIGN, V4, P661
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525
   Wettergreen MA, 2005, ANN BIOMED ENG, V33, P1333, DOI 10.1007/s10439-005-6744-1
   Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005
   Zhang JC, 2005, POLYMER, V46, P4979, DOI 10.1016/j.polymer.20058.02.120
NR 35
TC 43
Z9 43
U1 1
U2 19
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JAN
PY 2011
VL 133
IS 1
AR 011001
DI 10.1115/1.4002933
PG 12
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 700TQ
UT WOS:000285767600001
PM 21186891
DA 2018-10-20
ER

PT J
AU Behan, BL
   DeWitt, DG
   Bogdanowicz, DR
   Koppes, AN
   Bale, SS
   Thompson, DM
AF Behan, Brenda L.
   DeWitt, Daniel G.
   Bogdanowicz, Danielle R.
   Koppes, Abigail N.
   Bale, Shyam S.
   Thompson, Deanna M.
TI Single-walled carbon nanotubes alter Schwann cell behavior
   differentially within 2D and 3D environments
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE single-walled carbon nanotubes; nanoparticle cytotoxicity; hydrogel;
   Schwann cells; neural engineering
ID PERIPHERAL-NERVE REGENERATION; RAT SPINAL-CORD; A549 LUNG-CELLS;
   IN-VITRO; NEURITE OUTGROWTH; CYTOTOXICITY; REPAIR; EXPOSURE;
   NANOMATERIALS; KERATINOCYTES
AB Both spinal cord injury (SCI) and large-gap peripheral nerve defects can be debilitating affecting a patient's long-term quality of life and presently, there is no suitable treatment for functional regeneration of these injured tissues. A number of works have suggested the benefits of electrical stimulation to promote both glial migration and neuronal extension. In this work, an electrically conductive hydrogel containing single-walled carbon nanotubes (SWCNT) for neural engineering applications is presented and the Schwann cell (SC) response to SWCNT is examined in both 2D and 3D microenvironments. Results from clonogenic and alamarBlue (R) assays in 2D indicate that SWCNT (10-50 mu g mL(-1)) inhibit SC proliferation but do not affect cell viability. Following SWCNT exposure in 2D, changes in SC morphology can be observed with the nanomaterial attached to the cell membrane at concentrations as low as 10 mu g mL(-1). In contrast to the results gathered in 2D, SC embedded within the 3D hydrogel loaded with 10-50 mu g mL(-1) of SWCNT exhibited little or no measurable change in cell proliferation, viability, or morphology as assessed using a digestion assay, alamarBlue, and confocal microscopy. Collectively, this highlights that an electrically-conductive SWCNT collagen I-Matrigel (TM) biomaterial may be suitable for neural tissue engineering and is able to sustain populations of SC. Findings suggest that 2D nanoparticle toxicity assays may not be accurate predictors of the 3D response, further motivating the examination of these materials in a more physiologically relevant environment. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 46-57, 2011.
C1 [Behan, Brenda L.; DeWitt, Daniel G.; Bogdanowicz, Danielle R.; Koppes, Abigail N.; Thompson, Deanna M.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [DeWitt, Daniel G.; Koppes, Abigail N.; Bale, Shyam S.; Thompson, Deanna M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
   [Bale, Shyam S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA.
RP Thompson, DM (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM thompd4@rpi.edu
OI Koppes, Abigail/0000-0003-0433-9290
FU Nanoscale Science and Engineering Initiative of the National Science
   Foundation (NSF) [DMR-0642573]; IDEA [J50480]
FX Contract grant sponsor: Nanoscale Science and Engineering Initiative of
   the National Science Foundation (NSF); contract grant number:
   DMR-0642573; Contract grant sponsor: New York State Spinal Cord Injury
   Research Program IDEA; contract grant number: J50480
CR Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X
   Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406
   Belkas JS, 2004, OPER TECH ORTHOP, V14, P190
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   BORGENS RB, 1994, EXP NEUROL, V128, P41, DOI 10.1006/exnr.1994.1111
   Casey A, 2008, TOXICOL LETT, V179, P78, DOI 10.1016/j.toxlet.2008.04.006
   Casey A, 2007, CARBON, V45, P1425, DOI 10.1016/j.carbon.2007.03.033
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Funk D, 2007, EUR J CELL BIOL, V86, P207, DOI 10.1016/j.ejcb.2006.12.006
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3
   Herzog E, 2007, TOXICOL LETT, V174, P49, DOI 10.1016/j.toxlet.2007.08.009
   Homenick CM, 2010, J MATER CHEM, V20, P2887, DOI 10.1039/b925799c
   Hussain MA, 2009, CURR SCI INDIA, V96, P664
   *INV CORP, ALAMARBLUE ASS INF P
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   KHAN Y, 2002, RESONANCE, V7, P8
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   LEE J, 2009, ADV FUNCT MATER, V18, P23
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   Natsuki T, 2004, CARBON, V42, P2147, DOI 10.1016/j.carbon.2004.04.022
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Rosner BI, 2005, EXP NEUROL, V195, P81, DOI 10.1016/j.expneurol.2005.04.003
   Shapiro S, 2005, J NEUROSURG-SPINE, V2, P1
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Takami T, 2002, J NEUROSCI, V22, P6670
   Thompson DM, 2004, ANN BIOMED ENG, V32, P1120
   Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030
   *UN, UN PROD DESCR HIPCO
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Witzmann FA, 2006, NANOMED-NANOTECHNOL, V2, P158, DOI 10.1016/j.nano.2006.07.005
   Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
NR 53
TC 35
Z9 35
U1 3
U2 48
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 46
EP 57
DI 10.1002/jbm.a.32939
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400006
PM 20949573
DA 2018-10-20
ER

PT J
AU Beuvelot, J
   Pascaretti-Grizon, F
   Filmon, R
   Moreau, MF
   Basle, MF
   Chappard, D
AF Beuvelot, Johanne
   Pascaretti-Grizon, Florence
   Filmon, Robert
   Moreau, Marie-Fracoise
   Basle, Michel F.
   Chappard, Daniel
TI In vitro assessment of osteoblast and macrophage mobility in presence of
   beta-TCP particles by videomicroscopy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE beta-TCP; cell mobility; videomicroscopy; osteoblast; macrophage
ID BONE-GRAFT SUBSTITUTES; SINUS FLOOR AUGMENTATION; MESENCHYMAL
   STEM-CELLS; TRICALCIUM PHOSPHATE; CALCIUM-PHOSPHATE; OSTEOGENIC
   DIFFERENTIATION; VOID FILLER; GROWTH; POROSITY; TISSUE
AB beta-TCP is widely used to repair bone defects due to its good biocompatibility, macroporosity (favoring bone ingrowth) and bioresorbability. However, cell interactions with the biomaterial at the first times of implantation remain largely unknown. We have observed cell behaviors in direct contact with beta-TCP particles using long-term culture under videomicroscopy. Osteoblastlike cells (SaOs-2) and macrophages (J774.2 and mouse peritoneal macrophages) were cultured in the presence of beta-TCP particles. For each experiment, images from 20 independent fields were acquired and stored every 15 min during 8 days. At the end of the culture, they were combined to generate time lapse videos; coverslips were fixed and observed by scanning electron microscopy (SEM). SaOs-2 proliferation was determined by counting cells on six different and independent fields at days 1, 3, and 6. Videos showed the capacity of cells to displace the particles. Dynamic follow-up showed active proliferation of SaOs-2 occurring in the direction of the particles. J774.2 and peritoneal macrophages did not proliferate but came in direct contact with the particles and actively eroded them. SEM showed that cells were stretched and fixed onto the surface and seemed to climb from the coverslip to the particles. The long-term culture under videomicroscopy allowed a better understanding of the colonization process of beta-TCP particles by osteoblastlike cells and macrophages. Data obtained from long-term videomicroscopy are in agreement with in vivo observations confirming the interest of beta-TCP to promote osteogenesis. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 108-115, 2011.
C1 [Beuvelot, Johanne; Pascaretti-Grizon, Florence; Filmon, Robert; Moreau, Marie-Fracoise; Basle, Michel F.; Chappard, Daniel] INSERM, Fac Med, LHEA, U922, F-49045 Angers, France.
RP Chappard, D (reprint author), INSERM, Fac Med, LHEA, U922, F-49045 Angers, France.
EM daniel.chappard@univ-angers.fr
FU Contrat de Plan Etat-Region; INSERM
FX Contract grant sponsors: Contrat de Plan Etat-Region "Pays de la Loire"
   in the Bioregos 2 program, INSERM
CR Albee FH, 1920, ANN SURG, V71, P32
   Aybar B, 2004, CLIN ORAL IMPLAN RES, V15, P119, DOI 10.1111/j.1600-0501.2004.01002.x
   Beuvelot J, 2009, J BIOMED MATER RES B, V90B, P873, DOI 10.1002/jbm.b.31357
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   Coelho PG, 2009, MAT SCI ENG C-MATER, V29, P2085, DOI 10.1016/j.msec.2009.04.013
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Dallas SL, 2009, CELLS TISSUES ORGANS, V189, P6, DOI 10.1159/000151745
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   ERIKSEN EF, 1990, J BONE MINER RES, V5, P311, DOI 10.1002/jbmr.5650050402
   Espinosa L, 2002, J CELL SCI, V115, P3837, DOI 10.1242/jcs.00062
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Filmon R, 2009, IMAGE ANAL STEREOL, V28, P1
   FROST HM, 1989, CALCIFIED TISSUE INT, V45, P131, DOI 10.1007/BF02556053
   Ghosh SK, 2008, J BIOMED MATER RES B, V86B, P217, DOI 10.1002/jbm.b.31009
   Gunzburg R, 2002, ORTHOPEDICS, V25, pS591
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Hinz P, 2002, ORTHOPEDICS, V25, pS597
   [侯喜君 Hou Xijun], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P9627
   Inoue M, 2004, J BIOMED MATER RES A, V70A, P585, DOI 10.1002/jbm.a.30116
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   John A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015007
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Klein MO, 2007, CLIN ORAL IMPLAN RES, V18, P40, DOI 10.1111/j.1600-0501.2006.01279.x
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Kralova V, 2009, TOXICOL IN VITRO, V23, P1497, DOI 10.1016/j.tiv.2009.07.012
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Mabilleau G, 2004, BIOMATERIALS, V25, P5155, DOI 10.1016/j.biomaterials.2003.12.026
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Meeder P J, 1994, Injury, V25 Suppl 1, pA2
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nyangoga H, 2010, ACTA BIOMATER, V6, P3310, DOI 10.1016/j.actbio.2010.01.042
   Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   RATZAN KR, 1972, INFECT IMMUN, V5, P499
   Saito M, 2000, J Orthop Sci, V5, P275, DOI 10.1007/s007760050163
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Sivakumar P, 2006, J CELL SCI, V119, P1350, DOI 10.1242/jcs.02830
   Takeuchi H, 2009, DENT MATER J, V28, P595, DOI 10.4012/dmj.28.595
   Tanaka T, 2008, J BIOMED MATER RES B, V86B, P453, DOI 10.1002/jbm.b.31041
   Tao J, 2009, CELLS TISSUES ORGANS, V190, P185, DOI 10.1159/000218139
   VESELY P, 1992, J ANAT, V181, P277
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 48
TC 5
Z9 6
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 108
EP 115
DI 10.1002/jbm.a.32959
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400013
PM 21105158
DA 2018-10-20
ER

PT J
AU Szott, LM
   Stein, MJ
   Ratner, BD
   Horbett, TA
AF Szott, Luisa Mayorga
   Stein, M. Jeanette
   Ratner, Buddy D.
   Horbett, Thomas A.
TI Complement activation on poly(ethylene oxide)-like radiofrequency glow
   discharge-deposited surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE complement activation; foreign body response; poly(ethylene oxide);
   protein adsorption; biocompatibility
ID SELF-ASSEMBLED MONOLAYERS; BIOMATERIAL SURFACES; ALTERNATIVE PATHWAY;
   PLASMON RESONANCE; GOLD SURFACES; PROTEINS; FIBRINOGEN; ADHESION;
   DERIVATIZATION; INFLAMMATION
AB Nonspecific protein adsorption, particularly fibrinogen (Fg), is thought to be an initiating step in the foreign body response (FBR) to biomaterials by promoting phagocyte attachment. In previous studies, we therefore prepared radiofrequency glow discharge (ethylene oxide)-like tetraglyme (CH(3)O(CH(2)CH(2)O)(4)CH(3)) coatings adsorbing <10 ng/cm(2) Fg and showed that they had the expected low monocyte adhesion in vitro. However, when these were implanted in vivo, many adherent inflammatory cells and a fibrous capsule were found, suggesting the role of alternative proteins, such as activated complement proteins, in the FBR to these materials. We therefore investigated complement interactions with the tetraglyme surfaces. First, because of its well-known role in complement C3 activation, we measured the hydroxyl group (-OH) content of tetraglyme, but found it to be low. Second, we measured C3 adsorption to tetraglyme from plasma. Low amounts of C3 adsorbed on tetraglyme, although it displayed higher binding strength than the control surfaces. Finally, complement activation was determined by measuring C3a and SC5b-9 levels in serum after incubating with tetraglyme, as well as other surfaces that served as positive and negative controls, namely poly(vinyl alcohol) (PVA) hydrogels, Silastic sheeting, and poly(ethylene glycol) self-assembled monolayers with different end groups. Despite displaying low hydroxyl group concentration, relatively high C3a and SC5b-9 levels were found in serum exposed to tetraglyme, similar to the values in our positive control, PVA. Our results support the conclusion that complement activation by tetraglyme is a possible mechanism involved in the FBR to these biomaterials. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 150-161, 2011.
C1 [Szott, Luisa Mayorga; Stein, M. Jeanette; Ratner, Buddy D.; Horbett, Thomas A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Ratner, Buddy D.; Horbett, Thomas A.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Horbett, TA (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM thomas.horbett@gmail.com
FU NSF [UWEB EEC9529161]; NIH [T32 GM065098]; NESAC/BIO [NIH 5P41 EB002027]
FX Contract grant sponsor: NSF; contract grant number: UWEB EEC9529161;
   Contract grant sponsor: NIH; contract grant number: T32 GM065098;
   Contract grant sponsor: NESAC/BIO; contract grant number: NIH 5P41
   EB002027
CR Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Baron S., 1996, MED MICROBIOLOGY
   Batniji Rami K, 2002, Arch Facial Plast Surg, V4, P111, DOI 10.1001/archfaci.4.2.111
   BERGER M, 1994, J MATER SCI-MATER M, V5, P622, DOI 10.1007/BF00120343
   Black JP, 2000, BIOMATERIALS, V21, P2287, DOI 10.1016/S0142-9612(00)00155-1
   Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w
   CHILKOTI A, 1991, CHEM MATER, V3, P51, DOI 10.1021/cm00013a016
   CHILKOTI A, 1991, SURF INTERFACE ANAL, V17, P567, DOI 10.1002/sia.740170805
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   GRAHAM DJ, 2001, THESIS U WASHINGTON, P327
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Hirata I, 2000, COLLOID SURFACE B, V18, P285, DOI 10.1016/S0927-7765(99)00154-X
   HORBETT TA, HYDROGELS MED PHARM, V1, P127
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jang HS, 2006, COLLOID SURFACE B, V50, P141, DOI 10.1016/j.colsurfb.2006.03.024
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Johnston EE, 2005, LANGMUIR, V21, P870, DOI 10.1021/la036274s
   Kuby J., 1997, IMMUNOLOGY
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Lee CY, 2006, BIOINTERPHASES, V1, P82, DOI 10.1116/1.2219110
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   MAYORGA LE, 2008, THESIS U WASHINGTON
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   PAN S, 1997, MAT SCI ENG C, V7, P51
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   Peracchia MT, 1997, LIFE SCI, V61, P749, DOI 10.1016/S0024-3205(97)00539-0
   Rabb H, 2002, AM J KIDNEY DIS, V39, P587, DOI 10.1053/ajkd.2002.31416
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   SHEN M, 2001, THESIS U WASHINGTON
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Szott LM, 2010, J BIOMED MATER RES A, V95A, P1252, DOI 10.1002/jbm.a.32944
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   Walker HK, 1990, CLIN METHODS HIST PH
   Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h
NR 41
TC 18
Z9 19
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 150
EP 161
DI 10.1002/jbm.a.32954
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400018
PM 21105163
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Collie, AMB
   Bota, PCS
   Johns, RE
   Maier, RV
   Stayton, PS
AF Collie, Angela M. B.
   Bota, Paige C. S.
   Johns, Rachel E.
   Maier, Ronald V.
   Stayton, Patrick S.
TI Differential monocyte/macrophage interleukin-1 beta production due to
   biomaterial topography requires the beta 2 integrin signaling pathway
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE monocyte; macrophage; biomaterial; topography; integrin
ID GIANT-CELL FORMATION; TITANIUM SURFACE-TOPOGRAPHY; PRIMARY HUMAN
   MONOCYTES; KAPPA-B ACTIVATION; SELECTIVE-INHIBITION; IN-VITRO;
   MACROPHAGES; RECEPTOR; ADHESION; EXPRESSION
AB Monocytes/macrophages are crucial mediators of the host response to biomaterials, and their level of activation can be directly affected by material characteristics. Previous work has demonstrated that primary human monocytes cultured on polytetrafluoroethylene materials of varying topography but identical surface chemistry are differentially affected. Monocytes/macrophages on biaxially-expanded polytetrafluoroethylene with an average intranodal distance of 4.4 mu m (4.4-ePTFE) produced higher levels of the inflammatory cytokine interleukin-1 beta (IL-1 beta) compared with monocytes/macrophages on nonporous polytetrafluoroethylene (np-PTFE). The current study provides a mechanistic understanding of this response. Scanning electron microscopy revealed that monocytes/macrophages cultured on np-PTFE were more spread than those on 4.4-ePTFE. In addition, the actin cytoskeleton and intact beta 2 integrin receptors were necessary for IL-1 beta production by monocytes/macrophages on 4.4-ePTFE. This IL-1 beta production also required the transcription factor nuclear factor kappa-B, another component of the beta 2 integrin signaling pathway, although it may not be the primary transcription factor involved. These studies demonstrate the importance of several beta 2 integrin signaling components to the monocyte/macrophage response to biomaterial topography. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 162-169, 2011.
C1 [Collie, Angela M. B.; Bota, Paige C. S.; Johns, Rachel E.; Stayton, Patrick S.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98104 USA.
RP Collie, AMB (reprint author), Cleveland Clin, Pathol & Lab Med Inst, Mail Code L25,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM bookwaam@hotmail.com
FU Whitaker Foundation; Medical Scientist Training Program [NIH GM07266];
   NSF UWEB ERC [EEC 9529161]; Engineered Biomaterials Training Program
   [NIH GM065098]
FX Contract grant sponsor: Whitaker Foundation (to P.C.S.B); Contract grant
   sponsor: Medical Scientist Training Program; contract grant number: NIH
   GM07266 (to A.M.B.C.); Contract grant sponsor: Engineered Biomaterials
   Training Program; contract grant number: NIH GM065098 (to A.M.B.C.);
   Contract grant sponsor: NSF UWEB ERC; contract grant number: EEC 9529161
CR Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   CARLOS TM, 1994, BLOOD, V84, P2068
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x
   DeNichilo MO, 1996, J BIOL CHEM, V271, P11016, DOI 10.1074/jbc.271.18.11016
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Grainger DW, 2003, J BIOMAT SCI-POLYM E, V14, P973, DOI 10.1163/156856203322381456
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054
   KATZ DA, 1995, SURGERY, V118, P154, DOI 10.1016/S0039-6060(05)80318-6
   Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652
   May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rezzonico R, 2000, BLOOD, V95, P3868
   Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Schuler P, 2003, CELL COMMUN ADHES, V10, P17, DOI 10.1080/15419060390220440
   Shi C, 2001, CIRC RES, V89, P859, DOI 10.1161/hh2201.099166
   Sitrin RG, 1998, J IMMUNOL, V161, P1462
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   YAHARA I, 1982, J CELL BIOL, V92, P69, DOI 10.1083/jcb.92.1.69
NR 38
TC 17
Z9 18
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 162
EP 169
DI 10.1002/jbm.a.32963
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400019
PM 21105164
DA 2018-10-20
ER

PT J
AU Kou, PM
   Babensee, JE
AF Kou, Peng Meng
   Babensee, Julia E.
TI Macrophage and dendritic cell phenotypic diversity in the context of
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE macrophages; dendritic cells; biomaterials
ID TOLL-LIKE RECEPTORS; FOREIGN-BODY RESPONSE; REGULATORY T-CELLS;
   ALTERNATIVELY ACTIVATED MACROPHAGES; SELF-ASSEMBLED MONOLAYERS;
   ANTIGEN-PRESENTING CELLS; INNATE IMMUNE-RESPONSES; HOST TISSUE
   RESPONSES; NECROSIS-FACTOR-ALPHA; IN-VIVO
AB Macrophages (W Phi)) and dendritic cells (DCs) are critical antigen presenting cells that play pivotal roles in host responses to biomaterial implants. Although M Phi s have been widely studied for their roles in the inflammatory responses against biomaterials, the roles that DCs play in the host responses toward implanted materials have only recently been explored. DCs are of significant research interest because of the emergence of a large number of combination products that cross-traditional medical device boundaries. These products combine biomaterials with biologics, including cells, nucleic acids, and/or proteins. The biomaterial component may evoke an inflammatory response, primarily mediated by neutrophils and M Phi s, whereas the biologic component may elicit an immunogenic immune response, initiated by DCs involving lymphocyte activation. Control of M Phi phenotypic balance from proinflammatory M1 to reparative M2 is a goal of investigators to optimize the host response to biomaterials. Similarly, control of DC phenotype from proinflammatory to toleragenic is of interest in vaccine delivery and tissue engineering/transplantation situations, respectively. This review discusses the interconnection between innate and adaptive immunity, the comparative and contrasting phenotypes and roles of M Phi s and DCs in immunity, their responses to biomaterials and the strategies to modulate their phenotype for applications in tissue engineering and vaccine delivery. Furthermore, the collaboration between and unique roles of DCs and M Phi s needs to be addressed in future studies to gain a more complete picture of host responses toward combination products. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 239-260, 2011.
C1 [Kou, Peng Meng; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Babensee, Julia E.] Emory Univ, Atlanta, GA 30332 USA.
   [Kou, Peng Meng; Babensee, Julia E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   ALBINA JE, 1995, J IMMUNOL, V155, P4391
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3
   Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x
   Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bajtay Z, 2006, IMMUNOL LETT, V104, P46, DOI 10.1016/j.imlet.2005.11.023
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Barchet W, 2005, SEMIN IMMUNOL, V17, P253, DOI 10.1016/j.smim.2005.05.008
   BECKER S, 1987, J IMMUNOL, V139, P3703
   Benencia F, 1999, IMMUNOLOGY, V98, P363
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005
   Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772
   Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J
   Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Brown KA, 1997, CLIN EXP IMMUNOL, V107, P601, DOI 10.1046/j.1365-2249.1997.d01-951.x
   Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007
   Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163
   Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046
   Chang DT, 2009, CELL MOL BIOENG, V2, P573, DOI 10.1007/s12195-009-0088-0
   Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763
   Cravens PD, 2002, IMMUNOL CELL BIOL, V80, P497, DOI 10.1046/j.1440-1711.2002.01118.x
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DEVITA VT, 2008, CANC PRINCIPLES PRAC, P3200
   Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240
   Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037
   Eckhardt A, 2009, BIOMATERIALS, V30, P1665, DOI 10.1016/j.biomaterials.2008.09.024
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8
   Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184
   ESSNER R, 1989, J IMMUNOL, V142, P3857
   EZEKOWITZ RAB, 1984, CONTEMP TOP IMMUNOBI, V13, P33
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729
   Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6
   Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558
   Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784
   Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331
   Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   HARDING CV, 1994, J IMMUNOL, V153, P4925
   Harris HE, 2006, EMBO REP, V7, P774, DOI 10.1038/sj.embor.7400759
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36
   Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829
   Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001
   Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200
   Ichiyasu H, 2004, AM J RESP CELL MOL, V30, P761, DOI 10.1165/rcmb.2003-0370OC
   Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086
   Janeway CA, 1999, CURR BIOL, V9, pR342, DOI 10.1016/S0960-9822(99)80209-7
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   JANEWAY CA, 2004, IMMUNOBIOLOGY THE IM
   Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Jones JA, 2008, J BIOMED MATER RES A, V86A, P261, DOI 10.1002/jbm.a.31660
   Joyce DA, 1996, CYTOKINE, V8, P49, DOI 10.1006/cyto.1996.0007
   Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   KATO K, 1989, MED MICROBIOL IMMUN, V178, P337
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kindt TJ, 2007, KUBY IMMUNOLOGY
   Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0
   Kou PM, 2010, ACTA BIOMATER, V6, P2621, DOI 10.1016/j.actbio.2010.01.023
   KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942
   Kwissa M, 2007, EXPERT REV VACCINES, V6, P673, DOI 10.1586/14760584.6.5.673
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lan YY, 2006, J IMMUNOL, V177, P5868, DOI 10.4049/jimmunol.177.9.5868
   Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x
   Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013
   Li H, 2006, EMBO J, V25, P4097, DOI 10.1038/sj.emboj.7601289
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Ludewig B, 1998, J VIROL, V72, P3812
   MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097
   MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   Mahnke K, 1996, J LEUKOCYTE BIOL, V60, P465
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X
   Mariani TJ, 1998, MOL BIOL CELL, V9, P1411, DOI 10.1091/mbc.9.6.1411
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5
   Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526
   Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8
   MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Muller G, 2002, J INVEST DERMATOL, V119, P836, DOI 10.1046/j.1523-1747.2002.00496.x
   MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443
   Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954
   Murthy N, 2003, BIOCONJUGATE CHEM, V14, P412, DOI 10.1021/bc020056d
   Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522
   Norton LW, 2010, J CONTROL RELEASE, V146, P341, DOI 10.1016/j.jconrel.2010.05.032
   NORTON LW, 2009, INNATE ADAPTIVE IMMU
   Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8
   Pannetier D, 2004, J VIROL, V78, P10516, DOI 10.1128/JVI.78.19.10516-10524.2004
   PARK J, CONTROL DENDRI UNPUB
   PARK J, BIOMATERIAL DE UNPUB
   Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071
   Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165
   Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060
   Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x
   Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   REID KBM, 1981, ANNU REV BIOCHEM, V50, P433, DOI 10.1146/annurev.bi.50.070181.002245
   Reis ES, 2008, MOL IMMUNOL, V45, P1952, DOI 10.1016/j.molimm.2007.10.031
   Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010
   Reis ES, 2006, INFLAMM RES, V55, P179, DOI 10.1007/s00011-006-0068-y
   Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x
   Riboldi E, 2005, J IMMUNOL, V175, P2788, DOI 10.4049/jimmunol.175.5.2788
   Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Roos A, 2004, EUR J IMMUNOL, V34, P921, DOI 10.1002/eji.200424904
   Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567
   Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122
   Schakel K, 2002, IMMUNITY, V17, P289, DOI 10.1016/S1074-7613(02)00393-X
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1487, DOI 10.1002/jbm.a.32487
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Shen H, 2003, J CONTROL RELEASE, V86, P339, DOI 10.1016/S0168-3659(02)00354-1
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821
   Shi ZC, 2009, J BIOL CHEM, V284, P20540, DOI 10.1074/jbc.M109.022541
   Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746
   Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720
   SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672
   Sodhi A, 2002, J INTERF CYTOK RES, V22, P517, DOI 10.1089/10799900252981990
   Stacey KJ, 2000, CURR TOP MICROBIOL, V247, P41
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   STEINMAN RM, 2006, DENDRITIC CELLS TRAN, P17
   Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Thacker RI, 2008, EXP MOL PATHOL, V84, P122, DOI 10.1016/j.yexmp.2008.01.001
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Tosi MF, 2005, J ALLERGY CLIN IMMUN, V116, P241, DOI 10.1016/j.jaci.2005.05.036
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Underhill DM, 2003, EUR J IMMUNOL, V33, P1767, DOI 10.1002/eji.200324037
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276
   Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Volkmann A, 1997, J IMMUNOL, V158, P693
   Wang X, 2008, J MED VIROL, V80, P11, DOI 10.1002/jmv.21029
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   Werling D, 2004, IMMUNOLOGY, V111, P41, DOI [10.1111/j.1365-2567.2004.01781.x, 10.1046/j.1365-2567.2003.01781.x]
   West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831
   Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2007, J BIOMED MATER RES A, V80A, P7, DOI 10.1002/jbm.a.30832
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089
   Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130
   Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588
   Zingarelli B, 1996, J IMMUNOL, V156, P350
   Zugates GT, 2005, ISRAEL J CHEM, V45, P477, DOI 10.1560/7C67-5X19-PEJ8-PXUN
NR 240
TC 95
Z9 99
U1 3
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2011
VL 96A
IS 1
BP 239
EP 260
DI 10.1002/jbm.a.32971
PG 22
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 690WX
UT WOS:000285041400028
PM 21105173
DA 2018-10-20
ER

PT J
AU Wang, YB
   Zheng, YF
   Wei, SC
   Li, M
AF Wang, Y. B.
   Zheng, Y. F.
   Wei, S. C.
   Li, M.
TI In vitro study on Zr-based bulk metallic glasses as potential
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Zr-based bulk metallic glasses; in vitro biocompatibility; corrosion
   resistance; electrochemical measurements; cytotoxicity
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ZR65AL7.5NI10CU17.5 AMORPHOUS
   ALLOY; PHOSPHATE-BUFFERED SOLUTION; CORROSION BEHAVIOR; POLARIZATION
   BEHAVIOR; MECHANICAL-PROPERTIES; ANODIC-POLARIZATION; TI-6AL-7NB ALLOY;
   STAINLESS-STEEL; HANKS-SOLUTION
AB With pure Ti and pure Zr as controls, the corrosion resistance, ion release behavior, and in vitro biocompatibility of Be-containing Zr(41)Ti(14)Cu(12)Ni(10)Be(23) bulk metallic glass (BMG) (LM1), Zr(44)Ti(11)Cu(10)Ni(10)Be(25) BMG (LM1b), and Be-free Zr(57)Nb(5)Cu(15.4)Ni(12.6)Al(10) BMG (LM106) were investigated in terms of electrochemical measurements in simulated body fluid (SBF) with pH value 7.4 and artificial saliva (AS) with pH value 6.3, and 3-[4,4-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay using L929 and NIH3T3 cells, aiming to assess the feasibility of Zr-based BMGs as potential biomaterial. It was found that LM1b showed superior corrosion resistance to LM106 and LM1 in both SBF and AS, and comparable with pure Ti and pure Zr. After 7200 s immersion, a two-layer structure oxide film was formed on LM1, LM1b, and pure Zr surfaces, while one-layer structure oxide film was formed on LM106 and pure Ti surfaces. The pitting corrosion potentials of LM1b were much higher than that of LM1, LM106, and pure Zr, resulting in very few ions releasing into the electrolytes. No Be ion could be detected but a little amount of Cu ion was detected for LM106, LM1, and LM1b after immersion in Dulbecco's modified Eagle's medium for 72 h at 37 degrees C. The indirect cytotoxicity results show that LM106, LM1, and LM1b extracts had no cytotoxicity to L929 and NIH3T3 cells. The direct cytotoxicity results show that cells could adhere well on the Zr-based BMG surface as in pure Ti and Zr. Lower cell proliferation rate of LM106 and LM1 is observed when compared with LM1b, which was found to be caused by Cu ion releasing rather than by Be ion. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 34-46,2011.
C1 [Wang, Y. B.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Wang, Y. B.; Zheng, Y. F.; Wei, S. C.] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Wei, S. C.] Peking Univ, Sch Stomatol, Beijing 100081, Peoples R China.
   [Wei, S. C.] Peking Univ, Hosp Stomatol, Beijing 100081, Peoples R China.
   [Li, M.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Wang, Yanbo/E-8046-2010; BAI, JIE/D-7448-2016
OI Zheng, Yufeng/0000-0002-7402-9979; Wang, Yanbo/0000-0002-3184-4201; 
FU National Natural Science Foundation of China [30770580]; National Key
   Scientific Program-Nanoscience and Nanotechnology [2007CB936103];
   Program for New Century Excellent Talents in University [NCET-07-0033]
FX Contract grant sponsor: The National Natural Science Foundation of
   China; contract grant number: 30770580; Contract grant sponsor: The
   National Key Scientific Program-Nanoscience and Nanotechnology; contract
   grant number: 2007CB936103; Contract grant sponsor: Program for New
   Century Excellent Talents in University; contract grant number:
   NCET-07-0033
CR Bai L, 2008, J NON-CRYST SOLIDS, V354, P3935, DOI 10.1016/j.jnoncrysol.2008.05.015
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   Colic M, 2009, ACTA BIOMATER, V6, P308
   Colic M, 2010, J BIOMATER APPL, V25, P269, DOI 10.1177/0885328209354613
   Cortizo MC, 2004, BIOL TRACE ELEM RES, V102, P129, DOI 10.1385/BTER:102:1-3:129
   Garcia-Alonso MC, 2003, BIOMATERIALS, V24, P19, DOI 10.1016/S0142-9612(02)00237-5
   Green BA, 2008, CORROS SCI, V50, P1825, DOI 10.1016/j.corsci.2008.03.011
   Hayami T, 2007, MATER LETT, V61, P2667, DOI 10.1016/j.matlet.2006.10.019
   Hiromoto S, 2000, CORROS SCI, V42, P1651, DOI 10.1016/S0010-938X(00)00022-6
   Hiromoto S, 2002, ELECTROCHIM ACTA, V47, P1343, DOI 10.1016/S0013-4686(01)00876-3
   Hiromoto S, 2000, CORROS SCI, V42, P2193, DOI 10.1016/S0010-938X(00)00056-1
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Inoue A, 1997, MAT SCI ENG A-STRUCT, V226, P401, DOI 10.1016/S0921-5093(97)80051-2
   Jiang WH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2762282
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lavos-Valereto C, 2002, J BIOMED MATER RES, V63, P664, DOI 10.1002/jbm.10351
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Lewis G, 2007, BIO-MED MATER ENG, V17, P97
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2007, MAT SCI ENG A-STRUCT, V449, P193, DOI 10.1016/j.msea.2006.02.255
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Mockers O, 2002, DENT MATER, V18, P311, DOI 10.1016/S0109-5641(01)00055-0
   Morrison ML, 2007, J NON-CRYST SOLIDS, V353, P2115, DOI 10.1016/j.jnoncrysol.2007.03.012
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Morrison ML, 2004, INTERMETALLICS, V12, P1177, DOI 10.1016/j.intermet.2004.04.005
   Oak JJ, 2007, MAT SCI ENG A-STRUCT, V449, P220, DOI 10.1016/j.msea.2006.02.307
   Oak JJ, 2009, MAT SCI ENG C-BIO S, V29, P322, DOI 10.1016/j.msec.2008.07.009
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PEKER A, 1993, APPL PHYS LETT, V63, P2342, DOI 10.1063/1.110520
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   Rondelli G, 2006, J BIOMED MATER RES B, V79B, P320, DOI 10.1002/jbm.b.30545
   Salimon AI, 2004, MAT SCI ENG A-STRUCT, V375, P385, DOI 10.1016/j.msea.2003.10.167
   Schroeder V, 1998, SCRIPTA MATER, V38, P1481, DOI 10.1016/S1359-6462(98)00089-X
   Scully JR, 2007, J MATER RES, V22, P302, DOI 10.1557/JMR.2007.0051
   Sharma SK, 2008, J MATER SCI, V43, P5495, DOI 10.1007/s10853-008-2834-4
   Shim HM, 2005, J BIOMED MATER RES B, V73B, P252, DOI 10.1002/jbm.b.30206
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Telford M, 2004, MATER TODAY, V7, P36, DOI 10.1016/S1369-7021(04)00124-5
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   WONG D, 1988, YALE J BIOL MED, V61, P1
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   ZELIKOFF JT, 1986, CELL BIOL TOXICOL, V2, P369, DOI 10.1007/BF00121852
   Zhai QW, 2000, J CELL PHYSIOL, V184, P161, DOI 10.1002/1097-4652(200008)184:2<161::AID-JCP3>3.3.CO;2-E
NR 48
TC 33
Z9 33
U1 1
U2 36
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 34
EP 46
DI 10.1002/jbm.b.31725
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500005
PM 21061358
DA 2018-10-20
ER

PT J
AU Yang, B
   Gong, CY
   Qian, ZY
   Zhao, X
   Li, ZY
   Zhou, ST
   Qi, XR
   Zhong, QA
   Luo, F
   Wei, YQ
AF Yang, Bing
   Gong, Chang Yang
   Qian, Zhi Yong
   Zhao, Xia
   Li, Zheng Yu
   Zhou, Sheng Tao
   Qi, Xiao Rong
   Zhong, Qian
   Luo, Feng
   Wei, Yu Quan
TI Prevention of abdominal adhesion formation by thermosensitive
   PECE-hydrogel in a rat uterine horn model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesion prevention; uterine horn model; PECE-hydrogel; thermosensitive;
   biocompatible
ID POSTSURGICAL ADHESIONS; HYALURONAN HYDROGELS; MESOTHELIAL CELLS; RABBIT
   MODEL; MULTICENTER; REDUCTION; PATHOPHYSIOLOGY; REGENERATION;
   REFORMATION; OBSTRUCTION
AB In this work, we investigated the efficacy of PECE-hydrogel in preventing postsurgical peritoneal adhesions in the rat uterine horn model. Standardized surgical traumas were applied to the peritoneum of the abdominal wall and the uterine horns. PECE hydrogel was applied to the two wound surfaces. Animals were euthanized at different times after surgery, and the gross necropsy findings were documented. Adhesion formation was assessed according to adhesion extent and adhesion severity, and the hydrogel degradation and healing of peritoneal wounds were observed. The remesothelialization was dynamically observed by scanning electron microscope. The results showed that none of the animals in the hydrogel-treated group (n = 12) developed adhesion. In contrast, all untreated animals (n = 12) had adhesions that could only be separated by sharp dissection (p < 0.001). The hydrogel could adhere to the peritoneal wounds and gradually disappear from the wounds within 7-9 days and transformed into viscous fluid being completely absorbed within 12 days. The injured parietal and visceral peritoneum was remesothelialized in about 7 and 9 days, respectively. This work confirmed that PECE hydrogel holds promise as a novel absorbable biomaterial for the reduction of postoperative adhesions after laparotomy. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 96B: 57-66, 2011.
C1 [Qian, Zhi Yong] Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China.
   Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.
   Sichuan Univ, W China Med Sch, W China Hosp, Ctr Canc, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, W China Hosp 2, Dept Gynecol & Obstet, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com; xia-zhao@126.com
RI Gong, Changyang/D-7911-2012; Qian, Zhiyong/C-2706-2009
FU National 863 Project [2007AA021804, 2007AA021902]; National Natural
   Science Foundation [NSFC20704027]; Chinese Key Basic Research Program
   [2010CB529906]
FX Contract grant sponsor: National 863 Project; contract grant numbers:
   2007AA021804, 2007AA021902; Contract grant sponsor: National Natural
   Science Foundation; contract grant number: NSFC20704027; Contract grant
   sponsor: Chinese Key Basic Research Program; contract grant number:
   2010CB529906
CR [Anonymous], 1995, FERTIL STERIL, V63, P709
   Arnold PB, 2000, FERTIL STERIL, V73, P157, DOI 10.1016/S0015-0282(99)00464-1
   Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   DELACO PA, 1998, FERTIL STERIL, V69, P318
   Diamond MP, 1998, FERTIL STERIL, V69, P1067, DOI 10.1016/S0015-0282(98)00057-0
   Diamond MP, 2001, HUM REPROD UPDATE, V7, P567, DOI 10.1093/humupd/7.6.567
   Dijkstra FR, 2000, SCAND J GASTROENTE S, V232, P52
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   Foley-Comer AJ, 2002, J CELL SCI, V115, P1383
   FOTEV Z, 1987, J PATHOL, V151, P209, DOI 10.1002/path.1711510309
   Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   HANEY AF, 1992, FERTIL STERIL, V57, P202
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   Holmdahl Lena, 1999, European Journal of Surgery, V165, P1012
   Interceed(TC7) Adhesion Barrier Study Group, 1989, FERTIL STERIL, V51, P933
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   Liu YC, 2005, FERTIL STERIL, V83, P1275, DOI 10.1016/j.fertnstert.2004.09.038
   Marana R, 1997, HUM REPROD, V12, P1935, DOI 10.1093/humrep/12.9.1935
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   Mutsaers SE, 1997, EUR J CELL BIOL, V72, P24
   Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x
   Mutsaers SE, 2000, J PATHOL, V190, P86
   Nishioka Y, 2008, RENAL FAILURE, V30, P97, DOI 10.1080/08860220701741619
   Osada H, 1999, J INT MED RES, V27, P233, DOI 10.1177/030006059902700503
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Rout UK, 2003, FERTIL STERIL, V79, P138, DOI 10.1016/S0015-0282(02)04569-7
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SULEIMAN H, 2002, BIOCHEM SOC T, V30, P126
   Ustun C, 1998, GYNECOL OBSTET INVES, V46, P202, DOI 10.1159/000010034
   Wallwiener M, 2006, FERTIL STERIL, V86, P1266, DOI 10.1016/j.fertnstert.2006.05.023
   Yeo Y, 2007, ANN SURG, V245, P819, DOI 10.1097/01.sla.0000251519.49405.55
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
NR 35
TC 11
Z9 11
U1 1
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 57
EP 66
DI 10.1002/jbm.b.31739
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500007
PM 20967774
DA 2018-10-20
ER

PT J
AU Floden, EW
   Malak, SFF
   Basil-Jones, MM
   Negron, L
   Fisher, JN
   Lun, S
   Dempsey, SG
   Haverkamp, RG
   Ward, BR
   May, BCH
AF Floden, Evan W.
   Malak, Sharif F. F.
   Basil-Jones, Melissa M.
   Negron, Leonardo
   Fisher, James N.
   Lun, Stan
   Dempsey, Sandi G.
   Haverkamp, Richard G.
   Ward, Brian R.
   May, Barnaby C. H.
TI Biophysical characterization of ovine forestomach extracellular matrix
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE extracellular matrix; forestomach propria submucosa; SAXS; biophysical;
   tissue engineering; wound healing
ID BIAXIAL MECHANICAL-BEHAVIOR; X-RAY-DIFFRACTION; INTESTINAL SUBMUCOSA;
   URINARY-BLADDER; HERNIA REPAIR; CROSS-LINKING; SCAFFOLDS; TISSUE; BONE;
   ALLODERM
AB Ovine forestomach matrix (OFM) is a native and functional decellularized extracellular matrix biomaterial that supports cell adhesion and proliferation and is remodeled during the course of tissue regeneration. Small angle X-ray scattering demonstrated that OFM retains a native collagen architecture (d spacing = 63.5 +/- 0.2 nm, orientation index = 20 degrees). The biophysical properties of OFM were further defined using ball-burst, uniaxial and suture retention testing, as well as a quantification of aqueous permeability. OFM biomaterial was relatively strong (yield stress = 10.15 +/- 1.81 MPa) and elastic (modulus = 0.044 +/- 0.009 GPa). Lamination was used to generate new OFM-based biomaterials with a range of biophysical properties. The resultant multi-ply OFM biomaterials had suitable biophysical characteristics for clinical applications where the grafted biomaterial is under load. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 968: 67 75, 2011.
C1 [Floden, Evan W.; Negron, Leonardo; Fisher, James N.; Lun, Stan; Dempsey, Sandi G.; Ward, Brian R.; May, Barnaby C. H.] Mesynthes Ltd, Lower Hutt 5040, New Zealand.
   [Malak, Sharif F. F.] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand.
   [Basil-Jones, Melissa M.; Haverkamp, Richard G.] Massey Univ, Sch Engn & Adv Technol, Palmerston North 4442, New Zealand.
RP May, BCH (reprint author), Mesynthes Ltd, Lower Hutt 5040, New Zealand.
EM barnaby.may@mesynthes.com
RI Haverkamp, Richard/H-1149-2012; Floden, Evan/H-2115-2015
OI Haverkamp, Richard/0000-0002-3890-7105; Floden,
   Evan/0000-0002-5431-190X; Fisher, James Neil/0000-0002-1876-088X;
   Negron, Leonardo/0000-0003-3852-3002
FU Foundation for Research Science and Technology (New Zealand) [MSMA0701]
FX We acknowledge the Foundation for Research Science and Technology (New
   Zealand) MSMA0701 for funding this project. SAXS analysis was undertaken
   on the SAXS/WAXS beamline at the Australian Synchrotron, Victoria,
   Australia. Author Disclosure: E.W.F., S.L., B.R.W., and B.C.H.M. are
   shareholders of Mesynthes Limited.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   BADYLAK JS, 2000, PURDUE RES FDN ASSIG
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barber FA, 2009, ARTHROSCOPY, V25, P1233, DOI 10.1016/j.arthro.2009.05.012
   Basil-Jones MM, 2010, J AGR FOOD CHEM, V58, P5286, DOI 10.1021/jf100436c
   Cameron GJ, 2002, J STRUCT BIOL, V137, P15, DOI 10.1006/jsbi.2002.4459
   Cedola A, 2006, PHYS MED BIOL, V51, pN109, DOI 10.1088/0031-9155/51/6/N02
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Gilbert TW, 2008, BIOMATERIALS, V29, P4775, DOI 10.1016/j.biomaterials.2008.08.022
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GUIDOIN R, 1987, J BIOMED MATER RES, V21, P65, DOI 10.1002/jbm.820210111
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Lee JM, 1996, J MATER SCI-MATER M, V7, P531, DOI 10.1007/BF00122176
   Lin HJ, 2009, AM J SURG, V197, P603
   Lin HJ, 2009, AM J SURG, V197, P599, DOI 10.1016/j.amjsurg.2008.12.022
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   *MILL RES GROUP, US MARK SOFT TISS RE
   Misra S, 2008, HERNIA, V12, P247, DOI 10.1007/s10029-007-0319-z
   Morgan Adam S, 2004, Arch Facial Plast Surg, V6, P308, DOI 10.1001/archfaci.6.5.308
   NAIMARK WA, 1995, J MATER SCI-MATER M, V6, P235, DOI 10.1007/BF00146862
   Nguyen TD, 2009, TISSUE ENG PT A, V15, P957, DOI 10.1089/ten.tea.2007.0384
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Runza M, 1999, ANESTH ANALG, V88, P1317, DOI 10.1097/00000539-199906000-00022
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van't Riet M, 2004, SURG ENDOSC, V18, P681, DOI 10.1007/s00464-003-9054-4
   Vural E, 2006, LARYNGOSCOPE, V116, P394, DOI 10.1097/01.mlg.0000194691.32551.24
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Yoder JH, 2010, CLIN BIOMECH, V25, P378, DOI 10.1016/j.clinbiomech.2010.01.004
NR 37
TC 18
Z9 18
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2011
VL 96B
IS 1
BP 67
EP 75
DI 10.1002/jbm.b.31740
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 693LL
UT WOS:000285225500008
PM 21053262
DA 2018-10-20
ER

PT J
AU Nishat, N
   Rasool, R
   Khan, SA
   Parveen, S
AF Nishat, Nahid
   Rasool, Raza
   Khan, Shamim Ahmad
   Parveen, Shadma
TI Synthesis and characterization of metal-incorporated aniline
   formaldehyde resin modified by amino acid for antimicrobial applications
SO JOURNAL OF COORDINATION CHEMISTRY
LA English
DT Article
DE Amino acid; Coordination polymers; Thermogravimetric analysis;
   Antimicrobial activity
ID COORDINATION POLYMERS; SCHIFF-BASE; BIOLOGICAL-ACTIVITY;
   TRANSITION-METALS; CHELATE POLYMERS; COMPLEXES; ANTIBACTERIAL;
   COPPER(II); NICKEL(II); COBALT(II)
AB Advances in metal incorporated resins are now an active field of research. To develop resin having better antimicrobial and thermal activity, a series of metal-chelated resins have been synthesized by the condensation of (4-aminobenzene-1,3-diyl) dimethanol with 2,6-diaminohexanoic acid in alkaline medium and then this polymeric ligand further reacts with transition metal ions forming various coordination polymers. (4-Aminobenzene-1,3-diyl) dimethanol was initially prepared by the reaction of aniline and formaldehyde in 1 : 2 molar ratio in alkaline medium. The analytical data reveal that the polymer metal complexes of Mn(II), Co(II), and Ni(II) are coordinated with two water molecules, which are further supported by FTIR spectra and TGA data. Comparative analyses of the polymer metal complexes in thermal curves show better thermal stability than the polymeric ligand. Since these resins are relatively stable at high temperatures, they can be used for medical and biomaterial applications requiring thermal sterilization, solvent-resist coating materials because of their insoluble nature, and antifouling coating materials owing to antimicrobial activity in fields such as life-saving medical devices and the bottoms of ships.
C1 [Nishat, Nahid; Rasool, Raza; Khan, Shamim Ahmad; Parveen, Shadma] Jamia Millia Islamia, Dept Chem, Mat Res Lab, New Delhi 110025, India.
RP Nishat, N (reprint author), Jamia Millia Islamia, Dept Chem, Mat Res Lab, New Delhi 110025, India.
EM nishat_nchem08@yahoo.com
FU UGC-CSIR (New Delhi, India); Third World Academy of Sciences, Italy' for
   UV-Visible spectrophotometer [EZ-201, 00-047 RG/CHE/AS]
FX R. Rasool is thankful to UGC-CSIR (New Delhi, India) for Enancial
   assistance. The authors express their sincere thanks to "The Third World
   Academy of Sciences, Italy'' for UV-Visible spectrophotometer EZ-201
   (Perkin Elmer) through research grant scheme No. 00-047 RG/CHE/AS.
CR Ahmad T., 2007, APPL ORGANOMET CHEM, V21, P1013
   Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013
   Cazacu M, 2004, J ORGANOMET CHEM, V689, P3005, DOI 10.1016/j.jorganchem.2004.05.051
   Chen R, 2011, CHEM COMMUN, V47, P8136, DOI 10.1039/c1cc11837d
   Chohan ZH, 2007, APPL ORGANOMET CHEM, V21, P294, DOI 10.1002/aoc.1200
   El-Gahami MA, 2004, J INORG ORGANOMET P, V14, P117, DOI 10.1023/B:JOIP.0000028090.36100.0f
   Ganguly R, 2008, COORDIN CHEM REV, V252, P1027, DOI 10.1016/j.ccr.2008.01.005
   Hasnain S, 2011, J COORD CHEM, V64, P952, DOI 10.1080/00958972.2011.559230
   HASSAN MU, 2002, MAIN GROUP MET CHEM, V25, P291
   Ibrahim Y, 2003, TRANSIT METAL CHEM, V28, P399
   Islam M.B., 2007, BANGLADESH J SCI IND, V42, P475
   Jayakumar R, 2004, J APPL POLYM SCI, V92, P710, DOI 10.1002/app.13674
   Kaliyappan T, 2000, PROG POLYM SCI, V25, P343, DOI 10.1016/S0079-6700(00)00005-8
   Kaminski W, 1997, SEPAR SCI TECHNOL, V32, P2659, DOI 10.1080/01496399708006962
   Kemp W., 1996, PROTON NMR SPECTRA N
   Kitagawa S, 2005, CHEM SOC REV, V34, P109, DOI 10.1039/b313997m
   Kumar D, 2011, J COORD CHEM, V64, P590, DOI 10.1080/00958972.2011.552108
   LEVER A, 1984, INORGANIC ELECT SPEC
   Liu WS, 2004, J AM CHEM SOC, V126, P2280, DOI 10.1021/ja036635q
   Marcu M, 2003, APPL ORGANOMET CHEM, V17, P693, DOI 10.1002/aoc.486
   Mart H, 2005, J MACROMOL SCI PURE, VA42, P1197, DOI 10.1080/10601320500189471
   Nishat N, 2008, J APPL POLYM SCI, V110, P3305, DOI 10.1002/app.28752
   Nishat N, 2011, J INORG ORGANOMET P, V21, P673, DOI 10.1007/s10904-011-9457-y
   Nishat N, 2011, J APPL POLYM SCI, V122, P2756, DOI 10.1002/app.34100
   Nishat N, 2011, J THERM ANAL CALORIM, V105, P969, DOI 10.1007/s10973-011-1442-8
   Nishat N, 2010, J COORD CHEM, V63, P3944, DOI 10.1080/00958972.2010.526207
   Nishat N, 2010, J COORD CHEM, V63, P1273, DOI 10.1080/00958971003728296
   Patel SH, 2007, J MACROMOL SCI A, V44, P599, DOI 10.1080/10601320701284881
   Qu ZR, 2003, INORG CHEM, V42, P7710, DOI 10.1021/ic034685q
   Raman N, 2003, P INDIAN AS-CHEM SCI, V115, P161
   Rivas BL, 2000, POLYM BULL, V44, P445, DOI 10.1007/s002890070064
   Shulman A., 1964, CHELATING AGENTS MET
   Slenters TV, 2008, J MATER CHEM, V18, P5359, DOI 10.1039/b813026d
   Tharmaraj P, 2009, J COORD CHEM, V62, P2220, DOI 10.1080/00958970902783576
   Ward MD, 2005, J SOLID STATE ELECTR, V9, P778, DOI 10.1007/s10008-005-0668-4
   WINTERTON N, 2000, ANNU REP PROG CHEM A, V96, P557
   Xue W, 2011, CHEM COMMUN, V47, P10233, DOI 10.1039/c1cc12852c
NR 37
TC 10
Z9 10
U1 1
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0095-8972
J9 J COORD CHEM
JI J. Coord. Chem.
PY 2011
VL 64
IS 23
BP 4054
EP 4065
DI 10.1080/00958972.2011.636426
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 881GT
UT WOS:000299471300002
DA 2018-10-20
ER

PT J
AU Du, MC
   Song, WX
   Cui, Y
   Yang, Y
   Li, JB
AF Du, Mingchun
   Song, Weixing
   Cui, Yue
   Yang, Yang
   Li, Junbai
TI Fabrication and biological application of nano-hydroxyapatite
   (nHA)/alginate (ALG) hydrogel as scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; MECHANICAL-PROPERTIES;
   FUTURE-DIRECTIONS; CELL-ADHESION; SILK FIBROIN; IN-VITRO; ALGINATE;
   GELATIN; BIOMATERIALS; DELIVERY
AB We have fabricated tubular hydrogel scaffolds of nano-hydroxyapatite (nHA)/alginate (ALG) via a layer-by-layer (LbL) technique. Using Ca2+ as a crosslinker, nHA was assembled with ALG to form a hydrogel network. The inner diameter of scaffolds could be controlled from 0.5 mm to 7 mm by varying the assembled layer numbers of nHA/ALG pairs. By changing the nHA concentration, we can also control the crosslinking degree of the hydrogel network, and further change the mechanical properties, swelling behavior, permeability and diffusivity of the scaffolds. The elastic modulus of the hydrogel scaffolds was regulated from 0.98 +/- 0.05 MPa to 2.78 +/- 0.08 MPa as the concentration of nHA was changed from 50 mg mL(-1) to 300 mg mL(-1), which reached the requirements of avascular soft tissue. The diffusion coefficient was tuned from 23.84 x 10(-7) cm(2) s(-1) to 9.92 x 10(-7) cm(2) s(-1) for controlled mass transport in the hydrogel network. Moreover, human embryo skin fibroblast (ESF) culture experiments prove that nHA can improve cellular adhesion on the hydrogel surface. These results thus suggest that the assembled nHA/ALG hydrogel scaffolds are an attractive biomaterial for great potential application in soft tissue engineering.
C1 [Du, Mingchun; Cui, Yue; Li, Junbai] Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, BNLMS,Int Joint Lab, Beijing 100190, Peoples R China.
   [Song, Weixing; Yang, Yang] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China.
RP Li, JB (reprint author), Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, BNLMS,Int Joint Lab, Bei Yi Jie 2, Beijing 100190, Peoples R China.
EM jbli@iccas.ac.cn
RI Li, Junbai/M-4351-2016
OI Li, Junbai/0000-0001-9575-3125
FU National Basic Research Program of China (973 program) [2007CB35900];
   National Natural Science Foundation of China [NNSFC 20833010]
FX This work was financially supported by National Basic Research Program
   of China (973 program 2007CB35900) and National Natural Science
   Foundation of China (NNSFC 20833010).
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bolter M, 2002, BIOL FERT SOILS, V36, P249, DOI 10.1007/s00374-002-0537-6
   Bouhadir KH, 2001, BIOMATERIALS, V22, P2625, DOI 10.1016/S0142-9612(01)00003-5
   Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   Chu C, 2009, TISSUE ENG PT A, V15, P255, DOI 10.1089/ten.tea.2008.0100
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Correlo VM, 2005, MACROMOL MATER ENG, V290, P1157, DOI 10.1002/mame.200500163
   Desrochers J., 2007, J ARMITAGE SIEINT SO, V6796, P79607
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dunkers JP, 2003, OPT EXPRESS, V11, P3074, DOI 10.1364/OE.11.003074
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Harris JR, 2002, J OTOLARYNGOL, V31, P89, DOI 10.2310/7070.2002.18928
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kima H. W., 2005, BIOMATERIALS, V26, P5221
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Li JS, 2008, J BIOMED MATER RES B, V86B, P381, DOI 10.1002/jbm.b.31031
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mohamed KR, 2008, MAT SCI ENG C-BIO S, V28, P1087, DOI 10.1016/j.msec.2007.04.040
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Pascual B, 1999, BIOMATERIALS, V20, P465, DOI 10.1016/S0142-9612(98)00192-6
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Schumann R, 1998, MAR ECOL PROG SER, V163, P77, DOI 10.3354/meps163077
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sikorski P, 2007, BIOMACROMOLECULES, V8, P2098, DOI 10.1021/bm0701503
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Su P. J., 2008, SPIEINT SOC OPT ENG, V6858, pH8580
   Sun JS, 2005, BIOMATERIALS, V26, P3953, DOI 10.1016/j.biomaterials.2004.10.016
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Willenberg BJ, 2006, J BIOMED MATER RES A, V79A, P440, DOI 10.1002/jbm.a.30942
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilson J. C., 2005, TISSUE ENG, V11, P1
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   WOO S, 1988, AM AC ORTH SURG S, P401
   Yang DZ, 2008, J APPL POLYM SCI, V110, P3328, DOI 10.1002/app.28829
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Yang Y, 2007, BIOMATERIALS, V28, P3083, DOI 10.1016/j.biomaterials.2007.03.019
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 54
TC 26
Z9 26
U1 5
U2 86
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 7
BP 2228
EP 2236
DI 10.1039/c0jm02869j
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 714UN
UT WOS:000286834600032
DA 2018-10-20
ER

PT J
AU Jang, JH
   Choi, YM
   Choi, YY
   Joo, MK
   Park, MH
   Choi, BG
   Kang, EY
   Jeong, B
AF Jang, Ji Hye
   Choi, Yoon Mi
   Choi, Yun Young
   Joo, Min Kyung
   Park, Min Hee
   Choi, Bo Gyu
   Kang, Eun Young
   Jeong, Byeongmoon
TI pH/temperature sensitive chitosan-g-(PA-PEG) aqueous solutions as new
   thermogelling systems
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID BLOCK-COPOLYMER HYDROGELS; CHITOSAN-BASED HYDROGELS; DRUG-DELIVERY;
   IN-SITU; SECONDARY STRUCTURE; PHYSICAL GELATION; THERMAL GELATION;
   POLYPEPTIDE; PEG; TEMPERATURE
AB As a new thermal gelling polymer aqueous solution, we are reporting a poly(ethylene glycol)-poly (alanine) grafted chitosan (CS-g-(PA-PEG)) system. The sol-gel transition temperature and the modulus of the in situ-formed thermal gel at 37 degrees C changed 17 -> 27 -> 32 degrees C and 396 -> 241 -> 43 Pa, respectively, as the pH increased from 3.0 to 6.5 and to 9.0. The mechanism of such a pH/temperature sensitive behaviour of the CS-g-(PA-PEG) aqueous solution was investigated by studying changes in the conformation of chitosan, polyalanine and PEG of the CS-g-(PA-PEG). As the temperature increased, ammonium groups of the chitosan partially deprotonated to a neutral form, the a-helical content of the polyalanine increased and molecular motion of the PEG decreased. Such changes cooperatively increase the hydrophobicity and viscosity of CS-g-(PA-PEG), resulting in the sol-gel transition of the polymer aqueous solution with increasing temperature. As the pH increased, ammonium groups of the chitosan deprotonated to a neutral form and the alpha-helical content of polyalanine decreased, which induce a change in the nanoassembly of the polymer. CS-g-(PA-PEG) significantly increased the gel modulus of a previously reported PEG grafted chitosan (CS-g-PEG) thermal gel by incorporating the alpha-helical polyalanine moieties between CS and PEG. The CS-g-(PA-PEG) could be a promising biomaterial as a new robust thermogel with pH and temperature sensitivity.
C1 [Jang, Ji Hye; Choi, Yoon Mi; Choi, Yun Young; Joo, Min Kyung; Park, Min Hee; Choi, Bo Gyu; Kang, Eun Young; Jeong, Byeongmoon] Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Dept Bioinspired Sci WCU, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
FU MEST of Korea [2010-0000832, 2010-0001487, R31-2008-000-10010-0]; Seoul
   RBD Program [10816]
FX This work was supported by the National Research Foundation grant funded
   by the MEST of Korea (Grant number: 2010-0000832, 2010-0001487 and
   R31-2008-000-10010-0) and the Seoul R&BD Program (10816).
CR Ayres L, 2005, MACROMOLECULES, V38, P1699, DOI 10.1021/ma047923p
   Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015
   Barbosa JS, 2010, ADV ENG MATER, V12, pB37, DOI 10.1002/adem.200980152
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Booth C, 2000, MACROMOL RAPID COMM, V21, P501, DOI 10.1002/1521-3927(20000601)21:9<501::AID-MARC501>3.0.CO;2-R
   Casettari L, 2010, BIOMACROMOLECULES, V11, P2854, DOI 10.1021/bm100522c
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Chae SY, 2005, J CONTROL RELEASE, V102, P383, DOI 10.1016/j.jconrel.2004.10.012
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cho JY, 2005, BIOMACROMOLECULES, V6, P3267, DOI 10.1021/bm050313s
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi YY, 2010, J MATER CHEM, V20, P3416, DOI 10.1039/b922956f
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Couto DS, 2009, ACTA BIOMATER, V5, P115, DOI 10.1016/j.actbio.2008.08.006
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Filion D, 2007, BIOMACROMOLECULES, V8, P3224, DOI 10.1021/bm700520m
   Ganji F, 2008, CARBOHYD POLYM, V74, P435, DOI 10.1016/j.carbpol.2008.03.017
   Hamley IW, 2005, BIOMACROMOLECULES, V6, P1310, DOI 10.1021/bm049286g
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b
   Kim JY, 2009, MACROMOLECULES, V42, P3147, DOI 10.1021/ma900341m
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Martin SR, 2008, METHOD CELL BIOL, V84, P263, DOI 10.1016/S009l-679X(07)84010-6
   Ngoenkam J, 2010, INT J PHARMACEUT, V391, P115, DOI 10.1016/j.ijpharm.2010.02.028
   Oh HJ, 2008, MACROMOLECULES, V41, P8204, DOI 10.1021/ma8014504
   Park SY, 2007, MACROMOL RAPID COMM, V28, P1172, DOI 10.1002/marc.200600914
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Radu LC, 2009, MACROMOL BIOSCI, V9, P36, DOI 10.1002/mabi.200800193
   Sa-Lima H, 2010, SOFT MATTER, V6, P5184, DOI 10.1039/c0sm00041h
   Shim WS, 2006, BIOMACROMOLECULES, V7, P1935, DOI 10.1021/bm0600567
   Suh JM, 2005, ADV MATER, V17, P118, DOI 10.1002/adma.200400905
   Yoshikawa HY, 2011, J AM CHEM SOC, V133, P1367, DOI 10.1021/ja1060615
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 42
TC 28
Z9 28
U1 1
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 14
BP 5484
EP 5491
DI 10.1039/c0jm03894f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 738RJ
UT WOS:000288659500041
DA 2018-10-20
ER

PT J
AU Beuvier, T
   Calvignac, B
   Delcroix, GEJR
   Tran, MK
   Kodjikian, S
   Delorme, N
   Bardeau, JF
   Gibaud, A
   Boury, F
AF Beuvier, Thomas
   Calvignac, Brice
   Delcroix, Gaetan Jean-Robert
   My Kien Tran
   Kodjikian, Stephanie
   Delorme, Nicolas
   Bardeau, Jean-Francois
   Gibaud, Alain
   Boury, Frank
TI Synthesis of hollow vaterite CaCO3 microspheres in supercritical carbon
   dioxide medium
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CALCIUM-CARBONATE; CO2; PARTICLES; PHASE; PRECIPITATION; FABRICATION;
   MORPHOLOGY; CRYSTALLIZATION; TRANSFORMATION; AGGREGATION
AB We here describe a rapid method for synthesizing hollow core, porous crystalline calcium carbonate microspheres composed of vaterite using supercritical carbon dioxide in aqueous media, without surfactants. We show that the reaction in alkaline media rapidly conducts to the formation of microspheres with an average diameter of 5 mu m. SEM, TEM and AFM observations reveal that the microspheres have a hollow core of around 0.7 mu m width and are composed of nanograins with an average diameter of 40 nm. These nanograins are responsible for the high specific surface area of 16 m(2) g(-1) deduced from nitrogen absorption/desorption isotherms, which moreover confers an important porosity to the microspheres. We believe this work may pave the way for the elaboration of a biomaterial with a large potential for therapeutic as well as diagnostic applications.
C1 [Calvignac, Brice; Delcroix, Gaetan Jean-Robert; My Kien Tran; Boury, Frank] Lunam Univ Maine, INSERM Ingn Vectorisat Particulaire U646, IBS CHU ANGERS, F-49933 Angers 9, France.
   [Beuvier, Thomas; Delorme, Nicolas; Bardeau, Jean-Francois; Gibaud, Alain] Univ Maine, Lunam Univ Maine, Lab Phys Etat Condense, UMR CNRS 6087, F-72085 Le Mans, France.
   [Kodjikian, Stephanie] Univ Maine, Lunam Univ Maine, Lab Oxydes & Fluorures, UMR CNRS 6010, F-72085 Le Mans, France.
RP Boury, F (reprint author), Lunam Univ Maine, INSERM Ingn Vectorisat Particulaire U646, IBS CHU ANGERS, Batiment IRIS,4 Rue Larrey, F-49933 Angers 9, France.
EM thomas.beuvier@univ-lemans.fr; brice.calvignac@univ-angers.fr;
   delcroix.gaetan@gmail.com; mykiend2002@yahoo.com;
   stephanie.kodjikian@univ-lemans.fr; nicolas.delorme@univ-lemans.fr;
   jean-francois.bardeau@univ-lemans.fr; alain.gibaud@univ-lemans.fr;
   frank.boury@univ-angers.fr
RI Calvignac, Brice/K-4789-2015; Boury, Frank/L-1834-2015
OI Calvignac, Brice/0000-0002-2007-5750; Nicolas,
   Delorme/0000-0003-4195-2000
FU ANR (France) [ANR-09-PIRI-0004-01]; Regional research program (Pays de
   Loire, France-Bioregos program); CNRS (France)
FX The authors thank the financial support of ANR (France-Project
   ANR-09-PIRI-0004-01), Regional research program (Pays de Loire,
   France-Bioregos program) and CNRS (France). The authors thank the
   Institut des Materiaux Jean Rouxel (Nantes, France) for nitrogen
   adsorption/desorption measurements and the SCIAM laboratory (Angers,
   France) for SEM analysis.
CR Bing Z, 2007, EUR POLYM J, V43, P4814, DOI 10.1016/j.eurpolymj.2007.08.014
   BOURY F, 2007, METHOD PREPARING PAR
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   Darr JA, 1999, CHEM REV, V99, P495, DOI 10.1021/cr970036i
   Dickinson SR, 2001, ANALYST, V126, P1118, DOI 10.1039/b103004n
   Domingo C, 2004, J CRYST GROWTH, V271, P268, DOI 10.1016/j.jcrysgro.2004.07.060
   Fenghour A, 1998, J PHYS CHEM REF DATA, V27, P31, DOI 10.1063/1.556013
   Ferrentino G, 2010, J SUPERCRIT FLUID, V52, P142, DOI 10.1016/j.supflu.2009.10.005
   Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1
   Gu W, 2006, J MATER CHEM, V16, P3312, DOI 10.1039/b607184h
   Han YS, 2006, J MATER SCI, V41, P4663, DOI 10.1007/s10853-006-0037-4
   Han YS, 2005, J CRYST GROWTH, V276, P541, DOI 10.1016/j.jcrysgro.2004.11.408
   Hou WT, 2005, J CRYST GROWTH, V282, P214, DOI 10.1016/j.jcrysgro.2005.04.102
   Im SH, 2005, NAT MATER, V4, P671, DOI 10.1038/nmat1448
   Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8
   Kato T, 2010, MRS BULL, V35, P127, DOI 10.1557/mrs2010.632
   Kitamura M, 2001, J COLLOID INTERF SCI, V236, P318, DOI 10.1006/jcis.2000.7398
   Kontoyannis CG, 2000, ANALYST, V125, P251, DOI 10.1039/a908609i
   Pan Y, 2007, MATER LETT, V61, P2810, DOI 10.1016/j.matlet.2006.10.034
   Pan Y, 2010, LANGMUIR, V26, P4184, DOI 10.1021/la904067q
   Peng CY, 2010, COLLOID SURFACE A, V353, P132, DOI 10.1016/j.colsurfa.2009.11.004
   Qi LM, 2002, ADV MATER, V14, P300
   Shivkumara C, 2006, MATER RES BULL, V41, P1455, DOI 10.1016/j.materresbull.2006.01.026
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Span R, 1996, J PHYS CHEM REF DATA, V25, P1509, DOI 10.1063/1.555991
   Tong H, 2004, BIOMATERIALS, V25, P3923, DOI 10.1016/j.biomaterials.2003.10.038
   Wakayama H, 2005, J MATER CHEM, V15, P1134, DOI 10.1039/b418569b
   WALSH D, 1995, NATURE, V377, P320, DOI 10.1038/377320a0
   Watanabe H, 2009, ADV POWDER TECHNOL, V20, P89, DOI 10.1016/j.apt.2008.10.004
   Wei W, 2008, J AM CHEM SOC, V130, P15808, DOI 10.1021/ja8039585
   Yan GW, 2008, MATER RES BULL, V43, P2069, DOI 10.1016/j.materresbull.2007.09.014
   Yu JG, 2006, ADV FUNCT MATER, V16, P2035, DOI 10.1002/adfm.200600552
NR 32
TC 36
Z9 37
U1 4
U2 73
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2011
VL 21
IS 26
BP 9757
EP 9761
DI 10.1039/c1jm10770d
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 780SC
UT WOS:000291878100047
DA 2018-10-20
ER

PT J
AU Cacaina, D
   Areva, S
   Laaksonen, H
   Simon, S
   Ylanen, H
AF Cacaina, D.
   Areva, S.
   Laaksonen, H.
   Simon, S.
   Ylanen, H.
TI Preparation and complex characterization of silica holmium sol-gel
   monoliths
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLY(L-LACTIC ACID) MICROSPHERES; INTERNAL RADIATION-THERAPY; IN-VITRO;
   BIOACTIVE GLASSES; LIVER-TUMORS; STATE; YTTRIUM; SURFACE;
   ACETYLACETONATE; CAO-P2O5-SIO2
AB Amorphous, sol-gel derived SiO(2) are known to biocompatible and bioresorbable materials. Biodegradable and inert materials containing radioactive isotopes have potential application as delivery vehicles of the beta radiation to the cancer tumors inside the body. Incorporation of holmium in the sol-gel derived SiO(2) could lead to the formation of a biodegradable material which could be used as carrier biomaterial for the radiation of radioactive holmium to the various cancer sites. The homogeneity of the prepared sol-gel silica holmium monoliths was investigated by Back Scattered Electron Imaging of Scanning Electron Microscope equipped with Energy Dispersive X-ray Analysis, X-ray Induced Photoelectron Spectroscopy and Nuclear Magnetic Resonance Spectroscopy. The biodegradation of the monoliths was investigated in Simulated Body Fluid and TRIS (Trizma pre-set Crystals) solution. The results show that by suitable tailoring of the sol-gel processing parameters holmium can be homogeneously incorporated in the silica matrix with a controlled biodegradation rate.
C1 [Cacaina, D.; Areva, S.; Laaksonen, H.; Ylanen, H.] Univ Turku, Turku Biomat Ctr, SF-20500 Turku, Finland.
   [Areva, S.; Laaksonen, H.; Ylanen, H.] Tampere Univ Technol, Dept Biomed Engn, FIN-33101 Tampere, Finland.
   [Simon, S.] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
RP Cacaina, D (reprint author), Univ Turku, Turku Biomat Ctr, Itainen Pitkakatu 4 B PharmaCity, SF-20500 Turku, Finland.
EM dana.cacaina@yahoo.com
FU The Finnish Funding Agency for Technology and Innovation [40118/06]
FX The Finnish Funding Agency for Technology and Innovation (TEKES-Project
   40118/06) is acknowledged for the financial support of this work. Thanks
   to T. Radu and R.V.F. Turcu from Babes-Bolyai University for the XPS and
   NMR measurements and Department of Physical Chemistry of angstrom bo
   Akademi University for N<INF>2</INF>-sorption measurements.
CR Aparicio M, 2005, CERAM INT, V31, P631, DOI 10.1016/j.ceramint.2004.08.002
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Bult W, 2010, PHARM RES-DORDR, V27, P2205, DOI 10.1007/s11095-010-0226-3
   Cacaina D, 2007, J OPTOELECTRON ADV M, V9, P2566
   Cacaina D, 2006, J MATER SCI-MATER M, V17, P709, DOI 10.1007/s10856-006-9681-0
   CACAINA D, 2007, J MATER SCI, V19, P1225
   CACAINA D, 2005, KEY ENG MATER, V411, P284
   Coelho C, 2006, J SOL-GEL SCI TECHN, V40, P181, DOI 10.1007/s10971-006-7431-x
   Conzone SD, 2002, J BIOMED MATER RES, V60, P260, DOI 10.1002/jbm.10047
   Day DE, 1993, INTRO BIOCERAMICS, V1, P305
   Drake KO, 2005, SOLID STATE NUCL MAG, V27, P28, DOI 10.1016/j.ssnmr.2004.08.008
   Eighmy T. T., 1999, Surface Science Spectra, V6, P193, DOI 10.1116/1.1247925
   Hafeli UO, 2001, APPL RADIAT ISOTOPES, V54, P869, DOI 10.1016/S0969-8043(00)00313-4
   Hench L. L., 1993, INTRO BIOCERAMICS, V1, P1
   Ho S, 1998, CANCER, V83, P1894, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1894::AID-CNCR4>3.3.CO;2-F
   Jokinen M, 1998, J SOL-GEL SCI TECHN, V12, P159, DOI 10.1023/A:1008642117227
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kennedy AS, 2006, INT J RADIAT ONCOL, V65, P412, DOI 10.1016/j.ijrobp.2005.12.051
   Kennedy AS, 2004, INT J RADIAT ONCOL, V60, P1552, DOI 10.1016/j.ijrobp.2004.09.004
   Kepinski L, 2003, MATER CHEM PHYS, V81, P396, DOI 10.1016/S0254-0584(03)00031-2
   Khattak GD, 2004, J NON-CRYST SOLIDS, V337, P174, DOI 10.1016/j.jnoncrysol.2003.08.088
   LANG WC, 1975, FARADAY DISCUSS, V60, P37, DOI 10.1039/dc9756000037
   LIN W, 2004, J NUCL MED, V41, P1892
   LIVAGE J, 1988, PROG SOLID STATE CH, V18, P259, DOI 10.1016/0079-6786(88)90005-2
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   Nijsen JFW, 2002, BIOMATERIALS, V23, P1831, DOI 10.1016/S0142-9612(01)00309-X
   Nijsen JFW, 2002, CURR MED CHEM, V9, P73, DOI 10.2174/0929867023371454
   Nijsen JFW, 2001, BIOMATERIALS, V22, P3073, DOI 10.1016/S0142-9612(01)00055-2
   Parmentier J, 2001, SOLID STATE SCI, V3, P495, DOI 10.1016/S1293-2558(01)01151-7
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   PRADO D, 2000, MAT RES, V3, P61
   Ramila A, 2001, BIOMATERIALS, V22, P2301, DOI 10.1016/S0142-9612(00)00419-1
   ROBERTO WS, 2003, ARTIF ORGANS, V27, P420
   Sepulveda P, 2001, J BIOMED MATER RES, V58, P734, DOI 10.1002/jbm.10026
   Simon V, 2007, SOLID STATE COMMUN, V141, P42, DOI 10.1016/j.ssc.2006.09.036
   Smits MLJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-70
   Vente MAD, 2008, EUR J NUCL MED MOL I, V35, P1259, DOI 10.1007/s00259-008-0747-8
   Vente MAD, 2010, EUR RADIOL, V20, P862, DOI 10.1007/s00330-009-1613-1
   Vente MAD, 2010, EXPERT REV MED DEVIC, V7, P581, DOI 10.1586/ERD.10.48
   Viitala R, 2005, J SOL-GEL SCI TECHN, V36, P147, DOI 10.1007/s10971-005-5286-1
   Viitala R, 2002, BIOMATERIALS, V23, P3073, DOI 10.1016/S0142-9612(02)00017-0
   WHITE JE, 1994, KEY ENG MAT, V94-9, P181, DOI 10.4028/www.scientific.net/KEM.94-95.181
   Wickremesekera JK, 2001, INT J RADIAT ONCOL, V49, P1015, DOI 10.1016/S0360-3016(00)01420-6
   Yoshida K, 1999, J BIOMED MATER RES, V46, P221, DOI 10.1002/(SICI)1097-4636(199908)46:2<221::AID-JBM11>3.0.CO;2-T
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
   Zotov N, 1998, AM MINERAL, V83, P823
NR 47
TC 3
Z9 3
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2011
VL 22
IS 1
BP 29
EP 40
DI 10.1007/s10856-010-4186-2
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736TF
UT WOS:000288516300004
PM 21132520
DA 2018-10-20
ER

PT J
AU Thakurta, SG
   Subramanian, A
AF Thakurta, Sanjukta Guha
   Subramanian, Anuradha
TI Evaluation of in situ albumin binding surfaces: a study of protein
   adsorption and platelet adhesion
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ACUTE INFLAMMATORY RESPONSES; OXIDE)
   COUPLING-POLYMER; SERUM-ALBUMIN; PLASMA; BIOMATERIALS; ACTIVATION;
   FIBRINOGEN; BLOOD; VITRO
AB Surface modification strategies that take advantage of the passivation effects of albumin are important in the development of biomaterial surfaces. In this study, linear peptides (LP1, LP2) and a small chemical ligand (SCL) with albumin binding affinities were grafted onto silane functionalized silicon substrates. Surfaces were characterized with contact angle and ellipsometric measurements, and densities of immobilized ligands were assessed spectro-scopically. Ellipsometrically measured thickness correlated with the predicted molecular lengths of grafted moieties. Contact angle analysis indicated that the LP1 and LP2 functionalized surfaces were hydrophilic compared to SCL functionalized and control surfaces. Adsorption of albumin from human serum was evaluated and quantified via specific enzyme-linked immunosorbent assays and 2D gel electrophoresis. The following trend was noted for surface adsorbed albumin: LP1 > LP2 > SCL > C, with LP1 derivatized surfaces having similar to 2.450 mu g/cm(2) of bound albumin. LP1 derivatized surfaces possessed the least number of adsorbed platelets with rounded platelet morphology when compared to control surface.
C1 [Thakurta, Sanjukta Guha; Subramanian, Anuradha] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
EM asubramanian2@unl.edu
FU NSF [CTS-0411632]; Army Research Laboratory [W911NF-04-2-0011]
FX This work was partially supported by NSF Grant CTS-0411632 and Army
   Research Laboratory W911NF-04-2-0011. We are thankful to Gaye Homer,
   University of Nebraska Health Center, Lincoln, NE for letting us use the
   platelet counting instrument; Dr. H. Chen and Dr. Y. Joe. Zhou of
   microscopy facility of Center of Biotechnology; Dr. D. W. Thompson and
   Dr. T. Hofmann of Center for Materials Research and Analysis, University
   of Nebraska, Lincoln, NE for in hand training at SEM and Ellipsometry
   facility, respectively.
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BRASH JL, 1988, MAKROMOL CHEM-M SYMP, V17, P441, DOI 10.1002/masy.19880170133
   Cao L, 2006, J BIOMED MATER RES A, V79A, P788, DOI 10.1002/jbm.a.30908
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHANDY T, 1985, BIOMATERIALS, V6, P416, DOI 10.1016/0142-9612(85)90103-6
   CHANDY T, 1992, ARTIF ORGANS, V16, P568
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Demiryas N, 2007, J APPL POLYM SCI, V105, P1808, DOI 10.1002/app.26187
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Frautschi JR, 1995, J BIOMAT SCI-POLYM E, V7, P563
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Guhathakurta S, 2007, J ELECTROCHEM SOC, V154, pP136, DOI 10.1146/1.2779951
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Keogh James R., 1996, Cells and Materials, V6, P209
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   KEOGH JR, 1992, J BIOMED MATER RES, V26, P441, DOI 10.1002/jbm.820260403
   Lyman D J, 1972, Adv Nephrol Necker Hosp, V2, P97
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1969, J BIOMED MATER RES, V3, P175
   Ma ZY, 2006, REACT FUNCT POLYM, V66, P618, DOI 10.1016/j.reactfunctpolym.2005.10.014
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   McFarland CD, 1998, J BIOMAT SCI-POLYM E, V9, P1227, DOI 10.1163/156856298X00749
   MUSTARD JF, 1970, PHARMACOL REV, V22, P97
   Odabasi M, 2004, J APPL POLYM SCI, V93, P719, DOI 10.1002/app.20485
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Riccitelli S D, 1985, Trans Am Soc Artif Intern Organs, V31, P250
   Sato AK, 2002, BIOTECHNOL PROGR, V18, P182, DOI 10.1021/bp010181o
   Sharma C P, 1987, J Biomater Appl, V2, P205, DOI 10.1177/088532828700200202
   SIMAL-GANDARA J, 1993, FOOD ADDIT CONTAM A, V10, P555
   Subramanian A, 1997, SO BIOMM ENGN CONF P, P57, DOI 10.1109/SBEC.1997.583213
   SUBRAMANIAN A, 1994, J CHROMATOGR A, V672, P11, DOI 10.1016/0021-9673(94)80590-3
   Subramanian A, 2006, CARBOHYD POLYM, V66, P321, DOI 10.1016/j.carbpol.2006.03.022
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TAOA W, 2008, APPL SURF SCI, V254, P2831
   THAKURTA G, 2009, DESIGN DEV SITU ALBU
   VANOSS CJ, 1987, ADV COLLOID INTERFAC, V28, P35, DOI 10.1016/0001-8686(87)80008-8
   VANOSS CJ, 1969, INTERFACIAL FORCES A
   VROMAN L, 1972, B NEW YORK ACAD MED, V48, P302
   Wang DA, 2001, J BIOMAT SCI-POLYM E, V12, P1123, DOI 10.1163/15685620152691896
   Wang DA, 2002, BIOCONJUGATE CHEM, V13, P792, DOI 10.1021/bc0255079
   Wu YD, 2007, J BIOMED MATER RES A, V81A, P956, DOI 10.1002/jbm.a.31105
   WU YSF, 2005, J BIOMED MATER RES A, V74, P238
NR 50
TC 11
Z9 11
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2011
VL 22
IS 1
BP 137
EP 149
DI 10.1007/s10856-010-4169-3
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736TF
UT WOS:000288516300014
PM 21120589
DA 2018-10-20
ER

PT J
AU Dupret-Bories, A
   Schultz, P
   Vrana, NE
   Lavalle, P
   Vautier, D
   Debry, C
AF Dupret-Bories, Agnes
   Schultz, Philippe
   Vrana, Nihal Engin
   Lavalle, Philippe
   Vautier, Dominique
   Debry, Christian
TI Development of surgical protocol for implantation of tracheal prostheses
   in sheep
SO JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
LA English
DT Article
DE artificial larynx; epithelium; function; laryngeal cancer;
   laryngectomees; outcome; porous titanium; prosthetic surgery;
   rehabilitation; sheep; surgical protocol; survival rate
ID CARINAL REPLACEMENT; AORTIC ALLOGRAFTS; SURVIVAL ANALYSIS; POROUS
   TITANIUM; HOMOGRAFT; AUTOGRAFT; SURGERY; TISSUE
AB This article documents experiments performed in ewes to design an artificial larynx. The artificial larynx is composed of a hollow, porous tube that elongates the trachea and is capped with a valve that acts as a laryngeal sphincter. Through an industrial collaboration, our team developed a porous biomaterial that can be colonized by cervical tissues. This biomaterial has been used in animals to replace part of the trachea, but it is meant to eventually substitute for laryngeal cartilage. The tracheal prosthesis is a hollow cylindrical tube composed of titanium microbeads. We performed a study in large animals to establish an optimal surgical protocol for tracheal replacement in humans. The study included 11 sheep (n = 11) and compared 5 methods of implantation. We successfully established an optimal three-step surgical protocol to make the porous-titanium tracheal prosthesis functional: (1) large lumen endoprosthetics, (2) colonization by the peripheral tissues, and (3) endoprosthetic epithelialization. This study is the first step in developing an artificial larynx because it successfully identifies a biomaterial capable of extending the trachea to allow it to open at the junction of the upper aerodigestive tracts.
C1 [Dupret-Bories, Agnes; Schultz, Philippe; Debry, Christian] Hop Hautepierre, Hop Univ Strasbourg, Dept Otorhinolaryngol, Strasbourg, France.
   [Dupret-Bories, Agnes; Schultz, Philippe; Debry, Christian] Hop Hautepierre, Hop Univ Strasbourg, Tech Res Team, Strasbourg, France.
   [Vrana, Nihal Engin; Lavalle, Philippe; Vautier, Dominique] INSERM, Dept Res, Unite 977, Strasbourg, France.
RP Dupret-Bories, A (reprint author), CHU Hautepierre, Dept Otorhinolaryngol, Ave Moliere, F-67098 Strasbourg, France.
EM agnes.dupret@chru-strasbourg.fr
RI Lavalle, Philippe/E-6328-2016; Vrana, Nihal/A-2029-2010
OI Lavalle, Philippe/0000-0001-8798-912X; Vrana, Nihal/0000-0002-5398-6710;
   Dupret-Bories, Agnes/0000-0002-7068-3500
FU Reseau National des Technologies de Sante de l'Agence Nationale de la
   Recherche [French National Research Agency]
FX This material was based on work supported by the Reseau National des
   Technologies de Sante de l'Agence Nationale de la Recherche [French
   National Research Agency], PROTimplant Project.
CR Anoosh F, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-23
   Azorin JF, 2006, EUR J CARDIO-THORAC, V29, P261, DOI 10.1016/j.ejcts.2005.11.026
   Babin E, 2008, J OTOLARYNGOL-HEAD N, V37, P495, DOI 10.2310/7070.2008.0094
   Brian E, 2007, REV PNEUMOL CLIN, V63, P224, DOI 10.1016/S0761-8417(07)90127-3
   Coraux C, 2005, M S-MED SCI, V21, P1063
   Davidson MB, 2009, ANN THORAC SURG, V88, P1006, DOI 10.1016/j.athoracsur.2009.01.044
   Dodge-Khatami Ali, 2003, Asian Cardiovasc Thorac Ann, V11, P245
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Grillo HC, 2003, ANN THORAC SURG, V75, P1039, DOI 10.1016/S0003-4975(02)04109-7
   Grillo HC, 2003, ANN THORAC SURG, V75, P610, DOI 10.1016/S0003-4975(02)04108-5
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Guillemot F, 2002, J COLLOID INTERF SCI, V255, P75, DOI 10.1006/jcis.2002.8623
   *I LAB AN RES NAT, 2010, COMM UPD GUID CAR US, P43891
   Ko PJ, 2009, LARYNGOSCOPE, V119, P2331, DOI 10.1002/lary.20615
   Kojima K, 2003, FASEB J, V17, P823, DOI 10.1096/fj.02-0462com
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makris D, 2007, CURR OPIN PULM MED, V13, P278, DOI 10.1097/MCP.0b013e32816b5c3b
   Makris D, 2010, CHEST, V137, P60, DOI 10.1378/chest.09-1275
   Martinod E, 2000, CR ACAD SCI III-VIE, V323, P455, DOI 10.1016/S0764-4469(00)00150-5
   Martinod E, 2001, REV MAL RESPIR, V18, P639
   NEVILLE WE, 1976, J THORAC CARDIOV SUR, V72, P596
   Schultz P, 2007, EUR ARCH OTO-RHINO-L, V264, P433, DOI 10.1007/s00405-006-0195-7
   Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5
   Schultz P, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P201
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   Seguin A, 2006, ANN THORAC SURG, V81, P1068, DOI 10.1016/j.athoracsur.2005.07.079
   Seguin A, 2009, ANN THORAC SURG, V87, P861, DOI 10.1016/j.athoracsur.2008.11.038
   ten Hallers EJO, 2004, BIOMATERIALS, V25, P1533, DOI 10.1016/S0142-9612(03)00500-3
   Tojo T, 1998, ANN THORAC SURG, V66, P209, DOI 10.1016/S0003-4975(98)00270-7
   Wurtz A, 2010, J THORAC CARDIOV SUR, V140, P387, DOI 10.1016/j.jtcvs.2010.01.043
NR 30
TC 6
Z9 8
U1 0
U2 7
PU JOURNAL REHAB RES & DEV
PI BALTIMORE
PA DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET,
   BALTIMORE, MD 21202-4051 USA
SN 0748-7711
J9 J REHABIL RES DEV
JI J. Rehabil. Res. Dev.
PY 2011
VL 48
IS 7
BP 851
EP 863
DI 10.1682/JRRD.2010.10.0194
PG 13
WC Rehabilitation
SC Rehabilitation
GA 828LV
UT WOS:000295503400010
PM 21938669
OA Bronze
DA 2018-10-20
ER

PT J
AU Yamazaki, T
   Ikeda, T
   Lim, B
   Okumura, K
   Ishida, M
   Sawada, K
AF Yamazaki, Tomoyuki
   Ikeda, Takaaki
   Lim, Byounghyun
   Okumura, Koichi
   Ishida, Makoto
   Sawada, Kazuaki
TI Smart Integrated Sensor for Multiple Detections of Glucose and L-Lactate
   Using On-Chip Electrochemical System
SO JOURNAL OF SENSORS
LA English
DT Article
ID CMOS SENSOR; L-LYSINE; OXIDASE; ELECTRODE; FABRICATION; BIOCHIP;
   REACTOR; SAMPLES; DESIGN; LAYER
AB Multiple sensor electrodes, a supplementary electrode, a reference electrode, and signal-processing circuits were integrated on a single chip to develop a chip-shaped electrochemical sensing system. L-lactate and glucose were measured using on-chip working electrodes modified by polyion complex to immobilize lactate oxidase and glucose oxidase, respectively. Cyclic voltammetry measurements were conducted using an on-chip potentiostat. Selective and quantitative detection of glucose and L-lactate and the interference behavior were studied. Hydrogen peroxide generated by enzymatic reactions was detected by an increase in anodic oxidation current. Reaction currents at +0.7 V versus Ag/AgCl were used to obtain calibration plots. The measured dynamic ranges for L-lactate and glucose were 0.2-1.0mM and 2.0-8.0mM, respectively. The sensitivities were 65 nA/mM and 15 nA/mM, respectively, using a working electrode of 0.5mm(2). The 3 sigma detection limit was 0.19mMand 1.1mM, respectively. We have achieved multiple biomaterial detections on a circuit-equipped single chip. This integrated electrochemical sensor chip could be the best candidate for realizing point-of-care testing due to its portability and potential for mass production.
C1 [Yamazaki, Tomoyuki; Ikeda, Takaaki; Lim, Byounghyun; Okumura, Koichi; Ishida, Makoto; Sawada, Kazuaki] Toyohashi Univ Technol, Elect & Informat Engn Dept, Toyohashi, Aichi 4418580, Japan.
   [Yamazaki, Tomoyuki] Hioki EE Corp, New Prod Dev Dept, Ueda, Nagano 3861192, Japan.
   [Ishida, Makoto; Sawada, Kazuaki] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan.
RP Yamazaki, T (reprint author), Toyohashi Univ Technol, Elect & Informat Engn Dept, C3-601,1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM yamazaki-t@int.ee.tut.ac.jp
FU Global COE Program "Frontiers of Intelligent Sensing" from the Ministry
   of Education, Culture, Sports, Science and Technology
FX The authors thank Professor Fumio Mizutani for information on the
   polyion complex method and Mr. Naoto Nakayama for helpful discussions.
   This work was supported in part by the Global COE Program "Frontiers of
   Intelligent Sensing" from the Ministry of Education, Culture, Sports,
   Science and Technology.
CR Avramescu A, 2002, ANAL CHIM ACTA, V458, P203, DOI 10.1016/S0003-2670(01)01580-X
   Baader J., 2010, BIOSENS BIOELECTRON, V26, P1839
   Barbaro M, 2006, SENSOR ACTUAT B-CHEM, V118, P41, DOI 10.1016/j.snb.2006.04.010
   Cheng YT, 2007, SENSOR ACTUAT B-CHEM, V120, P758, DOI 10.1016/j.snb.2006.03.045
   de Oliveira ACA, 2005, ANAL CHIM ACTA, V535, P213, DOI 10.1016/j.aca.2004.11.053
   Fischer LM, 2009, MICROELECTRON ENG, V86, P1282, DOI 10.1016/j.mee.2008.11.045
   Frebel H, 1997, SENSOR ACTUAT B-CHEM, V43, P87, DOI 10.1016/S0925-4005(97)00133-0
   Haccoun J, 2006, BIOELECTROCHEMISTRY, V68, P218, DOI 10.1016/j.bioelechem.2005.09.001
   IIJIMA S, 1993, ANAL CHIM ACTA, V281, P483, DOI 10.1016/0003-2670(93)85006-6
   Jia WZ, 2010, TRAC-TREND ANAL CHEM, V29, P306, DOI 10.1016/j.trac.2010.01.006
   Kurita R, 2002, SENSOR ACTUAT B-CHEM, V87, P296, DOI 10.1016/S0925-4005(02)00249-6
   Levine PM, 2008, IEEE J SOLID-ST CIRC, V43, P1859, DOI 10.1109/JSSC.2008.925407
   Liu SQ, 2007, BIOSENS BIOELECTRON, V22, P905, DOI 10.1016/j.bios.2006.03.019
   MIZUTANI F, 1995, ANAL CHIM ACTA, V314, P233, DOI 10.1016/0003-2670(95)00278-8
   Mizutani F, 1996, DENKI KAGAKU, V64, P1266
   Pan DW, 2005, SENSOR ACTUAT B-CHEM, V104, P68, DOI 10.1016/j.snb.2004.04.100
   Parra A, 2006, ANAL CHIM ACTA, V555, P308, DOI 10.1016/j.aca.2005.09.025
   Patel NG, 2000, SENSOR ACTUAT B-CHEM, V67, P134, DOI 10.1016/S0925-4005(00)00410-X
   Shi Y, 2008, SENSOR ACTUAT B-CHEM, V131, P516, DOI 10.1016/j.snb.2007.12.053
   Tokuda T, 2007, SENSOR ACTUAT A-PHYS, V135, P315, DOI 10.1016/j.sna.2006.08.027
   Yamazaki T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DL11
NR 21
TC 2
Z9 2
U1 0
U2 16
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-725X
EI 1687-7268
J9 J SENSORS
JI J. Sens.
PY 2011
AR 190284
DI 10.1155/2011/190284
PG 7
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA V31DS
UT WOS:000208864900003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Carnio, S
   Serena, E
   Rossi, CA
   De Coppi, P
   Elvassore, N
   Vitiello, L
AF Carnio, Silvia
   Serena, Elena
   Rossi, Carlo Alberto
   De Coppi, Paolo
   Elvassore, Nicola
   Vitiello, Libero
TI Three-dimensional porous scaffold allows long-term wild-type cell
   delivery in dystrophic muscle
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE collagen scaffold; biomaterials; reservoir; muscle precursor cells;
   dystrophin; mdx
ID DUCHENNE MUSCULAR-DYSTROPHY; HUMAN MYOBLAST TRANSPLANTATION; NORMAL
   MYOGENIC CELLS; SKELETAL-MUSCLE; COLLAGEN SCAFFOLD; PRECURSOR CELLS;
   SATELLITE CELLS; STEM-CELLS; THERAPY; REGENERATION
AB Duchenne muscular dystrophy (DMD) is caused by the lack of dystrophin; affected muscles are characterized by continuous bouts of muscle degeneration, eventually leading to the exhaustion of the endogenous satellite cell pool. At present, only palliative treatments are available, although several gene and cell therapy-based approaches are being studied. In this study we proposed to overcome the limitations hampering intramuscular cell injection by using a biomaterial-based strategy. In particular, we used a three-dimensional (3D) collagen porous scaffold to deliver myogenic precursor cells (MPCs) in vivo in the mdx murine model of DMD. MPCs, derived from single fibres of wild-type donors, were expanded in vitro, seeded onto collagen scaffolds and implanted into the tibialis anterior muscles of normal and mdx mice. As a control, cells were delivered via direct intramuscular cell injection in the contralateral muscles. Scaffold-delivered MPCs displayed lower apoptosis and higher proliferation than injected cells; in terms of dystrophin restoration, collagen scaffolds yielded better results than direct injections. Importantly, time-course experiments indicated that the scaffolds acted as a cell reservoir, although cell migration was mostly contained within 400 mu m from the scaffold-host tissue interface. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Carnio, Silvia; Serena, Elena; Elvassore, Nicola] Univ Padua, Dept Chem Engn, I-35100 Padua, Italy.
   [Carnio, Silvia; Vitiello, Libero] Univ Padua, Dept Biol, I-35121 Padua, Italy.
   [Carnio, Silvia; Rossi, Carlo Alberto; Elvassore, Nicola] Venetian Inst Mol Med, Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Univ Padua, Stem Cell Proc Lab, I-35100 Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Univ Padua, Div Paediat Surg, Dept Paediat, I-35100 Padua, Italy.
   [Rossi, Carlo Alberto; De Coppi, Paolo] UCL Inst Child Hlth, Surg Unit, London, England.
   [Rossi, Carlo Alberto; De Coppi, Paolo] Great Ormond St Hosp Sick Children, London, England.
RP Elvassore, N (reprint author), Univ Padua, Dept Chem Engn, Via Marzolo 9, I-35100 Padua, Italy.
EM nicola.elvassore@unipd.it; libero.vitiello@unipd.it
OI De Coppi, Paolo/0000-0002-1659-0207
FU Ministry of Research; University of Padova; Fondazione Telethon
   [GGP07216]; Foundation Il Sangue; Great Ormond Street Hospital Childrens
   Charity [V1230]
FX We thank the Italian Ministry of Research, the University of Padova,
   Fondazione Telethon (Grant No. GGP07216, to P.D.C.) and Foundation Il
   Sangue. No conflict of interest, economic or academic, exists for any of
   the authors.
CR Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113
   Bian WN, 2008, IEEE ENG MED BIOL, V27, P109, DOI 10.1109/MEMB.2008.928460
   Boldrin L, 2007, TISSUE ENG, V13, P253, DOI 10.1089/ten.2006.0093
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Ciardelli G, 2010, J BIOMED MATER RES A, V92A, P137, DOI 10.1002/jbm.a.32344
   Cimetta E, 2007, INT J ARTIF ORGANS, V30, P415
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8
   Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970
   GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0
   Hill E, 2006, TISSUE ENG, V12, P1295, DOI 10.1089/ten.2006.12.1295
   HUARD J, 1991, CLIN SCI, V81, P287, DOI 10.1042/cs0810287
   HUARD J, 1992, MUSCLE NERVE, V15, P550, DOI 10.1002/mus.880150504
   HUARD J, 1994, MUSCLE NERVE, V17, P224, DOI 10.1002/mus.880170214
   Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X
   KINOSHITA I, 1994, MUSCLE NERVE, V17, P1407, DOI 10.1002/mus.880171210
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Muntoni F, 2007, CURR OPIN NEUROL, V20, P590, DOI 10.1097/WCO.0b013e3282efc157
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145
   Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384
   Serena E, 2008, NEUROL RES, V30, P207, DOI 10.1179/174313208X281109
   Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023
   Skuk D, 2003, J NEUROPATH EXP NEUR, V62, P951, DOI 10.1093/jnen/62.9.951
   Skuk D, 2006, J NEUROPATH EXP NEUR, V65, P371, DOI 10.1097/01.jnen.0000218443.45782.81
   Tremblay JP, 2008, MOL THER, V16, P1907, DOI 10.1038/mt.2008.243
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
NR 34
TC 11
Z9 11
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2011
VL 5
IS 1
BP 1
EP 10
DI 10.1002/term.282
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 697AB
UT WOS:000285481400001
PM 20607681
DA 2018-10-20
ER

PT J
AU Branford, OA
   Brown, RA
   McGrouther, DA
   Grobbelaar, AO
   Mudera, V
AF Branford, O. A.
   Brown, R. A.
   McGrouther, D. A.
   Grobbelaar, A. O.
   Mudera, V.
TI Shear-aggregated fibronectin with anti-adhesive properties
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE anti-adhesion; biomaterial; cell attachment; fibronectin; interface;
   tendon
ID HEPARIN-BINDING DOMAIN; FLEXOR TENDON REPAIR; EXTRACELLULAR-MATRIX
   PROTEINS; DAMAGED SPINAL-CORD; PLASMA FIBRONECTIN; CELL ATTACHMENT;
   POSTOPERATIVE ADHESIONS; PERITENDINOUS ADHESIONS; BIOLOGICAL-ACTIVITIES;
   SYNOVIAL FIBROBLASTS
AB Biomaterials based on proteins, such as fibronectin, have the potential to guide cell and tissue behaviour during healing as a function of their unique mechanical and bioactive properties. Fibronectin has been reported as a scaffold for attachment of fibroblasts and subsequent deposition of collagen. We have recently developed a derivative process of shear-aggregated fibronectin that prevents cell attachment without causing cell death. This has potential applications in clinical situations where adhesions form across gliding surfaces and cause loss of function, e. g. peritoneal or flexor tendon adhesions. This in vitro study tested this derivative fibronectin biomaterial and its effects on aggressive adhesion-forming cells, using rabbit flexor tendon synovial fibroblasts. We investigated degradation of the novel biomaterial, and attachment of fibroblasts to glass coated with the biomaterial, relative to fibroblast attachment to uncoated and fibronectin-coated glass. We assessed infiltration of the derivative fibronectin biomaterial by fibroblasts and cytotoxicity of the biomaterial to fibroblasts. The interaction between fibroblasts and the derivative fibronectin biomaterial was visualized using time-lapse photography. The derivative fibronectin biomaterial dissolved by 88% of its mass by 3 weeks. Fibroblast attachment to the novel biomaterial was significantly reduced at 6 h. After 24 h of exposure to the novel biomaterial, fibroblasts did not migrate into it, there was no cell death and no attachment was seen using time-lapse. This novel derivative fibronectin biomaterial combines inhibition of fibroblast attachment with barrier effects and has suitable mechanical properties for surgical use in preventing adhesions in vivo. Copyright. (C) 2010 John Wiley & Sons, Ltd.
C1 [Branford, O. A.; Grobbelaar, A. O.] Mt Vernon Hosp, RAFT, Northwood HA6 2RN, Middx, England.
   [Brown, R. A.; Mudera, V.] Univ Coll London, Div Surg & Intervent Sci, Tissue Repair & Engn Ctr, Inst Orthopaed, Stanmore, Middx, England.
   [McGrouther, D. A.] Univ Manchester Plast & Reconstruct Surg Res, Manchester, Lancs, England.
RP Branford, OA (reprint author), Mt Vernon Hosp, RAFT, Leopold Muller Bldg, Northwood HA6 2RN, Middx, England.
EM olivier.branford@totalise.co.uk
OI Branford, Olivier/0000-0003-3711-3394
FU Big Lottery UK; Biotechnology and Biological Sciences Research Council
FX This project was supported by the Big Lottery UK and the Biotechnology
   and Biological Sciences Research Council. The cold precipitate raw
   material for the mats was donated from Bio Products Laboratory, Elstree,
   UK. We would like to thank Dr James Phillips, and Rebecca Porter,
   University College London Tissue Repair and Engineering Centre, for
   their technical help with this study. There are no financial or personal
   relationships between ourselves and others that might bias this work. No
   potential conflicts of interest exist in this study.
CR AHMED Z, 1999, ADHESION, V42, P331
   ASHLEY F L, 1964, Plast Reconstr Surg, V33, P411, DOI 10.1097/00006534-196405000-00001
   AUSTIN RT, 1979, INJURY, V10, P211, DOI 10.1016/0020-1383(79)90011-1
   Beredjiklian PK, 2003, J BONE JOINT SURG AM, V85A, P539, DOI 10.2106/00004623-200303000-00025
   Branford OA, 2008, PLAST RECONSTR SURG, V121, P781, DOI 10.1097/01.prs.0000299373.25294.65
   BRIGMAN BE, 1994, J ORTHOPAED RES, V12, P253, DOI 10.1002/jor.1100120215
   BROWN RA, 1983, LANCET, V2, P1058
   BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9
   BURT A, 1992, ANIMAL CELL BIOTECHN, P158
   Chung AS, 2009, J BIOMED MATER RES A, V89A, P841, DOI 10.1002/jbm.a.32431
   CLARK RAF, 1988, J BIOL CHEM, V263, P12115
   Clark RAF, 2003, J INVEST DERMATOL, V121, P695, DOI 10.1046/j.1523-1747.2003.12484.x
   COSGRIFF TM, 1983, VOX SANG, V44, P98, DOI 10.1111/j.1423-0410.1983.tb04109.x
   CZOP JK, 1982, J IMMUNOL, V129, P2678
   DARBY I, 1990, LAB INVEST, V63, P21
   DJERKOVIC GS, 2005, INT J ARTIF ORGANS, V28, P284
   EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4
   ESKELAND G, 1977, J BONE JOINT SURG BR, V59, P206
   Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416
   FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018
   Fukai F, 2000, CELL MOL BIOL, V46, P145
   Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189
   Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076
   GELBERMAN RH, 1991, J HAND SURG-AM, V16A, P686, DOI 10.1016/0363-5023(91)90195-H
   Golash A, 2003, J HAND SURG-BRIT EUR, V28B, P113, DOI 10.1016/S0266-7681(02)00249-8/jhsb.2003.0851
   GRINNELL F, 1994, J INVEST DERMATOL, V103, P155, DOI 10.1111/1523-1747.ep12392625
   GRINNELL F, 1992, J INVEST DERMATOL, V98, P410, DOI 10.1111/1523-1747.ep12499839
   GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206
   Hanff G, 1998, J HAND SURG-AM, V23A, P658, DOI 10.1016/S0363-5023(98)80052-X
   Harding SI, 2002, BIOPROC BIOSYST ENG, V25, P53, DOI 10.1007/s004490100268
   Harding SI, 2000, BIOPROCESS ENG, V22, P159, DOI 10.1007/s004490050025
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   HIRAIZUMI Y, 1995, SPINE, V20, P2272, DOI 10.1097/00007632-199511000-00002
   HOFER U, 1990, J BIOL CHEM, V265, P14561
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   HOMANDBERG GA, 1992, J BIOL CHEM, V267, P3597
   HOMANDBERG GA, 1987, BIOPOLYMERS, V26, P2087, DOI 10.1002/bip.360261208
   HOMANDBERG GA, 1986, BIOCHIM BIOPHYS ACTA, V874, P61, DOI 10.1016/0167-4838(86)90102-0
   Jeekel H., 1997, EUR J SURG S, V579, P43
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kato R, 2001, EXP CELL RES, V265, P54, DOI 10.1006/excr.2001.5179
   Khan U, 1996, J HAND SURG-BRIT EUR, V21B, P813, DOI 10.1016/S0266-7681(96)80199-9
   Khan U, 2000, J BONE JOINT SURG BR, V82B, P1054, DOI 10.1302/0301-620X.82B7.9892
   Khan U, 1997, PLAST RECONSTR SURG, V99, P465, DOI 10.1097/00006534-199702000-00023
   Khan U, 1998, J HAND SURG-AM, V23A, P266, DOI 10.1016/S0363-5023(98)80125-1
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Kitsis CK, 1998, J HAND SURG-BRIT EUR, V23B, P344, DOI 10.1016/S0266-7681(98)80055-7
   KULICK MI, 1986, J HAND SURG-AM, V11A, P110, DOI 10.1016/S0363-5023(86)80116-2
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   Menzies D, 2001, ANN ROY COLL SURG, V83, P40
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   MEREDITH JE, 1997, ANN R COLL SURG ENGL, V7, P146
   MOORADIAN DL, 1992, INVEST OPHTH VIS SCI, V33, P3034
   MOULD AP, 1991, EMBO J, V10, P4089, DOI 10.1002/j.1460-2075.1991.tb04985.x
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   OBARA M, 1988, FDS, V53, P649
   Oharazawa H, 2005, OPHTHAL RES, V37, P191, DOI 10.1159/000086595
   Peck FH, 1998, J HAND SURG-BRIT EUR, V23B, P41, DOI 10.1016/S0266-7681(98)80216-7
   PETERSON WW, 1990, J HAND SURG-AM, V15A, P48, DOI 10.1016/S0363-5023(09)91105-4
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   POTENZA AD, 1963, J BONE JOINT SURG AM, V45, P1217, DOI 10.2106/00004623-196345060-00009
   POTENZA AD, 1962, J BONE JOINT SURG AM, V44, P49, DOI 10.2106/00004623-196244010-00004
   Priestley JV, 2002, J PHYSIOL-PARIS, V96, P123, DOI 10.1016/S0928-4257(01)00088-2
   Ragoowansi R, 2003, J HAND SURG-BRIT EUR, V28B, P465, DOI 10.1016/S0266-7681(03)00140-2
   RIEDERERHENDERSON MA, 1983, IN VITRO CELL DEV B, V19, P127
   ROCCO M, 1983, J BIOL CHEM, V258, P4545
   RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   Sakata N, 2000, CONNECT TISSUE RES, V41, P213, DOI 10.3109/03008200009005291
   SCOVILL WA, 1978, ANN SURG, V188, P521, DOI 10.1097/00000658-197810000-00009
   Sethi KK, 2002, CELL MOTIL CYTOSKEL, V52, P231, DOI 10.1002/cm.10047
   SHIMOOKA T, 1988, CELL STRUCT FUNCT, V13, P515, DOI 10.1247/csf.13.515
   SIDDIQI NA, 1995, J APPL BIOMATER, V6, P43, DOI 10.1002/jab.770060107
   SKORSTENGAARD K, 1986, EUR J BIOCHEM, V154, P15, DOI 10.1111/j.1432-1033.1986.tb09353.x
   STACK MS, 1993, J BIOL CHEM, V268, P18924
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   STARK HH, 1977, J BONE JOINT SURG AM, V59, P908, DOI 10.2106/00004623-197759070-00012
   Strickland J W, 1985, Hand Clin, V1, P167
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   THOMAS SC, 1986, CLIN ORTHOP RELAT R, P281
   TSUKADA H, 1995, CIRC RES, V77, P651, DOI 10.1161/01.RES.77.4.651
   Underwood S, 2001, BIOTECHNOL BIOENG, V73, P295, DOI 10.1002/bit.1062
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   WHITBY DJ, 1991, DEVELOPMENT, V112, P651
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   WILKE MS, 1991, J INVEST DERMATOL, V97, P573, DOI 10.1111/1523-1747.ep12481915
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
   YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105
   Zavahir F, 2001, J MATER SCI-MATER M, V12, P1005, DOI 10.1023/A:1012877504092
   ZLATOPOL'SKII A D, 1989, Biokhimiya, V54, P74
   ZLATOPOLSKY AD, 1992, BIOCHEM BIOPH RES CO, V183, P383, DOI 10.1016/0006-291X(92)90492-4
NR 101
TC 6
Z9 6
U1 0
U2 7
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JAN
PY 2011
VL 5
IS 1
BP 20
EP 31
DI 10.1002/term.284
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 697AB
UT WOS:000285481400003
PM 20652877
DA 2018-10-20
ER

PT J
AU Vavken, P
   Joshi, SM
   Murray, MM
AF Vavken, Patrick
   Joshi, Shilpa M.
   Murray, Martha M.
TI Fibrin concentration affects ACL fibroblast proliferation and collagen
   synthesis
SO KNEE
LA English
DT Article
DE Fibrin; Wound healing; Fibroblast; Tissue engineering
ID ANTERIOR CRUCIATE LIGAMENT; PLATELET-RICH PLASMA; MESENCHYMAL
   STEM-CELLS; REPAIR; SCAFFOLD; KNEE; OSTEOARTHRITIS; DEPENDENCE;
   SEALANTS; THROMBIN
AB Fibrin is a frequently used biomaterial in surgery and tissue engineering. While it has been shown that fibrin supports cellular proliferation and biosynthesis, there is a scarcity of studies focusing on the effects of fibrin concentration. The objective of this study is to assess the effect of fibrin concentrations around the physiological concentration of 3 mg/ml on the behavior of ligament fibroblasts. Fibroblasts were obtained from the anterior cruciate ligaments of four pigs and seeded throughout fibrin gels of either 1, 3, or 6 mg/ml fibrin. The gels were collected at 2, 6, and 10 days for measurement of DNA and collagen content. We found that both DNA and collagen content increased significantly over time in gels made with all concentrations of fibrin. However, the increases were significantly lower in gels made with the higher concentrations of fibrin (3 and 6 mg/ml). Microscopic assessment of FITC-labeled gels showed a decrease in pore size at high fibrin concentrations, which might be a reason for the observed effect on bioactivity. To enhance cell behavior and thus clinical results fibrin applications should build on physiologic or sub-physiologic concentrations, and those with higher concentrations, such as currently available sealants, should be used cautiously. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Vavken, Patrick; Joshi, Shilpa M.; Murray, Martha M.] Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med, Boston, MA 02115 USA.
RP Vavken, P (reprint author), Harvard Univ, Childrens Hosp Boston, Dept Orthoped Surg, Sch Med, 300 Longwood Ave,Enders 1016, Boston, MA 02115 USA.
EM patrick.vavken@childrens.harvard.edu
FU NIH-NIAMS [R01 AR052772]
FX This study was supported by the NIH-NIAMS grant R01 AR052772.
CR Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   ARNESON D, 1976, THROMB RES, V8, P31, DOI 10.1016/0049-3848(76)90120-1
   ARRUDA V, 2008, HARRISONS PRINCIPLES, pCH110
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Cheras PA, 1997, CLIN ORTHOP RELAT R, P57
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   GIDDINGS JC, 1971, J CLIN PATHOL, V24, P467, DOI 10.1136/jcp.24.5.467
   Gorodetsky R, 1999, J INVEST DERMATOL, V112, P866, DOI 10.1046/j.1523-1747.1999.00600.x
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Kamolz LP, 2005, BURNS, V31, P25, DOI 10.1016/j.burns.2004.06.015
   Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601
   Kratz A, 2008, HARRISONS PRINCIPLES
   MASTRANGELO A, 2009, J ORTHOP RE IN PRESS
   Mastrangelo AN, 2010, J ORTHOP RES, V28, P644, DOI 10.1002/jor.21018
   Meana A, 1998, BURNS, V24, P621, DOI 10.1016/S0305-4179(98)00107-7
   Mohtadi N, 2006, CLIN J SPORT MED, V16, P457, DOI 10.1097/01.jsm.0000248844.39498.1f
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2009, CLIN SPORT MED, V28, P51, DOI 10.1016/j.csm.2008.08.005
   Murray MM, 2009, J ORTHOP RES, V27, P639, DOI 10.1002/jor.20796
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2006, J ORTHOP RES, V24, P508, DOI 10.1002/jor.20054
   Murray MM, 2004, AM J SPORT MED, V32, P1484, DOI 10.1177/0363546504263700
   Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827
   Pandit AS, 2000, J BIOMATER APPL, V14, P229, DOI 10.1177/088532820001400303
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   VAVKEN P, 2009, J ORTHOP RES
   VAVKEN P, 2009, TISSUE ENG PART A, DOI DOI 10.1089/TEN.TEA.2009.0147
   Visna P, 2004, ACTA CHIR BELG, V104, P709, DOI 10.1080/00015458.2004.11679648
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
NR 32
TC 17
Z9 18
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-0160
EI 1873-5800
J9 KNEE
JI Knee
PD JAN
PY 2011
VL 18
IS 1
BP 42
EP 46
DI 10.1016/j.knee.2009.12.008
PG 5
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 715FP
UT WOS:000286866300009
PM 20080411
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhao, SW
   Chen, A
   Revzin, A
   Pan, TR
AF Zhao, Siwei
   Chen, Arnold
   Revzin, Alexander
   Pan, Tingrui
TI Stereomask lithography (SML): a universal multi-object micro-patterning
   technique for biological applications
SO LAB ON A CHIP
LA English
DT Article
ID EMBRYONIC STEM-CELLS; ARRAYS; CULTURE; MICROARRAYS; GROWTH;
   PHOTOLITHOGRAPHY; DIFFERENTIATION; ORIENTATION; FABRICATION; TECHNOLOGY
AB The advent of biological micro-patterning techniques has given new impetus to many areas of biological research, including quantitative biochemical analysis, tissue engineering, biosensing, and regenerative medicine. Derived from photolithography or soft lithography, current bio-patterning approaches have yet to completely address the needs of out-of-cleanroom, universal applicability, high feature resolution, as well as multi-object placement, though many have shown great promise to precisely pattern one specific biomaterial. In this paper, we present a novel versatile biological lithography technique to achieve integrated multi-object patterning with high feature resolution and high adaptability to various biomaterials, referred to as stereomask lithography (SML). Successive patterning of multiple objects is enabled by using unique three-dimensional masks (i.e., the stereomasks), which lay out current micropatterns while protecting pre-existing biological features on the substrate. Furthermore, high-precision reversible alignment among multiple bio-objects is achieved by adopting a peg-in-hole design between the substrate and stereomasks. We demonstrate that the SML technique is capable of constructing a complex biological microenvironment with various bio-functional components at the single-cell resolution, which to the best of our knowledge has not been realized before.
C1 [Zhao, Siwei; Chen, Arnold; Pan, Tingrui] Univ Calif Davis, Dept Biomed Engn, MiNI Lab, Davis, CA 95616 USA.
RP Pan, TR (reprint author), Univ Calif Davis, Dept Biomed Engn, MiNI Lab, Davis, CA 95616 USA.
EM tingrui@ucdavis.edu
FU National Science Foundation [ECCS-0846502, EFRI BSBA- 0937997]
FX This work is supported in part by National Science Foundation CAREER
   ECCS-0846502 and EFRI BSBA- 0937997. The authors would like to thank Dr
   Julie Sutcliffe and Dr Laura Marcu for use of the microscopes, and Dr
   Jiyoun Lee and Ms Jun Yan for technical assistance with cell culture and
   fluorescent microscopy. In addition, we would acknowledge DuPont Company
   for generously providing PerMX dry film samples.
CR Blicharz TM, 2009, ANAL CHEM, V81, P2106, DOI 10.1021/ac802181j
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen Y, 2003, CANCER RES, V63, P1927
   Choudhuri S, 2004, J BIOCHEM MOL TOXIC, V18, P171, DOI 10.1002/jbt.20023
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498
   Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gunderson Kevin L., 2009, V529, P197, DOI 10.1007/978-1-59745-538-1_13
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Ilic B., 2000, BIOMED MICRODEVICES, V2, P6
   Inoue I, 2001, LAB CHIP, V1, P50, DOI 10.1039/b103931h
   Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Lee JY, 2008, LANGMUIR, V24, P2232, DOI 10.1021/la702883d
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   LIJEON N, 2002, NAT BIOTECHNOL, V20, P826
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Ma HC, 2006, DRUG DISCOV TODAY, V11, P661, DOI 10.1016/j.drudis.2006.05.002
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Naffar-Abu-Amara S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001457
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0
   Pan T, 2006, J MICROELECTROMECH S, V15, P267, DOI 10.1109/JMEMS.2005.859200
   Pirone DM, 2004, J MAMMARY GLAND BIOL, V9, P405, DOI 10.1007/s10911-004-1410-z
   Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Shah SS, 2009, ACS APPL MATER INTER, V1, P2592, DOI 10.1021/am900508m
   Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076
   Tan CP, 2010, NANO LETT, V10, P719, DOI 10.1021/nl903968s
   Tan CP, 2009, INTEGR BIOL, V1, P587, DOI 10.1039/b908036h
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786
   Vulto P, 2005, LAB CHIP, V5, P158, DOI [10.1039/b411885e, 10.1039/b411885c]
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Zhao SW, 2009, LAB CHIP, V9, P1128, DOI 10.1039/b817925e
   Zhu H, 2008, LAB CHIP, V8, P2197, DOI 10.1039/b810244a
NR 48
TC 21
Z9 21
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 2
BP 224
EP 230
DI 10.1039/c0lc00275e
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 697LI
UT WOS:000285514700005
PM 21113523
DA 2018-10-20
ER

PT J
AU Ghafar-Zadeh, E
   Waldeisen, JR
   Lee, LP
AF Ghafar-Zadeh, Ebrahim
   Waldeisen, John R.
   Lee, Luke P.
TI Engineered approaches to the stem cell microenvironment for cardiac
   tissue regeneration
SO LAB ON A CHIP
LA English
DT Review
ID SMOOTH-MUSCLE-CELLS; FLUID SHEAR-STRESS; ELECTRICAL-STIMULATION;
   IN-VITRO; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; CARDIOMYOCYTE
   PHENOTYPE; ENDOTHELIAL-CELLS; FIELD STIMULATION; PROGENITOR CELLS
AB Micro- and nanoscale engineering approaches in medicine have the potential to recreate physiologically relevant stem cell microenvironments to enhance our understanding of stem cell behaviour and bring stem cell therapy closer to fruition. The realization of such advancements will impact a number of therapeutic applications, the most immediate of which may be the repair of heart tissue. Despite profound advances in creating physiologically relevant in vivo stem cell niches through the control of biochemical regulatory factors, further synergism of innovative techniques promise to elucidate the impact of a number of physical cues such as stem cell differentiation into cardiac cells, the electromechanical coupling among these cells, and the formation of bioengineered cardiac tissue grafts. This review examines the recent physiologically relevant micro-and nanoengineering efforts that have been made to address these factors. In Sections II and III, we introduce the traditional focuses of stem cell derived cardiac tissue: differentiation directed by transcription factors and structural cues within the stem cell niche. However, the majority of this review, Sections IV-VII, endeavours to highlight innovative and unconventional microscale engineering techniques that have employed topographic, biomaterial, microfluidic, mechanical, electrical, and optical stimulation for stem cell based cardiac tissue engineering.
C1 [Ghafar-Zadeh, Ebrahim; Waldeisen, John R.; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Waldeisen, John R.; Lee, Luke P.] Univ Calif Berkeley, UCSF Grad Program Bioengn, Berkeley, CA 94720 USA.
RP Lee, LP (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM lplee@berkeley.edu
FU Natural Sciences and Engineering Research Council (NSERC) of Canada
FX E. G. gratefully acknowledges support from the Natural Sciences and
   Engineering Research Council (NSERC) of Canada for awarding him a
   Post-Doctoral Fellowship.
CR Abilez O, 2006, J SURG RES, V132, P170, DOI 10.1016/j.jss.2006.2.017
   ALLEGRE G, 1994, NEUROSCI LETT, V180, P261, DOI 10.1016/0304-3940(94)90534-7
   [Anonymous], 2010, HEART DIS STROK UPD
   Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Au HTH, 2009, LAB CHIP, V9, P564, DOI 10.1039/b810034a
   BALABAN P, 1992, LASER SURG MED, V12, P329, DOI 10.1002/lsm.1900120315
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Belus A, 2003, J PHYSIOL-LONDON, V546, P501, DOI 10.1113/jphysiol.2002.027573
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Bursac Nenad, 2009, IEEE Eng Med Biol Mag, V28, P84, DOI 10.1109/MEMB.2009.931792
   Cantz T, 2010, ADV BIOCHEM ENG BIOT, V123, P107, DOI 10.1007/10_2010_74
   Chen MQ, 2010, BIOTECHNOL PROGR, V26, P1164, DOI 10.1002/btpr.431
   Chen MQ, 2009, CELL MOL BIOENG, V2, P625, DOI 10.1007/s12195-009-0096-0
   Chiu LL, 2008, TISSUE ENG PART A, V14, P1
   Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Chronis N, 2003, OPT EXPRESS, V11, P2370, DOI 10.1364/OE.11.002370
   Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169
   Cohen-Karni T., 2010, P NATL ACAD SCI USA, V107, P15
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Di Carlo D, 2006, ANAL CHEM, V78, P7918
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dvir T., 2010, NAT REV MOL CELL BIO, V12, P36
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   FORK RL, 1971, SCIENCE, V171, P907, DOI 10.1126/science.171.3974.907
   Genovese JA, 2008, BIOCHEM BIOPH RES CO, V370, P450, DOI 10.1016/j.bbrc.2008.03.115
   GIMENO MA, 1967, NATURE, V214, P1014, DOI 10.1038/2141014a0
   Gottwald E, 2007, LAB CHIP, V7, P777, DOI 10.1039/b618488j
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050
   Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056
   Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282
   Huang NF, 2007, TISSUE ENG, V13, P1809, DOI 10.1089/ten.2006.0096
   Huang Y, 2010, ARCH MED RES, V41, P497, DOI 10.1016/j.arcmed.2010.10.002
   Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305
   Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166
   Jeong KH, 2004, OPT EXPRESS, V12, P2494, DOI 10.1364/OPEX.12.002494
   Kaasik A, 2010, CARDIOVASC RES, V87, P83, DOI 10.1093/cvr/cvq039
   Kamkin AG, 2008, PHYSL MOL BIOL CELL
   Kamkin A, 2010, MECHANOSENS CELLS TI, V3, P239, DOI 10.1007/978-90-481-2850-1_9
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Kawahara Y, 2006, PATHOBIOLOGY, V73, P288, DOI 10.1159/000099123
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khine M, 2005, LAB CHIP, V5, P38, DOI 10.1039/b408352k
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kreysing MK, 2008, OPT EXPRESS, V16, P16984, DOI 10.1364/OE.16.016984
   Kurpinski Kyle, 2006, Molecular & Cellular Biomechanics, V3, P21
   Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038
   Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614
   Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030
   Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034
   Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631
   Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Malleo D, 2010, MICROFLUID NANOFLUID, V9, P191, DOI 10.1007/s10404-009-0534-2
   Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Martherus RSRM, 2010, BIOTECHNIQUES, V48, P65, DOI 10.2144/000113308
   Mayer-Wagner S, 2011, BIOELECTROMAGNETICS, V32, P283, DOI 10.1002/bem.20633
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Murtuza B, 2009, TISSUE ENG PART B-RE, V15, P443, DOI 10.1089/ten.TEB.2009.0006
   Musunuru K., 2010, ANNU REV MED, V61, P287
   Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562
   NATHAN RD, 1976, J GEN PHYSIOL, V67, P27, DOI 10.1085/jgp.67.1.27
   Neild A, 2007, BIOTECHNOL BIOENG, V97, P1335, DOI 10.1002/bit.21315
   Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Oberti S, 2010, ULTRASONICS, V50, P247, DOI 10.1016/j.ultras.2009.09.004
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Oyamada Y, 1996, EXP CELL RES, V229, P318, DOI 10.1006/excr.1996.0377
   Park JS, 2007, FRONT BIOSCI-LANDMRK, V12, P5098, DOI 10.2741/2551
   Park JY, 2009, LAB CHIP, V9, P2194, DOI 10.1039/b822006a
   Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896
   Peters A, 2009, TISSUE ENG PART B-RE, V15, P225, DOI [10.1089/ten.teb.2009.0049, 10.1089/ten.TEB.2009.0049]
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Rabaey K, 2010, NAT REV MICROBIOL, V8, P706, DOI 10.1038/nrmicro2422
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M., 2010, P NATL ACAD SCI USA, V107, P3329
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731
   Sachinidis A, 2003, CELL PHYSIOL BIOCHEM, V13, P423, DOI 10.1159/000075130
   Sauer H., 1996, J CELL BIOCHEM, V74, P710
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e
   Sheng T, 2005, CIRCULATION, V111, P2438, DOI 10.1161/01.CIR.0000167553.49133.81
   Shi JJ, 2008, LAB CHIP, V8, P221, DOI 10.1039/b716321e
   Shi JJ, 2009, LAB CHIP, V9, P3354, DOI 10.1039/b915113c
   Shi JJ, 2009, LAB CHIP, V9, P2890, DOI 10.1039/b910595f
   Shimko VF, 2008, TISSUE ENG PT A, V14, P49, DOI 10.1089/ten.a.2007.0092
   Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m
   Smith NI, 2008, OPT EXPRESS, V16, P8604, DOI 10.1364/OE.16.008604
   Sraj I, 2010, BIOMED OPT EXPRESS, V1, P482, DOI 10.1364/BOE.1.000482
   Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004
   Stern-Straeter J, 2005, J CELL MOL MED, V9, P883, DOI 10.1111/j.1582-4934.2005.tb00386.x
   Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Suzuki K, 2000, CIRCULATION, V102, P216
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Teo S. K., 2010, PHYS REV A, V81, P1
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tsai MT, 2009, J ORTHOP RES, V27, P1169, DOI 10.1002/jor.20862
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Villa M, 2010, BIOMED MICRODEVICES, V12, P253, DOI 10.1007/s10544-009-9380-y
   Villa-Diaz LG, 2009, LAB CHIP, V9, P1749, DOI 10.1039/b820380f
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wang Y., 2006, NATURE, V441, P1097
   Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504
   Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Wu X. S., 1995, ENCYCLO HDB BIOMATE
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Xu WR, 2004, EXP BIOL MED, V229, P623
   Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yeh ETH, 2003, CIRCULATION, V108, P2070, DOI 10.1161/01.CIR.0000099501.52718.70
   Yi FF, 2009, ARCH MED RES, V40, P339, DOI 10.1016/j.arcmed.2009.06.005
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann Wolfram-Hubertus, 2007, Trends Cardiovasc Med, V17, P134, DOI 10.1016/j.tcm.2007.02.007
   Zimmermann WH, 2009, PEDIATR CARDIOL, V30, P716, DOI 10.1007/s00246-009-9405-6
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
NR 160
TC 45
Z9 47
U1 3
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
EI 1473-0189
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 18
BP 3031
EP 3048
DI 10.1039/c1lc20284g
PG 18
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 812BT
UT WOS:000294263400001
PM 21785806
DA 2018-10-20
ER

PT J
AU Luecha, J
   Hsiao, A
   Brodsky, S
   Liu, GL
   Kokini, JL
AF Luecha, Jarupat
   Hsiao, Austin
   Brodsky, Serena
   Liu, Gang Logan
   Kokini, Jozef L.
TI Green microfluidic devices made of corn proteins
SO LAB ON A CHIP
LA English
DT Article
ID ALPHA-ZEIN PROTEINS; SOFT LITHOGRAPHY; SURFACE-MORPHOLOGY; TENSILE
   PROPERTIES; CROSS-LINKING; WATER-VAPOR; MAIZE; FILMS; CYTOCOMPATIBILITY;
   BIOMATERIAL
AB An alternative green microfluidic device made of zein, a prolamin of corn, can be utilized as a disposable environmentally friendly microchip especially in agriculture applications. Using standard soft lithography and stereo lithography techniques, we fabricated thin zein films with microfluidic chambers and channels. These were bonded to both a glass slide and another zein film. The zein film with microfluidic features bonds irreversibly with other surfaces by vapor-deposition of ethanol to create an adhesive layer resulting in very little or no trapped air and small shape distortion. Zein-zein and zein-glass microfluidic devices demonstrated sufficient strength to facilitate fluid flow in a complex microfluidic design that showed no leakage under high hydraulic pressure. Zein-glass microfluidic devices with serpentine mixing design showed successful fluid manipulation as a concentration gradient of Rhodamine B solution was generated. The ease of fabrication and bonding and the flexibility and moldability of zein offer attractive possibilities for microfluidic device design and manufacturing. These devices can include several unit operations with mixing being one of the most commonly used. The zein-based microfluidic devices, made entirely from a biopolymer from agricultural origin, offer alternative environmentally friendly material choices that are less dependent on limited petroleum based polymer resources.
C1 [Hsiao, Austin; Liu, Gang Logan] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Luecha, Jarupat; Kokini, Jozef L.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.
   [Hsiao, Austin; Liu, Gang Logan] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Brodsky, Serena] Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61801 USA.
   [Liu, Gang Logan] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
RP Liu, GL (reprint author), Univ Illinois, Dept Bioengn, 1304 W Springfield Ave, Urbana, IL 61801 USA.
EM loganliu@illinois.edu; kokini@illinois.edu
FU Thai government; USDA [2007-35603-17744]
FX The authors thank to Scott Robinson, Catherine Wallace and Leilei Yin
   from Beckman Institute, University of Illinois Urbana-Champaign for
   their help in SEM imaging and fluorescence spectroscopy. Ms. Luecha
   thanks the Thai government for the financial support through the Royal
   Thai Government Scholarship. This work was partly supported by USDA
   grant 2007-35603-17744.
CR Altunakar B., 2010, P 13 NAN C EXP, V2
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Core J., 2002, AGR RES, V50, P20
   Domachuk P, 2010, ADV MATER, V22, P249, DOI 10.1002/adma.200900821
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   ESEN A, 1986, PLANT PHYSIOL, V80, P623, DOI 10.1104/pp.80.3.623
   ESEN A, 1987, J CEREAL SCI, V5, P117, DOI 10.1016/S0733-5210(87)80015-2
   Hernandez-Izquierdo VM, 2008, J FOOD SCI, V73, pR30, DOI 10.1111/j.1750-3841.2007.00636.x
   Kim S, 2004, IND CROP PROD, V20, P291, DOI 10.1016/j.indcrop.2003.10.013
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Lafleur JP, 2010, TALANTA, V81, P722, DOI 10.1016/j.talanta.2009.12.001
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lawton JW, 2004, CEREAL CHEM, V81, P1, DOI 10.1094/CCHEM.2004.81.1.1
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Lazstity R., 1996, CEREAL PROTEINS, P185
   LEHMAN RL, 2004, ADHESIVE CRC HDB MEC, P30
   Liu CM, 2010, J MATER SCI, V45, P6775, DOI 10.1007/s10853-010-4774-z
   Madeka H, 1996, CEREAL CHEM, V73, P433
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Neethirajan S, 2011, LAB CHIP, V11, P1574, DOI [10.1039/c0lc00230e, 10.1039/c01c00230e]
   Okos J.R., 2007, FOOD DEHYDRATION HDB, P601
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Parris N, 1997, J AGR FOOD CHEM, V45, P1596, DOI 10.1021/jf960809o
   Powell DE, 1999, ENVIRON SCI TECHNOL, V33, P3706, DOI 10.1021/es9903476
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Shi K, 2009, J AGR FOOD CHEM, V57, P2186, DOI 10.1021/jf803559v
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sidorova JM, 2009, NAT PROTOC, V4, P849, DOI 10.1038/nprot.2009.54
   Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045
   Sun QS, 2005, BIOPOLYMERS, V78, P268, DOI 10.1002/bip.20298
   TATHAM AS, 1993, J BIOL CHEM, V268, P26253
   Tsao CW, 2009, MICROFLUID NANOFLUID, V6, P1, DOI 10.1007/s10404-008-0361-x
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang HJ, 2009, COLLOID SURFACE B, V69, P109, DOI 10.1016/j.colsurfb.2008.11.015
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xi YQ, 2010, TALANTA, V82, P1072, DOI 10.1016/j.talanta.2010.06.007
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
NR 39
TC 15
Z9 15
U1 3
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PY 2011
VL 11
IS 20
BP 3419
EP 3425
DI 10.1039/c1lc20726a
PG 7
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 825JT
UT WOS:000295270100008
PM 21918783
DA 2018-10-20
ER

PT S
AU Peng, WX
   Xue, Q
   Wu, FJ
   Zhang, X
   Zhang, ZF
AF Peng Wan-xi
   Xue Qiu
   Wu Feng-juan
   Zhang Xu
   Zhang Zhong-feng
BE Zeng, D
TI Analysis on Health Risk of Volatile Organic Compounds of Smoked Bamboo
   Biomaterial by TD-GC-MS
SO MATERIALS, MECHATRONICS AND AUTOMATION, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT International Conference on Materials, Mechatronics and Automation
   (ICMMA 2011)
CY JAN 15-16, 2011
CL Melbourne, AUSTRALIA
SP Natl Univ Singapore, Int Sci & Engn Ctr
DE Health risk; Smoked bamboo; Volatile organic compounds; Biomaterial;
   TD-GC-MS
AB Smoked bamboo, which was made by bamboo in high temperature smoke, is a new indoors materials. In order to evaluate its potential health risk to human settlements, the volatile organic compounds of smoked bamboo biomaterial were adsorbed and determined by TD-GC-MS. And the main constituents of volatiles at 60 degrees C were cyclononasiloxane, octadecamethyl-(35.14%), acetic acid(23.27%), cyclotrisiloxane, hexamethyl- (9.53%), bicyclo[4.4.0]dec-1-ene,2-isoprop yl-5-methyl-9-methylene-(7.56%), silane, 1,4-phenylenebis[trimethyl(4.32%), 1,3-benzodioxole, 5-(2-propenyl)- (3.47%), cedrol(2.75%), etc. (2) The main constituents of volatiles at 130 degrees C were acetic acid(43.78%), 2,5-furandione, dihydro-3- methylene-(16.57%), 1,3-benzodioxole, 5-(1-propenyl)-,(z)-(6.75%), octasiloxane, 1,1,3,3,5,5,7,7,9,9, 11,11,13, 13,15,15- hexadecamethyl -(4.09%), bicyclo[2.2.1]heptan-2-one, 1,7,7- trimethyl-, (1s)- (3.21%), etc. Generally, the smoked bamboo biomaterial was safe under 60-130 degrees C.
C1 [Peng Wan-xi; Xue Qiu; Wu Feng-juan; Zhang Xu; Zhang Zhong-feng] Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
RP Peng, WX (reprint author), Cent S Univ Forestry & Technol, Sch Mat Sci & Engn, Changsha, Hunan, Peoples R China.
EM pengwanxi@163.com
CR DU Chungui, 2004, J AGR SCI YANBIAN U, V26, P50
   Flander K. D, 2008, CONSTR BUILD MATER, V38, P323
   Lugt PVD, 2006, CONSTR BUILD MATER, V20, P648
   Qisheng ZH, 2007, CHINA FORESTRY IND A, VA3, P22
   Wanxi P., 2010, ADV MAT RES, V129-131, P60
   ZHIYONG H, 2005, FOOD SCI TECHNOLOGY, P98
NR 6
TC 0
Z9 0
U1 3
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2011
VL 467-469
BP 1697
EP 1701
DI 10.4028/www.scientific.net/KEM.467-469.1697
PG 5
WC Automation & Control Systems; Engineering, Manufacturing; Materials
   Science, Multidisciplinary
SC Automation & Control Systems; Engineering; Materials Science
GA BZY38
UT WOS:000303364701050
DA 2018-10-20
ER

PT J
AU Szot, CS
   Buchanan, CF
   Gatenholm, P
   Rylander, MN
   Freeman, JW
AF Szot, Christopher S.
   Buchanan, Cara F.
   Gatenholm, Paul
   Rylander, Marissa Nichole
   Freeman, Joseph W.
TI Investigation of cancer cell behavior on nanofibrous scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanofibrous scaffold; Electrospinning; Polycaprolactone; Collagen I;
   Bacterial cellulose; Cancer
ID MESENCHYMAL STEM-CELLS; BACTERIAL CELLULOSE; IN-VITRO; TISSUE;
   DIFFERENTIATION; PROLIFERATION; EXPRESSION; CARTILAGE; POROSITY; FIBERS
AB Tissue engineering and the use of nanofibrous biomaterial scaffolds offer a unique perspective for studying cancer development in vitro. Current in vitro models of tumorigenesis are limited by the use of static, two-dimensional (2D) cell culture monolayers that lack the structural architecture necessary for cell-cell interaction and three-dimensional (3D) scaffolds that are too simplistic for studying basic pathological mechanisms. In this study, two nanofibrous biomaterials that mimic the structure of the extracellular matrix, bacterial cellulose and electrospun polycaprolactone (PCL)/collagen I, were investigated as potential 3D scaffolds for an in vitro cancer model. Multiple cancer cell lines were cultured on each scaffold material and monitored for cell viability, proliferation, adhesion, infiltration, and morphology. Both bacterial cellulose and electrospun PCL/collagen I, which have nanoscale structures on the order of 100-500 nm, have been used in many diverse tissue engineering applications. Cancer cell adhesion and growth were limited on bacterial cellulose, while all cellular processes were enhanced on the electrospun scaffolds. This initial analysis has demonstrated the potential of electrospun PCL/collagen I scaffolds toward the development of an improved 3D in vitro cancer model. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Szot, Christopher S.; Buchanan, Cara F.; Gatenholm, Paul; Rylander, Marissa Nichole; Freeman, Joseph W.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   [Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
RP Freeman, JW (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM jwfreeman@vt.edu
RI Rylander, Marissa Nichole/F-2455-2014
FU Institute for Critical Technology and Applied Sciences at Virginia Tech
FX We would like to thank Dr. Sang Jin Lee for his assistance with
   electrospinning the PCL/collagen scaffolds and Dr. Aase Bodin for her
   contribution of bacterial cellulose. This work was funded by the
   Institute for Critical Technology and Applied Sciences at Virginia Tech.
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Esguerra M., 2009, J BIOMED MAT RES A
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li SM, 2005, BIOMACROMOLECULES, V6, P489, DOI 10.1021/bm049458+
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Rhodes NP, 2004, J MATER SCI-MATER M, V15, P391, DOI 10.1023/B:JMSM.0000021108.74004.7e
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Subramanian A, 2005, J BIOMAT SCI-POLYM E, V16, P861, DOI 10.1163/1568562054255682
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 33
TC 25
Z9 25
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 1
PY 2011
VL 31
IS 1
SI SI
BP 37
EP 42
DI 10.1016/j.msec.2009.12.005
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA 704HG
UT WOS:000286041100007
DA 2018-10-20
ER

PT S
AU Pinheiro, ALB
   Aciole, GTS
   Soares, LGP
   Correia, NA
   dos Santos, JN
AF Pinheiro, Antonio Luiz B.
   Aciole, Gilberth T. S.
   Soares, Luiz G. P.
   Correia, Neandder A.
   dos Santos, Jean N.
BE Hamblin, MR
   Waynant, RW
   Anders, J
TI Effects of LED Phototherapy on Bone Defects Grafted with MTA, Bone
   Morphogenetic Proteins and Guided Bone Regeneration in a Rodent Model: A
   Description of the Bone Repair by Light Microscopy
SO MECHANISMS FOR LOW-LIGHT THERAPY VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Mechanisms for Low-Light Therapy VI
CY JAN 22-23, 2011
CL San Francisco, CA
SP SPIE
DE Biomaterial; Light Emitting Diode; Mineral trioxide aggregate
ID MINERAL TRIOXIDE AGGREGATE; END FILLING MATERIALS; INFRARED-LASER LIGHT;
   IN-VIVO; RAMAN-SPECTROSCOPY; DENTAL IMPLANTS; DIABETIC-RATS; BOVINE
   BONE; PHOTOBIOMODULATION; TISSUE
AB We carried out a histological analysis on surgical bone defects grafted or not with MTA, treated or not with LED, BMPs and GBR. We have used several models to assess the effects of laser on bone. Benefits of the isolated or combined use them on bone healing has been suggested. There is no previous report on their association with LED light. 90 rats were divided into 10 groups. On Groups II and I the defect were filled with the clot. On Group II, were further irradiated. On groups III-VI, defect was filled with MTA + Collagen gel (III); animals of group IV were further irradiated. On groups V and VI, the defects filled with the MTA were covered with a membrane. Animals of Group VI were further irradiated. On Groups VII and VIII a pool of BMPs was added to the MTA and was further irradiated. On groups IX and X, the MTA + BMP graft was covered with a membrane. On group X, the defect was further irradiated. LED (lambda 850 +/- 10nm, 150mW, A=0.5cm(2), 54s, 0.3W/cm(2), 16 J/cm(2)) was applied at 48 h intervals during 15 days. Specimens were taken, processed, cut and stained with H&E and Sirius red and underwent histological analysis. The results showed that MTA seemed not being affected by LED light. However, its use positively affected healing around the graft. It is concluded that MTA is not affected by the LED light due to it characteristics, but beneficial results with LED usage was found.
C1 [Pinheiro, Antonio Luiz B.; Aciole, Gilberth T. S.; Soares, Luiz G. P.; Correia, Neandder A.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio Luiz B.] Univ Camilo Castelo Branco, BR-12245230 Sao Jose, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Pinheiro, Antonio Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico - CNPq for providing financial support for this
   project.
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Al-Watban FAH, 2003, J CLIN LASER MED SUR, V21, P249, DOI 10.1089/104454703322564451
   BIBIKOVA A, 1995, ANAT REC, V241, P123, DOI 10.1002/ar.1092410116
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   Camilleri J, 2006, INT ENDOD J, V39, P747, DOI 10.1111/j.1365-2591.2006.01135.x
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121
   Economides N, 2003, INT ENDOD J, V36, P44, DOI 10.1046/j.0143-2885.2003.00611.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Lanzafame RJQ, 2004, J CLIN LASER MED SUR, V22, P1, DOI 10.1089/104454704773660895
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Perez AL, 2003, INT ENDOD J, V36, P564, DOI 10.1046/j.1365-2591.2003.00691.x
   Perinpanayagam H, 2009, J CAN DENT ASSOC, V75, P369
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   Rox Anderson R, 2002, LASER SURG MED, V30
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Silva AN, 2002, J CLIN LASER MED SUR, V20, P83, DOI 10.1089/104454702753768061
   Sommer AP, 2001, J CLIN LASER MED SUR, V19, P29, DOI 10.1089/104454701750066910
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   Vo-Dinh T, 2003, BIOMEDICAL PHOTONICS, P4821
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Whelan H. T, 2002, LASERS SURG MED S14, V30, P14
   Whelan HT, 2002, J CLIN LASER MED SUR, V20, P319, DOI 10.1089/104454702320901107
   Whelan HT, 2001, AIP CONF PROC, V552, P35
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
NR 46
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8424-6
J9 PROC SPIE
PY 2011
VL 7887
AR 78870F
DI 10.1117/12.875836
PG 7
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BXY13
UT WOS:000297594100008
DA 2018-10-20
ER

PT J
AU Reinis, A
   Pilmane, M
   Stunda, A
   Vetra, J
   Kroica, J
   Rostoka, D
   Salms, G
   Vostroilovs, A
   Dons, A
   Berzina-Cimdina, L
AF Reinis, Aigars
   Pilmane, Mara
   Stunda, Agnese
   Vetra, Janis
   Kroica, Juta
   Rostoka, Dagnija
   Salms, Girts
   Vostroilovs, Antons
   Dons, Aleksejs
   Berzina-Cimdina, Liga
TI An In Vitro and In Vivo Study on the Intensity of Adhesion and
   Colonization by Staphylococcus epidermidis and Pseudomonas aeruginosa on
   Originally Synthesized Biomaterials With Different Chemical Composition
   and Modified Surfaces and Their Effect on Expression of TNF-alpha,
   beta-Defensin 2 and IL-10 in Tissues
SO MEDICINA-LITHUANIA
LA English
DT Article
DE biomaterials; Staphylococcus epidermidis; Pseudomonas aeruginosa;
   interleukin 10; tumor necrosis factor alpha; beta-defensin 2
ID DIAGNOSIS
AB The aim of this study was to determine adhesion and colonization of bacteria on the surface of originally synthesized glass-ceramic biomaterials and their effect on inflammation reactions in tissues surrounding the implant.
   Materials and Methods. Biomaterial discs were contaminated with bacterial suspensions of 10, 10(2), and 10(3) colony forming units (CFU)/mL (P aeruginosa ATCC 27853 and S. epidermidis ATCC 12228), and after 2 hours of cultivation, the intensity of bacterial adhesion was determined. For in vivo tests, the samples were contaminated with 10(2) and 10(3) CFU/mL cultivated at 37 degrees C for 2 h to ensure bacterial adhesion. Contaminated biomaterial samples were implanted in the interscapular area of chinchilla rabbits for 2 and 4 weeks. The biomaterials were removed, and using plate count and sonification methods, bacterial colonization on the surface of biomaterials was determined. Moreover, the expression of TNF-alpha, beta-defensin 2, and IL-10 in the surrounding tissues was assessed by using immunohistochemistry methods.
   Results. P aeruginosa more intensively colonized biomaterials in the in vivo study as compared with S. epidermidis. 11-10 is a regulatory cytokine, which reduces the intensity of inflammatory cell activity, thus reducing nonspecific resistance of the organism.
   Conclusions. The expression of TNF-alpha and IL-10 was not affected by short (2 and 4 weeks) biomaterial implantation. Pronounced cytokine expression in tissues around implanted biomaterials contaminated with P aeruginosa was observed.
C1 [Reinis, Aigars; Kroica, Juta; Rostoka, Dagnija] Riga Stradins Univ, Dept Biol & Microbiol, LV-1007 Riga, Latvia.
   [Pilmane, Mara; Vetra, Janis] Riga Stradins Univ, Inst Anat & Anthropol, LV-1007 Riga, Latvia.
   [Stunda, Agnese; Berzina-Cimdina, Liga] Riga Tech Univ, Ctr Dev & Innovat Biomat, Riga, Latvia.
   [Salms, Girts; Vostroilovs, Antons] Riga Stradins Univ, Inst Stomatol, LV-1007 Riga, Latvia.
   [Dons, Aleksejs] Riga Stradins Univ, Fac Med, LV-1007 Riga, Latvia.
RP Reinis, A (reprint author), Riga Stradins Univ, Dept Biol & Microbiol, Dzirciema 16, LV-1007 Riga, Latvia.
EM areinis@apollo.lv
OI Stunda-Zujeva, Agnese/0000-0003-4970-5186
FU European Social Fund within the project "Multidisciplinary Research in
   Biomaterials Technology of New Scientist Group"
   [2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, PVS ID1380]
FX This work was partly supported by the European Social Fund within the
   project "Multidisciplinary Research in Biomaterials Technology of New
   Scientist Group," No. 2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, (PVS
   ID1380)
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Jones LC, 2001, J BONE JOINT SURG BR, V83B, P448, DOI 10.1302/0301-620X.83B3.10734
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Pavlova A, 2011, ADV MATER RES-SWITZ, V222, P301, DOI 10.4028/www.scientific.net/AMR.222.301
   Reinis A, 2010, IFMBE PROC, V31, P1204, DOI 10.1007/978-3-642-14515-5_305
   Sampedro MF, 2010, SPINE, V35, P1218, DOI 10.1097/BRS.0b013e3181c3b2f3
   Schneider JJ, 2005, J MOL MED-JMM, V83, P587, DOI 10.1007/s00109-005-0657-1
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   SLUTSKY L, 2001, BIOL ASPECTS BIOMATE, P25
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Yuehuei H.A, 2000, HDB BACTERIAL ADHESI, P11
NR 15
TC 4
Z9 4
U1 0
U2 3
PU KAUNAS UNIV MEDICINE & VILNIUS UNIV
PI KAUNAS
PA KAUNAS UNIV MEDICINE, A MICKEVICIAUS 9, KAUNAS, LT-44307, LITHUANIA
SN 1010-660X
J9 MED LITH
JI Med. Lith.
PY 2011
VL 47
IS 10
BP 560
EP 565
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 878FG
UT WOS:000299240300006
PM 22186120
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Menchaca-Campos, C
   Hernandez-del Fabbro, S
   Sarmiento-Bustos, E
   Cruz-Silva, R
   Garcia-Sanchez, MA
   Bahena, D
   Uruchurtu, J
AF Menchaca-Campos, C.
   Hernandez-del Fabbro, S.
   Sarmiento-Bustos, E.
   Cruz-Silva, R.
   Garcia-Sanchez, M. A.
   Bahena, D.
   Uruchurtu, J.
BE PalomarPardave, M
   Rodriguez, FJ
   Uruchurtu, J
   RomeroRomo, MA
   Casillas, N
TI Electrochemical Noise Analysis for Nylon/Titanium Hybrid Materials
SO MES 26: ELECTROCHEMISTRY AS A TOOL FOR SUSTAINABLE DEVELOPMENT
SE ECS Transactions
LA English
DT Proceedings Paper
CT 26th National Meeting of the Mexican-Electrochemical-Society (MES) / 4th
   Meeting of the Mexican Section of the Electrochemical-Society (ECS)
CY MAY 29-JUN 03, 2011
CL Mexico City, MEXICO
SP Mexican Electrochem Soc (MES), Electrochem Soc (ECS), Mexican Sect
ID BEHAVIOR
AB Development of hybrid materials is a necessity. Polymeric materials are widely used in industry because their superior properties. In this work, synthesis, characterization and electrochemical noise evaluation of hybrid materials casted from nylon 6-6 and titanium are involved. Synthesis was carried out with 30, 40 and 50% wt of titanium functionalized with APTES. The materials obtained were characterized through scanning electron microscopy (SEM), thermal analysis (TA), infrared spectroscopy (IR) and electrochemical noise technique in Hank solution to simulate the internal fluids of the human body, in terms of biomaterial application, amongst others. SEM shows a homogenous material. Concentration of titanium was verified with TA. IR spectra show differences between Ny-Ti at different concentrations. Hybrid material made with 50% wt titanium present the lower resistance and the 30% wt the highest, as electrochemical noise resistance confirms. All samples show high resistivity in atmospheric conditions, while in Hank solution electrochemical characteristics were observed.
C1 [Menchaca-Campos, C.; Hernandez-del Fabbro, S.; Cruz-Silva, R.; Bahena, D.; Uruchurtu, J.] UAEM, Ctr Invest Ingn & Ciencias Aplicadas, Av Univ 1001, Cuernavaca 62209, Morelos, Mexico.
   [Menchaca-Campos, C.; Garcia-Sanchez, M. A.] Univ Autonoma Metropolitana Iztapalapa, Depto Quim, Mexico City 09340, DF, Mexico.
   [Menchaca-Campos, C.; Bahena, D.] Univ Tecnol Emiliano Zapata Estado Morelos, Zapata 62790, Mexico.
RP Menchaca-Campos, C (reprint author), UAEM, Ctr Invest Ingn & Ciencias Aplicadas, Av Univ 1001, Cuernavaca 62209, Morelos, Mexico.
CR Botana J., 2006, RUIDO ELECTROQUIMICO, P51
   Castano-Marras C.Ma., 2002, DYNA INGENIERA IND, V77, P1
   Cottis R., 1999, ELECTROCHEMICAL IMPE, P71
   Gonzalez-Nunez M. A., 2003, J CORROSION SCI ENG, V6, pC117
   Kearns J.R., 1996, STP ASTM, V1277, P446
   MAGILL JH, 1981, POLYMER, V22, P43, DOI 10.1016/0032-3861(81)90075-6
   Marcellan A, 2006, POLYMER, V47, P367, DOI 10.1016/j.polymer.2005.10.093
   Neirinck B, 2009, ADV ENG MATER, V11, P633, DOI 10.1002/adem.200900074
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
SN 1938-5862
BN 978-1-56677-940-1
J9 ECS TRANSACTIONS
PY 2011
VL 36
IS 1
BP 83
EP 92
DI 10.1149/1.3660601
PG 10
WC Electrochemistry
SC Electrochemistry
GA BDM07
UT WOS:000313723300009
DA 2018-10-20
ER

PT J
AU Winn, B
   Quarles, CD
   Marcus, RK
   LaBerge, M
AF Winn, Brad
   Quarles, C. Derrick, Jr.
   Marcus, R. Kenneth
   LaBerge, Martine
TI Nickel ions inhibit alpha-actin expression and decrease aspect ratio of
   rat vascular smooth muscle cells in vitro
SO METALLOMICS
LA English
DT Article
ID SHAPE-MEMORY METAL; TECHNIQUE ICP-AES; NI-TI ALLOYS; MECHANICAL STRAIN;
   STAINLESS-STEEL; MULTIELEMENT ANALYSIS; INDUCED GENOTOXICITY; CORROSION
   PRODUCTS; CALCIUM-CHANNELS; BODY-FLUIDS
AB Traditionally, in vitro material biocompatibility studies involved evaluating cell response when cultured in the presence of a sample of the material. In this study, we present a different approach to evaluate the biocompatibility of a metallic biomaterial. Our study is based on estimating what local concentrations of metallic ions are present at the site of implantation of an endovascular stent based on other studies in the literature. We then quantify the concentrations of metallic ions present in our conditioned media in which Nitinol wires were allowed to corrode, and compare cell response to ion concentrations in order to provide better experimental reproducibility. This is important to eliminate the variability of ion release rates from metals (even from the same lot) under similar conditions. Cell culture experiments using vascular smooth muscle cells exposed to clinically significant concentrations of nickel ions released from Nitinol showed two important responses. A decrease in cell aspect ratios showing a morphological change possibly indicating a shift towards a more synthetic phenotype was observed. Secondly, a decrease in alpha-actin expression was characterized by immunostaining with a fluorescent tag. At the highest concentration tested, average fluorescence decreased by approximately 26%, indicating a loss of the cellular contractile mechanism. However, the ion concentrations utilized in this study did not significantly affect cellular proliferation.
C1 [Winn, Brad; Quarles, C. Derrick, Jr.; Marcus, R. Kenneth; LaBerge, Martine] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Winn, B (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
CR Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Butcher JT, 2006, BIOMATERIALS, V27, P5252, DOI 10.1016/j.biomaterials.2006.05.040
   Castro J, 2009, ANAL METHODS-UK, V1, P188, DOI 10.1039/b9ay00080a
   CONWAY K, 1987, CARCINOGENESIS, V8, P1115, DOI 10.1093/carcin/8.8.1115
   Costa M, 2001, MOL CELL BIOCHEM, V222, P205, DOI 10.1023/A:1017978500031
   DalleDonne I, 1999, BBA-GEN SUBJECTS, V1426, P32, DOI 10.1016/S0304-4165(98)00120-2
   Faxon D., 2001, RESTENOSIS GUIDE THE
   Gunaratnam M, 2004, TOXICOL IN VITRO, V18, P245, DOI 10.1016/j.tiv.2003.08.014
   Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje
   HEATH JC, 1967, BRIT J CANCER, V21, P768, DOI 10.1038/bjc.1967.90
   HENNIG FF, 1992, J TRACE ELEM ELECT H, V6, P239
   Hillen U, 2002, CONTACT DERMATITIS, V47, P353, DOI 10.1034/j.1600-0536.2002.470607.x
   Hong YC, 1997, ENVIRON HEALTH PERSP, V105, P744, DOI 10.1289/ehp.97105744
   Hu YH, 1998, FASEB J, V12, P1135
   Ke QD, 2007, TOXICOL APPL PHARM, V219, P18, DOI 10.1016/j.taap.2006.08.013
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1
   Li Q, 2009, TOXICOL APPL PHARM, V235, P191, DOI 10.1016/j.taap.2008.12.005
   Li WD, 1996, TOXICOL APPL PHARM, V136, P101, DOI 10.1006/taap.1996.0012
   Liu DL, 2002, CLIN EXP PHARMACOL P, V29, P395, DOI 10.1046/j.1440-1681.2002.03674.x
   Lynn S, 1997, BIOL TRACE ELEM RES, V59, P1, DOI 10.1007/BF02783224
   Mills I, 1997, J CELL PHYSIOL, V170, P228, DOI 10.1002/(SICI)1097-4652(199703)170:3<228::AID-JCP2>3.0.CO;2-Q
   MLINAR B, 1993, J PHYSIOL-LONDON, V469, P639, DOI 10.1113/jphysiol.1993.sp019835
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   PAZZAGLIA UE, 1983, ACTA ORTHOP SCAND, V54, P574, DOI 10.3109/17453678308992891
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Rahil-Khazen R, 2002, J TRACE ELEM MED BIO, V16, P15, DOI 10.1016/S0946-672X(02)80004-9
   Rahil-Khazen R, 2000, SCAND J CLIN LAB INV, V60, P677, DOI 10.1080/00365510050216402
   Rose E C, 1998, J Orofac Orthop, V59, P253, DOI 10.1007/BF01321792
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   RZUCIDLO E, 2007, J VASC SURG, V45
   SAFAR ME, 1981, CIRCULATION, V63, P393, DOI 10.1161/01.CIR.63.2.393
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   Shih CC, 2001, J BIOMED MATER RES, V57, P200, DOI 10.1002/1097-4636(200111)57:2<200::AID-JBM1159>3.0.CO;2-5
   SUDHIR K, 1993, J CLIN INVEST, V92, P3003, DOI 10.1172/JCI116923
   SUNDERMAN FW, 1989, J ORTHOPAED RES, V7, P307, DOI 10.1002/jor.1100070302
   Wataha JC, 2001, J BIOMED MATER RES, V58, P537, DOI 10.1002/jbm.1052.abs
   WEBB M, 1972, BRIT J CANCER, V26, P292, DOI 10.1038/bjc.1972.39
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741
NR 43
TC 4
Z9 4
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1756-5901
J9 METALLOMICS
JI Metallomics
PY 2011
VL 3
IS 9
BP 934
EP 940
DI 10.1039/c1mt00035g
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 814KF
UT WOS:000294449100006
PM 21766118
DA 2018-10-20
ER

PT J
AU Pandis, L
   Zavan, B
   Bassetto, F
   Ferroni, L
   Iacobellis, L
   Abatangelo, G
   Lepidi, S
   Cortivo, R
   Vindigni, V
AF Pandis, Laura
   Zavan, Barbara
   Bassetto, Franco
   Ferroni, Letizia
   Iacobellis, Laura
   Abatangelo, Giovanni
   Lepidi, Sandro
   Cortivo, Roberta
   Vindigni, Vincenzo
TI HYALURONIC ACID BIODEGRADABLE MATERIAL FOR RECONSTRUCTION OF VASCULAR
   WALL: A PRELIMINARY STUDY IN RATS
SO MICROSURGERY
LA English
DT Article
ID CAROTID-ARTERY ENDARTERECTOMY; ENDOTHELIAL PROGENITOR CELLS;
   SMOOTH-MUSCLE-CELLS; IN-VIVO; PULMONARY-ARTERY; ANIMAL-MODEL; TISSUE;
   SCAFFOLD; PATCHES; ELASTIN
AB The objective of this preliminary study was to develop a reabsorbable vascular patch that did not require in vitro cell or biochemical preconditioning for vascular wall repair. Patches were composed only of hyaluronic acid (HA). Twenty male Wistar rats weighing 250-350 g were used. The abdominal aorta was exposed and isolated. A rectangular breach (1 mm x 5 mm) was made on vessel wall and arterial defect was repaired with HA made patch. Performance was assessed at 1, 2, 4, 8, and 16 weeks after surgery by histology and immunohistochemistry. Extracellular matrix components were evaluated by molecular biological methods. After 16 weeks, the biomaterial was almost completely degraded and replaced by a neoartery wall composed of endothelial cells, smooth muscle cells, collagen, and elastin fibers organized in layers. In conclusion, HA patches provide a provisional three-dimensional support to interact with cells for the control of their function, guiding the spatially and temporally multicellular processes of artery regeneration. (C) 2011 Wiley-Liss, Inc. Microsurgery 31:138-145, 2011.
C1 [Pandis, Laura; Bassetto, Franco; Vindigni, Vincenzo] Univ Padua, Clin Plast & Reconstruct Surg, I-35100 Padua, Italy.
   [Zavan, Barbara; Ferroni, Letizia; Iacobellis, Laura; Abatangelo, Giovanni; Cortivo, Roberta] Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
   [Lepidi, Sandro] Univ Padua, Clin Vasc Surg, I-35100 Padua, Italy.
RP Vindigni, V (reprint author), Univ Padua, Clin Plast & Reconstruct Surg, Via Giustiniani 2, I-35100 Padua, Italy.
EM vincenzo.vindigni@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Aburahma Ali F, 2004, Semin Vasc Surg, V17, P243, DOI 10.1016/S0895-7967(04)00044-4
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   BOND R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000071
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Cho SW, 2005, BIOMATERIALS, V26, P1915, DOI 10.1016/j.biomaterials.2004.06.018
   DallaLibera L, 1997, J MUSCLE RES CELL M, V18, P295
   Fox CJ, 2005, J VASC SURG, V41, P638, DOI 10.1016/j.jvs.2005.01.010
   Genasetti A, 2008, CONNECT TISSUE RES, V49, P120, DOI 10.1080/03008200802148462
   Hertzer NR, 2006, J VASC SURG, V43, P959, DOI 10.1016/j.jvs.2005.12.060
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Jacobowitz GR, 2001, ANN VASC SURG, V15, P281, DOI 10.1007/s100160010086
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Kothapalli CR, 2009, TISSUE ENG PT A, V15, P103, DOI 10.1089/ten.tea.2007.0390
   Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   LEPIDI S, 2006, FASEB J, V20, P103, DOI DOI 10.1096/FJ.05-4802FJE
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mendelson K, 2007, CARDIOVASC PATHOL, V16, P277, DOI 10.1016/j.carpath.2007.03.008
   Mettler BA, 2008, ANN THORAC SURG, V86, P132, DOI 10.1016/j.athoracsur.2008.02.074
   Milella E, 2002, BIOMATERIALS, V23, P1053, DOI 10.1016/S0142-9612(01)00217-4
   MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481
   MONCHAUX E, 2010, FRONT BIOSCI SCHOL E, V1, P239
   Muto A, 2009, J VASC SURG, V50, P206, DOI 10.1016/j.jvs.2009.01.062
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Pasquinelli G, 2009, TISSUE ENG PT A, V15, P2751, DOI 10.1089/ten.tea.2008.0232
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Smaill BH, 2000, J THORAC CARDIOV SUR, V120, P1053, DOI 10.1067/mtc.2000.110187
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tremblay D, 2009, ANN THORAC SURG, V88, P1484, DOI 10.1016/j.athoracsur.2009.07.023
   Tsai JW, 2009, ANN VASC SURG, V23, P374, DOI 10.1016/j.avsg.2008.10.004
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   Vindigni V, 2009, INT J MOL SCI, V10, P2972, DOI 10.3390/ijms10072972
   Wong P, 2002, ANN VASC SURG, V16, P407, DOI 10.1007/s10016-001-0163-z
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
NR 50
TC 2
Z9 2
U1 2
U2 15
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0738-1085
J9 MICROSURG
JI Microsurgery
PY 2011
VL 31
IS 2
BP 138
EP 145
DI 10.1002/micr.20856
PG 8
WC Surgery
SC Surgery
GA 725KJ
UT WOS:000287643300009
PM 21268111
DA 2018-10-20
ER

PT J
AU Rodriguez-Cabello, JC
   Martin, L
   Girotti, A
   Garcia-Arevalo, C
   Arias, FJ
   Alonso, M
AF Carlos Rodriguez-Cabello, J.
   Martin, Laura
   Girotti, Alessandra
   Garcia-Arevalo, Carmen
   Javier Arias, F.
   Alonso, Matilde
TI Emerging applications of multifunctional elastin-like recombinamers
SO NANOMEDICINE
LA English
DT Review
DE drug delivery; elastin-like recombinamers; nanodevices; protein
   purification; surface engineering; tissue engineering
ID EXTRACELLULAR-MATRIX PROTEINS; POLYPEPTIDE-DOXORUBICIN CONJUGATE;
   INVERSE TEMPERATURE TRANSITION; CELL-ADHESION; DRUG-DELIVERY;
   CROSS-LINKING; BIOMEDICAL APPLICATIONS; SOLID TUMORS; POLYMERS; DESIGN
AB Elastin-like recombinamers have grown in popularity in the field of protein-inspired biomimetic materials and have found widespread use in biomedical applications. Modern genetic-engineering techniques have allowed the design of multifunctional materials with an extraordinary control over their architecture and physicochemical properties, such as stimuli-responsiveness, monodispersity, biocompatibility or self-assembly, amongst others. Indeed, these materials are playing an increasingly important role in a diverse range of applications, such as drug delivery, tissue engineering and 'smart' systems. Herein, we review some of the most interesting examples of recent advances, and progressive applications of elastin-like recombinamers in biomaterial and nano-engineering sciences in recent years.
C1 [Carlos Rodriguez-Cabello, J.; Martin, Laura; Girotti, Alessandra; Garcia-Arevalo, Carmen; Javier Arias, F.; Alonso, Matilde] Univ Valladolid, CIBER BBN, Bioforge Grp, E-47011 Valladolid, Spain.
RP Rodriguez-Cabello, JC (reprint author), Univ Valladolid, CIBER BBN, Bioforge Grp, Edificio I D,Paseo de Belen 11, E-47011 Valladolid, Spain.
EM cabello@bioforge.uva.es
RI Arias, Francisco Javier/A-2640-2012; Rodriguez-Cabello, Jose
   Carlos/G-6555-2017; Girotti, Alessandra/D-4325-2012; ALONSO,
   MATILDE/G-6719-2017; Martin, Laura/J-9291-2017; Garcia-Arevalo,
   Carmen/N-6120-2018
OI Arias, Francisco Javier/0000-0001-8584-3768; Rodriguez-Cabello, Jose
   Carlos/0000-0002-3438-858X; Girotti, Alessandra/0000-0003-4754-7022;
   ALONSO, MATILDE/0000-0002-6853-8427; Martin, Laura/0000-0002-6583-8731; 
FU EU; Ministerio de Ciencia e Innovacion - Inoicio (MICINN) [MAT
   2007-66275-C02-01, MAT 2007-61604, MAT 2009-14195-C03-03,
   PSE-300100-2006-2001]; Junta de Castilla y Leon (JCyL) [VA034A09,
   VA030A08]; El Centro de Investigacion Biomedica en Red en Bioingenieria,
   Biomateriales y Nanomedicina [CB06-01-0003]; Instituto de Salud Carlos
   III under the 'Network Center of Regenerative Medicine and Cellular
   Therapy of Castilla and Leon'
FX The authors acknowledge financial support through the European Regional
   Development Fund from the EU, from the Ministerio de Ciencia e
   Innovacion - Inoicio (MICINN; projects MAT 2007-66275-C02-01, MAT
   2007-61604, MAT 2009-14195-C03-03 and PSE-300100-2006-2001), the Junta
   de Castilla y Leon (JCyL; projects VA034A09 and VA030A08), the El Centro
   de Investigacion Biomedica en Red en Bioingenieria, Biomateriales y
   Nanomedicina (project CB06-01-0003), the JCyL and the Instituto de Salud
   Carlos III under the 'Network Center of Regenerative Medicine and
   Cellular Therapy of Castilla and Leon'. The authors have no other
   relevant affiliations or financial involvement with any organization or
   entity with a financial interest in or financial conflict with the
   subject matter or materials discussed in the manuscript apart from those
   disclosed.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Alonso M, 2001, MACROMOLECULES, V34, P8072, DOI 10.1021/ma010455o
   Alvarez-Rodriguez R, 2010, EUR POLYM J, V46, P643, DOI 10.1016/j.eurpolymj.2009.12.022
   Alvarez-Rodriguez R, 2010, MACROMOL RAPID COMM, V31, P568, DOI 10.1002/marc.200900727
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Aparicio C, 2009, Journal of Medical Devices, V3, DOI 10.1115/1.3190476
   Araujo R, 2009, BIOMACROMOLECULES, V10, P1655, DOI 10.1021/bm9002943
   Barbosa JS, 2010, ADV ENG MATER, V12, pB37, DOI 10.1002/adem.200980152
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015
   Rodriguez-Cabello JC, 2009, POLYMER, V50, P5159, DOI 10.1016/j.polymer.2009.08.032
   Rodrikuez-Cabello JC, 2006, NANOMEDICINE-UK, V1, P267, DOI 10.2217/17435889.1.3.267
   Carlsen A, 2009, CURR OPIN COLLOID IN, V14, P329, DOI 10.1016/j.cocis.2009.04.007
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Costa RR, 2009, ADV FUNCT MATER, V19, P3210, DOI 10.1002/adfm.200900568
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Elloumi I, 2006, BIOMATERIALS, V27, P3451, DOI 10.1016/j.biomaterials.2006.02.003
   Fahmi A, 2010, ADV FUNCT MATER, V20, P1011, DOI 10.1002/adfm.200902013
   Floquet N, 2004, BIOPOLYMERS, V76, P266, DOI 10.1002/bip.20029
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Furgeson DY, 2006, J CONTROL RELEASE, V110, P362, DOI 10.1016/j.jconrel.2005.10.006
   Garcia Y, 2009, TISSUE ENG PT A, V15, P887, DOI 10.1089/ten.tea.2008.0104
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Kim W, 2010, ANGEW CHEM INT EDIT, V49, P4257, DOI 10.1002/anie.201001356
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee J, 2001, MACROMOLECULES, V34, P4114, DOI 10.1021/ma0015673
   Li B, 2001, J MOL BIOL, V305, P581, DOI 10.1006/jmbi.2000.4306
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   MacEwan SR, 2010, NANOMEDICINE-UK, V5, P793, DOI 10.2217/NNM.10.50
   Machado R, 2009, J NANO RES, V6, P133, DOI 10.4028/www.scientific.net/JNanoR.6.133
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/nmat2569, 10.1038/NMAT2569]
   Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007
   Martin L, 2010, SOFT MATTER, V6, P1121, DOI 10.1039/b923684h
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Martin L, 2009, SOFT MATTER, V5, P1591, DOI 10.1039/b823488d
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martinez-Osorio H, 2009, CURR EYE RES, V34, P48, DOI 10.1080/02713680802542053
   Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jcornel.2005.08.007
   Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/o09-161, 10.1139/O09-161]
   Nagapudi K, 2002, MACROMOLECULES, V35, P1730, DOI 10.1021/ma011429t
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   NICOL A, 1993, J BIOMED MATER RES, V27, P801, DOI 10.1002/jbm.820270613
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Ozturk N, 2009, BIOMATERIALS, V30, P5417, DOI 10.1016/j.biomaterials.2009.06.044
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   Ribeiro A, 2009, BIOPHYS J, V97, P312, DOI 10.1016/j.bpj.2009.03.030
   Rodriguez-Cabello JC, 2006, ADV POLYM SCI, V200, P119, DOI 10.1007/12_047
   Rodriguez-Cabello JC, 2005, PROG POLYM SCI, V30, P1119, DOI 10.1016/j.progpolymsci.2005.07.004
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Sallach RE, 2009, BIOMATERIALS, V30, P409, DOI 10.1016/j.biomaterials.2008.09.040
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Shokouhi B, 2010, BIOMATERIALS, V31, P5759, DOI 10.1016/j.biomaterials.2010.04.015
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Urry D.W., 2006, WHAT SUSTAINS LIFE C
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   Wada A, 2003, J AM CHEM SOC, V125, P16228, DOI 10.1021/ja036459l
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wu YQ, 2009, BIOMACROMOLECULES, V10, P19, DOI 10.1021/bm801033f
NR 77
TC 34
Z9 34
U1 2
U2 22
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JAN
PY 2011
VL 6
IS 1
BP 111
EP 122
DI 10.2217/NNM.10.141
PG 12
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 733SZ
UT WOS:000288284500020
PM 21182423
DA 2018-10-20
ER

PT J
AU Brown, CP
   Rosei, F
   Traversa, E
   Licoccia, S
AF Brown, Cameron P.
   Rosei, Federico
   Traversa, Enrico
   Licoccia, Silvia
TI Spider silk as a load bearing biomaterial: tailoring mechanical
   properties via structural modifications
SO NANOSCALE
LA English
DT Article
ID DRAGLINE SILK; FTIR SPECTROSCOPY; GLASSY POLYMERS; BETA-SHEET;
   TOUGHNESS; DESIGN; MATRIX; SUPERCONTRACTION; MICROSTRUCTURE;
   NANOSTRUCTURE
AB Spider silk shows great potential as a biomaterial: in addition to biocompatibility and biodegradability, its strength and toughness are greater than native biological fibres (e. g. collagen), with toughness exceeding that of synthetic fibres (e. g. nylon). Although the ultimate tensile strength and toughness at failure are unlikely to be limiting factors, its yield strain of 2% is insufficient, particularly for biomedical application because of the inability to mimic the complex ultrastructure of natural tissues with current tissue engineering approaches. To harness the full potential of spider silk as a biomaterial, it is therefore necessary to increase its yield strain. In this paper, we discuss the means by which the mechanical properties of spider silk, particularly the yield strain, can be optimized through structural modifications.
C1 [Brown, Cameron P.; Licoccia, Silvia] Univ Roma Tor Vergata, Ctr NAST, Dipartimento Sci & Tecnol Chim, I-000133 Rome, Italy.
   [Brown, Cameron P.; Rosei, Federico] Univ Quebec, Inst Natl Rech Sci, Varennes, PQ, Canada.
   [Traversa, Enrico] Natl Inst Mat Sci, Int Res Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki 3050044, Japan.
RP Brown, CP (reprint author), Univ Roma Tor Vergata, Ctr NAST, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-000133 Rome, Italy.
EM brown@emt.inrs.ca; rosei@emt.inrs.ca
RI Brown, Cameron/G-5594-2011; Traversa, Enrico/E-4547-2011
OI Brown, Cameron/0000-0003-2520-9030; Traversa, Enrico/0000-0001-6336-941X
FU Ministry for Foreign Affairs of Italy (Direzione Generale per la
   Promozione e la Cooperazione Culturale); Ministere pour le Developpement
   Economique, de l'Innovation et l'Exportation (Province of Quebec); FRSQ;
   Canada Research Chairs program; NSERC
FX This work was supported by the The Ministry for Foreign Affairs of Italy
   (Direzione Generale per la Promozione e la Cooperazione Culturale) and
   the Ministere pour le Developpement Economique, de l'Innovation et
   l'Exportation (Province of Quebec) under the framework of the
   Italy-Quebec Joint Laboratory in Nanostructured Materials for Energy,
   Catalysis and Biomedical Applications. C. P. B acknowledges partial
   salary support from the FRSQ Post-Doctoral Fellowship programme. F. R.
   acknowledges partial salary support from the Canada Research Chairs
   program and funding from NSERC (Discovery Grant).
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   ALTMAN DG, 2003, BIOMATERIALS, V24, P401
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ARGON AS, 1973, PHILOS MAG, V28, P839, DOI 10.1080/14786437308220987
   Ball P, 2001, NATURE, V409, P413, DOI 10.1038/35053198
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   Broom N.D, 1988, COLLAGEN FRAMEWORK A, V2, P244
   Carmichael S, 1999, INT J BIOL MACROMOL, V24, P219, DOI 10.1016/S0141-8130(99)00008-2
   CRIST B, 1997, YIELD PROCESSES GLAS
   DENNY M, 1976, J EXP BIOL, V65, P483
   Dicko C, 2008, BIOMACROMOLECULES, V9, P216, DOI 10.1021/bm701069y
   Du N, 2006, BIOPHYS J, V91, P4528, DOI 10.1529/biophysj.106.089144
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   GLIOVI A, 2008, MACROMOLECULES, V41, P390
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b
   Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Keten S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385388
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Keten S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061913
   Khatiwala CB, 2006, AM J PHYSIOL-CELL PH, V290, pC1640, DOI 10.1152/ajpcell.00455.2005
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   LIU XY, 2008, BIOMACROMOLECULES, V9, P116
   Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmet1534
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   MARTINEZ G, 1995, J STRUCT BIOL, V114, P23, DOI 10.1006/jsbi.1995.1002
   MASDEN B, 1999, INT J BIOL MACROMOL, V24, P301
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   OLOYEDE A, 1994, CLIN BIOMECH, V9, P149, DOI 10.1016/0268-0033(94)90014-0
   Papadopoulos P, 2007, EUR PHYS J E, V24, P193, DOI 10.1140/epje/i2007-10229-9
   Papadopoulos P, 2008, COLLOID POLYM SCI, V287, P231
   Peng XN, 2005, BIOMACROMOLECULES, V6, P302, DOI 10.1021/bm049598j
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   PORTER D, 2009, ADV MATER, V21, P1
   Porter D, 2007, NANO TODAY, V2, P6, DOI 10.1016/S1748-0132(07)70071-3
   ROBERTSON RE, 1966, J CHEM PHYS, V44, P3950, DOI 10.1063/1.1726558
   Rong WZ, 2004, NANO LETT, V4, P2287, DOI 10.1021/nl0487368
   Rousseau ME, 2007, J AM CHEM SOC, V129, P3897, DOI 10.1021/ja067471r
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   WORK RW, 1985, J EXP BIOL, V118, P379
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang Y, 2005, ADV MATER, V17, P84, DOI 10.1002/adma.200400344
   Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z
NR 58
TC 16
Z9 19
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PY 2011
VL 3
IS 3
BP 870
EP 876
DI 10.1039/c0nr00752h
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 732VR
UT WOS:000288218300007
PM 21212901
DA 2018-10-20
ER

PT B
AU Daud, N
   Shanks, RA
AF Daud, Norlinda
   Shanks, Robert A.
BE Laudon, M
   Romanowicz, B
TI Biomimetic High Filler Content Composites using Bisphenol-A Ethoxy
   Diacrylate
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE composite; biomimetic; thermomechanical property; biomaterial;
   viscoelasticity; thermal stability
ID SURFACE-TREATED FILLERS; POLYPROPYLENE COMPOSITES
AB Biomimetic composites of Bisphenol-A ethoxy diacrylate with 77-86 % fillers content were prepared by in situ polymerization using two compacting techniques. Centrifugating produced more compacted composites compared with a compression moulding method. Either method was much different from natural formation from layer-by-layer construction, however the composites formed were of high filler content, without achieving the 95 %.w/w level in nature. The filler space was efficiently filled by using a combination of nano and microsize fillers. The composites were effectively compacted so that wetting and adhesion at the resin-filler interface would provide optimum cohesion.
C1 [Daud, Norlinda; Shanks, Robert A.] RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
RP Daud, N (reprint author), RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
OI Shanks, Robert/0000-0003-3790-5148
CR Genovese A, 2008, COMPOS PART A-APPL S, V39, P398, DOI 10.1016/j.compositesa.2007.09.009
   Luz GM, 2010, COMPOS SCI TECHNOL, V70, P1777, DOI 10.1016/j.compscitech.2010.05.013
   Ren Z, 2003, POLYM POLYM COMPOS, V11, P541, DOI 10.1177/096739110301100703
   Ren Z, 2002, POLYM POLYM COMPOS, V10, P173, DOI 10.1177/096739110201000203
   Ren Z, 2001, J APPL POLYM SCI, V79, P1942, DOI 10.1002/1097-4628(20010314)79:11<1942::AID-APP1001>3.0.CO;2-P
   Reynaud E, 2001, POLYMER, V42, P8759, DOI 10.1016/S0032-3861(01)00446-3
   Shanks RA, 1997, POLYM NETWORK BLEND, V7, P87
   Tamerler C, 2007, ACTA BIOMATER, V3, P289, DOI 10.1016/j.actbio.2006.10.009
   Zhu AP, 2008, APPL SURF SCI, V254, P3745, DOI 10.1016/j.apsusc.2007.11.042
NR 9
TC 0
Z9 0
U1 0
U2 0
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 159
EP 162
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000043
DA 2018-10-20
ER

PT B
AU Ansari, MNM
   Shanks, RA
AF Ansari, M. N. M.
   Shanks, Robert A.
BE Laudon, M
   Romanowicz, B
TI Cellulose Fiber and Nano-Fiber Composites based on Castor
   Oil-Polyurethane Matrix
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE bio-composite; biomaterial; natural resource; natural fiber; cellulose;
   urethane
ID MECHANICAL-PROPERTIES; NANOCOMPOSITES; DEGRADATION; RESISTANCE; BEHAVIOR
AB Hybrid cellulose composites comprising woven hemp fabric interspersed with microcrystalline cellulose in a matrix of castor oil based polyurethane. The compsoites were derived from natural resources except for the diisocyanate required for chain extension and crosslinking, together with likely interfacial bonding with the cellulose components. The composites were characterised using scanning electron and optical microscopy, thermogravimetry and infrared spectroscopy. Mechanical properties measured were creep, recovery and modulated force thermomechanical analysis. Multiplexed frequency was used to obtain activation energy for the glass transition. The composites were semi -flexible, with hiigh tensile strength and toughness, the main damping peak was centred on ambient temperature making the composites suitable for vibration damping application.
C1 [Ansari, M. N. M.] RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
   Univ Tenaga Nas, Coll Engn, Mech Engn, Kajang, Malaysia.
RP Ansari, MNM (reprint author), RMIT Univ, Sch Appl Sci, Box 2476 GPO, Melbourne, Vic 3001, Australia.
EM ansari@uniten.edu.my
OI Shanks, Robert/0000-0003-3790-5148
CR Cao X, 2008, EXPRESS POLYM LETT, V2, P502, DOI 10.3144/expresspolymlett.2008.60
   Kechaou B, 2010, EXPRESS POLYM LETT, V4, P171, DOI 10.3144/expresspolymlett.2010.22
   Kumar MNS, 2007, J APPL POLYM SCI, V105, P3153, DOI 10.1002/app.24481
   Madbouly SA, 2009, PROG POLYM SCI, V34, P1283, DOI 10.1016/j.progpolymsci.2009.08.002
   Marklund E, 2008, COMPOS SCI TECHNOL, V68, P2156, DOI 10.1016/j.compscitech.2008.03.011
   Ouajai S, 2005, POLYM DEGRAD STABIL, V89, P327, DOI 10.1016/j.polymdegradstab.2005.01.016
   Ouajai S, 2009, COMPOS SCI TECHNOL, V69, P2119, DOI 10.1016/j.compscitech.2009.05.005
   Spoljaric S, 2009, COMPOS PART A-APPL S, V40, P791, DOI 10.1016/j.compositesa.2009.03.011
   Wielage B, 2003, J MATER PROCESS TECH, V139, P140, DOI 10.1016/S0924-0136(03)00195-X
   Wong S, 2008, COMPOS INTERFACE, V15, P131, DOI 10.1163/156855408783810894
   Wu JH, 2010, COMPOS SCI TECHNOL, V70, P1258, DOI 10.1016/j.compscitech.2010.03.014
   Zhang QL, 2008, J POLYM SCI POL PHYS, V46, P1243, DOI 10.1002/polb.21458
NR 12
TC 0
Z9 0
U1 1
U2 2
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 179
EP 182
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000048
DA 2018-10-20
ER

PT B
AU Olyveira, GM
   Costa, LMM
   Basmaji, P
AF Olyveira, G. M.
   Costa, L. M. M.
   Basmaji, Pierre
BE Laudon, M
   Romanowicz, B
TI Nanoskin Bacterial cellulose structured- Towards the Development of
   regenerative medicine
SO NANOTECHNOLOGY 2011: BIO SENSORS, INSTRUMENTS, MEDICAL, ENVIRONMENT AND
   ENERGY, NSTI-NANOTECH 2011, VOL 3
LA English
DT Proceedings Paper
CT NSTI Nanotechnology Conference and Expo
CY JUN 13-16, 2011
CL Boston, MA
SP Clean Technol & Sustainable Ind Org, European Patent Off, Greenberg Traurig, Innovat & Mat Sci Inst, Jackson Walker LLP, Linde Nanomaterials, Lockheed Martin, Nano Sci & Technol Inst, Nano Tech Japan, NanoEurope Fair & Conf, Nanpolis Suzhou, Suzhou Nanotech Co Ltd, Natl Inst Standards & Technol, Ctr Nanoscale Sci & Technol, Fraunhofer, Res Germany, TechConnect, Technol Innovat Program, Canadian Trade Commiss Serv, Italian Trade Commiss
DE Nanoskin (R); bacterial cellulose; artificial blood vessels
ID BIOMEDICAL APPLICATIONS; MICROBIAL CELLULOSE; CELL-ADHESION; SURFACE;
   MICROFIBRILS; ADSORPTION; CULTURE; PROTEIN; FILMS
AB Bacterial cellulose (BC) has established to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, especially for medical devices. In fact, biomedical devices recently have gained a significant amount of attention because of increased interesting tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process. It has unique properties that make it an exciting candidate as a vascular graft material: strength, good integration into host tissue, and flexibility of production in various shapes and sizes. In this article, the structural features of microbial cellulose and its properties are discussed with AFM and SEM and novel bionanocomposites from BC/collagen and BC/chitosan are presented for artificial blood vessels by modifying culture medium of bacterial cellulose.
C1 [Olyveira, G. M.; Costa, L. M. M.] Univ Fed Abc, CCNH, Rua Santa Adelia 166, Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, Sao Carlos, SP, Brazil.
RP Olyveira, GM (reprint author), Univ Fed Abc, CCNH, Rua Santa Adelia 166, Santo Andre, SP, Brazil.
EM gmolyveira@yahoo.com.br; pierre@innovatecsco.com
CR Alves CM, 2007, BIOMATERIALS, V28, P307, DOI 10.1016/j.biomaterials.2006.09.010
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Basmaji P., 2010, NMEE 2010 SEM WHICH
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Borges JP, 2001, MECH COMPOS MATER, V37, P257, DOI 10.1023/A:1010650803273
   Cienchanska D., 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Gatenholm P, 2010, MRS BULL, V35, P208, DOI 10.1557/mrs2010.653
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Hult EL, 2003, CARBOHYD POLYM, V53, P9, DOI 10.1016/S0144-8617(02)00297-7
   Olyveira G. M., 2010, 3 SEM INT NAN NAN HA
   Orts WJ, 2005, J POLYM ENVIRON, V13, P301, DOI 10.1007/s10924-005-5514-3
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   WATANABE K, 1995, BIOSCI BIOTECH BIOCH, V59, P65, DOI 10.1271/bbb.59.65
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
NR 22
TC 0
Z9 1
U1 0
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-4398-7138-6
PY 2011
BP 267
EP 270
PG 4
WC Energy & Fuels; Engineering, Environmental; Nanoscience &
   Nanotechnology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Energy & Fuels; Engineering; Science & Technology - Other Topics;
   Research & Experimental Medicine; Materials Science
GA BG9XC
UT WOS:000394061000071
DA 2018-10-20
ER

PT B
AU Xing, ZC
   Yuan, J
   Chae, WP
   Kang, IK
   Kim, SY
AF Xing, Zhi-Cai
   Yuan, Jiang
   Chae, Won-Pyo
   Kang, Inn-Kyu
   Kim, Suk-Young
BE Ying, F
TI Keratin Nanofibers as a Biomaterial
SO NANOTECHNOLOGY AND BIOSENSORS
LA English
DT Proceedings Paper
CT International Conference on Nanotechnology and Biosensors
CY DEC 28-30, 2010
CL Hong Kong, PEOPLES R CHINA
SP Asia Pacific Chem Biol Environm Engn Soc
DE biodegradability; NIH3T3 cells; keratin; nanofiber; poly(ethylene oxide)
ID KERATEINE BLEND FILMS; SILK; WATER; JETS
AB Keratin is one of the most abundant proteins which can be used in a variety of biomedical applications due to its biocompatibility and biodegradability. However, keratin is insoluble in solvents and soluble in few solvent systems, which lead to a limitation in its processability for further utilization. In this study, keratin was extracted and chemically modified by reacting sulfide side group with iodoacetic acid to enhance its solubility in organic solvent. The modified keratin (m-keratin) was then blended with poly (ethylene oxide) (PEO) in different proportions, dissolved in 2,2,2,-trifluoroethanol (TFE), and electrospun to produce nanofibrous mats. The m-keratin nanofibers were obtained by crosslinking the m-keratin/PEO nanofibrous mats with glutaraldehyde vapor (25%) and washed with distilled water for 3 times to remove PEO. The morphology, diameter distribution, biodegradation, and interaction of NIH 3T3 cells with nanofibrous mats were investigated. The results showed that the crosslinked m-keratin nanofibrous mats have a potential to be used in tissue engineering and wound dressing.
C1 [Xing, Zhi-Cai; Yuan, Jiang; Chae, Won-Pyo; Kang, Inn-Kyu] Kyungpook Natl Univ, Dept Polymer Sci & Engn, Daegu 702701, South Korea.
   [Kim, Suk-Young] Yeungnam Univ, Sch Mat Sci & Engn, Gyongbuk 712749, South Korea.
RP Kang, IK (reprint author), Kyungpook Natl Univ, Dept Polymer Sci & Engn, Daegu 702701, South Korea.
EM ikkang@knu.ac.kr
FU Biotechnology development project [2009-0090907]; Ministry of Education,
   Science and Technology of Korea [2010-0011125]
FX This research was supported by the research grants of the Biotechnology
   development project (2009-0090907) and by the grant of 2010-0011125 from
   Ministry of Education, Science and Technology of Korea.
CR Alessio V., 2008, J POLYM SCI B, V46, P1193, DOI [10.1002/polb.21452, DOI 10.1002/POLB.21452]
   Aluigi A, 2007, J APPL POLYM SCI, V104, P863, DOI 10.1002/app.25623
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Andreia V., 2008, BIOMACROMOLECULES, V9, P1299, DOI [10.1021/bm7012789, DOI 10.1021/BM7012789]
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   Fu ZL, 1998, LANGMUIR, V14, P4300, DOI 10.1021/la971382y
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Larrondo L, 1981, POLYM SCI SER B, V19, P909, DOI DOI 10.1002/P0L.1981.180190601
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Wnek G., 2003, NANO LETT, V3, P231
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yuan J, 2009, MACROMOL RES, V17, P850, DOI 10.1007/BF03218625
NR 21
TC 1
Z9 1
U1 0
U2 1
PU INT ASSOC COMPUTER SCIENCE & INFORMATION TECHNOLOGY PRESS-IACSIT PRESS
PI SINGAPORE
PA SINGAPORE OFFICE, NO. 07-42, BLK 708, JURONG WEST STREET 81, SINGAPORE,
   00000, SINGAPORE
BN 978-981-08-8643-1
PY 2011
BP 120
EP 124
PG 5
WC Engineering, Environmental; Engineering, Chemical; Nanoscience &
   Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BG9RL
UT WOS:000393717700028
DA 2018-10-20
ER

PT J
AU Dvir, T
   Timko, BP
   Kohane, DS
   Langer, R
AF Dvir, Tal
   Timko, Brian P.
   Kohane, Daniel S.
   Langer, Robert
TI Nanotechnological strategies for engineering complex tissues
SO NATURE NANOTECHNOLOGY
LA English
DT Review
ID NANOWIRE TRANSISTOR ARRAYS; MESENCHYMAL STEM-CELLS; CARBON NANOTUBES;
   EXTRACELLULAR-MATRIX; DELIVERY-SYSTEM; ALGINATE SCAFFOLDS; NEURONAL
   GROWTH; DEVICE ARRAYS; RGD PEPTIDE; IN-VITRO
AB Tissue engineering aims at developing functional substitutes for damaged tissues and organs. Before transplantation, cells are generally seeded on biomaterial scaffolds that recapitulate the extracellular matrix and provide cells with information that is important for tissue development. Here we review the nanocomposite nature of the extracellular matrix, describe the design considerations for different tissues and discuss the impact of nanostructures on the properties of scaffolds and their uses in monitoring the behaviour of engineered tissues. We also examine the different nanodevices used to trigger certain processes for tissue development, and offer our view on the principal challenges and prospects of applying nanotechnology in tissue engineering.
C1 [Dvir, Tal; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Dvir, Tal; Timko, Brian P.; Kohane, Daniel S.] Harvard Univ, Lab Biomat & Drug Delivery, Childrens Hosp Boston, Div Crit Care Med,Sch Med,Dept Anesthesiol, Boston, MA 02115 USA.
   [Timko, Brian P.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Dvir, T (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM rlanger@mit.edu
OI Timko, Brian/0000-0002-7958-8980
FU National Institutes of Health [DE13023, DE016516, EB006365,
   R01GM073626]; NSF [BES-0609182]; American Heart Association; NIH
   National Institute of General Medical Sciences
FX This work was supported by the National Institutes of Health grants
   DE13023, DE016516, EB006365 and R01GM073626, and NSF grant BES-0609182.
   T.D. acknowledges a Postdoctoral Fellowship from the American Heart
   Association. B.P.T. acknowledges a Ruth L. Kirschstein National Research
   Service Award from the NIH National Institute of General Medical
   Sciences. We thank S. Cohen, S. McAllister and B. Tian for their
   comments.
CR Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Barone PW, 2009, ACS NANO, V3, P3869, DOI 10.1021/nn901025x
   Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bettinger CJ, 2009, TISSUE ENG PT A, V15, P1321, DOI 10.1089/ten.tea.2008.0134
   Bhattacharyya S, 2009, J BIOMED NANOTECHNOL, V5, P69, DOI 10.1166/jbn.2009.032
   Bianco A, 2010, INT J ARTIF ORGANS, V33, P271
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003
   Casper CL, 2007, BIOMACROMOLECULES, V8, P1116, DOI 10.1021/bm061003s
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]
   Chan CK, 2006, NANOMEDICINE-UK, V1, P177, DOI 10.2217/17435889.1.2.177
   Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079
   Cohen-Karni T, 2010, NANO LETT, V10, P1098, DOI 10.1021/nl1002608
   Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Eschermann JF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194138
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fan DL, 2010, NAT NANOTECHNOL, V5, P545, DOI [10.1038/NNANO.2010.104, 10.1038/nnano.2010.104]
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Gui XC, 2010, ACS NANO, V4, P2320, DOI 10.1021/nn100114d
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Heino J, 2009, CURR PHARM DESIGN, V15, P1309, DOI 10.2174/138161209787846720
   Heller DA, 2009, NAT NANOTECHNOL, V4, P114, DOI [10.1038/nnano.2008.369, 10.1038/NNANO.2008.369]
   Heo SJ, 2009, TISSUE ENG PT A, V15, P977, DOI 10.1089/ten.tea.2008.0190
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kunzmann A, 2011, BBA-GEN SUBJECTS, V1810, P361, DOI 10.1016/j.bbagen.2010.04.007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445702
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lim DK, 2010, NAT MATER, V9, P60, DOI [10.1038/NMAT2596, 10.1038/nmat2596]
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mallouk TE, 2009, SCI AM, V300, P72, DOI 10.1038/scientificamerican0509-72
   Massobrio G, 2008, NANO LETT, V8, P4433, DOI 10.1021/nl802341r
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pappas TC, 2007, NANO LETT, V7, P513, DOI 10.1021/nl062513v
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   PETERSEN TH, SCIENCE, V329, P538
   Pislaru SV, 2006, CIRCULATION, V114, pI314, DOI 10.1161/CIRCULATIONAHA.105.001446
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rexeisen EL, 2009, LANGMUIR, V26, P1953
   Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842
   Schofer MD, 2009, J MATER SCI-MATER M, V20, P1535, DOI 10.1007/s10856-009-3719-z
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suhr J, 2007, NAT NANOTECHNOL, V2, P417, DOI 10.1038/nnano.2007.186
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tian BZ, 2010, SCIENCE, V329, P830, DOI 10.1126/science.1192033
   Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/NNANO.2009.304, 10.1038/nnano.2009.304]
   Timko BP, 2010, IEEE T NANOTECHNOL, V9, P269, DOI 10.1109/TNANO.2009.2031807
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Wu SL, 2008, NANO LETT, V8, P3803, DOI 10.1021/nl802145n
   Xu J, 2008, J BIOMED MATER RES A, V87A, P819, DOI 10.1002/jbm.a.31826
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zhang LJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175101
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhou HJ, 2009, BIOMATERIALS, V30, P1715, DOI 10.1016/j.biomaterials.2008.12.016
   Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 108
TC 672
Z9 687
U1 28
U2 554
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD JAN
PY 2011
VL 6
IS 1
BP 13
EP 22
DI 10.1038/NNANO.2010.246
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 698EB
UT WOS:000285574000007
PM 21151110
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Aboushwareb, T
   Mckenzie, P
   Wezel, F
   Southgate, J
   Badlani, G
AF Aboushwareb, Tamer
   Mckenzie, Patrick
   Wezel, Felix
   Southgate, Jennifer
   Badlani, Gopal
TI Is Tissue Engineering and Biomaterials the Future for Lower Urinary
   Tract Dysfunction (LUTD)/Pelvic Organ Prolapse (POP)?
SO NEUROUROLOGY AND URODYNAMICS
LA English
DT Article
DE biomaterials; pelvic floor; regenerative medicine
ID SMALL-INTESTINAL SUBMUCOSA; RANDOMIZED CONTROLLED-TRIAL; ACELLULAR
   MATRIX GRAFT; SMOOTH-MUSCLE-CELLS; FREE VAGINAL TAPE;
   STRESS-INCONTINENCE; BLADDER AUGMENTATION; STEM-CELLS; IN-VITRO;
   UROTHELIAL CELLS
AB The fields of tissue engineering and regenerative medicine have seen major advances over the span of the past two decades, with biomaterials playing a central role. Although the term "regenerative medicine" has been applied to encompass most fields of medicine, in fact urology has been one of the most progressive. Many urological applications have been investigated over the past decades, with the culmination of these technologies in the introduction of the first laboratory-produced organ to be placed in a human body. 1 With the quality of life issues associated with urinary incontinence, there is a strong driver to identify and introduce new technologies and the potential exists for further major advancements from regenerative medicine approaches using biomaterials, cells or a combination of both. A central question is why use biomaterials? The answer rests on the need to make up for inadequate or lack of autologous tissue, to decrease morbidity and to improve long-term efficacy. Thus, the ideal biomaterial needs to meet the following criteria: (1) Provide mechanical and structural support, (2) Maintain compliance and be biocompatible with surrounding tissues, and (3) Be "fit for purpose" by meeting specific application needs ranging from static support to bioactive cell signaling. In essence, this represents a wide range of biomaterials with a spectrum of potential applications, from use as a supportive or bulking implant alone, to implanted biomaterials that promote integration and eventual replacement by infiltrating host cells, or scaffolds pre-seeded with cells prior to implant. In this review we shall discuss the structural versus the integrative uses of biomaterials by referring to two key areas in urology of (1) pelvic organ support for prolapse and stress urinary incontinence, and (2) bladder replacement/augmentation. Neurourol. Urodynam. 30:775-782, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Aboushwareb, Tamer; Mckenzie, Patrick; Badlani, Gopal] Wake Forest Univ, Dept Urol, Winston Salem, NC 27109 USA.
   [Aboushwareb, Tamer] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA.
   [Wezel, Felix; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
   [Wezel, Felix] Univ Med Ctr, Dept Urol, Mannheim, Germany.
RP Badlani, G (reprint author), Wake Forest Univ, Dept Urol, Winston Salem, NC 27109 USA.
EM gbadlani@wfubmc.edu
OI Southgate, Jennifer/0000-0002-0135-480X
CR Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Amrute KV, 2009, THESCIENTIFICWORLDJO, V9, P23, DOI 10.1100/tsw.2009.7
   ANDUS T, 1993, DIGEST DIS SCI, V38, P1638, DOI 10.1007/BF01303172
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Baker SC, 2008, BIOMATERIALS, V29, P3357, DOI 10.1016/j.biomaterials.2008.04.033
   Benassi L, 2002, Minerva Ginecol, V54, P317
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Buchsbaum GM, 2002, OBSTET GYNECOL, V100, P226, DOI 10.1016/S0029-7844(02)02076-8
   Cain MP, 2010, J UROLOGY, V183, P2124, DOI 10.1016/j.juro.2010.03.067
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen B, 2004, NEUROUROL URODYNAM, V23, P119, DOI 10.1002/nau.20012
   Chen B, 2003, AM J OBSTET GYNECOL, V189, P89, DOI 10.1067/mob.2003.373
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Chen BH, 2002, INT UROGYNECOL J PEL, V13, P80, DOI 10.1007/s001920200020
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen Y, 2004, NEUROUROL URODYNAM, V23, P367, DOI 10.1002/nau.20006
   Chopra B, 2008, TOXICOL PATHOL, V36, P485, DOI 10.1177/0192623308315672
   COHEN JR, 1987, SURG GYNECOL OBSTET, V164, P355
   Culligan P, 2005, OBSTET GYNECOL, V106, P29, DOI 10.1097/01.AOG.0000165824.62167.c1
   Curti P, 2010, PELVIC FLOOR DISORDERS: IMAGING AND MULTIDISCIPLINARY APPROACH TO MANAGEMENT, P235, DOI 10.1007/978-88-470-1542-5_28
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Del Popolo G, 2008, EUR UROL, V53, P1013, DOI 10.1016/j.eururo.2007.09.034
   Delancey JOL, 2004, GASTROENTEROLOGY, V126, pS23, DOI 10.1053/j.gastro.2003.10.080
   Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   Dwyer PL, 2006, INT UROGYNECOL J, V17, pS10, DOI 10.1007/s00192-006-0103-0
   Eberli D, 2009, BJU INT, V103, P248, DOI 10.1111/j.1464-410X.2008.08001.x
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2004.04675.x
   Fu Q, 2010, UROLOGY, V75, P718, DOI 10.1016/j.urology.2009.10.003
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   GADEK JE, 1992, AM J MED, V92, pS27, DOI 10.1016/0002-9343(92)90604-A
   GANROT PO, 1967, SCAND J CLIN LAB INV, V19, P205, DOI 10.3109/00365516709090627
   Gomez DE, 1997, EUR J CELL BIOL, V74, P111
   Hafez AT, 2003, J UROLOGY, V170, P1639, DOI 10.1097/01.ju.0000083887.58315.7e
   Hafez AT, 2003, J UROLOGY, V169, P2316, DOI 10.1097/01.ju.0000067485.51252.f5
   HAFEZ AT, 2003, J UROLOGY, V170, P41
   HARRIS ED, 1984, COLLAGEN REL RES, V4, P493
   Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002
   Hautmann RE, 2006, WORLD J UROL, V24, P305, DOI 10.1007/s00345-006-0105-z
   HORWITZ AL, 1977, P NATL ACAD SCI USA, V74, P897, DOI 10.1073/pnas.74.3.897
   Hoshi A, 2008, TRANSPLANTATION, V85, P1617, DOI 10.1097/TP.0b013e318170572b
   Hosper NA, 2010, BIOMATERIALS, V31, P3910, DOI 10.1016/j.biomaterials.2010.01.129
   HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Karlovsky Matthew E, 2005, Curr Urol Rep, V6, P376, DOI 10.1007/s11934-005-0057-7
   Karsenty G, 2008, EUR UROL, V53, P275, DOI 10.1016/j.eururo.2007.10.013
   Keane DP, 1997, BRIT J OBSTET GYNAEC, V104, P994, DOI 10.1111/j.1471-0528.1997.tb12055.x
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Kleinert S, 2008, LANCET, V372, P789, DOI 10.1016/S0140-6736(08)61320-3
   KONDO A, 1994, NEUROUROL URODYNAM, V13, P507, DOI 10.1002/nau.1930130502
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kushner L, 2006, J UROLOGY, V175, P108
   Kushner L, 2004, NEUROUROL URODYNAM, V23, P198, DOI 10.1002/nau.10174
   Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032
   Liapis A, 2002, EUR UROL, V41, P469, DOI 10.1016/S0302-2838(02)00033-7
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Maher C, 2008, NEUROUROL URODYNAM, V27, P3, DOI 10.1002/nau.20542
   MALLYA SK, 1990, BIOCHEMISTRY-US, V29, P10628, DOI 10.1021/bi00499a008
   McAteer H, 2007, J TISSUE ENG REGEN M, V1, P343, DOI 10.1002/term.36
   McKenzie P, 2010, CURR OPIN UROL, V20, P291, DOI 10.1097/MOU.0b013e32833a4436
   Mushkat Y, 1996, AM J OBSTET GYNECOL, V174, P617, DOI 10.1016/S0002-9378(96)70437-4
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Paraiso MFR, 2004, OBSTET GYNECOL, V104, P1249, DOI 10.1097/AOG.0000146290.10472.b3
   PARKS WC, 1990, AM J RESP CELL MOL, V2, P399, DOI 10.1165/ajrcmb/2.5.399
   Patel PD, 2007, INDIAN J UROL, V23, P135, DOI 10.4103/0970-1591.32064
   Petros P E, 1993, Scand J Urol Nephrol Suppl, V153, P1
   Peyrat L, 2002, BJU INT, V89, P61, DOI 10.1046/j.1464-4096.2001.01813.x
   Praud C, 2007, CELL TRANSPLANT, V16, P741, DOI 10.3727/000000007783465118
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   RECHBERGER T, 1993, EUR J OBSTET GYN R B, V49, P187, DOI 10.1016/0028-2243(93)90268-H
   Rechberger T, 1998, AM J OBSTET GYNECOL, V179, P1511, DOI 10.1016/S0002-9378(98)70017-1
   Rizk DEE, 2006, INT UROGYNECOL J, V17, P436, DOI 10.1007/s00192-005-0055-9
   SAULNIER JM, 1991, CLIN CHIM ACTA, V200, P129, DOI 10.1016/0009-8981(91)90084-P
   SMITH ARB, 1989, BRIT J OBSTET GYNAEC, V96, P24, DOI 10.1111/j.1471-0528.1989.tb01571.x
   Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56
   Soergel TM, 2004, J UROLOGY, V172, P51
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   Southgate J, 2002, CULTURE EPITHELIAL C, P381, DOI DOI 10.1002/0471221201.CH12
   Stein J, 1996, CLIN CHEM, V42, P222
   STEWART M, 1982, BRIT J SURG, V69, P414, DOI 10.1002/bjs.1800690720
   Stohrer M, 2009, EUR UROL, V56, P81, DOI 10.1016/j.eururo.2009.04.028
   Tanaka ST, 2010, TISSUE ENG PT A, V16, P2121, DOI 10.1089/ten.TEA.2009.0557
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   TURNER A, 2010, EUR UROL IN PRESS
   Turner AM, 2007, WOODHEAD PUBL MATER, P445, DOI 10.1533/9781845693817.2.445
   ULMSTEN U, 1987, ACTA OBSTET GYN SCAN, V66, P455, DOI 10.3109/00016348709022054
   VERSI E, 1988, BRIT J OBSTET GYNAEC, V95, P147, DOI 10.1111/j.1471-0528.1988.tb06844.x
   Visco AG, 2003, AM J OBSTET GYNECOL, V189, P102, DOI 10.1067/mob.2003.372
   Vishwajit S, 2009, CURR BLADDER DYSFUNC, V4, P13, DOI 10.1007/s11884-009-0003-5
   Wiesmann HP, 2009, FUNDAMENTALS TISSUE, P457
   Wood D, 2008, CURR OPIN UROL, V18, P564, DOI 10.1097/MOU.0b013e32830f9402
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 104
TC 20
Z9 24
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0733-2467
J9 NEUROUROL URODYNAM
JI Neurourol. Urodyn.
PY 2011
VL 30
IS 5
BP 775
EP 782
DI 10.1002/nau.21101
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 777DO
UT WOS:000291595700026
PM 21661029
DA 2018-10-20
ER

PT S
AU Zhou, YL
   Luo, DM
   Hu, WY
   Li, YC
   Hodgson, P
   Wen, C
AF Zhou, Ying-Long
   Luo, Dong-Mei
   Hu, Wang-Yu
   Li, Yuncang
   Hodgson, Peter
   Wen, Cui'e
BE Zhou, HY
   Gu, TL
   Yang, DG
   Jiang, ZY
   Zeng, JM
TI Compressive Properties of Hot-rolled Mg-Zr-Ca Alloys for Biomedical
   Applications
SO NEW AND ADVANCED MATERIALS, PTS 1 AND 2
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 2nd International Conference on Manufacturing Science and Engineering
CY APR 09-11, 2011
CL Guilin, PEOPLES R CHINA
SP Guangxi Univ, Guilin Univ Elect Technol, Univ Wollongong, Korea Maritime Univ, Hong Kong Ind Technol Res Ctr
DE Compressive Property; Mg-Zr-Ca alloy; Hot-rolling; Biomaterial;
   Microstructure
ID MAGNESIUM ALLOYS; CORROSION; BIOMATERIALS; BONE
AB This paper investigated the microstructures and compressive properties of hot-rolled Mg-Zr-Ca alloys for biomedical applications. The microstructures of the Mg-Zr-Ca alloys were examined by X-ray diffraction analysis and optical microscopy, and the compressive properties were determined from compressive tests. The experimental results indicate that the hot-rolled Mg-Zr-Ca alloys with 1% Ca are composed of one single alpha phase and those alloys with 2% Ca consist of both Mg2Ca and alpha phase. The hot-rolled Mg-Zr-Ca alloys exhibit typical elongated microstructures with obvious fibrous stripe, and have much higher compressive strength and lower compressive modulus than pure Mg. All the studied alloys have much higher compressive yield strength than the human bone (90 similar to 140 MPa) and comparable modulus with the human bone, suggesting that they have a great potential to be good candidates for biomedical applications.
C1 [Zhou, Ying-Long; Luo, Dong-Mei] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Hu, Wang-Yu] Hunan Univ, Dept Appl Phys, Changsha 410082, Hunan, Peoples R China.
   [Li, Yuncang; Hodgson, Peter; Wen, Cui'e] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
EM ylzhou@fosu.edu.cn; dmluo@fosu.edu.cn; wangyuhu2001cn@yahoo.com.cn;
   yuncang.li@deakin.edu.au; peter.hodgson@deakin.edu.au;
   cuie.wen@deakin.edu.au
RI Hu, Wangyu/B-5762-2009; Wen, Cuie/I-2872-2012; Li, Yuncang/I-5832-2012
OI Hu, Wangyu/0000-0001-7416-3994; Wen, Cuie/0000-0001-8008-3536; Li,
   Yuncang/0000-0003-4290-4772
FU Key Scientific and Technological Projects of Guangdong Province, PR
   China [2008B010600003];  [AISRF-BF030031]
FX This work was supported by the Key Scientific and Technological Projects
   of Guangdong Province, PR China (Project No. 2008B010600003) and
   AISRF-BF030031, Australia.
CR [艾延龄 AI Yanling], 2005, [机械工程材料, Materials for Mechanical Engineering], V29, P3
   ASM International, 1992, ASM HDB, V3
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu H, 2007, MAGNESIUM ALLOYS FAB
   Zhou Y.-L., ADV SCI LET IN PRESS
NR 11
TC 9
Z9 10
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-035-0
J9 ADV MATER RES-SWITZ
PY 2011
VL 197-198
BP 56
EP +
DI 10.4028/www.scientific.net/AMR.197-198.56
PN 1,2
PG 2
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BVM03
UT WOS:000291849700012
DA 2018-10-20
ER

PT S
AU Wilson, D
   Florido, A
   Valderrama, C
   de Labastida, MF
   Alegret, S
   del Valle, M
AF Wilson, D.
   Florido, A.
   Valderrama, C.
   Fernandez de Labastida, M.
   Alegret, S.
   del Valle, M.
BE Gouma, P
TI Electronic Tongue-FIA system for the Monitoring of Heavy Metal
   Biosorption Processes
SO OLFACTION AND ELECTRONIC NOSE: PROCEEDINGS OF THE 14TH INTERNATIONAL
   SYMPOSIUM ON OLFACTION AND ELECTRONIC NOSE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 14th International Symposium on Olfaction and Electronic Nose
CY MAY 02-05, 2011
CL Rockefeller Univ, New York, NY
SP SUNY Stoney Brook, Engn Conf Int (ECI), Alpha MOS, Int Soc Olfact & Chem Sensors, Amer Ceramic Soc, Infratec, Synkera
HO Rockefeller Univ
DE grape stalk wastes; copper sorption; ion-selective electrode;
   flow-injection; electronic tongue; on-line monitoring
AB An automated flow injection potentiometric (PIP) system with electronic tongue detection (ET) was used for the monitoring of biosorption processes of heavy metals on waste biomaterial. Grape stalk wastes were used as biosorbent to remove Cu2+ ions in a fixed-bed column setup. For the monitoring, the used ET employed a sensor array formed by Cu2+ and Ca2+ selective electrodes and two generic heavy-metal electrodes. The subsequent cross-response obtained was processed by a multilayer artificial neural network (ANN) model in order to resolve the concentrations of the monitored species. The coupling of the electronic tongue with the automation features of the flow-injection system (ET-FIP) allowed us to accurately characterize the biosorption process, through obtaining its breakthrough curves. In parallel, fractions of the extract solution were analyzed by atomic absorption spectroscopy in order to validate the results obtained with the reported methodology.
C1 [Wilson, D.; Alegret, S.; del Valle, M.] Univ Autonoma Barcelona, Dept Chem, Sensors & Biosensors Grp, Edifici Cn, E-08193 Barcelona, Spain.
   [Florido, A.; Valderrama, C.; Fernandez de Labastida, M.] Univ Politecn Cataluna, Dept Chem Engn, Barcelona 08028, Spain.
RP Wilson, D (reprint author), Univ Autonoma Barcelona, Dept Chem, Sensors & Biosensors Grp, Edifici Cn, E-08193 Barcelona, Spain.
EM manel.delvalle@uab.es
RI Valderrama, Cesar/D-1092-2011; del Valle, Manuel/D-8171-2011
OI Valderrama, Cesar/0000-0001-6711-8183; del Valle,
   Manuel/0000-0002-1032-8611; Florido, Antonio/0000-0003-4266-7236;
   Wilson, Deivy/0000-0001-9509-5273
FU MICINN (Spanish Ministry of Science and Innovation)
   [CTM2008-06776-C02-02/TECNO, TEC2007-68012-C03-02/MIC]
FX This work was supported by MICINN (Spanish Ministry of Science and
   Innovation) projects CTM2008-06776-C02-02/TECNO and
   TEC2007-68012-C03-02/MIC.
CR Florido A, 2010, ANAL CHIM ACTA, V668, P26, DOI 10.1016/j.aca.2010.01.019
NR 1
TC 0
Z9 0
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0920-0
J9 AIP CONF PROC
PY 2011
VL 1362
BP 98
EP +
DI 10.1063/1.3626320
PG 2
WC Engineering, Biomedical; Physics, Applied
SC Engineering; Physics
GA BXE77
UT WOS:000295913500035
DA 2018-10-20
ER

PT J
AU Ronkko, S
   Kaarniranta, K
   Kalesnykas, G
   Uusitalo, H
AF Ronkko, Seppo
   Kaarniranta, Kai
   Kalesnykas, Giedrius
   Uusitalo, Hannu
TI Biocompatibility of Different Poly(Lactide-Coglycolide) Polymers
   Implanted into the Subconjunctival Space in Rats
SO OPHTHALMIC RESEARCH
LA English
DT Article
DE Biocompatibility; Biodegradable; Fibronectin; Polymers
ID BIODEGRADABLE SCLERAL PLUGS; FIBRONECTIN MATRIX; CELL-ADHESION; IN-VIVO;
   PLASMA FIBRONECTIN; CONTROLLED-RELEASE; EIIIA SEGMENT; MICROSPHERES;
   COLLAGEN; SURGERY
AB Aims: Biomaterials are widely used in ophthalmology, and biodegradable polymers have been evaluated for use in surgery, tissue engineering and targeted drug delivery. We examined the tissue reactions attributable to 3 biodegradable polymers in the rat eye. Methods: Inion GTR (TM) membrane [a blend of 85:15 poly(L-lactide-coglycolide) and 70:30 poly(L-lactide-co-1,3-trimethylene carbonate) copolymers in a molar ratio of 70:30], a 50:50 molar ratio of poly(DL-lactide-coglycolide) (PDLGA 50:50), and a 85:15 molar ratio of poly(DL-lactide-coglycolide) (PDLGA 85:15) were surgically implanted into the subconjuctival space of rat eyes. Biocompatibility was evaluated by following the eyes clinically and with histo-and immunohistochemical techniques. Results: No clinical signs of inflammation were observed around the implants during follow-up. However, immunohistochemical sections revealed increased accumulation of magrophages around PDLGA 85:15 at 2 weeks and of myofibroblasts around GTR membrane material at 1 month. The order of the degradation time of the material was GTR membrane material > PDLGA 85:15 > PDLGA 50:50; Fourier transform infrared microscopy revealed some differences in the degradation behavior of the polymers. Immunohistochemical staining for plasma or cellular fibronectin was observed around all implants. Conclusions: Despite the different decay times and influences on the expression levels of fibronectins, all polymers evoked rather similar tissue reactions during the observation period. This study provides new data on the biocompatibility of biomaterials in rat eyes. Our findings of the tissue decay of the implant and biomaterial-induced tissue reaction may help in the development of better biomaterials for eye surgery with optimal drug delivery properties. Copyright (C) 2011 S. Karger AG, Basel
C1 [Ronkko, Seppo; Kaarniranta, Kai; Kalesnykas, Giedrius] Univ Eastern Finland, Dept Ophthalmol, Sch Med, Inst Clin Med, FI-70211 Kuopio, Finland.
   [Kaarniranta, Kai] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland.
   [Uusitalo, Hannu] Univ Tampere, FIN-33101 Tampere, Finland.
   [Uusitalo, Hannu] Tampere Univ Hosp, Tampere, Finland.
RP Ronkko, S (reprint author), Univ Eastern Finland, Dept Ophthalmol, Sch Med, Inst Clin Med, POB 1627, FI-70211 Kuopio, Finland.
EM Seppo.Ronkko@uef.fi
OI Kaarniranta, Kai/0000-0003-2600-8679
FU Finnish Academy; Finnish Eye Foundation; Finnish Eye and Tissue Bank
   Foundation; Finnish Medical Foundation; Finnish Funding Agency for
   Technology and Innovation; Finnish Cultural Foundation; Kuopio
   University Foundation
FX This work was supported by the Finnish Academy, the Finnish Eye
   Foundation, the Finnish Eye and Tissue Bank Foundation, the Finnish
   Medical Foundation, Finnish Funding Agency for Technology and
   Innovation, the Finnish Cultural Foundation and Kuopio University
   Foundation. We thank Paivi Perttula, Anne-Mari Haapaniemi, Erika Oksala
   and Tiina Sistonen for their technical assistance and Ewen MacDonald,
   DPharm, for revising the English language of the manuscript.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Bertram JP, 2009, J MICROENCAPSUL, V26, P18, DOI 10.1080/02652040802095250
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Cai J., 1997, POLYM INT, V42, P373
   Cardillo JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P81, DOI 10.1001/archophthalmol.2009.352
   Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823
   Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623
   Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GINDE RM, 1987, J APPL POLYM SCI, V33, P2411, DOI 10.1002/app.1987.070330712
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Kivalo M, 1999, J MATER SCI-MATER M, V10, P53, DOI 10.1023/A:1008896211886
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x
   Lu DW, 2000, J OCUL PHARMACOL TH, V16, P529, DOI 10.1089/jop.2000.16.529
   Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   MIAN M, 1992, INT J TISSUE REACT, V14, P1
   Mosher DF, 2001, NAT MED, V7, P290, DOI 10.1038/85426
   Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100
   Nuss Katja M R, 2008, Open Orthop J, V2, P66, DOI 10.2174/1874325000802010066
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Peng YJ, 2010, J BIOMED MATER RES A, V94A, P426, DOI 10.1002/jbm.a.32697
   Rabowsky JH, 1996, OPHTHALMOLOGY, V103, P800
   Ronkko S, 2009, J BIOMED MATER RES A, V88A, P717, DOI 10.1002/jbm.a.31932
   RUOSLAHTI E, 1973, BIOCHIM BIOPHYS ACTA, V322, P352, DOI 10.1016/0005-2795(73)90310-3
   Sakurai E, 2001, INVEST OPHTH VIS SCI, V42, P2043
   Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P4845, DOI 10.1167/iovs.02-1228
   Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x
   Steffensen B, 2002, MATRIX BIOL, V21, P399, DOI 10.1016/S0945-053X(02)00032-X
   TAMKUN JW, 1983, J BIOL CHEM, V258, P4641
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200
   Wang Y, 2004, BIOMATERIALS, V25, P4279, DOI 10.1016/j.biomaterials.2003.10.075
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1
   Xie LX, 2001, CORNEA, V20, P748, DOI 10.1097/00003226-200110000-00015
   Yasukawa T, 2001, ADV DRUG DELIVER REV, V52, P25, DOI 10.1016/S0169-409X(01)00192-2
   Zhu KJ, 2003, J MICROENCAPSUL, V20, P731, DOI 10.1080/02652040310001600785
NR 46
TC 4
Z9 4
U1 1
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0030-3747
EI 1423-0259
J9 OPHTHALMIC RES
JI Ophthalmic Res.
PY 2011
VL 46
IS 2
BP 55
EP 65
DI 10.1159/000322996
PG 11
WC Ophthalmology
SC Ophthalmology
GA 799EI
UT WOS:000293266200001
PM 21228610
DA 2018-10-20
ER

PT S
AU Rossi, F
   Matteini, P
   Ratto, F
   Menabuoni, L
   Lenzetti, I
   Pini, R
AF Rossi, Francesca
   Matteini, Paolo
   Ratto, Fulvio
   Menabuoni, Luca
   Lenzetti, Ivo
   Pini, Roberto
BE Manns, F
   Soderberg, PG
   Ho, A
TI Laser welding of chitosan-GNRs films for the closure of a capsulorhexis
SO OPHTHALMIC TECHNOLOGIES XXI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Ophthalmic Technologies XXI
CY JAN 22-24, 2011
CL San Francisco, CA
SP SPIE, Topcon Adv Biomed Imaging Lab, Swedish Ophthalmol Soc, Resident Opt Course
DE gold nanorods; chitosan patch; laser welding; capsulorhexis
ID GOLD NANORODS
AB In this work we present the first attempt to close the anterior lens capsule bag by the use of chitosan patches, where Gold Nanorods (GNRs) are embedded. GNRs exhibit intense localized plasmon resonances at optical frequencies in the near infrared (NIR): upon excitation with a NIR laser, a strong photothermal effect is produced, which can be exploited to develop minimally invasive therapies. Here we use the chitosan-GNRs films as a novel NIR sensitive nanocomposite for the photothermal conversion of NIR laser light during surgical interventions of tissue welding. Chitosan is an attractive biomaterial due to its biodegradability, biocompatibility, antimicrobial and wound healing-promoting activity. Colloidal GNRs were embedded in chitosan based, highly stabilized, flexible and easy-to-handle films, which were stored in water until the time of surgery. In these preliminary tests, a capsulorhexis was performed in freshly enucleated porcine eyes. The lens was aspired, then the patch was put onto the capsule bag and welded: a diode laser (810 nm) was used to deliver single spots (200 mu m core diameter optical fiber) of local capsule/patch adhesion. Then the bag was refilled with silicon oil. The result is an immediate closure of the capsular tissue, with high mechanical strength. The laser welded chitosan-GNRs films are an innovative and highly stable solution to be exploited for the treatment of capsular breaks and for the implementation of a lens refilling procedure.
C1 [Rossi, Francesca; Matteini, Paolo; Ratto, Fulvio; Pini, Roberto] CNR, Inst Appl Pys Nello Carrara, Via Madonna del Piano 10, I-50019 Florence, Italy.
   [Menabuoni, Luca; Lenzetti, Ivo] U O Oculist Osped Misericordia & Dolce, Prato, Italy.
RP Rossi, F (reprint author), CNR, Inst Appl Pys Nello Carrara, Via Madonna del Piano 10, I-50019 Florence, Italy.
RI Matteini, Paolo/N-3725-2015; Rossi, Francesca/A-5105-2010
OI Rossi, Francesca/0000-0002-1199-8019; Menabuoni,
   Luca/0000-0002-7741-9964
CR Matteini P, 2010, PROC SPIE, V7574, DOI 10.1117/12.840923
   Matteini P, 2010, ADV MATER, V22, P4313, DOI 10.1002/adma.201002228
   PINI R, 2008, BIOL MED PHYS BIOMED, V15, P275
   Pini R, 2008, OPHTHAL SURG LAS IM, V39, P260, DOI 10.3928/15428877-20080501-12
   Ratto F., 2008, OPHTHALMIC TECHNOLOG, V6844
   Ratto F, 2010, J NANOPART RES, V12, P2029, DOI 10.1007/s11051-009-9712-0
   Ratto F, 2009, NANOMED-NANOTECHNOL, V5, P143, DOI 10.1016/j.nano.2008.10.002
NR 7
TC 1
Z9 1
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8422-2
J9 PROC SPIE
PY 2011
VL 7885
AR 78851O
DI 10.1117/12.876476
PG 4
WC Optics
SC Optics
GA BXY08
UT WOS:000297590500035
DA 2018-10-20
ER

PT J
AU Verma, S
   Jain, SL
   Sain, B
AF Verma, Sanny
   Jain, Suman L.
   Sain, Bir
TI An efficient biomaterial supported bifunctional organocatalyst (ES-SO3-
   C5H5NH+) for the synthesis of beta-amino carbonyls
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID AZA-MICHAEL REACTIONS; CATALYZED CONJUGATE ADDITION; ASYMMETRIC
   ORGANOCATALYSIS; ALPHA,BETA-ETHYLENIC COMPOUNDS; ENANTIOSELECTIVE
   SYNTHESIS; ORGANIC CATALYSTS; IONIC LIQUIDS; WATER; ACID; ALKENES
AB A biomaterial supported organocatalyst, readily synthesized by the reaction of chemically modified sulfonic group containing expanded corn starch with pyridine exhibited excellent catalytic activity for the synthesis of beta-amino carbonyls in excellent yields via aza-Michael addition of amines to electron deficient alkenes. A remarkable enhancement in the reaction rates was observed with the prepared bifunctional organocatalyst in comparison to the either starch grafted sulfonic acid or the corresponding homogeneous pyridinium p-toluenesulfonate.
C1 [Verma, Sanny; Jain, Suman L.; Sain, Bir] Indian Inst Petr, Div Chem Sci, Mohkampur 248005, Dehradun, India.
RP Jain, SL (reprint author), Indian Inst Petr, Div Chem Sci, Mohkampur 248005, Dehradun, India.
EM suman@iip.res.in; birsain@iip.res.in
RI Sain, Bir/F-8603-2010
FU CSIR, New Delhi
FX We are thankful to the Director, IIP for his kind permission to publish
   these results. SV acknowledges CSIR, New Delhi, for his Research
   Fellowship. We kindly acknowledge Dr J. K. Gupta for TGA analysis,
   Analytical Division, for IR, elemental analysis and GCMS analysis and Dr
   A. K. Sinha for providing surface area analysis.
CR ASLAM UM, 2010, RENEWABLE ENERGY RES
   BARTOLI G, 1994, J ORG CHEM, V59, P5328, DOI 10.1021/jo00097a039
   BARTOLI G, 2001, J ORG CHEM, V66, P9055
   Benaglia M, 2003, CHEM REV, V103, P3401, DOI 10.1021/cr010440o
   Benaglia M., 2009, RECOVERABLE RECYCLAB
   Biermann U, 2000, ANGEW CHEM INT EDIT, V39, P2206, DOI 10.1002/1521-3773(20000703)39:13<2206::AID-ANIE2206>3.0.CO;2-P
   Biermann U, 2000, ANGEW CHEM, V112, P2292
   Cardillo G, 1996, CHEM SOC REV, V25, P117, DOI 10.1039/cs9962500117
   Chaudhuri MK, 2005, TETRAHEDRON LETT, V46, P8329, DOI 10.1016/j.tetlet.2005.09.167
   Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d
   Cozzi F, 2006, ADV SYNTH CATAL, V348, P1367, DOI 10.1002/adsc.200606096
   Dalko PI, 2004, ANGEW CHEM INT EDIT, V43, P5138, DOI 10.1002/anie.200400650
   Ding K., 2008, HDB ASYMMETRIC HETER
   Dondoni A, 2008, ANGEW CHEM INT EDIT, V47, P4638, DOI 10.1002/anie.200704684
   GIMBERT C, 2007, TETRAHEDRON, V63, P8035
   Guidotti M., 2007, CATALYSIS RENEWABLES, P257
   Guillena G, 2006, TETRAHEDRON-ASYMMETR, V17, P1465, DOI 10.1016/j.tetasy.2006.05.020
   Hayashi Y, 1996, J AM CHEM SOC, V118, P5502, DOI 10.1021/ja960766s
   Hegedus LS, 2009, J AM CHEM SOC, V131, P17995, DOI 10.1021/ja908581u
   JENNER G, 1995, TETRAHEDRON LETT, V36, P233, DOI 10.1016/0040-4039(94)02215-W
   Kantam ML, 2005, ADV SYNTH CATAL, V347, P763, DOI 10.1002/adsc.200404361
   Kumar R, 2006, GREEN CHEM, V8, P356, DOI 10.1039/b517397c
   Lee DH, 2009, ADV SYNTH CATAL, V351, P2912, DOI 10.1002/adsc.200900495
   Li L, 2009, J AM CHEM SOC, V131, P11648, DOI 10.1021/ja9034494
   Loh TP, 1998, SYNLETT, P975
   Maiti SK, 2008, J MOL CATAL A-CHEM, V287, P135, DOI 10.1016/j.molcata.2008.03.008
   Maruoka K, 2008, ORG PROCESS RES DEV, V12, P679, DOI 10.1021/op7002979
   MATSUBARA S, 1994, CHEM LETT, P827, DOI 10.1246/cl.1994.827
   Melchiorre P, 2008, ANGEW CHEM INT EDIT, V47, P6138, DOI 10.1002/anie.200705523
   Palomo C, 2009, CHEM SOC REV, V38, P632, DOI 10.1039/b708453f
   Pettersen D, 2007, TETRAHEDRON LETT, V48, P7805, DOI 10.1016/j.tetlet.2007.09.012
   Polshettiwar V, 2010, TETRAHEDRON, V66, P1091, DOI 10.1016/j.tet.2009.11.015
   Ranu BC, 2007, TETRAHEDRON LETT, V48, P141, DOI 10.1016/j.tetlet.2006.10.142
   Reboule I., 2005, TETRAHEDRON LETT, V46, P7761
   Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m
   ROSSITER BE, 1992, CHEM REV, V92, P771, DOI 10.1021/cr00013a002
   Sakthivel A, 2006, CATAL COMMUN, V7, P302, DOI 10.1016/j.catcom.2005.11.017
   Seayad J, 2005, ORG BIOMOL CHEM, V3, P719, DOI 10.1039/b415217b
   Shaabani A, 2008, CATAL COMMUN, V9, P13, DOI 10.1016/j.catcom.2007.05.021
   Surendra K, 2006, TETRAHEDRON LETT, V47, P2125, DOI 10.1016/j.tetlet.2006.01.124
   Xu LW, 2004, NEW J CHEM, V28, P183, DOI 10.1039/b312047c
   Xu LW, 2003, CHEM COMMUN, P2570, DOI 10.1039/b307733k
   Yadav JS, 2003, CHEM LETT, V32, P988, DOI 10.1246/cl.2003.988
NR 43
TC 24
Z9 24
U1 1
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PY 2011
VL 9
IS 7
BP 2314
EP 2318
DI 10.1039/c0ob00965b
PG 5
WC Chemistry, Organic
SC Chemistry
GA 735YM
UT WOS:000288456700037
PM 21321768
DA 2018-10-20
ER

PT J
AU Reynolds, MM
   Annich, GM
AF Reynolds, Melissa M.
   Annich, Gail M.
TI The artificial endothelium
SO ORGANOGENESIS
LA English
DT Article
DE extracorporeal circulation; nitric oxide; platelet; biomaterial
   interface; artificial endothelium; rabbit; activation
ID NITRIC-OXIDE RELEASE; EXTRACORPOREAL-CIRCULATION; CATALYTIC GENERATION;
   POLYMERIC COATINGS; S-NITROSOTHIOLS; CARDIOPULMONARY BYPASS; PLATELET
   ACTIVATION; BLOOD COMPATIBILITY; IN-SITU; HEPARIN
C1 [Annich, Gail M.] Univ Michigan, Div Pediat Crit Care Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
   [Reynolds, Melissa M.] Colorado State Univ, Dept Chem, Coll Nat Sci, Sch Biomed Engn,Coll Engn, Ft Collins, CO 80523 USA.
RP Annich, GM (reprint author), Univ Michigan, Div Pediat Crit Care Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.
EM gannich@med.umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Edmunds L H Jr, 1995, ASAIO J, V41, P824, DOI 10.1097/00002480-199510000-00002
   Edmunds LH, 2002, PERFUSION-UK, V17, P243, DOI 10.1191/0267659102pf585oa
   *ELSO, 2009, ECMO REG EXTR LIF SU
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   Eynden FV, 2008, J CARDIAC SURG, V23, P288, DOI 10.1111/j.1540-8191.2008.00682.x
   Gorman RC, 1996, J THORAC CARDIOV SUR, V112, P557, DOI 10.1016/S0022-5223(96)70295-7
   HAYASHI Y, 1998, ASAIO, V44, P456
   Hwang S, 2006, ANGEW CHEM INT EDIT, V45, P2745, DOI 10.1002/anie.200503588
   Hwang S, 2008, BIOMATERIALS, V29, P2443, DOI 10.1016/j.biomaterials.2008.02.004
   Keh D, 1999, EUR J CLIN INVEST, V29, P344
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Mangoush O, 2007, EUR J CARDIO-THORAC, V31, P1058, DOI 10.1016/j.ejcts.2007.01.029
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   Mellgren K, 1996, ANN THORAC SURG, V61, P1194, DOI 10.1016/0003-4975(96)00017-3
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Murray DWG, 1937, SURGERY, V2, P163
   Oh BK, 2004, BIOMATERIALS, V25, P283, DOI 10.1016/S0142-9612(03)00530-1
   Oh BK, 2003, J AM CHEM SOC, V125, P9552, DOI 10.1021/ja035775x
   PLOTZ F B, 1992, Perfusion (London), V7, P27, DOI 10.1177/026765919200700106
   RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   VAUGHN M, 1998, AM J PHYSIOL, V274, P2163
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhou ZR, 2005, BIOMATERIALS, V26, P6506, DOI 10.1016/j.biomaterials.2005.04.046
NR 34
TC 24
Z9 25
U1 2
U2 12
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1547-6278
J9 ORGANOGENESIS
JI Organogenesis
PD JAN-MAR
PY 2011
VL 7
IS 1
BP 42
EP 49
DI 10.4161/org.7.1.14029
PG 8
WC Biochemistry & Molecular Biology; Developmental Biology; Engineering,
   Biomedical
SC Biochemistry & Molecular Biology; Developmental Biology; Engineering
GA 759RS
UT WOS:000290266700007
PM 21289481
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Chen, Q
   Chan, KC
   Liu, L
AF Chen, Q.
   Chan, K. C.
   Liu, L.
TI Tribological characterisation of Zr-based bulk metallic glass in
   simulated physiological media
SO PHILOSOPHICAL MAGAZINE
LA English
DT Article
DE metallic glass; biomaterial; friction; tribology; wear
ID SUPERCOOLED LIQUID; RESISTANCE
AB Due to their excellent wear resistant properties and high strength, as well as a low Young's modulus, Zr-based bulk metallic glasses (BMGs) are potentially suitable biomaterials for low-friction arthroplasty. The wear characteristics of the Zr(60.14)Cu(22.31)Fe(4.85)Al(9.7)Ag(3) bulk amorphous alloy against ultra-high-molecular-weight polyethylene (UHMWPE) compared to a CoCrMo/UHMWPE combination were investigated in two different wear screening test devices, reciprocating and unidirectional. Hank's solution and sterile calf bovine serum were selected as the lubricant fluid media. It was found that different fluid media had insignificant effect on polyethylene wear against BMG counterfaces. The wear behaviour obtained on both test devices demonstrated that Zr-based BMG achieved UHMWPE counterface wear rates superior to conventional cast CoCrMo alloy, where the wear rate of UHMWPE is decreased by over 20 times. The tribological performance of these joints is superior to that of conventional metal-on-polymer designs. Contact angle measurements suggested that the advantage of BMG over a CoCrMo alloy counterface is attributed to its highly hydrophilic surfaces.
C1 [Chen, Q.; Chan, K. C.] Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
   [Liu, L.] Huazhong Univ Sci & Technol, State Key Lab Mat Proc & Die & Mould Technol, Wuhan 430074, Peoples R China.
RP Chen, Q (reprint author), Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
EM hustcq@gmail.com
RI Chan, K.C./A-2311-2014; Chen, Qi/A-6167-2010; BAI, JIE/D-7448-2016
OI Chan, K.C./0000-0002-6173-5532; 
FU Research Grants Council of The Hong Kong Special Administration Region
   [PolyU5112/07 E]
FX This work was financially supported by the Research Grants Council of
   The Hong Kong Special Administration Region (Project No. PolyU5112/07
   E). The authors would like to thank Mr. S.Y.Lau at the Materials
   Engineering Laboratory of The Hong Kong Polytechnic University for
   assistance in the wear tests.
CR Black J., 1998, HDB BIOMATERIAL PROP
   Borruto A, 2005, TRIBOL LETT, V20, P1, DOI 10.1007/s11249-005-7787-z
   El-Domiaty A, 2002, J MATER ENG PERFORM, V11, P577, DOI 10.1361/105994902770343845
   Greer AL, 2002, INT MATER REV, V47, P87, DOI 10.1179/095066001225001067
   Inoue A, 1999, MAT SCI ENG A-STRUCT, V267, P171, DOI 10.1016/S0921-5093(99)00089-1
   Inoue A, 2010, INT J APPL GLASS SCI, V1, P273, DOI 10.1111/j.2041-1294.2010.00019.x
   Kawamura Y, 1998, ACTA MATER, V46, P253, DOI 10.1016/S1359-6454(97)00235-8
   Liu L, 2008, J BIOMED MATER RES A, V86A, P160, DOI 10.1002/jbm.a.31425
   Liu L, 2010, INTERMETALLICS, V18, P1978, DOI 10.1016/j.intermet.2010.02.039
   Liu Z, 2009, J ALLOY COMPD, V487, P152, DOI 10.1016/j.jallcom.2009.08.030
   Morrison ML, 2005, J BIOMED MATER RES A, V74A, P430, DOI 10.1002/jbm.a.30361
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   OVERHOLSER R, 2006, P MAT PROC MED DEV C, P37
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   Zhang QS, 2009, SCRIPTA MATER, V61, P241, DOI 10.1016/j.scriptamat.2009.03.056
NR 16
TC 18
Z9 18
U1 2
U2 34
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1478-6435
J9 PHILOS MAG
JI Philos. Mag.
PY 2011
VL 91
IS 28
BP 3705
EP 3715
DI 10.1080/14786435.2011.589867
PG 11
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Physics
GA 869FQ
UT WOS:000298583100004
DA 2018-10-20
ER

PT S
AU Xiong, Y
   Ye, WN
AF Xiong, Yule
   Ye, Winnie N.
BE Kashyap, R
   Tetu, M
   Kleiman, RN
TI Vertically Coupled Si-based Athermal Double-Ring Biosensor
SO PHOTONICS NORTH 2011
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Photonics North
CY MAY 16-18, 2011
CL Ottawa, CANADA
SP Ontario Photon Ind Network (OPIN), Quebec Photon Network, Institut Nat dOptique (INO), Canadian Photon Consortium (CPC), Universite Laval, photonique et Laser, Centre doptique
DE double-ring; ring resonator; biosensor; temperature;
   silicon-on-insulator; waveguide
ID RESONATORS; SILICON
AB A silicon-based athermal double-ring resonator biosensor with a vertically coupled configuration is developed. We present an optimal design of the sensor structure by specifying the radii of the reference and the sensing rings, the vertical coupling offset, d, between the two rings and the bus waveguide, and the lateral offset, l, between the edges of the rings and the bus waveguide. By using Lumerical software package, we demonstrate that the optimal vertical and lateral offsets are d=325 nm and l=-80 nm, respectively. One major challenge faced by ring based biosensors is their temperature dependent characteristics. In this study, the sensing ring is exposed to the biomaterial under test, while the reference ring provides a temperature-insensitive reference to the sensing measurements. By assuming the biomaterial medium has small variations in temperature, we conclude that the proposed biosensor device offers temperature insensitive measurement, where the temperature effects are fully corrected by the reference ring response. The doublering sensors are proposed to be fabricated with the local oxidation of silicon process, without the need for advanced lithography methods such as e-beam or deep UV lithography. In addition, the vertically coupled double-ring configuration allows precise control of the critical coupling separation between the rings and the bus waveguide. The proposed silicon double-ring biosensor can be used for highly sensitive and stable sensing for both biomedical and environmental applications.
C1 [Xiong, Yule; Ye, Winnie N.] Carleton Univ, Dept Elect, Ottawa, ON K1S 5B6, Canada.
RP Xiong, Y (reprint author), Carleton Univ, Dept Elect, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.
EM winnie_ye@doe.carleton.ca
RI Ye, Winnie/E-1651-2011
OI Ye, Winnie/0000-0003-2817-4531
CR Bienstman P., 2007, OPT EXPRESS, V15, P7610
   Chamanzar M, 2010, APPL PHYS B-LASERS O, V101, P263, DOI 10.1007/s00340-010-4034-6
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Kusko M, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/6/064012
   Little BE, 1999, IEEE PHOTONIC TECH L, V11, P215, DOI 10.1109/68.740708
   Rowe LK, 2007, ELECTRON LETT, V43, P392, DOI 10.1049/el:20073680
   Vos K. D., 2009, IEEE PHOTONICS J, V1, P225
   Washburn AL, 2009, ANAL CHEM, V81, P9499, DOI 10.1021/ac902006p
   Xu DX, 2010, OPT LETT, V35, P2771, DOI 10.1364/OL.35.002771
   Xu D.-X, 2008, GROUP 4 PHOT 5 IEEE, P398
   Xu DX, 2010, OPT EXPRESS, V18, P22867, DOI 10.1364/OE.18.022867
   Yalcin A, 2006, IEEE J SEL TOP QUANT, V12, P148, DOI 10.1109/JSTQE.2005.863003
   Ye WN, 2008, IEEE PHOTONIC TECH L, V20, P885, DOI 10.1109/LPT.2008.922338
NR 13
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-81948-581-6
J9 PROC SPIE
PY 2011
VL 8007
AR 80070V
DI 10.1117/12.905392
PG 8
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA BXX89
UT WOS:000297560400031
DA 2018-10-20
ER

PT J
AU Xu, PF
   Noh, H
   Lee, JH
   Cha, JN
AF Xu, Phyllis F.
   Noh, Hyunwoo
   Lee, Ju Hun
   Cha, Jennifer N.
TI DNA mediated assembly of single walled carbon nanotubes: role of DNA
   linkers and annealing
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID SEPARATION; DISPERSION; ARRAYS; ROUTE; FILMS
AB With the high demand for nanoelectronic devices, extensive research has focused on the use of single walled carbon nanotubes (CNTs) due to their high electron carrier mobility, large tensile strength, and single nanometer dimensions. Despite their promise, however, their applicability has been greatly hindered by the inherent difficulties of both separating nanotubes of different chiralities and diameters and positioning them from metallic tubes and positioning them in a precise location on a surface. In recent years, single stranded DNA (ssDNA) has been identified as a potential solution for both of these problems since DNA can be used to both separate the different types of CNTs as well as direct their organization. We demonstrate here the first principles on how to guide CNT assembly directly on surfaces from solution by specific DNA hybridization. It was found that the specific DNA sequence used to disperse the carbon nanotubes greatly influences the adsorption and specificity of nanotube binding to the surface. Furthermore, we demonstrate here that thermal annealing can correct misaligned tubes or incorrect binding. These studies provide an excellent foundation for employing two-dimensional DNA templates for CNT organization for nanoelectronic logic and memory based applications. Furthermore, using a single biomaterial to both sort and place CNTs in minimal steps would greatly help the throughput, manufacturability, and cost of such devices.
C1 [Cha, Jennifer N.] Univ CA, Dept Nanoengn & Mat Sci, La Jolla, CA 92093 USA.
   Univ CA, Engn Program, La Jolla, CA 92093 USA.
RP Cha, JN (reprint author), Univ CA, Dept Nanoengn & Mat Sci, 9500 Gilman Dr,M-C 0448, La Jolla, CA 92093 USA.
EM jencha@ucsd.edu
RI Lee, Ju Hun/H-3851-2013
FU Office of Naval Research [N00014-09-01-0250]; National Science
   Foundation [CMMI-7045043]; DARPA [N66001-09-1-2093]
FX The authors thank Dr Andrew Goodwin for manuscript editing, Mr Matt
   Nakatsuka for help with the zeta potential measurements and Prof. Shyni
   Varghese for use of a UV-vis spectrophotometer. This work is financially
   supported by the Office of Naval Research (Award Number:
   N00014-09-01-0250), the National Science Foundation (CMMI-7045043) and
   the DARPA YFA Program (N66001-09-1-2093).
CR Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52
   Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l
   Gao JB, 2004, J AM CHEM SOC, V126, P16698, DOI 10.1021/ja044499z
   Hazani M, 2004, CHEM PHYS LETT, V391, P389, DOI 10.1016/j.cplett.2004.05.042
   Keren K, 2003, SCIENCE, V302, P1380, DOI 10.1126/science.1091022
   Ko H, 2004, J PHYS CHEM B, V108, P4385, DOI 10.1021/jp031229e
   Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534
   Lay MD, 2004, NANO LETT, V4, P603, DOI 10.1021/nl035233d
   Li XL, 2007, J AM CHEM SOC, V129, P4890, DOI 10.1021/ja071114e
   Maeda Y, 2005, J AM CHEM SOC, V127, P10287, DOI 10.1021/ja051774o
   Maeda Y, 2006, J AM CHEM SOC, V128, P12239, DOI 10.1021/ja063776u
   Martel R, 2008, ACS NANO, V2, P2195, DOI 10.1021/nn800723u
   Maune H. T., 2009, NAT NANOTECHNOL, V5, P61
   Meitl MA, 2004, NANO LETT, V4, P1643, DOI 10.1021/nl0491935
   Noh H, 2010, ACS NANO, V4, P5076, DOI 10.1021/nn101593d
   Noh H, 2009, ACS NANO, V3, P2376, DOI 10.1021/nn900559m
   Postma HWC, 2001, SCIENCE, V293, P76, DOI 10.1126/science.1061797
   Qiu HX, 2009, J AM CHEM SOC, V131, P16529, DOI 10.1021/ja906932p
   Ramesh S, 2007, J PHYS CHEM C, V111, P17827, DOI 10.1021/jp071322t
   Rao SG, 2003, NATURE, V425, P36, DOI 10.1038/425036a
   Tu XM, 2008, NANO RES, V1, P185, DOI 10.1007/s12274-008-8022-7
   Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116
   Valentin E, 2002, MICROELECTRON ENG, V61-2, P491, DOI 10.1016/S0167-9317(02)00580-4
   Voggu R, 2010, J AM CHEM SOC, V132, P5560, DOI 10.1021/ja100190p
   Wang YH, 2006, P NATL ACAD SCI USA, V103, P2026, DOI 10.1073/pnas.0511022103
   Xin HJ, 2003, J AM CHEM SOC, V125, P8710, DOI 10.1021/ja035902p
   Yan YH, 2007, SMALL, V3, P24, DOI 10.1002/smll.200600354
   Zhang L, 2008, J AM CHEM SOC, V130, P2686, DOI 10.1021/ja7106492
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
NR 30
TC 11
Z9 11
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PY 2011
VL 13
IS 21
BP 10004
EP 10008
DI 10.1039/c0cp02815k
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 765TR
UT WOS:000290732000011
PM 21336403
DA 2018-10-20
ER

PT J
AU Budzynska, A
   Wieckowska-Szakiel, M
   Sadowska, B
   Kalemba, D
   Rozalska, B
AF Budzynska, Aleksandra
   Wieckowska-Szakiel, Marzena
   Sadowska, Beata
   Kalemba, Danuta
   Rozalska, Barbara
TI Antibiofilm Activity of Selected Plant Essential Oils and their Major
   Components
SO POLISH JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE biofilm eradication; biomaterial-associated infections; essential oils
ID TEA-TREE OIL; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL ACTIVITY; BIOFILMS;
   ANTIBACTERIAL; RESISTANT; ANTIFUNGAL; MRSA
AB The aim of the study was to examine the antibiofilm activity of selected essential oils (EO): Lavandula angustifolia (LEO), Melaleuca alternifolia (TTO), Melissa officinalis (MEO) and some of their major constituents: linalool, linalyl acetate, a-terpineol, terpinen-4-ol. Biofilms were formed by Staphylococcus aureus ATCC 29213 and Escherichia coli NCTC 8196 on the surface of medical biomaterials (urinary catheter, infusion tube and surgical mesh). TTC reduction assay was used for the evaluation of mature biofilm eradication from these surfaces. Moreover, time-dependent eradication of biofilms preformed in polystyrene 96-well culture microplates was examined and expressed as minimal biofilm eradication concentration (evaluated by MTT reduction assay). TTO, alpha-terpineol and terpinen-4-ol as well as MEO, showed stronger anti-biofilm activity than LEO and linalool or linalyl acetate. Among the biomaterials tested, surgical mesh was the surface most prone to persistent colonization since biofilms formed on it, both by S. mucus and E. coli, were difficult to destroy. The killing rate studies of S. aureus biofilm treated with TTO, LEO, MEO and some of their constituents revealed that partial (50%) destruction of 24-h-old biofilms (MBEC50) was achieved by the concentration 4-8 x MIC after 1 h, whereas 2-4 x MIC was enough to obtain 90% reduction in biomass metabolic activity (MBEC90) after just 4 h of treatment. A similar dose-dependent effect was observed for E. coli biofilm which, however, was more susceptible to the action of phytochemicals than the biofilms of S. aureus. It is noteworthy that an evident decrease in biofilm cells metabolic activity does not always lead to their total destruction and eradication.
C1 [Rozalska, Barbara] Univ Lodz, Dept Immunol & Infect Biol, Inst Microbiol Biotechnol & Immunol, PL-90237 Lodz, Poland.
   [Kalemba, Danuta] Tech Univ Lodz, Inst Gen Food Chem, PL-90924 Lodz, Poland.
RP Rozalska, B (reprint author), Univ Lodz, Dept Immunol & Infect Biol, Inst Microbiol Biotechnol & Immunol, Banacha 12-16, PL-90237 Lodz, Poland.
EM rozab@biol.uni.lodz.pl
RI Kalemba, Danuta/P-4183-2018
OI Kalemba, Danuta/0000-0002-4018-5260
CR Amalaradjou MAR, 2010, J UROLOGY, V184, P358, DOI 10.1016/j.juro.2010.03.006
   Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106
   Brady A, 2006, J MED MICROBIOL, V55, P1375, DOI 10.1099/jmm.0.46558-0
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Budzynska Aleksandra, 2009, Medycyna Doswiadczalna i Mikrobiologia, V61, P281
   Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006
   Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103
   Chao S, 2008, FLAVOUR FRAG J, V23, P444, DOI 10.1002/ffj.1904
   Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124
   Durig A, 2010, APPL MICROBIOL BIOT, V87, P309, DOI 10.1007/s00253-010-2471-0
   Fabian D, 2006, TOXICOL IN VITRO, V20, P1435, DOI 10.1016/j.tiv.2006.06.012
   Flemming K, 2009, J ANTIMICROB CHEMOTH, V63, P136, DOI 10.1093/jac/dkn464
   Gibbons S, 2008, PLANTA MED, V74, P594, DOI 10.1055/s-2008-1074518
   Gursoy UK, 2009, ANAEROBE, V15, P164, DOI 10.1016/j.anaerobe.2009.02.004
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   HOSSAINZADEGAN H, 2009, ACTA MED IRANICA, V47, P35
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719
   Karpanen TJ, 2008, J ANTIMICROB CHEMOTH, V62, P1031, DOI 10.1093/jac/dkn325
   Kwiecinski J, 2009, INT J ANTIMICROB AG, V33, P343, DOI 10.1016/j.ijantimicag.2008.08.028
   Mimica-Dukic N, 2004, J AGR FOOD CHEM, V52, P2485, DOI 10.1021/jf030698a
   Reichling J, 2009, FORSCH KOMPLEMENTMED, V16, P79, DOI 10.1159/000207196
   Roller S, 2009, J ALTERN COMPLEM MED, V15, P275, DOI 10.1089/acm.2008.0268
   Rozalska Barbara, 1998, Medycyna Doswiadczalna i Mikrobiologia, V50, P115
   Walencka E, 2007, PLANTA MED, V73, P545, DOI 10.1055/s-2007-967179
   Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191
   Warnke PH, 2006, PHYTOMEDICINE, V13, P463, DOI 10.1016/j.phymed.2005.09.012
NR 27
TC 31
Z9 35
U1 1
U2 28
PU POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS
PI WARSAW
PA CHELMSKA STR 30-34, WARSAW, 00-725, POLAND
SN 1733-1331
J9 POL J MICROBIOL
JI Pol. J. Microbiol.
PY 2011
VL 60
IS 1
BP 35
EP 41
PG 7
WC Microbiology
SC Microbiology
GA 742FY
UT WOS:000288927900005
PM 21630572
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Peng, ZY
   Peng, ZP
   Shen, YQ
AF Peng, Zhiyuan
   Peng, Zhiping
   Shen, Yongqiang
TI Fabrication and Properties of Gelatin/Chitosan Composite Hydrogel
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE Chitosan; Composite hydrogel; Fabrication; Gelatin; Properties
ID BIOCOMPATIBILITY; SCAFFOLDS; ADHESION; RELEASE; DESIGN
AB Gelatin/chitosan hydrogels were prepared by using glutaraldehyde as crosslinker. The porous structure was confirmed by scanning electron microscope (SEM). Swelling ratios of the hydrogels with various ratio of gelatin to chitosan and crosslinker reagent dosage were studied in phosphate-buffered saline (PBS). In addition, in-vitro cytotoxicity was assessed via MTT assay with fibroblastic cell cultured in hydrogel extractions. It was found that by increasing glutaraldehyde dosage and chitosan content, the swelling ratio of the hydrogels decreased in buffer solutions. The MTT test showed that the gelatin/chitosan hydrogel clearly presented adequate cell viability, non-toxicity, and suitable properties. Therefore, these developed blends, based on gelatin and chitosan has broadened the number of choices of biomaterials to be potentially used in biomedical applications such as biomaterial, drug delivery vehicles and skin tissue engineering.
C1 [Peng, Zhiyuan; Peng, Zhiping; Shen, Yongqiang] Jishou Univ, Coll Chem & Chem Engn, Jishou 416000, Peoples R China.
RP Peng, ZY (reprint author), Jishou Univ, Coll Chem & Chem Engn, Jishou 416000, Peoples R China.
EM z_ypeng@126.com
CR [Anonymous], 2006, 10993 ISO 11
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Costa ED, 2009, J MATER SCI-MATER M, V20, P553, DOI 10.1007/s10856-008-3627-7
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lim YM, 2010, MACROMOL RES, V18, P29, DOI 10.1007/s13233-009-0068-1
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Peng ZY, 2011, POLYM-PLAST TECHNOL, V50, P245, DOI 10.1080/03602559.2010.531438
   Peng ZY, 2010, INT J POLYM MATER, V59, P450, DOI 10.1080/00914030903538637
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   Yang ZY, 2010, SCI CHINA LIFE SCI, V53, P215, DOI 10.1007/s11427-010-0036-1
   Zhang WF, 2009, J MATER SCI-MATER M, V20, P1321, DOI 10.1007/s10856-008-3680-2
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
NR 19
TC 31
Z9 32
U1 8
U2 35
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2011
VL 50
IS 11
BP 1160
EP 1164
DI 10.1080/03602559.2011.574670
PG 5
WC Polymer Science
SC Polymer Science
GA 885JO
UT WOS:000299775400012
DA 2018-10-20
ER

PT J
AU Cui, J
   Kratz, K
   Hiebl, B
   Jung, F
   Lendlein, A
AF Cui, J.
   Kratz, K.
   Hiebl, B.
   Jung, F.
   Lendlein, A.
TI Soft poly(n-butyl acrylate) networks with tailored mechanical properties
   designed as substrates for in vitro models
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Polymers for Advanced Technologies (PAT
   2009)
CY OCT 11-14, 2009
CL Jerusalem, ISRAEL
DE biomaterial; hydrophobic polymer; poly(n-butyl acrylate); soft polymer
   networks; adjustable mechanical properties
ID SHAPE-MEMORY PROPERTIES; MESENCHYMAL STEM-CELLS; POLYMER NETWORKS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; STERILIZATION; MOTILITY; ADHESION;
   BEHAVIOR; CYTOTOXICITY; STIMULATION
AB Mechanical conditioning can serve as a potent tool to influence mechano-responsive cells, which plays a prominent role during formation and regeneration of functional tissue. Recently, the differentiation of mesenchymal stem cells could be influenced by the local stiffness of hydrogels used as 2D substrates. However, the mechanical properties and the swellability of hydrogels in physiological liquids are difficult to control precisely as their properties strongly depend on physical parameters like ionic strength or pH value. Here, we explored amorphous, hydrophobic poly(n-butyl acrylate) networks (cPnBA) as soft substrates for cell culture system with adjustable mechanical properties. cPnBAs were synthesized via bulk radical polymerization from n-butyl acrylate (nBA) and poly(propylene glycol) dimethacrylate (PPGDMA) as crosslinker. The Young's modulus for cPnBAs determined by tensile tests could be systematically adjusted from 100 kPa to 10 MPa by increasing the PPGDMA-content at ambient temperature, while the glass transition temperature (T-g) was found to increase from -46 to -22 degrees C. All cPnBAs exhibited similar surface properties with a surface roughness (R-q) in the range from 1.4 to 0.4 mu m and advancing contact angles from 115 degrees to 100 degrees, which remained constant after ethylene oxide sterilization. The extracts of sterilized materials were tested for cytotoxic effects with L929 cells. All tested samples were non-cytotoxic. The functional integrity of cell membranes and mitochondrial activity stayed unaffected. The investigated polymer networks are promising candidates as soft substrates for passive mechanical stimulation of cells in vitro in cell culture devices or in vivo as implant coatings. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Cui, J.; Kratz, K.; Hiebl, B.; Jung, F.; Lendlein, A.] Geesthacht GmbH, GKSS Res Ctr, Polymer Res Inst, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Cui, J.; Kratz, K.; Hiebl, B.; Jung, F.; Lendlein, A.] Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Geesthacht GmbH, GKSS Res Ctr, Polymer Res Inst, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI Kratz, Karl/K-7115-2013; Lendlein, Andreas/K-9553-2013; Jung,
   Friedrich/L-1301-2013
OI Kratz, Karl/0000-0002-9229-4266; Lendlein, Andreas/0000-0003-4126-4670;
   Jung, Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Bartzoka V, 1999, ADV MATER, V11, P257, DOI 10.1002/(SICI)1521-4095(199903)11:3<257::AID-ADMA257>3.0.CO;2-S
   Briganti E, 2006, J MATER SCI-MATER M, V17, P259, DOI 10.1007/s10856-006-7312-4
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Chen CC, 2009, MATER LETT, V63, P1872, DOI 10.1016/j.matlet.2009.05.073
   Cortese B, 2009, ADV FUNCT MATER, V19, P2961, DOI 10.1002/adfm.200900918
   Cranfield C, 2006, INT J BIOMED IMAGING, DOI 10.1155/IJBI/2006/21304
   Cui J, 2011, POLYM ADVAN TECHNOL, V22, P180, DOI 10.1002/pat.1733
   Cui J, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/6/065019
   Cui J, 2009, MATER RES SOC SYMP P, V1190, P93
   Disher D. E., 2005, SCIENCE, V310, P1139
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FDA, 2002, STER REV GUID K90 1
   Frias C, 2010, J BIOMECH, V43, P1061, DOI 10.1016/j.jbiomech.2009.12.010
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Goveia VR, 2007, REV LAT-AM ENFERM, V15, P373, DOI 10.1590/S0104-11692007000300002
   Ha-Anh T, 2005, POLYM TEST, V24, P775, DOI 10.1016/j.polymertesting.2005.03.016
   Hiebl B, 2010, J BIOTECHNOL, V148, P76, DOI 10.1016/j.jbiotec.2010.01.006
   Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]
   Kadow-Romacker A, 2009, CELLS TISSUES ORGANS, V190, P61, DOI 10.1159/000178022
   Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432
   Kelch S, 2008, ADV ENG MATER, V10, P494, DOI 10.1002/adem.200700339
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kommareddy KP, 2010, BIOINTERPHASES, V5, P45, DOI 10.1116/1.3431524
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836
   Nair PD, 1995, J BIOMATER APPL, V10, P121, DOI 10.1177/088532829501000203
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ogura K, 2003, J SOC RHEOL JPN, V31, P85
   Perry MJ, 2009, MED ENG PHYS, V31, P42, DOI 10.1016/j.medengphy.2008.04.003
   Pompe T, 2009, BIOPHYS J, V97, P2154, DOI 10.1016/j.bpj.2009.07.047
   Prasitsilp M, 2003, J MATER SCI-MATER M, V14, P595, DOI 10.1023/A:1024066806347
   Rickert D, 2007, LARYNGO RHINO OTOL, V86, P507, DOI 10.1055/s-2007-966091
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Spiller D, 2009, J MATER SCI-MATER M, V20, P2511, DOI 10.1007/s10856-009-3823-0
   Ueki Y, 2010, BIOCHEM BIOPH RES CO, V394, P94, DOI 10.1016/j.bbrc.2010.02.115
NR 41
TC 21
Z9 21
U1 3
U2 32
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD JAN
PY 2011
VL 22
IS 1
SI SI
BP 126
EP 132
DI 10.1002/pat.1816
PG 7
WC Polymer Science
SC Polymer Science
GA 702GE
UT WOS:000285881800019
DA 2018-10-20
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI CUTTING MECHANICS OF HIGH SPEED DRY MACHINING OF MAGNESIUM-CALCIUM
   BIOMEDICAL ALLOY USING INTERNAL STATE VARIABLE PLASTICITY MODEL
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE 2011, VOL 1
LA English
DT Proceedings Paper
CT 6th ASME International Manufacturing Science and Engineering Conference
   / 4th JSME/ASME International Conference on Materials and Processing
CY JUN 13-17, 2011
CL Oregon State Univ, Corvallis, OR
HO Oregon State Univ
DE High speed machining; dry cutting; cutting mechanics; FEA; biomaterial;
   magnesium alloy
ID SURFACE
AB Magnesium-Calcium (MgCa) alloys have become attractive orthopedic biomaterials due to their biodegradability, biocompatibility, and congruent mechanical properties with bone tissues. However, process mechanics of machining biomedical Mg Ca alloys is poorly understood. Mechanical properties of the biomedical magnesium alloy at high strain rates and large strains are determined by using the split-Hopkinson pressure bar testing method. Internal state variable (ISV) plasticity model is implemented to understand the dynamic material behavior under cutting conditions. A finite element simulation model has been developed to study the chip formation during high speed dry cutting of MgCa0.8 (wt %) alloy. Continuous chip formation predicted by the FE simulation is verified by high speed dry face milling of MgCa0.8 using polycrystalline diamond (PCD) inserts. Chip ignition is known as the most hazardous aspect of machining Mg alloys. The predicted temperature distributions may well explain the reason for machining safety of high-speed dry cutting of MgCa0.8 alloy.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Byrne G, 2003, CIRP ANN-MANUF TECHN, V52, P483, DOI 10.1016/S0007-8506(07)60200-5
   Danilenko B.D., 2009, RUSS ENG RES, V29, P316
   DAVIES EDH, 1963, J MECH PHYS SOLIDS, V11, P155, DOI 10.1016/0022-5096(63)90050-4
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, P 7 INT C MG ALL THE, P895
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Fang FZ, 2005, J MATER PROCESS TECH, V167, P119, DOI 10.1016/j.jmatprotec.2004.10.002
   Friemuth T, 1999, ADV ENG MATER, V1, P183, DOI 10.1002/(SICI)1527-2648(199912)1:3/4<183::AID-ADEM183>3.3.CO;2-M
   Gama B, 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gray III G. T., 2000, ASM HDB, V8
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Guo YB, 2002, J MANUF SCI E-T ASME, V124, P189, DOI 10.1115/1.1430678
   Hallum D, 1995, AM MACH, V139, P48
   Lathrop J. F., 1996, SAND978218 SANDIA LA
   Massalski T.B., 1990, 927928 ASM INT
   Pedersen W, 2006, J MATER PROCESS TECH, V172, P417, DOI 10.1016/j.jmatprotec.2005.07.016
   Salahshoor M, 2009, INT J MACH TOOL MANU, V49, P1136, DOI 10.1016/j.ijmachtools.2009.07.016
   Salahshoor M., 2010, P ASME INT MAN SCI E
   Salahshoor M., 2009, P ASM MPMD C EXP MIN
   Sanz C, 2007, P 7 INT C MG ALL THE, P916
   Schmidt J., 1998, ALUMINIUM, V74, P412
   Schwerin R, 2007, P 7 INT C MG ALL THE, P922
   Tomac N., 1991, ANN CIRP, V40, P79
   Tonshoff HK, 1997, SURF COAT TECH, V94-5, P610, DOI 10.1016/S0257-8972(97)00505-7
   Tonshoff HK, 1999, MATERIALWISS WERKST, V30, P401
   Tonshoff HK, 2000, MG ALLOYS THEIR APP, P406
   Videm M, 1994, SAE T, V103, P213
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
NR 31
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4430-4
PY 2011
BP 85
EP 92
PG 8
WC Engineering, Mechanical
SC Engineering
GA BFJ30
UT WOS:000320096800012
DA 2018-10-20
ER

PT B
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
GP ASME
TI PROCESS MECHANICS IN DEEP ROLLING OF MAGNESIUM-CALCIUM (MgCa)
   BIOMATERIAL
SO PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE 2011, VOL 1
LA English
DT Proceedings Paper
CT 6th ASME International Manufacturing Science and Engineering Conference
   / 4th JSME/ASME International Conference on Materials and Processing
CY JUN 13-17, 2011
CL Oregon State Univ, Corvallis, OR
HO Oregon State Univ
DE Deep rolling; magnesium alloy; orthopedic biomaterial; contact
   mechanics; FEA
ID RESIDUAL-STRESS STABILITY; STAINLESS-STEEL AISI-304; TI-6AL-4V ALLOY;
   BONE-RESORPTION; SURFACE; FATIGUE; PERFORMANCE; PROPERTY; BEHAVIOR
AB Magnesium-Calcium (MgCa) alloys have received considerable attention recently in medical device manufacturing industry specially in making biodegradable bone implants. Deep rolling (DR) is as a promising manufacturing technique to adjust surface characteristics of implants with the ultimate goal of being able to adjust corrosion rates of MgCa implants. Contact mechanics between rolling ball and the workpiece is essential to understand the DR process. Contact mechanics is further complicated by the normal force reduction due to hydraulic pressure loss at the tip of DR tool, and the penetration depth reduction due to elastic recovery. The measured normal force, in this study, shows maximum 23% reduction compared to theoretical value. The normal force drop is not uniform and increases with increasing applied pressure. A 2D axisymmetric, semi-infinite FEM model is developed and validated to predict the amount of elastic recovery after deep rolling. The dynamic mechanical behavior of the material is simulated using the internal state variable (ISV) plasticity model and implemented in FEM code using a user material subroutine. The simulated dent geometry agrees with the measured ones in terms of profile and depth. Simulation results suggest 8% elastic recovery on average.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR [Anonymous], 2008, ABAQUS US MAN
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bozdana AT, 2008, MATER SCI TECH-LOND, V24, P1378, DOI 10.1179/174328408X302431
   Brinksmeier E, 2008, CIRP ANN-MANUF TECHN, V57, P541, DOI 10.1016/j.cirp.2008.03.100
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, ADV MATER RES-SWITZ, V22, P67, DOI 10.4028/www.scientific.net/AMR.22.67
   Denkena B., 2005, P 5 EUSP INT C MONT
   Disegi J. A., 2009, P ASM MPMD C EXP MIN
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gill CM, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/174005
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Isaksson H., 2003, BIOENG C, P1041
   Jayaraman N., 2007, P ASIP PALM SPER CA
   Juijerm P, 2007, SCRIPTA MATER, V56, P745, DOI 10.1016/j.scriptamat.2007.01.021
   Lathrop J. F., 1996, SAND978218 SANDIA LA
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Majzoobi GH, 2009, MAT SCI ENG A-STRUCT, V516, P235, DOI 10.1016/j.msea.2009.03.020
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nikitin I, 2008, MAT SCI ENG A-STRUCT, V491, P297, DOI 10.1016/j.msea.2008.03.034
   Nikitin I, 2007, MAT SCI ENG A-STRUCT, V465, P176, DOI 10.1016/j.msea.2007.02.004
   Prevey P., 2009, P ASM MPMD C EXP MIN
   Prevey PS, 2007, MATER SCI FORUM, V539-543, P3807, DOI 10.4028/www.scientific.net/MSF.539-543.3807
   Prevey PS, 2006, J ENG GAS TURB POWER, V128, P865, DOI 10.1115/1.1807414
   Prevey PS, 2004, INT J FATIGUE, V26, P975, DOI 10.1016/j.ijfatigue.2004.01.010
   Salahshoor M., 2009, P ASM MPMD C EXP MIN
   Scheel J. E., 2009, SAFE LIFE CONVERSION
   Schuh A., 2006, J BIOMED MATER RES B, DOI [10.1002/jbmb, DOI 10.1002/JBMB]
   Seemikeri CY, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896121
   SEILER HG, 1987, HDB TOXICITY INORGAN
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Tsuji N, 2008, MAT SCI ENG A-STRUCT, V488, P139, DOI 10.1016/j.msea.2007.11.079
   Tsuji N, 2009, MAT SCI ENG A-STRUCT, V499, P482, DOI 10.1016/j.msea.2008.09.008
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
NR 35
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4430-4
PY 2011
BP 303
EP 311
PG 9
WC Engineering, Mechanical
SC Engineering
GA BFJ30
UT WOS:000320096800038
DA 2018-10-20
ER

PT J
AU Mohammadi, H
AF Mohammadi, H.
TI Nanocomposite biomaterial mimicking aortic heart valve leaflet
   mechanical behaviour
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE material characterization; uniaxial tensile test; anisotropy; heart
   valve leaflet; hyperelasticity
ID POLY(VINYL ALCOHOL) HYDROGELS; BIOMEDICAL APPLICATIONS; CELLULOSE;
   FIBERS
AB The main problem with polymeric heart valves (which are already biocompatible) is that they usually fail in the long term owing to tearing and calcification of the leaflets under high dynamic tensile bending stress and oxidative reactions with blood. To overcome this shortcoming, it is hypothesized that synthetic valve leaflets which mimic native valve leaflet structure fabricated from fibre-reinforced composite material will optimize leaflet stresses and decrease tears and perforations. The objective of this study is to develop a PVA-BC (polyvinyl alcohol-bacterial cellulose)-based hydrogel that mimics not only the non-linear mechanical properties displayed by porcine heart valves, but also their anisotropic behaviour. By applying a controlled strain to the PVA samples, while undergoing low-temperature thermal cycling, it was possible to create oriented mechanical properties in PVA hydrogels. The oriented stress-strain properties of porcine aortic valves were matched simultaneously by a PVA hydrogel (15 per cent PVA, 0.5 BC cycle 4, 75 per cent initial tensile strain). This novel technique allows the control of anisotropy to PVA hydrogel, and gives a broad range of control of its mechanical properties, for specific medical device applications.
C1 Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
RP Mohammadi, H (reprint author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.
EM hadim74@gmail.com
FU Canadian Institutes of Health Research (CIHR)
FX The author would like to thank the Canadian Institutes of Health
   Research (CIHR) for a Vascular Research Training Award.
CR CASCONE MG, 1995, J MATER SCI-MATER M, V6, P71, DOI 10.1007/BF00120410
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   FUNG YC, 1996, BIOMECHANICS MECH PR, P75
   GALLOCHER LS, 2006, J BIOMED MATER RES B, V79, P325
   Gordon M, 1999, THESIS U W ONTARIO
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Joseph G, 2003, J CHEM TECHNOL BIOT, V78, P964, DOI 10.1002/jctb.869
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2001, Patent No. [WO 2001061026 (A1), 2001061026]
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Mohammadi H, 2009, P I MECH ENG H, V223, P697, DOI 10.1243/09544119JEIM493
   Mori Y, 1997, J MATER SCI, V32, P491, DOI 10.1023/A:1018586307534
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   SURESH S, 1998, FATIGUE MAT, P21
NR 18
TC 16
Z9 17
U1 3
U2 30
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2011
VL 225
IS H7
BP 718
EP 722
DI 10.1177/0954411911399826
PG 5
WC Engineering, Biomedical
SC Engineering
GA 808SY
UT WOS:000293999900010
PM 21870379
DA 2018-10-20
ER

PT J
AU Kurniawan, D
   Nor, FM
   Lee, HY
   Lim, JY
AF Kurniawan, D.
   Nor, F. M.
   Lee, H. Y.
   Lim, J. Y.
TI Elastic properties of polycaprolactone at small strains are
   significantly affected by strain rate and temperature
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE polycaprolactone; mechanical properties; strain rate; temperature
ID POLYMERS; DEFORMATION; SCAFFOLD; BEHAVIOR; STRESS; DESIGN; BONE
AB Tensile tests were conducted on polycaprolactone at various strain rates and temperatures. Focusing on the mechanical properties within only the small-strain elastic region, i.e. up to the inflection point in the stress-strain diagram, it was found that strain rate and temperature had significant effects on the polymer. This finding implies that the effects of strain rate and temperature on the elastic properties of polycaprolactone should be considered in the design and manufacture of rigidity-sensitive, load-bearing applications, including use as biomaterial for scaffolds in tissue engineering applications.
C1 [Kurniawan, D.; Nor, F. M.; Lee, H. Y.; Lim, J. Y.] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul 100715, South Korea.
RP Lim, JY (reprint author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul 100715, South Korea.
EM jylim@dongguk.edu
RI Kurniawan, Denni/C-2703-2008
OI Kurniawan, Denni/0000-0002-4179-0454; Nor, Fethma M./0000-0001-5430-7866
FU Ministry of Education, Science, and Technology, Korea [S2009A000400056]
FX This work was supported by the Ministry of Education, Science, and
   Technology, Korea (grant number S2009A000400056).
CR [Anonymous], D638 ASTM
   Arnoult M, 2007, POLYMER, V48, P1012, DOI 10.1016/j.polymer.2006.12.053
   ARRUDA EM, 1995, MECH MATER, V19, P193, DOI 10.1016/0167-6636(94)00034-E
   Baas E, 2010, J BIOMECH, V43, P733, DOI 10.1016/j.jbiomech.2009.10.016
   Boyce MC, 2000, POLYMER, V41, P2183, DOI 10.1016/S0032-3861(99)00406-1
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FLORY PJ, 1962, J AM CHEM SOC, V84, P2857, DOI 10.1021/ja00874a004
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Guarino V, 2010, P I MECH ENG H, V224, P1389, DOI 10.1243/09544119JEIM744
   Gueguen O, 2010, MECH MATER, V42, P1, DOI 10.1016/j.mechmat.2009.04.012
   Hobeika S, 2000, MACROMOLECULES, V33, P1827, DOI 10.1021/ma9910484
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LU Z, 2002, P IUTAM S THEOR NUM, P41
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ohashi F, 2002, POLYM ENG SCI, V42, P1046, DOI 10.1002/pen.11011
   Rajagopalan S, 2006, MED IMAGE ANAL, V10, P693, DOI 10.1016/j.media.2006.06.001
   Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040
   Sanz-Herrera JA, 2010, J BIOMECH, V43, P2480, DOI 10.1016/j.jbiomech.2010.05.027
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
NR 23
TC 6
Z9 6
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PY 2011
VL 225
IS H10
BP 1015
EP 1020
DI 10.1177/0954411911413059
PG 6
WC Engineering, Biomedical
SC Engineering
GA 824DS
UT WOS:000295182900008
PM 22204123
DA 2018-10-20
ER

PT J
AU Goncalves, PP
   Singh, MK
   Silva, VS
   Marques, F
   Marques, A
   Leduc, PR
   Gracio, J
   Marques, PAAP
   Goncalves, G
   Sousa, ACM
AF Goncalves, Paula P.
   Singh, Manoj K.
   Silva, Virgilia S.
   Marques, Filipa
   Marques, Ana
   LeDuc, Philip R.
   Gracio, Jose
   Marques, Paula A. A. P.
   Goncalves, Gil
   Sousa, Antonio C. M.
TI Automated high-throughput screening of carbon nanotube-based
   bio-nanocomposites for bone cement applications
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Conference on Nanomaterials and Nanotechnology (NANO)
CY DEC 13-16, 2010
CL Tiruchengode, INDIA
DE bone cement; carbon nanotubes; high-throughput methodology;
   nanocomposites; nanotechnology; orthopedic materials
ID BIOMEDICAL APPLICATIONS; COMPOSITES; BIOCOMPATIBILITY; CERAMICS
AB In this work we demonstrate the potential of using an automated cell viability analyzer for developing high-throughput screening of orthopedic bioactive materials. We used a biomaterial of carbon nanotubes (CNTs)-based composite integrated with hydroxyapatite/ polymethyl methacrylate (HA/PMMA) with controlled physical and chemical properties to evaluate the usefulness of morphometric analysis in conjunction with trypan blue dye exclusion assays in MG63 cell cultures. The MG63 cell line, derived from human bone osteo sarcoma, is often used as a model for studying osteoblast-like cellular response to bioactive materials for orthopedic surgery. The viability analyzer, Vi-CELLTM XR, Beckman Coulter, was used with trypan blue dye exclusion method in cell suspensions obtained after trypsinization along with determining the distribution plots of cell diameter and circularity, which are critical cellular characteristics. In addition, the activity of alkaline phosphatase (ALP), a typical representation of osteogenic activity of osteoblasts, was also measured spectrophotometrically using p-nitrophenol phosphate as the substrate. Comparative analysis of the frequency histogram of average cell diameter and circularity allowed for the analyses of significant alterations in cell morphology not only over time in control cultures (spherical vs. a flat morphology) but also with respect to PMMA and HA nanocomposites. After cell exposure to HA/PMMA/CNTs, a shift toward loss of cell circularity was observed. The appearances of more differentiated morphologic features were well correlated with the increase of secreted ALP activity. In conclusion, the evaluation of material-induced changes of cell morphology could represent a valuable prescreening test for bioactive properties.
C1 [LeDuc, Philip R.; Gracio, Jose; Marques, Paula A. A. P.; Goncalves, Gil; Sousa, Antonio C. M.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.
   [Goncalves, Paula P.; Silva, Virgilia S.; Marques, Filipa; Marques, Ana] Univ Aveiro, Dept Biol & CESAM, P-3810193 Aveiro, Portugal.
   [Singh, Manoj K.] Univ Aveiro, Nanotechnol Res Div, Ctr Mech Technol & Automat, P-3810193 Aveiro, Portugal.
RP Gracio, J (reprint author), Carnegie Mellon Univ, Dept Mech Engn, 415 Scaife Hall,5000 Forbes Ave, Pittsburgh, PA 15213 USA.
EM pgoncalves@ua.pt; mksingh@ua.pt
RI LeDuc, Philip/M-1103-2014; Silva, Virgilia/D-9914-2011; FMUP,
   CINTESIS/C-6631-2014; Division, Nanotechnology/O-2342-2013; Singh,
   Manoj/D-1366-2012; Grupo, AE/B-3302-2014; Marques, Paula/A-7371-2008;
   Research Unit, TEMA/H-9264-2012; Goncalves, Gil/M-7640-2013; Sousa,
   Antonio/D-2348-2013; Polonia Goncalves, Maria Paula/B-1056-2011
OI LeDuc, Philip/0000-0001-6397-2905; Silva, Virgilia/0000-0002-1962-6543;
   FMUP, CINTESIS/0000-0001-7248-2086; Singh, Manoj/0000-0003-3044-1010;
   Grupo, AE/0000-0002-0913-4772; Marques, Paula/0000-0002-7498-452X;
   Goncalves, Gil/0000-0002-2302-9661; Sousa, Antonio/0000-0001-6046-1368;
   Polonia Goncalves, Maria Paula/0000-0001-6891-3963; Gracio,
   Jose/0000-0002-0343-4387; Marques, Filipa Daniela/0000-0002-6387-1917
FU International Iberian Laboratory of Nanotechnology
   [NANO/NMed-AT/0115/2007]; Portuguese Foundation of Science and
   Technology; University of Aveiro; Carnegie Mellon University; 
   [SFRH/BPD/14677/2003]
FX This work was supported by the International Iberian Laboratory of
   Nanotechnology (NANO/NMed-AT/0115/2007), the Portuguese Foundation of
   Science and Technology (Program Compromise with Science (to M. K. S. and
   P. M.) and SFRH/BPD/14677/2003 (to V. S. S.)) and the research and
   development agreement between the University of Aveiro and Carnegie
   Mellon University.
CR Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11
   Chlopek J, 2006, CARBON, V44, P1106, DOI 10.1016/j.carbon.2005.11.022
   Curtin WA, 2004, MATER TODAY, V7, P44, DOI 10.1016/S1369-7021(04)00508-5
   Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Haque S, 2007, LANGMUIR, V23, P6671, DOI 10.1021/la063517i
   Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kis A, 2004, NAT MATER, V3, P153, DOI 10.1038/nmat1076
   LIDEN E, 1995, J AM CERAM SOC, V78, P1761, DOI 10.1111/j.1151-2916.1995.tb08886.x
   Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4
   Peigney A, 2003, NAT MATER, V2, P15, DOI 10.1038/nmat794
   Pelletier MH, 2010, ACTA BIOMATER, V6, P886, DOI 10.1016/j.actbio.2009.09.016
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Singh MK, 2008, ADV FUNCT MATER, V18, P694, DOI 10.1002/adfm.200700888
   Singh MK, 2010, NANOSCALE, V2, P2855, DOI 10.1039/c0nr00237b
   Szabo S E, 2004, Lab Hematol, V10, P109, DOI 10.1532/LH96.04020
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   White AA, 2007, INT J APPL CERAM TEC, V4, P1, DOI 10.1111/j.1744-7402.2007.02113.x
NR 21
TC 1
Z9 1
U1 1
U2 19
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0033-4545
EI 1365-3075
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PY 2011
VL 83
IS 11
BP 2063
EP 2069
DI 10.1351/PAC-CON-11-04-06
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 871MO
UT WOS:000298742400009
DA 2018-10-20
ER

PT J
AU Lainka, E
   Bielak, M
   Hilger, V
   Basu, O
   Neudorf, U
   Wittkowski, H
   Holzinger, D
   Roth, J
   Niehues, T
   Foell, D
AF Lainka, Elke
   Bielak, Maria
   Hilger, Volker
   Basu, Oliver
   Neudorf, Ulrich
   Wittkowski, Helmut
   Holzinger, Dirk
   Roth, Johannes
   Niehues, Tim
   Foell, Dirk
TI Translational research network and patient registry for
   auto-inflammatory diseases
SO RHEUMATOLOGY
LA English
DT Article
DE Registry for auto-inflammatory diseases; Biomaterial bank; Hereditary
   periodic fever; FMF; TNF receptor 1-associated periodic syndrome;
   Hyperimmunoglobulinaemia D and periodic fever syndrome;
   Cryopyrin-associated periodic syndrome; Pharyngitis and adenopathy
   syndrome; Systemic-onset JIA
ID HEREDITARY AUTOINFLAMMATORY SYNDROMES; JUVENILE IDIOPATHIC ARTHRITIS;
   FAMILIAL MEDITERRANEAN FEVER; NEUTROPHIL-DERIVED S100A12; PERIODIC
   FEVERS; PROTEIN; DISORDERS; MUTATIONS; MRP14; PHAGOCYTES
AB Methods. In 2009, a federally funded clinical and research consortium (AID-Net) was established, including an online registry for AIDs (http://www.aid-register.uk-essen.de). Inclusion criteria are disease-associated mutations for hereditary periodic fever syndromes [FMF, hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS), TNF receptor 1-associated periodic syndrome (TRAPS) and cryopyrin-associated periodic syndrome (CAPS)], or, alternatively, clinically confirmed AID, systemic-onset JIA (SoJIA) and periodic fever, aphthous stomatitis, pharyngitis and adenopathy (PFAPA) syndrome with unknown genetic background. Patients were recruited to the registry and patient material was deposited in biomaterial banks (DNA/serum). In addition, basic research projects were initiated that focus on molecular mechanisms of AID.
   Results. During the first 9 months, 117 patients (65 males, 52 females; age 1-21 years) have been recorded and classified as FMF (n = 84), HIDS (n = 1), TRAPS (n = 3) and CAPS (n = 1); clinically confirmed AID (n = 5); SoJIA (n = 22); and PFAPA (n = 1). One hundred and fifty blood samples of 18 patients were included in biomaterial banks.
   Conclusion. Recruitment and follow-up of patients with AID will enable us to comprehensively address the correlation between clinical and epidemiological data, genetics and biomarkers. The translational approach may help to identify genetic or inflammatory markers relevant for the course and outcome of diseases.
C1 [Lainka, Elke; Bielak, Maria; Neudorf, Ulrich] Univ Duisburg Essen, Childrens Hosp, Dept Paediat Rheumatol, Essen, Germany.
   [Wittkowski, Helmut; Foell, Dirk] Univ Childrens Hosp Munster, Dept Gen Paediat, Munster, Germany.
   [Wittkowski, Helmut; Holzinger, Dirk; Roth, Johannes] Univ Hosp Munster, Inst Immunol, Munster, Germany.
   [Niehues, Tim] HELIOS Klinikum Krefeld, Dept Paediat, Krefeld, Germany.
RP Lainka, E (reprint author), Univ Duisburg Essen, Childrens Hosp, Dept Paediat Rheumatol, Essen, Germany.
EM elke.lainka@uni-due.de
OI Holzinger, Dirk/0000-0002-8062-8820
FU Federal Ministry of Education and Research (BMBF) [01GM08104]
FX The AID-Net consortium is supported by the Federal Ministry of Education
   and Research (BMBF project 01GM08104).
CR Aksentijevich I, 2001, AM J HUM GENET, V69, P301, DOI 10.1086/321976
   Church LD, 2006, SPRINGER SEMIN IMMUN, V27, P494, DOI 10.1007/s00281-006-0015-6
   Cooper David N, 2006, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s12
   de Menthiere CS, 2003, NUCLEIC ACIDS RES, V31, P282, DOI 10.1093/nar/gkg031
   DEPELCH M, 2001, CURR OPIN IMMUNOL, V13, P539
   Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938
   Drenth JPH, 2001, NEW ENGL J MED, V345, P1748, DOI 10.1056/NEJMra010200
   Farasat S, 2008, ARCH DERMATOL, V144, P392, DOI 10.1001/archderm.144.3.392
   Fietta Pieranna, 2004, Acta Biomed, V75, P92
   Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531
   Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170
   Gattorno M, 2008, ARTHRITIS RHEUM-US, V58, P1823, DOI 10.1002/art.23474
   Gattorno M, 2009, PEDIATRICS, V124, pE721, DOI 10.1542/peds.2009-0088
   Glock J., 2006, GMS MED INFORM BIOM, V2, pDoc06
   Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137
   Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Kallinich T, 2010, ANN RHEUM DIS, V69, P677, DOI 10.1136/ard.2009.114363
   Kastner Daniel L, 2005, Hematology Am Soc Hematol Educ Program, P74
   Lainka E, 2009, RHEUMATOLOGY, V48, P987, DOI 10.1093/rheumatology/kep140
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851
   Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720
   Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8
   Rammes A, 1997, J BIOL CHEM, V272, P9496
   RENG CM, 2006, SCHRIFTREIHE TMF
   Schneider R, 1998, BAILLIERE CLIN RHEUM, V12, P245, DOI 10.1016/S0950-3579(98)80018-6
   Simon A, 2006, RHEUMATOLOGY, V45, P269, DOI 10.1093/rheumatology/kei138
   Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b
   Touitou I, 2009, RHEUMATOLOGY, V48, P665, DOI 10.1093/rheumatology/kep056
   Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019
   Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446
   Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638
   Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29
   Wittkowski H, 2008, ARTHRITIS RHEUM, V58, P3924, DOI 10.1002/art.24137
   Woo P, 2006, NAT CLIN PRACT RHEUM, V2, P28, DOI 10.1038/ncprheum0084
   Yao Q, 2008, RHEUMATOLOGY, V47, P946, DOI 10.1093/rheumatology/ken118
NR 37
TC 21
Z9 21
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD JAN
PY 2011
VL 50
IS 1
BP 237
EP 242
DI 10.1093/rheumatology/keq270
PG 6
WC Rheumatology
SC Rheumatology
GA 692ZD
UT WOS:000285193500032
PM 21148158
OA Bronze
DA 2018-10-20
ER

PT J
AU Tsai, IY
   Kuo, CC
   Tomczyk, N
   Stachelek, SJ
   Composto, RJ
   Eckmann, DM
AF Tsai, Irene Y.
   Kuo, Chin-Chen
   Tomczyk, Nancy
   Stachelek, Stanley J.
   Composto, Russell J.
   Eckmann, David M.
TI Human macrophage adhesion on polysaccharide patterned surfaces
SO SOFT MATTER
LA English
DT Article
ID GIANT-CELL FORMATION; ENDOTHELIAL GLYCOCALYX; MICROPATTERNED SURFACES;
   TERTIARY STRUCTURES; EPITHELIAL-CELLS; AQUEOUS-SOLUTION;
   HYALURONIC-ACID; DEXTRAN; TOPOGRAPHY; PROTEINS
AB Despite many advances in designing biocompatible materials, inflammation remains a problem in medical devices and implants. We report two methods, microcontact printing and photodegradation by UV exposure, to pattern dextran and hyaluronic acid on glass, as well as demonstrate their utility for use as an anti-inflammatory biomaterial. The dextran/glass patterned surface can be further modified by grafting hyaluronic acid to glass, creating a binary polysaccharide patterned surface. We used two geometries, 90 mu m squares and 22 mu m stripes, to study the human macrophage (THP-1) adhesion on the patterned surfaces containing dextran, hyaluronic acid and the binary pattern. The results indicate that a majority of the macrophages are non-adherent on hyaluronic acid for three day culture. The ranking of surfaces according to macrophage adhesion is 3-aminopropyltriethoxysilane-modified glass culture dish, dextranized surfaces, glass, and hyaluronic acid-modified surfaces. On the binary pattern of dextran and hyaluronic acid, macrophages preferentially attach and adhere to the dextranized area. Patterned surfaces provide an excellent platform for mimicking the complexity of the glycocalyx and investigating the interface between this surface and cells. This binary polysaccharide pattern also offers a new route to address anti-inflammatory potential of surface coatings on biomaterials in a high through-put fashion.
C1 [Tomczyk, Nancy; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Tsai, Irene Y.; Kuo, Chin-Chen; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   [Stachelek, Stanley J.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
EM eckmanndm@uphs.upenn.edu
FU NIH [R01-HL060230, T32-GM007612]; NSF/NSEC [DMR08-32802]; NSF/Polymer
   Program [DMR0907493]
FX This work was supported by NIH grants R01-HL060230 and T32-GM007612. RJC
   acknowledges partial support from NSF/NSEC (DMR08-32802) and NSF/Polymer
   Program (DMR0907493). Use of University of Pennsylvania Nano/Bio
   Interface Center AFM/TIRF instrument is acknowledged.
CR Ahmad SA, 2010, LANGMUIR, V26, P9937, DOI 10.1021/la100438d
   Andersson AS, 2003, IEEE T NANOBIOSCI, V2, P49, DOI 10.1109/TNB.2003.813934
   Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.0.CO;2-M
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chacko BK, 2005, FASEB J, V19, pA776
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeMond AL, 2007, CURR OPIN IMMUNOL, V19, P722, DOI 10.1016/j.coi.2007.07.008
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Goto M, 2008, ANAL BIOANAL CHEM, V390, P817, DOI 10.1007/s00216-007-1496-4
   Gray DS, 2004, BIOSENS BIOELECTRON, V19, P1765, DOI 10.1016/j.bios.2004.03.016
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lei YG, 2011, BIOMATERIALS, V32, P39, DOI 10.1016/j.biomaterials.2010.08.103
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Lu YX, 2008, LANGMUIR, V24, P8050, DOI 10.1021/la800998n
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   Miksa D, 2006, BIOMACROMOLECULES, V7, P557, DOI 10.1021/bm050601o
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   Okochi N, 2009, LANGMUIR, V25, P6947, DOI 10.1021/la9006668
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Peramo A, 2006, LANGMUIR, V22, P3228, DOI 10.1021/la051166m
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   SABATIE J, 1988, CARBOHYD POLYM, V9, P287, DOI 10.1016/0144-8617(88)90047-1
   Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642
   Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Squire JM, 2001, J STRUCT BIOL, V136, P239, DOI 10.1006/jsbi.2002.4441
   Tsai IY, 2007, METHOD CELL BIOL, V83, P67, DOI 10.1016/S0091-679X(07)83004-4
   Tsai IY, 2011, COLLOID SURFACE B, V84, P241, DOI 10.1016/j.colsurfb.2011.01.006
   Tsai IY, 2004, J BIOMED MATER RES A, V71A, P462, DOI 10.1002/jbm.a.30183
   Veiseh M, 2007, LANGMUIR, V23, P4472, DOI 10.1021/la062849k
   Wang B, 2005, MACROMOL BIOSCI, V5, P767, DOI 10.1002/mabi.200500037
   Wang DY, 2007, J BIOMED MATER RES B, V80B, P447, DOI 10.1002/jbm.b.30616
   WARD BJ, 1993, CARDIOVASC RES, V27, P384, DOI 10.1093/cvr/27.3.384
   Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100
   Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Zhang G, 2003, LANGMUIR, V19, P9850, DOI 10.1021/la035084e
   Zheng N, 2010, SCI CHINA TECHNOL SC, V53, P257, DOI 10.1007/s11431-009-0288-9
   Zhou Y, 2004, MICROCHIM ACTA, V147, P21, DOI 10.1007/s00604-004-0223-5
NR 49
TC 12
Z9 12
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 7
BP 3599
EP 3606
DI 10.1039/c0sm01353f
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 738XZ
UT WOS:000288677200069
PM 21479122
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gomes, S
   Leonor, IB
   Mano, JF
   Reis, RL
   Kaplan, DL
AF Gomes, Silvia
   Leonor, Isabel B.
   Mano, Joao F.
   Reis, Rui L.
   Kaplan, David L.
TI Spider silk-bone sialoprotein fusion proteins for bone tissue
   engineering
SO SOFT MATTER
LA English
DT Article
ID HYDROXYAPATITE NUCLEATION; ESCHERICHIA-COLI; BLOCK-COPOLYMERS; CELL
   ATTACHMENT; DRAGLINE SILK; STEM-CELLS; COLLAGEN; MINERALIZATION;
   BIOMATERIALS; OSTEOPONTIN
AB The remarkable mechanical characteristics of the spider silk protein major ampullate spidroin protein suggest this polymer as a promising biomaterial to consider for the fabrication of scaffolds for bone regeneration. Herein, a new functionalized spider silk-bone sialoprotein fusion protein was designed, cloned, expressed, purified and the osteogenic activity studied. Bone sialoprotein (BSP) is a multidomain protein with the ability to induce cell attachment and differentiation and the deposition of calcium phosphates (CaP). Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) was used to assess the secondary structure of the fusion protein. In vitro mineralization studies demonstrated that this new fusion protein with BSP retained the ability to induce the deposition of CaP. Studies in vitro indicated that human mesenchymal stem cells had significant improvement towards osteogenic outcomes when cultivated in the presence of the new fusion protein vs. silk alone. The present work demonstrates the potential of this new fusion protein for future applications in bone regeneration.
C1 [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Res Group Biomat Biodegradables & Biomimet 3BS, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, Taipas, Guimaraes, Portugal.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] IBB Inst Biotechnol & Bioengn, PT Associated Lab, Guimaraes, Portugal.
   [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   [Kaplan, David L.] Tufts Univ, Dept Phys, Medford, MA 02155 USA.
RP Reis, RL (reprint author), Univ Minho, Res Group Biomat Biodegradables & Biomimet 3BS, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, AvePk, Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt; David.Kaplan@tufts.edu
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Reis, Rui
   L./A-8938-2008; Gomes, Silvia/J-6099-2013; Leonor, Isabel/B-5260-2011
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Reis,
   Rui L./0000-0002-4295-6129; Leonor, Isabel/0000-0002-4319-4883; Gomes,
   Silvia/0000-0002-4881-7808
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/28603/2006]; European NoE EXPERTISSUES [NMP3-CT-2004-500283];
   agency EU-EC; FCT agency [PTDC/FIS/68517/2006,
   PTDC/EBB-EBI/109093/2008]; NIH, Tissue Engineering Resource Center [P41
   EB002520]; NIH [EB003210, DE017207]
FX The authors acknowledge Olena Rabotyagova for advice in protein sequence
   design. Silvia Gomes thanks Portuguese Foundation for Science and
   Technology (FCT) for providing her PhD grant SFRH/BD/28603/2006. This
   work was carried out under the scope of European NoE EXPERTISSUES
   (NMP3-CT-2004-500283), the FIND & BIND project funded by the agency
   EU-EC (FP7 program), the FCT R&D project Proteo-Light
   (PTDC/FIS/68517/2006) funded by the FCT agency, the Chimera project
   (PTDC/EBB-EBI/109093/2008) funded by the FCT agency, and the NIH (P41
   EB002520) Tissue Engineering Resource Center and the NIH (EB003210 and
   DE017207).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885
   Bernards MT, 2008, COLLOID SURFACE B, V64, P236, DOI 10.1016/j.colsurfb.2008.01.025
   BERNARDS MT, 2007, J BIOMED MATER RES A, P779
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CHOONG PFM, 1993, J ORTHOPAED RES, V11, P638, DOI 10.1002/jor.1100110505
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200
   Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146
   FLEISH H, 1961, AM J PHYSIOL, V200, P1296
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   FUJISAWA R, 1995, CALCIFIED TISSUE INT, V56, P140, DOI 10.1007/BF00296346
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246
   Graf HL, 2008, INT J ORAL MAX SURG, V37, P634, DOI 10.1016/j.ijom.2008.01.021
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Higuchi A, 2003, J BIOMED MATER RES A, V65A, P369, DOI 10.1002/jbm.a.10428
   HIRSCHLER A, 1990, FEMS MICROBIOL ECOL, V73, P211, DOI 10.1016/0378-1097(90)90732-6
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   JACKSON SF, 1957, PROC R SOC SER B-BIO, V146, P270, DOI 10.1098/rspb.1957.0010
   Jeon WB, 2011, BMB REP, V44, P22, DOI 10.5483/BMBRep.2011.44.1.22
   Karadag A, 2004, J NATL CANCER I, V96, P956, DOI 10.1093/jnci/djh169
   Karadag A, 2006, J BONE MINER RES, V21, P1627, DOI 10.1359/JBMR.060710
   Kruyt MC, 2009, J ORTHOP RES, V27, P1055, DOI 10.1002/jor.20830
   Lancaster M. V., 1996, [No title captured], Patent No. [US 5501959, 5501959]
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lian J B, 1995, Iowa Orthop J, V15, P118
   LIU Q, 1996, 5 WORLD BIOM C TOR
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Schmidt C, 2002, J BIOMED MATER RES, V63, P252, DOI 10.1002/jbm.10185
   Smeenk JM, 2006, MACROMOLECULES, V39, P2989, DOI 10.1021/ma0521654
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Wang JX, 2006, CALCIFIED TISSUE INT, V79, P179, DOI 10.1007/s00223-006-0018-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Werten MWT, 2008, BIOMACROMOLECULES, V9, P1705, DOI 10.1021/bm701111z
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Xu L, 2007, BIOMATERIALS, V28, P750, DOI 10.1016/j.biomaterials.2006.09.022
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200
   Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348
NR 62
TC 23
Z9 23
U1 2
U2 32
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 10
BP 4964
EP 4973
DI 10.1039/c1sm05024a
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 759FZ
UT WOS:000290227400052
DA 2018-10-20
ER

PT J
AU Yue, TT
   Zhang, XR
AF Yue, Tongtao
   Zhang, Xianren
TI Molecular understanding of receptor-mediated membrane responses to
   ligand-coated nanoparticles
SO SOFT MATTER
LA English
DT Article
ID DISSIPATIVE PARTICLE DYNAMICS; GOLD NANOPARTICLES; MESOSCOPIC
   SIMULATION; BIOLOGICAL-MEMBRANES; COMPUTER-SIMULATION;
   BILAYER-MEMBRANES; LIPID-MEMBRANES; CELLULAR UPTAKE; ENDOCYTOSIS;
   MECHANISM
AB The cytotoxicity of nanoparticles (NPs) and their potential applications in drug delivery and intracellular imaging have been extensively investigated, and a thorough molecular understanding of how cellular membrane responds to the introduction of NPs is essential for biomaterial design. In this work, N-varied dissipative particle dynamics (DPD) simulation is applied to investigate how a membrane responds to adsorption of ligand-coated NP. Depending on the membrane surface tension, ligand area density and NP size, four kinds of membrane responses are observed: membrane rupture, NP adhesion, NP penetration, and receptor-mediated endocytosis. While endocytosis provides an effective pathway for cellular uptake of NPs, the NP penetration and NP-induced membrane rupture are related to cytotoxicity. These results support the recent experimental reports that NPs have a Janus face for their biomedical applications: serving as carriers for the transmembrane transport of drug and causing cytotoxicity.
C1 [Yue, Tongtao; Zhang, Xianren] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Div Mol & Mat Simulat, Beijing, Peoples R China.
RP Zhang, XR (reprint author), Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Div Mol & Mat Simulat, Beijing, Peoples R China.
EM zhangxr@mail.buct.edu.cn
RI Yue, Tongtao/H-3348-2014; Zhang, Xianren/P-6595-2015
OI Zhang, Xianren/0000-0002-8026-9012
FU National Natural Science Foundation of China [20736005, 20876004]
FX The authors thank "Chemical Grid Project" of BUCT for the generous
   allocations of computer time and excellent technical assistance. This
   work was financially supported by National Natural Science Foundation of
   China (No. 20736005 and No. 20876004).
CR Alexeev A, 2008, ACS NANO, V2, P1117, DOI 10.1021/nn8000998
   Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003
   Ba HJ, 2010, NANO LETT, V10, P3006, DOI 10.1021/nl101454a
   Bechet D, 2008, TRENDS BIOTECHNOL, V26, P612, DOI 10.1016/j.tibtech.2008.07.007
   Chen HM, 1997, J COLLOID INTERF SCI, V190, P118, DOI 10.1006/jcis.1997.4865
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Chithrani BD, 2009, NANOMED-NANOTECHNOL, V5, P118, DOI 10.1016/j.nano.2009.01.008
   Cho EC, 2009, NANO LETT, V9, P1080, DOI 10.1021/nl803487r
   Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Deserno M, 2002, J PHYS CHEM B, V106, P5543, DOI 10.1021/jp0138476
   ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001
   Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Ginzburg VV, 2007, NANO LETT, V7, P3716, DOI 10.1021/nl072053l
   Grafmuller A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218101
   Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Groot RD, 2001, BIOPHYS J, V81, P725, DOI 10.1016/S0006-3495(01)75737-2
   Groot RD, 1997, J CHEM PHYS, V107, P4423, DOI 10.1063/1.474784
   Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851
   HONG B, 2006, J PHYS CHEM B, V111, P5837
   HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Jeng RL, 2001, CURR BIOL, V11, pR691, DOI 10.1016/S0960-9822(01)00410-9
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940
   Kranenburg M, 2005, J PHYS CHEM B, V109, P6553, DOI 10.1021/jp0457646
   LERNER DM, 1993, BIOPHYS J, V65, P73, DOI 10.1016/S0006-3495(93)81071-3
   Leroueil PR, 2007, ACCOUNTS CHEM RES, V40, P335, DOI 10.1021/ar600012y
   Li SY, 2010, BIOPHYS J, V98, P2554, DOI 10.1016/j.bpj.2010.02.032
   Li SY, 2009, J PHYS CHEM B, V113, P14431, DOI 10.1021/jp9053567
   Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792
   Lipowsky R, 1998, EUROPHYS LETT, V43, P219, DOI 10.1209/epl/i1998-00343-4
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   McNerny DQ, 2010, WIRES NANOMED NANOBI, V2, P249, DOI 10.1002/wnan.79
   MEYER FJ, 2008, BIOPHYS J, V95, P1851
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Noguchi H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.021903
   Peetla C, 2009, LANGMUIR, V25, P2369, DOI 10.1021/la803361y
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840
   Roiter Y, 2008, NANO LETT, V8, P941, DOI 10.1021/nl080080l
   Shillcock JC, 2005, NAT MATER, V4, P225, DOI 10.1038/nmat1333
   Smith KA, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2766953
   Venturoli M, 2005, BIOPHYS J, V88, P1778, DOI 10.1529/biophysj.104.050849
   Venturoli M, 2006, PHYS REP, V437, P1, DOI 10.1016/j.physrep.2006.07.006
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Wallace EJ, 2008, NANO LETT, V8, P2751, DOI 10.1021/nl801217f
   Wang ZJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2060666
   Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yan LT, 2009, ACS NANO, V3, P2171, DOI 10.1021/nn9004236
   Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/nnano.2010.141, 10.1038/NNANO.2010.141]
   Yue TT, 2010, SOFT MATTER, V6, P6109, DOI 10.1039/c0sm00418a
   Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393
   Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619
NR 60
TC 73
Z9 75
U1 3
U2 58
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 19
BP 9104
EP 9112
DI 10.1039/c1sm05398a
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 822YE
UT WOS:000295085700053
DA 2018-10-20
ER

PT J
AU Liu, RX
   Milani, AH
   Saunders, JM
   Freemont, TJ
   Saunders, BR
AF Liu, Ruixue
   Milani, Amir H.
   Saunders, Jennifer. M.
   Freemont, Tony J.
   Saunders, Brian R.
TI Tuning the swelling and mechanical properties of pH-responsive doubly
   crosslinked microgels using particle composition
SO SOFT MATTER
LA English
DT Article
ID HYDROGEL SCAFFOLDS; HYBRID MICROGELS; LINKING POLYMER; GEL POINT;
   TRANSITIONS; BEHAVIOR; ACID; NANOPARTICLES; DISPERSIONS; SUSPENSIONS
AB pH-Responsive microgel particles are crosslinked polymer colloid particles that swell when the pH approaches the pK(a). They have attracted a great deal of interest because of the ability to prepare stimulus responsive dispersions. Microgels that have only one form of crosslinking are termed singly crosslinked microgels (SX microgels). SX microgels are defined here as microgel particles that contain intra-particle linkages as the only source of covalent crosslinks. Recently, we introduced the first examples of a new family of pH-responsive doubly crosslinked microgel (DX microgels) [Liu et al., Soft Matter, 2011, 7, 4696]. DX microgels are hydrogels composed of covalently-linked functionalised SX microgel particles. DX microgels contain inter-particle crosslinking as well as intra-particle crosslinking. Here, we investigate pH-responsive DX microgels prepared using a new, more versatile, microgel functionalisation strategy. Carbodiimide chemistry is used to vinyl-functionalise poly(MMA/MAA/EGDMA) (methyl methacrylate, methacrylic acid and ethyleneglycol dimethacrylate) microgels (abbreviated as M-EGD). The DX microgels were prepared using pH-triggered inter-penetration of 2-aminoethylmethacrylate (AEM) functionalised SX microgels and free-radical crosslinking. The DX microgels based on M-EGD had built-in microporosity. Furthermore, dynamic rheology data show for the first time that the elastic modulus of DX microgels is proportional to the extent of vinyl group functionalisation. The generality of this approach was demonstrated by the preparation of DX microgels based on poly(EA/MAA/BDD) (ethylacrylate and 1, 4-butanediol diacrylate), which is abbreviated as E-BDD. The pH-responsive DX microgels have high elastic modulus values, swell strongly and have low sol fractions. They are injectable and the DX microgels have improved swelling at low pH which should increase the pH range for potential biomaterial applications. The data are compared with those reported by Liu et al. and the differences discussed.
C1 [Liu, Ruixue; Milani, Amir H.; Saunders, Jennifer. M.; Saunders, Brian R.] Univ Manchester, Manchester Mat Sci Ctr, Sch Mat, Biomat Res Grp, Manchester M1 7HS, Lancs, England.
   [Liu, Ruixue] Zhengzhou Univ Light Ind, Sch Mat & Chem Engn, Zhengzhou 450002, Peoples R China.
   [Freemont, Tony J.] Univ Manchester, Sch Med, Div Regenerat Med, Manchester M13 9PT, Lancs, England.
RP Saunders, BR (reprint author), Univ Manchester, Manchester Mat Sci Ctr, Sch Mat, Biomat Res Grp, Grosvenor St, Manchester M1 7HS, Lancs, England.
RI Freemont, Tony/A-9000-2015
OI Freemont, Tony/0000-0002-9780-208X; Saunders, Brian/0000-0003-1410-2967
FU EPSRC; UMIP; Engineering and Physical Sciences Research Council
   [EP/G026610/1]
FX BRS and AJF would like to thank the EPSRC for funding RL for this work.
   We also acknowledge funding from UMIP for AHM. Robert Bird is thanked
   for assistance with SEM.
CR Agrawal M, 2008, J MATER CHEM, V18, P2581, DOI 10.1039/b802102c
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bradley M, 2005, LANGMUIR, V21, P2750, DOI 10.1021/la047322r
   Cai T, 2008, MACROMOLECULES, V41, P9508, DOI 10.1021/ma802035d
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   Cho EC, 2010, LANGMUIR, V26, P3854, DOI 10.1021/la903350j
   Chougnet A, 2007, RHEOL ACTA, V46, P793, DOI 10.1007/s00397-006-0126-y
   CORNELIUS VJ, 2007, P SPIE INT SOC OPTIC, V6417
   Dai JH, 2006, LANGMUIR, V22, P4274, DOI 10.1021/la0600550
   Debord SB, 2003, J PHYS CHEM B, V107, P2927, DOI 10.1021/jp026783n
   Dupin D, 2007, LANGMUIR, V23, P4035, DOI 10.1021/la063278z
   Fernandez-Nieves A, 2000, MACROMOLECULES, V33, P2114, DOI 10.1021/ma991520l
   FERNANDEZBARBER.A, 2009, INTERFACE SCI, V147, P88
   FitzGerald PA, 2008, LANGMUIR, V24, P10228, DOI 10.1021/la8017425
   Friedrich T, 2011, LANGMUIR, V27, P2997, DOI 10.1021/la104585k
   Gan TT, 2009, BIOMACROMOLECULES, V10, P1410, DOI 10.1021/bm900022m
   Hoare T, 2008, CURR OPIN COLLOID IN, V13, P413, DOI 10.1016/j.cocis.2008.03.004
   Hoare T, 2006, LANGMUIR, V22, P7342, DOI 10.1021/la0608718
   Jha AK, 2010, SOFT MATTER, V6, P5045, DOI 10.1039/c0sm00101e
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Lally S, 2007, J COLLOID INTERF SCI, V316, P367, DOI 10.1016/j.jcis.2007.08.030
   Lally S, 2011, COLLOID POLYM SCI, V289, P647, DOI 10.1007/s00396-010-2366-8
   Lally S, 2009, COLLOID POLYM SCI, V287, P335, DOI 10.1007/s00396-008-1994-8
   Lapeyre V, 2009, LANGMUIR, V25, P4659, DOI 10.1021/la9003438
   Lemmers M, 2011, SOFT MATTER, V7, P1378, DOI 10.1039/c0sm00767f
   Liu RX, 2011, SOFT MATTER, V7, P4696, DOI 10.1039/c1sm05216k
   Longo GS, 2011, MACROMOLECULES, V44, P147, DOI 10.1021/ma102312y
   Lyon LA, 2009, CHEM SOC REV, V38, P865, DOI 10.1039/b715522k
   Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   Pinprayoon O, 2008, J COLLOID INTERF SCI, V321, P315, DOI 10.1016/j.jcis.2008.02.037
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   RODRIGUEZ BE, 1994, MACROMOLECULES, V27, P6642, DOI 10.1021/ma00100a058
   Sahiner N, 2006, COLLOID POLYM SCI, V284, P1121, DOI 10.1007/s00396-006-1489-4
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   SAUNDERS BR, 2009, INTERFACE SCI, V147, P147
   Saunders JM, 2007, SOFT MATTER, V3, P486, DOI 10.1039/b613943d
   Senff H, 2000, COLLOID POLYM SCI, V278, P830, DOI 10.1007/s003960000329
   Thompson KL, 2008, POLYM DEGRAD STABIL, V93, P1460, DOI 10.1016/j.polymdegradstab.2008.05.013
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   WINTER HH, 1987, POLYM ENG SCI, V27, P1698, DOI 10.1002/pen.760272209
   Yang M, 2010, MACROMOLECULES, V43, P10645, DOI 10.1021/ma1022555
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P27, DOI 10.1021/bm050832v
   Zhou B, 2007, POLYMER, V48, P2874, DOI 10.1016/j.polymer.2007.03.025
   2011, SCIFINDER SCHOLAR
NR 46
TC 18
Z9 18
U1 3
U2 61
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 19
BP 9297
EP 9306
DI 10.1039/c1sm05922j
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 822YE
UT WOS:000295085700075
DA 2018-10-20
ER

PT J
AU Stasiak, J
   Zaffora, A
   Costantino, ML
   Moggridge, GD
AF Stasiak, Joanna
   Zaffora, Adriano
   Costantino, Maria Laura
   Moggridge, Geoff D.
TI A real time SAXS study of oriented block copolymers during fast cyclical
   deformation, with potential application for prosthetic heart valves
SO SOFT MATTER
LA English
DT Article
ID ESTER) THERMOPLASTIC ELASTOMERS; STYRENE TRIBLOCK COPOLYMER;
   X-RAY-SCATTERING; CYLINDRICAL MORPHOLOGY; MECHANICAL-PROPERTIES;
   BUTADIENE; BEHAVIOR; POLYSTYRENE; BIOMATERIAL; DEGRADATION
AB Simultaneous small angle X-ray scattering (SAXS) and force measurements have been recorded during tensile loading/unloading deformation cycles of three oriented thermoplastic elastomers. SAXS patterns were obtained in only 10 ms, during deformation. Over this timescale, the microstructure of the materials reacted instantly to the applied deformation. Microstructural changes were followed over 10 000 cycles, each cycle period being less than 1 s. Morphological evolution from the initial state as the deformation proceeded has been linked to mechanical properties. The direction of orientation was the most significant parameter determining the mechanical strength of tested materials, followed by styrene weight fraction. Samples oriented parallel to the deformation direction showed greater resistance to applied force and also better microstructural reversibility over the 10 000 cycles.
C1 [Stasiak, Joanna; Moggridge, Geoff D.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.
   [Zaffora, Adriano; Costantino, Maria Laura] Politecn Milan, Dept Struct Engn, I-20133 Milan, Italy.
RP Stasiak, J (reprint author), Univ Cambridge, Dept Chem Engn & Biotechnol, Pembroke St, Cambridge CB2 3RA, England.
EM js744@cam.ac.uk; gdm14@cam.ac.uk
RI COSTANTINO, MARIA LAURA/A-8700-2012; Stasiak, Joanna/C-6612-2015
OI COSTANTINO, MARIA LAURA/0000-0001-6974-2692; Stasiak,
   Joanna/0000-0002-8132-8694
FU EPSRC [EP/E035299/1]; Engineering and Physical Sciences Research Council
   [EP/F007663/1]
FX The authors thank the EPSRC for financial support for this work under
   Grant EP/E035299/1 and Diamond Light Source, Harwell, U.K. for the
   provision of beamtime on I22 and in particular for scientific support
   from Marc Malfois and Nick Terrill. In additions the authors thank Dr
   Adam Squires (University of Reading) and Amanda Talhat (University of
   Cambridge) for help with the experiments.
CR Allen NS, 2004, POLYM DEGRAD STABIL, V86, P11, DOI 10.1016/j.polymdegradstab.2003.10.010
   *DIAM LIGHT SOURC, 122 NONCR DIFFR
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   FAKIROV S, 1992, POLYMER, V33, P3818, DOI 10.1016/0032-3861(92)90368-7
   FAKIROV S, 1991, POLYMER, V32, P1173, DOI 10.1016/0032-3861(91)90218-8
   Gallocher SL, 2006, J BIOMED MATER RES B, V79B, P325, DOI 10.1002/jbm.b.30546
   Hess K, 1944, Z PHYS CHEM-LEIPZIG, V193, P196
   Honeker CC, 2000, MACROMOLECULES, V33, P9395, DOI 10.1021/ma000593y
   Jiang DD, 2000, POLYM DEGRAD STABIL, V68, P75, DOI 10.1016/S0141-3910(99)00167-6
   Kennedy JE, 2009, J MATER SCI, V44, P889, DOI 10.1007/s10853-008-3156-2
   Kwee T, 2005, POLYMER, V46, P4480, DOI 10.1016/j.polymer.2005.02.031
   Meng S, 2005, POLYMER, V46, P5580, DOI 10.1016/j.polymer.2005.05.030
   Nagura M, 2009, J APPL POLYM SCI, V113, P2462, DOI 10.1002/app.30027
   PAKULA T, 1985, MACROMOLECULES, V18, P1294, DOI 10.1021/ma00148a044
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Puskas JE, 2003, EUR POLYM J, V39, P2041, DOI 10.1016/S0014-3057(03)00130-7
   Puskas JE, 2009, POLYMER, V50, P591, DOI 10.1016/j.polymer.2008.10.061
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   SAKOTA K, 1976, J APPL POLYM SCI, V20, P2811, DOI 10.1002/app.1976.070201015
   Stasiak J, 2010, SOFT MATTER, V6, P1941, DOI 10.1039/c000975j
   Stasiak J, 2010, FUNCT MATER LETT, V3, P249, DOI 10.1142/S1793604710001342
   Stasiak J, 2009, MACROMOLECULES, V42, P5256, DOI 10.1021/ma8026639
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Xu JB, 2007, POLYM DEGRAD STABIL, V92, P1682, DOI 10.1016/j.polymdegradstab.2007.06.008
NR 25
TC 7
Z9 7
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PY 2011
VL 7
IS 24
BP 11475
EP 11482
DI 10.1039/c1sm06503c
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 853KS
UT WOS:000297425700022
DA 2018-10-20
ER

PT J
AU Ponnusamy, KE
   Iyer, S
   Gupta, G
   Khanna, AJ
AF Ponnusamy, Karthikeyan E.
   Iyer, Sravisht
   Gupta, Gaurav
   Khanna, A. Jay
TI Instrumentation of the osteoporotic spine: biomechanical and clinical
   considerations
SO SPINE JOURNAL
LA English
DT Review
DE Osteoporosis; Vertebral compression fractures; Pedicle screws; Anterior
   approaches; Instrumentation; Vertebral augmentation
ID PEDICLE SCREW FIXATION; CALCIUM-PHOSPHATE CEMENT; BONE-MINERAL DENSITY;
   PULLOUT STRENGTH; END-PLATE; IN-VIVO; VERTEBROPLASTY AUGMENTATION;
   KYPHOPLASTY AUGMENTATION; COMPRESSION FRACTURES; VERTEBRAL COLLAPSE
AB BACKGROUND CONTEXT: Osteoporosis is a major health-care problem that is increasing in magnitude with the aging population. Such patients are more prone to develop painful and debilitating spinal deformities but are difficult to treat. Currently, no definitive treatment algorithm has been established.
   PURPOSE: To review the failure modes of instrumentation and novel surgical treatments of spinal deformities in patients with osteoporosis with the goal of improving surgical care.
   STUDY DESIGN/SETTING: Review article.
   METHODS: We systematically searched PubMed for articles regarding instrumentation failure modes and surgical treatments of spinal deformities in patients with osteoporosis and summarized current treatment options.
   RESULTS: The surgical treatment options are severely limited because of the tendency for instrument failure secondary to pullout and subsidence, leading to revision procedures; multiple levels and multiple fixation points are recommended to minimize the risk. The literature supports the use of vertebroplasty in conjunction with pedicle screw-based instrumentation for treating more severe spinal deformities. Other techniques and modifications with evidence of reduced failure risk are bicortical screws, hydroxyapatite coatings, double screws, and expandable screws. Anterior approaches may provide another avenue of treatment, but only a few studies have been conducted on these implants in patients with osteoporosis.
   CONCLUSIONS: Spinal deformities in patients with osteoporosis are difficult to treat because of their debilitating and progressive nature. Novel surgical approaches and instruments have been designed to decrease construct failures in this patient population by reducing implant pullout, subsidence, and incidence of revision surgery. The success of these techniques depends on integrating biomaterial, biologic, and biomechanical aspects with clinical considerations. Synthesizing this myriad of aspects will lead to improved treatment options for patients with osteoporosis who are suffering from spinal deformities. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ponnusamy, Karthikeyan E.; Gupta, Gaurav] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   [Iyer, Sravisht] Harvard Univ, Harvard Med Sch, Div Hlth Sci & Technol, Cambridge, MA 02138 USA.
   [Khanna, A. Jay] Johns Hopkins Univ Hosp, Dept Orthopaed Surg, Baltimore, MD 21287 USA.
   [Khanna, A. Jay] Johns Hopkins Univ Hosp, Dept Biomed Engn, Baltimore, MD 21287 USA.
RP Khanna, AJ (reprint author), Care of Henze EP, Johns Hopkins Bayview Med Ctr, Dept Orthopaed Surg, 4940 Eastern Ave,A665, Baltimore, MD 21224 USA.
EM ehenze1@jhmi.edu
CR Aldini NN, 2002, J ORTHOPAED RES, V20, P1217
   Andreassen GS, 2004, ARCH ORTHOP TRAUM SU, V124, P161, DOI 10.1007/s00402-004-0642-0
   Aydogan M, 2009, J SPINAL DISORD TECH, V22, P444, DOI 10.1097/BSD.0b013e31818e0945
   BABA H, 1995, PARAPLEGIA, V33, P281, DOI 10.1038/sc.1995.64
   Babat L Brett, 2005, Spine J, V5, P542, DOI 10.1016/j.spinee.2005.01.008
   Bai B, 2001, SPINE, V26, P2679, DOI 10.1097/00007632-200112150-00009
   Bonnick Sydney L, 2006, Clin Cornerstone, V8, P28, DOI 10.1016/S1098-3597(06)80063-3
   Bostrom MPG, 1997, SPINE, V22, p38S, DOI 10.1097/00007632-199712151-00007
   Bransford R, 2007, EUR SPINE J, V16, P557, DOI 10.1007/s00586-006-0212-y
   Breeze SW, 1998, SPINE, V23, P1829, DOI 10.1097/00007632-199809010-00004
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Burval DJ, 2007, SPINE, V32, P1077, DOI 10.1097/01.brs.0000261566.38422.40
   Chapman JR, 1996, J BIOMECH ENG-T ASME, V118, P391, DOI 10.1115/1.2796022
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   Chen CS, 2005, MED ENG PHYS, V27, P487, DOI 10.1016/j.medengphy.2004.12.007
   Chen SI, 2003, MED ENG PHYS, V25, P275, DOI 10.1016/S1350-4533(02)00219-9
   Clausen JD, 1996, J NEUROSURG, V84, P1039, DOI 10.3171/jns.1996.84.6.1039
   COE JD, 1990, SPINE, V15, P902, DOI 10.1097/00007632-199009000-00012
   Cook S D, 2001, Spine J, V1, P109, DOI 10.1016/S1529-9430(01)00020-1
   Cook S D, 2001, Am J Orthop (Belle Mead NJ), V30, P387
   Cook Stephen D, 2004, Spine J, V4, P402, DOI 10.1016/j.spinee.2003.11.010
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Das K, 2001, J NEUROSURG, V94, P174, DOI 10.3171/spi.2001.94.1.0174
   DAWSON EG, 2003, SPINAL DEFORMITIES C, P195
   del Real RP, 2003, J BIOMED MATER RES A, V65A, P30, DOI 10.1002/jbm.a.10432
   Deligianni D, 2005, J SPINAL DISORD TECH, V18, P257
   Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214
   DeWald CJ, 2006, SPINE, V31, pS144, DOI 10.1097/01.brs.0000236893.65878.39
   Erbe EM, 2001, EUR SPINE J, V10, pS147, DOI 10.1007/s005860100288
   Ergur I, 2007, EUR SPINE J, V16, P1519, DOI 10.1007/s00586-007-0326-x
   ESSES SI, 1991, SPINE, V16, pS283, DOI 10.1097/00007632-199106001-00021
   Ferguson SJ, 2002, EUR SPINE J, V11, P527, DOI 10.1007/s00586-002-0449-z
   Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605
   Frankel BM, 2007, J NEUROSURG-SPINE, V7, P47, DOI 10.3171/SPI-07/07/047
   Gaines RW, 2000, J BONE JOINT SURG AM, V82A, P1458, DOI 10.2106/00004623-200010000-00013
   Gass M, 2006, AM J MED, V119, p3S, DOI 10.1016/j.amjmed.2005.12.017
   Gezici AR, 2009, J KOREAN NEUROSURG S, V46, P45, DOI 10.3340/jkns.2009.46.1.45
   GILBERT SG, 1993, J SPINAL DISORD, V6, P513, DOI 10.1097/00002517-199306060-00007
   Goldhahn J, 2006, ARCH ORTHOP TRAUM SU, V126, P554, DOI 10.1007/s00402-006-0185-7
   Goldhahn J, 2006, J ORTHOP RES, V24, P917, DOI 10.1002/jor.20133
   Grant JP, 2002, J ORTHOP RES, V20, P1115, DOI 10.1016/S0736-0266(02)00039-6
   HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008
   Hasegawa K, 1997, SPINE, V22, P958, DOI 10.1097/00007632-199705010-00004
   Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010
   Heini PF, 2005, OSTEOPOROSIS INT, V16, pS85, DOI 10.1007/s00198-004-1723-1
   Heller JG, 1996, J BONE JOINT SURG AM, V78A, P1315, DOI 10.2106/00004623-199609000-00004
   Hitchon PW, 2003, SPINE, V28, P9, DOI 10.1097/00007632-200301010-00004
   Hoshikawa A, 2003, BIOMATERIALS, V24, P4967, DOI 10.1016/S0142-9612(03)00422-8
   Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008
   Huang TJ, 2003, CLIN BIOMECH, V18, pS40, DOI 10.1016/S0268-0033(03)00083-4
   Jiang L, 2007, J SPINAL DISORD TECH, V20, P430, DOI 10.1097/BSD.0b013e318030e945
   Jost B, 1998, EUR SPINE J, V7, P132
   Keller TS, 2003, SPINE, V28, P455, DOI 10.1097/00007632-200303010-00009
   Kettler A, 2006, CLIN BIOMECH, V21, P676, DOI 10.1016/j.clinbiomech.2006.02.005
   Kim WJ, 2006, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000200237.22308.93
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   Kobayashi H, 2010, J BIOMED MATER RES A, V92A, P596, DOI 10.1002/jbm.a.32397
   KOSTUIK JP, 1993, SPINE, V18, P1273, DOI 10.1097/00007632-199308000-00005
   Kwon BK, 2006, SPINE, V31, P1943, DOI 10.1097/01.brs.0000229258.83071.db
   Larsson S, 2006, SCAND J SURG, V95, P111, DOI 10.1177/145749690609500206
   Lehman RA, 2002, SPINE, V27, P806, DOI 10.1097/00007632-200204150-00006
   Lehman Ronald A Jr, 2004, Spine J, V4, P36, DOI 10.1016/S1529-9430(03)00427-3
   Lehman RA, 2010, SPINE, V35, P146, DOI 10.1097/BRS.0b013e3181b71a96
   LICHT NJ, 1992, SPINE, V17, P892, DOI 10.1097/00007632-199208000-00006
   Lieberman IH, 1998, SPINE, V23, P908, DOI 10.1097/00007632-199804150-00012
   Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020
   Lim TH, 2001, SPINE, V26, P951, DOI 10.1097/00007632-200104150-00021
   Linhardt O, 2006, INT ORTHOP, V30, P366, DOI 10.1007/s00264-006-0100-4
   Linhardt O, 2006, J SPINAL DISORD TECH, V19, P87, DOI 10.1097/01.bsd.0000177212.52583.bd
   Lippuner K, 2003, EUR SPINE J, V12, pS132, DOI 10.1007/s00586-003-0608-x
   Luk KDK, 2005, SPINE, V30, P525, DOI 10.1097/01.brs.0000154649.55589.bf
   Margulies J Y, 1997, Eur Spine J, V6, P245, DOI 10.1007/BF01322446
   MATHEWS HH, 1995, SPINE, V20, P1797, DOI 10.1097/00007632-199508150-00009
   MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271
   Moore DC, 1997, SPINE, V22, P1696, DOI 10.1097/00007632-199708010-00003
   Mutsuzaki H, 2007, J MATER SCI-MATER M, V18, P1799, DOI 10.1007/s10856-007-3051-4
   *NAT OST FDN, 2005, FAST FACTS OST
   Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904
   Ngu BB, 2006, SPINE, V31, pE166, DOI 10.1097/01.brs.0000202747.90508.0d
   Pateder DB, 2007, ORTHOP CLIN N AM, V38, P409, DOI 10.1016/j.ocl.2007.03.010
   Ponnusamy K, 2009, SPINE, V34, P2104, DOI 10.1097/BRS.0b013e3181b20212
   Ragel BT, 2007, NEUROSURGERY, V61, P317, DOI 10.1227/01.neu.0000303988.57493.b6
   Reinhold M, 2006, SPINE, V31, P406, DOI 10.1097/01.brs.0000199894.63450.70
   Renner SM, 2004, SPINE, V29, pE212, DOI 10.1097/00007632-200406010-00020
   Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801
   Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388
   Sanden B, 2000, EUR SPINE J, V9, P534, DOI 10.1007/s005860000180
   Sarzier JS, 2002, J NEUROSURG, V96, P309, DOI 10.3171/spi.2002.96.3.0309
   Smit RS, 2008, ARCH ORTHOP TRAUM SU, V128, P989, DOI 10.1007/s00402-008-0680-0
   Spivak JM, 1999, SPINE, V24, P334, DOI 10.1097/00007632-199902150-00005
   Steffen T, 2000, SPINE, V25, P1077, DOI 10.1097/00007632-200005010-00007
   Tan JS, 2004, SPINE, V29, P1723, DOI 10.1097/01.BRS.0000134569.63542.49
   Tomita S, 2004, SPINE, V29, P1203, DOI 10.1097/00007632-200406010-00009
   Tsai CH, 2008, BIOMATERIALS, V29, P984, DOI 10.1016/j.biomaterials.2007.10.014
   Tsuchiya K, 2006, SPINE, V31, P303, DOI 10.1097/01.brs.0000197193.81296.f1
   Uchida K, 2006, J NEUROSURG-SPINE, V4, P454, DOI 10.3171/spi.2006.4.6.454
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wheeler DL, 2007, SPINE J, V7, P308, DOI 10.1016/j.spinee.2006.01.005
   Yazu N, 2005, J ORTHOP SCI, V10, P56, DOI 10.1007/s00776-004-0862-8
   Yildirim OS, 2006, SPINE, V31, pE215, DOI 10.1097/01.brs.0000210221.00778.c7
   Yilmaz C, 2006, J SPINAL DISORD TECH, V19, P373, DOI 10.1097/01.bsd.0000210115.94273.76
   ZINDRICK MR, 1986, CLIN ORTHOP RELAT R, P99
   ZUCHERMAN JF, 1995, SPINE, V20, P2029, DOI 10.1097/00007632-199509150-00015
NR 105
TC 56
Z9 67
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD JAN
PY 2011
VL 11
IS 1
BP 54
EP 63
DI 10.1016/j.spinee.2010.09.024
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 696AP
UT WOS:000285414600013
PM 21168099
DA 2018-10-20
ER

PT J
AU Walsh, WR
   Oliver, RA
   Gage, G
   Yu, Y
   Bell, D
   Bellemore, J
   Adkisson, HD
AF Walsh, William R.
   Oliver, Rema A.
   Gage, Gary
   Yu, Yan
   Bell, David
   Bellemore, Jeremy
   Adkisson, Huston Davis
TI Application of Resorbable Poly(Lactide-co-Glycolide) with Entangled
   Hyaluronic Acid as an Autograft Extender for Posterolateral
   Intertransverse Lumbar Fusion in Rabbits
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID DEMINERALIZED BONE-MATRIX; SPINAL-FUSION; IN-VITRO; CELL-PROLIFERATION;
   GROWTH-FACTOR; REPAIR; CD44; SCAFFOLDS; DIFFERENTIATION; ARTHRODESIS
AB Facilitating fusion between bony segments in a reliable and reproducible manner using a synthetic bone graft material has a number of benefits for the surgeon as well as the patient. Although autograft remains the gold standard, associated comorbidities continue to drive the development of new biomaterials for use in spinal fusion. The ability of autograft alone and autograft combined with a radiolucent biomaterial composed of resorbable osteoconductive poly(lactide-co-glycolide) with entangled hyaluronic acid to facilitate fusion was examined in a single-level noninstrumented posterolateral intertransverse lumbar fusion model in New Zealand White rabbits. Progressive bone formation was demonstrated radiographically for the extender group (synthetic biomaterial plus autograft) between 3 and 6 months. Computed tomography revealed a new cortical shell in the fusion mass at 3 and 6 months for both study groups. Tensile testing at 6 months demonstrated that the quality of bone formed between the intertransverse space was equivalent for both study groups. Histologic evaluation of the fusion mass revealed new bone on and adjacent to the transverse processes with the synthetic biomaterial group that extended laterally, supporting the osteoconductive nature of the material. Histological evidence of endochondral bone growth in the intertransverse space was observed for the autograft plus synthetic biomaterial group. Bone remodeling, new marrow spaces, and peripheral cortices were observed for each study group at 3 months that matured by 6 months. These findings support the use of a radiolucent biosynthetic material comprising poly(lactide-co-glycolide) with integrated hyaluronic acid as an autograft extender for lumbar intertransverse fusion.
C1 [Walsh, William R.; Oliver, Rema A.; Yu, Yan; Bell, David; Bellemore, Jeremy] Univ New S Wales, Prince Wales Hosp, Surg & Orthopaed Res Labs, Randwick, NSW 2031, Australia.
   [Gage, Gary; Adkisson, Huston Davis] ISTO Technol Inc, St Louis, MO USA.
RP Walsh, WR (reprint author), Univ New S Wales, Prince Wales Hosp, Surg & Orthopaed Res Labs, Randwick, NSW 2031, Australia.
EM w.walsh@unsw.edu.au
OI Walsh, William/0000-0002-5023-6148
FU ISTO Technologies
FX This study was performed by financial support provided by ISTO
   Technologies. Gary Gage and H. Davis Adkisson are paid employees of ISTO
   Technologies.
CR Adkisson H.D., 2007, 53 ANN M ORTH RES SO
   Ariyoshi W, 2005, J BIOL CHEM, V280, P18967, DOI 10.1074/jbc.M412740200
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1997, J SPINAL DISORD, V10, P1
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Cao JJ, 2005, J BONE MINER RES, V20, P30, DOI 10.1359/JBMR.041014
   Caplan AI, 2000, TISSUE ENG, V6, P1, DOI 10.1089/107632700320838
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   Damien CJ, 2002, SPINE, V27, pS50, DOI 10.1097/01.BRS.0000020736.40268.AO
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   KNUDSON CB, 1993, FASEB J, V7, P1233
   Lee CT, 2006, J MATER SCI-MATER M, V17, P1411, DOI 10.1007/s10856-006-0617-5
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   Lilli C, 2002, J BIOMED MATER RES, V63, P577, DOI 10.1002/jbm.10301
   LOCCI P, 1995, CELL TISSUE RES, V281, P317
   Macri C., 2007, ADV DRUG DELIV REV, V59, P1366
   Morone MA, 1998, SPINE, V23, P159, DOI 10.1097/00007632-199801150-00003
   Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.04-1376fje
   Noonan KJ, 1996, J ORTHOP RES, V14, P573, DOI 10.1002/jor.1100140411
   NUGENT PJ, 1993, CLIN ORTHOP RELAT R, P107
   Palumbo Mark, 2004, Spine J, V4, P287
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SASAKI T, 1995, BONE, V16, P9, DOI 10.1016/S8756-3282(94)00001-8
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Valdes M, 2007, SPINE J, V7, P318, DOI 10.1016/j.spinee.2006.02.005
   Valdes Mauricio, 2004, Spine J, V4, P293
   Walsh WR, 2009, EUR SPINE J, V18, P1610, DOI 10.1007/s00586-009-1034-5
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   Yee AJM, 2004, SPINE, V29, P1308, DOI 10.1097/01.BRS.0000127184.43765.61
   Yee AJM, 2003, SPINE, V28, P2435
   Zou LJ, 2008, J ORTHOP RES, V26, P713, DOI 10.1002/jor.20539
NR 35
TC 7
Z9 7
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JAN
PY 2011
VL 17
IS 1-2
BP 213
EP 220
DI 10.1089/ten.tea.2010.0008
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 703QQ
UT WOS:000285995800021
PM 20712417
OA Green Published
DA 2018-10-20
ER

PT J
AU Lee, JH
   Wang, HJ
   Kaplan, JB
   Lee, WY
AF Lee, Joung-Hyun
   Wang, Hongjun
   Kaplan, Jeffrey B.
   Lee, Woo Y.
TI Microfluidic Approach to Create Three-Dimensional Tissue Models for
   Biofilm-Related Infection of Orthopaedic Implants
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; MINERALIZED MATRIX DEPOSITION; 3D
   PERFUSION CULTURE; DEVICES; GROWTH; MICROFABRICATION; COLONIZATION;
   INTEGRATION; DETACHMENT; INCREASES
AB With conventional in vitro culture methods, it is difficult to study complex interactions of host cells with pathogens and drugs in physiologically relevant microenvironments. To simulate orthopaedic implant-associated infection, a multi-channel microfluidic device was used to (1) observe in real-time the development of osteoblasts into three-dimensional (3D) tissue-like structures and (2) study how this development was influenced by phenotypes of Staphylococcus epidermidis. In the absence of bacteria, osteoblasts formed a confluent layer on the bottom channel surface, gradually migrated to the side and top surfaces, and formed calcified 3D nodular structures in 8 days. The delivery timing and concentration of an antibiotic were controlled to produce small colony variants, sessile biofilms, or dead cells of S. epidermidis. In the presence of the small colony variants, osteoblasts initially adhered, and spread, but were killed within 2 days. In contrast, the sessile biofilms and dead bacteria cells did not significantly interfere with the formation of tissue-like structures. The results suggest the possibility of creating in vitro tissue-biofilm-biomaterial interfaces and therefore 3D tissue models, as an entirely new method of studying biofilm-related infection of orthopaedic implants with physiological relevance.
C1 [Lee, Joung-Hyun; Lee, Woo Y.] Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
   [Wang, Hongjun] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.
   [Kaplan, Jeffrey B.] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA.
RP Lee, WY (reprint author), Stevens Inst Technol, Dept Chem Engn & Mat Sci, Hoboken, NJ 07030 USA.
EM wlee@stevens.edu
FU National Science Foundation [NIRT-CBET 0708379]
FX This study was supported by the National Science Foundation (NIRT-CBET
   0708379). We thank Prof. Matthew Libera at Stevens Institute of
   Technology for support and discussion.
CR Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1993, INT J ARTIF ORGANS, V16, P765
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Frommelt L, 2006, INJURY, V37, P87, DOI 10.1016/j.injury.2006.04.014
   Futai N, 2006, LAB CHIP, V6, P149, DOI 10.1039/b510901a
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Griffith L., 2002, 3 SMITH NEPH INT S T, P72
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Khare MD, 2007, J INFECTION, V54, P146, DOI 10.1016/j.jinf.2006.03.002
   Kuijer R, 2007, BIOMATERIALS, V28, P5148, DOI 10.1016/j.biomaterials.2007.06.003
   Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002
   Lee J. H., 2010, ACTA BIOMATER
   Lee JH, 2008, BIOMED MICRODEVICES, V10, P489, DOI 10.1007/s10544-007-9157-0
   Long M., 2009, PRIV SEM STEV I TECH
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Matl FD, 2008, ANTIMICROB AGENTS CH, V52, P1957, DOI 10.1128/AAC.01438-07
   Monzon M, 2001, J ANTIMICROB CHEMOTH, V48, P793, DOI 10.1093/jac/48.6.793
   Multi-Agency Tissue Engineering Science Interagency Working Group, 2007, ADV TISS SCI ENG
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   RICHARDS RG, 2006, INJURY, V37, pS113
   Rusu-Balaita L, 2003, POLYM BULL, V50, P91, DOI 10.1007/s00289-003-0144-1
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182
   Tang HY, 2007, J BIOMED MATER RES A, V80A, P885, DOI 10.1002/jbm.a.30952
   van Gennip M., 2009, ASM C BIOF 2009 CANC
   Vaudaux P, 2006, INJURY, V37, P15, DOI 10.1016/j.injury.2006.04.004
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Widmer AF, 1997, NUTRITION, V13, pS18, DOI 10.1016/S0899-9007(97)00218-9
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   ZEILER HJ, 1987, AM J MED, V82, P87
   Zimmerli W., 2004, NEW ENGL J MED, V351, P1701
NR 43
TC 24
Z9 25
U1 1
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JAN
PY 2011
VL 17
IS 1
BP 39
EP 48
DI 10.1089/ten.tec.2010.0285
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 702DL
UT WOS:000285874700005
PM 20618080
DA 2018-10-20
ER

PT J
AU Li, B
   Li, J
   Xia, J
   Kennedy, JF
   Yie, X
   Liu, TG
AF Li, B.
   Li, J.
   Xia, J.
   Kennedy, J. F.
   Yie, X.
   Liu, T. G.
TI Effect of gamma irradiation on the condensed state structure and
   mechanical properties of konjac glucomannan/chitosan blend films
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Konjac glucomannan; Chitosan; Blend film; Gamma irradiation;
   Biomaterial; Condensed state structure; Mechanical properties;
   Miscibility
ID PHYSICAL-PROPERTIES; CHITOSAN SCAFFOLDS; SODIUM ALGINATE; BEAN FLOURS;
   STARCH; RADIATION; DEGRADATION; RICE; BIOCOMPATIBILITY; MAIZE
AB Konjac glucomannan and chitosan blend films with different blend ratio were gamma irradiated up to 80 kGy, The mechanical properties achieved their maximum under 25 kGy dose, the tensile strength and breaking elongation of KC2 were enhanced about 40% and 30%, respectively. No change occurred in the primary group such as hydroxyl and acetyl of the blend films during irradiation. The effect of irradiation decreased with the increase of konjac glucomannan content, and the blend film KC2 irradiated by 25 kGy had the highest cystallinity. The miscibility of KGM and CHI in the blend film also played an important role in keeping its morphology, in addition to the content of chitosan when the films were irradiated. 25 kGy gamma irradiation was not only a useful sterilization method for the film biomaterial but also an efficient modification method for enhancing the properties of KC2. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Li, B.; Li, J.; Xia, J.; Yie, X.; Liu, T. G.] Huazhong Agr Univ, Coll Food Sci, Wuhan 430070, Peoples R China.
   [Kennedy, J. F.] Inst Adv Sci, Chembiotech Labs, Bromsgrove B60 4JE, Worcs, England.
RP Li, B (reprint author), Huazhong Agr Univ, Coll Food Sci, Wuhan 430070, Peoples R China.
EM libinfood@mail.hzau.edu.cn
FU National 863 plans projects; Program for New Century Excellent Talents
   in University, China; Program for Excellent Young Talents in Hubei,
   China
FX Contract grant sponsors: National 863 plans projects, Program for New
   Century Excellent Talents in University, China: and Program for
   Excellent Young Talents in Hubei, China.
CR Abu JO, 2006, FOOD CHEM, V95, P386, DOI 10.1016/j.foodchem.2005.01.008
   Bao JS, 2005, STARCH-STARKE, V57, P480, DOI 10.1002/star.200500422
   Bao JS, 2002, J AGR FOOD CHEM, V50, P336, DOI 10.1021/jf010230c
   Bao JS, 2001, J FOOD QUALITY, V24, P327, DOI 10.1111/j.1745-4557.2001.tb00612.x
   Cao Wenling, 2005, Nuclear Techniques, V28, P187
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Choi WS, 2002, POLYM DEGRAD STABIL, V78, P533, DOI 10.1016/S0141-3910(02)00226-4
   Fang YE, 1997, NUCL TECHNIQUES, V20, P226
   *GB, 44561996 GBT
   Huang MF, 2005, INT J BIOL MACROMOL, V36, P98, DOI 10.1016/j.ijbiomac.2005.04.002
   JIANG TD, 2002, CHITOSAN, P38
   Kang B, 2007, POLYM DEGRAD STABIL, V92, P359, DOI 10.1016/j.polymdegradstab.2006.12.006
   Kume T, 2002, RADIAT PHYS CHEM, V63, P625, DOI 10.1016/S0969-806X(01)00558-8
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Li B, 2006, CARBOHYD POLYM, V65, P488, DOI 10.1016/j.carbpol.2006.02.006
   Li B, 2006, CARBOHYD POLYM, V64, P510, DOI 10.1016/j.carbpol.2005.11.001
   Li B, 2004, J APPL POLYM SCI, V93, P2775, DOI 10.1002/app.20769
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MAJETI NN, 2002, REACTIVE FUNCT POLYM, V46, P1
   Nagasawa N, 2004, CARBOHYD POLYM, V58, P109, DOI 10.1016/j.carbpol.2004.04.021
   Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   Pathak C. P., 2003, United States Patent, Patent No. [6,639,014, 6639014]
   Prawitwong P, 2007, FOOD HYDROCOLLOID, V21, P1362, DOI 10.1016/j.foodhyd.2006.10.015
   RAYASDUARTE P, 1993, J FOOD SCI, V58, P389, DOI 10.1111/j.1365-2621.1993.tb04282.x
   Rombo GO, 2004, J SCI FOOD AGR, V84, P350, DOI 10.1002/jsfa.1663
   Rombo GO, 2001, J SCI FOOD AGR, V81, P497, DOI 10.1002/jsfa.838
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   SOKHEY AS, 1993, FOOD STRUCT, V12, P397
   Wang K, 2002, INT J PHARM, V244, P117, DOI 10.1016/S0378-5173(02)00324-1
   Wasikiewicz JM, 2005, RADIAT PHYS CHEM, V73, P287, DOI 10.1016/j.radphyschem.2004.09.021
   Xiao CB, 2000, J APPL POLYM SCI, V76, P509, DOI 10.1002/(SICI)1097-4628(20000425)76:4<509::AID-APP8>3.0.CO;2-2
   YANG F, 2003, J DIALYSIS ARTIFICIA, V14, P13
   Ye X, 2006, CARBOHYD POLYM, V64, P532, DOI 10.1016/j.carbpol.2005.11.005
   Zhai ML, 2004, CARBOHYD POLYM, V57, P83, DOI 10.1016/j.carbpol.2004.04.003
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang Y, 2001, J NON-CRYST SOLIDS, V282, P159, DOI 10.1016/S0022-3093(01)00345-3
NR 37
TC 30
Z9 37
U1 2
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 1
PY 2011
VL 83
IS 1
BP 44
EP 51
DI 10.1016/j.carbpol.2010.07.017
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 675DH
UT WOS:000283805600007
DA 2018-10-20
ER

EF